###18162466	23035,5579

The O X
phosphatase O X
PHLPP I-MISC 23239
controls O X
the O X
cellular O X
levels O X
of O X
protein O X
kinase O X
C O X
. O X
The O X
life O X
cycle O X
of O X
protein O X
kinase O X
C O X
( O X
PKC O X
) O X
is O X
controlled O X
by O X
multiple O X
phosphorylation O X
and O X
dephosphorylation O X
steps O X
. O X

The O X
maturation O X
of O X
PKC O X
requires O X
three O X
ordered O X
phosphorylations O X
, O X
one O X
at O X
the O X
activation O X
loop O X
and O X
two O X
at O X
COOH O X
- O X
terminal O X
sites O X
, O X
the O X
turn O X
motif O X
and O X
the O X
hydrophobic O X
motif O X
, O X
to O X
yield O X
a O X
stable O X
and O X
signaling O X
- O X
competent O X
enzyme O X
. O X

Dephosphorylation O X
of O X
the O X
enzyme O X
leads O X
to O X
protein O X
degradation O X
. O X

We O X
have O X
recently O X
discovered O X
a O X
novel O X
family O X
of O X
protein O X
phosphatases O X
named O X
PH I-MISC 23239
domain I-MISC 23239
leucine I-MISC 23239
- I-MISC 23239
rich I-MISC 23239
repeat I-MISC 23239
protein I-MISC 23239
phosphatase I-MISC 23239
( O X
PHLPP I-MISC 23239
) O X
whose O X
members O X
terminate O X
Akt O X
signaling O X
by O X
dephosphorylating O X
the O X
hydrophobic O X
motif O X
on O X
Akt O X
. O X

Here O X
we O X
show O X
that O X
the O X
two O X
PHLPP I-MISC 23239
isoforms O X
, O X
PHLPP1 I-MISC 23239
and O X
PHLPP2 I-MISC 23035
, O X
also O X
dephosphorylate O X
the O X
hydrophobic O X
motif O X
on O X
PKC I-MISC 5579
betaII I-MISC 5579
, O X
an O X
event O X
that O X
shunts O X
PKC O X
to O X
the O X
detergent O X
- O X
insoluble O X
fraction O X
, O X
effectively O X
terminating O X
its O X
life O X
cycle O X
. O X

Deletion O X
mutagenesis O X
reveals O X
that O X
the O X
PH O X
domain O X
is O X
necessary O X
for O X
the O X
effective O X
dephosphorylation O X
of O X
PKC I-MISC 5579
betaII I-MISC 5579
by O X
PHLPP I-MISC 23239
in O X
cells O X
, O X
whereas O X
the O X
PDZ O X
- O X
binding O X
motif O X
, O X
required O X
for O X
Akt O X
regulation O X
, O X
is O X
dispensable O X
. O X

The O X
phorbol O X
ester O X
- O X
mediated O X
dephosphorylation O X
of O X
the O X
hydrophobic O X
site O X
, O X
but O X
not O X
the O X
turn O X
motif O X
or O X
activation O X
loop O X
, O X
is O X
insensitive O X
to O X
okadaic O X
acid O X
, O X
consistent O X
with O X
PHLPP I-MISC 23239
, O X
a O X
PP2C O X
family O X
member O X
, O X
controlling O X
the O X
hydrophobic O X
site O X
. O X

In O X
addition O X
, O X
knockdown O X
of O X
PHLPP I-MISC 23239
expression O X
reduces O X
the O X
rate O X
of O X
phorbol O X
ester O X
- O X
triggered O X
dephosphorylation O X
of O X
the O X
hydrophobic O X
motif O X
, O X
but O X
not O X
turn O X
motif O X
, O X
of O X
PKC I-MISC 5578
alpha I-MISC 5578
. O X

Last O X
, O X
we O X
show O X
that O X
depletion O X
of O X
PHLPP I-MISC 23239
in O X
colon O X
cancer O X
and O X
normal O X
breast O X
epithelial O X
cells O X
results O X
in O X
an O X
increase O X
in O X
conventional O X
and O X
novel O X
PKC O X
levels O X
. O X

These O X
data O X
reveal O X
that O X
PHLPP I-MISC 23239
controls O X
the O X
cellular O X
levels O X
of O X
PKC O X
by O X
specifically O X
dephosphorylating O X
the O X
hydrophobic O X
motif O X
, O X
thus O X
destabilizing O X
the O X
enzyme O X
and O X
promoting O X
its O X
degradation O X
. O X

###15070733	8945,7465

M O X
- O X
phase O X
kinases O X
induce O X
phospho O X
- O X
dependent O X
ubiquitination O X
of O X
somatic O X
Wee1 I-MISC 7465
by O X
SCFbeta O X
- O X
TrCP O X
. O X

Wee1 I-MISC 7465
, O X
the O X
Cdc2 I-MISC 983
inhibitory O X
kinase O X
, O X
needs O X
to O X
be O X
down O X
- O X
regulated O X
at O X
the O X
onset O X
of O X
mitosis O X
to O X
ensure O X
rapid O X
activation O X
of O X
Cdc2 I-MISC 983
. O X

Previously O X
, O X
we O X
have O X
shown O X
that O X
human O X
somatic O X
Wee1 I-MISC 7465
( O X
Wee1A I-MISC 7465
) O X
is O X
down O X
- O X
regulated O X
both O X
by O X
protein O X
phosphorylation O X
and O X
degradation O X
, O X
but O X
the O X
underlying O X
mechanisms O X
had O X
not O X
been O X
elucidated O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
have O X
identified O X
the O X
beta I-MISC 23291
- I-MISC 23291
transducin I-MISC 23291
repeat I-MISC 23291
- I-MISC 23291
containing I-MISC 23291
protein I-MISC 23291
1 I-MISC 23291
/ I-MISC 23291
2 I-MISC 23291
( O X
beta I-MISC 8945
- I-MISC 8945
TrCP1 I-MISC 8945
/ I-MISC 8945
2 I-MISC 8945
) O X
F O X
- O X
box O X
protein O X
- O X
containing O X
SKP1 I-MISC 6500
/ O X
Cul1 I-MISC 8454
/ O X
F O X
- O X
box O X
protein O X
( O X
SCF I-MISC 4254
) O X
complex O X
( O X
SCF I-MISC 4254
( O X
beta I-MISC 8945
- I-MISC 8945
TrCP1 I-MISC 8945
/ I-MISC 8945
2 I-MISC 8945
)) O X
as O X
an O X
E3 O X
ubiquitin O X
ligase O X
for O X
Wee1A I-MISC 7465
ubiquitination O X
. O X

Although O X
Wee1A I-MISC 7465
lacks O X
a O X
consensus O X
DS O X
( O X
p O X
) O X
GXXS O X
( O X
p O X
) O X
phospho O X
- O X
dependent O X
binding O X
motif O X
for O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
, O X
recognition O X
of O X
Wee1A I-MISC 7465
by O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
depended O X
on O X
phosphorylation O X
, O X
and O X
two O X
serine O X
residues O X
in O X
Wee1A I-MISC 7465
, O X
S53 O X
and O X
S123 O X
, O X
were O X
found O X
to O X
be O X
the O X
most O X
important O X
phosphorylation O X
sites O X
for O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
recognition O X
. O X

We O X
have O X
found O X
also O X
that O X
the O X
major O X
M O X
- O X
phase O X
kinases O X
polo I-MISC 5347
- I-MISC 5347
like I-MISC 5347
kinase I-MISC 5347
1 I-MISC 5347
( O X
Plk1 I-MISC 5347
) O X
and O X
Cdc2 I-MISC 983
are O X
responsible O X
for O X
the O X
phosphorylation O X
of O X
S53 O X
and O X
S123 O X
, O X
respectively O X
, O X
and O X
that O X
in O X
each O X
case O X
phosphorylation O X
generates O X
an O X
unconventional O X
phospho O X
- O X
degron O X
( O X
signal O X
for O X
degradation O X
) O X
that O X
can O X
be O X
recognized O X
by O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
. O X

Phosphorylation O X
of O X
Wee1A I-MISC 7465
by O X
these O X
kinases O X
cooperatively O X
stimulated O X
the O X
recognition O X
and O X
ubiquitination O X
of O X
Wee1A I-MISC 7465
by O X
SCF I-MISC 4254
( O X
beta I-MISC 8945
- I-MISC 8945
TrCP1 I-MISC 8945
/ I-MISC 8945
2 I-MISC 8945
) O X
in O X
vitro O X
. O X

Mutation O X
of O X
these O X
residues O X
or O X
depletion O X
of O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
by O X
small O X
- O X
interfering O X
RNA O X
treatment O X
increased O X
the O X
stability O X
of O X
Wee1A I-MISC 7465
in O X
HeLa O X
cells O X
. O X

Moreover O X
, O X
our O X
analysis O X
indicates O X
that O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
- O X
dependent O X
degradation O X
of O X
Wee1A I-MISC 7465
is O X
important O X
for O X
the O X
normal O X
onset O X
of O X
M O X
- O X
phase O X
in O X
vivo O X
. O X

These O X
results O X
also O X
establish O X
the O X
existence O X
of O X
a O X
feedback O X
loop O X
between O X
Cdc2 I-MISC 983
and O X
Wee1A I-MISC 7465
in O X
somatic O X
cells O X
that O X
depends O X
on O X
ubiquitination O X
and O X
protein O X
degradation O X
and O X
ensures O X
the O X
rapid O X
activation O X
of O X
Cdc2 I-MISC 983
when O X
cells O X
are O X
ready O X
to O X
divide O X
. O X

###8840966	1021,1031

A O X
p18 I-MISC 1031
mutant O X
defective O X
in O X
CDK6 I-MISC 1021
binding O X
in O X
human O X
breast O X
cancer O X
cells O X
. O X

Progression O X
from O X
G1 O X
to O X
the O X
S O X
- O X
phase O X
of O X
the O X
cell O X
cycle O X
is O X
controlled O X
by O X
a O X
family O X
of O X
low O X
molecular O X
weight O X
cyclin O X
- O X
dependent O X
kinase O X
( O X
CDK O X
) O X
inhibitors O X
. O X

The O X
importance O X
of O X
these O X
proteins O X
in O X
cell O X
growth O X
control O X
is O X
underscored O X
by O X
the O X
observation O X
that O X
some O X
members O X
of O X
this O X
family O X
are O X
deleted O X
or O X
mutated O X
in O X
human O X
cancers O X
. O X

For O X
example O X
, O X
the O X
gene O X
encoding O X
the O X
CDK O X
inhibitor O X
p18 I-MISC 1031
is O X
located O X
on O X
a O X
segment O X
of O X
chromosome O X
1 O X
that O X
is O X
often O X
abnormal O X
in O X
human O X
breast O X
tumors O X
. O X

We O X
have O X
identified O X
an O X
alanine O X
to O X
proline O X
substitution O X
at O X
codon O X
72 O X
of O X
the O X
p18 I-MISC 1031
gene O X
in O X
BT O X
- O X
20 O X
human O X
breast O X
cancer O X
cells O X
. O X

This O X
mutation O X
abrogates O X
the O X
ability O X
of O X
p18 I-MISC 1031
to O X
interact O X
with O X
CDK6 I-MISC 1021
and O X
renders O X
p18 I-MISC 1031
deficient O X
in O X
suppressing O X
cell O X
growth O X
in O X
a O X
colony O X
formation O X
assay O X
. O X

Our O X
results O X
suggest O X
that O X
p18 I-MISC 1031
inactivation O X
by O X
point O X
mutations O X
may O X
contribute O X
to O X
deregulated O X
growth O X
control O X
in O X
certain O X
cell O X
lines O X
and O X
/ O X
or O X
tumors O X
. O X

###21658387	120892,207

LRRK2 I-MISC 120892
directly O X
phosphorylates O X
Akt1 I-MISC 207
as O X
a O X
possible O X
physiological O X
substrate O X
: O X
impairment O X
of O X
the O X
kinase O X
activity O X
by O X
Parkinson O X
' O X
s O X
disease O X
- O X
associated O X
mutations O X
. O X

LRRK2 I-MISC 120892
is O X
the O X
causal O X
molecule O X
for O X
autosomal O X
- O X
dominant O X
familial O X
Parkinson O X
' O X
s O X
disease O X
, O X
although O X
its O X
true O X
function O X
, O X
including O X
its O X
physiological O X
substrates O X
, O X
remains O X
unknown O X
. O X

Here O X
, O X
using O X
in O X
vitro O X
kinase O X
assay O X
with O X
recombinant O X
proteins O X
, O X
we O X
demonstrated O X
for O X
the O X
first O X
time O X
that O X
LRRK2 I-MISC 120892
directly O X
phosphorylates O X
Akt1 I-MISC 207
, O X
a O X
central O X
molecule O X
involved O X
in O X
signal O X
transduction O X
for O X
cell O X
survival O X
and O X
prevention O X
of O X
apoptosis O X
. O X

Ser473 O X
, O X
one O X
of O X
two O X
amino O X
acids O X
essential O X
for O X
Akt1 I-MISC 207
activation O X
, O X
was O X
the O X
target O X
site O X
for O X
LRRK2 I-MISC 120892
. O X

A O X
knockdown O X
experiment O X
using O X
intact O X
cells O X
also O X
demonstrated O X
LRRK2 I-MISC 120892
- O X
mediated O X
phosphorylation O X
of O X
Akt1 I-MISC 207
( O X
Ser473 O X
), O X
suggesting O X
that O X
Akt1 I-MISC 207
is O X
a O X
convincing O X
candidate O X
for O X
the O X
physiological O X
substrate O X
of O X
LRRK2 I-MISC 120892
. O X

The O X
disease O X
- O X
associated O X
mutations O X
, O X
R1441C O X
, O X
G2019S O X
, O X
and O X
I2020T O X
, O X
exhibited O X
reduced O X
interaction O X
with O X
, O X
and O X
phosphorylation O X
of O X
, O X
Akt1 I-MISC 207
, O X
suggesting O X
one O X
possible O X
mechanism O X
for O X
the O X
neurodegeneration O X
caused O X
by O X
LRRK2 I-MISC 120892
mutations O X
. O X

###19878303	1080,281831

Deletion O X
of O X
Phe508 O X
in O X
the O X
first O X
nucleotide O X
- O X
binding O X
domain O X
of O X
the O X
cystic I-MISC 1080
fibrosis I-MISC 1080
transmembrane I-MISC 1080
conductance I-MISC 1080
regulator I-MISC 1080
increases O X
its O X
affinity O X
for O X
the O X
heat I-MISC 281831
shock I-MISC 281831
cognate I-MISC 281831
70 I-MISC 281831
chaperone O X
. O X

The O X
primary O X
cause O X
of O X
cystic O X
fibrosis O X
( O X
CF O X
), O X
the O X
most O X
frequent O X
fatal O X
genetic O X
disease O X
in O X
Caucasians O X
, O X
is O X
deletion O X
of O X
phenylalanine O X
at O X
position O X
508 O X
( O X
F508del O X
), O X
located O X
in O X
the O X
first O X
nucleotide O X
- O X
binding O X
domain O X
( O X
NBD1 O X
) O X
of O X
the O X
CF I-MISC 1080
transmembrane I-MISC 1080
conductance I-MISC 1080
regulator I-MISC 1080
( O X
CFTR I-MISC 1080
) O X
protein O X
. O X

F508del O X
- O X
CFTR I-MISC 1080
is O X
recognized O X
by O X
the O X
endoplasmic O X
reticulum O X
quality O X
control O X
( O X
ERQC O X
), O X
which O X
targets O X
it O X
for O X
proteasomal O X
degradation O X
, O X
preventing O X
this O X
misfolded O X
but O X
partially O X
functional O X
Cl O X
(-) O X
channel O X
from O X
reaching O X
the O X
cell O X
membrane O X
. O X

We O X
recently O X
proposed O X
that O X
the O X
ERQC O X
proceeds O X
along O X
several O X
checkpoints O X
, O X
the O X
first O X
of O X
which O X
, O X
utilizing O X
the O X
chaperone O X
heat I-MISC 281831
shock I-MISC 281831
cognate I-MISC 281831
70 I-MISC 281831
( O X
Hsc70 I-MISC 281831
), O X
is O X
the O X
major O X
one O X
directing O X
F508del O X
- O X
CFTR I-MISC 1080
for O X
proteolysis O X
. O X

Therefore O X
, O X
a O X
detailed O X
characterization O X
of O X
the O X
interaction O X
occurring O X
between O X
F508del O X
- O X
CFTR I-MISC 1080
and O X
Hsc70 I-MISC 281831
is O X
critical O X
to O X
clarify O X
the O X
mechanism O X
that O X
senses O X
misfolded O X
F508del O X
- O X
CFTR I-MISC 1080
in O X
vivo O X
. O X

Here O X
, O X
we O X
determined O X
by O X
surface O X
plasmon O X
resonance O X
that O X
: O X
( O X
a O X
) O X
F508del O X
- O X
murine O X
( O X
m O X
) O X
NBD1 O X
binds O X
Hsc70 I-MISC 281831
with O X
higher O X
affinity O X
( O X
K O X
( O X
D O X
), O X
2 O X
. O X
6 O X
nm O X
) O X
than O X
wild O X
- O X
type O X
( O X
wt O X
) O X
mNBD1 O X
( O X
13 O X
. O X
9 O X
nm O X
); O X
( O X
b O X
) O X
ATP O X
and O X
ADP O X
dramatically O X
reduce O X
NBD1 O X
- O X
Hsc70 I-MISC 281831
binding O X
; O X
( O X
c O X
) O X
the O X
F508del O X
mutation O X
increases O X
by O X
approximately O X
six O X
- O X
fold O X
the O X
ATP O X
concentration O X
required O X
to O X
inhibit O X
the O X
NBD1 O X
- O X
Hsc70 I-MISC 281831
interaction O X
( O X
IC O X
( O X
50 O X
); O X
wt O X
- O X
mNBD1 O X
, O X
19 O X
. O X
7 O X
microm O X
ATP O X
); O X
and O X
( O X
d O X
) O X
the O X
small O X
molecule O X
CFTR I-MISC 1080
corrector O X
4a O X
( O X
C4a O X
), O X
but O X
not O X
VRT O X
- O X
325 O X
( O X
V325 O X
; O X
both O X
rescuing O X
F508del O X
- O X
CFTR I-MISC 1080
traffic O X
), O X
significantly O X
reduces O X
F508del O X
- O X
mNBD1 O X
binding O X
to O X
Hsc70 I-MISC 281831
, O X
by O X
approximately O X
30 O X
%. O X

Altogether O X
, O X
these O X
results O X
provide O X
a O X
novel O X
, O X
robust O X
quantitative O X
characterization O X
of O X
Hsc70 I-MISC 281831
- O X
NBD1 O X
binding O X
, O X
bringing O X
detailed O X
insights O X
into O X
the O X
molecular O X
basis O X
of O X
CF O X
. O X

Moreover O X
, O X
we O X
show O X
how O X
this O X
surface O X
plasmon O X
resonance O X
assay O X
helps O X
to O X
elucidate O X
the O X
mechanism O X
of O X
action O X
of O X
small O X
corrective O X
molecules O X
, O X
demonstrating O X
its O X
potential O X
to O X
validate O X
additional O X
therapeutic O X
compounds O X
for O X
CF O X
. O X

###9571151	695,9467

Identification O X
and O X
characterization O X
of O X
a O X
novel O X
SH3 O X
- O X
domain O X
binding O X
protein O X
, O X
Sab I-MISC 9467
, O X
which O X
preferentially O X
associates O X
with O X
Bruton I-MISC 695
' I-MISC 695
s I-MISC 695
tyrosine I-MISC 695
kinase I-MISC 695
( O X
BtK I-MISC 695
). O X

Protein O X
interaction O X
cloning O X
method O X
was O X
used O X
to O X
identify O X
a O X
novel O X
molecule O X
, O X
Sab I-MISC 9467
, O X
which O X
binds O X
to O X
the O X
SH3 O X
domain O X
of O X
Bruton I-MISC 695
' I-MISC 695
s I-MISC 695
tyrosine I-MISC 695
kinase I-MISC 695
( O X
Btk I-MISC 695
), O X
the O X
deficient O X
cytoplasmic O X
tyrosine O X
kinase O X
in O X
human O X
X O X
- O X
linked O X
agammaglobulinemia O X
and O X
murine O X
X O X
- O X
linked O X
immunodeficiency O X
. O X

Immunoprecipitation O X
using O X
the O X
anti O X
- O X
Sab I-MISC 9467
antibody O X
identified O X
the O X
protein O X
product O X
of O X
the O X
gene O X
as O X
a O X
70 O X
kDa O X
molecule O X
. O X

While O X
Sab I-MISC 9467
does O X
not O X
have O X
a O X
proline O X
- O X
rich O X
sequence O X
, O X
it O X
was O X
shown O X
to O X
bind O X
to O X
Btk I-MISC 695
through O X
the O X
commonly O X
conserved O X
structure O X
among O X
SH3 O X
domains O X
. O X

Remarkably O X
, O X
Sab I-MISC 9467
exhibited O X
a O X
high O X
preference O X
for O X
binding O X
to O X
Btk I-MISC 695
rather O X
than O X
to O X
other O X
cytoplasmic O X
tyrosine O X
kinases O X
, O X
which O X
suggests O X
a O X
unique O X
role O X
of O X
Sab I-MISC 9467
in O X
the O X
Btk I-MISC 695
signal O X
transduction O X
pathway O X
. O X

###17170703	841,367

A O X
novel O X
function O X
of O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
in O X
the O X
regulation O X
of O X
androgen O X
- O X
receptor O X
- O X
driven O X
gene O X
expression O X
. O X

Transcriptional O X
regulation O X
by O X
the O X
androgen I-MISC 367
receptor I-MISC 367
( O X
AR I-MISC 367
) O X
is O X
critical O X
for O X
male O X
sexual O X
development O X
and O X
prostate O X
cancer O X
. O X

In O X
this O X
study O X
, O X
we O X
used O X
an O X
expression O X
cloning O X
strategy O X
to O X
identify O X
molecules O X
that O X
regulate O X
AR I-MISC 367
- O X
driven O X
transcription O X
. O X

Screening O X
of O X
a O X
human O X
cDNA O X
library O X
resulted O X
in O X
isolation O X
of O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
( O X
Casp8 I-MISC 841
), O X
an O X
initiator O X
caspase O X
that O X
mediates O X
death O X
- O X
receptor O X
- O X
induced O X
apoptosis O X
. O X

Casp8 I-MISC 841
repressed O X
AR I-MISC 367
- O X
dependent O X
gene O X
expression O X
independently O X
of O X
its O X
apoptotic O X
protease O X
activity O X
by O X
disrupting O X
AR I-MISC 367
amino O X
- O X
terminal O X
and O X
carboxy O X
- O X
terminal O X
( O X
N O X
/ O X
C O X
) O X
interaction O X
and O X
inhibiting O X
androgen O X
- O X
induced O X
AR I-MISC 367
nuclear O X
localization O X
. O X

Protein O X
- O X
protein O X
interaction O X
analysis O X
revealed O X
that O X
three O X
motifs O X
in O X
Casp8 I-MISC 841
specifically O X
interacted O X
with O X
the O X
motifs O X
that O X
are O X
known O X
to O X
be O X
involved O X
in O X
AR I-MISC 367
N O X
/ O X
C O X
interaction O X
. O X

Substitutions O X
of O X
the O X
amino O X
- O X
acid O X
residues O X
critical O X
for O X
AR I-MISC 367
- O X
Casp8 I-MISC 841
interactions O X
abolished O X
the O X
Casp8 I-MISC 841
- O X
mediated O X
inhibition O X
of O X
AR I-MISC 367
transactivation O X
. O X

In O X
addition O X
, O X
knockdown O X
of O X
Casp8 I-MISC 841
by O X
RNA O X
interference O X
specifically O X
affected O X
the O X
androgen O X
- O X
dependent O X
expression O X
of O X
AR I-MISC 367
- O X
targeting O X
genes O X
in O X
LNCaP O X
cells O X
. O X

These O X
results O X
indicate O X
that O X
Casp8 I-MISC 841
has O X
a O X
novel O X
function O X
beyond O X
its O X
known O X
role O X
in O X
the O X
mediation O X
of O X
apoptosis O X
. O X

###18725399	851125,852060	853376,852060

A O X
direct O X
interaction O X
between O X
the O X
Utp6 I-MISC 852060
half O X
- O X
a O X
- O X
tetratricopeptide O X
repeat O X
domain O X
and O X
a O X
specific O X
peptide O X
in O X
Utp21 I-MISC 851125
is O X
essential O X
for O X
efficient O X
pre O X
- O X
rRNA O X
processing O X
. O X

The O X
small O X
subunit O X
( O X
SSU O X
) O X
processome O X
is O X
a O X
ribosome O X
biogenesis O X
intermediate O X
that O X
assembles O X
from O X
its O X
subcomplexes O X
onto O X
the O X
pre O X
- O X
18S O X
rRNA O X
with O X
yet O X
unknown O X
order O X
and O X
structure O X
. O X

Here O X
, O X
we O X
investigate O X
the O X
architecture O X
of O X
the O X
UtpB O X
subcomplex O X
of O X
the O X
SSU O X
processome O X
, O X
focusing O X
on O X
the O X
interaction O X
between O X
the O X
half O X
- O X
a O X
- O X
tetratricopeptide O X
repeat O X
( O X
HAT O X
) O X
domain O X
of O X
Utp6 I-MISC 852060
and O X
a O X
specific O X
peptide O X
in O X
Utp21 I-MISC 851125
. O X

We O X
present O X
a O X
comprehensive O X
map O X
of O X
the O X
interactions O X
within O X
the O X
UtpB O X
subcomplex O X
and O X
further O X
show O X
that O X
the O X
N O X
- O X
terminal O X
domain O X
of O X
Utp6 I-MISC 852060
interacts O X
with O X
Utp18 I-MISC 853376
while O X
the O X
HAT O X
domain O X
interacts O X
with O X
Utp21 I-MISC 851125
. O X

Using O X
a O X
panel O X
of O X
point O X
and O X
deletion O X
mutants O X
of O X
Utp6 I-MISC 852060
, O X
we O X
show O X
that O X
an O X
intact O X
HAT O X
domain O X
is O X
essential O X
for O X
efficient O X
pre O X
- O X
rRNA O X
processing O X
and O X
cell O X
growth O X
. O X

Further O X
investigation O X
of O X
the O X
Utp6 I-MISC 852060
- O X
Utp21 I-MISC 851125
interaction O X
using O X
both O X
genetic O X
and O X
biophysical O X
methods O X
shows O X
that O X
the O X
HAT O X
domain O X
binds O X
a O X
specific O X
peptide O X
ligand O X
in O X
Utp21 I-MISC 851125
, O X
the O X
first O X
example O X
of O X
a O X
HAT O X
domain O X
peptide O X
ligand O X
, O X
with O X
a O X
dissociation O X
constant O X
of O X
10 O X
muM O X
. O X

###16510448	5111,57804

Functional O X
roles O X
of O X
p12 I-MISC 57804
, O X
the O X
fourth O X
subunit O X
of O X
human O X
DNA I-MISC 5424
polymerase I-MISC 5424
delta I-MISC 5424
. O X

Mammalian O X
DNA I-MISC 5424
polymerase I-MISC 5424
delta I-MISC 5424
( O X
pol O X
delta O X
), O X
a O X
key O X
enzyme O X
of O X
chromosomal O X
DNA O X
replication O X
, O X
consists O X
of O X
four O X
subunits O X
as O X
follows O X
: O X
the O X
catalytic O X
subunit O X
; O X
p125 I-MISC 11196
, O X
which O X
is O X
tightly O X
associated O X
with O X
the O X
p50 I-MISC 4790
subunit O X
; O X
p68 I-MISC 10714
, O X
a O X
proliferating O X
cell O X
nuclear O X
antigen O X
( O X
PCNA I-MISC 5111
)- O X
binding O X
protein O X
; O X
and O X
a O X
fourth O X
subunit O X
, O X
p12 I-MISC 57804
. O X

In O X
this O X
study O X
, O X
the O X
functional O X
roles O X
of O X
the O X
p12 I-MISC 57804
subunit O X
of O X
pol O X
delta O X
were O X
studied O X
. O X

The O X
inter O X
- O X
subunit O X
interactions O X
of O X
the O X
p12 I-MISC 57804
subunit O X
were O X
determined O X
by O X
yeast O X
two O X
- O X
hybrid O X
assays O X
and O X
by O X
pulldown O X
assays O X
. O X

These O X
assays O X
revealed O X
that O X
p12 I-MISC 57804
interacts O X
with O X
p125 I-MISC 11196
as O X
well O X
as O X
p50 I-MISC 4790
. O X

This O X
dual O X
interaction O X
of O X
p12 I-MISC 57804
suggests O X
that O X
it O X
may O X
serve O X
to O X
stabilize O X
the O X
p125 I-MISC 11196
- O X
p50 I-MISC 4790
interaction O X
. O X

p12 I-MISC 57804
was O X
shown O X
to O X
be O X
a O X
novel O X
PCNA I-MISC 5111
- O X
binding O X
protein O X
. O X

This O X
was O X
confirmed O X
by O X
identification O X
of O X
a O X
PCNA I-MISC 5111
- O X
binding O X
motif O X
at O X
its O X
N O X
terminus O X
by O X
binding O X
assays O X
and O X
by O X
site O X
- O X
directed O X
mutagenesis O X
. O X

The O X
activities O X
and O X
reaction O X
products O X
of O X
recombinant O X
pol O X
delta O X
containing O X
a O X
p12 I-MISC 57804
mutant O X
defective O X
in O X
PCNA I-MISC 5111
binding O X
, O X
as O X
well O X
as O X
purified O X
recombinant O X
pol O X
delta O X
and O X
its O X
subassemblies O X
, O X
were O X
analyzed O X
. O X

Our O X
results O X
indicate O X
that O X
p12 I-MISC 57804
contributes O X
to O X
PCNA I-MISC 5111
- O X
dependent O X
pol O X
delta O X
activity O X
, O X
i O X
. O X
e O X
. O X

the O X
p12 I-MISC 57804
- O X
PCNA I-MISC 5111
interaction O X
is O X
functional O X
. O X

Our O X
data O X
indicate O X
that O X
both O X
p12 I-MISC 57804
and O X
p68 I-MISC 10714
are O X
required O X
for O X
optimal O X
pol O X
delta O X
activity O X
. O X

This O X
supports O X
the O X
hypothesis O X
that O X
the O X
interaction O X
between O X
pol O X
delta O X
and O X
PCNA I-MISC 5111
is O X
a O X
divalent O X
one O X
that O X
involves O X
p12 I-MISC 57804
and O X
p68 I-MISC 10714
. O X

We O X
propose O X
a O X
model O X
in O X
which O X
pol O X
delta O X
interacts O X
with O X
PCNA I-MISC 5111
via O X
at O X
least O X
two O X
of O X
its O X
subunits O X
, O X
and O X
one O X
in O X
which O X
p12 I-MISC 57804
could O X
play O X
a O X
role O X
in O X
stabilizing O X
the O X
overall O X
pol O X
delta O X
- O X
PCNA I-MISC 5111
complex O X
as O X
well O X
as O X
pol O X
delta O X
itself O X
. O X

###17350650	6050,6035

Inhibition O X
of O X
human O X
pancreatic O X
ribonuclease O X
by O X
the O X
human O X
ribonuclease I-MISC 6050
inhibitor I-MISC 6050
protein O X
. O X

The O X
ribonuclease I-MISC 6050
inhibitor I-MISC 6050
protein O X
( O X
RI I-MISC 27102
) O X
binds O X
to O X
members O X
of O X
the O X
bovine O X
pancreatic O X
ribonuclease O X
( O X
RNase I-MISC 282340
A I-MISC 282340
) O X
superfamily O X
with O X
an O X
affinity O X
in O X
the O X
femtomolar O X
range O X
. O X

Here O X
, O X
we O X
report O X
on O X
structural O X
and O X
energetic O X
aspects O X
of O X
the O X
interaction O X
between O X
human O X
RI I-MISC 27102
( O X
hRI I-MISC 27102
) O X
and O X
human O X
pancreatic O X
ribonuclease O X
( O X
RNase I-MISC 6035
1 I-MISC 6035
). O X

The O X
structure O X
of O X
the O X
crystalline O X
hRI I-MISC 27102
x O X
RNase I-MISC 6035
1 I-MISC 6035
complex O X
was O X
determined O X
at O X
a O X
resolution O X
of O X
1 O X
. O X
95 O X
A O X
, O X
revealing O X
the O X
formation O X
of O X
19 O X
intermolecular O X
hydrogen O X
bonds O X
involving O X
13 O X
residues O X
of O X
RNase I-MISC 6035
1 I-MISC 6035
. O X

In O X
contrast O X
, O X
only O X
nine O X
such O X
hydrogen O X
bonds O X
are O X
apparent O X
in O X
the O X
structure O X
of O X
the O X
complex O X
between O X
porcine O X
RI I-MISC 27102
and O X
RNase I-MISC 6035
A I-MISC 6035
. O X
hRI I-MISC 27102
, O X
which O X
is O X
anionic O X
, O X
also O X
appears O X
to O X
use O X
its O X
horseshoe O X
- O X
shaped O X
structure O X
to O X
engender O X
long O X
- O X
range O X
Coulombic O X
interactions O X
with O X
RNase I-MISC 6035
1 I-MISC 6035
, O X
which O X
is O X
cationic O X
. O X

In O X
accordance O X
with O X
the O X
structural O X
data O X
, O X
the O X
hRI I-MISC 27102
. O X
RNase I-MISC 6035
1 I-MISC 6035
complex O X
was O X
found O X
to O X
be O X
extremely O X
stable O X
( O X
t I-MISC 1070703
( I-MISC 1070703
1 I-MISC 1070703
/ I-MISC 1070703
2 I-MISC 1070703
)= I-MISC 1070703
81 I-MISC 1070703
days O X
; O X
K O X
( O X
d O X
)= O X
2 O X
. O X
9 O X
x O X
10 O X
(- O X
16 O X
) O X
M O X
). O X

Site O X
- O X
directed O X
mutagenesis O X
experiments O X
enabled O X
the O X
identification O X
of O X
two O X
cationic O X
residues O X
in O X
RNase I-MISC 6035
1 I-MISC 6035
, O X
Arg39 O X
and O X
Arg91 O X
, O X
that O X
are O X
especially O X
important O X
for O X
both O X
the O X
formation O X
and O X
stability O X
of O X
the O X
complex O X
, O X
and O X
are O X
thus O X
termed O X
" O X
electrostatic O X
targeting O X
residues O X
". O X

Disturbing O X
the O X
electrostatic O X
attraction O X
between O X
hRI I-MISC 27102
and O X
RNase I-MISC 6035
1 I-MISC 6035
yielded O X
a O X
variant O X
of O X
RNase I-MISC 6035
1 I-MISC 6035
that O X
maintained O X
ribonucleolytic O X
activity O X
and O X
conformational O X
stability O X
but O X
had O X
a O X
2 O X
. O X
8 O X
x O X
10 O X
( O X
3 O X
)- O X
fold O X
lower O X
association O X
rate O X
for O X
complex O X
formation O X
and O X
5 O X
. O X
9 O X
x O X
10 O X
( O X
9 O X
)- O X
fold O X
lower O X
affinity O X
for O X
hRI I-MISC 27102
. O X

This O X
variant O X
of O X
RNase I-MISC 6035
1 I-MISC 6035
, O X
which O X
exhibits O X
the O X
largest O X
decrease O X
in O X
RI I-MISC 27102
affinity O X
of O X
any O X
engineered O X
ribonuclease O X
, O X
is O X
also O X
toxic O X
to O X
human O X
erythroleukemia O X
cells O X
. O X

Together O X
, O X
these O X
results O X
provide O X
new O X
insight O X
into O X
an O X
unusual O X
and O X
important O X
protein O X
- O X
protein O X
interaction O X
, O X
and O X
could O X
expedite O X
the O X
development O X
of O X
human O X
ribonucleases O X
as O X
chemotherapeutic O X
agents O X
. O X

###18171471	395832,396416

Multiple O X
paxillin I-MISC 395832
binding O X
sites O X
regulate O X
FAK I-MISC 396416
function O X
. O X

BACKGROUND O X
: O X
FAK I-MISC 396416
localization O X
to O X
focal O X
adhesions O X
is O X
essential O X
for O X
its O X
activation O X
and O X
function O X
. O X

Localization O X
of O X
FAK I-MISC 396416
is O X
mediated O X
through O X
the O X
C O X
- O X
terminal O X
focal O X
adhesion O X
targeting O X
( O X
FAT O X
) O X
domain O X
. O X

Recent O X
structural O X
analyses O X
have O X
revealed O X
two O X
paxillin I-MISC 395832
- O X
binding O X
sites O X
in O X
the O X
FAT O X
domain O X
of O X
FAK I-MISC 396416
. O X

To O X
define O X
the O X
role O X
of O X
paxillin I-MISC 395832
binding O X
to O X
each O X
site O X
on O X
FAK I-MISC 396416
, O X
point O X
mutations O X
have O X
been O X
engineered O X
to O X
specifically O X
disrupt O X
paxillin I-MISC 395832
binding O X
to O X
each O X
docking O X
site O X
on O X
the O X
FAT O X
domain O X
of O X
FAK I-MISC 396416
individually O X
or O X
in O X
combination O X
. O X

RESULTS O X
: O X
These O X
mutants O X
have O X
been O X
characterized O X
and O X
reveal O X
an O X
important O X
role O X
for O X
paxillin I-MISC 395832
binding O X
in O X
FAK I-MISC 396416
subcellular O X
localization O X
and O X
signaling O X
. O X

One O X
paxillin I-MISC 395832
- O X
binding O X
site O X
( O X
comprised O X
of O X
alpha O X
- O X
helices O X
1 O X
and O X
4 O X
of O X
the O X
FAT O X
domain O X
) O X
plays O X
a O X
more O X
prominent O X
role O X
in O X
localization O X
than O X
the O X
other O X
. O X

Mutation O X
of O X
either O X
paxillin I-MISC 395832
- O X
binding O X
site O X
has O X
similar O X
effects O X
on O X
FAK I-MISC 396416
activation O X
and O X
downstream O X
signaling O X
. O X

However O X
, O X
the O X
sites O X
aren O X
' O X
t O X
strictly O X
redundant O X
as O X
each O X
mutant O X
exhibits O X
phosphorylation O X
/ O X
signaling O X
defects O X
distinct O X
from O X
wild O X
type O X
FAK I-MISC 396416
and O X
a O X
mutant O X
completely O X
defective O X
for O X
paxillin I-MISC 395832
binding O X
. O X

CONCLUSION O X
: O X
The O X
studies O X
demonstrate O X
that O X
the O X
two O X
paxillin I-MISC 395832
- O X
binding O X
sites O X
of O X
FAK I-MISC 396416
are O X
not O X
redundant O X
and O X
that O X
both O X
sites O X
are O X
required O X
for O X
FAK I-MISC 396416
function O X
. O X

###7644498	22377,10413	22378,10413

The O X
WW O X
domain O X
of O X
Yes I-MISC 10413
- I-MISC 10413
associated I-MISC 10413
protein I-MISC 10413
binds O X
a O X
proline O X
- O X
rich O X
ligand O X
that O X
differs O X
from O X
the O X
consensus O X
established O X
for O X
Src O X
homology O X
3 O X
- O X
binding O X
modules O X
. O X

The O X
WW O X
domain O X
has O X
previously O X
been O X
described O X
as O X
a O X
motif O X
of O X
38 O X
semiconserved O X
residues O X
found O X
in O X
seemingly O X
unrelated O X
proteins O X
, O X
such O X
as O X
dystrophin I-MISC 1756
, O X
Yes I-MISC 10413
- I-MISC 10413
associated I-MISC 10413
protein I-MISC 10413
( O X
YAP I-MISC 10413
), O X
and O X
two O X
transcriptional O X
regulators O X
, O X
Rsp I-MISC 23327
- I-MISC 23327
5 I-MISC 23327
and O X
FE65 I-MISC 322
. O X

The O X
molecular O X
function O X
of O X
the O X
WW O X
domain O X
has O X
been O X
unknown O X
until O X
this O X
time O X
. O X

Using O X
a O X
functional O X
screen O X
of O X
a O X
cDNA O X
expression O X
library O X
, O X
we O X
have O X
identified O X
two O X
putative O X
ligands O X
of O X
the O X
WW O X
domain O X
of O X
YAP I-MISC 10413
, O X
which O X
we O X
named O X
WBP I-MISC 22377
- I-MISC 22377
1 I-MISC 22377
and O X
WBP I-MISC 22378
- I-MISC 22378
2 I-MISC 22378
. O X

Peptide O X
sequence O X
comparison O X
between O X
the O X
two O X
partial O X
clones O X
revealed O X
a O X
homologous O X
region O X
consisting O X
of O X
a O X
proline O X
- O X
rich O X
domain O X
followed O X
by O X
a O X
tyrosine O X
residue O X
( O X
with O X
the O X
shared O X
sequence O X
PPPPY O X
), O X
which O X
we O X
shall O X
call O X
the O X
PY O X
motif O X
. O X

Binding O X
assays O X
and O X
site O X
- O X
specific O X
mutagenesis O X
have O X
shown O X
that O X
the O X
PY O X
motif O X
binds O X
with O X
relatively O X
high O X
affinity O X
and O X
specificity O X
to O X
the O X
WW O X
domain O X
of O X
YAP I-MISC 10413
, O X
with O X
the O X
preliminary O X
consensus O X
XPPXY O X
being O X
critical O X
for O X
binding O X
. O X

Herein O X
, O X
we O X
have O X
implicated O X
the O X
WW O X
domain O X
with O X
a O X
role O X
in O X
mediating O X
protein O X
- O X
protein O X
interactions O X
, O X
as O X
a O X
variant O X
of O X
the O X
paradigm O X
set O X
by O X
Src O X
homology O X
3 O X
domains O X
and O X
their O X
proline O X
- O X
rich O X
ligands O X
. O X

###21586138	57630,6478

Possible O X
role O X
of O X
death O X
receptor O X
- O X
mediated O X
apoptosis O X
by O X
the O X
E3 O X
ubiquitin O X
ligases O X
Siah2 I-MISC 6478
and O X
POSH I-MISC 57630
. O X

BACKGROUND O X
: O X
A O X
functioning O X
ubiquitin O X
proteasome O X
system O X
( O X
UPS O X
) O X
is O X
essential O X
for O X
a O X
number O X
of O X
diverse O X
cellular O X
processes O X
and O X
maintenance O X
of O X
overall O X
cellular O X
homeostasis O X
. O X

The O X
ability O X
of O X
proteasome O X
inhibitors O X
, O X
such O X
as O X
Velcade O X
, O X
to O X
promote O X
extrinsic O X
apoptotic O X
effects O X
illustrates O X
the O X
importance O X
of O X
the O X
ubiquitin O X
proteasome O X
system O X
in O X
the O X
regulation O X
of O X
death O X
receptor O X
signaling O X
. O X

Here O X
, O X
we O X
set O X
out O X
to O X
define O X
the O X
UPS O X
machinery O X
, O X
particularly O X
the O X
E3 O X
ubiquitin O X
ligases O X
, O X
that O X
repress O X
apoptosis O X
through O X
the O X
extrinsic O X
pathway O X
. O X

A O X
cell O X
- O X
based O X
genome O X
- O X
wide O X
E3 O X
ligase O X
siRNA O X
screen O X
was O X
established O X
to O X
monitor O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
activity O X
following O X
the O X
addition O X
of O X
TRAIL I-MISC 8743
. O X

RESULTS O X
: O X
Data O X
from O X
the O X
high O X
- O X
throughput O X
screen O X
revealed O X
that O X
targeting O X
the O X
RING O X
- O X
finger O X
containing O X
E3 O X
ligase O X
Siah2 I-MISC 6478
as O X
well O X
as O X
the O X
signaling O X
platform O X
molecule O X
POSH I-MISC 57630
( O X
SH3RF1 I-MISC 57630
) O X
conferred O X
robust O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
activation O X
in O X
response O X
to O X
TRAIL I-MISC 8743
stimulus O X
. O X

Silencing O X
Siah2 I-MISC 6478
or O X
POSH I-MISC 57630
in O X
prostate O X
cancer O X
cells O X
led O X
to O X
increased O X
caspase O X
activity O X
and O X
apoptosis O X
in O X
response O X
to O X
both O X
TRAIL I-MISC 8743
and O X
Fas I-MISC 356
ligand I-MISC 356
. O X

The O X
E3 O X
activity O X
of O X
Siah2 I-MISC 6478
was O X
responsible O X
for O X
mediating O X
apoptosis O X
resistance O X
; O X
while O X
POSH I-MISC 57630
protein O X
levels O X
were O X
critical O X
for O X
maintaining O X
viability O X
. O X

Further O X
characterization O X
of O X
Siah2 I-MISC 6478
revealed O X
it O X
to O X
function O X
downstream O X
of O X
early O X
death O X
receptor O X
events O X
in O X
the O X
apoptotic O X
pathway O X
. O X

The O X
observed O X
apoptosis O X
resistance O X
provides O X
one O X
biological O X
explanation O X
for O X
the O X
induction O X
of O X
Siah2 I-MISC 6478
and O X
POSH I-MISC 57630
reported O X
in O X
lung O X
and O X
prostate O X
cancer O X
, O X
respectively O X
. O X

Expanding O X
on O X
an O X
initial O X
yeast O X
- O X
two O X
- O X
hybrid O X
screen O X
we O X
have O X
confirmed O X
a O X
physical O X
interaction O X
between O X
E3 O X
ligases O X
Siah2 I-MISC 6478
and O X
POSH I-MISC 57630
. O X

Utilizing O X
a O X
yeast O X
- O X
two O X
- O X
hybrid O X
mapping O X
approach O X
we O X
have O X
defined O X
the O X
spacer O X
region O X
of O X
POSH I-MISC 57630
, O X
more O X
specifically O X
the O X
RPxAxVxP O X
motif O X
encompassing O X
amino O X
acids O X
601 O X
- O X
607 O X
, O X
to O X
be O X
the O X
site O X
of O X
Siah2 I-MISC 6478
binding O X
. O X

CONCLUSIONS O X
: O X
The O X
data O X
presented O X
here O X
define O X
POSH I-MISC 57630
and O X
Siah2 I-MISC 6478
as O X
important O X
mediators O X
of O X
death O X
receptor O X
mediated O X
apoptosis O X
and O X
suggest O X
targeting O X
the O X
interaction O X
of O X
these O X
two O X
E3 O X
ligases O X
is O X
a O X
promising O X
novel O X
cancer O X
therapeutic O X
strategy O X
. O X

###17699755	828661,839300

Independent O X
and O X
interdependent O X
functions O X
of O X
LAF1 I-MISC 828661
and O X
HFR1 I-MISC 839300
in O X
phytochrome O X
A O X
signaling O X
. O X

Several O X
positive O X
regulators O X
of O X
phytochrome O X
A O X
signaling O X
-- O X
e O X
. O X
g O X
., O X
LAF1 I-MISC 828661
, O X
HFR1 I-MISC 839300
, O X
and O X
HY5 O X
-- O X
operate O X
downstream O X
from O X
the O X
photoreceptor O X
, O X
but O X
their O X
relative O X
sites O X
of O X
action O X
in O X
the O X
transduction O X
pathway O X
are O X
unknown O X
. O X

Here O X
, O X
we O X
show O X
that O X
HFR1RNAi O X
/ O X
laf1 I-MISC 828661
or O X
hfr1 I-MISC 839300
- O X
201 O X
/ O X
LAF1RNAi O X
generated O X
by O X
RNA O X
interference O X
( O X
RNAi O X
) O X
has O X
an O X
additive O X
phenotype O X
under O X
FR O X
light O X
compared O X
with O X
the O X
single O X
mutants O X
, O X
hfr1 I-MISC 839300
- O X
201 O X
or O X
laf1 I-MISC 828661
. O X

This O X
result O X
indicates O X
that O X
LAF1 I-MISC 828661
and O X
HFR1 I-MISC 839300
function O X
in O X
largely O X
independent O X
pathways O X
. O X

LAF1 I-MISC 828661
, O X
an O X
R2R3 O X
- O X
MYB O X
factor O X
, O X
interacts O X
with O X
HFR1 I-MISC 839300
, O X
a O X
basic O X
helix O X
- O X
loop O X
- O X
helix O X
( O X
bHLH O X
) O X
factor O X
, O X
and O X
this O X
interaction O X
is O X
abolished O X
by O X
the O X
R97A O X
mutation O X
in O X
the O X
LAF1 I-MISC 828661
R2R3 O X
domain O X
. O X

Polyubiquitinations O X
of O X
LAF1 I-MISC 828661
and O X
HFR1 I-MISC 839300
by O X
the O X
COP1 I-MISC 64326
E3 O X
ligase O X
in O X
vitro O X
are O X
inhibited O X
by O X
LAF1 I-MISC 828661
/ O X
HFR1 I-MISC 839300
association O X
. O X

Consistent O X
with O X
this O X
result O X
, O X
endogenous O X
HFR1 I-MISC 839300
is O X
less O X
stable O X
in O X
laf1 I-MISC 828661
compared O X
with O X
wild O X
type O X
, O X
and O X
similarly O X
, O X
LAF1 I-MISC 828661
- O X
3HA O X
expressed O X
from O X
a O X
transgene O X
is O X
also O X
less O X
stable O X
in O X
hfr1 I-MISC 839300
- O X
201 O X
than O X
wild O X
type O X
. O X

In O X
transgenic O X
plants O X
, O X
HFR1 I-MISC 839300
levels O X
are O X
significantly O X
elevated O X
upon O X
induced O X
expression O X
of O X
LAF1 I-MISC 828661
but O X
not O X
LAF1 I-MISC 828661
( O X
R97A O X
). O X

Moreover O X
, O X
induced O X
expression O X
of O X
LAF1 I-MISC 828661
but O X
not O X
LAF1 I-MISC 828661
( O X
R97A O X
) O X
delays O X
post O X
- O X
translational O X
HFR1 I-MISC 839300
degradation O X
in O X
FR O X
light O X
. O X

Constitutive O X
coexpression O X
of O X
HFR1 I-MISC 839300
and O X
LAF1 I-MISC 828661
but O X
not O X
HFR1 I-MISC 839300
and O X
LAF1 I-MISC 828661
( O X
R97A O X
) O X
confers O X
FR O X
hypersensitivity O X
in O X
double O X
transgenic O X
plants O X
. O X

Our O X
results O X
show O X
that O X
in O X
addition O X
to O X
their O X
independent O X
functions O X
in O X
phyA O X
signaling O X
, O X
LAF1 I-MISC 828661
and O X
HFR1 I-MISC 839300
also O X
cooperate O X
post O X
- O X
translationally O X
to O X
stabilize O X
each O X
other O X
through O X
inhibition O X
of O X
ubiquitination O X
by O X
COP1 I-MISC 64326
, O X
thereby O X
enhancing O X
phyA O X
photoresponses O X
. O X

###14551211	855132,851813

Separation O X
- O X
of O X
- O X
function O X
mutants O X
of O X
yeast O X
Ku80 O X
reveal O X
a O X
Yku80p I-MISC 855132
- O X
Sir4p I-MISC 851813
interaction O X
involved O X
in O X
telomeric O X
silencing O X
. O X

The O X
Saccharomyces O X
cerevisiae O X
Ku O X
heterodimer O X
comprising O X
Yku70p I-MISC 855328
and O X
Yku80p I-MISC 855132
is O X
involved O X
in O X
telomere O X
maintenance O X
and O X
DNA O X
repair O X
by O X
the O X
pathway O X
of O X
non O X
- O X
homologous O X
end O X
joining O X
. O X

It O X
is O X
also O X
a O X
key O X
regulator O X
of O X
transcriptional O X
silencing O X
of O X
genes O X
placed O X
in O X
close O X
proximity O X
to O X
telomeres O X
. O X

Here O X
, O X
we O X
describe O X
the O X
identification O X
of O X
separation O X
- O X
of O X
- O X
function O X
mutants O X
of O X
Yku80p I-MISC 855132
that O X
exhibit O X
defects O X
in O X
silencing O X
but O X
not O X
DNA O X
repair O X
and O X
show O X
that O X
these O X
mutations O X
map O X
to O X
an O X
evolutionarily O X
conserved O X
domain O X
within O X
Yku80p I-MISC 855132
. O X

Furthermore O X
, O X
we O X
reveal O X
that O X
Yku80p I-MISC 855132
interacts O X
with O X
the O X
silent O X
information O X
regulator O X
protein O X
Sir4p I-MISC 851813
and O X
that O X
this O X
interaction O X
is O X
mediated O X
by O X
the O X
N O X
- O X
terminal O X
200 O X
amino O X
acid O X
residues O X
of O X
Sir4p I-MISC 851813
. O X

Notably O X
, O X
this O X
interaction O X
also O X
requires O X
the O X
region O X
of O X
Yku80p I-MISC 855132
that O X
contains O X
the O X
sites O X
of O X
the O X
silencing O X
defective O X
mutations O X
. O X

Finally O X
, O X
we O X
show O X
that O X
these O X
mutations O X
impair O X
the O X
Yku80p I-MISC 855132
- O X
Sir4p I-MISC 851813
interaction O X
and O X
recruitment O X
of O X
Sir3p I-MISC 851163
to O X
telomeric O X
regions O X
in O X
vivo O X
. O X

Taken O X
together O X
with O X
other O X
data O X
, O X
these O X
findings O X
indicate O X
that O X
the O X
Yku80p I-MISC 855132
- O X
Sir4p I-MISC 851813
interaction O X
plays O X
a O X
vital O X
role O X
in O X
the O X
assembly O X
of O X
telomeric O X
heterochromatin O X
. O X

###17289029	1499,84662

The O X
Kr O X
ppel O X
- O X
like O X
zinc O X
finger O X
protein O X
Glis2 I-MISC 84662
functions O X
as O X
a O X
negative O X
modulator O X
of O X
the O X
Wnt O X
/ O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
signaling O X
pathway O X
. O X

To O X
gain O X
insight O X
into O X
the O X
mechanism O X
by O X
which O X
Gli I-MISC 84662
- I-MISC 84662
similar I-MISC 84662
2 I-MISC 84662
( O X
Glis2 I-MISC 84662
) O X
regulates O X
transcription O X
, O X
we O X
performed O X
yeast O X
- O X
two O X
hybrid O X
cDNA O X
library O X
screening O X
using O X
Glis2 I-MISC 84662
as O X
bait O X
. O X

This O X
screening O X
identified O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
as O X
a O X
potential O X
Glis2 I-MISC 84662
- O X
interacting O X
protein O X
. O X

Mammalian O X
two O X
- O X
hybrid O X
, O X
co O X
- O X
immunoprecipitation O X
, O X
and O X
GST O X
- O X
pulldown O X
analyses O X
supported O X
the O X
interaction O X
between O X
Glis2 I-MISC 84662
and O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
. O X

Pulldown O X
analyses O X
with O X
several O X
Glis2 I-MISC 84662
deletion O X
mutants O X
indicated O X
that O X
the O X
1st O X
zinc O X
finger O X
motif O X
of O X
Glis2 I-MISC 84662
is O X
critical O X
for O X
its O X
interaction O X
with O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
, O X
while O X
the O X
armadillo O X
repeats O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
are O X
important O X
in O X
its O X
interaction O X
with O X
Glis2 I-MISC 84662
. O X

Reporter O X
analyses O X
showed O X
that O X
Glis2 I-MISC 84662
represses O X
T I-MISC 3172
- I-MISC 3172
cell I-MISC 3172
factor I-MISC 3172
( O X
TCF I-MISC 3172
)- O X
mediated O X
transcriptional O X
activation O X
. O X

In O X
addition O X
, O X
Glis2 I-MISC 84662
represses O X
the O X
expression O X
of O X
the O X
TCF I-MISC 3172
target O X
gene O X
cyclin I-MISC 595
D1 I-MISC 595
. O X

Our O X
results O X
indicate O X
that O X
Glis2 I-MISC 84662
interacts O X
with O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
suggest O X
that O X
Glis2 I-MISC 84662
functions O X
as O X
a O X
negative O X
modulator O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
/ O X
TCF I-MISC 3172
- O X
mediated O X
transcription O X
. O X

###20935100	1249352,1246846

Crl I-MISC 1246846
binds O X
to O X
domain O X
2 O X
of O X
( O X
S O X
) O X
and O X
confers O X
a O X
competitive O X
advantage O X
on O X
a O X
natural O X
rpoS I-MISC 1249352
mutant O X
of O X
Salmonella O X
enterica O X
serovar O X
Typhi O X
. O X

The O X
RpoS I-MISC 1249352
sigma O X
factor O X
( O X
( O X
S O X
)) O X
is O X
the O X
master O X
regulator O X
of O X
the O X
bacterial O X
response O X
to O X
a O X
variety O X
of O X
stresses O X
. O X

Mutants O X
in O X
rpoS I-MISC 1249352
arise O X
in O X
bacterial O X
populations O X
in O X
the O X
absence O X
of O X
stress O X
, O X
probably O X
as O X
a O X
consequence O X
of O X
a O X
subtle O X
balance O X
between O X
self O X
- O X
preservation O X
and O X
nutritional O X
competence O X
. O X

We O X
characterized O X
here O X
one O X
natural O X
rpoS I-MISC 1249352
mutant O X
of O X
Salmonella O X
enterica O X
serovar O X
Typhi O X
( O X
Ty19 O X
). O X

We O X
show O X
that O X
the O X
rpoS I-MISC 1249352
allele O X
of O X
Ty19 O X
( O X
rpoS I-MISC 1249352
( O X
Ty19 O X
)) O X
led O X
to O X
the O X
synthesis O X
of O X
a O X
( O X
S O X
)( O X
Ty19 O X
) O X
protein O X
carrying O X
a O X
single O X
glycine O X
- O X
to O X
- O X
valine O X
substitution O X
at O X
position O X
282 O X
in O X
( O X
S O X
) O X
domain O X
4 O X
, O X
which O X
was O X
much O X
more O X
dependent O X
than O X
the O X
wild O X
- O X
type O X
( O X
S O X
) O X
protein O X
on O X
activation O X
by O X
Crl I-MISC 1246846
, O X
a O X
chaperone O X
- O X
like O X
protein O X
that O X
increases O X
the O X
affinity O X
of O X
( O X
S O X
) O X
for O X
the O X
RNA O X
polymerase O X
core O X
enzyme O X
( O X
E O X
). O X

We O X
used O X
the O X
bacterial O X
adenylate O X
cyclase O X
two O X
- O X
hybrid O X
system O X
to O X
demonstrate O X
that O X
Crl I-MISC 1246846
bound O X
to O X
residues O X
72 O X
to O X
167 O X
of O X
( O X
S O X
) O X
domain O X
2 O X
and O X
that O X
G282V O X
substitution O X
did O X
not O X
directly O X
affect O X
Crl I-MISC 1246846
binding O X
. O X

However O X
, O X
this O X
substitution O X
drastically O X
reduced O X
the O X
ability O X
of O X
( O X
S O X
)( O X
Ty19 O X
) O X
to O X
bind O X
E O X
in O X
a O X
surface O X
plasmon O X
resonance O X
assay O X
, O X
a O X
defect O X
partially O X
rescued O X
by O X
Crl I-MISC 1246846
. O X

The O X
modeled O X
structure O X
of O X
the O X
E O X
( O X
S O X
) O X
holoenzyme O X
suggested O X
that O X
substitution O X
G282V O X
could O X
directly O X
disrupt O X
a O X
favorable O X
interaction O X
between O X
( O X
S O X
) O X
and O X
E O X
. O X
The O X
rpoS I-MISC 1249352
( O X
Ty19 O X
) O X
allele O X
conferred O X
a O X
competitive O X
fitness O X
when O X
the O X
bacterial O X
population O X
was O X
wild O X
type O X
for O X
crl I-MISC 1246846
but O X
was O X
outcompeted O X
in O X
/\ O X
crl I-MISC 1246846
populations O X
. O X

Thus O X
, O X
these O X
results O X
indicate O X
that O X
the O X
competitive O X
advantage O X
of O X
the O X
rpoS I-MISC 1249352
( O X
Ty19 O X
) O X
mutant O X
is O X
dependent O X
on O X
Crl I-MISC 1246846
and O X
suggest O X
that O X
crl I-MISC 1246846
plays O X
a O X
role O X
in O X
the O X
appearance O X
of O X
rpoS I-MISC 1249352
mutants O X
in O X
bacterial O X
populations O X
. O X

###15247908	1793,9844

PH O X
domain O X
of O X
ELMO I-MISC 9844
functions O X
in O X
trans O X
to O X
regulate O X
Rac O X
activation O X
via O X
Dock180 I-MISC 1793
. O X

The O X
members O X
of O X
the O X
Dock180 I-MISC 1793
superfamily O X
of O X
proteins O X
are O X
novel O X
guanine O X
nucleotide O X
exchange O X
factors O X
( O X
GEF O X
) O X
for O X
Rho O X
family O X
GTPases O X
and O X
are O X
linked O X
to O X
multiple O X
biological O X
processes O X
from O X
worms O X
to O X
mammals O X
. O X

ELMO I-MISC 9844
is O X
a O X
critical O X
regulator O X
of O X
Dock180 I-MISC 1793
, O X
and O X
the O X
Dock180 I-MISC 1793
- O X
ELMO I-MISC 9844
complex O X
functions O X
as O X
a O X
bipartite O X
GEF O X
for O X
Rac O X
. O X

We O X
identified O X
a O X
mechanism O X
wherein O X
the O X
PH O X
domain O X
of O X
ELMO I-MISC 9844
, O X
by O X
binding O X
the O X
Dock180 I-MISC 1793
- O X
Rac O X
complex O X
in O X
trans O X
, O X
stabilizes O X
Rac O X
in O X
the O X
nucleotide O X
- O X
free O X
transition O X
state O X
. O X

Mutagenesis O X
studies O X
reveal O X
that O X
this O X
ELMO I-MISC 9844
PH O X
domain O X
- O X
dependent O X
regulation O X
is O X
essential O X
for O X
the O X
Dock180 I-MISC 1793
- O X
ELMO I-MISC 9844
complex O X
to O X
function O X
in O X
phagocytosis O X
and O X
cell O X
migration O X
. O X

Genetic O X
rescue O X
studies O X
in O X
Caenorhabditis O X
elegans O X
using O X
ELMO I-MISC 9844
and O X
its O X
homolog O X
CED I-MISC 172890
- I-MISC 172890
12 I-MISC 172890
support O X
the O X
above O X
observations O X
in O X
vivo O X
. O X

These O X
data O X
reveal O X
a O X
new O X
mode O X
of O X
action O X
of O X
PH O X
domains O X
and O X
a O X
novel O X
, O X
evolutionarily O X
conserved O X
mechanism O X
by O X
which O X
a O X
bipartite O X
GEF O X
can O X
activate O X
Rac O X
. O X

###20972459	23558,25937

WW O X
domain O X
- O X
mediated O X
interaction O X
with O X
Wbp2 I-MISC 23558
is O X
important O X
for O X
the O X
oncogenic O X
property O X
of O X
TAZ I-MISC 25937
. O X

The O X
transcriptional O X
co O X
- O X
activators O X
YAP O X
and O X
TAZ I-MISC 25937
are O X
downstream O X
targets O X
inhibited O X
by O X
the O X
Hippo O X
tumor O X
suppressor O X
pathway O X
. O X

YAP O X
and O X
TAZ I-MISC 25937
both O X
possess O X
WW O X
domains O X
, O X
which O X
are O X
important O X
protein O X
- O X
protein O X
interaction O X
modules O X
that O X
mediate O X
interaction O X
with O X
proline O X
- O X
rich O X
motifs O X
, O X
most O X
commonly O X
PPXY O X
. O X

The O X
WW O X
domains O X
of O X
YAP O X
have O X
complex O X
regulatory O X
roles O X
as O X
exemplified O X
by O X
recent O X
reports O X
showing O X
that O X
they O X
can O X
positively O X
or O X
negatively O X
influence O X
YAP O X
activity O X
in O X
a O X
cell O X
and O X
context O X
- O X
specific O X
manner O X
. O X

In O X
this O X
study O X
, O X
we O X
show O X
that O X
the O X
WW O X
domain O X
of O X
TAZ I-MISC 25937
is O X
important O X
for O X
it O X
to O X
transform O X
both O X
MCF10A O X
and O X
NIH3T3 O X
cells O X
and O X
to O X
activate O X
transcription O X
of O X
ITGB2 I-MISC 16414
but O X
not O X
CTGF I-MISC 14219
, O X
as O X
introducing O X
point O X
mutations O X
into O X
the O X
WW O X
domain O X
of O X
TAZ I-MISC 25937
( O X
WWm O X
) O X
abolished O X
its O X
transforming O X
and O X
transcription O X
- O X
promoting O X
ability O X
. O X

Using O X
a O X
proteomic O X
approach O X
, O X
we O X
discovered O X
potential O X
regulatory O X
proteins O X
that O X
interact O X
with O X
TAZ I-MISC 25937
WW O X
domain O X
and O X
identified O X
Wbp2 I-MISC 23558
. O X

The O X
interaction O X
of O X
Wbp2 I-MISC 23558
with O X
TAZ I-MISC 25937
is O X
dependent O X
on O X
the O X
WW O X
domain O X
of O X
TAZ I-MISC 25937
and O X
the O X
PPXY O X
- O X
containing O X
C O X
- O X
terminal O X
region O X
of O X
Wbp2 I-MISC 23558
. O X

Knockdown O X
of O X
endogenous O X
Wbp2 I-MISC 23558
suppresses O X
, O X
whereas O X
overexpression O X
of O X
Wbp2 I-MISC 23558
enhances O X
, O X
TAZ I-MISC 25937
- O X
driven O X
transformation O X
. O X

Forced O X
interaction O X
of O X
WWm O X
with O X
Wbp2 I-MISC 23558
by O X
direct O X
C O X
- O X
terminal O X
fusion O X
of O X
full O X
- O X
length O X
Wbp2 I-MISC 23558
or O X
its O X
TAZ I-MISC 25937
- O X
interacting O X
C O X
- O X
terminal O X
domain O X
restored O X
the O X
transforming O X
and O X
transcription O X
- O X
promoting O X
ability O X
of O X
TAZ I-MISC 25937
. O X

These O X
results O X
suggest O X
that O X
the O X
WW O X
domain O X
- O X
mediated O X
interaction O X
with O X
Wbp2 I-MISC 23558
promotes O X
the O X
transforming O X
ability O X
of O X
TAZ I-MISC 25937
. O X

###10444103	4330328,4334140

Determination O X
of O X
the O X
motif O X
responsible O X
for O X
interaction O X
between O X
the O X
rice O X
APETALA1 O X
/ O X
AGAMOUS O X
- O X
LIKE9 O X
family O X
proteins O X
using O X
a O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

A O X
MADS O X
family O X
gene O X
, O X
OsMADS6 I-MISC 4330328
, O X
was O X
isolated O X
from O X
a O X
rice O X
( O X
Oryza O X
sativa O X
L O X
.) O X
young O X
flower O X
cDNA O X
library O X
using O X
OsAMDS1 O X
as O X
a O X
probe O X
. O X

With O X
this O X
clone O X
, O X
various O X
MADS O X
box O X
genes O X
that O X
encode O X
for O X
protein O X
- O X
to O X
- O X
protein O X
interaction O X
partners O X
of O X
the O X
OsMADS6 I-MISC 4330328
protein O X
were O X
isolated O X
by O X
the O X
yeast O X
two O X
- O X
hybrid O X
screening O X
method O X
. O X

On O X
the O X
basis O X
of O X
sequence O X
homology O X
, O X
OsMADS6 I-MISC 4330328
and O X
the O X
selected O X
partners O X
can O X
be O X
classified O X
in O X
the O X
APETALA1 O X
/ O X
AGAMOUS O X
- O X
LIKE9 O X
( O X
AP1 O X
/ O X
AGL9 O X
) O X
family O X
. O X

One O X
of O X
the O X
interaction O X
partners O X
, O X
OsMADS14 I-MISC 4334140
, O X
was O X
selected O X
for O X
further O X
study O X
. O X

Both O X
genes O X
began O X
expression O X
at O X
early O X
stages O X
of O X
flower O X
development O X
, O X
and O X
their O X
expression O X
was O X
extended O X
into O X
the O X
later O X
stages O X
. O X

In O X
mature O X
flowers O X
the O X
OsMADS6 I-MISC 4330328
transcript O X
was O X
detectable O X
in O X
lodicules O X
and O X
also O X
weakly O X
in O X
sterile O X
lemmas O X
and O X
carpels O X
, O X
whereas O X
the O X
OsMADS14 I-MISC 4334140
transcript O X
was O X
detectable O X
in O X
sterile O X
lemmas O X
, O X
paleas O X
/ O X
lemmas O X
, O X
stamens O X
, O X
and O X
carpels O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
we O X
demonstrated O X
that O X
the O X
region O X
containing O X
of O X
the O X
109th O X
to O X
137th O X
amino O X
acid O X
residues O X
of O X
OsMADS6 I-MISC 4330328
is O X
indispensable O X
in O X
the O X
interaction O X
with O X
OsMADS14 I-MISC 4334140
. O X

Site O X
- O X
directed O X
mutation O X
analysis O X
revealed O X
that O X
the O X
four O X
periodical O X
leucine O X
residues O X
within O X
the O X
region O X
are O X
essential O X
for O X
this O X
interaction O X
. O X

Furthermore O X
, O X
it O X
was O X
shown O X
that O X
the O X
14 O X
amino O X
acid O X
residues O X
located O X
immediately O X
downstream O X
of O X
the O X
K O X
domain O X
enhance O X
the O X
interaction O X
, O X
and O X
that O X
the O X
two O X
leucine O X
residues O X
within O X
this O X
region O X
play O X
an O X
important O X
role O X
in O X
that O X
enhancement O X
. O X

###17298945	7157,9820

The O X
conserved O X
CPH O X
domains O X
of O X
Cul7 I-MISC 9820
and O X
PARC I-MISC 78309
are O X
protein O X
- O X
protein O X
interaction O X
modules O X
that O X
bind O X
the O X
tetramerization O X
domain O X
of O X
p53 I-MISC 7157
. O X

Cul7 I-MISC 9820
is O X
a O X
member O X
of O X
the O X
Cullin O X
Ring O X
Ligase O X
( O X
CRL O X
) O X
family O X
and O X
is O X
required O X
for O X
normal O X
mouse O X
development O X
and O X
cellular O X
proliferation O X
. O X

Recently O X
, O X
a O X
region O X
of O X
Cul7 I-MISC 9820
that O X
is O X
highly O X
conserved O X
in O X
the O X
p53 I-MISC 7157
- O X
associated O X
, O X
Parkin O X
- O X
like O X
cytoplasmic O X
protein O X
PARC I-MISC 78309
, O X
was O X
shown O X
to O X
bind O X
p53 I-MISC 7157
directly O X
. O X

Here O X
we O X
identify O X
the O X
CPH O X
domains O X
( O X
conserved O X
domain O X
within O X
Cul7 I-MISC 9820
, O X
PARC I-MISC 78309
, O X
and O X
HERC2 I-MISC 15204
proteins O X
) O X
of O X
both O X
Cul7 I-MISC 9820
and O X
PARC I-MISC 78309
as O X
p53 I-MISC 7157
interaction O X
domains O X
using O X
size O X
exclusion O X
chromatography O X
and O X
NMR O X
spectroscopy O X
. O X

We O X
present O X
the O X
first O X
structure O X
of O X
the O X
evolutionarily O X
conserved O X
CPH O X
domain O X
and O X
provide O X
novel O X
insight O X
into O X
the O X
Cul7 I-MISC 9820
- O X
p53 I-MISC 7157
interaction O X
. O X

The O X
NMR O X
structure O X
of O X
the O X
Cul7 I-MISC 9820
- O X
CPH O X
domain O X
reveals O X
a O X
fold O X
similar O X
to O X
peptide O X
interaction O X
modules O X
such O X
as O X
the O X
SH3 O X
, O X
Tudor O X
, O X
and O X
KOW O X
domains O X
. O X

The O X
p53 I-MISC 7157
interaction O X
surface O X
of O X
both O X
Cul7 I-MISC 9820
and O X
PARC I-MISC 78309
CPH O X
domains O X
was O X
mapped O X
to O X
a O X
conserved O X
surface O X
distinct O X
from O X
the O X
analogous O X
peptide O X
- O X
binding O X
regions O X
of O X
SH3 O X
, O X
KOW O X
, O X
and O X
Tudor O X
domains O X
, O X
suggesting O X
a O X
novel O X
mode O X
of O X
interaction O X
. O X

The O X
CPH O X
domain O X
interaction O X
surface O X
of O X
p53 I-MISC 7157
resides O X
in O X
the O X
tetramerization O X
domain O X
and O X
is O X
formed O X
by O X
residues O X
contributed O X
by O X
at O X
least O X
two O X
subunits O X
. O X

###9425168	12927,396416

Identification O X
of O X
p130Cas I-MISC 12927
as O X
a O X
mediator O X
of O X
focal I-MISC 396416
adhesion I-MISC 396416
kinase I-MISC 396416
- O X
promoted O X
cell O X
migration O X
. O X

Previously O X
we O X
have O X
demonstrated O X
that O X
focal I-MISC 396416
adhesion I-MISC 396416
kinase I-MISC 396416
( O X
FAK I-MISC 396416
)- O X
promoted O X
migration O X
on O X
fibronectin I-MISC 14268
( O X
FN I-MISC 14268
) O X
by O X
its O X
overexpression O X
in O X
CHO O X
cells O X
is O X
dependent O X
on O X
FAK I-MISC 396416
autophosphorylation O X
at O X
Y397 O X
and O X
subsequent O X
binding O X
of O X
Src I-MISC 20779
to O X
this O X
site O X
. O X

In O X
this O X
report O X
, O X
we O X
have O X
examined O X
the O X
role O X
of O X
FAK I-MISC 396416
association O X
with O X
Grb2 I-MISC 14784
and O X
p130 I-MISC 70769
( O X
Cas O X
), O X
two O X
downstream O X
events O X
of O X
the O X
FAK I-MISC 396416
/ O X
Src I-MISC 20779
complex O X
that O X
could O X
mediate O X
integrin O X
- O X
stimulated O X
activation O X
of O X
extracellular O X
signal O X
- O X
regulated O X
kinases O X
( O X
Erks O X
). O X

We O X
show O X
that O X
a O X
Y925F O X
FAK I-MISC 14083
mutant O X
was O X
able O X
to O X
promote O X
cell O X
migration O X
as O X
efficiently O X
as O X
FAK I-MISC 396416
and O X
that O X
the O X
transfected O X
FAK I-MISC 396416
demonstrated O X
no O X
detectable O X
association O X
with O X
Grb2 I-MISC 14784
in O X
CHO O X
cells O X
. O X

In O X
contrast O X
, O X
cells O X
expressing O X
a O X
FAK I-MISC 396416
P712 O X
/ O X
715A O X
mutant O X
demonstrated O X
a O X
level O X
of O X
migration O X
comparable O X
to O X
that O X
of O X
control O X
cells O X
. O X

This O X
mutation O X
did O X
not O X
affect O X
FAK I-MISC 396416
kinase O X
activity O X
, O X
autophosphorylation O X
, O X
or O X
Src I-MISC 20779
association O X
but O X
did O X
significantly O X
reduce O X
p130 I-MISC 70769
( O X
Cas O X
) O X
association O X
with O X
FAK I-MISC 396416
. O X

Furthermore O X
, O X
FAK I-MISC 14083
expression O X
in O X
CHO O X
cells O X
increased O X
tyrosine O X
phosphorylation O X
of O X
p130 I-MISC 70769
( O X
Cas O X
) O X
and O X
its O X
subsequent O X
binding O X
to O X
several O X
SH2 O X
domains O X
, O X
which O X
depended O X
on O X
both O X
the O X
p130 I-MISC 70769
( O X
Cas O X
) O X
binding O X
site O X
and O X
the O X
Src I-MISC 20779
binding O X
site O X
. O X

However O X
, O X
we O X
did O X
not O X
detect O X
increased O X
activation O X
of O X
Erks O X
in O X
cells O X
expressing O X
FAK I-MISC 396416
, O X
and O X
the O X
MEK I-MISC 17242
inhibitor O X
PD98059 O X
did O X
not O X
decrease O X
FAK I-MISC 14083
- O X
promoted O X
cell O X
migration O X
. O X

Finally O X
, O X
we O X
show O X
that O X
coexpression O X
of O X
p130 I-MISC 70769
( O X
Cas O X
) O X
further O X
increased O X
cell O X
migration O X
on O X
FN I-MISC 14268
and O X
coexpression O X
of O X
the O X
p130 I-MISC 70769
( O X
Cas O X
) O X
SH3 O X
domain O X
alone O X
functioned O X
as O X
a O X
dominant O X
negative O X
mutant O X
and O X
decreased O X
cell O X
migration O X
. O X

Together O X
, O X
these O X
results O X
demonstrate O X
that O X
p130 I-MISC 70769
( O X
Cas O X
), O X
but O X
not O X
Grb2 I-MISC 14784
, O X
is O X
a O X
mediator O X
of O X
FAK I-MISC 14083
- O X
promoted O X
cell O X
migration O X
and O X
suggest O X
that O X
FAK I-MISC 396416
/ O X
p130 I-MISC 70769
( O X
Cas O X
) O X
complex O X
targets O X
downstream O X
pathways O X
other O X
than O X
Erks O X
in O X
mediating O X
FAK I-MISC 14083
- O X
promoted O X
cell O X
migration O X
. O X

###21471202	4038,50964

Bone O X
overgrowth O X
- O X
associated O X
mutations O X
in O X
the O X
LRP4 I-MISC 4038
gene O X
impair O X
sclerostin I-MISC 50964
facilitator O X
function O X
. O X

Humans O X
lacking O X
sclerostin I-MISC 50964
display O X
progressive O X
bone O X
overgrowth O X
due O X
to O X
increased O X
bone O X
formation O X
. O X

Although O X
it O X
is O X
well O X
established O X
that O X
sclerostin I-MISC 50964
is O X
an O X
osteocyte O X
- O X
secreted O X
bone O X
formation O X
inhibitor O X
, O X
the O X
underlying O X
molecular O X
mechanisms O X
are O X
not O X
fully O X
elucidated O X
. O X

We O X
identified O X
in O X
tandem O X
affinity O X
purification O X
proteomics O X
screens O X
LRP4 I-MISC 4038
( O X
low O X
density O X
lipoprotein O X
- O X
related O X
protein O X
4 O X
) O X
as O X
a O X
sclerostin I-MISC 50964
interaction O X
partner O X
. O X

Biochemical O X
assays O X
with O X
recombinant O X
proteins O X
confirmed O X
that O X
sclerostin I-MISC 50964
LRP4 B-MISC 4038
interaction O X
is O X
direct O X
. O X

Interestingly O X
, O X
in O X
vitro O X
overexpression O X
and O X
RNAi O X
- O X
mediated O X
knockdown O X
experiments O X
revealed O X
that O X
LRP4 I-MISC 4038
specifically O X
facilitates O X
the O X
previously O X
described O X
inhibitory O X
action O X
of O X
sclerostin I-MISC 50964
on O X
Wnt1 I-MISC 7471
/ O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
signaling O X
. O X

We O X
found O X
the O X
extracellular O X
b O X
- O X
propeller O X
structured O X
domain O X
of O X
LRP4 I-MISC 4038
to O X
be O X
required O X
for O X
this O X
sclerostin I-MISC 50964
facilitator O X
activity O X
. O X

Immunohistochemistry O X
demonstrated O X
that O X
LRP4 I-MISC 4038
protein O X
is O X
present O X
in O X
human O X
and O X
rodent O X
osteoblasts O X
and O X
osteocytes O X
, O X
both O X
presumed O X
target O X
cells O X
of O X
sclerostin I-MISC 50964
action O X
. O X

Silencing O X
of O X
LRP4 I-MISC 4038
by O X
lentivirus O X
- O X
mediated O X
shRNA O X
delivery O X
blocked O X
sclerostin I-MISC 50964
inhibitory O X
action O X
on O X
in O X
vitro O X
bone O X
mineralization O X
. O X

Notably O X
, O X
we O X
identified O X
two O X
mutations O X
in O X
LRP4 I-MISC 4038
( O X
R1170W O X
and O X
W1186S O X
) O X
in O X
patients O X
suffering O X
from O X
bone O X
overgrowth O X
. O X

We O X
found O X
that O X
these O X
mutations O X
impair O X
LRP4 I-MISC 4038
interaction O X
with O X
sclerostin I-MISC 50964
and O X
its O X
concomitant O X
sclerostin I-MISC 50964
facilitator O X
effect O X
. O X

Together O X
these O X
data O X
indicate O X
that O X
the O X
interaction O X
of O X
sclerostin I-MISC 50964
with O X
LRP4 I-MISC 4038
is O X
required O X
to O X
mediate O X
the O X
inhibitory O X
function O X
of O X
sclerostin I-MISC 50964
on O X
bone O X
formation O X
, O X
thus O X
identifying O X
a O X
novel O X
role O X
for O X
LRP4 I-MISC 4038
in O X
bone O X
. O X

###11278685	10413,7161

Physical O X
interaction O X
with O X
Yes I-MISC 10413
- I-MISC 10413
associated I-MISC 10413
protein I-MISC 10413
enhances O X
p73 I-MISC 7161
transcriptional O X
activity O X
. O X

Specific O X
protein O X
- O X
protein O X
interactions O X
are O X
involved O X
in O X
a O X
large O X
number O X
of O X
cellular O X
processes O X
and O X
are O X
mainly O X
mediated O X
by O X
structurally O X
and O X
functionally O X
defined O X
domains O X
. O X

Here O X
we O X
report O X
that O X
the O X
nuclear O X
phosphoprotein O X
p73 I-MISC 7161
can O X
engage O X
in O X
a O X
physical O X
association O X
with O X
the O X
Yes I-MISC 10413
- I-MISC 10413
associated I-MISC 10413
protein I-MISC 10413
( O X
YAP I-MISC 10413
). O X

This O X
association O X
occurs O X
under O X
physiological O X
conditions O X
as O X
shown O X
by O X
reciprocal O X
co O X
- O X
immunoprecipitation O X
of O X
complexes O X
from O X
lysates O X
of O X
P19 I-MISC 83430
cells O X
. O X

The O X
WW O X
domain O X
of O X
YAP I-MISC 10413
and O X
the O X
PPPPY O X
motif O X
of O X
p73 I-MISC 7161
are O X
directly O X
involved O X
in O X
the O X
association O X
. O X

Furthermore O X
, O X
as O X
required O X
for O X
ligands O X
to O X
group O X
I O X
WW O X
domains O X
, O X
the O X
terminal O X
tyrosine O X
( O X
Y O X
) O X
of O X
the O X
PPPPY O X
motif O X
of O X
p73 I-MISC 7161
was O X
shown O X
to O X
be O X
essential O X
for O X
the O X
association O X
with O X
YAP I-MISC 10413
. O X

Unlike O X
p73alpha O X
, O X
p73beta O X
, O X
and O X
p63alpha O X
, O X
which O X
bind O X
to O X
YAP I-MISC 10413
, O X
the O X
endogenous O X
as O X
well O X
as O X
exogenously O X
expressed O X
wild O X
- O X
type O X
p53 I-MISC 22060
( O X
wt O X
- O X
p53 I-MISC 22060
) O X
and O X
the O X
p73gamma O X
isoform O X
do O X
not O X
interact O X
with O X
YAP I-MISC 10413
. O X

Indeed O X
, O X
we O X
documented O X
that O X
YAP I-MISC 10413
interacts O X
only O X
with O X
those O X
members O X
of O X
the O X
p53 I-MISC 22060
family O X
that O X
have O X
a O X
well O X
conserved O X
PPXY O X
motif O X
, O X
a O X
target O X
sequence O X
for O X
WW O X
domains O X
. O X

Overexpression O X
of O X
YAP I-MISC 10413
causes O X
an O X
increase O X
of O X
p73alpha O X
transcriptional O X
activity O X
. O X

Differential O X
interaction O X
of O X
YAP I-MISC 10413
with O X
members O X
of O X
the O X
p53 I-MISC 22060
family O X
may O X
provide O X
a O X
molecular O X
explanation O X
for O X
their O X
functional O X
divergence O X
in O X
signaling O X
. O X

###16766694	820850,820850

Analysis O X
of O X
the O X
Arabidopsis O X
rsr4 I-MISC 831738
- I-MISC 831738
1 I-MISC 831738
/ I-MISC 831738
pdx1 I-MISC 831738
- I-MISC 831738
3 I-MISC 831738
mutant O X
reveals O X
the O X
critical O X
function O X
of O X
the O X
PDX1 I-MISC 820850
protein O X
family O X
in O X
metabolism O X
, O X
development O X
, O X
and O X
vitamin O X
B6 O X
biosynthesis O X
. O X

Vitamin O X
B6 O X
represents O X
a O X
highly O X
important O X
group O X
of O X
compounds O X
ubiquitous O X
in O X
all O X
living O X
organisms O X
. O X

It O X
has O X
been O X
demonstrated O X
to O X
alleviate O X
oxidative O X
stress O X
and O X
in O X
its O X
phosphorylated O X
form O X
participates O X
as O X
a O X
cofactor O X
in O X
> O X
100 O X
biochemical O X
reactions O X
. O X

By O X
means O X
of O X
a O X
genetic O X
approach O X
, O X
we O X
have O X
identified O X
a O X
novel O X
mutant O X
, O X
rsr4 O X
- O X
1 O X
( O X
for O X
reduced O X
sugar O X
response O X
), O X
with O X
aberrant O X
root O X
and O X
leaf O X
growth O X
that O X
requires O X
supplementation O X
of O X
vitamin O X
B6 O X
for O X
normal O X
development O X
. O X

Cloning O X
of O X
the O X
mutated O X
gene O X
revealed O X
that O X
rsr4 O X
- O X
1 O X
carries O X
a O X
point O X
mutation O X
in O X
a O X
member O X
of O X
the O X
PDX1 I-MISC 820850
/ O X
SOR1 O X
/ O X
SNZ I-MISC 818510
( O X
for O X
Pyridoxine I-MISC 820850
biosynthesis I-MISC 820850
protein I-MISC 820850
1 I-MISC 820850
/ O X
Singlet O X
oxygen O X
resistant O X
1 O X
/ O X
Snooze O X
) O X
family O X
that O X
leads O X
to O X
reduced O X
vitamin O X
B6 O X
content O X
. O X

Consequently O X
, O X
metabolism O X
is O X
broadly O X
altered O X
, O X
mainly O X
affecting O X
amino O X
acid O X
, O X
raffinose O X
, O X
and O X
shikimate O X
contents O X
and O X
trichloroacetic O X
acid O X
cycle O X
constituents O X
. O X

Yeast O X
two O X
- O X
hybrid O X
and O X
pull O X
- O X
down O X
analyses O X
showed O X
that O X
Arabidopsis O X
thaliana O X
PDX1 I-MISC 820850
proteins O X
can O X
form O X
oligomers O X
. O X

Interestingly O X
, O X
the O X
mutant O X
form O X
of O X
PDX1 I-MISC 820850
has O X
severely O X
reduced O X
capability O X
to O X
oligomerize O X
, O X
potentially O X
suggesting O X
that O X
oligomerization O X
is O X
important O X
for O X
function O X
. O X

In O X
summary O X
, O X
our O X
results O X
demonstrate O X
the O X
critical O X
function O X
of O X
the O X
PDX1 I-MISC 820850
protein O X
family O X
for O X
metabolism O X
, O X
whole O X
- O X
plant O X
development O X
, O X
and O X
vitamin O X
B6 O X
biosynthesis O X
in O X
higher O X
plants O X
. O X

###20802522	4602,7341

A O X
functional O X
SUMO I-MISC 7341
- O X
interacting O X
motif O X
in O X
the O X
transactivation O X
domain O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
regulates O X
its O X
myeloid O X
transforming O X
ability O X
. O X

c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
is O X
an O X
essential O X
hematopoietic O X
transcription O X
factor O X
that O X
controls O X
proliferation O X
and O X
differentiation O X
of O X
progenitors O X
during O X
blood O X
cell O X
development O X
. O X

Whereas O X
sumoylation O X
of O X
the O X
C O X
- O X
terminal O X
regulatory O X
domain O X
( O X
CRD O X
) O X
is O X
known O X
to O X
have O X
a O X
major O X
impact O X
on O X
the O X
activity O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
, O X
no O X
role O X
for O X
noncovalent O X
binding O X
of O X
small O X
ubiquitin O X
- O X
like O X
modifier O X
( O X
SUMO I-MISC 7341
) O X
to O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
has O X
been O X
described O X
. O X

Based O X
on O X
the O X
consensus O X
SUMO I-MISC 7341
- O X
interacting O X
motif O X
( O X
SIM O X
), O X
we O X
identified O X
and O X
examined O X
putative O X
SIMs O X
in O X
human O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
. O X

Interaction O X
and O X
reporter O X
assays O X
showed O X
that O X
the O X
SIM O X
in O X
the O X
in O X
the O X
transactivation O X
domain O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
( O X
V O X
( O X
267 O X
) O X
NIV O X
) O X
is O X
functional O X
. O X

This O X
motif O X
is O X
necessary O X
for O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
to O X
be O X
able O X
to O X
interact O X
noncovalently O X
with O X
SUMO I-MISC 7341
, O X
preferentially O X
SUMO2 I-MISC 6613
/ I-MISC 6613
3 I-MISC 6613
. O X

Destroying O X
the O X
SUMO I-MISC 7341
- O X
binding O X
properties O X
by O X
mutation O X
resulted O X
in O X
a O X
large O X
increase O X
in O X
the O X
transactivation O X
potential O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
. O X

Mutational O X
analysis O X
and O X
overexpression O X
of O X
conjugation O X
- O X
defective O X
SUMO I-MISC 7341
argued O X
against O X
intramolecular O X
repression O X
caused O X
by O X
sumoylated O X
CRD O X
and O X
in O X
favor O X
of O X
SUMO I-MISC 7341
- O X
dependent O X
repression O X
in O X
trans O X
. O X

Using O X
both O X
a O X
myeloid O X
cell O X
line O X
- O X
based O X
assay O X
and O X
a O X
primary O X
hematopoietic O X
cell O X
assay O X
, O X
we O X
addressed O X
the O X
transforming O X
abilities O X
of O X
SUMO I-MISC 7341
binding O X
and O X
conjugation O X
mutants O X
. O X

Interestingly O X
, O X
only O X
loss O X
of O X
SUMO I-MISC 7341
binding O X
, O X
and O X
not O X
SUMO I-MISC 7341
conjugation O X
, O X
enhanced O X
the O X
myeloid O X
transformational O X
potential O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
. O X

c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
with O X
the O X
SIM O X
mutated O X
conferred O X
a O X
higher O X
proliferative O X
ability O X
than O X
the O X
wild O X
- O X
type O X
and O X
caused O X
an O X
effective O X
differentiation O X
block O X
. O X

This O X
establishes O X
SUMO I-MISC 7341
binding O X
as O X
a O X
mechanism O X
involved O X
in O X
modulating O X
the O X
transactivation O X
activity O X
of O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
, O X
and O X
responsible O X
for O X
keeping O X
the O X
transforming O X
potential O X
of O X
the O X
oncoprotein O X
in O X
check O X
. O X

###21292163	55149,55149

Structural O X
basis O X
for O X
dimerization O X
and O X
activity O X
of O X
human O X
PAPD1 I-MISC 55149
, O X
a O X
noncanonical O X
poly O X
( O X
A O X
) O X
polymerase O X
. O X

Poly O X
( O X
A O X
) O X
polymerases O X
( O X
PAPs O X
) O X
are O X
found O X
in O X
most O X
living O X
organisms O X
and O X
have O X
important O X
roles O X
in O X
RNA O X
function O X
and O X
metabolism O X
. O X

Here O X
, O X
we O X
report O X
the O X
crystal O X
structure O X
of O X
human O X
PAPD1 I-MISC 55149
, O X
a O X
noncanonical O X
PAP O X
that O X
can O X
polyadenylate O X
RNAs O X
in O X
the O X
mitochondria O X
( O X
also O X
known O X
as O X
mtPAP I-MISC 55149
) O X
and O X
oligouridylate O X
histone O X
mRNAs O X
( O X
TUTase1 I-MISC 55149
). O X

The O X
overall O X
structure O X
of O X
the O X
palm O X
and O X
fingers O X
domains O X
is O X
similar O X
to O X
that O X
in O X
the O X
canonical O X
PAPs O X
. O X

The O X
active O X
site O X
is O X
located O X
at O X
the O X
interface O X
between O X
the O X
two O X
domains O X
, O X
with O X
a O X
large O X
pocket O X
that O X
can O X
accommodate O X
the O X
substrates O X
. O X

The O X
structure O X
reveals O X
the O X
presence O X
of O X
a O X
previously O X
unrecognized O X
domain O X
in O X
the O X
N O X
- O X
terminal O X
region O X
of O X
PAPD1 I-MISC 55149
, O X
with O X
a O X
backbone O X
fold O X
that O X
is O X
similar O X
to O X
that O X
of O X
RNP O X
- O X
type O X
RNA O X
binding O X
domains O X
. O X

This O X
domain O X
( O X
named O X
the O X
RL O X
domain O X
), O X
together O X
with O X
a O X
b O X
- O X
arm O X
insertion O X
in O X
the O X
palm O X
domain O X
, O X
contributes O X
to O X
dimerization O X
of O X
PAPD1 I-MISC 55149
. O X

Surprisingly O X
, O X
our O X
mutagenesis O X
and O X
biochemical O X
studies O X
show O X
that O X
dimerization O X
is O X
required O X
for O X
the O X
catalytic O X
activity O X
of O X
PAPD1 I-MISC 55149
. O X

###12819209	5618,7534

Threonine O X
391 O X
phosphorylation O X
of O X
the O X
human O X
prolactin I-MISC 5618
receptor I-MISC 5618
mediates O X
a O X
novel O X
interaction O X
with O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
proteins I-MISC 7534
. O X

The O X
prolactin I-MISC 5618
receptor I-MISC 5618
( O X
PrlR I-MISC 5618
) O X
is O X
a O X
member O X
of O X
the O X
cytokine O X
receptor O X
superfamily O X
that O X
lacks O X
an O X
intrinsic O X
kinase O X
domain O X
and O X
relies O X
on O X
the O X
cytoplasmic O X
Jak O X
tyrosine O X
kinases O X
to O X
transduce O X
signals O X
. O X

Prolactin O X
- O X
induced O X
Jak2 I-MISC 3717
activation O X
and O X
consequent O X
tyrosine O X
phosphorylation O X
of O X
the O X
receptor O X
and O X
downstream O X
signaling O X
molecules O X
have O X
been O X
studied O X
, O X
but O X
phosphorylation O X
of O X
the O X
PrlR I-MISC 5618
on O X
serine O X
or O X
threonine O X
residues O X
has O X
not O X
been O X
reported O X
. O X

Here O X
we O X
describe O X
a O X
novel O X
interaction O X
between O X
the O X
PrlR I-MISC 5618
and O X
the O X
phosphoserine O X
/ O X
phosphothreonine O X
- O X
binding O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
proteins I-MISC 7534
. O X

This O X
association O X
is O X
mediated O X
by O X
the O X
KCST391WP O X
motif O X
, O X
which O X
occurs O X
in O X
the O X
major O X
functional O X
isoform O X
of O X
the O X
human O X
receptor O X
and O X
is O X
conserved O X
among O X
a O X
wide O X
variety O X
of O X
species O X
. O X

Mutagenesis O X
of O X
threonine O X
391 O X
to O X
alanine O X
significantly O X
impaired O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
binding O X
to O X
the O X
PrlR I-MISC 5618
in O X
both O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
pulldown O X
and O X
coimmunoprecipitation O X
assays O X
. O X

In O X
breast O X
carcinoma O X
and O X
mouse O X
mammary O X
epithelial O X
cell O X
lines O X
, O X
the O X
endogenous O X
receptor O X
was O X
found O X
to O X
associate O X
with O X
glutathione I-MISC 54486
S I-MISC 54486
- I-MISC 54486
transferase I-MISC 54486
- O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
proteins I-MISC 7534
independent O X
of O X
prolactin O X
stimulation O X
. O X

A O X
phospho O X
- O X
specific O X
peptide O X
antibody O X
was O X
generated O X
and O X
used O X
to O X
demonstrate O X
phosphorylation O X
of O X
Thr391 O X
in O X
vivo O X
. O X

Phosphorylation O X
of O X
this O X
site O X
was O X
found O X
to O X
be O X
sensitive O X
to O X
okadaic O X
acid O X
, O X
a O X
specific O X
inhibitor O X
of O X
serine O X
/ O X
threonine O X
protein O X
phosphatases O X
. O X

Interestingly O X
, O X
the O X
T391A O X
PrlR I-MISC 5618
mutant O X
exhibited O X
increased O X
basal O X
and O X
prolactin O X
- O X
induced O X
tyrosine O X
phosphorylation O X
compared O X
with O X
the O X
wild O X
- O X
type O X
receptor O X
. O X

This O X
was O X
accompanied O X
by O X
a O X
ligand O X
- O X
induced O X
increase O X
in O X
protein O X
kinase O X
B O X
and O X
Erk I-MISC 2048
activation O X
but O X
not O X
that O X
of O X
Stat5a I-MISC 6776
. O X

Phosphorylation O X
of O X
the O X
receptor O X
on O X
Thr391 O X
may O X
therefore O X
provide O X
a O X
new O X
mechanism O X
by O X
which O X
prolactin O X
signaling O X
is O X
attenuated O X
. O X

###12612071	5308,5308

Dominant O X
negative O X
dimerization O X
of O X
a O X
mutant O X
homeodomain O X
protein O X
in O X
Axenfeld O X
- O X
Rieger O X
syndrome O X
. O X

Axenfeld O X
- O X
Rieger O X
syndrome O X
is O X
an O X
autosomal O X
- O X
dominant O X
disorder O X
caused O X
by O X
mutations O X
in O X
the O X
PITX2 I-MISC 5308
homeodomain O X
protein O X
. O X

We O X
have O X
studied O X
the O X
mechanism O X
underlying O X
the O X
dominant O X
negative O X
K88E O X
mutation O X
, O X
which O X
occurs O X
at O X
position O X
50 O X
of O X
the O X
homeodomain O X
. O X

By O X
using O X
yeast O X
two O X
- O X
hybrid O X
and O X
in O X
vitro O X
pulldown O X
assays O X
, O X
we O X
have O X
documented O X
that O X
PITX2a O X
can O X
form O X
homodimers O X
in O X
the O X
absence O X
of O X
DNA O X
. O X

Moreover O X
, O X
the O X
K88E O X
mutant O X
had O X
even O X
stronger O X
dimerization O X
ability O X
, O X
primarily O X
due O X
to O X
interactions O X
involving O X
the O X
C O X
- O X
terminal O X
region O X
. O X

Dimerization O X
allowed O X
cooperative O X
binding O X
of O X
wild O X
- O X
type O X
( O X
WT O X
) O X
PITX2a O X
to O X
DNA O X
containing O X
tandem O X
bicoid O X
sites O X
in O X
a O X
head O X
- O X
to O X
- O X
tail O X
orientation O X
( O X
Hill O X
coefficient O X
, O X
1 O X
. O X
73 O X
). O X

In O X
contrast O X
, O X
the O X
WT O X
- O X
K88E O X
heterodimer O X
bound O X
the O X
tandem O X
sites O X
with O X
greatly O X
reduced O X
cooperativity O X
and O X
decreased O X
transactivation O X
activity O X
. O X

To O X
further O X
explore O X
the O X
role O X
of O X
position O X
50 O X
in O X
PITX2a O X
dimerization O X
, O X
we O X
introduced O X
a O X
charge O X
- O X
conservative O X
mutation O X
of O X
lysine O X
to O X
arginine O X
( O X
K88R O X
). O X

The O X
K88R O X
protein O X
had O X
greatly O X
reduced O X
binding O X
to O X
a O X
TAATCC O X
element O X
and O X
did O X
not O X
specifically O X
bind O X
any O X
other O X
TAATNN O X
motif O X
. O X

Like O X
K88E O X
, O X
K88R O X
formed O X
relatively O X
stronger O X
dimers O X
with O X
WT O X
. O X

As O X
predicted O X
by O X
our O X
model O X
, O X
the O X
K88R O X
protein O X
acted O X
in O X
a O X
dominant O X
negative O X
manner O X
to O X
suppress O X
WT O X
PITX2a O X
activity O X
. O X

These O X
results O X
suggest O X
that O X
the O X
position O X
50 O X
residue O X
in O X
the O X
PITX2 I-MISC 5308
homeodomain O X
plays O X
an O X
important O X
role O X
in O X
both O X
DNA O X
binding O X
and O X
dimerization O X
activities O X
. O X

###16478480	801,3756

Inhibition O X
of O X
human O X
ether O X
go O X
- O X
go O X
potassium O X
channels O X
by O X
Ca2 O X
+/ O X
calmodulin I-MISC 801
binding O X
to O X
the O X
cytosolic O X
N O X
- O X
and O X
C O X
- O X
termini O X
. O X

Human O X
ether O X
go O X
- O X
go O X
potassium O X
channels O X
( O X
hEAG1 I-MISC 3756
) O X
open O X
in O X
response O X
to O X
membrane O X
depolarization O X
and O X
they O X
are O X
inhibited O X
by O X
Ca2 O X
+/ O X
calmodulin I-MISC 801
( O X
CaM I-MISC 801
), O X
presumably O X
binding O X
to O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
the O X
channel O X
subunits O X
. O X

Deletion O X
of O X
the O X
cytosolic O X
N O X
- O X
terminal O X
domain O X
resulted O X
in O X
complete O X
abolition O X
of O X
Ca2 O X
+/ O X
CaM I-MISC 801
sensitivity O X
suggesting O X
the O X
existence O X
of O X
further O X
CaM I-MISC 801
binding O X
sites O X
. O X

A O X
peptide O X
array O X
- O X
based O X
screen O X
of O X
the O X
entire O X
cytosolic O X
protein O X
of O X
hEAG1 I-MISC 3756
identified O X
three O X
putative O X
CaM I-MISC 801
- O X
binding O X
domains O X
, O X
two O X
in O X
the O X
C O X
- O X
terminus O X
( O X
BD O X
- O X
C1 O X
: O X
674 O X
- O X
683 O X
, O X
BD O X
- O X
C2 O X
: O X
711 O X
- O X
721 O X
) O X
and O X
one O X
in O X
the O X
N O X
- O X
terminus O X
( O X
BD O X
- O X
N O X
: O X
151 O X
- O X
165 O X
). O X

Binding O X
of O X
GST O X
- O X
fusion O X
proteins O X
to O X
Ca2 O X
+/ O X
CaM I-MISC 801
was O X
assayed O X
with O X
fluorescence O X
correlation O X
spectroscopy O X
, O X
surface O X
plasmon O X
resonance O X
spectroscopy O X
and O X
precipitation O X
assays O X
. O X

In O X
the O X
presence O X
of O X
Ca2 O X
+, O X
BD O X
- O X
N O X
and O X
BD O X
- O X
C2 O X
provided O X
dissociation O X
constants O X
in O X
the O X
nanomolar O X
range O X
, O X
BD O X
- O X
C1 O X
bound O X
with O X
lower O X
affinity O X
. O X

Mutations O X
in O X
the O X
binding O X
domains O X
reduced O X
inhibition O X
of O X
the O X
functional O X
channels O X
by O X
Ca2 O X
+/ O X
CaM I-MISC 801
. O X

Employment O X
of O X
CaM I-MISC 801
- O X
EF O X
- O X
hand O X
mutants O X
showed O X
that O X
CaM I-MISC 801
binding O X
to O X
the O X
N O X
- O X
and O X
C O X
- O X
terminus O X
are O X
primarily O X
dependent O X
on O X
EF O X
- O X
hand O X
motifs O X
3 O X
and O X
4 O X
. O X

Hence O X
, O X
closure O X
of O X
EAG O X
channels O X
presumably O X
requires O X
the O X
binding O X
of O X
multiple O X
CaM I-MISC 801
molecules O X
in O X
a O X
manner O X
more O X
complex O X
than O X
previously O X
assumed O X
. O X

###10512882	396442,396416

Complex O X
formation O X
with O X
focal I-MISC 396416
adhesion I-MISC 396416
kinase I-MISC 396416
: O X
A O X
mechanism O X
to O X
regulate O X
activity O X
and O X
subcellular O X
localization O X
of O X
Src I-MISC 396442
kinases O X
. O X

Tyrosine O X
phosphorylation O X
of O X
focal I-MISC 396416
adhesion I-MISC 396416
kinase I-MISC 396416
( O X
FAK I-MISC 396416
) O X
creates O X
a O X
high O X
- O X
affinity O X
binding O X
site O X
for O X
the O X
src I-MISC 396442
homology O X
2 O X
domain O X
of O X
the O X
Src I-MISC 396442
family O X
of O X
tyrosine O X
kinases O X
. O X

Assembly O X
of O X
a O X
complex O X
between O X
FAK I-MISC 396416
and O X
Src I-MISC 396442
kinases O X
may O X
serve O X
to O X
regulate O X
the O X
subcellular O X
localization O X
and O X
the O X
enzymatic O X
activity O X
of O X
members O X
of O X
the O X
Src I-MISC 396442
family O X
of O X
kinases O X
. O X

We O X
show O X
that O X
simultaneous O X
overexpression O X
of O X
FAK I-MISC 396416
and O X
pp60 O X
( O X
c I-MISC 396442
- I-MISC 396442
src I-MISC 396442
) O X
or O X
p59 I-MISC 352990
( O X
fyn O X
) O X
results O X
in O X
the O X
enhancement O X
of O X
the O X
tyrosine O X
phosphorylation O X
of O X
a O X
limited O X
number O X
of O X
cellular O X
substrates O X
, O X
including O X
paxillin O X
. O X

Under O X
these O X
conditions O X
, O X
tyrosine O X
phosphorylation O X
of O X
paxillin O X
is O X
largely O X
cell O X
adhesion O X
dependent O X
. O X

FAK I-MISC 396416
mutants O X
defective O X
for O X
Src I-MISC 396442
binding O X
or O X
focal O X
adhesion O X
targeting O X
fail O X
to O X
cooperate O X
with O X
pp60 O X
( O X
c I-MISC 396442
- I-MISC 396442
src I-MISC 396442
) O X
or O X
p59 I-MISC 352990
( O X
fyn O X
) O X
to O X
induce O X
paxillin O X
phosphorylation O X
, O X
whereas O X
catalytically O X
defective O X
FAK I-MISC 396416
mutants O X
can O X
direct O X
paxillin O X
phosphorylation O X
. O X

The O X
negative O X
regulatory O X
site O X
of O X
pp60 O X
( O X
c I-MISC 396442
- I-MISC 396442
src I-MISC 396442
) O X
is O X
hypophosphorylated O X
when O X
in O X
complex O X
with O X
FAK I-MISC 396416
, O X
and O X
coexpression O X
with O X
FAK I-MISC 396416
leads O X
to O X
a O X
redistribution O X
of O X
pp60 O X
( O X
c I-MISC 396442
- I-MISC 396442
src I-MISC 396442
) O X
from O X
a O X
diffuse O X
cellular O X
location O X
to O X
focal O X
adhesions O X
. O X

A O X
FAK I-MISC 396416
mutant O X
defective O X
for O X
Src I-MISC 396442
binding O X
does O X
not O X
effectively O X
induce O X
the O X
translocation O X
of O X
pp60 O X
( O X
c I-MISC 396442
- I-MISC 396442
src I-MISC 396442
) O X
to O X
focal O X
adhesions O X
. O X

These O X
results O X
suggest O X
that O X
association O X
with O X
FAK I-MISC 396416
can O X
alter O X
the O X
localization O X
of O X
Src I-MISC 396442
kinases O X
and O X
that O X
FAK I-MISC 396416
functions O X
to O X
direct O X
phosphorylation O X
of O X
cellular O X
substrates O X
by O X
recruitment O X
of O X
Src I-MISC 396442
kinases O X
. O X

###22892567	58942,21770

Cacnb4 I-MISC 58942
directly O X
couples O X
electrical O X
activity O X
to O X
gene O X
expression O X
, O X
a O X
process O X
defective O X
in O X
juvenile O X
epilepsy O X
. O X

Calcium O X
current O X
through O X
voltage O X
- O X
gated O X
calcium O X
channels O X
( O X
VGCC O X
) O X
controls O X
gene O X
expression O X
. O X

Here O X
, O X
we O X
describe O X
a O X
novel O X
signalling O X
pathway O X
in O X
which O X
the O X
VGCC O X
Cacnb4 I-MISC 58942
subunit O X
directly O X
couples O X
neuronal O X
excitability O X
to O X
transcription O X
. O X

Electrical O X
activity O X
induces O X
Cacnb4 I-MISC 58942
association O X
to O X
Ppp2r5d I-MISC 21770
, O X
a O X
regulatory O X
subunit O X
of O X
PP2A I-MISC 5524
phosphatase O X
, O X
followed O X
by O X
( O X
i O X
) O X
nuclear O X
translocation O X
of O X
Cacnb4 I-MISC 58942
/ O X
Ppp2r5d I-MISC 21770
/ O X
PP2A I-MISC 5524
, O X
( O X
ii O X
) O X
association O X
with O X
the O X
tyrosine I-MISC 7054
hydroxylase I-MISC 7054
( O X
TH I-MISC 7054
) O X
gene O X
promoter O X
through O X
the O X
nuclear O X
transcription O X
factor O X
thyroid I-MISC 7067
hormone I-MISC 7067
receptor I-MISC 7067
alpha I-MISC 7067
( O X
TRa I-MISC 6955
), O X
and O X
( O X
iii O X
) O X
histone O X
binding O X
through O X
association O X
of O X
Cacnb4 I-MISC 58942
with O X
HP1y O X
concomitantly O X
with O X
Ser I-MISC 3190220
( I-MISC 3190220
10 I-MISC 3190220
) O X
histone O X
H3 O X
dephosphorylation O X
by O X
PP2A I-MISC 5524
. O X

This O X
signalling O X
cascade O X
leads O X
to O X
TH I-MISC 7054
gene O X
repression O X
by O X
Cacnb4 I-MISC 58942
and O X
is O X
controlled O X
by O X
the O X
state O X
of O X
interaction O X
between O X
the O X
SH3 O X
and O X
guanylate I-MISC 2987
kinase I-MISC 2987
( O X
GK I-MISC 2987
) O X
modules O X
of O X
Cacnb4 I-MISC 58942
. O X

The O X
human O X
R482X O X
CACNB4 I-MISC 58942
mutation O X
, O X
responsible O X
for O X
a O X
form O X
of O X
juvenile O X
myoclonic O X
epilepsy O X
, O X
prevents O X
association O X
with O X
Ppp2r5 O X
and O X
nuclear O X
targeting O X
of O X
the O X
complex O X
by O X
altering O X
Cacnb4 I-MISC 58942
conformation O X
. O X

These O X
findings O X
demonstrate O X
that O X
an O X
intact O X
VGCC O X
subunit O X
acts O X
as O X
a O X
repressor O X
recruiting O X
platform O X
to O X
control O X
neuronal O X
gene O X
expression O X
. O X

###25143260	1728,1728

Collapse O X
of O X
the O X
native O X
structure O X
caused O X
by O X
a O X
single O X
amino O X
acid O X
exchange O X
in O X
human O X
NAD I-MISC 1728
( I-MISC 1728
P I-MISC 1728
) I-MISC 1728
H I-MISC 1728
: I-MISC 1728
quinone I-MISC 1728
oxidoreductase I-MISC 1728
( I-MISC 1728
1 I-MISC 1728
.). O X

Human O X
NAD I-MISC 1728
( I-MISC 1728
P I-MISC 1728
) I-MISC 1728
H I-MISC 1728
: I-MISC 1728
quinone I-MISC 1728
oxidoreductase I-MISC 1728
1 I-MISC 1728
( O X
NQO1 I-MISC 1728
) O X
is O X
essential O X
for O X
the O X
antioxidant O X
defense O X
system O X
, O X
stabilization O X
of O X
tumor O X
suppressors O X
( O X
e O X
. O X
g O X
. O X

p53 I-MISC 7157
, O X
p33 I-MISC 3621
, O X
and O X
p73 I-MISC 7161
), O X
and O X
activation O X
of O X
quinone O X
- O X
based O X
chemotherapeutics O X
. O X

Overexpression O X
of O X
NQO1 I-MISC 1728
in O X
many O X
solid O X
tumors O X
, O X
coupled O X
with O X
its O X
ability O X
to O X
convert O X
quinone O X
- O X
based O X
chemotherapeutics O X
into O X
potent O X
cytotoxic O X
compounds O X
, O X
have O X
made O X
it O X
a O X
very O X
attractive O X
target O X
for O X
anticancer O X
drugs O X
. O X

A O X
naturally O X
occurring O X
single O X
- O X
nucleotide O X
polymorphism O X
( O X
C609T O X
) O X
leading O X
to O X
an O X
amino O X
acid O X
exchange O X
( O X
P187S O X
) O X
has O X
been O X
implicated O X
in O X
the O X
development O X
of O X
various O X
cancers O X
and O X
poor O X
survival O X
rates O X
following O X
anthracyclin O X
- O X
based O X
adjuvant O X
chemotherapy O X
. O X

Despite O X
its O X
importance O X
for O X
cancer O X
prediction O X
and O X
therapy O X
, O X
the O X
exact O X
molecular O X
basis O X
for O X
the O X
loss O X
of O X
function O X
in O X
NQO1 I-MISC 1728
P187S O X
is O X
currently O X
unknown O X
. O X

Therefore O X
, O X
we O X
solved O X
the O X
crystal O X
structure O X
of O X
NQO1 I-MISC 1728
P187S O X
. O X

Surprisingly O X
, O X
this O X
structure O X
is O X
almost O X
identical O X
to O X
NQO1 I-MISC 1728
. O X

Employing O X
a O X
combination O X
of O X
NMR O X
spectroscopy O X
and O X
limited O X
proteolysis O X
experiments O X
, O X
we O X
demonstrated O X
that O X
the O X
single O X
amino O X
acid O X
exchange O X
destabilized O X
interactions O X
between O X
the O X
core O X
and O X
C O X
- O X
terminus O X
, O X
leading O X
to O X
depopulation O X
of O X
the O X
native O X
structure O X
in O X
solution O X
. O X

This O X
collapse O X
of O X
the O X
native O X
structure O X
diminished O X
cofactor O X
affinity O X
and O X
led O X
to O X
a O X
less O X
competent O X
FAD O X
- O X
binding O X
pocket O X
, O X
thus O X
severely O X
compromising O X
the O X
catalytic O X
capacity O X
of O X
the O X
variant O X
protein O X
. O X

Hence O X
, O X
our O X
findings O X
provide O X
a O X
rationale O X
for O X
the O X
loss O X
of O X
function O X
in O X
NQO1 I-MISC 1728
P187S O X
with O X
a O X
frequently O X
occurring O X
single O X
- O X
nucleotide O X
polymorphism O X
. O X

DATABASE O X
: O X
Structural O X
data O X
are O X
available O X
in O X
the O X
Protein O X
Data O X
Bank O X
under O X
the O X
accession O X
numbers O X
4cet O X
( O X
P187S O X
variant O X
with O X
dicoumarol O X
) O X
and O X
4cf6 O X
( O X
P187S O X
variant O X
with O X
Cibacron O X
blue O X
). O X

STRUCTURED O X
DIGITAL O X
ABSTRACT O X
: O X
NQO1 I-MISC 1728
P187S O X
and O X
NQO1 I-MISC 1728
P187S O X
bind O X
by O X
nuclear O X
magnetic O X
resonance O X
( O X
View O X
interaction O X
) O X
NQO1 I-MISC 1728
P187S O X
and O X
NQO1 I-MISC 1728
P187S O X
bind O X
by O X
x O X
- O X
ray O X
crystallography O X
( O X
1 O X
, O X
2 O X
) O X
NQO1 I-MISC 1728
and O X
NQO1 I-MISC 1728
bind O X
by O X
molecular O X
sieving O X
( O X
1 O X
, O X
2 O X
). O X

###19185023	548626,374143

PPTX I-MISC 548626
, O X
a O X
pentraxin O X
domain O X
- O X
containing O X
protein O X
, O X
interacts O X
with O X
the O X
T1 O X
domain O X
of O X
K O X
v O X
4 O X
. O X

Voltage O X
- O X
gated O X
K O X
(+) O X
( O X
K O X
( O X
v O X
)) O X
channels O X
reside O X
as O X
tetramers O X
in O X
the O X
membrane O X
. O X

The O X
events O X
that O X
coordinate O X
folding O X
, O X
trafficking O X
, O X
and O X
tetramerization O X
are O X
mediated O X
by O X
an O X
array O X
of O X
associated O X
proteins O X
and O X
phospholipids O X
whose O X
identification O X
is O X
vital O X
to O X
understanding O X
the O X
dynamic O X
nature O X
of O X
channel O X
expression O X
and O X
activity O X
. O X

An O X
interaction O X
between O X
an O X
A O X
- O X
type O X
K O X
(+) O X
channel O X
, O X
K I-MISC 374143
( I-MISC 374143
v I-MISC 374143
) I-MISC 374143
4 I-MISC 374143
. I-MISC 374143
2 I-MISC 374143
, O X
and O X
a O X
protein O X
containing O X
a O X
pentraxin O X
domain O X
( O X
PPTX I-MISC 548626
) O X
was O X
demonstrated O X
in O X
the O X
cochlea O X
( O X
Duzhyy O X
et O X
al O X
. O X

[ O X
2005 O X
] O X
J O X
. O X
Biol O X
. O X

Chem O X
. O X

280 O X
: O X
15165 O X
- O X
15172 O X
). O X

Here O X
, O X
we O X
present O X
results O X
based O X
on O X
fold O X
recognition O X
and O X
homology O X
modeling O X
that O X
revealed O X
the O X
tetramerization O X
( O X
T1 O X
) O X
domain O X
of O X
K I-MISC 374143
( I-MISC 374143
v I-MISC 374143
) I-MISC 374143
4 I-MISC 374143
. I-MISC 374143
2 I-MISC 374143
as O X
a O X
potential O X
docking O X
site O X
for O X
interacting O X
proteins O X
such O X
as O X
PPTX I-MISC 548626
. O X

By O X
using O X
this O X
model O X
, O X
putative O X
sites O X
were O X
experimentally O X
tested O X
with O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
to O X
assay O X
interactions O X
between O X
PPTX I-MISC 548626
and O X
the O X
T1 O X
domain O X
of O X
K I-MISC 374143
( I-MISC 374143
v I-MISC 374143
) I-MISC 374143
4 I-MISC 374143
. I-MISC 374143
2 I-MISC 374143
wild O X
type O X
( O X
wt O X
) O X
and O X
mutants O X
( O X
mut O X
). O X

Results O X
showed O X
that O X
amino O X
acid O X
residues O X
86 O X
and O X
118 O X
in O X
the O X
T1 O X
domain O X
are O X
essential O X
for O X
interaction O X
, O X
because O X
replacing O X
these O X
negatively O X
charged O X
with O X
neutrally O X
charged O X
amino O X
acids O X
inhibits O X
interactions O X
. O X

Cotransfections O X
of O X
Chinese O X
hamster O X
ovary O X
cells O X
with O X
PPTX I-MISC 548626
and O X
K O X
( O X
v O X
) O X
4 O X
. O X
2wt O X
further O X
revealed O X
that O X
PPTX I-MISC 548626
increases O X
K I-MISC 374143
( I-MISC 374143
v I-MISC 374143
) I-MISC 374143
4 I-MISC 374143
. I-MISC 374143
2 I-MISC 374143
wt O X
expression O X
in O X
vitro O X
when O X
analyzing O X
total O X
lysates O X
, O X
whereas O X
interactions O X
with O X
K I-MISC 374143
( I-MISC 374143
v I-MISC 374143
) I-MISC 374143
4 I-MISC 374143
. I-MISC 374143
2 I-MISC 374143
microt O X
resulted O X
in O X
a O X
decrease O X
. O X

These O X
studies O X
suggest O X
that O X
portions O X
of O X
the O X
T1 O X
domain O X
can O X
act O X
as O X
docking O X
sites O X
for O X
proteins O X
such O X
as O X
PPTX I-MISC 548626
, O X
further O X
underscoring O X
the O X
significance O X
of O X
this O X
domain O X
. O X

###15709751	105835,24392

Novel O X
rab O X
GAP O X
- O X
like O X
protein O X
, O X
CIP85 I-MISC 27352
, O X
interacts O X
with O X
connexin43 I-MISC 24392
and O X
induces O X
its O X
degradation O X
. O X

Gap O X
junctions O X
play O X
critical O X
roles O X
in O X
tissue O X
function O X
and O X
homeostasis O X
. O X

Connexin43 I-MISC 24392
( O X
Cx43 I-MISC 24392
) O X
is O X
a O X
major O X
gap O X
junction O X
protein O X
expressed O X
in O X
the O X
mammalian O X
heart O X
and O X
other O X
tissues O X
and O X
may O X
be O X
regulated O X
by O X
its O X
interaction O X
with O X
other O X
cellular O X
proteins O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
we O X
identified O X
a O X
novel O X
Cx43 I-MISC 24392
- O X
interacting O X
protein O X
of O X
85 O X
- O X
kDa O X
, O X
CIP85 I-MISC 27352
, O X
which O X
contains O X
a O X
single O X
TBC O X
, O X
SH3 O X
, O X
and O X
RUN O X
domain O X
, O X
in O X
addition O X
to O X
a O X
short O X
coiled O X
coil O X
region O X
. O X

Homologues O X
containing O X
this O X
unique O X
combination O X
of O X
domains O X
were O X
found O X
in O X
human O X
, O X
D O X
. O X
melanogaster O X
, O X
and O X
C O X
. O X
elegans O X
. O X

CIP85 I-MISC 105835
mRNA O X
is O X
expressed O X
ubiquitously O X
in O X
mouse O X
and O X
human O X
tissues O X
. O X

In O X
vitro O X
interaction O X
assays O X
and O X
in O X
vivo O X
co O X
- O X
immunoprecipitation O X
experiments O X
confirmed O X
the O X
interaction O X
of O X
endogenous O X
CIP85 I-MISC 27352
with O X
Cx43 I-MISC 24392
. O X

In O X
vitro O X
interaction O X
experiments O X
using O X
CIP85 I-MISC 27352
mutants O X
with O X
in O X
- O X
frame O X
deletions O X
of O X
the O X
TBC O X
, O X
SH3 O X
, O X
and O X
RUN O X
domains O X
indicated O X
that O X
the O X
SH3 O X
domain O X
of O X
CIP85 I-MISC 27352
is O X
involved O X
in O X
its O X
interaction O X
with O X
Cx43 I-MISC 24392
. O X

Conversely O X
, O X
analysis O X
of O X
Cx43 I-MISC 24392
mutants O X
with O X
proline O X
to O X
alanine O X
substitutions O X
in O X
the O X
two O X
proline O X
- O X
rich O X
regions O X
of O X
Cx43 I-MISC 24392
revealed O X
that O X
the O X
P O X
( O X
253 O X
) O X
LSP O X
( O X
256 O X
) O X
motif O X
is O X
an O X
important O X
determinant O X
of O X
the O X
ability O X
of O X
Cx43 I-MISC 24392
to O X
interact O X
with O X
CIP85 I-MISC 27352
. O X

Laser O X
- O X
scanning O X
confocal O X
microscopy O X
showed O X
that O X
CIP85 I-MISC 27352
colocalized O X
with O X
Cx43 I-MISC 24392
at O X
the O X
cell O X
periphery O X
, O X
particularly O X
in O X
areas O X
reminiscent O X
of O X
gap O X
junction O X
plaques O X
. O X

The O X
functional O X
importance O X
of O X
the O X
interaction O X
between O X
CIP85 I-MISC 27352
and O X
Cx43 I-MISC 24392
was O X
suggested O X
by O X
the O X
observation O X
that O X
CIP85 I-MISC 27352
appears O X
to O X
induce O X
the O X
turnover O X
of O X
Cx43 I-MISC 24392
through O X
the O X
lysosomal O X
pathway O X
. O X

###11923305	5786,6714

Mitotic O X
activation O X
of O X
protein O X
- O X
tyrosine O X
phosphatase O X
alpha O X
and O X
regulation O X
of O X
its O X
Src I-MISC 6714
- O X
mediated O X
transforming O X
activity O X
by O X
its O X
sites O X
of O X
protein O X
kinase O X
C O X
phosphorylation O X
. O X

During O X
mitosis O X
, O X
the O X
catalytic O X
activity O X
of O X
protein O X
- O X
tyrosine O X
phosphatase O X
( O X
PTP O X
) O X
alpha O X
is O X
enhanced O X
, O X
and O X
its O X
inhibitory O X
binding O X
to O X
Grb2 I-MISC 2885
, O X
which O X
specifically O X
blocks O X
Src I-MISC 6714
dephosphorylation O X
, O X
is O X
decreased O X
. O X

These O X
effects O X
act O X
synergistically O X
to O X
activate O X
Src I-MISC 6714
in O X
mitosis O X
. O X

We O X
show O X
here O X
that O X
these O X
effects O X
are O X
abrogated O X
by O X
mutation O X
of O X
Ser180 O X
and O X
/ O X
or O X
Ser204 O X
, O X
the O X
sites O X
of O X
protein O X
kinase O X
C O X
- O X
mediated O X
phosphorylation O X
within O X
PTPalpha I-MISC 5786
. O X

Moreover O X
, O X
either O X
a O X
Ser O X
- O X
to O X
- O X
Ala O X
substitution O X
or O X
serine O X
dephosphorylation O X
specifically O X
eliminated O X
the O X
ability O X
of O X
PTPalpha I-MISC 5786
to O X
dephosphorylate O X
and O X
activate O X
Src I-MISC 6714
even O X
during O X
interphase O X
. O X

This O X
explains O X
why O X
the O X
substitutions O X
eliminated O X
PTPalpha I-MISC 5786
transforming O X
activity O X
, O X
even O X
though O X
PTPalpha I-MISC 5786
interphase O X
dephosphorylation O X
of O X
nonspecific O X
substrates O X
was O X
only O X
slightly O X
decreased O X
. O X

This O X
occurred O X
without O X
change O X
in O X
the O X
phosphorylation O X
of O X
PTPalpha I-MISC 5786
at O X
Tyr789 O X
, O X
which O X
is O X
required O X
for O X
" O X
phosphotyrosine O X
displacement O X
" O X
during O X
Src I-MISC 6714
dephosphorylation O X
. O X

Thus O X
, O X
in O X
addition O X
to O X
increasing O X
PTPalpha I-MISC 5786
nonspecific O X
catalytic O X
activity O X
, O X
Ser180 O X
and O X
Ser204 O X
phosphorylation O X
( O X
along O X
with O X
Tyr789 O X
phosphorylation O X
) O X
regulates O X
PTPalpha I-MISC 5786
substrate O X
specificity O X
. O X

This O X
involves O X
serine O X
phosphorylation O X
- O X
dependent O X
differential O X
modulation O X
of O X
the O X
affinity O X
of O X
Tyr O X
( O X
P O X
) O X
789 O X
for O X
the O X
Src I-MISC 6714
and O X
Grb2 I-MISC 2885
SH2 O X
domains O X
. O X

The O X
results O X
suggest O X
that O X
protein O X
kinase O X
C O X
may O X
participate O X
in O X
the O X
mitotic O X
activation O X
of O X
PTPalpha I-MISC 5786
and O X
Src I-MISC 6714
and O X
that O X
there O X
are O X
intramolecular O X
interactions O X
between O X
the O X
PTPalpha I-MISC 5786
C O X
- O X
terminal O X
and O X
membrane O X
- O X
proximal O X
regions O X
that O X
are O X
regulated O X
, O X
at O X
least O X
in O X
part O X
, O X
by O X
serine O X
phosphorylation O X
. O X

###12799422	5829,1398	9564,1398

Tyrosine O X
phosphorylation O X
of O X
the O X
CrkII I-MISC 1398
adaptor O X
protein O X
modulates O X
cell O X
migration O X
. O X

CrkII I-MISC 1398
belongs O X
to O X
a O X
family O X
of O X
adaptor O X
proteins O X
that O X
become O X
tyrosine O X
phosphorylated O X
after O X
various O X
stimuli O X
. O X

We O X
examined O X
the O X
role O X
of O X
CrkII I-MISC 1398
tyrosine O X
phosphorylation O X
in O X
fibronectin O X
- O X
induced O X
cell O X
migration O X
. O X

Overexpression O X
of O X
CrkII I-MISC 1398
inhibited O X
dephosphorylation O X
of O X
focal O X
adhesion O X
components O X
such O X
as O X
p130 I-MISC 9221
Crk O X
- O X
associated O X
substrate O X
( O X
p130cas I-MISC 9564
) O X
and O X
paxillin I-MISC 5829
by O X
protein I-MISC 5770
tyrosine I-MISC 5770
phosphatase I-MISC 5770
1B I-MISC 5770
( O X
PTP1B I-MISC 5770
). O X

Tyrosine O X
- O X
phosphorylated O X
CrkII I-MISC 1398
was O X
dephosphorylated O X
by O X
PTP1B I-MISC 5770
both O X
in O X
vitro O X
and O X
in O X
vivo O X
, O X
showing O X
for O X
the O X
first O X
time O X
that O X
PTP1B I-MISC 5770
directly O X
dephosphorylates O X
CrkII I-MISC 1398
. O X

A O X
CrkII I-MISC 1398
mutant O X
in O X
which O X
tyrosine O X
residue O X
221 O X
was O X
substituted O X
by O X
phenylalanine O X
( O X
CrkII I-MISC 1398
- O X
Y221F O X
) O X
could O X
not O X
be O X
tyrosine O X
phosphorylated O X
, O X
and O X
it O X
showed O X
significantly O X
increased O X
binding O X
to O X
p130cas I-MISC 9564
and O X
paxillin I-MISC 5829
. O X

Enhanced O X
binding O X
of O X
CrkII I-MISC 1398
to O X
p130cas I-MISC 9564
has O X
been O X
reported O X
to O X
promote O X
cell O X
migration O X
. O X

Nonphosphorylated O X
CrkII I-MISC 1398
- O X
Y221F O X
promoted O X
HT1080 O X
cell O X
migration O X
on O X
fibronectin O X
, O X
whereas O X
wild O X
- O X
type O X
CrkII I-MISC 1398
did O X
not O X
at O X
moderate O X
expression O X
levels O X
. O X

Moreover O X
, O X
co O X
- O X
expression O X
of O X
CrkII I-MISC 1398
and O X
PTP1B I-MISC 5770
promoted O X
HT1080 O X
cell O X
migration O X
on O X
fibronectin O X
and O X
retained O X
tyrosine O X
phosphorylation O X
and O X
binding O X
of O X
p130cas I-MISC 9564
to O X
CrkII I-MISC 1398
, O X
whereas O X
paxillin I-MISC 5829
tyrosine O X
phosphorylation O X
was O X
reduced O X
. O X

These O X
findings O X
support O X
the O X
concepts O X
that O X
CrkII I-MISC 1398
binding O X
activity O X
is O X
regulated O X
by O X
tyrosine O X
kinases O X
and O X
phosphatases O X
, O X
and O X
that O X
tyrosine O X
phosphorylation O X
of O X
CrkII I-MISC 1398
can O X
downmodulate O X
cell O X
migration O X
mediated O X
by O X
the O X
focal O X
adhesion O X
kinase O X
/ O X
p130cas I-MISC 9564
pathway O X
. O X

###25616961	29978,3178

ALS O X
- O X
linked O X
mutations O X
in O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
or O X
hnRNPA1 I-MISC 3178
reduce O X
interaction O X
between O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
and O X
hnRNPA1 I-MISC 3178
. O X

Amyotrophic O X
lateral O X
sclerosis O X
( O X
ALS O X
)- O X
linked O X
mutations O X
in O X
UBQLN2 I-MISC 29978
and O X
some O X
members O X
of O X
the O X
heterogeneous O X
nuclear O X
ribonucleoproteins O X
( O X
hnRNPs O X
) O X
family O X
cause O X
ALS O X
. O X

Most O X
mutations O X
in O X
UBQLN2 I-MISC 29978
are O X
missense O X
mutations O X
that O X
occur O X
in O X
and O X
around O X
a O X
PXX O X
repeat O X
motif O X
located O X
in O X
the O X
central O X
domain O X
of O X
the O X
encoded O X
protein O X
. O X

However O X
, O X
neither O X
the O X
function O X
of O X
the O X
PXX O X
motif O X
nor O X
the O X
mechanism O X
by O X
which O X
mutations O X
in O X
UBQLN2 I-MISC 29978
cause O X
ALS O X
is O X
known O X
. O X

We O X
screened O X
a O X
yeast O X
two O X
- O X
hybrid O X
library O X
using O X
the O X
central O X
domain O X
of O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
hoping O X
to O X
identify O X
proteins O X
whose O X
binding O X
is O X
affected O X
by O X
the O X
UBQLN2 I-MISC 29978
mutations O X
. O X

Three O X
such O X
interactors O X
were O X
identified O X
- O X
hnRNPA1 I-MISC 3178
, O X
hnRNPA3 I-MISC 220988
and O X
hnRNPU I-MISC 3192
- O X
all O X
members O X
of O X
the O X
hnRNP I-MISC 3183
family O X
. O X

The O X
interacting O X
region O X
in O X
each O X
of O X
these O X
proteins O X
was O X
their O X
glycine O X
- O X
rich O X
domain O X
, O X
the O X
domain O X
most O X
frequently O X
mutated O X
in O X
hnRNP I-MISC 3183
- O X
related O X
proteins O X
that O X
cause O X
ALS O X
. O X

We O X
focused O X
on O X
hnRNPA1 I-MISC 3178
, O X
because O X
a O X
mutation O X
in O X
the O X
protein O X
causes O X
ALS O X
. O X

We O X
confirmed O X
the O X
interaction O X
between O X
wild O X
- O X
type O X
( O X
WT O X
) O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
and O X
hnRNPA1 I-MISC 3178
proteins O X
in O X
vitro O X
and O X
in O X
cells O X
. O X

In O X
contrast O X
, O X
all O X
five O X
ALS O X
mutations O X
in O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
that O X
we O X
examined O X
had O X
reduced O X
binding O X
with O X
WT O X
hnRNPA1 I-MISC 3178
. O X

In O X
addition O X
, O X
hnRNPA1 I-MISC 3178
carrying O X
the O X
D262V O X
missense O X
mutation O X
that O X
causes O X
ALS O X
failed O X
to O X
bind O X
WT O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
. O X

Overexpression O X
of O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
containing O X
the O X
ALS O X
mutations O X
increased O X
cell O X
death O X
and O X
, O X
for O X
several O X
of O X
the O X
mutants O X
, O X
this O X
correlated O X
with O X
increased O X
translocation O X
of O X
hnRNPA1 I-MISC 3178
to O X
the O X
cytoplasm O X
. O X

Knockdown O X
of O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
led O X
to O X
increased O X
turnover O X
of O X
hnRNPA1 I-MISC 3178
, O X
indicating O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
functions O X
to O X
stabilize O X
hnRNPA1 I-MISC 3178
. O X

The O X
discovery O X
that O X
ubiquilin I-MISC 29978
- I-MISC 29978
2 I-MISC 29978
interacts O X
with O X
hnRNP I-MISC 3183
proteins O X
and O X
that O X
mutation O X
in O X
either O X
protein O X
disrupts O X
interaction O X
suggests O X
a O X
connection O X
between O X
proteostasis O X
and O X
RNA O X
metabolism O X
. O X

###23870315	8575,23586

Mutual O X
antagonism O X
between O X
the O X
Ebola O X
virus O X
VP35 O X
protein O X
and O X
the O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
activator O X
PACT I-MISC 8575
determines O X
infection O X
outcome O X
. O X

The O X
cytoplasmic O X
pattern O X
recognition O X
receptor O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
is O X
activated O X
by O X
viral O X
RNA O X
and O X
induces O X
type O X
I O X
IFN O X
responses O X
to O X
control O X
viral O X
replication O X
. O X

The O X
cellular O X
dsRNA O X
binding O X
protein O X
PACT I-MISC 8575
can O X
also O X
activate O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
. O X

To O X
counteract O X
innate O X
antiviral O X
responses O X
, O X
some O X
viruses O X
, O X
including O X
Ebola O X
virus O X
( O X
EBOV O X
), O X
encode O X
proteins O X
that O X
antagonize O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
signaling O X
. O X

Here O X
, O X
we O X
show O X
that O X
EBOV O X
VP35 O X
inhibits O X
PACT I-MISC 8575
- O X
induced O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
ATPase O X
activity O X
in O X
a O X
dose O X
- O X
dependent O X
manner O X
. O X

The O X
interaction O X
of O X
PACT I-MISC 8575
with O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
is O X
disrupted O X
by O X
wild O X
- O X
type O X
VP35 O X
, O X
but O X
not O X
by O X
VP35 O X
mutants O X
that O X
are O X
unable O X
to O X
bind O X
PACT I-MISC 8575
. O X

In O X
addition O X
, O X
PACT I-MISC 8575
- O X
VP35 O X
interaction O X
impairs O X
the O X
association O X
between O X
VP35 O X
and O X
the O X
viral O X
polymerase O X
, O X
thereby O X
diminishing O X
viral O X
RNA O X
synthesis O X
and O X
modulating O X
EBOV O X
replication O X
. O X

PACT I-MISC 8575
- O X
deficient O X
cells O X
are O X
defective O X
in O X
IFN O X
induction O X
and O X
are O X
insensitive O X
to O X
VP35 O X
function O X
. O X

These O X
data O X
support O X
a O X
model O X
in O X
which O X
the O X
VP35 O X
- O X
PACT I-MISC 8575
interaction O X
is O X
mutually O X
antagonistic O X
and O X
plays O X
a O X
fundamental O X
role O X
in O X
determining O X
the O X
outcome O X
of O X
EBOV O X
infection O X
. O X

###10206957	850755,854840

The O X
catalytic O X
mechanism O X
of O X
endoplasmic O X
reticulum O X
signal I-MISC 850755
peptidase I-MISC 850755
appears O X
to O X
be O X
distinct O X
from O X
most O X
eubacterial O X
signal I-MISC 850755
peptidases I-MISC 850755
. O X

Many O X
type O X
I O X
signal I-MISC 850755
peptidases I-MISC 850755
from O X
eubacterial O X
cells O X
appear O X
to O X
contain O X
a O X
serine O X
/ O X
lysine O X
catalytic O X
dyad O X
. O X

In O X
contrast O X
, O X
our O X
data O X
show O X
that O X
the O X
signal I-MISC 850755
peptidase I-MISC 850755
complex I-MISC 850755
from O X
the O X
endoplasmic O X
reticulum O X
lacks O X
an O X
apparent O X
catalytic O X
lysine O X
. O X

Instead O X
, O X
a O X
serine O X
, O X
histidine O X
, O X
and O X
two O X
aspartic O X
acids O X
are O X
important O X
for O X
signal I-MISC 850755
peptidase I-MISC 850755
activity O X
by O X
the O X
Sec11p I-MISC 854840
subunit O X
of O X
the O X
yeast O X
signal I-MISC 850755
peptidase I-MISC 850755
complex O X
. O X

Amino O X
acids O X
critical O X
to O X
the O X
eubacterial O X
signal I-MISC 850755
peptidases I-MISC 850755
and O X
Sec11p I-MISC 854840
are O X
, O X
however O X
, O X
positioned O X
similarly O X
along O X
their O X
primary O X
sequences O X
, O X
suggesting O X
the O X
presence O X
of O X
a O X
common O X
structural O X
element O X
( O X
s O X
) O X
near O X
the O X
catalytic O X
sites O X
of O X
these O X
enzymes O X
. O X

###20453063	55636,57680

CHD8 I-MISC 57680
interacts O X
with O X
CHD7 I-MISC 55636
, O X
a O X
protein O X
which O X
is O X
mutated O X
in O X
CHARGE O X
syndrome O X
. O X

CHARGE O X
syndrome O X
is O X
an O X
autosomal O X
dominant O X
disorder O X
caused O X
in O X
about O X
two O X
- O X
third O X
of O X
cases O X
by O X
mutations O X
in O X
the O X
CHD7 I-MISC 55636
gene O X
. O X

For O X
other O X
genetic O X
diseases O X
e O X
. O X
g O X
. O X

hereditary O X
spastic O X
paraplegia O X
, O X
it O X
was O X
shown O X
that O X
interacting O X
partners O X
are O X
involved O X
in O X
the O X
underlying O X
cause O X
of O X
the O X
disease O X
. O X

These O X
data O X
encouraged O X
us O X
to O X
search O X
for O X
CHD7 I-MISC 55636
binding O X
partners O X
by O X
a O X
yeast O X
two O X
- O X
hybrid O X
library O X
screen O X
and O X
CHD8 I-MISC 57680
was O X
identified O X
as O X
an O X
interacting O X
partner O X
. O X

The O X
result O X
was O X
confirmed O X
by O X
a O X
direct O X
yeast O X
two O X
- O X
hybrid O X
analysis O X
, O X
co O X
- O X
immunoprecipitation O X
studies O X
and O X
by O X
a O X
bimolecular O X
fluorescence O X
complementation O X
assay O X
. O X

To O X
investigate O X
the O X
function O X
of O X
CHD7 I-MISC 55636
missense O X
mutations O X
in O X
the O X
CHD7 I-MISC 55636
- O X
CHD8 I-MISC 57680
interacting O X
area O X
on O X
the O X
binding O X
capacity O X
of O X
both O X
proteins O X
, O X
we O X
included O X
three O X
known O X
missense O X
mutations O X
( O X
p O X
. O X
His2096Arg O X
, O X
p O X
. O X
Val2102Ile O X
and O X
p O X
. O X
Gly2108Arg O X
) O X
and O X
one O X
newly O X
identified O X
missense O X
mutation O X
( O X
p O X
. O X
Trp2091Arg O X
) O X
in O X
the O X
CHD7 I-MISC 55636
gene O X
and O X
performed O X
both O X
direct O X
yeast O X
two O X
- O X
hybrid O X
and O X
co O X
- O X
immunoprecipitation O X
studies O X
. O X

In O X
the O X
direct O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
the O X
CHD7 I-MISC 55636
- O X
CHD8 I-MISC 57680
interaction O X
was O X
disrupted O X
by O X
the O X
missense O X
mutations O X
p O X
. O X
Trp2091Arg O X
, O X
p O X
. O X
His2096Arg O X
and O X
p O X
. O X
Gly2108Arg O X
, O X
whereas O X
in O X
the O X
co O X
- O X
immunoprecipitation O X
studies O X
disruption O X
of O X
the O X
CHD7 I-MISC 55636
- O X
CHD8 I-MISC 57680
interaction O X
by O X
the O X
mutations O X
could O X
not O X
be O X
observed O X
. O X

The O X
results O X
lead O X
to O X
the O X
hypothesis O X
that O X
CHD7 I-MISC 55636
and O X
CHD8 I-MISC 57680
proteins O X
are O X
interacting O X
directly O X
and O X
indirectly O X
via O X
additional O X
linker O X
proteins O X
. O X

Disruption O X
of O X
the O X
direct O X
CHD7 I-MISC 55636
- O X
CHD8 I-MISC 57680
interaction O X
might O X
change O X
the O X
conformation O X
of O X
a O X
putative O X
large O X
CHD7 I-MISC 55636
- O X
CHD8 I-MISC 57680
complex O X
and O X
could O X
be O X
a O X
disease O X
mechanism O X
in O X
CHARGE O X
syndrome O X
. O X

###16151013	598,27113

PUMA O X
couples O X
the O X
nuclear O X
and O X
cytoplasmic O X
proapoptotic O X
function O X
of O X
p53 O X
. O X

The O X
Trp53 O X
tumor O X
suppressor O X
gene O X
product O X
( O X
p53 O X
) O X
functions O X
in O X
the O X
nucleus O X
to O X
regulate O X
proapoptotic O X
genes O X
, O X
whereas O X
cytoplasmic O X
p53 O X
directly O X
activates O X
proapoptotic O X
Bcl O X
- O X
2 O X
proteins O X
to O X
permeabilize O X
mitochondria O X
and O X
initiate O X
apoptosis O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
a O X
tripartite O X
nexus O X
between O X
Bcl I-MISC 598
- I-MISC 598
xL I-MISC 598
, O X
cytoplasmic O X
p53 O X
, O X
and O X
PUMA I-MISC 27113
coordinates O X
these O X
distinct O X
p53 O X
functions O X
. O X

After O X
genotoxic O X
stress O X
, O X
Bcl I-MISC 598
- I-MISC 598
xL I-MISC 598
sequestered O X
cytoplasmic O X
p53 O X
. O X

Nuclear O X
p53 O X
caused O X
expression O X
of O X
PUMA O X
, O X
which O X
then O X
displaced O X
p53 O X
from O X
Bcl I-MISC 598
- I-MISC 598
xL I-MISC 598
, O X
allowing O X
p53 O X
to O X
induce O X
mitochondrial O X
permeabilization O X
. O X

Mutant O X
Bcl I-MISC 598
- I-MISC 598
xL I-MISC 598
that O X
bound O X
p53 O X
, O X
but O X
not O X
PUMA O X
, O X
rendered O X
cells O X
resistant O X
to O X
p53 O X
- O X
induced O X
apoptosis O X
irrespective O X
of O X
PUMA O X
expression O X
. O X

Thus O X
, O X
PUMA O X
couples O X
the O X
nuclear O X
and O X
cytoplasmic O X
proapoptotic O X
functions O X
of O X
p53 O X
. O X

###9422760	26469,9051

Identification O X
of O X
a O X
novel O X
polyproline O X
recognition O X
site O X
in O X
the O X
cytoskeletal O X
associated O X
protein O X
, O X
proline O X
serine O X
threonine O X
phosphatase O X
interacting O X
protein O X
. O X

Protein O X
- O X
protein O X
interactions O X
are O X
often O X
mediated O X
by O X
the O X
recognition O X
of O X
proline O X
- O X
rich O X
domains O X
by O X
SH3 O X
or O X
WW O X
modules O X
. O X

Previously O X
, O X
we O X
demonstrated O X
that O X
the O X
PEST O X
- O X
type O X
protein O X
- O X
tyrosine O X
phosphatase O X
, O X
PTP I-MISC 26469
HSCF I-MISC 26469
( O X
hematopoietic O X
stem O X
cell O X
fraction O X
), O X
bound O X
to O X
a O X
novel O X
cytoskeletal O X
associated O X
protein O X
, O X
proline O X
serine O X
threonine O X
phosphatase O X
interacting O X
protein O X
( O X
PST I-MISC 9051
PIP I-MISC 9051
), O X
via O X
an O X
interaction O X
between O X
the O X
proline O X
- O X
rich O X
COOH O X
terminus O X
of O X
the O X
PTP O X
and O X
a O X
site O X
within O X
the O X
putative O X
coiled O X
- O X
coil O X
domain O X
of O X
PST I-MISC 9051
PIP I-MISC 9051
. O X

Here O X
we O X
describe O X
a O X
more O X
detailed O X
analysis O X
of O X
this O X
interaction O X
. O X

Earlier O X
data O X
suggested O X
that O X
the O X
NH2 O X
terminus O X
of O X
PST I-MISC 9051
PIP I-MISC 9051
was O X
important O X
for O X
binding O X
to O X
the O X
phosphatase O X
, O X
and O X
deletion O X
of O X
the O X
NH2 O X
- O X
terminal O X
50 O X
amino O X
acids O X
of O X
the O X
PST I-MISC 9051
PIP I-MISC 9051
resulted O X
in O X
an O X
apparently O X
misfolded O X
protein O X
that O X
was O X
incapable O X
of O X
binding O X
PTP I-MISC 26469
HSCF I-MISC 26469
. O X

To O X
examine O X
the O X
region O X
involved O X
with O X
binding O X
to O X
PTP I-MISC 26469
HSCF I-MISC 26469
, O X
alanine O X
- O X
scanning O X
mutants O X
were O X
produced O X
at O X
intervals O X
throughout O X
PST I-MISC 9051
PIP I-MISC 9051
. O X

This O X
analysis O X
demonstrated O X
that O X
a O X
tryptophan O X
at O X
position O X
232 O X
was O X
essential O X
for O X
binding O X
in O X
vitro O X
. O X

Transfection O X
experiments O X
demonstrated O X
that O X
the O X
Trp232 O X
mutant O X
protein O X
was O X
capable O X
of O X
association O X
with O X
the O X
cortical O X
cytoskeleton O X
but O X
was O X
not O X
bound O X
to O X
PTP I-MISC 26469
HSCF I-MISC 26469
in O X
vivo O X
. O X

Alanine O X
scanning O X
of O X
a O X
peptide O X
derived O X
from O X
the O X
COOH O X
- O X
terminal O X
proline O X
- O X
rich O X
domain O X
of O X
PTP I-MISC 26469
HSCF I-MISC 26469
revealed O X
that O X
a O X
subset O X
of O X
prolines O X
, O X
as O X
well O X
as O X
other O X
residues O X
, O X
was O X
required O X
for O X
efficient O X
binding O X
to O X
PST I-MISC 9051
PIP I-MISC 9051
, O X
and O X
introduction O X
of O X
alanines O X
at O X
some O X
of O X
these O X
positions O X
in O X
the O X
protein O X
resulted O X
in O X
decreased O X
binding O X
to O X
PST I-MISC 9051
PIP I-MISC 9051
in O X
vitro O X
and O X
in O X
vivo O X
. O X

Analysis O X
of O X
in O X
vivo O X
tyrosine O X
phosphorylation O X
of O X
the O X
Trp232 O X
mutant O X
of O X
PST I-MISC 9051
PIP I-MISC 9051
in O X
the O X
presence O X
of O X
v O X
- O X
Src O X
revealed O X
that O X
this O X
protein O X
was O X
phosphorylated O X
more O X
efficiently O X
than O X
the O X
wild O X
- O X
type O X
molecule O X
. O X

Thus O X
, O X
the O X
interaction O X
between O X
PTP I-MISC 26469
HSCF I-MISC 26469
and O X
PST I-MISC 9051
PIP I-MISC 9051
is O X
mediated O X
by O X
a O X
novel O X
site O X
in O X
the O X
cytoskeletal O X
associated O X
protein O X
which O X
interacts O X
with O X
residues O X
within O X
the O X
proline O X
- O X
rich O X
COOH O X
terminus O X
of O X
the O X
phosphatase O X
. O X

###20935634	355,8772

The O X
Fas I-MISC 355
- O X
FADD I-MISC 8772
death O X
domain O X
complex O X
structure O X
reveals O X
the O X
basis O X
of O X
DISC O X
assembly O X
and O X
disease O X
mutations O X
. O X

The O X
death O X
- O X
inducing O X
signaling O X
complex O X
( O X
DISC O X
) O X
formed O X
by O X
the O X
death O X
receptor O X
Fas I-MISC 355
, O X
the O X
adaptor O X
protein O X
FADD I-MISC 8772
and O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
mediates O X
the O X
extrinsic O X
apoptotic O X
program O X
. O X

Mutations O X
in O X
Fas I-MISC 355
that O X
disrupt O X
the O X
DISC O X
cause O X
autoimmune O X
lymphoproliferative O X
syndrome O X
( O X
ALPS O X
). O X

Here O X
we O X
show O X
that O X
the O X
Fas I-MISC 355
- O X
FADD I-MISC 8772
death O X
domain O X
( O X
DD O X
) O X
complex O X
forms O X
an O X
asymmetric O X
oligomeric O X
structure O X
composed O X
of O X
5 O X
- O X
7 O X
Fas I-MISC 355
DD O X
and O X
5 O X
FADD I-MISC 8772
DD O X
, O X
whose O X
interfaces O X
harbor O X
ALPS O X
- O X
associated O X
mutations O X
. O X

Structure O X
- O X
based O X
mutations O X
disrupt O X
the O X
Fas I-MISC 355
- O X
FADD I-MISC 8772
interaction O X
in O X
vitro O X
and O X
in O X
living O X
cells O X
; O X
the O X
severity O X
of O X
a O X
mutation O X
correlates O X
with O X
the O X
number O X
of O X
occurrences O X
of O X
a O X
particular O X
interaction O X
in O X
the O X
structure O X
. O X

The O X
highly O X
oligomeric O X
structure O X
explains O X
the O X
requirement O X
for O X
hexameric O X
or O X
membrane O X
- O X
bound O X
FasL I-MISC 356
in O X
Fas I-MISC 355
signaling O X
. O X

It O X
also O X
predicts O X
strong O X
dominant O X
negative O X
effects O X
from O X
Fas I-MISC 355
mutations O X
, O X
which O X
are O X
confirmed O X
by O X
signaling O X
assays O X
. O X

The O X
structure O X
optimally O X
positions O X
the O X
FADD I-MISC 8772
death O X
effector O X
domain O X
( O X
DED O X
) O X
to O X
interact O X
with O X
the O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
DED O X
for O X
caspase O X
recruitment O X
and O X
higher O X
- O X
order O X
aggregation O X
. O X

###22354040	855132,851266

RPA O X
facilitates O X
telomerase I-MISC 851028
activity O X
at O X
chromosome O X
ends O X
in O X
budding O X
and O X
fission O X
yeasts O X
. O X

In O X
Saccharomyces O X
cerevisiae O X
, O X
the O X
telomerase I-MISC 851028
complex O X
binds O X
to O X
chromosome O X
ends O X
and O X
is O X
activated O X
in O X
late O X
S O X
- O X
phase O X
through O X
a O X
process O X
coupled O X
to O X
the O X
progression O X
of O X
the O X
replication O X
fork O X
. O X

Here O X
, O X
we O X
show O X
that O X
the O X
single O X
- O X
stranded O X
DNA O X
- O X
binding O X
protein O X
RPA O X
( O X
replication O X
protein O X
A O X
) O X
binds O X
to O X
the O X
two O X
daughter O X
telomeres O X
during O X
telomere O X
replication O X
but O X
only O X
its O X
binding O X
to O X
the O X
leading O X
- O X
strand O X
telomere O X
depends O X
on O X
the O X
Mre11 O X
/ O X
Rad50 O X
/ O X
Xrs2 O X
( O X
MRX O X
) O X
complex O X
. O X

We O X
further O X
demonstrate O X
that O X
RPA O X
specifically O X
co O X
- O X
precipitates O X
with O X
yKu I-MISC 855132
, O X
Cdc13 O X
and O X
telomerase I-MISC 851028
. O X

The O X
interaction O X
of O X
RPA O X
with O X
telomerase I-MISC 851028
appears O X
to O X
be O X
mediated O X
by O X
both O X
yKu I-MISC 855132
and O X
the O X
telomerase I-MISC 851028
subunit O X
Est1 I-MISC 851028
. O X

Moreover O X
, O X
a O X
mutation O X
in O X
Rfa1 I-MISC 851266
that O X
affects O X
both O X
the O X
interaction O X
with O X
yKu I-MISC 855132
and O X
telomerase I-MISC 851028
reduces O X
the O X
dramatic O X
increase O X
in O X
telomere O X
length O X
of O X
a O X
rif1 O X
/\, O X
rif2 O X
/\ O X
double O X
mutant O X
. O X

Finally O X
, O X
we O X
show O X
that O X
the O X
RPA O X
/ O X
telomerase I-MISC 851028
association O X
and O X
function O X
are O X
conserved O X
in O X
Schizosaccharomyces O X
pombe O X
. O X

Our O X
results O X
indicate O X
that O X
in O X
both O X
yeasts O X
, O X
RPA O X
directly O X
facilitates O X
telomerase I-MISC 851028
activity O X
at O X
chromosome O X
ends O X
. O X

###15864306	8483,7040

A O X
functional O X
SNP O X
in O X
CILP I-MISC 8483
, O X
encoding O X
cartilage I-MISC 8483
intermediate I-MISC 8483
layer I-MISC 8483
protein I-MISC 8483
, O X
is O X
associated O X
with O X
susceptibility O X
to O X
lumbar O X
disc O X
disease O X
. O X

Lumbar O X
disc O X
disease O X
( O X
LDD O X
) O X
is O X
caused O X
by O X
degeneration O X
of O X
intervertebral O X
discs O X
of O X
the O X
lumbar O X
spine O X
. O X

One O X
of O X
the O X
most O X
common O X
musculoskeletal O X
disorders O X
, O X
LDD O X
has O X
strong O X
genetic O X
determinants O X
. O X

Using O X
a O X
case O X
- O X
control O X
association O X
study O X
, O X
we O X
identified O X
a O X
functional O X
SNP O X
( O X
1184T O X
--> O X
C O X
, O X
resulting O X
in O X
the O X
amino O X
acid O X
substitution O X
I395T O X
) O X
in O X
CILP I-MISC 8483
, O X
which O X
encodes O X
the O X
cartilage I-MISC 8483
intermediate I-MISC 8483
layer I-MISC 8483
protein I-MISC 8483
, O X
that O X
acts O X
as O X
a O X
modulator O X
of O X
LDD O X
susceptibility O X
. O X

CILP I-MISC 8483
was O X
expressed O X
abundantly O X
in O X
intervertebral O X
discs O X
, O X
and O X
its O X
expression O X
increased O X
as O X
disc O X
degeneration O X
progressed O X
. O X

CILP I-MISC 8483
colocalized O X
with O X
TGF I-MISC 7040
- I-MISC 7040
beta1 I-MISC 7040
in O X
clustering O X
chondrocytes O X
and O X
their O X
territorial O X
matrices O X
in O X
intervertebral O X
discs O X
. O X

CILP I-MISC 8483
inhibited O X
TGF I-MISC 7040
- I-MISC 7040
beta1 I-MISC 7040
- O X
mediated O X
induction O X
of O X
cartilage O X
matrix O X
genes O X
through O X
direct O X
interaction O X
with O X
TGF I-MISC 7040
- I-MISC 7040
beta1 I-MISC 7040
and O X
inhibition O X
of O X
TGF I-MISC 7040
- I-MISC 7040
beta1 I-MISC 7040
signaling O X
. O X

The O X
susceptibility O X
- O X
associated O X
1184C O X
allele O X
showed O X
increased O X
binding O X
and O X
inhibition O X
of O X
TGF I-MISC 7040
- I-MISC 7040
beta1 I-MISC 7040
. O X

Therefore O X
, O X
we O X
conclude O X
that O X
the O X
extracellular O X
matrix O X
protein O X
CILP I-MISC 8483
regulates O X
TGF O X
- O X
beta O X
signaling O X
and O X
that O X
this O X
regulation O X
has O X
a O X
crucial O X
role O X
in O X
the O X
etiology O X
and O X
pathogenesis O X
of O X
LDD O X
. O X

Our O X
study O X
also O X
adds O X
to O X
the O X
list O X
of O X
connective O X
tissue O X
diseases O X
that O X
are O X
associated O X
with O X
TGF O X
- O X
beta O X
. O X

###16446454	940450,843928

F O X
- O X
box O X
- O X
like O X
domain O X
in O X
the O X
polerovirus I-MISC 940450
protein I-MISC 940450
P0 I-MISC 940450
is O X
required O X
for O X
silencing O X
suppressor O X
function O X
. O X

Plants O X
employ O X
small O X
RNA O X
- O X
mediated O X
posttranscriptional O X
gene O X
silencing O X
as O X
a O X
virus O X
defense O X
mechanism O X
. O X

In O X
response O X
, O X
plant O X
viruses O X
encode O X
proteins O X
that O X
can O X
suppress O X
RNA O X
silencing O X
, O X
but O X
the O X
mode O X
of O X
action O X
of O X
most O X
such O X
proteins O X
is O X
poorly O X
understood O X
. O X

Here O X
, O X
we O X
show O X
that O X
the O X
silencing O X
suppressor O X
protein O X
P0 I-MISC 940450
of O X
two O X
Arabidopsis O X
- O X
infecting O X
poleroviruses O X
interacts O X
by O X
means O X
of O X
a O X
conserved O X
minimal O X
F O X
- O X
box O X
motif O X
with O X
Arabidopsis O X
thaliana O X
orthologs O X
of O X
S I-MISC 843928
- I-MISC 843928
phase I-MISC 843928
kinase I-MISC 843928
- I-MISC 843928
related I-MISC 843928
protein I-MISC 843928
1 I-MISC 843928
( O X
SKP1 I-MISC 843928
), O X
a O X
component O X
of O X
the O X
SCF O X
family O X
of O X
ubiquitin O X
E3 O X
ligases O X
. O X

Point O X
mutations O X
in O X
the O X
F O X
- O X
box O X
- O X
like O X
motif O X
abolished O X
the O X
P0 I-MISC 940450
- O X
SKP1 I-MISC 843928
ortholog O X
interaction O X
, O X
diminished O X
virus O X
pathogenicity O X
, O X
and O X
inhibited O X
the O X
silencing O X
suppressor O X
activity O X
of O X
P0 I-MISC 940450
. O X

Knockdown O X
of O X
expression O X
of O X
a O X
SKP1 I-MISC 843928
ortholog O X
in O X
Nicotiana O X
benthamiana O X
rendered O X
the O X
plants O X
resistant O X
to O X
polerovirus O X
infection O X
. O X

Together O X
, O X
the O X
results O X
support O X
a O X
model O X
in O X
which O X
P0 I-MISC 940450
acts O X
as O X
an O X
F O X
- O X
box O X
protein O X
that O X
targets O X
an O X
essential O X
component O X
of O X
the O X
host O X
posttranscriptional O X
gene O X
silencing O X
machinery O X
. O X

###19712061	120892,120892

Homo O X
- O X
and O X
heterodimerization O X
of O X
ROCO O X
kinases O X
: O X
LRRK2 I-MISC 120892
kinase O X
inhibition O X
by O X
the O X
LRRK2 I-MISC 120892
ROCO O X
fragment O X
. O X

Mutations O X
in O X
the O X
gene O X
encoding O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
are O X
the O X
most O X
common O X
cause O X
of O X
autosomal O X
- O X
dominant O X
familial O X
and O X
late O X
- O X
onset O X
sporadic O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

LRRK2 I-MISC 120892
is O X
a O X
large O X
multi O X
- O X
domain O X
protein O X
featuring O X
a O X
GTP O X
- O X
binding O X
C O X
- O X
terminal O X
of O X
Ras O X
of O X
complex O X
proteins O X
( O X
ROC O X
) O X
( O X
ROCO O X
) O X
domain O X
combination O X
unique O X
for O X
the O X
ROCO O X
protein O X
family O X
, O X
directly O X
followed O X
by O X
a O X
kinase O X
domain O X
. O X

Dimerization O X
is O X
a O X
well O X
- O X
established O X
phenomenon O X
among O X
protein O X
kinases O X
. O X

Here O X
, O X
we O X
confirm O X
LRRK2 I-MISC 120892
self O X
- O X
interaction O X
, O X
and O X
provide O X
evidence O X
for O X
general O X
homo O X
- O X
and O X
heterodimerization O X
potential O X
among O X
the O X
ROCO O X
kinase O X
family O X
( O X
LRRK2 I-MISC 120892
, O X
LRRK1 I-MISC 79705
, O X
and O X
death I-MISC 1612
- I-MISC 1612
associated I-MISC 1612
protein I-MISC 1612
kinase I-MISC 1612
1 I-MISC 1612
). O X

The O X
ROCO O X
domain O X
was O X
critically O X
, O X
though O X
not O X
exclusively O X
involved O X
in O X
dimerization O X
, O X
as O X
a O X
LRRK2 I-MISC 120892
deletion O X
mutant O X
lacking O X
the O X
ROCO O X
domain O X
retained O X
dimeric O X
properties O X
. O X

GTP O X
binding O X
did O X
not O X
appear O X
to O X
influence O X
ROCO O X
( O X
LRRK2 I-MISC 120892
) O X
self O X
- O X
interaction O X
. O X

Interestingly O X
, O X
ROCO O X
( O X
LRRK2 I-MISC 120892
) O X
fragments O X
exerted O X
an O X
inhibitory O X
effect O X
on O X
both O X
wild O X
- O X
type O X
and O X
the O X
elevated O X
G2019S O X
LRRK2 I-MISC 120892
autophosphorylation O X
activity O X
. O X

Insertion O X
of O X
PD O X
mutations O X
into O X
ROCO O X
( O X
LRRK2 I-MISC 120892
) O X
reduced O X
self O X
- O X
interaction O X
and O X
led O X
to O X
a O X
reduction O X
of O X
LRRK2 I-MISC 120892
kinase O X
inhibition O X
. O X

Collectively O X
, O X
these O X
results O X
suggest O X
a O X
functional O X
link O X
between O X
ROCO O X
interactions O X
and O X
kinase O X
activity O X
of O X
wild O X
- O X
type O X
and O X
mutant O X
LRRK2 I-MISC 120892
. O X

Importantly O X
, O X
our O X
finding O X
of O X
ROCO O X
( O X
LRRK2 I-MISC 120892
) O X
fragment O X
- O X
mediated O X
LRRK2 I-MISC 120892
kinase O X
inhibition O X
offers O X
a O X
novel O X
lead O X
for O X
drug O X
design O X
and O X
thus O X
might O X
have O X
important O X
implications O X
for O X
new O X
therapeutic O X
avenues O X
in O X
PD O X
. O X

###16963136	887,19247

An O X
ITIM O X
- O X
like O X
motif O X
within O X
the O X
CCK2 I-MISC 887
receptor I-MISC 887
sequence O X
required O X
for O X
interaction O X
with O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
and O X
the O X
activation O X
of O X
the O X
AKT I-MISC 207
pathway O X
. O X

SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
is O X
a O X
tyrosine O X
phosphatase O X
which O X
functions O X
as O X
a O X
positive O X
regulator O X
downstream O X
of O X
RTKs O X
, O X
activating O X
growth O X
- O X
stimulatory O X
signalling O X
pathways O X
. O X

To O X
date O X
, O X
very O X
few O X
G O X
protein O X
- O X
coupled O X
receptors O X
( O X
GPCRs O X
) O X
have O X
been O X
shown O X
to O X
be O X
connected O X
to O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
and O X
very O X
little O X
is O X
known O X
about O X
the O X
positive O X
role O X
of O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
in O X
GPCR O X
signalling O X
. O X

The O X
CCK2 I-MISC 887
receptor I-MISC 887
( O X
CCK2R I-MISC 887
), O X
a O X
GPCR O X
, O X
is O X
now O X
recognized O X
to O X
mediate O X
mitogenic O X
effects O X
of O X
gastrin I-MISC 2520
on O X
gastrointestinal O X
cells O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
demonstrate O X
the O X
role O X
of O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
in O X
the O X
activation O X
of O X
the O X
AKT I-MISC 207
pathway O X
by O X
the O X
CCK2R I-MISC 887
in O X
COS O X
- O X
7 O X
cells O X
transfected O X
with O X
the O X
CCK2R I-MISC 887
and O X
in O X
a O X
pancreatic O X
cancer O X
cell O X
line O X
expressing O X
the O X
endogenous O X
receptor O X
. O X

Using O X
surface O X
plasmon O X
resonance O X
analysis O X
, O X
we O X
identified O X
a O X
highly O X
conserved O X
ITIM O X
motif O X
, O X
containing O X
the O X
tyrosine O X
residue O X
438 O X
, O X
located O X
in O X
the O X
C O X
- O X
terminal O X
intracellular O X
tail O X
of O X
the O X
CCK2R I-MISC 887
which O X
directly O X
interacts O X
with O X
the O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
SH2 O X
domains O X
. O X

The O X
interaction O X
was O X
confirmed O X
by O X
pull O X
down O X
assays O X
and O X
co O X
- O X
immunoprecipitation O X
of O X
the O X
receptor O X
with O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
. O X

This O X
interaction O X
was O X
transiently O X
increased O X
following O X
gastrin I-MISC 2520
stimulation O X
of O X
the O X
CCK2R I-MISC 887
and O X
correlated O X
with O X
the O X
tyrosine O X
phosphorylation O X
of O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
. O X

Mutational O X
analysis O X
of O X
the O X
key O X
ITIM O X
residue O X
438 O X
confirmed O X
that O X
the O X
CCK2R I-MISC 887
ITIM O X
sequence O X
is O X
required O X
for O X
interaction O X
with O X
SHP I-MISC 19247
- I-MISC 19247
2 I-MISC 19247
and O X
the O X
activation O X
of O X
the O X
AKT I-MISC 207
pathway O X
. O X

###20664522	1460,1639	65201,1639	1460,65201	1460,65201	5347,65201	5347,65201

Phosphorylation O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
by O X
Plk1 I-MISC 5347
and O X
CK2 I-MISC 1460
promotes O X
timely O X
formation O X
of O X
kinetochore O X
- O X
microtubule O X
attachments O X
. O X

CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
is O X
implicated O X
in O X
the O X
formation O X
of O X
kinetochore O X
- O X
microtubule O X
attachments O X
through O X
direct O X
interaction O X
with O X
the O X
dynein O X
/ O X
dynactin I-MISC 1639
complex O X
. O X

However O X
, O X
whether O X
this O X
important O X
function O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
is O X
regulated O X
by O X
phosphorylation O X
is O X
unknown O X
. O X

Herein O X
, O X
we O X
have O X
identified O X
polo I-MISC 5347
- I-MISC 5347
like I-MISC 5347
kinase I-MISC 5347
1 I-MISC 5347
( O X
Plk1 I-MISC 5347
) O X
and O X
casein I-MISC 1460
kinase I-MISC 1460
2 I-MISC 1460
( O X
CK2 I-MISC 1460
) O X
as O X
two O X
kinases O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
and O X
mapped O X
S195 O X
and O X
S1318 I-MISC 1079475
as O X
their O X
respective O X
phosphorylation O X
sites O X
. O X

We O X
showed O X
that O X
a O X
CK2 I-MISC 1460
unphosphorylatable O X
mutant O X
lost O X
its O X
ability O X
to O X
bind O X
to O X
dynactin I-MISC 1639
and O X
to O X
localize O X
to O X
kinetochores O X
during O X
prometaphase O X
, O X
indicating O X
that O X
the O X
CK2 I-MISC 1460
phosphorylation O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
is O X
involved O X
in O X
its O X
dynactin I-MISC 1639
- O X
mediated O X
kinetochore O X
localization O X
. O X

Furthermore O X
, O X
we O X
provide O X
evidence O X
that O X
Plk1 I-MISC 5347
phosphorylation O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
at O X
S195 O X
enhances O X
its O X
association O X
with O X
CK2 I-MISC 1460
. O X

Finally O X
, O X
we O X
detected O X
defects O X
in O X
the O X
formation O X
of O X
kinetochore O X
fibres O X
in O X
cells O X
expressing O X
the O X
CLIP O X
- O X
S195A O X
and O X
- O X
S1318A O X
, O X
but O X
not O X
the O X
CLIP O X
- O X
S195E O X
and O X
- O X
S1318D O X
, O X
confirming O X
that O X
Plk1 I-MISC 5347
- O X
and O X
CK2 I-MISC 1460
- O X
associated O X
phosphorylations O X
of O X
CLIP I-MISC 65201
- I-MISC 65201
170 I-MISC 65201
are O X
involved O X
in O X
the O X
timely O X
formation O X
of O X
kinetochore O X
- O X
microtubule O X
attachments O X
in O X
mitosis O X
. O X

###12861019	5829,175532

RNF5 I-MISC 6048
, O X
a O X
RING O X
finger O X
protein O X
that O X
regulates O X
cell O X
motility O X
by O X
targeting O X
paxillin I-MISC 5829
ubiquitination O X
and O X
altered O X
localization O X
. O X

RNF5 I-MISC 175532
is O X
a O X
RING O X
finger O X
protein O X
found O X
to O X
be O X
important O X
in O X
the O X
growth O X
and O X
development O X
of O X
Caenorhabditis O X
elegans O X
. O X

The O X
search O X
for O X
RNF5 I-MISC 175532
- O X
associated O X
proteins O X
via O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
identified O X
a O X
LIM O X
- O X
containing O X
protein O X
in O X
C O X
. O X
elegans O X
which O X
shows O X
homology O X
with O X
human O X
paxillin I-MISC 5829
. O X

Here O X
we O X
demonstrate O X
that O X
the O X
human O X
homologue O X
of O X
RNF5 I-MISC 6048
associates O X
with O X
the O X
amino O X
- O X
terminal O X
domain O X
of O X
paxillin I-MISC 5829
, O X
resulting O X
in O X
its O X
ubiquitination O X
. O X

RNF5 I-MISC 6048
requires O X
intact O X
RING O X
and O X
C O X
- O X
terminal O X
domains O X
to O X
mediate O X
paxillin I-MISC 5829
ubiquitination O X
. O X

Whereas O X
RNF5 I-MISC 6048
mediates O X
efficient O X
ubiquitination O X
of O X
paxillin I-MISC 5829
in O X
vivo O X
, O X
protein O X
extracts O X
were O X
required O X
for O X
in O X
vitro O X
ubiquitination O X
, O X
suggesting O X
that O X
additional O X
modifications O X
and O X
/ O X
or O X
an O X
associated O X
E3 O X
ligase O X
assist O X
RNF5 I-MISC 6048
targeting O X
of O X
paxillin I-MISC 5829
ubiquitination O X
. O X

Mutant O X
Ubc13 I-MISC 7334
efficiently O X
inhibits O X
RNF5 I-MISC 6048
ubiquitination O X
, O X
suggesting O X
that O X
RNF5 I-MISC 6048
generates O X
polychain O X
ubiquitin O X
of O X
the O X
K63 O X
topology O X
. O X

Expression O X
of O X
RNF5 I-MISC 6048
increases O X
the O X
cytoplasmic O X
distribution O X
of O X
paxillin I-MISC 5829
while O X
decreasing O X
its O X
localization O X
within O X
focal O X
adhesions O X
, O X
where O X
it O X
is O X
primarily O X
seen O X
under O X
normal O X
growth O X
. O X

Concomitantly O X
, O X
RNF5 I-MISC 6048
expression O X
results O X
in O X
inhibition O X
of O X
cell O X
motility O X
. O X

Via O X
targeting O X
of O X
paxillin I-MISC 5829
ubiquitination O X
, O X
which O X
alters O X
its O X
localization O X
, O X
RNF5 I-MISC 6048
emerges O X
as O X
a O X
novel O X
regulator O X
of O X
cell O X
motility O X
. O X

###14508515	4627,4221

Menin I-MISC 4221
, O X
a O X
tumor O X
suppressor O X
, O X
associates O X
with O X
nonmuscle O X
myosin I-MISC 79784
II O X
- O X
A O X
heavy O X
chain O X
. O X

MEN1 I-MISC 4221
is O X
a O X
likely O X
tumor O X
suppressor O X
gene O X
that O X
encodes O X
a O X
novel O X
protein O X
, O X
menin I-MISC 4221
. O X

Menin I-MISC 4221
is O X
a O X
610 O X
amino O X
- O X
acid O X
residue O X
protein O X
with O X
as O X
yet O X
unknown O X
function O X
( O X
s O X
). O X

We O X
have O X
used O X
tandem O X
affinity O X
purification O X
and O X
mass O X
spectroscopy O X
to O X
isolate O X
and O X
identify O X
proteins O X
associating O X
with O X
menin I-MISC 4221
from O X
cultured O X
HeLa O X
cell O X
extracts O X
. O X

This O X
strategy O X
has O X
resulted O X
in O X
the O X
isolation O X
and O X
identification O X
of O X
nonmuscle O X
myosin I-MISC 79784
type O X
II O X
- O X
A O X
heavy O X
chain O X
( O X
NMHC I-MISC 4627
II I-MISC 4627
- I-MISC 4627
A I-MISC 4627
) O X
as O X
a O X
menin I-MISC 4221
interacting O X
protein O X
. O X

This O X
interaction O X
was O X
confirmed O X
by O X
glutathione O X
- O X
S O X
- O X
transferase O X
pulldown O X
assays O X
, O X
by O X
coimmunoprecipitation O X
, O X
and O X
by O X
actin O X
selection O X
of O X
myosin I-MISC 79784
. O X

We O X
have O X
further O X
identified O X
the O X
amino O X
- O X
terminal O X
region O X
of O X
menin I-MISC 4221
and O X
the O X
head O X
domain O X
of O X
NMHC I-MISC 4627
II I-MISC 4627
- I-MISC 4627
A I-MISC 4627
to O X
be O X
regions O X
required O X
for O X
this O X
interaction O X
. O X

Moreover O X
menin I-MISC 4221
was O X
seen O X
to O X
colocalize O X
with O X
this O X
myosin I-MISC 79784
isoform O X
in O X
the O X
cleavage O X
furrow O X
of O X
dividing O X
cells O X
by O X
indirect O X
immunofluoresence O X
. O X

These O X
data O X
indicate O X
that O X
menin I-MISC 4221
through O X
binding O X
to O X
NMHC I-MISC 4627
II I-MISC 4627
- I-MISC 4627
A I-MISC 4627
could O X
participate O X
in O X
cell O X
division O X
and O X
in O X
other O X
processes O X
that O X
involve O X
NMHC I-MISC 4627
II I-MISC 4627
- I-MISC 4627
A I-MISC 4627
. O X

###21247419	19416,13864

Rasd1 I-MISC 19416
interacts O X
with O X
Ear2 I-MISC 13587
( O X
Nr2f6 I-MISC 13864
) O X
to O X
regulate O X
renin O X
transcription O X
. O X

BACKGROUND O X
: O X
The O X
Rasd1 I-MISC 19416
protein O X
is O X
a O X
dexamethasone O X
induced O X
monomeric O X
Ras O X
- O X
like O X
G O X
protein O X
that O X
oscillates O X
in O X
the O X
suprachiasmatic O X
nucleus O X
( O X
SCN O X
). O X

Previous O X
studies O X
have O X
shown O X
that O X
Rasd1 I-MISC 19416
modulates O X
multiple O X
signaling O X
cascades O X
. O X

However O X
, O X
it O X
is O X
still O X
unclear O X
exactly O X
how O X
Rasd1 I-MISC 19416
carries O X
out O X
its O X
function O X
. O X

Studying O X
protein O X
- O X
protein O X
interactions O X
involving O X
Rasd1 I-MISC 19416
may O X
provide O X
insights O X
into O X
its O X
biological O X
functions O X
in O X
different O X
contexts O X
. O X

RESULTS O X
: O X
To O X
further O X
explore O X
the O X
molecular O X
function O X
of O X
Rasd1 I-MISC 19416
, O X
we O X
performed O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
and O X
identified O X
Ear2 I-MISC 13587
, O X
a O X
negative O X
regulator O X
of O X
renin O X
transcription O X
, O X
as O X
an O X
interaction O X
partner O X
of O X
Rasd1 I-MISC 19416
. O X

We O X
validated O X
the O X
interaction O X
in O X
vitro O X
and O X
in O X
transfected O X
COS O X
- O X
7 O X
cells O X
. O X

We O X
further O X
confirmed O X
the O X
interaction O X
of O X
endogenous O X
Rasd1 I-MISC 51655
and O X
Ear2 I-MISC 2063
from O X
HEK293T O X
cell O X
and O X
mouse O X
brain O X
extract O X
. O X

Rasd1 I-MISC 19416
inhibited O X
transcriptional O X
repression O X
by O X
Ear2 I-MISC 13587
on O X
a O X
renin O X
promoter O X
- O X
luciferase O X
reporter O X
construct O X
both O X
in O X
the O X
presence O X
and O X
absence O X
of O X
all O X
- O X
trans O X
- O X
retinoic O X
acid O X
. O X

Moreover O X
, O X
real O X
- O X
time O X
RT O X
- O X
PCR O X
showed O X
upregulation O X
of O X
endogenous O X
renin O X
transcription O X
in O X
As4 O X
. O X
1 O X
cells O X
over O X
- O X
expressing O X
Rasd1 I-MISC 19416
. O X

We O X
demonstrated O X
that O X
the O X
ligand O X
binding O X
domain O X
of O X
Ear2 I-MISC 13587
is O X
required O X
for O X
physical O X
and O X
functional O X
interaction O X
between O X
the O X
two O X
proteins O X
. O X

In O X
addition O X
, O X
we O X
demonstrated O X
that O X
shRNA O X
- O X
mediated O X
knockdown O X
of O X
Rasd1 I-MISC 19416
results O X
in O X
further O X
repression O X
of O X
Ear2 I-MISC 13587
- O X
mediated O X
renin O X
transcription O X
, O X
whereas O X
induction O X
of O X
Rasd1 I-MISC 19416
by O X
dexamethasone O X
counteracts O X
the O X
effects O X
of O X
shRNA O X
- O X
mediated O X
Rasd1 I-MISC 19416
knockdown O X
. O X

Finally O X
, O X
our O X
study O X
showed O X
that O X
Rasd1 I-MISC 19416
missense O X
mutations O X
not O X
only O X
attenuate O X
their O X
physical O X
interaction O X
with O X
Ear2 I-MISC 13587
but O X
also O X
abolish O X
their O X
ability O X
to O X
counteract O X
repression O X
of O X
renin O X
transcription O X
mediated O X
by O X
Ear2 I-MISC 13587
. O X

CONCLUSIONS O X
: O X
Our O X
study O X
provides O X
evidence O X
for O X
physical O X
and O X
functional O X
interactions O X
between O X
Rasd1 I-MISC 19416
and O X
Ear2 I-MISC 13587
. O X

The O X
results O X
suggest O X
that O X
their O X
interactions O X
are O X
involved O X
in O X
renin O X
transcriptional O X
regulation O X
. O X

These O X
findings O X
not O X
only O X
reveal O X
a O X
novel O X
role O X
for O X
Rasd1 I-MISC 19416
- O X
medated O X
signaling O X
but O X
also O X
provide O X
the O X
basis O X
for O X
potential O X
intervention O X
of O X
renin O X
expression O X
. O X

###22661693	888659,888659

Mycobacterium O X
tuberculosis O X
protein O X
kinase O X
K O X
enables O X
growth O X
adaptation O X
through O X
translation O X
control O X
. O X

Mycobacterium O X
tuberculosis O X
serine O X
/ O X
threonine O X
protein O X
kinases O X
( O X
STPKs O X
) O X
are O X
responsible O X
for O X
orchestrating O X
critical O X
metabolic O X
and O X
physiological O X
changes O X
that O X
dictate O X
mycobacterial O X
growth O X
adaptation O X
. O X

Previously O X
, O X
we O X
established O X
that O X
PknK O X
participates O X
in O X
regulatory O X
pathways O X
that O X
slow O X
the O X
growth O X
of O X
M O X
. O X
tuberculosis O X
in O X
a O X
variety O X
of O X
in O X
vitro O X
stress O X
environments O X
and O X
during O X
persistent O X
infection O X
in O X
mice O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
have O X
elaborated O X
on O X
the O X
mechanism O X
of O X
PknK O X
- O X
mediated O X
regulation O X
. O X

Through O X
transcription O X
profiling O X
of O X
wild O X
- O X
type O X
H37Rv O X
and O X
a O X
/\ O X
pknK O X
mutant O X
strain O X
during O X
logarithmic O X
and O X
stationary O X
growth O X
phases O X
, O X
we O X
determined O X
that O X
PknK O X
regulates O X
the O X
expression O X
of O X
a O X
large O X
subset O X
of O X
tRNA O X
genes O X
so O X
that O X
regulation O X
is O X
synchronized O X
with O X
growth O X
phase O X
and O X
cellular O X
energy O X
status O X
. O X

Elevated O X
levels O X
of O X
wild O X
- O X
type O X
M O X
. O X
tuberculosis O X
PknK O X
( O X
PknK I-MISC 888659
( I-MISC 888659
Mtb I-MISC 888659
)), O X
but O X
not O X
phosphorylation O X
- O X
defective O X
PknK I-MISC 888659
( I-MISC 888659
Mtb I-MISC 888659
), O X
in O X
Mycobacterium O X
smegmatis O X
cause O X
significant O X
retardation O X
of O X
the O X
growth O X
rate O X
and O X
altered O X
colony O X
morphology O X
. O X

We O X
investigated O X
a O X
role O X
for O X
PknK O X
in O X
translational O X
control O X
and O X
established O X
that O X
PknK O X
directs O X
the O X
inhibition O X
of O X
in O X
vitro O X
transcription O X
and O X
translation O X
processes O X
in O X
a O X
phosphorylation O X
- O X
dependent O X
manner O X
. O X

Increasing O X
concentrations O X
of O X
ATP O X
or O X
PknK O X
exert O X
cooperative O X
effects O X
and O X
enhance O X
the O X
inhibitory O X
function O X
of O X
PknK O X
. O X

Furthermore O X
, O X
truncation O X
and O X
mutational O X
analyses O X
of O X
PknK O X
revealed O X
that O X
PknK O X
is O X
autoregulated O X
via O X
intramolecular O X
interactions O X
with O X
its O X
C O X
- O X
terminal O X
region O X
. O X

Significantly O X
, O X
the O X
invariant O X
lysine O X
55 O X
residue O X
was O X
only O X
essential O X
for O X
activity O X
in O X
the O X
full O X
- O X
length O X
PknK O X
protein O X
, O X
and O X
the O X
truncated O X
mutant O X
proteins O X
were O X
active O X
. O X

A O X
model O X
for O X
PknK O X
autoregulation O X
is O X
proposed O X
and O X
discussed O X
. O X

###17909018	1029,1019

A O X
CDKN2A I-MISC 1029
mutation O X
in O X
familial O X
melanoma O X
that O X
abrogates O X
binding O X
of O X
p16INK4a I-MISC 1029
to O X
CDK4 I-MISC 1019
but O X
not O X
CDK6 I-MISC 1021
. O X

The O X
CDKN2A I-MISC 1029
locus O X
encodes O X
two O X
distinct O X
proteins O X
, O X
p16INK4a I-MISC 1029
and O X
p14ARF I-MISC 1029
, O X
both O X
of O X
which O X
are O X
implicated O X
in O X
replicative O X
senescence O X
and O X
tumor O X
suppression O X
in O X
different O X
contexts O X
. O X

Here O X
, O X
we O X
describe O X
the O X
characterization O X
of O X
a O X
novel O X
strain O X
of O X
human O X
diploid O X
fibroblasts O X
( O X
designated O X
Milan O X
HDFs O X
) O X
from O X
an O X
individual O X
who O X
is O X
homozygous O X
for O X
the O X
R24P O X
mutation O X
in O X
p16INK4a I-MISC 1029
. O X

As O X
this O X
mutation O X
occurs O X
in O X
the O X
first O X
exon O X
of O X
INK4a I-MISC 1029
( O X
exon O X
1alpha O X
), O X
it O X
has O X
no O X
effect O X
on O X
the O X
primary O X
sequence O X
of O X
p14 I-MISC 1029
( O X
ARF O X
). O X

Based O X
on O X
both O X
in O X
vitro O X
and O X
in O X
vivo O X
analyses O X
, O X
the O X
R24P O X
variant O X
is O X
specifically O X
defective O X
for O X
binding O X
to O X
CDK4 I-MISC 1019
but O X
remains O X
able O X
to O X
associate O X
with O X
CDK6 I-MISC 1021
. O X

Nevertheless O X
, O X
Milan O X
HDFs O X
behave O X
as O X
if O X
they O X
are O X
p16INK4a I-MISC 1029
deficient O X
, O X
in O X
terms O X
of O X
sensitivity O X
to O X
spontaneous O X
and O X
oncogene O X
- O X
induced O X
senescence O X
, O X
and O X
the O X
R24P O X
variant O X
has O X
little O X
effect O X
on O X
proliferation O X
when O X
ectopically O X
expressed O X
in O X
normal O X
fibroblasts O X
. O X

It O X
can O X
, O X
however O X
, O X
impair O X
the O X
proliferation O X
of O X
U20S O X
cells O X
, O X
presumably O X
because O X
they O X
express O X
more O X
CDK6 I-MISC 1021
than O X
primary O X
fibroblasts O X
. O X

These O X
observations O X
suggest O X
that O X
CDK4 I-MISC 1019
and O X
CDK6 I-MISC 1021
are O X
not O X
functionally O X
redundant O X
and O X
underscore O X
the O X
importance O X
of O X
CDK4 I-MISC 1019
in O X
the O X
development O X
of O X
melanoma O X
. O X

###12679424	3667,18708

A O X
novel O X
T608R O X
missense O X
mutation O X
in O X
insulin I-MISC 3667
receptor I-MISC 3667
substrate I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
identified O X
in O X
a O X
subject O X
with O X
type O X
2 O X
diabetes O X
impairs O X
metabolic O X
insulin O X
signaling O X
. O X

Naturally O X
occurring O X
mutations O X
in O X
insulin I-MISC 3667
receptor I-MISC 3667
substrate I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
( O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
) O X
have O X
previously O X
been O X
implicated O X
in O X
impaired O X
insulin O X
action O X
. O X

We O X
now O X
report O X
a O X
novel O X
mutation O X
in O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
with O X
substitution O X
of O X
Arg O X
for O X
Thr O X
( O X
608 O X
) O X
that O X
was O X
identified O X
in O X
a O X
patient O X
with O X
type O X
2 O X
diabetes O X
mellitus O X
. O X

We O X
detected O X
the O X
T608R O X
mutation O X
in O X
1 O X
of O X
136 O X
chromosomes O X
from O X
diabetic O X
patients O X
and O X
in O X
0 O X
of O X
120 O X
chromosomes O X
from O X
nondiabetic O X
controls O X
, O X
suggesting O X
that O X
this O X
is O X
a O X
rare O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
variant O X
. O X

Conservation O X
of O X
Thr O X
( O X
608 O X
) O X
in O X
human O X
, O X
monkey O X
, O X
rat O X
, O X
mouse O X
, O X
and O X
chicken O X
IRS I-MISC 101749888
- I-MISC 101749888
1 I-MISC 101749888
sequences O X
is O X
consistent O X
with O X
a O X
crucial O X
function O X
for O X
this O X
residue O X
. O X

Moreover O X
, O X
Thr O X
( O X
608 O X
) O X
is O X
located O X
near O X
the O X
YMXM O X
motif O X
containing O X
Tyr O X
( O X
612 O X
) O X
that O X
is O X
important O X
for O X
binding O X
and O X
activation O X
of O X
phosphoinositol I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
( O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
). O X

To O X
investigate O X
whether O X
the O X
T608R O X
mutation O X
impairs O X
insulin O X
signaling O X
, O X
we O X
transiently O X
transfected O X
NIH O X
- O X
3T3 O X
( O X
IR O X
) O X
cells O X
with O X
hemagglutinin O X
- O X
tagged O X
wild O X
- O X
type O X
or O X
T608R O X
mutant O X
IRS I-MISC 16367
- I-MISC 16367
1 I-MISC 16367
constructs O X
. O X

Recombinant O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
immunoprecipitated O X
from O X
transfected O X
cells O X
treated O X
with O X
or O X
without O X
insulin O X
was O X
subjected O X
to O X
immunoblotting O X
for O X
the O X
p85 I-MISC 5296
regulatory O X
subunit O X
of O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
as O X
well O X
as O X
a O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
assay O X
. O X

As O X
expected O X
, O X
in O X
control O X
cells O X
transfected O X
with O X
wild O X
- O X
type O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
, O X
insulin O X
stimulation O X
caused O X
an O X
increase O X
in O X
p85 I-MISC 5296
coimmunoprecipitated O X
with O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
as O X
well O X
as O X
a O X
10 O X
- O X
fold O X
increase O X
in O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
- O X
associated O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
activity O X
. O X

Interestingly O X
, O X
when O X
cells O X
transfected O X
with O X
IRS1 I-MISC 3667
- O X
T608R O X
were O X
stimulated O X
with O X
insulin O X
, O X
both O X
the O X
amount O X
of O X
p85 I-MISC 5296
coimmunoprecipitated O X
with O X
IRS1 I-MISC 3667
- O X
T608R O X
as O X
well O X
as O X
the O X
associated O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
activity O X
were O X
approximately O X
50 O X
% O X
less O X
than O X
those O X
observed O X
with O X
wild O X
- O X
type O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
. O X

Moreover O X
, O X
in O X
rat O X
adipose O X
cells O X
, O X
overexpression O X
of O X
IRS1 I-MISC 25467
- O X
T608R O X
resulted O X
in O X
significantly O X
less O X
translocation O X
of O X
GLUT4 I-MISC 25139
to O X
the O X
cell O X
surface O X
than O X
comparable O X
overexpression O X
of O X
wild O X
- O X
type O X
IRS I-MISC 25467
- I-MISC 25467
1 I-MISC 25467
. O X

We O X
conclude O X
that O X
a O X
naturally O X
occurring O X
substitution O X
of O X
Arg O X
for O X
Thr O X
( O X
608 O X
) O X
in O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
is O X
a O X
rare O X
human O X
mutation O X
that O X
may O X
contribute O X
to O X
insulin O X
resistance O X
by O X
impairing O X
metabolic O X
signaling O X
through O X
PI I-MISC 18708
3 I-MISC 18708
- I-MISC 18708
kinase I-MISC 18708
- O X
dependent O X
pathways O X
. O X

###17704763	838883,835842

ZEITLUPE I-MISC 835842
is O X
a O X
circadian O X
photoreceptor O X
stabilized O X
by O X
GIGANTEA I-MISC 838883
in O X
blue O X
light O X
. O X

The O X
circadian O X
clock O X
is O X
essential O X
for O X
coordinating O X
the O X
proper O X
phasing O X
of O X
many O X
important O X
cellular O X
processes O X
. O X

Robust O X
cycling O X
of O X
key O X
clock O X
elements O X
is O X
required O X
to O X
maintain O X
strong O X
circadian O X
oscillations O X
of O X
these O X
clock O X
- O X
controlled O X
outputs O X
. O X

Rhythmic O X
expression O X
of O X
the O X
Arabidopsis O X
thaliana O X
F O X
- O X
box O X
protein O X
ZEITLUPE I-MISC 835842
( O X
ZTL O X
) O X
is O X
necessary O X
to O X
sustain O X
a O X
normal O X
circadian O X
period O X
by O X
controlling O X
the O X
proteasome O X
- O X
dependent O X
degradation O X
of O X
a O X
central O X
clock O X
protein O X
, O X
TIMING I-MISC 836259
OF I-MISC 836259
CAB I-MISC 836259
EXPRESSION I-MISC 836259
1 I-MISC 836259
( O X
TOC1 I-MISC 836259
). O X

ZTL O X
messenger O X
RNA O X
is O X
constitutively O X
expressed O X
, O X
but O X
ZTL O X
protein O X
levels O X
oscillate O X
with O X
a O X
threefold O X
change O X
in O X
amplitude O X
through O X
an O X
unknown O X
mechanism O X
. O X

Here O X
we O X
show O X
that O X
GIGANTEA I-MISC 838883
( O X
GI I-MISC 838883
) O X
is O X
essential O X
to O X
establish O X
and O X
sustain O X
oscillations O X
of O X
ZTL O X
by O X
a O X
direct O X
protein O X
- O X
protein O X
interaction O X
. O X

GI I-MISC 838883
, O X
a O X
large O X
plant O X
- O X
specific O X
protein O X
with O X
a O X
previously O X
undefined O X
molecular O X
role O X
, O X
stabilizes O X
ZTL O X
in O X
vivo O X
. O X

Furthermore O X
, O X
the O X
ZTL O X
- O X
GI I-MISC 838883
interaction O X
is O X
strongly O X
and O X
specifically O X
enhanced O X
by O X
blue O X
light O X
, O X
through O X
the O X
amino O X
- O X
terminal O X
flavin O X
- O X
binding O X
LIGHT O X
, O X
OXYGEN O X
OR O X
VOLTAGE O X
( O X
LOV O X
) O X
domain O X
of O X
ZTL O X
. O X

Mutations O X
within O X
this O X
domain O X
greatly O X
diminish O X
ZTL O X
- O X
GI I-MISC 838883
interactions O X
, O X
leading O X
to O X
strongly O X
reduced O X
ZTL O X
levels O X
. O X

Notably O X
, O X
a O X
C82A O X
mutation O X
in O X
the O X
LOV O X
domain O X
, O X
implicated O X
in O X
the O X
flavin O X
- O X
dependent O X
photochemistry O X
, O X
eliminates O X
blue O X
- O X
light O X
- O X
enhanced O X
binding O X
of O X
GI I-MISC 838883
to O X
ZTL O X
. O X

These O X
data O X
establish O X
ZTL O X
as O X
a O X
blue O X
- O X
light O X
photoreceptor O X
, O X
which O X
facilitates O X
its O X
own O X
stability O X
through O X
a O X
blue O X
- O X
light O X
- O X
enhanced O X
GI I-MISC 838883
interaction O X
. O X

Because O X
the O X
regulation O X
of O X
GI I-MISC 838883
transcription O X
is O X
clock O X
- O X
controlled O X
, O X
consequent O X
GI I-MISC 838883
protein O X
cycling O X
confers O X
a O X
post O X
- O X
translational O X
rhythm O X
on O X
ZTL O X
protein O X
. O X

This O X
mechanism O X
of O X
establishing O X
and O X
sustaining O X
robust O X
oscillations O X
of O X
ZTL O X
results O X
in O X
the O X
high O X
- O X
amplitude O X
TOC1 I-MISC 836259
rhythms O X
necessary O X
for O X
proper O X
clock O X
function O X
. O X

###12432066	16202,3987

Assembly O X
of O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
precedes O X
and O X
is O X
essential O X
for O X
localization O X
of O X
each O X
component O X
to O X
cell O X
- O X
matrix O X
adhesion O X
sites O X
. O X

PINCH I-MISC 3987
, O X
integrin I-MISC 16202
- I-MISC 16202
linked I-MISC 16202
kinase I-MISC 16202
( O X
ILK I-MISC 16202
) O X
and O X
calponin I-MISC 55742
homology I-MISC 55742
- I-MISC 55742
containing I-MISC 55742
ILK I-MISC 55742
- I-MISC 55742
binding I-MISC 55742
protein I-MISC 55742
( O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
) O X
form O X
a O X
ternary O X
complex O X
that O X
plays O X
crucial O X
roles O X
at O X
cell O X
- O X
extracellular O X
matrix O X
adhesion O X
sites O X
. O X

To O X
understand O X
the O X
mechanism O X
underlying O X
the O X
complex O X
formation O X
and O X
recruitment O X
to O X
cell O X
- O X
adhesion O X
sites O X
we O X
have O X
undertaken O X
a O X
combined O X
structural O X
, O X
mutational O X
and O X
cell O X
biological O X
analysis O X
. O X

Three O X
- O X
dimensional O X
structure O X
- O X
based O X
point O X
mutations O X
identified O X
specific O X
PINCH I-MISC 3987
and O X
ILK I-MISC 16202
sites O X
that O X
mediate O X
the O X
complex O X
formation O X
. O X

Analyses O X
of O X
the O X
binding O X
defective O X
point O X
mutants O X
revealed O X
that O X
the O X
assembly O X
of O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
is O X
essential O X
for O X
their O X
localization O X
to O X
cell O X
- O X
extracellular O X
matrix O X
adhesion O X
sites O X
. O X

The O X
formation O X
of O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
precedes O X
integrin O X
- O X
mediated O X
cell O X
adhesion O X
and O X
spreading O X
. O X

Furthermore O X
, O X
inhibition O X
of O X
protein O X
kinase O X
C O X
, O X
but O X
not O X
that O X
of O X
actin O X
polymerization O X
, O X
inhibited O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
formation O X
, O X
suggesting O X
that O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
likely O X
serves O X
as O X
a O X
downstream O X
effector O X
of O X
protein O X
kinase O X
C O X
in O X
the O X
cellular O X
control O X
of O X
focal O X
adhesion O X
assembly O X
. O X

Finally O X
, O X
we O X
provide O X
evidence O X
that O X
the O X
formation O X
of O X
the O X
PINCH I-MISC 3987
- O X
ILK I-MISC 16202
- O X
CH I-MISC 55742
- I-MISC 55742
ILKBP I-MISC 55742
complex O X
, O X
while O X
necessary O X
, O X
is O X
not O X
sufficient O X
for O X
ILK I-MISC 16202
localization O X
to O X
cell O X
- O X
extracellular O X
matrix O X
adhesion O X
sites O X
. O X

These O X
results O X
provide O X
new O X
insights O X
into O X
the O X
molecular O X
mechanism O X
underlying O X
the O X
assembly O X
and O X
regulation O X
of O X
cell O X
- O X
matrix O X
adhesion O X
structures O X
. O X

###19860830	100009227,7534

The O X
interaction O X
between O X
casein O X
kinase O X
Ialpha O X
and O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
is O X
phosphorylation O X
dependent O X
. O X

We O X
have O X
previously O X
shown O X
that O X
casein O X
kinase O X
( O X
CK O X
) O X
Ialpha O X
from O X
mammalian O X
brain O X
phosphorylates O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
zeta I-MISC 7534
and O X
tau O X
isoforms O X
on O X
residue O X
233 O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
show O X
that O X
CKIalpha I-MISC 100009227
associates O X
with O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

The O X
interaction O X
between O X
CKIalpha I-MISC 100009227
and O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
is O X
dependent O X
on O X
CKIalpha I-MISC 100009227
phosphorylation O X
, O X
unlike O X
centaurin I-MISC 11033
- I-MISC 11033
alpha1 I-MISC 11033
( O X
also O X
known O X
as O X
ADAP1 I-MISC 11033
), O X
which O X
binds O X
to O X
unphosphorylated O X
CKIalpha I-MISC 100009227
on O X
the O X
same O X
region O X
. O X

CKIalpha I-MISC 100009227
preferentially O X
interacts O X
with O X
mammalian O X
eta O X
and O X
gamma O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
isoforms O X
, O X
and O X
peptides O X
that O X
bind O X
to O X
the O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
binding O X
pocket O X
prevent O X
this O X
interaction O X
. O X

The O X
region O X
containing O X
Ser218 O X
in O X
this O X
CKIalpha I-MISC 100009227
binding O X
site O X
was O X
mutated O X
and O X
the O X
interaction O X
between O X
CKIalpha I-MISC 100009227
and O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
was O X
reduced O X
. O X

We O X
subsequently O X
identified O X
a O X
second O X
phosphorylation O X
- O X
dependent O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
binding O X
site O X
within O X
CKIalpha I-MISC 100009227
containing O X
Ser242 O X
that O X
may O X
be O X
the O X
principal O X
site O X
of O X
interaction O X
. O X

We O X
also O X
show O X
that O X
both O X
fission O X
and O X
budding O X
yeast O X
CKI O X
kinase O X
homologues O X
phosphorylate O X
mammalian O X
and O X
budding O X
yeast O X
( O X
BMH1 I-MISC 856924
and I-MISC 856924
BMH2 I-MISC 856924
) I-MISC 856924
14 I-MISC 856924
- I-MISC 856924
3 I-MISC 856924
- I-MISC 856924
3 I-MISC 856924
at O X
the O X
equivalent O X
site O X
. O X

###20840750	18627,12953

Identification O X
of O X
two O X
amino O X
acids O X
in O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
mouse O X
CRY2 I-MISC 12953
essential O X
for O X
PER2 I-MISC 18627
interaction O X
. O X

BACKGROUND O X
: O X
Cryptochromes O X
( O X
CRYs O X
) O X
are O X
a O X
class O X
of O X
flavoprotein O X
blue O X
- O X
light O X
signaling O X
receptors O X
found O X
in O X
plants O X
and O X
animals O X
, O X
and O X
they O X
control O X
plant O X
development O X
and O X
the O X
entrainment O X
of O X
circadian O X
rhythms O X
. O X

They O X
also O X
act O X
as O X
integral O X
parts O X
of O X
the O X
central O X
circadian O X
oscillator O X
in O X
humans O X
and O X
other O X
animals O X
. O X

In O X
mammals O X
, O X
the O X
CLOCK I-MISC 9575
- I-MISC 9575
BMAL1 I-MISC 9575
heterodimer O X
activates O X
transcription O X
of O X
the O X
Per O X
and O X
Cry O X
genes O X
as O X
well O X
as O X
clock I-MISC 9575
- O X
regulated O X
genes O X
. O X

The O X
PER2 I-MISC 8864
proteins O X
interact O X
with O X
CRY O X
and O X
CKI O X
, O X
and O X
the O X
resulting O X
ternary O X
complexes O X
translocate O X
into O X
the O X
nucleus O X
, O X
where O X
they O X
negatively O X
regulate O X
the O X
transcription O X
of O X
Per O X
and O X
Cry O X
core O X
clock I-MISC 9575
genes O X
and O X
other O X
clock I-MISC 9575
- O X
regulated O X
output O X
genes O X
. O X

Recent O X
studies O X
have O X
indicated O X
that O X
the O X
extended O X
C O X
- O X
termini O X
of O X
the O X
mammalian O X
CRYs O X
, O X
as O X
compared O X
to O X
photolyase O X
proteins O X
, O X
interact O X
with O X
PER O X
proteins O X
. O X

RESULTS O X
: O X
We O X
identified O X
a O X
region O X
on O X
mCRY2 I-MISC 12953
( O X
between O X
residues O X
493 O X
and O X
512 O X
) O X
responsible O X
for O X
direct O X
physical O X
interaction O X
with O X
mPER2 I-MISC 18627
by O X
mammalian O X
two O X
- O X
hybrid O X
and O X
co O X
- O X
immunoprecipitation O X
assays O X
. O X

Moreover O X
, O X
using O X
oligonucleotide O X
- O X
based O X
degenerate O X
PCR O X
, O X
we O X
discovered O X
that O X
mutation O X
of O X
Arg O X
- O X
501 O X
and O X
Lys O X
- O X
503 O X
of O X
mCRY2 I-MISC 12953
within O X
this O X
C O X
- O X
terminal O X
region O X
totally O X
abolishes O X
interaction O X
with O X
PER2 I-MISC 8864
. O X

CONCLUSIONS O X
: O X
Our O X
results O X
identify O X
mCRY2 I-MISC 12953
amino O X
acid O X
residues O X
that O X
interact O X
with O X
the O X
mPER2 I-MISC 18627
binding O X
region O X
and O X
suggest O X
the O X
potential O X
for O X
rational O X
drug O X
design O X
to O X
inhibit O X
CRYs O X
for O X
specific O X
therapeutic O X
approaches O X
. O X

###19798056	1213,10040

Participation O X
of O X
Tom1L1 I-MISC 10040
in O X
EGF O X
- O X
stimulated O X
endocytosis O X
of O X
EGF I-MISC 1956
receptor I-MISC 1956
. O X

Although O X
many O X
proteins O X
have O X
been O X
shown O X
to O X
participate O X
in O X
ligand O X
- O X
stimulated O X
endocytosis O X
of O X
EGF I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
), O X
the O X
adaptor O X
protein O X
responsible O X
for O X
interaction O X
of O X
activated O X
EGFR I-MISC 1956
with O X
endocytic O X
machinery O X
remains O X
elusive O X
. O X

We O X
show O X
here O X
that O X
EGF O X
stimulates O X
transient O X
tyrosine O X
phosphorylation O X
of O X
Tom1L1 I-MISC 10040
by O X
the O X
Src O X
family O X
kinases O X
, O X
resulting O X
in O X
transient O X
interaction O X
of O X
Tom1L1 I-MISC 10040
with O X
the O X
activated O X
EGFR I-MISC 1956
bridged O X
by O X
Grb2 I-MISC 2885
and O X
Shc I-MISC 6464
. O X

Cytosolic O X
Tom1L1 I-MISC 10040
is O X
recruited O X
onto O X
the O X
plasma O X
membrane O X
and O X
subsequently O X
redistributes O X
into O X
the O X
early O X
endosome O X
. O X

Mutant O X
forms O X
of O X
Tom1L1 I-MISC 10040
defective O X
in O X
Tyr O X
- O X
phosphorylation O X
or O X
interaction O X
with O X
Grb2 I-MISC 2885
are O X
incapable O X
of O X
interaction O X
with O X
EGFR I-MISC 1956
. O X

These O X
mutants O X
behave O X
as O X
dominant O X
- O X
negative O X
mutants O X
to O X
inhibit O X
endocytosis O X
of O X
EGFR I-MISC 1956
. O X

RNAi O X
- O X
mediated O X
knockdown O X
of O X
Tom1L1 I-MISC 10040
inhibits O X
endocytosis O X
of O X
EGFR I-MISC 1956
. O X

The O X
C O X
- O X
terminal O X
tail O X
of O X
Tom1L1 I-MISC 10040
contains O X
a O X
novel O X
clathrin O X
- O X
interacting O X
motif O X
responsible O X
for O X
interaction O X
with O X
the O X
C O X
- O X
terminal O X
region O X
of O X
clathrin I-MISC 1213
heavy I-MISC 1213
chain I-MISC 1213
, O X
which O X
is O X
important O X
for O X
exogenous O X
Tom1L1 I-MISC 10040
to O X
rescue O X
endocytosis O X
of O X
EGFR I-MISC 1956
in O X
Tom1L1 I-MISC 10040
knocked O X
- O X
down O X
cells O X
. O X

These O X
results O X
suggest O X
that O X
EGF O X
triggers O X
a O X
transient O X
Grb2 I-MISC 2885
/ O X
Shc I-MISC 6464
- O X
mediated O X
association O X
of O X
EGFR I-MISC 1956
with O X
Tyr O X
- O X
phosphorylated O X
Tom1L1 I-MISC 10040
to O X
engage O X
the O X
endocytic O X
machinery O X
for O X
endocytosis O X
of O X
the O X
ligand O X
- O X
receptor O X
complex O X
. O X

###20935625	58,1759

Direct O X
dynamin I-MISC 1759
- O X
actin I-MISC 58
interactions O X
regulate O X
the O X
actin I-MISC 58
cytoskeleton O X
. O X

The O X
large O X
GTPase O X
dynamin I-MISC 1759
assembles O X
into O X
higher O X
order O X
structures O X
that O X
are O X
thought O X
to O X
promote O X
endocytosis O X
. O X

Dynamin I-MISC 1759
also O X
regulates O X
the O X
actin I-MISC 58
cytoskeleton O X
through O X
an O X
unknown O X
, O X
GTPase O X
- O X
dependent O X
mechanism O X
. O X

Here O X
, O X
we O X
identify O X
a O X
highly O X
conserved O X
site O X
in O X
dynamin I-MISC 1759
that O X
binds O X
directly O X
to O X
actin I-MISC 58
filaments O X
and O X
aligns O X
them O X
into O X
bundles O X
. O X

Point O X
mutations O X
in O X
the O X
actin I-MISC 58
- O X
binding O X
domain O X
cause O X
aberrant O X
membrane O X
ruffling O X
and O X
defective O X
actin I-MISC 58
stress O X
fibre O X
formation O X
in O X
cells O X
. O X

Short O X
actin I-MISC 58
filaments O X
promote O X
dynamin I-MISC 1759
assembly O X
into O X
higher O X
order O X
structures O X
, O X
which O X
in O X
turn O X
efficiently O X
release O X
the O X
actin I-MISC 58
- O X
capping O X
protein O X
( O X
CP O X
) O X
gelsolin I-MISC 2934
from O X
barbed O X
actin I-MISC 58
ends O X
in O X
vitro O X
, O X
allowing O X
for O X
elongation O X
of O X
actin I-MISC 58
filaments O X
. O X

Together O X
, O X
our O X
results O X
support O X
a O X
model O X
in O X
which O X
assembled O X
dynamin I-MISC 1759
, O X
generated O X
through O X
interactions O X
with O X
short O X
actin I-MISC 58
filaments O X
, O X
promotes O X
actin I-MISC 58
polymerization O X
via O X
displacement O X
of O X
actin I-MISC 58
- O X
CPs O X
. O X

###27013965	120892,120892

Protective O X
LRRK2 I-MISC 120892
R1398H O X
Variant O X
Enhances O X
GTPase O X
and O X
Wnt O X
Signaling O X
Activity O X
. O X

Mutations O X
in O X
LRRK2 I-MISC 120892
are O X
a O X
common O X
cause O X
of O X
familial O X
and O X
idiopathic O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

Recently O X
, O X
the O X
LRRK2 I-MISC 120892
GTPase O X
domain O X
R1398H O X
variant O X
was O X
suggested O X
in O X
genetic O X
studies O X
to O X
confer O X
protection O X
against O X
PD O X
but O X
mechanistic O X
data O X
supporting O X
this O X
is O X
lacking O X
. O X

Here O X
, O X
we O X
present O X
evidence O X
that O X
R1398H O X
affects O X
GTPase O X
function O X
, O X
axon O X
outgrowth O X
, O X
and O X
Wnt O X
signaling O X
in O X
a O X
manner O X
opposite O X
to O X
pathogenic O X
LRRK2 I-MISC 120892
mutations O X
. O X

LRRK2 I-MISC 120892
R1398H O X
GTPase O X
domain O X
dimerization O X
and O X
GTP O X
hydrolysis O X
were O X
increased O X
whereas O X
GTP O X
binding O X
was O X
reduced O X
, O X
leading O X
to O X
a O X
decrease O X
in O X
active O X
GTP O X
- O X
bound O X
LRRK2 I-MISC 120892
. O X

This O X
protective O X
variant O X
also O X
increased O X
axon O X
length O X
of O X
primary O X
cortical O X
neurones O X
in O X
comparison O X
to O X
wild O X
- O X
type O X
LRRK2 I-MISC 120892
, O X
whereas O X
the O X
R1441G O X
LRRK2 I-MISC 120892
pathogenic O X
mutant O X
decreased O X
axon O X
outgrowth O X
. O X

Importantly O X
, O X
R1398H O X
enhanced O X
the O X
stimulatory O X
effect O X
of O X
LRRK2 I-MISC 120892
on O X
canonical O X
Wnt O X
signaling O X
whereas O X
the O X
G2385R O X
risk O X
variant O X
, O X
in O X
accordance O X
with O X
all O X
previously O X
tested O X
pathogenic O X
LRRK2 I-MISC 120892
mutants O X
, O X
had O X
the O X
opposite O X
effect O X
. O X

Molecular O X
modeling O X
placed O X
R1398H O X
in O X
close O X
proximity O X
to O X
PD O X
- O X
causing O X
mutations O X
suggesting O X
that O X
this O X
protective O X
LRRK2 I-MISC 120892
variant O X
, O X
like O X
familial O X
mutations O X
, O X
affects O X
intramolecular O X
RocCOR O X
domain O X
interactions O X
. O X

Thus O X
, O X
our O X
data O X
suggest O X
that O X
R1398H O X
LRRK2 I-MISC 120892
is O X
a O X
bona O X
fide O X
protective O X
variant O X
. O X

The O X
opposite O X
effects O X
of O X
protective O X
versus O X
PD O X
associated O X
LRRK2 I-MISC 120892
variants O X
on O X
GTPase O X
function O X
and O X
canonical O X
Wnt O X
signaling O X
activity O X
also O X
suggests O X
that O X
regulation O X
of O X
these O X
two O X
basic O X
signaling O X
mechanisms O X
is O X
important O X
for O X
neuronal O X
function O X
. O X

We O X
conclude O X
that O X
LRRK2 I-MISC 120892
mediated O X
Wnt O X
signaling O X
and O X
GTPase O X
function O X
are O X
fundamental O X
in O X
conferring O X
disease O X
susceptibility O X
and O X
have O X
clear O X
implications O X
for O X
therapeutic O X
target O X
identification O X
. O X

###12351681	35956,40554	43283,40554

A O X
heterotrimeric O X
death O X
domain O X
complex O X
in O X
Toll I-MISC 43222
signaling O X
. O X

Signaling O X
from O X
the O X
transmembrane O X
receptor O X
Toll I-MISC 43222
to O X
Rel I-MISC 41087
- O X
related O X
transcription O X
factors O X
regulates O X
dorsoventral O X
patterning O X
of O X
the O X
Drosophila O X
embryo O X
, O X
as O X
well O X
as O X
larval O X
and O X
adult O X
immunity O X
. O X

To O X
identify O X
additional O X
pathway O X
components O X
, O X
we O X
have O X
used O X
double O X
- O X
stranded O X
RNA O X
interference O X
to O X
investigate O X
Drosophila O X
counterparts O X
of O X
genes O X
that O X
regulate O X
the O X
mammalian O X
Rel I-MISC 5966
family O X
member O X
NF O X
- O X
kappaB O X
. O X

Experiments O X
in O X
cultured O X
cells O X
reveal O X
that O X
the O X
fly O X
orthologue O X
of O X
the O X
adaptor O X
protein O X
MyD88 I-MISC 35956
is O X
essential O X
for O X
signal O X
transduction O X
from O X
Toll I-MISC 43222
to O X
a O X
second O X
adaptor O X
protein O X
, O X
Tube I-MISC 40554
. O X

By O X
using O X
coimmunoprecipitation O X
studies O X
, O X
we O X
find O X
a O X
heterotrimeric O X
association O X
of O X
the O X
death O X
domains O X
of O X
MyD88 I-MISC 35956
, O X
Tube I-MISC 40554
, O X
and O X
the O X
protein O X
kinase O X
Pelle I-MISC 43283
. O X

Site O X
- O X
directed O X
mutational O X
analyses O X
of O X
interaction O X
sites O X
defined O X
by O X
crystallographic O X
studies O X
demonstrate O X
that O X
Tube I-MISC 40554
recruits O X
MyD88 I-MISC 35956
and O X
Pelle I-MISC 43283
into O X
the O X
heterotrimer O X
by O X
two O X
distinct O X
binding O X
surfaces O X
on O X
the O X
Tube I-MISC 40554
death O X
domain O X
. O X

Furthermore O X
, O X
functional O X
assays O X
confirm O X
that O X
the O X
formation O X
of O X
this O X
heterotrimer O X
is O X
critical O X
for O X
signal O X
transduction O X
by O X
the O X
Toll I-MISC 43222
pathway O X
. O X

###14715275	3772007,39844

Rpp20 I-MISC 3772007
interacts O X
with O X
SMN I-MISC 39844
and O X
is O X
re O X
- O X
distributed O X
into O X
SMN I-MISC 39844
granules O X
in O X
response O X
to O X
stress O X
. O X

Spinal O X
muscular O X
atrophy O X
( O X
SMA O X
) O X
is O X
a O X
neurodegenerative O X
disorder O X
resulting O X
from O X
homozygous O X
loss O X
of O X
the O X
SMN1 I-MISC 39844
gene O X
. O X

To O X
investigate O X
SMN I-MISC 39844
functions O X
, O X
we O X
undertook O X
the O X
yeast O X
two O X
- O X
hybrid O X
screens O X
and O X
identified O X
Drosophila O X
Rpp20 I-MISC 3772007
, O X
a O X
subunit O X
of O X
the O X
RNase I-MISC 44392
P I-MISC 44392
and O X
RNase O X
MRP O X
holoenzymes O X
, O X
to O X
interact O X
with O X
the O X
Drosophila O X
SMN I-MISC 39844
protein O X
. O X

Interaction O X
between O X
human O X
SMN I-MISC 39844
and O X
Rpp20 I-MISC 3772007
was O X
validated O X
by O X
in O X
vitro O X
binding O X
assays O X
and O X
co O X
- O X
immunoprecipitation O X
. O X

The O X
exons O X
3 O X
- O X
4 O X
of O X
SMN I-MISC 39844
are O X
necessary O X
and O X
sufficient O X
for O X
binding O X
to O X
Rpp20 I-MISC 3772007
. O X

Binding O X
efficiency O X
between O X
Rpp20 I-MISC 3772007
and O X
SMNs O X
with O X
mutations O X
in O X
the O X
Y O X
- O X
G O X
domain O X
is O X
abrogated O X
or O X
reduced O X
and O X
correlated O X
with O X
severity O X
of O X
SMA O X
disease O X
. O X

Immunofluorescence O X
results O X
indicate O X
that O X
Rpp20 I-MISC 3772007
is O X
diffusely O X
distributed O X
throughout O X
the O X
cytoplasm O X
with O X
higher O X
concentration O X
observed O X
in O X
the O X
nucleus O X
. O X

However O X
, O X
in O X
response O X
to O X
stress O X
, O X
SMN I-MISC 39844
forms O X
aggregates O X
and O X
redistributes O X
Rpp20 I-MISC 3772007
into O X
punctuated O X
cytoplasmic O X
SMN I-MISC 39844
granules O X
. O X

Our O X
findings O X
suggest O X
a O X
possible O X
functional O X
association O X
of O X
SMN I-MISC 39844
with O X
RNase I-MISC 44392
P I-MISC 44392
and O X
RNase O X
MRP O X
complexes O X
. O X

###16000169	5111,10714

An O X
in O X
vivo O X
analysis O X
of O X
the O X
localisation O X
and O X
interactions O X
of O X
human O X
p66 I-MISC 10714
DNA B-MISC 5425
polymerase I-MISC 5425
delta I-MISC 5425
subunit O X
. O X

BACKGROUND O X
: O X
DNA I-MISC 5425
polymerase I-MISC 5425
delta I-MISC 5425
is O X
essential O X
for O X
eukaryotic O X
DNA O X
replication O X
and O X
also O X
plays O X
a O X
role O X
in O X
DNA O X
repair O X
. O X

The O X
processivity O X
of O X
this O X
polymerase O X
complex O X
is O X
dependent O X
upon O X
its O X
interaction O X
with O X
the O X
sliding O X
clamp O X
PCNA I-MISC 5111
and O X
the O X
polymerase O X
- O X
PCNA I-MISC 5111
interaction O X
is O X
largely O X
mediated O X
through O X
the O X
p66 I-MISC 10714
polymerase O X
subunit O X
. O X

We O X
have O X
analysed O X
the O X
interactions O X
of O X
the O X
human O X
p66 I-MISC 10714
DNA B-MISC 5425
polymerase I-MISC 5425
delta I-MISC 5425
subunit O X
with O X
PCNA I-MISC 5111
and O X
with O X
components O X
of O X
the O X
DNA I-MISC 5425
polymerase I-MISC 5425
delta I-MISC 5425
complex O X
in O X
vivo O X
. O X

RESULTS O X
: O X
Using O X
the O X
two O X
- O X
hybrid O X
system O X
, O X
we O X
have O X
mapped O X
the O X
interaction O X
domains O X
for O X
binding O X
to O X
the O X
p50 I-MISC 4790
polymerase O X
delta O X
subunit O X
and O X
with O X
PCNA I-MISC 5111
to O X
the O X
N O X
- O X
terminus O X
and O X
the O X
C O X
- O X
terminus O X
of O X
p66 I-MISC 10714
, O X
respectively O X
. O X

Co O X
- O X
immunoprecipitation O X
experiments O X
confirm O X
that O X
these O X
interaction O X
domains O X
are O X
functional O X
in O X
vivo O X
. O X

Expression O X
of O X
EGFP O X
- O X
p66 I-MISC 10714
shows O X
that O X
it O X
is O X
a O X
nuclear O X
protein O X
which O X
co O X
- O X
localises O X
with O X
PCNA I-MISC 5111
throughout O X
the O X
cell O X
cycle O X
. O X

p66 I-MISC 10714
is O X
localised O X
to O X
sites O X
of O X
DNA O X
replication O X
during O X
S O X
phase O X
and O X
to O X
repair O X
foci O X
following O X
DNA O X
damage O X
. O X

We O X
have O X
identified O X
a O X
functional O X
nuclear O X
localisation O X
sequence O X
and O X
shown O X
that O X
localisation O X
to O X
replication O X
foci O X
is O X
not O X
dependent O X
upon O X
active O X
nuclear O X
import O X
. O X

Sub O X
- O X
domains O X
of O X
p66 I-MISC 10714
act O X
as O X
dominant O X
negative O X
suppressors O X
of O X
colony O X
formation O X
, O X
suggesting O X
that O X
p66 I-MISC 10714
forms O X
an O X
essential O X
structural O X
link O X
between O X
the O X
p50 I-MISC 4790
subunit O X
and O X
PCNA I-MISC 5111
. O X

Analysis O X
of O X
the O X
C O X
- O X
terminal O X
PCNA I-MISC 5111
binding O X
motif O X
shows O X
that O X
deletion O X
of O X
the O X
QVSITGFF O X
core O X
motif O X
results O X
in O X
a O X
reduced O X
affinity O X
for O X
PCNA I-MISC 5111
, O X
while O X
deletion O X
of O X
a O X
further O X
20 O X
amino O X
acids O X
completely O X
abolishes O X
the O X
interaction O X
. O X

A O X
reduced O X
affinity O X
for O X
PCNA I-MISC 5111
correlates O X
with O X
reduced O X
targeting O X
to O X
replication O X
foci O X
. O X

We O X
have O X
confirmed O X
the O X
p66 I-MISC 10714
- O X
PCNA I-MISC 5111
interaction O X
in O X
vivo O X
using O X
fluorescence O X
resonance O X
energy O X
transfer O X
( O X
FRET O X
) O X
techniques O X
. O X

CONCLUSION O X
: O X
We O X
have O X
defined O X
the O X
regions O X
of O X
p66 I-MISC 10714
required O X
for O X
its O X
interaction O X
with O X
PCNA I-MISC 5111
and O X
the O X
p50 I-MISC 4790
polymerase O X
subunit O X
. O X

We O X
demonstrate O X
a O X
functional O X
link O X
between O X
PCNA I-MISC 5111
interaction O X
and O X
localisation O X
to O X
replication O X
foci O X
and O X
show O X
that O X
there O X
is O X
a O X
direct O X
interaction O X
between O X
p66 I-MISC 10714
and O X
PCNA I-MISC 5111
in O X
living O X
cells O X
during O X
DNA O X
replication O X
. O X

The O X
dominant O X
negative O X
effect O X
upon O X
growth O X
resulting O X
from O X
expression O X
of O X
p66 I-MISC 10714
sub O X
- O X
domains O X
confirms O X
that O X
the O X
p66 I-MISC 10714
- O X
PCNA I-MISC 5111
interaction O X
is O X
essential O X
in O X
vivo O X
. O X

###11402167	832494,833502

Molecular O X
characterization O X
of O X
functional O X
domains O X
in O X
the O X
protein O X
kinase O X
SOS2 I-MISC 833502
that O X
is O X
required O X
for O X
plant O X
salt O X
tolerance O X
. O X

The O X
SOS3 I-MISC 832494
( O X
for O X
SALT I-MISC 832494
OVERLY I-MISC 832494
SENSITIVE3 I-MISC 832494
) O X
calcium O X
binding O X
protein O X
and O X
SOS2 I-MISC 833502
protein O X
kinase O X
are O X
required O X
for O X
sodium O X
and O X
potassium O X
ion O X
homeostasis O X
and O X
salt O X
tolerance O X
in O X
Arabidopsis O X
. O X

We O X
have O X
shown O X
previously O X
that O X
SOS3 I-MISC 832494
interacts O X
with O X
and O X
activates O X
the O X
SOS2 I-MISC 833502
protein O X
kinase O X
. O X

We O X
report O X
here O X
the O X
identification O X
of O X
a O X
SOS3 I-MISC 832494
binding O X
motif O X
in O X
SOS2 I-MISC 833502
that O X
also O X
serves O X
as O X
the O X
kinase O X
autoinhibitory O X
domain O X
. O X

Yeast O X
two O X
- O X
hybrid O X
assays O X
as O X
well O X
as O X
in O X
vitro O X
binding O X
assays O X
revealed O X
a O X
21 O X
- O X
amino O X
acid O X
motif O X
in O X
the O X
regulatory O X
domain O X
of O X
SOS2 I-MISC 833502
that O X
is O X
necessary O X
and O X
sufficient O X
for O X
interaction O X
with O X
SOS3 I-MISC 832494
. O X

Database O X
searches O X
revealed O X
a O X
large O X
family O X
of O X
SOS2 I-MISC 833502
- O X
like O X
protein O X
kinases O X
containing O X
such O X
a O X
SOS3 I-MISC 832494
binding O X
motif O X
. O X

Using O X
a O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
we O X
show O X
that O X
these O X
SOS2 I-MISC 833502
- O X
like O X
kinases O X
interact O X
with O X
members O X
of O X
the O X
SOS3 I-MISC 832494
family O X
of O X
calcium O X
binding O X
proteins O X
. O X

Two O X
- O X
hybrid O X
assays O X
also O X
revealed O X
interaction O X
between O X
the O X
N O X
- O X
terminal O X
kinase O X
domain O X
and O X
the O X
C O X
- O X
terminal O X
regulatory O X
domain O X
within O X
SOS2 I-MISC 833502
, O X
suggesting O X
that O X
the O X
regulatory O X
domain O X
may O X
inhibit O X
kinase O X
activity O X
by O X
blocking O X
substrate O X
access O X
to O X
the O X
catalytic O X
site O X
. O X

Removal O X
of O X
the O X
regulatory O X
domain O X
of O X
SOS2 I-MISC 833502
, O X
including O X
the O X
SOS3 I-MISC 832494
binding O X
motif O X
, O X
resulted O X
in O X
constitutive O X
activation O X
of O X
the O X
protein O X
kinase O X
, O X
indicating O X
that O X
the O X
SOS3 I-MISC 832494
binding O X
motif O X
can O X
serve O X
as O X
a O X
kinase O X
autoinhibitory O X
domain O X
. O X

Constitutively O X
active O X
SOS2 I-MISC 833502
that O X
is O X
SOS3 I-MISC 832494
independent O X
also O X
was O X
produced O X
by O X
changing O X
Thr O X
( O X
168 O X
) O X
to O X
Asp O X
in O X
the O X
activation O X
loop O X
of O X
the O X
SOS2 I-MISC 833502
kinase O X
domain O X
. O X

Combining O X
the O X
Thr O X
( O X
168 O X
)- O X
to O X
- O X
Asp O X
mutation O X
with O X
the O X
autoinhibitory O X
domain O X
deletion O X
created O X
a O X
superactive O X
SOS2 I-MISC 833502
kinase O X
. O X

These O X
results O X
provide O X
insights O X
into O X
regulation O X
of O X
the O X
kinase O X
activities O X
of O X
SOS2 I-MISC 833502
and O X
the O X
SOS2 I-MISC 833502
family O X
of O X
protein O X
kinases O X
. O X

###22303461	120892,4137

LRRK2 I-MISC 120892
phosphorylates O X
tubulin O X
- O X
associated O X
tau I-MISC 4137
but O X
not O X
the O X
free O X
molecule O X
: O X
LRRK2 I-MISC 120892
- O X
mediated O X
regulation O X
of O X
the O X
tau I-MISC 4137
- O X
tubulin O X
association O X
and O X
neurite O X
outgrowth O X
. O X

Leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
), O X
a O X
large O X
protein O X
kinase O X
containing O X
multi O X
- O X
functional O X
domains O X
, O X
has O X
been O X
identified O X
as O X
the O X
causal O X
molecule O X
for O X
autosomal O X
- O X
dominant O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

In O X
the O X
present O X
study O X
, O X
we O X
demonstrated O X
for O X
the O X
first O X
time O X
that O X
( O X
i O X
) O X
LRRK2 I-MISC 120892
interacts O X
with O X
tau I-MISC 4137
in O X
a O X
tubulin O X
- O X
dependent O X
manner O X
; O X
( O X
ii O X
) O X
LRRK2 I-MISC 120892
directly O X
phosphorylates O X
tubulin O X
- O X
associated O X
tau I-MISC 4137
, O X
but O X
not O X
free O X
tau I-MISC 4137
; O X
( O X
iii O X
) O X
LRRK2 I-MISC 120892
phosphorylates O X
tau I-MISC 4137
at O X
Thr181 O X
as O X
one O X
of O X
the O X
target O X
sites O X
; O X
and O X
( O X
iv O X
) O X
The O X
PD O X
- O X
associated O X
LRRK2 I-MISC 120892
mutations O X
, O X
G2019S O X
and O X
I2020T O X
, O X
elevated O X
the O X
degree O X
of O X
tau I-MISC 4137
- O X
phosphorylation O X
. O X

These O X
results O X
provide O X
direct O X
proof O X
that O X
tau I-MISC 4137
is O X
a O X
physiological O X
substrate O X
for O X
LRRK2 I-MISC 120892
. O X

Furthermore O X
, O X
we O X
revealed O X
that O X
LRRK2 I-MISC 120892
- O X
mediated O X
phosphorylation O X
of O X
tau I-MISC 4137
reduces O X
its O X
tubulin O X
- O X
binding O X
ability O X
. O X

Our O X
results O X
suggest O X
that O X
LRRK2 I-MISC 120892
plays O X
an O X
important O X
role O X
as O X
a O X
physiological O X
regulator O X
for O X
phosphorylation O X
- O X
mediated O X
dissociation O X
of O X
tau I-MISC 4137
from O X
microtubules O X
, O X
which O X
is O X
an O X
integral O X
aspect O X
of O X
microtubule O X
dynamics O X
essential O X
for O X
neurite O X
outgrowth O X
and O X
axonal O X
transport O X
. O X

###11423549	87,7791

Analysis O X
of O X
the O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
/ O X
zyxin I-MISC 7791
interaction O X
. O X

The O X
yeast O X
two O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
search O X
for O X
interaction O X
partners O X
of O X
human O X
zyxin I-MISC 7791
. O X

Screening O X
of O X
two O X
different O X
cDNA O X
libraries O X
, O X
one O X
prepared O X
from O X
human O X
placenta O X
, O X
the O X
other O X
from O X
human O X
heart O X
, O X
yielded O X
several O X
positive O X
clones O X
that O X
occurred O X
in O X
both O X
searches O X
, O X
including O X
clones O X
coding O X
for O X
cyclophilin O X
, O X
nebulette O X
, O X
and O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
. O X

The O X
zyxin I-MISC 7791
/ O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
interaction O X
was O X
analyzed O X
in O X
detail O X
. O X

By O X
site O X
- O X
directed O X
mutagenesis O X
, O X
a O X
linear O X
motif O X
of O X
6 O X
amino O X
acids O X
( O X
Phe O X
- O X
Gly O X
- O X
Pro O X
- O X
Val O X
- O X
Val O X
- O X
Ala O X
) O X
present O X
at O X
the O X
N O X
terminus O X
of O X
zyxin I-MISC 7791
was O X
found O X
to O X
play O X
a O X
critical O X
role O X
. O X

Replacement O X
of O X
a O X
single O X
amino O X
acid O X
within O X
this O X
motif O X
abolished O X
binding O X
to O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
in O X
blot O X
overlays O X
as O X
well O X
as O X
in O X
living O X
cells O X
. O X

On O X
the O X
other O X
hand O X
, O X
the O X
interaction O X
site O X
in O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
was O X
mapped O X
to O X
a O X
conformational O X
determinant O X
present O X
in O X
the O X
center O X
of O X
the O X
protein O X
as O X
demonstrated O X
by O X
a O X
fragment O X
deletion O X
analysis O X
. O X

This O X
binding O X
site O X
involved O X
a O X
tandem O X
array O X
of O X
two O X
complete O X
spectrin O X
- O X
like O X
domains O X
. O X

Only O X
fragments O X
that O X
were O X
able O X
to O X
dimerize O X
in O X
yeast O X
also O X
bound O X
to O X
zyxin I-MISC 7791
, O X
suggesting O X
that O X
dimerization O X
of O X
alpha I-MISC 87
- I-MISC 87
actinin I-MISC 87
is O X
essential O X
for O X
zyxin I-MISC 7791
binding O X
. O X

###21073465	120892,120892

Insight O X
into O X
the O X
mode O X
of O X
action O X
of O X
the O X
LRRK2 I-MISC 120892
Y1699C O X
pathogenic O X
mutant O X
. O X

Mutations O X
in O X
the O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
gene O X
are O X
the O X
most O X
prevalent O X
known O X
cause O X
of O X
autosomal O X
dominant O X
Parkinson O X
' O X
s O X
disease O X
. O X

The O X
LRRK2 I-MISC 120892
gene O X
encodes O X
a O X
Roco O X
protein O X
featuring O X
a O X
Ras O X
of O X
complex O X
proteins O X
( O X
ROC O X
) O X
GTPase O X
and O X
a O X
kinase O X
domain O X
linked O X
by O X
the O X
C O X
- O X
terminal O X
of O X
ROC O X
( O X
COR O X
) O X
domain O X
. O X

Here O X
, O X
we O X
explored O X
the O X
effects O X
of O X
the O X
Y1699C O X
pathogenic O X
LRRK2 I-MISC 120892
mutation O X
in O X
the O X
COR O X
domain O X
on O X
GTPase O X
activity O X
and O X
interactions O X
within O X
the O X
catalytic O X
core O X
of O X
LRRK2 I-MISC 120892
. O X

We O X
observed O X
a O X
decrease O X
in O X
GTPase O X
activity O X
for O X
LRRK2 I-MISC 120892
Y1699C O X
comparable O X
to O X
the O X
decrease O X
observed O X
for O X
the O X
R1441C O X
pathogenic O X
mutant O X
and O X
the O X
T1348N O X
dysfunctional O X
mutant O X
. O X

To O X
study O X
the O X
underlying O X
mechanism O X
, O X
we O X
explored O X
the O X
dimerization O X
in O X
the O X
catalytic O X
core O X
of O X
LRRK2 I-MISC 120892
. O X

ROC O X
- O X
COR O X
dimerization O X
was O X
significantly O X
weakened O X
by O X
the O X
Y1699C O X
or O X
R1441C O X
/ O X
G O X
mutation O X
. O X

Using O X
a O X
competition O X
assay O X
, O X
we O X
demonstrated O X
that O X
the O X
intra O X
- O X
molecular O X
ROC O X
: O X
COR O X
interaction O X
is O X
favoured O X
over O X
ROC O X
: O X
ROC O X
dimerization O X
. O X

Interestingly O X
, O X
the O X
intra O X
- O X
molecular O X
ROC O X
: O X
COR O X
interaction O X
was O X
strengthened O X
by O X
the O X
Y1699C O X
mutation O X
. O X

This O X
is O X
supported O X
by O X
a O X
3D O X
homology O X
model O X
of O X
the O X
ROC O X
- O X
COR O X
tandem O X
of O X
LRRK2 I-MISC 120892
, O X
showing O X
that O X
Y1699 I-MISC 1146646
is O X
positioned O X
at O X
the O X
intra O X
- O X
molecular O X
ROC O X
: O X
COR O X
interface O X
. O X

In O X
conclusion O X
, O X
our O X
data O X
provides O X
mechanistic O X
insight O X
into O X
the O X
mode O X
of O X
action O X
of O X
the O X
Y1699C O X
LRRK2 I-MISC 120892
mutant O X
: O X
the O X
Y1699C O X
substitution O X
, O X
situated O X
at O X
the O X
intra O X
- O X
molecular O X
ROC O X
: O X
COR O X
interface O X
, O X
strengthens O X
the O X
intra O X
- O X
molecular O X
ROC O X
: O X
COR O X
interaction O X
, O X
thereby O X
locally O X
weakening O X
the O X
dimerization O X
of O X
LRRK2 I-MISC 120892
at O X
the O X
ROC O X
- O X
COR O X
tandem O X
domain O X
resulting O X
in O X
decreased O X
GTPase O X
activity O X
. O X

###24835508	237336,2957

Activity O X
of O X
the O X
upstream O X
TATA O X
- O X
less O X
promoter O X
of O X
the O X
p21 I-MISC 1026
( I-MISC 1026
Waf1 I-MISC 1026
/ I-MISC 1026
Cip1 I-MISC 1026
) I-MISC 1026
gene O X
depends O X
on O X
transcription I-MISC 2957
factor I-MISC 2957
IIA I-MISC 2957
( O X
TFIIA I-MISC 2957
) O X
in O X
addition O X
to O X
TFIIA I-MISC 2957
- O X
reactive O X
TBP O X
- O X
like O X
protein O X
. O X

TATA I-MISC 237336
- I-MISC 237336
binding I-MISC 237336
protein I-MISC 237336
- I-MISC 237336
like I-MISC 237336
protein I-MISC 237336
( O X
TLP I-MISC 237336
) O X
binds O X
to O X
transcription I-MISC 2957
factor I-MISC 2957
IIA I-MISC 2957
( O X
TFIIA I-MISC 2957
) O X
with O X
high O X
affinity O X
, O X
although O X
the O X
significance O X
of O X
this O X
binding O X
is O X
poorly O X
understood O X
. O X

In O X
this O X
study O X
, O X
we O X
investigated O X
the O X
role O X
of O X
TFIIA I-MISC 2957
in O X
transcriptional O X
regulation O X
of O X
the O X
p21 I-MISC 1026
( I-MISC 1026
Waf1 I-MISC 1026
/ I-MISC 1026
Cip1 I-MISC 1026
) I-MISC 1026
( O X
p21 I-MISC 1026
) O X
gene O X
. O X

It O X
has O X
been O X
shown O X
that O X
TLP I-MISC 237336
is O X
indispensable O X
for O X
p53 I-MISC 7157
- O X
activated O X
transcription O X
from O X
an O X
upstream O X
TATA O X
- O X
less O X
promoter O X
of O X
the O X
p21 I-MISC 1026
gene O X
. O X

We O X
found O X
that O X
mutant O X
TLPs O X
having O X
decreased O X
TFIIA I-MISC 2957
- O X
binding O X
ability O X
exhibited O X
weakened O X
transcriptional O X
activation O X
function O X
for O X
the O X
upstream O X
promoter O X
. O X

Activity O X
of O X
the O X
upstream O X
promoter O X
was O X
enhanced O X
considerably O X
by O X
an O X
increased O X
amount O X
of O X
TFIIA I-MISC 2957
in O X
a O X
p53 I-MISC 7157
- O X
dependent O X
manner O X
, O X
whereas O X
activity O X
of O X
the O X
TATA O X
- O X
containing O X
downstream O X
promoter O X
was O X
enhanced O X
only O X
slightly O X
. O X

TFIIA I-MISC 2957
potentiated O X
the O X
upstream O X
promoter O X
additively O X
with O X
TLP I-MISC 237336
. O X

Although O X
TFIIA I-MISC 2957
is O X
recruited O X
to O X
both O X
promoters O X
, O X
activity O X
of O X
the O X
upstream O X
promoter O X
was O X
much O X
more O X
dependent O X
on O X
TFIIA I-MISC 2957
. O X

Recruitment O X
of O X
TFIIA I-MISC 2957
and O X
TLP I-MISC 237336
to O X
the O X
upstream O X
promoter O X
was O X
augmented O X
in O X
etoposide O X
- O X
treated O X
cells O X
, O X
in O X
which O X
the O X
amount O X
of O X
TFIIA I-MISC 2957
- O X
TLP I-MISC 237336
complex O X
is O X
increased O X
, O X
and O X
TFIIA I-MISC 2957
- O X
reactive O X
TLP I-MISC 237336
was O X
required O X
for O X
the O X
recruitment O X
of O X
both O X
factors O X
. O X

It O X
was O X
confirmed O X
that O X
etoposide O X
- O X
stimulated O X
transcription O X
depends O X
on O X
TLP I-MISC 237336
. O X

We O X
also O X
found O X
that O X
TFIIA I-MISC 2957
- O X
reactive O X
TLP I-MISC 237336
acts O X
to O X
decrease O X
cell O X
growth O X
rate O X
, O X
which O X
can O X
be O X
explained O X
by O X
interaction O X
of O X
the O X
p21 I-MISC 1026
promoter O X
with O X
the O X
transcription O X
factors O X
that O X
we O X
examined O X
. O X

The O X
results O X
of O X
the O X
present O X
study O X
suggest O X
that O X
the O X
upstream O X
TATA O X
- O X
less O X
promoter O X
of O X
p21 I-MISC 1026
needs O X
TFIIA I-MISC 2957
and O X
TFIIA I-MISC 2957
- O X
reactive O X
TLP I-MISC 237336
for O X
p53 I-MISC 7157
- O X
dependent O X
transcriptional O X
enhancement O X
. O X

###18067539	945651,945510

Different O X
regions O X
of O X
Mlc I-MISC 945510
and O X
NagC O X
, O X
homologous O X
transcriptional O X
repressors O X
controlling O X
expression O X
of O X
the O X
glucose O X
and O X
N O X
- O X
acetylglucosamine O X
phosphotransferase O X
systems O X
in O X
Escherichia O X
coli O X
, O X
are O X
required O X
for O X
inducer O X
signal O X
recognition O X
. O X

Mlc I-MISC 945510
and O X
NagC O X
are O X
two O X
homologous O X
transcription O X
factors O X
which O X
bind O X
to O X
similar O X
DNA O X
targets O X
but O X
for O X
which O X
the O X
inducing O X
signals O X
and O X
mechanisms O X
of O X
activation O X
are O X
very O X
different O X
. O X

Displacing O X
Mlc I-MISC 945510
from O X
its O X
DNA O X
binding O X
sites O X
necessitates O X
its O X
sequestration O X
to O X
the O X
inner O X
membrane O X
via O X
an O X
interaction O X
with O X
PtsG I-MISC 945651
( O X
EIICB I-MISC 945651
( I-MISC 945651
Glc I-MISC 945651
)), O X
while O X
NagC O X
is O X
displaced O X
from O X
its O X
DNA O X
targets O X
by O X
interacting O X
with O X
GlcNAc6P O X
. O X

We O X
have O X
isolated O X
mutations O X
in O X
both O X
proteins O X
which O X
prevent O X
the O X
inactivation O X
of O X
the O X
repressors O X
by O X
growth O X
on O X
glucose O X
or O X
GlcNAc O X
. O X

These O X
mutations O X
are O X
located O X
in O X
different O X
and O X
specific O X
regions O X
of O X
each O X
protein O X
. O X

For O X
Mlc I-MISC 945510
changes O X
at O X
the O X
C O X
- O X
terminal O X
make O X
it O X
a O X
constitutive O X
repressor O X
and O X
also O X
prevent O X
it O X
from O X
binding O X
to O X
EIIB I-MISC 945651
( I-MISC 945651
Glc I-MISC 945651
). O X

Mutations O X
in O X
NagC O X
, O X
at O X
positions O X
which O X
form O X
a O X
structural O X
motif O X
resembling O X
a O X
glucose O X
binding O X
site O X
in O X
Mlc I-MISC 945510
, O X
produce O X
permanently O X
repressing O X
forms O X
of O X
NagC O X
, O X
suggesting O X
that O X
this O X
motif O X
forms O X
a O X
GlcNAc6P O X
binding O X
site O X
in O X
NagC O X
. O X

The O X
pattern O X
of O X
repression O X
by O X
chimeric O X
proteins O X
of O X
NagC O X
and O X
Mlc I-MISC 945510
confirms O X
the O X
importance O X
of O X
the O X
C O X
- O X
terminal O X
region O X
of O X
Mlc I-MISC 945510
for O X
both O X
repression O X
and O X
inducer O X
binding O X
and O X
demonstrate O X
that O X
the O X
helix O X
- O X
turn O X
- O X
helix O X
DNA O X
- O X
binding O X
motif O X
is O X
not O X
sufficient O X
to O X
determine O X
the O X
specificity O X
of O X
interaction O X
of O X
the O X
repressor O X
with O X
DNA O X
. O X

###19625296	1855,120892

Mutations O X
in O X
the O X
LRRK2 I-MISC 120892
Roc O X
- O X
COR O X
tandem O X
domain O X
link O X
Parkinson O X
' O X
s O X
disease O X
to O X
Wnt O X
signalling O X
pathways O X
. O X

Mutations O X
in O X
PARK8 I-MISC 120892
, O X
encoding O X
LRRK2 I-MISC 120892
, O X
are O X
the O X
most O X
common O X
known O X
cause O X
of O X
Parkinson O X
' O X
s O X
disease O X
. O X

The O X
LRRK2 I-MISC 120892
Roc O X
- O X
COR O X
tandem O X
domain O X
exhibits O X
GTPase O X
activity O X
controlling O X
LRRK2 I-MISC 120892
kinase O X
activity O X
via O X
an O X
intramolecular O X
process O X
. O X

We O X
report O X
the O X
interaction O X
of O X
LRRK2 I-MISC 120892
with O X
the O X
dishevelled O X
family O X
of O X
phosphoproteins O X
( O X
DVL1 I-MISC 1855
- O X
3 O X
), O X
key O X
regulators O X
of O X
Wnt O X
( O X
Wingless O X
/ O X
Int O X
) O X
signalling O X
pathways O X
important O X
for O X
axon O X
guidance O X
, O X
synapse O X
formation O X
and O X
neuronal O X
maintenance O X
. O X

Interestingly O X
, O X
DVLs O X
can O X
interact O X
with O X
and O X
mediate O X
the O X
activation O X
of O X
small O X
GTPases O X
with O X
structural O X
similarity O X
to O X
the O X
LRRK2 I-MISC 120892
Roc O X
domain O X
. O X

The O X
LRRK2 I-MISC 120892
Roc O X
- O X
COR O X
domain O X
and O X
the O X
DVL1 I-MISC 1855
DEP O X
domain O X
were O X
necessary O X
and O X
sufficient O X
for O X
LRRK2 I-MISC 120892
- O X
DVL1 I-MISC 1855
interaction O X
. O X

Co O X
- O X
expression O X
of O X
DVL1 I-MISC 1855
increased O X
LRRK2 I-MISC 120892
steady O X
- O X
state O X
protein O X
levels O X
, O X
an O X
effect O X
that O X
was O X
dependent O X
on O X
the O X
DEP O X
domain O X
. O X

Strikingly O X
, O X
LRRK2 I-MISC 120892
- O X
DVL1 I-MISC 1855
- O X
3 O X
interactions O X
were O X
disrupted O X
by O X
the O X
familial O X
PARK8 I-MISC 120892
mutation O X
Y1699C O X
, O X
whereas O X
pathogenic O X
mutations O X
at O X
residues O X
R1441 I-MISC 175683
and O X
R1728 O X
strengthened O X
LRRK2 I-MISC 120892
- O X
DVL1 I-MISC 1855
interactions O X
. O X

Co O X
- O X
expression O X
of O X
DVL1 I-MISC 1855
with O X
LRRK2 I-MISC 120892
in O X
mammalian O X
cells O X
resulted O X
in O X
the O X
redistribution O X
of O X
LRRK2 I-MISC 120892
to O X
typical O X
cytoplasmic O X
DVL1 I-MISC 1855
aggregates O X
in O X
HEK293 O X
and O X
SH O X
- O X
SY5Y O X
cells O X
and O X
co O X
- O X
localization O X
in O X
neurites O X
and O X
growth O X
cones O X
of O X
differentiated O X
dopaminergic O X
SH O X
- O X
SY5Y O X
cells O X
. O X

This O X
is O X
the O X
first O X
report O X
of O X
the O X
modulation O X
of O X
a O X
key O X
LRRK2 I-MISC 120892
- O X
accessory O X
protein O X
interaction O X
by O X
PARK8 I-MISC 120892
Roc O X
- O X
COR O X
domain O X
mutations O X
segregating O X
with O X
Parkinson O X
' O X
s O X
disease O X
. O X

Since O X
the O X
DVL1 I-MISC 1855
DEP O X
domain O X
is O X
known O X
to O X
be O X
involved O X
in O X
the O X
regulation O X
of O X
small O X
GTPases O X
, O X
we O X
propose O X
that O X
: O X
( O X
i O X
) O X
DVLs O X
may O X
influence O X
LRRK2 I-MISC 120892
GTPase O X
activity O X
, O X
and O X
( O X
ii O X
) O X
Roc O X
- O X
COR O X
domain O X
mutations O X
modulating O X
LRRK2 I-MISC 120892
- O X
DVL I-MISC 1855
interactions O X
indirectly O X
influence O X
kinase O X
activity O X
. O X

Our O X
findings O X
also O X
link O X
LRRK2 I-MISC 120892
to O X
Wnt O X
signalling O X
pathways O X
, O X
suggesting O X
novel O X
pathogenic O X
mechanisms O X
and O X
new O X
targets O X
for O X
genetic O X
analysis O X
in O X
Parkinson O X
' O X
s O X
disease O X
. O X

###22345554	80854,9971

Direct O X
methylation O X
of O X
FXR I-MISC 9971
by O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
, O X
a O X
lysine O X
methyltransferase O X
, O X
regulates O X
the O X
expression O X
of O X
FXR I-MISC 9971
target O X
genes O X
. O X

The O X
farnesoid I-MISC 9971
X I-MISC 9971
receptor I-MISC 9971
( O X
FXR I-MISC 9971
) O X
is O X
a O X
ligand O X
( O X
bile O X
acid O X
)- O X
dependent O X
nuclear O X
receptor O X
that O X
regulates O X
target O X
genes O X
involved O X
in O X
every O X
aspect O X
of O X
bile O X
acid O X
homeostasis O X
. O X

Upon O X
binding O X
of O X
ligand O X
, O X
FXR I-MISC 9971
recruits O X
an O X
array O X
of O X
coactivators O X
and O X
associated O X
proteins O X
, O X
some O X
of O X
which O X
have O X
intrinsic O X
enzymatic O X
activity O X
that O X
modify O X
histones O X
or O X
even O X
components O X
of O X
the O X
transcriptional O X
complex O X
. O X

In O X
this O X
study O X
, O X
we O X
show O X
chromatin O X
occupancy O X
by O X
the O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
methyltransferase O X
at O X
the O X
FXR I-MISC 9971
response O X
element O X
( O X
FXRE O X
) O X
and O X
direct O X
methylation O X
of O X
FXR I-MISC 9971
in O X
vivo O X
and O X
in O X
vitro O X
at O X
lysine O X
206 O X
. O X
siRNA O X
depletion O X
of O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
in O X
the O X
Huh I-MISC 284424
- I-MISC 284424
7 I-MISC 284424
liver O X
cell O X
line O X
decreased O X
endogenous O X
mRNAs O X
of O X
the O X
FXR I-MISC 9971
target O X
genes O X
, O X
the O X
short O X
heterodimer O X
partner O X
( O X
SHP I-MISC 8431
) O X
and O X
bile I-MISC 8647
salt I-MISC 8647
export I-MISC 8647
pump I-MISC 8647
( O X
BSEP I-MISC 8647
). O X

Mutation O X
of O X
the O X
methylation O X
site O X
at O X
K206 O X
of O X
FXR I-MISC 9971
to O X
an O X
arginine O X
prevented O X
methylation O X
by O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
. O X

A O X
pan O X
- O X
methyllysine O X
antibody O X
recognized O X
the O X
wild O X
- O X
type O X
FXR I-MISC 9971
but O X
not O X
the O X
K206R O X
mutant O X
form O X
. O X

An O X
electromobility O X
shift O X
assay O X
showed O X
that O X
methylation O X
by O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
enhanced O X
binding O X
of O X
FXR I-MISC 9971
/ O X
retinoic O X
X O X
receptor O X
- O X
a O X
to O X
the O X
FXRE O X
. O X

Interaction O X
between O X
hinge O X
domain O X
of O X
FXR I-MISC 9971
( O X
containing O X
K206 O X
) O X
and O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
was O X
confirmed O X
by O X
coimmunoprecipitation O X
, O X
GST O X
pull O X
down O X
, O X
and O X
mammalian O X
two O X
- O X
hybrid O X
experiments O X
. O X

Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
overexpression O X
in O X
Huh I-MISC 284424
- I-MISC 284424
7 I-MISC 284424
cells O X
significantly O X
enhanced O X
transactivation O X
of O X
the O X
SHP I-MISC 8431
and O X
BSEP I-MISC 8647
promoters O X
in O X
a O X
ligand O X
- O X
dependent O X
fashion O X
by O X
wild O X
- O X
type O X
FXR I-MISC 9971
but O X
not O X
the O X
K206R O X
mutant O X
FXR I-MISC 9971
. O X

A O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
mutant O X
deficient O X
in O X
methyltransferase O X
activity O X
was O X
also O X
not O X
effective O X
in O X
increasing O X
transactivation O X
of O X
the O X
BSEP I-MISC 8647
promoter O X
. O X

These O X
studies O X
demonstrate O X
that O X
posttranslational O X
methylation O X
of O X
FXR I-MISC 9971
by O X
Set7 I-MISC 80854
/ I-MISC 80854
9 I-MISC 80854
contributes O X
to O X
the O X
transcriptional O X
activation O X
of O X
FXR I-MISC 9971
- O X
target O X
genes O X
. O X

###23299941	851163,851163

Dimerization O X
of O X
Sir3 I-MISC 851163
via O X
its O X
C O X
- O X
terminal O X
winged O X
helix O X
domain O X
is O X
essential O X
for O X
yeast O X
heterochromatin O X
formation O X
. O X

Gene O X
silencing O X
in O X
budding O X
yeast O X
relies O X
on O X
the O X
binding O X
of O X
the O X
Silent O X
Information O X
Regulator O X
( O X
Sir O X
) O X
complex O X
to O X
chromatin O X
, O X
which O X
is O X
mediated O X
by O X
extensive O X
interactions O X
between O X
the O X
Sir O X
proteins O X
and O X
nucleosomes O X
. O X

Sir3 I-MISC 851163
, O X
a O X
divergent O X
member O X
of O X
the O X
AAA O X
+ O X
ATPase O X
- O X
like O X
family O X
, O X
contacts O X
both O X
the O X
histone O X
H4 O X
tail O X
and O X
the O X
nucleosome O X
core O X
. O X

Here O X
, O X
we O X
present O X
the O X
structure O X
and O X
function O X
of O X
the O X
conserved O X
C O X
- O X
terminal O X
domain O X
of O X
Sir3 I-MISC 851163
, O X
comprising O X
138 O X
amino O X
acids O X
. O X

This O X
module O X
adopts O X
a O X
variant O X
winged O X
helix O X
- O X
turn O X
- O X
helix O X
( O X
wH O X
) O X
architecture O X
that O X
exists O X
as O X
a O X
stable O X
homodimer O X
in O X
solution O X
. O X

Mutagenesis O X
shows O X
that O X
the O X
self O X
- O X
association O X
mediated O X
by O X
this O X
domain O X
is O X
essential O X
for O X
holo O X
- O X
Sir3 I-MISC 851163
dimerization O X
. O X

Its O X
loss O X
impairs O X
Sir3 I-MISC 851163
loading O X
onto O X
nucleosomes O X
in O X
vitro O X
and O X
eliminates O X
silencing O X
at O X
telomeres O X
and O X
HM O X
loci O X
in O X
vivo O X
. O X

Replacing O X
the O X
Sir3 I-MISC 851163
wH O X
domain O X
with O X
an O X
unrelated O X
bacterial O X
dimerization O X
motif O X
restores O X
both O X
HM O X
and O X
telomeric O X
repression O X
in O X
sir3 I-MISC 851163
/\ O X
cells O X
. O X

In O X
contrast O X
, O X
related O X
wH O X
domains O X
of O X
archaeal O X
and O X
human O X
members O X
of O X
the O X
Orc1 I-MISC 4998
/ O X
Sir3 I-MISC 851163
family O X
are O X
monomeric O X
and O X
have O X
DNA O X
binding O X
activity O X
. O X

We O X
speculate O X
that O X
a O X
dimerization O X
function O X
for O X
the O X
wH O X
evolved O X
with O X
Sir3 I-MISC 851163
' O X
s O X
ability O X
to O X
facilitate O X
heterochromatin O X
formation O X
. O X

###11046132	5159,100009196

Platelet O X
- O X
derived O X
growth O X
factor O X
receptor O X
association O X
with O X
Na I-MISC 100009196
(+)/ I-MISC 100009196
H I-MISC 100009196
(+) I-MISC 100009196
exchanger I-MISC 100009196
regulatory I-MISC 100009196
factor I-MISC 100009196
potentiates O X
receptor O X
activity O X
. O X

Platelet O X
- O X
derived O X
growth O X
factor O X
( O X
PDGF O X
) O X
is O X
a O X
potent O X
mitogen O X
for O X
many O X
cell O X
types O X
. O X

The O X
PDGF I-MISC 5159
receptor I-MISC 5159
( O X
PDGFR I-MISC 5159
) O X
is O X
a O X
receptor O X
tyrosine O X
kinase O X
that O X
mediates O X
the O X
mitogenic O X
effects O X
of O X
PDGF O X
by O X
binding O X
to O X
and O X
/ O X
or O X
phosphorylating O X
a O X
variety O X
of O X
intracellular O X
signaling O X
proteins O X
upon O X
PDGF O X
- O X
induced O X
receptor O X
dimerization O X
. O X

We O X
show O X
here O X
that O X
the O X
Na I-MISC 100009196
(+)/ I-MISC 100009196
H I-MISC 100009196
(+) I-MISC 100009196
exchanger I-MISC 100009196
regulatory I-MISC 100009196
factor I-MISC 100009196
( O X
NHERF I-MISC 100009196
; O X
also O X
known O X
as O X
EBP50 I-MISC 100009196
), O X
a O X
protein O X
not O X
previously O X
known O X
to O X
interact O X
with O X
the O X
PDGFR I-MISC 5159
, O X
binds O X
to O X
the O X
PDGFR I-MISC 5159
carboxyl O X
terminus O X
( O X
PDGFR I-MISC 5159
- O X
CT O X
) O X
with O X
high O X
affinity O X
via O X
a O X
PDZ O X
( O X
PSD I-MISC 1742
- I-MISC 1742
95 I-MISC 1742
/ O X
Dlg O X
/ O X
Z0 O X
- O X
1 O X
homology O X
) O X
domain O X
- O X
mediated O X
interaction O X
and O X
potentiates O X
PDGFR I-MISC 5159
autophosphorylation O X
and O X
extracellular I-MISC 5594
signal I-MISC 5594
- I-MISC 5594
regulated I-MISC 5594
kinase I-MISC 5594
( O X
ERK I-MISC 5594
) O X
activation O X
in O X
cells O X
. O X

A O X
point O X
- O X
mutated O X
version O X
of O X
the O X
PDGFR I-MISC 5159
, O X
with O X
the O X
terminal O X
leucine O X
changed O X
to O X
alanine O X
( O X
L1106A O X
), O X
cannot O X
bind O X
NHERF I-MISC 100009196
in O X
vitro O X
and O X
is O X
markedly O X
impaired O X
relative O X
to O X
the O X
wild O X
- O X
type O X
receptor O X
with O X
regard O X
to O X
PDGF O X
- O X
induced O X
autophosphorylation O X
and O X
activation O X
of O X
ERK I-MISC 5594
in O X
cells O X
. O X

NHERF I-MISC 100009196
potentiation O X
of O X
PDGFR I-MISC 5159
signaling O X
depends O X
on O X
the O X
capacity O X
of O X
NHERF I-MISC 100009196
to O X
oligomerize O X
. O X

NHERF I-MISC 100009196
oligomerizes O X
in O X
vitro O X
when O X
bound O X
with O X
PDGFR I-MISC 5159
- O X
CT O X
, O X
and O X
a O X
truncated O X
version O X
of O X
the O X
first O X
NHERF I-MISC 100009196
PDZ O X
domain O X
that O X
can O X
bind O X
PDGFR I-MISC 5159
- O X
CT O X
but O X
which O X
does O X
not O X
oligomerize O X
reduces O X
PDGFR I-MISC 5159
tyrosine O X
kinase O X
activity O X
when O X
transiently O X
overexpressed O X
in O X
cells O X
. O X

PDGFR I-MISC 5159
activity O X
in O X
cells O X
can O X
also O X
be O X
regulated O X
in O X
a O X
NHERF I-MISC 100009196
- O X
dependent O X
fashion O X
by O X
stimulation O X
of O X
the O X
beta O X
( O X
2 O X
)- O X
adrenergic O X
receptor O X
, O X
a O X
known O X
cellular O X
binding O X
partner O X
for O X
NHERF I-MISC 100009196
. O X

These O X
findings O X
reveal O X
that O X
NHERF I-MISC 100009196
can O X
directly O X
bind O X
to O X
the O X
PDGFR I-MISC 5159
and O X
potentiate O X
PDGFR I-MISC 5159
activity O X
, O X
thus O X
elucidating O X
both O X
a O X
novel O X
mechanism O X
by O X
which O X
PDGFR I-MISC 5159
activity O X
can O X
be O X
regulated O X
and O X
a O X
new O X
cellular O X
role O X
for O X
the O X
PDZ O X
domain O X
- O X
containing O X
adapter O X
protein O X
NHERF I-MISC 100009196
. O X

###21203436	821400,818429

Arabidopsis O X
MKS1 I-MISC 821400
is O X
involved O X
in O X
basal O X
immunity O X
and O X
requires O X
an O X
intact O X
N O X
- O X
terminal O X
domain O X
for O X
proper O X
function O X
. O X

BACKGROUND O X
: O X
Innate O X
immune O X
signaling O X
pathways O X
in O X
animals O X
and O X
plants O X
are O X
regulated O X
by O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
( O X
MAPK O X
) O X
cascades O X
. O X

MAP I-MISC 828151
kinase I-MISC 828151
4 I-MISC 828151
( O X
MPK4 I-MISC 828151
) O X
functions O X
downstream O X
of O X
innate O X
immune O X
receptors O X
via O X
a O X
nuclear O X
substrate O X
MKS1 I-MISC 821400
to O X
regulate O X
the O X
activity O X
of O X
the O X
WRKY33 I-MISC 818429
transcription O X
factor O X
, O X
which O X
in O X
turn O X
controls O X
the O X
production O X
of O X
anti O X
- O X
microbial O X
phytoalexins O X
. O X

METHODOLOGY O X
/ O X
PRINCIPAL O X
FINDINGS O X
: O X
We O X
investigate O X
the O X
role O X
of O X
MKS1 I-MISC 821400
in O X
basal O X
resistance O X
and O X
the O X
importance O X
of O X
its O X
N O X
- O X
and O X
C O X
- O X
terminal O X
domains O X
for O X
MKS1 I-MISC 821400
function O X
. O X

We O X
used O X
the O X
information O X
that O X
mks1 I-MISC 821400
loss O X
- O X
of O X
- O X
function O X
partially O X
suppresses O X
the O X
mpk4 I-MISC 828151
loss O X
- O X
of O X
- O X
function O X
phenotype O X
, O X
and O X
that O X
transgenic O X
expression O X
of O X
functional O X
MKS1 I-MISC 821400
in O X
mpk4 I-MISC 828151
/ O X
mks1 I-MISC 821400
double O X
mutants O X
reverted O X
the O X
mpk4 I-MISC 828151
dwarf O X
phenotype O X
. O X

Transformation O X
of O X
mks1 I-MISC 821400
/ O X
mpk4 I-MISC 828151
with O X
mutant O X
versions O X
of O X
MKS1 I-MISC 821400
constructs O X
showed O X
that O X
a O X
single O X
amino O X
acid O X
substitution O X
in O X
a O X
putative O X
MAP O X
kinase O X
docking O X
domain O X
, O X
MKS1 I-MISC 821400
- O X
L32A O X
, O X
or O X
a O X
truncated O X
MKS1 I-MISC 821400
version O X
unable O X
to O X
interact O X
with O X
WRKY33 I-MISC 818429
, O X
were O X
deficient O X
in O X
reverting O X
the O X
double O X
mutant O X
to O X
the O X
mpk4 I-MISC 828151
phenotype O X
. O X

These O X
results O X
demonstrate O X
functional O X
requirement O X
in O X
MKS1 I-MISC 821400
for O X
the O X
interaction O X
with O X
MPK4 I-MISC 828151
and O X
WRKY33 I-MISC 818429
. O X

In O X
addition O X
, O X
nuclear O X
localization O X
of O X
MKS1 I-MISC 821400
was O X
shown O X
to O X
depend O X
on O X
an O X
intact O X
N O X
- O X
terminal O X
domain O X
. O X

Furthermore O X
, O X
loss O X
- O X
of O X
- O X
function O X
mks1 I-MISC 821400
mutants O X
exhibited O X
increased O X
susceptibility O X
to O X
strains O X
of O X
Pseudomonas O X
syringae O X
and O X
Hyaloperonospora O X
arabidopsidis O X
, O X
indicating O X
that O X
MKS1 I-MISC 821400
plays O X
a O X
role O X
in O X
basal O X
defense O X
responses O X
. O X

CONCLUSIONS O X
: O X
Taken O X
together O X
, O X
our O X
results O X
indicate O X
that O X
MKS1 I-MISC 821400
function O X
and O X
subcellular O X
location O X
requires O X
an O X
intact O X
N O X
- O X
terminus O X
important O X
for O X
both O X
MPK4 I-MISC 828151
and O X
WRKY33 I-MISC 818429
interactions O X
. O X

###8940045	2155,2152

Factor I-MISC 2155
VII I-MISC 2155
central O X
. O X

A O X
novel O X
mutation O X
in O X
the O X
catalytic O X
domain O X
that O X
reduces O X
tissue I-MISC 2152
factor I-MISC 2152
binding O X
, O X
impairs O X
activation O X
by O X
factor I-MISC 2159
Xa I-MISC 2159
, O X
and O X
abolishes O X
amidolytic O X
and O X
coagulant O X
activity O X
. O X

Factor I-MISC 2155
VII I-MISC 2155
is O X
a O X
vitamin O X
K O X
- O X
dependent O X
zymogen O X
of O X
a O X
serine O X
protease O X
that O X
participates O X
in O X
the O X
initial O X
phase O X
of O X
blood O X
coagulation O X
. O X

A O X
factor I-MISC 2155
VII I-MISC 2155
molecular O X
variant O X
( O X
factor I-MISC 2155
VII I-MISC 2155
Central O X
) O X
was O X
identified O X
in O X
a O X
24 O X
- O X
year O X
- O X
old O X
male O X
with O X
severe O X
factor I-MISC 2155
VII I-MISC 2155
deficiency O X
and O X
whose O X
plasma O X
factor I-MISC 2155
VII I-MISC 2155
antigen O X
was O X
38 O X
% O X
of O X
normal O X
, O X
but O X
expressed O X
< O X
1 O X
% O X
factor I-MISC 2155
VII I-MISC 2155
procoagulant O X
activity O X
. O X

DNA O X
sequence O X
analysis O X
of O X
the O X
patient O X
' O X
s O X
factor I-MISC 2155
VII I-MISC 2155
gene O X
revealed O X
a O X
thymidine O X
to O X
cytidine O X
transition O X
at O X
nucleotide O X
10907 O X
in O X
exon O X
VIII O X
that O X
results O X
in O X
a O X
novel O X
amino O X
acid O X
substitution O X
of O X
Phe328 O X
to O X
Ser O X
. O X

The O X
patient O X
was O X
homozygous O X
for O X
this O X
mutation O X
, O X
whereas O X
each O X
parent O X
of O X
the O X
patient O X
was O X
heterozygous O X
for O X
this O X
mutation O X
. O X

To O X
investigate O X
the O X
molecular O X
properties O X
of O X
this O X
variant O X
, O X
a O X
recombinant O X
F328S O X
factor I-MISC 2155
VII I-MISC 2155
mutant O X
was O X
prepared O X
and O X
analyzed O X
in O X
relation O X
to O X
wild O X
- O X
type O X
factor I-MISC 2155
VII I-MISC 2155
. O X

F328S O X
factor I-MISC 2155
VII I-MISC 2155
exhibited O X
< O X
1 O X
% O X
factor I-MISC 2155
VII I-MISC 2155
procoagulant O X
activity O X
and O X
a O X
2 O X
- O X
fold O X
decreased O X
affinity O X
for O X
tissue I-MISC 2152
factor I-MISC 2152
and O X
failed O X
to O X
activate O X
factor O X
X O X
or O X
IX O X
in O X
the O X
presence O X
of O X
tissue I-MISC 2152
factor I-MISC 2152
following O X
activation O X
by O X
factor I-MISC 2159
Xa I-MISC 2159
. O X

In O X
addition O X
, O X
F328S O X
factor O X
VIIa O X
exhibited O X
no O X
detectable O X
amidolytic O X
activity O X
in O X
the O X
presence O X
of O X
tissue I-MISC 2152
factor I-MISC 2152
. O X

The O X
rate O X
of O X
F328S O X
factor I-MISC 2155
VII I-MISC 2155
activation O X
by O X
factor I-MISC 2159
Xa I-MISC 2159
was O X
markedly O X
decreased O X
relative O X
to O X
the O X
rate O X
of O X
wild O X
- O X
type O X
factor I-MISC 2155
VII I-MISC 2155
activation O X
as O X
revealed O X
by O X
densitometry O X
scanning O X
of O X
SDS O X
gels O X
. O X

Temporal O X
analysis O X
of O X
this O X
reaction O X
by O X
SDS O X
- O X
polyacrylamide O X
gel O X
electrophoresis O X
also O X
revealed O X
the O X
formation O X
of O X
two O X
novel O X
F328S O X
factor I-MISC 2155
VII I-MISC 2155
degradation O X
products O X
( O X
40 O X
and O X
9 O X
kDa O X
) O X
resulting O X
from O X
factor I-MISC 2159
Xa I-MISC 2159
proteolysis O X
of O X
the O X
Arg315 O X
- O X
Lys316 O X
peptide O X
bond O X
in O X
intact O X
F328S O X
factor I-MISC 2155
VII I-MISC 2155
. O X

Computer O X
modeling O X
and O X
molecular O X
dynamics O X
simulations O X
of O X
the O X
serine O X
protease O X
domain O X
of O X
factor O X
VIIa O X
suggested O X
that O X
the O X
inability O X
of O X
F328S O X
factor O X
VIIa O X
to O X
cleave O X
substrates O X
may O X
result O X
from O X
the O X
apparent O X
formation O X
of O X
a O X
hydrogen O X
bond O X
between O X
Tyr377 O X
and O X
Asp338 O X
, O X
a O X
residue O X
at O X
the O X
bottom O X
of O X
the O X
substrate O X
- O X
binding O X
pocket O X
important O X
for O X
the O X
interaction O X
of O X
substrate O X
arginine O X
side O X
chains O X
with O X
the O X
enzyme O X
. O X

These O X
findings O X
suggest O X
that O X
Phe328 O X
, O X
which O X
is O X
conserved O X
in O X
prothrombin O X
, O X
factor O X
IX O X
, O X
factor O X
X O X
, O X
factor I-MISC 2155
VII I-MISC 2155
, O X
and O X
trypsin O X
, O X
is O X
important O X
for O X
factor O X
VIIa O X
catalysis O X
. O X

###23290633	10999,348938

Interactions O X
between O X
FATP4 I-MISC 10999
and O X
ichthyin I-MISC 348938
in O X
epidermal O X
lipid O X
processing O X
may O X
provide O X
clues O X
to O X
the O X
pathogenesis O X
of O X
autosomal O X
recessive O X
congenital O X
ichthyosis O X
. O X

BACKGROUND O X
: O X
Autosomal O X
recessive O X
congenital O X
ichthyosis O X
( O X
ARCI O X
) O X
is O X
caused O X
by O X
mutations O X
in O X
>= O X
10 O X
different O X
genes O X
, O X
of O X
which O X
transglutaminase I-MISC 7051
- I-MISC 7051
1 I-MISC 7051
( O X
TGM1 I-MISC 7051
) O X
predominates O X
. O X

A O X
rare O X
form O X
is O X
ichthyosis O X
prematurity O X
syndrome O X
( O X
IPS O X
) O X
caused O X
by O X
mutations O X
in O X
SLC27A4 I-MISC 10999
encoding O X
fatty I-MISC 10999
acid I-MISC 10999
transporter I-MISC 10999
protein I-MISC 10999
4 I-MISC 10999
( O X
FATP4 I-MISC 10999
), O X
believed O X
to O X
be O X
an O X
acyl O X
- O X
CoA O X
synthetase O X
activating O X
long O X
- O X
and O X
very O X
- O X
long O X
- O X
chain O X
FA O X
. O X

Another O X
ARCI O X
is O X
caused O X
by O X
mutations O X
in O X
NIPAL4 I-MISC 348938
, O X
coding O X
for O X
ichthyin I-MISC 348938
, O X
which O X
is O X
proposed O X
to O X
be O X
a O X
magnesium O X
transporter O X
or O X
a O X
trans O X
- O X
membrane O X
receptor O X
. O X

A O X
possible O X
interaction O X
between O X
FATP4 I-MISC 10999
and O X
ichthyin I-MISC 348938
has O X
not O X
been O X
studied O X
before O X
. O X

OBJECTIVE O X
: O X
To O X
find O X
common O X
denominators O X
in O X
the O X
pathogenesis O X
of O X
ARCI O X
. O X

METHODS O X
: O X
FATP4 I-MISC 10999
and O X
ichthyin I-MISC 348938
were O X
analyzed O X
by O X
immunofluorescence O X
and O X
proximity O X
ligation O X
assay O X
( O X
PLA O X
) O X
in O X
healthy O X
and O X
ARCI O X
patient O X
skin O X
and O X
in O X
in O X
vitro O X
models O X
of O X
ARCI O X
epidermis O X
. O X

RESULTS O X
: O X
Both O X
proteins O X
were O X
expressed O X
in O X
the O X
upper O X
stratum O X
granulosum O X
of O X
normal O X
epidermis O X
and O X
PLA O X
confirmed O X
a O X
close O X
interaction O X
between O X
FATP4 I-MISC 10999
and O X
ichthyin I-MISC 348938
. O X

In O X
IPS O X
skin O X
lacking O X
FATP4 I-MISC 10999
we O X
found O X
reduced O X
ichthyin I-MISC 348938
expression O X
and O X
this O X
finding O X
could O X
be O X
reproduced O X
in O X
organotypic O X
epidermis O X
with O X
siRNA O X
silenced O X
SLC27A4 I-MISC 10999
. O X

In O X
contrast O X
, O X
increased O X
FATP4 I-MISC 10999
staining O X
was O X
found O X
in O X
patients O X
with O X
ichthyin I-MISC 348938
( O X
NIPAL4 I-MISC 348938
) O X
mutations O X
and O X
in O X
organotypic O X
epidermis O X
with O X
silenced O X
NIPAL4 I-MISC 348938
. O X

In O X
patients O X
with O X
TGM1 I-MISC 7051
mutations O X
, O X
the O X
expression O X
of O X
both O X
FATP4 I-MISC 10999
and O X
ichthyin I-MISC 348938
was O X
increased O X
, O X
but O X
the O X
PLA O X
signal O X
was O X
low O X
probably O X
indicating O X
a O X
malfunctioning O X
protein O X
interaction O X
. O X

CONCLUSION O X
: O X
Our O X
study O X
suggests O X
that O X
FATP4 I-MISC 10999
, O X
ichthyin I-MISC 348938
and O X
TGM1 I-MISC 7051
interact O X
in O X
lipid O X
processing O X
essential O X
for O X
maintaining O X
the O X
epidermal O X
barrier O X
function O X
. O X

It O X
is O X
also O X
hypothesized O X
that O X
ichthyin I-MISC 348938
serves O X
as O X
Mg O X
( O X
2 O X
+)- O X
transporter O X
for O X
FATP4 I-MISC 10999
in O X
this O X
process O X
. O X

###15485833	852536,8976

ARPC1 O X
/ O X
Arc40 I-MISC 852536
mediates O X
the O X
interaction O X
of O X
the O X
actin I-MISC 851532
- I-MISC 851532
related I-MISC 851532
protein I-MISC 851532
2 I-MISC 851532
and I-MISC 851532
3 I-MISC 851532
complex O X
with O X
Wiskott I-MISC 8976
- I-MISC 8976
Aldrich I-MISC 8976
syndrome I-MISC 8976
protein I-MISC 8976
family O X
activators O X
. O X

The O X
actin I-MISC 851532
- I-MISC 851532
related I-MISC 851532
protein I-MISC 851532
2 I-MISC 851532
and I-MISC 851532
3 I-MISC 851532
( O X
Arp2 I-MISC 851532
/ I-MISC 851532
3 I-MISC 851532
) O X
complex O X
is O X
a O X
seven O X
- O X
subunit O X
protein O X
complex O X
that O X
nucleates O X
actin O X
filaments O X
at O X
the O X
cell O X
cortex O X
. O X

Despite O X
extensive O X
cross O X
- O X
linking O X
, O X
crystallography O X
, O X
genetic O X
and O X
biochemical O X
studies O X
, O X
the O X
contribution O X
of O X
each O X
subunit O X
to O X
the O X
activity O X
of O X
the O X
complex O X
remains O X
largely O X
unclear O X
. O X

In O X
this O X
study O X
we O X
characterized O X
the O X
function O X
of O X
the O X
40 O X
- O X
kDa O X
subunit O X
, O X
ARPC1 O X
/ O X
Arc40 I-MISC 852536
, O X
of O X
the O X
yeast O X
Arp2 I-MISC 851532
/ O X
3 O X
complex O X
. O X

We O X
showed O X
that O X
this O X
subunit O X
is O X
indeed O X
a O X
stable O X
component O X
of O X
the O X
Arp2 I-MISC 851532
/ O X
3 O X
complex O X
, O X
but O X
its O X
highly O X
unusual O X
electrophoretic O X
mobility O X
eluded O X
detection O X
in O X
previous O X
studies O X
. O X

Recombinant O X
Arc40 I-MISC 852536
bound O X
the O X
VCA O X
domain O X
of O X
Wiskott I-MISC 8976
- I-MISC 8976
Aldrich I-MISC 8976
syndrome I-MISC 8976
protein I-MISC 8976
family O X
activators O X
at O X
a O X
K O X
( O X
d O X
) O X
of O X
0 O X
. O X
45 O X
mum O X
, O X
close O X
to O X
that O X
of O X
the O X
full O X
complex O X
with O X
VCA O X
( O X
0 O X
. O X
30 O X
microm O X
), O X
and O X
this O X
interaction O X
was O X
dependent O X
on O X
the O X
conserved O X
tryptophan O X
at O X
the O X
COOH O X
terminus O X
of O X
VCA O X
. O X

Using O X
a O X
newly O X
constructed O X
Delta O X
arc40 I-MISC 852536
yeast O X
strain O X
, O X
we O X
showed O X
that O X
loss O X
of O X
Arc40 I-MISC 852536
severely O X
reduced O X
the O X
binding O X
affinity O X
of O X
the O X
Arp2 I-MISC 851532
/ O X
3 O X
complex O X
with O X
VCA O X
as O X
well O X
as O X
the O X
nucleation O X
activity O X
of O X
the O X
complex O X
, O X
suggesting O X
that O X
Arc40 I-MISC 852536
contains O X
an O X
important O X
contact O X
site O X
of O X
the O X
Arp2 I-MISC 851532
/ O X
3 O X
complex O X
with O X
VCA O X
. O X

The O X
Delta O X
arc40 I-MISC 852536
cells O X
exhibited O X
reduced O X
growth O X
rate O X
, O X
loss O X
of O X
actin O X
patches O X
, O X
and O X
accumulation O X
of O X
cables O X
like O X
actin O X
aggregates O X
, O X
phenotypes O X
typical O X
of O X
other O X
subunit O X
nulls O X
, O X
suggesting O X
that O X
Arc40 I-MISC 852536
functions O X
exclusively O X
within O X
the O X
Arp2 I-MISC 851532
/ I-MISC 851532
3 I-MISC 851532
complex O X
. O X

###18550827	825648,814786

Genetic O X
analysis O X
of O X
CAND1 I-MISC 814786
- O X
CUL1 I-MISC 8454
interactions O X
in O X
Arabidopsis O X
supports O X
a O X
role O X
for O X
CAND1 I-MISC 814786
- O X
mediated O X
cycling O X
of O X
the O X
SCFTIR1 O X
complex O X
. O X

SKP1 O X
- O X
Cullin1 I-MISC 825648
- O X
F O X
- O X
box O X
protein O X
( O X
SCF I-MISC 4254
) O X
ubiquitin O X
- O X
ligases O X
regulate O X
numerous O X
aspects O X
of O X
eukaryotic O X
growth O X
and O X
development O X
. O X

Cullin I-MISC 143384
- O X
Associated O X
and O X
Neddylation O X
- O X
Dissociated O X
( O X
CAND1 I-MISC 814786
) O X
modulates O X
SCF I-MISC 4254
function O X
through O X
its O X
interactions O X
with O X
the O X
CUL1 I-MISC 8454
subunit O X
. O X

Although O X
biochemical O X
studies O X
with O X
human O X
CAND1 I-MISC 814786
suggested O X
that O X
CAND1 I-MISC 814786
plays O X
a O X
negative O X
regulatory O X
role O X
by O X
sequestering O X
CUL1 I-MISC 8454
and O X
preventing O X
SCF I-MISC 4254
complex O X
assembly O X
, O X
genetic O X
studies O X
in O X
Arabidopsis O X
have O X
shown O X
that O X
cand1 I-MISC 814786
mutants O X
exhibit O X
reduced O X
SCF I-MISC 4254
activity O X
, O X
demonstrating O X
that O X
CAND1 I-MISC 814786
is O X
required O X
for O X
optimal O X
SCF I-MISC 4254
function O X
in O X
vivo O X
. O X

Together O X
, O X
these O X
genetic O X
and O X
biochemical O X
studies O X
have O X
suggested O X
a O X
model O X
of O X
CAND1 I-MISC 814786
- O X
mediated O X
cycles O X
of O X
SCF I-MISC 4254
complex O X
assembly O X
and O X
disassembly O X
. O X

Here O X
, O X
using O X
the O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
complex O X
of O X
the O X
Arabidopsis O X
auxin O X
response O X
pathway O X
, O X
we O X
test O X
the O X
SCF I-MISC 4254
cycling O X
model O X
with O X
Arabidopsis O X
mutant O X
derivatives O X
of O X
CAND1 I-MISC 814786
and O X
CUL1 I-MISC 8454
that O X
have O X
opposing O X
effects O X
on O X
the O X
CAND1 I-MISC 814786
- O X
CUL1 I-MISC 8454
interaction O X
. O X

We O X
find O X
that O X
the O X
disruption O X
of O X
the O X
CAND1 I-MISC 814786
- O X
CUL1 I-MISC 8454
interaction O X
results O X
in O X
an O X
increased O X
abundance O X
of O X
assembled O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
complex O X
. O X

In O X
contrast O X
, O X
stabilization O X
of O X
the O X
CAND1 I-MISC 814786
- O X
CUL1 I-MISC 8454
interaction O X
diminishes O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
complex O X
abundance O X
. O X

The O X
fact O X
that O X
both O X
decreased O X
and O X
increased O X
CAND1 I-MISC 814786
- O X
CUL1 I-MISC 8454
interactions O X
result O X
in O X
reduced O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
activity O X
in O X
vivo O X
strongly O X
supports O X
the O X
hypothesis O X
that O X
CAND1 I-MISC 814786
- O X
mediated O X
cycling O X
is O X
required O X
for O X
optimal O X
SCF I-MISC 4254
function O X
. O X

###16137687	51429,8867

SNX9 I-MISC 51429
as O X
an O X
adaptor O X
for O X
linking O X
synaptojanin I-MISC 8867
- I-MISC 8867
1 I-MISC 8867
to O X
the O X
Cdc42 I-MISC 998
effector O X
ACK1 I-MISC 10188
. O X

Sorting I-MISC 51429
nexin I-MISC 51429
9 I-MISC 51429
( O X
SNX9 I-MISC 51429
, O X
also O X
referred O X
to O X
as O X
SH3PX1 I-MISC 51429
) O X
is O X
a O X
binding O X
partner O X
for O X
the O X
non O X
- O X
receptor O X
and O X
Cdc42 I-MISC 998
- O X
associated O X
kinase O X
( O X
ACK O X
) O X
in O X
Drosophila O X
and O X
mammals O X
. O X

ACK1 I-MISC 10188
is O X
known O X
to O X
bind O X
clathrin O X
and O X
influence O X
EGF O X
receptor O X
endocytosis O X
. O X

SNX9 I-MISC 51429
comprises O X
an O X
N O X
- O X
terminal O X
Src O X
homology O X
domain O X
3 O X
( O X
SH3 O X
), O X
a O X
central O X
PHOX O X
homology O X
( O X
PX O X
) O X
domain O X
, O X
and O X
a O X
carboxyl O X
- O X
terminal O X
coiled O X
- O X
coil O X
region O X
. O X

In O X
order O X
to O X
investigate O X
SNX9 I-MISC 51429
further O X
we O X
have O X
made O X
use O X
of O X
a O X
novel O X
in O X
vivo O X
biotinylation O X
system O X
to O X
label O X
various O X
GST O X
- O X
SH3 O X
domains O X
and O X
perform O X
blot O X
overlays O X
, O X
thereby O X
identifying O X
synaptojanin I-MISC 8867
- I-MISC 8867
1 I-MISC 8867
as O X
a O X
partner O X
for O X
SNX9 I-MISC 51429
. O X

Biotinylated O X
SH3 O X
domains O X
were O X
also O X
used O X
for O X
specific O X
identification O X
of O X
target O X
proline O X
- O X
rich O X
sequences O X
in O X
synaptojanin O X
and O X
ACK1 I-MISC 10188
on O X
synthetic O X
peptides O X
arrays O X
. O X

Direct O X
assessment O X
of O X
SH3 O X
binding O X
efficiencies O X
at O X
different O X
positions O X
within O X
the O X
extensive O X
proline O X
- O X
rich O X
regions O X
of O X
these O X
proteins O X
were O X
thus O X
determined O X
. O X

While O X
SNX9 I-MISC 51429
targets O X
a O X
number O X
of O X
sequences O X
within O X
the O X
proline O X
- O X
rich O X
regions O X
of O X
synaptojanin O X
, O X
a O X
single O X
site O X
was O X
identified O X
in O X
human O X
ACK1 I-MISC 10188
. O X

By O X
testing O X
the O X
association O X
of O X
various O X
truncations O X
of O X
ACK1 I-MISC 10188
with O X
SNX9 I-MISC 51429
we O X
confirmed O X
the O X
dominant O X
SNX9 I-MISC 51429
binding O X
domain O X
in O X
human O X
ACK1 I-MISC 10188
( O X
residues O X
920 O X
- O X
955 O X
). O X

In O X
the O X
presence O X
of O X
SNX9 I-MISC 51429
we O X
find O X
that O X
synaptojanin O X
is O X
able O X
to O X
colocalize O X
with O X
distinct O X
ACK1 I-MISC 10188
containing O X
vesicles O X
, O X
indicating O X
that O X
this O X
tyrosine O X
kinase O X
is O X
linked O X
to O X
many O X
components O X
involved O X
in O X
vesicle O X
dynamics O X
including O X
clathrin O X
, O X
AP2 I-MISC 7020
and O X
synaptojanin I-MISC 8867
- I-MISC 8867
1 I-MISC 8867
. O X

###15805487	826470,826470

N O X
- O X
terminal O X
domain O X
- O X
mediated O X
homodimerization O X
is O X
required O X
for O X
photoreceptor O X
activity O X
of O X
Arabidopsis O X
CRYPTOCHROME I-MISC 826470
1 I-MISC 826470
. O X

Cryptochromes O X
( O X
CRY O X
) O X
are O X
blue O X
light O X
receptors O X
that O X
share O X
sequence O X
similarity O X
with O X
photolyases O X
, O X
flavoproteins O X
that O X
catalyze O X
the O X
repair O X
of O X
UV O X
light O X
- O X
damaged O X
DNA O X
. O X

Transgenic O X
Arabidopsis O X
thaliana O X
seedlings O X
expressing O X
the O X
C O X
- O X
terminal O X
domains O X
of O X
the O X
Arabidopsis O X
CRY O X
fused O X
to O X
beta O X
- O X
glucuronidase O X
( O X
GUS O X
) O X
display O X
a O X
constitutive O X
photomorphogenic O X
( O X
COP O X
) O X
phenotype O X
, O X
indicating O X
that O X
the O X
signaling O X
mechanism O X
of O X
Arabidopsis O X
CRY O X
is O X
mediated O X
through O X
the O X
C O X
- O X
terminal O X
domain O X
. O X

The O X
role O X
of O X
the O X
Arabidopsis O X
CRY O X
N O X
- O X
terminal O X
photolyase O X
- O X
like O X
domain O X
in O X
CRY O X
action O X
remains O X
poorly O X
understood O X
. O X

Here O X
, O X
we O X
report O X
the O X
essential O X
role O X
of O X
the O X
Arabidopsis O X
CRY1 I-MISC 826470
N O X
- O X
terminal O X
domain O X
( O X
CNT1 O X
) O X
in O X
the O X
light O X
activation O X
of O X
CRY1 I-MISC 826470
photoreceptor O X
activity O X
. O X

Yeast O X
two O X
- O X
hybrid O X
assay O X
, O X
in O X
vitro O X
binding O X
, O X
in O X
vivo O X
chemical O X
cross O X
- O X
linking O X
, O X
gel O X
filtration O X
, O X
and O X
coimmunoprecipitation O X
studies O X
indicate O X
that O X
CRY1 I-MISC 826470
homodimerizes O X
in O X
a O X
light O X
- O X
independent O X
manner O X
. O X

Mutagenesis O X
and O X
transgenic O X
studies O X
demonstrate O X
that O X
CNT1 O X
- O X
mediated O X
dimerization O X
is O X
required O X
for O X
light O X
activation O X
of O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
CRY1 I-MISC 826470
( O X
CCT1 I-MISC 817786
). O X

Transgenic O X
data O X
and O X
native O X
gel O X
electrophoresis O X
studies O X
suggest O X
that O X
multimerization O X
of O X
GUS O X
is O X
both O X
responsible O X
and O X
required O X
for O X
mediating O X
a O X
COP O X
phenotype O X
on O X
fusion O X
to O X
CCT1 I-MISC 817786
. O X

These O X
results O X
indicate O X
that O X
the O X
properties O X
of O X
the O X
GUS O X
multimer O X
are O X
analogous O X
to O X
those O X
of O X
the O X
light O X
- O X
modified O X
CNT1 O X
dimer O X
. O X

Irradiation O X
with O X
blue O X
light O X
modifies O X
the O X
properties O X
of O X
the O X
CNT1 O X
dimer O X
, O X
resulting O X
in O X
a O X
change O X
in O X
CCT1 I-MISC 817786
, O X
activating O X
CCT1 I-MISC 817786
, O X
and O X
eventually O X
triggering O X
the O X
CRY1 I-MISC 826470
signaling O X
pathway O X
. O X

###22817896	8737,8737

The O X
RIP1 I-MISC 8737
/ O X
RIP3 O X
necrosome O X
forms O X
a O X
functional O X
amyloid O X
signaling O X
complex O X
required O X
for O X
programmed O X
necrosis O X
. O X

RIP1 I-MISC 8737
and O X
RIP3 O X
kinases O X
are O X
central O X
players O X
in O X
TNF O X
- O X
induced O X
programmed O X
necrosis O X
. O X

Here O X
, O X
we O X
report O X
that O X
the O X
RIP O X
homotypic O X
interaction O X
motifs O X
( O X
RHIMs O X
) O X
of O X
RIP1 I-MISC 8737
and O X
RIP3 O X
mediate O X
the O X
assembly O X
of O X
heterodimeric O X
filamentous O X
structures O X
. O X

The O X
fibrils O X
exhibit O X
classical O X
characteristics O X
of O X
b O X
- O X
amyloids O X
, O X
as O X
shown O X
by O X
Thioflavin O X
T O X
( O X
ThT O X
) O X
and O X
Congo O X
red O X
( O X
CR O X
) O X
binding O X
, O X
circular O X
dichroism O X
, O X
infrared O X
spectroscopy O X
, O X
X O X
- O X
ray O X
diffraction O X
, O X
and O X
solid O X
- O X
state O X
NMR O X
. O X

Structured O X
amyloid O X
cores O X
are O X
mapped O X
in O X
RIP1 I-MISC 8737
and O X
RIP3 O X
that O X
are O X
flanked O X
by O X
regions O X
of O X
mobility O X
. O X

The O X
endogenous O X
RIP1 I-MISC 8737
/ O X
RIP3 O X
complex O X
isolated O X
from O X
necrotic O X
cells O X
binds O X
ThT O X
, O X
is O X
ultrastable O X
, O X
and O X
has O X
a O X
fibrillar O X
core O X
structure O X
, O X
whereas O X
necrosis O X
is O X
partially O X
inhibited O X
by O X
ThT O X
, O X
CR O X
, O X
and O X
another O X
amyloid O X
dye O X
, O X
HBX O X
. O X

Mutations O X
in O X
the O X
RHIMs O X
of O X
RIP1 I-MISC 8737
and O X
RIP3 O X
that O X
are O X
defective O X
in O X
the O X
interaction O X
compromise O X
cluster O X
formation O X
, O X
kinase O X
activation O X
, O X
and O X
programmed O X
necrosis O X
in O X
vivo O X
. O X

The O X
current O X
study O X
provides O X
insight O X
into O X
the O X
structural O X
changes O X
that O X
occur O X
when O X
RIP O X
kinases O X
are O X
triggered O X
to O X
execute O X
different O X
signaling O X
outcomes O X
and O X
expands O X
the O X
realm O X
of O X
amyloids O X
to O X
complex O X
formation O X
and O X
signaling O X
. O X

###19033529	843609,817927

HAB1 I-MISC 843609
- O X
SWI3B I-MISC 817927
interaction O X
reveals O X
a O X
link O X
between O X
abscisic O X
acid O X
signaling O X
and O X
putative O X
SWI O X
/ O X
SNF O X
chromatin O X
- O X
remodeling O X
complexes O X
in O X
Arabidopsis O X
. O X

Abscisic O X
acid O X
( O X
ABA O X
) O X
has O X
an O X
important O X
role O X
for O X
plant O X
growth O X
, O X
development O X
, O X
and O X
stress O X
adaptation O X
. O X

HYPERSENSITIVE I-MISC 843609
TO I-MISC 843609
ABA1 I-MISC 843609
( O X
HAB1 I-MISC 843609
) O X
is O X
a O X
protein O X
phosphatase O X
type O X
2C O X
that O X
plays O X
a O X
key O X
role O X
as O X
a O X
negative O X
regulator O X
of O X
ABA O X
signaling O X
; O X
however O X
, O X
the O X
molecular O X
details O X
of O X
HAB1 I-MISC 843609
action O X
in O X
this O X
process O X
are O X
not O X
known O X
. O X

A O X
two O X
- O X
hybrid O X
screen O X
revealed O X
that O X
SWI3B I-MISC 817927
, O X
an O X
Arabidopsis O X
thaliana O X
homolog O X
of O X
the O X
yeast O X
SWI3 I-MISC 853264
subunit O X
of O X
SWI O X
/ O X
SNF O X
chromatin O X
- O X
remodeling O X
complexes O X
, O X
is O X
a O X
prevalent O X
interacting O X
partner O X
of O X
HAB1 I-MISC 843609
. O X

The O X
interaction O X
mapped O X
to O X
the O X
N O X
- O X
terminal O X
half O X
of O X
SWI3B I-MISC 817927
and O X
required O X
an O X
intact O X
protein O X
phosphatase O X
catalytic O X
domain O X
. O X

Bimolecular O X
fluorescence O X
complementation O X
and O X
coimmunoprecipitation O X
assays O X
confirmed O X
the O X
interaction O X
of O X
HAB1 I-MISC 843609
and O X
SWI3B I-MISC 817927
in O X
the O X
nucleus O X
of O X
plant O X
cells O X
. O X

swi3b I-MISC 817927
mutants O X
showed O X
a O X
reduced O X
sensitivity O X
to O X
ABA O X
- O X
mediated O X
inhibition O X
of O X
seed O X
germination O X
and O X
growth O X
and O X
reduced O X
expression O X
of O X
the O X
ABA O X
- O X
responsive O X
genes O X
RAB18 I-MISC 840987
and O X
RD29B I-MISC 835306
. O X

Chromatin O X
immunoprecipitation O X
experiments O X
showed O X
that O X
the O X
presence O X
of O X
HAB1 I-MISC 843609
in O X
the O X
vicinity O X
of O X
RD29B I-MISC 835306
and O X
RAB18 I-MISC 840987
promoters O X
was O X
abolished O X
by O X
ABA O X
, O X
which O X
suggests O X
a O X
direct O X
involvement O X
of O X
HAB1 I-MISC 843609
in O X
the O X
regulation O X
of O X
ABA O X
- O X
induced O X
transcription O X
. O X

Additionally O X
, O X
our O X
results O X
uncover O X
SWI3B I-MISC 817927
as O X
a O X
novel O X
positive O X
regulator O X
of O X
ABA O X
signaling O X
and O X
suggest O X
that O X
HAB1 I-MISC 843609
modulates O X
ABA O X
response O X
through O X
the O X
regulation O X
of O X
a O X
putative O X
SWI O X
/ O X
SNF O X
chromatin O X
- O X
remodeling O X
complex O X
. O X

###22529269	64421,5591	3981,64421

Artemis I-MISC 64421
C O X
- O X
terminal O X
region O X
facilitates O X
V O X
( O X
D O X
) O X
J O X
recombination O X
through O X
its O X
interactions O X
with O X
DNA I-MISC 3981
Ligase I-MISC 3981
IV I-MISC 3981
and O X
DNA I-MISC 5591
- I-MISC 5591
PKcs I-MISC 5591
. O X

Artemis I-MISC 64421
is O X
an O X
endonuclease O X
that O X
opens O X
coding O X
hairpin O X
ends O X
during O X
V O X
( O X
D O X
) O X
J O X
recombination O X
and O X
has O X
critical O X
roles O X
in O X
postirradiation O X
cell O X
survival O X
. O X

A O X
direct O X
role O X
for O X
the O X
C O X
- O X
terminal O X
region O X
of O X
Artemis I-MISC 64421
in O X
V O X
( O X
D O X
) O X
J O X
recombination O X
has O X
not O X
been O X
defined O X
, O X
despite O X
the O X
presence O X
of O X
immunodeficiency O X
and O X
lymphoma O X
development O X
in O X
patients O X
with O X
deletions O X
in O X
this O X
region O X
. O X

Here O X
, O X
we O X
report O X
that O X
the O X
Artemis I-MISC 64421
C O X
- O X
terminal O X
region O X
directly O X
interacts O X
with O X
the O X
DNA O X
- O X
binding O X
domain O X
of O X
Ligase O X
IV O X
, O X
a O X
DNA O X
Ligase O X
which O X
plays O X
essential O X
roles O X
in O X
DNA O X
repair O X
and O X
V O X
( O X
D O X
) O X
J O X
recombination O X
. O X

The O X
Artemis I-MISC 64421
- O X
Ligase O X
IV O X
interaction O X
is O X
specific O X
and O X
occurs O X
independently O X
of O X
the O X
presence O X
of O X
DNA O X
and O X
DNA I-MISC 5591
- I-MISC 5591
protein I-MISC 5591
kinase I-MISC 5591
catalytic I-MISC 5591
subunit I-MISC 5591
( O X
DNA I-MISC 5591
- I-MISC 5591
PKcs I-MISC 5591
), O X
another O X
protein O X
known O X
to O X
interact O X
with O X
the O X
Artemis I-MISC 64421
C O X
- O X
terminal O X
region O X
. O X

Point O X
mutations O X
in O X
Artemis I-MISC 64421
that O X
disrupt O X
its O X
interaction O X
with O X
Ligase O X
IV O X
or O X
DNA I-MISC 5591
- I-MISC 5591
PKcs I-MISC 5591
reduce O X
V O X
( O X
D O X
) O X
J O X
recombination O X
, O X
and O X
Artemis I-MISC 64421
mutations O X
that O X
affect O X
interactions O X
with O X
Ligase O X
IV O X
and O X
DNA I-MISC 5591
- I-MISC 5591
PKcs I-MISC 5591
show O X
additive O X
detrimental O X
effects O X
on O X
coding O X
joint O X
formation O X
. O X

Signal O X
joint O X
formation O X
remains O X
unaffected O X
. O X

Our O X
data O X
reveal O X
that O X
the O X
C O X
- O X
terminal O X
region O X
of O X
Artemis I-MISC 64421
influences O X
V O X
( O X
D O X
) O X
J O X
recombination O X
through O X
its O X
interaction O X
with O X
both O X
Ligase O X
IV O X
and O X
DNA I-MISC 5591
- I-MISC 5591
PKcs I-MISC 5591
. O X

###14561633	822415,834133	832523,834133

A O X
contradictory O X
GLABRA3 I-MISC 834133
allele O X
helps O X
define O X
gene O X
interactions O X
controlling O X
trichome O X
development O X
in O X
Arabidopsis O X
. O X

Previously O X
characterized O X
Arabidopsis O X
gl3 I-MISC 834133
mutants O X
have O X
trichomes O X
that O X
are O X
smaller O X
, O X
less O X
branched O X
and O X
undergo O X
fewer O X
rounds O X
of O X
endoreplication O X
than O X
wild O X
- O X
type O X
trichomes O X
. O X

A O X
new O X
gl3 I-MISC 834133
mutant O X
, O X
called O X
gl3 I-MISC 834133
- O X
sst O X
, O X
has O X
oddly O X
shaped O X
trichomes O X
that O X
over O X
expand O X
during O X
early O X
development O X
, O X
undergo O X
more O X
endoreduplication O X
and O X
that O X
have O X
a O X
striking O X
nuclear O X
morphology O X
. O X

The O X
mutant O X
nuclei O X
consist O X
of O X
many O X
interconnected O X
lobes O X
; O X
however O X
, O X
only O X
a O X
single O X
set O X
of O X
polytene O X
- O X
like O X
chromosomes O X
reside O X
in O X
the O X
mutant O X
nuclei O X
. O X

The O X
predicted O X
gl3 I-MISC 834133
- O X
sst O X
polypeptide O X
has O X
a O X
Leu O X
to O X
Phe O X
substitution O X
( O X
codon O X
78 O X
) O X
within O X
a O X
region O X
responsible O X
for O X
protein O X
- O X
protein O X
interaction O X
. O X

Yeast O X
interaction O X
assays O X
comparing O X
GL3 I-MISC 834133
with O X
gl3 I-MISC 834133
- O X
sst O X
proteins O X
show O X
that O X
the O X
mutant O X
protein O X
interaction O X
with O X
GL1 I-MISC 822415
and O X
TTG1 I-MISC 832523
is O X
decreased O X
by O X
75 O X
% O X
and O X
50 O X
%, O X
respectively O X
, O X
but O X
there O X
is O X
no O X
difference O X
in O X
its O X
interaction O X
with O X
TRY O X
. O X

Furthermore O X
, O X
TRY O X
has O X
the O X
ability O X
to O X
prevent O X
the O X
GL1 I-MISC 822415
GL3 B-MISC 834133
interaction O X
and O X
the O X
GL1 I-MISC 822415
gl3 B-MISC 834133
- O X
sst O X
interaction O X
is O X
even O X
more O X
sensitive O X
to O X
TRY O X
. O X

Analysis O X
of O X
plants O X
expressing O X
functional O X
GFP O X
- O X
tagged O X
versions O X
of O X
GL1 I-MISC 822415
, O X
GL3 I-MISC 834133
and O X
TRY O X
show O X
that O X
the O X
proteins O X
are O X
localized O X
in O X
trichome O X
nuclei O X
. O X

These O X
results O X
have O X
been O X
used O X
to O X
model O X
trichome O X
initiation O X
in O X
terms O X
of O X
protein O X
interactions O X
and O X
threshold O X
levels O X
of O X
activator O X
complex O X
. O X

###12902344	25252,8945

Regulation O X
of O X
the O X
discs O X
large O X
tumor O X
suppressor O X
by O X
a O X
phosphorylation O X
- O X
dependent O X
interaction O X
with O X
the O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
ubiquitin O X
ligase O X
receptor O X
. O X

The O X
discs O X
large O X
( O X
hDlg I-MISC 25252
) O X
tumor O X
suppressor O X
is O X
intimately O X
involved O X
in O X
the O X
control O X
of O X
cell O X
contact O X
, O X
polarity O X
, O X
and O X
proliferation O X
by O X
interacting O X
with O X
several O X
components O X
of O X
the O X
epithelial O X
junctional O X
complex O X
and O X
with O X
the O X
APC O X
tumor O X
suppressor O X
protein O X
. O X

In O X
epithelial O X
cells O X
, O X
hDlg I-MISC 25252
protein O X
stability O X
is O X
regulated O X
through O X
the O X
ubiquitin O X
- O X
proteasome O X
pathway O X
: O X
hDlg I-MISC 25252
is O X
actively O X
degraded O X
in O X
isolated O X
cells O X
, O X
whereas O X
it O X
accumulates O X
upon O X
cell O X
- O X
cell O X
contact O X
. O X

During O X
neoplastic O X
transformation O X
of O X
epithelial O X
cells O X
, O X
loss O X
of O X
the O X
differentiated O X
morphology O X
and O X
progression O X
toward O X
a O X
metastatic O X
phenotype O X
correlate O X
with O X
down O X
- O X
regulation O X
of O X
hDlg I-MISC 25252
levels O X
and O X
loss O X
of O X
contact O X
- O X
dependent O X
stabilization O X
. O X

Here O X
we O X
show O X
that O X
upon O X
hyperphosphorylation O X
, O X
hDlg I-MISC 25252
interacts O X
with O X
the O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
ubiquitin O X
ligase O X
receptor O X
through O X
a O X
DSGLPS O X
motif O X
within O X
its O X
Src O X
homology O X
3 O X
domain O X
. O X

As O X
a O X
consequence O X
, O X
overexpression O X
of O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
enhances O X
ubiquitination O X
of O X
Dlg I-MISC 25252
protein O X
and O X
decreases O X
its O X
stability O X
, O X
whereas O X
a O X
dominant O X
negative O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
mutant O X
inhibits O X
this O X
process O X
. O X

Furthermore O X
, O X
a O X
mutant O X
Dlg I-MISC 25252
protein O X
that O X
is O X
unable O X
to O X
bind O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
displays O X
a O X
higher O X
protein O X
stability O X
and O X
is O X
insensitive O X
to O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
. O X

Using O X
RNA O X
interference O X
, O X
we O X
also O X
demonstrate O X
that O X
endogenous O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
regulates O X
hDlg I-MISC 25252
protein O X
levels O X
in O X
epithelial O X
cells O X
. O X

Finally O X
, O X
we O X
show O X
that O X
beta I-MISC 8945
- I-MISC 8945
TrCP I-MISC 8945
selectively O X
induces O X
the O X
degradation O X
of O X
the O X
membrane O X
- O X
cytoplasmic O X
pool O X
, O X
without O X
affecting O X
the O X
nuclear O X
pool O X
of O X
hDlg I-MISC 25252
. O X

###17276458	2885,5338

The O X
Grb2 I-MISC 2885
/ O X
PLD2 I-MISC 5338
interaction O X
is O X
essential O X
for O X
lipase O X
activity O X
, O X
intracellular O X
localization O X
and O X
signaling O X
in O X
response O X
to O X
EGF O X
. O X

The O X
adaptor O X
protein O X
Grb2 I-MISC 2885
associates O X
with O X
phospholipase I-MISC 5338
D2 I-MISC 5338
( O X
PLD2 I-MISC 5338
), O X
but O X
it O X
is O X
not O X
known O X
if O X
this O X
interaction O X
is O X
necessary O X
for O X
the O X
functionality O X
of O X
the O X
lipase O X
in O X
vivo O X
. O X

We O X
demonstrate O X
that O X
stable O X
short O X
hairpin O X
RNA O X
( O X
shRNA O X
)- O X
based O X
silencing O X
of O X
Grb2 I-MISC 2885
, O X
a O X
critical O X
signal O X
transducer O X
of O X
the O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
and O X
linker O X
to O X
the O X
Ras O X
/ O X
Erk I-MISC 5594
pathway O X
, O X
resulted O X
in O X
the O X
reduction O X
of O X
PLD2 I-MISC 5338
activity O X
in O X
COS7 O X
cells O X
. O X

Transfection O X
of O X
a O X
Grb2 I-MISC 2885
construct O X
refractory O X
to O X
shGrb2 O X
silencing O X
( O X
XGrb2 I-MISC 6491
( I-MISC 6491
SiL I-MISC 6491
)) O X
into O X
the O X
Grb2 I-MISC 2885
- O X
knockdown O X
cells O X
( O X
COS7 O X
( O X
shGrb2 O X
)), O X
resulted O X
in O X
the O X
nearly O X
full O X
rescue O X
of O X
PLD2 I-MISC 5338
activity O X
. O X

However O X
, O X
Grb2 I-MISC 2885
- O X
R86K O X
, O X
an O X
SH2 O X
- O X
deficient O X
mutant O X
of O X
Grb2 I-MISC 2885
that O X
is O X
incapable O X
of O X
binding O X
to O X
PLD2 I-MISC 5338
, O X
failed O X
to O X
induce O X
an O X
enhancement O X
of O X
the O X
impaired O X
PLD2 I-MISC 5338
activity O X
in O X
COS7 O X
( O X
shGrb2 O X
) O X
cells O X
. O X

Grb2 I-MISC 2885
and O X
PLD2 I-MISC 5338
are O X
directly O X
associated O X
and O X
Grb2 I-MISC 2885
is O X
brought O X
down O X
with O X
anti O X
- O X
myc O X
antibodies O X
irrespective O X
of O X
the O X
presence O X
or O X
absence O X
of O X
EGFR I-MISC 1956
activation O X
. O X

Immunofluorescence O X
microscopy O X
showed O X
that O X
co O X
- O X
transfected O X
PLD2 I-MISC 5338
and O X
Grb2 I-MISC 2885
re O X
- O X
localize O X
to O X
Golgi O X
- O X
like O X
structures O X
after O X
EGF O X
stimulation O X
. O X

Since O X
this O X
was O X
not O X
observed O X
in O X
cotransfection O X
experiments O X
with O X
Grb2 I-MISC 2885
and O X
PLD2 I-MISC 5338
- O X
Y169 O X
/ O X
179F O X
, O X
a O X
lipase O X
mutant O X
that O X
does O X
not O X
bind O X
to O X
Grb2 I-MISC 2885
, O X
we O X
inferred O X
that O X
Grb2 I-MISC 2885
serves O X
to O X
hijack O X
PLD2 I-MISC 5338
to O X
the O X
perinuclear O X
Golgi O X
region O X
through O X
its O X
SH2 O X
domain O X
. O X

Supporting O X
this O X
is O X
the O X
finding O X
that O X
the O X
primary O X
cell O X
line O X
HUVEC O X
expresses O X
PLD2 I-MISC 5338
diffusely O X
in O X
the O X
cytoplasm O X
and O X
in O X
the O X
perinuclear O X
Golgi O X
region O X
, O X
where O X
PLD2 I-MISC 5338
and O X
Grb2 I-MISC 2885
colocalize O X
. O X

Such O X
colocalization O X
in O X
primary O X
cells O X
increased O X
after O X
stimulation O X
with O X
EGF O X
. O X

These O X
results O X
demonstrate O X
for O X
the O X
first O X
time O X
that O X
the O X
presence O X
of O X
Grb2 I-MISC 2885
and O X
its O X
interaction O X
with O X
localized O X
intracellular O X
structures O X
is O X
essential O X
for O X
PLD2 I-MISC 5338
activity O X
and O X
signaling O X
in O X
vivo O X
. O X

###18256029	10016,310	311,10016	7251,10016	10015,10016	57048,10016

Identification O X
of O X
Alix I-MISC 10015
- O X
type O X
and O X
Non O X
- O X
Alix I-MISC 10015
- O X
type O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
- O X
binding O X
sites O X
in O X
human O X
phospholipid I-MISC 57048
scramblase I-MISC 57048
3 I-MISC 57048
: O X
differential O X
binding O X
to O X
an O X
alternatively O X
spliced O X
isoform O X
and O X
amino O X
acid O X
- O X
substituted O X
mutants O X
. O X

ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
, O X
a O X
prototypic O X
member O X
of O X
the O X
penta O X
- O X
EF O X
- O X
hand O X
protein O X
family O X
, O X
interacts O X
with O X
Alix I-MISC 10015
at O X
its O X
C O X
- O X
terminal O X
Pro O X
- O X
rich O X
region O X
containing O X
four O X
tandem O X
PXY O X
repeats O X
. O X

Human O X
phospholipid I-MISC 57048
scramblase I-MISC 57048
3 I-MISC 57048
( O X
PLSCR3 I-MISC 57048
) O X
has O X
a O X
similar O X
sequence O X
( O X
ABS O X
- O X
1 O X
) O X
in O X
its O X
N O X
- O X
terminal O X
region O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
found O X
that O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
interacts O X
with O X
PLSCR3 I-MISC 57048
expressed O X
in O X
HEK293 O X
cells O X
in O X
a O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
manner O X
by O X
co O X
- O X
immunoprecipitation O X
, O X
pulldown O X
with O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
( O X
GST O X
) O X
fused O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
and O X
an O X
overlay O X
assay O X
using O X
biotin O X
- O X
labeled O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
. O X

The O X
GST O X
fusion O X
protein O X
of O X
an O X
alternatively O X
spliced O X
isoform O X
of O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
, O X
GST O X
- O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
( O X
DeltaGF122 O X
), O X
pulled O X
down O X
green O X
fluorescent O X
protein O X
( O X
GFP O X
)- O X
fused O X
PLSCR3 I-MISC 57048
but O X
not O X
GFP O X
Alix I-MISC 10015
. O X

Deletion O X
of O X
a O X
region O X
containing O X
ABS O X
- O X
1 O X
was O X
not O X
sufficient O X
to O X
abrogate O X
the O X
binding O X
. O X

A O X
second O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
- O X
binding O X
site O X
( O X
ABS O X
- O X
2 O X
) O X
was O X
essential O X
for O X
interaction O X
with O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
( O X
DeltaGF122 O X
). O X

Real O X
- O X
time O X
interaction O X
analyses O X
with O X
a O X
surface O X
plasmon O X
resonance O X
biosensor O X
using O X
synthetic O X
oligopeptides O X
and O X
recombinant O X
proteins O X
corroborated O X
direct O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
binding O X
of O X
ABS O X
- O X
1 O X
to O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
and O X
that O X
of O X
ABS O X
- O X
2 O X
to O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
as O X
well O X
as O X
to O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
( O X
DeltaGF122 O X
). O X

The O X
sequence O X
of O X
ABS O X
- O X
2 O X
contains O X
multiple O X
prolines O X
and O X
two O X
phenylalanines O X
, O X
among O X
which O X
Phe O X
( O X
49 O X
) O X
was O X
found O X
to O X
be O X
critical O X
, O X
because O X
its O X
substitution O X
with O X
Ala O X
or O X
Tyr O X
caused O X
a O X
loss O X
of O X
binding O X
ability O X
by O X
pulldown O X
assays O X
using O X
oligopeptide O X
- O X
immobilized O X
beads O X
. O X

ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
- O X
interacting O X
proteins O X
were O X
classified O X
into O X
two O X
groups O X
based O X
on O X
binding O X
ability O X
to O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
( O X
DeltaGF122 O X
): O X
( O X
i O X
) O X
isoform O X
- O X
non O X
- O X
interactive O X
( O X
ABS O X
- O X
1 O X
) O X
types O X
, O X
including O X
Alix I-MISC 10015
, O X
annexin I-MISC 310
A7 I-MISC 310
, O X
annexin I-MISC 311
A11 I-MISC 311
, O X
and O X
TSG101 I-MISC 7251
and O X
( O X
ii O X
) O X
isoform O X
- O X
interactive O X
( O X
ABS O X
- O X
2 O X
) O X
types O X
including O X
PLSCR3 I-MISC 57048
, O X
PLSCR4 I-MISC 57088
and O X
Sec31A I-MISC 22872
. O X

GST O X
- O X
pulldown O X
assays O X
using O X
single O X
amino O X
acid O X
- O X
substituted O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
mutants O X
revealed O X
differences O X
in O X
binding O X
specificities O X
between O X
the O X
two O X
groups O X
, O X
suggesting O X
structural O X
flexibility O X
in O X
ALG I-MISC 10016
- I-MISC 10016
2 I-MISC 10016
- O X
ligand O X
complex O X
formation O X
. O X

###9388232	596,572	598,572	596,581	598,581

Dimerization O X
properties O X
of O X
human O X
BAD I-MISC 572
. O X

Identification O X
of O X
a O X
BH O X
- O X
3 O X
domain O X
and O X
analysis O X
of O X
its O X
binding O X
to O X
mutant O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
proteins O X
. O X

Bad I-MISC 12015
, O X
an O X
inducer O X
of O X
programmed O X
cell O X
death O X
, O X
was O X
recently O X
isolated O X
from O X
a O X
mouse O X
cDNA O X
library O X
by O X
its O X
ability O X
to O X
bind O X
to O X
the O X
anti O X
- O X
apoptotic O X
protein O X
BCL I-MISC 12043
- I-MISC 12043
2 I-MISC 12043
. O X

Sequence O X
analysis O X
suggested O X
that O X
Bad I-MISC 572
was O X
a O X
member O X
of O X
the O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
gene O X
family O X
that O X
encodes O X
both O X
inducers O X
and O X
inhibitors O X
of O X
programmed O X
cell O X
death O X
. O X

To O X
further O X
analyze O X
the O X
role O X
of O X
BAD I-MISC 572
in O X
the O X
network O X
of O X
homo O X
- O X
and O X
heterodimers O X
formed O X
by O X
the O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
, O X
we O X
have O X
cloned O X
the O X
human O X
homologue O X
of O X
BAD I-MISC 572
and O X
assessed O X
its O X
biological O X
activity O X
and O X
its O X
interactions O X
with O X
wild O X
type O X
and O X
mutant O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
proteins O X
. O X

Our O X
results O X
indicate O X
that O X
the O X
human O X
BAD I-MISC 572
protein O X
, O X
like O X
its O X
mouse O X
homologue O X
, O X
is O X
able O X
to O X
induce O X
apoptosis O X
when O X
transfected O X
into O X
mammalian O X
cells O X
. O X

Furthermore O X
, O X
in O X
yeast O X
two O X
- O X
hybrid O X
assays O X
as O X
well O X
as O X
quantitative O X
in O X
vitro O X
interaction O X
assays O X
, O X
human O X
Bad I-MISC 572
interacted O X
with O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
. O X

Sequence O X
alignments O X
of O X
human O X
BAD I-MISC 572
revealed O X
the O X
presence O X
of O X
a O X
BH O X
- O X
3 O X
homology O X
domain O X
as O X
seen O X
in O X
other O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
proteins O X
. O X

Peptides O X
derived O X
from O X
this O X
domain O X
were O X
able O X
to O X
completely O X
inhibit O X
the O X
dimerization O X
of O X
BAD I-MISC 572
with O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
. O X

Thus O X
, O X
as O X
previously O X
shown O X
for O X
BAX I-MISC 581
, O X
BAK O X
, O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
, O X
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
, O X
the O X
BH3 O X
domain O X
of O X
BAD I-MISC 572
is O X
required O X
for O X
its O X
dimerization O X
with O X
other O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
proteins O X
. O X

BAD I-MISC 572
was O X
further O X
analyzed O X
for O X
its O X
ability O X
to O X
bind O X
to O X
various O X
mutants O X
of O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
that O X
have O X
lost O X
the O X
ability O X
to O X
bind O X
BAX I-MISC 581
and O X
BAK O X
, O X
some O X
of O X
which O X
retain O X
biological O X
activity O X
and O X
some O X
of O X
which O X
do O X
not O X
. O X

Surprisingly O X
, O X
all O X
of O X
the O X
mutated O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
proteins O X
analyzed O X
strongly O X
interacted O X
with O X
human O X
BAD I-MISC 572
. O X

Our O X
data O X
thus O X
indicate O X
that O X
mutations O X
in O X
BCL I-MISC 596
- I-MISC 596
2 I-MISC 596
and O X
BCL I-MISC 598
- I-MISC 598
XL I-MISC 598
can O X
differentially O X
affect O X
the O X
heterodimeric O X
binding O X
of O X
different O X
death O X
- O X
promoting O X
proteins O X
and O X
have O X
implications O X
concerning O X
the O X
relationship O X
between O X
heterodimerization O X
and O X
biological O X
activity O X
. O X

###12117771	23139,54825

Protocadherin I-MISC 54825
LKC I-MISC 54825
, O X
a O X
new O X
candidate O X
for O X
a O X
tumor O X
suppressor O X
of O X
colon O X
and O X
liver O X
cancers O X
, O X
its O X
association O X
with O X
contact O X
inhibition O X
of O X
cell O X
proliferation O X
. O X

Protocadherins O X
are O X
a O X
major O X
subfamily O X
of O X
the O X
cadherin O X
superfamily O X
, O X
but O X
little O X
is O X
known O X
about O X
their O X
functions O X
and O X
intracellular O X
signal O X
transduction O X
. O X

We O X
cloned O X
a O X
novel O X
human O X
protocadherin O X
gene O X
, O X
containing O X
seven O X
EC O X
domains O X
, O X
and O X
identified O X
functional O X
aspects O X
of O X
this O X
gene O X
. O X

The O X
gene O X
was O X
predominantly O X
expressed O X
in O X
liver O X
, O X
kidney O X
and O X
colon O X
tissues O X
, O X
and O X
was O X
thus O X
designated O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
. O X

The O X
expression O X
of O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
is O X
markedly O X
reduced O X
in O X
cancers O X
arising O X
from O X
these O X
tissues O X
at O X
both O X
transcriptional O X
and O X
protein O X
levels O X
. O X

To O X
investigate O X
the O X
effects O X
of O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
expression O X
in O X
colon O X
cancer O X
, O X
we O X
introduced O X
the O X
gene O X
into O X
colon O X
cancer O X
cell O X
line O X
HCT116 O X
, O X
which O X
does O X
not O X
express O X
this O X
gene O X
. O X

Significantly O X
, O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
expression O X
induced O X
contact O X
inhibition O X
of O X
cell O X
proliferation O X
although O X
it O X
did O X
not O X
affect O X
growth O X
rate O X
. O X

When O X
grown O X
to O X
post O X
- O X
confluence O X
in O X
monolayer O X
cells O X
cultures O X
, O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
- O X
expressing O X
HCT116 O X
no O X
longer O X
formed O X
multiple O X
cell O X
layers O X
and O X
showed O X
the O X
typical O X
paving O X
stone O X
morphology O X
of O X
normal O X
epithelial O X
cells O X
. O X

Furthermore O X
, O X
expression O X
of O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
suppressed O X
tumor O X
formation O X
of O X
HCT116 O X
cells O X
in O X
a O X
nude O X
mouse O X
model O X
. O X

In O X
addition O X
, O X
we O X
identified O X
a O X
protein O X
, O X
hMAST205 I-MISC 23139
( O X
microtubule O X
- O X
associated O X
serine O X
/ O X
threonine O X
kinase O X
- O X
205 O X
kDa O X
), O X
which O X
interacted O X
with O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
; O X
the O X
interaction O X
occurring O X
between O X
the O X
PDZ O X
domain O X
of O X
hMAST205 I-MISC 23139
and O X
C O X
- O X
terminal O X
tail O X
of O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
. O X

Our O X
results O X
suggest O X
that O X
Protocadherin I-MISC 54825
LKC I-MISC 54825
, O X
which O X
directly O X
binds O X
PDZ I-MISC 10207
protein I-MISC 10207
, O X
is O X
a O X
molecular O X
switch O X
for O X
contact O X
inhibition O X
of O X
epithelial O X
cells O X
in O X
the O X
liver O X
, O X
kidney O X
and O X
colon O X
tissues O X
. O X

###15143163	23184,4041

The O X
LRP5 I-MISC 4041
high O X
- O X
bone O X
- O X
mass O X
G171V O X
mutation O X
disrupts O X
LRP5 I-MISC 4041
interaction O X
with O X
Mesd I-MISC 23184
. O X

The O X
mechanism O X
by O X
which O X
the O X
high O X
- O X
bone O X
- O X
mass O X
( O X
HBM O X
) O X
mutation O X
( O X
G171V O X
) O X
of O X
the O X
Wnt O X
coreceptor O X
LRP5 I-MISC 4041
regulates O X
canonical O X
Wnt O X
signaling O X
was O X
investigated O X
. O X

The O X
mutation O X
was O X
previously O X
shown O X
to O X
reduce O X
DKK1 I-MISC 22943
- O X
mediated O X
antagonism O X
, O X
suggesting O X
that O X
the O X
first O X
YWTD O X
repeat O X
domain O X
where O X
G171 O X
is O X
located O X
may O X
be O X
responsible O X
for O X
DKK O X
- O X
mediated O X
antagonism O X
. O X

However O X
, O X
we O X
found O X
that O X
the O X
third O X
YWTD O X
repeat O X
, O X
but O X
not O X
the O X
first O X
repeat O X
domain O X
, O X
is O X
required O X
for O X
DKK1 I-MISC 22943
- O X
mediated O X
antagonism O X
. O X

Instead O X
, O X
we O X
found O X
that O X
the O X
G171V O X
mutation O X
disrupted O X
the O X
interaction O X
of O X
LRP5 I-MISC 4041
with O X
Mesd I-MISC 23184
, O X
a O X
chaperone O X
protein O X
for O X
LRP5 I-MISC 4041
/ I-MISC 4041
6 I-MISC 4041
that O X
is O X
required O X
for O X
transport O X
of O X
the O X
coreceptors O X
to O X
cell O X
surfaces O X
, O X
resulting O X
in O X
fewer O X
LRP5 I-MISC 4041
molecules O X
on O X
the O X
cell O X
surface O X
. O X

Although O X
the O X
reduction O X
in O X
the O X
number O X
of O X
cell O X
surface O X
LRP5 I-MISC 4041
molecules O X
led O X
to O X
a O X
reduction O X
in O X
Wnt O X
signaling O X
in O X
a O X
paracrine O X
paradigm O X
, O X
the O X
mutation O X
did O X
not O X
appear O X
to O X
affect O X
the O X
activity O X
of O X
coexpressed O X
Wnt O X
in O X
an O X
autocrine O X
paradigm O X
. O X

Together O X
with O X
the O X
observation O X
that O X
osteoblast O X
cells O X
produce O X
autocrine O X
canonical O X
Wnt O X
, O X
Wnt7b I-MISC 7477
, O X
and O X
that O X
osteocytes O X
produce O X
paracrine O X
DKK1 I-MISC 22943
, O X
we O X
think O X
that O X
the O X
G171V O X
mutation O X
may O X
cause O X
an O X
increase O X
in O X
Wnt O X
activity O X
in O X
osteoblasts O X
by O X
reducing O X
the O X
number O X
of O X
targets O X
for O X
paracrine O X
DKK1 I-MISC 22943
to O X
antagonize O X
without O X
affecting O X
the O X
activity O X
of O X
autocrine O X
Wnt O X
. O X

###10373560	9088,983	891,9088

Overproduction O X
of O X
human O X
Myt1 I-MISC 9088
kinase I-MISC 9088
induces O X
a O X
G2 O X
cell O X
cycle O X
delay O X
by O X
interfering O X
with O X
the O X
intracellular O X
trafficking O X
of O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
complexes O X
. O X

The O X
Myt1 I-MISC 4661
protein O X
kinase O X
functions O X
to O X
negatively O X
regulate O X
Cdc2 I-MISC 983
- O X
cyclin O X
B O X
complexes O X
by O X
phosphorylating O X
Cdc2 I-MISC 983
on O X
threonine O X
14 O X
and O X
tyrosine O X
15 O X
. O X

Throughout O X
interphase O X
, O X
human O X
Myt1 I-MISC 4661
localizes O X
to O X
the O X
endoplasmic O X
reticulum O X
and O X
Golgi O X
complex O X
, O X
whereas O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
complexes O X
shuttle O X
between O X
the O X
nucleus O X
and O X
the O X
cytoplasm O X
. O X

Here O X
we O X
report O X
that O X
overproduction O X
of O X
either O X
kinase O X
- O X
active O X
or O X
kinase O X
- O X
inactive O X
forms O X
of O X
Myt1 I-MISC 4661
blocked O X
the O X
nuclear O X
- O X
cytoplasmic O X
shuttling O X
of O X
cyclin I-MISC 891
B1 I-MISC 891
and O X
caused O X
cells O X
to O X
delay O X
in O X
the O X
G2 O X
phase O X
of O X
the O X
cell O X
cycle O X
. O X

The O X
COOH O X
- O X
terminal O X
63 O X
amino O X
acids O X
of O X
Myt1 I-MISC 4661
were O X
identified O X
as O X
a O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
interaction O X
domain O X
. O X

Myt1 I-MISC 4661
mutants O X
lacking O X
this O X
domain O X
no O X
longer O X
bound O X
cyclin I-MISC 891
B1 I-MISC 891
and O X
did O X
not O X
efficiently O X
phosphorylate O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
complexes O X
in O X
vitro O X
. O X

In O X
addition O X
, O X
cells O X
overproducing O X
mutant O X
forms O X
of O X
Myt1 I-MISC 4661
lacking O X
the O X
interaction O X
domain O X
exhibited O X
normal O X
trafficking O X
of O X
cyclin I-MISC 891
B1 I-MISC 891
and O X
unperturbed O X
cell O X
cycle O X
progression O X
. O X

These O X
results O X
suggest O X
that O X
the O X
docking O X
of O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
complexes O X
to O X
the O X
COOH O X
terminus O X
of O X
Myt1 I-MISC 4661
facilitates O X
the O X
phosphorylation O X
of O X
Cdc2 I-MISC 983
by O X
Myt1 I-MISC 4661
and O X
that O X
overproduction O X
of O X
Myt1 I-MISC 4661
perturbs O X
cell O X
cycle O X
progression O X
by O X
sequestering O X
Cdc2 I-MISC 983
- O X
cyclin I-MISC 891
B1 I-MISC 891
complexes O X
in O X
the O X
cytoplasm O X
. O X

###18647389	274,9185	2885,9185

The O X
central O X
proline O X
rich O X
region O X
of O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
plays O X
a O X
regulatory O X
role O X
in O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
endocytosis O X
by O X
binding O X
to O X
14 O X
- O X
3 O X
- O X
3 O X
and O X
SH3 O X
domain O X
- O X
containing O X
proteins O X
. O X

BACKGROUND O X
: O X
The O X
human O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
( O X
Partner I-MISC 9185
of I-MISC 9185
RalBP1 I-MISC 9185
) O X
protein O X
is O X
highly O X
conserved O X
in O X
mammals O X
where O X
it O X
has O X
been O X
suggested O X
to O X
function O X
as O X
a O X
molecular O X
scaffold O X
recruiting O X
proteins O X
involved O X
in O X
vesicular O X
traffic O X
and O X
linking O X
them O X
to O X
the O X
actin O X
cytoskeleton O X
remodeling O X
machinery O X
. O X

More O X
recently O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
was O X
found O X
highly O X
expressed O X
in O X
androgen O X
- O X
dependent O X
prostate O X
cancer O X
cell O X
lines O X
, O X
while O X
one O X
of O X
its O X
isoforms O X
( O X
isoform O X
2 O X
) O X
is O X
down O X
regulated O X
during O X
prostate O X
cancer O X
progression O X
. O X

RESULTS O X
: O X
In O X
this O X
report O X
we O X
characterize O X
the O X
central O X
proline O X
rich O X
domain O X
of O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
and O X
we O X
describe O X
for O X
the O X
first O X
time O X
its O X
functional O X
role O X
in O X
receptor O X
endocytosis O X
. O X

We O X
show O X
that O X
the O X
ectopic O X
expression O X
of O X
this O X
domain O X
has O X
a O X
dominant O X
negative O X
effect O X
on O X
the O X
endocytosis O X
of O X
activated O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
while O X
leaving O X
transferrin I-MISC 7018
receptor O X
endocytosis O X
unaffected O X
. O X

By O X
a O X
combination O X
of O X
different O X
approaches O X
( O X
phage O X
display O X
, O X
bioinformatics O X
predictions O X
, O X
peptide O X
arrays O X
, O X
mutagenic O X
analysis O X
, O X
in O X
vivo O X
co O X
- O X
immunoprecipitation O X
), O X
we O X
have O X
identified O X
two O X
closely O X
spaced O X
binding O X
motifs O X
for O X
14 O X
- O X
3 O X
- O X
3 O X
and O X
for O X
the O X
SH3 O X
of O X
the O X
proteins O X
Amphiphysin I-MISC 274
II I-MISC 274
and O X
Grb2 I-MISC 2885
. O X

Differently O X
from O X
wild O X
type O X
, O X
proline O X
rich O X
domains O X
that O X
are O X
altered O X
in O X
these O X
motifs O X
do O X
not O X
inhibit O X
EGFR I-MISC 1956
endocytosis O X
, O X
suggesting O X
that O X
these O X
binding O X
motifs O X
play O X
a O X
functional O X
role O X
in O X
this O X
process O X
. O X

CONCLUSION O X
: O X
Our O X
findings O X
are O X
relevant O X
to O X
the O X
characterization O X
of O X
the O X
molecular O X
mechanism O X
underlying O X
the O X
involvement O X
of O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
, O X
SH3 O X
and O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
in O X
receptor O X
endocytosis O X
, O X
suggesting O X
that O X
14 O X
- O X
3 O X
- O X
3 O X
could O X
work O X
by O X
bridging O X
the O X
EGF O X
receptor O X
and O X
the O X
scaffold O X
protein O X
POB1 I-MISC 9185
/ O X
REPS2 I-MISC 9185
. O X

###11520064	14367,94221

Identification O X
of O X
a O X
PDZ O X
domain O X
containing O X
Golgi O X
protein O X
, O X
GOPC I-MISC 94221
, O X
as O X
an O X
interaction O X
partner O X
of O X
frizzled I-MISC 14367
. O X

The O X
frizzled I-MISC 14367
gene O X
is O X
evolutionally O X
conserved O X
in O X
a O X
wide O X
variety O X
of O X
organisms O X
including O X
mammals O X
, O X
and O X
in O X
Drosophila O X
, O X
frizzled I-MISC 14367
is O X
implicated O X
in O X
the O X
development O X
of O X
planar O X
polarity O X
. O X

We O X
describe O X
here O X
the O X
isolation O X
and O X
characterization O X
of O X
a O X
Golgi O X
protein O X
, O X
GOPC I-MISC 94221
, O X
as O X
a O X
frizzled I-MISC 14367
interacting O X
protein O X
. O X

GOPC I-MISC 94221
comprises O X
one O X
PDZ O X
domain O X
, O X
two O X
coiled O X
- O X
coil O X
motifs O X
and O X
two O X
evolutionally O X
conserved O X
regions O X
. O X

Immunofluorescence O X
studies O X
indicated O X
that O X
a O X
significant O X
fraction O X
of O X
GOPC I-MISC 94221
protein O X
was O X
localized O X
in O X
the O X
Golgi O X
apparatus O X
. O X

Using O X
a O X
series O X
of O X
deletion O X
mutants O X
, O X
we O X
show O X
that O X
both O X
coiled O X
- O X
coil O X
motifs O X
and O X
a O X
C O X
- O X
terminal O X
conserved O X
region O X
were O X
required O X
for O X
its O X
Golgi O X
localization O X
. O X

Interestingly O X
, O X
deletion O X
mutants O X
that O X
lack O X
a O X
N O X
- O X
terminal O X
conserved O X
region O X
or O X
coiled O X
- O X
coil O X
motifs O X
formed O X
aggresome O X
- O X
like O X
perinuclear O X
structure O X
. O X

Interaction O X
of O X
GOPC I-MISC 94221
and O X
frizzled I-MISC 14367
was O X
observed O X
both O X
in O X
vivo O X
and O X
in O X
vitro O X
, O X
and O X
the O X
PDZ O X
domain O X
of O X
GOPC I-MISC 94221
and O X
the O X
C O X
- O X
terminal O X
Ser O X
/ O X
Thr O X
- O X
X O X
- O X
Val O X
motif O X
of O X
frizzled I-MISC 14367
were O X
required O X
for O X
their O X
interaction O X
. O X

Immunofluorescence O X
studies O X
indicated O X
that O X
, O X
although O X
frizzled I-MISC 14367
was O X
a O X
membrane O X
protein O X
, O X
it O X
was O X
localized O X
at O X
the O X
Golgi O X
apparatus O X
as O X
well O X
, O X
and O X
colocalization O X
of O X
GOPC I-MISC 94221
and O X
frizzled I-MISC 14367
at O X
the O X
Golgi O X
apparatus O X
was O X
observed O X
. O X

Furthermore O X
, O X
when O X
GOPC I-MISC 94221
was O X
coexpressed O X
with O X
frizzled I-MISC 14367
, O X
translocation O X
of O X
GOPC I-MISC 94221
to O X
the O X
plasma O X
membrane O X
was O X
observed O X
. O X

Importantly O X
, O X
brefeldin O X
A O X
interrupted O X
not O X
only O X
the O X
localization O X
of O X
GOPC I-MISC 94221
to O X
the O X
Golgi O X
apparatus O X
but O X
also O X
the O X
translocation O X
of O X
frizzled I-MISC 14367
to O X
the O X
plasma O X
membrane O X
, O X
indicating O X
that O X
the O X
Golgi O X
structure O X
was O X
required O X
for O X
the O X
proper O X
subcellular O X
localization O X
of O X
frizzled I-MISC 14367
. O X

Taken O X
together O X
, O X
these O X
results O X
indicate O X
that O X
GOPC I-MISC 94221
may O X
play O X
a O X
role O X
in O X
the O X
vesicle O X
transport O X
of O X
frizzled I-MISC 14367
from O X
the O X
Golgi O X
apparatus O X
to O X
the O X
plasma O X
membrane O X
. O X

###21554542	3167975,3167975

Roles O X
of O X
conserved O X
arginines O X
in O X
ATP O X
- O X
binding O X
domains O X
of O X
AAA O X
+ O X
chaperone O X
ClpB O X
from O X
Thermus O X
thermophilus O X
. O X

ClpB O X
, O X
a O X
member O X
of O X
the O X
expanded O X
superfamily O X
of O X
ATPases O X
associated O X
with O X
diverse O X
cellular O X
activities O X
( O X
AAA O X
+), O X
forms O X
a O X
ring O X
- O X
shaped O X
hexamer O X
and O X
cooperates O X
with O X
the O X
DnaK O X
chaperone O X
system O X
to O X
reactivate O X
aggregated O X
proteins O X
in O X
an O X
ATP O X
- O X
dependent O X
manner O X
. O X

The O X
ClpB O X
protomer O X
consists O X
of O X
an O X
N O X
- O X
terminal O X
domain O X
, O X
an O X
AAA O X
+ O X
module O X
( O X
AAA I-MISC 3167975
- I-MISC 3167975
1 I-MISC 3167975
), O X
a O X
middle O X
domain O X
, O X
and O X
a O X
second O X
AAA O X
+ O X
module O X
( O X
AAA I-MISC 3167975
- I-MISC 3167975
2 I-MISC 3167975
). O X

Each O X
AAA O X
+ O X
module O X
contains O X
highly O X
conserved O X
WalkerA O X
and O X
WalkerB O X
motifs O X
, O X
and O X
two O X
arginines O X
( O X
AAA I-MISC 3167975
- I-MISC 3167975
1 I-MISC 3167975
) O X
or O X
one O X
arginine O X
( O X
AAA I-MISC 3167975
- I-MISC 3167975
2 I-MISC 3167975
). O X

Here O X
, O X
we O X
investigated O X
the O X
roles O X
of O X
these O X
arginines O X
( O X
Arg322 O X
, O X
Arg323 O X
, O X
and O X
Arg747 O X
) O X
of O X
ClpB O X
from O X
Thermus O X
thermophilus O X
in O X
the O X
ATPase O X
cycle O X
and O X
chaperone O X
function O X
by O X
alanine O X
substitution O X
. O X

These O X
mutations O X
did O X
not O X
affect O X
nucleotide O X
binding O X
, O X
but O X
did O X
inhibit O X
the O X
hydrolysis O X
of O X
the O X
bound O X
ATP O X
and O X
slow O X
the O X
threading O X
of O X
the O X
denatured O X
protein O X
through O X
the O X
central O X
pore O X
of O X
the O X
T O X
. O X
thermophilus O X
ClpB O X
ring O X
, O X
which O X
severely O X
impaired O X
the O X
chaperone O X
functions O X
. O X

Previously O X
, O X
it O X
was O X
demonstrated O X
that O X
ATP O X
binding O X
to O X
the O X
AAA I-MISC 3167975
- I-MISC 3167975
1 I-MISC 3167975
module O X
induced O X
motion O X
of O X
the O X
middle O X
domain O X
and O X
stabilized O X
the O X
ClpB O X
hexamer O X
. O X

However O X
, O X
the O X
arginine O X
mutations O X
of O X
the O X
AAA I-MISC 3167975
- I-MISC 3167975
1 I-MISC 3167975
module O X
destabilized O X
the O X
ClpB O X
hexamer O X
, O X
even O X
though O X
ATP O X
- O X
induced O X
motion O X
of O X
the O X
middle O X
domain O X
was O X
not O X
affected O X
. O X

These O X
results O X
indicated O X
that O X
the O X
three O X
arginines O X
are O X
crucial O X
for O X
ATP O X
hydrolysis O X
and O X
chaperone O X
activity O X
, O X
but O X
not O X
for O X
ATP O X
binding O X
. O X

In O X
addition O X
, O X
the O X
two O X
arginines O X
in O X
AAA I-MISC 3167975
- I-MISC 3167975
1 I-MISC 3167975
and O X
the O X
ATP O X
- O X
induced O X
motion O X
of O X
the O X
middle O X
domain O X
independently O X
contribute O X
to O X
the O X
stabilization O X
of O X
the O X
hexamer O X
. O X

###21681199	1018885,1018885

The O X
role O X
of O X
trimerization O X
in O X
the O X
osmoregulated O X
betaine O X
transporter O X
BetP I-MISC 1018885
. O X

The O X
osmoregulated O X
betaine O X
transporter O X
BetP I-MISC 1018885
is O X
a O X
stable O X
trimer O X
. O X

Structural O X
studies O X
have O X
shown O X
that O X
individual O X
protomers O X
can O X
adopt O X
distinct O X
transport O X
conformations O X
, O X
implying O X
a O X
functional O X
role O X
for O X
the O X
trimeric O X
state O X
in O X
transport O X
, O X
although O X
the O X
role O X
of O X
trimerization O X
in O X
regulation O X
is O X
not O X
yet O X
understood O X
. O X

We O X
designed O X
putative O X
monomeric O X
mutants O X
by O X
molecular O X
- O X
dynamics O X
simulations O X
and O X
in O X
silico O X
alanine O X
- O X
scanning O X
mutagenesis O X
. O X

Several O X
mutants O X
including O X
BetP I-MISC 1018885
- O X
W101A O X
/ O X
T351A O X
were O X
monomeric O X
in O X
detergent O X
as O X
well O X
as O X
in O X
the O X
membrane O X
, O X
as O X
shown O X
by O X
blue O X
native O X
gel O X
electrophoresis O X
, O X
crosslinking O X
and O X
electron O X
microscopy O X
. O X

This O X
monomeric O X
form O X
retains O X
the O X
ability O X
to O X
accumulate O X
betaine O X
, O X
but O X
is O X
no O X
longer O X
regulated O X
by O X
hyperosmotic O X
shock O X
. O X

###19515790	823732,817675

ROOT O X
UV O X
- O X
B O X
SENSITIVE2 O X
acts O X
with O X
ROOT O X
UV O X
- O X
B O X
SENSITIVE1 O X
in O X
a O X
root O X
ultraviolet O X
B O X
- O X
sensing O X
pathway O X
. O X

Ultraviolet O X
B O X
light O X
( O X
UV O X
- O X
B O X
; O X
280 O X
- O X
320 O X
nm O X
) O X
perception O X
and O X
signaling O X
are O X
well O X
- O X
known O X
phenomena O X
in O X
plants O X
, O X
although O X
no O X
specific O X
UV O X
- O X
B O X
photoreceptors O X
have O X
yet O X
been O X
identified O X
. O X

We O X
previously O X
reported O X
on O X
the O X
root O X
UV O X
- O X
B O X
sensitive1 O X
( O X
rus1 I-MISC 823732
) O X
mutants O X
in O X
Arabidopsis O X
( O X
Arabidopsis O X
thaliana O X
), O X
which O X
display O X
a O X
block O X
to O X
development O X
under O X
very O X
- O X
low O X
- O X
fluence O X
- O X
rate O X
UV O X
- O X
B O X
(< O X
0 O X
. O X
1 O X
mumol O X
m O X
(- O X
2 O X
) O X
s O X
(- O X
1 O X
)) O X
after O X
the O X
seedling O X
emerges O X
from O X
the O X
seed O X
. O X

Here O X
, O X
we O X
report O X
the O X
analysis O X
and O X
cloning O X
of O X
the O X
rus2 I-MISC 817675
- O X
1 O X
mutation O X
in O X
Arabidopsis O X
. O X

The O X
phenotype O X
of O X
rus2 I-MISC 817675
- O X
1 O X
mutant O X
seedlings O X
is O X
virtually O X
indistinguishable O X
from O X
the O X
phenotype O X
of O X
rus1 I-MISC 823732
seedlings O X
. O X

A O X
map O X
- O X
based O X
approach O X
was O X
used O X
to O X
clone O X
RUS2 I-MISC 817675
. O X

RUS2 I-MISC 817675
encodes O X
a O X
domain O X
of O X
unknown O X
function O X
( O X
DUF647 O X
)- O X
containing O X
protein O X
that O X
is O X
homologous O X
to O X
the O X
RUS1 I-MISC 823732
protein O X
. O X

rus1 I-MISC 823732
- O X
2 O X
rus2 I-MISC 817675
- O X
1 O X
double O X
mutant O X
seedlings O X
have O X
the O X
same O X
phenotype O X
as O X
both O X
rus1 I-MISC 823732
and O X
rus2 I-MISC 817675
single O X
mutants O X
, O X
suggesting O X
that O X
the O X
two O X
genes O X
work O X
in O X
the O X
same O X
pathway O X
. O X

RUS2 I-MISC 817675
- O X
Green O X
Fluorescent O X
Protein O X
shows O X
a O X
similar O X
expression O X
pattern O X
as O X
that O X
of O X
RUS1 I-MISC 823732
- O X
Green O X
Fluorescent O X
Protein O X
, O X
and O X
RUS1 I-MISC 823732
and O X
RUS2 I-MISC 817675
proteins O X
interact O X
physically O X
in O X
yeast O X
. O X

This O X
protein O X
- O X
protein O X
interaction O X
depends O X
on O X
the O X
DUF647 O X
domain O X
, O X
and O X
site O X
- O X
directed O X
mutagenesis O X
identified O X
specific O X
residues O X
in O X
DUF647 O X
that O X
are O X
required O X
for O X
both O X
protein O X
- O X
protein O X
interaction O X
and O X
physiological O X
function O X
. O X

Six O X
RUS O X
genes O X
are O X
found O X
in O X
Arabidopsis O X
, O X
rice O X
( O X
Oryza O X
sativa O X
), O X
and O X
moss O X
( O X
Physcomitrella O X
patens O X
), O X
and O X
one O X
RUS O X
member O X
, O X
RUS3 O X
, O X
is O X
conserved O X
in O X
plants O X
and O X
animals O X
. O X

Our O X
results O X
demonstrate O X
that O X
RUS2 I-MISC 817675
works O X
with O X
RUS1 I-MISC 823732
in O X
a O X
root O X
UV O X
- O X
B O X
- O X
sensing O X
pathway O X
that O X
plays O X
a O X
vital O X
role O X
in O X
Arabidopsis O X
early O X
seedling O X
morphogenesis O X
and O X
development O X
. O X

###9414278	2155,2152

Factor I-MISC 2155
VII I-MISC 2155
deficiency O X
caused O X
by O X
a O X
structural O X
variant O X
N57D O X
of O X
the O X
first O X
epidermal O X
growth O X
factor O X
domain O X
. O X

We O X
have O X
previously O X
described O X
a O X
kindred O X
with O X
factor I-MISC 2155
VII I-MISC 2155
( O X
FVII I-MISC 2155
) O X
deficiency O X
whose O X
members O X
exhibited O X
reduced O X
procoagulant O X
activity O X
relative O X
to O X
FVII I-MISC 2155
antigen O X
concentration O X
. O X

In O X
this O X
report O X
, O X
the O X
molecular O X
genetic O X
basis O X
of O X
the O X
FVII I-MISC 2155
defect O X
has O X
been O X
determined O X
to O X
be O X
a O X
heterozygous O X
substitution O X
of O X
Asp O X
for O X
Asn O X
at O X
position O X
57 O X
in O X
the O X
first O X
epidermal O X
growth O X
factor O X
( O X
EGF O X
) O X
domain O X
. O X

Recombinant O X
FVII I-MISC 2155
( O X
N57D O X
) O X
cDNA O X
was O X
created O X
by O X
site O X
- O X
directed O X
mutagenesis O X
and O X
transiently O X
expressed O X
in O X
human O X
293 O X
cells O X
. O X

The O X
transfected O X
cells O X
synthesized O X
an O X
immunoprecipitable O X
protein O X
with O X
an O X
apparent O X
molecular O X
weight O X
of O X
50 O X
kD O X
. O X

Quantitation O X
of O X
expression O X
by O X
FVII I-MISC 2155
enzyme O X
- O X
linked O X
immunosorbent O X
assay O X
indicated O X
that O X
mutant O X
protein O X
yields O X
were O X
consistently O X
low O X
, O X
typically O X
10 O X
% O X
to O X
30 O X
% O X
of O X
wild O X
- O X
type O X
FVII I-MISC 2155
. O X

FVII I-MISC 2155
( O X
N57D O X
) O X
protein O X
did O X
not O X
accumulate O X
intracellularly O X
, O X
and O X
Northern O X
blot O X
analysis O X
indicated O X
equivalent O X
FVII I-MISC 2155
mRNA O X
levels O X
in O X
293 O X
cells O X
expressing O X
either O X
wild O X
- O X
type O X
FVII I-MISC 2155
or O X
FVII I-MISC 2155
( O X
N57D O X
). O X

Secreted O X
FVII I-MISC 2155
( O X
N57D O X
) O X
protein O X
did O X
not O X
bind O X
tissue I-MISC 2152
factor I-MISC 2152
, O X
exhibited O X
no O X
procoagulant O X
activity O X
, O X
and O X
failed O X
to O X
bind O X
a O X
conformation O X
- O X
dependent O X
monoclonal O X
antibody O X
specific O X
for O X
the O X
first O X
EGF O X
domain O X
of O X
FVII I-MISC 2155
. O X

Molecular O X
modeling O X
of O X
the O X
first O X
EGF O X
domain O X
of O X
FVII I-MISC 2155
predicted O X
that O X
the O X
N57D O X
amino O X
acid O X
substitution O X
would O X
disrupt O X
tertiary O X
bonding O X
structure O X
. O X

We O X
conclude O X
that O X
the O X
N57D O X
mutation O X
affects O X
folding O X
of O X
the O X
first O X
EGF O X
domain O X
of O X
FVII I-MISC 2155
resulting O X
in O X
decreased O X
cellular O X
secretion O X
of O X
a O X
mutant O X
FVII I-MISC 2155
molecule O X
, O X
which O X
is O X
unable O X
to O X
bind O X
tissue I-MISC 2152
factor I-MISC 2152
and O X
is O X
therefore O X
biologically O X
inactive O X
. O X

###19765570	8624357,8625242	8625242,8625242

The O X
Galpha4 I-MISC 8625242
G O X
protein O X
subunit O X
interacts O X
with O X
the O X
MAP I-MISC 8624357
kinase I-MISC 8624357
ERK2 O X
using O X
a O X
D O X
- O X
motif O X
that O X
regulates O X
developmental O X
morphogenesis O X
in O X
Dictyostelium O X
. O X

G O X
protein O X
Galpha O X
subunits O X
contribute O X
to O X
the O X
specificity O X
of O X
different O X
signal O X
transduction O X
pathways O X
in O X
Dictyostelium O X
discoideum O X
but O X
Galpha O X
subunit O X
- O X
effector O X
interactions O X
have O X
not O X
been O X
previously O X
identified O X
. O X

The O X
requirement O X
of O X
the O X
Dictyostelium O X
Galpha4 I-MISC 8625242
subunit O X
for O X
MAP I-MISC 8624357
kinase I-MISC 8624357
( O X
MAPK O X
) O X
activation O X
and O X
the O X
identification O X
of O X
a O X
putative O X
MAPK O X
docking O X
site O X
( O X
D O X
- O X
motif O X
) O X
in O X
this O X
subunit O X
suggested O X
a O X
possible O X
interaction O X
between O X
the O X
Galpha4 I-MISC 8625242
subunit O X
and O X
MAPKs O X
. O X

In O X
vivo O X
association O X
of O X
the O X
Galpha4 I-MISC 8625242
subunit O X
and O X
ERK2 O X
was O X
demonstrated O X
by O X
pull O X
- O X
down O X
and O X
co O X
- O X
immunoprecipitation O X
assays O X
. O X

Alteration O X
of O X
the O X
D O X
- O X
motif O X
reduced O X
Galpha4 I-MISC 8625242
subunit O X
- O X
ERK2 O X
interactions O X
but O X
only O X
slightly O X
altered O X
MAPK O X
activation O X
in O X
response O X
to O X
folate O X
. O X

Expression O X
of O X
the O X
Galpha4 I-MISC 8625242
subunit O X
with O X
the O X
altered O X
D O X
- O X
motif O X
in O X
galpha4 I-MISC 8625242
(-) O X
cells O X
allowed O X
for O X
slug O X
formation O X
but O X
not O X
the O X
morphogenesis O X
associated O X
with O X
culmination O X
. O X

Expression O X
of O X
this O X
mutant O X
Galpha4 I-MISC 8625242
subunit O X
was O X
sufficient O X
to O X
rescue O X
chemotactic O X
movement O X
to O X
folate O X
. O X

Alteration O X
of O X
the O X
D O X
- O X
motif O X
also O X
reduced O X
the O X
aggregation O X
defect O X
associated O X
with O X
constitutively O X
active O X
Galpha4 I-MISC 8625242
subunits O X
. O X

These O X
results O X
suggest O X
Galpha4 I-MISC 8625242
subunit O X
- O X
MAPK O X
interactions O X
are O X
necessary O X
for O X
developmental O X
morphogenesis O X
but O X
not O X
for O X
chemotaxis O X
to O X
folate O X
. O X

###22430200	10616,55072

A O X
non O X
- O X
canonical O X
UBA O X
- O X
UBL O X
interaction O X
forms O X
the O X
linear O X
- O X
ubiquitin O X
- O X
chain O X
assembly O X
complex O X
. O X

HOIL I-MISC 10616
- I-MISC 10616
1L I-MISC 10616
and O X
its O X
binding O X
partner O X
HOIP I-MISC 55072
are O X
essential O X
components O X
of O X
the O X
E3 O X
- O X
ligase O X
complex O X
that O X
generates O X
linear O X
ubiquitin O X
( O X
Ub O X
) O X
chains O X
, O X
which O X
are O X
critical O X
regulators O X
of O X
NF O X
- O X
kB O X
activation O X
. O X

Using O X
crystallographic O X
and O X
mutational O X
approaches O X
, O X
we O X
characterize O X
the O X
unexpected O X
structural O X
basis O X
for O X
the O X
specific O X
interaction O X
between O X
the O X
Ub O X
- O X
like O X
domain O X
( O X
UBL O X
) O X
of O X
HOIL I-MISC 10616
- I-MISC 10616
1L I-MISC 10616
and O X
the O X
Ub O X
- O X
associated O X
domain O X
( O X
UBA O X
) O X
of O X
HOIP I-MISC 55072
. O X

Our O X
data O X
indicate O X
the O X
functional O X
significance O X
of O X
this O X
non O X
- O X
canonical O X
mode O X
of O X
UBA O X
- O X
UBL O X
interaction O X
in O X
E3 O X
complex O X
formation O X
and O X
subsequent O X
NF O X
- O X
kB O X
activation O X
. O X

This O X
study O X
highlights O X
the O X
versatility O X
and O X
specificity O X
of O X
protein O X
- O X
protein O X
interactions O X
involving O X
Ub O X
/ O X
UBLs O X
and O X
their O X
cognate O X
proteins O X
. O X

###17047026	317719,317719

Non O X
- O X
invasive O X
genetic O X
diagnosis O X
of O X
male O X
infertility O X
using O X
spermatozoal O X
RNA O X
: O X
KLHL10 I-MISC 317719
mutations O X
in O X
oligozoospermic O X
patients O X
impair O X
homodimerization O X
. O X

Infertility O X
affects O X
an O X
estimated O X
7 O X
% O X
of O X
men O X
worldwide O X
, O X
nearly O X
a O X
quarter O X
of O X
whom O X
are O X
diagnosed O X
as O X
idiopathic O X
. O X

The O X
genetic O X
etiologies O X
of O X
idiopathic O X
male O X
infertility O X
are O X
unknown O X
, O X
partly O X
due O X
to O X
lack O X
of O X
simple O X
diagnostic O X
techniques O X
. O X

Moreover O X
, O X
the O X
transmission O X
risk O X
of O X
such O X
genetic O X
defects O X
to O X
offspring O X
born O X
from O X
assisted O X
reproductive O X
techniques O X
is O X
increasingly O X
becoming O X
a O X
concern O X
for O X
physicians O X
and O X
infertile O X
couples O X
. O X

We O X
explored O X
the O X
feasibility O X
of O X
obtaining O X
full O X
- O X
length O X
mRNAs O X
from O X
transcriptionally O X
inert O X
human O X
spermatozoa O X
in O X
semen O X
as O X
a O X
non O X
- O X
invasive O X
diagnostic O X
tool O X
for O X
identifying O X
germline O X
mutations O X
in O X
candidate O X
infertility O X
- O X
associated O X
genes O X
. O X

The O X
efficacy O X
of O X
reverse O X
- O X
transcription O X
PCR O X
on O X
spermatozoal O X
RNA O X
from O X
infertile O X
patients O X
with O X
wide O X
- O X
ranging O X
sperm O X
concentrations O X
varied O X
between O X
91 O X
and O X
99 O X
% O X
for O X
multiple O X
haploid O X
germ O X
cell O X
- O X
expressed O X
genes O X
. O X

Using O X
this O X
methodology O X
, O X
we O X
identified O X
seven O X
oligozoospermic O X
patients O X
with O X
missense O X
and O X
splicing O X
mutations O X
in O X
the O X
germ O X
cell O X
- O X
specific O X
gene O X
, O X
KLHL10 I-MISC 317719
. O X

Three O X
of O X
270 O X
( O X
1 O X
. O X
1 O X
%) O X
severely O X
oligozoospermic O X
patients O X
(< O X
10 O X
( O X
6 O X
) O X
sperm O X
/ O X
ml O X
) O X
harbor O X
KLHL10 I-MISC 317719
alterations O X
that O X
were O X
absent O X
in O X
394 O X
controls O X
and O X
exhibited O X
significant O X
association O X
( O X
P O X
= O X
0 O X
. O X
02 O X
). O X

Two O X
KLHL10 I-MISC 317719
missense O X
mutations O X
( O X
A313T O X
and O X
Q216P O X
) O X
resulted O X
in O X
impaired O X
homodimerization O X
with O X
the O X
wild O X
- O X
type O X
protein O X
in O X
yeast O X
interaction O X
assays O X
, O X
suggesting O X
a O X
functional O X
deficiency O X
. O X

This O X
study O X
demonstrates O X
the O X
utility O X
of O X
this O X
approach O X
for O X
analysis O X
of O X
haploid O X
germ O X
cell O X
- O X
expressed O X
genes O X
regulating O X
post O X
- O X
meiotic O X
events O X
including O X
sperm O X
maturation O X
, O X
motility O X
and O X
fertilization O X
. O X

The O X
development O X
of O X
non O X
- O X
invasive O X
techniques O X
to O X
analyze O X
genetic O X
defects O X
of O X
human O X
spermatogenesis O X
, O X
previously O X
possible O X
only O X
with O X
invasive O X
testis O X
biopsies O X
, O X
provides O X
important O X
diagnostic O X
and O X
therapeutic O X
implications O X
for O X
reproductive O X
medicine O X
. O X

###16003391	819232,817245

AtBAG6 I-MISC 819232
, O X
a O X
novel O X
calmodulin I-MISC 817245
- O X
binding O X
protein O X
, O X
induces O X
programmed O X
cell O X
death O X
in O X
yeast O X
and O X
plants O X
. O X

Calmodulin I-MISC 817245
( O X
CaM I-MISC 817245
) O X
influences O X
many O X
cellular O X
processes O X
by O X
interacting O X
with O X
various O X
proteins O X
. O X

Here O X
, O X
we O X
isolated O X
AtBAG6 I-MISC 819232
, O X
an O X
Arabidopsis O X
CaM I-MISC 817245
- O X
binding O X
protein O X
that O X
contains O X
a O X
central O X
BCL O X
- O X
2 O X
- O X
associated O X
athanogene O X
( O X
BAG O X
) O X
domain O X
. O X

In O X
yeast O X
and O X
plants O X
, O X
overexpression O X
of O X
AtBAG6 I-MISC 819232
induced O X
cell O X
death O X
phenotypes O X
consistent O X
with O X
programmed O X
cell O X
death O X
( O X
PCD O X
). O X

Recombinant O X
AtBAG6 I-MISC 819232
had O X
higher O X
affinity O X
for O X
CaM I-MISC 817245
in O X
the O X
absence O X
of O X
free O X
Ca2 O X
+ O X
than O X
in O X
its O X
presence O X
. O X

An O X
IQ O X
motif O X
( O X
IQXXXRGXXXR O X
, O X
where O X
X O X
denotes O X
any O X
amino O X
- O X
acid O X
) O X
was O X
required O X
for O X
Ca2 O X
+- O X
independent O X
CaM I-MISC 817245
complex O X
formation O X
and O X
single O X
amino O X
- O X
acid O X
changes O X
within O X
this O X
motif O X
abrogated O X
both O X
AtBAG6 I-MISC 819232
- O X
activated O X
CaM I-MISC 817245
- O X
binding O X
and O X
cell O X
death O X
in O X
yeast O X
and O X
plants O X
. O X

A O X
134 O X
- O X
amino O X
- O X
acid O X
stretch O X
, O X
encompassing O X
both O X
the O X
IQ O X
motif O X
and O X
BAG O X
domain O X
, O X
was O X
sufficient O X
to O X
induce O X
cell O X
death O X
. O X

Agents O X
generating O X
oxygen O X
radicals O X
, O X
which O X
are O X
known O X
to O X
be O X
involved O X
in O X
plant O X
PCD O X
, O X
specifically O X
induced O X
the O X
AtBAG6 I-MISC 819232
transcript O X
. O X

Collectively O X
, O X
these O X
results O X
suggest O X
that O X
AtBAG6 I-MISC 819232
is O X
a O X
stress O X
- O X
upregulated O X
CaM I-MISC 817245
- O X
binding O X
protein O X
involved O X
in O X
plant O X
PCD O X
. O X

###15150219	824923,828213

Interactions O X
between O X
the O X
nitrogen O X
signal O X
transduction O X
protein O X
PII I-MISC 828213
and O X
N I-MISC 824923
- I-MISC 824923
acetyl I-MISC 824923
glutamate I-MISC 824923
kinase I-MISC 824923
in O X
organisms O X
that O X
perform O X
oxygenic O X
photosynthesis O X
. O X

PII I-MISC 828213
, O X
one O X
of O X
the O X
most O X
conserved O X
signal O X
transduction O X
proteins O X
, O X
is O X
believed O X
to O X
be O X
a O X
key O X
player O X
in O X
the O X
coordination O X
of O X
nitrogen O X
assimilation O X
and O X
carbon O X
metabolism O X
in O X
bacteria O X
, O X
archaea O X
, O X
and O X
plants O X
. O X

However O X
, O X
the O X
identity O X
of O X
PII I-MISC 828213
receptors O X
remains O X
elusive O X
, O X
particularly O X
in O X
photosynthetic O X
organisms O X
. O X

Here O X
we O X
used O X
yeast O X
two O X
- O X
hybrid O X
approaches O X
to O X
identify O X
new O X
PII I-MISC 828213
receptors O X
and O X
to O X
explore O X
the O X
extent O X
of O X
conservation O X
of O X
PII I-MISC 828213
signaling O X
mechanisms O X
between O X
eubacteria O X
and O X
photosynthetic O X
eukaryotes O X
. O X

Screening O X
of O X
Synechococcus O X
sp O X
. O X

strain O X
PCC O X
7942 O X
libraries O X
with O X
PII I-MISC 828213
as O X
bait O X
resulted O X
in O X
identification O X
of O X
N I-MISC 824923
- I-MISC 824923
acetyl I-MISC 824923
glutamate I-MISC 824923
kinase I-MISC 824923
( O X
NAGK I-MISC 824923
), O X
a O X
key O X
enzyme O X
in O X
the O X
biosynthesis O X
of O X
arginine O X
. O X

The O X
integrity O X
of O X
Ser49 O X
, O X
a O X
residue O X
conserved O X
in O X
PII I-MISC 828213
proteins O X
from O X
organisms O X
that O X
perform O X
oxygenic O X
photosynthesis O X
, O X
appears O X
to O X
be O X
essential O X
for O X
NAGK I-MISC 824923
binding O X
. O X

The O X
effect O X
of O X
glnB O X
mutations O X
on O X
NAGK I-MISC 824923
activity O X
is O X
consistent O X
with O X
positive O X
regulation O X
of O X
NAGK I-MISC 824923
by O X
PII I-MISC 828213
. O X

Phylogenetic O X
and O X
yeast O X
two O X
- O X
hybrid O X
analyses O X
strongly O X
suggest O X
that O X
there O X
was O X
conservation O X
of O X
the O X
NAGK I-MISC 824923
- O X
PII I-MISC 828213
regulatory O X
interaction O X
in O X
the O X
evolution O X
of O X
cyanobacteria O X
and O X
chloroplasts O X
, O X
providing O X
insight O X
into O X
the O X
function O X
of O X
eukaryotic O X
PII I-MISC 828213
- O X
like O X
proteins O X
. O X

###9528852	8314,672

BAP1 I-MISC 8314
: O X
a O X
novel O X
ubiquitin O X
hydrolase O X
which O X
binds O X
to O X
the O X
BRCA1 I-MISC 672
RING O X
finger O X
and O X
enhances O X
BRCA1 I-MISC 672
- O X
mediated O X
cell O X
growth O X
suppression O X
. O X

We O X
have O X
identified O X
a O X
novel O X
protein O X
, O X
BAP1 I-MISC 8314
, O X
which O X
binds O X
to O X
the O X
RING O X
finger O X
domain O X
of O X
the O X
Breast O X
/ O X
Ovarian O X
Cancer O X
Susceptibility O X
Gene O X
product O X
, O X
BRCA1 I-MISC 672
. O X

BAP1 I-MISC 8314
is O X
a O X
nuclear O X
- O X
localized O X
, O X
ubiquitin O X
carboxy O X
- O X
terminal O X
hydrolase O X
, O X
suggesting O X
that O X
deubiquitinating O X
enzymes O X
may O X
play O X
a O X
role O X
in O X
BRCA1 I-MISC 672
function O X
. O X

BAP1 I-MISC 8314
binds O X
to O X
the O X
wild O X
- O X
type O X
BRCA1 I-MISC 672
- O X
RING O X
finger O X
, O X
but O X
not O X
to O X
germline O X
mutants O X
of O X
the O X
BRCA1 I-MISC 672
- O X
RING O X
finger O X
found O X
in O X
breast O X
cancer O X
kindreds O X
. O X

BAP1 I-MISC 104416
and O X
BRCA1 I-MISC 12189
are O X
temporally O X
and O X
spatially O X
co O X
- O X
expressed O X
during O X
murine O X
breast O X
development O X
and O X
remodeling O X
, O X
and O X
show O X
overlapping O X
patterns O X
of O X
subnuclear O X
distribution O X
. O X

BAP1 I-MISC 8314
resides O X
on O X
human O X
chromosome O X
3p21 O X
. O X
3 O X
; O X
intragenic O X
homozygous O X
rearrangements O X
and O X
deletions O X
of O X
BAP1 I-MISC 8314
have O X
been O X
found O X
in O X
lung O X
carcinoma O X
cell O X
lines O X
. O X

BAP1 I-MISC 8314
enhances O X
BRCA1 I-MISC 672
- O X
mediated O X
inhibition O X
of O X
breast O X
cancer O X
cell O X
growth O X
and O X
is O X
the O X
first O X
nuclear O X
- O X
localized O X
ubiquitin O X
carboxy O X
- O X
terminal O X
hydrolase O X
to O X
be O X
identified O X
. O X

BAP1 I-MISC 8314
may O X
be O X
a O X
new O X
tumor O X
suppressor O X
gene O X
which O X
functions O X
in O X
the O X
BRCA1 I-MISC 672
growth O X
control O X
pathway O X
. O X

###24805197	3270,20191

The O X
arrhythmogenic O X
human O X
HRC I-MISC 3270
point O X
mutation O X
S96A O X
leads O X
to O X
spontaneous O X
Ca O X
( O X
2 O X
+) O X
release O X
due O X
to O X
an O X
impaired O X
ability O X
to O X
buffer O X
store O X
Ca O X
( O X
2 O X
+). O X

The O X
Ser96Ala O X
( O X
S96A O X
) O X
mutation O X
within O X
the O X
histidine O X
rich O X
Ca O X
( O X
2 O X
+) O X
binding O X
protein O X
( O X
HRC I-MISC 3270
) O X
has O X
recently O X
been O X
linked O X
to O X
cardiac O X
arrhythmias O X
in O X
idiopathic O X
dilated O X
cardiomyopathy O X
patients O X
, O X
potentially O X
attributable O X
to O X
an O X
increase O X
in O X
spontaneous O X
Ca O X
( O X
2 O X
+) O X
release O X
events O X
. O X

However O X
, O X
the O X
molecular O X
mechanism O X
connecting O X
the O X
S96A O X
mutation O X
of O X
HRC I-MISC 3270
to O X
increased O X
Ca O X
( O X
2 O X
+) O X
release O X
events O X
remains O X
unclear O X
. O X

Previous O X
findings O X
by O X
our O X
group O X
indicate O X
that O X
these O X
spontaneous O X
Ca O X
( O X
2 O X
+) O X
release O X
events O X
may O X
be O X
linked O X
to O X
store O X
overload O X
induced O X
Ca O X
( O X
2 O X
+) O X
release O X
( O X
SOICR O X
) O X
via O X
the O X
cardiac O X
ryanodine O X
receptor O X
( O X
RyR2 I-MISC 20191
). O X

Therefore O X
, O X
in O X
the O X
present O X
study O X
we O X
sought O X
to O X
determine O X
whether O X
HRC I-MISC 3270
wild O X
type O X
( O X
HRC I-MISC 3270
WT O X
) O X
and O X
S96A O X
mutant O X
( O X
HRC I-MISC 3270
S96A O X
) O X
expression O X
has O X
a O X
direct O X
effect O X
on O X
SOICR O X
. O X

Using O X
both O X
cytosolic O X
and O X
intra O X
- O X
Ca O X
( O X
2 O X
+) O X
store O X
measurements O X
in O X
human O X
embryonic O X
kidney O X
cells O X
expressing O X
RyR2 I-MISC 20191
, O X
we O X
found O X
that O X
HRC I-MISC 3270
WT O X
significantly O X
inhibited O X
the O X
propensity O X
for O X
SOICR O X
by O X
buffering O X
store O X
free O X
Ca O X
( O X
2 O X
+) O X
and O X
inhibiting O X
store O X
Ca O X
( O X
2 O X
+) O X
uptake O X
. O X

In O X
contrast O X
, O X
HRC I-MISC 3270
S96A O X
exhibited O X
a O X
markedly O X
suppressed O X
inhibitory O X
effect O X
on O X
SOICR O X
, O X
which O X
was O X
attributed O X
to O X
an O X
impaired O X
ability O X
to O X
buffer O X
store O X
Ca O X
( O X
2 O X
+) O X
and O X
reduce O X
store O X
Ca O X
( O X
2 O X
+) O X
uptake O X
. O X

In O X
addition O X
to O X
impairing O X
the O X
ability O X
of O X
HRC I-MISC 3270
to O X
regulate O X
bulk O X
store O X
Ca O X
( O X
2 O X
+), O X
a O X
proximity O X
ligation O X
assay O X
demonstrated O X
that O X
the O X
S96A O X
mutation O X
also O X
disrupts O X
the O X
Ca O X
( O X
2 O X
+) O X
microdomain O X
around O X
the O X
RyR2 I-MISC 20191
, O X
as O X
it O X
alters O X
the O X
Ca O X
( O X
2 O X
+) O X
dependent O X
association O X
of O X
RyR2 I-MISC 20191
and O X
HRC I-MISC 3270
. O X

Importantly O X
, O X
in O X
contrast O X
to O X
previous O X
reports O X
, O X
the O X
absence O X
of O X
triadin O X
in O X
our O X
experimental O X
model O X
illustrates O X
that O X
the O X
S96A O X
mutation O X
in O X
HRC I-MISC 3270
can O X
alter O X
the O X
propensity O X
for O X
SOICR O X
without O X
any O X
interaction O X
with O X
triadin O X
. O X

Collectively O X
, O X
our O X
results O X
demonstrate O X
that O X
the O X
human O X
HRC I-MISC 3270
mutation O X
S96A O X
leads O X
to O X
an O X
increase O X
in O X
spontaneous O X
Ca O X
( O X
2 O X
+) O X
release O X
and O X
ultimately O X
arrhythmias O X
by O X
disrupting O X
the O X
regulation O X
of O X
intra O X
- O X
store O X
free O X
Ca O X
( O X
2 O X
+). O X

This O X
is O X
primarily O X
due O X
to O X
an O X
impaired O X
ability O X
to O X
act O X
as O X
an O X
effective O X
bulk O X
and O X
local O X
microdomain O X
store O X
Ca O X
( O X
2 O X
+) O X
buffer O X
. O X

###11157984	10458,998

Cdc42Hs I-MISC 998
facilitates O X
cytoskeletal O X
reorganization O X
and O X
neurite O X
outgrowth O X
by O X
localizing O X
the O X
58 O X
- O X
kD O X
insulin O X
receptor O X
substrate O X
to O X
filamentous O X
actin O X
. O X

Cdc42Hs I-MISC 998
is O X
involved O X
in O X
cytoskeletal O X
reorganization O X
and O X
is O X
required O X
for O X
neurite O X
outgrowth O X
in O X
N1E O X
- O X
115 O X
cells O X
. O X

To O X
investigate O X
the O X
molecular O X
mechanism O X
by O X
which O X
Cdc42Hs I-MISC 998
regulates O X
these O X
processes O X
, O X
a O X
search O X
for O X
novel O X
Cdc42Hs I-MISC 998
protein O X
partners O X
was O X
undertaken O X
by O X
yeast O X
two O X
- O X
hybrid O X
assay O X
. O X

Here O X
, O X
we O X
identify O X
the O X
58 O X
- O X
kD O X
substrate O X
of O X
the O X
insulin O X
receptor O X
tyrosine O X
kinase O X
( O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
) O X
as O X
a O X
Cdc42Hs I-MISC 998
target O X
. O X

IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
is O X
a O X
brain O X
- O X
enriched O X
protein O X
comprising O X
at O X
least O X
four O X
protein O X
- O X
protein O X
interaction O X
sites O X
: O X
a O X
Cdc42Hs I-MISC 998
binding O X
site O X
, O X
an O X
Src O X
homology O X
( O X
SH O X
) O X
3 O X
- O X
binding O X
site O X
, O X
an O X
SH3 O X
domain O X
, O X
and O X
a O X
tryptophan O X
, O X
tyrptophan O X
( O X
WW O X
)- O X
binding O X
domain O X
. O X

Expression O X
of O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
in O X
Swiss O X
3T3 O X
cells O X
leads O X
to O X
reorganization O X
of O X
the O X
filamentous O X
( O X
F O X
)- O X
actin O X
cytoskeleton O X
, O X
involving O X
loss O X
of O X
stress O X
fibers O X
and O X
formation O X
of O X
filopodia O X
and O X
clusters O X
. O X

In O X
N1E O X
- O X
115 O X
cells O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
induces O X
neurite O X
outgrowth O X
with O X
high O X
complexity O X
. O X

Expression O X
of O X
a O X
deletion O X
mutant O X
of O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
, O X
which O X
lacks O X
the O X
SH3 O X
- O X
and O X
WW O X
- O X
binding O X
domains O X
, O X
induced O X
neurite O X
extension O X
without O X
complexity O X
in O X
N1E O X
- O X
115 O X
cells O X
. O X

In O X
Swiss O X
3T3 O X
cells O X
and O X
N1E O X
- O X
115 O X
cells O X
, O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
colocalizes O X
with O X
F O X
- O X
actin O X
in O X
clusters O X
and O X
filopodia O X
. O X

An O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
( O X
1267N O X
) O X
mutant O X
unable O X
to O X
bind O X
Cdc42Hs I-MISC 998
failed O X
to O X
localize O X
with O X
F O X
- O X
actin O X
to O X
induce O X
neurite O X
outgrowth O X
or O X
significant O X
cytoskeletal O X
reorganization O X
. O X

These O X
results O X
suggest O X
that O X
Cdc42Hs I-MISC 998
facilitates O X
cytoskeletal O X
reorganization O X
and O X
neurite O X
outgrowth O X
by O X
localizing O X
protein O X
complexes O X
via O X
adaptor O X
proteins O X
such O X
as O X
IRS I-MISC 10458
- I-MISC 10458
58 I-MISC 10458
to O X
F O X
- O X
actin O X
. O X

###22014570	1499,2305

FoxM1 I-MISC 2305
promotes O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
nuclear O X
localization O X
and O X
controls O X
Wnt O X
target O X
- O X
gene O X
expression O X
and O X
glioma O X
tumorigenesis O X
. O X

Wnt O X
/ O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
signaling O X
is O X
essential O X
for O X
stem O X
cell O X
regulation O X
and O X
tumorigenesis O X
, O X
but O X
its O X
molecular O X
mechanisms O X
are O X
not O X
fully O X
understood O X
. O X

Here O X
, O X
we O X
report O X
that O X
FoxM1 I-MISC 2305
is O X
a O X
downstream O X
component O X
of O X
Wnt O X
signaling O X
and O X
is O X
critical O X
for O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
transcriptional O X
function O X
in O X
tumor O X
cells O X
. O X

Wnt3a I-MISC 89780
increases O X
the O X
level O X
and O X
nuclear O X
translocation O X
of O X
FoxM1 I-MISC 2305
, O X
which O X
binds O X
directly O X
to O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
enhances O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
nuclear O X
localization O X
and O X
transcriptional O X
activity O X
. O X

Genetic O X
deletion O X
of O X
FoxM1 I-MISC 2305
in O X
immortalized O X
neural O X
stem O X
cells O X
abolishes O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
nuclear O X
localization O X
. O X

FoxM1 I-MISC 2305
mutations O X
that O X
disrupt O X
the O X
FoxM1 I-MISC 2305
- I-MISC 2305
b I-MISC 2305
- B-MISC 1499
catenin I-MISC 1499
interaction O X
or O X
FoxM1 I-MISC 2305
nuclear O X
import O X
prevent O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
nuclear O X
accumulation O X
in O X
tumor O X
cells O X
. O X

FoxM1 I-MISC 2305
- I-MISC 2305
b I-MISC 2305
- B-MISC 1499
catenin I-MISC 1499
interaction O X
controls O X
Wnt O X
target O X
gene O X
expression O X
, O X
is O X
required O X
for O X
glioma O X
formation O X
, O X
and O X
represents O X
a O X
mechanism O X
for O X
canonical O X
Wnt O X
signaling O X
during O X
tumorigenesis O X
. O X

###11018522	17475,3815

The O X
direct O X
association O X
of O X
the O X
multiple O X
PDZ O X
domain O X
containing O X
proteins O X
( O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
) O X
with O X
the O X
human O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
C O X
- O X
terminus O X
is O X
regulated O X
by O X
tyrosine O X
kinase O X
activity O X
. O X

We O X
have O X
identified O X
the O X
multiple O X
PDZ O X
domain O X
containing O X
protein O X
( O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
or O X
MPDZ I-MISC 17475
) O X
as O X
a O X
novel O X
binding O X
partner O X
of O X
the O X
human O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
. O X

c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
binds O X
specifically O X
to O X
the O X
10th O X
PDZ O X
domain O X
of O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
via O X
its O X
C O X
- O X
terminal O X
sequence O X
. O X

Furthermore O X
, O X
a O X
kinase O X
negative O X
- O X
mutant O X
receptor O X
interacted O X
more O X
strongly O X
with O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
than O X
the O X
wild O X
- O X
type O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
. O X

Strikingly O X
, O X
a O X
constitutively O X
activated O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
( O X
D816V O X
- O X
Kit O X
) O X
did O X
not O X
bind O X
to O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
, O X
although O X
this O X
oncogenic O X
form O X
retains O X
the O X
PDZ O X
binding O X
motif O X
' O X
HDDV O X
' O X
at O X
the O X
C O X
- O X
terminal O X
end O X
. O X

Deletion O X
of O X
V967 O X
of O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
abolished O X
binding O X
to O X
MUPP I-MISC 17475
- I-MISC 17475
1 I-MISC 17475
and O X
drastically O X
reduced O X
its O X
tyrosine O X
kinase O X
activity O X
, O X
suggesting O X
that O X
the O X
structure O X
of O X
the O X
C O X
- O X
terminal O X
tail O X
of O X
c I-MISC 3815
- I-MISC 3815
Kit I-MISC 3815
influences O X
its O X
enzymatic O X
activity O X
. O X

###16571665	825714,835809

Fibrillin I-MISC 825714
expression O X
is O X
regulated O X
by O X
abscisic O X
acid O X
response O X
regulators O X
and O X
is O X
involved O X
in O X
abscisic O X
acid O X
- O X
mediated O X
photoprotection O X
. O X

Fibrillins O X
are O X
lipid O X
- O X
binding O X
proteins O X
of O X
plastids O X
that O X
are O X
induced O X
under O X
abiotic O X
stress O X
conditions O X
. O X

In O X
response O X
to O X
environmental O X
stress O X
, O X
plants O X
generate O X
abscisic O X
acid O X
( O X
ABA O X
) O X
as O X
an O X
endogenous O X
signal O X
. O X

We O X
show O X
that O X
ABA O X
treatment O X
and O X
fibrillin I-MISC 825714
accumulation O X
enhance O X
the O X
tolerance O X
of O X
photosystem O X
II O X
toward O X
light O X
stress O X
- O X
triggered O X
photoinhibition O X
in O X
Arabidopsis O X
. O X

ABA O X
induces O X
fibrillin I-MISC 825714
accumulation O X
, O X
and O X
the O X
ABA I-MISC 835809
response I-MISC 835809
regulators I-MISC 835809
ABI1 I-MISC 828714
and O X
ABI2 I-MISC 835809
regulate O X
fibrillin I-MISC 825714
expression O X
. O X

The O X
abundance O X
of O X
fibrillin I-MISC 825714
transcripts O X
was O X
specifically O X
reduced O X
in O X
the O X
ABA O X
- O X
insensitive O X
abi1 I-MISC 828714
mutant O X
but O X
not O X
in O X
the O X
abi2 I-MISC 835809
mutant O X
. O X

However O X
, O X
leaves O X
of O X
abi2 I-MISC 835809
revealed O X
in O X
comparison O X
to O X
WT O X
and O X
abi1 I-MISC 828714
enhanced O X
fibrillin I-MISC 825714
levels O X
, O X
pointing O X
to O X
a O X
posttranscriptional O X
control O X
mechanism O X
. O X

Protein O X
interaction O X
analysis O X
identified O X
the O X
protein O X
phosphatase O X
ABI2 I-MISC 835809
to O X
target O X
the O X
preprotein O X
of O X
fibrillin I-MISC 825714
. O X

Interaction O X
was O X
abrogated O X
either O X
by O X
deleting O X
the O X
signal O X
peptide O X
of O X
prefibrillin O X
or O X
by O X
the O X
single O X
amino O X
acid O X
exchange O X
present O X
in O X
the O X
phosphatase O X
- O X
deficient O X
abi2 I-MISC 835809
protein O X
. O X

Thus O X
, O X
ABI1 I-MISC 828714
and O X
ABI2 I-MISC 835809
seem O X
to O X
control O X
fibrillin I-MISC 825714
expression O X
that O X
is O X
involved O X
in O X
mediating O X
ABA O X
- O X
induced O X
photoprotection O X
. O X

###18769030	171373,105689

The O X
RCC1 I-MISC 1104
domain O X
of O X
protein O X
associated O X
with O X
Myc I-MISC 4609
( O X
PAM I-MISC 105689
) O X
interacts O X
with O X
and O X
regulates O X
KCC2 I-MISC 171373
. O X

GABAergic O X
and O X
glycinergic O X
function O X
is O X
dependent O X
on O X
neuronal O X
intracellular O X
chloride O X
. O X

The O X
neuron O X
- O X
specific O X
electroneutral O X
potassium O X
( O X
K O X
(+)) O X
and O X
chloride O X
( O X
Cl O X
(-)) O X
cotransporter O X
( O X
KCC2 I-MISC 171373
), O X
is O X
a O X
key O X
regulator O X
of O X
neuronal O X
Cl O X
(-), O X
yet O X
little O X
is O X
known O X
about O X
KCC2 I-MISC 171373
regulation O X
. O X

Using O X
yeast O X
two O X
- O X
hybrid O X
, O X
we O X
identified O X
Protein I-MISC 105689
Associated I-MISC 105689
with I-MISC 105689
Myc I-MISC 105689
( O X
PAM I-MISC 105689
) O X
as O X
a O X
binding O X
partner O X
of O X
KCC2 I-MISC 171373
. O X

The O X
RCC1 I-MISC 1104
( O X
Regulator O X
of O X
Chromatin O X
Condensation O X
) O X
domain O X
of O X
PAM I-MISC 105689
binds O X
to O X
the O X
carboxyl O X
terminus O X
of O X
KCC2 I-MISC 171373
, O X
as O X
demonstrated O X
through O X
yeast O X
two O X
- O X
hybrid O X
and O X
GST O X
- O X
pull O X
- O X
down O X
assays O X
. O X

RCC1 I-MISC 1104
/ O X
PAM I-MISC 105689
and O X
full O X
- O X
length O X
KCC2 I-MISC 171373
coimmunoprecipitate O X
following O X
heterologous O X
co O X
- O X
expression O X
in O X
HEK293 O X
cells O X
. O X

Additionally O X
, O X
( O X
86 O X
) O X
Rb O X
/ O X
K O X
(+) O X
uptake O X
assays O X
in O X
this O X
model O X
system O X
show O X
that O X
RCC1 I-MISC 1104
/ O X
PAM I-MISC 105689
causes O X
increased O X
KCC2 I-MISC 171373
- O X
mediated O X
flux O X
. O X

After O X
narrowing O X
down O X
RCC1 I-MISC 1104
/ O X
PAM I-MISC 105689
binding O X
to O X
a O X
20 O X
amino O X
acid O X
region O X
on O X
the O X
KCC2 I-MISC 171373
carboxyl O X
terminus O X
, O X
we O X
created O X
a O X
point O X
mutant O X
in O X
this O X
region O X
to O X
eliminate O X
interaction O X
between O X
the O X
KCC2 I-MISC 171373
carboxyl O X
terminus O X
and O X
RCC1 I-MISC 1104
/ O X
PAM I-MISC 105689
. O X

This O X
same O X
mutation O X
abolishes O X
N O X
- O X
ethylmaleimide O X
activation O X
of O X
KCC2 I-MISC 171373
, O X
suggesting O X
that O X
PAM I-MISC 105689
plays O X
a O X
role O X
in O X
modulating O X
KCC2 I-MISC 171373
function O X
. O X

###8417317	853548,854387

Interactions O X
among O X
the O X
subunits O X
of O X
the O X
G O X
protein O X
involved O X
in O X
Saccharomyces O X
cerevisiae O X
mating O X
. O X

The O X
SCG1 I-MISC 856394
( O X
GPA1 I-MISC 856394
), O X
STE4 I-MISC 854387
, O X
and O X
STE18 I-MISC 853548
genes O X
of O X
Saccharomyces O X
cerevisiae O X
encode O X
mating O X
- O X
pathway O X
components O X
whose O X
amino O X
acid O X
sequences O X
are O X
similar O X
to O X
those O X
of O X
the O X
alpha O X
, O X
beta O X
, O X
and O X
gamma O X
subunits O X
, O X
respectively O X
, O X
of O X
mammalian O X
G O X
proteins O X
. O X

Genetic O X
evidence O X
suggests O X
that O X
the O X
STE4 I-MISC 854387
and O X
STE18 I-MISC 853548
gene O X
products O X
interact O X
. O X

The O X
mating O X
defects O X
of O X
a O X
set O X
of O X
ste4 I-MISC 854387
mutants O X
were O X
partially O X
suppressed O X
by O X
the O X
overexpression O X
of O X
STE18 I-MISC 853548
, O X
and O X
, O X
moreover O X
, O X
a O X
combination O X
of O X
partially O X
defective O X
ste4 I-MISC 854387
and O X
ste18 I-MISC 853548
alleles O X
created O X
a O X
totally O X
sterile O X
phenotype O X
, O X
whereas O X
such O X
synthetic O X
sterility O X
was O X
not O X
observed O X
when O X
the O X
ste18 I-MISC 853548
allele O X
was O X
combined O X
with O X
a O X
weakly O X
sterile O X
ste11 I-MISC 851076
allele O X
. O X

Others O X
have O X
provided O X
genetic O X
evidence O X
consistent O X
with O X
an O X
interaction O X
between O X
the O X
SCG1 I-MISC 856394
( O X
GPA1 I-MISC 856394
) O X
and O X
STE4 I-MISC 854387
gene O X
products O X
. O X

We O X
have O X
examined O X
the O X
physical O X
interactions O X
of O X
these O X
subunits O X
by O X
using O X
an O X
in O X
vivo O X
protein O X
association O X
assay O X
. O X

The O X
STE4 I-MISC 854387
and O X
STE18 I-MISC 853548
gene O X
products O X
associated O X
with O X
each O X
other O X
, O X
and O X
this O X
association O X
was O X
disrupted O X
by O X
a O X
mutation O X
in O X
the O X
STE4 I-MISC 854387
gene O X
product O X
whose O X
phenotype O X
was O X
partially O X
suppressed O X
by O X
overexpression O X
of O X
STE18 I-MISC 853548
. O X

The O X
STE4 I-MISC 854387
and O X
SCG1 I-MISC 856394
( O X
GPA1 I-MISC 856394
) O X
gene O X
products O X
also O X
interacted O X
in O X
the O X
assay O X
, O X
whereas O X
we O X
detected O X
no O X
association O X
of O X
the O X
SCG1 I-MISC 856394
( O X
GPA1 I-MISC 856394
) O X
and O X
STE18 I-MISC 853548
gene O X
products O X
. O X

###19236849	1457,23411

Carboxy O X
- O X
terminal O X
phosphorylation O X
of O X
SIRT1 I-MISC 23411
by O X
protein I-MISC 1457
kinase I-MISC 1457
CK2 I-MISC 1457
. O X

Previous O X
analyses O X
of O X
the O X
sirtuin O X
family O X
of O X
histone O X
deacetylases O X
and O X
its O X
most O X
prominent O X
member O X
SIRT1 I-MISC 23411
have O X
focused O X
primarily O X
on O X
the O X
identification O X
of O X
cellular O X
targets O X
exploring O X
the O X
underlying O X
molecular O X
mechanisms O X
of O X
its O X
implicated O X
function O X
in O X
the O X
control O X
of O X
metabolic O X
homeostasis O X
, O X
differentiation O X
, O X
apoptosis O X
and O X
cell O X
survival O X
. O X

So O X
far O X
, O X
little O X
is O X
known O X
about O X
the O X
regulation O X
of O X
SIRT1 I-MISC 23411
itself O X
. O X

In O X
the O X
study O X
presented O X
herein O X
, O X
we O X
assigned O X
the O X
main O X
region O X
of O X
SIRT1 I-MISC 23411
in O X
vivo O X
phosphorylation O X
to O X
amino O X
acids O X
643 O X
- O X
691 O X
of O X
the O X
unique O X
carboxy O X
- O X
terminal O X
domain O X
. O X

Furthermore O X
, O X
we O X
demonstrate O X
that O X
SIRT1 I-MISC 23411
is O X
a O X
substrate O X
for O X
protein I-MISC 1457
kinase I-MISC 1457
CK2 I-MISC 1457
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

Both O X
, O X
deletion O X
construct O X
analyses O X
and O X
serine O X
- O X
to O X
- O X
alanine O X
mutations O X
identified O X
SIRT1 I-MISC 23411
Ser O X
- O X
659 O X
and O X
Ser O X
- O X
661 O X
as O X
major O X
CK2 O X
phosphorylation O X
sites O X
that O X
are O X
phosphorylated O X
in O X
vivo O X
as O X
well O X
. O X

###10659709	842733,830586	842733,838812

NPR1 I-MISC 842733
differentially O X
interacts O X
with O X
members O X
of O X
the O X
TGA O X
/ O X
OBF O X
family O X
of O X
transcription O X
factors O X
that O X
bind O X
an O X
element O X
of O X
the O X
PR I-MISC 815949
- I-MISC 815949
1 I-MISC 815949
gene O X
required O X
for O X
induction O X
by O X
salicylic O X
acid O X
. O X

NPR1 I-MISC 842733
is O X
a O X
critical O X
component O X
of O X
the O X
salicylic O X
acid O X
( O X
SA O X
)- O X
mediated O X
signal O X
transduction O X
pathway O X
leading O X
to O X
the O X
induction O X
of O X
defense O X
genes O X
, O X
such O X
as O X
the O X
pathogenesis I-MISC 815949
- I-MISC 815949
related I-MISC 815949
( I-MISC 815949
PR I-MISC 815949
)- I-MISC 815949
1 I-MISC 815949
gene O X
, O X
and O X
enhanced O X
disease O X
resistance O X
. O X

Using O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
we O X
identified O X
several O X
NPR1 I-MISC 842733
- O X
interacting O X
proteins O X
( O X
NIPs O X
). O X

Two O X
of O X
these O X
NIPs O X
are O X
members O X
of O X
the O X
TGA O X
/ O X
OBF O X
family O X
of O X
basic O X
leucine O X
zipper O X
( O X
bZIP O X
) O X
transcription O X
factors O X
; O X
this O X
family O X
has O X
been O X
implicated O X
in O X
the O X
activation O X
of O X
SA O X
- O X
responsive O X
genes O X
, O X
including O X
PR I-MISC 815949
- I-MISC 815949
1 I-MISC 815949
. O X

Six O X
TGA O X
family O X
members O X
were O X
tested O X
and O X
shown O X
to O X
differentially O X
interact O X
with O X
NPR1 I-MISC 842733
: O X
TGA2 I-MISC 830586
and O X
TGA3 I-MISC 838812
showed O X
strong O X
affinity O X
for O X
NPR1 I-MISC 842733
; O X
TGA5 I-MISC 830587
and O X
TGA6 I-MISC 820405
exhibited O X
weaker O X
affinity O X
; O X
and O X
TGA1 I-MISC 836646
and O X
TGA4 O X
displayed O X
little O X
or O X
no O X
detectable O X
interaction O X
with O X
NPR1 I-MISC 842733
, O X
respectively O X
. O X

Interestingly O X
, O X
the O X
amino O X
- O X
termini O X
of O X
these O X
factors O X
were O X
found O X
to O X
decrease O X
their O X
stability O X
in O X
yeast O X
and O X
differentially O X
affect O X
their O X
apparent O X
affinity O X
toward O X
NPR1 I-MISC 842733
. O X

The O X
interacting O X
regions O X
on O X
NPR1 I-MISC 842733
and O X
the O X
TGA O X
factors O X
were O X
also O X
defined O X
. O X

Each O X
of O X
four O X
point O X
mutations O X
in O X
NPR1 I-MISC 842733
that O X
disrupt O X
SA O X
signaling O X
in O X
Arabidopsis O X
completely O X
blocked O X
interaction O X
of O X
NPR1 I-MISC 842733
with O X
TGA2 I-MISC 830586
and O X
TGA3 I-MISC 838812
. O X

TGA2 I-MISC 830586
and O X
TGA3 I-MISC 838812
were O X
also O X
found O X
to O X
bind O X
the O X
SA O X
- O X
responsive O X
element O X
of O X
the O X
Arabidopsis O X
PR I-MISC 815949
- I-MISC 815949
1 I-MISC 815949
promoter O X
. O X

These O X
results O X
directly O X
link O X
NPR1 I-MISC 842733
to O X
SA O X
- O X
induced O X
PR I-MISC 815949
- I-MISC 815949
1 I-MISC 815949
expression O X
through O X
members O X
of O X
the O X
TGA O X
family O X
of O X
transcription O X
factors O X
. O X

###20124439	338328,4023

Chylomicronemia O X
with O X
low O X
postheparin O X
lipoprotein I-MISC 100689191
lipase I-MISC 100689191
levels O X
in O X
the O X
setting O X
of O X
GPIHBP1 I-MISC 338328
defects O X
. O X

BACKGROUND O X
: O X
Recent O X
studies O X
in O X
mice O X
have O X
established O X
that O X
an O X
endothelial O X
cell O X
protein O X
, O X
glycosylphosphatidylinositol I-MISC 68453
- I-MISC 68453
anchored I-MISC 68453
high I-MISC 68453
- I-MISC 68453
density I-MISC 68453
lipoprotein I-MISC 68453
- I-MISC 68453
binding I-MISC 68453
protein I-MISC 68453
1 I-MISC 68453
( O X
GPIHBP1 I-MISC 68453
), O X
is O X
essential O X
for O X
the O X
lipolytic O X
processing O X
of O X
triglyceride O X
- O X
rich O X
lipoproteins O X
. O X

METHODS O X
AND O X
RESULTS O X
: O X
We O X
report O X
the O X
discovery O X
of O X
a O X
homozygous O X
missense O X
mutation O X
in O X
GPIHBP1 I-MISC 338328
in O X
a O X
young O X
boy O X
with O X
severe O X
chylomicronemia O X
. O X

The O X
mutation O X
, O X
p O X
. O X
C65Y O X
, O X
replaces O X
a O X
conserved O X
cysteine O X
in O X
the O X
GPIHBP1 I-MISC 338328
lymphocyte O X
antigen O X
6 O X
domain O X
with O X
a O X
tyrosine O X
and O X
is O X
predicted O X
to O X
perturb O X
protein O X
structure O X
by O X
interfering O X
with O X
the O X
formation O X
of O X
a O X
disulfide O X
bond O X
. O X

Studies O X
with O X
transfected O X
Chinese O X
hamster O X
ovary O X
cells O X
showed O X
that O X
GPIHBP1 I-MISC 100759460
- O X
C65Y O X
reaches O X
the O X
cell O X
surface O X
but O X
has O X
lost O X
the O X
ability O X
to O X
bind O X
lipoprotein I-MISC 100689191
lipase I-MISC 100689191
( O X
LPL I-MISC 100689191
). O X

When O X
the O X
GPIHBP1 I-MISC 338328
- O X
C65Y O X
homozygote O X
was O X
given O X
an O X
intravenous O X
bolus O X
of O X
heparin O X
, O X
only O X
trace O X
amounts O X
of O X
LPL I-MISC 4023
entered O X
the O X
plasma O X
. O X

We O X
also O X
observed O X
very O X
low O X
levels O X
of O X
LPL I-MISC 4023
in O X
the O X
postheparin O X
plasma O X
of O X
a O X
subject O X
with O X
chylomicronemia O X
who O X
was O X
homozygous O X
for O X
a O X
different O X
GPIHBP1 I-MISC 338328
mutation O X
( O X
p O X
. O X
Q115P O X
). O X

When O X
the O X
GPIHBP1 I-MISC 338328
- O X
Q115P O X
homozygote O X
was O X
given O X
a O X
6 O X
- O X
hour O X
infusion O X
of O X
heparin O X
, O X
a O X
significant O X
amount O X
of O X
LPL I-MISC 4023
appeared O X
in O X
the O X
plasma O X
, O X
resulting O X
in O X
a O X
fall O X
in O X
the O X
plasma O X
triglyceride O X
levels O X
from O X
1780 O X
to O X
120 O X
mg O X
/ O X
dL O X
. O X

CONCLUSIONS O X
: O X
We O X
identified O X
a O X
novel O X
GPIHBP1 I-MISC 338328
missense O X
mutation O X
( O X
p O X
. O X
C65Y O X
) O X
associated O X
with O X
defective O X
LPL I-MISC 4023
binding O X
in O X
a O X
young O X
boy O X
with O X
severe O X
chylomicronemia O X
. O X

We O X
also O X
show O X
that O X
homozygosity O X
for O X
the O X
C65Y O X
or O X
Q115P O X
mutations O X
is O X
associated O X
with O X
low O X
levels O X
of O X
LPL I-MISC 4023
in O X
the O X
postheparin O X
plasma O X
, O X
demonstrating O X
that O X
GPIHBP1 I-MISC 338328
is O X
important O X
for O X
plasma O X
triglyceride O X
metabolism O X
in O X
humans O X
. O X

###15632183	819358,830273

A O X
unique O X
sequence O X
motif O X
in O X
the O X
54 O X
- O X
kDa O X
subunit O X
of O X
the O X
chloroplast O X
signal O X
recognition O X
particle O X
mediates O X
binding O X
to O X
the O X
43 O X
- O X
kDa O X
subunit O X
. O X

Chloroplasts O X
contain O X
a O X
novel O X
type O X
of O X
signal O X
recognition O X
particle O X
( O X
cpSRP O X
) O X
that O X
consists O X
of O X
two O X
proteins O X
, O X
cpSRP54 I-MISC 819358
and O X
cpSRP43 I-MISC 830273
. O X

cpSRP O X
is O X
involved O X
in O X
the O X
post O X
- O X
translational O X
targeting O X
of O X
the O X
nuclear O X
encoded O X
light O X
- O X
harvesting O X
chlorophyll O X
- O X
binding O X
proteins O X
( O X
LHCPs O X
) O X
to O X
the O X
thylakoid O X
membrane O X
by O X
forming O X
a O X
soluble O X
cpSRP O X
. O X
LHCP O X
transit O X
complex O X
in O X
the O X
stroma O X
. O X

Despite O X
high O X
sequence O X
homology O X
between O X
chloroplast O X
and O X
cytosolic O X
SRP54 I-MISC 6729
proteins O X
, O X
the O X
54 I-MISC 819358
- I-MISC 819358
kDa I-MISC 819358
subunit I-MISC 819358
of I-MISC 819358
cpSRP I-MISC 819358
is O X
unique O X
in O X
its O X
ability O X
to O X
bind O X
cpSRP43 I-MISC 830273
. O X

In O X
this O X
report O X
, O X
we O X
identified O X
a O X
10 O X
- O X
amino O X
acid O X
long O X
segment O X
of O X
cpSRP54 I-MISC 819358
that O X
forms O X
the O X
cpSRP43 I-MISC 830273
- O X
binding O X
site O X
. O X

This O X
segment O X
is O X
located O X
at O X
position O X
530 O X
- O X
539 O X
close O X
to O X
the O X
C O X
terminus O X
of O X
cpSRP54 I-MISC 819358
. O X

In O X
addition O X
, O X
we O X
demonstrate O X
that O X
arginine O X
at O X
position O X
537 O X
is O X
essential O X
for O X
binding O X
cpSRP43 I-MISC 830273
and O X
that O X
mutation O X
of O X
arginine O X
536 O X
drastically O X
reduced O X
cpSRP43 I-MISC 830273
binding O X
. O X

Mutations O X
within O X
the O X
cpSRP43 I-MISC 830273
- O X
binding O X
site O X
of O X
cpSRP54 I-MISC 819358
that O X
reduced O X
or O X
completely O X
abolished O X
cpSRP O X
complex O X
formation O X
also O X
did O X
inhibit O X
transit O X
complex O X
formation O X
and O X
integration O X
of O X
LHCP O X
into O X
the O X
thylakoid O X
membrane O X
, O X
reflecting O X
the O X
importance O X
of O X
these O X
residues O X
for O X
LHCP O X
targeting O X
. O X

Alignment O X
studies O X
revealed O X
that O X
the O X
cpSRP43 I-MISC 830273
- O X
binding O X
site O X
is O X
conserved O X
in O X
chloroplast O X
SRP54 I-MISC 6729
proteins O X
and O X
is O X
not O X
present O X
in O X
any O X
SRP54 I-MISC 6729
subunit O X
of O X
cytosolic O X
SRPs O X
. O X

###10633111	1137497,1137498	1137498,1137498

The O X
Agrobacterium O X
T O X
- O X
DNA O X
transport O X
pore O X
proteins O X
VirB8 I-MISC 1137497
, O X
VirB9 I-MISC 1137498
, O X
and O X
VirB10 I-MISC 1224327
interact O X
with O X
one O X
another O X
. O X

The O X
VirB O X
proteins O X
of O X
Agrobacterium O X
tumefaciens O X
form O X
a O X
transport O X
pore O X
to O X
transfer O X
DNA O X
from O X
bacteria O X
to O X
plants O X
. O X

The O X
assembly O X
of O X
the O X
transport O X
pore O X
will O X
require O X
interaction O X
among O X
the O X
constituent O X
proteins O X
. O X

The O X
identification O X
of O X
proteins O X
that O X
interact O X
with O X
one O X
another O X
can O X
provide O X
clues O X
to O X
the O X
assembly O X
of O X
the O X
transport O X
pore O X
. O X

We O X
studied O X
interaction O X
among O X
four O X
putative O X
transport O X
pore O X
proteins O X
, O X
VirB7 I-MISC 6382049
, O X
VirB8 I-MISC 1137497
, O X
VirB9 I-MISC 1137498
and O X
VirB10 I-MISC 1224327
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
assay O X
, O X
we O X
observed O X
that O X
VirB8 I-MISC 1137497
, O X
VirB9 I-MISC 1137498
, O X
and O X
VirB10 I-MISC 1224327
interact O X
with O X
one O X
another O X
. O X

In O X
vitro O X
studies O X
using O X
protein O X
fusions O X
demonstrated O X
that O X
VirB10 I-MISC 1224327
interacts O X
with O X
VirB9 I-MISC 1137498
and O X
itself O X
. O X

These O X
results O X
suggest O X
that O X
the O X
outer O X
membrane O X
VirB7 I-MISC 6382049
- O X
VirB9 I-MISC 1137498
complex O X
interacts O X
with O X
the O X
inner O X
membrane O X
proteins O X
VirB8 I-MISC 1137497
and O X
VirB10 I-MISC 1224327
for O X
the O X
assembly O X
of O X
the O X
transport O X
pore O X
. O X

Fusions O X
that O X
contain O X
small O X
, O X
defined O X
segments O X
of O X
the O X
proteins O X
were O X
used O X
to O X
define O X
the O X
interaction O X
domains O X
of O X
VirB8 I-MISC 1137497
and O X
VirB9 I-MISC 1137498
. O X

All O X
interaction O X
domains O X
of O X
both O X
proteins O X
mapped O X
to O X
the O X
N O X
- O X
terminal O X
half O X
of O X
the O X
proteins O X
. O X

Two O X
separate O X
domains O X
at O X
the O X
N O X
- O X
and O X
C O X
- O X
terminal O X
ends O X
of O X
VirB9 I-MISC 1137498
are O X
involved O X
in O X
its O X
homotypic O X
interaction O X
, O X
suggesting O X
that O X
VirB9 I-MISC 1137498
forms O X
a O X
higher O X
oligomer O X
. O X

We O X
observed O X
that O X
the O X
alteration O X
of O X
serine O X
at O X
position O X
87 O X
of O X
VirB8 I-MISC 1137497
to O X
leucine O X
abolished O X
its O X
DNA O X
transfer O X
function O X
. O X

Studies O X
on O X
the O X
interaction O X
of O X
the O X
mutant O X
protein O X
with O X
the O X
other O X
VirB O X
proteins O X
showed O X
that O X
the O X
VirB8S87L O X
mutant O X
is O X
defective O X
in O X
interaction O X
with O X
VirB9 I-MISC 1137498
. O X

The O X
mutant O X
, O X
however O X
, O X
interacted O X
efficiently O X
with O X
VirB8 I-MISC 1137497
and O X
VirB10 I-MISC 1224327
, O X
suggesting O X
that O X
the O X
VirB8 I-MISC 1137497
- O X
VirB9 I-MISC 1137498
interaction O X
is O X
essential O X
for O X
DNA O X
transfer O X
. O X

###22291198	829301,820135

The O X
ubiquitin O X
E3 O X
ligase O X
LOSS I-MISC 820135
OF I-MISC 820135
GDU2 I-MISC 820135
is O X
required O X
for O X
GLUTAMINE I-MISC 829301
DUMPER1 I-MISC 829301
- O X
induced O X
amino O X
acid O X
secretion O X
in O X
Arabidopsis O X
. O X

Amino O X
acids O X
serve O X
as O X
transport O X
forms O X
for O X
organic O X
nitrogen O X
in O X
the O X
plant O X
, O X
and O X
multiple O X
transport O X
steps O X
are O X
involved O X
in O X
cellular O X
import O X
and O X
export O X
. O X

While O X
the O X
nature O X
of O X
the O X
export O X
mechanism O X
is O X
unknown O X
, O X
overexpression O X
of O X
GLUTAMINE I-MISC 829301
DUMPER1 I-MISC 829301
( O X
GDU1 I-MISC 829301
) O X
in O X
Arabidopsis O X
( O X
Arabidopsis O X
thaliana O X
) O X
led O X
to O X
increased O X
amino O X
acid O X
export O X
. O X

To O X
gain O X
insight O X
into O X
GDU1 I-MISC 829301
' O X
s O X
role O X
, O X
we O X
searched O X
for O X
ethyl O X
- O X
methanesulfonate O X
suppressor O X
mutants O X
and O X
performed O X
yeast O X
- O X
two O X
- O X
hybrid O X
screens O X
. O X

Both O X
methods O X
uncovered O X
the O X
same O X
gene O X
, O X
LOSS I-MISC 820135
OF I-MISC 820135
GDU2 I-MISC 820135
( O X
LOG2 I-MISC 820135
), O X
which O X
encodes O X
a O X
RING O X
- O X
type O X
E3 O X
ubiquitin O X
ligase O X
. O X

The O X
interaction O X
between O X
LOG2 I-MISC 820135
and O X
GDU1 I-MISC 829301
was O X
confirmed O X
by O X
glutathione O X
S O X
- O X
transferase O X
pull O X
- O X
down O X
, O X
in O X
vitro O X
ubiquitination O X
, O X
and O X
in O X
planta O X
coimmunoprecipitation O X
experiments O X
. O X

Confocal O X
microscopy O X
and O X
subcellular O X
fractionation O X
indicated O X
that O X
LOG2 I-MISC 820135
and O X
GDU1 I-MISC 829301
both O X
localized O X
to O X
membranes O X
and O X
were O X
enriched O X
at O X
the O X
plasma O X
membrane O X
. O X

LOG2 I-MISC 820135
expression O X
overlapped O X
with O X
GDU1 I-MISC 829301
in O X
the O X
xylem O X
and O X
phloem O X
tissues O X
of O X
Arabidopsis O X
. O X

The O X
GDU1 I-MISC 829301
protein O X
encoded O X
by O X
the O X
previously O X
characterized O X
intragenic O X
suppressor O X
mutant O X
log1 I-MISC 817376
- O X
1 O X
, O X
with O X
an O X
arginine O X
in O X
place O X
of O X
a O X
conserved O X
glycine O X
, O X
failed O X
to O X
interact O X
in O X
the O X
multiple O X
assays O X
, O X
suggesting O X
that O X
the O X
Gdu1D O X
phenotype O X
requires O X
the O X
interaction O X
of O X
GDU1 I-MISC 829301
with O X
LOG2 I-MISC 820135
. O X

This O X
hypothesis O X
was O X
supported O X
by O X
suppression O X
of O X
the O X
Gdu1D O X
phenotype O X
after O X
reduction O X
of O X
LOG2 I-MISC 820135
expression O X
using O X
either O X
artificial O X
microRNAs O X
or O X
a O X
LOG2 I-MISC 820135
T O X
- O X
DNA O X
insertion O X
. O X

Altogether O X
, O X
in O X
accordance O X
with O X
the O X
emerging O X
bulk O X
of O X
data O X
showing O X
membrane O X
protein O X
regulation O X
via O X
ubiquitination O X
, O X
these O X
data O X
suggest O X
that O X
the O X
interaction O X
of O X
GDU1 I-MISC 829301
and O X
the O X
ubiquitin O X
ligase O X
LOG2 I-MISC 820135
plays O X
a O X
significant O X
role O X
in O X
the O X
regulation O X
of O X
amino O X
acid O X
export O X
from O X
plant O X
cells O X
. O X

###17875641	2539634,2541987

Wobble O X
inosine O X
tRNA O X
modification O X
is O X
essential O X
to O X
cell O X
cycle O X
progression O X
in O X
G O X
( O X
1 O X
)/ O X
S O X
and O X
G O X
( O X
2 O X
)/ O X
M O X
transitions O X
in O X
fission O X
yeast O X
. O X

Inosine O X
( O X
I O X
) O X
at O X
position O X
34 O X
( O X
wobble O X
position O X
) O X
of O X
tRNA O X
is O X
formed O X
by O X
the O X
hydrolytic O X
deamination O X
of O X
a O X
genomically O X
encoded O X
adenosine O X
( O X
A O X
). O X

The O X
enzyme O X
catalyzing O X
this O X
reaction O X
, O X
termed O X
tRNA O X
A O X
: O X
34 O X
deaminase O X
, O X
is O X
the O X
heterodimeric O X
Tad2p I-MISC 2539634
/ O X
ADAT2 I-MISC 2539634
. O X
Tad3p I-MISC 2541987
/ O X
ADAT3 O X
complex O X
in O X
eukaryotes O X
. O X

In O X
budding O X
yeast O X
, O X
deletion O X
of O X
each O X
subunit O X
is O X
lethal O X
, O X
indicating O X
that O X
the O X
wobble O X
inosine O X
tRNA O X
modification O X
is O X
essential O X
for O X
viability O X
; O X
however O X
, O X
most O X
of O X
its O X
physiological O X
roles O X
remain O X
unknown O X
. O X

To O X
identify O X
novel O X
cell O X
cycle O X
mutants O X
in O X
fission O X
yeast O X
, O X
we O X
isolated O X
the O X
tad3 I-MISC 2541987
- O X
1 O X
mutant O X
that O X
is O X
allelic O X
to O X
the O X
tad3 I-MISC 2541987
(+) O X
gene O X
encoding O X
a O X
homolog O X
of O X
budding O X
yeast O X
Tad3p I-MISC 2541987
. O X

Interestingly O X
, O X
the O X
tad3 I-MISC 2541987
- O X
1 O X
mutant O X
cells O X
principally O X
exhibited O X
cell O X
cycle O X
- O X
specific O X
phenotype O X
, O X
namely O X
temperature O X
- O X
sensitive O X
and O X
irreversible O X
cell O X
cycle O X
arrest O X
both O X
in O X
G O X
( O X
1 O X
) O X
and O X
G O X
( O X
2 O X
). O X

Further O X
analyses O X
revealed O X
that O X
in O X
the O X
tad3 I-MISC 2541987
- O X
1 O X
mutant O X
cells O X
, O X
the O X
S257N O X
mutation O X
that O X
occurred O X
in O X
the O X
catalytically O X
inactive O X
Tad3 I-MISC 2541987
subunit O X
affected O X
its O X
association O X
with O X
catalytically O X
active O X
Tad2 I-MISC 2539634
subunit O X
, O X
leading O X
to O X
an O X
impairment O X
in O X
the O X
A O X
to O X
I O X
conversion O X
at O X
position O X
34 O X
of O X
tRNA O X
. O X

In O X
tad3 I-MISC 2541987
- O X
1 O X
mutant O X
cells O X
, O X
the O X
overexpression O X
of O X
the O X
tad3 I-MISC 2541987
(+) O X
gene O X
completely O X
suppressed O X
the O X
decreased O X
tRNA O X
inosine O X
content O X
. O X

Notably O X
, O X
the O X
overexpression O X
of O X
the O X
tad2 I-MISC 2539634
(+) O X
gene O X
partially O X
suppressed O X
the O X
temperature O X
- O X
sensitive O X
phenotype O X
and O X
the O X
decreased O X
tRNA O X
inosine O X
content O X
, O X
indicating O X
that O X
the O X
tad3 I-MISC 2541987
- O X
1 O X
mutant O X
phenotype O X
is O X
because O X
of O X
the O X
insufficient O X
I O X
( O X
34 O X
) O X
formation O X
of O X
tRNA O X
. O X

These O X
results O X
suggest O X
that O X
the O X
wobble O X
inosine O X
tRNA O X
modification O X
is O X
essential O X
for O X
cell O X
cycle O X
progression O X
in O X
the O X
G O X
( O X
1 O X
)/ O X
S O X
and O X
G O X
( O X
2 O X
)/ O X
M O X
transitions O X
in O X
fission O X
yeast O X
. O X

###18203920	837958,837958

Membrane O X
association O X
of O X
the O X
Arabidopsis O X
ARF O X
exchange O X
factor O X
GNOM I-MISC 837958
involves O X
interaction O X
of O X
conserved O X
domains O X
. O X

The O X
GNOM I-MISC 837958
protein O X
plays O X
a O X
fundamental O X
role O X
in O X
Arabidopsis O X
thaliana O X
development O X
by O X
regulating O X
endosome O X
- O X
to O X
- O X
plasma O X
membrane O X
trafficking O X
required O X
for O X
polar O X
localization O X
of O X
the O X
auxin O X
efflux O X
carrier O X
PIN1 I-MISC 843693
. O X

GNOM I-MISC 837958
is O X
a O X
family O X
member O X
of O X
large O X
ARF O X
guanine O X
nucleotide O X
exchange O X
factors O X
( O X
ARF O X
- O X
GEFs O X
), O X
which O X
regulate O X
vesicle O X
formation O X
by O X
activating O X
ARF O X
GTPases O X
on O X
specific O X
membranes O X
in O X
animals O X
, O X
plants O X
, O X
and O X
fungi O X
. O X

However O X
, O X
apart O X
from O X
the O X
catalytic O X
exchange O X
activity O X
of O X
the O X
SEC7 O X
domain O X
, O X
the O X
functional O X
significance O X
of O X
other O X
conserved O X
domains O X
is O X
virtually O X
unknown O X
. O X

Here O X
, O X
we O X
show O X
that O X
a O X
distinct O X
N O X
- O X
terminal O X
domain O X
of O X
GNOM I-MISC 837958
mediates O X
dimerization O X
and O X
in O X
addition O X
interacts O X
heterotypically O X
with O X
two O X
other O X
conserved O X
domains O X
in O X
vivo O X
. O X

In O X
contrast O X
with O X
N O X
- O X
terminal O X
dimerization O X
, O X
the O X
heterotypic O X
interaction O X
is O X
essential O X
for O X
GNOM I-MISC 837958
function O X
, O X
as O X
mutations O X
abolishing O X
this O X
interaction O X
inactivate O X
the O X
GNOM I-MISC 837958
protein O X
and O X
compromise O X
its O X
membrane O X
association O X
. O X

Our O X
results O X
suggest O X
a O X
general O X
model O X
of O X
large O X
ARF O X
- O X
GEF O X
function O X
in O X
which O X
regulated O X
changes O X
in O X
protein O X
conformation O X
control O X
membrane O X
association O X
of O X
the O X
exchange O X
factor O X
and O X
, O X
thus O X
, O X
activation O X
of O X
ARFs O X
. O X

###16286470	5594,1843

Cooperation O X
of O X
ERK I-MISC 5594
and O X
SCFSkp2 O X
for O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
destruction O X
provides O X
a O X
positive O X
feedback O X
regulation O X
of O X
proliferating O X
signaling O X
. O X

The O X
dual O X
- O X
specificity O X
MAPK O X
phosphatase O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
/ O X
CL100 I-MISC 1843
/ O X
DUSP1 I-MISC 1843
is O X
an O X
inducible O X
nuclear O X
protein O X
controlled O X
by O X
p44 I-MISC 10561
/ O X
42 O X
MAPK O X
( O X
ERK1 I-MISC 5595
/ I-MISC 5595
2 I-MISC 5595
) O X
in O X
a O X
negative O X
feedback O X
mechanism O X
to O X
inhibit O X
kinase O X
activity O X
. O X

Here O X
, O X
we O X
report O X
on O X
the O X
molecular O X
basis O X
for O X
a O X
novel O X
positive O X
feedback O X
mechanism O X
to O X
sustain O X
ERK I-MISC 5594
activation O X
by O X
triggering O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
proteolysis O X
. O X

Active O X
ERK2 I-MISC 5594
docking O X
to O X
the O X
DEF O X
motif O X
( O X
FXFP O X
, O X
residues O X
339 O X
- O X
342 O X
) O X
of O X
N O X
- O X
terminally O X
truncated O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
in O X
vitro O X
initiated O X
phosphorylation O X
at O X
the O X
Ser O X
( O X
296 O X
)/ O X
Ser O X
( O X
323 O X
) O X
domain O X
, O X
which O X
was O X
not O X
affected O X
by O X
substituting O X
Ala O X
for O X
Ser O X
at O X
Ser O X
( O X
359 O X
)/ O X
Ser O X
( O X
364 O X
). O X

The O X
DEF O X
and O X
Ser O X
( O X
296 O X
)/ O X
Ser O X
( O X
323 O X
) O X
sites O X
were O X
essential O X
for O X
ubiquitin O X
- O X
mediated O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
proteolysis O X
stimulated O X
by O X
MKK1 I-MISC 5604
- O X
ERK I-MISC 5594
signaling O X
in O X
H293 O X
cells O X
, O X
whereas O X
the O X
N O X
- O X
terminal O X
domain O X
and O X
Ser O X
( O X
359 O X
)/ O X
Ser O X
( O X
364 O X
) O X
sites O X
were O X
dispensable O X
. O X

ERK I-MISC 5594
activation O X
by O X
serum O X
increased O X
the O X
endogenous O X
level O X
of O X
ubiquitinated O X
phospho O X
- O X
Ser O X
( O X
296 O X
) O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
and O X
the O X
degradation O X
of O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
. O X

Intriguingly O X
, O X
active O X
ERK I-MISC 5594
- O X
promoted O X
phospho O X
- O X
Ser O X
( O X
296 O X
) O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
bound O X
to O X
SCF I-MISC 4254
( O X
Skp2 I-MISC 6502
) O X
ubiquitin O X
ligase O X
in O X
vivo O X
and O X
in O X
vitro O X
. O X

Forced O X
expression O X
of O X
Skp2 I-MISC 6502
enhanced O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
polyubiquitination O X
and O X
proteolysis O X
upon O X
ERK I-MISC 5594
activation O X
, O X
whereas O X
depletion O X
of O X
endogenous O X
Skp2 I-MISC 6502
suppressed O X
such O X
events O X
. O X

The O X
kinetics O X
of O X
ERK I-MISC 5594
signaling O X
stimulated O X
by O X
serum O X
correlated O X
with O X
the O X
endogenous O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
degradation O X
rate O X
in O X
a O X
Skp2 I-MISC 6502
- O X
dependent O X
manner O X
. O X

Thus O X
, O X
MKP I-MISC 1843
- I-MISC 1843
1 I-MISC 1843
proteolysis O X
can O X
be O X
achieved O X
via O X
ERK I-MISC 5594
and O X
SCF I-MISC 4254
( O X
Skp2 I-MISC 6502
) O X
cooperation O X
, O X
thereby O X
sustaining O X
ERK I-MISC 5594
activation O X
. O X

###11134025	173914,180367

Structural O X
properties O X
and O X
mechanisms O X
that O X
govern O X
association O X
of O X
C O X
kinase O X
adapter O X
1 O X
with O X
protein O X
kinase O X
C3 O X
and O X
the O X
cell O X
periphery O X
. O X

Association O X
of O X
an O X
atypical O X
protein O X
kinase O X
C O X
( O X
aPKC O X
) O X
with O X
an O X
adapter O X
protein O X
can O X
affect O X
the O X
location O X
, O X
activity O X
, O X
substrate O X
specificity O X
, O X
and O X
physiological O X
role O X
of O X
the O X
phosphotransferase O X
. O X

Knowledge O X
of O X
mechanisms O X
that O X
govern O X
formation O X
and O X
intracellular O X
targeting O X
of O X
aPKC O X
. O X
adapter O X
protein O X
complexes O X
is O X
limited O X
. O X

Caenorhabditis O X
elegans O X
protein O X
kinase O X
C O X
adapter O X
proteins O X
( O X
CKA1 I-MISC 180367
and O X
CKA1S O X
) O X
bind O X
and O X
target O X
aPKCs O X
and O X
provide O X
prototypes O X
for O X
mechanistic O X
analysis O X
. O X

CKA1 I-MISC 180367
binds O X
an O X
aPKC O X
( O X
PKC3 I-MISC 173914
) O X
via O X
a O X
phosphotyrosine O X
binding O X
( O X
PTB O X
) O X
domain O X
. O X

A O X
distinct O X
, O X
Arg O X
/ O X
Lys O X
- O X
rich O X
N O X
- O X
terminal O X
region O X
targets O X
CKA1 I-MISC 180367
to O X
the O X
cell O X
periphery O X
. O X

We O X
discovered O X
that O X
a O X
short O X
segment O X
(( O X
212 O X
) O X
GGIDNGAFHEHEI O X
( O X
224 O X
)) O X
of O X
the O X
V O X
( O X
2 O X
) O X
( O X
linker O X
) O X
region O X
of O X
PKC3 I-MISC 173914
creates O X
a O X
binding O X
surface O X
that O X
interacts O X
with O X
the O X
PTB O X
domain O X
of O X
CKA1 I-MISC 180367
/ O X
CKA1S O X
. O X

The O X
docking O X
domain O X
of O X
PKC3 I-MISC 173914
differs O X
from O X
classical O X
PTB O X
ligands O X
by O X
the O X
absence O X
of O X
Tyr O X
and O X
Pro O X
. O X

Substitution O X
of O X
Ile O X
( O X
214 O X
), O X
Asn O X
( O X
216 O X
), O X
or O X
Phe O X
( O X
219 O X
) O X
with O X
Ala O X
abrogates O X
binding O X
of O X
PKC3 I-MISC 173914
with O X
CKA1 I-MISC 180367
; O X
these O X
residues O X
cooperatively O X
configure O X
a O X
docking O X
site O X
that O X
complements O X
an O X
apolar O X
surface O X
of O X
the O X
CKA1 I-MISC 180367
PTB O X
domain O X
. O X

Phosphorylation O X
site O X
domains O X
( O X
PSD1 I-MISC 176027
, O X
residues O X
11 O X
- O X
25 O X
; O X
PSD2 O X
, O X
residues O X
61 O X
- O X
77 O X
) O X
in O X
CKA1 I-MISC 180367
route O X
the O X
adapter O X
( O X
and O X
tethered O X
PKC3 I-MISC 173914
) O X
to O X
the O X
cell O X
periphery O X
. O X

Phosphorylation O X
of O X
Ser O X
( O X
17 O X
) O X
and O X
Ser O X
( O X
65 O X
) O X
in O X
PSDs I-MISC 176027
1 I-MISC 176027
and I-MISC 176027
2 I-MISC 176027
elicits O X
translocation O X
of O X
CKA1 I-MISC 180367
from O X
the O X
cell O X
surface O X
to O X
cytoplasm O X
. O X

Activities O X
of O X
DAG O X
- O X
stimulated O X
PKCs O X
and O X
opposing O X
protein O X
Ser O X
/ O X
Thr O X
phosphatases O X
can O X
dynamically O X
regulate O X
the O X
distribution O X
of O X
adapter O X
protein O X
between O X
the O X
cell O X
periphery O X
and O X
cytoplasm O X
. O X

###22279592	1947,2064

ErbB2 I-MISC 2064
, O X
EphrinB1 I-MISC 1947
, O X
Src I-MISC 6714
kinase O X
and O X
PTPN13 I-MISC 5783
signaling O X
complex O X
regulates O X
MAP O X
kinase O X
signaling O X
in O X
human O X
cancers O X
. O X

In O X
non O X
- O X
cancerous O X
cells O X
, O X
phosphorylated O X
proteins O X
exist O X
transiently O X
, O X
becoming O X
de O X
- O X
phosphorylated O X
by O X
specific O X
phosphatases O X
that O X
terminate O X
propagation O X
of O X
signaling O X
pathways O X
. O X

In O X
cancers O X
, O X
compromised O X
phosphatase O X
activity O X
and O X
/ O X
or O X
expression O X
occur O X
and O X
contribute O X
to O X
tumor O X
phenotype O X
. O X

The O X
non O X
- O X
receptor O X
phosphatase O X
, O X
PTPN13 I-MISC 5783
, O X
has O X
recently O X
been O X
dubbed O X
a O X
putative O X
tumor O X
suppressor O X
. O X

It O X
decreased O X
expression O X
in O X
breast O X
cancer O X
correlates O X
with O X
decreased O X
overall O X
survival O X
. O X

Here O X
we O X
show O X
that O X
PTPN13 I-MISC 5783
regulates O X
a O X
new O X
signaling O X
complex O X
in O X
breast O X
cancer O X
consisting O X
of O X
ErbB2 I-MISC 2064
, O X
Src I-MISC 6714
, O X
and O X
EphrinB1 I-MISC 1947
. O X

To O X
our O X
knowledge O X
, O X
this O X
signaling O X
complex O X
has O X
not O X
been O X
previously O X
described O X
. O X

Co O X
- O X
immunoprecipitation O X
and O X
localization O X
studies O X
demonstrate O X
that O X
EphrinB1 I-MISC 1947
, O X
a O X
PTPN13 I-MISC 5783
substrate O X
, O X
interacts O X
with O X
ErbB2 I-MISC 2064
. O X

In O X
addition O X
, O X
the O X
oncogenic O X
V660E O X
ErbB2 I-MISC 2064
mutation O X
enhances O X
this O X
interaction O X
, O X
while O X
Src I-MISC 6714
kinase O X
mediates O X
EphrinB1 I-MISC 1947
phosphorylation O X
and O X
subsequent O X
MAP O X
Kinase O X
signaling O X
. O X

Decreased O X
PTPN13 I-MISC 5783
function O X
further O X
enhances O X
signaling O X
. O X

The O X
association O X
of O X
oncogene O X
kinases O X
( O X
ErbB2 I-MISC 2064
, O X
Src I-MISC 6714
), O X
a O X
signaling O X
transmembrane O X
ligand O X
( O X
EphrinB1 I-MISC 1947
) O X
and O X
a O X
phosphatase O X
tumor O X
suppressor O X
( O X
PTPN13 I-MISC 5783
) O X
suggest O X
that O X
EphrinB1 I-MISC 1947
may O X
be O X
a O X
relevant O X
therapeutic O X
target O X
in O X
breast O X
cancers O X
harboring O X
ErbB2 I-MISC 2064
- O X
activating O X
mutations O X
and O X
decreased O X
PTPN13 I-MISC 5783
expression O X
. O X

###20067578	120892,5608

MKK6 I-MISC 5608
binds O X
and O X
regulates O X
expression O X
of O X
Parkinson O X
' O X
s O X
disease O X
- O X
related O X
protein O X
LRRK2 I-MISC 120892
. O X

Mutations O X
in O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
are O X
prevalent O X
causes O X
of O X
late O X
- O X
onset O X
Parkinson O X
' O X
s O X
disease O X
. O X

Here O X
, O X
we O X
show O X
that O X
LRRK2 I-MISC 120892
binds O X
to O X
MAPK I-MISC 5608
kinases I-MISC 5608
( I-MISC 5608
MKK I-MISC 5608
) I-MISC 5608
3 I-MISC 5608
, I-MISC 5608
6 I-MISC 5608
, I-MISC 5608
and I-MISC 5608
7 I-MISC 5608
, O X
and O X
that O X
LRRK2 I-MISC 120892
is O X
able O X
to O X
phosphorylate O X
MKK3 I-MISC 5608
, I-MISC 5608
6 I-MISC 5608
and I-MISC 5608
7 I-MISC 5608
. O X

Over O X
- O X
expression O X
of O X
LRRK2 I-MISC 120892
and O X
MKK6 I-MISC 5608
increased O X
the O X
steady O X
state O X
levels O X
of O X
each O X
protein O X
beyond O X
that O X
observed O X
with O X
over O X
- O X
expression O X
of O X
either O X
protein O X
alone O X
. O X

Co O X
- O X
expression O X
increased O X
levels O X
of O X
MKK6 I-MISC 5608
in O X
the O X
membrane O X
more O X
than O X
in O X
the O X
cytoplasm O X
. O X

The O X
increased O X
expression O X
of O X
LRRK2 I-MISC 120892
and O X
MKK6 I-MISC 5608
requires O X
MKK6 I-MISC 5608
activity O X
. O X

The O X
disease O X
- O X
linked O X
LRRK2 I-MISC 120892
mutations O X
, O X
G2019S O X
, O X
R1441C O X
and O X
I2020T O X
, O X
enhance O X
binding O X
of O X
LRRK2 I-MISC 120892
to O X
MKK6 I-MISC 5608
. O X

This O X
interaction O X
was O X
further O X
supported O X
by O X
in O X
vivo O X
studies O X
in O X
C O X
. O X
elegans O X
. O X

RNAi O X
knockdown O X
in O X
C O X
. O X
elegans O X
of O X
the O X
endogenous O X
orthologs O X
for O X
MKK6 I-MISC 5608
or O X
p38 O X
, O X
sek I-MISC 181043
- I-MISC 181043
1 I-MISC 181043
and O X
pmk I-MISC 191743
- I-MISC 191743
1 I-MISC 191743
, O X
abolishes O X
LRRK2 I-MISC 120892
- O X
mediated O X
protection O X
against O X
mitochondrial O X
stress O X
. O X

These O X
results O X
were O X
confirmed O X
by O X
deletion O X
of O X
sek I-MISC 181043
- I-MISC 181043
1 I-MISC 181043
in O X
C O X
. O X
elegans O X
. O X

These O X
data O X
demonstrate O X
that O X
MKKs O X
and O X
LRRK2 I-MISC 120892
function O X
in O X
similar O X
biological O X
pathways O X
, O X
and O X
support O X
a O X
role O X
for O X
LRRK2 I-MISC 120892
in O X
modulating O X
the O X
cellular O X
stress O X
response O X
. O X

###24366945	22213,22213

Dimeric O X
Ube2g2 I-MISC 22213
simultaneously O X
engages O X
donor O X
and O X
acceptor O X
ubiquitins O X
to O X
form O X
Lys48 O X
- O X
linked O X
ubiquitin O X
chains O X
. O X

Cellular O X
adaptation O X
to O X
proteotoxic O X
stress O X
at O X
the O X
endoplasmic O X
reticulum O X
( O X
ER O X
) O X
depends O X
on O X
Lys48 O X
- O X
linked O X
polyubiquitination O X
by O X
ER O X
- O X
associated O X
ubiquitin O X
ligases O X
( O X
E3s O X
) O X
and O X
subsequent O X
elimination O X
of O X
ubiquitinated O X
retrotranslocation O X
products O X
by O X
the O X
proteasome O X
. O X

The O X
ER O X
- O X
associated O X
E3 O X
gp78 O X
ubiquitinates O X
misfolded O X
proteins O X
by O X
transferring O X
preformed O X
Lys48 O X
- O X
linked O X
ubiquitin O X
chains O X
from O X
the O X
cognate O X
E2 O X
Ube2g2 I-MISC 22213
to O X
substrates O X
. O X

Here O X
we O X
demonstrate O X
that O X
Ube2g2 I-MISC 22213
synthesizes O X
linkage O X
specific O X
ubiquitin O X
chains O X
by O X
forming O X
an O X
unprecedented O X
homodimer O X
: O X
The O X
dimerization O X
of O X
Ube2g2 I-MISC 22213
, O X
mediated O X
primarily O X
by O X
electrostatic O X
interactions O X
between O X
two O X
Ube2g2s O X
, O X
is O X
also O X
facilitated O X
by O X
the O X
charged O X
ubiquitin O X
molecules O X
. O X

Mutagenesis O X
studies O X
show O X
that O X
Ube2g2 I-MISC 22213
dimerization O X
is O X
required O X
for O X
ER O X
- O X
associated O X
degradation O X
( O X
ERAD O X
). O X

In O X
addition O X
to O X
E2 O X
dimerization O X
, O X
we O X
show O X
that O X
a O X
highly O X
conserved O X
arginine O X
residue O X
in O X
the O X
donor O X
Ube2g2 I-MISC 22213
senses O X
the O X
presence O X
of O X
an O X
aspartate O X
in O X
the O X
acceptor O X
ubiquitin O X
to O X
position O X
only O X
Lys48 O X
of O X
ubiquitin O X
in O X
proximity O X
to O X
the O X
donor O X
E2 O X
active O X
site O X
. O X

These O X
results O X
reveal O X
an O X
unanticipated O X
mode O X
of O X
E2 O X
self O X
- O X
association O X
that O X
allows O X
the O X
E2 O X
to O X
effectively O X
engage O X
two O X
ubiquitins O X
to O X
specifically O X
synthesize O X
Lys48 O X
- O X
linked O X
ubiquitin O X
chains O X
. O X

###12445118	818581,836431	818581,843928

COI1 I-MISC 818581
links O X
jasmonate O X
signalling O X
and O X
fertility O X
to O X
the O X
SCF O X
ubiquitin O X
- O X
ligase O X
complex O X
in O X
Arabidopsis O X
. O X

Jasmonates O X
( O X
JAs O X
) O X
regulate O X
Arabidopsis O X
thaliana O X
wound O X
and O X
defence O X
responses O X
, O X
pollen O X
development O X
, O X
and O X
stress O X
- O X
related O X
growth O X
inhibition O X
. O X

Significantly O X
, O X
each O X
of O X
these O X
responses O X
requires O X
COI1 I-MISC 818581
, O X
an O X
F O X
- O X
box O X
protein O X
. O X

Other O X
F O X
- O X
box O X
proteins O X
interact O X
with O X
SKP1 I-MISC 843928
and O X
cullin O X
proteins O X
to O X
form O X
SCF O X
complexes O X
that O X
selectively O X
recruit O X
regulatory O X
proteins O X
targeted O X
for O X
ubiquitination O X
. O X

To O X
determine O X
whether O X
COI1 I-MISC 818581
also O X
functions O X
in O X
an O X
SCF O X
complex O X
, O X
we O X
have O X
characterized O X
Arabidopsis O X
proteins O X
that O X
bind O X
to O X
COI1 I-MISC 818581
. O X

An O X
Arabidopsis O X
cDNA O X
expression O X
library O X
was O X
screened O X
in O X
yeast O X
for O X
clones O X
that O X
produce O X
proteins O X
which O X
can O X
bind O X
to O X
COI1 I-MISC 818581
. O X

We O X
recovered O X
two O X
SKP1 I-MISC 843928
homologues O X
and O X
a O X
histone I-MISC 836431
deacetylase I-MISC 836431
. O X

The O X
Arabidopsis O X
F O X
- O X
box O X
protein O X
TIR1 I-MISC 856729
interacted O X
with O X
SKP1 I-MISC 843928
proteins O X
, O X
but O X
not O X
with O X
the O X
histone I-MISC 836431
deacetylase I-MISC 836431
. O X

Mutant O X
COI1 I-MISC 818581
proteins O X
revealed O X
that O X
the O X
F O X
- O X
box O X
is O X
required O X
for O X
interaction O X
with O X
SKP1s O X
, O X
but O X
that O X
sequences O X
in O X
leucine O X
- O X
rich O X
repeat O X
domains O X
are O X
required O X
for O X
interaction O X
with O X
the O X
histone I-MISC 836431
deacetylase I-MISC 836431
. O X

Epitope O X
- O X
tagged O X
COI1 I-MISC 818581
was O X
introduced O X
into O X
Arabidopsis O X
plants O X
and O X
cell O X
cultures O X
. O X

Co O X
- O X
immunoprecipitation O X
experiments O X
confirmed O X
the O X
interaction O X
in O X
planta O X
of O X
COI1 I-MISC 818581
with O X
SKP1 I-MISC 843928
- O X
like O X
proteins O X
and O X
histone I-MISC 836431
deacetylase I-MISC 836431
, O X
and O X
also O X
indicated O X
that O X
COI1 I-MISC 818581
interacted O X
with O X
cullin O X
. O X

These O X
results O X
suggest O X
that O X
COI1 I-MISC 818581
forms O X
an O X
SCFCOI1 O X
complex O X
in O X
vivo O X
. O X

COI1 I-MISC 818581
is O X
therefore O X
expected O X
to O X
form O X
a O X
functional O X
E3 O X
- O X
type O X
ubiquitin O X
ligase O X
in O X
plants O X
and O X
to O X
regulate O X
expression O X
of O X
jasmonate O X
responsive O X
genes O X
, O X
possibly O X
by O X
targeted O X
ubiquitination O X
of O X
a O X
histone I-MISC 836431
deacetylase I-MISC 836431
. O X

###20150898	852666,852276

Regulation O X
of O X
clathrin O X
adaptor O X
function O X
in O X
endocytosis O X
: O X
novel O X
role O X
for O X
the O X
SAM I-MISC 852666
domain O X
. O X

During O X
clathrin O X
- O X
mediated O X
endocytosis O X
, O X
adaptor O X
proteins O X
play O X
central O X
roles O X
in O X
coordinating O X
the O X
assembly O X
of O X
clathrin O X
coats O X
and O X
cargo O X
selection O X
. O X

Here O X
we O X
characterize O X
the O X
binding O X
of O X
the O X
yeast O X
endocytic O X
adaptor O X
Sla1p I-MISC 852276
to O X
clathrin O X
through O X
a O X
variant O X
clathrin O X
- O X
binding O X
motif O X
that O X
is O X
negatively O X
regulated O X
by O X
the O X
Sla1p I-MISC 852276
SHD2 O X
domain O X
. O X

The O X
crystal O X
structure O X
of O X
SHD2 O X
identifies O X
the O X
domain O X
as O X
a O X
sterile O X
alpha O X
- O X
motif O X
( O X
SAM I-MISC 852666
) O X
domain O X
and O X
shows O X
a O X
propensity O X
to O X
oligomerize O X
. O X

By O X
co O X
- O X
immunoprecipitation O X
, O X
Sla1p I-MISC 852276
binds O X
to O X
clathrin O X
and O X
self O X
- O X
associates O X
in O X
vivo O X
. O X

Mutations O X
in O X
the O X
clathrin O X
- O X
binding O X
motif O X
that O X
abolish O X
clathrin O X
binding O X
and O X
structure O X
- O X
based O X
mutations O X
in O X
SHD2 O X
that O X
impede O X
self O X
- O X
association O X
result O X
in O X
endocytosis O X
defects O X
and O X
altered O X
dynamics O X
of O X
Sla1p I-MISC 852276
assembly O X
at O X
the O X
sites O X
of O X
endocytosis O X
. O X

These O X
results O X
define O X
a O X
novel O X
mechanism O X
for O X
negative O X
regulation O X
of O X
clathrin O X
binding O X
by O X
an O X
adaptor O X
and O X
suggest O X
a O X
role O X
for O X
SAM I-MISC 852666
domains O X
in O X
clathrin O X
- O X
mediated O X
endocytosis O X
. O X

###10531343	53420,53420	20981,20981	20981,53420	53420,54524	54524,54526	54524,54524	20981,54526	20981,54524	53420,54526

Conserved O X
N O X
- O X
terminal O X
cysteine O X
motif O X
is O X
essential O X
for O X
homo O X
- O X
and O X
heterodimer O X
formation O X
of O X
synaptotagmins O X
III O X
, O X
V O X
, O X
VI I-MISC 54524
, O X
and O X
X O X
. O X

The O X
synaptotagmins O X
now O X
constitute O X
a O X
large O X
family O X
of O X
membrane O X
proteins O X
characterized O X
by O X
one O X
transmembrane O X
region O X
and O X
two O X
C2 O X
domains O X
. O X

Dimerization O X
of O X
synaptotagmin O X
( O X
Syt I-MISC 20979
) I-MISC 20979
I I-MISC 20979
, O X
a O X
putative O X
low O X
affinity O X
Ca O X
( O X
2 O X
+) O X
sensor O X
for O X
neurotransmitter O X
release O X
, O X
is O X
thought O X
to O X
be O X
important O X
for O X
expression O X
of O X
function O X
during O X
exocytosis O X
of O X
synaptic O X
vesicles O X
. O X

However O X
, O X
little O X
is O X
known O X
about O X
the O X
self O X
- O X
dimerization O X
properties O X
of O X
other O X
isoforms O X
. O X

In O X
this O X
study O X
, O X
we O X
demonstrate O X
that O X
a O X
subclass O X
of O X
synaptotagmins O X
( O X
III O X
, O X
V I-MISC 53420
, O X
VI O X
, O X
and O X
X I-MISC 54526
) O X
( O X
Ibata O X
, O X
K O X
., O X
Fukuda O X
, O X
M O X
., O X
and O X
Mikoshiba O X
, O X
K O X
. O X
( O X
1998 O X
) O X
J O X
. O X
Biol O X
. O X

Chem O X
. O X

273 O X
, O X
12267 O X
- O X
12273 O X
) O X
forms O X
beta O X
- O X
mercaptoethanol O X
- O X
sensitive O X
homodimers O X
and O X
identify O X
three O X
evolutionarily O X
conserved O X
cysteine O X
residues O X
at O X
the O X
N O X
terminus O X
( O X
N O X
- O X
terminal O X
cysteine O X
motif O X
, O X
at O X
amino O X
acids O X
10 O X
, O X
21 O X
, O X
and O X
33 O X
of O X
mouse O X
Syt I-MISC 20981
III I-MISC 20981
) O X
that O X
are O X
not O X
conserved O X
in O X
other O X
isoforms O X
. O X

Site O X
- O X
directed O X
mutagenesis O X
of O X
these O X
cysteine O X
residues O X
and O X
co O X
- O X
immunoprecipitation O X
experiments O X
clearly O X
indicate O X
that O X
the O X
first O X
cysteine O X
residue O X
is O X
essential O X
for O X
the O X
stable O X
homodimer O X
formation O X
of O X
Syt O X
III O X
, O X
V O X
, O X
or O X
VI O X
, O X
and O X
heterodimer O X
formation O X
between O X
Syts O X
III O X
, O X
V O X
, O X
VI O X
, O X
and O X
X O X
. O X

We O X
also O X
show O X
that O X
native O X
Syt I-MISC 20981
III I-MISC 20981
from O X
mouse O X
brain O X
forms O X
a O X
beta O X
- O X
mercaptoethanol O X
- O X
sensitive O X
homodimer O X
. O X

Our O X
results O X
suggest O X
that O X
the O X
cysteine O X
- O X
based O X
heterodimerization O X
between O X
Syt O X
III O X
and O X
Syt I-MISC 53420
V I-MISC 53420
, O X
VI O X
, O X
or O X
X O X
, O X
which O X
have O X
different O X
biochemical O X
properties O X
, O X
may O X
modulate O X
the O X
proposed O X
function O X
of O X
Syt I-MISC 20981
III I-MISC 20981
as O X
a O X
putative O X
high O X
affinity O X
Ca O X
( O X
2 O X
+) O X
sensor O X
for O X
neurotransmitter O X
release O X
. O X

###10629049	3054,10488

Mutations O X
in O X
host I-MISC 3054
cell I-MISC 3054
factor I-MISC 3054
1 I-MISC 3054
separate O X
its O X
role O X
in O X
cell O X
proliferation O X
from O X
recruitment O X
of O X
VP16 I-MISC 3054
and O X
LZIP I-MISC 10488
. O X

Host I-MISC 3054
cell I-MISC 3054
factor I-MISC 3054
1 I-MISC 3054
( O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
) O X
is O X
a O X
nuclear O X
protein O X
required O X
for O X
progression O X
through O X
G O X
( O X
1 O X
) O X
phase O X
of O X
the O X
cell O X
cycle O X
and O X
, O X
via O X
its O X
association O X
with O X
VP16 I-MISC 3054
, O X
transcriptional O X
activation O X
of O X
the O X
herpes O X
simplex O X
virus O X
immediate O X
- O X
early O X
genes O X
. O X

Both O X
functions O X
require O X
a O X
six O X
- O X
bladed O X
beta O X
- O X
propeller O X
domain O X
encoded O X
by O X
residues O X
1 O X
to O X
380 O X
of O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
as O X
well O X
as O X
an O X
additional O X
amino O X
- O X
terminal O X
region O X
. O X

The O X
beta O X
- O X
propeller O X
domain O X
is O X
well O X
conserved O X
in O X
HCF O X
homologues O X
, O X
consistent O X
with O X
a O X
critical O X
cellular O X
function O X
. O X

To O X
date O X
, O X
the O X
only O X
known O X
cellular O X
target O X
of O X
the O X
beta O X
- O X
propeller O X
is O X
a O X
bZIP O X
transcription O X
factor O X
known O X
as O X
LZIP I-MISC 10488
or O X
Luman O X
. O X

Whether O X
the O X
interaction O X
between O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
and O X
LZIP I-MISC 10488
is O X
required O X
for O X
cell O X
proliferation O X
remains O X
to O X
be O X
determined O X
. O X

In O X
this O X
study O X
, O X
we O X
used O X
directed O X
mutations O X
to O X
show O X
that O X
all O X
six O X
blades O X
of O X
the O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
beta O X
- O X
propeller O X
contribute O X
to O X
VP16 I-MISC 3054
- O X
induced O X
complex O X
assembly O X
, O X
association O X
with O X
LZIP I-MISC 10488
, O X
and O X
cell O X
cycle O X
progression O X
. O X

Although O X
LZIP I-MISC 10488
and O X
VP16 I-MISC 3054
share O X
a O X
common O X
tetrapeptide O X
HCF O X
- O X
binding O X
motif O X
, O X
our O X
results O X
reveal O X
profound O X
differences O X
in O X
their O X
interaction O X
with O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
. O X

Importantly O X
, O X
with O X
several O X
of O X
the O X
mutants O X
we O X
observe O X
a O X
poor O X
correlation O X
between O X
the O X
ability O X
to O X
associate O X
with O X
LZIP I-MISC 10488
and O X
promote O X
cell O X
proliferation O X
in O X
the O X
context O X
of O X
the O X
full O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
amino O X
terminus O X
, O X
arguing O X
that O X
the O X
HCF I-MISC 3054
- I-MISC 3054
1 I-MISC 3054
beta O X
- O X
propeller O X
domain O X
must O X
target O X
other O X
cellular O X
transcription O X
factors O X
in O X
order O X
to O X
contribute O X
to O X
G O X
( O X
1 O X
) O X
progression O X
. O X

###17157260	852295,854230

Yng1 I-MISC 854230
PHD O X
finger O X
binding O X
to O X
H3 O X
trimethylated O X
at O X
K4 O X
promotes O X
NuA3 O X
HAT O X
activity O X
at O X
K14 O X
of O X
H3 O X
and O X
transcription O X
at O X
a O X
subset O X
of O X
targeted O X
ORFs O X
. O X

Posttranslational O X
histone O X
modifications O X
participate O X
in O X
modulating O X
the O X
structure O X
and O X
function O X
of O X
chromatin O X
. O X

Promoters O X
of O X
transcribed O X
genes O X
are O X
enriched O X
with O X
K4 O X
trimethylation O X
and O X
hyperacetylation O X
on O X
the O X
N O X
- O X
terminal O X
tail O X
of O X
histone I-MISC 852295
H3 I-MISC 852295
. O X

Recently O X
, O X
PHD O X
finger O X
proteins O X
, O X
like O X
Yng1 I-MISC 854230
in O X
the O X
NuA3 O X
HAT O X
complex O X
, O X
were O X
shown O X
to O X
interact O X
with O X
H3K4me3 O X
, O X
indicating O X
a O X
biochemical O X
link O X
between O X
K4 O X
methylation O X
and O X
hyperacetylation O X
. O X

By O X
using O X
a O X
combination O X
of O X
mass O X
spectrometry O X
, O X
biochemistry O X
, O X
and O X
NMR O X
, O X
we O X
detail O X
the O X
Yng1 I-MISC 854230
PHD O X
- O X
H3K4me3 O X
interaction O X
and O X
the O X
importance O X
of O X
NuA3 O X
- O X
dependent O X
acetylation O X
at O X
K14 O X
. O X

Furthermore O X
, O X
genome O X
- O X
wide O X
ChIP O X
- O X
Chip O X
analysis O X
demonstrates O X
colocalization O X
of O X
Yng1 I-MISC 854230
and O X
H3K4me3 O X
in O X
vivo O X
. O X

Disrupting O X
the O X
K4me3 O X
binding O X
of O X
Yng1 I-MISC 854230
altered O X
K14ac O X
and O X
transcription O X
at O X
certain O X
genes O X
, O X
thereby O X
demonstrating O X
direct O X
in O X
vivo O X
evidence O X
of O X
sequential O X
trimethyl O X
binding O X
, O X
acetyltransferase O X
activity O X
, O X
and O X
gene O X
regulation O X
by O X
NuA3 O X
. O X

Our O X
data O X
support O X
a O X
general O X
mechanism O X
of O X
transcriptional O X
control O X
through O X
which O X
histone O X
acetylation O X
upstream O X
of O X
gene O X
activation O X
is O X
promoted O X
partially O X
through O X
availability O X
of O X
H3K4me3 O X
, O X
" O X
read O X
" O X
by O X
binding O X
modules O X
in O X
select O X
subunits O X
. O X

###22579287	1956,1956

Oncogenic O X
mutations O X
counteract O X
intrinsic O X
disorder O X
in O X
the O X
EGFR I-MISC 1956
kinase O X
and O X
promote O X
receptor O X
dimerization O X
. O X

The O X
mutation O X
and O X
overexpression O X
of O X
the O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
are O X
associated O X
with O X
the O X
development O X
of O X
a O X
variety O X
of O X
cancers O X
, O X
making O X
this O X
prototypical O X
dimerization O X
- O X
activated O X
receptor O X
tyrosine O X
kinase O X
a O X
prominent O X
target O X
of O X
cancer O X
drugs O X
. O X

Using O X
long O X
- O X
timescale O X
molecular O X
dynamics O X
simulations O X
, O X
we O X
find O X
that O X
the O X
N O X
lobe O X
dimerization O X
interface O X
of O X
the O X
wild O X
- O X
type O X
EGFR I-MISC 1956
kinase O X
domain O X
is O X
intrinsically O X
disordered O X
and O X
that O X
it O X
becomes O X
ordered O X
only O X
upon O X
dimerization O X
. O X

Our O X
simulations O X
suggest O X
, O X
moreover O X
, O X
that O X
some O X
cancer O X
- O X
linked O X
mutations O X
distal O X
to O X
the O X
dimerization O X
interface O X
, O X
particularly O X
the O X
widespread O X
L834R O X
mutation O X
( O X
also O X
referred O X
to O X
as O X
L858R O X
), O X
facilitate O X
EGFR I-MISC 1956
dimerization O X
by O X
suppressing O X
this O X
local O X
disorder O X
. O X

Corroborating O X
these O X
findings O X
, O X
our O X
biophysical O X
experiments O X
and O X
kinase O X
enzymatic O X
assays O X
indicate O X
that O X
the O X
L834R O X
mutation O X
causes O X
abnormally O X
high O X
activity O X
primarily O X
by O X
promoting O X
EGFR I-MISC 1956
dimerization O X
rather O X
than O X
by O X
allowing O X
activation O X
without O X
dimerization O X
. O X

We O X
also O X
find O X
that O X
phosphorylation O X
of O X
EGFR I-MISC 1956
kinase O X
domain O X
at O X
Tyr845 O X
may O X
suppress O X
the O X
intrinsic O X
disorder O X
, O X
suggesting O X
a O X
molecular O X
mechanism O X
for O X
autonomous O X
EGFR I-MISC 1956
signaling O X
. O X

###10814541	7295,10628

A O X
possible O X
interaction O X
of O X
thioredoxin I-MISC 7295
with O X
VDUP1 I-MISC 10628
in O X
HeLa O X
cells O X
detected O X
in O X
a O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

Human O X
thioredoxin I-MISC 7295
( O X
hTrx I-MISC 7295
), O X
a O X
small O X
ubiquitous O X
protein O X
with O X
strong O X
reducing O X
potential O X
, O X
has O X
multiple O X
biological O X
functions O X
, O X
including O X
signal O X
transduction O X
and O X
regulation O X
of O X
the O X
activity O X
of O X
transcription O X
factors O X
. O X

hTrx I-MISC 7295
expression O X
is O X
enhanced O X
in O X
HPV O X
- O X
transformed O X
cancer O X
cells O X
; O X
however O X
, O X
the O X
role O X
of O X
hTrx I-MISC 7295
in O X
the O X
malignant O X
cells O X
is O X
not O X
fully O X
understood O X
. O X

We O X
employed O X
a O X
yeast O X
two O X
- O X
hybrid O X
system O X
to O X
search O X
for O X
proteins O X
that O X
bind O X
to O X
hTrx I-MISC 7295
in O X
HeLa O X
cells O X
, O X
a O X
type O X
of O X
HPV O X
- O X
transformed O X
human O X
cervical O X
cancer O X
cell O X
. O X

In O X
a O X
screen O X
of O X
1 O X
. O X
62 O X
x O X
10 O X
( O X
6 O X
) O X
yeast O X
cotransformed O X
with O X
a O X
HeLa O X
cDNA O X
library O X
and O X
an O X
hTrx I-MISC 7295
vector O X
, O X
13 O X
clones O X
were O X
identified O X
as O X
candidates O X
for O X
hTrx I-MISC 7295
- O X
binding O X
proteins O X
. O X

Among O X
them O X
, O X
3 O X
clones O X
were O X
found O X
to O X
code O X
in O X
frame O X
for O X
the O X
carboxyl O X
- O X
terminal O X
portion O X
of O X
VDUP1 I-MISC 10628
protein O X
, O X
lacking O X
at O X
most O X
the O X
first O X
155 O X
residues O X
from O X
the O X
start O X
codon O X
. O X

A O X
reconstructed O X
clone O X
carrying O X
the O X
full O X
- O X
length O X
VDUP1 I-MISC 10628
coding O X
sequence O X
also O X
showed O X
the O X
ability O X
to O X
bind O X
to O X
an O X
hTrx I-MISC 7295
fusion O X
protein O X
. O X

Loss O X
of O X
interaction O X
between O X
VDUP1 I-MISC 10628
and O X
hTrx I-MISC 7295
was O X
observed O X
either O X
when O X
two O X
cysteines O X
( O X
Cys O X
32 O X
and O X
35 O X
) O X
in O X
hTrx I-MISC 7295
were O X
substituted O X
by O X
serines O X
or O X
when O X
the O X
deletion O X
in O X
VDUP1 I-MISC 10628
was O X
extended O X
from O X
amino O X
acid O X
position O X
155 O X
to O X
225 O X
or O X
beyond O X
. O X

The O X
71 O X
- O X
mer O X
peptide O X
fragment O X
( O X
position O X
155 O X
- O X
225 O X
) O X
of O X
VDUP I-MISC 10628
- I-MISC 10628
1 I-MISC 10628
alone O X
did O X
not O X
bind O X
to O X
hTrx I-MISC 7295
. O X

###17347647	11840,57584

Structural O X
basis O X
for O X
ARF1 I-MISC 11840
- O X
mediated O X
recruitment O X
of O X
ARHGAP21 I-MISC 57584
to O X
Golgi O X
membranes O X
. O X

ARHGAP21 I-MISC 57584
is O X
a O X
Rho O X
family O X
GTPase O X
- O X
activating O X
protein O X
( O X
RhoGAP O X
) O X
that O X
controls O X
the O X
Arp2 I-MISC 10097
/ O X
3 O X
complex O X
and O X
F O X
- O X
actin O X
dynamics O X
at O X
the O X
Golgi O X
complex O X
by O X
regulating O X
the O X
activity O X
of O X
the O X
small O X
GTPase O X
Cdc42 I-MISC 998
. O X

ARHGAP21 I-MISC 57584
is O X
recruited O X
to O X
the O X
Golgi O X
by O X
binding O X
to O X
another O X
small O X
GTPase O X
, O X
ARF1 I-MISC 11840
. O X

Here O X
, O X
we O X
present O X
the O X
crystal O X
structure O X
of O X
the O X
activated O X
GTP O X
- O X
bound O X
form O X
of O X
ARF1 I-MISC 11840
in O X
a O X
complex O X
with O X
the O X
Arf O X
- O X
binding O X
domain O X
( O X
ArfBD O X
) O X
of O X
ARHGAP21 I-MISC 57584
at O X
2 O X
. O X
1 O X
A O X
resolution O X
. O X

We O X
show O X
that O X
ArfBD O X
comprises O X
a O X
PH O X
domain O X
adjoining O X
a O X
C O X
- O X
terminal O X
alpha O X
helix O X
, O X
and O X
that O X
ARF1 I-MISC 11840
interacts O X
with O X
both O X
of O X
these O X
structural O X
motifs O X
through O X
its O X
switch O X
regions O X
and O X
triggers O X
structural O X
rearrangement O X
of O X
the O X
PH O X
domain O X
. O X

We O X
used O X
site O X
- O X
directed O X
mutagenesis O X
to O X
confirm O X
that O X
both O X
the O X
PH O X
domain O X
and O X
the O X
helical O X
motif O X
are O X
essential O X
for O X
the O X
binding O X
of O X
ArfBD O X
to O X
ARF1 I-MISC 11840
and O X
for O X
its O X
recruitment O X
to O X
the O X
Golgi O X
. O X

Our O X
data O X
demonstrate O X
that O X
two O X
well O X
- O X
known O X
small O X
GTPase O X
- O X
binding O X
motifs O X
, O X
the O X
PH O X
domain O X
and O X
the O X
alpha O X
helical O X
motif O X
, O X
can O X
combine O X
to O X
create O X
a O X
novel O X
mode O X
of O X
binding O X
to O X
Arfs O X
. O X

###10318831	67903,20352	67903,20353

A O X
PDZ O X
protein O X
regulates O X
the O X
distribution O X
of O X
the O X
transmembrane O X
semaphorin O X
, O X
M O X
- O X
SemF I-MISC 9037
. O X

M O X
- O X
SemF I-MISC 9037
is O X
a O X
membrane O X
- O X
associated O X
, O X
neurally O X
enriched O X
member O X
of O X
the O X
semaphorin O X
family O X
of O X
axon O X
guidance O X
signals O X
. O X

We O X
considered O X
whether O X
the O X
cytoplasmic O X
domain O X
of O X
M O X
- O X
SemF I-MISC 9037
might O X
possess O X
a O X
signaling O X
function O X
and O X
/ O X
or O X
might O X
control O X
the O X
distribution O X
of O X
M O X
- O X
SemF I-MISC 9037
on O X
the O X
cell O X
surface O X
. O X

We O X
identify O X
a O X
PDZ O X
- O X
containing O X
neural O X
protein O X
as O X
an O X
M O X
- O X
SemF I-MISC 9037
cytoplasmic O X
domain O X
- O X
associated O X
protein O X
( O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
). O X

SEMCAP I-MISC 54810
- I-MISC 54810
2 I-MISC 54810
is O X
a O X
closely O X
related O X
nonneuronal O X
protein O X
. O X

SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
has O X
recently O X
also O X
been O X
identified O X
as O X
GIPC I-MISC 67903
, O X
by O X
virtue O X
of O X
its O X
interaction O X
with O X
the O X
RGS I-MISC 5308
protein O X
GAIP I-MISC 10287
in O X
vitro O X
( O X
De O X
Vries O X
, O X
L O X
., O X
Lou O X
, O X
X O X
., O X
Zhao O X
, O X
G O X
., O X
Zheng O X
, O X
B O X
., O X
and O X
Farquhar O X
, O X
M O X
. O X
G O X
. O X
( O X
1998 O X
) O X
Proc O X
. O X

Natl O X
. O X

Acad O X
. O X

Sci O X
. O X

U O X
. O X
S O X
. O X
A O X
. O X

95 O X
, O X
12340 O X
- O X
12345 O X
). O X

Expression O X
studies O X
support O X
the O X
notion O X
that O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( O X
GIPC I-MISC 67903
) O X
interacts O X
with O X
M O X
- O X
SemF I-MISC 9037
, O X
but O X
not O X
GAIP I-MISC 10287
, O X
in O X
brain O X
. O X

Lung O X
SEMCAP I-MISC 54810
- I-MISC 54810
2 I-MISC 54810
and O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( O X
GIPC I-MISC 67903
) O X
are O X
potential O X
partners O X
for O X
both O X
GAIP I-MISC 10287
and O X
M O X
- O X
SemF I-MISC 9037
. O X

The O X
protein O X
interaction O X
requires O X
the O X
single O X
PDZ O X
domain O X
of O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( I-MISC 10755
GIPC I-MISC 67903
) I-MISC 10755
and O X
the O X
carboxyl O X
- O X
terminal O X
four O X
residues O X
of O X
M O X
- O X
SemF I-MISC 9037
, O X
ESSV O X
. O X

While O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( I-MISC 10755
GIPC I-MISC 67903
) I-MISC 10755
also O X
interacts O X
with O X
SemC I-MISC 20352
, O X
it O X
does O X
not O X
interact O X
with O X
other O X
proteins O X
containing O X
a O X
class O X
I O X
PDZ O X
binding O X
motif O X
, O X
nor O X
does O X
M O X
- O X
SemF I-MISC 9037
interact O X
with O X
other O X
class O X
I O X
PDZ O X
proteins O X
. O X

Co O X
- O X
expression O X
of O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( I-MISC 10755
GIPC I-MISC 67903
) I-MISC 10755
induces O X
the O X
redistribution O X
of O X
dispersed O X
M O X
- O X
SemF I-MISC 9037
into O X
detergent O X
- O X
resistant O X
aggregates O X
in O X
HEK293 O X
cells O X
. O X

Thus O X
, O X
SEMCAP I-MISC 20353
- I-MISC 20353
1 I-MISC 20353
( I-MISC 10755
GIPC I-MISC 67903
) I-MISC 10755
appears O X
to O X
regulate O X
the O X
subcellular O X
distribution O X
of O X
M O X
- O X
SemF I-MISC 9037
in O X
brain O X
, O X
and O X
SEMCAPs O X
could O X
link O X
M O X
- O X
SemF I-MISC 9037
to O X
G O X
protein O X
signal O X
transduction O X
pathways O X
. O X

###22575647	4193,8431

An O X
autoregulatory O X
feedback O X
loop O X
between O X
Mdm2 I-MISC 4193
and O X
SHP I-MISC 8431
that O X
fine O X
tunes O X
Mdm2 I-MISC 4193
and O X
SHP I-MISC 8431
stability O X
. O X

Mdm2 I-MISC 4193
is O X
a O X
crucial O X
negative O X
regulator O X
of O X
the O X
tumor O X
suppressor O X
function O X
of O X
p53 I-MISC 7157
. O X

However O X
, O X
little O X
is O X
known O X
about O X
Mdm2 I-MISC 4193
protein O X
stability O X
regulation O X
by O X
other O X
tumor O X
suppressors O X
. O X

Nuclear O X
receptor O X
small O X
heterodimer O X
partner O X
( O X
SHP I-MISC 8431
, O X
NROB2 O X
) O X
functions O X
as O X
a O X
tumor O X
suppressor O X
in O X
liver O X
cancer O X
. O X

We O X
show O X
here O X
a O X
surprising O X
finding O X
of O X
a O X
feedback O X
regulatory O X
loop O X
between O X
SHP I-MISC 8431
and O X
Mdm2 I-MISC 4193
. O X

SHP I-MISC 8431
stabilizes O X
Mdm2 I-MISC 4193
protein O X
by O X
abrogating O X
Mdm2 I-MISC 4193
self O X
- O X
ubiquitination O X
, O X
and O X
Mdm2 I-MISC 4193
in O X
turn O X
attenuates O X
SHP I-MISC 8431
protein O X
levels O X
under O X
p53 I-MISC 7157
- O X
deficient O X
conditions O X
. O X

Such O X
cross O X
- O X
regulation O X
critically O X
depends O X
on O X
the O X
physical O X
interaction O X
of O X
SHP I-MISC 8431
with O X
Mdm2 I-MISC 4193
through O X
the O X
SHP I-MISC 8431
K170 O X
residue O X
. O X

The O X
Mdm2 I-MISC 4193
- O X
SHP I-MISC 8431
interplay O X
represents O X
a O X
novel O X
component O X
of O X
Mdm2 I-MISC 4193
signaling O X
that O X
is O X
likely O X
to O X
dictate O X
Mdm2 I-MISC 4193
activity O X
and O X
function O X
. O X

###16166382	1973,1982

Structural O X
basis O X
for O X
the O X
enhancement O X
of O X
eIF4A I-MISC 1973
helicase O X
activity O X
by O X
eIF4G I-MISC 1982
. O X

The O X
eukaryotic I-MISC 1973
translation I-MISC 1973
initiation I-MISC 1973
factors I-MISC 1973
4A I-MISC 1973
( O X
eIF4A I-MISC 1973
) O X
and O X
4G O X
( O X
eIF4G I-MISC 1982
) O X
are O X
crucial O X
for O X
the O X
assembly O X
of O X
the O X
translationally O X
active O X
ribosome O X
. O X

Together O X
with O X
eIF4E I-MISC 1977
, O X
they O X
form O X
the O X
eIF4F O X
complex O X
, O X
which O X
recruits O X
the O X
40S O X
subunit O X
to O X
the O X
5 O X
' O X
cap O X
of O X
mRNA O X
. O X

The O X
two O X
- O X
domain O X
RNA O X
helicase O X
eIF4A I-MISC 1973
is O X
a O X
very O X
weak O X
helicase O X
by O X
itself O X
, O X
but O X
the O X
activity O X
is O X
enhanced O X
upon O X
interaction O X
with O X
the O X
scaffolding O X
protein O X
eIF4G I-MISC 1982
. O X

Here O X
we O X
show O X
that O X
, O X
albeit O X
both O X
eIF4A I-MISC 1973
domains O X
play O X
a O X
role O X
in O X
binding O X
the O X
middle O X
domain O X
of O X
eIF4G I-MISC 1982
( O X
eIF4G I-MISC 1982
- I-MISC 1982
m I-MISC 1982
, O X
amino O X
acids O X
745 O X
- O X
1003 O X
), O X
the O X
main O X
interaction O X
surface O X
is O X
located O X
on O X
the O X
C O X
- O X
terminal O X
domain O X
. O X

We O X
use O X
NMR O X
spectroscopy O X
to O X
define O X
the O X
binding O X
site O X
and O X
find O X
that O X
the O X
contact O X
surface O X
is O X
adjacent O X
to O X
the O X
RNA O X
-, O X
ATP O X
-, O X
and O X
eIF4A I-MISC 1973
- O X
NTD O X
- O X
interacting O X
regions O X
. O X

Mutations O X
of O X
interface O X
residues O X
abrogated O X
binding O X
, O X
confirmed O X
the O X
interface O X
, O X
and O X
showed O X
that O X
the O X
N O X
- O X
terminal O X
end O X
of O X
eIF4G I-MISC 1982
- I-MISC 1982
m I-MISC 1982
interacts O X
with O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
eIF4A I-MISC 1973
. O X

The O X
data O X
suggest O X
that O X
eIF4G I-MISC 1982
- I-MISC 1982
m I-MISC 1982
forms O X
a O X
soft O X
clamp O X
to O X
stabilize O X
the O X
closed O X
interdomain O X
orientation O X
of O X
eIF4A I-MISC 1973
. O X

This O X
model O X
can O X
explain O X
the O X
cooperativity O X
between O X
all O X
binding O X
partners O X
of O X
eIF4A I-MISC 1973
( O X
eIF4G I-MISC 1982
, O X
RNA O X
, O X
ATP O X
) O X
and O X
stimulation O X
of O X
eIF4A I-MISC 1973
activity O X
in O X
the O X
eIF4F O X
complex O X
. O X

###10846174	3565776,179943

Disruption O X
of O X
the O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
. O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
complex O X
by O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
is O X
a O X
critical O X
step O X
for O X
programmed O X
cell O X
death O X
in O X
Caenorhabditis O X
elegans O X
. O X

In O X
the O X
nematode O X
Caenorhabditis O X
elegans O X
, O X
the O X
apoptotic O X
machinery O X
is O X
composed O X
of O X
four O X
basic O X
elements O X
: O X
the O X
caspase O X
CED O X
- O X
3 O X
, O X
the O X
Apaf O X
- O X
1 O X
homologue O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
, O X
and O X
the O X
Bcl O X
- O X
2 O X
family O X
members O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
and O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
. O X

The O X
ced I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
( O X
n1950 O X
) O X
gain O X
- O X
of O X
- O X
function O X
mutation O X
prevents O X
most O X
, O X
if O X
not O X
all O X
, O X
somatic O X
cell O X
deaths O X
in O X
C O X
. O X
elegans O X
. O X

It O X
encodes O X
a O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
protein O X
with O X
a O X
glycine O X
- O X
to O X
- O X
glutamate O X
substitution O X
at O X
position O X
169 O X
, O X
which O X
is O X
located O X
within O X
the O X
highly O X
conserved O X
Bcl O X
- O X
2 O X
homology O X
1 O X
domain O X
. O X

We O X
performed O X
biochemical O X
analyses O X
with O X
the O X
CED O X
- O X
9G169E O X
protein O X
to O X
gain O X
insight O X
into O X
the O X
mechanism O X
of O X
programmed O X
cell O X
death O X
. O X

We O X
find O X
that O X
CED O X
- O X
9G169E O X
retains O X
the O X
ability O X
to O X
bind O X
both O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
and O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
, O X
although O X
its O X
affinity O X
for O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
is O X
reduced O X
. O X

In O X
contrast O X
to O X
the O X
behavior O X
of O X
wild O X
- O X
type O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
, O X
the O X
interaction O X
between O X
CED O X
- O X
9G169E O X
and O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
is O X
not O X
disrupted O X
by O X
expression O X
of O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
. O X

Furthermore O X
, O X
CED I-MISC 317
- I-MISC 317
4 I-MISC 317
and O X
CED O X
- O X
9G169E O X
co O X
- O X
localizes O X
with O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
to O X
the O X
mitochondria O X
in O X
mammalian O X
cells O X
, O X
and O X
expression O X
of O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
does O X
not O X
induce O X
translocation O X
of O X
CED I-MISC 317
- I-MISC 317
4 I-MISC 317
to O X
the O X
cytosol O X
. O X

Finally O X
, O X
the O X
ability O X
of O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
to O X
promote O X
apoptosis O X
is O X
impaired O X
by O X
the O X
replacement O X
of O X
wild O X
- O X
type O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
with O X
CED O X
- O X
9G169E O X
, O X
and O X
this O X
effect O X
is O X
correlated O X
with O X
the O X
inability O X
of O X
EGL I-MISC 179943
- I-MISC 179943
1 I-MISC 179943
to O X
induce O X
the O X
displacement O X
of O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
from O X
the O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
. O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
complex O X
. O X

These O X
studies O X
suggest O X
that O X
the O X
release O X
of O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
from O X
the O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
. O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
complex O X
is O X
a O X
necessary O X
step O X
for O X
induction O X
of O X
programmed O X
cell O X
death O X
in O X
C O X
. O X
elegans O X
. O X

###20849418	9798,23473

Autolytic O X
activity O X
of O X
human O X
calpain I-MISC 23473
7 I-MISC 23473
is O X
enhanced O X
by O X
ESCRT O X
- O X
III O X
- O X
related O X
protein O X
IST1 I-MISC 9798
through O X
MIT O X
- O X
MIM O X
interaction O X
. O X

Calpain I-MISC 23473
7 I-MISC 23473
, O X
a O X
mammalian O X
ortholog O X
of O X
yeast O X
Cpl1 I-MISC 855186
/ O X
Rim13 I-MISC 855186
and O X
fungal O X
PalB O X
, O X
is O X
an O X
atypical O X
calpain O X
that O X
lacks O X
a O X
penta O X
- O X
EF O X
- O X
hand O X
domain O X
. O X

Previously O X
, O X
we O X
reported O X
that O X
a O X
region O X
containing O X
a O X
tandem O X
repeat O X
of O X
microtubule O X
- O X
interacting O X
and O X
transport O X
( O X
MIT O X
) O X
domains O X
in O X
calpain I-MISC 23473
7 I-MISC 23473
interacts O X
with O X
a O X
subset O X
of O X
endosomal O X
sorting O X
complex O X
required O X
for O X
transport O X
( O X
ESCRT O X
)- O X
III O X
- O X
related O X
proteins O X
, O X
suggesting O X
involvement O X
of O X
calpain I-MISC 23473
7 I-MISC 23473
in O X
the O X
ESCRT O X
system O X
. O X

Although O X
yeast O X
and O X
fungal O X
calpains O X
are O X
thought O X
to O X
be O X
involved O X
in O X
alkaline O X
adaptation O X
via O X
limited O X
proteolysis O X
of O X
specific O X
transcription O X
factors O X
, O X
proteolytic O X
activity O X
of O X
calpain I-MISC 23473
7 I-MISC 23473
has O X
not O X
been O X
demonstrated O X
yet O X
. O X

In O X
this O X
study O X
, O X
we O X
investigated O X
the O X
interaction O X
between O X
calpain I-MISC 23473
7 I-MISC 23473
and O X
a O X
newly O X
reported O X
ESCRT O X
- O X
III O X
family O X
member O X
, O X
increased O X
sodium O X
tolerance O X
- O X
1 O X
( O X
IST1 I-MISC 9798
), O X
which O X
possesses O X
two O X
different O X
types O X
of O X
MIT O X
- O X
interacting O X
motifs O X
( O X
MIM1 I-MISC 100073347
and O X
MIM2 O X
). O X

We O X
found O X
that O X
glutathione I-MISC 373156
- I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
( O X
GST I-MISC 373156
)- O X
fused O X
tandem O X
MIT O X
domains O X
of O X
calpain I-MISC 23473
7 I-MISC 23473
( O X
calpain O X
7MIT O X
) O X
pulled O X
down O X
FLAG O X
- O X
tagged O X
IST1 I-MISC 9798
expressed O X
in O X
HEK293T O X
cells O X
. O X

Coimmunoprecipitation O X
assays O X
with O X
various O X
deletion O X
or O X
point O X
mutants O X
of O X
epitope O X
- O X
tagged O X
calpain I-MISC 23473
7 I-MISC 23473
and O X
IST1 I-MISC 9798
revealed O X
that O X
both O X
repetitive O X
MIT O X
domains O X
and O X
MIMs O X
are O X
required O X
for O X
efficient O X
interaction O X
. O X

Direct O X
MIT O X
- O X
MIM O X
binding O X
was O X
confirmed O X
by O X
a O X
pulldown O X
experiment O X
with O X
GST I-MISC 373156
- O X
fused O X
IST1 I-MISC 9798
MIM O X
and O X
purified O X
recombinant O X
calpain O X
7MIT O X
. O X

Furthermore O X
, O X
we O X
found O X
that O X
the O X
GST I-MISC 373156
- O X
MIM O X
protein O X
enhances O X
the O X
autolysis O X
of O X
purified O X
Strep O X
- O X
tagged O X
monomeric O X
green O X
fluorescent O X
protein O X
( O X
mGFP O X
)- O X
fused O X
calpain I-MISC 23473
7 I-MISC 23473
( O X
mGFP O X
- O X
calpain I-MISC 23473
7 I-MISC 23473
- O X
Strep O X
). O X

The O X
autolysis O X
was O X
almost O X
completely O X
abolished O X
by O X
10 O X
mmN O X
- O X
ethylmaleimide O X
but O X
only O X
partially O X
inhibited O X
by O X
1 O X
mm O X
leupeptin O X
or O X
E O X
- O X
64 O X
. O X

The O X
putative O X
catalytic O X
Cys290 O X
- O X
substituted O X
mutant O X
( O X
mGFP O X
- O X
calpain I-MISC 23473
7 I-MISC 23473
( O X
C290S O X
)- O X
Strep O X
) O X
showed O X
no O X
autolytic O X
activity O X
. O X

These O X
results O X
demonstrate O X
for O X
the O X
first O X
time O X
that O X
human O X
calpain I-MISC 23473
7 I-MISC 23473
is O X
proteolytically O X
active O X
, O X
and O X
imply O X
that O X
calpain I-MISC 23473
7 I-MISC 23473
is O X
activated O X
in O X
the O X
ESCRT O X
system O X
. O X

###15171681	6286,6271

Heterodimeric O X
interaction O X
and O X
interfaces O X
of O X
S100A1 I-MISC 6271
and O X
S100P I-MISC 6286
. O X

With O X
the O X
widespread O X
use O X
of O X
yeast O X
two O X
- O X
hybrid O X
systems O X
, O X
many O X
heterodimeric O X
forms O X
of O X
S100 O X
proteins O X
have O X
been O X
found O X
, O X
although O X
their O X
biological O X
significance O X
is O X
unknown O X
. O X

In O X
the O X
present O X
study O X
, O X
S100A1 I-MISC 6271
was O X
found O X
to O X
interact O X
with O X
another O X
S100 O X
protein O X
, O X
S100P I-MISC 6286
, O X
by O X
using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

The O X
binding O X
parameters O X
of O X
the O X
interaction O X
were O X
obtained O X
using O X
an O X
optical O X
biosensor O X
and O X
show O X
that O X
S100P I-MISC 6286
has O X
a O X
slightly O X
higher O X
affinity O X
for O X
S100A1 I-MISC 6271
( O X
K O X
( O X
d O X
)= O X
10 O X
- O X
20 O X
nM O X
) O X
when O X
compared O X
with O X
that O X
for O X
self O X
- O X
association O X
( O X
K O X
( O X
d O X
)= O X
40 O X
- O X
120 O X
nM O X
). O X

The O X
physical O X
interaction O X
of O X
S100A1 I-MISC 6271
and O X
S100P I-MISC 6286
was O X
also O X
demonstrated O X
in O X
living O X
mammalian O X
cells O X
using O X
a O X
fluorescence O X
resonance O X
energy O X
transfer O X
technique O X
. O X

Preincubation O X
of O X
recombinant O X
S100P I-MISC 6286
with O X
S100A1 I-MISC 6271
, O X
before O X
the O X
biosensor O X
assay O X
, O X
reduced O X
by O X
up O X
to O X
50 O X
% O X
the O X
binding O X
of O X
S100P I-MISC 6286
to O X
a O X
recombinant O X
C O X
- O X
terminal O X
fragment O X
of O X
non O X
- O X
muscle O X
myosin O X
A O X
, O X
one O X
of O X
its O X
target O X
molecules O X
. O X

Site O X
- O X
specific O X
mutations O X
of O X
S100P I-MISC 6286
and O X
S100A1 I-MISC 6271
, O X
combined O X
with O X
homology O X
modelling O X
of O X
an O X
S100P I-MISC 6286
/ O X
S100A1 I-MISC 6271
heterodimer O X
using O X
known O X
S100P I-MISC 6286
and O X
S100A1 I-MISC 6271
structures O X
, O X
allowed O X
the O X
hydrophobic O X
interactions O X
at O X
the O X
dimeric O X
interface O X
of O X
the O X
heterodimer O X
to O X
be O X
defined O X
and O X
provide O X
an O X
explanation O X
for O X
the O X
heterodimerization O X
of O X
S100P I-MISC 6286
and O X
S100A1 I-MISC 6271
at O X
the O X
molecular O X
level O X
. O X

These O X
results O X
have O X
revealed O X
the O X
similarities O X
and O X
the O X
differences O X
between O X
the O X
S100P I-MISC 6286
homodimer O X
and O X
the O X
S100A1 I-MISC 6271
/ O X
S100P I-MISC 6286
heterodimer O X
. O X

###17296936	29386,546

Interaction O X
between O X
chromatin O X
proteins O X
MECP2 I-MISC 29386
and O X
ATRX I-MISC 546
is O X
disrupted O X
by O X
mutations O X
that O X
cause O X
inherited O X
mental O X
retardation O X
. O X

Mutations O X
in O X
the O X
human O X
methyl O X
- O X
CpG O X
- O X
binding O X
protein O X
gene O X
MECP2 I-MISC 29386
cause O X
the O X
neurological O X
disorder O X
Rett O X
syndrome O X
and O X
some O X
cases O X
of O X
X O X
- O X
linked O X
mental O X
retardation O X
( O X
XLMR O X
). O X

We O X
report O X
that O X
MeCP2 I-MISC 29386
interacts O X
with O X
ATRX I-MISC 546
, O X
a O X
SWI2 O X
/ O X
SNF2 O X
DNA O X
helicase O X
/ O X
ATPase I-MISC 13417
that O X
is O X
mutated O X
in O X
ATRX I-MISC 546
syndrome O X
( O X
alpha O X
- O X
thalassemia O X
/ O X
mental O X
retardation O X
, O X
X O X
- O X
linked O X
). O X

MeCP2 I-MISC 29386
can O X
recruit O X
the O X
helicase O X
domain O X
of O X
ATRX I-MISC 546
to O X
heterochromatic O X
foci O X
in O X
living O X
mouse O X
cells O X
in O X
a O X
DNA O X
methylation O X
- O X
dependent O X
manner O X
. O X

Also O X
, O X
ATRX I-MISC 546
localization O X
is O X
disrupted O X
in O X
neurons O X
of O X
Mecp2 I-MISC 29386
- O X
null O X
mice O X
. O X

Point O X
mutations O X
within O X
the O X
methylated O X
DNA O X
- O X
binding O X
domain O X
of O X
MeCP2 I-MISC 29386
that O X
cause O X
Rett O X
syndrome O X
or O X
X O X
- O X
linked O X
mental O X
retardation O X
inhibit O X
its O X
interaction O X
with O X
ATRX I-MISC 546
in O X
vitro O X
and O X
its O X
localization O X
in O X
vivo O X
without O X
affecting O X
methyl O X
- O X
CpG O X
binding O X
. O X

We O X
propose O X
that O X
disruption O X
of O X
the O X
MeCP2 I-MISC 29386
- O X
ATRX I-MISC 546
interaction O X
leads O X
to O X
pathological O X
changes O X
that O X
contribute O X
to O X
mental O X
retardation O X
. O X

###10206962	50671,50671

Dibromopropanone O X
cross O X
- O X
linking O X
of O X
the O X
phosphopantetheine O X
and O X
active O X
- O X
site O X
cysteine O X
thiols O X
of O X
the O X
animal O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
can O X
occur O X
both O X
inter O X
- O X
and O X
intrasubunit O X
. O X

Reevaluation O X
of O X
the O X
side O X
- O X
by O X
- O X
side O X
, O X
antiparallel O X
subunit O X
model O X
. O X

The O X
objective O X
of O X
this O X
study O X
was O X
to O X
test O X
a O X
new O X
model O X
for O X
the O X
homodimeric O X
animal O X
FAS O X
which O X
implies O X
that O X
the O X
condensation O X
reaction O X
can O X
be O X
catalyzed O X
by O X
the O X
amino O X
- O X
terminal O X
beta O X
- O X
ketoacyl O X
synthase O X
domain O X
in O X
cooperation O X
with O X
the O X
penultimate O X
carboxyl O X
- O X
terminal O X
acyl O X
carrier O X
protein O X
domain O X
of O X
either O X
subunit O X
. O X

Treatment O X
of O X
animal O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
dimers O X
with O X
dibromopropanone O X
generates O X
three O X
new O X
molecular O X
species O X
with O X
decreased O X
electrophoretic O X
mobilities O X
; O X
none O X
of O X
these O X
species O X
are O X
formed O X
by O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
mutant O X
dimers O X
lacking O X
either O X
the O X
active O X
- O X
site O X
cysteine O X
of O X
the O X
beta O X
- O X
ketoacyl O X
synthase O X
domain O X
( O X
C161A O X
) O X
or O X
the O X
phosphopantetheine O X
thiol O X
of O X
the O X
acyl O X
carrier O X
protein O X
domain O X
( O X
S2151A O X
). O X

A O X
double O X
affinity O X
- O X
labeling O X
strategy O X
was O X
used O X
to O X
isolate O X
dimers O X
that O X
carried O X
one O X
or O X
both O X
mutations O X
on O X
one O X
or O X
both O X
subunits O X
; O X
the O X
heterodimers O X
were O X
treated O X
with O X
dibromopropanone O X
and O X
analyzed O X
by O X
a O X
combination O X
of O X
sodium O X
dodecyl O X
sulfate O X
/ O X
polyacrylamide O X
gel O X
electrophoresis O X
, O X
Western O X
blotting O X
, O X
gel O X
filtration O X
, O X
and O X
matrix O X
- O X
assisted O X
laser O X
desorption O X
mass O X
spectrometry O X
. O X

Thus O X
the O X
two O X
slowest O X
moving O X
of O X
these O X
species O X
, O X
which O X
accounted O X
for O X
45 O X
and O X
15 O X
% O X
of O X
the O X
total O X
, O X
were O X
identified O X
as O X
doubly O X
and O X
singly O X
cross O X
- O X
linked O X
dimers O X
, O X
respectively O X
, O X
whereas O X
the O X
fastest O X
moving O X
species O X
, O X
which O X
accounted O X
for O X
35 O X
% O X
of O X
the O X
total O X
, O X
was O X
identified O X
as O X
originating O X
from O X
internally O X
cross O X
- O X
linked O X
subunits O X
. O X

These O X
results O X
show O X
that O X
the O X
two O X
polypeptides O X
of O X
the O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
are O X
oriented O X
such O X
that O X
head O X
- O X
to O X
- O X
tail O X
contacts O X
are O X
formed O X
both O X
between O X
and O X
within O X
subunits O X
, O X
and O X
provide O X
the O X
first O X
structural O X
evidence O X
in O X
support O X
of O X
the O X
new O X
model O X
. O X

###11375976	472,7013

Telomeric O X
protein O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
as O X
an O X
important O X
ATM I-MISC 472
target O X
in O X
response O X
to O X
double O X
strand O X
DNA O X
breaks O X
. O X

ATM I-MISC 472
mutations O X
are O X
responsible O X
for O X
the O X
genetic O X
disease O X
ataxia O X
- O X
telangiectasia O X
( O X
A O X
- O X
T O X
). O X

ATM I-MISC 472
encodes O X
a O X
protein O X
kinase O X
that O X
is O X
activated O X
by O X
ionizing O X
radiation O X
- O X
induced O X
double O X
strand O X
DNA O X
breaks O X
. O X

Cells O X
derived O X
from O X
A O X
- O X
T O X
patients O X
show O X
many O X
abnormalities O X
, O X
including O X
accelerated O X
telomere O X
loss O X
and O X
hypersensitivity O X
to O X
ionizing O X
radiation O X
; O X
they O X
enter O X
into O X
mitosis O X
and O X
apoptosis O X
after O X
DNA O X
damage O X
. O X

Pin2 I-MISC 7013
was O X
originally O X
identified O X
as O X
a O X
protein O X
involved O X
in O X
G O X
( O X
2 O X
)/ O X
M O X
regulation O X
and O X
is O X
almost O X
identical O X
to O X
TRF1 I-MISC 7013
, O X
a O X
telomeric O X
protein O X
that O X
negatively O X
regulates O X
telomere O X
elongation O X
. O X

Pin2 I-MISC 7013
and O X
TRF1 I-MISC 7013
, O X
probably O X
encoded O X
by O X
the O X
same O X
gene O X
, O X
PIN2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
, O X
are O X
regulated O X
during O X
the O X
cell O X
cycle O X
. O X

Furthermore O X
, O X
up O X
- O X
regulation O X
of O X
Pin2 I-MISC 7013
or O X
TRF1 I-MISC 7013
induces O X
mitotic O X
entry O X
and O X
apoptosis O X
, O X
a O X
phenotype O X
similar O X
to O X
that O X
of O X
A O X
- O X
T O X
cells O X
after O X
DNA O X
damage O X
. O X

These O X
results O X
suggest O X
that O X
ATM I-MISC 472
may O X
regulate O X
the O X
function O X
of O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
, O X
but O X
their O X
exact O X
relationship O X
remains O X
unknown O X
. O X

Here O X
we O X
show O X
that O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
coimmunoprecipitated O X
with O X
ATM I-MISC 472
, O X
and O X
its O X
phosphorylation O X
was O X
increased O X
in O X
an O X
ATM I-MISC 472
- O X
dependent O X
manner O X
by O X
ionizing O X
DNA O X
damage O X
. O X

Furthermore O X
, O X
activated O X
ATM I-MISC 472
directly O X
phosphorylated O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
preferentially O X
on O X
the O X
conserved O X
Ser O X
( O X
219 O X
)- O X
Gln O X
site O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

The O X
biological O X
significance O X
of O X
this O X
phosphorylation O X
is O X
substantiated O X
by O X
functional O X
analyses O X
of O X
the O X
phosphorylation O X
site O X
mutants O X
. O X

Although O X
expression O X
of O X
Pin2 I-MISC 7013
and O X
its O X
mutants O X
has O X
no O X
detectable O X
effect O X
on O X
telomere O X
length O X
in O X
transient O X
transfection O X
, O X
a O X
Pin2 I-MISC 7013
mutant O X
refractory O X
to O X
ATM I-MISC 472
phosphorylation O X
on O X
Ser O X
( O X
219 O X
) O X
potently O X
induces O X
mitotic O X
entry O X
and O X
apoptosis O X
and O X
increases O X
radiation O X
hypersensitivity O X
of O X
A O X
- O X
T O X
cells O X
. O X

In O X
contrast O X
, O X
Pin2 I-MISC 7013
mutants O X
mimicking O X
ATM I-MISC 472
phosphorylation O X
on O X
Ser O X
( O X
219 O X
) O X
completely O X
fail O X
to O X
induce O X
apoptosis O X
and O X
also O X
reduce O X
radiation O X
hypersensitivity O X
of O X
A O X
- O X
T O X
cells O X
. O X

Interestingly O X
, O X
the O X
phenotype O X
of O X
the O X
phosphorylation O X
- O X
mimicking O X
mutants O X
is O X
the O X
same O X
as O X
that O X
which O X
resulted O X
from O X
inhibition O X
of O X
endogenous O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
in O X
A O X
- O X
T O X
cells O X
by O X
its O X
dominant O X
- O X
negative O X
mutants O X
. O X

These O X
results O X
demonstrate O X
for O X
the O X
first O X
time O X
that O X
ATM I-MISC 472
interacts O X
with O X
and O X
phosphorylates O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
and O X
suggest O X
that O X
Pin2 I-MISC 7013
/ O X
TRF1 I-MISC 7013
may O X
be O X
involved O X
in O X
the O X
cellular O X
response O X
to O X
double O X
strand O X
DNA O X
breaks O X
. O X

###14594812	817170,820816

Arabidopsis O X
phospholipase I-MISC 820816
Dalpha1 I-MISC 820816
interacts O X
with O X
the O X
heterotrimeric O X
G I-MISC 817170
- I-MISC 817170
protein I-MISC 817170
alpha I-MISC 817170
- I-MISC 817170
subunit I-MISC 817170
through O X
a O X
motif O X
analogous O X
to O X
the O X
DRY O X
motif O X
in O X
G O X
- O X
protein O X
- O X
coupled O X
receptors O X
. O X

Phospholipase I-MISC 820816
D I-MISC 820816
( O X
PLD I-MISC 820816
) O X
and O X
heterotrimeric O X
G O X
- O X
protein O X
both O X
play O X
important O X
, O X
diverse O X
roles O X
in O X
cellular O X
regulation O X
and O X
signal O X
transduction O X
. O X

Here O X
we O X
have O X
determined O X
the O X
physical O X
interaction O X
between O X
plant O X
PLD I-MISC 820816
and O X
the O X
only O X
canonical O X
alpha O X
- O X
subunit O X
( O X
Galpha I-MISC 817170
) O X
of O X
the O X
G O X
- O X
protein O X
in O X
Arabidopsis O X
thaliana O X
and O X
the O X
molecular O X
basis O X
for O X
the O X
interaction O X
. O X

PLDalpha1 I-MISC 820816
expressed O X
in O X
either O X
Escherichia O X
coli O X
or O X
Arabidopsis O X
was O X
co O X
- O X
precipitated O X
with O X
Galpha I-MISC 817170
. O X

PLDalpha1 I-MISC 820816
contains O X
a O X
sequence O X
motif O X
analogous O X
to O X
the O X
G O X
alpha O X
- O X
interacting O X
DRY O X
motif O X
normally O X
conserved O X
in O X
G O X
- O X
protein O X
- O X
coupled O X
receptors O X
. O X

Mutation O X
of O X
the O X
central O X
Lys O X
residue O X
PLD I-MISC 820816
( O X
K564A O X
) O X
of O X
this O X
motif O X
abolished O X
the O X
PLDalpha1 I-MISC 820816
- O X
Galpha I-MISC 817170
binding O X
, O X
whereas O X
mutation O X
of O X
the O X
two O X
flanking O X
residues O X
PLD I-MISC 820816
( O X
E563A O X
) O X
and O X
PLD I-MISC 820816
( O X
F565A O X
) O X
decreased O X
the O X
binding O X
. O X

Addition O X
of O X
Galpha I-MISC 817170
to O X
PLDalpha1 I-MISC 820816
inhibited O X
PLDalpha1 I-MISC 820816
activity O X
, O X
whereas O X
the O X
PLD I-MISC 820816
( O X
K564A O X
) O X
mutation O X
that O X
disrupted O X
the O X
Galpha I-MISC 817170
- O X
PLDalpha1 I-MISC 820816
binding O X
abolished O X
the O X
inhibition O X
. O X

GTP O X
relieved O X
the O X
Galpha I-MISC 817170
inhibition O X
of O X
PLDalpha1 I-MISC 820816
activity O X
and O X
also O X
inhibited O X
the O X
binding O X
between O X
PLDalpha1 I-MISC 820816
and I-MISC 820816
Galpha I-MISC 817170
. O X

Meanwhile O X
, O X
the O X
PLDalpha1 I-MISC 820816
- O X
Galpha I-MISC 817170
interaction O X
stimulated O X
the O X
intrinsic O X
GTPase O X
activity O X
of O X
Galpha I-MISC 817170
. O X

Therefore O X
, O X
these O X
results O X
have O X
demonstrated O X
the O X
direct O X
binding O X
between O X
Galpha I-MISC 817170
and O X
PLDalpha1 I-MISC 820816
, O X
identified O X
the O X
DRY O X
motif O X
on O X
PLDalpha1 I-MISC 820816
as O X
the O X
site O X
for O X
the O X
interaction O X
, O X
and O X
indicated O X
that O X
the O X
interaction O X
modulates O X
reciprocally O X
the O X
activities O X
of O X
PLDalpha1 I-MISC 820816
and I-MISC 820816
Galpha I-MISC 817170
. O X

###16098514	6009,2475	121268,2475

Analysis O X
of O X
mTOR I-MISC 2475
signaling O X
by O X
the O X
small O X
G O X
- O X
proteins O X
, O X
Rheb I-MISC 6009
and O X
RhebL1 I-MISC 121268
. O X

The O X
small O X
G O X
protein O X
Rheb I-MISC 6009
( O X
Ras O X
homologue O X
enriched O X
in O X
brain O X
) O X
is O X
known O X
to O X
promote O X
mammalian I-MISC 2475
target I-MISC 2475
of I-MISC 2475
rapamycin I-MISC 2475
( O X
mTOR I-MISC 2475
) O X
signaling O X
. O X

In O X
this O X
study O X
, O X
we O X
show O X
that O X
Rheb I-MISC 121268
like I-MISC 121268
- I-MISC 121268
1 I-MISC 121268
protein I-MISC 121268
( O X
RhebL1 I-MISC 121268
) O X
rescues O X
mTOR I-MISC 2475
signaling O X
during O X
nutrient O X
withdrawal O X
and O X
that O X
tuberous O X
sclerosis O X
complex O X
- O X
1 O X
( O X
TSC O X
) O X
and O X
TSC2 I-MISC 7249
impairs O X
RhebL1 I-MISC 121268
- O X
mediated O X
signaling O X
through O X
mTOR I-MISC 2475
. O X

We O X
identify O X
critical O X
residues O X
within O X
the O X
switch O X
I O X
region O X
( O X
N41 O X
) O X
and O X
' O X
constitutive O X
' O X
effector O X
( O X
Ec O X
) O X
region O X
( O X
Y O X
/ O X
F54 O X
and O X
L56 O X
) O X
of O X
Rheb I-MISC 6009
and O X
RhebL1 I-MISC 121268
, O X
which O X
are O X
required O X
for O X
their O X
efficient O X
activation O X
of O X
mTOR I-MISC 2475
signaling O X
. O X

Mutation O X
of O X
Rheb I-MISC 6009
and O X
RhebL1 I-MISC 121268
at O X
N41 O X
impaired O X
their O X
interaction O X
with O X
mTOR I-MISC 2475
, O X
which O X
identifies O X
mTOR I-MISC 2475
as O X
a O X
common O X
downstream O X
target O X
of O X
both O X
Rheb I-MISC 6009
and O X
RhebL1 I-MISC 121268
. O X

###25117763	108909,12005

Structure O X
and O X
mechanism O X
of O X
the O X
unique O X
C2 O X
domain O X
of O X
Aida I-MISC 393763
. O X

Axin I-MISC 108909
interactor I-MISC 108909
, I-MISC 108909
dorsalization I-MISC 108909
- I-MISC 108909
associated I-MISC 108909
( O X
Aida I-MISC 393763
) O X
was O X
identified O X
as O X
a O X
regulatory O X
factor O X
that O X
utilizes O X
its O X
C O X
- O X
terminal O X
region O X
to O X
interact O X
with O X
axis O X
formation O X
inhibitor O X
( O X
Axin I-MISC 12005
). O X

Aida I-MISC 393763
abrogates O X
the O X
Axin I-MISC 12005
- O X
mediated O X
Jun I-MISC 335916
N O X
- O X
terminal O X
kinase O X
activation O X
required O X
for O X
proper O X
dorsalization O X
during O X
zebrafish O X
embryonic O X
development O X
, O X
and O X
thus O X
functions O X
as O X
a O X
proventralization O X
factor O X
. O X

Here O X
, O X
we O X
report O X
the O X
structure O X
of O X
Aida I-MISC 393763
C O X
- O X
terminal O X
fragments O X
, O X
which O X
adopt O X
a O X
conventional O X
C2 O X
domain O X
topology O X
. O X

We O X
also O X
demonstrate O X
that O X
Aida I-MISC 393763
can O X
specifically O X
bind O X
to O X
phosphoinositides O X
in O X
a O X
Ca O X
( O X
2 O X
+) O X
- O X
independent O X
manner O X
, O X
and O X
is O X
able O X
to O X
associate O X
with O X
the O X
cell O X
membrane O X
via O X
a O X
novel O X
positively O X
charged O X
surface O X
, O X
namely O X
a O X
basic O X
loop O X
. O X

Mutation O X
of O X
the O X
positively O X
charged O X
patch O X
on O X
the O X
basic O X
loop O X
leads O X
to O X
destabilization O X
of O X
the O X
Aida I-MISC 393763
- O X
membrane O X
association O X
or O X
disruption O X
of O X
the O X
Aida I-MISC 393763
- O X
Axin I-MISC 12005
interaction O X
, O X
resulting O X
in O X
impaired O X
Jun I-MISC 335916
N O X
- O X
terminal O X
kinase O X
inhibition O X
. O X

Together O X
, O X
our O X
findings O X
provide O X
a O X
molecular O X
basis O X
for O X
C2 O X
domain O X
- O X
mediated O X
Aida I-MISC 393763
- O X
membrane O X
and O X
Aida I-MISC 393763
- O X
Axin I-MISC 12005
associations O X
. O X

DATABASE O X
: O X
The O X
atomic O X
coordinates O X
and O X
structure O X
factors O X
of O X
the O X
mouse O X
Aida I-MISC 108909
C2 O X
domain O X
( O X
code O X
: O X
2QZ5 O X
) O X
and O X
the O X
zebrafish O X
Aida I-MISC 393763
C2 O X
domain O X
( O X
code O X
: O X
2QZQ O X
) O X
have O X
been O X
deposited O X
in O X
the O X
Protein O X
Data O X
Bank O X
( O X
http O X
:// O X
www O X
. O X
rcsb O X
. O X
org O X
/) O X
STRUCTURED O X
DIGITAL O X
ABSTRACT O X
: O X
AIDA I-MISC 393763
physically O X
interacts O X
with O X
Axin I-MISC 12005
by O X
anti O X
tag O X
coimmunoprecipitation O X
( O X
View O X
interaction O X
). O X

###8114715	3932,5777

Lck I-MISC 3932
- O X
dependent O X
tyrosyl O X
phosphorylation O X
of O X
the O X
phosphotyrosine O X
phosphatase O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
in O X
murine O X
T O X
cells O X
. O X

The O X
phosphorylation O X
and O X
dephosphorylation O X
of O X
proteins O X
on O X
tyrosyl O X
residues O X
are O X
key O X
regulatory O X
mechanisms O X
in O X
T O X
- O X
cell O X
signal O X
transduction O X
and O X
are O X
controlled O X
by O X
the O X
opposing O X
activities O X
of O X
protein O X
tyrosine O X
kinases O X
and O X
phosphotyrosyl O X
phosphatases O X
( O X
PTPs O X
). O X

In O X
T O X
cells O X
, O X
several O X
nontransmembrane O X
protein O X
tyrosine O X
kinases O X
are O X
associated O X
with O X
receptors O X
; O X
for O X
example O X
, O X
Lck I-MISC 3932
is O X
bound O X
to O X
the O X
coreceptors O X
CD4 I-MISC 12504
and O X
CD8 O X
and O X
becomes O X
activated O X
upon O X
their O X
stimulation O X
. O X

In O X
comparison O X
, O X
little O X
is O X
known O X
about O X
the O X
role O X
of O X
nontransmembrane O X
PTPs O X
in O X
early O X
T O X
- O X
cell O X
signaling O X
. O X

SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
( O X
PTP1C I-MISC 5777
, O X
HCP I-MISC 5777
, O X
SHP I-MISC 5777
) O X
is O X
a O X
nontransmembrane O X
PTP O X
expressed O X
primarily O X
in O X
hematopoietic O X
cells O X
, O X
including O X
T O X
cells O X
. O X

We O X
have O X
found O X
that O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
is O X
basally O X
phosphorylated O X
on O X
serine O X
in O X
resting O X
T O X
cells O X
. O X

Upon O X
stimulation O X
of O X
CD4 I-MISC 12504
or O X
CD8 O X
either O X
in O X
a O X
T O X
- O X
cell O X
hybridoma O X
cell O X
line O X
or O X
in O X
primary O X
thymocytes O X
, O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
becomes O X
tyrosyl O X
phosphorylated O X
. O X

Moreover O X
, O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
is O X
constitutively O X
phosphorylated O X
on O X
tyrosine O X
in O X
the O X
Lck I-MISC 3932
- O X
overexpressing O X
lymphoma O X
cell O X
line O X
LSTRA O X
. O X

SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
is O X
also O X
a O X
good O X
substrate O X
for O X
recombinant O X
Lck I-MISC 3932
in O X
vitro O X
. O X

Comparisons O X
of O X
the O X
tryptic O X
phosphopeptide O X
maps O X
of O X
wild O X
- O X
type O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
and O X
deletion O X
and O X
point O X
mutations O X
establish O X
that O X
the O X
two O X
sites O X
( O X
Y O X
- O X
536 O X
and O X
Y O X
- O X
564 O X
) O X
which O X
are O X
directly O X
phosphorylated O X
by O X
Lck I-MISC 3932
in O X
vitro O X
are O X
also O X
phosphorylated O X
in O X
vivo O X
in O X
LSTRA O X
cells O X
. O X

One O X
of O X
these O X
sites O X
( O X
Y O X
- O X
564 O X
) O X
is O X
phosphorylated O X
in O X
T O X
cells O X
in O X
response O X
to O X
Lck I-MISC 3932
activation O X
. O X

We O X
conclude O X
that O X
SH I-MISC 5777
- I-MISC 5777
PTP1 I-MISC 5777
undergoes O X
Lck I-MISC 3932
- O X
dependent O X
tyrosyl O X
phosphorylation O X
in O X
T O X
cells O X
and O X
likely O X
plays O X
a O X
role O X
in O X
early O X
T O X
- O X
cell O X
signaling O X
. O X

###14669021	37687,43327

A O X
proposed O X
role O X
for O X
the O X
Polycomb O X
group O X
protein O X
dRING I-MISC 43327
in O X
meiotic O X
sister O X
- O X
chromatid O X
cohesion O X
. O X

ORD I-MISC 37687
protein O X
is O X
required O X
for O X
accurate O X
chromosome O X
segregation O X
during O X
male O X
and O X
female O X
meiosis O X
in O X
Drosophila O X
melanogaster O X
. O X

Null O X
ord I-MISC 37687
mutations O X
result O X
in O X
random O X
segregation O X
of O X
sister O X
chromatids O X
during O X
both O X
meiotic O X
divisions O X
because O X
cohesion O X
is O X
completely O X
abolished O X
prior O X
to O X
kinetochore O X
capture O X
of O X
microtubules O X
during O X
meiosis O X
I O X
. O X

Previous O X
analyses O X
of O X
mutant O X
ord I-MISC 37687
alleles O X
have O X
led O X
us O X
to O X
propose O X
that O X
the O X
C O X
- O X
terminal O X
half O X
of O X
the O X
ORD I-MISC 37687
protein O X
mediates O X
protein O X
- O X
protein O X
interactions O X
that O X
are O X
essential O X
for O X
sister O X
- O X
chromatid O X
cohesion O X
. O X

To O X
identify O X
proteins O X
that O X
interact O X
with O X
ORD I-MISC 37687
, O X
we O X
conducted O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
using O X
an O X
ORD I-MISC 37687
bait O X
and O X
isolated O X
dRING I-MISC 43327
, O X
a O X
core O X
subunit O X
of O X
the O X
Drosophila O X
Polycomb O X
repressive O X
complex O X
1 O X
. O X

We O X
show O X
that O X
a O X
missense O X
mutation O X
in O X
ORD I-MISC 37687
completely O X
ablates O X
the O X
two O X
- O X
hybrid O X
interaction O X
with O X
dRING I-MISC 43327
and O X
prevents O X
nuclear O X
retention O X
of O X
the O X
mutant O X
ORD I-MISC 37687
protein O X
in O X
male O X
meiotic O X
cells O X
. O X

Using O X
affinity O X
- O X
purified O X
antibodies O X
generated O X
against O X
full O X
- O X
length O X
recombinant O X
dRING I-MISC 43327
, O X
we O X
demonstrate O X
that O X
dRING I-MISC 43327
protein O X
is O X
expressed O X
in O X
the O X
male O X
and O X
female O X
gonads O X
and O X
colocalizes O X
extensively O X
with O X
ORD I-MISC 37687
on O X
the O X
chromatin O X
of O X
primary O X
spermatocytes O X
during O X
G2 O X
of O X
meiosis O X
. O X

Our O X
results O X
suggest O X
a O X
novel O X
role O X
for O X
the O X
Polycomb O X
group O X
protein O X
dRING I-MISC 43327
and O X
are O X
consistent O X
with O X
the O X
model O X
that O X
interaction O X
of O X
dRING I-MISC 43327
and O X
ORD I-MISC 37687
is O X
required O X
to O X
promote O X
the O X
proper O X
segregation O X
of O X
meiotic O X
chromosomes O X
. O X

###11069292	837479,816394

Phytochrome I-MISC 816394
B I-MISC 816394
binds O X
with O X
greater O X
apparent O X
affinity O X
than O X
phytochrome O X
A O X
to O X
the O X
basic O X
helix O X
- O X
loop O X
- O X
helix O X
factor O X
PIF3 I-MISC 837479
in O X
a O X
reaction O X
requiring O X
the O X
PAS O X
domain O X
of O X
PIF3 I-MISC 837479
. O X

The O X
signaling O X
pathways O X
by O X
which O X
the O X
phytochrome O X
( O X
phy O X
) O X
family O X
of O X
photoreceptors O X
transmits O X
sensory O X
information O X
to O X
light O X
- O X
regulated O X
genes O X
remain O X
to O X
be O X
fully O X
defined O X
. O X

Evidence O X
for O X
a O X
relatively O X
direct O X
pathway O X
has O X
been O X
provided O X
by O X
the O X
binding O X
of O X
one O X
member O X
of O X
the O X
family O X
, O X
phyB I-MISC 816394
, O X
to O X
a O X
promoter O X
- O X
element O X
- O X
bound O X
, O X
basic O X
helix O X
- O X
loop O X
- O X
helix O X
protein O X
, O X
PIF3 I-MISC 837479
, O X
specifically O X
upon O X
light O X
- O X
induced O X
conversion O X
of O X
the O X
photoreceptor O X
molecule O X
to O X
its O X
biologically O X
active O X
conformer O X
( O X
Pfr O X
). O X

Here O X
, O X
we O X
show O X
that O X
phyA O X
also O X
binds O X
selectively O X
and O X
reversibly O X
to O X
PIF3 I-MISC 837479
upon O X
photoconversion O X
to O X
Pfr O X
, O X
but O X
that O X
the O X
apparent O X
affinity O X
of O X
PIF3 I-MISC 837479
for O X
phyA O X
is O X
10 O X
- O X
fold O X
lower O X
than O X
for O X
phyB I-MISC 816394
. O X

This O X
result O X
is O X
consistent O X
with O X
previous O X
in O X
vivo O X
data O X
from O X
PIF3 I-MISC 837479
- O X
deficient O X
Arabidopsis O X
, O X
indicating O X
that O X
PIF3 I-MISC 837479
has O X
a O X
major O X
role O X
in O X
phyB I-MISC 816394
signaling O X
, O X
but O X
a O X
more O X
minor O X
role O X
in O X
phyA O X
signaling O X
. O X

We O X
also O X
show O X
that O X
phyB I-MISC 816394
binds O X
stoichiometrically O X
to O X
PIF3 I-MISC 837479
at O X
an O X
equimolar O X
ratio O X
, O X
suggesting O X
that O X
the O X
resultant O X
complex O X
is O X
the O X
unit O X
active O X
in O X
transcriptional O X
regulation O X
at O X
target O X
promoters O X
. O X

Deletion O X
mapping O X
suggests O X
that O X
a O X
37 O X
- O X
aa O X
segment O X
present O X
at O X
the O X
N O X
terminus O X
of O X
phyB I-MISC 816394
, O X
but O X
absent O X
from O X
phyA O X
, O X
contributes O X
strongly O X
to O X
the O X
high O X
binding O X
affinity O X
of O X
phyB I-MISC 816394
for O X
PIF3 I-MISC 837479
. O X

Conversely O X
, O X
deletion O X
mapping O X
and O X
point O X
mutation O X
analysis O X
of O X
PIF3 I-MISC 837479
for O X
determinants O X
involved O X
in O X
recognition O X
of O X
phyB I-MISC 816394
indicates O X
that O X
the O X
PAS O X
domain O X
of O X
PIF3 I-MISC 837479
is O X
a O X
major O X
contributor O X
to O X
this O X
interaction O X
, O X
but O X
that O X
a O X
second O X
determinant O X
in O X
the O X
C O X
- O X
terminal O X
domain O X
is O X
also O X
necessary O X
. O X

###22854040	10133,79735

Optineurin I-MISC 10133
mediates O X
a O X
negative O X
regulation O X
of O X
Rab8 I-MISC 4218
by O X
the O X
GTPase O X
- O X
activating O X
protein O X
TBC1D17 I-MISC 79735
. O X

Rab I-MISC 4218
GTPases O X
regulate O X
various O X
membrane O X
trafficking O X
pathways O X
but O X
the O X
mechanisms O X
by O X
which O X
GTPase O X
- O X
activating O X
proteins O X
recognise O X
specific O X
Rabs O X
are O X
not O X
clear O X
. O X

Rab8 I-MISC 4218
is O X
involved O X
in O X
controlling O X
several O X
trafficking O X
processes O X
, O X
including O X
the O X
trafficking O X
of O X
transferrin I-MISC 7018
receptor O X
from O X
the O X
early O X
endosome O X
to O X
the O X
recycling O X
endosome O X
. O X

Here O X
, O X
we O X
provide O X
evidence O X
to O X
show O X
that O X
TBC1D17 I-MISC 79735
, O X
a O X
Rab I-MISC 4218
GTPase O X
- O X
activating O X
protein O X
, O X
through O X
its O X
catalytic O X
activity O X
, O X
regulates O X
Rab8 I-MISC 4218
- O X
mediated O X
endocytic O X
trafficking O X
of O X
transferrin I-MISC 7018
receptor O X
. O X

Optineurin I-MISC 10133
, O X
a O X
Rab8 I-MISC 4218
- O X
binding O X
effector O X
protein O X
, O X
mediates O X
the O X
interaction O X
and O X
colocalisation O X
of O X
TBC1D17 I-MISC 79735
with O X
Rab8 I-MISC 4218
. O X

A O X
non O X
- O X
catalytic O X
region O X
of O X
TBC1D17 I-MISC 79735
is O X
required O X
for O X
direct O X
interaction O X
with O X
optineurin I-MISC 10133
. O X

Co O X
- O X
expression O X
of O X
Rab8 I-MISC 4218
, O X
but O X
not O X
other O X
Rabs O X
tested O X
, O X
rescues O X
the O X
inhibition O X
of O X
transferrin I-MISC 7018
receptor O X
trafficking O X
by O X
TBC1D17 I-MISC 79735
. O X

The O X
activated O X
GTP O X
- O X
bound O X
form O X
of O X
Rab8 I-MISC 4218
is O X
localised O X
to O X
the O X
tubules O X
emanating O X
from O X
the O X
endocytic O X
recycling O X
compartment O X
. O X

Through O X
its O X
catalytic O X
activity O X
, O X
TBC1D17 I-MISC 79735
inhibits O X
recruitment O X
of O X
Rab8 I-MISC 4218
to O X
the O X
tubules O X
and O X
reduces O X
colocalisation O X
of O X
transferrin I-MISC 7037
receptor I-MISC 7037
and O X
Rab8 I-MISC 4218
. O X

Knockdown O X
of O X
optineurin I-MISC 10133
or O X
TBC1D17 I-MISC 79735
results O X
in O X
enhanced O X
recruitment O X
of O X
Rab8 I-MISC 4218
to O X
the O X
tubules O X
. O X

A O X
glaucoma O X
- O X
associated O X
mutant O X
of O X
optineurin I-MISC 10133
, O X
E50K O X
, O X
causes O X
enhanced O X
inhibition O X
of O X
Rab8 I-MISC 4218
by O X
TBC1D17 I-MISC 79735
, O X
resulting O X
in O X
defective O X
endocytic O X
recycling O X
of O X
transferrin I-MISC 7018
receptor O X
. O X

Our O X
results O X
show O X
that O X
TBC1D17 I-MISC 79735
, O X
through O X
its O X
interaction O X
with O X
optineurin I-MISC 10133
, O X
regulates O X
Rab8 I-MISC 4218
- O X
mediated O X
endocytic O X
recycling O X
of O X
transferrin I-MISC 7018
receptor O X
and O X
recruitment O X
of O X
Rab8 I-MISC 4218
to O X
the O X
endocytic O X
recycling O X
tubules O X
. O X

We O X
describe O X
a O X
mechanism O X
of O X
regulating O X
a O X
Rab I-MISC 4218
GTPase O X
by O X
an O X
effector O X
protein O X
( O X
optineurin I-MISC 10133
) O X
that O X
acts O X
as O X
an O X
adaptor O X
to O X
bring O X
together O X
a O X
Rab I-MISC 4218
( O X
Rab8 I-MISC 4218
) O X
and O X
its O X
GTPase O X
- O X
activating O X
protein O X
( O X
TBC1D17 I-MISC 79735
). O X

###9047334	50671,50671

Mapping O X
of O X
functional O X
interactions O X
between O X
domains O X
of O X
the O X
animal O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
by O X
mutant O X
complementation O X
in O X
vitro O X
. O X

Polypeptides O X
of O X
the O X
animal O X
fatty I-MISC 50671
acid I-MISC 50671
synthase I-MISC 50671
( O X
FAS I-MISC 50671
) O X
consist O X
of O X
three O X
amino O X
- O X
terminal O X
catalytic O X
domains O X
, O X
beta I-MISC 54995
- I-MISC 54995
ketoacyl I-MISC 54995
synthase I-MISC 54995
, O X
malonyl O X
/ O X
acetyltransacylase O X
, O X
and O X
dehydrase O X
, O X
separated O X
by O X
a O X
600 O X
- O X
residue O X
structural O X
core O X
from O X
four O X
carboxyl O X
- O X
terminal O X
catalytic O X
domains O X
, O X
enoyl O X
reductase O X
, O X
beta O X
- O X
ketoacyl O X
reductase O X
, O X
acyl O X
carrier O X
protein O X
, O X
and O X
thioesterase O X
. O X

In O X
the O X
active O X
dimeric O X
form O X
of O X
the O X
protein O X
the O X
two O X
identical O X
multifunctional O X
polypeptides O X
are O X
oriented O X
head O X
- O X
to O X
- O X
tail O X
such O X
that O X
two O X
sites O X
for O X
palmitate O X
synthesis O X
are O X
formed O X
at O X
the O X
subunit O X
interface O X
. O X

In O X
order O X
to O X
map O X
the O X
functional O X
interactions O X
between O X
domains O X
of O X
the O X
two O X
subunits O X
that O X
contribute O X
to O X
the O X
two O X
sites O X
of O X
synthesis O X
, O X
we O X
have O X
utilized O X
a O X
strategy O X
based O X
on O X
complementation O X
analysis O X
in O X
vitro O X
of O X
modified O X
FASs O X
carrying O X
mutations O X
in O X
specific O X
catalytic O X
domains O X
. O X

Homodimeric O X
mutant O X
FASs O X
lacking O X
functional O X
beta I-MISC 54995
- I-MISC 54995
ketoacyl I-MISC 54995
synthase I-MISC 54995
( O X
KS O X
-), O X
dehydrase O X
( O X
DH O X
-), O X
acyl O X
carrier O X
protein O X
( O X
ACP O X
-), O X
or O X
thioesterase O X
( O X
TE O X
-) O X
domains O X
, O X
as O X
well O X
as O X
heterodimers O X
formed O X
between O X
ACP O X
- O X
and O X
TE O X
- O X
subunits O X
, O X
between O X
ACP O X
- O X
and O X
DH O X
- O X
subunits O X
, O X
and O X
between O X
DH O X
- O X
and O X
TE O X
- O X
subunits O X
, O X
were O X
unable O X
to O X
synthesize O X
fatty O X
acids O X
. O X

However O X
, O X
heterodimers O X
formed O X
between O X
KS O X
- O X
and O X
either O X
DH O X
-, O X
ACP O X
-, O X
or O X
TE O X
- O X
subunits O X
regained O X
partial O X
FAS I-MISC 50671
activity O X
. O X

These O X
data O X
indicate O X
that O X
the O X
dehydrase O X
domain O X
, O X
although O X
located O X
in O X
the O X
amino O X
- O X
terminal O X
half O X
of O X
the O X
polypeptide O X
, O X
should O X
be O X
assigned O X
to O X
the O X
complementation O X
group O X
located O X
in O X
the O X
carboxy O X
- O X
terminal O X
half O X
that O X
includes O X
the O X
acyl O X
carrier O X
protein O X
and O X
thioesterase O X
domains O X
. O X

Thus O X
, O X
the O X
current O X
model O X
for O X
the O X
animal O X
FAS I-MISC 50671
must O X
be O X
revised O X
to O X
reflect O X
the O X
finding O X
that O X
the O X
two O X
constituent O X
polypeptides O X
are O X
not O X
simply O X
positioned O X
side O X
- O X
by O X
- O X
side O X
in O X
a O X
fully O X
extended O X
conformation O X
but O X
are O X
coiled O X
in O X
a O X
manner O X
that O X
allows O X
the O X
dehydrase O X
domain O X
to O X
access O X
the O X
beta O X
- O X
hydroxyacyl O X
- O X
ACP O X
located O X
more O X
than O X
1100 O X
residues O X
distant O X
on O X
the O X
same O X
subunit O X
. O X

###23520446	1956,6790

Protein O X
phosphorylation O X
profiling O X
using O X
an O X
in O X
situ O X
proximity O X
ligation O X
assay O X
: O X
phosphorylation O X
of O X
AURKA I-MISC 6790
- O X
elicited O X
EGFR I-MISC 1956
- O X
Thr654 O X
and O X
EGFR I-MISC 1956
- O X
Ser1046 O X
in O X
lung O X
cancer O X
cells O X
. O X

The O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
), O X
which O X
is O X
up O X
- O X
regulated O X
in O X
lung O X
cancer O X
, O X
involves O X
the O X
activation O X
of O X
mitogenic O X
signals O X
and O X
triggers O X
multiple O X
signaling O X
cascades O X
. O X

To O X
dissect O X
these O X
EGFR I-MISC 1956
cascades O X
, O X
we O X
used O X
14 O X
different O X
phospho O X
- O X
EGFR I-MISC 1956
antibodies O X
to O X
quantify O X
protein O X
phosphorylation O X
using O X
an O X
in O X
situ O X
proximity O X
ligation O X
assay O X
( O X
in O X
situ O X
PLA O X
). O X

Phosphorylation O X
at O X
EGFR I-MISC 1956
- O X
Thr654 O X
and O X
- O X
Ser1046 O X
was O X
EGF O X
- O X
dependent O X
in O X
the O X
wild O X
- O X
type O X
( O X
WT O X
) O X
receptor O X
but O X
EGF O X
- O X
independent O X
in O X
a O X
cell O X
line O X
carrying O X
the O X
EGFR I-MISC 1956
- O X
L858R O X
mutation O X
. O X

Using O X
a O X
ProtoAarray O X
containing O X
5000 O X
recombinant O X
proteins O X
on O X
the O X
protein O X
chip O X
, O X
we O X
found O X
that O X
AURKA I-MISC 6790
interacted O X
with O X
the O X
EGFR I-MISC 1956
- O X
L861Q O X
mutant O X
. O X

Moreover O X
, O X
overexpression O X
of O X
EGFR I-MISC 1956
could O X
form O X
a O X
complex O X
with O X
AURKA I-MISC 6790
, O X
and O X
the O X
inhibitors O X
of O X
AURKA I-MISC 6790
and O X
EGFR I-MISC 1956
decreased O X
EGFR I-MISC 1956
- O X
Thr654 O X
and O X
- O X
Ser1046 O X
phosphorylation O X
. O X

Immunohistochemical O X
staining O X
of O X
stage O X
I O X
lung O X
adenocarcinoma O X
tissues O X
demonstrated O X
a O X
positive O X
correlation O X
between O X
AURKA I-MISC 6790
expression O X
and O X
phosphorylation O X
of O X
EGFR I-MISC 1956
at O X
Thr654 O X
and O X
Ser1046 O X
in O X
EGFR I-MISC 1956
- O X
mutant O X
specimens O X
, O X
but O X
not O X
in O X
EGFR I-MISC 1956
- O X
WT O X
specimens O X
. O X

The O X
interplay O X
between O X
EGFR I-MISC 1956
and O X
AURKA I-MISC 6790
provides O X
an O X
explanation O X
for O X
the O X
difference O X
in O X
EGF O X
dependency O X
between O X
EGFR I-MISC 1956
- O X
WT O X
and O X
EGFR I-MISC 1956
- O X
mutant O X
cells O X
and O X
may O X
provide O X
a O X
new O X
therapeutic O X
strategy O X
for O X
lung O X
cancer O X
patients O X
carrying O X
EGFR I-MISC 1956
mutations O X
. O X

###17721446	851803,851811

Rad9 I-MISC 851803
BRCT O X
domain O X
interaction O X
with O X
phosphorylated O X
H2AX O X
regulates O X
the O X
G1 O X
checkpoint O X
in O X
budding O X
yeast O X
. O X

Phosphorylation O X
of O X
histone O X
H2A I-MISC 851811
or O X
H2AX O X
is O X
an O X
early O X
and O X
sensitive O X
marker O X
of O X
DNA O X
damage O X
in O X
eukaryotic O X
cells O X
, O X
although O X
mutation O X
of O X
the O X
conserved O X
damage O X
- O X
dependent O X
phosphorylation O X
site O X
is O X
well O X
tolerated O X
. O X

Here O X
, O X
we O X
show O X
that O X
H2A I-MISC 851811
phosphorylation O X
is O X
required O X
for O X
cell O X
- O X
cycle O X
arrest O X
in O X
response O X
to O X
DNA O X
damage O X
at O X
the O X
G1 O X
/ O X
S O X
transition O X
in O X
budding O X
yeast O X
. O X

Furthermore O X
, O X
we O X
show O X
that O X
the O X
tandem O X
BRCT O X
domain O X
of O X
Rad9 I-MISC 851803
interacts O X
directly O X
with O X
phosphorylated O X
H2A I-MISC 851811
in O X
vitro O X
and O X
that O X
a O X
rad9 I-MISC 851803
point O X
mutation O X
that O X
abolishes O X
this O X
interaction O X
results O X
in O X
in O X
vivo O X
phenotypes O X
that O X
are O X
similar O X
to O X
those O X
caused O X
by O X
an O X
H2A I-MISC 851811
phosphorylation O X
site O X
mutation O X
. O X

Remarkably O X
, O X
similar O X
checkpoint O X
defects O X
are O X
also O X
caused O X
by O X
a O X
Rad9 I-MISC 851803
Tudor O X
domain O X
mutation O X
that O X
impairs O X
Rad9 I-MISC 851803
chromatin O X
association O X
already O X
in O X
undamaged O X
cells O X
. O X

These O X
findings O X
indicate O X
that O X
constitutive O X
Tudor O X
domain O X
- O X
mediated O X
and O X
damage O X
- O X
specific O X
BRCT O X
domain O X
- O X
phospho O X
- O X
H2A I-MISC 851811
- O X
dependent O X
interactions O X
of O X
Rad9 I-MISC 851803
with O X
chromatin O X
cooperate O X
to O X
establish O X
G1 O X
checkpoint O X
arrest O X
. O X

###19933576	77053,23224	4000,77053

Mammalian O X
SUN O X
protein O X
interaction O X
networks O X
at O X
the O X
inner O X
nuclear O X
membrane O X
and O X
their O X
role O X
in O X
laminopathy O X
disease O X
processes O X
. O X

The O X
nuclear O X
envelope O X
( O X
NE O X
) O X
LINC O X
complex O X
, O X
in O X
mammals O X
comprised O X
of O X
SUN O X
domain O X
and O X
nesprin O X
proteins O X
, O X
provides O X
a O X
direct O X
connection O X
between O X
the O X
nuclear O X
lamina O X
and O X
the O X
cytoskeleton O X
, O X
which O X
contributes O X
to O X
nuclear O X
positioning O X
and O X
cellular O X
rigidity O X
. O X

SUN1 I-MISC 77053
and O X
SUN2 I-MISC 25777
interact O X
with O X
lamin I-MISC 4000
A O X
, O X
but O X
lamin I-MISC 4000
A O X
is O X
only O X
required O X
for O X
NE O X
localization O X
of O X
SUN2 I-MISC 25777
, O X
and O X
it O X
remains O X
unclear O X
how O X
SUN1 I-MISC 77053
is O X
anchored O X
. O X

Here O X
, O X
we O X
identify O X
emerin I-MISC 2010
and O X
short O X
nesprin I-MISC 23224
- I-MISC 23224
2 I-MISC 23224
isoforms O X
as O X
novel O X
nucleoplasmic O X
binding O X
partners O X
of O X
SUN1 I-MISC 77053
/ I-MISC 77053
2 I-MISC 77053
. O X

These O X
have O X
overlapping O X
binding O X
sites O X
distinct O X
from O X
the O X
lamin I-MISC 4000
A O X
binding O X
site O X
. O X

However O X
, O X
we O X
demonstrate O X
that O X
tight O X
association O X
of O X
SUN1 I-MISC 77053
with O X
the O X
nuclear O X
lamina O X
depends O X
upon O X
a O X
short O X
motif O X
within O X
residues O X
209 O X
- O X
228 O X
, O X
a O X
region O X
that O X
does O X
not O X
interact O X
significantly O X
with O X
known O X
SUN1 I-MISC 77053
binding O X
partners O X
. O X

Moreover O X
, O X
SUN1 I-MISC 77053
localizes O X
correctly O X
in O X
cells O X
lacking O X
emerin I-MISC 2010
. O X

Importantly O X
then O X
, O X
the O X
major O X
determinant O X
of O X
SUN1 I-MISC 77053
NE O X
localization O X
has O X
yet O X
to O X
be O X
identified O X
. O X

We O X
further O X
find O X
that O X
a O X
subset O X
of O X
lamin I-MISC 4000
A O X
mutations O X
, O X
associated O X
with O X
laminopathies O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
( O X
EDMD O X
) O X
and O X
Hutchinson O X
- O X
Gilford O X
progeria O X
syndrome O X
( O X
HGPS I-MISC 4000
), O X
disrupt O X
lamin I-MISC 4000
A O X
interaction O X
with O X
SUN1 I-MISC 77053
and O X
SUN2 I-MISC 25777
. O X

Despite O X
this O X
, O X
NE O X
localization O X
of O X
SUN1 I-MISC 77053
and O X
SUN2 I-MISC 25777
is O X
not O X
impaired O X
in O X
cell O X
lines O X
from O X
either O X
class O X
of O X
patients O X
. O X

Intriguingly O X
, O X
SUN1 I-MISC 77053
expression O X
at O X
the O X
NE O X
is O X
instead O X
enhanced O X
in O X
a O X
significant O X
proportion O X
of O X
HGPS I-MISC 4000
but O X
not O X
EDMD O X
cells O X
and O X
strongly O X
correlates O X
with O X
pre O X
- O X
lamin I-MISC 4000
A O X
accumulation O X
due O X
to O X
preferential O X
interaction O X
of O X
SUN1 I-MISC 77053
with O X
pre O X
- O X
lamin I-MISC 4000
A O X
. O X

We O X
propose O X
that O X
these O X
different O X
perturbations O X
in O X
lamin I-MISC 4000
A O X
- O X
SUN O X
protein O X
interactions O X
may O X
underlie O X
the O X
opposing O X
effects O X
of O X
EDMD O X
and O X
HGPS I-MISC 4000
mutations O X
on O X
nuclear O X
and O X
cellular O X
mechanics O X
. O X

###10336672	25252,24409	24409,29495

Differential O X
interaction O X
of O X
the O X
tSXV O X
motifs O X
of O X
the O X
NR1 I-MISC 24408
and O X
NR2A I-MISC 24409
NMDA O X
receptor O X
subunits O X
with O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
. O X

The O X
NR1 I-MISC 24408
and O X
NR2 O X
subunits O X
of O X
the O X
N O X
- O X
methyl O X
- O X
D O X
- O X
aspartate O X
( O X
NMDA O X
) O X
receptor O X
are O X
encoded O X
by O X
distinct O X
genes O X
. O X

In O X
the O X
rat O X
brain O X
, O X
four O X
C O X
- O X
terminal O X
variants O X
of O X
the O X
NR1 I-MISC 24408
subunit O X
( O X
NR1 I-MISC 24408
- O X
1 O X
to O X
NR1 I-MISC 24408
- O X
4 O X
) O X
are O X
encoded O X
by O X
a O X
single O X
gene O X
, O X
and O X
are O X
generated O X
by O X
alternative O X
splicing O X
of O X
the O X
C1 O X
and O X
C2 O X
exon O X
cassettes O X
, O X
while O X
four O X
different O X
genes O X
encode O X
the O X
NR2 O X
subunits O X
( O X
NR2 O X
A O X
- O X
D O X
). O X

Functional O X
NMDA O X
receptors O X
result O X
from O X
the O X
heteromultimeric O X
assembly O X
of O X
NR1 I-MISC 24408
variants O X
with O X
distinct O X
NR2 O X
subunits O X
. O X

The O X
NR2B I-MISC 24410
subunit O X
interacts O X
with O X
post I-MISC 29495
- I-MISC 29495
synaptic I-MISC 29495
density I-MISC 29495
protein I-MISC 29495
95 I-MISC 29495
( O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
), O X
SAP97 I-MISC 25252
and O X
members O X
of O X
the O X
membrane O X
- O X
associated O X
guanylate O X
- O X
like O X
kinase O X
( O X
MAGUK O X
) O X
family O X
of O X
proteins O X
. O X

This O X
interaction O X
occurs O X
through O X
the O X
binding O X
of O X
the O X
C O X
- O X
terminal O X
tSXV O X
intracellular O X
motif O X
of O X
the O X
NR2B I-MISC 24410
subunit O X
to O X
the O X
N O X
- O X
terminal O X
PDZ O X
( O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
, O X
discs O X
- O X
large O X
, O X
ZO O X
- O X
1 O X
) O X
domains O X
of O X
the O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
proteins O X
. O X

Both O X
NR1 I-MISC 24408
- O X
3 O X
and O X
NR1 I-MISC 24408
- O X
4 O X
also O X
display O X
a O X
consensus O X
C O X
- O X
terminal O X
tSXV O X
motif O X
. O X

Using O X
the O X
two O X
- O X
hybrid O X
genetic O X
system O X
in O X
yeast O X
and O X
site O X
- O X
directed O X
mutagenesis O X
, O X
we O X
compared O X
the O X
binding O X
of O X
the O X
NR2A I-MISC 24409
, O X
NR1 I-MISC 24408
- O X
3 O X
and O X
NR1 I-MISC 24408
- O X
4 O X
tSXV O X
motifs O X
with O X
the O X
PDZ O X
domains O X
of O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
. O X

The O X
main O X
conclusions O X
of O X
the O X
present O X
report O X
are O X
that O X
: O X
( O X
i O X
) O X
while O X
NR2A I-MISC 24409
displays O X
a O X
strong O X
interaction O X
with O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
, O X
the O X
NR1 I-MISC 24408
- O X
3 O X
and O X
NR1 I-MISC 24408
- O X
4 O X
NMDA O X
receptor O X
subunits O X
do O X
not O X
display O X
any O X
interaction O X
despite O X
the O X
presence O X
of O X
tSXV O X
motifs O X
; O X
( O X
ii O X
) O X
the O X
C O X
- O X
terminal O X
tSXV O X
motif O X
of O X
the O X
NR2A I-MISC 24409
subunit O X
is O X
mandatory O X
but O X
not O X
sufficient O X
for O X
efficient O X
interaction O X
with O X
the O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
proteins O X
; O X
( O X
iii O X
) O X
as O X
yet O X
unidentified O X
upstream O X
sequences O X
of O X
the O X
receptor O X
subunits O X
determine O X
whether O X
the O X
tSXV O X
motifs O X
will O X
bind O X
to O X
the O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
and O X
SAP97 I-MISC 25252
PDZ O X
domains O X
; O X
( O X
iv O X
) O X
different O X
tSXV O X
motifs O X
elicit O X
interactions O X
of O X
variable O X
strengths O X
; O X
and O X
( O X
v O X
) O X
residues O X
in O X
positions O X
- O X
3 O X
and O X
- O X
4 O X
modulate O X
the O X
binding O X
affinity O X
of O X
the O X
C O X
- O X
terminal O X
tSXV O X
motifs O X
. O X

Using O X
immunohistochemistry O X
, O X
we O X
also O X
compared O X
the O X
distribution O X
of O X
the O X
PSD I-MISC 29495
- I-MISC 29495
95 I-MISC 29495
, O X
NR2A I-MISC 24409
and O X
SAP97 I-MISC 25252
proteins O X
in O X
adult O X
rat O X
brain O X
, O X
and O X
we O X
show O X
that O X
in O X
the O X
cortex O X
, O X
hippocampus O X
and O X
cerebellum O X
, O X
there O X
is O X
evidence O X
for O X
colocalization O X
of O X
these O X
proteins O X
. O X

###10880439	801,3756

Inhibition O X
of O X
human O X
ether O X
go O X
- O X
go O X
potassium O X
channels O X
by O X
Ca O X
( O X
2 O X
+)/ O X
calmodulin I-MISC 801
. O X

Intracellular O X
Ca O X
( O X
2 O X
+) O X
inhibits O X
voltage O X
- O X
gated O X
potassium O X
channels O X
of O X
the O X
ether O X
go O X
- O X
go O X
( O X
EAG O X
) O X
family O X
. O X

To O X
identify O X
the O X
underlying O X
molecular O X
mechanism O X
, O X
we O X
expressed O X
the O X
human O X
version O X
hEAG1 I-MISC 3756
in O X
Xenopus O X
oocytes O X
. O X

The O X
channels O X
lost O X
Ca O X
( O X
2 O X
+) O X
sensitivity O X
when O X
measured O X
in O X
cell O X
- O X
free O X
membrane O X
patches O X
. O X

However O X
, O X
Ca O X
( O X
2 O X
+) O X
sensitivity O X
could O X
be O X
restored O X
by O X
application O X
of O X
recombinant O X
calmodulin I-MISC 801
( O X
CaM I-MISC 801
). O X

In O X
the O X
presence O X
of O X
CaM I-MISC 801
, O X
half O X
inhibition O X
of O X
hEAG1 I-MISC 3756
channels O X
was O X
obtained O X
in O X
100 O X
nM O X
Ca O X
( O X
2 O X
+). O X

Overlay O X
assays O X
using O X
labelled O X
CaM I-MISC 801
and O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
( O X
GST O X
) O X
fusion O X
fragments O X
of O X
hEAG1 I-MISC 3756
demonstrated O X
direct O X
binding O X
of O X
CaM I-MISC 801
to O X
a O X
C O X
- O X
terminal O X
domain O X
( O X
hEAG1 I-MISC 3756
amino O X
acids O X
673 O X
- O X
770 O X
). O X

Point O X
mutations O X
within O X
this O X
section O X
revealed O X
a O X
novel O X
CaM I-MISC 801
- O X
binding O X
domain O X
putatively O X
forming O X
an O X
amphipathic O X
helix O X
with O X
both O X
sides O X
being O X
important O X
for O X
binding O X
. O X

The O X
binding O X
of O X
CaM I-MISC 801
to O X
hEAG1 I-MISC 3756
is O X
, O X
in O X
contrast O X
to O X
Ca O X
( O X
2 O X
+)- O X
activated O X
potassium O X
channels O X
, O X
Ca O X
( O X
2 O X
+) O X
dependent O X
, O X
with O X
an O X
apparent O X
K O X
( O X
D O X
) O X
of O X
480 O X
nM O X
. O X

Co O X
- O X
expression O X
experiments O X
of O X
wild O X
- O X
type O X
and O X
mutant O X
channels O X
revealed O X
that O X
the O X
binding O X
of O X
one O X
CaM I-MISC 801
molecule O X
per O X
channel O X
complex O X
is O X
sufficient O X
for O X
channel O X
inhibition O X
. O X

###10704439	854191,853439

MAD3 I-MISC 853439
encodes O X
a O X
novel O X
component O X
of O X
the O X
spindle O X
checkpoint O X
which O X
interacts O X
with O X
Bub3p I-MISC 854191
, O X
Cdc20p I-MISC 852762
, O X
and O X
Mad2p I-MISC 853422
. O X

We O X
show O X
that O X
MAD3 I-MISC 853439
encodes O X
a O X
novel O X
58 O X
- O X
kD O X
nuclear O X
protein O X
which O X
is O X
not O X
essential O X
for O X
viability O X
, O X
but O X
is O X
an O X
integral O X
component O X
of O X
the O X
spindle O X
checkpoint O X
in O X
budding O X
yeast O X
. O X

Sequence O X
analysis O X
reveals O X
two O X
regions O X
of O X
Mad3p I-MISC 853439
that O X
are O X
46 O X
and O X
47 O X
% O X
identical O X
to O X
sequences O X
in O X
the O X
NH O X
( O X
2 O X
)- O X
terminal O X
region O X
of O X
the O X
budding O X
yeast O X
Bub1 I-MISC 853100
protein O X
kinase O X
. O X

Bub1p I-MISC 853100
is O X
known O X
to O X
bind O X
Bub3p I-MISC 854191
( O X
Roberts O X
et O X
al O X
. O X

1994 O X
) O X
and O X
we O X
use O X
two O X
- O X
hybrid O X
assays O X
and O X
coimmunoprecipitation O X
experiments O X
to O X
show O X
that O X
Mad3p I-MISC 853439
can O X
also O X
bind O X
to O X
Bub3p I-MISC 854191
. O X

In O X
addition O X
, O X
we O X
find O X
that O X
Mad3p I-MISC 853439
interacts O X
with O X
Mad2p I-MISC 853422
and O X
the O X
cell O X
cycle O X
regulator O X
Cdc20p I-MISC 852762
. O X

We O X
show O X
that O X
the O X
two O X
regions O X
of O X
homology O X
between O X
Mad3p I-MISC 853439
and O X
Bub1p I-MISC 853100
are O X
crucial O X
for O X
these O X
interactions O X
and O X
identify O X
loss O X
of O X
function O X
mutations O X
within O X
each O X
domain O X
of O X
Mad3p I-MISC 853439
. O X

We O X
discuss O X
roles O X
for O X
Mad3p I-MISC 853439
and O X
its O X
interactions O X
with O X
other O X
spindle O X
checkpoint O X
proteins O X
and O X
with O X
Cdc20p I-MISC 852762
, O X
the O X
target O X
of O X
the O X
checkpoint O X
. O X

###11454208	854158,856366

The O X
negative O X
regulator O X
Opi1 I-MISC 856366
of O X
phospholipid O X
biosynthesis O X
in O X
yeast O X
contacts O X
the O X
pleiotropic O X
repressor O X
Sin3 I-MISC 854158
and O X
the O X
transcriptional O X
activator O X
Ino2 I-MISC 851701
. O X

Structural O X
genes O X
of O X
phospholipid O X
biosynthesis O X
in O X
the O X
yeast O X
Saccharomyces O X
cerevisiae O X
are O X
transcriptionally O X
co O X
- O X
regulated O X
by O X
ICRE O X
( O X
inositol O X
/ O X
choline O X
- O X
responsive O X
element O X
) O X
promoter O X
motifs O X
. O X

Gene O X
activation O X
by O X
an O X
ICRE O X
is O X
mediated O X
by O X
binding O X
of O X
the O X
Ino2 I-MISC 851701
/ O X
Ino4 I-MISC 854042
transcription O X
factor O X
, O X
whereas O X
repression O X
in O X
the O X
presence O X
of O X
high O X
concentrations O X
of O X
inositol O X
and O X
choline O X
( O X
IC O X
) O X
requires O X
an O X
intact O X
Opi1 I-MISC 856366
repressor O X
. O X

However O X
, O X
the O X
mechanism O X
of O X
specific O X
repression O X
and O X
the O X
functional O X
interplay O X
among O X
these O X
regulators O X
remained O X
unclear O X
from O X
previous O X
work O X
. O X

Using O X
in O X
vivo O X
as O X
well O X
as O X
in O X
vitro O X
interaction O X
assays O X
, O X
we O X
show O X
binding O X
of O X
the O X
pleiotropic O X
repressor O X
Sin3 I-MISC 854158
to O X
the O X
pathway O X
- O X
specific O X
regulator O X
Opi1 I-MISC 856366
. O X

The O X
paired O X
amphipathic O X
helix O X
1 O X
( O X
PAH1 O X
) O X
within O X
Sin3 I-MISC 854158
and O X
OSID O X
( O X
Opi1 I-MISC 856366
- O X
Sin3 I-MISC 854158
interaction O X
domain O X
) O X
in O X
the O X
N O X
- O X
terminus O X
of O X
Opi1 I-MISC 856366
were O X
mapped O X
as O X
contact O X
sites O X
. O X

The O X
regulatory O X
significance O X
of O X
the O X
Opi1 I-MISC 856366
- O X
Sin3 I-MISC 854158
interaction O X
was O X
shown O X
by O X
the O X
obvious O X
deregulation O X
of O X
an O X
ICRE O X
- O X
dependent O X
reporter O X
gene O X
in O X
a O X
sin3 I-MISC 854158
mutant O X
. O X

Opi1 I-MISC 856366
also O X
interacts O X
with O X
a O X
newly O X
identified O X
functional O X
domain O X
of O X
the O X
transcriptional O X
activator O X
Ino2 I-MISC 851701
( O X
RID O X
, O X
repressor O X
interaction O X
domain O X
). O X

These O X
results O X
define O X
the O X
molecular O X
composition O X
of O X
the O X
transcription O X
complex O X
mediating O X
control O X
of O X
ICRE O X
- O X
dependent O X
genes O X
and O X
allow O X
a O X
hypothesis O X
on O X
the O X
flow O X
of O X
regulatory O X
information O X
in O X
response O X
to O X
phospholipid O X
precursors O X
. O X

###20890284	10870,22914

The O X
structural O X
basis O X
for O X
intramembrane O X
assembly O X
of O X
an O X
activating O X
immunoreceptor O X
complex O X
. O X

Many O X
receptors O X
that O X
activate O X
cells O X
of O X
the O X
immune O X
system O X
are O X
multisubunit O X
membrane O X
protein O X
complexes O X
in O X
which O X
ligand O X
recognition O X
and O X
signaling O X
functions O X
are O X
contributed O X
by O X
separate O X
protein O X
modules O X
. O X

Receptors O X
and O X
signaling O X
subunits O X
assemble O X
through O X
contacts O X
among O X
basic O X
and O X
acidic O X
residues O X
in O X
their O X
transmembrane O X
domains O X
to O X
form O X
the O X
functional O X
complexes O X
. O X

Here O X
we O X
report O X
the O X
nuclear O X
magnetic O X
resonance O X
( O X
NMR O X
) O X
structure O X
of O X
the O X
membrane O X
- O X
embedded O X
, O X
heterotrimeric O X
assembly O X
formed O X
by O X
association O X
of O X
the O X
DAP12 I-MISC 7305
signaling O X
module O X
with O X
the O X
natural O X
killer O X
( O X
NK O X
) O X
cell O X
- O X
activating O X
receptor O X
NKG2C O X
. O X

The O X
main O X
intramembrane O X
contact O X
site O X
is O X
formed O X
by O X
a O X
complex O X
electrostatic O X
network O X
involving O X
five O X
hydrophilic O X
transmembrane O X
residues O X
. O X

Functional O X
mutagenesis O X
demonstrated O X
that O X
similar O X
polar O X
intramembrane O X
motifs O X
are O X
also O X
important O X
for O X
assembly O X
of O X
the O X
NK O X
cell O X
- O X
activating O X
NKG2D I-MISC 22914
- O X
DAP10 I-MISC 10870
complex O X
and O X
the O X
T I-MISC 6962
cell I-MISC 6962
antigen I-MISC 6962
receptor I-MISC 6962
( O X
TCR I-MISC 6962
)- O X
invariant O X
signaling O X
protein O X
CD3 O X
complex O X
. O X

This O X
structural O X
motif O X
therefore O X
lies O X
at O X
the O X
core O X
of O X
the O X
molecular O X
organization O X
of O X
many O X
activating O X
immunoreceptors O X
. O X

###8626665	2958,2958

Transcription O X
factor O X
IIA O X
mutations O X
show O X
activator O X
- O X
specific O X
defects O X
and O X
reveal O X
a O X
IIA O X
function O X
distinct O X
from O X
stimulation O X
of O X
TBP I-MISC 6908
- O X
DNA O X
binding O X
. O X

The O X
general O X
transcription O X
factor O X
IIA O X
( O X
TFIIA I-MISC 2958
) O X
binds O X
to O X
the O X
TATA I-MISC 6908
binding I-MISC 6908
protein I-MISC 6908
( O X
TBP I-MISC 6908
) O X
and O X
mediates O X
transcriptional O X
activation O X
by O X
distinct O X
classes O X
of O X
activators O X
. O X

To O X
elucidate O X
the O X
function O X
of O X
TFIIA I-MISC 2958
in O X
transcriptional O X
activation O X
, O X
point O X
mutants O X
were O X
created O X
in O X
the O X
human O X
TFIIA I-MISC 2958
- I-MISC 2958
gamma I-MISC 2958
subunit O X
at O X
positions O X
conserved O X
with O X
the O X
yeast O X
homologue O X
. O X

We O X
have O X
identified O X
a O X
class O X
of O X
TFIIA I-MISC 2958
mutants O X
that O X
stimulate O X
TBP I-MISC 6908
- O X
DNA O X
binding O X
( O X
T O X
- O X
A O X
complex O X
) O X
but O X
fail O X
to O X
support O X
transcriptional O X
activation O X
by O X
several O X
different O X
activators O X
, O X
suggesting O X
that O X
these O X
mutants O X
are O X
defective O X
in O X
their O X
ability O X
to O X
facilitate O X
an O X
activation O X
step O X
subsequent O X
to O X
TBP I-MISC 6908
promoter O X
binding O X
. O X

Point O X
mutations O X
of O X
the O X
hydrophobic O X
core O X
of O X
conserved O X
residues O X
from O X
65 O X
to O X
74 O X
resulted O X
in O X
various O X
activation O X
- O X
defective O X
phenotypes O X
. O X

These O X
residues O X
were O X
found O X
to O X
be O X
important O X
for O X
TFIIA I-MISC 2958
gamma I-MISC 2958
- O X
gamma O X
interactions O X
, O X
suggesting O X
that O X
gamma O X
- O X
gamma O X
interactions O X
are O X
critical O X
for O X
TFIIA I-MISC 2958
function O X
as O X
a O X
coactivator O X
. O X

A O X
subset O X
of O X
these O X
TFIIA I-MISC 2958
- I-MISC 2958
gamma I-MISC 2958
mutations O X
disrupted O X
transcriptional O X
activation O X
by O X
all O X
activators O X
tested O X
, O X
except O X
for O X
the O X
Epstein O X
- O X
Barr O X
virus O X
- O X
encoded O X
Zta O X
protein O X
. O X

The O X
gamma O X
Y65F O X
, O X
gamma O X
W72A O X
, O X
and O X
gamma O X
W72F O X
mutants O X
mediate O X
Zta O X
activation O X
, O X
but O X
not O X
GAL4 I-MISC 3960
- O X
AH O X
, O X
AP O X
- O X
1 O X
, O X
GAL4 I-MISC 3960
- O X
CTF O X
, O X
or O X
GAL4 I-MISC 3960
- O X
VP16 I-MISC 3054
activation O X
. O X

The O X
gamma O X
W72A O X
mutant O X
failed O X
to O X
stimulate O X
TFIID O X
- O X
DNA O X
binding O X
( O X
D O X
- O X
A O X
complex O X
) O X
but O X
was O X
able O X
to O X
form O X
a O X
complex O X
with O X
TFIID O X
and O X
DNA O X
in O X
the O X
presence O X
of O X
Zta O X
( O X
Z O X
- O X
D O X
- O X
A O X
complex O X
). O X

Thus O X
, O X
the O X
ability O X
of O X
Zta O X
to O X
activate O X
transcription O X
with O X
gamma O X
W72A O X
appears O X
to O X
result O X
from O X
a O X
unique O X
ability O X
to O X
form O X
the O X
stable O X
Z O X
- O X
D O X
- O X
A O X
complex O X
with O X
this O X
mutant O X
. O X

Our O X
results O X
show O X
that O X
different O X
activators O X
utilize O X
the O X
general O X
factor O X
TFIIA I-MISC 2958
in O X
unique O X
ways O X
and O X
that O X
TFIIA I-MISC 2958
contributes O X
transcription O X
activation O X
functions O X
in O X
addition O X
to O X
the O X
facilitation O X
of O X
TBP I-MISC 6908
- O X
DNA O X
binding O X
. O X

###25600339	5605,673

Tunable O X
- O X
combinatorial O X
mechanisms O X
of O X
acquired O X
resistance O X
limit O X
the O X
efficacy O X
of O X
BRAF I-MISC 673
/ O X
MEK I-MISC 5609
cotargeting O X
but O X
result O X
in O X
melanoma O X
drug O X
addiction O X
. O X

Combined O X
BRAF I-MISC 673
- O X
and O X
MEK I-MISC 5609
- O X
targeted O X
therapy O X
improves O X
upon O X
BRAF I-MISC 673
inhibitor O X
( O X
BRAFi O X
) O X
therapy O X
but O X
is O X
still O X
beset O X
by O X
acquired O X
resistance O X
. O X

We O X
show O X
that O X
melanomas O X
acquire O X
resistance O X
to O X
combined O X
BRAF I-MISC 673
and O X
MEK I-MISC 5609
inhibition O X
by O X
augmenting O X
or O X
combining O X
mechanisms O X
of O X
single O X
- O X
agent O X
BRAFi O X
resistance O X
. O X

These O X
double O X
- O X
drug O X
resistance O X
- O X
associated O X
genetic O X
configurations O X
significantly O X
altered O X
molecular O X
interactions O X
underlying O X
MAPK I-MISC 5605
pathway O X
reactivation O X
. O X

( O X
V600E O X
) O X
BRAF I-MISC 673
, O X
expressed O X
at O X
supraphysiological O X
levels O X
because O X
of O X
( O X
V600E O X
) O X
BRAF I-MISC 673
ultra O X
- O X
amplification O X
, O X
dimerized O X
with O X
and O X
activated O X
CRAF I-MISC 5894
. O X

In O X
addition O X
, O X
MEK I-MISC 5609
mutants O X
enhanced O X
interaction O X
with O X
overexpressed O X
( O X
V600E O X
) O X
BRAF I-MISC 673
via O X
a O X
regulatory O X
interface O X
at O X
R662 O X
of O X
( O X
V600E O X
) O X
BRAF I-MISC 673
. O X

Importantly O X
, O X
melanoma O X
cell O X
lines O X
selected O X
for O X
resistance O X
to O X
BRAFi O X
+ O X
MEKi O X
, O X
but O X
not O X
those O X
to O X
BRAFi O X
alone O X
, O X
displayed O X
robust O X
drug O X
addiction O X
, O X
providing O X
a O X
potentially O X
exploitable O X
therapeutic O X
opportunity O X
. O X

###19103591	947053,947054

Analyzing O X
the O X
interaction O X
of O X
RseA I-MISC 947053
and O X
RseB O X
, O X
the O X
two O X
negative O X
regulators O X
of O X
the O X
sigmaE O X
envelope O X
stress O X
response O X
, O X
using O X
a O X
combined O X
bioinformatic O X
and O X
experimental O X
strategy O X
. O X

The O X
Escherichia O X
coli O X
envelope O X
stress O X
response O X
is O X
controlled O X
by O X
the O X
alternative O X
sigma O X
factor O X
, O X
sigma O X
( O X
E O X
), O X
and O X
is O X
induced O X
when O X
unfolded O X
outer O X
membrane O X
proteins O X
accumulate O X
in O X
the O X
periplasm O X
. O X

The O X
response O X
is O X
initiated O X
by O X
sequential O X
cleavage O X
of O X
the O X
membrane O X
- O X
spanning O X
antisigma I-MISC 947054
factor I-MISC 947054
, O X
RseA I-MISC 947053
. O X

RseB O X
is O X
an O X
important O X
negative O X
regulator O X
of O X
envelope O X
stress O X
response O X
that O X
exerts O X
its O X
negative O X
effects O X
onsigma O X
( O X
E O X
) O X
activity O X
through O X
its O X
binding O X
to O X
RseA I-MISC 947053
. O X

In O X
this O X
study O X
, O X
we O X
analyze O X
the O X
interaction O X
between O X
RseA I-MISC 947053
and O X
RseB O X
. O X

We O X
found O X
that O X
tight O X
binding O X
of O X
RseB O X
to O X
RseA I-MISC 947053
required O X
intact O X
RseB O X
. O X

Using O X
programs O X
that O X
performed O X
global O X
and O X
local O X
sequence O X
alignment O X
of O X
RseB O X
and O X
RseA I-MISC 947053
, O X
we O X
found O X
regions O X
of O X
high O X
similarity O X
and O X
performed O X
alanine O X
substitution O X
mutagenesis O X
to O X
test O X
the O X
hypothesis O X
that O X
these O X
regions O X
were O X
functionally O X
important O X
. O X

This O X
protocol O X
is O X
based O X
on O X
the O X
hypothesis O X
that O X
functionally O X
dependent O X
regions O X
of O X
two O X
proteins O X
co O X
- O X
evolve O X
and O X
therefore O X
are O X
likely O X
to O X
be O X
sequentially O X
conserved O X
. O X

This O X
procedure O X
allowed O X
us O X
to O X
identify O X
both O X
an O X
N O X
- O X
terminal O X
and O X
C O X
- O X
terminal O X
region O X
in O X
RseB O X
important O X
for O X
binding O X
to O X
RseA I-MISC 947053
. O X

We O X
extensively O X
analyzed O X
the O X
C O X
- O X
terminal O X
region O X
, O X
which O X
aligns O X
with O X
a O X
region O X
of O X
RseA I-MISC 947053
coincident O X
with O X
the O X
major O X
RseB O X
binding O X
determinant O X
in O X
RseA I-MISC 947053
. O X

Both O X
allele O X
- O X
specific O X
suppression O X
analysis O X
and O X
cysteine O X
- O X
mediated O X
disulfide O X
bond O X
formation O X
indicated O X
that O X
this O X
C O X
- O X
terminal O X
region O X
of O X
similarity O X
of O X
RseA I-MISC 947053
and O X
RseB O X
identifies O X
a O X
contact O X
site O X
between O X
the O X
two O X
proteins O X
. O X

We O X
suggest O X
a O X
similar O X
protocol O X
can O X
be O X
successfully O X
applied O X
to O X
pairs O X
of O X
non O X
- O X
homologous O X
but O X
functionally O X
linked O X
proteins O X
to O X
find O X
specific O X
regions O X
of O X
the O X
protein O X
sequences O X
that O X
are O X
important O X
for O X
establishing O X
functional O X
linkage O X
. O X

###16834334	16518,16518

Andersen O X
' O X
s O X
syndrome O X
mutation O X
effects O X
on O X
the O X
structure O X
and O X
assembly O X
of O X
the O X
cytoplasmic O X
domains O X
of O X
Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
. O X

Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
channels O X
play O X
a O X
key O X
role O X
in O X
maintaining O X
the O X
correct O X
resting O X
potential O X
in O X
eukaryotic O X
cells O X
. O X

Recently O X
, O X
specific O X
amino O X
acid O X
mutations O X
in O X
the O X
Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
inwardly O X
rectifying O X
potassium O X
channel O X
have O X
been O X
found O X
to O X
cause O X
Andersen O X
' O X
s O X
Syndrome O X
in O X
humans O X
. O X

Here O X
, O X
we O X
have O X
characterized O X
individual O X
Andersen O X
' O X
s O X
Syndrome O X
mutants O X
R218Q O X
, O X
G300V O X
, O X
E303K O X
, O X
and O X
delta314 O X
- O X
315 O X
and O X
have O X
found O X
multiple O X
effects O X
on O X
the O X
ability O X
of O X
the O X
cytoplasmic O X
domains O X
in O X
Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
channels O X
to O X
form O X
proper O X
tetrameric O X
assemblies O X
. O X

For O X
the O X
R218Q O X
mutation O X
, O X
we O X
identified O X
a O X
second O X
site O X
mutation O X
( O X
T309K O X
) O X
that O X
restored O X
tetrameric O X
assembly O X
but O X
not O X
function O X
. O X

We O X
successfully O X
crystallized O X
and O X
solved O X
the O X
structure O X
( O X
at O X
2 O X
. O X
0 O X
A O X
) O X
of O X
the O X
N O X
- O X
and O X
C O X
- O X
terminal O X
cytoplasmic O X
domains O X
of O X
Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
- O X
R218Q O X
/ O X
T309K O X
( O X
S O X
). O X

This O X
new O X
structure O X
revealed O X
multiple O X
conformations O X
of O X
the O X
G O X
- O X
loop O X
and O X
CD O X
loop O X
, O X
providing O X
an O X
explanation O X
for O X
channels O X
that O X
assemble O X
but O X
do O X
not O X
conduct O X
ions O X
. O X

Interestingly O X
, O X
Glu303 O X
forms O X
both O X
intra O X
- O X
and O X
intersubunit O X
salt O X
bridges O X
, O X
depending O X
on O X
the O X
conformation O X
of O X
the O X
G O X
- O X
loop O X
, O X
suggesting O X
that O X
the O X
E303K O X
mutant O X
stabilizes O X
both O X
closed O X
and O X
open O X
G O X
- O X
loop O X
conformations O X
. O X

In O X
the O X
Kir2 I-MISC 16518
. I-MISC 16518
1 I-MISC 16518
- O X
R218Q O X
/ O X
T309K O X
( O X
S O X
) O X
structure O X
, O X
we O X
discovered O X
that O X
the O X
DE O X
loop O X
forms O X
a O X
hydrophobic O X
pocket O X
that O X
binds O X
2 O X
- O X
methyl O X
- O X
2 O X
, O X
4 O X
- O X
pentanediol O X
, O X
which O X
is O X
located O X
near O X
the O X
putative O X
G O X
( O X
betagamma O X
)- O X
activation O X
site O X
of O X
Kir3 O X
channels O X
. O X

Finally O X
, O X
we O X
observed O X
a O X
potassium O X
ion O X
bound O X
to O X
the O X
cytoplasmic O X
domain O X
for O X
this O X
class O X
of O X
K O X
+ O X
channels O X
. O X

###14567693	100009226,8671

Direct O X
extracellular O X
interaction O X
between O X
carbonic I-MISC 100009226
anhydrase I-MISC 100009226
IV I-MISC 100009226
and O X
the O X
human O X
NBC1 I-MISC 8671
sodium O X
/ O X
bicarbonate O X
co O X
- O X
transporter O X
. O X

Sodium O X
/ O X
bicarbonate O X
co O X
- O X
transporters O X
( O X
NBC O X
) O X
are O X
crucial O X
in O X
the O X
regulation O X
of O X
intracellular O X
pH O X
( O X
pH I-MISC 2821
( I-MISC 2821
i I-MISC 2821
)) O X
and O X
HCO O X
( O X
3 O X
)(-) O X
metabolism O X
. O X

Electrogenic O X
NBC1 I-MISC 8671
catalyzes O X
HCO O X
( O X
3 O X
)(-) O X
fluxes O X
in O X
mammalian O X
kidney O X
, O X
pancreas O X
, O X
and O X
heart O X
cells O X
. O X

Carbonic I-MISC 100009226
anhydrase I-MISC 100009226
IV I-MISC 100009226
( O X
CAIV I-MISC 100009226
), O X
which O X
is O X
also O X
present O X
in O X
these O X
tissues O X
, O X
is O X
glycosylphosphatidyl O X
inositol O X
- O X
anchored O X
to O X
the O X
outer O X
surface O X
of O X
the O X
plasma O X
membrane O X
where O X
it O X
catalyzes O X
the O X
hydration O X
- O X
dehydration O X
of O X
CO O X
( O X
2 O X
)/ O X
HCO O X
( O X
3 O X
)(-). O X

The O X
physical O X
and O X
functional O X
interactions O X
of O X
CAIV I-MISC 100009226
and O X
NBC1 I-MISC 8671
were O X
investigated O X
. O X

NBC1 I-MISC 8671
activity O X
was O X
measured O X
by O X
changes O X
of O X
pH I-MISC 2821
( I-MISC 2821
i I-MISC 2821
) I-MISC 2821
in O X
NBC1 I-MISC 8671
- O X
transfected O X
HEK293 O X
cells O X
subjected O X
to O X
acid O X
loads O X
. O X

Cotransfection O X
of O X
CAIV I-MISC 100009226
with O X
NBC1 I-MISC 8671
increased O X
the O X
rate O X
of O X
pH I-MISC 2821
( I-MISC 2821
i I-MISC 2821
) I-MISC 2821
recovery O X
by O X
44 O X
+/- O X
3 O X
%, O X
as O X
compared O X
to O X
NBC1 I-MISC 8671
- O X
alone O X
. O X

In O X
contrast O X
, O X
CAIV I-MISC 100009226
did O X
not O X
increase O X
the O X
functional O X
activity O X
of O X
G767T O X
- O X
NBC1 I-MISC 8671
( O X
mutated O X
on O X
the O X
fourth O X
extracellular O X
loop O X
( O X
EC4 O X
) O X
of O X
NBC1 I-MISC 8671
), O X
and O X
G767T O X
- O X
NBC1 I-MISC 8671
, O X
unlike O X
wild O X
- O X
type O X
NBC1 I-MISC 8671
, O X
did O X
not O X
interact O X
with O X
CAIV I-MISC 100009226
in O X
glutathione O X
- O X
S O X
- O X
transferase O X
pull O X
- O X
down O X
assays O X
. O X

This O X
indicates O X
that O X
G767 O X
of O X
NBC1 I-MISC 8671
is O X
directly O X
involved O X
in O X
CAIV I-MISC 100009226
interaction O X
. O X

NBC1 I-MISC 8671
- O X
mediated O X
pH I-MISC 2821
( I-MISC 2821
i I-MISC 2821
) I-MISC 2821
recovery O X
rate O X
after O X
acid O X
load O X
was O X
inhibited O X
by O X
40 O X
+/- O X
7 O X
% O X
when O X
coexpressed O X
with O X
the O X
inactive O X
human O X
CAII I-MISC 760
mutant O X
, O X
V143Y O X
. O X

V143Y O X
CAII I-MISC 760
competes O X
with O X
endogenous O X
CAII I-MISC 760
for O X
interaction O X
with O X
NBC1 I-MISC 8671
at O X
the O X
inner O X
surface O X
of O X
the O X
plasma O X
membrane O X
, O X
which O X
indicates O X
that O X
NBC1 I-MISC 8671
/ O X
CAII I-MISC 760
interaction O X
is O X
needed O X
for O X
full O X
pH I-MISC 2821
( I-MISC 2821
i I-MISC 2821
) I-MISC 2821
recovery O X
activity O X
. O X

We O X
conclude O X
that O X
CAIV I-MISC 100009226
binds O X
EC4 O X
of O X
NBC1 I-MISC 8671
, O X
and O X
this O X
interaction O X
is O X
essential O X
for O X
full O X
NBC1 I-MISC 8671
activity O X
. O X

The O X
tethering O X
of O X
CAII I-MISC 760
and O X
CAIV I-MISC 100009226
close O X
to O X
the O X
NBC1 I-MISC 8671
HCO O X
( O X
3 O X
)(-) O X
transport O X
site O X
maximizes O X
the O X
transmembrane O X
HCO O X
( O X
3 O X
)(-) O X
gradient O X
local O X
to O X
NBC1 I-MISC 8671
and O X
thereby O X
activates O X
the O X
transport O X
rate O X
. O X

###16682949	54820,983	54820,22891

Centrosomal O X
proteins O X
Nde1 I-MISC 54820
and O X
Su48 I-MISC 22891
form O X
a O X
complex O X
regulated O X
by O X
phosphorylation O X
. O X

The O X
centrosome O X
modulates O X
spindle O X
formation O X
and O X
plays O X
a O X
critical O X
role O X
in O X
guiding O X
proper O X
segregation O X
of O X
chromosomes O X
during O X
cell O X
division O X
. O X

Centrosome O X
aberrations O X
, O X
frequently O X
seen O X
in O X
human O X
tumors O X
, O X
may O X
cause O X
abnormal O X
chromosome O X
segregation O X
and O X
contribute O X
to O X
malignant O X
transformation O X
. O X

To O X
explore O X
the O X
components O X
of O X
the O X
centrosomes O X
, O X
we O X
previously O X
identified O X
a O X
novel O X
centrosomal O X
protein O X
called O X
Su48 I-MISC 22891
. O X

To O X
further O X
characterize O X
the O X
Su48 I-MISC 22891
- O X
containing O X
protein O X
ensemble O X
in O X
the O X
centrosome O X
, O X
we O X
performed O X
yeast O X
two O X
- O X
hybrid O X
screens O X
and O X
isolated O X
a O X
number O X
of O X
Su48 I-MISC 22891
- O X
interacting O X
molecules O X
, O X
including O X
the O X
centrosomal O X
protein O X
Nde1 I-MISC 54820
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
Su48 I-MISC 22891
can O X
associate O X
with O X
Nde1 I-MISC 54820
. O X

Moreover O X
, O X
we O X
found O X
that O X
Nde1 I-MISC 54820
is O X
subjected O X
to O X
phosphorylation O X
in O X
vivo O X
. O X

In O X
particular O X
, O X
we O X
identified O X
six O X
putative O X
Cdc2 I-MISC 983
phosphorylation O X
sites O X
in O X
Nde1 I-MISC 54820
and O X
found O X
that O X
alteration O X
of O X
these O X
sites O X
diminishes O X
phosphorylation O X
by O X
Cdc2 I-MISC 983
in O X
vitro O X
and O X
affects O X
the O X
stability O X
of O X
Su48 I-MISC 22891
- O X
Nde1 I-MISC 54820
interactions O X
and O X
the O X
centrosomal O X
localization O X
of O X
Nde1 I-MISC 54820
. O X

Ablation O X
of O X
Nde1 I-MISC 54820
by O X
gene O X
specific O X
small O X
interfering O X
RNA O X
causes O X
mitotic O X
delay O X
and O X
cell O X
death O X
, O X
coupled O X
with O X
a O X
modest O X
decrease O X
in O X
the O X
incidence O X
of O X
the O X
cells O X
that O X
harbor O X
excessive O X
centrosomes O X
. O X

Collectively O X
, O X
our O X
findings O X
indicate O X
that O X
Nde1 I-MISC 54820
can O X
form O X
a O X
protein O X
complex O X
with O X
Su48 I-MISC 22891
in O X
the O X
centrosome O X
and O X
plays O X
an O X
important O X
role O X
for O X
successful O X
mitosis O X
. O X

###21220045	1824,5318

A O X
novel O X
desmocollin I-MISC 1824
- I-MISC 1824
2 I-MISC 1824
mutation O X
reveals O X
insights O X
into O X
the O X
molecular O X
link O X
between O X
desmosomes O X
and O X
gap O X
junctions O X
. O X

BACKGROUND O X
: O X
Cellular O X
adhesion O X
mediated O X
by O X
cardiac O X
desmosomes O X
is O X
a O X
prerequisite O X
for O X
proper O X
electric O X
propagation O X
mediated O X
by O X
gap O X
junctions O X
in O X
the O X
myocardium O X
. O X

However O X
, O X
the O X
molecular O X
principles O X
underlying O X
this O X
interdependence O X
are O X
not O X
fully O X
understood O X
. O X

OBJECTIVE O X
: O X
The O X
purpose O X
of O X
this O X
study O X
was O X
to O X
determine O X
potential O X
causes O X
of O X
right O X
ventricular O X
conduction O X
abnormalities O X
in O X
a O X
patient O X
with O X
borderline O X
diagnosis O X
of O X
arrhythmogenic O X
right O X
ventricular O X
cardiomyopathy O X
. O X

METHODS O X
: O X
To O X
assess O X
molecular O X
changes O X
, O X
the O X
patient O X
' O X
s O X
myocardial O X
tissue O X
was O X
analyzed O X
for O X
altered O X
desmosomal O X
and O X
gap O X
junction O X
( O X
connexin43 I-MISC 2697
) O X
protein O X
levels O X
and O X
localization O X
. O X

In O X
vitro O X
functional O X
studies O X
were O X
performed O X
to O X
characterize O X
the O X
consequences O X
of O X
the O X
desmosomal O X
mutations O X
. O X

RESULTS O X
: O X
Loss O X
of O X
plakoglobin I-MISC 5318
signal O X
was O X
evident O X
at O X
the O X
cell O X
junctions O X
despite O X
expression O X
of O X
the O X
protein O X
at O X
control O X
levels O X
. O X

Although O X
the O X
distribution O X
of O X
connexin43 I-MISC 2697
was O X
not O X
altered O X
, O X
total O X
protein O X
levels O X
were O X
reduced O X
and O X
changes O X
in O X
phosphorylation O X
were O X
observed O X
. O X

The O X
truncation O X
mutant O X
in O X
desmocollin O X
- O X
2a O X
is O X
deficient O X
in O X
binding O X
plakoglobin I-MISC 5318
. O X

Moreover O X
, O X
the O X
ability O X
of O X
desmocollin I-MISC 1824
- I-MISC 1824
2a I-MISC 1824
to O X
directly O X
interact O X
with O X
connexin43 I-MISC 2697
was O X
abolished O X
by O X
the O X
mutation O X
. O X

No O X
pathogenic O X
potential O X
of O X
the O X
desmoglein I-MISC 1829
- I-MISC 1829
2 I-MISC 1829
missense O X
change O X
was O X
identified O X
. O X

CONCLUSION O X
: O X
The O X
observed O X
abnormalities O X
in O X
gap O X
junction O X
protein O X
expression O X
and O X
phosphorylation O X
, O X
which O X
precede O X
an O X
overt O X
cardiac O X
phenotype O X
, O X
likely O X
are O X
responsible O X
for O X
slow O X
myocardial O X
conduction O X
in O X
this O X
patient O X
. O X

At O X
the O X
molecular O X
level O X
, O X
altered O X
binding O X
properties O X
of O X
the O X
desmocollin I-MISC 1824
- I-MISC 1824
2a I-MISC 1824
mutant O X
may O X
contribute O X
to O X
the O X
changes O X
in O X
connexin43 I-MISC 2697
. O X

In O X
particular O X
, O X
the O X
newly O X
identified O X
interaction O X
between O X
the O X
desmocollin I-MISC 1824
- I-MISC 1824
2a I-MISC 1824
isoform O X
and O X
connexin43 I-MISC 2697
provides O X
novel O X
insights O X
into O X
the O X
molecular O X
link O X
between O X
desmosomes O X
and O X
gap O X
junctions O X
. O X

###12732628	4338,4338	4338,4338

Mechanistic O X
studies O X
of O X
human O X
molybdopterin O X
synthase O X
reaction O X
and O X
characterization O X
of O X
mutants O X
identified O X
in O X
group O X
B O X
patients O X
of O X
molybdenum O X
cofactor O X
deficiency O X
. O X

Biosynthesis O X
of O X
the O X
molybdenum O X
cofactor O X
involves O X
the O X
initial O X
formation O X
of O X
precursor O X
Z O X
, O X
its O X
subsequent O X
conversion O X
to O X
molybdopterin O X
( O X
MPT O X
) O X
by O X
MPT O X
synthase O X
, O X
and O X
attachment O X
of O X
molybdenum O X
to O X
the O X
dithiolene O X
moiety O X
of O X
MPT O X
. O X

The O X
sulfur O X
used O X
for O X
the O X
formation O X
of O X
the O X
dithiolene O X
group O X
of O X
MPT O X
exists O X
in O X
the O X
form O X
of O X
a O X
thiocarboxylate O X
group O X
at O X
the O X
C O X
terminus O X
of O X
the O X
smaller O X
subunit O X
of O X
MPT O X
synthase O X
. O X

Human O X
MPT O X
synthase O X
contains O X
the O X
MOCS2A I-MISC 4338
and O X
MOCS2B I-MISC 4338
proteins O X
that O X
display O X
homology O X
to O X
the O X
Escherichia O X
coli O X
proteins O X
MoaD O X
and O X
MoaE O X
, O X
respectively O X
. O X

MOCS2A I-MISC 4338
and O X
MOCS2B I-MISC 4338
were O X
purified O X
after O X
heterologous O X
expression O X
in O X
E O X
. O X
coli O X
, O X
and O X
the O X
separately O X
purified O X
subunits O X
readily O X
assemble O X
into O X
a O X
functional O X
MPT O X
synthase O X
tetramer O X
. O X

The O X
rate O X
of O X
conversion O X
of O X
precursor O X
Z O X
to O X
MPT O X
by O X
the O X
human O X
enzyme O X
is O X
slower O X
than O X
that O X
of O X
the O X
eubacterial O X
homologue O X
. O X

To O X
obtain O X
insights O X
into O X
the O X
molecular O X
mechanism O X
leading O X
to O X
human O X
molybdenum O X
cofactor O X
deficiency O X
, O X
site O X
- O X
specific O X
mutations O X
identified O X
in O X
patients O X
showing O X
symptoms O X
of O X
molybdenum O X
cofactor O X
deficiency O X
were O X
generated O X
. O X

Characterization O X
of O X
a O X
V7F O X
substitution O X
in O X
MOCS2A I-MISC 4338
, O X
identified O X
in O X
a O X
patient O X
with O X
an O X
unusual O X
mild O X
form O X
of O X
the O X
disease O X
, O X
showed O X
that O X
the O X
mutation O X
weakens O X
the O X
interaction O X
between O X
MOCS2A I-MISC 4338
and O X
MOCS2B I-MISC 4338
, O X
whereas O X
a O X
MOCS2B I-MISC 4338
- O X
E168K O X
mutation O X
identified O X
in O X
a O X
severely O X
affected O X
patient O X
attenuates O X
binding O X
of O X
precursor O X
Z O X
. O X

###18216290	24669,84686

Selective O X
targeting O X
of O X
the O X
gamma1 I-MISC 24669
isoform I-MISC 24669
of I-MISC 24669
protein I-MISC 24669
phosphatase I-MISC 24669
1 I-MISC 24669
to O X
F O X
- O X
actin O X
in O X
intact O X
cells O X
requires O X
multiple O X
domains O X
in O X
spinophilin I-MISC 84686
and O X
neurabin O X
. O X

Protein I-MISC 5464
phosphatase I-MISC 5464
1 I-MISC 5464
( O X
PP1 I-MISC 5464
) O X
catalytic O X
subunits O X
dephosphorylate O X
specific O X
substrates O X
in O X
discrete O X
subcellular O X
compartments O X
to O X
modulate O X
many O X
cellular O X
processes O X
. O X

Canonical O X
PP1 I-MISC 5464
- O X
binding O X
motifs O X
( O X
R O X
/ O X
K O X
- O X
V O X
/ O X
I O X
- O X
X O X
- O X
F O X
) O X
in O X
a O X
family O X
of O X
proteins O X
mediate O X
subcellular O X
targeting O X
, O X
and O X
the O X
amino O X
acids O X
that O X
form O X
the O X
binding O X
pocket O X
for O X
the O X
canonical O X
motif O X
are O X
identical O X
in O X
all O X
PP1 I-MISC 5464
isoforms O X
. O X

However O X
, O X
PP1gamma1 I-MISC 24669
but O X
not O X
PP1beta I-MISC 5500
is O X
selectively O X
localized O X
to O X
F O X
- O X
actin O X
- O X
rich O X
dendritic O X
spines O X
in O X
neurons O X
. O X

Although O X
the O X
F O X
- O X
actin O X
- O X
binding O X
proteins O X
neurabin O X
I O X
and O X
spinophilin I-MISC 84686
( O X
neurabin I-MISC 84686
II I-MISC 84686
) O X
also O X
bind O X
PP1 I-MISC 5464
, O X
their O X
role O X
in O X
PP1 I-MISC 5464
isoform O X
selective O X
targeting O X
in O X
intact O X
cells O X
is O X
poorly O X
understood O X
. O X

We O X
show O X
here O X
that O X
spinophilin I-MISC 84686
selectively O X
targets O X
PP1gamma1 I-MISC 24669
, O X
but O X
not O X
PP1beta I-MISC 5500
, O X
to O X
F O X
- O X
actin O X
- O X
rich O X
cortical O X
regions O X
of O X
intact O X
cells O X
. O X

Mutation O X
of O X
a O X
PP1gamma1 I-MISC 24669
selectivity O X
determinant O X
( O X
N O X
( O X
464 O X
) O X
EDYDRR O X
( O X
470 O X
) O X
in O X
spinophilin I-MISC 84686
: O X
conserved O X
as O X
residues O X
473 O X
- O X
479 O X
in O X
neurabin O X
) O X
to O X
VKDYDTW O X
severely O X
attenuated O X
PP1gamma1 I-MISC 24669
interactions O X
with O X
neurabins O X
in O X
vitro O X
and O X
in O X
cells O X
and O X
disrupted O X
PP1gamma1 I-MISC 24669
targeting O X
to O X
F O X
- O X
actin O X
. O X

This O X
domain O X
is O X
not O X
involved O X
in O X
the O X
weaker O X
interactions O X
of O X
neurabins O X
with O X
PP1beta I-MISC 5500
. O X

In O X
contrast O X
, O X
mutation O X
of O X
the O X
canonical O X
PP1 I-MISC 5464
- O X
binding O X
motif O X
attenuated O X
interactions O X
of O X
neurabins O X
with O X
both O X
isoforms O X
. O X

Thus O X
, O X
selective O X
targeting O X
of O X
PP1gamma1 I-MISC 24669
to O X
F O X
- O X
actin O X
by O X
neurabins O X
in O X
intact O X
cells O X
requires O X
both O X
the O X
canonical O X
PP1 I-MISC 5464
- O X
binding O X
motif O X
and O X
an O X
auxiliary O X
PP1gamma1 I-MISC 24669
- O X
selectivity O X
determinant O X
. O X

###15483055	8615885,8622150

Dictyostelium O X
PAKc I-MISC 8615885
is O X
required O X
for O X
proper O X
chemotaxis O X
. O X

We O X
have O X
identified O X
a O X
new O X
Dictyostelium O X
p21 O X
- O X
activated O X
protein O X
kinase O X
, O X
PAKc I-MISC 8615885
, O X
that O X
we O X
demonstrate O X
to O X
be O X
required O X
for O X
proper O X
chemotaxis O X
. O X

PAKc I-MISC 8615885
contains O X
a O X
Rac O X
- O X
GTPase O X
binding O X
( O X
CRIB O X
) O X
and O X
autoinhibitory O X
domain O X
, O X
a O X
PAK O X
- O X
related O X
kinase O X
domain O X
, O X
an O X
N O X
- O X
terminal O X
phosphatidylinositol O X
binding O X
domain O X
, O X
and O X
a O X
C O X
- O X
terminal O X
extension O X
related O X
to O X
the O X
Gbetagamma O X
binding O X
domain O X
of O X
Saccharomyces O X
cerevisiae O X
Ste20 O X
, O X
the O X
latter O X
two O X
domains O X
being O X
required O X
for O X
PAKc I-MISC 8615885
transient O X
localization O X
to O X
the O X
plasma O X
membrane O X
. O X

In O X
response O X
to O X
chemoattractant O X
stimulation O X
, O X
PAKc I-MISC 8615885
kinase O X
activity O X
is O X
rapidly O X
and O X
transiently O X
activated O X
, O X
with O X
activity O X
levels O X
peaking O X
at O X
approximately O X
10 O X
s O X
. O X
pakc I-MISC 8615885
null O X
cells O X
exhibit O X
a O X
loss O X
of O X
polarity O X
and O X
produce O X
multiple O X
lateral O X
pseudopodia O X
when O X
placed O X
in O X
a O X
chemoattractant O X
gradient O X
. O X

PAKc I-MISC 8615885
preferentially O X
binds O X
the O X
Dictyostelium O X
Rac O X
protein O X
RacB I-MISC 8622150
, O X
and O X
point O X
mutations O X
in O X
the O X
conserved O X
CRIB O X
that O X
abrogate O X
this O X
binding O X
result O X
in O X
misregulated O X
kinase O X
activation O X
and O X
chemotaxis O X
defects O X
. O X

We O X
also O X
demonstrate O X
that O X
a O X
null O X
mutation O X
lacking O X
the O X
PAK O X
family O X
member O X
myosin O X
I O X
heavy O X
chain O X
kinase O X
( O X
MIHCK O X
) O X
shows O X
mild O X
chemotaxis O X
defects O X
, O X
including O X
the O X
formation O X
of O X
lateral O X
pseudopodia O X
. O X

A O X
null O X
strain O X
lacking O X
both O X
PAKc I-MISC 8615885
and O X
the O X
PAK O X
family O X
member O X
MIHCK O X
exhibits O X
severe O X
loss O X
of O X
cell O X
movement O X
, O X
suggesting O X
that O X
PAKc I-MISC 8615885
and O X
MIHCK O X
may O X
cooperate O X
to O X
regulate O X
a O X
common O X
chemotaxis O X
pathway O X
. O X

###21481793	154796,4771	154796,55114

A O X
tight O X
junction O X
- O X
associated O X
Merlin I-MISC 18016
- O X
angiomotin I-MISC 154796
complex O X
mediates O X
Merlin I-MISC 18016
' O X
s O X
regulation O X
of O X
mitogenic O X
signaling O X
and O X
tumor O X
suppressive O X
functions O X
. O X

The O X
Merlin I-MISC 18016
/ O X
NF2 I-MISC 18016
tumor O X
suppressor O X
restrains O X
cell O X
growth O X
and O X
tumorigenesis O X
by O X
controlling O X
contact O X
- O X
dependent O X
inhibition O X
of O X
proliferation O X
. O X

We O X
have O X
identified O X
a O X
tight O X
- O X
junction O X
- O X
associated O X
protein O X
complex O X
comprising O X
Merlin I-MISC 18016
, O X
Angiomotin I-MISC 154796
, O X
Patj O X
, O X
and O X
Pals1 I-MISC 56217
. O X

We O X
demonstrate O X
that O X
Angiomotin I-MISC 154796
functions O X
downstream O X
of O X
Merlin I-MISC 18016
and O X
upstream O X
of O X
Rich1 I-MISC 70497
, O X
a O X
small O X
GTPase O X
Activating O X
Protein O X
, O X
as O X
a O X
positive O X
regulator O X
of O X
Rac1 I-MISC 19353
. O X

Merlin I-MISC 18016
, O X
through O X
competitive O X
binding O X
to O X
Angiomotin I-MISC 154796
, O X
releases O X
Rich1 I-MISC 70497
from O X
the O X
Angiomotin I-MISC 154796
- O X
inhibitory O X
complex O X
, O X
allowing O X
Rich1 I-MISC 70497
to O X
inactivate O X
Rac1 I-MISC 19353
, O X
ultimately O X
leading O X
to O X
attenuation O X
of O X
Rac1 I-MISC 19353
and O X
Ras O X
- O X
MAPK O X
pathways O X
. O X

Patient O X
- O X
derived O X
Merlin I-MISC 4771
mutants O X
show O X
diminished O X
binding O X
capacities O X
to O X
Angiomotin I-MISC 154796
and O X
are O X
unable O X
to O X
dissociate O X
Rich1 I-MISC 55114
from O X
Angiomotin I-MISC 154796
or O X
inhibit O X
MAPK O X
signaling O X
. O X

Depletion O X
of O X
Angiomotin I-MISC 154796
in O X
Nf2 I-MISC 18016
(-/-) O X
Schwann O X
cells O X
attenuates O X
the O X
Ras O X
- O X
MAPK O X
signaling O X
pathway O X
, O X
impedes O X
cellular O X
proliferation O X
in O X
vitro O X
and O X
tumorigenesis O X
in O X
vivo O X
. O X

###15292222	1613,4659

Identification O X
and O X
characterization O X
of O X
zipper I-MISC 1613
- I-MISC 1613
interacting I-MISC 1613
protein I-MISC 1613
kinase I-MISC 1613
as O X
the O X
unique O X
vascular O X
smooth O X
muscle O X
myosin O X
phosphatase O X
- O X
associated O X
kinase O X
. O X

Excitation O X
- O X
contraction O X
coupling O X
in O X
smooth O X
muscle O X
involves O X
activation O X
of O X
myosin I-MISC 23209
light I-MISC 23209
chain I-MISC 23209
( O X
MLC I-MISC 23209
) O X
phosphorylation O X
, O X
which O X
increases O X
activity O X
of O X
the O X
myosin O X
actin O X
- O X
activated O X
ATPase O X
, O X
resulting O X
in O X
contraction O X
. O X

Phosphorylation O X
of O X
MLC I-MISC 23209
phosphatase O X
( O X
SMPP O X
- O X
1M O X
) O X
by O X
Rho O X
- O X
associated O X
kinase O X
or O X
endogenous O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
inhibits O X
SMPP O X
- O X
1M O X
, O X
enhancing O X
MLC I-MISC 23209
phosphorylation O X
and O X
contraction O X
. O X

However O X
, O X
the O X
precise O X
identity O X
of O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
remains O X
unclear O X
. O X

Biochemical O X
evidence O X
strongly O X
supports O X
the O X
idea O X
that O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
is O X
related O X
to O X
the O X
human O X
serine O X
/ O X
threonine O X
leucine O X
zipper I-MISC 1613
- I-MISC 1613
interacting I-MISC 1613
protein I-MISC 1613
kinase I-MISC 1613
( O X
hZIPK I-MISC 1613
), O X
which O X
is O X
important O X
in O X
cell O X
apoptosis O X
, O X
and O X
the O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
has O X
therefore O X
been O X
called O X
ZIP O X
- O X
like O X
kinase O X
( O X
MacDonald O X
, O X
J O X
. O X

A O X
., O X
Borman O X
, O X
M O X
. O X
A O X
., O X
Murani O X
, O X
A O X
., O X
Somlyo O X
, O X
A O X
. O X
V O X
., O X
Hartshorne O X
, O X
D O X
. O X
J O X
., O X
and O X
Haystead O X
, O X
T O X
. O X
A O X
. O X
J O X
. O X

( O X
2001 O X
) O X
Proc O X
. O X

Natl O X
. O X

Acad O X
. O X

Sci O X
. O X

U O X
. O X
S O X
. O X
A O X
. O X

98 O X
, O X
2419 O X
- O X
2424 O X
). O X

Whether O X
the O X
vascular O X
smooth O X
muscle O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
is O X
a O X
truncated O X
version O X
of O X
hZIPK I-MISC 1613
, O X
native O X
hZIPK I-MISC 1613
, O X
or O X
a O X
unique O X
homologue O X
of O X
hZIPK I-MISC 1613
is O X
unclear O X
. O X

Here O X
we O X
show O X
that O X
only O X
native O X
hZIPK I-MISC 1613
mRNA O X
and O X
protein O X
are O X
detectable O X
in O X
human O X
vascular O X
smooth O X
muscle O X
cells O X
( O X
VSMCs O X
). O X

High O X
stringency O X
screening O X
of O X
a O X
human O X
aortic O X
cDNA O X
library O X
for O X
the O X
SMPP O X
- O X
1M O X
- O X
associated O X
kinase O X
identified O X
18 O X
positive O X
clones O X
, O X
all O X
of O X
which O X
proved O X
to O X
be O X
clones O X
of O X
hZIPK I-MISC 1613
. O X

PCR O X
- O X
based O X
studies O X
of O X
VSMC O X
RNA O X
revealed O X
native O X
hZIPK I-MISC 1613
transcripts O X
but O X
no O X
evidence O X
for O X
splice O X
variants O X
of O X
hZIPK I-MISC 1613
or O X
a O X
ZIP O X
- O X
like O X
kinase O X
. O X

Northern O X
blotting O X
studies O X
of O X
multiple O X
vascular O X
and O X
non O X
- O X
vascular O X
tissue O X
RNAs O X
, O X
including O X
human O X
bladder O X
RNA O X
, O X
showed O X
only O X
2 O X
. O X
3 O X
kb O X
of O X
mRNA O X
predicted O X
for O X
full O X
- O X
length O X
hZIPK I-MISC 1613
. O X

Immunoblotting O X
showed O X
native O X
full O X
- O X
length O X
52 O X
- O X
kDa O X
hZIPK I-MISC 1613
expression O X
in O X
VSMCs O X
. O X

Full O X
- O X
length O X
and O X
N O X
- O X
terminal O X
hZIPK I-MISC 1613
bound O X
the O X
C O X
- O X
terminal O X
domain O X
( O X
amino O X
acids O X
681 O X
- O X
847 O X
) O X
of O X
the O X
myosin I-MISC 4659
binding I-MISC 4659
subunit I-MISC 4659
( O X
MBS O X
) O X
of O X
SMPP O X
- O X
1M O X
. O X

hZIPK I-MISC 1613
immunoprecipitated O X
with O X
the O X
MBS O X
of O X
SMPP O X
- O X
1M O X
and O X
dominant O X
negative O X
RhoA I-MISC 387
inhibited O X
the O X
hZIPK I-MISC 1613
- O X
MBS O X
interaction O X
. O X

These O X
data O X
identify O X
hZIPK I-MISC 1613
as O X
the O X
unique O X
SMPP O X
- O X
1 O X
- O X
associated O X
kinase O X
expressed O X
in O X
human O X
vesicular O X
smooth O X
muscle O X
and O X
support O X
a O X
role O X
for O X
Rho O X
in O X
promoting O X
the O X
hZIPK I-MISC 1613
- O X
MBS O X
interaction O X
. O X

###16511572	1111,4194

14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
binds O X
to O X
MDMX I-MISC 4194
that O X
is O X
phosphorylated O X
by O X
UV O X
- O X
activated O X
Chk1 I-MISC 1111
, O X
resulting O X
in O X
p53 I-MISC 7157
activation O X
. O X

It O X
has O X
been O X
shown O X
that O X
MDMX I-MISC 4194
inhibits O X
the O X
activity O X
of O X
the O X
tumor O X
suppressor O X
p53 I-MISC 7157
by O X
primarily O X
cooperating O X
with O X
the O X
p53 I-MISC 7157
feedback O X
regulator O X
MDM2 I-MISC 4193
. O X

Here O X
, O X
our O X
study O X
shows O X
that O X
this O X
inhibition O X
can O X
be O X
overcome O X
by O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
and O X
Chk1 I-MISC 1111
. O X

14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
was O X
identified O X
as O X
an O X
MDMX I-MISC 4194
- O X
associated O X
protein O X
via O X
an O X
immuno O X
- O X
affinity O X
purification O X
- O X
coupled O X
mass O X
spectrometry O X
. O X

Consistently O X
, O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
directly O X
interacted O X
with O X
MDMX I-MISC 4194
in O X
vitro O X
, O X
and O X
this O X
interaction O X
was O X
stimulated O X
by O X
MDMX I-MISC 4194
phosphorylation O X
in O X
vitro O X
and O X
in O X
cells O X
. O X

Interestingly O X
, O X
in O X
response O X
to O X
UV O X
irradiation O X
, O X
the O X
wild O X
- O X
type O X
, O X
but O X
not O X
the O X
kinase O X
- O X
dead O X
mutant O X
, O X
Chk1 I-MISC 1111
phosphorylated O X
MDMX I-MISC 4194
at O X
serine O X
367 O X
, O X
enhanced O X
the O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
- O X
MDMX I-MISC 4194
binding O X
and O X
the O X
cytoplasmic O X
retaining O X
of O X
MDMX I-MISC 4194
. O X

The O X
Chk1 I-MISC 1111
specific O X
inhibitor O X
UCN O X
- O X
01 O X
repressed O X
all O X
of O X
these O X
effects O X
. O X

Moreover O X
, O X
overexpression O X
of O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
, O X
but O X
not O X
its O X
mutant O X
K50E O X
, O X
which O X
did O X
not O X
bind O X
to O X
MDMX I-MISC 4194
, O X
suppressed O X
MDMX I-MISC 4194
- O X
enhanced O X
p53 I-MISC 7157
ubiquitination O X
, O X
leading O X
to O X
p53 I-MISC 7157
stabilization O X
and O X
activation O X
. O X

Finally O X
, O X
ablation O X
of O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
by O X
siRNA O X
reduced O X
UV O X
- O X
induced O X
p53 I-MISC 7157
level O X
and O X
G1 O X
arrest O X
. O X

Thus O X
, O X
these O X
results O X
demonstrate O X
14 I-MISC 7532
- I-MISC 7532
3 I-MISC 7532
- I-MISC 7532
3gamma I-MISC 7532
and O X
Chk1 I-MISC 1111
as O X
two O X
novel O X
regulators O X
of O X
MDMX I-MISC 4194
in O X
response O X
to O X
UV O X
irradiation O X
. O X

###21642453	946401,946393

Identification O X
of O X
an O X
anchor O X
residue O X
for O X
CheA I-MISC 946401
- O X
CheY I-MISC 946393
interactions O X
in O X
the O X
chemotaxis O X
system O X
of O X
Escherichia O X
coli O X
. O X

Transfer O X
of O X
a O X
phosphoryl O X
group O X
from O X
autophosphorylated O X
CheA I-MISC 946401
( O X
P O X
- O X
CheA I-MISC 946401
) O X
to O X
CheY I-MISC 946393
is O X
an O X
important O X
step O X
in O X
the O X
bacterial O X
chemotaxis O X
signal O X
transduction O X
pathway O X
. O X

This O X
reaction O X
involves O X
CheY I-MISC 946393
( O X
i O X
) O X
binding O X
to O X
the O X
P2 O X
domain O X
of O X
P O X
- O X
CheA I-MISC 946401
and O X
then O X
( O X
ii O X
) O X
acquiring O X
the O X
phosphoryl O X
group O X
from O X
the O X
P1 O X
domain O X
. O X

Crystal O X
structures O X
indicated O X
numerous O X
side O X
chain O X
interactions O X
at O X
the O X
CheY I-MISC 946393
- O X
P2 O X
binding O X
interface O X
. O X

To O X
investigate O X
the O X
individual O X
contributions O X
of O X
the O X
P2 O X
side O X
chains O X
involved O X
in O X
these O X
contacts O X
, O X
we O X
analyzed O X
the O X
effects O X
of O X
eight O X
alanine O X
substitution O X
mutations O X
on O X
CheA I-MISC 946401
- O X
CheY I-MISC 946393
binding O X
interactions O X
. O X

An O X
F214A O X
substitution O X
in O X
P2 O X
caused O X
1 O X
, O X
000 O X
- O X
fold O X
reduction O X
in O X
CheA I-MISC 946401
- O X
CheY I-MISC 946393
binding O X
affinity O X
, O X
while O X
Ala O X
substitutions O X
at O X
other O X
P2 O X
positions O X
had O X
small O X
effects O X
( O X
E171A O X
, O X
E178A O X
, O X
and O X
I216A O X
) O X
or O X
no O X
detectable O X
effects O X
( O X
H181A O X
, O X
D202A O X
, O X
D207A O X
, O X
and O X
C213A O X
) O X
on O X
binding O X
affinity O X
. O X

These O X
results O X
are O X
discussed O X
in O X
relation O X
to O X
previous O X
in O X
silico O X
predictions O X
of O X
hot O X
- O X
spot O X
and O X
anchor O X
positions O X
at O X
the O X
CheA I-MISC 946401
- O X
CheY I-MISC 946393
interface O X
. O X

We O X
also O X
investigated O X
the O X
consequences O X
of O X
these O X
mutations O X
for O X
chemotaxis O X
signal O X
transduction O X
in O X
living O X
cells O X
. O X

CheA I-MISC 946401
( O X
F214A O X
) O X
was O X
defective O X
in O X
mediating O X
localization O X
of O X
CheY I-MISC 946393
- O X
YFP O X
to O X
the O X
large O X
clusters O X
of O X
signaling O X
proteins O X
that O X
form O X
at O X
the O X
poles O X
of O X
Escherichia O X
coli O X
cells O X
, O X
while O X
the O X
other O X
CheA I-MISC 946401
variants O X
did O X
not O X
differ O X
from O X
wild O X
- O X
type O X
( O X
wt O X
) O X
CheA I-MISC 946401
( O X
CheA I-MISC 946401
( O X
wt O X
)) O X
in O X
this O X
regard O X
. O X

In O X
our O X
set O X
of O X
mutants O X
, O X
only O X
CheA I-MISC 946401
( O X
F214A O X
) O X
exhibited O X
a O X
markedly O X
diminished O X
ability O X
to O X
support O X
chemotaxis O X
in O X
motility O X
agar O X
assays O X
. O X

Surprisingly O X
, O X
however O X
, O X
in O X
FRET O X
assays O X
that O X
monitored O X
receptor O X
- O X
regulated O X
production O X
of O X
phospho O X
- O X
CheY I-MISC 946393
, O X
CheA I-MISC 946401
( O X
F214A O X
) O X
( O X
and O X
each O X
of O X
the O X
other O X
Ala O X
substitution O X
mutants O X
) O X
performed O X
just O X
as O X
well O X
as O X
CheA I-MISC 946401
( O X
wt O X
). O X

Overall O X
, O X
our O X
findings O X
indicate O X
that O X
F214 O X
serves O X
as O X
an O X
anchor O X
residue O X
at O X
the O X
CheA I-MISC 946401
- O X
CheY I-MISC 946393
interface O X
and O X
makes O X
an O X
important O X
contribution O X
to O X
the O X
binding O X
energy O X
in O X
vitro O X
and O X
in O X
vivo O X
; O X
however O X
, O X
loss O X
of O X
this O X
contribution O X
does O X
not O X
have O X
a O X
large O X
negative O X
effect O X
on O X
the O X
overall O X
ability O X
of O X
the O X
signaling O X
pathway O X
to O X
modulate O X
P O X
- O X
CheY I-MISC 946393
levels O X
in O X
response O X
to O X
chemoattractants O X
. O X

###16014621	843271,832467

The O X
plastid O X
division O X
protein O X
AtMinD1 I-MISC 832467
is O X
a O X
Ca2 O X
+- O X
ATPase O X
stimulated O X
by O X
AtMinE1 I-MISC 843271
. O X

Bacteria O X
and O X
plastids O X
divide O X
symmetrically O X
through O X
binary O X
fission O X
by O X
accurately O X
placing O X
the O X
division O X
site O X
at O X
midpoint O X
, O X
a O X
process O X
initiated O X
by O X
FtsZ O X
polymerization O X
, O X
which O X
forms O X
a O X
Z O X
- O X
ring O X
. O X

In O X
Escherichia O X
coli O X
precise O X
Z O X
- O X
ring O X
placement O X
at O X
midcell O X
depends O X
on O X
controlled O X
oscillatory O X
behavior O X
of O X
MinD O X
and O X
MinE O X
: O X
In O X
the O X
presence O X
of O X
ATP O X
MinD O X
interacts O X
with O X
the O X
FtsZ O X
inhibitor O X
MinC O X
and O X
migrates O X
to O X
the O X
membrane O X
where O X
the O X
MinD O X
- O X
MinC O X
complex O X
recruits O X
MinE O X
, O X
followed O X
by O X
MinD O X
- O X
mediated O X
ATP O X
hydrolysis O X
and O X
membrane O X
release O X
. O X

Although O X
correct O X
Z O X
- O X
ring O X
placement O X
during O X
Arabidopsis O X
plastid O X
division O X
depends O X
on O X
the O X
precise O X
localization O X
of O X
the O X
bacterial O X
homologs O X
AtMinD1 I-MISC 832467
and O X
AtMinE1 I-MISC 843271
, O X
the O X
underlying O X
mechanism O X
of O X
this O X
process O X
remains O X
unknown O X
. O X

Here O X
we O X
have O X
shown O X
that O X
AtMinD1 I-MISC 832467
is O X
a O X
Ca2 O X
+- O X
dependent O X
ATPase O X
and O X
through O X
mutation O X
analysis O X
demonstrated O X
the O X
physiological O X
importance O X
of O X
this O X
activity O X
where O X
loss O X
of O X
ATP O X
hydrolysis O X
results O X
in O X
protein O X
mislocalization O X
within O X
plastids O X
. O X

The O X
observed O X
mislocalization O X
is O X
not O X
due O X
to O X
disrupted O X
AtMinD1 I-MISC 832467
dimerization O X
, O X
however O X
; O X
the O X
active O X
site O X
AtMinD1 I-MISC 832467
( O X
K72A O X
) O X
mutant O X
is O X
unable O X
to O X
interact O X
with O X
the O X
topological O X
specificity O X
factor O X
AtMinE1 I-MISC 843271
. O X

We O X
have O X
shown O X
that O X
AtMinE1 I-MISC 843271
, O X
but O X
not O X
E O X
. O X
coli O X
MinE O X
, O X
stimulates O X
AtMinD1 I-MISC 832467
- O X
mediated O X
ATP O X
hydrolysis O X
, O X
but O X
in O X
contrast O X
to O X
prokaryotes O X
stimulation O X
occurs O X
in O X
the O X
absence O X
of O X
membrane O X
lipids O X
. O X

Although O X
AtMinD1 I-MISC 832467
appears O X
highly O X
evolutionarily O X
conserved O X
, O X
we O X
found O X
that O X
important O X
biochemical O X
and O X
cell O X
biological O X
properties O X
have O X
diverged O X
. O X

We O X
propose O X
that O X
correct O X
intraplastidic O X
AtMinD1 I-MISC 832467
localization O X
is O X
dependent O X
on O X
AtMinE1 I-MISC 843271
- O X
stimulated O X
, O X
Ca2 O X
+- O X
dependent O X
AtMinD1 I-MISC 832467
ATP O X
hydrolysis O X
, O X
ultimately O X
ensuring O X
precise O X
Z O X
- O X
ring O X
placement O X
and O X
symmetric O X
plastid O X
division O X
. O X

###12050133	14797,20473

Six3 I-MISC 20473
- O X
mediated O X
auto O X
repression O X
and O X
eye O X
development O X
requires O X
its O X
interaction O X
with O X
members O X
of O X
the O X
Groucho O X
- O X
related O X
family O X
of O X
co O X
- O X
repressors O X
. O X

Recent O X
findings O X
suggest O X
that O X
Six3 I-MISC 20473
, O X
a O X
member O X
of O X
the O X
evolutionarily O X
conserved O X
So O X
/ O X
Six O X
homeodomain O X
family O X
, O X
plays O X
an O X
important O X
role O X
in O X
vertebrate O X
visual O X
system O X
development O X
. O X

However O X
, O X
little O X
is O X
known O X
about O X
the O X
molecular O X
mechanisms O X
by O X
which O X
this O X
function O X
is O X
accomplished O X
. O X

Although O X
several O X
members O X
of O X
the O X
So O X
/ O X
Six O X
gene O X
family O X
interact O X
with O X
members O X
of O X
the O X
eyes O X
absent O X
( O X
Eya O X
) O X
gene O X
family O X
and O X
function O X
as O X
transcriptional O X
activators O X
, O X
Six3 I-MISC 20473
does O X
not O X
interact O X
with O X
any O X
known O X
member O X
of O X
the O X
Eya O X
family O X
. O X

Here O X
, O X
we O X
report O X
that O X
Grg4 I-MISC 21888
and O X
Grg5 I-MISC 14797
, O X
mouse O X
counterparts O X
of O X
the O X
Drosophila O X
transcriptional O X
co O X
- O X
repressor O X
Groucho O X
, O X
interact O X
with O X
mouse O X
Six3 I-MISC 20473
and O X
its O X
closely O X
related O X
member O X
Six6 I-MISC 20476
, O X
which O X
may O X
also O X
be O X
involved O X
in O X
vertebrate O X
eye O X
development O X
. O X

The O X
specificity O X
of O X
the O X
interaction O X
was O X
validated O X
by O X
co O X
- O X
immunoprecipitation O X
of O X
Six3 I-MISC 20473
and O X
Grg4 I-MISC 21888
complexes O X
from O X
cell O X
lines O X
. O X

We O X
also O X
show O X
that O X
the O X
interaction O X
between O X
Six3 I-MISC 20473
and O X
Grg5 I-MISC 14797
requires O X
the O X
Q O X
domain O X
of O X
Grg5 I-MISC 14797
and O X
a O X
conserved O X
phenylalanine O X
residue O X
present O X
in O X
an O X
eh1 O X
- O X
like O X
motif O X
located O X
in O X
the O X
Six O X
domain O X
of O X
Six3 I-MISC 20473
. O X

The O X
pattern O X
of O X
Grg5 I-MISC 14797
expression O X
in O X
the O X
mouse O X
ventral O X
forebrain O X
and O X
developing O X
optic O X
vesicles O X
overlapped O X
that O X
previously O X
reported O X
for O X
Six3 I-MISC 20473
and O X
Six6 I-MISC 20476
. O X

Using O X
PCR O X
, O X
we O X
identified O X
a O X
specific O X
DNA O X
motif O X
that O X
is O X
bound O X
by O X
Six3 I-MISC 20473
and O X
we O X
demonstrated O X
that O X
Six3 I-MISC 20473
acts O X
as O X
a O X
potent O X
transcriptional O X
repressor O X
upon O X
its O X
interaction O X
with O X
Groucho O X
- O X
related O X
members O X
. O X

We O X
also O X
demonstrated O X
that O X
this O X
interaction O X
is O X
required O X
for O X
Six3 I-MISC 20473
auto O X
repression O X
. O X

The O X
biological O X
significance O X
of O X
this O X
interaction O X
in O X
the O X
retina O X
and O X
lens O X
was O X
assessed O X
by O X
overexpression O X
experiments O X
using O X
either O X
wild O X
type O X
full O X
- O X
length O X
Six3 I-MISC 20473
cDNA O X
or O X
a O X
mutated O X
form O X
of O X
this O X
gene O X
in O X
which O X
the O X
interaction O X
with O X
Groucho O X
proteins O X
was O X
disrupted O X
. O X

Overexpression O X
of O X
wild O X
type O X
Six3 I-MISC 78974
by O X
in O X
vivo O X
retroviral O X
infection O X
of O X
newborn O X
rat O X
retinae O X
led O X
to O X
an O X
altered O X
photoreceptor O X
phenotype O X
, O X
while O X
the O X
in O X
ovo O X
electroporation O X
of O X
chicken O X
embryos O X
resulted O X
in O X
failure O X
of O X
lens O X
placode O X
invagination O X
and O X
production O X
of O X
delta O X
- O X
crystallin O X
- O X
negative O X
cells O X
within O X
the O X
placode O X
. O X

These O X
specific O X
alterations O X
were O X
not O X
seen O X
when O X
the O X
mutated O X
form O X
of O X
Six3 I-MISC 20473
cDNA O X
was O X
used O X
in O X
similar O X
experimental O X
approaches O X
, O X
indicating O X
that O X
Six3 I-MISC 20473
interaction O X
with O X
Groucho O X
proteins O X
plays O X
an O X
essential O X
role O X
in O X
vertebrate O X
eye O X
development O X
. O X

###15601840	2539020,2541587

Composition O X
and O X
architecture O X
of O X
the O X
Schizosaccharomyces O X
pombe O X
Rad18 I-MISC 2539020
( O X
Smc5 I-MISC 2541587
- O X
6 O X
) O X
complex O X
. O X

The O X
rad18 I-MISC 2539020
gene O X
of O X
Schizosaccharomyces O X
pombe O X
is O X
an O X
essential O X
gene O X
that O X
is O X
involved O X
in O X
several O X
different O X
DNA O X
repair O X
processes O X
. O X

Rad18 I-MISC 2539020
( O X
Smc6 I-MISC 2539020
) O X
is O X
a O X
member O X
of O X
the O X
structural O X
maintenance O X
of O X
chromosomes O X
( O X
SMC O X
) O X
family O X
and O X
, O X
together O X
with O X
its O X
SMC O X
partner O X
Spr18 I-MISC 2541587
( O X
Smc5 I-MISC 2541587
), O X
forms O X
the O X
core O X
of O X
a O X
high O X
- O X
molecular O X
- O X
weight O X
complex O X
. O X

We O X
show O X
here O X
that O X
both O X
S O X
. O X
pombe O X
and O X
human O X
Smc5 I-MISC 23137
and I-MISC 23137
- I-MISC 23137
6 I-MISC 23137
interact O X
through O X
their O X
hinge O X
domains O X
and O X
that O X
four O X
independent O X
temperature O X
- O X
sensitive O X
mutants O X
of O X
Rad18 I-MISC 2539020
( O X
Smc6 I-MISC 2539020
) O X
are O X
all O X
mutated O X
at O X
the O X
same O X
glycine O X
residue O X
in O X
the O X
hinge O X
region O X
. O X

This O X
mutation O X
abolishes O X
the O X
interactions O X
between O X
the O X
hinge O X
regions O X
of O X
Rad18 I-MISC 2539020
( O X
Smc6 I-MISC 2539020
) O X
and O X
Spr18 I-MISC 2541587
( O X
Smc5 I-MISC 2541587
), O X
as O X
does O X
mutation O X
of O X
a O X
conserved O X
glycine O X
in O X
the O X
hinge O X
region O X
of O X
Spr18 I-MISC 2541587
( O X
Smc5 I-MISC 2541587
). O X

We O X
purified O X
the O X
Smc5 I-MISC 2541587
- O X
6 O X
complex O X
from O X
S O X
. O X
pombe O X
and O X
identified O X
four O X
non O X
- O X
SMC O X
components O X
, O X
Nse1 O X
, O X
Nse2 O X
, O X
Nse3 I-MISC 56160
, O X
and O X
Rad62 O X
. O X

Nse3 I-MISC 56160
is O X
a O X
novel O X
protein O X
which O X
is O X
related O X
to O X
the O X
mammalian O X
MAGE O X
protein O X
family O X
, O X
many O X
members O X
of O X
which O X
are O X
specifically O X
expressed O X
in O X
cancer O X
tissue O X
. O X

In O X
initial O X
steps O X
to O X
understand O X
the O X
architecture O X
of O X
the O X
complex O X
, O X
we O X
identified O X
two O X
subcomplexes O X
containing O X
Rad18 I-MISC 2539020
- O X
Spr18 I-MISC 2541587
- O X
Nse2 O X
and O X
Nse1 O X
- O X
Nse3 I-MISC 56160
- O X
Rad62 O X
. O X

The O X
subcomplexes O X
are O X
probably O X
bridged O X
by O X
a O X
weaker O X
interaction O X
between O X
Nse2 O X
and O X
Nse3 I-MISC 56160
. O X

###16249186	1489171,5925	1489171,1871

Structure O X
of O X
the O X
human O X
Papillomavirus O X
E7 O X
oncoprotein O X
and O X
its O X
mechanism O X
for O X
inactivation O X
of O X
the O X
retinoblastoma O X
tumor O X
suppressor O X
. O X

The O X
E7 O X
oncoprotein O X
from O X
human O X
Papillomavirus O X
( O X
HPV O X
) O X
mediates O X
cell O X
transformation O X
in O X
part O X
by O X
binding O X
to O X
the O X
human O X
pRb I-MISC 5925
tumor O X
suppressor O X
protein O X
and O X
E2F I-MISC 1871
transcription O X
factors O X
, O X
resulting O X
in O X
the O X
dissociation O X
of O X
pRb I-MISC 5925
from O X
E2F I-MISC 1871
transcription O X
factors O X
and O X
the O X
premature O X
cell O X
progression O X
into O X
the O X
S O X
- O X
phase O X
of O X
the O X
cell O X
cycle O X
. O X

This O X
activity O X
is O X
mediated O X
by O X
the O X
LXCXE O X
motif O X
and O X
the O X
CR3 O X
zinc O X
binding O X
domain O X
of O X
the O X
E7 I-MISC 1489171
protein I-MISC 1489171
. O X

In O X
this O X
study O X
we O X
report O X
the O X
x O X
- O X
ray O X
crystal O X
structure O X
of O X
the O X
CR3 O X
region O X
of O X
HPV O X
E7 O X
and O X
a O X
structure O X
- O X
based O X
mutational O X
analysis O X
to O X
investigate O X
its O X
mode O X
of O X
pRb I-MISC 5925
and O X
E2F I-MISC 1871
binding O X
and O X
E2F I-MISC 1871
displacement O X
from O X
pRb I-MISC 5925
. O X

The O X
structure O X
reveals O X
a O X
novel O X
zinc O X
- O X
bound O X
E7 O X
- O X
CR3 O X
obligate O X
homodimer O X
that O X
contains O X
two O X
surface O X
patches O X
of O X
sequence O X
conservation O X
. O X

Mutation O X
of O X
residues O X
within O X
these O X
patches O X
reveals O X
that O X
one O X
patch O X
is O X
required O X
for O X
pRb I-MISC 5925
binding O X
, O X
whereas O X
the O X
other O X
is O X
required O X
for O X
E2F I-MISC 1871
binding O X
. O X

We O X
also O X
show O X
that O X
both O X
E7 O X
- O X
mediated O X
interactions O X
are O X
required O X
to O X
disrupt O X
pRb I-MISC 5925
. O X
E2F I-MISC 1871
complexes O X
. O X

Based O X
on O X
these O X
studies O X
we O X
present O X
a O X
mechanistic O X
model O X
for O X
how O X
E7 O X
displaces O X
E2F I-MISC 1871
from O X
pRb I-MISC 5925
. O X

Because O X
the O X
CR3 O X
region O X
of O X
HPV O X
E7 O X
has O X
no O X
detectable O X
homology O X
to O X
other O X
human O X
proteins O X
, O X
the O X
structure O X
- O X
function O X
studies O X
presented O X
here O X
provide O X
an O X
avenue O X
for O X
developing O X
small O X
molecule O X
compounds O X
that O X
inhibit O X
HPV O X
- O X
E7 O X
- O X
mediated O X
cell O X
transformation O X
. O X

###21505419	850349,855739

Structural O X
basis O X
for O X
endosomal O X
recruitment O X
of O X
ESCRT O X
- O X
I O X
by O X
ESCRT O X
- O X
0 O X
in O X
yeast O X
. O X

The O X
ESCRT O X
- O X
0 O X
and O X
ESCRT O X
- O X
I O X
complexes O X
coordinate O X
the O X
clustering O X
of O X
ubiquitinated O X
cargo O X
with O X
intralumenal O X
budding O X
of O X
the O X
endosomal O X
membrane O X
, O X
two O X
essential O X
steps O X
in O X
vacuolar O X
/ O X
lysosomal O X
protein O X
sorting O X
from O X
yeast O X
to O X
humans O X
. O X

The O X
1 O X
. O X
85 O X
- O X
crystal O X
structure O X
of O X
interacting O X
regions O X
of O X
the O X
yeast O X
ESCRT O X
- O X
0 O X
and O X
ESCRT O X
- O X
I O X
complexes O X
reveals O X
that O X
PSDP O X
motifs O X
of O X
the O X
Vps27 I-MISC 855739
ESCRT O X
- O X
0 O X
subunit O X
bind O X
to O X
a O X
novel O X
electropositive O X
N O X
- O X
terminal O X
site O X
on O X
the O X
UEV O X
domain O X
of O X
the O X
ESCRT O X
- O X
I O X
subunit O X
Vps23 I-MISC 850349
centred O X
on O X
Trp16 O X
. O X

This O X
novel O X
site O X
is O X
completely O X
different O X
from O X
the O X
C O X
- O X
terminal O X
part O X
of O X
the O X
human O X
UEV O X
domain O X
that O X
binds O X
to O X
P O X
( O X
S O X
/ O X
T O X
) O X
AP O X
motifs O X
of O X
human O X
ESCRT O X
- O X
0 O X
and O X
HIV O X
- O X
1 O X
Gag I-MISC 155030
. O X

Disruption O X
of O X
the O X
novel O X
PSDP O X
- O X
binding O X
site O X
eliminates O X
the O X
interaction O X
in O X
vitro O X
and O X
blocks O X
enrichment O X
of O X
Vps23 I-MISC 850349
in O X
endosome O X
- O X
related O X
class O X
E O X
compartments O X
in O X
yeast O X
cells O X
. O X

However O X
, O X
this O X
site O X
is O X
non O X
- O X
essential O X
for O X
sorting O X
of O X
the O X
ESCRT O X
cargo O X
Cps1 I-MISC 853267
. O X

Taken O X
together O X
, O X
these O X
results O X
show O X
how O X
a O X
conserved O X
motif O X
/ O X
domain O X
pair O X
can O X
evolve O X
to O X
use O X
strikingly O X
different O X
binding O X
modes O X
in O X
different O X
organisms O X
. O X

###22634751	5111,1028

Mutations O X
in O X
the O X
PCNA I-MISC 5111
- O X
binding O X
domain O X
of O X
CDKN1C I-MISC 1028
cause O X
IMAGe O X
syndrome O X
. O X

IMAGe O X
syndrome O X
( O X
intrauterine O X
growth O X
restriction O X
, O X
metaphyseal O X
dysplasia O X
, O X
adrenal O X
hypoplasia O X
congenita O X
and O X
genital O X
anomalies O X
) O X
is O X
an O X
undergrowth O X
developmental O X
disorder O X
with O X
life O X
- O X
threatening O X
consequences O X
. O X

An O X
identity O X
- O X
by O X
- O X
descent O X
analysis O X
in O X
a O X
family O X
with O X
IMAGe O X
syndrome O X
identified O X
a O X
17 O X
. O X
2 O X
- O X
Mb O X
locus O X
on O X
chromosome O X
11p15 O X
that O X
segregated O X
in O X
the O X
affected O X
family O X
members O X
. O X

Targeted O X
exon O X
array O X
capture O X
of O X
the O X
disease O X
locus O X
, O X
followed O X
by O X
high O X
- O X
throughput O X
genomic O X
sequencing O X
and O X
validation O X
by O X
dideoxy O X
sequencing O X
, O X
identified O X
missense O X
mutations O X
in O X
the O X
imprinted O X
gene O X
CDKN1C I-MISC 1028
( O X
also O X
known O X
as O X
P57KIP2 I-MISC 1028
) O X
in O X
two O X
familial O X
and O X
four O X
unrelated O X
patients O X
. O X

A O X
familial O X
analysis O X
showed O X
an O X
imprinted O X
mode O X
of O X
inheritance O X
in O X
which O X
only O X
maternal O X
transmission O X
of O X
the O X
mutation O X
resulted O X
in O X
IMAGe O X
syndrome O X
. O X

CDKN1C I-MISC 1028
inhibits O X
cell O X
- O X
cycle O X
progression O X
, O X
and O X
we O X
found O X
that O X
targeted O X
expression O X
of O X
IMAGe O X
- O X
associated O X
CDKN1C I-MISC 1028
mutations O X
in O X
Drosophila O X
caused O X
severe O X
eye O X
growth O X
defects O X
compared O X
to O X
wild O X
- O X
type O X
CDKN1C I-MISC 1028
, O X
suggesting O X
a O X
gain O X
- O X
of O X
- O X
function O X
mechanism O X
. O X

All O X
IMAGe O X
- O X
associated O X
mutations O X
clustered O X
in O X
the O X
PCNA I-MISC 5111
- O X
binding O X
domain O X
of O X
CDKN1C I-MISC 1028
and O X
resulted O X
in O X
loss O X
of O X
PCNA I-MISC 5111
binding O X
, O X
distinguishing O X
them O X
from O X
the O X
mutations O X
of O X
CDKN1C I-MISC 1028
that O X
cause O X
Beckwith O X
- O X
Wiedemann O X
syndrome O X
, O X
an O X
overgrowth O X
syndrome O X
. O X

###21057547	8312,18854

AXIN I-MISC 8312
is O X
an O X
essential O X
co O X
- O X
activator O X
for O X
the O X
promyelocytic I-MISC 18854
leukemia I-MISC 18854
protein I-MISC 18854
in O X
p53 I-MISC 7157
activation O X
. O X

The O X
PML I-MISC 18854
protein O X
is O X
best O X
known O X
for O X
its O X
role O X
as O X
a O X
tumor O X
suppressor O X
for O X
acute O X
promyelocytic O X
leukemia O X
. O X

Both O X
PML I-MISC 18854
and O X
the O X
key O X
Wnt O X
signaling O X
regulator O X
AXIN I-MISC 8312
regulate O X
p53 I-MISC 7157
- O X
dependent O X
apoptosis O X
in O X
response O X
to O X
DNA O X
damage O X
. O X

However O X
, O X
how O X
the O X
two O X
major O X
tumor O X
suppressors O X
coordinate O X
with O X
each O X
other O X
is O X
unknown O X
, O X
and O X
the O X
molecular O X
components O X
orchestrating O X
the O X
PML I-MISC 18854
- O X
induced O X
apoptosis O X
remain O X
enigmatic O X
. O X

Here O X
we O X
show O X
that O X
AXIN I-MISC 8312
interacts O X
with O X
PML I-MISC 18854
in O X
vivo O X
, O X
and O X
further O X
that O X
AXIN I-MISC 8312
, O X
PML I-MISC 18854
and O X
p53 I-MISC 7157
form O X
a O X
ternary O X
complex O X
. O X

Exposure O X
to O X
genotoxic O X
signals O X
including O X
UV O X
and O X
doxorubicin O X
induces O X
AXIN I-MISC 8312
to O X
enter O X
into O X
the O X
nucleus O X
where O X
it O X
colocalizes O X
with O X
PML I-MISC 18854
in O X
the O X
nuclear O X
bodies O X
. O X

Domain O X
- O X
mapping O X
experiments O X
revealed O X
that O X
the O X
C O X
- O X
terminal O X
region O X
( O X
aa O X
597 O X
- O X
832 O X
) O X
of O X
AXIN I-MISC 8312
is O X
responsible O X
for O X
its O X
interaction O X
with O X
PML I-MISC 18854
. O X

AXIN I-MISC 8312
fails O X
to O X
activate O X
p53 I-MISC 7157
in O X
PML I-MISC 18854
(-/-) O X
cells O X
, O X
and O X
conversely O X
, O X
PML I-MISC 18854
is O X
unable O X
to O X
activate O X
p53 I-MISC 7157
in O X
AXIN I-MISC 8312
- O X
null O X
SNU475 O X
cells O X
. O X

Consistently O X
, O X
knockdown O X
with O X
respective O X
siRNAs O X
revealed O X
that O X
AXIN I-MISC 8312
and O X
PML I-MISC 18854
depend O X
on O X
each O X
other O X
to O X
elevate O X
p53 I-MISC 7157
- O X
Ser O X
- O X
46 O X
phosphorylation O X
and O X
to O X
induce O X
apoptosis O X
after O X
treatment O X
with O X
genotoxins O X
. O X

Moreover O X
, O X
we O X
found O X
that O X
dominant O X
- O X
negative O X
mutants O X
of O X
PML I-MISC 18854
blocked O X
AXIN I-MISC 8312
- O X
induced O X
p53 I-MISC 7157
activation O X
, O X
and O X
that O X
AXIN I-MISC 8312
promotes O X
PML I-MISC 18854
sumoylation O X
, O X
a O X
modification O X
necessary O X
for O X
PML I-MISC 18854
functions O X
. O X

Our O X
finding O X
has O X
thus O X
provided O X
a O X
new O X
avenue O X
for O X
understanding O X
the O X
mechanism O X
by O X
which O X
PML I-MISC 18854
activates O X
p53 I-MISC 7157
and O X
exerts O X
its O X
role O X
as O X
a O X
tumor O X
suppressor O X
. O X

###10357812	64531,84018

Recruitment O X
of O X
an O X
alternatively O X
spliced O X
form O X
of O X
synaptojanin I-MISC 84018
2 I-MISC 84018
to O X
mitochondria O X
by O X
the O X
interaction O X
with O X
the O X
PDZ O X
domain O X
of O X
a O X
mitochondrial O X
outer O X
membrane O X
protein O X
. O X

Synaptojanin I-MISC 85238
1 I-MISC 85238
is O X
an O X
inositol O X
5 O X
'- O X
phosphatase O X
highly O X
enriched O X
in O X
nerve O X
terminals O X
with O X
a O X
putative O X
role O X
in O X
recycling O X
of O X
synaptic O X
vesicles O X
. O X

We O X
have O X
previously O X
described O X
synaptojanin I-MISC 84018
2 I-MISC 84018
, O X
which O X
is O X
more O X
broadly O X
expressed O X
as O X
multiple O X
alternatively O X
spliced O X
forms O X
. O X

Here O X
we O X
have O X
identified O X
and O X
characterized O X
a O X
novel O X
mitochondrial O X
outer O X
membrane O X
protein O X
, O X
OMP25 I-MISC 64531
, O X
with O X
a O X
single O X
PDZ O X
domain O X
that O X
specifically O X
binds O X
to O X
a O X
unique O X
motif O X
in O X
the O X
C O X
- O X
terminus O X
of O X
synaptojanin I-MISC 84018
2A I-MISC 84018
. O X

This O X
motif O X
is O X
encoded O X
by O X
the O X
exon O X
sequence O X
specific O X
to O X
synaptojanin I-MISC 84018
2A I-MISC 84018
. O X

OMP25 I-MISC 64531
mRNA O X
is O X
widely O X
expressed O X
in O X
rat O X
tissues O X
. O X

OMP25 I-MISC 64531
is O X
localized O X
to O X
the O X
mitochondrial O X
outer O X
membrane O X
via O X
the O X
C O X
- O X
terminal O X
transmembrane O X
region O X
, O X
with O X
the O X
PDZ O X
domain O X
facing O X
the O X
cytoplasm O X
. O X

Overexpression O X
of O X
OMP25 I-MISC 64531
results O X
in O X
perinuclear O X
clustering O X
of O X
mitochondria O X
in O X
transfected O X
cells O X
. O X

This O X
effect O X
is O X
mimicked O X
by O X
enforced O X
expression O X
of O X
synaptojanin I-MISC 84018
2A I-MISC 84018
on O X
the O X
mitochondrial O X
outer O X
membrane O X
, O X
but O X
not O X
by O X
the O X
synaptojanin I-MISC 84018
2A I-MISC 84018
mutants O X
lacking O X
the O X
inositol O X
5 O X
'- O X
phosphatase O X
domain O X
. O X

Our O X
findings O X
provide O X
evidence O X
that O X
OMP25 I-MISC 64531
mediates O X
recruitment O X
of O X
synaptojanin I-MISC 84018
2A I-MISC 84018
to O X
mitochondria O X
and O X
that O X
modulation O X
of O X
inositol O X
phospholipids O X
by O X
synaptojanin I-MISC 84018
2A I-MISC 84018
may O X
play O X
a O X
role O X
in O X
maintenance O X
of O X
the O X
intracellular O X
distribution O X
of O X
mitochondria O X
. O X

###11591686	947567,948496

Bacterial O X
two O X
- O X
hybrid O X
analysis O X
of O X
interactions O X
between O X
region O X
4 O X
of O X
the O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
subunit O X
of O X
RNA O X
polymerase O X
and O X
the O X
transcriptional O X
regulators O X
Rsd I-MISC 948496
from O X
Escherichia O X
coli O X
and O X
AlgQ O X
from O X
Pseudomonas O X
aeruginosa O X
. O X

A O X
number O X
of O X
transcriptional O X
regulators O X
mediate O X
their O X
effects O X
through O X
direct O X
contact O X
with O X
the O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
subunit O X
of O X
Escherichia O X
coli O X
RNA O X
polymerase O X
( O X
RNAP O X
). O X

In O X
particular O X
, O X
several O X
regulators O X
have O X
been O X
shown O X
to O X
contact O X
a O X
C O X
- O X
terminal O X
portion O X
of O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
that O X
harbors O X
conserved O X
region O X
4 O X
. O X

This O X
region O X
of O X
sigma O X
contains O X
a O X
putative O X
helix O X
- O X
turn O X
- O X
helix O X
DNA O X
- O X
binding O X
motif O X
that O X
contacts O X
the O X
- O X
35 O X
element O X
of O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
)- O X
dependent O X
promoters O X
directly O X
. O X

Here O X
we O X
report O X
the O X
use O X
of O X
a O X
recently O X
developed O X
bacterial O X
two O X
- O X
hybrid O X
system O X
to O X
study O X
the O X
interaction O X
between O X
the O X
putative O X
anti O X
- O X
sigma O X
factor O X
Rsd I-MISC 948496
and O X
the O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
subunit O X
of O X
E O X
. O X
coli O X
RNAP O X
. O X

Using O X
this O X
system O X
, O X
we O X
found O X
that O X
Rsd I-MISC 948496
can O X
interact O X
with O X
an O X
86 O X
- O X
amino O X
- O X
acid O X
C O X
- O X
terminal O X
fragment O X
of O X
sigma O X
( O X
70 O X
) O X
and O X
also O X
that O X
amino O X
acid O X
substitution O X
R596H O X
, O X
within O X
region O X
4 O X
of O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
), O X
weakens O X
this O X
interaction O X
. O X

We O X
demonstrated O X
the O X
specificity O X
of O X
this O X
effect O X
by O X
showing O X
that O X
substitution O X
R596H O X
does O X
not O X
weaken O X
the O X
interaction O X
between O X
sigma O X
and O X
two O X
other O X
regulators O X
shown O X
previously O X
to O X
contact O X
region O X
4 O X
of O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
). O X

We O X
also O X
demonstrated O X
that O X
AlgQ O X
, O X
a O X
homolog O X
of O X
Rsd I-MISC 948496
that O X
positively O X
regulates O X
virulence O X
gene O X
expression O X
in O X
Pseudomonas O X
aeruginosa O X
, O X
can O X
contact O X
the O X
C O X
- O X
terminal O X
region O X
of O X
the O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
subunit O X
of O X
RNAP O X
from O X
this O X
organism O X
. O X

We O X
found O X
that O X
amino O X
acid O X
substitution O X
R600H O X
in O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
from O X
P O X
. O X
aeruginosa O X
, O X
corresponding O X
to O X
the O X
R596H O X
substitution O X
in O X
E O X
. O X
coli O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
), O X
specifically O X
weakens O X
the O X
interaction O X
between O X
AlgQ O X
and O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
). O X

Taken O X
together O X
, O X
our O X
findings O X
suggest O X
that O X
Rsd I-MISC 948496
and O X
AlgQ O X
contact O X
similar O X
surfaces O X
of O X
RNAP O X
present O X
in O X
region O X
4 O X
of O X
sigma I-MISC 947567
( I-MISC 947567
70 I-MISC 947567
) I-MISC 947567
and O X
probably O X
regulate O X
gene O X
expression O X
through O X
this O X
contact O X
. O X

###21172304	367,7832

BTG2 I-MISC 7832
is O X
an O X
LXXLL O X
- O X
dependent O X
co O X
- O X
repressor O X
for O X
androgen I-MISC 367
receptor I-MISC 367
transcriptional O X
activity O X
. O X

The O X
tumor O X
suppressor O X
gene O X
, O X
BTG2 I-MISC 7832
has O X
been O X
down O X
- O X
regulated O X
in O X
prostate O X
cancer O X
and O X
the O X
ectopic O X
expression O X
of O X
this O X
gene O X
has O X
been O X
shown O X
to O X
inhibit O X
prostate O X
cancer O X
cell O X
growth O X
. O X

Sequence O X
analysis O X
revealed O X
that O X
the O X
BTG2 I-MISC 7832
protein O X
contains O X
two O X
leucine O X
- O X
rich O X
motifs O X
(( O X
20 O X
) O X
LxxLL O X
( O X
24 O X
) O X
and O X
( O X
92 O X
) O X
LxxLL O X
( O X
96 O X
)), O X
which O X
are O X
usually O X
found O X
in O X
nuclear O X
receptor O X
co O X
- O X
factors O X
. O X

Based O X
on O X
this O X
, O X
we O X
postulated O X
that O X
there O X
will O X
be O X
an O X
association O X
between O X
BTG2 I-MISC 7832
and O X
AR I-MISC 367
. O X

In O X
this O X
study O X
, O X
we O X
discovered O X
that O X
BTG2 I-MISC 7832
directly O X
bound O X
to O X
the O X
androgen I-MISC 367
receptor I-MISC 367
( O X
AR I-MISC 367
) O X
in O X
the O X
absence O X
of O X
5a O X
- O X
dihydrotestosterone O X
( O X
DHT O X
), O X
and O X
in O X
the O X
presence O X
of O X
the O X
androgen O X
, O X
this O X
interaction O X
was O X
increased O X
. O X

BTG2 I-MISC 7832
bearing O X
the O X
mutant O X
( O X
20 O X
) O X
LxxLL O X
( O X
24 O X
) O X
motif O X
bound O X
to O X
AR I-MISC 367
equally O X
efficient O X
as O X
the O X
wild O X
- O X
type O X
BTG2 I-MISC 7832
, O X
while O X
BTG2 I-MISC 7832
bearing O X
the O X
mutant O X
( O X
92 O X
) O X
LxxLL O X
( O X
96 O X
) O X
motif O X
failed O X
to O X
interact O X
with O X
AR I-MISC 367
. O X

Functional O X
studies O X
indicated O X
that O X
ectopic O X
expression O X
of O X
BTG2 I-MISC 7832
caused O X
a O X
significant O X
inhibition O X
of O X
AR I-MISC 367
- O X
mediated O X
transcriptional O X
activity O X
and O X
a O X
decreased O X
growth O X
of O X
prostate O X
cancer O X
cells O X
. O X

Androgen O X
- O X
induced O X
promoter O X
activation O X
and O X
expression O X
of O X
prostate I-MISC 354
- I-MISC 354
specific I-MISC 354
antigen I-MISC 354
( I-MISC 354
PSA I-MISC 354
) I-MISC 354
are O X
significantly O X
attenuated O X
by O X
BTG2 I-MISC 7832
. O X

The O X
intact O X
( O X
92 O X
) O X
LxxLL O X
( O X
96 O X
) O X
motif O X
is O X
required O X
for O X
these O X
activities O X
. O X

These O X
findings O X
, O X
for O X
the O X
first O X
time O X
, O X
demonstrate O X
that O X
BTG2 I-MISC 7832
complexes O X
with O X
AR I-MISC 367
via O X
an O X
LxxLL O X
- O X
dependent O X
mechanism O X
and O X
may O X
play O X
a O X
role O X
in O X
prostate O X
cancer O X
via O X
modulating O X
the O X
AR I-MISC 367
signaling O X
pathway O X
. O X

###11940652	856382,850930

Cdc42 I-MISC 850930
regulation O X
of O X
kinase O X
activity O X
and O X
signaling O X
by O X
the O X
yeast O X
p21 O X
- O X
activated O X
kinase O X
Ste20 I-MISC 856382
. O X

The O X
Saccharomyces O X
cerevisiae O X
kinase O X
Ste20 I-MISC 856382
is O X
a O X
member O X
of O X
the O X
p21 O X
- O X
activated O X
kinase O X
( O X
PAK O X
) O X
family O X
with O X
several O X
functions O X
, O X
including O X
pheromone O X
- O X
responsive O X
signal O X
transduction O X
. O X

While O X
PAKs O X
are O X
usually O X
activated O X
by O X
small O X
G O X
proteins O X
and O X
Ste20 I-MISC 856382
binds O X
Cdc42 I-MISC 850930
, O X
the O X
role O X
of O X
Cdc42 I-MISC 850930
- O X
Ste20 I-MISC 856382
binding O X
has O X
been O X
controversial O X
, O X
largely O X
because O X
Ste20 I-MISC 856382
lacking O X
its O X
entire O X
Cdc42 I-MISC 850930
- O X
binding O X
( O X
CRIB O X
) O X
domain O X
retains O X
kinase O X
activity O X
and O X
pheromone O X
response O X
. O X

Here O X
we O X
show O X
that O X
, O X
unlike O X
CRIB O X
deletion O X
, O X
point O X
mutations O X
in O X
the O X
Ste20 I-MISC 856382
CRIB O X
domain O X
that O X
disrupt O X
Cdc42 I-MISC 850930
binding O X
also O X
disrupt O X
pheromone O X
signaling O X
. O X

We O X
also O X
found O X
that O X
Ste20 I-MISC 856382
kinase O X
activity O X
is O X
stimulated O X
by O X
GTP O X
- O X
bound O X
Cdc42 I-MISC 850930
in O X
vivo O X
and O X
this O X
effect O X
is O X
blocked O X
by O X
the O X
CRIB O X
point O X
mutations O X
. O X

Moreover O X
, O X
the O X
Ste20 I-MISC 856382
CRIB O X
and O X
kinase O X
domains O X
bind O X
each O X
other O X
, O X
and O X
mutations O X
that O X
disrupt O X
this O X
interaction O X
cause O X
hyperactive O X
kinase O X
activity O X
and O X
bypass O X
the O X
requirement O X
for O X
Cdc42 I-MISC 850930
binding O X
. O X

These O X
observations O X
demonstrate O X
that O X
the O X
Ste20 I-MISC 856382
CRIB O X
domain O X
is O X
autoinhibitory O X
and O X
that O X
this O X
negative O X
effect O X
is O X
antagonized O X
by O X
Cdc42 I-MISC 850930
to O X
promote O X
Ste20 I-MISC 856382
kinase O X
activity O X
and O X
signaling O X
. O X

Parallel O X
results O X
were O X
observed O X
for O X
filamentation O X
pathway O X
signaling O X
, O X
suggesting O X
that O X
the O X
requirement O X
for O X
Cdc42 I-MISC 850930
- O X
Ste20 I-MISC 856382
interaction O X
is O X
not O X
qualitatively O X
different O X
between O X
the O X
mating O X
and O X
filamentation O X
pathways O X
. O X

While O X
necessary O X
for O X
pheromone O X
signaling O X
, O X
the O X
role O X
of O X
the O X
Cdc42 I-MISC 850930
- O X
Ste20 I-MISC 856382
interaction O X
does O X
not O X
require O X
regulation O X
by O X
pheromone O X
or O X
the O X
pheromone O X
- O X
activated O X
G O X
beta O X
gamma O X
complex O X
, O X
because O X
the O X
CRIB O X
point O X
mutations O X
also O X
disrupt O X
signaling O X
by O X
activated O X
forms O X
of O X
the O X
kinase O X
cascade O X
scaffold O X
protein O X
Ste5 I-MISC 851680
. O X

In O X
total O X
, O X
our O X
observations O X
indicate O X
that O X
Cdc42 I-MISC 850930
converts O X
Ste20 I-MISC 856382
to O X
an O X
active O X
form O X
, O X
while O X
pathway O X
stimuli O X
regulate O X
the O X
ability O X
of O X
this O X
active O X
Ste20 I-MISC 856382
to O X
trigger O X
signaling O X
through O X
a O X
particular O X
pathway O X
. O X

###16299177	824920,821463

Arabidopsis O X
calcium O X
- O X
dependent O X
protein O X
kinase O X
AtCPK32 I-MISC 824920
interacts O X
with O X
ABF4 I-MISC 821463
, O X
a O X
transcriptional O X
regulator O X
of O X
abscisic O X
acid O X
- O X
responsive O X
gene O X
expression O X
, O X
and O X
modulates O X
its O X
activity O X
. O X

The O X
phytohormone O X
abscisic O X
acid O X
( O X
ABA O X
) O X
regulates O X
stress O X
- O X
responsive O X
gene O X
expression O X
during O X
vegetative O X
growth O X
. O X

The O X
ABA O X
regulation O X
of O X
many O X
genes O X
is O X
mediated O X
by O X
a O X
subfamily O X
of O X
basic O X
leucine O X
zipper O X
class O X
transcription O X
factors O X
referred O X
to O X
as O X
ABFs O X
( O X
i O X
. O X
e O X
. O X

ABF1 I-MISC 841395
- O X
ABF4 I-MISC 821463
), O X
whose O X
transcriptional O X
activity O X
is O X
induced O X
by O X
ABA O X
. O X

Here O X
we O X
show O X
that O X
a O X
calcium O X
- O X
dependent O X
protein O X
kinase O X
is O X
involved O X
in O X
the O X
ABA O X
- O X
dependent O X
activation O X
process O X
. O X

We O X
carried O X
out O X
yeast O X
two O X
- O X
hybrid O X
screens O X
to O X
identify O X
regulatory O X
components O X
of O X
ABF4 I-MISC 821463
function O X
and O X
isolated O X
AtCPK32 I-MISC 824920
as O X
an O X
ABF4 I-MISC 821463
- O X
interacting O X
protein O X
. O X

AtCPK32 I-MISC 824920
has O X
autophosphorylation O X
activity O X
and O X
can O X
phosphorylate O X
ABF4 I-MISC 821463
in O X
vitro O X
. O X

Mutational O X
analysis O X
indicated O X
that O X
serine O X
- O X
110 O X
of O X
ABF4 I-MISC 821463
, O X
which O X
is O X
highly O X
conserved O X
among O X
ABF O X
family O X
members O X
, O X
may O X
be O X
phosphorylated O X
by O X
AtCPK32 I-MISC 824920
. O X

The O X
serine O X
- O X
110 O X
residue O X
is O X
essential O X
for O X
ABF4 I-MISC 821463
- O X
AtCPK32 I-MISC 824920
interaction O X
, O X
and O X
transient O X
expression O X
assay O X
revealed O X
that O X
it O X
is O X
also O X
required O X
for O X
the O X
normal O X
transcriptional O X
function O X
of O X
ABF4 I-MISC 821463
. O X

The O X
expression O X
patterns O X
and O X
subcellular O X
localization O X
of O X
AtCPK32 I-MISC 824920
are O X
similar O X
to O X
those O X
of O X
ABF4 I-MISC 821463
. O X

Furthermore O X
, O X
its O X
overexpression O X
affects O X
both O X
ABA O X
sensitivity O X
and O X
the O X
expression O X
of O X
a O X
number O X
of O X
ABF4 I-MISC 821463
- O X
regulated O X
genes O X
. O X

Together O X
, O X
our O X
data O X
demonstrate O X
that O X
AtCPK32 I-MISC 824920
is O X
an O X
ABA O X
signaling O X
component O X
that O X
regulates O X
the O X
ABA O X
- O X
responsive O X
gene O X
expression O X
via O X
ABF4 I-MISC 821463
. O X

###17357085	14048,147912

Transcription O X
factor O X
SIX5 I-MISC 147912
is O X
mutated O X
in O X
patients O X
with O X
branchio O X
- O X
oto O X
- O X
renal O X
syndrome O X
. O X

Branchio O X
- O X
oto O X
- O X
renal O X
syndrome O X
( O X
BOR O X
) O X
is O X
an O X
autosomal O X
dominant O X
developmental O X
disorder O X
characterized O X
by O X
the O X
association O X
of O X
branchial O X
arch O X
defects O X
, O X
hearing O X
loss O X
, O X
and O X
renal O X
anomalies O X
. O X

Mutations O X
in O X
EYA1 I-MISC 14048
are O X
known O X
to O X
cause O X
BOR O X
. O X

More O X
recently O X
, O X
mutations O X
in O X
SIX1 I-MISC 6495
, O X
which O X
interacts O X
with O X
EYA1 I-MISC 14048
, O X
were O X
identified O X
as O X
an O X
additional O X
cause O X
of O X
BOR O X
. O X

A O X
second O X
member O X
of O X
the O X
SIX O X
family O X
of O X
proteins O X
, O X
unc I-MISC 191623
- I-MISC 191623
39 I-MISC 191623
( O X
SIX5 I-MISC 147912
), O X
has O X
also O X
been O X
reported O X
to O X
directly O X
interact O X
with O X
eya I-MISC 173293
- I-MISC 173293
1 I-MISC 173293
in O X
Caenorhabditis O X
elegans O X
. O X

We O X
hypothesized O X
that O X
this O X
interaction O X
would O X
be O X
conserved O X
in O X
humans O X
and O X
that O X
interactors O X
of O X
EYA1 I-MISC 14048
represent O X
good O X
candidate O X
genes O X
for O X
BOR O X
. O X

We O X
therefore O X
screened O X
a O X
cohort O X
of O X
95 O X
patients O X
with O X
BOR O X
for O X
mutations O X
in O X
SIX5 I-MISC 147912
. O X

Four O X
different O X
heterozygous O X
missense O X
mutations O X
were O X
identified O X
in O X
five O X
individuals O X
. O X

Functional O X
analyses O X
of O X
these O X
mutations O X
demonstrated O X
that O X
two O X
mutations O X
affect O X
EYA1 I-MISC 14048
- O X
SIX5 I-MISC 147912
binding O X
and O X
the O X
ability O X
of O X
SIX5 I-MISC 147912
or O X
the O X
EYA1 I-MISC 14048
- O X
SIX5 I-MISC 147912
complex O X
to O X
activate O X
gene O X
transcription O X
. O X

We O X
thereby O X
identified O X
heterozygous O X
mutations O X
in O X
SIX5 I-MISC 147912
as O X
a O X
novel O X
cause O X
of O X
BOR O X
. O X

###12414623	4292,9156

Functional O X
alterations O X
of O X
human O X
exonuclease I-MISC 9156
1 I-MISC 9156
mutants O X
identified O X
in O X
atypical O X
hereditary O X
nonpolyposis O X
colorectal O X
cancer O X
syndrome O X
. O X

Hereditary O X
Nonpolyposis O X
Colorectal O X
Cancer O X
( O X
HNPCC O X
) O X
is O X
a O X
genetically O X
heterogeneous O X
disorder O X
caused O X
by O X
germ O X
- O X
line O X
mutations O X
in O X
one O X
of O X
several O X
DNA O X
mismatch O X
repair O X
( O X
MMR O X
) O X
genes O X
, O X
most O X
commonly O X
in O X
hMSH2 I-MISC 4436
and O X
hMLH1 I-MISC 4292
. O X

Human O X
exonuclease I-MISC 9156
1 I-MISC 9156
( O X
hExo1 I-MISC 9156
) O X
possesses O X
both O X
5 O X
' O X
exonuclease O X
and O X
flap O X
endonuclease O X
activities O X
and O X
plays O X
a O X
role O X
in O X
DNA O X
repair O X
, O X
recombination O X
, O X
and O X
replication O X
. O X

The O X
enzyme O X
interacts O X
with O X
MMR O X
proteins O X
, O X
hMsh2 I-MISC 4436
, O X
hMlh1 I-MISC 4292
, O X
and O X
hMsh3 I-MISC 4437
. O X

Recently O X
, O X
eight O X
missense O X
mutations O X
in O X
hEXO1 I-MISC 9156
were O X
identified O X
in O X
atypical O X
HNPCC O X
patients O X
, O X
who O X
have O X
been O X
screened O X
to O X
be O X
negative O X
for O X
hMSH2 I-MISC 4436
, O X
hMLH1 I-MISC 4292
, O X
and O X
hMSH6 I-MISC 2956
mutations O X
. O X

To O X
address O X
the O X
question O X
of O X
whether O X
these O X
mutations O X
cause O X
susceptibility O X
to O X
HNPCC O X
, O X
in O X
vitro O X
nuclease O X
activity O X
and O X
protein O X
- O X
protein O X
interaction O X
assays O X
were O X
performed O X
in O X
this O X
study O X
. O X

We O X
found O X
that O X
two O X
mutants O X
, O X
E109K O X
and O X
L410R O X
, O X
lost O X
their O X
exonuclease O X
activities O X
while O X
retaining O X
their O X
capacity O X
to O X
bind O X
to O X
the O X
DNA O X
substrate O X
. O X

Three O X
other O X
mutants O X
, O X
P640S O X
, O X
G759E O X
, O X
and O X
P770L O X
, O X
displayed O X
a O X
reduced O X
capacity O X
to O X
interact O X
with O X
hMsh2 I-MISC 4436
. O X

The O X
combination O X
of O X
these O X
three O X
point O X
mutations O X
leads O X
to O X
the O X
binding O X
capacity O X
with O X
hMsh2 I-MISC 4436
to O X
nearly O X
zero O X
. O X

Evidence O X
made O X
available O X
in O X
this O X
study O X
sheds O X
light O X
on O X
the O X
pathogenesis O X
of O X
HNPCC O X
, O X
perhaps O X
initiated O X
by O X
an O X
additional O X
MMR O X
gene O X
, O X
hEXO1 I-MISC 9156
. O X

###20363945	29200594,29200594	29200594,29200597

Functional O X
dissection O X
of O X
the O X
conjugative O X
coupling O X
protein O X
TrwB I-MISC 29200594
. O X

The O X
conjugative O X
coupling O X
protein O X
TrwB I-MISC 29200594
is O X
responsible O X
for O X
connecting O X
the O X
relaxosome O X
to O X
the O X
type O X
IV O X
secretion O X
system O X
during O X
conjugative O X
DNA O X
transfer O X
of O X
plasmid O X
R388 O X
. O X

It O X
is O X
directly O X
involved O X
in O X
transport O X
of O X
the O X
relaxase O X
TrwC O X
, O X
and O X
it O X
displays O X
an O X
ATPase O X
activity O X
probably O X
involved O X
in O X
DNA O X
pumping O X
. O X

We O X
designed O X
a O X
conjugation O X
assay O X
in O X
which O X
the O X
frequency O X
of O X
DNA O X
transfer O X
is O X
directly O X
proportional O X
to O X
the O X
amount O X
of O X
TrwB I-MISC 29200594
. O X

A O X
collection O X
of O X
point O X
mutants O X
was O X
constructed O X
in O X
the O X
TrwB I-MISC 29200594
cytoplasmic O X
domain O X
on O X
the O X
basis O X
of O X
the O X
crystal O X
structure O X
of O X
TrwB I-MISC 29200594
Delta O X
N70 O X
, O X
targeting O X
the O X
nucleotide O X
triphosphate O X
( O X
NTP O X
)- O X
binding O X
region O X
, O X
the O X
cytoplasmic O X
surface O X
, O X
or O X
the O X
internal O X
channel O X
in O X
the O X
hexamer O X
. O X

An O X
additional O X
set O X
of O X
transfer O X
- O X
deficient O X
mutants O X
was O X
obtained O X
by O X
random O X
mutagenesis O X
. O X

Most O X
mutants O X
were O X
impaired O X
in O X
both O X
DNA O X
and O X
protein O X
transport O X
. O X

We O X
found O X
that O X
the O X
integrity O X
of O X
the O X
nucleotide O X
binding O X
domain O X
is O X
absolutely O X
required O X
for O X
TrwB I-MISC 29200594
function O X
, O X
which O X
is O X
also O X
involved O X
in O X
monomer O X
- O X
monomer O X
interactions O X
. O X

Polar O X
residues O X
surrounding O X
the O X
entrance O X
and O X
inside O X
the O X
internal O X
channel O X
were O X
important O X
for O X
TrwB I-MISC 29200594
function O X
and O X
may O X
be O X
involved O X
in O X
interactions O X
with O X
the O X
relaxosomal O X
components O X
. O X

Finally O X
, O X
the O X
N O X
- O X
terminal O X
transmembrane O X
domain O X
of O X
TrwB I-MISC 29200594
was O X
subjected O X
to O X
random O X
mutagenesis O X
followed O X
by O X
a O X
two O X
- O X
hybrid O X
screen O X
for O X
mutants O X
showing O X
enhanced O X
protein O X
- O X
protein O X
interactions O X
with O X
the O X
related O X
TrwE I-MISC 29200597
protein O X
of O X
Bartonella O X
tribocorum O X
. O X

Several O X
point O X
mutants O X
were O X
obtained O X
with O X
mutations O X
in O X
the O X
transmembranal O X
helices O X
: O X
specifically O X
, O X
one O X
proline O X
from O X
each O X
protein O X
may O X
be O X
the O X
key O X
residue O X
involved O X
in O X
the O X
interaction O X
of O X
the O X
coupling O X
protein O X
with O X
the O X
type O X
IV O X
secretion O X
apparatus O X
. O X

###18046459	3482,3481

Structure O X
and O X
functional O X
analysis O X
of O X
the O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
/ O X
IGF2R I-MISC 3482
interaction O X
. O X

Embryonic O X
development O X
and O X
normal O X
growth O X
require O X
exquisite O X
control O X
of O X
insulin O X
- O X
like O X
growth O X
factors O X
( O X
IGFs O X
). O X

In O X
mammals O X
the O X
extracellular O X
region O X
of O X
the O X
cation I-MISC 3482
- I-MISC 3482
independent I-MISC 3482
mannose I-MISC 3482
- I-MISC 3482
6 I-MISC 3482
- I-MISC 3482
phosphate I-MISC 3482
receptor I-MISC 3482
has O X
gained O X
an O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
- O X
binding O X
function O X
and O X
is O X
termed O X
type O X
II O X
IGF O X
receptor O X
( O X
IGF2R I-MISC 3482
). O X

IGF2R I-MISC 3482
sequesters O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
; O X
imbalances O X
occur O X
in O X
cancers O X
and O X
IGF2R I-MISC 3482
is O X
implicated O X
in O X
tumour O X
suppression O X
. O X

We O X
report O X
crystal O X
structures O X
of O X
IGF2R I-MISC 3482
domains O X
11 O X
- O X
12 O X
, O X
11 O X
- O X
12 O X
- O X
13 O X
- O X
14 O X
and O X
domains O X
11 O X
- O X
12 O X
- O X
13 O X
/ O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
complex O X
. O X

A O X
distinctive O X
juxtaposition O X
of O X
these O X
domains O X
provides O X
the O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
- O X
binding O X
unit O X
, O X
with O X
domain O X
11 O X
directly O X
interacting O X
with O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
and O X
domain O X
13 O X
modulating O X
binding O X
site O X
flexibility O X
. O X

Our O X
complex O X
shows O X
that O X
Phe19 O X
and O X
Leu53 O X
of O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
lock O X
into O X
a O X
hydrophobic O X
pocket O X
unique O X
to O X
domain O X
11 O X
of O X
mammalian O X
IGF2Rs O X
. O X

Mutagenesis O X
analyses O X
confirm O X
this O X
IGF I-MISC 3481
- I-MISC 3481
II I-MISC 3481
' O X
binding O X
- O X
hotspot O X
', O X
revealing O X
that O X
IGF O X
- O X
binding O X
proteins O X
and O X
IGF2R I-MISC 3482
have O X
converged O X
on O X
the O X
same O X
high O X
- O X
affinity O X
site O X
. O X

###16148006	26413,19279	26413,67603

ERK2 I-MISC 26413
shows O X
a O X
restrictive O X
and O X
locally O X
selective O X
mechanism O X
of O X
recognition O X
by O X
its O X
tyrosine O X
phosphatase O X
inactivators O X
not O X
shared O X
by O X
its O X
activator O X
MEK1 I-MISC 5604
. O X

The O X
two O X
regulatory O X
residues O X
that O X
control O X
the O X
enzymatic O X
activity O X
of O X
the O X
mitogen O X
- O X
activated O X
protein O X
( O X
MAP O X
) O X
kinase O X
ERK2 I-MISC 26413
are O X
phosphorylated O X
by O X
the O X
unique O X
MAP O X
kinase O X
kinases O X
MEK1 I-MISC 5604
/ I-MISC 5604
2 I-MISC 5604
and O X
dephosphorylated O X
by O X
several O X
tyrosine O X
- O X
specific O X
and O X
dual O X
specificity O X
protein O X
phosphatases O X
. O X

Selective O X
docking O X
interactions O X
facilitate O X
these O X
phosphorylation O X
and O X
dephosphorylation O X
events O X
, O X
controlling O X
the O X
specificity O X
and O X
duration O X
of O X
the O X
MAP O X
kinase O X
activation O X
- O X
inactivation O X
cycles O X
. O X

We O X
have O X
analyzed O X
the O X
contribution O X
of O X
specific O X
residues O X
of O X
ERK2 I-MISC 26413
in O X
the O X
physical O X
and O X
functional O X
interaction O X
with O X
the O X
ERK2 I-MISC 26413
phosphatase O X
inactivators O X
PTP I-MISC 19279
- I-MISC 19279
SL I-MISC 19279
and O X
MKP I-MISC 67603
- I-MISC 67603
3 I-MISC 67603
and O X
with O X
its O X
activator O X
MEK1 I-MISC 5604
. O X

Single O X
mutations O X
in O X
ERK2 I-MISC 26413
that O X
abrogated O X
the O X
dephosphorylation O X
by O X
endogenous O X
tyrosine O X
phosphatases O X
from O X
HEK293 O X
cells O X
still O X
allowed O X
efficient O X
phosphorylation O X
by O X
endogenous O X
MEK1 I-MISC 5604
/ I-MISC 5604
2 I-MISC 5604
. O X

Discrete O X
ERK2 I-MISC 26413
mutations O X
at O X
the O X
ERK2 I-MISC 26413
docking O X
groove O X
differentially O X
affected O X
binding O X
and O X
inactivation O X
by O X
PTP I-MISC 19279
- I-MISC 19279
SL I-MISC 19279
and O X
MKP I-MISC 67603
- I-MISC 67603
3 I-MISC 67603
. O X

Remarkably O X
, O X
the O X
cytosolic O X
retention O X
of O X
ERK2 I-MISC 26413
by O X
its O X
activator O X
MEK1 I-MISC 5604
was O X
not O X
affected O X
by O X
any O X
of O X
the O X
analyzed O X
ERK2 I-MISC 26413
single O X
amino O X
acid O X
substitutions O X
. O X

A O X
chimeric O X
MEK1 I-MISC 5604
protein O X
, O X
containing O X
the O X
kinase O X
interaction O X
motif O X
of O X
PTP I-MISC 19279
- I-MISC 19279
SL I-MISC 19279
, O X
bound O X
tightly O X
to O X
ERK2 I-MISC 26413
through O X
its O X
docking O X
groove O X
and O X
behaved O X
as O X
a O X
gain O X
- O X
of O X
- O X
function O X
MAP O X
kinase O X
kinase O X
that O X
hyperactivated O X
ERK2 I-MISC 26413
. O X

Our O X
results O X
provide O X
evidence O X
that O X
the O X
ERK2 I-MISC 26413
docking O X
groove O X
is O X
more O X
restrictive O X
and O X
selective O X
for O X
its O X
tyrosine O X
phosphatase O X
inactivators O X
than O X
for O X
MEK1 I-MISC 5604
/ I-MISC 5604
2 I-MISC 5604
and O X
indicate O X
that O X
distinct O X
ERK2 I-MISC 26413
residues O X
modulate O X
the O X
docking O X
interactions O X
with O X
activating O X
and O X
inactivating O X
effectors O X
. O X

###19176810	120892,8772

The O X
Parkinson O X
disease O X
protein O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
transduces O X
death O X
signals O X
via O X
Fas O X
- O X
associated O X
protein O X
with O X
death O X
domain O X
and O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
in O X
a O X
cellular O X
model O X
of O X
neurodegeneration O X
. O X

Neurodegenerative O X
illnesses O X
such O X
as O X
Parkinson O X
and O X
Alzheimer O X
disease O X
are O X
an O X
increasingly O X
prevalent O X
problem O X
in O X
aging O X
societies O X
, O X
yet O X
no O X
therapies O X
exist O X
that O X
retard O X
or O X
prevent O X
neurodegeneration O X
. O X

Dominant O X
missense O X
mutations O X
in O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
are O X
the O X
most O X
common O X
genetic O X
cause O X
of O X
Parkinson O X
disease O X
( O X
PD O X
), O X
but O X
the O X
mechanisms O X
by O X
which O X
mutant O X
forms O X
of O X
LRRK2 I-MISC 120892
disrupt O X
neuronal O X
function O X
and O X
cause O X
cell O X
death O X
remain O X
poorly O X
understood O X
. O X

We O X
report O X
that O X
LRRK2 I-MISC 120892
interacts O X
with O X
the O X
death O X
adaptor O X
Fas O X
- O X
associated O X
protein O X
with O X
death O X
domain O X
( O X
FADD I-MISC 8772
), O X
and O X
that O X
in O X
primary O X
neuronal O X
culture O X
LRRK2 I-MISC 120892
- O X
mediated O X
neurodegeneration O X
is O X
prevented O X
by O X
the O X
functional O X
inhibition O X
of O X
FADD I-MISC 8772
or O X
depletion O X
of O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
, O X
two O X
key O X
elements O X
of O X
the O X
extrinsic O X
cell O X
death O X
pathway O X
. O X

This O X
pathway O X
is O X
activated O X
by O X
disease O X
- O X
triggering O X
mutations O X
, O X
which O X
enhance O X
the O X
LRRK2 I-MISC 120892
- O X
FADD I-MISC 8772
association O X
and O X
the O X
consequent O X
recruitment O X
and O X
activation O X
of O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
. O X

These O X
results O X
establish O X
a O X
direct O X
molecular O X
link O X
between O X
a O X
mutant O X
PD O X
gene O X
and O X
the O X
activation O X
of O X
programmed O X
cell O X
death O X
signaling O X
, O X
and O X
suggest O X
that O X
FADD I-MISC 8772
/ O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
signaling O X
contributes O X
to O X
LRRK2 I-MISC 120892
- O X
induced O X
neuronal O X
death O X
. O X

###18093972	26118,15258

Ubiquitination O X
and O X
degradation O X
of O X
homeodomain I-MISC 15258
- I-MISC 15258
interacting I-MISC 15258
protein I-MISC 15258
kinase I-MISC 15258
2 I-MISC 15258
by O X
WD40 O X
repeat O X
/ O X
SOCS I-MISC 1154
box O X
protein O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
. O X

Homeodomain I-MISC 15258
- I-MISC 15258
interacting I-MISC 15258
protein I-MISC 15258
kinase I-MISC 15258
2 I-MISC 15258
( O X
HIPK2 I-MISC 15258
) O X
is O X
a O X
member O X
of O X
the O X
nuclear O X
protein O X
kinase O X
family O X
, O X
which O X
induces O X
both O X
p53 I-MISC 7157
- O X
and O X
CtBP O X
- O X
mediated O X
apoptosis O X
. O X

Levels O X
of O X
HIPK2 I-MISC 15258
were O X
increased O X
by O X
UV O X
irradiation O X
and O X
cisplatin O X
treatment O X
, O X
thereby O X
implying O X
the O X
degradation O X
of O X
HIPK2 I-MISC 15258
in O X
cells O X
under O X
normal O X
conditions O X
. O X

Here O X
, O X
we O X
indicate O X
that O X
HIPK2 I-MISC 15258
is O X
ubiquitinated O X
and O X
degraded O X
by O X
the O X
WD40 O X
- O X
repeat O X
/ O X
SOCS I-MISC 1154
box O X
protein O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
, O X
a O X
process O X
that O X
is O X
blocked O X
under O X
DNA O X
damage O X
conditions O X
. O X

Yeast O X
two O X
- O X
hybrid O X
screening O X
was O X
conducted O X
to O X
identify O X
the O X
proteins O X
that O X
interact O X
with O X
HIPK2 I-MISC 15258
. O X

WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
, O X
an O X
E3 O X
ubiquitin O X
ligase O X
, O X
was O X
characterized O X
as O X
an O X
HIPK2 I-MISC 15258
- O X
interacting O X
protein O X
. O X

The O X
coexpression O X
of O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
resulted O X
in O X
the O X
degradation O X
of O X
HIPK2 I-MISC 15258
via O X
its O X
C O X
- O X
terminal O X
region O X
. O X

Domain O X
analysis O X
of O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
showed O X
that O X
WD40 O X
- O X
repeats O X
and O X
the O X
SOCS I-MISC 1154
box O X
were O X
required O X
for O X
its O X
interaction O X
with O X
and O X
degradation O X
of O X
HIPK2 I-MISC 15258
, O X
respectively O X
. O X

In O X
support O X
of O X
the O X
degradation O X
of O X
HIPK2 I-MISC 15258
by O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
, O X
HIPK2 I-MISC 15258
was O X
polyubiquitinated O X
by O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
in O X
vitro O X
and O X
in O X
vivo O X
. O X

The O X
knockdown O X
of O X
endogenous O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
with O X
the O X
expression O X
of O X
short O X
hairpin O X
RNA O X
against O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
increases O X
the O X
stability O X
of O X
endogenous O X
HIPK2 I-MISC 15258
and O X
resulted O X
in O X
the O X
accumulation O X
of O X
HIPK2 I-MISC 15258
. O X

The O X
ubiquitination O X
and O X
degradation O X
of O X
HIPK2 I-MISC 15258
by O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
was O X
inhibited O X
completely O X
via O X
the O X
administration O X
of O X
DNA O X
damage O X
reagents O X
, O X
including O X
Adriamycin O X
and O X
cisplatin O X
. O X

These O X
findings O X
effectively O X
illustrate O X
the O X
regulatory O X
mechanisms O X
by O X
which O X
HIPK2 I-MISC 15258
is O X
maintained O X
at O X
a O X
low O X
level O X
, O X
by O X
WSB I-MISC 26118
- I-MISC 26118
1 I-MISC 26118
in O X
cells O X
under O X
normal O X
conditions O X
, O X
and O X
stabilized O X
by O X
genotoxic O X
stresses O X
. O X

###21803990	948430,947335

Stepwise O X
activity O X
of O X
ClpY I-MISC 948430
( O X
HslU I-MISC 948430
) O X
mutants O X
in O X
the O X
processive O X
degradation O X
of O X
Escherichia O X
coli O X
ClpYQ O X
( O X
HslUV O X
) O X
protease O X
substrates O X
. O X

In O X
Escherichia O X
coli O X
, O X
ClpYQ O X
( O X
HslUV O X
) O X
is O X
a O X
two O X
- O X
component O X
ATP O X
- O X
dependent O X
protease O X
composed O X
of O X
ClpY I-MISC 948430
( O X
HslU I-MISC 948430
), O X
an O X
ATPase O X
with O X
unfolding O X
activity O X
, O X
and O X
ClpQ O X
( O X
HslV O X
), O X
a O X
peptidase O X
. O X

In O X
the O X
ClpYQ O X
proteolytic O X
complex O X
, O X
the O X
hexameric O X
rings O X
of O X
ClpY I-MISC 948430
( O X
HslU I-MISC 948430
) O X
are O X
responsible O X
for O X
protein O X
recognition O X
, O X
unfolding O X
, O X
and O X
translocation O X
into O X
the O X
proteolytic O X
inner O X
chamber O X
of O X
the O X
dodecameric O X
ClpQ O X
( O X
HslV O X
). O X

Each O X
of O X
the O X
three O X
domains O X
, O X
N O X
, O X
I O X
, O X
and O X
C O X
, O X
in O X
ClpY I-MISC 948430
has O X
its O X
own O X
distinct O X
activity O X
. O X

The O X
double O X
loops O X
( O X
amino O X
acids O X
[ O X
aa O X
] O X
137 O X
to O X
150 O X
and O X
175 O X
to O X
209 O X
) O X
in O X
domain O X
I O X
of O X
ClpY I-MISC 948430
are O X
necessary O X
for O X
initial O X
recognition O X
/ O X
tethering O X
of O X
natural O X
substrates O X
such O X
as O X
SulA I-MISC 947335
, O X
a O X
cell O X
division O X
inhibitor O X
protein O X
. O X

The O X
highly O X
conserved O X
sequence O X
GYVG O X
( O X
aa O X
90 O X
to O X
93 O X
) O X
pore O X
I O X
site O X
, O X
along O X
with O X
the O X
GESSG O X
pore O X
II O X
site O X
( O X
aa O X
265 O X
to O X
269 O X
), O X
contribute O X
to O X
the O X
central O X
pore O X
of O X
ClpY I-MISC 948430
in O X
domain O X
N O X
. O X
These O X
two O X
central O X
loops O X
of O X
ClpY I-MISC 948430
are O X
in O X
the O X
center O X
of O X
its O X
hexameric O X
ring O X
in O X
which O X
the O X
energy O X
of O X
ATP O X
hydrolysis O X
allows O X
substrate O X
translocation O X
and O X
then O X
degradation O X
by O X
ClpQ O X
. O X

However O X
, O X
no O X
data O X
have O X
been O X
obtained O X
to O X
determine O X
the O X
effect O X
of O X
the O X
central O X
loops O X
on O X
substrate O X
binding O X
or O X
as O X
part O X
of O X
the O X
processivity O X
of O X
the O X
ClpYQ O X
complex O X
. O X

Thus O X
, O X
we O X
probed O X
the O X
features O X
of O X
ClpY I-MISC 948430
important O X
for O X
substrate O X
engagement O X
and O X
protease O X
processivity O X
via O X
random O X
PCR O X
or O X
site O X
- O X
specific O X
mutagenesis O X
. O X

In O X
yeast O X
two O X
- O X
hybrid O X
analysis O X
and O X
pulldown O X
assays O X
, O X
using O X
isolated O X
ClpY I-MISC 948430
mutants O X
and O X
the O X
pore O X
I O X
or O X
pore O X
II O X
site O X
of O X
ClpY I-MISC 948430
, O X
each O X
was O X
examined O X
for O X
its O X
influence O X
on O X
the O X
adjoining O X
structural O X
regions O X
of O X
the O X
substrates O X
. O X

The O X
pore O X
I O X
site O X
is O X
essential O X
for O X
the O X
translocation O X
of O X
the O X
engaged O X
substrates O X
. O X

Our O X
in O X
vivo O X
study O X
of O X
the O X
ClpY I-MISC 948430
mutants O X
also O X
revealed O X
that O X
an O X
ATP O X
- O X
binding O X
site O X
in O X
domain O X
N O X
, O X
separate O X
from O X
its O X
role O X
in O X
polypeptide O X
( O X
ClpY I-MISC 948430
) O X
oligomerization O X
, O X
is O X
required O X
for O X
complex O X
formation O X
with O X
ClpQ O X
. O X

Additionally O X
, O X
we O X
found O X
that O X
the O X
tyrosine O X
residue O X
at O X
position O X
408 O X
in O X
ClpY I-MISC 948430
is O X
critical O X
for O X
stabilization O X
of O X
hexamer O X
formation O X
between O X
subunits O X
. O X

Therefore O X
, O X
our O X
studies O X
suggest O X
that O X
stepwise O X
activities O X
of O X
the O X
ClpYQ O X
protease O X
are O X
necessary O X
to O X
facilitate O X
the O X
processive O X
degradation O X
of O X
its O X
natural O X
substrates O X
. O X

###17012600	821607,822098

NDR1 I-MISC 821607
interaction O X
with O X
RIN4 I-MISC 822098
mediates O X
the O X
differential O X
activation O X
of O X
multiple O X
disease O X
resistance O X
pathways O X
in O X
Arabidopsis O X
. O X

Recognition O X
of O X
pathogens O X
by O X
plants O X
involves O X
the O X
coordinated O X
efforts O X
of O X
molecular O X
chaperones O X
, O X
disease O X
resistance O X
( O X
R O X
) O X
proteins O X
, O X
and O X
components O X
of O X
disease O X
resistance O X
signaling O X
pathways O X
. O X

Characterization O X
of O X
events O X
associated O X
with O X
pathogen O X
perception O X
in O X
Arabidopsis O X
thaliana O X
has O X
advanced O X
understanding O X
of O X
molecular O X
genetic O X
mechanisms O X
associated O X
with O X
disease O X
resistance O X
and O X
protein O X
interactions O X
critical O X
for O X
the O X
activation O X
of O X
resistance O X
signaling O X
. O X

Regulation O X
of O X
R O X
protein O X
- O X
mediated O X
signaling O X
in O X
response O X
to O X
the O X
bacterial O X
pathogen O X
Pseudomonas O X
syringae O X
in O X
Arabidopsis O X
involves O X
the O X
physical O X
association O X
of O X
at O X
least O X
two O X
R O X
proteins O X
with O X
the O X
negative O X
regulator O X
RPM1 I-MISC 822098
INTERACTING I-MISC 822098
PROTEIN4 I-MISC 822098
( O X
RIN4 I-MISC 822098
). O X

While O X
the O X
RIN4 I-MISC 822098
- O X
RPS2 I-MISC 828715
( O X
for O X
RESISTANCE O X
TO O X
P O X
. O X
SYRINGAE2 O X
) O X
and O X
RIN4 I-MISC 822098
- O X
RPM1 I-MISC 819889
( O X
for O X
RESISTANCE O X
TO O X
P O X
. O X
SYRINGAE O X
PV O X
MACULICOLA1 O X
) O X
signaling O X
pathways O X
exhibit O X
differential O X
mechanisms O X
of O X
activation O X
in O X
terms O X
of O X
effector O X
action O X
, O X
the O X
requirement O X
for O X
NON I-MISC 821607
- I-MISC 821607
RACE I-MISC 821607
- I-MISC 821607
SPECIFIC I-MISC 821607
DISEASE I-MISC 821607
RESISTANCE1 I-MISC 821607
( O X
NDR1 I-MISC 821607
) O X
is O X
shared O X
. O X

Using O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
followed O X
by O X
a O X
series O X
of O X
coimmunoprecipitation O X
experiments O X
, O X
we O X
demonstrate O X
that O X
the O X
RIN4 I-MISC 822098
- O X
NDR1 I-MISC 821607
interaction O X
occurs O X
on O X
the O X
cytoplasmically O X
localized O X
N O X
- O X
terminal O X
portion O X
of O X
NDR1 I-MISC 821607
and O X
that O X
this O X
interaction O X
is O X
required O X
for O X
the O X
activation O X
of O X
resistance O X
signaling O X
following O X
infection O X
by O X
P O X
. O X
syringae O X
expressing O X
the O X
Cys O X
protease O X
Type O X
III O X
effector O X
protein O X
AvrRpt2 O X
. O X

We O X
demonstrate O X
that O X
like O X
RPS2 I-MISC 828715
and O X
RPM1 I-MISC 819889
, O X
NDR1 I-MISC 821607
also O X
associates O X
with O X
RIN4 I-MISC 822098
in O X
planta O X
. O X

We O X
suggest O X
that O X
this O X
interaction O X
serves O X
to O X
further O X
regulate O X
activation O X
of O X
disease O X
resistance O X
signaling O X
following O X
recognition O X
of O X
P O X
. O X
syringae O X
DC3000 O X
- O X
AvrRpt2 O X
by O X
Arabidopsis O X
. O X

###22487239	811,182	821,182	182,4854

Functional O X
analysis O X
of O X
the O X
Notch I-MISC 4854
ligand O X
Jagged1 I-MISC 182
missense O X
mutant O X
proteins O X
underlying O X
Alagille O X
syndrome O X
. O X

Heterozygous O X
mutations O X
in O X
the O X
JAG1 I-MISC 182
gene O X
, O X
encoding O X
Notch I-MISC 4854
ligand O X
Jagged1 I-MISC 182
, O X
cause O X
Alagille O X
syndrome O X
( O X
ALGS O X
). O X

As O X
most O X
of O X
the O X
mutations O X
are O X
nonsense O X
or O X
frameshift O X
mutations O X
producing O X
inactive O X
truncated O X
proteins O X
, O X
haplo O X
- O X
insufficiency O X
is O X
considered O X
the O X
major O X
pathogenic O X
mechanism O X
of O X
ALGS O X
. O X

However O X
, O X
the O X
molecular O X
mechanisms O X
by O X
which O X
the O X
missense O X
mutations O X
cause O X
ALGS O X
remain O X
unclear O X
. O X

Here O X
we O X
analyzed O X
the O X
functional O X
properties O X
of O X
four O X
ALGS O X
missense O X
mutant O X
proteins O X
, O X
P163L O X
, O X
R184H O X
, O X
G386R O X
and O X
C714Y O X
, O X
using O X
transfected O X
mammalian O X
cells O X
. O X

P163L O X
and O X
R184H O X
showed O X
Notch I-MISC 4854
- O X
binding O X
activities O X
similar O X
to O X
that O X
of O X
the O X
wild O X
- O X
type O X
when O X
assessed O X
by O X
immunoprecipitation O X
. O X

However O X
, O X
their O X
trans O X
- O X
activation O X
and O X
cis O X
- O X
inhibition O X
activities O X
were O X
almost O X
completely O X
impaired O X
. O X

These O X
mutant O X
proteins O X
localized O X
mainly O X
to O X
the O X
endoplasmic O X
reticulum O X
( O X
ER O X
), O X
suggesting O X
that O X
the O X
mutations O X
induced O X
improper O X
protein O X
folding O X
. O X

Furthermore O X
, O X
the O X
mutant O X
proteins O X
bound O X
more O X
strongly O X
to O X
the O X
ER O X
chaperone O X
proteins O X
calnexin I-MISC 821
and O X
calreticulin I-MISC 811
than O X
the O X
wild O X
- O X
type O X
did O X
. O X

C714Y O X
also O X
localized O X
to O X
the O X
ER O X
, O X
but O X
possessed O X
significant O X
trans O X
- O X
activation O X
activity O X
and O X
lacked O X
enhanced O X
binding O X
to O X
the O X
chaperones O X
, O X
indicating O X
a O X
less O X
severe O X
phenotype O X
. O X

The O X
properties O X
of O X
G386R O X
were O X
the O X
same O X
as O X
those O X
of O X
the O X
wild O X
- O X
type O X
. O X

Dominant O X
- O X
negative O X
effects O X
were O X
not O X
detected O X
for O X
any O X
mutant O X
protein O X
. O X

These O X
results O X
indicate O X
that O X
accumulation O X
in O X
the O X
ER O X
and O X
binding O X
to O X
the O X
chaperones O X
correlate O X
with O X
the O X
impaired O X
signal O X
- O X
transduction O X
activities O X
of O X
the O X
missense O X
mutant O X
proteins O X
, O X
which O X
may O X
contribute O X
to O X
the O X
pathogenic O X
mechanism O X
of O X
ALGS O X
. O X

Our O X
findings O X
, O X
which O X
suggest O X
the O X
requirement O X
for O X
cell O X
- O X
surface O X
localization O X
of O X
Jagged1 I-MISC 182
for O X
cis O X
- O X
inhibition O X
activities O X
, O X
also O X
provide O X
important O X
information O X
for O X
understanding O X
the O X
molecular O X
basis O X
of O X
Notch I-MISC 4854
- O X
signaling O X
pathways O X
. O X

###23357641	375790,114249	114249,15530

Nephronectin I-MISC 114249
binds O X
to O X
heparan I-MISC 15530
sulfate I-MISC 15530
proteoglycans I-MISC 15530
via O X
its O X
MAM O X
domain O X
. O X

Nephronectin I-MISC 114249
is O X
a O X
basement O X
membrane O X
protein O X
comprising O X
five O X
N O X
- O X
terminal O X
epidermal O X
growth O X
factor O X
( O X
EGF O X
)- O X
like O X
repeats O X
, O X
a O X
central O X
linker O X
segment O X
containing O X
an O X
Arg O X
- O X
Gly O X
- O X
Asp O X
( O X
RGD O X
) O X
motif O X
and O X
a O X
C O X
- O X
terminal O X
meprin O X
- O X
A5 O X
protein O X
- O X
receptor O X
protein O X
tyrosine O X
phosphatase O X
( O X
MAM O X
) O X
domain O X
. O X

Nephronectin I-MISC 114249
has O X
been O X
shown O X
to O X
interact O X
with O X
a8b1 O X
integrin O X
through O X
the O X
central O X
linker O X
segment O X
, O X
but O X
its O X
interactions O X
with O X
other O X
molecules O X
remain O X
to O X
be O X
elucidated O X
. O X

Here O X
, O X
we O X
examined O X
the O X
binding O X
of O X
nephronectin I-MISC 114249
to O X
a O X
panel O X
of O X
glycosaminoglycan O X
( O X
GAG O X
) O X
chains O X
. O X

Nephronectin I-MISC 114249
bound O X
strongly O X
to O X
heparin O X
and O X
chondroitin I-MISC 107869
sulfate I-MISC 107869
( I-MISC 107869
CS I-MISC 107869
)- I-MISC 107869
E I-MISC 107869
and O X
moderately O X
to O X
heparan O X
sulfate O X
( O X
HS O X
), O X
but O X
failed O X
to O X
bind O X
to O X
CS I-MISC 15526
- I-MISC 15526
A I-MISC 15526
, O X
CS O X
- O X
C O X
, O X
CS I-MISC 246277
- I-MISC 246277
D I-MISC 246277
, O X
dermatan O X
sulfate O X
and O X
hyaluronic O X
acid O X
. O X

Deletion O X
of O X
the O X
MAM O X
domain O X
severely O X
impaired O X
the O X
binding O X
of O X
nephronectin I-MISC 114249
to O X
heparin O X
but O X
not O X
CS I-MISC 107869
- I-MISC 107869
E I-MISC 107869
, O X
whereas O X
deletion O X
of O X
the O X
EGF O X
- O X
like O X
repeats O X
reduced O X
its O X
binding O X
to O X
CS I-MISC 107869
- I-MISC 107869
E I-MISC 107869
but O X
not O X
heparin O X
, O X
suggesting O X
that O X
nephronectin I-MISC 114249
interacts O X
with O X
CS I-MISC 107869
- I-MISC 107869
E I-MISC 107869
and O X
heparin O X
through O X
the O X
EGF O X
- O X
like O X
repeats O X
and O X
MAM O X
domain O X
, O X
respectively O X
. O X

Consistent O X
with O X
these O X
results O X
, O X
nephronectin I-MISC 114249
bound O X
to O X
agrin I-MISC 375790
and O X
perlecan I-MISC 15530
, O X
which O X
are O X
heparan I-MISC 15530
sulfate I-MISC 15530
proteoglycans I-MISC 15530
( O X
HSPGs I-MISC 15530
) O X
in O X
basement O X
membranes O X
, O X
in O X
HS O X
- O X
dependent O X
manners O X
. O X

Site O X
- O X
directed O X
mutagenesis O X
of O X
the O X
MAM O X
domain O X
revealed O X
that O X
multiple O X
basic O X
amino O X
acid O X
residues O X
in O X
the O X
putative O X
loop O X
regions O X
were O X
involved O X
in O X
the O X
binding O X
of O X
the O X
MAM O X
domain O X
to O X
agrin I-MISC 375790
. O X

The O X
binding O X
of O X
nephronectin I-MISC 114249
to O X
basement O X
membrane O X
HSPGs I-MISC 15530
was O X
further O X
confirmed O X
by O X
in O X
situ O X
nephronectin I-MISC 114249
overlay O X
assays O X
using O X
mouse O X
frozen O X
tissue O X
sections O X
. O X

Taken O X
together O X
, O X
these O X
findings O X
indicate O X
that O X
nephronectin I-MISC 114249
is O X
capable O X
of O X
binding O X
to O X
HSPGs I-MISC 15530
in O X
basement O X
membranes O X
via O X
the O X
MAM O X
domain O X
, O X
and O X
thereby O X
raise O X
the O X
possibility O X
that O X
interactions O X
with O X
basement O X
membrane O X
HSPGs I-MISC 15530
may O X
be O X
involved O X
in O X
the O X
deposition O X
of O X
nephronectin I-MISC 114249
onto O X
basement O X
membranes O X
. O X

###8246997	5970,5970

A O X
novel O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
complex O X
containing O X
p65 I-MISC 5970
homodimers O X
: O X
implications O X
for O X
transcriptional O X
control O X
at O X
the O X
level O X
of O X
subunit O X
dimerization O X
. O X

The O X
predominant O X
inducible O X
form O X
of O X
the O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
transcription O X
factor O X
is O X
a O X
heteromeric O X
complex O X
containing O X
two O X
Rel I-MISC 5966
- O X
related O X
DNA O X
- O X
binding O X
subunits O X
, O X
termed O X
p65 I-MISC 5970
and O X
p50 I-MISC 4790
. O X

Prior O X
transfection O X
studies O X
have O X
shown O X
that O X
when O X
these O X
p65 I-MISC 5970
and O X
p50 I-MISC 4790
subunits O X
are O X
expressed O X
independently O X
as O X
stable O X
homodimers O X
, O X
p65 I-MISC 5970
stimulates O X
kappa O X
B O X
- O X
directed O X
transcription O X
, O X
whereas O X
p50 I-MISC 4790
functions O X
as O X
a O X
kappa O X
B O X
- O X
specific O X
repressor O X
. O X

While O X
authentic O X
p50 I-MISC 4790
homodimers O X
( O X
previously O X
termed O X
KBF1 I-MISC 4790
) O X
have O X
been O X
detected O X
in O X
nuclear O X
extracts O X
from O X
nontransfected O X
cells O X
, O X
experimental O X
evidence O X
supporting O X
the O X
existence O X
of O X
p65 I-MISC 5970
homodimers O X
in O X
vivo O X
was O X
lacking O X
. O X

We O X
now O X
provide O X
direct O X
biochemical O X
evidence O X
for O X
the O X
presence O X
of O X
an O X
endogenous O X
pool O X
of O X
inducible O X
p65 I-MISC 5970
homodimers O X
in O X
intact O X
human O X
T O X
cells O X
. O X

As O X
with O X
the O X
prototypical O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
p50 B-MISC 4790
- O X
p65 I-MISC 5970
heterodimer O X
, O X
this O X
novel O X
p65 I-MISC 5970
homodimeric O X
form O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
is O X
functionally O X
sequestered O X
in O X
the O X
cytoplasm O X
but O X
rapidly O X
appears O X
in O X
the O X
nuclear O X
compartment O X
following O X
cellular O X
stimulation O X
. O X

Site O X
- O X
directed O X
mutagenesis O X
studies O X
indicate O X
that O X
the O X
homodimerization O X
function O X
of O X
p65 I-MISC 5970
is O X
dependent O X
upon O X
the O X
presence O X
of O X
cysteine O X
216 O X
and O X
a O X
conserved O X
recognition O X
motif O X
for O X
protein O X
kinase O X
A O X
( O X
RRPS O X
; O X
amino O X
acids O X
273 O X
to O X
276 O X
), O X
both O X
of O X
which O X
reside O X
within O X
a O X
91 O X
- O X
amino O X
- O X
acid O X
segment O X
of O X
the O X
Rel I-MISC 5966
homology O X
domain O X
that O X
mediates O X
self O X
- O X
association O X
. O X

In O X
contrast O X
, O X
mutations O X
at O X
these O X
two O X
sites O X
do O X
not O X
affect O X
heterodimerization O X
of O X
p65 I-MISC 5970
with O X
p50 I-MISC 4790
or O X
its O X
functional O X
interaction O X
with O X
I I-MISC 4792
kappa I-MISC 4792
B I-MISC 4792
alpha I-MISC 4792
. O X

These O X
later O X
findings O X
indicate O X
that O X
neither O X
homo O X
- O X
nor O X
heterodimer O X
formation O X
is O X
an O X
absolute O X
prerequisite O X
for O X
I I-MISC 4792
kappa I-MISC 4792
B I-MISC 4792
alpha I-MISC 4792
recognition O X
of O X
p65 I-MISC 5970
. O X

Taken O X
together O X
with O X
prior O X
in O X
vivo O X
transcription O X
studies O X
, O X
these O X
results O X
suggest O X
that O X
the O X
biological O X
activities O X
of O X
p65 I-MISC 5970
and O X
p50 I-MISC 4790
homodimers O X
are O X
independently O X
regulated O X
, O X
thereby O X
providing O X
an O X
integrated O X
and O X
flexible O X
control O X
mechanism O X
for O X
the O X
rapid O X
activation O X
and O X
repression O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
/ O X
Rel I-MISC 5966
- O X
directed O X
gene O X
expression O X
. O X

###15831486	13449,20779

Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
mediates O X
attenuation O X
of O X
epidermal O X
growth O X
factor O X
- O X
dependent O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
and O X
Akt I-MISC 207
activation O X
through O X
processive O X
recruitment O X
of O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
and O X
Csk I-MISC 1445
. O X

Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
has O X
previously O X
been O X
shown O X
to O X
associate O X
with O X
the O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
and O X
become O X
tyrosine O X
phosphorylated O X
in O X
response O X
to O X
EGF O X
stimulation O X
. O X

The O X
recruitment O X
of O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
to O X
the O X
EGFR I-MISC 1956
, O X
which O X
is O X
mediated O X
through O X
its O X
phosphotyrosine O X
binding O X
( O X
PTB O X
) O X
domain O X
, O X
results O X
in O X
attenuation O X
of O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
( O X
MAPK O X
) O X
activation O X
. O X

Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
' O X
s O X
ability O X
to O X
attenuate O X
EGF O X
- O X
driven O X
MAPK O X
activation O X
is O X
independent O X
of O X
its O X
ability O X
to O X
recruit O X
rasGAP O X
, O X
a O X
known O X
attenuator O X
of O X
MAPK O X
activity O X
, O X
suggesting O X
an O X
alternate O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
- O X
mediated O X
pathway O X
. O X

Herein O X
, O X
we O X
have O X
determined O X
the O X
structural O X
determinants O X
within O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
that O X
are O X
required O X
for O X
its O X
ability O X
to O X
attenuate O X
EGF O X
signaling O X
and O X
to O X
associate O X
with O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
and O X
with O X
the O X
Src O X
family O X
kinase O X
( O X
SFK O X
)- O X
inhibitory O X
kinase O X
, O X
Csk I-MISC 1445
. O X

We O X
demonstrate O X
that O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
associates O X
constitutively O X
with O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
through O X
an O X
SH3 O X
- O X
dependent O X
interaction O X
and O X
that O X
this O X
association O X
is O X
essential O X
to O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
' O X
s O X
ability O X
to O X
attenuate O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
activity O X
and O X
diminish O X
MAPK O X
and O X
Akt I-MISC 207
/ O X
PKB O X
activity O X
. O X

We O X
further O X
illustrate O X
that O X
EGF O X
- O X
dependent O X
phosphorylation O X
of O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
requires O X
SFK O X
activity O X
and O X
, O X
more O X
specifically O X
, O X
that O X
SFK O X
- O X
dependent O X
phosphorylation O X
of O X
tyrosine O X
402 O X
on O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
facilitates O X
the O X
inducible O X
recruitment O X
of O X
Csk I-MISC 1445
. O X

We O X
propose O X
that O X
recruitment O X
of O X
Csk I-MISC 1445
to O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
serves O X
to O X
bring O X
Csk I-MISC 1445
to O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
and O X
down O X
- O X
regulate O X
its O X
activity O X
, O X
resulting O X
in O X
a O X
concomitant O X
attenuation O X
of O X
MAPK O X
and O X
Akt I-MISC 207
/ O X
PKB O X
activity O X
. O X

Furthermore O X
, O X
we O X
demonstrate O X
that O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
can O X
abrogate O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
' O X
s O X
ability O X
to O X
protect O X
the O X
breast O X
cancer O X
cell O X
line O X
SKBR3 O X
from O X
anoikis O X
and O X
that O X
an O X
association O X
with O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
and O X
Csk I-MISC 1445
is O X
required O X
for O X
this O X
activity O X
. O X

Collectively O X
these O X
results O X
demonstrate O X
that O X
Dok I-MISC 13449
- I-MISC 13449
R I-MISC 13449
acts O X
as O X
an O X
EGFR I-MISC 1956
- O X
recruited O X
scaffolding O X
molecule O X
that O X
processively O X
assembles O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
and O X
Csk I-MISC 1445
to O X
attenuate O X
signaling O X
from O X
the O X
EGFR I-MISC 1956
. O X

###22904282	888164,2721310

Interaction O X
of O X
CarD I-MISC 2721310
with O X
RNA I-MISC 888164
polymerase I-MISC 888164
mediates O X
Mycobacterium O X
tuberculosis O X
viability O X
, O X
rifampin O X
resistance O X
, O X
and O X
pathogenesis O X
. O X

Mycobacterium O X
tuberculosis O X
infection O X
continues O X
to O X
cause O X
substantial O X
human O X
suffering O X
. O X

New O X
chemotherapeutic O X
strategies O X
, O X
which O X
require O X
insight O X
into O X
the O X
pathways O X
essential O X
for O X
M O X
. O X
tuberculosis O X
pathogenesis O X
, O X
are O X
imperative O X
. O X

We O X
previously O X
reported O X
that O X
depletion O X
of O X
the O X
CarD I-MISC 2721310
protein O X
in O X
mycobacteria O X
compromises O X
viability O X
, O X
resistance O X
to O X
oxidative O X
stress O X
and O X
fluoroquinolones O X
, O X
and O X
pathogenesis O X
. O X

CarD I-MISC 2721310
associates O X
with O X
the O X
RNA I-MISC 888164
polymerase I-MISC 888164
( O X
RNAP I-MISC 888164
), O X
but O X
it O X
has O X
been O X
unknown O X
which O X
of O X
the O X
diverse O X
functions O X
of O X
CarD I-MISC 2721310
are O X
mediated O X
through O X
the O X
RNAP I-MISC 888164
; O X
this O X
question O X
must O X
be O X
answered O X
to O X
understand O X
the O X
CarD I-MISC 2721310
mechanism O X
of O X
action O X
. O X

Herein O X
, O X
we O X
describe O X
the O X
interaction O X
between O X
the O X
M O X
. O X
tuberculosis O X
CarD I-MISC 2721310
and O X
the O X
RNAP I-MISC 888164
b I-MISC 888164
subunit I-MISC 888164
and O X
identify O X
point O X
mutations O X
that O X
weaken O X
this O X
interaction O X
. O X

The O X
characterization O X
of O X
mycobacterial O X
strains O X
with O X
attenuated O X
CarD I-MISC 2721310
/ O X
RNAP I-MISC 888164
b I-MISC 888164
interactions O X
demonstrates O X
that O X
the O X
CarD I-MISC 2721310
/ O X
RNAP I-MISC 888164
b I-MISC 888164
association O X
is O X
required O X
for O X
viability O X
and O X
resistance O X
to O X
oxidative O X
stress O X
but O X
not O X
for O X
fluoroquinolone O X
resistance O X
. O X

Weakening O X
the O X
CarD I-MISC 2721310
/ O X
RNAP I-MISC 888164
b I-MISC 888164
interaction O X
also O X
increases O X
the O X
sensitivity O X
of O X
mycobacteria O X
to O X
rifampin O X
and O X
streptomycin O X
. O X

Surprisingly O X
, O X
depletion O X
of O X
the O X
CarD I-MISC 2721310
protein O X
did O X
not O X
affect O X
sensitivity O X
to O X
rifampin O X
. O X

These O X
findings O X
define O X
the O X
CarD I-MISC 2721310
/ O X
RNAP I-MISC 888164
interaction O X
as O X
a O X
new O X
target O X
for O X
chemotherapeutic O X
intervention O X
that O X
could O X
also O X
improve O X
the O X
efficacy O X
of O X
rifampin O X
treatment O X
of O X
tuberculosis O X
. O X

In O X
addition O X
, O X
our O X
data O X
demonstrate O X
that O X
weakening O X
the O X
CarD I-MISC 2721310
/ O X
RNAP I-MISC 888164
b I-MISC 888164
interaction O X
does O X
not O X
completely O X
phenocopy O X
the O X
depletion O X
of O X
CarD I-MISC 2721310
and O X
support O X
the O X
existence O X
of O X
functions O X
for O X
CarD I-MISC 2721310
independent O X
of O X
direct O X
RNAP I-MISC 888164
binding O X
. O X

###8944023	580,672

Identification O X
of O X
a O X
RING O X
protein O X
that O X
can O X
interact O X
in O X
vivo O X
with O X
the O X
BRCA1 I-MISC 672
gene O X
product O X
. O X

The O X
hereditary O X
breast O X
and O X
ovarian O X
cancer O X
gene O X
, O X
BRCA1 I-MISC 672
, O X
encodes O X
a O X
large O X
polypeptide O X
that O X
contains O X
the O X
cysteine O X
- O X
rich O X
RING O X
motif O X
, O X
a O X
zinc O X
- O X
binding O X
domain O X
found O X
in O X
a O X
variety O X
of O X
regulatory O X
proteins O X
. O X

Here O X
we O X
describe O X
a O X
novel O X
protein O X
that O X
interacts O X
in O X
vivo O X
with O X
the O X
N O X
- O X
terminal O X
region O X
of O X
BRCA1 I-MISC 672
. O X

This O X
BRCA1 I-MISC 672
- O X
associated O X
RING O X
domain O X
( O X
BARD1 I-MISC 580
) O X
protein O X
contains O X
an O X
N O X
- O X
terminal O X
RING O X
motif O X
, O X
three O X
tandem O X
ankyrin O X
repeats O X
, O X
and O X
a O X
C O X
- O X
terminal O X
sequence O X
with O X
significant O X
homology O X
to O X
the O X
phylogenetically O X
conserved O X
BRCT O X
domains O X
that O X
lie O X
near O X
the O X
C O X
terminus O X
of O X
BRCA1 I-MISC 672
. O X

The O X
BARD1 I-MISC 580
/ O X
BRCA1 I-MISC 672
interaction O X
is O X
disrupted O X
by O X
BRCA1 I-MISC 672
missense O X
mutations O X
that O X
segregate O X
with O X
breast O X
cancer O X
susceptibility O X
, O X
indicating O X
that O X
BARD1 I-MISC 580
may O X
be O X
involved O X
in O X
mediating O X
tumour O X
suppression O X
by O X
BRCA1 I-MISC 672
. O X

###19559006	23189,55605

A O X
major O X
mutation O X
of O X
KIF21A I-MISC 55605
associated O X
with O X
congenital O X
fibrosis O X
of O X
the O X
extraocular O X
muscles O X
type O X
1 O X
( O X
CFEOM1 O X
) O X
enhances O X
translocation O X
of O X
Kank1 I-MISC 23189
to O X
the O X
membrane O X
. O X

Congenital O X
fibrosis O X
of O X
the O X
extraocular O X
muscles O X
type O X
1 O X
( O X
CFEOM1 O X
) O X
is O X
associated O X
with O X
heterozygous O X
mutations O X
in O X
the O X
KIF21A I-MISC 55605
gene O X
, O X
including O X
a O X
major O X
( O X
R954W O X
) O X
and O X
a O X
minor O X
( O X
M947T O X
) O X
mutation O X
. O X

Kank1 I-MISC 23189
, O X
which O X
regulates O X
actin O X
polymerization O X
, O X
cell O X
migration O X
and O X
neurite O X
outgrowth O X
, O X
interacted O X
with O X
the O X
third O X
and O X
fourth O X
coiled O X
- O X
coil O X
domains O X
of O X
KIF21A I-MISC 55605
protein O X
at O X
its O X
ankyrin O X
- O X
repeat O X
domain O X
. O X

While O X
both O X
KIF21A I-MISC 55605
( O X
R954W O X
) O X
and O X
KIF21A I-MISC 55605
( O X
M947T O X
) O X
enhanced O X
the O X
formation O X
of O X
a O X
heterodimer O X
with O X
the O X
wild O X
type O X
, O X
KIF21A I-MISC 55605
( O X
WT O X
), O X
these O X
mutants O X
also O X
enhanced O X
the O X
interaction O X
with O X
Kank1 I-MISC 23189
. O X

Knockdown O X
of O X
KIF21A I-MISC 55605
resulted O X
in O X
Kank1 I-MISC 23189
predominantly O X
occurring O X
in O X
the O X
cytosolic O X
fraction O X
, O X
while O X
KIF21A I-MISC 55605
( O X
WT O X
) O X
slightly O X
enhanced O X
the O X
translocation O X
of O X
Kank1 I-MISC 23189
to O X
the O X
membrane O X
fraction O X
. O X

Moreover O X
, O X
KIF21A I-MISC 55605
( O X
R954W O X
) O X
significantly O X
enhanced O X
the O X
translocation O X
of O X
Kank1 I-MISC 23189
to O X
the O X
membrane O X
fraction O X
. O X

These O X
results O X
suggest O X
that O X
KIF21A I-MISC 55605
regulates O X
the O X
distribution O X
of O X
Kank1 I-MISC 23189
and O X
that O X
KIF21A I-MISC 55605
mutations O X
associated O X
with O X
CFEOM1 O X
enhanced O X
the O X
accumulation O X
of O X
Kank1 I-MISC 23189
in O X
the O X
membrane O X
fraction O X
. O X

This O X
might O X
cause O X
an O X
abrogation O X
of O X
neuronal O X
development O X
in O X
cases O X
of O X
CFEOM1 O X
through O X
over O X
- O X
regulation O X
of O X
actin O X
polymerization O X
by O X
Kank1 I-MISC 23189
. O X

###21262861	55553,6473

SHOX I-MISC 6473
interacts O X
with O X
the O X
chondrogenic O X
transcription O X
factors O X
SOX5 I-MISC 6660
and O X
SOX6 I-MISC 55553
to O X
activate O X
the O X
aggrecan O X
enhancer O X
. O X

SHOX I-MISC 6473
( O X
short O X
stature O X
homeobox O X
- O X
containing O X
gene O X
) O X
encodes O X
a O X
transcription O X
factor O X
implicated O X
in O X
skeletal O X
development O X
. O X

SHOX I-MISC 6473
haploinsufficiency O X
has O X
been O X
demonstrated O X
in O X
Leri O X
- O X
Weill O X
dyschondrosteosis O X
( O X
LWD O X
), O X
a O X
skeletal O X
dysplasia O X
associated O X
with O X
disproportionate O X
short O X
stature O X
, O X
as O X
well O X
as O X
in O X
a O X
variable O X
proportion O X
of O X
cases O X
with O X
idiopathic O X
short O X
stature O X
( O X
ISS O X
). O X

In O X
order O X
to O X
gain O X
insight O X
into O X
the O X
SHOX I-MISC 6473
signalling O X
pathways O X
, O X
we O X
performed O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
to O X
identify O X
SHOX I-MISC 6473
- O X
interacting O X
proteins O X
. O X

Two O X
transcription O X
factors O X
, O X
SOX5 I-MISC 6660
and O X
SOX6 I-MISC 55553
, O X
were O X
identified O X
. O X

Co O X
- O X
immunoprecipitation O X
assays O X
confirmed O X
the O X
existence O X
of O X
the O X
SHOX I-MISC 6473
- O X
SOX5 I-MISC 6660
and O X
SHOX I-MISC 6473
- O X
SOX6 I-MISC 55553
interactions O X
in O X
human O X
cells O X
, O X
whereas O X
immunohistochemical O X
studies O X
demonstrated O X
the O X
coexpression O X
of O X
these O X
proteins O X
in O X
18 O X
- O X
and O X
32 O X
- O X
week O X
human O X
fetal O X
growth O X
plates O X
. O X

The O X
SHOX I-MISC 6473
homeodomain O X
and O X
the O X
SOX6 I-MISC 55553
HMG O X
domain O X
were O X
shown O X
to O X
be O X
implicated O X
in O X
the O X
SHOX I-MISC 6473
- O X
SOX6 I-MISC 55553
interaction O X
. O X

Moreover O X
, O X
different O X
SHOX I-MISC 6473
missense O X
mutations O X
, O X
identified O X
in O X
LWD O X
and O X
ISS O X
patients O X
, O X
disrupted O X
this O X
interaction O X
. O X

The O X
physiological O X
importance O X
of O X
these O X
interactions O X
was O X
investigated O X
by O X
studying O X
the O X
effect O X
of O X
SHOX I-MISC 6473
on O X
a O X
transcriptional O X
target O X
of O X
the O X
SOX O X
trio O X
, O X
Agc1 I-MISC 176
, O X
which O X
encodes O X
one O X
of O X
the O X
main O X
components O X
of O X
cartilage O X
, O X
aggrecan O X
. O X

Our O X
results O X
show O X
that O X
SHOX I-MISC 6473
cooperates O X
with O X
SOX5 I-MISC 6660
/ O X
SOX6 I-MISC 55553
and O X
SOX9 I-MISC 6662
in O X
the O X
activation O X
of O X
the O X
upstream O X
Agc1 I-MISC 176
enhancer O X
and O X
that O X
SHOX I-MISC 6473
mutations O X
affect O X
this O X
activation O X
. O X

In O X
conclusion O X
, O X
we O X
have O X
identified O X
SOX5 I-MISC 6660
and O X
SOX6 I-MISC 55553
as O X
the O X
first O X
two O X
SHOX I-MISC 6473
- O X
interacting O X
proteins O X
and O X
have O X
shown O X
that O X
this O X
interaction O X
regulates O X
aggrecan O X
expression O X
, O X
an O X
essential O X
factor O X
in O X
chondrogenesis O X
and O X
skeletal O X
development O X
. O X

###21697476	3783727,5451

Cellular O X
transcription O X
factor O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
interacts O X
with O X
the O X
Epstein O X
- O X
Barr O X
virus O X
BRLF1 I-MISC 3783727
protein O X
to O X
promote O X
disruption O X
of O X
viral O X
latency O X
. O X

The O X
Epstein O X
- O X
Barr O X
virus O X
( O X
EBV O X
) O X
latent O X
- O X
to O X
- O X
lytic O X
switch O X
is O X
an O X
essential O X
part O X
of O X
the O X
viral O X
life O X
cycle O X
, O X
but O X
the O X
cellular O X
factors O X
that O X
promote O X
viral O X
reactivation O X
are O X
not O X
well O X
defined O X
. O X

In O X
this O X
report O X
, O X
we O X
demonstrate O X
that O X
the O X
cellular O X
transcription O X
factor O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
cooperates O X
with O X
the O X
EBV O X
immediate O X
- O X
early O X
protein O X
BRLF1 I-MISC 3783727
( O X
R O X
, O X
Rta I-MISC 116535
) O X
to O X
induce O X
lytic O X
viral O X
reactivation O X
. O X

We O X
show O X
that O X
cotransfected O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
enhances O X
the O X
ability O X
of O X
BRLF1 I-MISC 3783727
to O X
activate O X
lytic O X
gene O X
expression O X
in O X
293 O X
cells O X
stably O X
infected O X
with O X
a O X
BRLF1 I-MISC 3783727
- O X
defective O X
EBV O X
mutant O X
( O X
BRLF1 I-MISC 3783727
- O X
stop O X
) O X
and O X
that O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
increases O X
BRLF1 I-MISC 3783727
- O X
mediated O X
activation O X
of O X
lytic O X
EBV O X
promoters O X
in O X
reporter O X
gene O X
assays O X
. O X

We O X
find O X
that O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
interacts O X
directly O X
with O X
BRLF1 I-MISC 3783727
in O X
vitro O X
and O X
that O X
a O X
mutant O X
BRLF1 I-MISC 3783727
protein O X
( O X
the O X
M140A O X
mutant O X
) O X
attenuated O X
for O X
the O X
ability O X
to O X
interact O X
with O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
in O X
vitro O X
is O X
also O X
resistant O X
to O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
- O X
mediated O X
transcriptional O X
enhancement O X
in O X
293 O X
BRLF1 I-MISC 3783727
- O X
stop O X
cells O X
. O X

Furthermore O X
, O X
we O X
show O X
that O X
cotransfected O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
augments O X
BRLF1 I-MISC 3783727
binding O X
to O X
a O X
variety O X
of O X
lytic O X
EBV O X
promoters O X
in O X
chromatin O X
immunoprecipitation O X
( O X
ChIP O X
) O X
assays O X
( O X
including O X
the O X
BZLF1 O X
, O X
BMRF1 O X
, O X
and O X
SM O X
promoters O X
) O X
and O X
that O X
BRLF1 I-MISC 3783727
tethers O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
to O X
lytic O X
EBV O X
promoters O X
. O X

In O X
addition O X
, O X
we O X
demonstrate O X
that O X
an O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
mutant O X
defective O X
in O X
DNA O X
binding O X
( O X
the O X
S335D O X
mutant O X
) O X
still O X
retains O X
the O X
ability O X
to O X
enhance O X
BRLF1 I-MISC 3783727
transcriptional O X
effects O X
. O X

Finally O X
, O X
we O X
show O X
that O X
knockdown O X
of O X
endogenous O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
expression O X
reduces O X
the O X
level O X
of O X
constitutive O X
lytic O X
EBV O X
gene O X
expression O X
in O X
both O X
EBV O X
- O X
positive O X
B O X
- O X
cell O X
and O X
EBV O X
- O X
positive O X
epithelial O X
cell O X
lines O X
. O X

These O X
results O X
suggest O X
that O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
acts O X
as O X
a O X
positive O X
regulator O X
of O X
EBV O X
lytic O X
gene O X
expression O X
and O X
that O X
this O X
effect O X
is O X
at O X
least O X
partially O X
mediated O X
through O X
its O X
interaction O X
with O X
the O X
viral O X
protein O X
BRLF1 I-MISC 3783727
. O X

###12571249	5578,6385

Direct O X
binding O X
of O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
cytoplasmic O X
domain O X
to O X
the O X
catalytic O X
domain O X
of O X
protein I-MISC 5578
kinase I-MISC 5578
C I-MISC 5578
alpha I-MISC 5578
( O X
PKC I-MISC 5578
alpha I-MISC 5578
) O X
increases O X
focal O X
adhesion O X
localization O X
of O X
PKC I-MISC 5578
alpha I-MISC 5578
. O X

Syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
is O X
a O X
transmembrane O X
heparan O X
sulfate O X
proteoglycan O X
that O X
acts O X
as O X
a O X
coreceptor O X
with O X
integrins O X
in O X
focal O X
adhesion O X
formation O X
. O X

The O X
central O X
region O X
of O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
cytoplasmic O X
domain O X
( O X
4V O X
; O X
LGKKPIYKK O X
) O X
binds O X
phosphatidylinositol O X
4 O X
, O X
5 O X
- O X
bisphosphate O X
, O X
and O X
together O X
they O X
regulate O X
protein I-MISC 5578
kinase I-MISC 5578
C I-MISC 5578
alpha I-MISC 5578
( O X
PKC I-MISC 5578
alpha I-MISC 5578
) O X
activity O X
. O X

Syndecan O X
4V O X
peptide O X
directly O X
potentiates O X
PKC I-MISC 5578
alpha I-MISC 5578
activity O X
, O X
leading O X
to O X
" O X
superactivation O X
" O X
of O X
the O X
enzyme O X
, O X
apparently O X
through O X
an O X
interaction O X
with O X
its O X
catalytic O X
domain O X
. O X

We O X
now O X
have O X
performed O X
yeast O X
two O X
- O X
hybrid O X
and O X
in O X
vitro O X
binding O X
assays O X
to O X
determine O X
the O X
interaction O X
sites O X
between O X
4V O X
and O X
PKC I-MISC 5578
alpha I-MISC 5578
. O X

Full O X
- O X
length O X
PKC I-MISC 5578
alpha I-MISC 5578
weakly O X
interacted O X
with O X
4V O X
by O X
yeast O X
two O X
- O X
hybrid O X
assays O X
, O X
but O X
PKC I-MISC 5578
alpha I-MISC 5578
constructs O X
that O X
lack O X
the O X
pseudosubstrate O X
region O X
or O X
constructs O X
of O X
the O X
whole O X
catalytic O X
domain O X
interacted O X
more O X
strongly O X
. O X

A O X
mutated O X
4V O X
sequence O X
( O X
4V O X
( O X
YF O X
): O X
LGKKPIFKK O X
) O X
did O X
not O X
interact O X
with O X
PKC I-MISC 5578
alpha I-MISC 5578
, O X
indicating O X
that O X
tyrosine O X
192 O X
in O X
the O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
cytoplasmic O X
domain O X
might O X
be O X
critical O X
for O X
this O X
interaction O X
. O X

Further O X
assays O X
identified O X
a O X
novel O X
interaction O X
site O X
in O X
the O X
C O X
terminus O X
of O X
the O X
catalytic O X
domain O X
of O X
PKC I-MISC 5578
alpha I-MISC 5578
( O X
amino O X
acid O X
sequence O X
513 O X
- O X
672 O X
). O X

This O X
encompasses O X
the O X
autophosphorylation O X
sites O X
, O X
which O X
are O X
implicated O X
in O X
activation O X
and O X
stability O X
. O X

Yeast O X
two O X
- O X
hybrid O X
data O X
were O X
confirmed O X
by O X
in O X
vitro O X
binding O X
and O X
coimmunoprecipitation O X
assays O X
. O X

The O X
interaction O X
of O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
with O X
PKC I-MISC 5578
alpha I-MISC 5578
appears O X
unique O X
since O X
PKC O X
delta O X
and O X
epsilon O X
did O X
not O X
interact O X
with O X
4V O X
in O X
yeast O X
two O X
- O X
hybrid O X
assays O X
or O X
coimmunoprecipitate O X
with O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
. O X

Finally O X
, O X
overexpression O X
of O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
in O X
rat O X
embryo O X
fibroblast O X
cells O X
, O X
but O X
not O X
expression O X
of O X
the O X
YF O X
mutant O X
, O X
increased O X
PKC I-MISC 5578
alpha I-MISC 5578
localization O X
to O X
focal O X
adhesions O X
. O X

The O X
data O X
support O X
a O X
mechanism O X
where O X
syndecan I-MISC 6385
- I-MISC 6385
4 I-MISC 6385
binds O X
PKC I-MISC 5578
alpha I-MISC 5578
and O X
localizes O X
it O X
to O X
focal O X
adhesions O X
, O X
whose O X
assembly O X
may O X
be O X
regulated O X
by O X
the O X
kinase O X
. O X

###15447654	843928,835842

Formation O X
of O X
an O X
SCF O X
( O X
ZTL I-MISC 835842
) O X
complex O X
is O X
required O X
for O X
proper O X
regulation O X
of O X
circadian O X
timing O X
. O X

The O X
circadian O X
timing O X
system O X
involves O X
an O X
autoregulatory O X
transcription O X
/ O X
translation O X
feedback O X
loop O X
that O X
incorporates O X
a O X
diverse O X
array O X
of O X
factors O X
to O X
maintain O X
a O X
24 O X
- O X
h O X
periodicity O X
. O X

In O X
Arabidopsis O X
a O X
novel O X
F O X
- O X
box O X
protein O X
, O X
ZEITLUPE I-MISC 835842
( O X
ZTL I-MISC 835842
), O X
plays O X
an O X
important O X
role O X
in O X
the O X
control O X
of O X
the O X
free O X
- O X
running O X
period O X
of O X
the O X
circadian O X
clock O X
. O X

As O X
a O X
class O X
, O X
F O X
- O X
box O X
proteins O X
are O X
well O X
- O X
established O X
components O X
of O X
the O X
Skp I-MISC 843928
/ O X
Cullin O X
/ O X
F O X
- O X
box O X
( O X
SCF O X
) O X
class O X
of O X
E3 O X
ubiquitin O X
ligases O X
that O X
link O X
the O X
target O X
substrates O X
to O X
the O X
core O X
ubiquitinating O X
activity O X
of O X
the O X
ligase O X
complex O X
via O X
direct O X
association O X
with O X
the O X
Skp I-MISC 843928
protein O X
. O X

Here O X
we O X
identify O X
and O X
characterize O X
the O X
SCFZTL O X
complex O X
in O X
detail O X
. O X

Yeast O X
two O X
- O X
hybrid O X
tests O X
demonstrate O X
the O X
sufficiency O X
and O X
necessity O X
of O X
the O X
F O X
- O X
box O X
domain O X
for O X
Arabidopsis O X
Skp I-MISC 843928
- O X
like O X
protein O X
( O X
ASK O X
) O X
interactions O X
and O X
the O X
dispensability O X
of O X
the O X
unique O X
N O X
- O X
terminal O X
LOV O X
domain O X
in O X
this O X
association O X
. O X

Co O X
- O X
immunoprecipitation O X
of O X
full O X
- O X
length O X
( O X
FL O X
) O X
ZTL I-MISC 835842
with O X
the O X
three O X
known O X
core O X
components O X
of O X
SCF O X
complexes O X
( O X
ASK1 I-MISC 843928
, O X
AtCUL1 I-MISC 825648
and O X
AtRBX1 I-MISC 832179
) O X
demonstrates O X
that O X
ZTL I-MISC 835842
can O X
assemble O X
into O X
an O X
SCF O X
complex O X
in O X
vivo O X
. O X

F O X
- O X
box O X
- O X
containing O X
truncated O X
versions O X
of O X
ZTL I-MISC 835842
( O X
LOV O X
- O X
F O X
and O X
F O X
- O X
kelch O X
) O X
can O X
complex O X
with O X
SCF O X
components O X
in O X
vivo O X
, O X
whereas O X
stably O X
expressed O X
LOV O X
or O X
kelch O X
domains O X
alone O X
cannot O X
. O X

Stable O X
expression O X
of O X
F O X
- O X
box O X
- O X
mutated O X
FL O X
ZTL I-MISC 835842
eliminates O X
the O X
shortened O X
period O X
caused O X
by O X
mild O X
ZTL I-MISC 835842
overexpression O X
and O X
also O X
abolishes O X
ASK1 I-MISC 843928
interaction O X
in O X
vivo O X
. O X

Reduced O X
levels O X
of O X
the O X
core O X
SCF O X
component O X
AtRBX1 I-MISC 832179
phenocopy O X
the O X
long O X
period O X
phenotype O X
of O X
ztl I-MISC 835842
loss O X
- O X
of O X
- O X
function O X
mutations O X
, O X
demonstrating O X
the O X
functional O X
significance O X
of O X
the O X
SCFZTL O X
complex O X
. O X

Taken O X
together O X
, O X
our O X
data O X
establish O X
SCFZTL O X
as O X
an O X
essential O X
SCF O X
class O X
E3 O X
ligase O X
controlling O X
circadian O X
period O X
in O X
plants O X
. O X

###10604475	3676,5829

Binding O X
of O X
paxillin I-MISC 5829
to O X
alpha4 I-MISC 3676
integrins I-MISC 3676
modifies O X
integrin O X
- O X
dependent O X
biological O X
responses O X
. O X

The O X
alpha4 I-MISC 3676
integrins I-MISC 3676
are O X
indispensable O X
for O X
embryogenesis O X
, O X
haematopoiesis O X
and O X
immune O X
responses O X
, O X
possibly O X
because O X
alpha4 I-MISC 3676
regulates O X
cellular O X
functions O X
differently O X
from O X
other O X
integrins O X
through O X
its O X
cytoplasmic O X
tail O X
. O X

We O X
used O X
novel O X
mimics O X
of O X
the O X
alpha4 I-MISC 3676
tail O X
to O X
identify O X
molecules O X
that O X
could O X
account O X
for O X
alpha4 I-MISC 3676
- O X
specific O X
signalling O X
. O X

Here O X
we O X
report O X
that O X
the O X
alpha4 I-MISC 3676
tail O X
, O X
but O X
not O X
several O X
other O X
alpha O X
- O X
subunit O X
tails O X
, O X
binds O X
tightly O X
to O X
the O X
signalling O X
adaptor O X
paxillin I-MISC 5829
. O X

Paxillin I-MISC 5829
physically O X
associated O X
with O X
alpha4 I-MISC 3676
integrins O X
in O X
Jurkat O X
T O X
cells O X
at O X
high O X
stoichiometry O X
, O X
and O X
joining O X
the O X
alpha4 I-MISC 3676
tail O X
to O X
alphaIIb O X
resulted O X
in O X
a O X
complex O X
of O X
integrin O X
alphaIIbbeta3 O X
with O X
paxillin I-MISC 5829
. O X

This O X
association O X
markedly O X
enhanced O X
the O X
rates O X
of O X
alphaIIbbeta3 O X
- O X
dependent O X
phosphorylation O X
of O X
focal O X
adhesion O X
kinase O X
and O X
cell O X
migration O X
. O X

It O X
also O X
reduced O X
cell O X
spreading O X
, O X
focal O X
adhesion O X
and O X
stress O X
fibre O X
formation O X
. O X

A O X
point O X
mutation O X
within O X
the O X
alpha4 I-MISC 3676
tail O X
that O X
disrupts O X
paxillin I-MISC 5829
binding O X
reversed O X
all O X
of O X
these O X
effects O X
. O X

Furthermore O X
, O X
alpha4beta1 O X
- O X
dependent O X
adhesion O X
to O X
VCAM I-MISC 22329
- I-MISC 22329
1 I-MISC 22329
led O X
to O X
spreading O X
of O X
mouse O X
embryonic O X
fibroblasts O X
derived O X
from O X
paxillin I-MISC 5829
- O X
null O X
but O X
not O X
from O X
wild O X
- O X
type O X
mice O X
. O X

Thus O X
, O X
the O X
tight O X
association O X
of O X
paxillin I-MISC 5829
with O X
the O X
alpha4 I-MISC 3676
tail O X
leads O X
to O X
distinct O X
biochemical O X
and O X
biological O X
responses O X
to O X
integrin O X
- O X
mediated O X
cell O X
adhesion O X
. O X

###21531806	878129,878129

Binding O X
and O X
spreading O X
of O X
ParB I-MISC 878129
on O X
DNA O X
determine O X
its O X
biological O X
function O X
in O X
Pseudomonas O X
aeruginosa O X
. O X

ParB I-MISC 878129
protein O X
of O X
Pseudomonas O X
aeruginosa O X
belongs O X
to O X
a O X
widely O X
represented O X
ParB I-MISC 878129
family O X
of O X
chromosomally O X
and O X
plasmid O X
- O X
encoded O X
partitioning O X
type O X
IA O X
proteins O X
. O X

Ten O X
putative O X
parS O X
sites O X
are O X
dispersed O X
in O X
the O X
P O X
. O X
aeruginosa O X
chromosome O X
, O X
with O X
eight O X
of O X
them O X
localizing O X
in O X
the O X
oriC O X
domain O X
. O X

After O X
binding O X
to O X
parS O X
, O X
ParB I-MISC 878129
spreads O X
on O X
the O X
DNA O X
, O X
causing O X
transcriptional O X
silencing O X
of O X
nearby O X
genes O X
( O X
A O X
. O X

A O X
. O X
Bartosik O X
et O X
al O X
., O X
J O X
. O X
Bacteriol O X
. O X

186 O X
: O X
6983 O X
- O X
6998 O X
, O X
2004 O X
). O X

We O X
have O X
studied O X
ParB I-MISC 878129
derivatives O X
impaired O X
in O X
spreading O X
either O X
due O X
to O X
loss O X
of O X
DNA O X
- O X
binding O X
ability O X
or O X
oligomerization O X
. O X

We O X
defined O X
specific O X
determinants O X
outside O X
of O X
the O X
helix O X
- O X
turn O X
- O X
helix O X
motif O X
responsible O X
for O X
DNA O X
binding O X
. O X

Analysis O X
confirmed O X
the O X
localization O X
of O X
the O X
main O X
dimerization O X
domain O X
in O X
the O X
C O X
terminus O X
of O X
ParB I-MISC 878129
but O X
also O X
mapped O X
another O X
self O X
- O X
interactive O X
domain O X
in O X
the O X
N O X
- O X
terminal O X
domain O X
. O X

Reverse O X
genetics O X
were O X
used O X
to O X
introduce O X
five O X
parB I-MISC 878129
alleles O X
impaired O X
in O X
spreading O X
into O X
the O X
P O X
. O X
aeruginosa O X
chromosome O X
. O X

The O X
single O X
amino O X
acid O X
substitutions O X
in O X
ParB I-MISC 878129
causing O X
a O X
defect O X
in O X
oligomerization O X
but O X
not O X
in O X
DNA O X
binding O X
caused O X
a O X
chromosome O X
segregation O X
defect O X
, O X
slowed O X
the O X
growth O X
rate O X
, O X
and O X
impaired O X
motilities O X
, O X
similarly O X
to O X
the O X
pleiotropic O X
phenotype O X
of O X
parB I-MISC 878129
- O X
null O X
mutants O X
, O X
indicating O X
that O X
the O X
ability O X
to O X
spread O X
is O X
vital O X
for O X
ParB I-MISC 878129
function O X
in O X
the O X
cell O X
. O X

The O X
toxicity O X
of O X
ParB I-MISC 878129
overproduction O X
in O X
Pseudomonas O X
spp O X
. O X

is O X
not O X
due O X
to O X
the O X
spreading O X
since O X
several O X
ParB I-MISC 878129
derivatives O X
defective O X
in O X
oligomerization O X
were O X
still O X
toxic O X
for O X
P O X
. O X
aeruginosa O X
when O X
provided O X
in O X
excess O X
. O X

###21569203	2335,28379874

The O X
A O X
domain O X
of O X
fibronectin I-MISC 2335
- O X
binding O X
protein O X
B O X
of O X
Staphylococcus O X
aureus O X
contains O X
a O X
novel O X
fibronectin I-MISC 2335
binding O X
site O X
. O X

The O X
fibronectin I-MISC 2335
- O X
binding O X
proteins O X
FnBPA I-MISC 28379874
and O X
FnBPB O X
are O X
multifunctional O X
adhesins O X
than O X
can O X
also O X
bind O X
to O X
fibrinogen O X
and O X
elastin O X
. O X

In O X
this O X
study O X
, O X
the O X
N2N3 O X
subdomains O X
of O X
region O X
A O X
of O X
FnBPB O X
were O X
shown O X
to O X
bind O X
fibrinogen O X
with O X
a O X
similar O X
affinity O X
to O X
those O X
of O X
FnBPA I-MISC 28379874
( O X
2 O X
M O X
). O X

The O X
binding O X
site O X
for O X
FnBPB O X
in O X
fibrinogen O X
was O X
localized O X
to O X
the O X
C O X
- O X
terminus O X
of O X
the O X
y O X
- O X
chain O X
. O X

Like O X
clumping O X
factor O X
A O X
, O X
region O X
A O X
of O X
FnBPB O X
bound O X
to O X
the O X
y O X
- O X
chain O X
of O X
fibrinogen O X
in O X
a O X
Ca O X
( O X
2 O X
+)- O X
inhibitable O X
manner O X
. O X

The O X
deletion O X
of O X
17 O X
residues O X
from O X
the O X
C O X
- O X
terminus O X
of O X
domain O X
N3 O X
and O X
the O X
substitution O X
of O X
two O X
residues O X
in O X
equivalent O X
positions O X
for O X
crucial O X
residues O X
for O X
fibrinogen O X
binding O X
in O X
clumping O X
factor O X
A O X
and O X
FnBPA I-MISC 28379874
eliminated O X
fibrinogen O X
binding O X
by O X
FnBPB O X
. O X

This O X
indicates O X
that O X
FnBPB O X
binds O X
fibrinogen O X
by O X
the O X
dock O X
- O X
lock O X
- O X
latch O X
mechanism O X
. O X

In O X
contrast O X
, O X
the O X
A O X
domain O X
of O X
FnBPB O X
bound O X
fibronectin I-MISC 2335
with O X
K O X
( O X
D O X
) O X
= O X
2 O X
. O X
5 O X
M O X
despite O X
lacking O X
any O X
of O X
the O X
known O X
fibronectin I-MISC 2335
- O X
binding O X
tandem O X
repeats O X
. O X

A O X
truncate O X
lacking O X
the O X
C O X
- O X
terminal O X
17 O X
residues O X
( O X
latching O X
peptide O X
) O X
bound O X
fibronectin I-MISC 2335
with O X
the O X
same O X
affinity O X
, O X
suggesting O X
that O X
the O X
FnBPB O X
A O X
domain O X
binds O X
fibronectin I-MISC 2335
by O X
a O X
novel O X
mechanism O X
. O X

The O X
substitution O X
of O X
the O X
two O X
residues O X
required O X
for O X
fibrinogen O X
binding O X
also O X
resulted O X
in O X
a O X
loss O X
of O X
fibronectin I-MISC 2335
binding O X
. O X

This O X
, O X
combined O X
with O X
the O X
observation O X
that O X
purified O X
subdomain O X
N3 O X
bound O X
fibronectin I-MISC 2335
with O X
a O X
measurable O X
, O X
but O X
reduced O X
, O X
K O X
( O X
D O X
) O X
of O X
20 O X
M O X
, O X
indicates O X
that O X
the O X
type O X
I O X
modules O X
of O X
fibronectin I-MISC 2335
bind O X
to O X
both O X
the O X
N2 O X
and O X
N3 O X
subdomains O X
. O X

The O X
fibronectin I-MISC 2335
- O X
binding O X
ability O X
of O X
the O X
FnBPB O X
A O X
domain O X
was O X
also O X
functional O X
when O X
the O X
protein O X
was O X
expressed O X
on O X
and O X
anchored O X
to O X
the O X
surface O X
of O X
staphylococcal O X
cells O X
, O X
showing O X
that O X
it O X
is O X
not O X
an O X
artifact O X
of O X
recombinant O X
protein O X
expression O X
. O X

###20921992	4170,12125

Prevention O X
of O X
cytokine O X
withdrawal O X
- O X
induced O X
apoptosis O X
by O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
requires O X
interaction O X
between O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
and O X
Bim I-MISC 10018
. O X

Growth O X
factor O X
withdrawal O X
from O X
hemopoietic O X
cells O X
results O X
in O X
activation O X
of O X
the O X
mitochondrial O X
pathway O X
of O X
apoptosis O X
. O X

Members O X
of O X
the O X
Bcl I-MISC 12125
- I-MISC 12125
2 I-MISC 12125
family O X
regulate O X
this O X
pathway O X
, O X
with O X
anti O X
- O X
apoptotic O X
members O X
counteracting O X
the O X
effects O X
of O X
pro O X
- O X
apoptotic O X
members O X
. O X

We O X
investigated O X
the O X
effect O X
on O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
function O X
of O X
mutation O X
at O X
a O X
conserved O X
threonine O X
163 O X
residue O X
( O X
T163 O X
) O X
in O X
its O X
proline O X
, O X
glutamate O X
, O X
serine O X
, O X
and O X
threonine O X
rich O X
( O X
PEST O X
) O X
region O X
. O X

Under O X
normal O X
growth O X
conditions O X
, O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
half O X
- O X
life O X
increased O X
with O X
alteration O X
of O X
T163 O X
to O X
glutamic O X
acid O X
, O X
but O X
decreased O X
with O X
mutation O X
to O X
alanine O X
. O X

However O X
, O X
both O X
T163 O X
mutants O X
exhibited O X
greater O X
pro O X
- O X
survival O X
effects O X
compared O X
with O X
the O X
wild O X
type O X
, O X
which O X
can O X
be O X
explained O X
by O X
an O X
increased O X
stability O X
of O X
the O X
T163A O X
mutant O X
in O X
cytokine O X
- O X
starved O X
conditions O X
. O X

Both O X
the O X
mutant O X
forms O X
exhibited O X
prolonged O X
binding O X
to O X
pro O X
- O X
apoptotic O X
Bim I-MISC 10018
in O X
cytokine O X
- O X
deprived O X
cells O X
. O X

The O X
extent O X
to O X
which O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
mutants O X
were O X
able O X
to O X
exert O X
their O X
anti O X
- O X
apoptotic O X
effects O X
correlated O X
with O X
their O X
ability O X
to O X
associate O X
with O X
Bim I-MISC 10018
. O X

We O X
further O X
observed O X
that O X
primary O X
bone O X
marrow O X
derived O X
macrophages O X
survived O X
following O X
cytokine O X
withdrawal O X
as O X
long O X
as O X
Bim I-MISC 10018
and O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
remained O X
associated O X
. O X

In O X
our O X
study O X
, O X
we O X
were O X
unable O X
to O X
detect O X
a O X
role O X
for O X
GSK O X
- O X
3 O X
- O X
mediated O X
regulation O X
of O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
expression O X
. O X

Based O X
on O X
these O X
results O X
we O X
propose O X
that O X
upon O X
cytokine O X
withdrawal O X
, O X
survival O X
of O X
hemopoietic O X
cells O X
depends O X
on O X
association O X
between O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
and O X
Bim I-MISC 10018
. O X

Furthermore O X
, O X
alteration O X
of O X
T163 O X
of O X
Mcl I-MISC 4170
- I-MISC 4170
1 I-MISC 4170
may O X
change O X
the O X
protein O X
such O X
that O X
its O X
association O X
with O X
Bim I-MISC 10018
is O X
affected O X
, O X
resulting O X
in O X
prolonged O X
association O X
and O X
increased O X
survival O X
. O X

###24256567	7535,72828

Insights O X
into O X
the O X
suppressor O X
of O X
T I-MISC 6962
- I-MISC 6962
cell I-MISC 6962
receptor I-MISC 6962
( O X
TCR I-MISC 6962
) O X
signaling O X
- O X
1 O X
( O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
)- O X
mediated O X
regulation O X
of O X
TCR I-MISC 6962
signaling O X
through O X
the O X
use O X
of O X
novel O X
substrate O X
- O X
trapping O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
phosphatase O X
variants O X
. O X

High O X
affinity O X
substrate O X
- O X
trapping O X
protein O X
tyrosine O X
phosphatases O X
have O X
been O X
widely O X
used O X
both O X
to O X
investigate O X
the O X
endogenous O X
targets O X
of O X
many O X
phosphatases O X
and O X
to O X
address O X
questions O X
of O X
substrate O X
specificity O X
. O X

Herein O X
, O X
we O X
extend O X
the O X
concept O X
of O X
a O X
substrate O X
- O X
trapping O X
phosphatase O X
to O X
include O X
an O X
enzyme O X
of O X
the O X
histidine O X
phosphatase O X
superfamily O X
. O X

This O X
is O X
the O X
first O X
description O X
of O X
substrate O X
- O X
trapping O X
technology O X
applied O X
to O X
a O X
member O X
of O X
the O X
histidine O X
phosphatase O X
family O X
. O X

The O X
phosphatase O X
suppressor O X
of O X
T I-MISC 72828
- I-MISC 72828
cell I-MISC 72828
receptor I-MISC 72828
signaling I-MISC 72828
( I-MISC 72828
Sts I-MISC 72828
)- I-MISC 72828
1 I-MISC 72828
has O X
recently O X
been O X
reported O X
to O X
negatively O X
regulate O X
signaling O X
downstream O X
of O X
the O X
T I-MISC 6962
- I-MISC 6962
cell I-MISC 6962
receptor I-MISC 6962
. O X

We O X
generated O X
high O X
- O X
affinity O X
substrate O X
- O X
trapping O X
variants O X
of O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
by O X
mutagenesis O X
of O X
key O X
active O X
site O X
residues O X
within O X
the O X
phosphatase O X
catalytic O X
domain O X
. O X

Mutation O X
of O X
both O X
the O X
nucleophilic O X
His380 O X
and O X
the O X
general O X
acid O X
Glu490 O X
yielded O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
enzymes O X
that O X
were O X
catalytically O X
inactive O X
but O X
showed O X
high O X
affinity O X
for O X
an O X
important O X
tyrosine O X
kinase O X
in O X
T O X
cells O X
that O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
is O X
known O X
to O X
regulate O X
, O X
Zap I-MISC 7535
- I-MISC 7535
70 I-MISC 7535
. O X

Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
substrate O X
- O X
trapping O X
mutants O X
isolated O X
tyrosine O X
- O X
phosphorylated O X
Zap I-MISC 7535
- I-MISC 7535
70 I-MISC 7535
from O X
lysates O X
of O X
activated O X
T O X
cells O X
, O X
validating O X
Zap I-MISC 7535
- I-MISC 7535
70 I-MISC 7535
as O X
a O X
possible O X
substrate O X
for O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
and O X
highlighting O X
the O X
efficacy O X
of O X
the O X
mutants O X
as O X
substrate O X
- O X
trapping O X
agents O X
. O X

Inhibition O X
of O X
the O X
Zap I-MISC 7535
- I-MISC 7535
70 I-MISC 7535
interaction O X
by O X
vanadate O X
suggests O X
that O X
the O X
substrate O X
- O X
trapping O X
effect O X
occurred O X
via O X
the O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
phosphatase O X
active O X
site O X
. O X

Finally O X
, O X
overexpression O X
of O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
substrate O X
- O X
trapping O X
mutants O X
in O X
T O X
cells O X
blocked O X
T I-MISC 6962
- I-MISC 6962
cell I-MISC 6962
receptor I-MISC 6962
signaling O X
, O X
confirming O X
the O X
inhibitory O X
effect O X
of O X
Sts I-MISC 72828
- I-MISC 72828
1 I-MISC 72828
on O X
Zap I-MISC 7535
- I-MISC 7535
70 I-MISC 7535
. O X

###15798189	850888,852724

Identification O X
of O X
a O X
novel O X
, O X
intraperoxisomal O X
pex14 I-MISC 852724
- O X
binding O X
site O X
in O X
pex13 I-MISC 850888
: O X
association O X
of O X
pex13 I-MISC 850888
with O X
the O X
docking O X
complex O X
is O X
essential O X
for O X
peroxisomal O X
matrix O X
protein O X
import O X
. O X

The O X
peroxisomal O X
docking O X
complex O X
is O X
a O X
key O X
component O X
of O X
the O X
import O X
machinery O X
for O X
matrix O X
proteins O X
. O X

The O X
core O X
protein O X
of O X
this O X
complex O X
, O X
Pex14 I-MISC 852724
, O X
is O X
thought O X
to O X
represent O X
the O X
initial O X
docking O X
site O X
for O X
the O X
import O X
receptors O X
Pex5 I-MISC 5830
and O X
Pex7 I-MISC 5191
. O X

Associated O X
with O X
this O X
complex O X
is O X
a O X
fraction O X
of O X
Pex13 I-MISC 850888
, O X
another O X
essential O X
component O X
of O X
the O X
import O X
machinery O X
. O X

Here O X
we O X
demonstrate O X
that O X
Pex13 I-MISC 850888
directly O X
binds O X
Pex14 I-MISC 852724
not O X
only O X
via O X
its O X
SH3 O X
domain O X
but O X
also O X
via O X
a O X
novel O X
intraperoxisomal O X
site O X
. O X

Furthermore O X
, O X
we O X
demonstrate O X
that O X
Pex5 I-MISC 5830
also O X
contributes O X
to O X
the O X
association O X
of O X
Pex13 I-MISC 850888
with O X
Pex14 I-MISC 852724
. O X

Peroxisome O X
function O X
was O X
affected O X
only O X
mildly O X
by O X
mutations O X
within O X
the O X
novel O X
Pex14 I-MISC 852724
interaction O X
site O X
of O X
Pex13 I-MISC 850888
or O X
by O X
the O X
non O X
- O X
Pex13 I-MISC 850888
- O X
interacting O X
mutant O X
Pex5 I-MISC 5830
( O X
W204A O X
). O X

However O X
, O X
when O X
these O X
constructs O X
were O X
tested O X
in O X
combination O X
, O X
PTS1 O X
- O X
dependent O X
import O X
and O X
growth O X
on O X
oleic O X
acid O X
were O X
severely O X
compromised O X
. O X

When O X
the O X
SH3 O X
domain O X
- O X
mediated O X
interaction O X
of O X
Pex13 I-MISC 850888
with O X
Pex14 I-MISC 852724
was O X
blocked O X
on O X
top O X
of O X
that O X
, O X
PTS2 O X
- O X
dependent O X
matrix O X
protein O X
import O X
was O X
completely O X
compromised O X
and O X
Pex13 I-MISC 850888
was O X
no O X
longer O X
copurified O X
with O X
the O X
docking O X
complex O X
. O X

We O X
conclude O X
that O X
the O X
association O X
of O X
Pex13 I-MISC 850888
with O X
Pex14 I-MISC 852724
is O X
an O X
essential O X
step O X
in O X
peroxisomal O X
protein O X
import O X
that O X
is O X
enabled O X
by O X
two O X
direct O X
interactions O X
and O X
by O X
one O X
that O X
is O X
mediated O X
by O X
Pex5 I-MISC 5830
, O X
a O X
result O X
which O X
indicates O X
a O X
novel O X
, O X
receptor O X
- O X
independent O X
function O X
of O X
Pex5 I-MISC 5830
. O X

###24553140	55054,836

A O X
Crohn O X
' O X
s O X
disease O X
variant O X
in O X
Atg16l1 I-MISC 77040
enhances O X
its O X
degradation O X
by O X
caspase I-MISC 12367
3 I-MISC 12367
. O X

Crohn O X
' O X
s O X
disease O X
is O X
a O X
debilitating O X
inflammatory O X
bowel O X
disease O X
( O X
IBD O X
) O X
that O X
can O X
involve O X
the O X
entire O X
digestive O X
tract O X
. O X

A O X
single O X
- O X
nucleotide O X
polymorphism O X
( O X
SNP O X
) O X
encoding O X
a O X
missense O X
variant O X
in O X
the O X
autophagy O X
gene O X
ATG16L1 I-MISC 77040
( O X
rs2241880 O X
, O X
Thr300Ala O X
) O X
is O X
strongly O X
associated O X
with O X
the O X
incidence O X
of O X
Crohn O X
' O X
s O X
disease O X
. O X

Numerous O X
studies O X
have O X
demonstrated O X
the O X
effect O X
of O X
ATG16L1 I-MISC 55054
deletion O X
or O X
deficiency O X
; O X
however O X
, O X
the O X
molecular O X
consequences O X
of O X
the O X
Thr300Ala O X
( O X
T300A O X
) O X
variant O X
remains O X
unknown O X
. O X

Here O X
we O X
show O X
that O X
amino O X
acids O X
296 O X
- O X
299 O X
constitute O X
a O X
caspase O X
cleavage O X
motif O X
in O X
ATG16L1 I-MISC 55054
and O X
that O X
the O X
T300A O X
variant O X
( O X
T316A O X
in O X
mice O X
) O X
significantly O X
increases O X
ATG16L1 I-MISC 55054
sensitization O X
to O X
caspase I-MISC 836
- I-MISC 836
3 I-MISC 836
- O X
mediated O X
processing O X
. O X

We O X
observed O X
that O X
death O X
- O X
receptor O X
activation O X
or O X
starvation O X
- O X
induced O X
metabolic O X
stress O X
in O X
human O X
and O X
murine O X
macrophages O X
increased O X
degradation O X
of O X
the O X
T300A O X
or O X
T316A O X
variants O X
of O X
ATG16L1 I-MISC 55054
, O X
respectively O X
, O X
resulting O X
in O X
diminished O X
autophagy O X
. O X

Knock O X
- O X
in O X
mice O X
harbouring O X
the O X
T316A O X
variant O X
showed O X
defective O X
clearance O X
of O X
the O X
ileal O X
pathogen O X
Yersinia O X
enterocolitica O X
and O X
an O X
elevated O X
inflammatory O X
cytokine O X
response O X
. O X

In O X
turn O X
, O X
deletion O X
of O X
the O X
caspase I-MISC 836
- I-MISC 836
3 I-MISC 836
- O X
encoding O X
gene O X
, O X
Casp3 I-MISC 836
, O X
or O X
elimination O X
of O X
the O X
caspase O X
cleavage O X
site O X
by O X
site O X
- O X
directed O X
mutagenesis O X
rescued O X
starvation O X
- O X
induced O X
autophagy O X
and O X
pathogen O X
clearance O X
, O X
respectively O X
. O X

These O X
findings O X
demonstrate O X
that O X
caspase I-MISC 836
3 I-MISC 836
activation O X
in O X
the O X
presence O X
of O X
a O X
common O X
risk O X
allele O X
leads O X
to O X
accelerated O X
degradation O X
of O X
ATG16L1 I-MISC 55054
, O X
placing O X
cellular O X
stress O X
, O X
apoptotic O X
stimuli O X
and O X
impaired O X
autophagy O X
in O X
a O X
unified O X
pathway O X
that O X
predisposes O X
to O X
Crohn O X
' O X
s O X
disease O X
. O X

###16267044	835815,100297344

The O X
plant O X
plasma O X
membrane O X
Ca2 O X
+ O X
pump O X
ACA8 I-MISC 835815
contains O X
overlapping O X
as O X
well O X
as O X
physically O X
separated O X
autoinhibitory O X
and O X
calmodulin I-MISC 100297344
- O X
binding O X
domains O X
. O X

In O X
plant O X
Ca O X
( O X
2 O X
+) O X
pumps O X
belonging O X
to O X
the O X
P O X
( O X
2B O X
) O X
subfamily O X
of O X
P O X
- O X
type O X
ATPases O X
, O X
the O X
N O X
- O X
terminal O X
cytoplasmic O X
domain O X
is O X
responsible O X
for O X
pump O X
autoinhibition O X
. O X

Binding O X
of O X
calmodulin I-MISC 100297344
( O X
CaM I-MISC 100297344
) O X
to O X
this O X
region O X
results O X
in O X
pump O X
activation O X
but O X
the O X
structural O X
basis O X
for O X
CaM I-MISC 100297344
activation O X
is O X
still O X
not O X
clear O X
. O X

All O X
residues O X
in O X
a O X
putative O X
CaM I-MISC 100297344
- O X
binding O X
domain O X
( O X
Arg O X
( O X
43 O X
) O X
to O X
Lys O X
( O X
68 O X
)) O X
were O X
mutagenized O X
and O X
the O X
resulting O X
recombinant O X
proteins O X
were O X
studied O X
with O X
respect O X
to O X
CaM I-MISC 100297344
binding O X
and O X
the O X
activation O X
state O X
. O X

The O X
results O X
demonstrate O X
that O X
( O X
i O X
) O X
the O X
binding O X
site O X
for O X
CaM I-MISC 100297344
is O X
overlapping O X
with O X
the O X
autoinhibitory O X
region O X
and O X
( O X
ii O X
) O X
the O X
autoinhibitory O X
region O X
comprises O X
significantly O X
fewer O X
residues O X
than O X
the O X
CaM I-MISC 100297344
- O X
binding O X
region O X
. O X

In O X
a O X
helical O X
wheel O X
projection O X
of O X
the O X
CaM I-MISC 100297344
- O X
binding O X
domain O X
, O X
residues O X
involved O X
in O X
autoinhibition O X
cluster O X
on O X
one O X
side O X
of O X
the O X
helix O X
, O X
which O X
is O X
proposed O X
to O X
interact O X
with O X
an O X
intramolecular O X
receptor O X
site O X
in O X
the O X
pump O X
. O X

Residues O X
influencing O X
CaM I-MISC 100297344
negatively O X
are O X
situated O X
on O X
the O X
other O X
face O X
of O X
the O X
helix O X
, O X
likely O X
to O X
face O X
the O X
cytosol O X
, O X
whereas O X
residues O X
controlling O X
CaM I-MISC 100297344
binding O X
positively O X
are O X
scattered O X
throughout O X
. O X

We O X
propose O X
that O X
early O X
CaM I-MISC 100297344
recognition O X
is O X
mediated O X
by O X
the O X
cytosolic O X
face O X
and O X
that O X
CaM I-MISC 100297344
subsequently O X
competes O X
with O X
the O X
intramolecular O X
autoinhibitor O X
in O X
binding O X
to O X
the O X
other O X
face O X
of O X
the O X
helix O X
. O X

###21468031	41602,41602

The O X
oligomeric O X
state O X
of O X
CtBP I-MISC 41602
determines O X
its O X
role O X
as O X
a O X
transcriptional O X
co O X
- O X
activator O X
and O X
co O X
- O X
repressor O X
of O X
Wingless O X
targets O X
. O X

C I-MISC 41602
- I-MISC 41602
terminal I-MISC 41602
- I-MISC 41602
binding I-MISC 41602
protein I-MISC 41602
( O X
CtBP I-MISC 41602
) O X
is O X
a O X
well O X
- O X
characterized O X
transcriptional O X
co O X
- O X
repressor O X
that O X
requires O X
homo O X
- O X
dimerization O X
for O X
its O X
activity O X
. O X

CtBP I-MISC 41602
can O X
both O X
repress O X
and O X
activate O X
Wingless O X
nuclear O X
targets O X
in O X
Drosophila O X
. O X

Here O X
, O X
we O X
examine O X
the O X
role O X
of O X
CtBP I-MISC 41602
dimerization O X
in O X
these O X
opposing O X
processes O X
. O X

CtBP I-MISC 41602
mutants O X
that O X
cannot O X
dimerize O X
are O X
able O X
to O X
promote O X
Wingless O X
signalling O X
, O X
but O X
are O X
defective O X
in O X
repressing O X
Wingless O X
targets O X
. O X

To O X
further O X
test O X
the O X
role O X
of O X
dimerization O X
in O X
repression O X
, O X
the O X
positions O X
of O X
basic O X
and O X
acidic O X
residues O X
that O X
form O X
inter O X
- O X
molecular O X
salt O X
bridges O X
in O X
the O X
CtBP I-MISC 41602
dimerization O X
interface O X
were O X
swapped O X
. O X

These O X
mutants O X
cannot O X
homo O X
- O X
dimerize O X
and O X
are O X
compromised O X
for O X
repression O X
. O X

However O X
, O X
their O X
co O X
- O X
expression O X
leads O X
to O X
hetero O X
- O X
dimerization O X
and O X
consequent O X
repression O X
of O X
Wingless O X
targets O X
. O X

Our O X
results O X
support O X
a O X
model O X
where O X
CtBP I-MISC 41602
is O X
a O X
gene O X
- O X
specific O X
regulator O X
of O X
Wingless O X
signalling O X
, O X
with O X
some O X
targets O X
requiring O X
CtBP I-MISC 41602
dimers O X
for O X
inhibition O X
while O X
other O X
targets O X
utilize O X
CtBP I-MISC 41602
monomers O X
for O X
activation O X
of O X
their O X
expression O X
. O X

Functional O X
interactions O X
between O X
CtBP I-MISC 41602
and O X
Pygopus O X
, O X
a O X
nuclear O X
protein O X
required O X
for O X
Wingless O X
signalling O X
, O X
support O X
a O X
model O X
where O X
monomeric O X
CtBP I-MISC 41602
acts O X
downstream O X
of O X
Pygopus O X
in O X
activating O X
some O X
Wingless O X
targets O X
. O X

###23532844	54806,4867	54806,9001

The O X
Joubert O X
syndrome O X
- O X
associated O X
missense O X
mutation O X
( O X
V443D O X
) O X
in O X
the O X
Abelson I-MISC 54806
- I-MISC 54806
helper I-MISC 54806
integration I-MISC 54806
site I-MISC 54806
1 I-MISC 54806
( O X
AHI1 I-MISC 54806
) O X
protein O X
alters O X
its O X
localization O X
and O X
protein O X
- O X
protein O X
interactions O X
. O X

BACKGROUND O X
: O X
Missense O X
mutations O X
in O X
AHI1 I-MISC 54806
result O X
in O X
the O X
neurodevelopmental O X
ciliopathy O X
called O X
Joubert O X
syndrome O X
. O X

RESULTS O X
: O X
Mutations O X
in O X
AHI1 I-MISC 54806
decrease O X
cilia O X
formation O X
, O X
alter O X
its O X
localization O X
and O X
stability O X
, O X
and O X
change O X
its O X
binding O X
to O X
HAP1 I-MISC 9001
and O X
NPHP1 I-MISC 4867
. O X

CONCLUSION O X
: O X
Mutations O X
in O X
AHI1 I-MISC 54806
affect O X
ciliogenesis O X
, O X
AHI1 I-MISC 54806
protein O X
localization O X
, O X
and O X
AHI1 I-MISC 54806
- O X
protein O X
interactions O X
. O X

SIGNIFICANCE O X
: O X
This O X
study O X
begins O X
to O X
describe O X
how O X
missense O X
mutations O X
in O X
AHI1 I-MISC 54806
can O X
cause O X
Joubert O X
syndrome O X
. O X

Mutations O X
in O X
AHI1 I-MISC 54806
cause O X
Joubert O X
syndrome O X
( O X
JBTS O X
), O X
a O X
neurodevelopmental O X
ciliopathy O X
, O X
characterized O X
by O X
midbrain O X
- O X
hindbrain O X
malformations O X
and O X
motor O X
/ O X
cognitive O X
deficits O X
. O X

Here O X
, O X
we O X
show O X
that O X
primary O X
cilia O X
( O X
PC O X
) O X
formation O X
is O X
decreased O X
in O X
fibroblasts O X
from O X
individuals O X
with O X
JBTS O X
and O X
AHI1 I-MISC 54806
mutations O X
. O X

Most O X
missense O X
mutations O X
in O X
AHI1 I-MISC 54806
, O X
causing O X
JBTS O X
, O X
occur O X
in O X
known O X
protein O X
domains O X
, O X
however O X
, O X
a O X
common O X
V443D O X
mutation O X
in O X
AHI1 I-MISC 54806
is O X
found O X
in O X
a O X
region O X
with O X
no O X
known O X
protein O X
motifs O X
. O X

We O X
show O X
that O X
cells O X
transfected O X
with O X
AHI1 I-MISC 54806
- O X
V443D O X
, O X
or O X
a O X
new O X
JBTS O X
- O X
causing O X
mutation O X
, O X
AHI1 I-MISC 54806
- O X
R351L O X
, O X
have O X
aberrant O X
localization O X
of O X
AHI1 I-MISC 54806
at O X
the O X
basal O X
bodies O X
of O X
PC O X
and O X
at O X
cell O X
- O X
cell O X
junctions O X
, O X
likely O X
through O X
decreased O X
binding O X
of O X
mutant O X
AHI1 I-MISC 54806
to O X
NPHP1 I-MISC 4867
( O X
another O X
JBTS O X
- O X
causing O X
protein O X
). O X

The O X
AHI1 I-MISC 54806
- O X
V443D O X
mutation O X
causes O X
decreased O X
AHI1 I-MISC 54806
stability O X
because O X
there O X
is O X
a O X
50 O X
% O X
reduction O X
in O X
AHI1 I-MISC 54806
- O X
V443D O X
protein O X
levels O X
compared O X
with O X
wild O X
type O X
AHI1 I-MISC 54806
. O X

Huntingtin I-MISC 9001
- I-MISC 9001
associated I-MISC 9001
protein I-MISC 9001
- I-MISC 9001
1 I-MISC 9001
( O X
Hap1 I-MISC 9001
) O X
is O X
a O X
regulatory O X
protein O X
that O X
binds O X
Ahi1 I-MISC 54806
, O X
and O X
Hap1 I-MISC 9001
knock O X
- O X
out O X
mice O X
have O X
been O X
reported O X
to O X
have O X
JBTS O X
- O X
like O X
phenotypes O X
, O X
suggesting O X
a O X
role O X
for O X
Hap1 I-MISC 9001
in O X
ciliogenesis O X
. O X

Fibroblasts O X
and O X
neurons O X
with O X
Hap1 I-MISC 9001
deficiency O X
form O X
PC O X
with O X
normal O X
growth O X
factor O X
- O X
induced O X
ciliary O X
signaling O X
, O X
indicating O X
that O X
the O X
Hap1 I-MISC 9001
JBTS O X
phenotype O X
is O X
likely O X
not O X
through O X
effects O X
at O X
PC O X
. O X

These O X
results O X
also O X
suggest O X
that O X
the O X
binding O X
of O X
Ahi1 I-MISC 54806
and O X
Hap1 I-MISC 9001
may O X
not O X
be O X
critical O X
for O X
ciliary O X
function O X
. O X

However O X
, O X
we O X
show O X
that O X
HAP1 I-MISC 9001
has O X
decreased O X
binding O X
to O X
AHI1 I-MISC 54806
- O X
V443D O X
indicating O X
that O X
this O X
altered O X
binding O X
could O X
be O X
responsible O X
for O X
the O X
JBTS O X
- O X
like O X
phenotype O X
through O X
an O X
unknown O X
pathway O X
. O X

Thus O X
, O X
these O X
JBTS O X
- O X
associated O X
missense O X
mutations O X
alter O X
their O X
subcellular O X
distribution O X
and O X
protein O X
interactions O X
, O X
compromising O X
functions O X
of O X
AHI1 I-MISC 54806
in O X
cell O X
polarity O X
and O X
cilium O X
- O X
mediated O X
signaling O X
, O X
thereby O X
contributing O X
to O X
JBTS O X
. O X

###26342861	11197,7474	11197,7476

Wnts O X
grasp O X
the O X
WIF O X
domain O X
of O X
Wnt I-MISC 11197
Inhibitory I-MISC 11197
Factor I-MISC 11197
1 I-MISC 11197
at O X
two O X
distinct O X
binding O X
sites O X
. O X

UNASSIGNED O X
: O X
Wnts O X
have O X
a O X
structure O X
resembling O X
a O X
hand O X
with O X
" O X
thumb O X
" O X
and O X
" O X
index O X
" O X
fingers O X
that O X
grasp O X
the O X
cysteine O X
rich O X
domains O X
of O X
Frizzled O X
receptors O X
at O X
two O X
distinct O X
binding O X
sites O X
. O X

In O X
the O X
present O X
work O X
we O X
show O X
that O X
the O X
WIF O X
domain O X
of O X
Wnt I-MISC 11197
Inhibitory I-MISC 11197
Factor I-MISC 11197
1 I-MISC 11197
is O X
also O X
bound O X
by O X
Wnts O X
at O X
two O X
sites O X
. O X

Using O X
C O X
- O X
terminal O X
domains O X
of O X
Wnt5a I-MISC 7474
and O X
Wnt7a I-MISC 7476
and O X
arginine O X
- O X
scanning O X
mutagenesis O X
of O X
the O X
WIF O X
domain O X
we O X
demonstrate O X
that O X
, O X
whereas O X
the O X
N O X
- O X
terminal O X
, O X
lipid O X
- O X
modified O X
" O X
thumb O X
" O X
of O X
Wnts O X
interacts O X
with O X
the O X
alkyl O X
- O X
binding O X
site O X
of O X
the O X
WIF O X
domain O X
, O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
Wnts O X
( O X
Wnt O X
- O X
CTD O X
) O X
binds O X
to O X
a O X
surface O X
on O X
the O X
opposite O X
side O X
of O X
the O X
WIF O X
domain O X
. O X

###19013460	851479,851654

Thiamin O X
- O X
dependent O X
transactivation O X
activity O X
of O X
PDC2 I-MISC 851654
in O X
Saccharomyces O X
cerevisiae O X
. O X

Yeast O X
genes O X
involved O X
in O X
thiamin O X
pyrophosphate O X
( O X
TPP O X
) O X
synthesis O X
are O X
transcriptionally O X
induced O X
in O X
response O X
to O X
thiamin O X
starvation O X
. O X

In O X
this O X
system O X
, O X
three O X
proteins O X
( O X
Thi2p I-MISC 852542
, O X
Thi3p I-MISC 851479
, O X
and O X
Pdc2p I-MISC 851654
) O X
act O X
as O X
positive O X
regulatory O X
factors O X
. O X

Thi3p I-MISC 851479
is O X
a O X
TPP O X
- O X
binding O X
protein O X
and O X
upregulates O X
THI O X
genes O X
expression O X
when O X
TPP O X
is O X
not O X
bound O X
. O X

We O X
found O X
here O X
that O X
Pdc2p I-MISC 851654
could O X
transactivate O X
gene O X
expression O X
and O X
interact O X
with O X
Thi3p I-MISC 851479
, O X
both O X
of O X
which O X
were O X
enhanced O X
by O X
thiamin O X
starvation O X
. O X

This O X
enhancement O X
of O X
the O X
transactivation O X
activity O X
was O X
not O X
observed O X
in O X
a O X
thi3 I-MISC 851479
strain O X
. O X

When O X
the O X
C O X
- O X
terminal O X
region O X
containing O X
the O X
deduced O X
Thi3p I-MISC 851479
- O X
interacting O X
domain O X
was O X
truncated O X
, O X
Pdc2p I-MISC 851654
expressed O X
striking O X
transactivation O X
activity O X
in O X
a O X
Thi3p I-MISC 851479
- O X
independent O X
fashion O X
. O X

We O X
explored O X
the O X
hypothesis O X
that O X
Thi3p I-MISC 851479
causes O X
a O X
conformational O X
change O X
in O X
Pdc2p I-MISC 851654
leading O X
to O X
full O X
transactivation O X
activity O X
under O X
favorable O X
conditions O X
. O X

###19682074	936266,936266

A O X
single O X
intersubunit O X
salt O X
bridge O X
affects O X
oligomerization O X
and O X
catalytic O X
activity O X
in O X
a O X
bacterial O X
quinone O X
reductase O X
. O X

YhdA I-MISC 936266
, O X
a O X
thermostable O X
NADPH O X
: O X
FMN O X
oxidoreductase O X
from O X
Bacillus O X
subtilis O X
, O X
reduces O X
quinones O X
via O X
a O X
ping O X
- O X
pong O X
bi O X
- O X
bi O X
mechanism O X
with O X
a O X
pronounced O X
preference O X
for O X
NADPH O X
. O X

The O X
enzyme O X
occurs O X
as O X
a O X
stable O X
tetramer O X
in O X
solution O X
. O X

The O X
two O X
extended O X
dimer O X
surfaces O X
are O X
packed O X
against O X
each O X
other O X
by O X
a O X
90 O X
rotation O X
of O X
one O X
dimer O X
with O X
respect O X
to O X
the O X
other O X
. O X

This O X
assembly O X
is O X
stabilized O X
by O X
the O X
formation O X
of O X
four O X
salt O X
bridges O X
between O X
K109 O X
and O X
D137 O X
of O X
the O X
neighbouring O X
protomers O X
. O X

To O X
investigate O X
the O X
importance O X
of O X
the O X
ion O X
pair O X
contacts O X
, O X
the O X
K109L O X
and O X
D137L O X
single O X
replacement O X
variants O X
, O X
as O X
well O X
as O X
the O X
K109L O X
/ O X
D137L O X
and O X
K109D O X
/ O X
D137K O X
double O X
replacement O X
variants O X
, O X
were O X
generated O X
, O X
expressed O X
, O X
purified O X
, O X
crystallized O X
and O X
biochemically O X
characterized O X
. O X

The O X
K109L O X
and O X
D137L O X
variants O X
form O X
dimers O X
instead O X
of O X
tetramers O X
, O X
whereas O X
the O X
K109L O X
/ O X
D137L O X
and O X
K109D O X
/ O X
D137K O X
variants O X
appear O X
to O X
exist O X
in O X
a O X
dimer O X
- O X
tetramer O X
equilibrium O X
in O X
solution O X
. O X

The O X
crystal O X
structures O X
of O X
the O X
K109L O X
and O X
D137L O X
variants O X
confirm O X
the O X
dimeric O X
state O X
, O X
with O X
the O X
K109L O X
/ O X
D137L O X
and O X
K109D O X
/ O X
D137K O X
variants O X
adopting O X
a O X
tetrameric O X
assembly O X
. O X

Interestingly O X
, O X
all O X
protein O X
variants O X
show O X
a O X
drastically O X
reduced O X
quinone O X
reductase O X
activity O X
in O X
steady O X
- O X
state O X
kinetics O X
. O X

Detailed O X
analysis O X
of O X
the O X
two O X
half O X
reactions O X
revealed O X
that O X
the O X
oxidative O X
half O X
reaction O X
is O X
not O X
affected O X
, O X
whereas O X
reduction O X
of O X
the O X
bound O X
FMN O X
cofactor O X
by O X
NADPH O X
is O X
virtually O X
abolished O X
. O X

Inspection O X
of O X
the O X
crystal O X
structures O X
indicates O X
that O X
the O X
side O X
chain O X
of O X
K109 O X
plays O X
a O X
dual O X
role O X
by O X
forming O X
a O X
salt O X
bridge O X
to O X
D137 O X
, O X
as O X
well O X
as O X
stabilizing O X
a O X
glycine O X
- O X
rich O X
loop O X
in O X
the O X
vicinity O X
of O X
the O X
FMN O X
cofactor O X
. O X

In O X
all O X
protein O X
variants O X
, O X
this O X
glycine O X
- O X
rich O X
loop O X
exhibits O X
a O X
much O X
higher O X
mobility O X
, O X
compared O X
to O X
the O X
wild O X
- O X
type O X
. O X

This O X
appears O X
to O X
be O X
incompatible O X
with O X
NADPH O X
binding O X
and O X
thus O X
leads O X
to O X
abrogation O X
of O X
flavin O X
reduction O X
. O X

###14532330	7957,5507

Laforin I-MISC 7957
, O X
the O X
dual O X
- O X
phosphatase O X
responsible O X
for O X
Lafora O X
disease O X
, O X
interacts O X
with O X
R5 O X
( O X
PTG O X
), O X
a O X
regulatory O X
subunit O X
of O X
protein O X
phosphatase O X
- O X
1 O X
that O X
enhances O X
glycogen O X
accumulation O X
. O X

Progressive O X
myoclonus O X
epilepsy O X
of O X
Lafora O X
type O X
( O X
LD O X
, O X
MIM O X
254780 O X
) O X
is O X
a O X
fatal O X
autosomal O X
recessive O X
disorder O X
characterized O X
by O X
the O X
presence O X
of O X
progressive O X
neurological O X
deterioration O X
, O X
myoclonus O X
, O X
epilepsy O X
and O X
polyglucosan O X
intracellular O X
inclusion O X
bodies O X
, O X
called O X
Lafora O X
bodies O X
. O X

Lafora O X
bodies O X
resemble O X
glycogen O X
with O X
reduced O X
branching O X
, O X
suggesting O X
an O X
alteration O X
in O X
glycogen O X
metabolism O X
. O X

Linkage O X
analysis O X
and O X
homozygosity O X
mapping O X
localized O X
EPM2A I-MISC 7957
, O X
a O X
major O X
gene O X
for O X
LD O X
, O X
to O X
chromosome O X
6q24 O X
. O X

EPM2A I-MISC 7957
encodes O X
a O X
protein O X
of O X
331 O X
amino O X
acids O X
( O X
named O X
laforin I-MISC 7957
) O X
with O X
two O X
domains O X
, O X
a O X
dual O X
- O X
specificity O X
phosphatase O X
domain O X
and O X
a O X
carbohydrate O X
binding O X
domain O X
. O X

Here O X
we O X
show O X
that O X
, O X
in O X
addition O X
, O X
laforin I-MISC 7957
interacts O X
with O X
itself O X
and O X
with O X
the O X
glycogen O X
targeting O X
regulatory O X
subunit O X
R5 O X
of O X
protein I-MISC 5507
phosphatase I-MISC 5507
1 I-MISC 5507
( O X
PP1 I-MISC 5507
). O X

R5 O X
is O X
the O X
human O X
homolog O X
of O X
the O X
murine O X
Protein I-MISC 53412
Targeting I-MISC 53412
to I-MISC 53412
Glycogen I-MISC 53412
, O X
a O X
protein O X
that O X
also O X
acts O X
as O X
a O X
molecular O X
scaffold O X
assembling O X
PP1 I-MISC 5507
with O X
its O X
substrate O X
, O X
glycogen O X
synthase O X
, O X
at O X
the O X
intracellular O X
glycogen O X
particles O X
. O X

The O X
laforin I-MISC 7957
- O X
R5 O X
interaction O X
was O X
confirmed O X
by O X
pull O X
- O X
down O X
and O X
co O X
- O X
localization O X
experiments O X
. O X

Full O X
- O X
length O X
laforin I-MISC 7957
is O X
required O X
for O X
the O X
interaction O X
. O X

However O X
, O X
a O X
minimal O X
central O X
region O X
of O X
R5 O X
( O X
amino O X
acids O X
116 O X
- O X
238 O X
), O X
including O X
the O X
binding O X
sites O X
for O X
glycogen O X
and O X
for O X
glycogen O X
synthase O X
, O X
is O X
sufficient O X
to O X
interact O X
with O X
laforin I-MISC 7957
. O X

Point O X
- O X
mutagenesis O X
of O X
the O X
glycogen O X
synthase O X
- O X
binding O X
site O X
completely O X
blocked O X
the O X
interaction O X
with O X
laforin I-MISC 7957
. O X

The O X
majority O X
of O X
the O X
EPM2A I-MISC 7957
missense O X
mutations O X
found O X
in O X
LD O X
patients O X
result O X
in O X
lack O X
of O X
phosphatase O X
activity O X
, O X
absence O X
of O X
binding O X
to O X
glycogen O X
and O X
lack O X
of O X
interaction O X
with O X
R5 O X
. O X

Interestingly O X
, O X
we O X
have O X
found O X
that O X
the O X
LD O X
- O X
associated O X
EPM2A I-MISC 7957
missense O X
mutation O X
G240S O X
has O X
no O X
effect O X
on O X
the O X
phosphatase O X
or O X
glycogen O X
binding O X
activities O X
of O X
laforin I-MISC 7957
but O X
disrupts O X
the O X
interaction O X
with O X
R5 O X
, O X
suggesting O X
that O X
binding O X
to O X
R5 O X
is O X
critical O X
for O X
the O X
laforin I-MISC 7957
function O X
. O X

These O X
results O X
place O X
laforin I-MISC 7957
in O X
the O X
context O X
of O X
a O X
multiprotein O X
complex O X
associated O X
with O X
intracellular O X
glycogen O X
particles O X
, O X
reinforcing O X
the O X
concept O X
that O X
laforin I-MISC 7957
is O X
involved O X
in O X
the O X
regulation O X
of O X
glycogen O X
metabolism O X
. O X

###11801603	331,56616

SMAC I-MISC 56616
negatively O X
regulates O X
the O X
anti O X
- O X
apoptotic O X
activity O X
of O X
melanoma O X
inhibitor O X
of O X
apoptosis O X
( O X
ML I-MISC 79444
- I-MISC 79444
IAP I-MISC 79444
). O X

Inhibitors O X
of O X
apoptosis O X
( O X
IAPs O X
) O X
physically O X
interact O X
with O X
a O X
variety O X
of O X
pro O X
- O X
apoptotic O X
proteins O X
and O X
inhibit O X
apoptosis O X
induced O X
by O X
diverse O X
stimuli O X
. O X

X I-MISC 331
- I-MISC 331
linked I-MISC 331
IAP I-MISC 331
( O X
X I-MISC 331
- I-MISC 331
IAP I-MISC 331
) O X
is O X
a O X
prototype O X
IAP I-MISC 248
family O X
member O X
that O X
inhibits O X
several O X
caspases O X
, O X
the O X
effector O X
proteases O X
of O X
apoptosis O X
. O X

The O X
inhibitory O X
activity O X
of O X
X I-MISC 331
- I-MISC 331
IAP I-MISC 331
is O X
regulated O X
by O X
SMAC I-MISC 56616
, O X
a O X
protein O X
that O X
is O X
processed O X
to O X
its O X
active O X
form O X
upon O X
receipt O X
of O X
a O X
death O X
stimulus O X
. O X

Cleaved O X
SMAC I-MISC 56616
binds O X
X I-MISC 331
- I-MISC 331
IAP I-MISC 331
and O X
antagonizes O X
its O X
anti O X
- O X
apoptotic O X
activity O X
. O X

Here O X
we O X
show O X
that O X
melanoma O X
IAP I-MISC 248
( O X
ML I-MISC 79444
- I-MISC 79444
IAP I-MISC 79444
), O X
a O X
potent O X
anti O X
- O X
cell O X
death O X
protein O X
and O X
caspase O X
inhibitor O X
, O X
physically O X
interacts O X
with O X
SMAC I-MISC 56616
through O X
its O X
BIR O X
( O X
baculovirus O X
IAP I-MISC 248
repeat O X
) O X
domain O X
. O X

In O X
addition O X
to O X
binding O X
full O X
- O X
length O X
SMAC I-MISC 56616
, O X
ML I-MISC 79444
- I-MISC 79444
IAP I-MISC 79444
BIR O X
associates O X
with O X
SMAC I-MISC 56616
peptides O X
that O X
are O X
derived O X
from O X
the O X
amino O X
terminus O X
of O X
active O X
, O X
processed O X
SMAC I-MISC 56616
. O X

This O X
high O X
affinity O X
interaction O X
is O X
very O X
specific O X
and O X
can O X
be O X
completely O X
abolished O X
by O X
single O X
amino O X
acid O X
mutations O X
either O X
in O X
the O X
amino O X
terminus O X
of O X
active O X
SMAC I-MISC 56616
or O X
in O X
the O X
BIR O X
domain O X
of O X
ML I-MISC 79444
- I-MISC 79444
IAP I-MISC 79444
. O X

In O X
cells O X
expressing O X
ML I-MISC 79444
- I-MISC 79444
IAP I-MISC 79444
and O X
X I-MISC 331
- I-MISC 331
IAP I-MISC 331
, O X
SMAC I-MISC 56616
coexpression O X
or O X
addition O X
of O X
SMAC I-MISC 56616
peptides O X
abrogates O X
the O X
ability O X
of O X
the O X
IAPs O X
to O X
inhibit O X
cell O X
death O X
. O X

These O X
results O X
demonstrate O X
the O X
feasibility O X
of O X
using O X
SMAC I-MISC 56616
peptides O X
as O X
a O X
way O X
to O X
sensitize O X
IAP I-MISC 248
- O X
expressing O X
cells O X
to O X
pro O X
- O X
apoptotic O X
stimuli O X
such O X
as O X
chemotherapeutic O X
agents O X
. O X

###20644138	899562,899562

Mutagenesis O X
of O X
conserved O X
amino O X
acids O X
of O X
Helicobacter O X
pylori O X
fur I-MISC 899562
reveals O X
residues O X
important O X
for O X
function O X
. O X

The O X
ferric I-MISC 899562
uptake I-MISC 899562
regulator I-MISC 899562
( O X
Fur I-MISC 899562
) O X
of O X
the O X
medically O X
important O X
pathogen O X
Helicobacter O X
pylori O X
is O X
unique O X
in O X
that O X
it O X
has O X
been O X
shown O X
to O X
function O X
as O X
a O X
repressor O X
both O X
in O X
the O X
presence O X
of O X
an O X
Fe2 O X
+ O X
cofactor O X
and O X
in O X
its O X
apo O X
( O X
non O X
- O X
Fe2 O X
+- O X
bound O X
) O X
form O X
. O X

However O X
, O X
virtually O X
nothing O X
is O X
known O X
concerning O X
the O X
amino O X
acid O X
residues O X
that O X
are O X
important O X
for O X
Fur I-MISC 899562
functioning O X
. O X

Therefore O X
, O X
mutations O X
in O X
six O X
conserved O X
amino O X
acid O X
residues O X
of O X
H O X
. O X
pylori O X
Fur I-MISC 899562
were O X
constructed O X
and O X
analyzed O X
for O X
their O X
impact O X
on O X
both O X
iron O X
- O X
bound O X
and O X
apo O X
repression O X
. O X

In O X
addition O X
, O X
accumulation O X
of O X
the O X
mutant O X
proteins O X
, O X
protein O X
secondary O X
structure O X
, O X
DNA O X
binding O X
ability O X
, O X
iron O X
binding O X
capacity O X
, O X
and O X
the O X
ability O X
to O X
form O X
higher O X
- O X
order O X
structures O X
were O X
also O X
examined O X
for O X
each O X
mutant O X
protein O X
. O X

While O X
none O X
of O X
the O X
mutated O X
residues O X
completely O X
abrogated O X
the O X
function O X
of O X
Fur I-MISC 899562
, O X
we O X
were O X
able O X
to O X
identify O X
residues O X
that O X
were O X
critical O X
for O X
both O X
iron O X
- O X
bound O X
and O X
apo O X
- O X
Fur I-MISC 899562
repression O X
. O X

One O X
mutation O X
, O X
V64A O X
, O X
did O X
not O X
alter O X
regulation O X
of O X
any O X
target O X
genes O X
. O X

However O X
, O X
each O X
of O X
the O X
five O X
remaining O X
mutations O X
showed O X
an O X
effect O X
on O X
either O X
iron O X
- O X
bound O X
or O X
apo O X
regulation O X
. O X

Of O X
these O X
, O X
H96A O X
, O X
E110A O X
, O X
and O X
E117A O X
mutations O X
altered O X
iron O X
- O X
bound O X
Fur I-MISC 899562
regulation O X
and O X
were O X
all O X
shown O X
to O X
influence O X
iron O X
binding O X
to O X
different O X
extents O X
. O X

Additionally O X
, O X
the O X
H96A O X
mutation O X
was O X
shown O X
to O X
alter O X
Fur I-MISC 899562
oligomerization O X
, O X
and O X
the O X
E110A O X
mutation O X
was O X
shown O X
to O X
impact O X
oligomerization O X
and O X
DNA O X
binding O X
. O X

Conversely O X
, O X
the O X
H134A O X
mutant O X
exhibited O X
changes O X
in O X
apo O X
- O X
Fur I-MISC 899562
regulation O X
that O X
were O X
the O X
result O X
of O X
alterations O X
in O X
DNA O X
binding O X
. O X

Although O X
the O X
E90A O X
mutant O X
exhibited O X
alterations O X
in O X
apo O X
- O X
Fur I-MISC 899562
regulation O X
, O X
this O X
mutation O X
did O X
not O X
affect O X
any O X
of O X
the O X
assessed O X
protein O X
functions O X
. O X

This O X
study O X
is O X
the O X
first O X
for O X
H O X
. O X
pylori O X
to O X
analyze O X
the O X
roles O X
of O X
specific O X
amino O X
acid O X
residues O X
of O X
Fur I-MISC 899562
in O X
function O X
and O X
continues O X
to O X
highlight O X
the O X
complexity O X
of O X
Fur I-MISC 899562
regulation O X
in O X
this O X
organism O X
. O X

###20360685	15270,26926

AIF I-MISC 26926
promotes O X
chromatinolysis O X
and O X
caspase O X
- O X
independent O X
programmed O X
necrosis O X
by O X
interacting O X
with O X
histone I-MISC 15270
H2AX I-MISC 15270
. O X

Programmed O X
necrosis O X
induced O X
by O X
DNA O X
alkylating O X
agents O X
, O X
such O X
as O X
MNNG O X
, O X
is O X
a O X
caspase O X
- O X
independent O X
mode O X
of O X
cell O X
death O X
mediated O X
by O X
apoptosis I-MISC 26926
- I-MISC 26926
inducing I-MISC 26926
factor I-MISC 26926
( O X
AIF I-MISC 26926
). O X

After O X
poly I-MISC 142
( I-MISC 142
ADP I-MISC 142
- I-MISC 142
ribose I-MISC 142
) I-MISC 142
polymerase I-MISC 142
1 I-MISC 142
, O X
calpain O X
, O X
and O X
Bax I-MISC 581
activation O X
, O X
AIF I-MISC 26926
moves O X
from O X
the O X
mitochondria O X
to O X
the O X
nucleus O X
where O X
it O X
induces O X
chromatinolysis O X
and O X
cell O X
death O X
. O X

The O X
mechanisms O X
underlying O X
the O X
nuclear O X
action O X
of O X
AIF I-MISC 26926
are O X
, O X
however O X
, O X
largely O X
unknown O X
. O X

We O X
show O X
here O X
that O X
, O X
through O X
its O X
C O X
- O X
terminal O X
proline O X
- O X
rich O X
binding O X
domain O X
( O X
PBD O X
, O X
residues O X
543 O X
- O X
559 O X
), O X
AIF I-MISC 26926
associates O X
in O X
the O X
nucleus O X
with O X
histone O X
H2AX I-MISC 15270
. O X

This O X
interaction O X
regulates O X
chromatinolysis O X
and O X
programmed O X
necrosis O X
by O X
generating O X
an O X
active O X
DNA O X
- O X
degrading O X
complex O X
with O X
cyclophilin I-MISC 5478
A I-MISC 5478
( O X
CypA I-MISC 5478
). O X

Deletion O X
or O X
directed O X
mutagenesis O X
in O X
the O X
AIF I-MISC 26926
C O X
- O X
terminal O X
PBD O X
abolishes O X
AIF I-MISC 26926
/ O X
H2AX I-MISC 15270
interaction O X
and O X
AIF I-MISC 26926
- O X
mediated O X
chromatinolysis O X
. O X

H2AX I-MISC 15270
genetic O X
ablation O X
or O X
CypA I-MISC 5478
downregulation O X
confers O X
resistance O X
to O X
programmed O X
necrosis O X
. O X

AIF I-MISC 26926
fails O X
to O X
induce O X
chromatinolysis O X
in O X
H2AX I-MISC 15270
or O X
CypA I-MISC 5478
- O X
deficient O X
nuclei O X
. O X

We O X
also O X
establish O X
that O X
H2AX I-MISC 15270
is O X
phosphorylated O X
at O X
Ser139 O X
after O X
MNNG O X
treatment O X
and O X
that O X
this O X
phosphorylation O X
is O X
critical O X
for O X
caspase O X
- O X
independent O X
programmed O X
necrosis O X
. O X

Overall O X
, O X
our O X
data O X
shed O X
new O X
light O X
in O X
the O X
mechanisms O X
regulating O X
programmed O X
necrosis O X
, O X
elucidate O X
a O X
key O X
nuclear O X
partner O X
of O X
AIF I-MISC 26926
, O X
and O X
uncover O X
an O X
AIF I-MISC 26926
apoptogenic O X
motif O X
. O X

###16203728	64127,55914

A O X
role O X
for O X
Erbin I-MISC 55914
in O X
the O X
regulation O X
of O X
Nod2 I-MISC 64127
- O X
dependent O X
NF O X
- O X
kappaB O X
signaling O X
. O X

Nod2 I-MISC 64127
is O X
an O X
intracellular O X
sensor O X
of O X
a O X
specific O X
bacterial O X
cell O X
wall O X
component O X
, O X
muramyl O X
dipeptide O X
, O X
and O X
activation O X
of O X
Nod2 I-MISC 64127
stimulates O X
an O X
inflammatory O X
response O X
. O X

Specific O X
mutations O X
of O X
Nod2 I-MISC 64127
have O X
been O X
associated O X
with O X
two O X
inflammatory O X
diseases O X
, O X
Crohn O X
disease O X
and O X
Blau O X
syndrome O X
, O X
and O X
are O X
thought O X
to O X
contribute O X
to O X
disease O X
susceptibility O X
through O X
altering O X
Nod2 I-MISC 64127
signaling O X
. O X

Association O X
of O X
disease O X
with O X
inappropriate O X
activation O X
of O X
Nod2 I-MISC 64127
highlights O X
the O X
importance O X
of O X
proper O X
regulation O X
of O X
Nod2 I-MISC 64127
activity O X
. O X

However O X
, O X
little O X
is O X
known O X
about O X
specific O X
regulation O X
of O X
the O X
Nod2 I-MISC 64127
pathway O X
. O X

We O X
performed O X
a O X
biochemical O X
screen O X
to O X
discover O X
potential O X
regulators O X
of O X
Nod2 I-MISC 64127
and O X
identified O X
Erbin I-MISC 55914
, O X
a O X
protein O X
involved O X
in O X
cell O X
polarity O X
, O X
receptor O X
localization O X
, O X
and O X
regulation O X
of O X
the O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
pathway O X
, O X
as O X
a O X
novel O X
Nod2 I-MISC 64127
- O X
interacting O X
protein O X
. O X

In O X
our O X
studies O X
, O X
we O X
demonstrate O X
specific O X
interaction O X
of O X
Erbin I-MISC 55914
and O X
Nod2 I-MISC 64127
both O X
in O X
vitro O X
and O X
in O X
vivo O X
and O X
characterize O X
the O X
regions O X
required O X
for O X
interaction O X
in O X
both O X
proteins O X
. O X

We O X
found O X
that O X
Nod2 I-MISC 64127
- O X
dependent O X
activation O X
of O X
NF O X
- O X
kappaB O X
and O X
cytokine O X
secretion O X
is O X
inhibited O X
by O X
Erbin I-MISC 55914
overexpression O X
, O X
whereas O X
Erbin I-MISC 55914
-/- O X
mouse O X
embryo O X
fibroblasts O X
show O X
an O X
increased O X
sensitivity O X
to O X
muramyl O X
dipeptide O X
. O X

These O X
studies O X
identify O X
Erbin I-MISC 55914
as O X
a O X
regulator O X
of O X
Nod2 I-MISC 64127
signaling O X
and O X
demonstrate O X
a O X
novel O X
role O X
for O X
Erbin I-MISC 55914
in O X
inflammatory O X
responses O X
. O X

###10869553	20198,20193

Heterocomplex O X
formation O X
between O X
metastasis O X
- O X
related O X
protein O X
S100A4 I-MISC 20198
( O X
Mts1 I-MISC 20198
) O X
and O X
S100A1 I-MISC 20193
as O X
revealed O X
by O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

S100A4 I-MISC 20198
( O X
Mts1 I-MISC 20198
) O X
is O X
a O X
Ca O X
( O X
2 O X
+)- O X
binding O X
protein O X
of O X
the O X
S100 O X
family O X
. O X

This O X
protein O X
plays O X
an O X
important O X
role O X
in O X
promoting O X
tumor O X
metastasis O X
. O X

In O X
order O X
to O X
identify O X
S100A4 I-MISC 20198
interacting O X
proteins O X
, O X
we O X
have O X
applied O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
as O X
an O X
in O X
vivo O X
approach O X
. O X

By O X
screening O X
a O X
mouse O X
mammary O X
adenocarcinoma O X
library O X
, O X
we O X
have O X
demonstrated O X
that O X
S100A4 I-MISC 20198
forms O X
a O X
heterocomplex O X
with O X
S100A1 I-MISC 20193
, O X
another O X
member O X
of O X
the O X
S100 O X
family O X
. O X

The O X
non O X
- O X
covalent O X
heterodimerization O X
was O X
confirmed O X
by O X
fluorescence O X
spectroscopy O X
and O X
electrospray O X
ionization O X
Fourier O X
transform O X
ion O X
cyclotron O X
resonance O X
mass O X
spectrometry O X
. O X

Mutational O X
analysis O X
revealed O X
that O X
replacement O X
of O X
Cys O X
( O X
76 O X
) O X
and O X
/ O X
or O X
Cys O X
( O X
81 O X
) O X
of O X
S100A4 I-MISC 20198
by O X
Ser O X
abolishes O X
the O X
S100A4 I-MISC 20198
/ O X
S100A1 I-MISC 20193
heterodimerization O X
, O X
but O X
does O X
not O X
affect O X
the O X
S100A4 I-MISC 20198
homodimerization O X
in O X
vivo O X
. O X

###17306257	6452,28988	6452,30011

Abl I-MISC 6452
- I-MISC 6452
SH3 I-MISC 6452
binding I-MISC 6452
protein I-MISC 6452
2 I-MISC 6452
, O X
3BP2 I-MISC 6452
, O X
interacts O X
with O X
CIN85 I-MISC 30011
and O X
HIP I-MISC 28988
- I-MISC 28988
55 I-MISC 28988
. O X

The O X
adapter O X
3BP2 I-MISC 6452
is O X
involved O X
in O X
leukocyte O X
signaling O X
downstream O X
Src O X
/ O X
Syk O X
- O X
kinases O X
coupled O X
immunoreceptors O X
. O X

Here O X
, O X
we O X
show O X
that O X
3BP2 I-MISC 6452
directly O X
interacts O X
with O X
the O X
endocytic O X
scaffold O X
protein O X
CIN85 I-MISC 30011
and O X
the O X
actin O X
- O X
binding O X
protein O X
HIP I-MISC 28988
- I-MISC 28988
55 I-MISC 28988
. O X

3BP2 I-MISC 6452
co O X
- O X
localized O X
with O X
CIN85 I-MISC 30011
and O X
HIP I-MISC 28988
- I-MISC 28988
55 I-MISC 28988
in O X
T O X
cell O X
rafts O X
and O X
at O X
the O X
T O X
cell O X
/ O X
APC O X
synapse O X
, O X
an O X
active O X
zone O X
of O X
receptors O X
and O X
proteins O X
recycling O X
. O X

A O X
binding O X
region O X
of O X
CIN85 I-MISC 30011
SH3 O X
domains O X
on O X
3BP2 I-MISC 6452
was O X
mapped O X
to O X
a O X
PVPTPR O X
motif O X
in O X
the O X
first O X
proline O X
- O X
rich O X
region O X
of O X
3BP2 I-MISC 6452
, O X
whereas O X
the O X
C O X
- O X
terminal O X
SH3 O X
domain O X
of O X
HIP I-MISC 28988
- I-MISC 28988
55 I-MISC 28988
bound O X
a O X
more O X
distal O X
proline O X
- O X
rich O X
domain O X
of O X
3BP2 I-MISC 6452
. O X

Together O X
, O X
our O X
data O X
suggest O X
an O X
unexpected O X
role O X
of O X
3BP2 I-MISC 6452
in O X
endocytic O X
and O X
cytoskeletal O X
regulation O X
through O X
its O X
interaction O X
with O X
CIN85 I-MISC 30011
and O X
HIP I-MISC 28988
- I-MISC 28988
55 I-MISC 28988
. O X

###7758105	8717,21937

The O X
TNF I-MISC 21937
receptor I-MISC 21937
1 I-MISC 21937
- O X
associated O X
protein O X
TRADD I-MISC 8717
signals O X
cell O X
death O X
and O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
activation O X
. O X

Many O X
diverse O X
activities O X
of O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
( O X
TNF I-MISC 7124
) O X
are O X
signaled O X
through O X
TNF I-MISC 21937
receptor I-MISC 21937
1 I-MISC 21937
( O X
TNFR1 I-MISC 21937
). O X

We O X
have O X
identified O X
a O X
novel O X
34 O X
kDa O X
protein O X
, O X
designated O X
TRADD I-MISC 8717
, O X
that O X
specifically O X
interacts O X
with O X
an O X
intracellular O X
domain O X
of O X
TNFR1 I-MISC 21937
known O X
to O X
be O X
essential O X
for O X
mediating O X
programmed O X
cell O X
death O X
. O X

Overexpression O X
of O X
TRADD I-MISC 8717
leads O X
to O X
two O X
major O X
TNF I-MISC 7124
- O X
induced O X
responses O X
, O X
apoptosis O X
and O X
activation O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
. O X

The O X
C O X
- O X
terminal O X
118 O X
amino O X
acids O X
of O X
TRADD I-MISC 8717
are O X
sufficient O X
to O X
trigger O X
both O X
of O X
these O X
activities O X
and O X
likewise O X
sufficient O X
for O X
interaction O X
with O X
the O X
death O X
domain O X
of O X
TNFR1 I-MISC 21937
. O X

TRADD I-MISC 8717
- O X
mediated O X
cell O X
death O X
can O X
be O X
suppressed O X
by O X
the O X
crmA O X
gene O X
, O X
which O X
encodes O X
a O X
specific O X
inhibitor O X
of O X
the O X
interleukin O X
- O X
1 O X
beta O X
- O X
converting O X
enzyme O X
. O X

However O X
, O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
activation O X
by O X
TRADD I-MISC 8717
is O X
not O X
inhibited O X
by O X
crmA O X
expression O X
, O X
demonstrating O X
that O X
the O X
signaling O X
pathways O X
for O X
TNF I-MISC 7124
- O X
induced O X
cell O X
death O X
and O X
NF I-MISC 4790
- I-MISC 4790
kappa I-MISC 4790
B I-MISC 4790
activation O X
are O X
distinct O X
. O X

###23446637	80184,9657

Pathogenic O X
NPHP5 I-MISC 9657
mutations O X
impair O X
protein O X
interaction O X
with O X
Cep290 I-MISC 80184
, O X
a O X
prerequisite O X
for O X
ciliogenesis O X
. O X

Mutations O X
in O X
the O X
human O X
NPHP5 I-MISC 9657
gene O X
cause O X
retinal O X
and O X
renal O X
disease O X
, O X
but O X
the O X
precise O X
mechanism O X
by O X
which O X
NPHP5 I-MISC 9657
functions O X
is O X
not O X
understood O X
. O X

We O X
report O X
that O X
NPHP5 I-MISC 9657
is O X
a O X
centriolar O X
protein O X
whose O X
depletion O X
inhibits O X
an O X
early O X
step O X
of O X
ciliogenesis O X
, O X
a O X
phenotype O X
reminiscent O X
of O X
Cep290 I-MISC 80184
loss O X
and O X
contrary O X
to O X
IFT88 I-MISC 8100
loss O X
. O X

Functional O X
dissection O X
of O X
NPHP5 I-MISC 9657
interactions O X
with O X
Cep290 I-MISC 80184
and O X
CaM O X
reveals O X
a O X
requirement O X
of O X
the O X
former O X
for O X
ciliogenesis O X
, O X
while O X
the O X
latter O X
prevents O X
NPHP5 I-MISC 9657
self O X
- O X
aggregation O X
. O X

Disease O X
- O X
causing O X
mutations O X
lead O X
to O X
truncated O X
products O X
unable O X
to O X
bind O X
Cep290 I-MISC 80184
and O X
localize O X
to O X
centrosomes O X
, O X
thereby O X
compromising O X
cilia O X
formation O X
. O X

In O X
contrast O X
, O X
a O X
modifier O X
mutation O X
cripples O X
CaM O X
binding O X
but O X
has O X
no O X
overt O X
effect O X
on O X
ciliogenesis O X
. O X

Drugs O X
that O X
antagonize O X
negative O X
regulators O X
of O X
the O X
ciliogenic O X
pathway O X
can O X
rescue O X
ciliogenesis O X
in O X
cells O X
depleted O X
of O X
NPHP5 I-MISC 9657
, O X
with O X
response O X
profiles O X
similar O X
to O X
those O X
of O X
Cep290 I-MISC 80184
- O X
but O X
not O X
IFT88 I-MISC 8100
- O X
depleted O X
cells O X
. O X

Our O X
results O X
uncover O X
the O X
underlying O X
molecular O X
basis O X
of O X
disease O X
and O X
provide O X
novel O X
insights O X
into O X
mitigating O X
NPHP5 I-MISC 9657
deficiency O X
. O X

###21460798	855861,852881

Mechanisms O X
of O X
pseudosubstrate O X
inhibition O X
of O X
the O X
anaphase O X
promoting O X
complex O X
by O X
Acm1 I-MISC 855861
. O X

The O X
anaphase O X
promoting O X
complex O X
( O X
APC O X
) O X
is O X
a O X
ubiquitin O X
ligase O X
that O X
promotes O X
the O X
degradation O X
of O X
cell O X
- O X
cycle O X
regulators O X
by O X
the O X
26S O X
proteasome O X
. O X

Cdc20 I-MISC 991
and O X
Cdh1 I-MISC 852881
are O X
WD40 O X
- O X
containing O X
APC O X
co O X
- O X
activators O X
that O X
bind O X
destruction O X
boxes O X
( O X
DB O X
) O X
and O X
KEN I-MISC 5116
boxes O X
within O X
substrates O X
to O X
recruit O X
them O X
to O X
the O X
APC O X
for O X
ubiquitination O X
. O X

Acm1 I-MISC 855861
is O X
an O X
APC O X
( O X
Cdh1 I-MISC 852881
) O X
inhibitor O X
that O X
utilizes O X
a O X
DB O X
and O X
a O X
KEN I-MISC 5116
box O X
to O X
bind O X
Cdh1 I-MISC 852881
and O X
prevent O X
substrate O X
binding O X
, O X
although O X
Acm1 I-MISC 855861
itself O X
is O X
not O X
a O X
substrate O X
. O X

We O X
investigated O X
what O X
differentiates O X
an O X
APC O X
substrate O X
from O X
an O X
inhibitor O X
. O X

We O X
identified O X
the O X
Acm1 I-MISC 855861
A O X
- O X
motif O X
that O X
interacts O X
with O X
Cdh1 I-MISC 852881
and O X
together O X
with O X
the O X
DB O X
and O X
KEN I-MISC 5116
box O X
is O X
required O X
for O X
APC O X
( O X
Cdh1 I-MISC 852881
) O X
inhibition O X
. O X

A O X
genetic O X
screen O X
identified O X
Cdh1 I-MISC 852881
WD40 O X
domain O X
residues O X
important O X
for O X
Acm1 I-MISC 855861
A O X
- O X
motif O X
interaction O X
and O X
inhibition O X
that O X
appears O X
to O X
reside O X
near O X
Cdh1 I-MISC 852881
residues O X
important O X
for O X
DB O X
recognition O X
. O X

Specific O X
lysine O X
insertion O X
mutations O X
within O X
Acm1 I-MISC 855861
promoted O X
its O X
ubiquitination O X
by O X
APC O X
( O X
Cdh1 I-MISC 852881
) O X
whereas O X
lysine O X
removal O X
from O X
the O X
APC O X
substrate O X
Hsl1 I-MISC 28960
converted O X
it O X
into O X
a O X
potent O X
APC O X
( O X
Cdh1 I-MISC 852881
) O X
inhibitor O X
. O X

These O X
findings O X
suggest O X
that O X
tight O X
Cdh1 I-MISC 852881
binding O X
combined O X
with O X
the O X
inaccessibility O X
of O X
ubiquitinatable O X
lysines O X
contributes O X
to O X
pseudosubstrate O X
inhibition O X
of O X
APC O X
( O X
Cdh1 I-MISC 852881
). O X

###22493017	945843,946345

Identification O X
of O X
functionally O X
important O X
TonB I-MISC 945843
- O X
ExbD I-MISC 946345
periplasmic O X
domain O X
interactions O X
in O X
vivo O X
. O X

In O X
gram O X
- O X
negative O X
bacteria O X
, O X
the O X
cytoplasmic O X
membrane O X
proton O X
- O X
motive O X
force O X
energizes O X
the O X
active O X
transport O X
of O X
TonB I-MISC 945843
- O X
dependent O X
ligands O X
through O X
outer O X
membrane O X
TonB I-MISC 945843
- O X
gated O X
transporters O X
. O X

In O X
Escherichia O X
coli O X
, O X
cytoplasmic O X
membrane O X
proteins O X
ExbB O X
and O X
ExbD I-MISC 946345
couple O X
the O X
proton O X
- O X
motive O X
force O X
to O X
conformational O X
changes O X
in O X
TonB I-MISC 945843
, O X
which O X
are O X
hypothesized O X
to O X
form O X
the O X
basis O X
of O X
energy O X
transduction O X
through O X
direct O X
contact O X
with O X
the O X
transporters O X
. O X

While O X
the O X
role O X
of O X
ExbB O X
is O X
not O X
well O X
understood O X
, O X
contact O X
between O X
periplasmic O X
domains O X
of O X
TonB I-MISC 945843
and O X
ExbD I-MISC 946345
is O X
required O X
, O X
with O X
the O X
conformational O X
response O X
of O X
TonB I-MISC 945843
to O X
presence O X
or O X
absence O X
of O X
proton O X
motive O X
force O X
being O X
modulated O X
through O X
ExbD I-MISC 946345
. O X

A O X
region O X
( O X
residues O X
92 O X
to O X
121 O X
) O X
within O X
the O X
ExbD I-MISC 946345
periplasmic O X
domain O X
was O X
previously O X
identified O X
as O X
being O X
important O X
for O X
TonB I-MISC 945843
interaction O X
. O X

Here O X
, O X
the O X
specific O X
sites O X
of O X
periplasmic O X
domain O X
interactions O X
between O X
that O X
region O X
and O X
the O X
TonB I-MISC 945843
carboxy O X
terminus O X
were O X
identified O X
by O X
examining O X
270 O X
combinations O X
of O X
45 O X
TonB I-MISC 945843
and O X
6 O X
ExbD I-MISC 946345
individual O X
cysteine O X
substitutions O X
for O X
disulfide O X
- O X
linked O X
heterodimer O X
formation O X
. O X

ExbD I-MISC 946345
residues O X
A92C O X
, O X
K97C O X
, O X
and O X
T109C O X
interacted O X
with O X
multiple O X
TonB I-MISC 945843
substitutions O X
in O X
four O X
regions O X
of O X
the O X
TonB I-MISC 945843
carboxy O X
terminus O X
. O X

Two O X
regions O X
were O X
on O X
each O X
side O X
of O X
the O X
TonB I-MISC 945843
residues O X
known O X
to O X
interact O X
with O X
the O X
TonB I-MISC 945843
box O X
of O X
TonB I-MISC 945843
- O X
gated O X
transporters O X
, O X
suggesting O X
that O X
ExbD I-MISC 946345
positions O X
TonB I-MISC 945843
for O X
correct O X
interaction O X
at O X
that O X
site O X
. O X

A O X
third O X
region O X
contained O X
a O X
functionally O X
important O X
glycine O X
residue O X
, O X
and O X
the O X
fourth O X
region O X
involved O X
a O X
highly O X
conserved O X
predicted O X
amphipathic O X
helix O X
. O X

Three O X
ExbD I-MISC 946345
substitutions O X
, O X
F103C O X
, O X
L115C O X
, O X
and O X
T121C O X
, O X
were O X
nonreactive O X
with O X
any O X
TonB I-MISC 945843
cysteine O X
substitutions O X
. O X

ExbD I-MISC 946345
D25 O X
, O X
a O X
candidate O X
to O X
be O X
on O X
a O X
proton O X
translocation O X
pathway O X
, O X
was O X
important O X
to O X
support O X
efficient O X
TonB I-MISC 945843
- O X
ExbD I-MISC 946345
heterodimerization O X
at O X
these O X
specific O X
regions O X
. O X

###10913138	6285,6271	6277,6285	6282,6285

S100A6 I-MISC 6277
and O X
S100A11 I-MISC 6282
are O X
specific O X
targets O X
of O X
the O X
calcium O X
- O X
and O X
zinc O X
- O X
binding O X
S100B I-MISC 6285
protein O X
in O X
vivo O X
. O X

In O X
solution O X
, O X
S100B I-MISC 6285
protein O X
is O X
a O X
noncovalent O X
homodimer O X
composed O X
of O X
two O X
subunits O X
associated O X
in O X
an O X
antiparallel O X
manner O X
. O X

Upon O X
calcium O X
binding O X
, O X
the O X
conformation O X
of O X
S100B I-MISC 6285
changes O X
dramatically O X
, O X
leading O X
to O X
the O X
exposure O X
of O X
hydrophobic O X
residues O X
at O X
the O X
surface O X
of O X
S100B I-MISC 6285
. O X

The O X
residues O X
in O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
S100B I-MISC 6285
encompassing O X
Phe O X
( O X
87 O X
) O X
and O X
Phe O X
( O X
88 O X
) O X
have O X
been O X
implicated O X
in O X
interaction O X
with O X
target O X
proteins O X
. O X

In O X
this O X
study O X
, O X
we O X
used O X
two O X
- O X
hybrid O X
technology O X
to O X
identify O X
specific O X
S100B I-MISC 6285
target O X
proteins O X
. O X

Using O X
S100B I-MISC 6285
as O X
bait O X
, O X
we O X
identify O X
S100A6 I-MISC 6277
and O X
S100A11 I-MISC 6282
as O X
specific O X
targets O X
for O X
S100B I-MISC 6285
. O X

S100A1 I-MISC 6271
, O X
the O X
closest O X
homologue O X
of O X
S100B I-MISC 6285
, O X
is O X
capable O X
of O X
interaction O X
with O X
S100B I-MISC 6285
but O X
does O X
not O X
interact O X
with O X
S100A6 I-MISC 6277
or O X
S100A11 I-MISC 6282
. O X

S100B I-MISC 6285
, O X
S100A6 I-MISC 6277
, O X
and O X
S100A11 I-MISC 6282
isoforms O X
are O X
co O X
- O X
regulated O X
and O X
co O X
- O X
localized O X
in O X
astrocytoma O X
U373 O X
cells O X
. O X

Furthermore O X
, O X
co O X
- O X
immunoprecipitation O X
experiments O X
demonstrated O X
that O X
Ca O X
( O X
2 O X
+)/ O X
Zn O X
( O X
2 O X
+) O X
stabilizes O X
S100B I-MISC 6285
- O X
S100A6 I-MISC 6277
and O X
S100B I-MISC 6285
- O X
S100A11 I-MISC 6282
heterocomplexes O X
. O X

Deletion O X
of O X
the O X
C O X
- O X
terminal O X
domain O X
or O X
mutation O X
of O X
Phe O X
( O X
87 O X
) O X
and O X
Phe O X
( O X
88 O X
) O X
residues O X
has O X
no O X
effect O X
on O X
S100B I-MISC 6285
homodimerization O X
and O X
heterodimerization O X
with O X
S100A1 I-MISC 6271
but O X
drastically O X
decreases O X
interaction O X
between O X
S100B I-MISC 6285
and O X
S100A6 I-MISC 6277
or O X
S100A11 I-MISC 6282
. O X

Our O X
data O X
suggest O X
that O X
the O X
interaction O X
between O X
S100B I-MISC 6285
and O X
S100A6 I-MISC 6277
or O X
S100A11 I-MISC 6282
should O X
not O X
be O X
viewed O X
as O X
a O X
typical O X
S100 O X
heterodimerization O X
but O X
rather O X
as O X
a O X
model O X
of O X
interaction O X
between O X
S100B I-MISC 6285
and O X
target O X
proteins O X
. O X

###21850687	10935,120892

Mutations O X
in O X
LRRK2 I-MISC 120892
increase O X
phosphorylation O X
of O X
peroxiredoxin I-MISC 10935
3 I-MISC 10935
exacerbating O X
oxidative O X
stress O X
- O X
induced O X
neuronal O X
death O X
. O X

Mutations O X
in O X
the O X
leucine I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
gene O X
are O X
responsible O X
for O X
autosomal O X
dominant O X
and O X
sporadic O X
Parkinson O X
disease O X
( O X
PD O X
), O X
possibly O X
exerting O X
their O X
effects O X
via O X
a O X
toxic O X
gain O X
of O X
function O X
. O X

A O X
common O X
p O X
. O X
G2019S O X
mutation O X
( O X
rs34637584 O X
: O X
A O X
> O X
G O X
) O X
is O X
responsible O X
for O X
up O X
to O X
30 O X
- O X
40 O X
% O X
of O X
PD O X
cases O X
in O X
some O X
ethnic O X
populations O X
. O X

Here O X
, O X
we O X
show O X
that O X
LRRK2 I-MISC 120892
interacts O X
with O X
human O X
peroxiredoxin I-MISC 10935
3 I-MISC 10935
( O X
PRDX3 I-MISC 10935
), O X
a O X
mitochondrial O X
member O X
of O X
the O X
antioxidant O X
family O X
of O X
thioredoxin I-MISC 7295
( O X
Trx I-MISC 7295
) O X
peroxidases O X
. O X

Importantly O X
, O X
mutations O X
in O X
the O X
LRRK2 I-MISC 120892
kinase O X
domain O X
significantly O X
increased O X
phosphorylation O X
of O X
PRDX3 I-MISC 10935
compared O X
to O X
wild O X
- O X
type O X
. O X

The O X
increase O X
in O X
PRDX3 I-MISC 10935
phosphorylation O X
was O X
associated O X
with O X
decreased O X
peroxidase O X
activity O X
and O X
increased O X
death O X
in O X
LRRK2 I-MISC 120892
- O X
expressing O X
but O X
not O X
in O X
LRRK2 I-MISC 120892
- O X
depleted O X
or O X
vector O X
- O X
transfected O X
neuronal O X
cells O X
. O X

LRRK2 I-MISC 120892
mutants O X
stimulated O X
mitochondrial O X
factors O X
involved O X
in O X
apoptosis O X
and O X
induced O X
production O X
of O X
reactive O X
oxygen O X
species O X
( O X
ROS O X
) O X
and O X
oxidative O X
modification O X
of O X
macromolecules O X
. O X

Furthermore O X
, O X
immunoblot O X
and O X
immunohistochemical O X
analysis O X
of O X
postmortem O X
human O X
PD O X
patients O X
carrying O X
the O X
p O X
. O X
G2019S O X
mutation O X
showed O X
a O X
marked O X
increase O X
in O X
phosphorylated O X
PRDX3 I-MISC 10935
( O X
p O X
- O X
PRDX3 I-MISC 10935
) O X
relative O X
to O X
normal O X
brain O X
. O X

We O X
showed O X
that O X
LRRK2 I-MISC 120892
mutations O X
increase O X
the O X
inhibition O X
of O X
an O X
endogenous O X
peroxidase O X
by O X
phosphorylation O X
promoting O X
dysregulation O X
of O X
mitochondrial O X
function O X
and O X
oxidative O X
damage O X
. O X

Our O X
findings O X
provide O X
a O X
mechanistic O X
link O X
between O X
the O X
enhanced O X
kinase O X
activity O X
of O X
PD O X
- O X
linked O X
LRRK2 I-MISC 120892
and O X
neuronal O X
cell O X
death O X
. O X

###18242179	7533,84254

14 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
Proteins O X
directly O X
regulate O X
Ca O X
( O X
2 O X
+)/ O X
calmodulin O X
- O X
dependent O X
protein O X
kinase O X
kinase O X
alpha O X
through O X
phosphorylation O X
- O X
dependent O X
multisite O X
binding O X
. O X

Ca O X
( O X
2 O X
+)/ O X
calmodulin O X
- O X
dependent O X
protein O X
kinase O X
kinase O X
alpha O X
( O X
CaMKKalpha I-MISC 84254
) O X
plays O X
critical O X
roles O X
in O X
the O X
modulation O X
of O X
neuronal O X
cell O X
survival O X
as O X
well O X
as O X
many O X
other O X
cellular O X
activities O X
. O X

Here O X
we O X
show O X
that O X
14 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
proteins O X
directly O X
regulate O X
CaMKKalpha I-MISC 84254
when O X
the O X
enzyme O X
is O X
phosphorylated O X
by O X
protein O X
kinase O X
A O X
on O X
either O X
Ser74 O X
or O X
Ser475 O X
. O X

Mutational O X
analysis O X
revealed O X
that O X
these O X
two O X
serines O X
are O X
both O X
functional O X
: O X
the O X
CaMKKalpha I-MISC 84254
mutant O X
with O X
a O X
mutation O X
at O X
either O X
of O X
these O X
residues O X
, O X
but O X
not O X
the O X
double O X
mutant O X
, O X
was O X
inhibited O X
significantly O X
by O X
14 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
. O X

The O X
mode O X
of O X
regulation O X
described O X
herein O X
differs O X
the O X
recently O X
described O X
mode O X
of O X
14 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
- I-MISC 7533
3 I-MISC 7533
regulation O X
of O X
CaMKKalpha I-MISC 84254
. O X

###24802387	117579,339403

The O X
electrostatic O X
interactions O X
of O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
with O X
receptor O X
RXFP4 I-MISC 339403
and O X
the O X
influence O X
of O X
its O X
B O X
- O X
chain O X
C O X
- O X
terminal O X
conformation O X
. O X

Relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
( O X
also O X
known O X
as O X
insulin I-MISC 117579
- I-MISC 117579
like I-MISC 117579
peptide I-MISC 117579
7 I-MISC 117579
) O X
is O X
an O X
insulin O X
/ O X
relaxin O X
- O X
superfamily O X
peptide O X
hormone O X
that O X
can O X
bind O X
and O X
activate O X
three O X
relaxin O X
- O X
family O X
peptide O X
receptors O X
: O X
RXFP3 I-MISC 51289
, O X
RXFP4 I-MISC 339403
, O X
and O X
RXFP1 I-MISC 59350
. O X

Recently O X
, O X
we O X
identified O X
key O X
electrostatic O X
interactions O X
between O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
and O X
its O X
cognate O X
receptor O X
RXFP3 I-MISC 51289
by O X
using O X
a O X
charge O X
- O X
exchange O X
mutagenesis O X
approach O X
. O X

In O X
the O X
present O X
study O X
, O X
the O X
electrostatic O X
interactions O X
between O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
and O X
RXFP4 I-MISC 339403
were O X
investigated O X
with O X
the O X
same O X
approach O X
. O X

Mutagenesis O X
of O X
the O X
negatively O X
charged O X
extracellular O X
residues O X
of O X
human O X
RXFP4 I-MISC 339403
identified O X
a O X
conserved O X
EXXXD O X
( O X
100 O X
- O X
104 O X
) O X
motif O X
that O X
is O X
essential O X
for O X
RXFP4 I-MISC 339403
activation O X
by O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
. O X

Mutagenesis O X
of O X
the O X
conserved O X
positively O X
charged O X
Arg O X
residues O X
of O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
demonstrated O X
that O X
B12Arg O X
, O X
B16Arg O X
and O X
B26Arg O X
were O X
all O X
involved O X
in O X
the O X
binding O X
and O X
activation O X
of O X
RXFP4 I-MISC 339403
, O X
especially O X
B26Arg O X
. O X

The O X
activity O X
complementation O X
between O X
the O X
mutant O X
ligands O X
and O X
the O X
mutant O X
receptors O X
suggested O X
two O X
probable O X
electrostatic O X
interaction O X
pairs O X
: O X
Glu100 O X
of O X
RXFP4 I-MISC 339403
versus O X
B26Arg O X
of O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
, O X
and O X
Asp104 O X
of O X
RXFP4 I-MISC 339403
versus O X
both O X
B12Arg O X
and O X
B16Arg O X
of O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
. O X

For O X
interaction O X
with O X
the O X
essential O X
EXXXD O X
motifs O X
of O X
both O X
RXFP3 I-MISC 51289
and O X
RXFP4 I-MISC 339403
, O X
a O X
folding O X
- O X
back O X
conformation O X
of O X
the O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
B O X
- O X
chain O X
C O X
- O X
terminus O X
seems O X
to O X
be O X
critical O X
, O X
because O X
it O X
brings O X
B26Arg O X
sufficiently O X
close O X
to O X
B12Arg O X
and O X
B16Arg O X
. O X

To O X
test O X
this O X
hypothesis O X
, O X
we O X
replaced O X
the O X
conserved O X
B23Gly O X
- O X
B24Gly O X
dipeptide O X
of O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
with O X
an O X
Ala O X
- O X
Ser O X
dipeptide O X
that O X
occupied O X
the O X
corresponding O X
position O X
of O X
insulin I-MISC 11172
- I-MISC 11172
like I-MISC 11172
peptide I-MISC 11172
5 I-MISC 11172
and O X
resulted O X
in O X
an O X
extended O X
helical O X
conformation O X
. O X

The O X
mutant O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
showed O X
a O X
significant O X
decrease O X
in O X
receptor O X
- O X
activation O X
potency O X
towards O X
both O X
RXFP3 I-MISC 51289
and O X
RXFP4 I-MISC 339403
, O X
suggesting O X
that O X
a O X
folding O X
- O X
back O X
conformation O X
of O X
the O X
B O X
- O X
chain O X
C O X
- O X
terminus O X
was O X
important O X
for O X
relaxin I-MISC 117579
- I-MISC 117579
3 I-MISC 117579
to O X
efficiently O X
interact O X
with O X
the O X
EXXXD O X
motifs O X
of O X
both O X
receptors O X
. O X

###12802020	7251,9146

TSG101 I-MISC 7251
interaction O X
with O X
HRS O X
mediates O X
endosomal O X
trafficking O X
and O X
receptor O X
down O X
- O X
regulation O X
. O X

Down O X
- O X
regulation O X
of O X
mitogenic O X
signaling O X
in O X
mammalian O X
cells O X
relies O X
in O X
part O X
on O X
endosomal O X
trafficking O X
of O X
activated O X
receptors O X
into O X
lysosomes O X
, O X
where O X
the O X
receptors O X
are O X
degraded O X
. O X

These O X
events O X
are O X
mediated O X
by O X
ubiquitination O X
of O X
the O X
endosomal O X
cargo O X
and O X
its O X
consequent O X
sorting O X
into O X
multivesicular O X
bodies O X
that O X
form O X
at O X
the O X
surfaces O X
of O X
late O X
endosomes O X
. O X

Tumor I-MISC 7251
susceptibility I-MISC 7251
gene I-MISC 7251
101 I-MISC 7251
( O X
tsg101 I-MISC 7251
) O X
recently O X
was O X
found O X
to O X
be O X
centrally O X
involved O X
in O X
this O X
process O X
. O X

Here O X
we O X
report O X
that O X
TSG101 I-MISC 7251
interacts O X
with O X
hepatocyte I-MISC 9146
growth I-MISC 9146
factor I-MISC 9146
- I-MISC 9146
regulated I-MISC 9146
tyrosine I-MISC 9146
kinase I-MISC 9146
substrate I-MISC 9146
( O X
HRS O X
), O X
an O X
early O X
endosomal O X
protein O X
, O X
and O X
that O X
disruption O X
of O X
this O X
interaction O X
impedes O X
endosomal O X
trafficking O X
and O X
endocytosis O X
- O X
mediated O X
degradation O X
of O X
mitogenic O X
receptors O X
. O X

TSG101 I-MISC 7251
/ O X
HRS O X
interaction O X
occurs O X
between O X
a O X
ubiquitin O X
- O X
binding O X
domain O X
of O X
TSG101 I-MISC 7251
and O X
two O X
distinct O X
proline O X
- O X
rich O X
regions O X
of O X
HRS O X
, O X
and O X
is O X
modulated O X
by O X
a O X
C O X
- O X
terminal O X
TSG101 I-MISC 7251
sequence O X
that O X
resembles O X
a O X
motif O X
targeted O X
in O X
HRS O X
. O X

Mutational O X
perturbation O X
of O X
TSG101 I-MISC 7251
/ O X
HRS O X
interaction O X
prevented O X
delivery O X
of O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
to O X
late O X
endosomes O X
, O X
resulted O X
in O X
the O X
cellular O X
accumulation O X
of O X
ubiquitinated O X
EGFR I-MISC 1956
in O X
early O X
endosomes O X
, O X
and O X
inhibited O X
ligand O X
- O X
induced O X
down O X
- O X
regulation O X
of O X
EGFR I-MISC 1956
. O X

Our O X
results O X
reveal O X
the O X
TSG101 I-MISC 7251
interaction O X
with O X
HRS O X
as O X
a O X
crucial O X
step O X
in O X
endocytic O X
down O X
- O X
regulation O X
of O X
mitogenic O X
signaling O X
and O X
suggest O X
a O X
role O X
for O X
this O X
interaction O X
in O X
linking O X
the O X
functions O X
of O X
early O X
and O X
late O X
endosomes O X
. O X

###11124807	174137,176548

Direct O X
protein O X
- O X
protein O X
interaction O X
between O X
the O X
intracellular O X
domain O X
of O X
TRA I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
and O X
the O X
transcription O X
factor O X
TRA O X
- O X
1A O X
modulates O X
feminizing O X
activity O X
in O X
C O X
. O X
elegans O X
. O X

In O X
the O X
nematode O X
Caenorhabditis O X
elegans O X
, O X
the O X
zinc O X
finger O X
transcriptional O X
regulator O X
TRA O X
- O X
1A O X
directs O X
XX O X
somatic O X
cells O X
to O X
adopt O X
female O X
fates O X
. O X

The O X
membrane O X
protein O X
TRA O X
- O X
2A O X
indirectly O X
activates O X
TRA O X
- O X
1A O X
by O X
binding O X
and O X
inhibiting O X
a O X
masculinizing O X
protein O X
, O X
FEM I-MISC 177734
- I-MISC 177734
3 I-MISC 177734
. O X

Here O X
we O X
report O X
that O X
a O X
part O X
of O X
the O X
intracellular O X
domain O X
of O X
TRA O X
- O X
2A O X
, O X
distinct O X
from O X
the O X
FEM I-MISC 177734
- I-MISC 177734
3 I-MISC 177734
binding O X
region O X
, O X
directly O X
binds O X
TRA O X
- O X
1A O X
. O X

Overproduction O X
of O X
this O X
TRA O X
- O X
1A O X
- O X
binding O X
region O X
has O X
tra I-MISC 176548
- I-MISC 176548
1 I-MISC 176548
- O X
dependent O X
feminizing O X
activity O X
in O X
somatic O X
tissues O X
, O X
indicating O X
that O X
the O X
interaction O X
enhances O X
TRA O X
- O X
1A O X
activity O X
. O X

Consistent O X
with O X
this O X
hypothesis O X
, O X
we O X
show O X
that O X
tra I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
( O X
mx O X
) O X
mutations O X
, O X
which O X
weakly O X
masculinize O X
somatic O X
tissues O X
, O X
disrupt O X
the O X
TRA I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
/ O X
TRA O X
- O X
1A O X
interaction O X
. O X

Paradoxically O X
, O X
tra I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
( O X
mx O X
) O X
mutations O X
feminize O X
the O X
XX O X
germ O X
line O X
, O X
as O X
do O X
tra I-MISC 176548
- I-MISC 176548
1 I-MISC 176548
mutations O X
mapping O X
to O X
the O X
TRA I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
binding O X
domain O X
. O X

We O X
propose O X
that O X
these O X
mutations O X
render O X
tra I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
insensitive O X
to O X
a O X
negative O X
regulator O X
in O X
the O X
XX O X
germ O X
line O X
, O X
and O X
we O X
speculate O X
that O X
this O X
regulator O X
targets O X
the O X
TRA I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
/ O X
TRA I-MISC 176548
- I-MISC 176548
1 I-MISC 176548
complex O X
. O X

The O X
intracellular O X
domain O X
of O X
TRA O X
- O X
2A O X
is O X
likely O X
to O X
be O X
produced O X
as O X
a O X
soluble O X
protein O X
in O X
vivo O X
through O X
proteolytic O X
cleavage O X
of O X
TRA O X
- O X
2A O X
or O X
through O X
translation O X
of O X
an O X
XX O X
germ O X
line O X
- O X
specific O X
mRNA O X
. O X

We O X
further O X
show O X
that O X
tagged O X
derivatives O X
of O X
the O X
intracellular O X
domain O X
of O X
TRA I-MISC 174137
- I-MISC 174137
2 I-MISC 174137
localize O X
to O X
the O X
nucleus O X
, O X
supporting O X
the O X
hypothesis O X
that O X
this O X
domain O X
is O X
capable O X
of O X
modulating O X
TRA O X
- O X
1A O X
activity O X
in O X
a O X
manner O X
reminiscent O X
of O X
Notch O X
and O X
Su O X
( O X
H O X
). O X

###18676636	2296,708

Human O X
p32 I-MISC 708
is O X
a O X
novel O X
FOXC1 I-MISC 2296
- O X
interacting O X
protein O X
that O X
regulates O X
FOXC1 I-MISC 2296
transcriptional O X
activity O X
in O X
ocular O X
cells O X
. O X

PURPOSE O X
: O X
Mutations O X
in O X
the O X
human O X
forkhead I-MISC 2296
box I-MISC 2296
C1 I-MISC 2296
gene O X
( O X
FOXC1 I-MISC 2296
) O X
cause O X
Axenfeld O X
- O X
Rieger O X
( O X
AR O X
) O X
malformations O X
, O X
often O X
leading O X
to O X
glaucoma O X
. O X

Understanding O X
the O X
function O X
of O X
FOXC1 I-MISC 2296
necessitates O X
characterizing O X
the O X
proteins O X
that O X
interact O X
with O X
FOXC1 I-MISC 2296
. O X

This O X
study O X
was O X
undertaken O X
to O X
isolate O X
FOXC1 I-MISC 2296
- O X
interacting O X
proteins O X
and O X
determine O X
their O X
effects O X
on O X
FOXC1 I-MISC 2296
. O X

METHODS O X
: O X
To O X
identify O X
FOXC1 I-MISC 2296
- O X
interacting O X
proteins O X
, O X
a O X
human O X
trabecular O X
meshwork O X
( O X
HTM O X
) O X
yeast O X
two O X
- O X
hybrid O X
( O X
Y2H O X
) O X
cDNA O X
library O X
was O X
screened O X
. O X

The O X
interaction O X
and O X
colocalization O X
between O X
FOXC1 I-MISC 2296
and O X
its O X
putative O X
protein O X
partner O X
were O X
confirmed O X
by O X
Ni O X
( O X
2 O X
+) O X
pull O X
- O X
down O X
assays O X
, O X
immunoprecipitation O X
, O X
and O X
immunofluorescence O X
, O X
respectively O X
. O X

The O X
electrophoretic O X
mobility O X
shift O X
assay O X
( O X
EMSA O X
) O X
was O X
used O X
to O X
study O X
the O X
effect O X
of O X
the O X
interacting O X
protein O X
on O X
FOXC1 I-MISC 2296
DNA O X
- O X
binding O X
ability O X
. O X

Dual O X
luciferase O X
assays O X
using O X
FOXC1 I-MISC 2296
reporter O X
plasmids O X
in O X
HTM O X
cells O X
were O X
performed O X
to O X
determine O X
the O X
effect O X
of O X
the O X
interaction O X
on O X
FOXC1 I-MISC 2296
transcription O X
activity O X
. O X

RESULTS O X
: O X
The O X
human O X
p32 I-MISC 708
protein O X
was O X
isolated O X
as O X
a O X
putative O X
FOXC1 I-MISC 2296
- O X
interacting O X
protein O X
from O X
a O X
Y2H O X
screen O X
. O X

The O X
interaction O X
of O X
FOXC1 I-MISC 2296
with O X
p32 I-MISC 708
was O X
confirmed O X
by O X
Ni O X
- O X
pull O X
- O X
down O X
assays O X
and O X
immunoprecipitation O X
. O X

Although O X
p32 I-MISC 708
is O X
predominantly O X
cytoplasmic O X
, O X
the O X
portion O X
of O X
p32 I-MISC 708
that O X
is O X
within O X
the O X
nucleus O X
colocalizes O X
with O X
FOXC1 I-MISC 2296
. O X

The O X
FOXC1 I-MISC 2296
forkhead O X
domain O X
( O X
FHD O X
) O X
was O X
identified O X
as O X
the O X
p32 I-MISC 708
interaction O X
domain O X
. O X

p32 I-MISC 708
significantly O X
inhibited O X
FOXC1 I-MISC 2296
- O X
mediated O X
transcription O X
activation O X
in O X
a O X
dose O X
- O X
dependent O X
manner O X
but O X
did O X
not O X
affect O X
FOXC1 I-MISC 2296
DNA O X
- O X
binding O X
ability O X
. O X

Of O X
interest O X
, O X
a O X
FOXC1 I-MISC 2296
mutation O X
F112S O X
displayed O X
an O X
impaired O X
interaction O X
with O X
p32 I-MISC 708
. O X

CONCLUSIONS O X
: O X
In O X
the O X
study O X
, O X
the O X
human O X
p32 I-MISC 708
protein O X
as O X
a O X
novel O X
regulator O X
of O X
FOXC1 I-MISC 2296
- O X
mediated O X
transcription O X
activation O X
. O X

Failure O X
of O X
p32 I-MISC 708
to O X
interact O X
with O X
FOXC1 I-MISC 2296
containing O X
the O X
disease O X
- O X
causing O X
F112S O X
mutation O X
indicates O X
that O X
impaired O X
protein O X
interaction O X
may O X
be O X
a O X
disease O X
mechanism O X
for O X
AR O X
malformations O X
. O X

###19172740	853178,853910

Structure O X
of O X
the O X
archaeal O X
Kae1 I-MISC 853910
/ O X
Bud32 I-MISC 853178
fusion O X
protein O X
MJ1130 I-MISC 1452026
: O X
a O X
model O X
for O X
the O X
eukaryotic O X
EKC O X
/ O X
KEOPS O X
subcomplex O X
. O X

The O X
EKC O X
/ O X
KEOPS O X
yeast O X
complex O X
is O X
involved O X
in O X
telomere O X
maintenance O X
and O X
transcription O X
. O X

The O X
Bud32p I-MISC 853178
and O X
kinase O X
- O X
associated O X
endopeptidase O X
1 O X
( O X
Kaelp O X
) O X
components O X
of O X
the O X
complex O X
are O X
totally O X
conserved O X
in O X
eukarya O X
and O X
archaea O X
. O X

Their O X
genes O X
are O X
fused O X
in O X
several O X
archaeal O X
genomes O X
, O X
suggesting O X
that O X
they O X
physically O X
interact O X
. O X

We O X
report O X
here O X
the O X
structure O X
of O X
the O X
Methanocaldococcus O X
jannaschii O X
Kae1 I-MISC 853910
/ O X
Bud32 I-MISC 853178
fusion O X
protein O X
MJ1130 I-MISC 1452026
. O X

Kae1 I-MISC 853910
is O X
an O X
iron O X
protein O X
with O X
an O X
ASKHA O X
fold O X
and O X
Bud32 I-MISC 853178
is O X
an O X
atypical O X
small O X
RIO O X
- O X
type O X
kinase O X
. O X

The O X
structure O X
MJ1130 I-MISC 1452026
suggests O X
that O X
association O X
with O X
Kae1 I-MISC 853910
maintains O X
the O X
Bud32 I-MISC 853178
kinase O X
in O X
an O X
inactive O X
state O X
. O X

We O X
indeed O X
show O X
that O X
yeast O X
Kae1p I-MISC 853910
represses O X
the O X
kinase O X
activity O X
of O X
yeast O X
Bud32p I-MISC 853178
. O X

Extensive O X
conserved O X
interactions O X
between O X
MjKae1 O X
and O X
MjBud32 O X
suggest O X
that O X
Kae1p I-MISC 853910
and O X
Bud32p I-MISC 853178
directly O X
interact O X
in O X
both O X
yeast O X
and O X
archaea O X
. O X

Mutations O X
that O X
disrupt O X
the O X
Kae1p I-MISC 853910
/ O X
Bud32p I-MISC 853178
interaction O X
in O X
the O X
context O X
of O X
the O X
yeast O X
complex O X
have O X
dramatic O X
effects O X
in O X
vivo O X
and O X
in O X
vitro O X
, O X
similar O X
to O X
those O X
observed O X
with O X
deletion O X
mutations O X
of O X
the O X
respective O X
components O X
. O X

Direct O X
interaction O X
between O X
Kae1p I-MISC 853910
and O X
Bud32p I-MISC 853178
in O X
yeast O X
is O X
required O X
both O X
for O X
the O X
transcription O X
and O X
the O X
telomere O X
homeostasis O X
function O X
of O X
EKC O X
/ O X
KEOPS O X
. O X

###10602478	58497,4830

Evidence O X
for O X
interaction O X
between O X
human O X
PRUNE I-MISC 58497
and O X
nm23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
NDPKinase O X
. O X

We O X
have O X
isolated O X
a O X
human O X
and O X
murine O X
homologue O X
of O X
the O X
Drosophila O X
prune I-MISC 31194
gene O X
through O X
dbEST I-MISC 53431
searches O X
. O X

The O X
gene O X
is O X
ubiquitously O X
expressed O X
in O X
human O X
adult O X
tissues O X
, O X
while O X
in O X
mouse O X
developing O X
embryos O X
a O X
high O X
level O X
of O X
expression O X
is O X
confined O X
to O X
the O X
nervous O X
system O X
particularly O X
in O X
the O X
dorsal O X
root O X
ganglia O X
, O X
cranial O X
nerves O X
, O X
and O X
neural O X
retina O X
. O X

The O X
gene O X
is O X
composed O X
of O X
eight O X
exons O X
and O X
is O X
located O X
in O X
the O X
1q21 O X
. O X
3 O X
chromosomal O X
region O X
. O X

A O X
pseudogene O X
has O X
been O X
sequenced O X
and O X
mapped O X
to O X
chromosomal O X
region O X
13q12 O X
. O X

PRUNE I-MISC 58497
protein O X
retains O X
the O X
four O X
characteristic O X
domains O X
of O X
DHH O X
phosphoesterases O X
. O X

The O X
synergism O X
between O X
prune I-MISC 58497
and O X
awdK O X
- O X
pn O X
in O X
Drosophila O X
has O X
led O X
various O X
authors O X
to O X
propose O X
an O X
interaction O X
between O X
these O X
genes O X
. O X

However O X
, O X
such O X
an O X
interaction O X
has O X
never O X
been O X
supported O X
by O X
biochemical O X
data O X
. O X

By O X
using O X
interaction O X
- O X
mating O X
and O X
in O X
vitro O X
co O X
- O X
immunoprecipitation O X
experiments O X
, O X
we O X
show O X
for O X
the O X
first O X
time O X
the O X
ability O X
of O X
human O X
PRUNE I-MISC 58497
to O X
interact O X
with O X
the O X
human O X
homologue O X
of O X
awd O X
protein O X
( O X
nm23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
). O X

In O X
contrast O X
, O X
PRUNE I-MISC 58497
is O X
impaired O X
in O X
its O X
interaction O X
with O X
nm O X
- O X
23 O X
- O X
H1 O X
- O X
S120G O X
mutant O X
, O X
a O X
gain O X
- O X
of O X
- O X
function O X
mutation O X
associated O X
with O X
advanced O X
neuroblastoma O X
stages O X
. O X

Consistently O X
, O X
PRUNE I-MISC 58497
and O X
nm23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
proteins O X
partially O X
colocalize O X
in O X
the O X
cytoplasm O X
. O X

The O X
data O X
presented O X
are O X
consistent O X
with O X
the O X
view O X
that O X
PRUNE I-MISC 58497
acts O X
as O X
a O X
negative O X
regulator O X
of O X
the O X
nm23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
protein O X
. O X

We O X
discuss O X
how O X
PRUNE I-MISC 58497
regulates O X
nm23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
protein O X
and O X
postulate O X
possible O X
implications O X
of O X
PRUNE I-MISC 58497
in O X
neuroblastoma O X
progression O X
. O X

###20691684	116643,68053	116643,83809	22230,116643

Isolation O X
of O X
a O X
point O X
- O X
mutated O X
p47 I-MISC 83809
lacking O X
binding O X
affinity O X
to O X
p97ATPase I-MISC 116643
. O X

p47 I-MISC 83809
, O X
a O X
p97 I-MISC 116643
- O X
binding O X
protein O X
, O X
functions O X
in O X
Golgi O X
membrane O X
fusion O X
together O X
with O X
p97 I-MISC 116643
and O X
VCIP135 I-MISC 80124
, O X
another O X
p97 I-MISC 116643
- O X
binding O X
protein O X
. O X

We O X
have O X
succeeded O X
in O X
creating O X
p47 I-MISC 83809
with O X
a O X
point O X
mutation O X
, O X
F253S O X
, O X
which O X
lacks O X
p97 I-MISC 116643
- O X
binding O X
affinity O X
. O X

p47 I-MISC 83809
mapping O X
experiments O X
revealed O X
that O X
p47 I-MISC 83809
had O X
two O X
p97 I-MISC 116643
- O X
binding O X
regions O X
and O X
the O X
F253S O X
mutation O X
occurred O X
in O X
the O X
first O X
p97 I-MISC 116643
- O X
binding O X
site O X
. O X

p47 I-MISC 83809
( O X
F253S O X
) O X
could O X
not O X
form O X
a O X
complex O X
with O X
p97 I-MISC 116643
and O X
did O X
not O X
caused O X
any O X
cisternal O X
regrowth O X
in O X
an O X
in O X
vitro O X
Golgi O X
reassembly O X
assay O X
. O X

In O X
addition O X
, O X
mutation O X
corresponding O X
to O X
the O X
p47 I-MISC 83809
F253S O X
mutation O X
in O X
p37 I-MISC 68053
and O X
ufd1 I-MISC 22230
also O X
abolished O X
their O X
binding O X
ability O X
to O X
p97 I-MISC 116643
. O X

###14527422	2542872,2542637

BTB O X
/ O X
POZ O X
domain O X
proteins O X
are O X
putative O X
substrate O X
adaptors O X
for O X
cullin I-MISC 2542637
3 I-MISC 2542637
ubiquitin O X
ligases O X
. O X

Cullins O X
( O X
CULs O X
) O X
are O X
subunits O X
of O X
a O X
prominent O X
class O X
of O X
RING O X
ubiquitin O X
ligases O X
. O X

Whereas O X
the O X
subunits O X
and O X
substrates O X
of O X
CUL1 O X
- O X
associated O X
SCF O X
complexes O X
and O X
CUL2 O X
ubiquitin O X
ligases O X
are O X
well O X
established O X
, O X
they O X
are O X
largely O X
unknown O X
for O X
other O X
cullin O X
family O X
members O X
. O X

We O X
show O X
here O X
that O X
S O X
. O X
pombe O X
CUL3 I-MISC 2542637
( O X
Pcu3p I-MISC 2542637
) O X
forms O X
a O X
complex O X
with O X
the O X
RING O X
protein O X
Pip1p O X
and O X
all O X
three O X
BTB O X
/ O X
POZ O X
domain O X
proteins O X
encoded O X
in O X
the O X
fission O X
yeast O X
genome O X
. O X

The O X
integrity O X
of O X
the O X
BTB O X
/ O X
POZ O X
domain O X
, O X
which O X
shows O X
similarity O X
to O X
the O X
cullin O X
binding O X
proteins O X
SKP1 O X
and O X
elongin O X
C O X
, O X
is O X
required O X
for O X
this O X
interaction O X
. O X

Whereas O X
Btb1p O X
and O X
Btb2p O X
are O X
stable O X
proteins O X
, O X
Btb3p I-MISC 2542872
is O X
ubiquitylated O X
and O X
degraded O X
in O X
a O X
Pcu3p I-MISC 2542637
- O X
dependent O X
manner O X
. O X

Btb3p I-MISC 2542872
degradation O X
requires O X
its O X
binding O X
to O X
a O X
conserved O X
N O X
- O X
terminal O X
region O X
of O X
Pcu3p I-MISC 2542637
that O X
precisely O X
maps O X
to O X
the O X
equivalent O X
SKP1 O X
/ O X
F O X
box O X
adaptor O X
binding O X
domain O X
of O X
CUL1 O X
. O X

We O X
propose O X
that O X
the O X
BTB O X
/ O X
POZ O X
domain O X
defines O X
a O X
recognition O X
motif O X
for O X
the O X
assembly O X
of O X
substrate O X
- O X
specific O X
RING O X
/ O X
cullin I-MISC 2542637
3 I-MISC 2542637
/ O X
BTB O X
ubiquitin O X
ligase O X
complexes O X
. O X

###18192679	3064,9001

Huntingtin I-MISC 9001
- I-MISC 9001
associated I-MISC 9001
protein I-MISC 9001
- I-MISC 9001
1 I-MISC 9001
is O X
a O X
modifier O X
of O X
the O X
age O X
- O X
at O X
- O X
onset O X
of O X
Huntington O X
' O X
s O X
disease O X
. O X

A O X
polyglutamine O X
repeat O X
expansion O X
of O X
more O X
than O X
36 O X
units O X
in O X
a O X
protein O X
called O X
huntingtin I-MISC 3064
( O X
htt I-MISC 3064
) O X
is O X
the O X
only O X
known O X
cause O X
of O X
Huntington O X
' O X
s O X
disease O X
( O X
HD O X
). O X

The O X
expanded O X
repeat O X
length O X
is O X
inversely O X
correlated O X
with O X
the O X
age O X
- O X
at O X
- O X
onset O X
( O X
AAO O X
), O X
however O X
, O X
the O X
onset O X
age O X
among O X
HD O X
patients O X
with O X
CAG O X
repeats O X
below O X
60 O X
units O X
varies O X
considerably O X
. O X

In O X
addition O X
to O X
environmental O X
factors O X
, O X
genetic O X
factors O X
different O X
from O X
the O X
expanded O X
CAG O X
repeat O X
length O X
can O X
modify O X
the O X
AAO O X
of O X
HD O X
. O X

We O X
hypothezised O X
that O X
htt I-MISC 3064
interacting O X
proteins O X
might O X
contribute O X
to O X
this O X
variation O X
in O X
the O X
AAO O X
and O X
investigated O X
human O X
htt I-MISC 9001
- I-MISC 9001
associated I-MISC 9001
protein I-MISC 9001
- I-MISC 9001
1 I-MISC 9001
( O X
HAP1 I-MISC 9001
) O X
using O X
genetic O X
and O X
functional O X
assays O X
. O X

We O X
identified O X
six O X
polymorphisms O X
in O X
the O X
HAP1 I-MISC 9001
gene O X
including O X
one O X
that O X
substitutes O X
methionine O X
( O X
M441 O X
) O X
for O X
threonine O X
( O X
T441 O X
) O X
at O X
amino O X
acid O X
441 O X
. O X

Analyzing O X
980 O X
European O X
HD O X
patients O X
, O X
we O X
found O X
that O X
patients O X
homozygous O X
for O X
the O X
M441 O X
genotype O X
show O X
an O X
8 O X
- O X
year O X
delay O X
in O X
the O X
AAO O X
. O X

Functional O X
assays O X
demonstrated O X
that O X
human O X
M441 O X
- O X
HAP1 I-MISC 9001
interacts O X
with O X
mutant O X
htt I-MISC 3064
more O X
tightly O X
than O X
does O X
human O X
T441 O X
- O X
HAP1 I-MISC 9001
, O X
reduces O X
soluble O X
htt I-MISC 3064
degraded O X
products O X
and O X
protects O X
against O X
htt I-MISC 3064
- O X
mediated O X
toxicity O X
. O X

We O X
thus O X
provide O X
genetic O X
and O X
functional O X
evidence O X
that O X
the O X
M441 O X
- O X
HAP1 I-MISC 9001
polymorphism O X
modifies O X
the O X
AAO O X
of O X
HD O X
. O X

###18226242	4673,155871

The O X
histone O X
chaperone O X
protein O X
Nucleosome O X
Assembly O X
Protein O X
- O X
1 O X
( O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
) O X
binds O X
HIV O X
- O X
1 O X
Tat I-MISC 155871
and O X
promotes O X
viral O X
transcription O X
. O X

BACKGROUND O X
: O X
Despite O X
the O X
large O X
amount O X
of O X
data O X
available O X
on O X
the O X
molecular O X
mechanisms O X
that O X
regulate O X
HIV O X
- O X
1 O X
transcription O X
, O X
crucial O X
information O X
is O X
still O X
lacking O X
about O X
the O X
interplay O X
between O X
chromatin O X
conformation O X
and O X
the O X
events O X
that O X
regulate O X
initiation O X
and O X
elongation O X
of O X
viral O X
transcription O X
. O X

During O X
transcriptional O X
activation O X
, O X
histone O X
acetyltransferases O X
and O X
ATP O X
- O X
dependent O X
chromatin O X
remodeling O X
complexes O X
cooperate O X
with O X
histone O X
chaperones O X
in O X
altering O X
chromatin O X
structure O X
. O X

In O X
particular O X
, O X
human O X
Nucleosome O X
Assembly O X
Protein O X
- O X
1 O X
( O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
) O X
is O X
known O X
to O X
act O X
as O X
a O X
histone O X
chaperone O X
that O X
shuttles O X
histones O X
H2A O X
/ O X
H2B I-MISC 8349
into O X
the O X
nucleus O X
, O X
assembles O X
nucleosomes O X
and O X
promotes O X
chromatin O X
fluidity O X
, O X
thereby O X
affecting O X
transcription O X
of O X
several O X
cellular O X
genes O X
. O X

RESULTS O X
: O X
Using O X
a O X
proteomic O X
screening O X
, O X
we O X
identified O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
as O X
a O X
novel O X
cellular O X
protein O X
interacting O X
with O X
HIV O X
- O X
1 O X
Tat I-MISC 155871
. O X

We O X
observed O X
that O X
Tat I-MISC 155871
specifically O X
binds O X
hNAP1 I-MISC 4673
, O X
but O X
not O X
other O X
members O X
of O X
the O X
same O X
family O X
of O X
factors O X
. O X

Binding O X
between O X
the O X
two O X
proteins O X
required O X
the O X
integrity O X
of O X
the O X
basic O X
domain O X
of O X
Tat I-MISC 155871
and O X
of O X
two O X
separable O X
domains O X
of O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
( O X
aa O X
162 O X
- O X
290 O X
and O X
290 O X
- O X
391 O X
). O X

Overexpression O X
of O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
significantly O X
enhanced O X
Tat I-MISC 155871
- O X
mediated O X
activation O X
of O X
the O X
LTR O X
. O X

Conversely O X
, O X
silencing O X
of O X
the O X
protein O X
decreased O X
viral O X
promoter O X
activity O X
. O X

To O X
explore O X
the O X
effects O X
of O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
on O X
viral O X
infection O X
, O X
a O X
reporter O X
HIV O X
- O X
1 O X
virus O X
was O X
used O X
to O X
infect O X
cells O X
in O X
which O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
had O X
been O X
either O X
overexpressed O X
or O X
knocked O X
- O X
down O X
. O X

Consistent O X
with O X
the O X
gene O X
expression O X
results O X
, O X
these O X
two O X
treatments O X
were O X
found O X
to O X
increase O X
and O X
inhibit O X
viral O X
infection O X
, O X
respectively O X
. O X

Finally O X
, O X
we O X
also O X
observed O X
that O X
the O X
overexpression O X
of O X
p300 I-MISC 2033
, O X
a O X
known O X
co O X
- O X
activator O X
of O X
both O X
Tat I-MISC 155871
and O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
, O X
enhanced O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
- O X
mediated O X
transcriptional O X
activation O X
as O X
well O X
as O X
its O X
interaction O X
with O X
Tat I-MISC 155871
. O X

CONCLUSION O X
: O X
Our O X
study O X
reveals O X
that O X
HIV O X
- O X
1 O X
Tat I-MISC 155871
binds O X
the O X
histone O X
chaperone O X
hNAP I-MISC 4673
- I-MISC 4673
1 I-MISC 4673
both O X
in O X
vitro O X
and O X
in O X
vivo O X
and O X
shows O X
that O X
this O X
interaction O X
participates O X
in O X
the O X
regulation O X
of O X
Tat I-MISC 155871
- O X
mediated O X
activation O X
of O X
viral O X
gene O X
expression O X
. O X

###21903585	11144,10635

RAD51 I-MISC 10635
- I-MISC 10635
associated I-MISC 10635
protein I-MISC 10635
1 I-MISC 10635
( O X
RAD51AP1 I-MISC 10635
) O X
interacts O X
with O X
the O X
meiotic O X
recombinase O X
DMC1 I-MISC 11144
through O X
a O X
conserved O X
motif O X
. O X

Homologous O X
recombination O X
( O X
HR O X
) O X
reactions O X
mediated O X
by O X
the O X
RAD51 I-MISC 5888
recombinase O X
are O X
essential O X
for O X
DNA O X
and O X
replication O X
fork O X
repair O X
, O X
genome O X
stability O X
, O X
and O X
tumor O X
suppression O X
. O X

RAD51 I-MISC 10635
- I-MISC 10635
associated I-MISC 10635
protein I-MISC 10635
1 I-MISC 10635
( O X
RAD51AP1 I-MISC 10635
) O X
is O X
an O X
important O X
HR O X
factor O X
that O X
associates O X
with O X
and O X
stimulates O X
the O X
recombinase O X
activity O X
of O X
RAD51 I-MISC 5888
. O X

We O X
have O X
recently O X
shown O X
that O X
RAD51AP1 I-MISC 10635
also O X
partners O X
with O X
the O X
meiotic O X
recombinase O X
DMC1 I-MISC 11144
, O X
displaying O X
isoform O X
- O X
specific O X
interactions O X
with O X
DMC1 I-MISC 11144
. O X

Here O X
, O X
we O X
have O X
characterized O X
the O X
DMC1 I-MISC 11144
interaction O X
site O X
in O X
RAD51AP1 I-MISC 10635
by O X
a O X
series O X
of O X
truncations O X
and O X
point O X
mutations O X
to O X
uncover O X
a O X
highly O X
conserved O X
WVPP O X
motif O X
critical O X
for O X
DMC1 I-MISC 11144
interaction O X
but O X
dispensable O X
for O X
RAD51 I-MISC 5888
association O X
. O X

This O X
RAD51AP1 I-MISC 10635
motif O X
is O X
reminiscent O X
of O X
the O X
FVPP O X
motif O X
in O X
the O X
tumor O X
suppressor O X
protein O X
BRCA2 I-MISC 675
that O X
mediates O X
DMC1 I-MISC 11144
interaction O X
. O X

These O X
results O X
further O X
implicate O X
RAD51AP1 I-MISC 10635
in O X
meiotic O X
HR O X
via O X
RAD51 I-MISC 5888
and O X
DMC1 I-MISC 11144
. O X

###12869544	839248,827934	839248,839248

Dimerization O X
of O X
Toc O X
- O X
GTPases O X
at O X
the O X
chloroplast O X
protein O X
import O X
machinery O X
. O X

Import O X
of O X
chloroplast O X
precursor O X
proteins O X
is O X
controlled O X
by O X
the O X
coordinate O X
action O X
of O X
two O X
homologous O X
GTPases O X
, O X
Toc159 I-MISC 827934
and O X
Toc33 I-MISC 839248
, O X
located O X
at O X
the O X
cytosol O X
- O X
outer O X
membrane O X
interface O X
. O X

Recent O X
studies O X
in O X
Arabidopsis O X
showed O X
that O X
the O X
cytosolic O X
form O X
of O X
the O X
precursor O X
binding O X
protein O X
Toc159 I-MISC 827934
is O X
targeted O X
to O X
its O X
receptor O X
at O X
the O X
import O X
machinery O X
, O X
Toc33 I-MISC 839248
, O X
via O X
heterodimerization O X
of O X
their O X
GTP O X
- O X
binding O X
domains O X
. O X

Toc33 I-MISC 839248
may O X
also O X
form O X
GDP O X
- O X
bound O X
homodimers O X
, O X
as O X
suggested O X
by O X
the O X
crystal O X
structure O X
of O X
its O X
pea O X
ortholog O X
. O X

Moreover O X
, O X
the O X
structural O X
data O X
suggested O X
that O X
arginine O X
130 O X
( O X
Arg130 O X
) O X
of O X
Arabidopsis O X
Toc33 I-MISC 839248
may O X
function O X
as O X
a O X
GTPase O X
- O X
activating O X
" O X
arginine O X
- O X
finger O X
" O X
at O X
the O X
other O X
monomer O X
in O X
the O X
Toc33 I-MISC 839248
dimer O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
Arg130 O X
of O X
Toc33 I-MISC 839248
does O X
not O X
function O X
as O X
an O X
Arginine O X
- O X
finger O X
. O X

A O X
mutant O X
, O X
Toc33 I-MISC 839248
- O X
R130A O X
, O X
binds O X
and O X
hydrolyzes O X
GTP O X
like O X
the O X
wild O X
type O X
. O X

However O X
, O X
we O X
demonstrate O X
that O X
Arg130 O X
is O X
involved O X
in O X
both O X
homodimerization O X
of O X
Toc33 I-MISC 839248
and O X
in O X
heterodimerization O X
with O X
the O X
GTP O X
- O X
binding O X
domain O X
of O X
Toc159 I-MISC 827934
. O X

The O X
dependence O X
of O X
Toc33 I-MISC 839248
homodimerization O X
on O X
Arg130 O X
is O X
mutual O X
, O X
requiring O X
the O X
presence O X
of O X
Arg130 O X
at O X
both O X
monomers O X
. O X

As O X
the O X
GTPase O X
is O X
not O X
activated O X
by O X
dimerization O X
, O X
it O X
may O X
be O X
activated O X
independently O X
at O X
either O X
monomer O X
, O X
possibly O X
even O X
before O X
dimerization O X
. O X

Independent O X
regulation O X
of O X
GTPase O X
activity O X
may O X
serve O X
to O X
coordinate O X
the O X
interactions O X
of O X
the O X
GTPases O X
during O X
the O X
import O X
of O X
proteins O X
into O X
the O X
chloroplast O X
. O X

###8702870	6789,6789

The O X
Ste20 I-MISC 27347
- I-MISC 27347
like I-MISC 27347
protein I-MISC 27347
kinase I-MISC 27347
, O X
Mst1 I-MISC 6789
, O X
dimerizes O X
and O X
contains O X
an O X
inhibitory O X
domain O X
. O X

The O X
human O X
serine O X
/ O X
threonine O X
protein O X
kinases O X
, O X
Mst1 I-MISC 6789
and O X
Mst2 I-MISC 6788
, O X
share O X
considerable O X
homology O X
to O X
Ste20 I-MISC 8428
and O X
p21 O X
- O X
activated O X
kinase O X
( O X
Pak O X
) O X
throughout O X
their O X
catalytic O X
domains O X
. O X

However O X
, O X
outside O X
the O X
catalytic O X
domains O X
there O X
are O X
no O X
significant O X
homologies O X
to O X
previously O X
described O X
Ste20 I-MISC 8428
- O X
like O X
kinases O X
or O X
other O X
proteins O X
. O X

To O X
understand O X
the O X
role O X
of O X
the O X
nonhomologous O X
regions O X
, O X
we O X
performed O X
a O X
structure O X
/ O X
function O X
analysis O X
of O X
Mst1 I-MISC 6789
. O X

A O X
series O X
of O X
COOH O X
- O X
terminal O X
and O X
internal O X
deletions O X
indicates O X
that O X
there O X
is O X
an O X
element O X
within O X
a O X
central O X
63 O X
- O X
amino O X
acid O X
region O X
of O X
the O X
molecule O X
that O X
inhibits O X
kinase O X
activity O X
. O X

Removal O X
of O X
this O X
domain O X
increases O X
kinase O X
activity O X
approximately O X
9 O X
- O X
fold O X
. O X

Coimmunoprecipitation O X
assays O X
, O X
the O X
yeast O X
two O X
- O X
hybrid O X
procedure O X
, O X
and O X
in O X
vitro O X
cross O X
- O X
linking O X
analysis O X
indicate O X
that O X
Mst1 I-MISC 6789
homodimerizes O X
and O X
that O X
the O X
extreme O X
COOH O X
- O X
terminal O X
57 O X
amino O X
acids O X
are O X
required O X
for O X
self O X
- O X
association O X
. O X

Size O X
exclusion O X
chromatography O X
indicates O X
that O X
Mst1 I-MISC 6789
is O X
associated O X
with O X
a O X
high O X
molecular O X
weight O X
complex O X
in O X
cells O X
, O X
suggesting O X
that O X
other O X
proteins O X
may O X
also O X
oligomerize O X
with O X
this O X
kinase O X
. O X

While O X
loss O X
of O X
dimerization O X
alone O X
does O X
not O X
affect O X
kinase O X
activity O X
, O X
a O X
molecule O X
lacking O X
both O X
the O X
dimerization O X
and O X
inhibitory O X
domains O X
is O X
not O X
as O X
active O X
as O X
one O X
which O X
lacks O X
only O X
the O X
inhibitory O X
domain O X
. O X

Comparison O X
of O X
Mst1 I-MISC 6789
and O X
Mst2 I-MISC 6788
indicates O X
that O X
both O X
functional O X
domains O X
lie O X
in O X
regions O X
conserved O X
between O X
the O X
two O X
molecules O X
. O X

###21376235	852582,856425

Mpk1 I-MISC 856425
MAPK O X
association O X
with O X
the O X
Paf1 I-MISC 852582
complex O X
blocks O X
Sen1 I-MISC 10934
- O X
mediated O X
premature O X
transcription O X
termination O X
. O X

The O X
Mpk1 I-MISC 856425
MAPK O X
of O X
the O X
yeast O X
cell O X
wall O X
integrity O X
pathway O X
uses O X
a O X
noncatalytic O X
mechanism O X
to O X
activate O X
transcription O X
of O X
stress O X
- O X
induced O X
genes O X
by O X
recruitment O X
of O X
initiation O X
factors O X
to O X
target O X
promoters O X
. O X

We O X
show O X
here O X
that O X
Mpk1 I-MISC 856425
additionally O X
serves O X
a O X
function O X
in O X
transcription O X
elongation O X
that O X
is O X
also O X
independent O X
of O X
its O X
catalytic O X
activity O X
. O X

This O X
function O X
is O X
mediated O X
by O X
an O X
interaction O X
between O X
Mpk1 I-MISC 856425
and O X
the O X
Paf1 I-MISC 852582
subunit O X
of O X
the O X
Paf1C O X
elongation O X
complex O X
. O X

A O X
mutation O X
in O X
Paf1 I-MISC 852582
that O X
blocks O X
this O X
interaction O X
causes O X
a O X
specific O X
defect O X
in O X
transcription O X
elongation O X
of O X
an O X
Mpk1 I-MISC 856425
- O X
induced O X
gene O X
, O X
which O X
results O X
from O X
Sen1 I-MISC 10934
- O X
dependent O X
premature O X
termination O X
through O X
a O X
Nab3 O X
- O X
binding O X
site O X
within O X
the O X
promoter O X
- O X
proximal O X
region O X
of O X
the O X
gene O X
. O X

Our O X
findings O X
reveal O X
a O X
regulatory O X
mechanism O X
in O X
which O X
Mpk1 I-MISC 856425
overcomes O X
transcriptional O X
attenuation O X
by O X
blocking O X
recruitment O X
of O X
the O X
Sen1 I-MISC 10934
- O X
Nrd1 I-MISC 4898
- O X
Nab3 O X
termination O X
complex O X
to O X
the O X
elongating O X
polymerase O X
. O X

Finally O X
, O X
we O X
demonstrate O X
that O X
this O X
mechanism O X
is O X
conserved O X
in O X
an O X
interaction O X
between O X
the O X
human O X
ERK5 O X
MAPK O X
and O X
human O X
Paf1 I-MISC 852582
. O X

###7629138	2885,6654	2885,6655

Differential O X
interactions O X
of O X
human O X
Sos1 I-MISC 6654
and O X
Sos2 I-MISC 6655
with O X
Grb2 I-MISC 2885
. O X

The O X
guanine O X
nucleotide O X
exchange O X
factor O X
Son O X
of O X
sevenless O X
( O X
Sos O X
) O X
performs O X
a O X
crucial O X
step O X
in O X
the O X
coupling O X
of O X
receptor O X
tyrosine O X
kinases O X
to O X
Ras O X
activation O X
. O X

Mammalian O X
cells O X
contain O X
two O X
related O X
but O X
distinct O X
Sos O X
proteins O X
, O X
Sos1 I-MISC 6654
and O X
Sos2 I-MISC 6655
. O X

Although O X
they O X
share O X
a O X
high O X
degree O X
of O X
overall O X
similarity O X
, O X
it O X
is O X
not O X
known O X
to O X
what O X
extent O X
their O X
biological O X
and O X
biochemical O X
properties O X
overlap O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
have O X
compared O X
the O X
interactions O X
of O X
the O X
two O X
human O X
homologues O X
of O X
Sos O X
, O X
hSos1 I-MISC 6654
and O X
hSos2 I-MISC 6655
, O X
with O X
the O X
adaptor O X
protein O X
Grb2 I-MISC 2885
. O X

We O X
show O X
that O X
hSos2 I-MISC 6655
interacts O X
with O X
Grb2 I-MISC 2885
via O X
its O X
proline O X
- O X
rich O X
COOH O X
- O X
terminal O X
domain O X
and O X
that O X
this O X
interaction O X
is O X
dependent O X
on O X
the O X
SH3 O X
domains O X
of O X
Grb2 I-MISC 2885
. O X

In O X
general O X
, O X
these O X
characteristics O X
are O X
similar O X
to O X
the O X
ones O X
reported O X
previously O X
for O X
the O X
interaction O X
of O X
hSos1 I-MISC 6654
with O X
Grb2 I-MISC 2885
. O X

However O X
, O X
the O X
apparent O X
binding O X
affinity O X
of O X
hSos2 I-MISC 6655
for O X
Grb2 I-MISC 2885
is O X
significantly O X
higher O X
relative O X
to O X
that O X
of O X
hSos1 I-MISC 6654
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

The O X
region O X
conferring O X
this O X
higher O X
binding O X
affinity O X
has O X
been O X
mapped O X
to O X
residues O X
1126 O X
- O X
1242 O X
of O X
the O X
hSos2 I-MISC 6655
COOH O X
- O X
terminal O X
domain O X
. O X

These O X
results O X
suggest O X
that O X
Sos1 I-MISC 6654
and O X
Sos2 I-MISC 6655
may O X
differentially O X
contribute O X
to O X
receptor O X
- O X
mediated O X
Ras O X
activation O X
. O X

###21601571	474180,403568

Valine O X
1532 O X
of O X
human O X
BRC O X
repeat O X
4 O X
plays O X
an O X
important O X
role O X
in O X
the O X
interaction O X
between O X
BRCA2 I-MISC 474180
and O X
RAD51 I-MISC 403568
. O X

The O X
breast O X
cancer O X
susceptibility O X
protein O X
BRCA2 I-MISC 474180
is O X
essential O X
for O X
recombinational O X
DNA O X
repair O X
. O X

BRCA2 I-MISC 474180
specifically O X
binds O X
to O X
RAD51 I-MISC 403568
via O X
eight O X
BRC O X
repeat O X
motifs O X
and O X
delivers O X
RAD51 I-MISC 403568
to O X
double O X
- O X
stranded O X
DNA O X
breaks O X
. O X

In O X
this O X
study O X
, O X
a O X
mammalian O X
two O X
- O X
hybrid O X
assay O X
and O X
competitive O X
ELISA O X
showed O X
that O X
the O X
interaction O X
between O X
BRC O X
repeat O X
4 O X
( O X
BRC4 O X
) O X
and O X
RAD51 I-MISC 403568
was O X
strengthened O X
by O X
the O X
substitution O X
of O X
a O X
single O X
BRC4 O X
amino O X
acid O X
from O X
valine O X
to O X
isoleucine O X
( O X
V1532I O X
). O X

However O X
, O X
the O X
cancer O X
- O X
associated O X
V1532F O X
mutant O X
exhibited O X
very O X
weak O X
interaction O X
with O X
RAD51 I-MISC 403568
. O X

This O X
study O X
used O X
a O X
comparative O X
analysis O X
of O X
BRC4 O X
between O X
animal O X
species O X
to O X
identify O X
V1532 O X
as O X
an O X
important O X
residue O X
that O X
interacts O X
with O X
RAD51 I-MISC 403568
. O X

###15951562	17776,5728	25252,5728	113970,5728

Binding O X
of O X
PTEN I-MISC 5728
to O X
specific O X
PDZ O X
domains O X
contributes O X
to O X
PTEN I-MISC 5728
protein O X
stability O X
and O X
phosphorylation O X
by O X
microtubule O X
- O X
associated O X
serine O X
/ O X
threonine O X
kinases O X
. O X

The O X
tumor O X
suppressor O X
phosphatase O X
PTEN I-MISC 5728
is O X
a O X
key O X
regulator O X
of O X
cell O X
growth O X
and O X
apoptosis O X
that O X
interacts O X
with O X
PDZ O X
domains O X
from O X
regulatory O X
proteins O X
, O X
including O X
MAGI I-MISC 113970
- I-MISC 113970
1 I-MISC 113970
/ I-MISC 113970
2 I-MISC 113970
/ I-MISC 113970
3 I-MISC 113970
, O X
hDlg I-MISC 25252
, O X
and O X
MAST205 I-MISC 17776
. O X

Here O X
we O X
identified O X
novel O X
PTEN I-MISC 5728
- O X
binding O X
PDZ O X
domains O X
within O X
the O X
MAST205 I-MISC 17776
- O X
related O X
proteins O X
, O X
syntrophin I-MISC 22983
- I-MISC 22983
associated I-MISC 22983
serine I-MISC 22983
/ I-MISC 22983
threonine I-MISC 22983
kinase I-MISC 22983
and O X
MAST3 I-MISC 23031
, O X
characterized O X
the O X
regions O X
of O X
PTEN I-MISC 5728
involved O X
in O X
its O X
interaction O X
with O X
distinctive O X
PDZ O X
domains O X
, O X
and O X
analyzed O X
the O X
functional O X
consequences O X
on O X
PTEN I-MISC 5728
of O X
PDZ O X
domain O X
binding O X
. O X

Using O X
a O X
panel O X
of O X
PTEN I-MISC 5728
mutations O X
, O X
as O X
well O X
as O X
PTEN I-MISC 5728
chimeras O X
containing O X
distinct O X
domains O X
of O X
the O X
related O X
protein O X
TPTE I-MISC 7179
, O X
we O X
found O X
that O X
the O X
PTP O X
and O X
C2 O X
domains O X
of O X
PTEN I-MISC 5728
do O X
not O X
affect O X
PDZ O X
domain O X
binding O X
and O X
that O X
the O X
C O X
- O X
terminal O X
tail O X
of O X
PTEN I-MISC 5728
( O X
residues O X
350 O X
- O X
403 O X
) O X
provides O X
selectivity O X
to O X
recognize O X
specific O X
PDZ O X
domains O X
from O X
MAGI I-MISC 113970
- I-MISC 113970
2 I-MISC 113970
, O X
hDlg I-MISC 25252
, O X
and O X
MAST205 I-MISC 17776
. O X

Binding O X
of O X
PTEN I-MISC 5728
to O X
the O X
PDZ O X
- O X
2 O X
domain O X
from O X
MAGI I-MISC 113970
- I-MISC 113970
2 I-MISC 113970
increased O X
PTEN I-MISC 5728
protein O X
stability O X
. O X

Furthermore O X
, O X
binding O X
of O X
PTEN I-MISC 5728
to O X
the O X
PDZ O X
domains O X
from O X
microtubule O X
- O X
associated O X
serine O X
/ O X
threonine O X
kinases O X
facilitated O X
PTEN I-MISC 5728
phosphorylation O X
at O X
its O X
C O X
terminus O X
by O X
these O X
kinases O X
. O X

Our O X
results O X
suggest O X
an O X
important O X
role O X
for O X
the O X
C O X
- O X
terminal O X
region O X
of O X
PTEN I-MISC 5728
in O X
the O X
selective O X
association O X
with O X
scaffolding O X
and O X
/ O X
or O X
regulatory O X
molecules O X
and O X
provide O X
evidence O X
that O X
PDZ O X
domain O X
binding O X
stabilizes O X
PTEN I-MISC 5728
and O X
targets O X
this O X
tumor O X
suppressor O X
for O X
phosphorylation O X
by O X
microtubule O X
- O X
associated O X
serine O X
/ O X
threonine O X
kinases O X
. O X

###25653285	15114,282004

Huntingtin I-MISC 15114
- I-MISC 15114
associated I-MISC 15114
protein I-MISC 15114
1 I-MISC 15114
( O X
HAP1 I-MISC 15114
) O X
is O X
a O X
cGMP O X
- O X
dependent O X
kinase O X
anchoring O X
protein O X
( O X
GKAP I-MISC 9229
) O X
specific O X
for O X
the O X
cGMP I-MISC 282004
- I-MISC 282004
dependent I-MISC 282004
protein I-MISC 282004
kinase I-MISC 282004
Ib O X
isoform O X
. O X

Protein O X
- O X
protein O X
interactions O X
are O X
important O X
in O X
providing O X
compartmentalization O X
and O X
specificity O X
in O X
cellular O X
signal O X
transduction O X
. O X

Many O X
studies O X
have O X
hallmarked O X
the O X
well O X
designed O X
compartmentalization O X
of O X
the O X
cAMP O X
- O X
dependent O X
protein O X
kinase O X
( O X
PKA O X
) O X
through O X
its O X
anchoring O X
proteins O X
. O X

Much O X
less O X
data O X
are O X
available O X
on O X
the O X
compartmentalization O X
of O X
its O X
closest O X
homolog O X
, O X
cGMP I-MISC 282004
- I-MISC 282004
dependent I-MISC 282004
protein I-MISC 282004
kinase I-MISC 282004
( O X
PKG I-MISC 282004
), O X
via O X
its O X
own O X
PKG I-MISC 282004
anchoring O X
proteins O X
( O X
GKAPs O X
). O X

For O X
the O X
enrichment O X
, O X
screening O X
, O X
and O X
discovery O X
of O X
( O X
novel O X
) O X
PKA O X
anchoring O X
proteins O X
, O X
a O X
plethora O X
of O X
methodologies O X
is O X
available O X
, O X
including O X
our O X
previously O X
described O X
chemical O X
proteomics O X
approach O X
based O X
on O X
immobilized O X
cAMP O X
or O X
cGMP O X
. O X

Although O X
this O X
method O X
was O X
demonstrated O X
to O X
be O X
effective O X
, O X
each O X
immobilized O X
cyclic O X
nucleotide O X
did O X
not O X
discriminate O X
in O X
the O X
enrichment O X
for O X
either O X
PKA O X
or O X
PKG I-MISC 282004
and O X
their O X
secondary O X
interactors O X
. O X

Hence O X
, O X
with O X
PKG I-MISC 282004
signaling O X
components O X
being O X
less O X
abundant O X
in O X
most O X
tissues O X
, O X
it O X
turned O X
out O X
to O X
be O X
challenging O X
to O X
enrich O X
and O X
identify O X
GKAPs O X
. O X

Here O X
we O X
extend O X
this O X
cAMP O X
- O X
based O X
chemical O X
proteomics O X
approach O X
using O X
competitive O X
concentrations O X
of O X
free O X
cyclic O X
nucleotides O X
to O X
isolate O X
each O X
kinase O X
and O X
its O X
secondary O X
interactors O X
. O X

Using O X
this O X
approach O X
, O X
we O X
identified O X
Huntingtin I-MISC 15114
- I-MISC 15114
associated I-MISC 15114
protein I-MISC 15114
1 I-MISC 15114
( O X
HAP1 I-MISC 15114
) O X
as O X
a O X
putative O X
novel O X
GKAP I-MISC 9229
. O X

Through O X
sequence O X
alignment O X
with O X
known O X
GKAPs O X
and O X
secondary O X
structure O X
prediction O X
analysis O X
, O X
we O X
defined O X
a O X
small O X
sequence O X
domain O X
mediating O X
the O X
interaction O X
with O X
PKG I-MISC 282004
Ib O X
but O X
not O X
PKG I-MISC 282004
Ia O X
. O X

In O X
vitro O X
binding O X
studies O X
and O X
site O X
- O X
directed O X
mutagenesis O X
further O X
confirmed O X
the O X
specificity O X
and O X
affinity O X
of O X
HAP1 I-MISC 15114
binding O X
to O X
the O X
PKG I-MISC 282004
Ib O X
N O X
terminus O X
. O X

These O X
data O X
fully O X
support O X
that O X
HAP1 I-MISC 15114
is O X
a O X
GKAP I-MISC 9229
, O X
anchoring O X
specifically O X
to O X
the O X
cGMP I-MISC 282004
- I-MISC 282004
dependent I-MISC 282004
protein I-MISC 282004
kinase I-MISC 282004
isoform O X
Ib O X
, O X
and O X
provide O X
further O X
evidence O X
that O X
also O X
PKG I-MISC 282004
spatiotemporal O X
signaling O X
is O X
largely O X
controlled O X
by O X
anchoring O X
proteins O X
. O X

###24412932	6622,25

c I-MISC 25
- I-MISC 25
Abl I-MISC 25
phosphorylates O X
a I-MISC 6622
- I-MISC 6622
synuclein I-MISC 6622
and O X
regulates O X
its O X
degradation O X
: O X
implication O X
for O X
a I-MISC 6622
- I-MISC 6622
synuclein I-MISC 6622
clearance O X
and O X
contribution O X
to O X
the O X
pathogenesis O X
of O X
Parkinson O X
' O X
s O X
disease O X
. O X

Increasing O X
evidence O X
suggests O X
that O X
the O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
protein O X
tyrosine O X
kinase O X
could O X
play O X
a O X
role O X
in O X
the O X
pathogenesis O X
of O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
) O X
and O X
other O X
neurodegenerative O X
disorders O X
. O X

c I-MISC 25
- I-MISC 25
Abl I-MISC 25
has O X
been O X
shown O X
to O X
regulate O X
the O X
degradation O X
of O X
two O X
proteins O X
implicated O X
in O X
the O X
pathogenesis O X
of O X
PD O X
, O X
parkin O X
and O X
a I-MISC 6622
- I-MISC 6622
synuclein I-MISC 6622
( O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
). O X

The O X
inhibition O X
of O X
parkin O X
' O X
s O X
neuroprotective O X
functions O X
is O X
regulated O X
by O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
- O X
mediated O X
phosphorylation O X
of O X
parkin O X
. O X

However O X
, O X
the O X
molecular O X
mechanisms O X
by O X
which O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
activity O X
regulates O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
toxicity O X
and O X
clearance O X
remain O X
unknown O X
. O X

Herein O X
, O X
using O X
NMR O X
spectroscopy O X
, O X
mass O X
spectrometry O X
, O X
in O X
vitro O X
enzymatic O X
assays O X
and O X
cell O X
- O X
based O X
studies O X
, O X
we O X
established O X
that O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
is O X
a O X
bona O X
fide O X
substrate O X
for O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
. O X

In O X
vitro O X
studies O X
demonstrate O X
that O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
directly O X
interacts O X
with O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
and O X
catalyzes O X
its O X
phosphorylation O X
mainly O X
at O X
tyrosine O X
39 O X
( O X
pY39 O X
) O X
and O X
to O X
a O X
lesser O X
extent O X
at O X
tyrosine O X
125 O X
( O X
pY125 O X
). O X

Analysis O X
of O X
human O X
brain O X
tissues O X
showed O X
that O X
pY39 O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
is O X
detected O X
in O X
the O X
brains O X
of O X
healthy O X
individuals O X
and O X
those O X
with O X
PD O X
. O X

However O X
, O X
only O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
protein O X
levels O X
were O X
found O X
to O X
be O X
upregulated O X
in O X
PD O X
brains O X
. O X

Interestingly O X
, O X
nilotinib O X
, O X
a O X
specific O X
inhibitor O X
of O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
kinase O X
activity O X
, O X
induces O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
protein O X
degradation O X
via O X
the O X
autophagy O X
and O X
proteasome O X
pathways O X
, O X
whereas O X
the O X
overexpression O X
of O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
in O X
the O X
rat O X
midbrains O X
enhances O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
expression O X
. O X

Together O X
, O X
these O X
data O X
suggest O X
that O X
changes O X
in O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
expression O X
, O X
activation O X
and O X
/ O X
or O X
c I-MISC 25
- I-MISC 25
Abl I-MISC 25
- O X
mediated O X
phosphorylation O X
of O X
Y39 O X
play O X
a O X
role O X
in O X
regulating O X
a I-MISC 6622
- I-MISC 6622
syn I-MISC 6622
clearance O X
and O X
contribute O X
to O X
the O X
pathogenesis O X
of O X
PD O X
. O X

###20007317	856060,1466445

Structural O X
basis O X
for O X
the O X
interaction O X
between O X
yeast O X
Spt O X
- O X
Ada O X
- O X
Gcn5 O X
acetyltransferase O X
( O X
SAGA O X
) O X
complex O X
components O X
Sgf11 I-MISC 856060
and O X
Sus1 I-MISC 1466445
. O X

Sus1 I-MISC 1466445
is O X
a O X
central O X
component O X
of O X
the O X
yeast O X
gene O X
gating O X
machinery O X
, O X
the O X
process O X
by O X
which O X
actively O X
transcribing O X
genes O X
such O X
as O X
GAL1 I-MISC 852308
become O X
associated O X
with O X
nuclear O X
pore O X
complexes O X
. O X

Sus1 I-MISC 1466445
is O X
a O X
component O X
of O X
both O X
the O X
SAGA O X
transcriptional O X
co O X
- O X
activator O X
complex O X
and O X
the O X
TREX O X
- O X
2 O X
complex O X
that O X
binds O X
to O X
nuclear O X
pore O X
complexes O X
. O X

TREX O X
- O X
2 O X
contains O X
two O X
Sus1 I-MISC 1466445
chains O X
that O X
have O X
an O X
articulated O X
helical O X
hairpin O X
fold O X
, O X
enabling O X
them O X
to O X
wrap O X
around O X
an O X
extended O X
alpha O X
- O X
helix O X
in O X
Sac3 I-MISC 851737
, O X
following O X
a O X
helical O X
hydrophobic O X
stripe O X
. O X

In O X
SAGA O X
, O X
Sus1 I-MISC 1466445
binds O X
to O X
Sgf11 I-MISC 856060
and O X
has O X
been O X
proposed O X
to O X
provide O X
a O X
link O X
between O X
SAGA O X
and O X
TREX O X
- O X
2 O X
. O X

We O X
present O X
here O X
the O X
crystal O X
structure O X
of O X
the O X
complex O X
between O X
Sus1 I-MISC 1466445
and O X
the O X
N O X
- O X
terminal O X
region O X
of O X
Sgf11 I-MISC 856060
that O X
forms O X
an O X
extended O X
alpha O X
- O X
helix O X
around O X
which O X
Sus1 I-MISC 1466445
wraps O X
in O X
a O X
manner O X
that O X
shares O X
some O X
similarities O X
with O X
the O X
Sus1 I-MISC 1466445
- O X
Sac3 I-MISC 851737
interface O X
in O X
TREX O X
- O X
2 O X
. O X

However O X
, O X
the O X
Sus1 I-MISC 1466445
- O X
binding O X
site O X
on O X
Sgf11 I-MISC 856060
is O X
somewhat O X
shorter O X
than O X
on O X
Sac3 I-MISC 851737
and O X
is O X
based O X
on O X
a O X
narrower O X
hydrophobic O X
stripe O X
. O X

Engineered O X
mutants O X
that O X
disrupt O X
the O X
Sgf11 I-MISC 856060
- O X
Sus1 I-MISC 1466445
interaction O X
in O X
vitro O X
confirm O X
the O X
importance O X
of O X
the O X
hydrophobic O X
helical O X
stripe O X
in O X
molecular O X
recognition O X
. O X

Helix O X
alpha1 O X
of O X
the O X
Sus1 I-MISC 1466445
- O X
articulated O X
hairpin O X
does O X
not O X
bind O X
directly O X
to O X
Sgf11 I-MISC 856060
and O X
adopts O X
a O X
wide O X
range O X
of O X
conformations O X
within O X
and O X
between O X
crystal O X
forms O X
, O X
consistent O X
with O X
the O X
presence O X
of O X
a O X
flexible O X
hinge O X
and O X
also O X
with O X
results O X
from O X
previous O X
extensive O X
mutagenesis O X
studies O X
( O X
Kl O X
ckner O X
, O X
C O X
., O X
Schneider O X
, O X
M O X
., O X
Lutz O X
, O X
S O X
., O X
Jani O X
, O X
D O X
., O X
Kressler O X
, O X
D O X
., O X
Stewart O X
, O X
M O X
., O X
Hurt O X
, O X
E O X
., O X
and O X
K O X
hler O X
, O X
A O X
. O X

( O X
2009 O X
) O X
J O X
. O X
Biol O X
. O X

Chem O X
. O X

284 O X
, O X
12049 O X
- O X
12056 O X
). O X

A O X
single O X
Sus1 I-MISC 1466445
molecule O X
cannot O X
bind O X
Sgf11 I-MISC 856060
and O X
Sac3 I-MISC 851737
simultaneously O X
and O X
this O X
, O X
combined O X
with O X
the O X
structure O X
of O X
the O X
Sus1 I-MISC 1466445
- O X
Sgf11 I-MISC 856060
complex O X
, O X
indicates O X
that O X
Sus1 I-MISC 1466445
forms O X
separate O X
subcomplexes O X
within O X
SAGA O X
and O X
TREX O X
- O X
2 O X
. O X

###22020124	55835,6491

The O X
human O X
microcephaly O X
protein O X
STIL I-MISC 6491
interacts O X
with O X
CPAP I-MISC 55835
and O X
is O X
required O X
for O X
procentriole O X
formation O X
. O X

Centriole O X
duplication O X
involves O X
the O X
growth O X
of O X
a O X
procentriole O X
next O X
to O X
the O X
parental O X
centriole O X
. O X

Mutations O X
in O X
STIL I-MISC 6491
and O X
CPAP I-MISC 55835
/ O X
CENPJ I-MISC 55835
cause O X
primary O X
microcephaly O X
( O X
MCPH O X
). O X

Here O X
, O X
we O X
show O X
that O X
human O X
STIL I-MISC 6491
has O X
an O X
asymmetric O X
localization O X
to O X
the O X
daughter O X
centriole O X
and O X
is O X
required O X
for O X
procentriole O X
formation O X
. O X

STIL I-MISC 6491
levels O X
oscillate O X
during O X
the O X
cell O X
cycle O X
. O X

Interestingly O X
, O X
STIL I-MISC 6491
interacts O X
directly O X
with O X
CPAP I-MISC 55835
and O X
forms O X
a O X
complex O X
with O X
hSAS6 I-MISC 163786
. O X

A O X
natural O X
mutation O X
of O X
CPAP I-MISC 55835
( O X
E1235V O X
) O X
that O X
causes O X
MCPH O X
in O X
humans O X
leads O X
to O X
significantly O X
lower O X
binding O X
to O X
STIL I-MISC 6491
. O X

Overexpression O X
of O X
STIL I-MISC 6491
induced O X
the O X
formation O X
of O X
multiple O X
procentrioles O X
around O X
the O X
parental O X
centriole O X
. O X

STIL I-MISC 6491
depletion O X
inhibited O X
normal O X
centriole O X
duplication O X
, O X
Plk4 I-MISC 10733
- O X
induced O X
centriole O X
amplification O X
, O X
and O X
CPAP I-MISC 55835
- O X
induced O X
centriole O X
elongation O X
, O X
and O X
resulted O X
in O X
a O X
failure O X
to O X
localize O X
hSAS6 I-MISC 163786
and O X
CPAP I-MISC 55835
to O X
the O X
base O X
of O X
the O X
nascent O X
procentriole O X
. O X

Furthermore O X
, O X
hSAS6 I-MISC 163786
depletion O X
hindered O X
STIL I-MISC 6491
targeting O X
to O X
the O X
procentriole O X
, O X
implying O X
that O X
STIL I-MISC 6491
and O X
hSAS6 I-MISC 163786
are O X
mutually O X
dependent O X
for O X
their O X
centriolar O X
localization O X
. O X

Together O X
, O X
our O X
results O X
indicate O X
that O X
the O X
two O X
MCPH O X
- O X
associated O X
proteins O X
STIL I-MISC 6491
and O X
CPAP I-MISC 55835
interact O X
with O X
each O X
other O X
and O X
are O X
required O X
for O X
procentriole O X
formation O X
, O X
implying O X
a O X
central O X
role O X
of O X
centriole O X
biogenesis O X
in O X
MCPH O X
. O X

###19647741	7534,4137

Phosphorylation O X
of O X
more O X
than O X
one O X
site O X
is O X
required O X
for O X
tight O X
interaction O X
of O X
human O X
tau I-MISC 4137
protein O X
with O X
14 I-MISC 7534
- I-MISC 7534
3 I-MISC 7534
- I-MISC 7534
3zeta I-MISC 7534
. O X

Serine O X
residues O X
phosphorylated O X
by O X
protein O X
kinase O X
A O X
( O X
PKA O X
) O X
in O X
the O X
shortest O X
isoform O X
of O X
human O X
tau I-MISC 4137
protein O X
( O X
tau3 I-MISC 4137
) O X
were O X
sequentially O X
replaced O X
by O X
alanine O X
and O X
interaction O X
of O X
phosphorylated O X
tau3 I-MISC 4137
and O X
its O X
mutants O X
with O X
14 O X
- O X
3 O X
- O X
3 O X
was O X
investigated O X
. O X

Mutation O X
S156A O X
slightly O X
decreased O X
interaction O X
of O X
phosphorylated O X
tau3 I-MISC 4137
with O X
14 O X
- O X
3 O X
- O X
3 O X
. O X

Double O X
mutations O X
S156A O X
/ O X
S267A O X
and O X
especially O X
S156A O X
/ O X
S235A O X
, O X
strongly O X
inhibited O X
interaction O X
of O X
phosphorylated O X
tau3 I-MISC 4137
with O X
14 O X
- O X
3 O X
- O X
3 O X
. O X

Thus O X
, O X
two O X
sites O X
located O X
in O X
the O X
Pro O X
- O X
rich O X
region O X
and O X
in O X
the O X
pseudo O X
repeats O X
of O X
tau3 I-MISC 4137
are O X
involved O X
in O X
phosphorylation O X
- O X
dependent O X
interaction O X
of O X
tau3 I-MISC 4137
with O X
14 O X
- O X
3 O X
- O X
3 O X
. O X

The O X
state O X
of O X
tau3 I-MISC 4137
phosphorylation O X
affects O X
the O X
mode O X
of O X
14 O X
- O X
3 O X
- O X
3 O X
binding O X
and O X
by O X
this O X
means O X
might O X
modify O X
tau I-MISC 4137
filament O X
formation O X
. O X

###17218263	3690,21894

Structural O X
basis O X
of O X
integrin O X
activation O X
by O X
talin I-MISC 21894
. O X

Regulation O X
of O X
integrin O X
affinity O X
( O X
activation O X
) O X
is O X
essential O X
for O X
metazoan O X
development O X
and O X
for O X
many O X
pathological O X
processes O X
. O X

Binding O X
of O X
the O X
talin I-MISC 21894
phosphotyrosine O X
- O X
binding O X
( O X
PTB O X
) O X
domain O X
to O X
integrin O X
beta O X
subunit O X
cytoplasmic O X
domains O X
( O X
tails O X
) O X
causes O X
activation O X
, O X
whereas O X
numerous O X
other O X
PTB O X
- O X
domain O X
- O X
containing O X
proteins O X
bind O X
integrins O X
without O X
activating O X
them O X
. O X

Here O X
we O X
define O X
the O X
structure O X
of O X
a O X
complex O X
between O X
talin I-MISC 21894
and O X
the O X
membrane O X
- O X
proximal O X
integrin I-MISC 3690
beta3 I-MISC 3690
cytoplasmic O X
domain O X
and O X
identify O X
specific O X
contacts O X
between O X
talin I-MISC 21894
and O X
the O X
integrin O X
tail O X
required O X
for O X
activation O X
. O X

We O X
used O X
structure O X
- O X
based O X
mutagenesis O X
to O X
engineer O X
talin I-MISC 21894
and O X
beta3 I-MISC 3690
variants O X
that O X
interact O X
with O X
comparable O X
affinity O X
to O X
the O X
wild O X
- O X
type O X
proteins O X
but O X
inhibit O X
integrin O X
activation O X
by O X
competing O X
with O X
endogenous O X
talin I-MISC 21894
. O X

These O X
results O X
reveal O X
the O X
structural O X
basis O X
of O X
talin I-MISC 21894
' O X
s O X
unique O X
ability O X
to O X
activate O X
integrins O X
, O X
identify O X
an O X
interaction O X
that O X
could O X
aid O X
in O X
the O X
design O X
of O X
therapeutics O X
to O X
block O X
integrin O X
activation O X
, O X
and O X
enable O X
engineering O X
of O X
cells O X
with O X
defects O X
in O X
the O X
activation O X
of O X
multiple O X
classes O X
of O X
integrins O X
. O X

###16127465	657,8200	658,8200

Activating O X
and O X
deactivating O X
mutations O X
in O X
the O X
receptor O X
interaction O X
site O X
of O X
GDF5 I-MISC 8200
cause O X
symphalangism O X
or O X
brachydactyly O X
type O X
A2 O X
. O X

Here O X
we O X
describe O X
2 O X
mutations O X
in O X
growth I-MISC 8200
and I-MISC 8200
differentiation I-MISC 8200
factor I-MISC 8200
5 I-MISC 8200
( O X
GDF5 I-MISC 8200
) O X
that O X
alter O X
receptor O X
- O X
binding O X
affinities O X
. O X

They O X
cause O X
brachydactyly O X
type O X
A2 O X
( O X
L441P O X
) O X
and O X
symphalangism O X
( O X
R438L O X
), O X
conditions O X
previously O X
associated O X
with O X
mutations O X
in O X
the O X
GDF5 I-MISC 8200
receptor O X
bone I-MISC 658
morphogenetic I-MISC 658
protein I-MISC 658
receptor I-MISC 658
type I-MISC 658
1b I-MISC 658
( O X
BMPR1B I-MISC 658
) O X
and O X
the O X
BMP O X
antagonist O X
NOGGIN I-MISC 18121
, O X
respectively O X
. O X

We O X
expressed O X
the O X
mutant O X
proteins O X
in O X
limb O X
bud O X
micromass O X
culture O X
and O X
treated O X
ATDC5 O X
and O X
C2C12 O X
cells O X
with O X
recombinant O X
GDF5 I-MISC 8200
. O X

Our O X
results O X
indicated O X
that O X
the O X
L441P O X
mutant O X
is O X
almost O X
inactive O X
. O X

The O X
R438L O X
mutant O X
, O X
in O X
contrast O X
, O X
showed O X
increased O X
biological O X
activity O X
when O X
compared O X
with O X
WT O X
GDF5 I-MISC 8200
. O X

Biosensor O X
interaction O X
analyses O X
revealed O X
loss O X
of O X
binding O X
to O X
BMPR1A I-MISC 657
and O X
BMPR1B I-MISC 658
ectodomains O X
for O X
the O X
L441P O X
mutant O X
, O X
whereas O X
the O X
R438L O X
mutant O X
showed O X
normal O X
binding O X
to O X
BMPR1B I-MISC 658
but O X
increased O X
binding O X
to O X
BMPR1A I-MISC 657
, O X
the O X
receptor O X
normally O X
activated O X
by O X
BMP2 I-MISC 12156
. O X

The O X
binding O X
to O X
NOGGIN I-MISC 18121
was O X
normal O X
for O X
both O X
mutants O X
. O X

Thus O X
, O X
the O X
brachydactyly O X
type O X
A2 O X
phenotype O X
( O X
L441P O X
) O X
is O X
caused O X
by O X
inhibition O X
of O X
the O X
ligand O X
- O X
receptor O X
interaction O X
, O X
whereas O X
the O X
symphalangism O X
phenotype O X
( O X
R438L O X
) O X
is O X
caused O X
by O X
a O X
loss O X
of O X
receptor O X
- O X
binding O X
specificity O X
, O X
resulting O X
in O X
a O X
gain O X
of O X
function O X
by O X
the O X
acquisition O X
of O X
BMP2 I-MISC 12156
- O X
like O X
properties O X
. O X

The O X
presented O X
experiments O X
have O X
identified O X
some O X
of O X
the O X
main O X
determinants O X
of O X
GDF5 I-MISC 8200
receptor O X
- O X
binding O X
specificity O X
in O X
vivo O X
and O X
open O X
new O X
prospects O X
for O X
generating O X
antagonists O X
and O X
superagonists O X
of O X
GDF5 I-MISC 8200
. O X

###19716822	842710,829541

Phosphorylation O X
of O X
the O X
Arabidopsis O X
AtrbohF I-MISC 842710
NADPH O X
oxidase O X
by O X
OST1 I-MISC 829541
protein O X
kinase O X
. O X

The O X
plant O X
hormone O X
abscisic O X
acid O X
( O X
ABA O X
) O X
triggers O X
production O X
of O X
reactive O X
oxygen O X
species O X
( O X
ROS O X
) O X
in O X
guard O X
cells O X
via O X
the O X
AtrbohD O X
and O X
AtrbohF I-MISC 842710
NADPH O X
oxidases O X
, O X
leading O X
to O X
stomatal O X
closure O X
. O X

The O X
ABA O X
- O X
activated O X
SnRK2 O X
protein O X
kinase O X
open I-MISC 829541
stomata I-MISC 829541
1 I-MISC 829541
( O X
OST1 I-MISC 829541
) O X
( O X
SRK2E I-MISC 829541
/ O X
SnRK2 I-MISC 829541
. I-MISC 829541
6 I-MISC 829541
) O X
acts O X
upstream O X
of O X
ROS O X
in O X
guard O X
cell O X
ABA O X
signaling O X
. O X

Here O X
, O X
we O X
report O X
that O X
OST1 I-MISC 829541
phosphorylates O X
Ser13 I-MISC 3190186
and O X
Ser174 O X
on O X
AtrbohF I-MISC 842710
. O X

In O X
addition O X
, O X
substitution O X
of O X
Ser174 O X
to O X
Ala O X
results O X
in O X
a O X
approximately O X
40 O X
% O X
reduction O X
in O X
the O X
phosphorylation O X
of O X
AtrbohF I-MISC 842710
by O X
OST1 I-MISC 829541
. O X

We O X
also O X
show O X
that O X
OST1 I-MISC 829541
physically O X
interacts O X
with O X
AtrbohF I-MISC 842710
. O X

These O X
results O X
provide O X
biochemical O X
evidence O X
suggesting O X
that O X
OST1 I-MISC 829541
regulates O X
AtrbohF I-MISC 842710
activity O X
. O X

###21135508	1674,4534

Myotubularin I-MISC 4534
controls O X
desmin I-MISC 1674
intermediate O X
filament O X
architecture O X
and O X
mitochondrial O X
dynamics O X
in O X
human O X
and O X
mouse O X
skeletal O X
muscle O X
. O X

Muscle O X
contraction O X
relies O X
on O X
a O X
highly O X
organized O X
intracellular O X
network O X
of O X
membrane O X
organelles O X
and O X
cytoskeleton O X
proteins O X
. O X

Among O X
the O X
latter O X
are O X
the O X
intermediate O X
filaments O X
( O X
IFs O X
), O X
a O X
large O X
family O X
of O X
proteins O X
mutated O X
in O X
more O X
than O X
30 O X
human O X
diseases O X
. O X

For O X
example O X
, O X
mutations O X
in O X
the O X
DES O X
gene O X
, O X
which O X
encodes O X
the O X
IF O X
desmin I-MISC 1674
, O X
lead O X
to O X
desmin I-MISC 1674
- O X
related O X
myopathy O X
and O X
cardiomyopathy O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
myotubularin I-MISC 4534
( O X
MTM1 I-MISC 4534
), O X
which O X
is O X
mutated O X
in O X
individuals O X
with O X
X O X
- O X
linked O X
centronuclear O X
myopathy O X
( O X
XLCNM O X
; O X
also O X
known O X
as O X
myotubular O X
myopathy O X
), O X
is O X
a O X
desmin I-MISC 1674
- O X
binding O X
protein O X
and O X
provide O X
evidence O X
for O X
direct O X
regulation O X
of O X
desmin I-MISC 1674
by O X
MTM1 I-MISC 4534
in O X
vitro O X
and O X
in O X
vivo O X
. O X

XLCNM O X
- O X
causing O X
mutations O X
in O X
MTM1 I-MISC 17772
disrupted O X
the O X
MTM1 I-MISC 17772
- O X
desmin I-MISC 13346
complex O X
, O X
resulting O X
in O X
abnormal O X
IF O X
assembly O X
and O X
architecture O X
in O X
muscle O X
cells O X
and O X
both O X
mouse O X
and O X
human O X
skeletal O X
muscles O X
. O X

Adeno O X
- O X
associated O X
virus O X
- O X
mediated O X
ectopic O X
expression O X
of O X
WT O X
MTM1 I-MISC 4534
in O X
Mtm1 I-MISC 4534
- O X
KO O X
muscle O X
reestablished O X
normal O X
desmin I-MISC 1674
expression O X
and O X
localization O X
. O X

In O X
addition O X
, O X
decreased O X
MTM1 I-MISC 4534
expression O X
and O X
XLCNM O X
- O X
causing O X
mutations O X
induced O X
abnormal O X
mitochondrial O X
positioning O X
, O X
shape O X
, O X
dynamics O X
, O X
and O X
function O X
. O X

We O X
therefore O X
conclude O X
that O X
MTM1 I-MISC 4534
is O X
a O X
major O X
regulator O X
of O X
both O X
the O X
desmin I-MISC 1674
cytoskeleton O X
and O X
mitochondria O X
homeostasis O X
, O X
specifically O X
in O X
skeletal O X
muscle O X
. O X

Defects O X
in O X
IF O X
stabilization O X
and O X
mitochondrial O X
dynamics O X
appear O X
as O X
common O X
physiopathological O X
features O X
of O X
centronuclear O X
myopathies O X
and O X
desmin I-MISC 1674
- O X
related O X
myopathies O X
. O X

###16260786	900095,899875

Molecular O X
basis O X
of O X
the O X
interaction O X
between O X
the O X
flagellar O X
export O X
proteins O X
FliI I-MISC 899875
and O X
FliH I-MISC 900095
from O X
Helicobacter O X
pylori O X
. O X

Bacterial O X
flagellar O X
protein O X
export O X
requires O X
an O X
ATPase O X
, O X
FliI I-MISC 899875
, O X
and O X
presumptive O X
inhibitor O X
, O X
FliH I-MISC 900095
. O X

We O X
have O X
explored O X
the O X
molecular O X
basis O X
for O X
FliI I-MISC 899875
/ O X
FliH I-MISC 900095
interaction O X
in O X
the O X
human O X
gastric O X
pathogen O X
Helicobacter O X
pylori O X
. O X

By O X
using O X
bioinformatic O X
and O X
biochemical O X
analyses O X
, O X
we O X
showed O X
that O X
residues O X
1 O X
- O X
18 O X
of O X
FliI I-MISC 899875
very O X
likely O X
form O X
an O X
amphipathic O X
alpha O X
- O X
helix O X
upon O X
interaction O X
with O X
FliH I-MISC 900095
, O X
and O X
that O X
residues O X
21 O X
- O X
91 O X
of O X
FliI I-MISC 899875
resemble O X
the O X
N O X
- O X
terminal O X
oligomerization O X
domain O X
of O X
the O X
F1 O X
- O X
ATPase O X
catalytic O X
subunits O X
. O X

A O X
truncated O X
FliI I-MISC 899875
-( O X
2 O X
- O X
91 O X
) O X
protein O X
was O X
shown O X
to O X
be O X
folded O X
, O X
although O X
the O X
N O X
- O X
terminal O X
18 O X
residues O X
were O X
likely O X
unstructured O X
. O X

Deletion O X
and O X
scanning O X
mutagenesis O X
showed O X
that O X
residues O X
1 O X
- O X
18 O X
of O X
FliI I-MISC 899875
were O X
essential O X
for O X
the O X
FliI I-MISC 899875
/ O X
FliH I-MISC 900095
interaction O X
. O X

Scanning O X
mutation O X
of O X
amino O X
acids O X
in O X
the O X
N O X
- O X
terminal O X
10 O X
residues O X
of O X
FliI I-MISC 899875
indicated O X
that O X
a O X
cluster O X
of O X
hydrophobic O X
residues O X
in O X
this O X
segment O X
was O X
critical O X
for O X
the O X
interaction O X
with O X
FliH I-MISC 900095
. O X

The O X
interaction O X
between O X
FliI I-MISC 899875
and O X
FliH I-MISC 900095
has O X
similarities O X
to O X
the O X
interaction O X
between O X
the O X
N O X
- O X
terminal O X
alpha O X
- O X
helix O X
of O X
the O X
F1 O X
- O X
ATPase O X
alpha O X
- O X
subunit O X
and O X
the O X
globular O X
domain O X
of O X
the O X
F1 O X
- O X
ATPase O X
delta O X
- O X
subunit O X
, O X
respectively O X
. O X

This O X
similarity O X
suggests O X
that O X
FliH I-MISC 900095
may O X
function O X
as O X
a O X
molecular O X
stator O X
. O X

###7518772	19262,14784	19262,20779

Phosphorylation O X
of O X
receptor I-MISC 19262
protein I-MISC 19262
- I-MISC 19262
tyrosine I-MISC 19262
phosphatase I-MISC 19262
alpha I-MISC 19262
on O X
Tyr789 O X
, O X
a O X
binding O X
site O X
for O X
the O X
SH3 O X
- O X
SH2 O X
- O X
SH3 O X
adaptor O X
protein O X
GRB I-MISC 14784
- I-MISC 14784
2 I-MISC 14784
in O X
vivo O X
. O X

Receptor I-MISC 19262
protein I-MISC 19262
- I-MISC 19262
tyrosine I-MISC 19262
phosphatase I-MISC 19262
alpha I-MISC 19262
( O X
RPTP I-MISC 19262
alpha I-MISC 19262
) O X
is O X
a O X
transmembrane O X
protein O X
with O X
a O X
short O X
extracellular O X
domain O X
( O X
123 O X
amino O X
acids O X
) O X
and O X
two O X
cytoplasmically O X
localized O X
protein O X
- O X
tyrosine O X
phosphatase O X
( O X
PTP O X
) O X
domains O X
. O X

Here O X
we O X
report O X
that O X
RPTP I-MISC 19262
alpha I-MISC 19262
is O X
constitutively O X
phosphorylated O X
on O X
tyrosine O X
in O X
NIH O X
3T3 O X
mouse O X
fibroblasts O X
. O X

The O X
in O X
vivo O X
tyrosine O X
phosphorylation O X
site O X
was O X
localized O X
to O X
the O X
C O X
- O X
terminus O X
of O X
RPTP I-MISC 19262
alpha I-MISC 19262
by O X
phosphopeptide O X
mapping O X
experiments O X
using O X
in O X
vivo O X
and O X
in O X
vitro O X
32P O X
- O X
labeled O X
RPTP I-MISC 19262
alpha I-MISC 19262
. O X

The O X
identity O X
of O X
this O X
site O X
as O X
Tyr789 O X
, O X
located O X
five O X
residues O X
from O X
the O X
C O X
- O X
terminus O X
, O X
was O X
confirmed O X
by O X
site O X
- O X
directed O X
mutagenesis O X
. O X

Transient O X
overexpression O X
of O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
together O X
with O X
RPTP I-MISC 19262
alpha I-MISC 19262
in O X
human O X
embryonic O X
kidney O X
293 O X
cells O X
increased O X
phosphorylation O X
of O X
Tyr789 O X
, O X
suggesting O X
that O X
c I-MISC 20779
- I-MISC 20779
Src I-MISC 20779
may O X
phosphorylate O X
RPTP I-MISC 19262
alpha I-MISC 19262
in O X
vivo O X
. O X

RPTP I-MISC 19262
alpha I-MISC 19262
had O X
autodephosphorylation O X
activity O X
in O X
vitro O X
. O X

When O X
expressed O X
in O X
293 O X
cells O X
the O X
level O X
of O X
Tyr789 O X
phosphorylation O X
was O X
higher O X
in O X
a O X
non O X
- O X
functional O X
mutant O X
of O X
RPTP I-MISC 19262
alpha I-MISC 19262
than O X
in O X
wild O X
type O X
RPTP I-MISC 19262
alpha I-MISC 19262
, O X
indicating O X
that O X
RPTP I-MISC 19262
alpha I-MISC 19262
may O X
have O X
autodephosphorylation O X
activity O X
in O X
vivo O X
as O X
well O X
. O X

The O X
sequence O X
on O X
the O X
C O X
- O X
terminal O X
side O X
of O X
Tyr789 O X
( O X
YANF O X
) O X
fits O X
the O X
consensus O X
binding O X
site O X
for O X
the O X
SH3 O X
- O X
SH2 O X
- O X
SH3 O X
adaptor O X
protein O X
GRB2 I-MISC 14784
( O X
YXNX O X
). O X

We O X
show O X
that O X
RPTP I-MISC 19262
alpha I-MISC 19262
, O X
but O X
not O X
a O X
mutant O X
of O X
RPTP I-MISC 19262
alpha I-MISC 19262
with O X
a O X
Tyr O X
--> O X
Phe O X
mutation O X
at O X
position O X
789 O X
, O X
bound O X
to O X
GRB2 I-MISC 14784
in O X
vitro O X
. O X

In O X
addition O X
, O X
RPTP I-MISC 19262
alpha I-MISC 19262
co O X
- O X
immunoprecipitated O X
with O X
GRB2 I-MISC 14784
from O X
NIH O X
3T3 O X
cells O X
, O X
demonstrating O X
that O X
GRB2 I-MISC 14784
bound O X
to O X
RPTP I-MISC 19262
alpha I-MISC 19262
in O X
vivo O X
. O X

The O X
guanine O X
nucleotide O X
releasing O X
factor O X
for O X
the O X
Ras O X
GTPase O X
, O X
Son O X
of O X
sevenless O X
( O X
Sos O X
), O X
which O X
associates O X
with O X
GRB2 I-MISC 14784
via O X
its O X
SH3 O X
domains O X
, O X
was O X
not O X
detected O X
in O X
RPTP I-MISC 19262
alpha I-MISC 19262
immunoprecipitates O X
. O X

Our O X
results O X
suggest O X
a O X
role O X
for O X
RPTP I-MISC 19262
alpha I-MISC 19262
in O X
attenuation O X
of O X
GRB2 I-MISC 14784
- O X
mediated O X
signaling O X
. O X

###15901727	947275,947274

Analysis O X
of O X
the O X
heteromeric O X
CsdA I-MISC 947275
- O X
CsdE I-MISC 947274
cysteine O X
desulfurase O X
, O X
assisting O X
Fe O X
- O X
S O X
cluster O X
biogenesis O X
in O X
Escherichia O X
coli O X
. O X

Biogenesis O X
of O X
iron O X
- O X
sulfur O X
( O X
Fe O X
- O X
S O X
) O X
cluster O X
- O X
containing O X
proteins O X
relies O X
on O X
assistance O X
of O X
complex O X
machineries O X
. O X

To O X
date O X
three O X
systems O X
, O X
NIF O X
, O X
ISC O X
, O X
and O X
SUF O X
, O X
were O X
reported O X
to O X
allow O X
maturation O X
of O X
Fe O X
- O X
S O X
proteins O X
. O X

Here O X
we O X
report O X
that O X
the O X
csdA I-MISC 947275
- O X
csdE I-MISC 947275
( O X
formally O X
ygdK O X
) O X
genes O X
of O X
Escherichia O X
coli O X
constitute O X
a O X
sulfur O X
- O X
generating O X
system O X
referred O X
to O X
as O X
CSD O X
which O X
also O X
contributes O X
to O X
Fe O X
- O X
S O X
biogenesis O X
in O X
vivo O X
. O X

This O X
conclusion O X
was O X
reached O X
by O X
applying O X
a O X
thorough O X
combination O X
of O X
both O X
in O X
vivo O X
and O X
in O X
vitro O X
strategies O X
and O X
techniques O X
. O X

Yeast O X
two O X
- O X
hybrid O X
analysis O X
allowed O X
us O X
to O X
show O X
that O X
CsdA I-MISC 947275
and O X
CsdE I-MISC 947274
interact O X
. O X

Enzymology O X
analysis O X
showed O X
that O X
CsdA I-MISC 947275
cysteine O X
desulfurase O X
activity O X
is O X
increased O X
2 O X
- O X
fold O X
in O X
the O X
presence O X
of O X
CsdE I-MISC 947274
. O X

Mass O X
spectrometry O X
analysis O X
and O X
site O X
- O X
directed O X
mutagenesis O X
showed O X
that O X
residue O X
Cys O X
- O X
61 O X
from O X
CsdE I-MISC 947274
acted O X
as O X
an O X
acceptor O X
site O X
for O X
sulfur O X
provided O X
by O X
cysteine O X
desulfurase O X
activity O X
of O X
CsdA I-MISC 947275
. O X

Genetic O X
investigations O X
revealed O X
that O X
the O X
csdA I-MISC 947275
- O X
csdE I-MISC 947275
genes O X
could O X
act O X
as O X
multicopy O X
suppressors O X
of O X
iscS O X
mutation O X
. O X

Moreover O X
, O X
both O X
in O X
vitro O X
and O X
in O X
vivo O X
investigations O X
pointed O X
to O X
a O X
specific O X
connection O X
between O X
the O X
CSD O X
system O X
and O X
quinolinate O X
synthetase O X
NadA O X
. O X

###21765395	30705,619412

Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
binds O X
and O X
ubiquitylates O X
activated O X
FGFR1 I-MISC 2260
to O X
control O X
its O X
endocytosis O X
and O X
function O X
. O X

Fibroblast I-MISC 2260
growth I-MISC 2260
factor I-MISC 2260
receptor I-MISC 2260
1 I-MISC 2260
( O X
FGFR1 I-MISC 2260
) O X
has O X
critical O X
roles O X
in O X
cellular O X
proliferation O X
and O X
differentiation O X
during O X
animal O X
development O X
and O X
adult O X
homeostasis O X
. O X

Here O X
, O X
we O X
show O X
that O X
human O X
Nedd4 I-MISC 619412
( O X
Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
), O X
an O X
E3 O X
ubiquitin O X
ligase O X
comprised O X
of O X
a O X
C2 O X
domain O X
, O X
4 O X
WW O X
domains O X
, O X
and O X
a O X
Hect O X
domain O X
, O X
regulates O X
endocytosis O X
and O X
signalling O X
of O X
FGFR1 I-MISC 2260
. O X

Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
binds O X
directly O X
to O X
and O X
ubiquitylates O X
activated O X
FGFR1 I-MISC 2260
, O X
by O X
interacting O X
primarily O X
via O X
its O X
WW3 O X
domain O X
with O X
a O X
novel O X
non O X
- O X
canonical O X
sequence O X
( O X
non O X
- O X
PY O X
motif O X
) O X
on O X
FGFR1 I-MISC 2260
. O X

Deletion O X
of O X
this O X
recognition O X
motif O X
( O X
FGFR1 I-MISC 2260
-/\ O X
6 O X
) O X
abolishes O X
Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
binding O X
and O X
receptor O X
ubiquitylation O X
, O X
and O X
impairs O X
endocytosis O X
of O X
activated O X
receptor O X
, O X
as O X
also O X
observed O X
upon O X
Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
knockdown O X
. O X

Accordingly O X
, O X
FGFR1 I-MISC 2260
-/\ O X
6 O X
, O X
or O X
Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
knockdown O X
, O X
exhibits O X
sustained O X
FGF O X
- O X
dependent O X
receptor O X
Tyr O X
phosphorylation O X
and O X
downstream O X
signalling O X
( O X
activation O X
of O X
FRS2a I-MISC 10818
, O X
Akt I-MISC 207
, O X
Erk1 I-MISC 5595
/ I-MISC 5595
2 I-MISC 5595
, O X
and O X
PLCy O X
). O X

Expression O X
of O X
FGFR1 I-MISC 2260
-/\ O X
6 O X
in O X
human O X
embryonic O X
neural O X
stem O X
cells O X
strongly O X
promotes O X
FGF2 I-MISC 2247
- O X
dependent O X
neuronal O X
differentiation O X
. O X

Furthermore O X
, O X
expression O X
of O X
this O X
FGFR1 I-MISC 30705
-/\ O X
6 O X
mutant O X
in O X
zebrafish O X
embryos O X
disrupts O X
anterior O X
neuronal O X
patterning O X
( O X
head O X
development O X
), O X
consistent O X
with O X
excessive O X
FGFR1 I-MISC 30705
signalling O X
. O X

These O X
results O X
identify O X
Nedd4 I-MISC 619412
- I-MISC 619412
1 I-MISC 619412
as O X
a O X
key O X
regulator O X
of O X
FGFR1 I-MISC 2260
endocytosis O X
and O X
signalling O X
during O X
neuronal O X
differentiation O X
and O X
embryonic O X
development O X
. O X

###9194564	7157,1387

Synergistic O X
activation O X
of O X
transcription O X
by O X
CBP I-MISC 1387
and O X
p53 I-MISC 7157
. O X

The O X
tumour O X
suppressor O X
p53 I-MISC 7157
is O X
a O X
transcriptional O X
regulator O X
whose O X
ability O X
to O X
inhibit O X
cell O X
growth O X
is O X
dependent O X
upon O X
its O X
transactivation O X
function O X
. O X

Here O X
we O X
demonstrate O X
that O X
the O X
transcription O X
factor O X
CBP I-MISC 1387
, O X
which O X
is O X
also O X
implicated O X
in O X
cell O X
proliferation O X
and O X
differentiation O X
, O X
acts O X
as O X
a O X
p53 I-MISC 7157
coactivator O X
and O X
potentiates O X
its O X
transcriptional O X
activity O X
. O X

The O X
amino O X
- O X
terminal O X
activation O X
domain O X
of O X
p53 I-MISC 7157
interacts O X
with O X
the O X
carboxy O X
- O X
terminal O X
portion O X
of O X
the O X
CBP I-MISC 1387
protein O X
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

In O X
transfected O X
SaoS O X
- O X
2 O X
cells O X
, O X
CBP I-MISC 1387
potentiates O X
activation O X
of O X
the O X
mdm I-MISC 4193
- I-MISC 4193
2 I-MISC 4193
gene O X
by O X
p53 I-MISC 7157
and O X
, O X
reciprocally O X
, O X
p53 I-MISC 7157
potentiates O X
activation O X
of O X
a O X
Gal4 I-MISC 3960
- O X
responsive O X
target O X
gene O X
by O X
a O X
Gal4 I-MISC 3960
( O X
1 O X
- O X
147 O X
)- O X
CBP I-MISC 1387
( O X
1678 O X
- O X
2441 O X
) O X
fusion O X
protein O X
. O X

A O X
double O X
point O X
mutation O X
that O X
destroys O X
the O X
transactivation O X
function O X
of O X
p53 I-MISC 7157
also O X
abolishes O X
its O X
binding O X
to O X
CBP I-MISC 1387
and O X
its O X
synergistic O X
function O X
with O X
CBP I-MISC 1387
. O X

The O X
ability O X
of O X
p53 I-MISC 7157
to O X
interact O X
physically O X
and O X
functionally O X
with O X
a O X
coactivator O X
( O X
CBP I-MISC 1387
) O X
that O X
has O X
histone O X
acetyltransferase O X
activity O X
and O X
with O X
components O X
( O X
TAFs O X
) O X
of O X
the O X
general O X
transcription O X
machinery O X
indicates O X
that O X
it O X
may O X
have O X
different O X
functions O X
in O X
a O X
multistep O X
activation O X
pathway O X
. O X

###16221672	11093,7450

ADAMTS13 I-MISC 11093
substrate O X
recognition O X
of O X
von I-MISC 7450
Willebrand I-MISC 7450
factor I-MISC 7450
A2 O X
domain O X
. O X

ADAMTS13 I-MISC 11093
controls O X
the O X
multimeric O X
size O X
of O X
circulating O X
von I-MISC 7450
Willebrand I-MISC 7450
factor I-MISC 7450
( O X
VWF I-MISC 7450
) O X
by O X
cleaving O X
the O X
Tyr1605 O X
- O X
Met1606 O X
bond O X
in O X
theA2 O X
domain O X
. O X

To O X
examine O X
substrate O X
recognition O X
, O X
we O X
expressed O X
in O X
bacteria O X
and O X
purified O X
three O X
A2 O X
( O X
VWF76 O X
-( O X
1593 O X
- O X
1668 O X
), O X
VWF115 O X
-( O X
1554 O X
- O X
1668 O X
), O X
VWFA2 O X
-( O X
1473 O X
- O X
1668 O X
)) O X
and O X
one O X
A2 O X
- O X
A3 O X
( O X
VWF115 O X
- O X
A3 O X
-( O X
1554 O X
- O X
1874 O X
)) O X
domain O X
fragments O X
. O X

Using O X
high O X
pressure O X
liquid O X
chromatography O X
analysis O X
, O X
the O X
initial O X
rates O X
of O X
VWF115 O X
cleavage O X
by O X
ADAMTS13 I-MISC 11093
at O X
different O X
substrate O X
concentrations O X
were O X
determined O X
, O X
and O X
from O X
this O X
the O X
kinetic O X
constants O X
were O X
derived O X
( O X
Km O X
1 O X
. O X
61 O X
microM O X
; O X
kcat O X
0 O X
. O X
14 O X
s O X
(- O X
1 O X
)), O X
from O X
which O X
the O X
specificity O X
constant O X
kcat O X
/ O X
Km O X
was O X
calculated O X
, O X
8 O X
. O X
70 O X
x O X
10 O X
( O X
4 O X
) O X
m O X
(- O X
1 O X
) O X
s O X
(- O X
1 O X
). O X

Similar O X
values O X
of O X
the O X
specificity O X
constant O X
were O X
obtained O X
for O X
VWF76 O X
and O X
VWF115 O X
- O X
A3 O X
. O X

To O X
identify O X
residues O X
important O X
for O X
recognition O X
and O X
proteolysis O X
of O X
VWF115 O X
, O X
we O X
introduced O X
certain O X
type O X
2A O X
von O X
Willebrand O X
disease O X
mutations O X
by O X
site O X
- O X
directed O X
mutagenesis O X
. O X

Although O X
most O X
were O X
cleaved O X
normally O X
, O X
one O X
( O X
D1614G O X
) O X
was O X
cleaved O X
approximately O X
8 O X
- O X
fold O X
slower O X
. O X

Mutagenesis O X
of O X
additional O X
charged O X
residues O X
predicted O X
to O X
be O X
in O X
close O X
proximity O X
to O X
Asp1614 O X
on O X
the O X
surface O X
of O X
the O X
A2 O X
domain O X
( O X
R1583A O X
, O X
D1587A O X
, O X
D1614A O X
, O X
E1615A O X
, O X
K1617A O X
, O X
E1638A O X
, O X
E1640A O X
) O X
revealed O X
up O X
to O X
13 O X
- O X
fold O X
reduction O X
in O X
kcat O X
/ O X
Km O X
for O X
D1587A O X
, O X
D1614A O X
, O X
E1615A O X
, O X
and O X
K1617A O X
mutants O X
. O X

When O X
introduced O X
into O X
the O X
intact O X
VWFA2 O X
domain O X
, O X
proteolysis O X
of O X
the O X
D1587A O X
, O X
D1614A O X
, O X
and O X
E1615A O X
mutants O X
was O X
also O X
slowed O X
, O X
particularly O X
in O X
the O X
presence O X
of O X
urea O X
. O X

Surface O X
plasmon O X
resonance O X
demonstrated O X
appreciable O X
reduction O X
in O X
binding O X
affinity O X
between O X
ADAMTS13 I-MISC 11093
and O X
VWF115 O X
mutants O X
( O X
KD O X
up O X
to O X
approximately O X
1 O X
. O X
3 O X
microM O X
), O X
compared O X
with O X
VWF115 O X
( O X
KD O X
20 O X
nM O X
). O X

These O X
results O X
demonstrate O X
an O X
important O X
role O X
for O X
Asp1614 O X
and O X
surrounding O X
charged O X
residues O X
in O X
the O X
binding O X
and O X
cleavage O X
of O X
the O X
VWFA2 O X
domain O X
by O X
ADAMTS13 I-MISC 11093
. O X

###12588987	1499,367

Beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
binds O X
to O X
the O X
activation O X
function O X
2 O X
region O X
of O X
the O X
androgen I-MISC 367
receptor I-MISC 367
and O X
modulates O X
the O X
effects O X
of O X
the O X
N O X
- O X
terminal O X
domain O X
and O X
TIF2 I-MISC 10499
on O X
ligand O X
- O X
dependent O X
transcription O X
. O X

Beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
is O X
a O X
multifunctional O X
molecule O X
that O X
is O X
activated O X
by O X
signaling O X
through O X
WNT O X
receptors O X
. O X

beta I-MISC 1499
- I-MISC 1499
Catenin I-MISC 1499
can O X
also O X
enhance O X
the O X
transcriptional O X
activity O X
of O X
some O X
steroid O X
hormone O X
receptors O X
such O X
as O X
the O X
androgen I-MISC 367
receptor I-MISC 367
and O X
retinoic O X
acid O X
receptor O X
alpha O X
. O X

Androgens O X
can O X
affect O X
nuclear O X
translocation O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
influence O X
its O X
subcellular O X
distribution O X
. O X

Using O X
mammalian O X
two O X
- O X
hybrid O X
binding O X
assays O X
, O X
analysis O X
of O X
reporter O X
gene O X
transcription O X
, O X
and O X
coimmunoprecipitation O X
, O X
we O X
now O X
show O X
that O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
binds O X
to O X
the O X
androgen I-MISC 367
receptor I-MISC 367
ligand O X
- O X
binding O X
domain O X
( O X
LBD O X
) O X
and O X
modulates O X
the O X
transcriptional O X
effects O X
of O X
TIF2 I-MISC 10499
and O X
the O X
androgen I-MISC 367
receptor I-MISC 367
N O X
- O X
terminal O X
domain O X
( O X
NTD O X
). O X

In O X
functional O X
assays O X
, O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
bound O X
to O X
androgen I-MISC 367
receptor I-MISC 367
only O X
in O X
the O X
presence O X
of O X
ligand O X
agonists O X
, O X
not O X
antagonists O X
. O X

Beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
binding O X
to O X
the O X
androgen I-MISC 367
receptor I-MISC 367
LBD O X
was O X
independent O X
of O X
and O X
cooperative O X
with O X
the O X
androgen I-MISC 367
receptor I-MISC 367
NTD O X
and O X
the O X
p160 I-MISC 10514
coactivator O X
TIF2 I-MISC 10499
, O X
both O X
of O X
which O X
bind O X
to O X
the O X
activation O X
function O X
2 O X
( O X
AF O X
- O X
2 O X
) O X
region O X
of O X
the O X
androgen I-MISC 367
receptor I-MISC 367
. O X

Different O X
mutations O X
of O X
androgen I-MISC 367
receptor I-MISC 367
helix O X
3 O X
amino O X
acids O X
disrupted O X
binding O X
of O X
androgen I-MISC 367
receptor I-MISC 367
NTD O X
and O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
. O X

beta I-MISC 1499
- I-MISC 1499
Catenin I-MISC 1499
, O X
androgen I-MISC 367
receptor I-MISC 367
NTD O X
, O X
and O X
TIF2 I-MISC 10499
binding O X
to O X
the O X
androgen I-MISC 367
receptor I-MISC 367
LBD O X
were O X
affected O X
similarly O X
by O X
a O X
subset O X
of O X
helix O X
12 O X
mutations O X
, O X
but O X
disruption O X
of O X
two O X
sites O X
on O X
helix O X
12 O X
affected O X
only O X
binding O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
not O X
of O X
TIF2 I-MISC 10499
or O X
the O X
androgen I-MISC 367
receptor I-MISC 367
NTD O X
. O X

Mutational O X
disruption O X
of O X
each O X
of O X
five O X
LXXLL O X
peptide O X
motifs O X
in O X
the O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
armadillo O X
repeats O X
did O X
not O X
disrupt O X
either O X
binding O X
to O X
androgen I-MISC 367
receptor I-MISC 367
or O X
transcriptional O X
coactivation O X
. O X

ICAT O X
, O X
an O X
inhibitor O X
of O X
T I-MISC 6934
- I-MISC 6934
cell I-MISC 6934
factor I-MISC 6934
4 I-MISC 6934
( O X
TCF I-MISC 6934
- I-MISC 6934
4 I-MISC 6934
), O X
and O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
binding O X
to O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
also O X
blocked O X
binding O X
of O X
the O X
androgen I-MISC 367
receptor I-MISC 367
LBD O X
. O X

We O X
also O X
demonstrated O X
cross O X
talk O X
between O X
the O X
WNT O X
and O X
androgen I-MISC 367
receptor I-MISC 367
signaling O X
pathways O X
because O X
excess O X
androgen I-MISC 367
receptor I-MISC 367
could O X
interfere O X
with O X
WNT O X
signaling O X
and O X
excess O X
TCF I-MISC 6934
- I-MISC 6934
4 I-MISC 6934
inhibited O X
the O X
interaction O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
androgen I-MISC 367
receptor I-MISC 367
. O X

Taken O X
together O X
, O X
the O X
data O X
show O X
that O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
can O X
bind O X
to O X
the O X
androgen I-MISC 367
receptor I-MISC 367
LBD O X
and O X
modulate O X
the O X
effects O X
of O X
the O X
androgen I-MISC 367
receptor I-MISC 367
NTD O X
and O X
TIF2 I-MISC 10499
on O X
transcription O X
. O X

###20952388	842951,817148

Molecular O X
association O X
of O X
the O X
Arabidopsis O X
ETR1 I-MISC 107784797
ethylene O X
receptor O X
and O X
a O X
regulator O X
of O X
ethylene O X
signaling O X
, O X
RTE1 I-MISC 817148
. O X

The O X
plant O X
hormone O X
ethylene O X
plays O X
important O X
roles O X
in O X
growth O X
and O X
development O X
. O X

Ethylene O X
is O X
perceived O X
by O X
a O X
family O X
of O X
membrane O X
- O X
bound O X
receptors O X
that O X
actively O X
repress O X
ethylene O X
responses O X
. O X

When O X
the O X
receptors O X
bind O X
ethylene O X
, O X
their O X
signaling O X
is O X
shut O X
off O X
, O X
activating O X
responses O X
. O X

REVERSION O X
- O X
TO O X
- O X
ETHYLENE O X
SENSITIVITY O X
( O X
RTE1 I-MISC 817148
) O X
encodes O X
a O X
novel O X
membrane O X
protein O X
conserved O X
in O X
plants O X
and O X
metazoans O X
. O X

Genetic O X
analyses O X
in O X
Arabidopsis O X
thaliana O X
suggest O X
that O X
RTE1 I-MISC 817148
promotes O X
the O X
signaling O X
state O X
of O X
the O X
ethylene O X
receptor O X
ETR1 I-MISC 842951
through O X
the O X
ETR1 I-MISC 842951
N O X
- O X
terminal O X
domain O X
. O X

RTE1 I-MISC 817148
and O X
ETR1 I-MISC 107784797
have O X
been O X
shown O X
to O X
co O X
- O X
localize O X
to O X
the O X
endoplasmic O X
reticulum O X
( O X
ER O X
) O X
and O X
Golgi O X
apparatus O X
in O X
Arabidopsis O X
. O X

Here O X
, O X
we O X
demonstrate O X
a O X
physical O X
association O X
of O X
RTE1 I-MISC 817148
and O X
ETR1 I-MISC 107784797
using O X
in O X
vivo O X
and O X
in O X
vitro O X
methods O X
. O X

Interaction O X
of O X
RTE1 I-MISC 817148
and O X
ETR1 I-MISC 107784797
was O X
revealed O X
in O X
vivo O X
by O X
bimolecular O X
fluorescence O X
complementation O X
( O X
BiFC O X
) O X
in O X
a O X
tobacco O X
cell O X
transient O X
assay O X
and O X
in O X
stably O X
transformed O X
Arabidopsis O X
. O X

The O X
association O X
was O X
also O X
observed O X
using O X
a O X
truncated O X
version O X
of O X
ETR1 I-MISC 107784797
comprising O X
the O X
N O X
terminus O X
( O X
amino O X
acids O X
1 O X
- O X
349 O X
). O X

Interaction O X
of O X
RTE1 I-MISC 817148
and O X
ETR1 I-MISC 107784797
was O X
confirmed O X
by O X
co O X
- O X
immunoprecipitation O X
from O X
Arabidopsis O X
. O X

The O X
interaction O X
occurs O X
with O X
high O X
affinity O X
( O X
K O X
( O X
d O X
), O X
117 O X
nM O X
) O X
based O X
on O X
tryptophan O X
fluorescence O X
spectroscopy O X
using O X
purified O X
recombinant O X
RTE1 I-MISC 817148
and O X
a O X
tryptophan O X
- O X
less O X
version O X
of O X
purified O X
recombinant O X
ETR1 I-MISC 107784797
. O X

An O X
amino O X
acid O X
substitution O X
( O X
C161Y O X
) O X
in O X
RTE1 I-MISC 817148
that O X
is O X
known O X
to O X
confer O X
an O X
ETR1 I-MISC 107784797
loss O X
- O X
of O X
- O X
function O X
phenotype O X
correspondingly O X
gives O X
a O X
nearly O X
12 O X
- O X
fold O X
increase O X
in O X
the O X
dissociation O X
constant O X
( O X
K O X
( O X
d O X
), O X
1 O X
. O X
38 O X
M O X
). O X

These O X
findings O X
indicate O X
that O X
a O X
high O X
affinity O X
association O X
of O X
RTE1 I-MISC 817148
and O X
ETR1 I-MISC 107784797
is O X
important O X
in O X
the O X
regulation O X
of O X
ETR1 I-MISC 107784797
. O X

###19013157	946267,945625

Features O X
of O X
a O X
twin O X
- O X
arginine O X
signal O X
peptide O X
required O X
for O X
recognition O X
by O X
a O X
Tat O X
proofreading O X
chaperone O X
. O X

The O X
twin O X
- O X
arginine O X
translocation O X
( O X
Tat O X
) O X
system O X
is O X
a O X
bacterial O X
protein O X
targeting O X
pathway O X
. O X

Tat O X
- O X
targeted O X
proteins O X
display O X
signal O X
peptides O X
containing O X
a O X
distinctive O X
SRRxFLK O X
' O X
twin O X
- O X
arginine O X
' O X
motif O X
. O X

The O X
Escherichia O X
coli O X
trimethylamine O X
N O X
- O X
oxide O X
reductase O X
( O X
TorA I-MISC 946267
) O X
bears O X
a O X
bifunctional O X
Tat O X
signal O X
peptide O X
, O X
which O X
directs O X
protein O X
export O X
and O X
serves O X
as O X
a O X
binding O X
site O X
for O X
the O X
TorD I-MISC 945625
biosynthetic O X
chaperone O X
. O X

Here O X
, O X
the O X
physical O X
interaction O X
between O X
TorD I-MISC 945625
and O X
the O X
TorA I-MISC 946267
signal O X
peptide O X
was O X
investigated O X
. O X

A O X
single O X
substitution O X
within O X
the O X
TorA I-MISC 946267
signal O X
peptide O X
( O X
L31Q O X
) O X
was O X
sufficient O X
to O X
impair O X
TorD I-MISC 945625
binding O X
. O X

Screening O X
of O X
a O X
random O X
torD I-MISC 945625
mutant O X
library O X
identified O X
a O X
variant O X
TorD I-MISC 945625
protein O X
( O X
Q7L O X
) O X
that O X
displayed O X
increased O X
binding O X
affinity O X
for O X
the O X
TorA I-MISC 946267
signal O X
peptide O X
. O X

###21435037	998,1252609

Interaction O X
of O X
the O X
Salmonella O X
Typhimurium O X
effector O X
protein O X
SopB I-MISC 1252609
with O X
host O X
cell O X
Cdc42 I-MISC 998
is O X
involved O X
in O X
intracellular O X
replication O X
. O X

The O X
phosphoinositide O X
phosphatase O X
SopB I-MISC 1252609
/ O X
SigD O X
is O X
a O X
type O X
III O X
secretion O X
system O X
effector O X
that O X
plays O X
multiple O X
roles O X
in O X
Salmonella O X
internalization O X
and O X
intracellular O X
survival O X
. O X

We O X
previously O X
reported O X
that O X
SopB I-MISC 1252609
complexed O X
with O X
and O X
inhibited O X
the O X
small O X
GTPase O X
Cdc42 I-MISC 850930
when O X
expressed O X
in O X
a O X
yeast O X
model O X
system O X
, O X
independently O X
of O X
its O X
phosphatase O X
activity O X
. O X

Here O X
we O X
show O X
that O X
human O X
Cdc42 I-MISC 998
, O X
but O X
not O X
Rac1 I-MISC 5879
, O X
interacts O X
with O X
catalytically O X
inactive O X
SopB I-MISC 1252609
when O X
coexpressed O X
in O X
Saccharomyces O X
cerevisiae O X
. O X

This O X
interaction O X
occurs O X
with O X
both O X
constitutively O X
active O X
and O X
non O X
- O X
activatable O X
Cdc42 I-MISC 998
, O X
suggesting O X
that O X
SopB I-MISC 1252609
binds O X
Cdc42 I-MISC 998
independently O X
of O X
its O X
activation O X
state O X
. O X

By O X
mutational O X
analysis O X
we O X
have O X
narrowed O X
the O X
Cdc42 I-MISC 998
- O X
interacting O X
region O X
of O X
SopB I-MISC 1252609
to O X
the O X
first O X
142 O X
amino O X
acids O X
, O X
and O X
isolated O X
a O X
collection O X
of O X
point O X
mutations O X
in O X
this O X
region O X
, O X
mainly O X
affecting O X
leucine O X
residues O X
conserved O X
in O X
the O X
related O X
Shigella O X
IpgD O X
protein O X
. O X

Such O X
mutations O X
yielded O X
SopB I-MISC 1252609
unable O X
to O X
interact O X
with O X
Cdc42 I-MISC 998
but O X
maintained O X
phosphatase O X
activity O X
. O X

SopB I-MISC 1252609
mutant O X
proteins O X
defective O X
for O X
binding O X
Cdc42 I-MISC 998
were O X
ubiquitinated O X
upon O X
translocation O X
in O X
mammalian O X
cells O X
, O X
but O X
their O X
localization O X
to O X
the O X
Salmonella O X
- O X
containing O X
vacuole O X
was O X
reduced O X
compared O X
with O X
wild O X
- O X
type O X
SopB I-MISC 1252609
. O X

Whereas O X
invasion O X
of O X
mammalian O X
cells O X
by O X
Salmonella O X
bearing O X
these O X
sopB I-MISC 1252609
mutations O X
was O X
not O X
affected O X
, O X
intracellular O X
replication O X
was O X
less O X
efficient O X
, O X
suggesting O X
that O X
SopB I-MISC 1252609
- O X
Cdc42 I-MISC 998
interaction O X
contributes O X
to O X
the O X
adaptation O X
of O X
Salmonella O X
to O X
the O X
intracellular O X
environment O X
. O X

###9488135	7124,7124	7124,7132	7124,7133

Crystal O X
structure O X
of O X
TNF I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
mutant O X
R31D O X
with O X
greater O X
affinity O X
for O X
receptor O X
R1 O X
compared O X
with O X
R2 O X
. O X

Crystal O X
structures O X
have O X
been O X
determined O X
of O X
recombinant O X
human O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
( O X
TNF I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
) O X
and O X
its O X
R31D O X
mutant O X
that O X
preferentially O X
binds O X
to O X
TNF I-MISC 7132
receptor I-MISC 7132
R1 I-MISC 7132
with O X
more O X
than O X
seven O X
times O X
the O X
relative O X
affinity O X
of O X
binding O X
to O X
receptor O X
R2 O X
. I-MISC 7133

Crystals I-MISC 7133
of O X
the O X
wild O X
- O X
type O X
TNF I-MISC 7124
were O X
of O X
space O X
group O X
P4 O X
( O X
1 O X
) O X
2 O X
( O X
1 O X
) O X
2 O X
and O X
had O X
unit O X
cell O X
dimensions O X
of O X
a O X
= O X
b O X
= O X
94 O X
. O X
7 O X
and O X
c O X
= O X
117 O X
. O X
4 O X
A O X
. O X
Refinement O X
of O X
the O X
structure O X
gave O X
an O X
R O X
- O X
factor O X
of O X
22 O X
. O X
3 O X
% O X
at O X
2 O X
. O X
5 O X
A O X
resolution O X
. O X

The O X
crystals O X
of O X
TNF I-MISC 7124
R31D O X
mutant O X
diffracted O X
to O X
2 O X
. O X
3 O X
A O X
resolution O X
, O X
and O X
were O X
of O X
identical O X
space O X
group O X
to O X
the O X
wild O X
type O X
with O X
unit O X
cell O X
dimensions O X
of O X
a O X
= O X
b O X
= O X
95 O X
. O X
4 O X
and O X
c O X
= O X
116 O X
. O X
2 O X
A O X
, O X
and O X
the O X
structure O X
was O X
refined O X
to O X
an O X
R O X
- O X
factor O X
of O X
21 O X
. O X
8 O X
%. O X

The O X
trimer O X
structures O X
of O X
the O X
wild O X
- O X
type O X
and O X
mutant O X
TNF I-MISC 7124
were O X
similar O X
with O X
a O X
root O X
mean O X
square O X
( O X
r O X
. O X
m O X
. O X
s O X
.) O X

deviation O X
of O X
0 O X
. O X
56 O X
A O X
for O X
Calpha O X
atoms O X
; O X
however O X
, O X
the O X
subunits O X
within O X
each O X
trimer O X
were O X
more O X
variable O X
with O X
an O X
average O X
r O X
. O X
m O X
. O X
s O X
. O X

deviation O X
of O X
1 O X
. O X
00 O X
A O X
on O X
Calpha O X
atoms O X
for O X
pairwise O X
comparison O X
of O X
subunits O X
. O X

Model O X
complexes O X
of O X
TNF I-MISC 7124
with O X
receptors O X
R1 O X
and O X
R2 O X
have O X
been O X
used O X
to O X
predict O X
TNF I-MISC 7132
- I-MISC 7132
receptor I-MISC 7132
interactions O X
. O X

Arg31 I-MISC 23237
in O X
all O X
three O X
subunits O X
of O X
wild O X
- O X
type O X
TNF I-MISC 7124
is O X
predicted O X
to O X
form O X
an O X
ionic O X
interaction O X
with O X
the O X
equivalent O X
glutamic O X
acid O X
in O X
both O X
receptors O X
R1 O X
and O X
R2 O X
. O X

Asp31 O X
of O X
the O X
TNF I-MISC 7124
R31D O X
mutant O X
is O X
predicted O X
to O X
interact O X
differently O X
with O X
the O X
two O X
receptors O X
. O X

The O X
side O X
chain O X
of O X
Asp31 O X
in O X
two O X
subunits O X
of O X
the O X
TNF I-MISC 7124
mutant O X
is O X
predicted O X
to O X
form O X
hydrogen O X
bond O X
interactions O X
with O X
Ser59 O X
or O X
Cys70 O X
of O X
R1 O X
, O X
while O X
it O X
has O X
no O X
predicted O X
interactions O X
with O X
R2 O X
. O X

The O X
loss O X
of O X
three O X
strong O X
ionic O X
interactions O X
of O X
Arg31 I-MISC 23237
and O X
the O X
electrostatic O X
repulsion O X
of O X
Asp31 O X
with O X
Glu O X
in O X
the O X
receptors O X
is O X
consistent O X
with O X
the O X
reduced O X
binding O X
of O X
the O X
R31D O X
mutant O X
to O X
both O X
receptors O X
relative O X
to O X
wild O X
- O X
type O X
TNF I-MISC 7124
. O X

The O X
replacement O X
of O X
these O X
ionic O X
interactions O X
by O X
two O X
weaker O X
hydrogen O X
bond O X
interactions O X
between O X
Asp31 O X
of O X
the O X
R31D O X
mutant O X
and O X
R1 O X
, O X
compared O X
with O X
no O X
interactions O X
with O X
R2 O X
, O X
is O X
in O X
agreement O X
with O X
the O X
observed O X
preferential O X
binding O X
of O X
the O X
R31D O X
mutant O X
to O X
R1 O X
over O X
R2 O X
. O X

Analysis O X
of O X
the O X
structure O X
and O X
function O X
of O X
receptor O X
- O X
discriminating O X
mutants O X
of O X
TNF I-MISC 7124
will O X
help O X
understand O X
the O X
biological O X
role O X
of O X
TNF I-MISC 7124
and O X
facilitate O X
its O X
use O X
as O X
an O X
antitumor O X
agent O X
. O X

###17719007	818839,818839	824981,824981

A O X
conserved O X
proline O X
residue O X
in O X
the O X
leucine O X
zipper O X
region O X
of O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
in O X
Arabidopsis O X
thaliana O X
interferes O X
with O X
the O X
formation O X
of O X
homodimer O X
. O X

Two O X
putative O X
Arabidopsis O X
E O X
group O X
bZIP O X
transcript O X
factors O X
, O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
, O X
are O X
nuclear O X
- O X
localized O X
and O X
their O X
transcriptional O X
activation O X
domain O X
is O X
in O X
their O X
N O X
- O X
terminal O X
region O X
. O X

By O X
searching O X
GenBank O X
, O X
we O X
found O X
other O X
eight O X
plant O X
homologues O X
of O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
. O X

All O X
of O X
them O X
have O X
a O X
proline O X
residue O X
in O X
the O X
third O X
heptad O X
of O X
zipper O X
region O X
. O X

Yeast O X
two O X
- O X
hybrid O X
assay O X
and O X
EMSA O X
showed O X
that O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
could O X
not O X
form O X
homodimer O X
while O X
their O X
mutant O X
forms O X
, O X
AtbZIP34m O X
and O X
AtbZIP61m O X
, O X
which O X
the O X
proline O X
residue O X
was O X
replaced O X
by O X
an O X
alanine O X
residue O X
in O X
the O X
zipper O X
region O X
, O X
could O X
form O X
homodimer O X
and O X
bind O X
G O X
- O X
box O X
element O X
. O X

These O X
results O X
suggest O X
that O X
the O X
conserved O X
proline O X
residue O X
interferes O X
with O X
the O X
homodimer O X
formation O X
. O X

However O X
, O X
both O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
could O X
form O X
heterodimers O X
with O X
members O X
of O X
I O X
group O X
and O X
S O X
group O X
transcription O X
factors O X
in O X
which O X
some O X
members O X
involved O X
in O X
vascular O X
development O X
. O X

So O X
we O X
speculate O X
that O X
AtbZIP34 I-MISC 818839
and O X
AtbZIP61 I-MISC 824981
may O X
participate O X
in O X
plant O X
development O X
via O X
interacting O X
with O X
other O X
group O X
bZIP O X
transcription O X
factors O X
. O X

###17626883	5295,282306

Mechanism O X
of O X
two O X
classes O X
of O X
cancer O X
mutations O X
in O X
the O X
phosphoinositide O X
3 O X
- O X
kinase O X
catalytic O X
subunit O X
. O X

Many O X
human O X
cancers O X
involve O X
up O X
- O X
regulation O X
of O X
the O X
phosphoinositide O X
3 O X
- O X
kinase O X
PI3Kalpha I-MISC 282306
, O X
with O X
oncogenic O X
mutations O X
identified O X
in O X
both O X
the O X
p110alpha I-MISC 282306
catalytic O X
and O X
the O X
p85alpha I-MISC 5295
regulatory O X
subunits O X
. O X

We O X
used O X
crystallographic O X
and O X
biochemical O X
approaches O X
to O X
gain O X
insight O X
into O X
activating O X
mutations O X
in O X
two O X
noncatalytic O X
p110alpha I-MISC 282306
domains O X
- O X
the O X
adaptor O X
- O X
binding O X
and O X
the O X
helical O X
domains O X
. O X

A O X
structure O X
of O X
the O X
adaptor O X
- O X
binding O X
domain O X
of O X
p110alpha I-MISC 282306
in O X
a O X
complex O X
with O X
the O X
p85alpha I-MISC 5295
inter O X
- O X
Src O X
homology O X
2 O X
( O X
inter O X
- O X
SH2 O X
) O X
domain O X
shows O X
that O X
oncogenic O X
mutations O X
in O X
the O X
adaptor O X
- O X
binding O X
domain O X
are O X
not O X
at O X
the O X
inter O X
- O X
SH2 O X
interface O X
but O X
in O X
a O X
polar O X
surface O X
patch O X
that O X
is O X
a O X
plausible O X
docking O X
site O X
for O X
other O X
domains O X
in O X
the O X
holo O X
p110 O X
/ O X
p85 I-MISC 5295
complex O X
. O X

We O X
also O X
examined O X
helical O X
domain O X
mutations O X
and O X
found O X
that O X
the O X
Glu545 O X
to O X
Lys545 O X
( O X
E545K O X
) O X
oncogenic O X
mutant O X
disrupts O X
an O X
inhibitory O X
charge O X
- O X
charge O X
interaction O X
with O X
the O X
p85 I-MISC 5295
N O X
- O X
terminal O X
SH2 O X
domain O X
. O X

These O X
studies O X
extend O X
our O X
understanding O X
of O X
the O X
architecture O X
of O X
PI3Ks O X
and O X
provide O X
insight O X
into O X
how O X
two O X
classes O X
of O X
mutations O X
that O X
cause O X
a O X
gain O X
in O X
function O X
can O X
lead O X
to O X
cancer O X
. O X

###16782870	855621,854656

Interaction O X
between O X
PCNA O X
and O X
diubiquitinated O X
Mcm10 I-MISC 854656
is O X
essential O X
for O X
cell O X
growth O X
in O X
budding O X
yeast O X
. O X

The O X
minichromosome I-MISC 854656
maintenance I-MISC 854656
protein I-MISC 854656
10 I-MISC 854656
( O X
Mcm10 I-MISC 854656
) O X
is O X
an O X
evolutionarily O X
conserved O X
factor O X
that O X
is O X
essential O X
for O X
replication O X
initiation O X
and O X
elongation O X
. O X

Mcm10 I-MISC 854656
is O X
part O X
of O X
the O X
eukaryotic O X
replication O X
fork O X
and O X
interacts O X
with O X
a O X
variety O X
of O X
proteins O X
, O X
including O X
the O X
Mcm2 O X
- O X
7 O X
helicase O X
and O X
DNA I-MISC 855621
polymerase I-MISC 855621
alpha I-MISC 855621
/ O X
primase O X
complexes O X
. O X

A O X
motif O X
search O X
revealed O X
a O X
match O X
to O X
the O X
proliferating O X
cell O X
nuclear O X
antigen O X
( O X
PCNA O X
)- O X
interacting O X
protein O X
( O X
PIP O X
) O X
box O X
in O X
Mcm10 I-MISC 854656
. O X

Here O X
, O X
we O X
demonstrate O X
a O X
direct O X
interaction O X
between O X
Mcm10 I-MISC 854656
and O X
PCNA O X
that O X
is O X
alleviated O X
by O X
mutations O X
in O X
conserved O X
residues O X
of O X
the O X
PIP O X
box O X
. O X

Interestingly O X
, O X
only O X
the O X
diubiquitinated O X
form O X
of O X
Mcm10 I-MISC 854656
binds O X
to O X
PCNA O X
. O X

Diubiquitination O X
of O X
Mcm10 I-MISC 854656
is O X
cell O X
cycle O X
regulated O X
; O X
it O X
first O X
appears O X
in O X
late O X
G O X
( O X
1 O X
) O X
and O X
persists O X
throughout O X
S O X
phase O X
. O X

During O X
this O X
time O X
, O X
diubiquitinated O X
Mcm10 I-MISC 854656
is O X
associated O X
with O X
chromatin O X
, O X
suggesting O X
a O X
direct O X
role O X
in O X
DNA O X
replication O X
. O X

Surprisingly O X
, O X
a O X
Y245A O X
substitution O X
in O X
the O X
PIP O X
box O X
of O X
Mcm10 I-MISC 854656
that O X
inhibits O X
the O X
interaction O X
with O X
PCNA O X
abolishes O X
cell O X
proliferation O X
. O X

This O X
severe O X
- O X
growth O X
phenotype O X
, O X
which O X
has O X
not O X
been O X
observed O X
for O X
analogous O X
mutations O X
in O X
other O X
PCNA O X
- O X
interacting O X
proteins O X
, O X
is O X
rescued O X
by O X
a O X
compensatory O X
mutation O X
in O X
PCNA O X
that O X
restores O X
interaction O X
with O X
Mcm10 I-MISC 854656
- O X
Y245A O X
. O X

Taken O X
together O X
, O X
our O X
results O X
suggest O X
that O X
diubiquitinated O X
Mcm10 I-MISC 854656
interacts O X
with O X
PCNA O X
to O X
facilitate O X
an O X
essential O X
step O X
in O X
DNA O X
elongation O X
. O X

###21063388	27327,26986

Two O X
PABPC1 I-MISC 37070
- O X
binding O X
sites O X
in O X
GW182 I-MISC 43808
proteins O X
promote O X
miRNA O X
- O X
mediated O X
gene O X
silencing O X
. O X

miRNA O X
- O X
mediated O X
gene O X
silencing O X
requires O X
the O X
GW182 I-MISC 43808
proteins O X
, O X
which O X
are O X
characterized O X
by O X
an O X
N O X
- O X
terminal O X
domain O X
that O X
interacts O X
with O X
Argonaute I-MISC 36544
proteins O X
( O X
AGOs O X
), O X
and O X
a O X
C O X
- O X
terminal O X
silencing O X
domain O X
( O X
SD O X
). O X

In O X
Drosophila O X
melanogaster O X
( O X
Dm O X
) O X
GW182 I-MISC 43808
and O X
a O X
human O X
( O X
Hs O X
) O X
orthologue O X
, O X
TNRC6C I-MISC 57690
, O X
the O X
SD O X
was O X
previously O X
shown O X
to O X
interact O X
with O X
the O X
cytoplasmic O X
poly O X
( O X
A O X
)- O X
binding O X
protein O X
( O X
PABPC1 I-MISC 26986
). O X

Here O X
, O X
we O X
show O X
that O X
two O X
regions O X
of O X
GW182 I-MISC 43808
proteins O X
interact O X
with O X
PABPC1 I-MISC 37070
: O X
the O X
first O X
contains O X
a O X
PABP O X
- O X
interacting O X
motif O X
2 O X
( O X
PAM2 O X
; O X
as O X
shown O X
before O X
for O X
TNRC6C I-MISC 57690
) O X
and O X
the O X
second O X
contains O X
the O X
M2 O X
and O X
C O X
- O X
terminal O X
sequences O X
in O X
the O X
SD O X
. O X

The O X
latter O X
mediates O X
indirect O X
binding O X
to O X
the O X
PABPC1 I-MISC 37070
N O X
- O X
terminal O X
domain O X
. O X

In O X
D O X
. O X
melanogaster O X
cells O X
, O X
the O X
second O X
binding O X
site O X
dominates O X
; O X
however O X
, O X
in O X
HsTNRC6A O X
- O X
C O X
the O X
PAM2 O X
motif O X
is O X
essential O X
for O X
binding O X
to O X
both O X
Hs O X
and O X
DmPABPC1 O X
. O X

Accordingly O X
, O X
a O X
single O X
amino O X
acid O X
substitution O X
in O X
the O X
TNRC6A I-MISC 27327
- O X
C O X
PAM2 O X
motif O X
abolishes O X
the O X
interaction O X
with O X
PABPC1 I-MISC 37070
. O X

This O X
mutation O X
also O X
impairs O X
TNRC6s O X
silencing O X
activity O X
. O X

Our O X
findings O X
reveal O X
that O X
despite O X
species O X
- O X
specific O X
differences O X
in O X
the O X
relative O X
strength O X
of O X
the O X
PABPC1 I-MISC 37070
- O X
binding O X
sites O X
, O X
the O X
interaction O X
between O X
GW182 I-MISC 43808
proteins O X
and O X
PABPC1 I-MISC 37070
is O X
critical O X
for O X
miRNA O X
- O X
mediated O X
silencing O X
in O X
animal O X
cells O X
. O X

###17213653	852290,856862

Peculiar O X
protein O X
- O X
protein O X
interactions O X
of O X
the O X
novel O X
endoplasmic O X
reticulum O X
membrane O X
protein O X
Rcr1 I-MISC 852290
and O X
ubiquitin O X
ligase O X
Rsp5 I-MISC 856862
. O X

Overproduction O X
of O X
the O X
ER O X
membrane O X
protein O X
Rcr1 I-MISC 852290
makes O X
Saccharomyces O X
cerevisiae O X
resistant O X
to O X
Congo O X
red O X
by O X
reducing O X
the O X
chitin O X
content O X
through O X
a O X
unknown O X
mechanism O X
. O X

By O X
both O X
co O X
- O X
immunoprecipitation O X
and O X
yeast O X
two O X
- O X
hybrid O X
experiments O X
, O X
specific O X
interaction O X
between O X
Rcr1 I-MISC 852290
and O X
the O X
ubiquitin I-MISC 856862
ligase I-MISC 856862
Rsp5 I-MISC 856862
was O X
found O X
. O X

This O X
binding O X
was O X
largely O X
mediated O X
by O X
a O X
singular O X
VPEY O X
sequence O X
in O X
Rcr1 I-MISC 852290
in O X
addition O X
to O X
PPSY O X
, O X
the O X
consensus O X
ligand O X
motif O X
of O X
the O X
WW O X
domains O X
. O X

Mutant O X
analysis O X
indicated O X
that O X
Rsp5 I-MISC 856862
and O X
other O X
Rcr1 I-MISC 852290
- O X
interacting O X
proteins O X
discovered O X
in O X
the O X
current O X
screen O X
were O X
not O X
engaged O X
in O X
Congo O X
red O X
resistance O X
. O X

###16858409	22031,228607

Regulation O X
of O X
antiviral O X
responses O X
by O X
a O X
direct O X
and O X
specific O X
interaction O X
between O X
TRAF3 I-MISC 22031
and O X
Cardif I-MISC 228607
. O X

Upon O X
recognition O X
of O X
viral O X
infection O X
, O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
and O X
Helicard O X
recruit O X
a O X
newly O X
identified O X
adapter O X
termed O X
Cardif I-MISC 228607
, O X
which O X
induces O X
type O X
I O X
interferon O X
( O X
IFN O X
)- O X
mediated O X
antiviral O X
responses O X
through O X
an O X
unknown O X
mechanism O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
TRAF3 I-MISC 22031
, O X
like O X
Cardif I-MISC 228607
, O X
is O X
required O X
for O X
type O X
I O X
interferon O X
production O X
in O X
response O X
to O X
intracellular O X
double O X
- O X
stranded O X
RNA O X
. O X

Cardif I-MISC 228607
- O X
mediated O X
IFNalpha O X
induction O X
occurs O X
through O X
a O X
direct O X
interaction O X
between O X
the O X
TRAF O X
domain O X
of O X
TRAF3 I-MISC 22031
and O X
a O X
TRAF O X
- O X
interaction O X
motif O X
( O X
TIM O X
) O X
within O X
Cardif I-MISC 228607
. O X

Interestingly O X
, O X
while O X
the O X
entire O X
N O X
- O X
terminus O X
of O X
TRAF3 I-MISC 22031
was O X
functionally O X
interchangeable O X
with O X
that O X
of O X
TRAF5 I-MISC 7188
, O X
the O X
TRAF O X
domain O X
of O X
TRAF3 I-MISC 22031
was O X
not O X
. O X

Our O X
data O X
suggest O X
that O X
this O X
distinction O X
is O X
due O X
to O X
an O X
inability O X
of O X
the O X
TRAF O X
domain O X
of O X
TRAF5 I-MISC 7188
to O X
bind O X
the O X
TIM O X
of O X
Cardif I-MISC 228607
. O X

Finally O X
, O X
we O X
show O X
that O X
preventing O X
association O X
of O X
TRAF3 I-MISC 22031
with O X
this O X
TIM O X
by O X
mutating O X
two O X
critical O X
amino O X
acids O X
in O X
the O X
TRAF O X
domain O X
also O X
abolishes O X
TRAF3 I-MISC 22031
- O X
dependent O X
IFN O X
production O X
following O X
viral O X
infection O X
. O X

Thus O X
, O X
our O X
findings O X
suggest O X
that O X
the O X
direct O X
and O X
specific O X
interaction O X
between O X
the O X
TRAF O X
domain O X
of O X
TRAF3 I-MISC 22031
and O X
the O X
TIM O X
of O X
Cardif I-MISC 228607
is O X
required O X
for O X
optimal O X
Cardif I-MISC 228607
- O X
mediated O X
antiviral O X
responses O X
. O X

###16762039	13016,3090	13017,3090

A O X
L225A O X
substitution O X
in O X
the O X
human O X
tumour O X
suppressor O X
HIC1 I-MISC 3090
abolishes O X
its O X
interaction O X
with O X
the O X
corepressor O X
CtBP O X
. O X

HIC1 I-MISC 3090
( O X
hypermethylated O X
in O X
cancer O X
) O X
is O X
a O X
tumour O X
suppressor O X
gene O X
located O X
in O X
17p13 O X
. O X
3 O X
, O X
a O X
region O X
frequently O X
hypermethylated O X
or O X
deleted O X
in O X
many O X
types O X
of O X
prevalent O X
human O X
tumour O X
. O X

HIC1 I-MISC 3090
is O X
also O X
a O X
candidate O X
for O X
a O X
contiguous O X
- O X
gene O X
syndrome O X
, O X
the O X
Miller O X
- O X
Dieker O X
syndrome O X
, O X
a O X
severe O X
form O X
of O X
lissencephaly O X
accompanied O X
by O X
developmental O X
anomalies O X
. O X

HIC1 I-MISC 3090
encodes O X
a O X
BTB O X
/ O X
POZ O X
- O X
zinc O X
finger O X
transcriptional O X
repressor O X
. O X

HIC1 I-MISC 3090
represses O X
transcription O X
via O X
two O X
autonomous O X
repression O X
domains O X
, O X
an O X
N O X
- O X
terminal O X
BTB O X
/ O X
POZ O X
and O X
a O X
central O X
region O X
, O X
by O X
trichostatin O X
A O X
- O X
insensitive O X
and O X
trichostatin O X
A O X
- O X
sensitive O X
mechanisms O X
, O X
respectively O X
. O X

The O X
HIC1 I-MISC 3090
central O X
region O X
recruits O X
the O X
corepressor O X
CtBP O X
( O X
C O X
- O X
terminal O X
binding O X
protein O X
) O X
through O X
a O X
conserved O X
GLDLSKK O X
motif O X
, O X
a O X
variant O X
of O X
the O X
consensus O X
C O X
- O X
terminal O X
binding O X
protein O X
interaction O X
domain O X
PxDLSxK O X
/ O X
R O X
. O X

Here O X
, O X
we O X
show O X
that O X
HIC1 I-MISC 3090
interacts O X
with O X
both O X
CtBP1 I-MISC 13016
and O X
CtBP2 I-MISC 13017
and O X
that O X
this O X
interaction O X
is O X
stimulated O X
by O X
agents O X
increasing O X
NADH O X
levels O X
. O X

Furthermore O X
, O X
point O X
mutation O X
of O X
two O X
CtBP2 I-MISC 13017
residues O X
forming O X
part O X
of O X
the O X
structure O X
of O X
the O X
recognition O X
cleft O X
for O X
a O X
PxDLS O X
motif O X
also O X
ablates O X
the O X
interaction O X
with O X
a O X
GxDLS O X
motif O X
. O X

Conversely O X
, O X
in O X
perfect O X
agreement O X
with O X
the O X
structural O X
data O X
and O X
the O X
universal O X
conservation O X
of O X
this O X
residue O X
in O X
all O X
C O X
- O X
terminal O X
binding O X
protein O X
- O X
interacting O X
motifs O X
, O X
mutation O X
of O X
the O X
central O X
leucine O X
residue O X
( O X
leucine O X
225 O X
in O X
HIC1 I-MISC 3090
) O X
abolishes O X
the O X
interaction O X
between O X
HIC1 I-MISC 3090
and O X
CtBP1 I-MISC 13016
or O X
CtBP2 I-MISC 13017
. O X

As O X
expected O X
from O X
the O X
corepressor O X
activity O X
of O X
CtBP O X
, O X
this O X
mutation O X
also O X
impairs O X
the O X
HIC1 I-MISC 3090
- O X
mediated O X
transcriptional O X
repression O X
. O X

These O X
results O X
thus O X
demonstrate O X
a O X
strong O X
conservation O X
in O X
the O X
binding O X
of O X
C O X
- O X
terminal O X
binding O X
protein O X
- O X
interacting O X
domains O X
despite O X
great O X
variability O X
in O X
their O X
amino O X
acid O X
sequences O X
. O X

Finally O X
, O X
this O X
L225A O X
point O X
mutation O X
could O X
also O X
provide O X
useful O X
knock O X
- O X
in O X
animal O X
models O X
to O X
study O X
the O X
role O X
of O X
the O X
HIC1 I-MISC 3090
- O X
CtBP O X
interaction O X
in O X
tumorigenesis O X
and O X
in O X
development O X
. O X

###11163258	7283,67203

LIS1 I-MISC 18472
regulates O X
CNS O X
lamination O X
by O X
interacting O X
with O X
mNudE I-MISC 67203
, O X
a O X
central O X
component O X
of O X
the O X
centrosome O X
. O X

LIS1 I-MISC 18472
, I-MISC 18472
a I-MISC 18472
microtubule I-MISC 18472
- I-MISC 18472
associated I-MISC 18472
protein I-MISC 18472
, O X
is O X
required O X
for O X
neuronal O X
migration O X
, O X
but O X
the O X
precise O X
mechanism O X
of O X
LIS1 I-MISC 18472
function O X
is O X
unknown O X
. O X

We O X
identified O X
a O X
LIS1 I-MISC 18472
interacting O X
protein O X
encoded O X
by O X
a O X
mouse O X
homolog O X
of O X
NUDE I-MISC 67203
, O X
a O X
nuclear O X
distribution O X
gene O X
in O X
A O X
. O X
nidulans O X
and O X
a O X
multicopy O X
suppressor O X
of O X
the O X
LIS1 I-MISC 18472
homolog O X
, O X
NUDF O X
. O X

mNudE I-MISC 67203
is O X
located O X
in O X
the O X
centrosome O X
or O X
microtubule O X
organizing O X
center O X
( O X
MTOC O X
), O X
and O X
interacts O X
with O X
six O X
different O X
centrosomal O X
proteins O X
. O X

Overexpression O X
of O X
mNudE I-MISC 67203
dissociates O X
gamma I-MISC 7283
- I-MISC 7283
tubulin I-MISC 7283
from O X
the O X
centrosome O X
and O X
disrupts O X
microtubule O X
organization O X
. O X

Missense O X
mutations O X
that O X
disrupt O X
LIS1 I-MISC 18472
function O X
block O X
LIS1 I-MISC 18472
- O X
mNudE I-MISC 67203
binding O X
. O X

Moreover O X
, O X
misexpression O X
of O X
the O X
LIS1 I-MISC 399199
binding O X
domain O X
of O X
mNudE I-MISC 67203
in O X
Xenopus O X
embryos O X
disrupts O X
the O X
architecture O X
and O X
lamination O X
of O X
the O X
CNS O X
. O X

Thus O X
, O X
LIS1 I-MISC 18472
- O X
mNudE I-MISC 67203
interactions O X
may O X
regulate O X
neuronal O X
migration O X
through O X
dynamic O X
reorganization O X
of O X
the O X
MTOC O X
. O X

###17881003	845,845

Characterization O X
of O X
human O X
cardiac O X
calsequestrin O X
and O X
its O X
deleterious O X
mutants O X
. O X

Mutations O X
of O X
conserved O X
residues O X
of O X
human O X
cardiac O X
calsequestrin O X
( O X
hCSQ2 I-MISC 845
), O X
a O X
high O X
- O X
capacity O X
, O X
low O X
- O X
affinity O X
Ca2 O X
+- O X
binding O X
protein O X
in O X
the O X
sarcoplasmic O X
reticulum O X
, O X
have O X
been O X
associated O X
with O X
catecholamine O X
- O X
induced O X
polymorphic O X
ventricular O X
tachycardia O X
( O X
CPVT O X
). O X

In O X
order O X
to O X
understand O X
the O X
molecular O X
mechanism O X
and O X
pathophysiological O X
link O X
between O X
these O X
CPVT O X
- O X
related O X
missense O X
mutations O X
of O X
hCSQ2 I-MISC 845
and O X
the O X
resulting O X
arrhythmias O X
, O X
we O X
generated O X
three O X
CPVT O X
- O X
causing O X
mutants O X
of O X
hCSQ2 I-MISC 845
( O X
R33Q O X
, O X
L167H O X
, O X
and O X
D307H O X
) O X
and O X
two O X
non O X
- O X
pathological O X
mutants O X
( O X
T66A O X
and O X
V76M O X
) O X
and O X
investigated O X
the O X
effect O X
of O X
these O X
mutations O X
. O X

In O X
addition O X
, O X
we O X
determined O X
the O X
crystal O X
structure O X
of O X
the O X
corresponding O X
wild O X
- O X
type O X
hCSQ2 I-MISC 845
to O X
gain O X
insight O X
into O X
the O X
structural O X
effects O X
of O X
those O X
mutations O X
. O X

Our O X
data O X
show O X
clearly O X
that O X
all O X
three O X
CPVT O X
- O X
related O X
mutations O X
lead O X
to O X
significant O X
reduction O X
in O X
Ca2 O X
+- O X
binding O X
capacity O X
in O X
spite O X
of O X
the O X
similarity O X
of O X
their O X
secondary O X
structures O X
to O X
that O X
of O X
the O X
wild O X
- O X
type O X
hCSQ2 I-MISC 845
. O X

Light O X
- O X
scattering O X
experiments O X
indicate O X
that O X
the O X
Ca2 O X
+- O X
dependent O X
monomer O X
- O X
polymer O X
transitions O X
of O X
the O X
mutants O X
are O X
quite O X
different O X
, O X
confirming O X
that O X
the O X
linear O X
polymerization O X
behavior O X
of O X
CSQ O X
is O X
linked O X
directly O X
to O X
its O X
high O X
- O X
capacity O X
Ca2 O X
+ O X
binding O X
. O X

R33Q O X
and O X
D307H O X
mutations O X
result O X
in O X
a O X
monomer O X
that O X
appears O X
to O X
be O X
unable O X
to O X
form O X
a O X
properly O X
oriented O X
dimer O X
. O X

On O X
the O X
other O X
hand O X
, O X
the O X
L167H O X
mutant O X
has O X
a O X
disrupted O X
hydrophobic O X
core O X
in O X
domain O X
II O X
, O X
resulting O X
in O X
high O X
molecular O X
aggregates O X
, O X
which O X
cannot O X
respond O X
to O X
Ca2 O X
+. O X

Although O X
one O X
of O X
the O X
non O X
- O X
pathological O X
mutants O X
, O X
T66A O X
, O X
shares O X
characteristics O X
with O X
the O X
wild O X
- O X
type O X
, O X
the O X
other O X
null O X
mutant O X
, O X
V76M O X
, O X
shows O X
significantly O X
altered O X
Ca2 O X
+- O X
binding O X
and O X
polymerization O X
behaviors O X
, O X
calling O X
for O X
careful O X
reconsideration O X
of O X
its O X
status O X
. O X

###16449236	2296,5308

Functional O X
interactions O X
between O X
FOXC1 I-MISC 2296
and O X
PITX2 I-MISC 5308
underlie O X
the O X
sensitivity O X
to O X
FOXC1 I-MISC 2296
gene O X
dose O X
in O X
Axenfeld O X
- O X
Rieger O X
syndrome O X
and O X
anterior O X
segment O X
dysgenesis O X
. O X

Axenfeld O X
- O X
Rieger O X
ocular O X
dysgenesis O X
is O X
associated O X
with O X
mutations O X
of O X
the O X
human O X
PITX2 I-MISC 5308
and O X
FOXC1 I-MISC 2296
genes O X
, O X
which O X
encode O X
transcription O X
factors O X
of O X
the O X
homeodomain O X
and O X
forkhead O X
types O X
, O X
respectively O X
. O X

We O X
have O X
identified O X
a O X
functional O X
link O X
between O X
FOXC1 I-MISC 2296
and O X
PITX2 I-MISC 5308
which O X
we O X
propose O X
underpins O X
the O X
similar O X
Axenfeld O X
- O X
Rieger O X
phenotype O X
caused O X
by O X
mutations O X
of O X
these O X
genes O X
. O X

FOXC1 I-MISC 2296
and O X
PITX2A O X
physically O X
interact O X
, O X
and O X
this O X
interaction O X
requires O X
crucial O X
functional O X
domains O X
on O X
both O X
proteins O X
: O X
the O X
C O X
- O X
terminal O X
activation O X
domain O X
of O X
FOXC1 I-MISC 2296
and O X
the O X
homeodomain O X
of O X
PITX2 I-MISC 5308
. O X

Immunofluorescence O X
further O X
shows O X
PITX2A O X
and O X
FOXC1 I-MISC 2296
to O X
be O X
colocalized O X
within O X
a O X
common O X
nuclear O X
subcompartment O X
. O X

Furthermore O X
, O X
PITX2A O X
can O X
function O X
as O X
a O X
negative O X
regulator O X
of O X
FOXC1 I-MISC 2296
transactivity O X
. O X

This O X
work O X
ties O X
both O X
proteins O X
into O X
a O X
common O X
pathway O X
and O X
offers O X
an O X
explanation O X
of O X
why O X
increased O X
FOXC1 I-MISC 2296
gene O X
dosage O X
produces O X
a O X
phenotype O X
resembling O X
that O X
of O X
PITX2 I-MISC 5308
deletions O X
and O X
mutations O X
. O X

Ocular O X
phenotypes O X
arise O X
despite O X
the O X
deregulated O X
expression O X
of O X
FOXC1 I-MISC 2296
- O X
target O X
genes O X
through O X
mutations O X
in O X
FOXC1 I-MISC 2296
or O X
PITX2 I-MISC 5308
. O X

Ultimately O X
, O X
PITX2 I-MISC 5308
loss O X
of O X
function O X
mutations O X
have O X
a O X
compound O X
effect O X
: O X
the O X
reduced O X
expression O X
of O X
PITX2 I-MISC 5308
- O X
target O X
genes O X
coupled O X
with O X
the O X
extensive O X
activation O X
of O X
FOXC1 I-MISC 2296
- O X
regulated O X
targets O X
. O X

Our O X
findings O X
indicate O X
that O X
the O X
functional O X
interaction O X
between O X
FOXC1 I-MISC 2296
and O X
PITX2A O X
underlies O X
the O X
sensitivity O X
to O X
FOXC1 I-MISC 2296
gene O X
dosage O X
in O X
Axenfeld O X
- O X
Rieger O X
syndrome O X
and O X
related O X
anterior O X
segment O X
dysgeneses O X
. O X

###21784946	944803,946033

Role O X
of O X
leucine O X
zipper O X
motifs O X
in O X
association O X
of O X
the O X
Escherichia O X
coli O X
cell O X
division O X
proteins O X
FtsL I-MISC 944803
and O X
FtsB I-MISC 946033
. O X

FtsL I-MISC 944803
and O X
FtsB I-MISC 946033
are O X
two O X
inner O X
- O X
membrane O X
proteins O X
that O X
are O X
essential O X
constituents O X
of O X
the O X
cell O X
division O X
apparatus O X
of O X
Escherichia O X
coli O X
. O X

In O X
this O X
study O X
, O X
we O X
demonstrate O X
that O X
the O X
leucine O X
zipper O X
- O X
like O X
( O X
LZ O X
) O X
motifs O X
, O X
located O X
in O X
the O X
periplasmic O X
domain O X
of O X
FtsL I-MISC 944803
and O X
FtsB I-MISC 946033
, O X
are O X
required O X
for O X
an O X
optimal O X
interaction O X
between O X
these O X
two O X
essential O X
proteins O X
. O X

###18768751	1793,9844

An O X
alpha O X
- O X
helical O X
extension O X
of O X
the O X
ELMO1 I-MISC 9844
pleckstrin O X
homology O X
domain O X
mediates O X
direct O X
interaction O X
to O X
DOCK180 I-MISC 1793
and O X
is O X
critical O X
in O X
Rac O X
signaling O X
. O X

The O X
mammalian O X
DOCK180 I-MISC 1793
protein O X
belongs O X
to O X
an O X
evolutionarily O X
conserved O X
protein O X
family O X
, O X
which O X
together O X
with O X
ELMO O X
proteins O X
, O X
is O X
essential O X
for O X
activation O X
of O X
Rac O X
GTPase O X
- O X
dependent O X
biological O X
processes O X
. O X

Here O X
, O X
we O X
have O X
analyzed O X
the O X
DOCK180 I-MISC 1793
- O X
ELMO1 I-MISC 9844
interaction O X
, O X
and O X
map O X
direct O X
interaction O X
interfaces O X
to O X
the O X
N O X
- O X
terminal O X
200 O X
amino O X
acids O X
of O X
DOCK180 I-MISC 1793
, O X
and O X
to O X
the O X
C O X
- O X
terminal O X
200 O X
amino O X
acids O X
of O X
ELMO1 I-MISC 9844
, O X
comprising O X
the O X
ELMO1 I-MISC 9844
PH O X
domain O X
. O X

Structural O X
and O X
biochemical O X
analysis O X
of O X
this O X
PH O X
domain O X
reveals O X
that O X
it O X
is O X
incapable O X
of O X
phospholipid O X
binding O X
, O X
but O X
instead O X
structurally O X
resembles O X
FERM O X
domains O X
. O X

Moreover O X
, O X
the O X
structure O X
revealed O X
an O X
N O X
- O X
terminal O X
amphiphatic O X
alpha O X
- O X
helix O X
, O X
and O X
point O X
mutants O X
of O X
invariant O X
hydrophobic O X
residues O X
in O X
this O X
helix O X
disrupt O X
ELMO1 I-MISC 9844
- O X
DOCK180 I-MISC 1793
complex O X
formation O X
. O X

A O X
secondary O X
interaction O X
between O X
ELMO1 I-MISC 9844
and O X
DOCK180 I-MISC 1793
is O X
conferred O X
by O X
the O X
DOCK180 I-MISC 1793
SH3 O X
domain O X
and O X
proline O X
- O X
rich O X
motifs O X
at O X
the O X
ELMO1 I-MISC 9844
C O X
- O X
terminus O X
. O X

Mutation O X
of O X
both O X
DOCK180 I-MISC 1793
- O X
interaction O X
sites O X
on O X
ELMO1 I-MISC 9844
is O X
required O X
to O X
disrupt O X
the O X
DOCK180 I-MISC 1793
- O X
ELMO1 I-MISC 9844
complex O X
. O X

Significantly O X
, O X
although O X
this O X
does O X
not O X
affect O X
DOCK180 I-MISC 1793
GEF O X
activity O X
toward O X
Rac O X
in O X
vivo O X
, O X
Rac O X
signaling O X
is O X
impaired O X
, O X
implying O X
additional O X
roles O X
for O X
ELMO O X
in O X
mediating O X
intracellular O X
Rac O X
signaling O X
. O X

###14504388	835809,833502

A O X
novel O X
domain O X
in O X
the O X
protein O X
kinase O X
SOS2 I-MISC 833502
mediates O X
interaction O X
with O X
the O X
protein I-MISC 835809
phosphatase I-MISC 835809
2C I-MISC 835809
ABI2 O X
. O X

SOS2 I-MISC 833502
( O X
salt I-MISC 833502
overly I-MISC 833502
sensitive I-MISC 833502
2 I-MISC 833502
) O X
is O X
a O X
serine O X
/ O X
threonine O X
protein O X
kinase O X
required O X
for O X
salt O X
tolerance O X
in O X
Arabidopsis O X
thaliana O X
. O X

In O X
this O X
study O X
, O X
we O X
identified O X
the O X
protein I-MISC 835809
phosphatase I-MISC 835809
2C I-MISC 835809
ABI2 O X
( O X
abscisic O X
acid O X
- O X
insensitive O X
2 O X
) O X
as O X
a O X
SOS2 I-MISC 833502
- O X
interacting O X
protein O X
. O X

Deletion O X
analysis O X
led O X
to O X
the O X
discovery O X
of O X
a O X
novel O X
protein O X
domain O X
of O X
37 O X
amino O X
acid O X
residues O X
, O X
designated O X
as O X
the O X
protein O X
phosphatase O X
interaction O X
( O X
PPI O X
) O X
motif O X
, O X
of O X
SOS2 I-MISC 833502
that O X
is O X
necessary O X
and O X
sufficient O X
for O X
interaction O X
with O X
ABI2 O X
. O X

The O X
PPI O X
motif O X
is O X
conserved O X
in O X
protein O X
kinases O X
of O X
the O X
SOS2 I-MISC 833502
family O X
( O X
i O X
. O X
e O X
., O X
protein O X
kinase O X
S O X
, O X
PKS O X
) O X
and O X
in O X
the O X
DNA O X
damage O X
repair O X
and O X
replication O X
block O X
checkpoint O X
kinase O X
, O X
Chk1 I-MISC 1111
, O X
from O X
various O X
organisms O X
including O X
humans O X
. O X

Mutations O X
in O X
the O X
conserved O X
amino O X
acid O X
residues O X
in O X
the O X
PPI O X
motif O X
abolish O X
the O X
interaction O X
of O X
SOS2 I-MISC 833502
with O X
ABI2 O X
. O X

We O X
also O X
identified O X
a O X
protein O X
kinase O X
interaction O X
domain O X
in O X
ABI2 O X
and O X
examined O X
the O X
interaction O X
specificity O X
between O X
PKS O X
and O X
the O X
ABI O X
phosphatases O X
. O X

We O X
found O X
that O X
some O X
PKSs O X
interact O X
strongly O X
with O X
ABI2 O X
whereas O X
others O X
interact O X
preferentially O X
with O X
ABI1 I-MISC 10006
. O X

The O X
interaction O X
between O X
SOS2 I-MISC 833502
and O X
ABI2 O X
was O X
disrupted O X
by O X
the O X
abi2 O X
- O X
1 O X
mutation O X
, O X
which O X
causes O X
increased O X
tolerance O X
to O X
salt O X
shock O X
and O X
abscisic O X
acid O X
insensitivity O X
in O X
plants O X
. O X

Our O X
results O X
establish O X
the O X
PPI O X
motif O X
and O X
the O X
protein O X
kinase O X
interaction O X
domain O X
as O X
novel O X
protein O X
interaction O X
domains O X
that O X
mediate O X
the O X
binding O X
between O X
the O X
SOS2 I-MISC 833502
family O X
of O X
protein O X
kinases O X
and O X
the O X
ABI1 I-MISC 10006
/ I-MISC 10006
2 I-MISC 10006
family O X
of O X
protein O X
phosphatases O X
. O X

###16002700	962,51744

Mutational O X
analysis O X
of O X
the O X
human O X
2B4 I-MISC 51744
( O X
CD244 I-MISC 51744
)/ O X
CD48 I-MISC 962
interaction O X
: O X
Lys68 O X
and O X
Glu70 O X
in O X
the O X
V O X
domain O X
of O X
2B4 I-MISC 51744
are O X
critical O X
for O X
CD48 I-MISC 962
binding O X
and O X
functional O X
activation O X
of O X
NK O X
cells O X
. O X

Interaction O X
between O X
receptors O X
and O X
ligands O X
plays O X
a O X
critical O X
role O X
in O X
the O X
generation O X
of O X
immune O X
responses O X
. O X

The O X
2B4 I-MISC 51744
( O X
CD244 I-MISC 51744
), O X
a O X
member O X
of O X
the O X
CD2 I-MISC 914
subset O X
of O X
the O X
Ig O X
superfamily O X
, O X
is O X
the O X
high O X
affinity O X
ligand O X
for O X
CD48 I-MISC 962
. O X

It O X
is O X
expressed O X
on O X
NK O X
cells O X
, O X
T O X
cells O X
, O X
monocytes O X
, O X
and O X
basophils O X
. O X

Recent O X
data O X
indicate O X
that O X
2B4 I-MISC 51744
/ O X
CD48 I-MISC 962
interactions O X
regulate O X
NK O X
and O X
T O X
lymphocyte O X
functions O X
. O X

In O X
human O X
NK O X
cells O X
, O X
2B4 I-MISC 51744
/ O X
CD48 I-MISC 962
interaction O X
induces O X
activation O X
signals O X
, O X
whereas O X
in O X
murine O X
NK O X
cells O X
it O X
sends O X
inhibitory O X
signals O X
. O X

To O X
determine O X
the O X
structural O X
basis O X
for O X
2B4 I-MISC 51744
/ O X
CD48 I-MISC 962
interaction O X
, O X
selected O X
amino O X
acid O X
residues O X
in O X
the O X
V O X
domain O X
of O X
the O X
human O X
2B4 I-MISC 51744
( O X
h2B4 I-MISC 51744
) O X
were O X
mutated O X
to O X
alanine O X
by O X
site O X
- O X
directed O X
mutagenesis O X
. O X

Following O X
transient O X
expression O X
of O X
these O X
mutants O X
in O X
B16F10 O X
melanoma O X
cells O X
, O X
their O X
interaction O X
with O X
soluble O X
CD48 I-MISC 12506
- O X
Fc O X
fusion O X
protein O X
was O X
assessed O X
by O X
flow O X
cytometry O X
. O X

We O X
identified O X
amino O X
acid O X
residues O X
in O X
the O X
extracellular O X
domain O X
of O X
h2B4 I-MISC 51744
that O X
are O X
involved O X
in O X
interacting O X
with O X
CD48 I-MISC 962
. O X

Binding O X
of O X
CD48 I-MISC 962
- O X
Fc O X
fusion O X
protein O X
to O X
RNK O X
- O X
16 O X
cells O X
stably O X
transfected O X
with O X
wild O X
- O X
type O X
and O X
a O X
double O X
- O X
mutant O X
Lys O X
( O X
68 O X
) O X
Ala O X
- O X
Glu O X
( O X
70 O X
) O X
Ala O X
h2B4 I-MISC 51744
further O X
demonstrated O X
that O X
Lys O X
( O X
68 O X
) O X
and O X
Glu O X
( O X
70 O X
) O X
in O X
the O X
V O X
domain O X
of O X
h2B4 I-MISC 51744
are O X
essential O X
for O X
2B4 I-MISC 51744
/ O X
CD48 I-MISC 962
interaction O X
. O X

Functional O X
analysis O X
indicated O X
that O X
Lys O X
( O X
68 O X
) O X
and O X
Glu O X
( O X
70 O X
) O X
in O X
the O X
extracellular O X
domain O X
of O X
h2B4 I-MISC 51744
play O X
a O X
key O X
role O X
in O X
the O X
activation O X
of O X
human O X
NK O X
cells O X
through O X
2B4 I-MISC 51744
/ O X
CD48 I-MISC 962
interaction O X
. O X

###16438971	840471,842081

A O X
novel O X
yeast O X
two O X
- O X
hybrid O X
approach O X
to O X
identify O X
CDPK O X
substrates O X
: O X
characterization O X
of O X
the O X
interaction O X
between O X
AtCPK11 I-MISC 840471
and O X
AtDi19 I-MISC 842081
, O X
a O X
nuclear O X
zinc O X
finger O X
protein O X
. O X

Calcium O X
- O X
dependent O X
protein O X
kinases O X
( O X
CDPKs O X
) O X
are O X
sensor O X
- O X
transducer O X
proteins O X
capable O X
of O X
decoding O X
calcium O X
signals O X
in O X
diverse O X
phosphorylation O X
- O X
dependent O X
calcium O X
signaling O X
networks O X
in O X
plants O X
and O X
some O X
protists O X
. O X

Using O X
a O X
novel O X
yeast O X
two O X
- O X
hybrid O X
( O X
YTH O X
) O X
approach O X
with O X
constitutively O X
active O X
and O X
/ O X
or O X
catalytically O X
inactive O X
forms O X
of O X
AtCPK11 I-MISC 840471
as O X
bait O X
, O X
we O X
identified O X
AtDi19 I-MISC 842081
as O X
an O X
AtCPK11 I-MISC 840471
- O X
interacting O X
protein O X
. O X

AtDi19 I-MISC 842081
is O X
a O X
member O X
of O X
a O X
small O X
family O X
of O X
stress O X
- O X
induced O X
genes O X
. O X

The O X
interaction O X
was O X
confirmed O X
using O X
pull O X
- O X
down O X
assays O X
with O X
in O X
vitro O X
translated O X
AtCPK11 I-MISC 840471
and O X
GST O X
- O X
AtDi19 I-MISC 842081
and O X
localization O X
studies O X
in O X
Arabidopsis O X
protoplasts O X
cotransfected O X
with O X
AtCPK11 I-MISC 840471
: O X
GFP O X
and O X
AtDi19 I-MISC 842081
: O X
DsRed2 O X
protein O X
fusions O X
. O X

We O X
further O X
showed O X
that O X
the O X
interaction O X
of O X
AtDi19 I-MISC 842081
is O X
specific O X
to O X
both O X
AtCPK4 I-MISC 826541
and O X
AtCPK11 I-MISC 840471
, O X
whereas O X
other O X
closely O X
related O X
CPKs O X
from O X
Arabidopsis O X
interacted O X
weakly O X
( O X
e O X
. O X
g O X
., O X
AtCPK12 I-MISC 832424
) O X
or O X
did O X
not O X
interact O X
( O X
e O X
. O X
g O X
., O X
AtCPK26 I-MISC 829980
, O X
AtCPK5 I-MISC 829685
and O X
AtCPK1 I-MISC 830366
) O X
with O X
AtDi19 I-MISC 842081
. O X

Deletion O X
analyses O X
showed O X
that O X
a O X
region O X
containing O X
two O X
predicted O X
nuclear O X
localization O X
signals O X
( O X
NLS O X
) O X
and O X
a O X
nuclear O X
export O X
signal O X
( O X
NES O X
) O X
of O X
AtDi19 I-MISC 842081
is O X
essential O X
for O X
interaction O X
with O X
AtCPK11 I-MISC 840471
. O X

We O X
further O X
demonstrated O X
that O X
AtDi19 I-MISC 842081
is O X
phosphorylated O X
by O X
AtCPK11 I-MISC 840471
in O X
a O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
manner O X
at O X
Thr105 O X
and O X
Ser107 O X
within O X
the O X
AtDi19 I-MISC 842081
bipartite O X
NLS O X
using O X
in O X
vitro O X
kinase O X
assays O X
. O X

Our O X
data O X
suggest O X
that O X
disruption O X
of O X
the O X
autoinhibitor O X
domain O X
leading O X
to O X
the O X
formation O X
of O X
a O X
constitutively O X
active O X
CDPK O X
may O X
stabilize O X
kinase O X
- O X
substrate O X
interactions O X
without O X
affecting O X
specificity O X
. O X

###20181956	6311,26986	57690,26986

Structural O X
basis O X
of O X
binding O X
of O X
P O X
- O X
body O X
- O X
associated O X
proteins O X
GW182 I-MISC 27327
and O X
ataxin I-MISC 6311
- I-MISC 6311
2 I-MISC 6311
by O X
the O X
Mlle O X
domain O X
of O X
poly I-MISC 26986
( I-MISC 26986
A I-MISC 26986
)- I-MISC 26986
binding I-MISC 26986
protein I-MISC 26986
. O X

Poly I-MISC 26986
( I-MISC 26986
A I-MISC 26986
)- I-MISC 26986
binding I-MISC 26986
protein I-MISC 26986
( O X
PABPC1 I-MISC 26986
) O X
is O X
involved O X
in O X
multiple O X
aspects O X
of O X
mRNA O X
processing O X
and O X
translation O X
. O X

It O X
is O X
a O X
component O X
of O X
RNA O X
stress O X
granules O X
and O X
binds O X
the O X
RNA O X
- O X
induced O X
silencing O X
complex O X
to O X
promote O X
degradation O X
of O X
silenced O X
mRNAs O X
. O X

Here O X
, O X
we O X
report O X
the O X
crystal O X
structures O X
of O X
the O X
C O X
- O X
terminal O X
Mlle O X
( O X
or O X
PABC O X
) O X
domain O X
in O X
complex O X
with O X
peptides O X
from O X
GW182 I-MISC 27327
( O X
TNRC6C I-MISC 57690
) O X
and O X
Ataxin I-MISC 6311
- I-MISC 6311
2 I-MISC 6311
. O X

The O X
structures O X
reveal O X
overlapping O X
binding O X
sites O X
but O X
with O X
unexpected O X
diversity O X
in O X
the O X
peptide O X
conformation O X
and O X
residues O X
involved O X
in O X
binding O X
. O X

The O X
mutagenesis O X
and O X
binding O X
studies O X
show O X
low O X
to O X
submicromolar O X
binding O X
affinity O X
with O X
overlapping O X
but O X
distinct O X
specificity O X
determinants O X
. O X

These O X
results O X
rationalize O X
the O X
role O X
of O X
the O X
Mlle O X
domain O X
of O X
PABPC1 I-MISC 26986
in O X
microRNA O X
- O X
mediated O X
mRNA O X
deadenylation O X
and O X
suggest O X
a O X
more O X
general O X
function O X
in O X
the O X
assembly O X
of O X
cytoplasmic O X
RNA O X
granules O X
. O X

###15205937	8048,88	8048,4892

Decreased O X
interactions O X
of O X
mutant O X
muscle I-MISC 8048
LIM I-MISC 8048
protein I-MISC 8048
( O X
MLP I-MISC 8048
) O X
with O X
N I-MISC 4892
- I-MISC 4892
RAP I-MISC 4892
and O X
alpha I-MISC 88
- I-MISC 88
actinin I-MISC 88
and O X
their O X
implication O X
for O X
hypertrophic O X
cardiomyopathy O X
. O X

Previous O X
work O X
has O X
shown O X
that O X
mutations O X
in O X
muscle I-MISC 8048
LIM I-MISC 8048
protein I-MISC 8048
( O X
MLP I-MISC 8048
) O X
can O X
cause O X
hypertrophic O X
cardiomyopathy O X
( O X
HCM O X
). O X

In O X
order O X
to O X
gain O X
an O X
insight O X
into O X
the O X
molecular O X
basis O X
of O X
the O X
disease O X
phenotype O X
, O X
we O X
analysed O X
the O X
binding O X
characteristics O X
of O X
wild O X
- O X
type O X
MLP I-MISC 8048
and O X
of O X
the O X
( O X
C58G O X
) O X
mutant O X
MLP I-MISC 8048
that O X
causes O X
hypertrophic O X
cardiomyopathy O X
. O X

We O X
show O X
that O X
MLP I-MISC 8048
can O X
form O X
a O X
ternary O X
complex O X
with O X
two O X
of O X
its O X
previously O X
documented O X
myofibrillar O X
ligand O X
proteins O X
, O X
N I-MISC 4892
- I-MISC 4892
RAP I-MISC 4892
and O X
alpha I-MISC 88
- I-MISC 88
actinin I-MISC 88
, O X
which O X
indicates O X
the O X
presence O X
of O X
distinct O X
, O X
non O X
- O X
overlapping O X
binding O X
sites O X
. O X

Our O X
data O X
also O X
show O X
that O X
, O X
in O X
comparison O X
to O X
wild O X
- O X
type O X
MLP I-MISC 8048
, O X
the O X
capacity O X
of O X
the O X
mutated O X
MLP I-MISC 8048
protein O X
to O X
bind O X
both O X
N I-MISC 4892
- I-MISC 4892
RAP I-MISC 4892
and O X
alpha I-MISC 88
- I-MISC 88
actinin I-MISC 88
is O X
significantly O X
decreased O X
. O X

In O X
addition O X
, O X
this O X
single O X
point O X
mutation O X
prevents O X
zinc O X
coordination O X
and O X
proper O X
folding O X
of O X
the O X
second O X
zinc O X
- O X
finger O X
in O X
the O X
first O X
LIM O X
domain O X
, O X
which O X
consequently O X
renders O X
the O X
protein O X
less O X
stable O X
and O X
more O X
susceptible O X
to O X
proteolysis O X
. O X

The O X
molecular O X
basis O X
for O X
HCM O X
- O X
causing O X
mutations O X
in O X
the O X
MLP I-MISC 8048
gene O X
might O X
therefore O X
be O X
an O X
alteration O X
in O X
the O X
equilibrium O X
of O X
interactions O X
of O X
the O X
ternary O X
complex O X
MLP I-MISC 8048
- O X
N I-MISC 4892
- I-MISC 4892
RAP I-MISC 4892
- O X
alpha I-MISC 88
- I-MISC 88
actinin I-MISC 88
. O X

This O X
assumption O X
is O X
supported O X
by O X
the O X
previous O X
observation O X
that O X
in O X
the O X
pathological O X
situation O X
accompanied O X
by O X
MLP I-MISC 8048
down O X
regulation O X
, O X
cardiomyocytes O X
try O X
to O X
compensate O X
for O X
the O X
decreased O X
stability O X
of O X
MLP I-MISC 8048
protein O X
by O X
increasing O X
the O X
expression O X
of O X
its O X
ligand O X
N I-MISC 4892
- I-MISC 4892
RAP I-MISC 4892
, O X
which O X
might O X
finally O X
result O X
in O X
the O X
development O X
of O X
myocyte O X
disarray O X
that O X
is O X
characteristic O X
of O X
this O X
disease O X
. O X

###12646039	841722,838073

Interactions O X
between O X
plant O X
RING O X
- O X
H2 O X
and O X
plant O X
- O X
specific O X
NAC O X
( O X
NAM O X
/ O X
ATAF1 I-MISC 839265
/ I-MISC 839265
2 I-MISC 839265
/ O X
CUC2 I-MISC 835478
) O X
proteins O X
: O X
RING O X
- O X
H2 O X
molecular O X
specificity O X
and O X
cellular O X
localization O X
. O X

Numerous O X
, O X
highly O X
conserved O X
RING O X
- O X
H2 O X
domains O X
are O X
found O X
in O X
the O X
model O X
plant O X
Arabidopsis O X
thaliana O X
( O X
thale O X
cress O X
). O X

To O X
characterize O X
potential O X
RING O X
- O X
H2 O X
protein O X
interactions O X
, O X
the O X
small O X
RING O X
- O X
H2 O X
protein O X
RHA2a I-MISC 838073
was O X
used O X
as O X
bait O X
in O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
. O X

RHA2a I-MISC 838073
interacted O X
with O X
one O X
of O X
the O X
plant O X
- O X
specific O X
NAC O X
[ O X
NAM O X
(' O X
no O X
apical O X
meristem O X
'), O X
ATAF1 I-MISC 839265
/ I-MISC 839265
2 I-MISC 839265
, O X
CUC2 I-MISC 835478
(' O X
cup O X
- O X
shaped O X
cotyledons O X
2 O X
')] O X
transcription O X
factors O X
, O X
here O X
named O X
ANAC I-MISC 841722
( O X
abscisic O X
acid O X
- O X
responsive O X
NAC O X
). O X

The O X
core O X
RING O X
- O X
H2 O X
domain O X
was O X
sufficient O X
for O X
the O X
interaction O X
. O X

The O X
ability O X
of O X
11 O X
structurally O X
diverse O X
RING O X
- O X
H2 O X
domains O X
to O X
interact O X
with O X
ANAC I-MISC 841722
was O X
then O X
examined O X
. O X

Robust O X
interaction O X
was O X
detected O X
for O X
three O X
of O X
the O X
domains O X
, O X
suggesting O X
multi O X
- O X
specificity O X
for O X
the O X
interaction O X
. O X

The O X
domains O X
that O X
interacted O X
with O X
ANAC I-MISC 841722
contain O X
a O X
glutamic O X
acid O X
residue O X
in O X
a O X
position O X
corresponding O X
to O X
a O X
proline O X
in O X
many O X
RING O X
- O X
H2 O X
domains O X
. O X

Conversion O X
of O X
this O X
glutamic O X
acid O X
residue O X
into O X
proline O X
in O X
RHA2a I-MISC 838073
decreased O X
its O X
ability O X
to O X
interact O X
with O X
ANAC I-MISC 841722
, O X
most O X
likely O X
by O X
changing O X
the O X
interaction O X
surface O X
. O X

This O X
suggested O X
that O X
a O X
short O X
, O X
divergent O X
region O X
in O X
RING O X
- O X
H2 O X
domains O X
modulate O X
interaction O X
specificity O X
. O X

ANAC I-MISC 841722
contains O X
a O X
degenerate O X
bipartite O X
nuclear O X
localization O X
signal O X
( O X
NLS O X
), O X
while O X
RHG1a O X
, O X
also O X
identified O X
as O X
an O X
ANAC I-MISC 841722
interaction O X
partner O X
, O X
contains O X
a O X
basic O X
NLS O X
. O X

Both O X
signals O X
localized O X
beta O X
- O X
glucuronidase O X
reporter O X
fusions O X
to O X
the O X
nucleus O X
. O X

N O X
- O X
terminally O X
truncated O X
RHA2a I-MISC 838073
also O X
directed O X
nuclear O X
localization O X
, O X
apparently O X
dependent O X
on O X
basic O X
amino O X
acids O X
in O X
the O X
RING O X
- O X
H2 O X
domain O X
. O X

Nuclear O X
co O X
- O X
localization O X
of O X
the O X
RING O X
- O X
H2 O X
proteins O X
and O X
ANAC I-MISC 841722
may O X
enable O X
their O X
interaction O X
in O X
vivo O X
to O X
regulate O X
the O X
activity O X
of O X
the O X
ANAC I-MISC 841722
transcription O X
factor O X
. O X

###21600204	945829,945098

Essential O X
residues O X
in O X
the O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
binding O X
site O X
of O X
Hha I-MISC 945098
, O X
a O X
co O X
- O X
regulator O X
of O X
horizontally O X
acquired O X
genes O X
in O X
Enterobacteria O X
. O X

Proteins O X
of O X
the O X
Hha I-MISC 945098
/ O X
YmoA O X
family O X
co O X
- O X
regulate O X
with O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
the O X
expression O X
of O X
horizontally O X
acquired O X
genes O X
in O X
Enterobacteria O X
. O X

Systematic O X
mutations O X
of O X
conserved O X
acidic O X
residues O X
in O X
Hha I-MISC 945098
have O X
allowed O X
the O X
identification O X
of O X
D48 O X
as O X
an O X
essential O X
residue O X
for O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
binding O X
and O X
the O X
involvement O X
of O X
E25 I-MISC 81618
. O X

Mutations O X
of O X
these O X
residues O X
resulted O X
in O X
deregulation O X
of O X
sensitive O X
genes O X
in O X
vivo O X
. O X

D48 O X
is O X
only O X
partially O X
solvent O X
accessible O X
, O X
yet O X
it O X
defines O X
the O X
functional O X
binding O X
interface O X
between O X
Hha I-MISC 945098
and O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
confirming O X
that O X
Hha I-MISC 945098
has O X
to O X
undergo O X
a O X
conformational O X
change O X
to O X
bind O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

Exposed O X
acidic O X
residues O X
, O X
such O X
as O X
E25 I-MISC 81618
, O X
may O X
electrostatically O X
facilitate O X
and O X
direct O X
the O X
approach O X
of O X
Hha I-MISC 945098
to O X
the O X
positively O X
charged O X
region O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
enabling O X
the O X
formation O X
of O X
the O X
final O X
complex O X
when O X
D48 O X
becomes O X
accessible O X
by O X
a O X
conformational O X
change O X
of O X
Hha I-MISC 945098
. O X

###9299557	22631,7128	22629,7128

A20 I-MISC 7128
inhibits O X
NF O X
- O X
kappaB O X
activation O X
independently O X
of O X
binding O X
to O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
. O X

The O X
A20 I-MISC 7128
protein O X
, O X
which O X
belongs O X
to O X
a O X
class O X
of O X
Cys2 O X
/ O X
Cys2 O X
zinc O X
finger O X
proteins O X
, O X
has O X
been O X
characterized O X
as O X
an O X
inhibitor O X
of O X
NF O X
- O X
kappaB O X
activation O X
. O X

In O X
order O X
to O X
clarify O X
its O X
molecular O X
mechanism O X
of O X
action O X
, O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
screen O X
for O X
interacting O X
proteins O X
. O X

We O X
report O X
that O X
different O X
isoforms O X
of O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
, O X
viz O X
. O X

eta I-MISC 22629
and O X
zeta I-MISC 22631
, O X
are O X
able O X
to O X
bind O X
A20 I-MISC 7128
, O X
involving O X
the O X
14 O X
- O X
3 O X
- O X
3 O X
- O X
binding O X
motif O X
RSKSDP O X
located O X
between O X
zinc O X
fingers O X
3 O X
and O X
4 O X
. O X

However O X
, O X
A20 I-MISC 7128
mutants O X
that O X
no O X
longer O X
associated O X
with O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
could O X
still O X
fully O X
inhibit O X
NF O X
- O X
kappaB O X
activation O X
induced O X
by O X
tumor O X
necrosis O X
factor O X
, O X
interleukin I-MISC 3553
- I-MISC 3553
1beta I-MISC 3553
or O X
phorbol O X
12 O X
- O X
myristate O X
13 O X
- O X
acetate O X
, O X
thus O X
excluding O X
a O X
crucial O X
role O X
for O X
14 O X
- O X
3 O X
- O X
3 O X
interaction O X
in O X
this O X
A20 I-MISC 7128
function O X
. O X

###11106648	12558,5770

Essential O X
tyrosine O X
residues O X
for O X
interaction O X
of O X
the O X
non O X
- O X
receptor O X
protein O X
- O X
tyrosine O X
phosphatase O X
PTP1B I-MISC 5770
with O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
. O X

Expression O X
of O X
a O X
dominant O X
- O X
negative O X
, O X
catalytically O X
inactive O X
form O X
of O X
the O X
nonreceptor O X
protein O X
- O X
tyrosine O X
phosphatase O X
PTP1B I-MISC 5770
in O X
L O X
- O X
cells O X
constitutively O X
expressing O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
results O X
in O X
loss O X
of O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
- O X
mediated O X
cell O X
- O X
cell O X
adhesion O X
. O X

PTP1B I-MISC 5770
interacts O X
directly O X
with O X
the O X
cytoplasmic O X
domain O X
of O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
, O X
and O X
this O X
association O X
is O X
regulated O X
by O X
phosphorylation O X
of O X
tyrosine O X
residues O X
in O X
PTP1B I-MISC 5770
. O X

The O X
following O X
three O X
tyrosine O X
residues O X
in O X
PTP1B I-MISC 5770
are O X
potential O X
substrates O X
for O X
tyrosine O X
kinases O X
: O X
Tyr O X
- O X
66 O X
, O X
Tyr O X
- O X
152 O X
, O X
and O X
Tyr O X
- O X
153 O X
. O X

To O X
determine O X
the O X
tyrosine O X
residue O X
( O X
s O X
) O X
that O X
are O X
crucial O X
for O X
the O X
cadherin O X
- O X
PTP1B I-MISC 5770
interaction O X
we O X
used O X
site O X
- O X
directed O X
mutagenesis O X
to O X
create O X
catalytically O X
inactive O X
PTP1B I-MISC 5770
constructs O X
bearing O X
additional O X
single O X
, O X
double O X
, O X
or O X
triple O X
mutations O X
in O X
which O X
tyrosine O X
was O X
substituted O X
by O X
phenylalanine O X
. O X

Mutation O X
Y152F O X
eliminates O X
binding O X
to O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
in O X
vitro O X
, O X
whereas O X
mutations O X
Y66F O X
and O X
Y153F O X
do O X
not O X
. O X

Overexpression O X
of O X
the O X
catalytically O X
inactive O X
PTP1B I-MISC 5770
with O X
the O X
Y152F O X
mutation O X
in O X
L O X
- O X
cells O X
constitutively O X
expressing O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
has O X
no O X
effect O X
on O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
- O X
mediated O X
adhesion O X
, O X
and O X
immunoprecipitation O X
reveals O X
that O X
the O X
mutant O X
Y152F O X
PTP1B I-MISC 5770
does O X
not O X
associate O X
with O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
in O X
situ O X
. O X

Furthermore O X
, O X
among O X
cells O X
overexpressing O X
the O X
Y152F O X
mutant O X
endogenous O X
PTP1B I-MISC 5770
associates O X
with O X
N I-MISC 12558
- I-MISC 12558
cadherin I-MISC 12558
and O X
is O X
tyrosine O X
- O X
phosphorylated O X
. O X

###10805725	1956,5287

Class O X
II O X
phosphoinositide I-MISC 5295
3 I-MISC 5295
- I-MISC 5295
kinases I-MISC 5295
are O X
downstream O X
targets O X
of O X
activated O X
polypeptide O X
growth O X
factor O X
receptors O X
. O X

The O X
class O X
II O X
phosphoinositide I-MISC 5295
3 I-MISC 5295
- I-MISC 5295
kinases I-MISC 5295
( O X
PI3K I-MISC 5295
) O X
PI3K I-MISC 5286
- I-MISC 5286
C2alpha I-MISC 5286
and O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
are O X
two O X
recently O X
identified O X
members O X
of O X
the O X
large O X
PI3K I-MISC 5295
family O X
. O X

Both O X
enzymes O X
are O X
characterized O X
by O X
the O X
presence O X
of O X
a O X
C2 O X
domain O X
at O X
the O X
carboxy O X
terminus O X
and O X
, O X
in O X
vitro O X
, O X
preferentially O X
utilize O X
phosphatidylinositol O X
and O X
phosphatidylinositol O X
4 O X
- O X
monophosphate O X
as O X
lipid O X
substrates O X
. O X

Little O X
is O X
understood O X
about O X
how O X
the O X
catalytic O X
activity O X
of O X
either O X
enzyme O X
is O X
regulated O X
in O X
vivo O X
. O X

In O X
this O X
study O X
, O X
we O X
demonstrate O X
that O X
PI3K I-MISC 5286
- I-MISC 5286
C2alpha I-MISC 5286
and O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
represent O X
two O X
downstream O X
targets O X
of O X
the O X
activated O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
( I-MISC 1956
EGF I-MISC 1956
) I-MISC 1956
receptor I-MISC 1956
in O X
human O X
carcinoma O X
- O X
derived O X
A431 O X
cells O X
. O X

Stimulation O X
of O X
quiescent O X
cultures O X
with O X
EGF O X
resulted O X
in O X
the O X
rapid O X
recruitment O X
of O X
both O X
enzymes O X
to O X
a O X
phosphotyrosine O X
signaling O X
complex O X
that O X
contained O X
the O X
EGF I-MISC 1956
receptor I-MISC 1956
and O X
Erb I-MISC 2064
- I-MISC 2064
B2 I-MISC 2064
. O X

Ligand O X
addition O X
also O X
induced O X
the O X
appearance O X
of O X
a O X
second O X
, O X
more O X
slowly O X
migrating O X
band O X
of O X
PI3K I-MISC 5286
- I-MISC 5286
C2alpha I-MISC 5286
and O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
immunoreactivity O X
on O X
sodium O X
dodecyl O X
sulfate O X
- O X
polyacrylamide O X
gel O X
electrophoresis O X
. O X

Since O X
both O X
PI3K I-MISC 5295
enzymes O X
can O X
utilize O X
Ca O X
( O X
2 O X
+) O X
as O X
an O X
essential O X
divalent O X
cation O X
in O X
lipid O X
kinase O X
assays O X
and O X
since O X
the O X
catalytic O X
activity O X
of O X
PI3K I-MISC 5286
- I-MISC 5286
C2alpha I-MISC 5286
is O X
refractory O X
to O X
the O X
inhibitor O X
wortmannin O X
, O X
these O X
properties O X
were O X
used O X
to O X
confirm O X
the O X
recruitment O X
of O X
each O X
PI3K I-MISC 5295
isozyme O X
to O X
the O X
activated O X
EGF I-MISC 1956
receptor I-MISC 1956
complex O X
. O X

To O X
examine O X
this O X
interaction O X
in O X
greater O X
detail O X
, O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
was O X
chosen O X
for O X
further O X
investigation O X
. O X

EGF O X
and O X
platelet O X
- O X
derived O X
growth O X
factor O X
also O X
stimulated O X
the O X
association O X
of O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
with O X
their O X
respective O X
receptors O X
in O X
other O X
cells O X
, O X
including O X
epithelial O X
cells O X
and O X
fibroblasts O X
. O X

The O X
use O X
of O X
EGF I-MISC 1956
receptor I-MISC 1956
mutants O X
and O X
phosphopeptides O X
derived O X
from O X
the O X
EGF I-MISC 1956
receptor I-MISC 1956
and O X
Erb I-MISC 2064
- I-MISC 2064
B2 I-MISC 2064
demonstrated O X
that O X
the O X
interaction O X
with O X
recombinant O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
occurs O X
through O X
E O X
( O X
p O X
) O X
YL O X
/ O X
I O X
phosphotyrosine O X
motifs O X
. O X

The O X
N O X
- O X
terminal O X
region O X
of O X
PI3K I-MISC 5287
- I-MISC 5287
C2beta I-MISC 5287
was O X
found O X
to O X
selectively O X
interact O X
with O X
the O X
EGF I-MISC 1956
receptor I-MISC 1956
in O X
vitro O X
, O X
suggesting O X
that O X
it O X
mediates O X
the O X
association O X
of O X
this O X
PI3K I-MISC 5295
with O X
the O X
receptor O X
. O X

However O X
, O X
the O X
mechanism O X
of O X
this O X
interaction O X
remains O X
unclear O X
. O X

We O X
conclude O X
that O X
class O X
II O X
PI3K I-MISC 5295
enzymes O X
may O X
contribute O X
to O X
the O X
generation O X
of O X
3 O X
' O X
phosphoinositides O X
following O X
the O X
activation O X
of O X
polypeptide O X
growth O X
factor O X
receptors O X
in O X
vivo O X
and O X
thus O X
mediate O X
certain O X
aspects O X
of O X
their O X
biological O X
activity O X
. O X

###10602480	64391,64513

Interaction O X
partners O X
of O X
Dlk I-MISC 64391
/ O X
ZIP I-MISC 64391
kinase I-MISC 64391
: O X
co O X
- O X
expression O X
of O X
Dlk I-MISC 64391
/ O X
ZIP I-MISC 64391
kinase I-MISC 64391
and O X
Par I-MISC 64513
- I-MISC 64513
4 I-MISC 64513
results O X
in O X
cytoplasmic O X
retention O X
and O X
apoptosis O X
. O X

Dlk I-MISC 64391
/ O X
ZIP I-MISC 64391
kinase I-MISC 64391
is O X
a O X
newly O X
discovered O X
serine O X
/ O X
threonine O X
kinase O X
which O X
, O X
due O X
to O X
its O X
homology O X
to O X
DAP O X
kinase O X
, O X
was O X
named O X
DAP I-MISC 64391
like I-MISC 64391
kinase I-MISC 64391
, O X
Dlk I-MISC 64391
. O X

This O X
kinase O X
is O X
tightly O X
associated O X
with O X
nuclear O X
structures O X
, O X
it O X
undergoes O X
extensive O X
autophosphorylation O X
and O X
phosphorylates O X
myosin O X
light O X
chain O X
and O X
core O X
histones O X
H3 O X
, O X
H2A O X
and O X
H4 O X
in O X
vitro O X
. O X

Moreover O X
, O X
it O X
possesses O X
a O X
leucine O X
zipper O X
which O X
mediates O X
interaction O X
with O X
transcription O X
factor O X
ATF I-MISC 468
- I-MISC 468
4 I-MISC 468
, O X
therefore O X
it O X
was O X
called O X
ZIP I-MISC 64391
kinase I-MISC 64391
. O X

We O X
employed O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
to O X
identify O X
interaction O X
partners O X
of O X
Dlk I-MISC 64391
that O X
might O X
serve O X
as O X
regulators O X
or O X
targets O X
. O X

Besides O X
ATF I-MISC 468
- I-MISC 468
4 I-MISC 468
and O X
others O X
we O X
found O X
Par I-MISC 64513
- I-MISC 64513
4 I-MISC 64513
, O X
a O X
modulator O X
of O X
transcription O X
factor O X
WT1 I-MISC 7490
and O X
mediator O X
of O X
apoptosis O X
. O X

Complex O X
formation O X
between O X
Dlk I-MISC 64391
and O X
Par I-MISC 64513
- I-MISC 64513
4 I-MISC 64513
was O X
confirmed O X
by O X
GST O X
pull O X
- O X
down O X
experiments O X
and O X
kinase O X
reactions O X
in O X
vitro O X
and O X
coexpression O X
experiments O X
in O X
vivo O X
. O X

The O X
interaction O X
domain O X
within O X
Dlk I-MISC 64391
was O X
mapped O X
to O X
an O X
arginine O X
- O X
rich O X
region O X
between O X
residues O X
338 O X
- O X
417 O X
, O X
rather O X
than O X
to O X
the O X
leucine O X
zipper O X
. O X

Strikingly O X
, O X
coexpression O X
of O X
Dlk I-MISC 64391
and O X
Par I-MISC 64513
- I-MISC 64513
4 I-MISC 64513
lead O X
to O X
relocation O X
of O X
Dlk I-MISC 64391
from O X
the O X
nucleus O X
to O X
the O X
cytoplasm O X
, O X
particularly O X
to O X
actin O X
filaments O X
. O X

These O X
interactions O X
provoked O X
a O X
dramatic O X
reorganization O X
of O X
the O X
cytoskeleton O X
and O X
morphological O X
symptoms O X
of O X
apoptosis O X
, O X
thus O X
suggesting O X
a O X
functional O X
relationship O X
between O X
Dlk I-MISC 64391
and O X
Par I-MISC 64513
- I-MISC 64513
4 I-MISC 64513
in O X
the O X
control O X
of O X
apoptosis O X
. O X

###19732766	3096,84916

Cirhin I-MISC 84916
up O X
- O X
regulates O X
a O X
canonical O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
element O X
through O X
strong O X
interaction O X
with O X
Cirip I-MISC 3096
/ O X
HIVEP1 I-MISC 3096
. O X

North O X
American O X
Indian O X
childhood O X
cirrhosis O X
( O X
NAIC O X
/ O X
CIRH1A I-MISC 84916
) O X
is O X
a O X
severe O X
autosomal O X
recessive O X
intrahepatic O X
cholestasis O X
. O X

All O X
NAIC O X
patients O X
have O X
a O X
homozygous O X
mutation O X
in O X
CIRH1A I-MISC 84916
that O X
changes O X
conserved O X
Arg565 O X
to O X
Trp O X
( O X
R565W O X
) O X
in O X
Cirhin I-MISC 84916
, O X
a O X
nucleolar O X
protein O X
of O X
unknown O X
function O X
. O X

Subcellular O X
localization O X
is O X
unaffected O X
by O X
the O X
mutation O X
. O X

Yeast O X
two O X
- O X
hybrid O X
screening O X
identified O X
Cirip I-MISC 3096
( O X
Cirhin I-MISC 3096
interaction I-MISC 3096
protein I-MISC 3096
) O X
and O X
found O X
that O X
interaction O X
between O X
Cirip I-MISC 3096
and O X
R565W O X
- O X
Cirhin I-MISC 84916
was O X
weakened O X
. O X

Co O X
- O X
immunoprecipitation O X
of O X
the O X
two O X
proteins O X
from O X
nuclear O X
extracts O X
of O X
HeLa O X
cells O X
strongly O X
supports O X
the O X
yeast O X
two O X
hybrid O X
results O X
. O X

Cirip I-MISC 3096
has O X
essentially O X
the O X
same O X
sequence O X
as O X
the O X
C O X
- O X
terminal O X
of O X
HIVEP1 I-MISC 3096
, O X
a O X
regulator O X
of O X
a O X
canonical O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
sequence O X
. O X

Since O X
Cirip I-MISC 3096
has O X
the O X
zinc O X
fingers O X
required O X
for O X
this O X
interaction O X
, O X
we O X
developed O X
an O X
in O X
vitro O X
assay O X
based O X
on O X
this O X
element O X
in O X
mammalian O X
cells O X
to O X
demonstrate O X
functional O X
Cirhin I-MISC 84916
- O X
Cirip I-MISC 3096
interaction O X
. O X

The O X
strong O X
positive O X
effect O X
of O X
Cirip I-MISC 3096
on O X
the O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
sequence O X
was O X
further O X
increased O X
by O X
both O X
Cirhin I-MISC 84916
and O X
R565W O X
- O X
Cirhin I-MISC 84916
. O X

Importantly O X
, O X
the O X
effect O X
of O X
R565W O X
- O X
Cirhin I-MISC 84916
was O X
weaker O X
than O X
that O X
of O X
the O X
wild O X
type O X
protein O X
. O X

We O X
observed O X
increased O X
levels O X
of O X
Cirhin I-MISC 84916
- O X
Cirip I-MISC 3096
complex O X
in O X
nuclear O X
extracts O X
in O X
the O X
presence O X
of O X
this O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
sequence O X
. O X

Our O X
hypothesis O X
is O X
that O X
Cirhin I-MISC 84916
is O X
a O X
transcriptional O X
regulatory O X
factor O X
of O X
this O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
sequence O X
and O X
could O X
be O X
a O X
participant O X
in O X
the O X
regulation O X
of O X
other O X
genes O X
with O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
responsive O X
elements O X
. O X

Since O X
the O X
activities O X
of O X
genes O X
regulated O X
through O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
responsive O X
elements O X
are O X
especially O X
important O X
during O X
development O X
, O X
this O X
interaction O X
may O X
be O X
a O X
key O X
to O X
explain O X
the O X
perinatal O X
appearance O X
of O X
NAIC O X
. O X

###10409688	854026,853071

The O X
Cap O X
- O X
binding O X
protein O X
eIF4E I-MISC 854026
promotes O X
folding O X
of O X
a O X
functional O X
domain O X
of O X
yeast O X
translation O X
initiation O X
factor O X
eIF4G1 I-MISC 853071
. O X

The O X
association O X
of O X
eucaryotic O X
translation O X
initiation O X
factor O X
eIF4G I-MISC 853071
with O X
the O X
cap O X
- O X
binding O X
protein O X
eIF4E I-MISC 854026
establishes O X
a O X
critical O X
link O X
between O X
the O X
mRNA O X
and O X
the O X
ribosome O X
during O X
translation O X
initiation O X
. O X

This O X
association O X
requires O X
a O X
conserved O X
seven O X
amino O X
acid O X
peptide O X
within O X
eIF4G I-MISC 853071
that O X
binds O X
to O X
eIF4E I-MISC 854026
. O X

Here O X
we O X
report O X
that O X
a O X
98 O X
- O X
amino O X
acid O X
fragment O X
of O X
S O X
. O X
cerevisiae O X
eIF4G1 I-MISC 853071
that O X
contains O X
this O X
eIF4E I-MISC 854026
binding O X
peptide O X
undergoes O X
an O X
unfolded O X
to O X
folded O X
transition O X
upon O X
binding O X
to O X
eIF4E I-MISC 854026
. O X

The O X
folding O X
of O X
the O X
eIF4G1 I-MISC 853071
domain O X
was O X
evidenced O X
by O X
the O X
eIF4E I-MISC 854026
- O X
dependent O X
changes O X
in O X
its O X
protease O X
sensitivity O X
and O X
( O X
1 O X
) O X
H O X
-( O X
15 O X
) O X
N O X
HSQC O X
NMR O X
spectrum O X
. O X

Analysis O X
of O X
a O X
series O X
of O X
charge O X
- O X
to O X
- O X
alanine O X
mutations O X
throughout O X
the O X
essential O X
55 O X
. O X
4 O X
- O X
kDa O X
core O X
of O X
yeast O X
eIF4G1 I-MISC 853071
also O X
revealed O X
substitutions O X
within O X
this O X
98 O X
- O X
amino O X
acid O X
region O X
that O X
led O X
to O X
reduced O X
eIF4E I-MISC 854026
binding O X
in O X
vivo O X
and O X
in O X
vitro O X
. O X

These O X
data O X
suggest O X
that O X
the O X
association O X
of O X
yeast O X
eIF4E I-MISC 854026
with O X
eIF4G1 I-MISC 853071
leads O X
to O X
the O X
formation O X
of O X
a O X
structured O X
domain O X
within O X
eIF4G1 I-MISC 853071
that O X
could O X
serve O X
as O X
a O X
specific O X
site O X
for O X
interactions O X
with O X
other O X
components O X
of O X
the O X
translational O X
apparatus O X
. O X

They O X
also O X
suggest O X
that O X
the O X
stability O X
of O X
the O X
native O X
eIF4E I-MISC 854026
- O X
eIF4G I-MISC 853071
complex O X
is O X
determined O X
by O X
amino O X
acid O X
residues O X
outside O X
of O X
the O X
conserved O X
seven O X
- O X
residue O X
consensus O X
sequence O X
. O X

###23511974	9662,55835

Human O X
microcephaly O X
protein O X
CEP135 I-MISC 9662
binds O X
to O X
hSAS I-MISC 163786
- I-MISC 163786
6 I-MISC 163786
and O X
CPAP I-MISC 55835
, O X
and O X
is O X
required O X
for O X
centriole O X
assembly O X
. O X

Centrioles O X
are O X
cylindrical O X
structures O X
that O X
are O X
usually O X
composed O X
of O X
nine O X
triplets O X
of O X
microtubules O X
( O X
MTs O X
) O X
organized O X
around O X
a O X
cartwheel O X
- O X
shaped O X
structure O X
. O X

Recent O X
studies O X
have O X
proposed O X
a O X
structural O X
model O X
of O X
the O X
SAS I-MISC 163786
- I-MISC 163786
6 I-MISC 163786
- O X
based O X
cartwheel O X
, O X
yet O X
we O X
do O X
not O X
know O X
the O X
molecular O X
detail O X
of O X
how O X
the O X
cartwheel O X
participates O X
in O X
centriolar O X
MT O X
assembly O X
. O X

In O X
this O X
study O X
, O X
we O X
demonstrate O X
that O X
the O X
human O X
microcephaly O X
protein O X
, O X
CEP135 I-MISC 9662
, O X
directly O X
interacts O X
with O X
hSAS I-MISC 163786
- I-MISC 163786
6 I-MISC 163786
via O X
its O X
carboxyl O X
- O X
terminus O X
and O X
with O X
MTs O X
via O X
its O X
amino O X
- O X
terminus O X
. O X

Unexpectedly O X
, O X
CEP135 I-MISC 9662
also O X
interacts O X
with O X
another O X
microcephaly O X
protein O X
CPAP I-MISC 55835
via O X
its O X
amino O X
terminal O X
domain O X
. O X

Depletion O X
of O X
CEP135 I-MISC 9662
not O X
only O X
perturbed O X
the O X
centriolar O X
localization O X
of O X
CPAP I-MISC 55835
, O X
but O X
also O X
blocked O X
CPAP I-MISC 55835
- O X
induced O X
centriole O X
elongation O X
. O X

Furthermore O X
, O X
CEP135 I-MISC 9662
depletion O X
led O X
to O X
abnormal O X
centriole O X
structures O X
with O X
altered O X
numbers O X
of O X
MT O X
triplets O X
and O X
shorter O X
centrioles O X
. O X

Overexpression O X
of O X
a O X
CEP135 I-MISC 9662
mutant O X
lacking O X
the O X
proper O X
interaction O X
with O X
hSAS I-MISC 163786
- I-MISC 163786
6 I-MISC 163786
had O X
a O X
dominant O X
- O X
negative O X
effect O X
on O X
centriole O X
assembly O X
. O X

We O X
propose O X
that O X
CEP135 I-MISC 9662
may O X
serve O X
as O X
a O X
linker O X
protein O X
that O X
directly O X
connects O X
the O X
central O X
hub O X
protein O X
, O X
hSAS I-MISC 163786
- I-MISC 163786
6 I-MISC 163786
, O X
to O X
the O X
outer O X
MTs O X
, O X
and O X
suggest O X
that O X
this O X
interaction O X
stabilizes O X
the O X
proper O X
cartwheel O X
structure O X
for O X
further O X
CPAP I-MISC 55835
- O X
mediated O X
centriole O X
elongation O X
. O X

###16126728	5515,3551

Positive O X
regulation O X
of O X
IkappaB O X
kinase O X
signaling O X
by O X
protein O X
serine O X
/ O X
threonine O X
phosphatase I-MISC 5515
2A I-MISC 5515
. O X

Transcription O X
factor O X
NF O X
- O X
kappaB O X
plays O X
a O X
key O X
regulatory O X
role O X
in O X
the O X
cellular O X
response O X
to O X
pro O X
- O X
inflammatory O X
cytokines O X
such O X
as O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
( O X
TNF I-MISC 7124
). O X

In O X
the O X
absence O X
of O X
TNF I-MISC 7124
, O X
NF O X
- O X
kappaB O X
is O X
sequestered O X
in O X
the O X
cytoplasm O X
by O X
inhibitory O X
IkappaB O X
proteins O X
. O X

Phosphorylation O X
of O X
IkappaBby O X
the O X
beta O X
- O X
catalytic O X
subunit O X
of O X
IKK O X
, O X
a O X
multicomponent O X
IkappaB O X
kinase O X
, O X
targets O X
the O X
inhibitor O X
for O X
proteolytic O X
destruction O X
and O X
facilitates O X
nuclear O X
translocation O X
of O X
NF O X
- O X
kappaB O X
. O X

This O X
pathway O X
is O X
initiated O X
by O X
TNF I-MISC 7124
- O X
dependent O X
phosphorylation O X
of O X
T O X
loop O X
serines O X
in O X
IKKbeta I-MISC 3551
, O X
which O X
greatly O X
stimulates O X
IkappaB O X
kinase O X
activity O X
. O X

Prior O X
in O X
vitro O X
mixing O X
experiments O X
indicate O X
that O X
protein O X
serine O X
/ O X
threonine O X
phosphatase I-MISC 5515
2A I-MISC 5515
( O X
PP2A I-MISC 5515
) O X
can O X
dephosphorylate O X
these O X
T O X
loop O X
serines O X
and O X
inactivate O X
IKK O X
, O X
suggesting O X
a O X
negative O X
regulatory O X
role O X
for O X
PP2A I-MISC 5515
in O X
IKK O X
signaling O X
. O X

Here O X
we O X
provided O X
several O X
in O X
vivo O X
lines O X
of O X
evidence O X
indicating O X
that O X
PP2A I-MISC 5515
plays O X
a O X
positive O X
rather O X
than O X
a O X
negative O X
role O X
in O X
the O X
regulation O X
of O X
IKK O X
. O X

First O X
, O X
TNF I-MISC 7124
- O X
induced O X
degradation O X
of O X
IkappaB O X
is O X
attenuated O X
in O X
cells O X
treated O X
with O X
okadaic O X
acid O X
or O X
fostriecin O X
, O X
two O X
potent O X
inhibitors O X
of O X
PP2A I-MISC 5515
. O X

Second O X
, O X
PP2A I-MISC 5515
forms O X
stable O X
complexes O X
with O X
IKK O X
in O X
untransfected O X
mammalian O X
cells O X
. O X

This O X
interaction O X
is O X
critically O X
dependent O X
on O X
amino O X
acid O X
residues O X
121 O X
- O X
179 O X
of O X
the O X
IKKgamma I-MISC 8517
regulatory O X
subunit O X
. O X

Third O X
, O X
deletion O X
of O X
the O X
PP2A I-MISC 5515
- O X
binding O X
site O X
in O X
IKKgamma I-MISC 8517
attenuates O X
T O X
loop O X
phosphorylation O X
and O X
catalytic O X
activation O X
of O X
IKKbeta I-MISC 3551
in O X
cells O X
treated O X
with O X
TNF I-MISC 7124
. O X

Taken O X
together O X
, O X
these O X
data O X
provide O X
strong O X
evidence O X
that O X
the O X
formation O X
of O X
IKK O X
. O X
PP2A I-MISC 5515
complexes O X
is O X
required O X
for O X
the O X
proper O X
induction O X
of O X
IkappaB O X
kinase O X
activity O X
in O X
vivo O X
. O X

###17986188	944778,944778

Dimerization O X
or O X
oligomerization O X
of O X
the O X
actin O X
- O X
like O X
FtsA I-MISC 944778
protein O X
enhances O X
the O X
integrity O X
of O X
the O X
cytokinetic O X
Z O X
ring O X
. O X

In O X
bacteria O X
, O X
the O X
actin O X
- O X
like O X
FtsA I-MISC 944778
protein O X
interacts O X
with O X
the O X
tubulin O X
- O X
like O X
FtsZ O X
protein O X
, O X
helping O X
to O X
assemble O X
the O X
cytokinetic O X
Z O X
ring O X
, O X
anchor O X
it O X
to O X
the O X
cytoplasmic O X
membrane O X
and O X
recruit O X
other O X
essential O X
divisome O X
proteins O X
. O X

FtsA I-MISC 944778
also O X
interacts O X
with O X
itself O X
, O X
but O X
it O X
is O X
not O X
clear O X
whether O X
this O X
self O X
- O X
interaction O X
is O X
required O X
for O X
its O X
full O X
functionality O X
. O X

Here O X
we O X
describe O X
new O X
dominant O X
negative O X
missense O X
mutations O X
in O X
Escherichia O X
coli O X
ftsA I-MISC 944778
that O X
specifically O X
inhibit O X
FtsA I-MISC 944778
homodimerization O X
and O X
simultaneously O X
cause O X
disruption O X
of O X
Z O X
rings O X
. O X

The O X
negative O X
effects O X
of O X
one O X
mutation O X
, O X
M71A O X
, O X
were O X
suppressed O X
by O X
altering O X
levels O X
of O X
certain O X
division O X
proteins O X
or O X
by O X
additional O X
mutations O X
in O X
ftsA I-MISC 944778
that O X
promote O X
increased O X
integrity O X
of O X
the O X
Z O X
ring O X
. O X

Remarkably O X
, O X
when O X
FtsA I-MISC 944778
, O X
FtsA I-MISC 944778
- O X
M71A O X
, O X
and O X
other O X
mutants O X
of O X
FtsA I-MISC 944778
that O X
compromise O X
self O X
- O X
interaction O X
were O X
connected O X
in O X
a O X
tandem O X
repeat O X
, O X
they O X
were O X
at O X
least O X
partially O X
functional O X
and O X
suppressed O X
defects O X
of O X
an O X
ftsZ84 O X
( O X
ts O X
) O X
mutation O X
. O X

This O X
gain O X
of O X
function O X
by O X
FtsA I-MISC 944778
tandems O X
further O X
suggested O X
that O X
FtsA I-MISC 944778
monomers O X
cause O X
deleterious O X
interactions O X
with O X
FtsZ O X
and O X
that O X
increased O X
dimerization O X
or O X
oligomerization O X
of O X
FtsA I-MISC 944778
enhances O X
its O X
ability O X
to O X
promote O X
Z O X
- O X
ring O X
integrity O X
. O X

Therefore O X
, O X
we O X
propose O X
that O X
FtsZ O X
assembly O X
is O X
regulated O X
by O X
the O X
extent O X
of O X
FtsA I-MISC 944778
oligomerization O X
. O X

###19197237	5824,5195	5830,5195

Structural O X
basis O X
for O X
competitive O X
interactions O X
of O X
Pex14 I-MISC 5195
with O X
the O X
import O X
receptors O X
Pex5 I-MISC 5830
and O X
Pex19 I-MISC 5824
. O X

Protein O X
import O X
into O X
peroxisomes O X
depends O X
on O X
a O X
complex O X
and O X
dynamic O X
network O X
of O X
protein O X
- O X
protein O X
interactions O X
. O X

Pex14 I-MISC 5195
is O X
a O X
central O X
component O X
of O X
the O X
peroxisomal O X
import O X
machinery O X
and O X
binds O X
the O X
soluble O X
receptors O X
Pex5 I-MISC 5830
and O X
Pex19 I-MISC 5824
, O X
which O X
have O X
important O X
function O X
in O X
the O X
assembly O X
of O X
peroxisome O X
matrix O X
and O X
membrane O X
, O X
respectively O X
. O X

We O X
show O X
that O X
the O X
N O X
- O X
terminal O X
domain O X
of O X
Pex14 I-MISC 5195
, O X
Pex14 I-MISC 5195
( O X
N O X
), O X
adopts O X
a O X
three O X
- O X
helical O X
fold O X
. O X

Pex5 I-MISC 5830
and O X
Pex19 I-MISC 5824
ligand O X
helices O X
bind O X
competitively O X
to O X
the O X
same O X
surface O X
in O X
Pex14 I-MISC 5195
( O X
N O X
) O X
albeit O X
with O X
opposite O X
directionality O X
. O X

The O X
molecular O X
recognition O X
involves O X
conserved O X
aromatic O X
side O X
chains O X
in O X
the O X
Pex5 I-MISC 5830
WxxxF O X
/ O X
Y O X
motif O X
and O X
a O X
newly O X
identified O X
F O X
/ O X
YFxxxF O X
sequence O X
in O X
Pex19 I-MISC 5824
. O X

The O X
Pex14 I-MISC 5195
- O X
Pex5 I-MISC 5830
complex O X
structure O X
reveals O X
molecular O X
details O X
for O X
a O X
critical O X
interaction O X
in O X
docking O X
Pex5 I-MISC 5830
to O X
the O X
peroxisomal O X
membrane O X
. O X

We O X
show O X
that O X
mutations O X
of O X
Pex14 I-MISC 5195
residues O X
located O X
in O X
the O X
Pex5 I-MISC 5830
/ O X
Pex19 I-MISC 5824
binding O X
region O X
disrupt O X
Pex5 I-MISC 5830
and O X
/ O X
or O X
Pex19 I-MISC 5824
binding O X
in O X
vitro O X
. O X

The O X
corresponding O X
full O X
- O X
length O X
Pex14 I-MISC 5195
variants O X
are O X
impaired O X
in O X
peroxisomal O X
membrane O X
localisation O X
in O X
vivo O X
, O X
showing O X
that O X
the O X
molecular O X
interactions O X
mediated O X
by O X
the O X
N O X
- O X
terminal O X
domain O X
modulate O X
peroxisomal O X
targeting O X
of O X
Pex14 I-MISC 5195
. O X

###20693326	947921,947921

Conserved O X
motifs O X
involved O X
in O X
ATP O X
hydrolysis O X
by O X
MalT I-MISC 947921
, O X
a O X
signal O X
transduction O X
ATPase O X
with O X
numerous O X
domains O X
from O X
Escherichia O X
coli O X
. O X

The O X
signal O X
transduction O X
ATPases O X
with O X
numerous O X
domains O X
( O X
STAND O X
) O X
are O X
sophisticated O X
signaling O X
proteins O X
that O X
are O X
related O X
to O X
AAA O X
+ O X
proteins O X
and O X
control O X
various O X
biological O X
processes O X
, O X
including O X
apoptosis O X
, O X
gene O X
expression O X
, O X
and O X
innate O X
immunity O X
. O X

They O X
function O X
as O X
tightly O X
regulated O X
switches O X
, O X
with O X
the O X
off O X
and O X
on O X
positions O X
corresponding O X
to O X
an O X
ADP O X
- O X
bound O X
, O X
monomeric O X
form O X
and O X
an O X
ATP O X
- O X
bound O X
, O X
multimeric O X
form O X
, O X
respectively O X
. O X

Protein O X
activation O X
is O X
triggered O X
by O X
inducer O X
binding O X
to O X
the O X
sensor O X
domain O X
. O X

ATP O X
hydrolysis O X
by O X
the O X
nucleotide O X
- O X
binding O X
oligomerization O X
domain O X
( O X
NOD O X
) O X
ensures O X
the O X
generation O X
of O X
the O X
ADP O X
- O X
bound O X
form O X
. O X

Here O X
, O X
we O X
use O X
MalT I-MISC 947921
, O X
an O X
Escherichia O X
coli O X
transcription O X
activator O X
, O X
as O X
a O X
model O X
system O X
to O X
identify O X
STAND O X
conserved O X
motifs O X
involved O X
in O X
ATP O X
hydrolysis O X
besides O X
the O X
catalytic O X
acidic O X
residue O X
. O X

Alanine O X
substitution O X
of O X
the O X
conserved O X
polar O X
residue O X
( O X
H131 O X
) O X
that O X
is O X
located O X
two O X
residues O X
downstream O X
from O X
the O X
catalytic O X
residue O X
( O X
D129 O X
) O X
blocks O X
ATP O X
hydrolysis O X
and O X
traps O X
MalT I-MISC 947921
in O X
an O X
active O X
, O X
ATP O X
- O X
bound O X
, O X
multimeric O X
form O X
. O X

This O X
polar O X
residue O X
is O X
also O X
conserved O X
in O X
AAA O X
+. O X

Based O X
on O X
AAA O X
+ O X
X O X
- O X
ray O X
structures O X
, O X
we O X
proposed O X
that O X
it O X
is O X
responsible O X
for O X
the O X
proper O X
positioning O X
of O X
the O X
catalytic O X
and O X
the O X
sensor O X
I O X
residues O X
for O X
the O X
hydrolytic O X
attack O X
. O X

Alanine O X
substitution O X
of O X
the O X
putative O X
STAND O X
sensor O X
I O X
( O X
R160 O X
) O X
abolished O X
MalT I-MISC 947921
activity O X
. O X

Substitutions O X
of O X
R171 O X
impaired O X
both O X
ATP O X
hydrolysis O X
and O X
multimerization O X
, O X
which O X
is O X
consistent O X
with O X
an O X
arginine O X
finger O X
function O X
and O X
provides O X
further O X
evidence O X
that O X
ATP O X
hydrolysis O X
is O X
primarily O X
catalyzed O X
by O X
MalT I-MISC 947921
multimers O X
. O X

###15733871	817245,828525

WRKY O X
group O X
IId O X
transcription O X
factors O X
interact O X
with O X
calmodulin I-MISC 817245
. O X

Calmodulin I-MISC 817245
( O X
CaM I-MISC 817245
) O X
is O X
a O X
ubiquitous O X
Ca O X
( O X
2 O X
+)- O X
binding O X
protein O X
known O X
to O X
regulate O X
diverse O X
cellular O X
functions O X
by O X
modulating O X
the O X
activity O X
of O X
various O X
target O X
proteins O X
. O X

We O X
isolated O X
a O X
cDNA O X
encoding O X
AtWRKY7 I-MISC 828525
, O X
a O X
novel O X
CaM I-MISC 817245
- O X
binding O X
transcription O X
factor O X
, O X
from O X
an O X
Arabidopsis O X
expression O X
library O X
with O X
horseradish O X
peroxidase O X
- O X
conjugated O X
CaM I-MISC 817245
. O X

CaM I-MISC 817245
binds O X
specifically O X
to O X
the O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
CaM I-MISC 817245
- O X
binding O X
domain O X
( O X
CaMBD O X
) O X
of O X
AtWRKY7 I-MISC 828525
, O X
as O X
shown O X
by O X
site O X
- O X
directed O X
mutagenesis O X
, O X
a O X
gel O X
mobility O X
shift O X
assay O X
, O X
a O X
split O X
- O X
ubiquitin O X
assay O X
, O X
and O X
a O X
competition O X
assay O X
using O X
a O X
Ca2 O X
+/ O X
CaM I-MISC 817245
- O X
dependent O X
enzyme O X
. O X

Furthermore O X
, O X
we O X
show O X
that O X
the O X
CaMBD O X
of O X
AtWRKY7 I-MISC 828525
is O X
a O X
conserved O X
structural O X
motif O X
( O X
C O X
- O X
motif O X
) O X
found O X
in O X
group O X
IId O X
of O X
the O X
WRKY O X
protein O X
family O X
. O X

###17855368	857,3397

Identification O X
of O X
a O X
novel O X
inhibitor I-MISC 3397
of I-MISC 3397
differentiation I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
( O X
ID I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
) O X
binding O X
partner O X
, O X
caveolin I-MISC 857
- I-MISC 857
1 I-MISC 857
, O X
and O X
its O X
role O X
in O X
epithelial O X
- O X
mesenchymal O X
transition O X
and O X
resistance O X
to O X
apoptosis O X
in O X
prostate O X
cancer O X
cells O X
. O X

Recently O X
, O X
ID I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
( O X
inhibitor O X
of O X
differentiation O X
/ O X
DNA O X
binding O X
) O X
is O X
suggested O X
as O X
an O X
oncogene O X
and O X
is O X
reported O X
to O X
promote O X
cell O X
proliferation O X
, O X
invasion O X
, O X
and O X
survival O X
in O X
several O X
types O X
of O X
human O X
cancer O X
cells O X
through O X
multiple O X
signaling O X
pathways O X
. O X

However O X
, O X
how O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
interacts O X
with O X
these O X
pathways O X
and O X
the O X
immediate O X
downstream O X
effectors O X
of O X
the O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
protein O X
are O X
not O X
known O X
. O X

In O X
this O X
study O X
, O X
using O X
a O X
yeast O X
two O X
- O X
hybrid O X
screening O X
technique O X
, O X
we O X
identified O X
a O X
novel O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
- O X
interacting O X
protein O X
, O X
caveolin I-MISC 857
- I-MISC 857
1 I-MISC 857
( O X
Cav O X
- O X
1 O X
), O X
a O X
cell O X
membrane O X
protein O X
, O X
and O X
a O X
positive O X
regulator O X
of O X
cell O X
survival O X
and O X
metastasis O X
in O X
prostate O X
cancer O X
. O X

Using O X
an O X
immunoprecipitation O X
method O X
, O X
we O X
found O X
that O X
the O X
helix O X
- O X
loop O X
- O X
helix O X
domain O X
of O X
the O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
protein O X
was O X
essential O X
for O X
the O X
physical O X
interaction O X
between O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
and O X
Cav O X
- O X
1 O X
. O X

In O X
addition O X
, O X
we O X
also O X
demonstrated O X
that O X
the O X
physical O X
interaction O X
between O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
and O X
Cav O X
- O X
1 O X
played O X
a O X
key O X
role O X
in O X
the O X
epithelial O X
- O X
mesenchymal O X
transition O X
and O X
increased O X
cell O X
migration O X
rate O X
as O X
well O X
as O X
resistance O X
to O X
taxol O X
- O X
induced O X
apoptosis O X
in O X
prostate O X
cancer O X
cells O X
. O X

Furthermore O X
, O X
our O X
results O X
revealed O X
that O X
this O X
effect O X
was O X
regulated O X
by O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
- O X
induced O X
Akt I-MISC 207
activation O X
through O X
promoting O X
the O X
binding O X
activity O X
between O X
Cav O X
- O X
1 O X
and O X
protein O X
phosphatase O X
2A O X
. O X

Our O X
study O X
demonstrates O X
a O X
novel O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
binding O X
partner O X
and O X
suggests O X
a O X
molecular O X
mechanism O X
that O X
mediates O X
the O X
function O X
of O X
Id I-MISC 3397
- I-MISC 3397
1 I-MISC 3397
in O X
promoting O X
prostate O X
cancer O X
progression O X
through O X
activation O X
of O X
the O X
Akt I-MISC 207
pathway O X
leading O X
to O X
cancer O X
cell O X
invasion O X
and O X
resistance O X
to O X
anticancer O X
drug O X
- O X
induced O X
apoptosis O X
. O X

###19632990	2220,5806

Synergy O X
between O X
ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
and O X
pentraxin I-MISC 5806
3 I-MISC 5806
boosts O X
innate O X
immune O X
recognition O X
and O X
complement O X
deposition O X
. O X

The O X
long O X
pentraxin I-MISC 5806
3 I-MISC 5806
( O X
PTX3 I-MISC 5806
) O X
is O X
a O X
multifunctional O X
soluble O X
pattern O X
recognition O X
molecule O X
that O X
is O X
crucial O X
in O X
innate O X
immune O X
protection O X
against O X
opportunistic O X
fungal O X
pathogens O X
such O X
as O X
Aspergillus O X
fumigatus O X
. O X

The O X
mechanisms O X
that O X
mediate O X
downstream O X
effects O X
of O X
PTX3 I-MISC 5806
are O X
largely O X
unknown O X
. O X

However O X
, O X
PTX3 I-MISC 5806
interacts O X
with O X
C1q I-MISC 712
from O X
the O X
classical O X
pathway O X
of O X
the O X
complement O X
. O X

The O X
ficolins O X
are O X
recognition O X
molecules O X
of O X
the O X
lectin O X
complement O X
pathway O X
sharing O X
structural O X
and O X
functional O X
characteristics O X
with O X
C1q I-MISC 712
. O X

Thus O X
, O X
we O X
investigated O X
whether O X
the O X
ficolins O X
( O X
Ficolin I-MISC 2219
- I-MISC 2219
1 I-MISC 2219
, I-MISC 2219
- I-MISC 2219
2 I-MISC 2219
, I-MISC 2219
and I-MISC 2219
- I-MISC 2219
3 I-MISC 2219
) O X
interact O X
with O X
PTX3 I-MISC 5806
and O X
whether O X
the O X
complexes O X
are O X
able O X
to O X
modulate O X
complement O X
activation O X
on O X
A O X
. O X
fumigatus O X
. O X

Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
could O X
be O X
affinity O X
- O X
isolated O X
from O X
human O X
plasma O X
on O X
immobilized O X
PTX3 I-MISC 5806
. O X

In O X
binding O X
studies O X
, O X
Ficolin I-MISC 2219
- I-MISC 2219
1 I-MISC 2219
and O X
particularly O X
Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
interacted O X
with O X
PTX3 I-MISC 5806
in O X
a O X
calcium O X
- O X
independent O X
manner O X
. O X

Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
, O X
but O X
not O X
Ficolin I-MISC 2219
- I-MISC 2219
1 I-MISC 2219
and O X
Ficolin I-MISC 8547
- I-MISC 8547
3 I-MISC 8547
, O X
bound O X
A O X
. O X
fumigatus O X
directly O X
, O X
but O X
this O X
binding O X
was O X
enhanced O X
by O X
PTX3 I-MISC 5806
and O X
vice O X
versa O X
. O X

Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
- O X
dependent O X
complement O X
deposition O X
on O X
the O X
surface O X
of O X
A O X
. O X
fumigatus O X
was O X
enhanced O X
by O X
PTX3 I-MISC 5806
. O X

A O X
polymorphism O X
in O X
the O X
FCN2 I-MISC 2220
gene O X
causing O X
a O X
T236M O X
amino O X
acid O X
change O X
in O X
the O X
fibrinogen O X
- O X
like O X
binding O X
domain O X
of O X
Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
, O X
which O X
affects O X
the O X
binding O X
to O X
GlcNAc O X
, O X
reduced O X
Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
binding O X
to O X
PTX3 I-MISC 5806
and O X
A O X
. O X
fumigatus O X
significantly O X
. O X

These O X
results O X
demonstrate O X
that O X
PTX3 I-MISC 5806
and O X
Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
may O X
recruit O X
each O X
other O X
on O X
pathogens O X
. O X

The O X
effect O X
was O X
alleviated O X
by O X
a O X
common O X
amino O X
acid O X
change O X
in O X
the O X
fibrinogen O X
- O X
like O X
domain O X
of O X
Ficolin I-MISC 2220
- I-MISC 2220
2 I-MISC 2220
. O X

Thus O X
, O X
components O X
of O X
the O X
humoral O X
innate O X
immune O X
system O X
, O X
which O X
activate O X
different O X
complement O X
pathways O X
, O X
cooperate O X
and O X
amplify O X
microbial O X
recognition O X
and O X
effector O X
functions O X
. O X

###24351927	120892,5566

Parkinson O X
- O X
related O X
LRRK2 I-MISC 120892
mutation O X
R1441C O X
/ O X
G O X
/ O X
H O X
impairs O X
PKA I-MISC 5566
phosphorylation O X
of O X
LRRK2 I-MISC 120892
and O X
disrupts O X
its O X
interaction O X
with O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
. O X

Leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
is O X
a O X
multidomain O X
protein O X
implicated O X
in O X
Parkinson O X
disease O X
( O X
PD O X
); O X
however O X
, O X
the O X
molecular O X
mechanism O X
and O X
mode O X
of O X
action O X
of O X
this O X
protein O X
remain O X
elusive O X
. O X

cAMP I-MISC 5566
- I-MISC 5566
dependent I-MISC 5566
protein I-MISC 5566
kinase I-MISC 5566
( O X
PKA I-MISC 5566
), O X
along O X
with O X
other O X
kinases O X
, O X
has O X
been O X
suggested O X
to O X
be O X
an O X
upstream O X
kinase O X
regulating O X
LRRK2 I-MISC 120892
function O X
. O X

Using O X
MS O X
, O X
we O X
detected O X
several O X
sites O X
phosphorylated O X
by O X
PKA I-MISC 5566
, O X
including O X
phosphorylation O X
sites O X
within O X
the O X
Ras O X
of O X
complex O X
proteins O X
( O X
ROC O X
) O X
GTPase O X
domain O X
as O X
well O X
as O X
some O X
previously O X
described O X
sites O X
( O X
S910 O X
and O X
S935 O X
). O X

We O X
systematically O X
mapped O X
those O X
sites O X
within O X
LRRK2 I-MISC 120892
and O X
investigated O X
their O X
functional O X
consequences O X
. O X

S1444 I-MISC 1076813
in O X
the O X
ROC O X
domain O X
was O X
confirmed O X
as O X
a O X
target O X
for O X
PKA I-MISC 5566
phosphorylation O X
using O X
ROC O X
single O X
- O X
domain O X
constructs O X
and O X
through O X
site O X
- O X
directed O X
mutagenesis O X
. O X

Phosphorylation O X
at O X
S1444 I-MISC 1076813
is O X
strikingly O X
reduced O X
in O X
the O X
major O X
PD O X
- O X
related O X
LRRK2 I-MISC 120892
mutations O X
R1441C O X
/ O X
G O X
/ O X
H O X
, O X
which O X
are O X
part O X
of O X
a O X
consensus O X
PKA I-MISC 5566
recognition O X
site O X
(( O X
1441 O X
) O X
RASpS O X
( O X
1444 O X
)). O X

Furthermore O X
, O X
our O X
work O X
establishes O X
S1444 I-MISC 1076813
as O X
a O X
PKA I-MISC 5566
- O X
regulated O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
docking O X
site O X
. O X

Experiments O X
of O X
direct O X
binding O X
to O X
the O X
three O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
isotypes O X
gamma O X
, O X
theta O X
, O X
and O X
zeta O X
with O X
phosphopeptides O X
encompassing O X
pS910 O X
, O X
pS935 O X
, O X
or O X
pS1444 O X
demonstrated O X
the O X
highest O X
affinities O X
to O X
phospho O X
- O X
S1444 I-MISC 1076813
. O X

Strikingly O X
, O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
binding O X
to O X
phospho O X
- O X
S1444 I-MISC 1076813
decreased O X
LRRK2 I-MISC 120892
kinase O X
activity O X
in O X
vitro O X
. O X

Moreover O X
, O X
substitution O X
of O X
S1444 I-MISC 1076813
by O X
alanine O X
or O X
by O X
introducing O X
the O X
mutations O X
R1441C O X
/ O X
G O X
/ O X
H O X
, O X
abrogating O X
PKA I-MISC 5566
phosphorylation O X
and O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
binding O X
, O X
resulted O X
in O X
increased O X
LRRK2 I-MISC 120892
kinase O X
activity O X
. O X

In O X
conclusion O X
, O X
these O X
data O X
clearly O X
demonstrate O X
that O X
LRRK2 I-MISC 120892
kinase O X
activity O X
is O X
modulated O X
by O X
PKA I-MISC 5566
- O X
mediated O X
binding O X
of O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
to O X
S1444 I-MISC 1076813
and O X
suggest O X
that O X
14 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
- I-MISC 56010
3 I-MISC 56010
interaction O X
with O X
LRRK2 I-MISC 120892
is O X
hampered O X
in O X
R1441C O X
/ O X
G O X
/ O X
H O X
- O X
mediated O X
PD O X
pathogenesis O X
. O X

###9264463	1499,12385	3728,12385

A O X
specific O X
domain O X
in O X
alpha I-MISC 12385
- I-MISC 12385
catenin I-MISC 12385
mediates O X
binding O X
to O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
or O X
plakoglobin I-MISC 3728
. O X

The O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
- O X
catenin O X
adhesion O X
complex O X
has O X
been O X
the O X
subject O X
of O X
many O X
structural O X
and O X
functional O X
studies O X
because O X
of O X
its O X
importance O X
in O X
development O X
, O X
normal O X
tissue O X
function O X
and O X
carcinogenesis O X
. O X

It O X
is O X
well O X
established O X
that O X
the O X
cytoplasmic O X
domain O X
of O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
binds O X
either O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
or O X
plakoglobin I-MISC 3728
, O X
which O X
both O X
can O X
assemble O X
alpha I-MISC 12385
- I-MISC 12385
catenin I-MISC 12385
into O X
the O X
complex O X
. O X

Recently O X
we O X
have O X
identified O X
an O X
alpha I-MISC 12385
- I-MISC 12385
catenin I-MISC 12385
binding O X
site O X
in O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
plakoglobin I-MISC 3728
and O X
postulated O X
, O X
based O X
on O X
sequence O X
analysis O X
, O X
that O X
these O X
protein O X
- O X
protein O X
interactions O X
are O X
mediated O X
by O X
a O X
hydrophobic O X
interaction O X
mechanism O X
. O X

Here O X
we O X
have O X
now O X
identified O X
the O X
reciprocal O X
complementary O X
binding O X
site O X
in O X
alpha I-MISC 12385
- I-MISC 12385
catenin I-MISC 12385
which O X
mediates O X
its O X
interaction O X
with O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
and O X
plakoglobin I-MISC 3728
. O X

Using O X
in O X
vitro O X
association O X
assays O X
with O X
C O X
- O X
terminal O X
truncations O X
of O X
alpha I-MISC 12385
- I-MISC 12385
catenin I-MISC 12385
expressed O X
as O X
recombinant O X
fusion O X
proteins O X
, O X
we O X
found O X
that O X
the O X
N O X
- O X
terminal O X
146 O X
amino O X
acids O X
are O X
required O X
for O X
this O X
interaction O X
. O X

We O X
then O X
identified O X
a O X
peptide O X
of O X
27 O X
amino O X
acids O X
within O X
this O X
sequence O X
( O X
amino O X
acid O X
positions O X
117 O X
- O X
143 O X
) O X
which O X
is O X
necessary O X
and O X
sufficient O X
to O X
bind O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
or O X
plakoglobin I-MISC 3728
. O X

As O X
shown O X
by O X
mutational O X
analysis O X
, O X
hydrophobic O X
amino O X
acids O X
within O X
this O X
binding O X
site O X
are O X
important O X
for O X
the O X
interaction O X
. O X

The O X
results O X
described O X
here O X
, O X
together O X
with O X
our O X
previous O X
work O X
, O X
give O X
strong O X
support O X
for O X
the O X
idea O X
that O X
these O X
proteins O X
associate O X
by O X
hydrophobic O X
interactions O X
of O X
two O X
alpha O X
- O X
helices O X
. O X

###10675328	40009,39753	40014,39753	40015,39753

Induction O X
of O X
apoptosis O X
by O X
Drosophila O X
reaper I-MISC 40015
, O X
hid I-MISC 40009
and O X
grim I-MISC 40014
through O X
inhibition O X
of O X
IAP I-MISC 39753
function O X
. O X

Induction O X
of O X
apoptosis O X
in O X
Drosophila O X
requires O X
the O X
activity O X
of O X
three O X
closely O X
linked O X
genes O X
, O X
reaper I-MISC 40015
, O X
hid I-MISC 40009
and O X
grim I-MISC 40014
. O X

Here O X
we O X
show O X
that O X
the O X
proteins O X
encoded O X
by O X
reaper I-MISC 40015
, O X
hid I-MISC 40009
and O X
grim I-MISC 40014
activate O X
cell O X
death O X
by O X
inhibiting O X
the O X
anti O X
- O X
apoptotic O X
activity O X
of O X
the O X
Drosophila O X
IAP1 I-MISC 39753
( O X
diap1 I-MISC 39753
) O X
protein O X
. O X

In O X
a O X
genetic O X
modifier O X
screen O X
, O X
both O X
loss O X
- O X
of O X
- O X
function O X
and O X
gain O X
- O X
of O X
- O X
function O X
alleles O X
in O X
the O X
endogenous O X
diap1 I-MISC 39753
gene O X
were O X
obtained O X
, O X
and O X
the O X
mutant O X
proteins O X
were O X
functionally O X
and O X
biochemically O X
characterized O X
. O X

Gain O X
- O X
of O X
- O X
function O X
mutations O X
in O X
diap1 I-MISC 39753
strongly O X
suppressed O X
reaper I-MISC 40015
-, O X
hid I-MISC 40009
- O X
and O X
grim I-MISC 40014
- O X
induced O X
apoptosis O X
. O X

Sequence O X
analysis O X
of O X
these O X
alleles O X
revealed O X
that O X
they O X
were O X
caused O X
by O X
single O X
amino O X
acid O X
changes O X
in O X
the O X
baculovirus O X
IAP I-MISC 39753
repeat O X
domains O X
of O X
diap1 I-MISC 39753
, O X
a O X
domain O X
implicated O X
in O X
binding O X
REAPER I-MISC 40015
, O X
HID I-MISC 40009
and O X
GRIM I-MISC 40014
. O X

Significantly O X
, O X
the O X
corresponding O X
mutant O X
DIAP1 I-MISC 39753
proteins O X
displayed O X
greatly O X
reduced O X
binding O X
of O X
REAPER I-MISC 40015
, O X
HID I-MISC 40009
and O X
GRIM I-MISC 40014
, O X
indicating O X
that O X
REAPER I-MISC 40015
, O X
HID I-MISC 40009
and O X
GRIM I-MISC 40014
kill O X
by O X
forming O X
a O X
complex O X
with O X
DIAP1 I-MISC 39753
. O X

These O X
data O X
provide O X
strong O X
in O X
vivo O X
evidence O X
for O X
a O X
previously O X
published O X
model O X
of O X
cell O X
death O X
regulation O X
in O X
Drosophila O X
. O X

###24785777	945654,945654

Homooligomerization O X
is O X
needed O X
for O X
stability O X
: O X
a O X
molecular O X
modelling O X
and O X
solution O X
study O X
of O X
Escherichia O X
coli O X
purine I-MISC 945654
nucleoside I-MISC 945654
phosphorylase I-MISC 945654
. O X

Although O X
many O X
enzymes O X
are O X
homooligomers O X
composed O X
of O X
tightly O X
bound O X
subunits O X
, O X
it O X
is O X
often O X
the O X
case O X
that O X
smaller O X
assemblies O X
of O X
such O X
subunits O X
, O X
or O X
even O X
individual O X
monomers O X
, O X
seem O X
to O X
have O X
all O X
the O X
structural O X
features O X
necessary O X
to O X
independently O X
conduct O X
catalysis O X
. O X

In O X
this O X
study O X
, O X
we O X
investigated O X
the O X
reasons O X
justifying O X
the O X
necessity O X
for O X
the O X
hexameric O X
form O X
of O X
Escherichia O X
coli O X
purine I-MISC 945654
nucleoside I-MISC 945654
phosphorylase I-MISC 945654
- O X
a O X
homohexamer O X
composed O X
of O X
three O X
linked O X
dimers O X
- O X
since O X
it O X
appears O X
that O X
the O X
dimer O X
is O X
the O X
smallest O X
unit O X
capable O X
of O X
catalyzing O X
the O X
reaction O X
, O X
according O X
to O X
the O X
currently O X
accepted O X
mechanism O X
. O X

Molecular O X
modelling O X
was O X
employed O X
to O X
probe O X
mutations O X
at O X
the O X
dimer O X
- O X
dimer O X
interface O X
that O X
would O X
result O X
in O X
a O X
dimeric O X
enzyme O X
form O X
. O X

In O X
this O X
way O X
, O X
both O X
in O X
silico O X
and O X
in O X
vitro O X
, O X
the O X
hexamer O X
was O X
successfully O X
transformed O X
into O X
dimers O X
. O X

However O X
, O X
modelling O X
and O X
solution O X
studies O X
show O X
that O X
, O X
when O X
isolated O X
, O X
dimers O X
cannot O X
maintain O X
the O X
appropriate O X
three O X
- O X
dimensional O X
structure O X
, O X
including O X
the O X
geometry O X
of O X
the O X
active O X
site O X
and O X
the O X
position O X
of O X
the O X
catalytically O X
important O X
amino O X
acids O X
. O X

Analytical O X
ultracentrifugation O X
proves O X
that O X
E O X
. O X
coli O X
purine I-MISC 945654
nucleoside I-MISC 945654
phosphorylase I-MISC 945654
dimeric O X
mutants O X
tend O X
to O X
dissociate O X
into O X
monomers O X
with O X
dissociation O X
constants O X
of O X
20 O X
- O X
80 O X
m O X
. O X
Consistently O X
, O X
the O X
catalytic O X
activity O X
of O X
these O X
mutants O X
is O X
negligible O X
, O X
at O X
least O X
6 O X
orders O X
of O X
magnitude O X
smaller O X
than O X
for O X
the O X
wild O X
- O X
type O X
enzyme O X
. O X

We O X
conclude O X
that O X
the O X
hexameric O X
architecture O X
of O X
E O X
. O X
coli O X
purine I-MISC 945654
nucleoside I-MISC 945654
phosphorylase I-MISC 945654
is O X
necessary O X
to O X
provide O X
stabilization O X
of O X
the O X
proper O X
three O X
- O X
dimensional O X
structure O X
of O X
the O X
dimeric O X
assembly O X
, O X
and O X
therefore O X
this O X
enzyme O X
is O X
the O X
obligate O X
( O X
obligatory O X
) O X
hexamer O X
. O X

STRUCTURED O X
DIGITAL O X
ABSTRACT O X
: O X
PNP O X
and O X
PNP O X
bind O X
by O X
molecular O X
sieving O X
( O X
1 O X
, O X
2 O X
, O X
3 O X
, O X
4 O X
). O X

###11323411	2549,5781

Phosphotyrosines O X
627 O X
and O X
659 O X
of O X
Gab1 I-MISC 2549
constitute O X
a O X
bisphosphoryl O X
tyrosine O X
- O X
based O X
activation O X
motif O X
( O X
BTAM O X
) O X
conferring O X
binding O X
and O X
activation O X
of O X
SHP2 I-MISC 5781
. O X

A O X
major O X
Grb2 I-MISC 2549
- I-MISC 2549
associated I-MISC 2549
binder I-MISC 2549
- I-MISC 2549
1 I-MISC 2549
( O X
Gab1 I-MISC 2549
) O X
binding O X
partner O X
in O X
epidermal O X
growth O X
factor O X
( O X
EGF O X
)- O X
stimulated O X
cells O X
is O X
protein O X
- O X
tyrosine O X
phosphatase O X
( O X
PTPase O X
) O X
SHP2 I-MISC 5781
, O X
which O X
contains O X
tandem O X
SH2 O X
domains O X
. O X

The O X
SHP2 I-MISC 5781
PTPase O X
activity O X
is O X
required O X
for O X
activation O X
of O X
the O X
extracellular I-MISC 5594
signal I-MISC 5594
- I-MISC 5594
regulated I-MISC 5594
kinase I-MISC 5594
( O X
ERK I-MISC 5594
) O X
subfamily O X
of O X
mitogen O X
- O X
activated O X
protein O X
( O X
MAP O X
) O X
kinase O X
by O X
EGF O X
. O X

To O X
investigate O X
the O X
mechanism O X
by O X
which O X
Gab1 I-MISC 2549
and O X
SHP2 I-MISC 5781
mediate O X
ERK I-MISC 5594
activation O X
, O X
we O X
characterized O X
the O X
Gab1 I-MISC 2549
- O X
SHP2 I-MISC 5781
interaction O X
. O X

We O X
found O X
that O X
both O X
Tyr O X
- O X
627 O X
and O X
Tyr O X
- O X
659 O X
of O X
Gab1 I-MISC 2549
were O X
required O X
for O X
SHP2 I-MISC 5781
binding O X
to O X
Gab1 I-MISC 2549
and O X
for O X
ERK2 I-MISC 5594
activation O X
by O X
EGF O X
. O X

Far O X
Western O X
blot O X
analysis O X
suggested O X
that O X
the O X
tandem O X
SH2 O X
domains O X
of O X
SHP2 I-MISC 5781
bind O X
to O X
Gab1 I-MISC 2549
in O X
a O X
specific O X
orientation O X
, O X
in O X
which O X
the O X
N O X
- O X
SH2 O X
domain O X
binds O X
to O X
phosphotyrosine O X
( O X
Tyr O X
( O X
P O X
))- O X
627 O X
and O X
the O X
C O X
- O X
SH2 O X
domain O X
binds O X
to O X
Tyr O X
( O X
P O X
)- O X
659 O X
. O X

When O X
assayed O X
with O X
peptide O X
substrates O X
, O X
SHP2 I-MISC 5781
PTPase O X
was O X
activated O X
by O X
a O X
bisphosphopeptide O X
containing O X
both O X
Tyr O X
( O X
P O X
)- O X
627 O X
and O X
Tyr O X
( O X
P O X
)- O X
659 O X
, O X
but O X
not O X
by O X
monophosphopeptides O X
containing O X
Tyr O X
( O X
P O X
)- O X
627 O X
or O X
Tyr O X
( O X
P O X
)- O X
659 O X
or O X
a O X
mixture O X
of O X
these O X
monophosphopeptides O X
. O X

These O X
results O X
suggest O X
that O X
Tyr O X
( O X
P O X
)- O X
627 O X
and O X
Tyr O X
( O X
P O X
)- O X
659 O X
of O X
Gab1 I-MISC 2549
constitute O X
a O X
bisphosphoryl O X
tyrosine O X
- O X
based O X
activation O X
motif O X
( O X
BTAM O X
) O X
that O X
binds O X
and O X
activates O X
SHP2 I-MISC 5781
. O X

Remarkably O X
, O X
while O X
a O X
constitutively O X
active O X
SHP2 I-MISC 5781
( O X
SHP2DeltaN I-MISC 5781
) O X
could O X
not O X
rescue O X
the O X
defect O X
of O X
a O X
SHP2 I-MISC 5781
- O X
binding O X
defective O X
Gab1 I-MISC 2549
( O X
Gab1FF I-MISC 2549
) O X
in O X
ERK2 I-MISC 5594
activation O X
, O X
expression O X
of O X
a O X
Gab1FF I-MISC 2549
- O X
SHP2DeltaN I-MISC 5781
chimera O X
resulted O X
in O X
constitutive O X
activation O X
of O X
ERK2 I-MISC 5594
in O X
transfected O X
cells O X
. O X

Thus O X
, O X
physical O X
association O X
of O X
activated O X
SHP2 I-MISC 5781
with O X
Gab1 I-MISC 2549
is O X
necessary O X
and O X
sufficient O X
to O X
mediate O X
the O X
ERK I-MISC 5594
mitogen O X
- O X
activated O X
protein O X
kinase O X
activation O X
. O X

Phosphopeptides O X
derived O X
from O X
Gab1 I-MISC 2549
were O X
dephosphorylated O X
by O X
active O X
SHP2 I-MISC 5781
in O X
vitro O X
. O X

Consistently O X
, O X
substrate O X
- O X
trapping O X
experiments O X
with O X
a O X
SHP2 I-MISC 5781
catalytic O X
inactive O X
mutant O X
suggested O X
that O X
Gab1 I-MISC 2549
was O X
a O X
SHP2 I-MISC 5781
PTPase O X
substrate O X
in O X
the O X
cells O X
. O X

Therefore O X
, O X
Gab1 I-MISC 2549
not O X
only O X
is O X
a O X
SHP2 I-MISC 5781
activator O X
but O X
also O X
is O X
a O X
target O X
of O X
its O X
PTPase O X
. O X

###23957209	5578,124056

Phosphorylation O X
of O X
Noxo1 I-MISC 124056
at O X
threonine O X
341 O X
regulates O X
its O X
interaction O X
with O X
Noxa1 I-MISC 10811
and O X
the O X
superoxide O X
- O X
producing O X
activity O X
of O X
Nox1 I-MISC 27035
. O X

Superoxide O X
production O X
by O X
Nox1 I-MISC 27035
, O X
a O X
member O X
of O X
the O X
Nox O X
family O X
NAPDH O X
oxidases O X
, O X
requires O X
expression O X
of O X
its O X
regulatory O X
soluble O X
proteins O X
Noxo1 I-MISC 124056
( O X
Nox I-MISC 124056
organizer I-MISC 124056
1 I-MISC 124056
) O X
and O X
Noxa1 I-MISC 10811
( O X
Nox I-MISC 10811
activator I-MISC 10811
1 I-MISC 10811
) O X
and O X
is O X
markedly O X
enhanced O X
upon O X
cell O X
stimulation O X
with O X
phorbol O X
12 O X
- O X
myristate O X
13 O X
- O X
acetate O X
( O X
PMA O X
), O X
a O X
potent O X
activator O X
of O X
protein I-MISC 5578
kinase I-MISC 5578
C I-MISC 5578
( O X
PKC I-MISC 5578
). O X

The O X
mechanism O X
underlying O X
PMA O X
- O X
induced O X
enhancement O X
of O X
Nox1 I-MISC 27035
activity O X
, O X
however O X
, O X
remains O X
to O X
be O X
elucidated O X
. O X

Here O X
we O X
show O X
that O X
, O X
in O X
response O X
to O X
PMA O X
, O X
Noxo1 I-MISC 124056
undergoes O X
phosphorylation O X
at O X
multiple O X
sites O X
, O X
which O X
is O X
inhibited O X
by O X
the O X
PKC I-MISC 5578
inhibitor O X
GF109203X O X
. O X

Among O X
them O X
, O X
Thr341 O X
in O X
Noxo1 I-MISC 124056
is O X
directly O X
phosphorylated O X
by O X
PKC I-MISC 5578
in O X
vitro O X
, O X
and O X
alanine O X
substitution O X
for O X
this O X
residue O X
reduces O X
not O X
only O X
PMA O X
- O X
induced O X
Noxo1 I-MISC 124056
phosphorylation O X
but O X
also O X
PMA O X
- O X
dependent O X
enhancement O X
of O X
Nox1 I-MISC 27035
- O X
catalyzed O X
superoxide O X
production O X
. O X

Phosphorylation O X
of O X
Thr341 O X
allows O X
Noxo1 I-MISC 124056
to O X
sufficiently O X
interact O X
with O X
Noxa1 I-MISC 10811
, O X
an O X
interaction O X
that O X
participates O X
in O X
Nox1 I-MISC 27035
activation O X
. O X

Thus O X
phosphorylation O X
of O X
Noxo1 I-MISC 124056
at O X
Thr341 O X
appears O X
to O X
play O X
a O X
crucial O X
role O X
in O X
PMA O X
- O X
elicited O X
activation O X
of O X
Nox1 I-MISC 27035
, O X
providing O X
a O X
molecular O X
link O X
between O X
PKC I-MISC 5578
- O X
mediated O X
signal O X
transduction O X
and O X
Nox1 I-MISC 27035
- O X
catalyzed O X
superoxide O X
production O X
. O X

Furthermore O X
, O X
Ser154 O X
in O X
Noxo1 I-MISC 124056
is O X
phosphorylated O X
in O X
both O X
resting O X
and O X
PMA O X
- O X
stimulated O X
cells O X
, O X
and O X
the O X
phosphorylation O X
probably O X
participates O X
in O X
a O X
PMA O X
- O X
independent O X
constitutive O X
activity O X
of O X
Nox1 I-MISC 27035
. O X

Ser154 O X
may O X
also O X
be O X
involved O X
in O X
protein O X
kinase O X
A O X
( O X
PKA O X
) O X
mediated O X
regulation O X
of O X
Nox1 I-MISC 27035
; O X
this O X
serine O X
is O X
the O X
major O X
residue O X
that O X
is O X
phosphorylated O X
by O X
PKA O X
in O X
vitro O X
. O X

Thus O X
phosphorylation O X
of O X
Noxo1 I-MISC 124056
at O X
Thr341 O X
and O X
at O X
Ser154 O X
appears O X
to O X
regulate O X
Nox1 I-MISC 27035
activity O X
in O X
different O X
manners O X
. O X

STRUCTURED O X
DIGITAL O X
ABSTRACT O X
: O X
Noxo1 I-MISC 124056
binds O X
to O X
p22phox O X
by O X
pull O X
down O X
( O X
1 O X
, O X
2 O X
, O X
3 O X
) O X
Noxo1 I-MISC 124056
binds O X
to O X
Noxo1 I-MISC 124056
by O X
pull O X
down O X
( O X
View O X
interaction O X
) O X
Noxa1 I-MISC 10811
binds O X
to O X
Noxo1 I-MISC 124056
by O X
pull O X
down O X
( O X
1 O X
, O X
2 O X
, O X
3 O X
, O X
4 O X
, O X
5 O X
). O X

###15350218	65125,24805

WNK1 I-MISC 65125
phosphorylates O X
synaptotagmin I-MISC 24805
2 I-MISC 24805
and O X
modulates O X
its O X
membrane O X
binding O X
. O X

WNK O X
( O X
with O X
no O X
lysine O X
[ O X
K O X
]) O X
protein O X
kinases O X
were O X
named O X
for O X
their O X
unique O X
active O X
site O X
organization O X
. O X

Mutations O X
in O X
WNK1 I-MISC 65125
and O X
WNK4 I-MISC 65266
cause O X
a O X
familial O X
form O X
of O X
hypertension O X
by O X
undefined O X
mechanisms O X
. O X

Here O X
, O X
we O X
report O X
that O X
WNK1 I-MISC 65125
selectively O X
binds O X
to O X
and O X
phosphorylates O X
synaptotagmin I-MISC 24805
2 I-MISC 24805
( O X
Syt2 I-MISC 24805
) O X
within O X
its O X
calcium O X
binding O X
C2 O X
domains O X
. O X

Endogenous O X
WNK1 I-MISC 65125
and O X
Syt2 I-MISC 24805
coimmunoprecipitate O X
and O X
colocalize O X
on O X
a O X
subset O X
of O X
secretory O X
granules O X
in O X
INS O X
- O X
1 O X
cells O X
. O X

Phosphorylation O X
by O X
WNK1 I-MISC 65125
increases O X
the O X
amount O X
of O X
Ca2 O X
+ O X
required O X
for O X
Syt2 I-MISC 24805
binding O X
to O X
phospholipid O X
vesicles O X
; O X
mutation O X
of O X
threonine O X
202 O X
, O X
a O X
WNK1 I-MISC 65125
phosphorylation O X
site O X
, O X
partially O X
prevents O X
this O X
change O X
. O X

These O X
findings O X
suggest O X
that O X
phosphorylation O X
of O X
Syts O X
by O X
WNK1 I-MISC 65125
can O X
regulate O X
Ca2 O X
+ O X
sensing O X
and O X
the O X
subsequent O X
Ca2 O X
+- O X
dependent O X
interactions O X
mediated O X
by O X
Syt O X
C2 O X
domains O X
. O X

These O X
findings O X
provide O X
a O X
biochemical O X
mechanism O X
that O X
could O X
lead O X
to O X
the O X
retention O X
or O X
insertion O X
of O X
proteins O X
in O X
the O X
plasma O X
membrane O X
. O X

Interruption O X
of O X
this O X
regulatory O X
pathway O X
may O X
disturb O X
membrane O X
events O X
that O X
regulate O X
ion O X
balance O X
. O X

###19162005	207,28984

Response O X
gene O X
to O X
complement O X
32 O X
is O X
required O X
for O X
C5b O X
- O X
9 O X
induced O X
cell O X
cycle O X
activation O X
in O X
endothelial O X
cells O X
. O X

Proliferation O X
of O X
vascular O X
endothelial O X
cells O X
( O X
EC O X
) O X
and O X
smooth O X
muscle O X
cells O X
( O X
SMC O X
) O X
is O X
a O X
critical O X
event O X
in O X
angiogenesis O X
and O X
atherosclerosis O X
. O X

We O X
previously O X
showed O X
that O X
the O X
C5b O X
- O X
9 O X
assembly O X
during O X
complement O X
activation O X
induces O X
cell O X
cycle O X
in O X
human O X
aortic O X
EC O X
( O X
AEC O X
) O X
and O X
SMC O X
. O X

C5b O X
- O X
9 O X
can O X
induce O X
the O X
expression O X
of O X
Response I-MISC 28984
Gene I-MISC 28984
to I-MISC 28984
Complement I-MISC 28984
( I-MISC 28984
RGC I-MISC 28984
)- I-MISC 28984
32 I-MISC 28984
and O X
over O X
expression O X
of O X
this O X
gene O X
leads O X
to O X
cell O X
cycle O X
activation O X
. O X

Therefore O X
, O X
the O X
present O X
study O X
was O X
carried O X
out O X
to O X
test O X
the O X
requirement O X
of O X
endogenous O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
for O X
the O X
cell O X
cycle O X
activation O X
induced O X
by O X
C5b O X
- O X
9 O X
by O X
knocking O X
- O X
down O X
its O X
expression O X
using O X
siRNA O X
. O X

We O X
identified O X
two O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
siRNAs O X
that O X
can O X
markedly O X
reduce O X
the O X
expression O X
of O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
mRNA O X
in O X
AEC O X
. O X

RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
silencing O X
in O X
these O X
cells O X
abolished O X
DNA O X
synthesis O X
induced O X
by O X
C5b O X
- O X
9 O X
and O X
serum O X
growth O X
factors O X
, O X
indicating O X
the O X
requirement O X
of O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
activity O X
for O X
S O X
- O X
phase O X
entry O X
. O X

RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
siRNA O X
knockdown O X
also O X
significantly O X
reduced O X
the O X
C5b O X
- O X
9 O X
induced O X
CDC2 I-MISC 983
activation O X
and O X
Akt I-MISC 207
phosphorylation O X
. O X

CDC2 I-MISC 983
does O X
not O X
play O X
a O X
role O X
in O X
G1 O X
/ O X
S O X
transition O X
in O X
HeLa O X
cells O X
stably O X
overexpressing O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
. O X

RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
was O X
found O X
to O X
physically O X
associate O X
with O X
Akt I-MISC 207
and O X
was O X
phosphorylated O X
by O X
Akt I-MISC 207
in O X
vitro O X
. O X

Mutation O X
of O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
protein O X
at O X
Ser O X
45 O X
and O X
Ser O X
47 O X
prevented O X
Akt I-MISC 207
mediated O X
phosphorylation O X
. O X

In O X
addition O X
, O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
was O X
found O X
to O X
regulate O X
the O X
release O X
of O X
growth O X
factors O X
from O X
AEC O X
. O X

All O X
these O X
data O X
together O X
suggest O X
that O X
cell O X
cycle O X
induction O X
by O X
C5b O X
- O X
9 O X
in O X
AEC O X
is O X
RGC I-MISC 28984
- I-MISC 28984
32 I-MISC 28984
dependent O X
and O X
this O X
is O X
in O X
part O X
through O X
regulation O X
of O X
Akt I-MISC 207
and O X
growth O X
factor O X
release O X
. O X

###11726501	854191,852762	854191,853422	854191,853439

Bub3 I-MISC 854191
interaction O X
with O X
Mad2 I-MISC 853422
, O X
Mad3 I-MISC 853439
and O X
Cdc20 I-MISC 852762
is O X
mediated O X
by O X
WD40 O X
repeats O X
and O X
does O X
not O X
require O X
intact O X
kinetochores O X
. O X

The O X
kinetochore O X
checkpoint O X
pathway O X
, O X
involving O X
the O X
Mad1 I-MISC 8379
, O X
Mad2 I-MISC 853422
, O X
Mad3 I-MISC 853439
, O X
Bub1 I-MISC 699
, O X
Bub3 I-MISC 854191
and O X
Mps1 I-MISC 219972
proteins O X
, O X
prevents O X
anaphase O X
entry O X
and O X
mitotic O X
exit O X
by O X
inhibiting O X
the O X
anaphase O X
promoting O X
complex O X
activator O X
Cdc20 I-MISC 852762
in O X
response O X
to O X
monopolar O X
attachment O X
of O X
sister O X
kinetochores O X
to O X
spindle O X
fibres O X
. O X

We O X
show O X
here O X
that O X
Cdc20 I-MISC 852762
, O X
which O X
had O X
previously O X
been O X
shown O X
to O X
interact O X
physically O X
with O X
Mad2 I-MISC 853422
and O X
Mad3 I-MISC 853439
, O X
associates O X
also O X
with O X
Bub3 I-MISC 854191
and O X
association O X
is O X
up O X
- O X
regulated O X
upon O X
checkpoint O X
activation O X
. O X

Moreover O X
, O X
co O X
- O X
fractionation O X
experiments O X
suggest O X
that O X
Mad2 I-MISC 853422
, O X
Mad3 I-MISC 853439
and O X
Bub3 I-MISC 854191
may O X
be O X
concomitantly O X
present O X
in O X
protein O X
complexes O X
with O X
Cdc20 I-MISC 852762
. O X

Formation O X
of O X
the O X
Bub3 I-MISC 854191
- O X
Cdc20 I-MISC 852762
complex O X
requires O X
all O X
kinetochore O X
checkpoint O X
proteins O X
but O X
, O X
surprisingly O X
, O X
not O X
intact O X
kinetochores O X
. O X

Conversely O X
, O X
point O X
mutations O X
altering O X
the O X
conserved O X
WD40 O X
motifs O X
of O X
Bub3 I-MISC 854191
, O X
which O X
might O X
be O X
involved O X
in O X
the O X
formation O X
of O X
a O X
beta O X
- O X
propeller O X
fold O X
devoted O X
to O X
protein O X
- O X
protein O X
interactions O X
, O X
disrupt O X
its O X
association O X
with O X
Mad2 I-MISC 853422
, O X
Mad3 I-MISC 853439
and O X
Cdc20 I-MISC 852762
, O X
as O X
well O X
as O X
proper O X
checkpoint O X
response O X
. O X

We O X
suggest O X
that O X
Bub3 I-MISC 854191
could O X
serve O X
as O X
a O X
platform O X
for O X
interactions O X
between O X
kinetochore O X
checkpoint O X
proteins O X
, O X
and O X
its O X
association O X
with O X
Mad2 I-MISC 853422
, O X
Mad3 I-MISC 853439
and O X
Cdc20 I-MISC 852762
might O X
be O X
instrumental O X
for O X
checkpoint O X
activation O X
. O X

###21108945	2033,4683

Acetyltransferase O X
p300 I-MISC 2033
regulates O X
NBS1 I-MISC 4683
- O X
mediated O X
DNA O X
damage O X
response O X
. O X

The O X
role O X
of O X
p300 I-MISC 2033
in O X
DNA O X
damage O X
response O X
is O X
unclear O X
. O X

To O X
understand O X
how O X
ATM O X
- O X
dependent O X
phosphorylation O X
of O X
p300 I-MISC 2033
affects O X
its O X
function O X
in O X
response O X
to O X
DNA O X
damage O X
, O X
we O X
present O X
evidence O X
that O X
S106 O X
of O X
p300 I-MISC 2033
, O X
which O X
is O X
phosphorylated O X
by O X
ATM O X
, O X
regulates O X
stability O X
of O X
NBS1 I-MISC 4683
and O X
recruitment O X
into O X
damaged O X
DNA O X
, O X
possibly O X
leading O X
to O X
regulation O X
of O X
DNA O X
repair O X
. O X

Non O X
- O X
phosphorylatable O X
p300 I-MISC 2033
( O X
S106A O X
) O X
destabilized O X
NBS1 I-MISC 4683
and O X
decreased O X
NBS1 I-MISC 4683
- O X
p300 I-MISC 2033
interaction O X
. O X

The O X
recruitment O X
of O X
NBS1 I-MISC 4683
into O X
damaged O X
DNA O X
was O X
impaired O X
in O X
the O X
presence O X
of O X
S106A O X
. O X

Also O X
, O X
a O X
dominant O X
negative O X
p300 I-MISC 2033
lacking O X
enzymatic O X
activity O X
induced O X
destabilization O X
of O X
NBS1 I-MISC 4683
, O X
suggesting O X
that O X
its O X
acetyltransferase O X
is O X
required O X
for O X
NBS1 I-MISC 4683
stability O X
. O X

These O X
results O X
indicate O X
that O X
phosphorylation O X
of O X
p300 I-MISC 2033
can O X
regulate O X
NBS1 I-MISC 4683
- O X
mediated O X
DNA O X
damage O X
response O X
, O X
and O X
that O X
these O X
events O X
occur O X
in O X
an O X
acetylation O X
- O X
dependent O X
manner O X
. O X

###16293620	3361711,3361714

Structural O X
determinants O X
for O X
the O X
binding O X
of O X
anthrax O X
lethal I-MISC 3361711
factor I-MISC 3361711
to O X
oligomeric O X
protective I-MISC 3361714
antigen I-MISC 3361714
. O X

Anthrax O X
lethal O X
toxin O X
assembles O X
at O X
the O X
surface O X
of O X
mammalian O X
cells O X
when O X
the O X
lethal I-MISC 3361711
factor I-MISC 3361711
( O X
LF I-MISC 3361711
) O X
binds O X
via O X
its O X
amino O X
- O X
terminal O X
domain O X
, O X
LF I-MISC 3361711
( O X
N O X
), O X
to O X
oligomeric O X
forms O X
of O X
activated O X
protective I-MISC 3361714
antigen I-MISC 3361714
( O X
PA I-MISC 3361714
). O X

LF I-MISC 3361711
x O X
PA I-MISC 3361714
complexes O X
are O X
then O X
trafficked O X
to O X
acidified O X
endosomes O X
, O X
where O X
PA I-MISC 3361714
forms O X
heptameric O X
pores O X
in O X
the O X
bounding O X
membrane O X
and O X
LF I-MISC 3361711
translocates O X
through O X
these O X
pores O X
to O X
the O X
cytosol O X
. O X

We O X
used O X
enhanced O X
peptide O X
amide O X
hydrogen O X
/ O X
deuterium O X
exchange O X
mass O X
spectrometry O X
and O X
directed O X
mutagenesis O X
to O X
define O X
the O X
surface O X
on O X
LF I-MISC 3361711
( O X
N O X
) O X
that O X
interacts O X
with O X
PA I-MISC 3361714
. O X
A O X
continuous O X
surface O X
encompassing O X
one O X
face O X
of O X
LF I-MISC 3361711
( O X
N O X
) O X
became O X
protected O X
from O X
deuterium O X
exchange O X
when O X
LF I-MISC 3361711
( O X
N O X
) O X
was O X
bound O X
to O X
a O X
PA I-MISC 3361714
dimer O X
. O X

Directed O X
mutational O X
analysis O X
demonstrated O X
that O X
residues O X
within O X
this O X
surface O X
on O X
LF I-MISC 3361711
( O X
N O X
) O X
interact O X
with O X
Lys O X
- O X
197 O X
on O X
two O X
PA I-MISC 3361714
subunits O X
simultaneously O X
, O X
thereby O X
showing O X
that O X
LF I-MISC 3361711
( O X
N O X
) O X
spans O X
the O X
PA I-MISC 3361714
subunit O X
: O X
subunit O X
interface O X
and O X
explaining O X
why O X
heptameric O X
PA I-MISC 3361714
binds O X
a O X
maximum O X
of O X
three O X
LF I-MISC 3361711
( O X
N O X
) O X
molecules O X
. O X

Our O X
results O X
elucidate O X
the O X
structural O X
basis O X
for O X
anthrax O X
lethal O X
toxin O X
assembly O X
and O X
may O X
be O X
useful O X
in O X
developing O X
drugs O X
to O X
block O X
toxin O X
action O X
. O X

###9467941	1489017,5829

Association O X
of O X
Bovine O X
Papillomavirus O X
Type O X
1 O X
E6 I-MISC 1489017
oncoprotein O X
with O X
the O X
focal O X
adhesion O X
protein O X
paxillin I-MISC 5829
through O X
a O X
conserved O X
protein O X
interaction O X
motif O X
. O X

We O X
have O X
found O X
that O X
the O X
E6 I-MISC 1489017
oncoprotein O X
of O X
Bovine O X
Papillomavirus O X
Type O X
1 O X
( O X
BE6 O X
) O X
as O X
well O X
as O X
the O X
E6 I-MISC 1489017
protein O X
of O X
the O X
cancer O X
associated O X
HPV O X
- O X
16 O X
( O X
16E6 O X
) O X
interact O X
with O X
the O X
focal O X
adhesion O X
protein O X
paxillin I-MISC 5829
. O X

Mutational O X
analysis O X
of O X
paxillin I-MISC 5829
revealed O X
that O X
BE6 O X
binds O X
paxillin I-MISC 5829
through O X
small O X
protein O X
interaction O X
motifs O X
called O X
LD O X
motifs O X
that O X
have O X
been O X
previously O X
identified O X
as O X
important O X
in O X
regulating O X
association O X
of O X
paxillin I-MISC 5829
with O X
vinculin I-MISC 7414
and O X
focal I-MISC 5747
adhesion I-MISC 5747
kinase I-MISC 5747
( O X
FAK I-MISC 5747
), O X
and O X
that O X
BE6 O X
can O X
interact O X
with O X
at O X
least O X
two O X
separate O X
binding O X
sites O X
on O X
paxillin I-MISC 5829
. O X

The O X
LD O X
motifs O X
of O X
paxillin I-MISC 5829
that O X
bind O X
BE6 O X
share O X
homology O X
with O X
the O X
E6 I-MISC 1489017
binding O X
site O X
of O X
E6 I-MISC 7337
- I-MISC 7337
AP I-MISC 7337
, O X
a O X
ubiquitin O X
ligase O X
that O X
together O X
with O X
16E6 O X
targets O X
the O X
degradation O X
of O X
the O X
p53 I-MISC 7157
tumor O X
suppressor O X
. O X

Paxillin I-MISC 5829
binding O X
to O X
BE6 O X
excludes O X
simultaneous O X
binding O X
to O X
E6 I-MISC 7337
- I-MISC 7337
AP I-MISC 7337
. O X

Mutational O X
analysis O X
of O X
BE6 O X
can O X
distinguish O X
the O X
interaction O X
of O X
BE6 O X
with O X
E6 I-MISC 7337
- I-MISC 7337
AP I-MISC 7337
compared O X
to O X
paxillin I-MISC 5829
and O X
revealed O X
that O X
the O X
interaction O X
of O X
BE6 O X
with O X
paxillin I-MISC 5829
may O X
be O X
necessary O X
for O X
the O X
induction O X
of O X
anchorage O X
independent O X
growth O X
of O X
cells O X
by O X
BE6 O X
. O X

###17641689	1387,81857	5914,81857	6256,81857

MED25 I-MISC 81857
is O X
distinct O X
from O X
TRAP220 I-MISC 5469
/ O X
MED1 I-MISC 5469
in O X
cooperating O X
with O X
CBP I-MISC 1387
for O X
retinoid O X
receptor O X
activation O X
. O X

We O X
isolated O X
MED25 I-MISC 81857
, O X
which O X
associates O X
with O X
retinoic O X
acid O X
( O X
RA O X
)- O X
bound O X
retinoic I-MISC 5914
acid I-MISC 5914
receptor I-MISC 5914
( O X
RAR I-MISC 5914
) O X
through O X
the O X
C O X
- O X
terminal O X
nuclear O X
hormone O X
receptor O X
( O X
NR O X
) O X
box O X
/ O X
LxxLL O X
motif O X
, O X
and O X
increases O X
RAR I-MISC 5914
/ O X
RXR I-MISC 6256
- O X
mediated O X
transcription O X
. O X

When O X
tethered O X
to O X
a O X
promoter O X
, O X
MED25 I-MISC 81857
showed O X
intrinsic O X
transcriptional O X
activity O X
in O X
its O X
PTOV O X
domain O X
, O X
which O X
is O X
likely O X
accomplished O X
by O X
direct O X
association O X
with O X
CBP I-MISC 1387
. O X

Reporter O X
assays O X
using O X
dominant O X
negatives O X
of O X
MED25 I-MISC 81857
demonstrated O X
the O X
importance O X
of O X
the O X
N O X
- O X
terminal O X
Mediator O X
- O X
binding O X
and O X
C O X
- O X
terminal O X
domains O X
in O X
CBP I-MISC 1387
and O X
RAR I-MISC 5914
/ O X
RXR I-MISC 6256
binding O X
, O X
which O X
affect O X
MED25 I-MISC 81857
activity O X
. O X

Downregulation O X
of O X
MED25 I-MISC 81857
specifically O X
reduced O X
RAR I-MISC 5914
but O X
not O X
thyroid O X
hormone O X
receptor O X
( O X
TR O X
) O X
activity O X
. O X

Stimulation O X
of O X
RAR I-MISC 5914
by O X
MED25 I-MISC 81857
was O X
correlated O X
with O X
enhanced O X
RA O X
cytotoxicity O X
in O X
vivo O X
. O X

Chromatin O X
immunoprecipitation O X
( O X
ChIP O X
) O X
assays O X
revealed O X
the O X
RA O X
- O X
dependent O X
recruitment O X
of O X
MED25 I-MISC 81857
to O X
the O X
RARbeta2 O X
promoter O X
. O X

Recruitment O X
of O X
CBP I-MISC 1387
and O X
TRAP220 I-MISC 5469
was O X
diminished O X
by O X
the O X
overexpression O X
of O X
a O X
MED25 I-MISC 81857
NR O X
box O X
deletion O X
mutant O X
, O X
and O X
by O X
treatment O X
with O X
MED25 I-MISC 81857
siRNA O X
. O X

Time O X
- O X
course O X
ChIP O X
assays O X
indicated O X
that O X
CBP I-MISC 1387
, O X
together O X
with O X
RAR I-MISC 5914
and O X
MED25 I-MISC 81857
, O X
is O X
recruited O X
early O X
, O X
whereas O X
TRAP220 I-MISC 5469
is O X
recruited O X
later O X
to O X
the O X
promoter O X
. O X

Our O X
data O X
suggest O X
that O X
MED25 I-MISC 81857
, O X
in O X
cooperation O X
with O X
CBP I-MISC 1387
and O X
Mediators O X
through O X
its O X
distinct O X
domains O X
, O X
imposes O X
a O X
selective O X
advantage O X
on O X
RAR I-MISC 5914
/ O X
RXR I-MISC 6256
activation O X
. O X

###24788516	11091,284058

Structural O X
analysis O X
of O X
the O X
KANSL1 I-MISC 284058
/ O X
WDR5 I-MISC 11091
/ O X
KANSL2 O X
complex O X
reveals O X
that O X
WDR5 I-MISC 11091
is O X
required O X
for O X
efficient O X
assembly O X
and O X
chromatin O X
targeting O X
of O X
the O X
NSL O X
complex O X
. O X

The O X
subunits O X
of O X
the O X
nonspecific O X
lethal O X
( O X
NSL O X
) O X
complex O X
, O X
which O X
include O X
the O X
histone O X
acetyltransferase O X
MOF O X
( O X
males O X
absent O X
on O X
the O X
first O X
), O X
play O X
important O X
roles O X
in O X
various O X
cellular O X
functions O X
, O X
including O X
transcription O X
regulation O X
and O X
stem O X
cell O X
identity O X
maintenance O X
and O X
reprogramming O X
, O X
and O X
are O X
frequently O X
misregulated O X
in O X
disease O X
. O X

Here O X
, O X
we O X
provide O X
the O X
first O X
biochemical O X
and O X
structural O X
insights O X
into O X
the O X
molecular O X
architecture O X
of O X
this O X
large O X
multiprotein O X
assembly O X
. O X

We O X
identified O X
several O X
direct O X
interactions O X
within O X
the O X
complex O X
and O X
show O X
that O X
KANSL1 I-MISC 284058
acts O X
as O X
a O X
scaffold O X
protein O X
interacting O X
with O X
four O X
other O X
subunits O X
, O X
including O X
WDR5 I-MISC 11091
, O X
which O X
in O X
turn O X
binds O X
KANSL2 O X
. O X

Structural O X
analysis O X
of O X
the O X
KANSL1 I-MISC 284058
/ O X
WDR5 I-MISC 11091
/ O X
KANSL2 O X
subcomplex O X
reveals O X
how O X
WDR5 I-MISC 11091
is O X
recruited O X
into O X
the O X
NSL O X
complex O X
via O X
conserved O X
linear O X
motifs O X
of O X
KANSL1 I-MISC 284058
and O X
KANSL2 O X
. O X

Using O X
structure O X
- O X
based O X
KANSL1 I-MISC 284058
mutants O X
in O X
transgenic O X
flies O X
, O X
we O X
show O X
that O X
the O X
KANSL1 I-MISC 284058
- O X
WDR5 I-MISC 11091
interaction O X
is O X
required O X
for O X
proper O X
assembly O X
, O X
efficient O X
recruitment O X
of O X
the O X
NSL O X
complex O X
to O X
target O X
promoters O X
, O X
and O X
fly O X
viability O X
. O X

Our O X
data O X
clearly O X
show O X
that O X
the O X
interactions O X
of O X
WDR5 I-MISC 11091
with O X
the O X
MOF O X
- O X
containing O X
NSL O X
complex O X
and O X
MLL I-MISC 35523
/ O X
COMPASS O X
histone O X
methyltransferase O X
complexes O X
are O X
mutually O X
exclusive O X
. O X

We O X
propose O X
that O X
rather O X
than O X
being O X
a O X
shared O X
subunit O X
, O X
WDR5 I-MISC 11091
plays O X
an O X
important O X
role O X
in O X
assembling O X
distinct O X
histone O X
- O X
modifying O X
complexes O X
with O X
different O X
epigenetic O X
regulatory O X
roles O X
. O X

###20494986	881908,881982

Cochaperone O X
interactions O X
in O X
export O X
of O X
the O X
type O X
III O X
needle O X
component O X
PscF O X
of O X
Pseudomonas O X
aeruginosa O X
. O X

Type O X
III O X
secretion O X
( O X
T3S O X
) O X
systems O X
allow O X
the O X
export O X
and O X
translocation O X
of O X
bacterial O X
effectors O X
into O X
the O X
host O X
cell O X
cytoplasm O X
. O X

Secretion O X
is O X
accomplished O X
by O X
an O X
80 O X
- O X
nm O X
- O X
long O X
needle O X
- O X
like O X
structure O X
composed O X
, O X
in O X
Pseudomonas O X
aeruginosa O X
, O X
of O X
the O X
polymerized O X
form O X
of O X
a O X
7 O X
- O X
kDa O X
protein O X
, O X
PscF O X
. O X

Two O X
proteins O X
, O X
PscG I-MISC 881982
and O X
PscE I-MISC 881908
, O X
stabilize O X
PscF O X
within O X
the O X
bacterial O X
cell O X
before O X
its O X
export O X
and O X
polymerization O X
. O X

In O X
this O X
work O X
we O X
screened O X
the O X
1 O X
, O X
320 O X
- O X
A O X
( O X
2 O X
) O X
interface O X
between O X
the O X
two O X
chaperones O X
, O X
PscE I-MISC 881908
and O X
PscG I-MISC 881982
, O X
by O X
site O X
- O X
directed O X
mutagenesis O X
and O X
determined O X
hot O X
spot O X
regions O X
that O X
are O X
important O X
for O X
T3S O X
function O X
in O X
vivo O X
and O X
complex O X
formation O X
in O X
vitro O X
. O X

Three O X
amino O X
acids O X
in O X
PscE I-MISC 881908
and O X
five O X
amino O X
acids O X
in O X
PscG I-MISC 881982
, O X
found O X
to O X
be O X
relevant O X
for O X
complex O X
formation O X
, O X
map O X
to O X
the O X
central O X
part O X
of O X
the O X
interacting O X
surface O X
. O X

Stability O X
assays O X
on O X
selected O X
mutants O X
performed O X
both O X
in O X
vitro O X
on O X
purified O X
PscE I-MISC 881908
- O X
PscG I-MISC 881982
complexes O X
and O X
in O X
vivo O X
on O X
P O X
. O X
aeruginosa O X
revealed O X
that O X
PscE I-MISC 881908
is O X
a O X
cochaperone O X
that O X
is O X
essential O X
for O X
the O X
stability O X
of O X
the O X
main O X
chaperone O X
, O X
PscG I-MISC 881982
. O X

Notably O X
, O X
when O X
overexpressed O X
from O X
a O X
bicistronic O X
construct O X
, O X
PscG I-MISC 881982
and O X
PscF O X
compensate O X
for O X
the O X
absence O X
of O X
PscE I-MISC 881908
in O X
cytotoxic O X
P O X
. O X
aeruginosa O X
. O X

These O X
results O X
show O X
that O X
all O X
of O X
the O X
information O X
needed O X
for O X
needle O X
protein O X
stabilization O X
and O X
folding O X
, O X
its O X
presentation O X
to O X
the O X
T3 O X
secreton O X
, O X
and O X
its O X
export O X
is O X
present O X
within O X
the O X
sequence O X
of O X
the O X
PscG I-MISC 881982
chaperone O X
. O X

###11604410	331,27429

HtrA2 I-MISC 27429
promotes O X
cell O X
death O X
through O X
its O X
serine I-MISC 2147
protease I-MISC 2147
activity O X
and O X
its O X
ability O X
to O X
antagonize O X
inhibitor O X
of O X
apoptosis O X
proteins O X
. O X

Inhibitor O X
of O X
apoptosis O X
( O X
IAP O X
) O X
proteins O X
inhibit O X
caspases O X
, O X
a O X
function O X
counteracted O X
by O X
IAP O X
antagonists O X
, O X
insect O X
Grim O X
, O X
HID O X
, O X
and O X
Reaper O X
and O X
mammalian O X
DIABLO I-MISC 56616
/ O X
Smac I-MISC 56616
. O X

We O X
now O X
demonstrate O X
that O X
HtrA2 I-MISC 27429
, O X
a O X
mammalian O X
homologue O X
of O X
the O X
Escherichia O X
coli O X
heat O X
shock O X
- O X
inducible O X
protein O X
HtrA O X
, O X
can O X
bind O X
to O X
MIHA O X
/ O X
XIAP I-MISC 331
, O X
MIHB O X
, O X
and O X
baculoviral O X
OpIAP O X
but O X
not O X
survivin O X
. O X

Although O X
produced O X
as O X
a O X
50 O X
- O X
kDa O X
protein O X
, O X
HtrA2 I-MISC 27429
is O X
processed O X
to O X
yield O X
an O X
active O X
serine I-MISC 2147
protease I-MISC 2147
with O X
an O X
N O X
terminus O X
similar O X
to O X
that O X
of O X
Grim O X
, O X
Reaper O X
, O X
HID O X
, O X
and O X
DIABLO I-MISC 56616
/ O X
Smac I-MISC 56616
that O X
mediates O X
its O X
interaction O X
with O X
XIAP I-MISC 331
. O X

HtrA2 I-MISC 27429
is O X
largely O X
membrane O X
- O X
associated O X
in O X
healthy O X
cells O X
, O X
with O X
a O X
significant O X
proportion O X
observed O X
within O X
the O X
mitochondria O X
, O X
but O X
in O X
response O X
to O X
UV O X
irradiation O X
, O X
HtrA2 I-MISC 27429
shifts O X
into O X
the O X
cytosol O X
, O X
where O X
it O X
can O X
interact O X
with O X
IAPs O X
. O X

HtrA2 I-MISC 27429
can O X
, O X
like O X
DIABLO I-MISC 56616
/ O X
Smac I-MISC 56616
, O X
prevent O X
XIAP I-MISC 331
inhibition O X
of O X
active O X
caspase I-MISC 836
3 I-MISC 836
in O X
vitro O X
and O X
is O X
able O X
to O X
counteract O X
XIAP I-MISC 331
protection O X
of O X
mammalian O X
NT2 O X
cells O X
against O X
UV O X
- O X
induced O X
cell O X
death O X
. O X

The O X
proapoptotic O X
activity O X
of O X
HtrA2 I-MISC 27429
in O X
vivo O X
involves O X
both O X
IAP O X
binding O X
and O X
serine I-MISC 2147
protease I-MISC 2147
activity O X
. O X

Mutations O X
of O X
either O X
the O X
N O X
- O X
terminal O X
alanine O X
of O X
mature O X
HtrA2 I-MISC 27429
essential O X
for O X
IAP O X
interaction O X
or O X
the O X
catalytic O X
serine O X
residue O X
reduces O X
the O X
ability O X
of O X
HtrA2 I-MISC 27429
to O X
promote O X
cell O X
death O X
, O X
whereas O X
a O X
complete O X
loss O X
in O X
proapoptotic O X
activity O X
is O X
observed O X
when O X
both O X
sites O X
are O X
mutated O X
. O X

###14594800	801,355

Calmodulin I-MISC 801
binding O X
to O X
the O X
Fas I-MISC 355
death O X
domain O X
. O X

Regulation O X
by O X
Fas I-MISC 355
activation O X
. O X

Fas I-MISC 355
( O X
APO I-MISC 355
- I-MISC 355
1 I-MISC 355
/ O X
CD95 I-MISC 355
) O X
is O X
a O X
cell O X
surface O X
receptor O X
that O X
initiates O X
apoptotic O X
pathways O X
, O X
and O X
its O X
cytoplasmic O X
domain O X
interacts O X
with O X
various O X
molecules O X
suggesting O X
that O X
Fas I-MISC 355
signaling O X
is O X
complex O X
and O X
regulated O X
by O X
multiple O X
proteins O X
. O X

Calmodulin I-MISC 801
( O X
CaM I-MISC 801
) O X
is O X
an O X
intracellular O X
Ca O X
( O X
2 O X
+)- O X
binding O X
protein O X
, O X
and O X
it O X
mediates O X
many O X
of O X
the O X
effects O X
of O X
Ca2 O X
+. O X

Here O X
, O X
we O X
demonstrate O X
that O X
CaM I-MISC 801
binds O X
to O X
Fas I-MISC 355
directly O X
and O X
identify O X
the O X
CaM I-MISC 801
- O X
binding O X
site O X
on O X
the O X
cytoplasmic O X
death O X
domain O X
( O X
DD O X
) O X
of O X
Fas I-MISC 355
. O X

Fas I-MISC 355
binds O X
to O X
CaM I-MISC 801
- O X
Sepharose O X
and O X
is O X
co O X
- O X
immunoprecipitated O X
with O X
CaM I-MISC 801
. O X

Other O X
death O X
receptors O X
, O X
such O X
as O X
tumor O X
necrosis O X
factor O X
receptor O X
, O X
DR4 O X
, O X
and O X
DR5 I-MISC 21933
do O X
not O X
bind O X
to O X
CaM I-MISC 801
. O X

The O X
interaction O X
between O X
Fas I-MISC 355
and O X
CaM I-MISC 801
is O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
. O X

Deletion O X
mapping O X
analysis O X
with O X
various O X
GST O X
- O X
fused O X
Fas I-MISC 355
cytoplasmic O X
domain O X
fragments O X
revealed O X
that O X
the O X
fragment O X
containing O X
helices O X
1 O X
, O X
2 O X
, O X
and O X
3 O X
of O X
the O X
Fas I-MISC 355
DD O X
has O X
the O X
CaM I-MISC 801
- O X
binding O X
ability O X
. O X

Sequence O X
analysis O X
of O X
this O X
fragment O X
predicted O X
a O X
potential O X
CaM I-MISC 801
- O X
binding O X
site O X
in O X
helix O X
2 O X
and O X
connected O X
loops O X
. O X

A O X
valine O X
254 O X
to O X
asparagine O X
mutation O X
in O X
this O X
region O X
, O X
which O X
is O X
analogous O X
to O X
the O X
identified O X
mutant O X
allele O X
of O X
Fas I-MISC 355
in O X
lpr O X
mice O X
that O X
have O X
a O X
deficiency O X
in O X
Fas I-MISC 355
- O X
mediated O X
apoptosis O X
, O X
showed O X
reduced O X
CaM I-MISC 801
binding O X
. O X

Computer O X
modeling O X
of O X
the O X
interaction O X
between O X
CaM I-MISC 801
and O X
helix O X
2 O X
of O X
the O X
Fas I-MISC 355
DD O X
predicted O X
that O X
amino O X
acids O X
, O X
which O X
are O X
important O X
for O X
Fas I-MISC 355
- O X
CaM I-MISC 801
binding O X
, O X
and O X
point O X
mutations O X
of O X
these O X
amino O X
acids O X
caused O X
reduced O X
Fas I-MISC 355
- O X
CaM I-MISC 801
binding O X
. O X

The O X
interaction O X
between O X
Fas I-MISC 355
and O X
CaM I-MISC 801
is O X
increased O X
approximately O X
2 O X
- O X
fold O X
early O X
upon O X
Fas I-MISC 355
activation O X
( O X
at O X
30 O X
min O X
) O X
and O X
is O X
decreased O X
to O X
approximately O X
50 O X
% O X
of O X
control O X
at O X
2 O X
h O X
. O X
These O X
findings O X
suggest O X
a O X
novel O X
function O X
of O X
CaM I-MISC 801
in O X
Fas I-MISC 355
- O X
mediated O X
apoptosis O X
. O X

###12634384	142,29031017

The O X
abundant O X
nuclear O X
enzyme O X
PARP I-MISC 142
participates O X
in O X
the O X
life O X
cycle O X
of O X
simian O X
virus O X
40 O X
and O X
is O X
stimulated O X
by O X
minor I-MISC 29031017
capsid I-MISC 29031017
protein I-MISC 29031017
VP3 I-MISC 29031017
. O X

The O X
abundant O X
nuclear O X
enzyme O X
poly I-MISC 142
( I-MISC 142
ADP I-MISC 142
- I-MISC 142
ribose I-MISC 142
) I-MISC 142
polymerase I-MISC 142
( O X
PARP I-MISC 142
) O X
functions O X
in O X
DNA O X
damage O X
surveillance O X
and O X
repair O X
and O X
at O X
the O X
decision O X
between O X
apoptosis O X
and O X
necrosis O X
. O X

Here O X
we O X
show O X
that O X
PARP I-MISC 142
binds O X
to O X
simian O X
virus O X
40 O X
( O X
SV40 O X
) O X
capsid O X
proteins O X
VP1 O X
and O X
VP3 I-MISC 29031017
. O X

Furthermore O X
, O X
its O X
enzymatic O X
activity O X
is O X
stimulated O X
by O X
VP3 I-MISC 29031017
but O X
not O X
by O X
VP1 O X
. O X

Experiments O X
with O X
purified O X
mutant O X
proteins O X
demonstrated O X
that O X
the O X
PARP I-MISC 142
binding O X
domain O X
in O X
VP3 I-MISC 29031017
is O X
localized O X
to O X
the O X
35 O X
carboxy O X
- O X
terminal O X
amino O X
acids O X
, O X
while O X
a O X
larger O X
peptide O X
of O X
49 O X
amino O X
acids O X
was O X
required O X
for O X
full O X
stimulation O X
of O X
its O X
activity O X
. O X

The O X
addition O X
of O X
3 O X
- O X
aminobenzamide O X
( O X
3 O X
- O X
AB O X
), O X
a O X
known O X
competitive O X
inhibitor O X
of O X
PARP I-MISC 142
, O X
demonstrated O X
that O X
PARP I-MISC 142
participates O X
in O X
the O X
SV40 O X
life O X
cycle O X
. O X

The O X
titer O X
of O X
SV40 O X
propagated O X
on O X
CV O X
- O X
1 O X
cells O X
was O X
reduced O X
by O X
3 O X
- O X
AB O X
in O X
a O X
dose O X
- O X
dependent O X
manner O X
. O X

Additional O X
experiments O X
showed O X
that O X
3 O X
- O X
AB O X
did O X
not O X
affect O X
viral O X
DNA O X
replication O X
or O X
capsid O X
protein O X
production O X
. O X

PARP I-MISC 142
did O X
not O X
modify O X
the O X
viral O X
capsid O X
proteins O X
in O X
in O X
vitro O X
poly O X
( O X
ADP O X
- O X
ribosylation O X
) O X
assays O X
, O X
implying O X
that O X
it O X
does O X
not O X
affect O X
SV40 O X
infectivity O X
. O X

On O X
the O X
other O X
hand O X
, O X
it O X
greatly O X
reduced O X
the O X
magnitude O X
of O X
the O X
host O X
cytopathic O X
effects O X
, O X
a O X
hallmark O X
of O X
SV40 O X
infection O X
. O X

Additional O X
experiments O X
suggested O X
that O X
the O X
stimulation O X
of O X
PARP I-MISC 142
activity O X
by O X
VP3 I-MISC 29031017
leads O X
the O X
infected O X
cell O X
to O X
a O X
necrotic O X
pathway O X
, O X
characterized O X
by O X
the O X
loss O X
of O X
membrane O X
integrity O X
, O X
thus O X
facilitating O X
the O X
release O X
of O X
mature O X
SV40 O X
virions O X
from O X
the O X
cells O X
. O X

Our O X
studies O X
identified O X
a O X
novel O X
function O X
of O X
the O X
minor O X
capsid O X
protein O X
VP3 I-MISC 29031017
in O X
the O X
recruitment O X
of O X
PARP I-MISC 142
for O X
the O X
SV40 O X
lytic O X
process O X
. O X

###12221107	26119,163	26119,3949

ARH I-MISC 26119
is O X
a O X
modular O X
adaptor O X
protein O X
that O X
interacts O X
with O X
the O X
LDL I-MISC 3949
receptor I-MISC 3949
, O X
clathrin O X
, O X
and O X
AP O X
- O X
2 O X
. O X

Mutations O X
in O X
the O X
phosphotyrosine O X
binding O X
domain O X
protein O X
ARH I-MISC 26119
cause O X
autosomal O X
recessive O X
hypercholesterolemia O X
, O X
a O X
disorder O X
caused O X
by O X
defective O X
internalization O X
of O X
low I-MISC 3949
density I-MISC 3949
lipoprotein I-MISC 3949
receptors I-MISC 3949
( O X
LDLR I-MISC 3949
) O X
in O X
the O X
liver O X
. O X

To O X
examine O X
the O X
function O X
of O X
ARH I-MISC 26119
, O X
we O X
used O X
pull O X
- O X
down O X
experiments O X
to O X
test O X
for O X
interactions O X
between O X
ARH I-MISC 26119
, O X
the O X
LDLR I-MISC 3949
, O X
and O X
proteins O X
involved O X
in O X
clathrin O X
- O X
mediated O X
endocytosis O X
. O X

The O X
phosphotyrosine O X
binding O X
domain O X
of O X
ARH I-MISC 26119
interacted O X
with O X
the O X
internalization O X
sequence O X
( O X
NPVY O X
) O X
in O X
the O X
cytoplasmic O X
tail O X
of O X
LDLR I-MISC 3949
in O X
a O X
sequence O X
- O X
specific O X
manner O X
. O X

Mutations O X
in O X
the O X
NPVY O X
sequence O X
that O X
were O X
previously O X
shown O X
to O X
decrease O X
LDLR I-MISC 3949
internalization O X
abolished O X
in O X
vitro O X
binding O X
to O X
ARH I-MISC 26119
. O X

Recombinant O X
ARH I-MISC 26119
bound O X
purified O X
bovine O X
clathrin O X
with O X
high O X
affinity O X
( O X
K O X
( O X
D O X
), O X
approximately O X
44 O X
nm O X
). O X

The O X
interaction O X
between O X
ARH I-MISC 26119
and O X
clathrin O X
was O X
mapped O X
to O X
a O X
canonical O X
clathrin O X
box O X
sequence O X
( O X
LLDLE O X
) O X
in O X
ARH I-MISC 26119
and O X
to O X
the O X
N O X
- O X
terminal O X
domain O X
of O X
the O X
clathrin O X
heavy O X
chain O X
. O X

A O X
highly O X
conserved O X
20 O X
- O X
amino O X
acid O X
sequence O X
in O X
the O X
C O X
- O X
terminal O X
region O X
of O X
ARH I-MISC 26119
bound O X
the O X
beta I-MISC 163
( I-MISC 163
2 I-MISC 163
)- I-MISC 163
adaptin I-MISC 163
subunit O X
of O X
AP O X
- O X
2 O X
. O X

Mutation O X
of O X
a O X
glutamic O X
acid O X
residue O X
in O X
the O X
appendage O X
domain O X
of O X
beta I-MISC 163
( I-MISC 163
2 I-MISC 163
)- I-MISC 163
adaptin I-MISC 163
that O X
is O X
required O X
for O X
interaction O X
with O X
the O X
adapter O X
protein O X
beta O X
- O X
arrestin O X
markedly O X
reduced O X
binding O X
to O X
ARH I-MISC 26119
. O X

These O X
data O X
are O X
consistent O X
with O X
the O X
hypothesis O X
that O X
ARH I-MISC 26119
functions O X
as O X
an O X
adaptor O X
protein O X
that O X
couples O X
LDLR I-MISC 3949
to O X
the O X
endocytic O X
machinery O X
. O X

###14707132	9943,29431

Characterization O X
of O X
OSR1 I-MISC 9943
, O X
a O X
member O X
of O X
the O X
mammalian O X
Ste20p I-MISC 8428
/ O X
germinal O X
center O X
kinase O X
subfamily O X
. O X

In O X
examining O X
the O X
protein O X
kinase O X
components O X
of O X
mitogen O X
- O X
activated O X
protein O X
( O X
MAP O X
) O X
kinase O X
( O X
MAPK O X
) O X
cascades O X
that O X
regulate O X
the O X
c I-MISC 44801
- I-MISC 44801
Jun I-MISC 44801
N I-MISC 44801
- I-MISC 44801
terminal I-MISC 44801
kinase I-MISC 44801
( O X
JNK I-MISC 44801
) O X
in O X
Drosophila O X
S2 O X
cells O X
, O X
we O X
previously O X
found O X
that O X
distinct O X
upstream O X
kinases O X
were O X
involved O X
in O X
responses O X
to O X
sorbitol O X
and O X
lipopolysaccharide O X
. O X

Here O X
we O X
have O X
extended O X
that O X
analysis O X
to O X
the O X
possible O X
MAPK O X
kinase O X
kinase O X
kinases O X
( O X
MAP4Ks O X
) O X
in O X
the O X
JNK I-MISC 5599
pathway O X
. O X

Fray O X
, O X
a O X
putative O X
Drosophila O X
MAP4K O X
, O X
provided O X
a O X
major O X
contribution O X
to O X
JNK I-MISC 44801
activation O X
by O X
sorbitol O X
. O X

To O X
explore O X
the O X
possible O X
link O X
to O X
JNK I-MISC 5599
in O X
mammalian O X
cells O X
, O X
we O X
isolated O X
and O X
characterized O X
OSR1 I-MISC 9943
( O X
oxidative I-MISC 9943
stress I-MISC 9943
- I-MISC 9943
responsive I-MISC 9943
1 I-MISC 9943
), O X
one O X
of O X
two O X
human O X
Fray O X
homologs O X
. O X

OSR1 I-MISC 9943
is O X
a O X
58 O X
- O X
kDa O X
protein O X
of O X
527 O X
amino O X
acids O X
that O X
is O X
widely O X
expressed O X
in O X
mammalian O X
tissues O X
and O X
cell O X
lines O X
. O X

Of O X
potential O X
regulators O X
surveyed O X
, O X
endogenous O X
OSR1 I-MISC 9943
is O X
activated O X
only O X
by O X
osmotic O X
stresses O X
, O X
notably O X
sorbitol O X
and O X
to O X
a O X
lesser O X
extent O X
NaCl O X
. O X

However O X
, O X
OSR1 I-MISC 9943
did O X
not O X
increase O X
the O X
activity O X
of O X
coexpressed O X
JNK I-MISC 5599
, O X
nor O X
did O X
it O X
activate O X
three O X
other O X
MAPKs O X
, O X
p38 I-MISC 5594
, O X
ERK2 I-MISC 5594
, O X
and O X
ERK5 I-MISC 5598
. O X

A O X
two O X
- O X
hybrid O X
screen O X
implicated O X
another O X
Ste20p I-MISC 8428
family O X
member O X
, O X
the O X
p21 I-MISC 644914
- O X
activated O X
protein O X
kinase O X
PAK1 I-MISC 29431
, O X
as O X
an O X
OSR1 I-MISC 9943
target O X
. O X

OSR1 I-MISC 9943
phosphorylated O X
threonine O X
84 O X
in O X
the O X
N O X
- O X
terminal O X
regulatory O X
domain O X
of O X
PAK1 I-MISC 29431
. O X

Replacement O X
of O X
threonine O X
84 O X
with O X
glutamate O X
reduced O X
the O X
activation O X
of O X
PAK1 I-MISC 29431
by O X
an O X
active O X
form O X
of O X
the O X
small O X
G O X
protein O X
Cdc42 I-MISC 998
, O X
suggesting O X
that O X
phosphorylation O X
by O X
OSR1 I-MISC 9943
modulates O X
the O X
G O X
protein O X
sensitivity O X
of O X
PAK O X
isoforms O X
. O X

###17586626	877855,877852	877851,877855

Assembly O X
of O X
the O X
MexAB I-MISC 877855,877852
- O X
OprM I-MISC 877851
multidrug O X
pump O X
of O X
Pseudomonas O X
aeruginosa O X
: O X
component O X
interactions O X
defined O X
by O X
the O X
study O X
of O X
pump O X
mutant O X
suppressors O X
. O X

In O X
an O X
effort O X
to O X
identify O X
key O X
domains O X
of O X
the O X
Pseudomonas O X
aeruginosa O X
MexAB I-MISC 877855,877852
- O X
OprM O X
drug O X
efflux O X
system O X
involved O X
in O X
component O X
interactions O X
, O X
extragenic O X
suppressors O X
of O X
various O X
inactivating O X
mutations O X
in O X
individual O X
pump O X
constituents O X
were O X
isolated O X
and O X
studied O X
. O X

The O X
multidrug O X
hypersusceptibility O X
of O X
P O X
. O X
aeruginosa O X
expressing O X
MexB I-MISC 877852
with O X
a O X
mutation O X
in O X
a O X
region O X
of O X
the O X
protein O X
implicated O X
in O X
oligomerization O X
( O X
G220S O X
) O X
was O X
suppressed O X
by O X
mutations O X
in O X
the O X
alpha O X
/ O X
beta O X
domain O X
of O X
MexA I-MISC 877855
. O X

MexB I-MISC 877852
( O X
G220S O X
) O X
showed O X
a O X
reduced O X
ability O X
to O X
bind O X
MexA I-MISC 877855
in O X
vivo O X
while O X
representative O X
MexA I-MISC 877855
suppressors O X
( O X
V66M O X
and O X
V259F O X
) O X
restored O X
the O X
MexA I-MISC 877855
- O X
MexB I-MISC 877852
interaction O X
. O X

Interestingly O X
, O X
these O X
suppressors O X
also O X
restored O X
resistance O X
in O X
P O X
. O X
aeruginosa O X
expressing O X
OprM O X
proteins O X
with O X
mutations O X
at O X
the O X
proximal O X
( O X
periplasmic O X
) O X
tip O X
of O X
OprM O X
that O X
is O X
predicted O X
to O X
interact O X
with O X
MexB I-MISC 877852
, O X
suggesting O X
that O X
these O X
suppressors O X
generally O X
overcame O X
defects O X
in O X
MexA I-MISC 877855
- O X
MexB I-MISC 877852
and O X
MexB I-MISC 877852
- O X
OprM O X
interaction O X
. O X

The O X
multidrug O X
hypersusceptibility O X
arising O X
from O X
a O X
mutation O X
in O X
the O X
helical O X
hairpin O X
of O X
MexA I-MISC 877855
implicated O X
in O X
OprM O X
interaction O X
( O X
V129M O X
) O X
was O X
suppressed O X
by O X
mutations O X
( O X
T198I O X
and O X
F439I O X
) O X
in O X
the O X
periplasmic O X
alpha O X
- O X
helical O X
barrel O X
of O X
OprM O X
. O X

Again O X
, O X
the O X
MexA I-MISC 877855
mutation O X
compromised O X
an O X
in O X
vivo O X
interaction O X
with O X
OprM O X
that O X
was O X
restored O X
by O X
the O X
T198I O X
and O X
F439I O X
substitutions O X
in O X
OprM O X
, O X
consistent O X
with O X
the O X
hairpin O X
domain O X
mediating O X
MexA I-MISC 877855
binding O X
to O X
this O X
region O X
of O X
OprM O X
. O X

Interestingly O X
, O X
these O X
OprM O X
suppressor O X
mutations O X
restored O X
multidrug O X
resistance O X
in O X
P O X
. O X
aeruginosa O X
expressing O X
MexB I-MISC 877852
( O X
G220S O X
). O X

Finally O X
, O X
the O X
oprM O X
( O X
T198I O X
) O X
suppressor O X
mutation O X
enhanced O X
the O X
yields O X
of O X
all O X
three O X
constituents O X
of O X
a O X
MexA I-MISC 877855
- O X
MexB I-MISC 877852
- O X
OprM O X
( O X
T198I O X
) O X
pump O X
as O X
detected O X
in O X
whole O X
- O X
cell O X
extracts O X
. O X

These O X
data O X
highlight O X
the O X
importance O X
of O X
MexA I-MISC 877855
and O X
interactions O X
with O X
this O X
adapter O X
in O X
promoting O X
MexAB O X
- O X
OprM O X
pump O X
assembly O X
and O X
in O X
stabilizing O X
the O X
pump O X
complex O X
. O X

###16488394	7454,7456

WASP I-MISC 7454
suppresses O X
the O X
growth O X
defect O X
of O X
Saccharomyces O X
cerevisiae O X
las17Delta O X
strain O X
in O X
the O X
presence O X
of O X
WIP I-MISC 7456
. O X

Wiskott O X
- O X
Aldrich O X
syndrome O X
is O X
caused O X
by O X
alterations O X
in O X
the O X
Wiskott O X
- O X
Aldrich O X
syndrome O X
protein O X
( O X
WASP I-MISC 7454
) O X
and O X
several O X
of O X
these O X
mutations O X
affect O X
WASP I-MISC 7454
' O X
s O X
interaction O X
with O X
WIP I-MISC 7456
( O X
WASP I-MISC 7456
- I-MISC 7456
interacting I-MISC 7456
protein I-MISC 7456
), O X
suggesting O X
that O X
loss O X
of O X
interaction O X
between O X
WASP I-MISC 7454
and O X
WIP I-MISC 7456
is O X
causal O X
to O X
the O X
disease O X
. O X

Las17p O X
is O X
the O X
yeast O X
homologue O X
of O X
WASP I-MISC 7454
and O X
las17Delta O X
strain O X
is O X
unable O X
to O X
grow O X
at O X
37 O X
degrees O X
C O X
. O X
We O X
show O X
that O X
Human O X
WASP I-MISC 7454
suppresses O X
the O X
growth O X
defect O X
of O X
Saccharomyces O X
cerevisiae O X
las17Delta O X
strain O X
, O X
only O X
in O X
the O X
presence O X
of O X
WIP I-MISC 7456
. O X

WIP I-MISC 7456
mediates O X
cortical O X
localisation O X
of O X
WASP I-MISC 7454
as O X
well O X
as O X
stabilise O X
WASP I-MISC 7454
in O X
yeast O X
cells O X
. O X

Mutations O X
which O X
affected O X
WASP I-MISC 7454
- O X
WIP I-MISC 7456
interaction O X
abolished O X
WASP I-MISC 7454
' O X
s O X
ability O X
to O X
suppress O X
the O X
growth O X
defect O X
of O X
las17Delta O X
strain O X
. O X

We O X
have O X
demonstrated O X
that O X
WASP I-MISC 7454
- O X
WIP I-MISC 7456
is O X
an O X
active O X
complex O X
and O X
WASP I-MISC 7454
' O X
s O X
ability O X
to O X
suppress O X
the O X
growth O X
defect O X
of O X
las17Delta O X
strain O X
is O X
dependent O X
on O X
the O X
presence O X
of O X
a O X
functional O X
Arp2 O X
/ O X
3 O X
activating O X
domain O X
of O X
WASP I-MISC 7454
and O X
also O X
the O X
Verprolin O X
domain O X
( O X
V O X
) O X
of O X
WIP I-MISC 7456
. O X

###20953186	7189,10758

Common O X
variants O X
at O X
TRAF3IP2 I-MISC 10758
are O X
associated O X
with O X
susceptibility O X
to O X
psoriatic O X
arthritis O X
and O X
psoriasis O X
. O X

Psoriatic O X
arthritis O X
( O X
PsA O X
) O X
is O X
an O X
inflammatory O X
joint O X
disease O X
that O X
is O X
distinct O X
from O X
other O X
chronic O X
arthritides O X
and O X
which O X
is O X
frequently O X
accompanied O X
by O X
psoriasis O X
vulgaris O X
( O X
PsV O X
) O X
and O X
seronegativity O X
for O X
rheumatoid O X
factor O X
. O X

We O X
conducted O X
a O X
genome O X
- O X
wide O X
association O X
study O X
in O X
609 O X
German O X
individuals O X
with O X
PsA O X
( O X
cases O X
) O X
and O X
990 O X
controls O X
with O X
replication O X
in O X
6 O X
European O X
cohorts O X
including O X
a O X
total O X
of O X
5 O X
, O X
488 O X
individuals O X
. O X

We O X
replicated O X
PsA O X
associations O X
at O X
HLA O X
- O X
C O X
and O X
IL12B I-MISC 3593
and O X
identified O X
a O X
new O X
association O X
at O X
TRAF3IP2 I-MISC 10758
( O X
rs13190932 O X
, O X
P O X
= O X
8 O X
. O X
56 O X
* O X
10 O X
). O X

TRAF3IP2 I-MISC 10758
was O X
also O X
associated O X
with O X
PsV O X
in O X
a O X
German O X
cohort O X
including O X
2 O X
, O X
040 O X
individuals O X
( O X
rs13190932 O X
, O X
P O X
= O X
1 O X
. O X
95 O X
* O X
10 O X
). O X

Sequencing O X
of O X
the O X
exons O X
of O X
TRAF3IP2 I-MISC 10758
identified O X
a O X
coding O X
variant O X
( O X
p O X
. O X
Asp10Asn O X
, O X
rs33980500 O X
) O X
as O X
the O X
most O X
significantly O X
associated O X
SNP O X
( O X
P O X
= O X
1 O X
. O X
13 O X
* O X
10 O X
, O X
odds O X
ratio O X
= O X
1 O X
. O X
95 O X
). O X

Functional O X
assays O X
showed O X
reduced O X
binding O X
of O X
this O X
TRAF3IP2 I-MISC 10758
variant O X
to O X
TRAF6 I-MISC 7189
, O X
suggesting O X
altered O X
modulation O X
of O X
immunoregulatory O X
signals O X
through O X
altered O X
TRAF O X
interactions O X
as O X
a O X
new O X
and O X
shared O X
pathway O X
for O X
PsA O X
and O X
PsV O X
. O X

###19242489	3691,5339

Structural O X
basis O X
of O X
the O X
interaction O X
between O X
integrin I-MISC 3691
alpha6beta4 I-MISC 3691
and O X
plectin I-MISC 5339
at O X
the O X
hemidesmosomes O X
. O X

The O X
interaction O X
between O X
the O X
integrin I-MISC 3691
alpha6beta4 I-MISC 3691
and O X
plectin I-MISC 5339
is O X
essential O X
for O X
the O X
assembly O X
and O X
stability O X
of O X
hemidesmosomes O X
, O X
which O X
are O X
junctional O X
adhesion O X
complexes O X
that O X
anchor O X
epithelial O X
cells O X
to O X
the O X
basement O X
membrane O X
. O X

We O X
describe O X
the O X
crystal O X
structure O X
at O X
2 O X
. O X
75 O X
A O X
resolution O X
of O X
the O X
primary O X
alpha6beta4 I-MISC 3691
- O X
plectin I-MISC 5339
complex O X
, O X
formed O X
by O X
the O X
first O X
pair O X
of O X
fibronectin O X
type O X
III O X
domains O X
and O X
the O X
N O X
- O X
terminal O X
region O X
of O X
the O X
connecting O X
segment O X
of O X
beta4 I-MISC 3691
and O X
the O X
actin O X
- O X
binding O X
domain O X
of O X
plectin I-MISC 5339
. O X

Two O X
missense O X
mutations O X
in O X
beta4 I-MISC 3691
( O X
R1225H O X
and O X
R1281W O X
) O X
linked O X
to O X
nonlethal O X
forms O X
of O X
epidermolysis O X
bullosa O X
prevent O X
essential O X
intermolecular O X
contacts O X
. O X

We O X
also O X
present O X
two O X
structures O X
at O X
1 O X
. O X
75 O X
and O X
2 O X
. O X
05 O X
A O X
resolution O X
of O X
the O X
beta4 I-MISC 3691
moiety O X
in O X
the O X
absence O X
of O X
plectin I-MISC 5339
, O X
which O X
reveal O X
a O X
major O X
rearrangement O X
of O X
the O X
connecting O X
segment O X
of O X
beta4 I-MISC 3691
on O X
binding O X
to O X
plectin I-MISC 5339
. O X

This O X
conformational O X
switch O X
is O X
correlated O X
with O X
the O X
way O X
alpha6beta4 I-MISC 3691
promotes O X
stable O X
adhesion O X
or O X
cell O X
migration O X
and O X
suggests O X
an O X
allosteric O X
control O X
of O X
the O X
integrin O X
. O X

###16619031	853752,853355

A O X
CDK O X
- O X
catalysed O X
regulatory O X
phosphorylation O X
for O X
formation O X
of O X
the O X
DNA O X
replication O X
complex O X
Sld2 I-MISC 853752
- O X
Dpb11 I-MISC 853355
. O X

Phosphorylation O X
often O X
regulates O X
protein O X
- O X
protein O X
interactions O X
to O X
control O X
biological O X
reactions O X
. O X

The O X
Sld2 I-MISC 853752
and O X
Dpb11 I-MISC 853355
proteins O X
of O X
budding O X
yeast O X
form O X
a O X
phosphorylation O X
- O X
dependent O X
complex O X
that O X
is O X
essential O X
for O X
chromosomal O X
DNA O X
replication O X
. O X

The O X
Sld2 I-MISC 853752
protein O X
has O X
a O X
cluster O X
of O X
11 O X
cyclin O X
- O X
dependent O X
kinase O X
( O X
CDK O X
) O X
phosphorylation O X
motifs O X
( O X
Ser O X
/ O X
Thr O X
- O X
Pro O X
), O X
six O X
of O X
which O X
match O X
the O X
canonical O X
sequences O X
Ser O X
/ O X
Thr O X
- O X
Pro O X
- O X
X O X
- O X
Lys O X
/ O X
Arg O X
, O X
Lys O X
/ O X
Arg O X
- O X
Ser O X
/ O X
Thr O X
- O X
Pro O X
and O X
Ser O X
/ O X
Thr O X
- O X
Pro O X
- O X
Lys O X
/ O X
Arg O X
. O X

Simultaneous O X
alanine O X
substitution O X
for O X
serine O X
or O X
threonine O X
in O X
all O X
the O X
canonical O X
CDK O X
- O X
phosphorylation O X
motifs O X
severely O X
reduces O X
complex O X
formation O X
between O X
Sld2 I-MISC 853752
and O X
Dpb11 I-MISC 853355
, O X
and O X
inhibits O X
DNA O X
replication O X
. O X

Here O X
we O X
show O X
that O X
phosphorylation O X
of O X
these O X
canonical O X
motifs O X
does O X
not O X
play O X
a O X
direct O X
role O X
in O X
complex O X
formation O X
, O X
but O X
rather O X
regulates O X
phosphorylation O X
of O X
another O X
residue O X
, O X
Thr84 O X
. O X

This O X
constitutes O X
a O X
non O X
- O X
canonical O X
CDK O X
- O X
phosphorylation O X
motif O X
within O X
a O X
28 O X
- O X
amino O X
- O X
acid O X
sequence O X
that O X
is O X
responsible O X
, O X
after O X
phosphorylation O X
, O X
for O X
binding O X
of O X
Sld2 I-MISC 853752
- O X
Dpb11 I-MISC 853355
. O X

We O X
further O X
suggest O X
that O X
CDK O X
- O X
catalysed O X
phosphorylation O X
of O X
sites O X
other O X
than O X
Thr84 O X
renders O X
Thr84 O X
accessible O X
to O X
CDK O X
. O X

Finally O X
, O X
we O X
argue O X
that O X
this O X
novel O X
mechanism O X
sets O X
a O X
threshold O X
of O X
CDK O X
activity O X
for O X
formation O X
of O X
the O X
essential O X
Sld2 I-MISC 853752
to O X
Dpb11 I-MISC 853355
complex O X
and O X
therefore O X
prevents O X
premature O X
DNA O X
replication O X
. O X

###15226396	395964,2241

Continuous O X
association O X
of O X
cadherin O X
with O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
requires O X
the O X
non O X
- O X
receptor O X
tyrosine O X
- O X
kinase O X
Fer I-MISC 2241
. O X

The O X
function O X
of O X
Type O X
1 O X
, O X
classic O X
cadherins O X
depends O X
on O X
their O X
association O X
with O X
the O X
actin O X
cytoskeleton O X
, O X
a O X
connection O X
mediated O X
by O X
alpha O X
- O X
and O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
. O X

The O X
phosphorylation O X
state O X
of O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
is O X
crucial O X
for O X
its O X
association O X
with O X
cadherin O X
and O X
thus O X
the O X
association O X
of O X
cadherin O X
with O X
the O X
cytoskeleton O X
. O X

We O X
now O X
show O X
that O X
the O X
phosphorylation O X
of O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
is O X
regulated O X
by O X
the O X
combined O X
activities O X
of O X
the O X
tyrosine O X
kinase O X
Fer I-MISC 2241
and O X
the O X
tyrosine O X
phosphatase O X
PTP1B I-MISC 19246
. O X

Fer I-MISC 2241
phosphorylates O X
PTP1B I-MISC 19246
at O X
tyrosine O X
152 O X
, O X
regulating O X
its O X
binding O X
to O X
cadherin O X
and O X
the O X
continuous O X
dephosphorylation O X
of O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
at O X
tyrosine O X
654 O X
. O X

Fer I-MISC 2241
interacts O X
with O X
cadherin O X
indirectly O X
, O X
through O X
p120ctn I-MISC 12388
. O X

We O X
have O X
mapped O X
the O X
interaction O X
domains O X
of O X
Fer I-MISC 2241
and O X
p120ctn I-MISC 12388
and O X
peptides O X
corresponding O X
to O X
these O X
sequences O X
release O X
Fer I-MISC 2241
from O X
p120ctn I-MISC 12388
in O X
vitro O X
and O X
in O X
live O X
cells O X
, O X
resulting O X
in O X
loss O X
of O X
cadherin O X
- O X
associated O X
PTP1B I-MISC 19246
, O X
an O X
increase O X
in O X
the O X
pool O X
of O X
tyrosine O X
phosphorylated O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
and O X
loss O X
of O X
cadherin O X
adhesion O X
function O X
. O X

The O X
effect O X
of O X
the O X
peptides O X
is O X
lost O X
when O X
a O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
mutant O X
with O X
a O X
substitution O X
at O X
tyrosine O X
654 O X
is O X
introduced O X
into O X
cells O X
. O X

Thus O X
, O X
Fer I-MISC 2241
phosphorylates O X
PTP1B I-MISC 19246
at O X
tyrosine O X
152 O X
enabling O X
it O X
to O X
bind O X
to O X
the O X
cytoplasmic O X
domain O X
of O X
cadherin O X
, O X
where O X
it O X
maintains O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
in O X
a O X
dephosphorylated O X
state O X
. O X

Cultured O X
fibroblasts O X
from O X
mouse O X
embryos O X
targeted O X
with O X
a O X
kinase O X
- O X
inactivating O X
ferD743R O X
mutation O X
have O X
lost O X
cadherin O X
- O X
associated O X
PTP1B I-MISC 19246
and O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
, O X
as O X
well O X
as O X
localization O X
of O X
cadherin O X
and O X
beta I-MISC 395964
- I-MISC 395964
catenin I-MISC 395964
in O X
areas O X
of O X
cell O X
- O X
cell O X
contacts O X
. O X

Expression O X
of O X
wild O X
- O X
type O X
Fer I-MISC 2241
or O X
culture O X
in O X
epidermal O X
growth O X
factor O X
restores O X
the O X
cadherin O X
complex O X
and O X
localization O X
at O X
cell O X
- O X
cell O X
contacts O X
. O X

###9398522	945829,945829

Clarification O X
of O X
the O X
dimerization O X
domain O X
and O X
its O X
functional O X
significance O X
for O X
the O X
Escherichia O X
coli O X
nucleoid O X
protein O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

The O X
Escherichia O X
coli O X
nucleoid O X
protein O X
, O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
, O X
functions O X
as O X
a O X
global O X
regulator O X
for O X
expression O X
of O X
a O X
wide O X
variety O X
of O X
genes O X
. O X

We O X
recently O X
analyzed O X
the O X
structure O X
- O X
function O X
relationship O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
with O X
special O X
reference O X
to O X
the O X
domains O X
responsible O X
for O X
transcriptional O X
repression O X
and O X
DNA O X
- O X
binding O X
, O X
respectively O X
. O X

However O X
, O X
identification O X
of O X
the O X
presumed O X
dimerization O X
domain O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
and O X
its O X
functional O X
significance O X
was O X
elusive O X
. O X

To O X
address O X
this O X
particular O X
issue O X
, O X
we O X
first O X
examined O X
a O X
set O X
of O X
N O X
- O X
terminally O X
or O X
C O X
- O X
terminally O X
truncated O X
forms O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
, O X
in O X
terms O X
of O X
their O X
so O X
- O X
called O X
dominant O X
- O X
negative O X
effect O X
on O X
the O X
in O X
vivo O X
function O X
of O X
the O X
wild O X
- O X
type O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

The O X
results O X
showed O X
that O X
certain O X
truncated O X
forms O X
exhibit O X
such O X
a O X
dominant O X
- O X
negative O X
effect O X
, O X
but O X
others O X
did O X
not O X
. O X

As O X
judged O X
by O X
the O X
results O X
of O X
the O X
dominant O X
- O X
negative O X
effect O X
, O X
it O X
was O X
assumed O X
that O X
a O X
relatively O X
central O X
portion O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
extending O X
from O X
residues O X
21 O X
to O X
63 O X
is O X
involved O X
in O X
dimerization O X
. O X

This O X
was O X
confirmed O X
by O X
an O X
in O X
vitro O X
chemical O X
cross O X
- O X
linking O X
analysis O X
and O X
a O X
gel O X
filtration O X
analysis O X
with O X
these O X
truncated O X
forms O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

Furthermore O X
, O X
the O X
use O X
of O X
the O X
dominant O X
- O X
negative O X
phenotype O X
, O X
caused O X
by O X
a O X
truncated O X
form O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
( O X
named O X
N91 O X
), O X
allowed O X
us O X
to O X
isolate O X
a O X
missense O X
mutant O X
, O X
which O X
was O X
expected O X
to O X
be O X
specifically O X
defective O X
in O X
dimerization O X
. O X

This O X
mutant O X
had O X
an O X
amino O X
acid O X
substitution O X
at O X
position O X
30 O X
( O X
Leu30 O X
to O X
Pro O X
) O X
in O X
N91 O X
consisting O X
of O X
the O X
N O X
- O X
terminal O X
91 O X
amino O X
acids O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

This O X
mutant O X
was O X
indeed O X
defective O X
in O X
the O X
in O X
vitro O X
ability O X
to O X
form O X
a O X
heterodimer O X
with O X
the O X
wild O X
- O X
type O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

When O X
this O X
particular O X
single O X
amino O X
acid O X
substitution O X
was O X
introduced O X
into O X
the O X
full O X
- O X
length O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
, O X
the O X
resultant O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
mutant O X
had O X
lost O X
the O X
ability O X
to O X
form O X
dimers O X
in O X
vitro O X
and O X
to O X
function O X
as O X
a O X
transcriptional O X
repressor O X
. O X

These O X
findings O X
collectively O X
provided O X
us O X
with O X
evidence O X
that O X
the O X
ability O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
to O X
form O X
a O X
dimer O X
is O X
crucial O X
for O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
to O X
function O X
as O X
a O X
transcriptional O X
repressor O X
. O X

###11359905	7157,25942

The O X
corepressor O X
mSin3a I-MISC 20466
interacts O X
with O X
the O X
proline O X
- O X
rich O X
domain O X
of O X
p53 I-MISC 7157
and O X
protects O X
p53 I-MISC 7157
from O X
proteasome O X
- O X
mediated O X
degradation O X
. O X

While O X
the O X
transactivation O X
function O X
of O X
the O X
tumor O X
suppressor O X
p53 I-MISC 7157
is O X
well O X
understood O X
, O X
less O X
is O X
known O X
about O X
the O X
transrepression O X
functions O X
of O X
this O X
protein O X
. O X

We O X
have O X
previously O X
shown O X
that O X
p53 I-MISC 7157
interacts O X
with O X
the O X
corepressor O X
protein O X
mSin3a I-MISC 20466
( O X
hereafter O X
designated O X
Sin3 I-MISC 25942
) O X
in O X
vivo O X
and O X
that O X
this O X
interaction O X
is O X
critical O X
for O X
the O X
ability O X
of O X
p53 I-MISC 7157
to O X
repress O X
gene O X
expression O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
demonstrate O X
that O X
expression O X
of O X
Sin3 I-MISC 25942
results O X
in O X
posttranslational O X
stabilization O X
of O X
both O X
exogenous O X
and O X
endogenous O X
p53 I-MISC 7157
, O X
due O X
to O X
an O X
inhibition O X
of O X
proteasome O X
- O X
mediated O X
degradation O X
of O X
this O X
protein O X
. O X

Stabilization O X
of O X
p53 I-MISC 7157
by O X
Sin3 I-MISC 25942
requires O X
the O X
Sin3 I-MISC 25942
- O X
binding O X
domain O X
, O X
determined O X
here O X
to O X
map O X
to O X
the O X
proline O X
- O X
rich O X
region O X
of O X
p53 I-MISC 7157
, O X
from O X
amino O X
acids O X
61 O X
to O X
75 O X
. O X

The O X
correlation O X
between O X
Sin3 I-MISC 25942
binding O X
and O X
stabilization O X
supports O X
the O X
hypothesis O X
that O X
this O X
domain O X
of O X
p53 I-MISC 7157
may O X
normally O X
be O X
subject O X
to O X
a O X
destabilizing O X
influence O X
. O X

The O X
finding O X
that O X
a O X
synthetic O X
mutant O X
of O X
p53 I-MISC 7157
lacking O X
the O X
Sin3 I-MISC 25942
- O X
binding O X
domain O X
has O X
an O X
increased O X
half O X
- O X
life O X
in O X
cells O X
, O X
compared O X
to O X
wild O X
- O X
type O X
p53 I-MISC 7157
, O X
supports O X
this O X
premise O X
. O X

Interestingly O X
, O X
unlike O X
retinoblastoma O X
tumor O X
suppressor O X
protein O X
, O X
MDMX I-MISC 4194
, O X
and O X
p14 I-MISC 11102
( O X
ARF O X
), O X
Sin3 I-MISC 25942
stabilizes O X
p53 I-MISC 7157
in O X
an O X
MDM2 I-MISC 4193
- O X
independent O X
manner O X
. O X

The O X
ability O X
of O X
Sin3 I-MISC 25942
to O X
stabilize O X
p53 I-MISC 7157
is O X
consistent O X
with O X
the O X
model O X
whereby O X
these O X
two O X
proteins O X
must O X
exist O X
on O X
a O X
promoter O X
for O X
extended O X
periods O X
, O X
in O X
order O X
for O X
repression O X
to O X
be O X
an O X
effective O X
mechanism O X
of O X
gene O X
regulation O X
. O X

This O X
model O X
is O X
consistent O X
with O X
our O X
data O X
indicating O X
that O X
, O X
unlike O X
the O X
p300 I-MISC 2033
- O X
p53 I-MISC 7157
complex O X
, O X
the O X
p53 I-MISC 7157
- O X
Sin3 I-MISC 25942
complex O X
is O X
immunologically O X
detectable O X
for O X
prolonged O X
periods O X
following O X
exposure O X
of O X
cells O X
to O X
agents O X
of O X
DNA O X
damage O X
. O X

###17711851	2802,64746

Identification O X
of O X
a O X
redox O X
- O X
sensitive O X
cysteine O X
in O X
GCP60 I-MISC 64746
that O X
regulates O X
its O X
interaction O X
with O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
. O X

Golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
is O X
ubiquitously O X
expressed O X
in O X
vertebrates O X
. O X

It O X
localizes O X
to O X
the O X
cytoplasmic O X
side O X
of O X
the O X
Golgi O X
and O X
has O X
a O X
large O X
C O X
- O X
terminal O X
coiled O X
- O X
coil O X
domain O X
. O X

The O X
noncoiled O X
- O X
coil O X
N O X
- O X
terminal O X
head O X
domain O X
contains O X
Golgi O X
targeting O X
information O X
, O X
a O X
cryptic O X
nuclear O X
localization O X
signal O X
, O X
and O X
three O X
caspase O X
cleavage O X
sites O X
. O X

Caspase O X
cleavage O X
of O X
the O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
head O X
domain O X
generates O X
different O X
fragments O X
that O X
can O X
translocate O X
to O X
the O X
nucleus O X
by O X
exposing O X
the O X
nuclear O X
localization O X
signal O X
. O X

We O X
have O X
previously O X
shown O X
that O X
GCP60 I-MISC 64746
, O X
a O X
Golgi O X
resident O X
protein O X
, O X
interacts O X
weakly O X
with O X
the O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
head O X
domain O X
but O X
has O X
a O X
strong O X
interaction O X
with O X
one O X
of O X
the O X
caspase O X
- O X
generated O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
fragments O X
( O X
residues O X
140 O X
- O X
311 O X
). O X

This O X
preferential O X
interaction O X
increases O X
the O X
Golgi O X
retention O X
of O X
the O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
fragment O X
in O X
cells O X
overexpressing O X
GCP60 I-MISC 64746
. O X

Here O X
we O X
studied O X
the O X
interaction O X
of O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
-( O X
140 O X
- O X
311 O X
) O X
with O X
GCP60 I-MISC 64746
and O X
identified O X
a O X
single O X
cysteine O X
residue O X
in O X
GCP60 I-MISC 64746
( O X
Cys O X
- O X
463 O X
) O X
that O X
is O X
critical O X
for O X
the O X
interaction O X
of O X
the O X
two O X
proteins O X
. O X

Mutation O X
of O X
the O X
cysteine O X
blocked O X
the O X
interaction O X
in O X
vitro O X
and O X
disrupted O X
the O X
ability O X
to O X
retain O X
the O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
fragment O X
at O X
the O X
Golgi O X
in O X
cells O X
. O X

We O X
also O X
found O X
that O X
Cys O X
- O X
463 O X
is O X
redox O X
- O X
sensitive O X
; O X
in O X
its O X
reduced O X
form O X
, O X
interaction O X
with O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
was O X
diminished O X
or O X
abolished O X
, O X
whereas O X
oxidation O X
of O X
the O X
Cys O X
- O X
463 O X
by O X
hydrogen O X
peroxide O X
restored O X
the O X
interaction O X
. O X

In O X
addition O X
, O X
incubation O X
with O X
a O X
nitric O X
oxide O X
donor O X
promoted O X
this O X
interaction O X
in O X
vitro O X
. O X

These O X
findings O X
suggest O X
that O X
nuclear O X
translocation O X
of O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
-( O X
140 O X
- O X
311 O X
) O X
is O X
a O X
highly O X
coordinated O X
event O X
regulated O X
not O X
only O X
by O X
cleavage O X
of O X
the O X
golgin I-MISC 2802
- I-MISC 2802
160 I-MISC 2802
head O X
but O X
also O X
by O X
the O X
oxidation O X
state O X
of O X
GCP60 I-MISC 64746
. O X

###20705607	7157,4194	4193,7322

Turning O X
the O X
RING O X
domain O X
protein O X
MdmX I-MISC 4194
into O X
an O X
active O X
ubiquitin O X
- O X
protein O X
ligase O X
. O X

The O X
related O X
RING O X
domain O X
proteins O X
MdmX I-MISC 4194
and O X
Mdm2 I-MISC 4193
are O X
best O X
known O X
for O X
their O X
role O X
as O X
negative O X
regulators O X
of O X
the O X
tumor O X
suppressor O X
p53 I-MISC 7157
. O X

However O X
, O X
although O X
Mdm2 I-MISC 4193
functions O X
as O X
a O X
ubiquitin O X
ligase O X
for O X
p53 I-MISC 7157
, O X
MdmX I-MISC 4194
does O X
not O X
have O X
appreciable O X
ubiquitin O X
ligase O X
activity O X
. O X

In O X
this O X
study O X
, O X
we O X
performed O X
a O X
mutational O X
analysis O X
of O X
the O X
RING O X
domain O X
of O X
MdmX I-MISC 4194
, O X
and O X
we O X
identified O X
two O X
distinct O X
regions O X
that O X
, O X
when O X
replaced O X
by O X
the O X
respective O X
regions O X
of O X
Mdm2 I-MISC 4193
, O X
turn O X
MdmX I-MISC 4194
into O X
an O X
active O X
ubiquitin O X
ligase O X
for O X
p53 I-MISC 7157
. O X

Mdm2 I-MISC 4193
and O X
MdmX I-MISC 4194
form O X
homodimers O X
as O X
well O X
as O X
heterodimers O X
with O X
each O X
other O X
. O X

One O X
of O X
the O X
regions O X
identified O X
localizes O X
to O X
the O X
dimer O X
interface O X
indicating O X
that O X
subtle O X
conformational O X
changes O X
in O X
this O X
region O X
either O X
affect O X
dimer O X
stability O X
and O X
/ O X
or O X
the O X
interaction O X
with O X
the O X
ubiquitin O X
- O X
conjugating O X
enzyme O X
UbcH5b I-MISC 7322
. O X

The O X
second O X
region O X
contains O X
the O X
cryptic O X
nucleolar O X
localization O X
signal O X
of O X
Mdm2 I-MISC 4193
but O X
is O X
also O X
assumed O X
to O X
be O X
involved O X
in O X
the O X
interaction O X
with O X
UbcH5b I-MISC 7322
. O X

Here O X
, O X
we O X
show O X
that O X
this O X
region O X
has O X
a O X
significant O X
impact O X
on O X
the O X
ability O X
of O X
respective O X
MdmX I-MISC 4194
mutants O X
to O X
functionally O X
interact O X
with O X
UbcH5b I-MISC 7322
in O X
vitro O X
supporting O X
the O X
notion O X
that O X
this O X
region O X
serves O X
two O X
distinct O X
functional O X
purposes O X
, O X
nucleolar O X
localization O X
and O X
ubiquitin O X
ligase O X
activity O X
. O X

Finally O X
, O X
evidence O X
is O X
provided O X
to O X
suggest O X
that O X
the O X
RING O X
domain O X
of O X
Mdm2 I-MISC 4193
not O X
only O X
binds O X
to O X
UbcH5b I-MISC 7322
but O X
also O X
acts O X
as O X
an O X
allosteric O X
activator O X
of O X
UbcH5b I-MISC 7322
. O X

###17350623	7428,5590

PKCzetaII O X
is O X
a O X
target O X
for O X
degradation O X
through O X
the O X
tumour O X
suppressor O X
protein O X
pVHL I-MISC 7428
. O X

PKCzetaII O X
is O X
a O X
rapidly O X
degraded O X
variant O X
of O X
PKCzeta I-MISC 5590
that O X
suppresses O X
epithelial O X
cell O X
polarisation O X
. O X

It O X
is O X
shown O X
here O X
that O X
PKCzetaII O X
is O X
a O X
target O X
for O X
the O X
E3 O X
ligase O X
and O X
tumour O X
suppressor O X
Von O X
Hippel O X
- O X
Lindau O X
protein O X
( O X
pVHL I-MISC 7428
). O X

Deletion O X
studies O X
demonstrate O X
that O X
the O X
C O X
- O X
terminal O X
region O X
is O X
required O X
for O X
the O X
pVHL I-MISC 7428
and O X
proteasome O X
dependent O X
turnover O X
of O X
PKCzetaII O X
, O X
however O X
it O X
is O X
the O X
N O X
- O X
terminal O X
PB1 O X
domain O X
of O X
PKCzetaII O X
that O X
is O X
required O X
for O X
pVHL I-MISC 7428
complex O X
formation O X
. O X

Reciprocal O X
deletion O X
studies O X
define O X
the O X
pVHL I-MISC 7428
effector O X
domain O X
as O X
the O X
dominant O X
PKCzetaII O X
binding O X
site O X
. O X

The O X
results O X
indicate O X
that O X
pVHL I-MISC 7428
recruits O X
PKCzetaII O X
via O X
its O X
PB1 O X
domain O X
and O X
causes O X
ubiquitination O X
and O X
degradation O X
via O X
the O X
distal O X
C O X
- O X
terminus O X
of O X
PKCzetaII O X
. O X

###18923418	3636118,3637052	3639672,3637052	3644820,3637052

The O X
IQGAP O X
Iqg1 I-MISC 3637052
is O X
a O X
regulatory O X
target O X
of O X
CDK O X
for O X
cytokinesis O X
in O X
Candida O X
albicans O X
. O X

Cyclin O X
- O X
dependent O X
kinases O X
( O X
CDKs O X
) O X
drive O X
and O X
coordinate O X
multiple O X
cell O X
- O X
cycle O X
events O X
, O X
including O X
construction O X
and O X
contraction O X
of O X
the O X
actomyosin O X
ring O X
during O X
cytokinesis O X
. O X

However O X
, O X
it O X
remains O X
unclear O X
whether O X
CDKs O X
regulate O X
cytokinesis O X
by O X
directly O X
targeting O X
components O X
of O X
the O X
ring O X
. O X

In O X
a O X
search O X
for O X
proteins O X
containing O X
consensus O X
CDK O X
phosphorylation O X
sites O X
in O X
Candida O X
albicans O X
, O X
we O X
found O X
that O X
the O X
IQGAP O X
Iqg1 I-MISC 3637052
contains O X
two O X
dense O X
clusters O X
of O X
19 O X
such O X
sites O X
flanking O X
the O X
actin O X
- O X
interacting O X
CH O X
domain O X
. O X

Here O X
, O X
we O X
show O X
that O X
Iqg1 I-MISC 3637052
is O X
indeed O X
a O X
phosphoprotein O X
that O X
undergoes O X
cell O X
- O X
cycle O X
- O X
dependent O X
phosphorylation O X
and O X
can O X
be O X
phosphorylated O X
by O X
purified O X
Clb O X
- O X
Cdc28 I-MISC 3644820
kinases O X
in O X
vitro O X
. O X

Mass O X
spectrometry O X
identified O X
several O X
phosphoserine O X
and O X
phosphothreonine O X
residues O X
among O X
these O X
CDK O X
sites O X
. O X

Mutating O X
15 O X
of O X
the O X
CDK O X
phosphorylation O X
sites O X
with O X
alanine O X
markedly O X
reduced O X
Iqg1 I-MISC 3637052
phosphorylation O X
in O X
vivo O X
. O X

The O X
15A O X
mutation O X
greatly O X
stabilized O X
Iqg1 I-MISC 3637052
, O X
caused O X
both O X
premature O X
assembly O X
and O X
delayed O X
disassembly O X
of O X
the O X
actomyosin O X
ring O X
, O X
blocked O X
Iqg1 I-MISC 3637052
interaction O X
with O X
the O X
actin O X
- O X
nucleating O X
proteins O X
Bni1 I-MISC 3636118
and O X
Bnr1 I-MISC 3639672
, O X
and O X
resulted O X
in O X
defects O X
in O X
cytokinesis O X
. O X

Our O X
data O X
therefore O X
strongly O X
support O X
the O X
idea O X
that O X
the O X
Cdc28 I-MISC 3644820
CDK O X
regulates O X
cytokinesis O X
partly O X
by O X
directly O X
phosphorylating O X
the O X
actomyosin O X
ring O X
component O X
Iqg1 I-MISC 3637052
. O X

###7561682	5829,5747

Direct O X
association O X
of O X
pp125FAK I-MISC 5747
with O X
paxillin I-MISC 5829
, O X
the O X
focal O X
adhesion O X
- O X
targeting O X
mechanism O X
of O X
pp125FAK I-MISC 5747
. O X

Focal I-MISC 5747
adhesion I-MISC 5747
kinase I-MISC 5747
( I-MISC 5747
pp125FAK I-MISC 5747
) O X
is O X
localized O X
to O X
focal O X
adhesions O X
and O X
tyrosine O X
phosphorylated O X
by O X
the O X
engagement O X
of O X
beta I-MISC 3688
1 I-MISC 3688
integrins I-MISC 3688
. O X

However O X
, O X
it O X
is O X
unclear O X
how O X
pp125FAK I-MISC 5747
is O X
linked O X
to O X
integrin O X
molecules O X
. O X

We O X
demonstrate O X
that O X
pp125FAK I-MISC 5747
is O X
directly O X
associated O X
with O X
paxillin I-MISC 5829
, O X
a O X
68 O X
- O X
kD O X
cytoskeleton O X
protein O X
. O X

The O X
COOH O X
- O X
terminal O X
domain O X
of O X
pp125FAK I-MISC 5747
spanning O X
FAK I-MISC 5747
residues O X
919 O X
- O X
1042 O X
is O X
sufficient O X
for O X
paxillin I-MISC 5829
binding O X
and O X
has O X
vinculin I-MISC 7414
- O X
homologous O X
amino O X
acids O X
, O X
which O X
are O X
essential O X
for O X
paxillin I-MISC 5829
binding O X
. O X

Microinjection O X
and O X
subsequent O X
immunohistochemical O X
analysis O X
reveal O X
that O X
glutathione O X
S O X
- O X
transferase O X
- O X
FAK I-MISC 5747
fusion O X
proteins O X
, O X
which O X
bind O X
to O X
paxillin I-MISC 5829
, O X
localize O X
to O X
focal O X
adhesions O X
, O X
whereas O X
fusion O X
proteins O X
with O X
no O X
paxillin I-MISC 5829
- O X
binding O X
activity O X
do O X
not O X
localize O X
to O X
focal O X
adhesions O X
. O X

These O X
findings O X
strongly O X
suggest O X
that O X
pp125FAK I-MISC 5747
is O X
localized O X
to O X
focal O X
adhesions O X
by O X
the O X
direct O X
association O X
with O X
paxillin I-MISC 5829
. O X

###11713520	821879,825473	839568,825473

Auxin O X
regulates O X
SCF I-MISC 4254
( O X
TIR1 O X
)- O X
dependent O X
degradation O X
of O X
AUX O X
/ O X
IAA O X
proteins O X
. O X

The O X
plant O X
hormone O X
auxin O X
is O X
central O X
in O X
many O X
aspects O X
of O X
plant O X
development O X
. O X

Previous O X
studies O X
have O X
implicated O X
the O X
ubiquitin O X
- O X
ligase O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
and O X
the O X
AUX O X
/ O X
IAA O X
proteins O X
in O X
auxin O X
response O X
. O X

Dominant O X
mutations O X
in O X
several O X
AUX O X
/ O X
IAA O X
genes O X
confer O X
pleiotropic O X
auxin O X
- O X
related O X
phenotypes O X
, O X
whereas O X
recessive O X
mutations O X
affecting O X
the O X
function O X
of O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
decrease O X
auxin O X
response O X
. O X

Here O X
we O X
show O X
that O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
is O X
required O X
for O X
AUX O X
/ O X
IAA O X
degradation O X
. O X

We O X
demonstrate O X
that O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
interacts O X
with O X
AXR2 I-MISC 821879
/ O X
IAA7 O X
and O X
AXR3 I-MISC 839568
/ O X
IAA17 I-MISC 825473
, O X
and O X
that O X
domain O X
II O X
of O X
these O X
proteins O X
is O X
necessary O X
and O X
sufficient O X
for O X
this O X
interaction O X
. O X

Further O X
, O X
auxin O X
stimulates O X
binding O X
of O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
to O X
the O X
AUX O X
/ O X
IAA O X
proteins O X
, O X
and O X
their O X
degradation O X
. O X

Because O X
domain O X
II O X
is O X
conserved O X
in O X
nearly O X
all O X
AUX O X
/ O X
IAA O X
proteins O X
in O X
Arabidopsis O X
, O X
we O X
propose O X
that O X
auxin O X
promotes O X
the O X
degradation O X
of O X
this O X
large O X
family O X
of O X
transcriptional O X
regulators O X
, O X
leading O X
to O X
diverse O X
downstream O X
effects O X
. O X

###19731236	5205,55754

Differential O X
effects O X
of O X
progressive O X
familial O X
intrahepatic O X
cholestasis O X
type O X
1 O X
and O X
benign O X
recurrent O X
intrahepatic O X
cholestasis O X
type O X
1 O X
mutations O X
on O X
canalicular O X
localization O X
of O X
ATP8B1 I-MISC 5205
. O X

Mutations O X
in O X
ATP8B1 I-MISC 5205
cause O X
progressive O X
familial O X
intrahepatic O X
cholestasis O X
type O X
1 O X
( O X
PFIC1 I-MISC 5205
) O X
and O X
benign O X
recurrent O X
intrahepatic O X
cholestasis O X
type O X
1 O X
( O X
BRIC1 O X
), O X
forming O X
a O X
spectrum O X
of O X
cholestatic O X
disease O X
. O X

Whereas O X
PFIC1 I-MISC 5205
is O X
a O X
progressive O X
, O X
endstage O X
liver O X
disease O X
, O X
BRIC1 O X
patients O X
suffer O X
from O X
episodic O X
periods O X
of O X
cholestasis O X
that O X
resolve O X
spontaneously O X
. O X

At O X
present O X
it O X
is O X
not O X
clear O X
how O X
the O X
type O X
and O X
location O X
of O X
the O X
mutations O X
relate O X
to O X
the O X
clinical O X
manifestations O X
of O X
PFIC1 I-MISC 5205
and O X
BRIC1 O X
. O X

ATP8B1 I-MISC 5205
localizes O X
to O X
the O X
canalicular O X
membrane O X
of O X
hepatocytes O X
where O X
it O X
mediates O X
the O X
inward O X
translocation O X
of O X
phosphatidylserine O X
. O X

ATP8B1 I-MISC 5205
interacts O X
with O X
CDC50A I-MISC 55754
, O X
which O X
is O X
required O X
for O X
endoplasmic O X
reticulum O X
exit O X
and O X
plasma O X
membrane O X
localization O X
. O X

In O X
this O X
study O X
we O X
analyzed O X
a O X
panel O X
of O X
missense O X
mutations O X
causing O X
PFIC1 I-MISC 5205
( O X
G308V O X
, O X
D554N O X
, O X
G1040R O X
) O X
or O X
BRIC1 O X
( O X
D70N O X
, O X
I661T O X
). O X

In O X
addition O X
, O X
we O X
included O X
two O X
mutations O X
that O X
have O X
been O X
associated O X
with O X
intrahepatic O X
cholestasis O X
of O X
pregnancy O X
( O X
ICP O X
) O X
( O X
D70N O X
, O X
R867C O X
). O X

We O X
examined O X
the O X
effect O X
of O X
these O X
mutations O X
on O X
protein O X
stability O X
and O X
interaction O X
with O X
CDC50A I-MISC 55754
in O X
Chinese O X
hamster O X
ovary O X
cells O X
, O X
and O X
studied O X
the O X
subcellular O X
localization O X
in O X
WIF O X
- O X
B9 O X
cells O X
. O X

Protein O X
stability O X
was O X
reduced O X
for O X
three O X
out O X
of O X
six O X
mutations O X
studied O X
. O X

Two O X
out O X
of O X
three O X
PFIC1 I-MISC 5205
mutant O X
proteins O X
did O X
not O X
interact O X
with O X
CDC50A I-MISC 55754
, O X
whereas O X
BRIC1 O X
/ O X
ICP O X
mutants O X
displayed O X
reduced O X
interaction O X
. O X

Importantly O X
, O X
none O X
of O X
the O X
PFIC1 I-MISC 5205
mutants O X
were O X
detectable O X
in O X
the O X
canalicular O X
membrane O X
of O X
WIF O X
- O X
B9 O X
cells O X
, O X
whereas O X
all O X
BRIC1 O X
/ O X
ICP O X
mutants O X
displayed O X
the O X
same O X
cellular O X
staining O X
pattern O X
as O X
wild O X
- O X
type O X
ATP8B1 I-MISC 5205
. O X

Our O X
data O X
indicate O X
that O X
PFIC1 I-MISC 5205
mutations O X
lead O X
to O X
the O X
complete O X
absence O X
of O X
canalicular O X
expression O X
, O X
whereas O X
in O X
BRIC1 O X
/ O X
ICP O X
residual O X
protein O X
is O X
expressed O X
in O X
the O X
canalicular O X
membrane O X
. O X

CONCLUSION O X
: O X
These O X
data O X
provide O X
an O X
explanation O X
for O X
the O X
difference O X
in O X
severity O X
between O X
the O X
phenotypes O X
of O X
PFIC1 I-MISC 5205
and O X
BRIC1 O X
. O X

###11397791	4846,801

Phosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
regulates O X
Ca O X
( O X
2 O X
+)/ O X
calmodulin O X
- O X
dependent O X
endothelial I-MISC 4846
nitric I-MISC 4846
oxide I-MISC 4846
synthase I-MISC 4846
activity O X
. O X

The O X
activity O X
of O X
the O X
endothelial I-MISC 4846
nitric I-MISC 4846
oxide I-MISC 4846
synthase I-MISC 4846
( O X
eNOS I-MISC 801
) O X
can O X
be O X
regulated O X
independently O X
of O X
an O X
increase O X
in O X
Ca O X
( O X
2 O X
+) O X
by O X
the O X
phosphorylation O X
of O X
Ser O X
( O X
1177 O X
) O X
but O X
results O X
only O X
in O X
a O X
low O X
nitric O X
oxide O X
( O X
NO O X
) O X
output O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
assessed O X
whether O X
the O X
agonist O X
- O X
induced O X
( O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
, O X
high O X
- O X
output O X
) O X
activation O X
of O X
eNOS I-MISC 801
is O X
associated O X
with O X
changes O X
in O X
the O X
phosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
in O X
the O X
calmodulin O X
( O X
CaM O X
)- O X
binding O X
domain O X
. O X

eNOS I-MISC 801
Thr O X
( O X
495 O X
) O X
was O X
constitutively O X
phosphorylated O X
in O X
porcine O X
aortic O X
endothelial O X
cells O X
and O X
was O X
rapidly O X
dephosphorylated O X
after O X
bradykinin I-MISC 3827
stimulation O X
. O X

In O X
the O X
same O X
cells O X
, O X
bradykinin I-MISC 3827
enhanced O X
the O X
phosphorylation O X
of O X
Ser O X
( O X
1177 O X
), O X
which O X
was O X
maximal O X
after O X
5 O X
minutes O X
, O X
and O X
abolished O X
by O X
the O X
CaM I-MISC 818
- I-MISC 818
dependent I-MISC 818
kinase I-MISC 818
II I-MISC 818
( O X
CaMKII I-MISC 818
) O X
inhibitor O X
KN O X
- O X
93 O X
. O X

Bradykinin I-MISC 3827
also O X
enhanced O X
the O X
association O X
of O X
CaMKII I-MISC 818
with O X
eNOS I-MISC 801
. O X

Phosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
was O X
attenuated O X
by O X
the O X
protein O X
kinase O X
C O X
( O X
PKC O X
) O X
inhibitor O X
Ro O X
31 O X
- O X
8220 O X
and O X
after O X
PKC O X
downregulation O X
using O X
phorbol O X
12 O X
- O X
myristate O X
13 O X
- O X
acetate O X
. O X

The O X
agonist O X
- O X
induced O X
dephosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
was O X
completely O X
Ca O X
( O X
2 O X
+)- O X
dependent O X
and O X
inhibited O X
by O X
the O X
PP1 I-MISC 5464
inhibitor O X
calyculin O X
A O X
. O X

Little O X
CaM O X
was O X
bound O X
to O X
eNOS I-MISC 801
immunoprecipitated O X
from O X
unstimulated O X
cells O X
, O X
but O X
the O X
agonist O X
- O X
induced O X
dephosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
enhanced O X
the O X
association O X
of O X
CaM O X
. O X

Mutation O X
of O X
Thr O X
( O X
495 O X
) O X
to O X
alanine O X
increased O X
CaM O X
binding O X
to O X
eNOS I-MISC 801
in O X
the O X
absence O X
of O X
cell O X
stimulation O X
, O X
whereas O X
the O X
corresponding O X
Asp O X
( O X
495 O X
) O X
mutant O X
bound O X
almost O X
no O X
CaM O X
. O X

Accordingly O X
, O X
NO O X
production O X
by O X
the O X
Ala O X
( O X
495 O X
) O X
mutant O X
was O X
more O X
sensitive O X
to O X
Ca O X
( O X
2 O X
+)/ O X
CaM O X
than O X
the O X
aspartate O X
mutant O X
. O X

These O X
results O X
suggest O X
that O X
the O X
dual O X
phosphorylation O X
of O X
Ser O X
( O X
1177 O X
) O X
and O X
Thr O X
( O X
495 O X
) O X
determines O X
the O X
activity O X
of O X
eNOS I-MISC 801
in O X
agonist O X
- O X
stimulated O X
endothelial O X
cells O X
. O X

Moreover O X
, O X
the O X
dephosphorylation O X
of O X
Thr O X
( O X
495 O X
) O X
by O X
PP1 I-MISC 5464
precedes O X
the O X
phosphorylation O X
of O X
Ser O X
( O X
1177 O X
) O X
by O X
CaMKII I-MISC 818
. O X

The O X
full O X
text O X
of O X
this O X
article O X
is O X
available O X
at O X
http O X
:// O X
www O X
. O X
circresaha O X
. O X
org O X
. O X

###16963558	956533,5296

Influenza O X
A O X
virus O X
NS1 I-MISC 956533
protein O X
binds O X
p85beta I-MISC 5296
and O X
activates O X
phosphatidylinositol I-MISC 5295
- I-MISC 5295
3 I-MISC 5295
- I-MISC 5295
kinase I-MISC 5295
signaling O X
. O X

Influenza O X
A O X
virus O X
NS1 I-MISC 956533
is O X
a O X
multifunctional O X
protein O X
, O X
and O X
in O X
virus O X
- O X
infected O X
cells O X
NS1 I-MISC 956533
modulates O X
a O X
number O X
of O X
host O X
- O X
cell O X
processes O X
by O X
interacting O X
with O X
cellular O X
factors O X
. O X

Here O X
, O X
we O X
report O X
that O X
NS1 I-MISC 956533
binds O X
directly O X
to O X
p85beta I-MISC 5296
, O X
a O X
regulatory O X
subunit O X
of O X
phosphatidylinositol I-MISC 5295
- I-MISC 5295
3 I-MISC 5295
- I-MISC 5295
kinase I-MISC 5295
( O X
PI3K I-MISC 5295
), O X
but O X
not O X
to O X
the O X
related O X
p85alpha I-MISC 5295
subunit O X
. O X

Activation O X
of O X
PI3K I-MISC 5295
in O X
influenza O X
virus O X
- O X
infected O X
cells O X
depended O X
on O X
genome O X
replication O X
, O X
and O X
showed O X
kinetics O X
that O X
correlated O X
with O X
NS1 I-MISC 956533
expression O X
. O X

Additionally O X
, O X
it O X
was O X
found O X
that O X
expression O X
of O X
NS1 I-MISC 956533
alone O X
was O X
sufficient O X
to O X
constitutively O X
activate O X
PI3K I-MISC 5295
, O X
causing O X
the O X
phosphorylation O X
of O X
a O X
downstream O X
mediator O X
of O X
PI3K I-MISC 5295
signal O X
transduction O X
, O X
Akt I-MISC 207
. O X

Mutational O X
analysis O X
of O X
a O X
potential O X
SH2 O X
- O X
binding O X
motif O X
within O X
NS1 I-MISC 956533
indicated O X
that O X
the O X
highly O X
conserved O X
tyrosine O X
at O X
residue O X
89 O X
is O X
important O X
for O X
both O X
the O X
interaction O X
with O X
p85beta I-MISC 5296
, O X
and O X
the O X
activation O X
of O X
PI3K I-MISC 5295
. O X

A O X
mutant O X
influenza O X
virus O X
( O X
A O X
/ O X
Udorn O X
/ O X
72 O X
) O X
expressing O X
NS1 I-MISC 956533
with O X
the O X
Y89F O X
amino O X
acid O X
substitution O X
exhibited O X
a O X
small O X
- O X
plaque O X
phenotype O X
, O X
and O X
grew O X
more O X
slowly O X
in O X
tissue O X
culture O X
than O X
WT O X
virus O X
. O X

These O X
data O X
suggest O X
that O X
activation O X
of O X
PI3K I-MISC 5295
signaling O X
in O X
influenza O X
A O X
virus O X
- O X
infected O X
cells O X
is O X
important O X
for O X
efficient O X
virus O X
replication O X
. O X

###12649160	2189,2175	2176,2178	2177,2178	2189,2188

Fanconi O X
anemia O X
protein O X
complex O X
: O X
mapping O X
protein O X
interactions O X
in O X
the O X
yeast O X
2 O X
- O X
and O X
3 O X
- O X
hybrid O X
systems O X
. O X

Fanconi O X
anemia O X
( O X
FA O X
) O X
is O X
an O X
autosomal O X
recessive O X
syndrome O X
characterized O X
by O X
progressive O X
bone O X
marrow O X
failure O X
and O X
cancer O X
predisposition O X
. O X

Eight O X
FA O X
complementation O X
groups O X
have O X
been O X
identified O X
. O X

The O X
FANCA I-MISC 2175
, O X
FANCC I-MISC 2176
, O X
FANCE I-MISC 2178
, O X
FANCF I-MISC 2188
, O X
and O X
FANCG I-MISC 2189
proteins O X
form O X
a O X
nuclear O X
complex O X
required O X
for O X
the O X
monoubiquination O X
of O X
the O X
FANCD2 I-MISC 2177
protein O X
. O X

To O X
investigate O X
the O X
architecture O X
of O X
the O X
FA O X
protein O X
complex O X
, O X
the O X
yeast O X
2 O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
map O X
contact O X
points O X
of O X
the O X
FANCA I-MISC 2175
/ O X
FANCG I-MISC 2189
, O X
FANCC I-MISC 2176
/ O X
FANCE I-MISC 2178
, O X
and O X
FANCF I-MISC 2188
/ O X
FANCG I-MISC 2189
interactions O X
. O X

FANCG I-MISC 2189
was O X
shown O X
to O X
interact O X
with O X
both O X
the O X
amino O X
- O X
terminus O X
of O X
FANCA I-MISC 2175
and O X
the O X
carboxyl O X
- O X
terminal O X
region O X
of O X
FANCF I-MISC 2188
. O X

A O X
FANCG I-MISC 2189
mutant O X
truncated O X
at O X
the O X
carboxyl O X
- O X
terminus O X
retained O X
the O X
ability O X
to O X
interact O X
with O X
FANCA I-MISC 2175
. O X

The O X
interaction O X
between O X
FANCG I-MISC 2189
and O X
FANCF I-MISC 2188
was O X
ablated O X
by O X
a O X
Leu71Pro O X
mutant O X
of O X
FANCG I-MISC 2189
. O X

A O X
central O X
region O X
of O X
FANCE I-MISC 2178
was O X
sufficient O X
for O X
FANCC I-MISC 2176
binding O X
. O X

A O X
Leu554Pro O X
mutant O X
of O X
FANCC I-MISC 2176
failed O X
to O X
interact O X
with O X
FANCE I-MISC 2178
. O X

To O X
further O X
examine O X
complex O X
assembly O X
, O X
the O X
yeast O X
3 O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
investigate O X
the O X
ability O X
of O X
FANCG I-MISC 2189
to O X
act O X
as O X
a O X
molecular O X
bridge O X
in O X
mediating O X
interaction O X
between O X
other O X
FA O X
proteins O X
. O X

FANCG I-MISC 2189
was O X
able O X
to O X
mediate O X
interaction O X
between O X
FANCA I-MISC 2175
and O X
FANCF I-MISC 2188
, O X
as O X
well O X
as O X
between O X
monomers O X
of O X
FANCA I-MISC 2175
. O X

Direct O X
interaction O X
between O X
FANCE I-MISC 2178
and O X
FANCD2 I-MISC 2177
was O X
also O X
demonstrated O X
in O X
the O X
yeast O X
2 O X
- O X
hybrid O X
system O X
. O X

This O X
interaction O X
involving O X
an O X
amino O X
- O X
terminal O X
region O X
of O X
FANCD2 I-MISC 2177
may O X
provide O X
a O X
link O X
between O X
the O X
FA O X
protein O X
complex O X
and O X
its O X
downstream O X
targets O X
. O X

###12813041	1163,6502

A O X
negatively O X
charged O X
amino O X
acid O X
in O X
Skp2 I-MISC 6502
is O X
required O X
for O X
Skp2 I-MISC 6502
- O X
Cks1 I-MISC 137529
interaction O X
and O X
ubiquitination O X
of O X
p27Kip1 I-MISC 1027
. O X

Proteolysis O X
of O X
cyclin O X
- O X
dependent O X
kinase O X
inhibitor O X
p27 I-MISC 3429
occurs O X
predominantly O X
in O X
the O X
late O X
G1 O X
phase O X
of O X
the O X
cell O X
cycle O X
through O X
a O X
ubiquitin O X
- O X
mediated O X
protein O X
degradation O X
pathway O X
. O X

Ubiquitination O X
of O X
p27 I-MISC 3429
requires O X
the O X
SCFSkp2 O X
ubiquitin O X
ligase O X
and O X
Skp2 I-MISC 6502
F O X
- O X
box O X
binding O X
protein O X
Cks1 I-MISC 137529
. O X

The O X
mechanisms O X
by O X
which O X
Skp2 I-MISC 6502
recognizes O X
Cks1 I-MISC 137529
to O X
ubiquitylate O X
p27 I-MISC 3429
remain O X
obscure O X
. O X

Here O X
we O X
show O X
that O X
Asp O X
- O X
331 O X
in O X
the O X
carboxyl O X
terminus O X
of O X
Skp2 I-MISC 6502
is O X
required O X
for O X
its O X
association O X
with O X
Cks1 I-MISC 137529
and O X
ubiquitination O X
of O X
p27 I-MISC 3429
. O X

Mutation O X
of O X
Asp O X
- O X
331 O X
to O X
Ala O X
disrupts O X
the O X
interaction O X
between O X
Skp2 I-MISC 6502
and O X
Cks1 I-MISC 137529
. O X

Although O X
Asp O X
- O X
331 O X
mutation O X
negates O X
the O X
ability O X
of O X
the O X
Skp1 I-MISC 1163
- O X
Cullin O X
- O X
F O X
- O X
box O X
protein O X
( O X
SCF O X
) O X
complex O X
to O X
ubiquitylate O X
p27 I-MISC 3429
, O X
such O X
a O X
mutation O X
has O X
no O X
effect O X
on O X
Skp2 I-MISC 6502
self O X
- O X
ubiquitination O X
. O X

A O X
conservative O X
change O X
from O X
Asp O X
to O X
Glu O X
at O X
position O X
331 O X
of O X
Skp2 I-MISC 6502
does O X
not O X
affect O X
Skp2 I-MISC 6502
- O X
Cks1 I-MISC 137529
interaction O X
. O X

Our O X
results O X
revealed O X
a O X
unique O X
requirement O X
for O X
a O X
negatively O X
charged O X
residue O X
in O X
the O X
carboxyl O X
- O X
terminal O X
region O X
of O X
Skp2 I-MISC 6502
in O X
recognition O X
of O X
Cks1 I-MISC 137529
and O X
ubiquitination O X
of O X
p27 I-MISC 3429
. O X

###16284401	116478,1399

Identification O X
of O X
a O X
switch O X
in O X
neurotrophin I-MISC 627
signaling O X
by O X
selective O X
tyrosine O X
phosphorylation O X
. O X

Neurotrophins O X
, O X
such O X
as O X
nerve O X
growth O X
factor O X
and O X
brain I-MISC 627
- I-MISC 627
derived I-MISC 627
neurotrophic I-MISC 627
factor I-MISC 627
, O X
activate O X
Trk I-MISC 4914
receptor O X
tyrosine O X
kinases O X
through O X
receptor O X
dimerization O X
at O X
the O X
cell O X
surface O X
followed O X
by O X
autophosphorylation O X
and O X
recruitment O X
of O X
intracellular O X
signaling O X
molecules O X
. O X

The O X
intracellular O X
pathways O X
used O X
by O X
neurotrophins O X
share O X
many O X
common O X
protein O X
substrates O X
that O X
are O X
used O X
by O X
other O X
receptor O X
tyrosine O X
kinases O X
( O X
RTK O X
), O X
such O X
as O X
Shc I-MISC 6464
, O X
Grb2 I-MISC 2885
, O X
FRS2 I-MISC 10818
, O X
and O X
phospholipase O X
C O X
- O X
gamma O X
. O X

Here O X
we O X
describe O X
a O X
novel O X
RTK O X
mechanism O X
that O X
involves O X
a O X
220 O X
- O X
kilodalton O X
membrane O X
tetraspanning O X
protein O X
, O X
ARMS O X
/ O X
Kidins220 I-MISC 116478
, O X
which O X
is O X
rapidly O X
tyrosine O X
phosphorylated O X
in O X
primary O X
neurons O X
after O X
neurotrophin I-MISC 627
treatment O X
. O X

ARMS O X
/ O X
Kidins220 I-MISC 116478
undergoes O X
multiple O X
tyrosine O X
phosphorylation O X
events O X
and O X
also O X
serine O X
phosphorylation O X
by O X
protein O X
kinase O X
D O X
. O X
We O X
have O X
identified O X
a O X
single O X
tyrosine O X
( O X
Tyr O X
( O X
1096 O X
)) O X
phosphorylation O X
event O X
in O X
ARMS O X
/ O X
Kidins220 I-MISC 116478
that O X
plays O X
a O X
critical O X
role O X
in O X
neurotrophin I-MISC 627
signaling O X
. O X

A O X
reassembled O X
complex O X
of O X
ARMS O X
/ O X
Kidins220 I-MISC 116478
and O X
CrkL I-MISC 1399
, O X
an O X
upstream O X
component O X
of O X
the O X
C3G I-MISC 2889
- O X
Rap1 O X
- O X
MAP O X
kinase O X
cascade O X
, O X
is O X
SH3 O X
- O X
dependent O X
. O X

However O X
, O X
Tyr O X
( O X
1096 O X
) O X
phosphorylation O X
enables O X
ARMS O X
/ O X
Kidins220 I-MISC 116478
to O X
recruit O X
CrkL I-MISC 1399
through O X
its O X
SH2 O X
domain O X
, O X
thereby O X
freeing O X
the O X
CrkL I-MISC 1399
SH3 O X
domain O X
to O X
engage O X
C3G I-MISC 2889
for O X
MAP O X
kinase O X
activation O X
in O X
a O X
neurotrophin I-MISC 627
dependent O X
manner O X
. O X

Accordingly O X
, O X
mutation O X
of O X
Tyr O X
( O X
1096 O X
) O X
abolished O X
CrkL I-MISC 1399
interaction O X
and O X
sustained O X
MAPK O X
kinase O X
activity O X
, O X
a O X
response O X
that O X
is O X
not O X
normally O X
observed O X
in O X
other O X
RTKs O X
. O X

Therefore O X
, O X
Trk I-MISC 4914
receptor O X
signaling O X
involves O X
an O X
inducible O X
switch O X
mechanism O X
through O X
an O X
unconventional O X
substrate O X
that O X
distinguishes O X
neurotrophin I-MISC 627
action O X
from O X
other O X
growth O X
factor O X
receptors O X
. O X

###16511560	4194,4193

Regulation O X
of O X
MDMX I-MISC 4194
nuclear O X
import O X
and O X
degradation O X
by O X
Chk2 I-MISC 50883
and I-MISC 50883
14 I-MISC 50883
- I-MISC 50883
3 I-MISC 50883
- I-MISC 50883
3 I-MISC 50883
. O X

The O X
MDM2 I-MISC 4193
homolog O X
MDMX I-MISC 4194
is O X
an O X
important O X
regulator O X
of O X
p53 I-MISC 22060
during O X
mouse O X
embryonic O X
development O X
. O X

DNA O X
damage O X
promotes O X
MDMX I-MISC 4194
phosphorylation O X
, O X
nuclear O X
translocation O X
, O X
and O X
degradation O X
by O X
MDM2 I-MISC 4193
. O X

Here O X
we O X
show O X
that O X
MDMX I-MISC 4194
copurifies O X
with O X
14 O X
- O X
3 O X
- O X
3 O X
, O X
and O X
DNA O X
damage O X
stimulates O X
MDMX I-MISC 4194
binding O X
to O X
14 O X
- O X
3 O X
- O X
3 O X
. O X

Chk2 I-MISC 50883
- O X
mediated O X
phosphorylation O X
of O X
MDMX I-MISC 4194
on O X
S367 O X
is O X
important O X
for O X
stimulating O X
14 O X
- O X
3 O X
- O X
3 O X
binding O X
, O X
MDMX I-MISC 4194
nuclear O X
import O X
by O X
a O X
cryptic O X
nuclear O X
import O X
signal O X
, O X
and O X
degradation O X
by O X
MDM2 I-MISC 4193
. O X

Mutation O X
of O X
MDMX I-MISC 4194
S367 O X
inhibits O X
ubiquitination O X
and O X
degradation O X
by O X
MDM2 I-MISC 4193
, O X
and O X
prevents O X
MDMX I-MISC 4194
nuclear O X
import O X
. O X

Expression O X
of O X
14 O X
- O X
3 O X
- O X
3 O X
stimulates O X
the O X
degradation O X
of O X
phosphorylated O X
MDMX I-MISC 4194
. O X

Chk2 I-MISC 50883
and O X
14 O X
- O X
3 O X
- O X
3 O X
cooperatively O X
stimulate O X
MDMX I-MISC 4194
ubiquitination O X
and O X
overcome O X
the O X
inhibition O X
of O X
p53 I-MISC 22060
by O X
MDMX I-MISC 4194
. O X

These O X
results O X
suggest O X
that O X
MDMX I-MISC 4194
- O X
14 O X
- O X
3 O X
- O X
3 O X
interaction O X
plays O X
a O X
role O X
in O X
p53 I-MISC 22060
response O X
to O X
DNA O X
damage O X
by O X
regulating O X
MDMX I-MISC 4194
localization O X
and O X
stability O X
. O X

###18165306	946982,944870

Analysis O X
of O X
YfgL I-MISC 946982
and O X
YaeT I-MISC 944870
interactions O X
through O X
bioinformatics O X
, O X
mutagenesis O X
, O X
and O X
biochemistry O X
. O X

In O X
Escherichia O X
coli O X
, O X
YaeT I-MISC 944870
, O X
together O X
with O X
four O X
lipoproteins O X
, O X
YfgL I-MISC 946982
, O X
YfiO O X
, O X
NlpB O X
, O X
and O X
SmpA O X
, O X
forms O X
a O X
complex O X
that O X
is O X
essential O X
for O X
beta O X
- O X
barrel O X
outer O X
membrane O X
protein O X
biogenesis O X
. O X

Data O X
suggest O X
that O X
YfgL I-MISC 946982
and O X
YfiO O X
make O X
direct O X
but O X
independent O X
physical O X
contacts O X
with O X
YaeT I-MISC 944870
. O X

Whereas O X
the O X
YaeT I-MISC 944870
- O X
YfiO O X
interaction O X
needs O X
NlpB O X
and O X
SmpA O X
for O X
complex O X
stabilization O X
, O X
the O X
YaeT I-MISC 944870
- O X
YfgL I-MISC 946982
interaction O X
does O X
not O X
. O X

Using O X
bioinformatics O X
, O X
genetics O X
, O X
and O X
biochemical O X
approaches O X
, O X
we O X
have O X
identified O X
three O X
residues O X
, O X
L173 O X
, O X
L175 O X
, O X
and O X
R176 O X
, O X
in O X
the O X
mature O X
YfgL I-MISC 946982
protein O X
that O X
are O X
critical O X
for O X
both O X
function O X
and O X
interactions O X
with O X
YaeT I-MISC 944870
. O X

A O X
single O X
substitution O X
at O X
any O X
of O X
these O X
sites O X
produces O X
no O X
phenotypic O X
defect O X
, O X
but O X
two O X
or O X
three O X
simultaneous O X
alterations O X
produce O X
mild O X
or O X
yfgL I-MISC 946982
- O X
null O X
phenotypes O X
, O X
respectively O X
. O X

Interestingly O X
, O X
biochemical O X
data O X
show O X
that O X
all O X
YfgL I-MISC 946982
variants O X
, O X
including O X
those O X
with O X
single O X
substitutions O X
, O X
have O X
weakened O X
in O X
vivo O X
YaeT I-MISC 944870
- O X
YfgL I-MISC 946982
interaction O X
. O X

These O X
defects O X
are O X
not O X
due O X
to O X
mislocalization O X
or O X
low O X
steady O X
- O X
state O X
levels O X
of O X
YfgL I-MISC 946982
. O X

Cysteine O X
- O X
directed O X
cross O X
- O X
linking O X
data O X
show O X
that O X
the O X
region O X
encompassing O X
L173 O X
, O X
L175 O X
, O X
and O X
R176 O X
makes O X
direct O X
contact O X
with O X
YaeT I-MISC 944870
. O X

Using O X
the O X
same O X
genetic O X
and O X
biochemical O X
strategies O X
, O X
it O X
was O X
found O X
that O X
altering O X
residues O X
D227 O X
and O X
D229 O X
in O X
another O X
region O X
of O X
YfgL I-MISC 946982
from O X
E221 O X
to O X
D229 O X
resulted O X
in O X
defective O X
YaeT I-MISC 944870
bindings O X
. O X

In O X
contrast O X
, O X
mutational O X
analysis O X
of O X
conserved O X
residues O X
V319 O X
to O X
H328 O X
of O X
YfgL I-MISC 946982
shows O X
that O X
they O X
are O X
important O X
for O X
YfgL I-MISC 946982
biogenesis O X
but O X
not O X
YfgL I-MISC 946982
- O X
YaeT I-MISC 944870
interactions O X
. O X

The O X
five O X
YfgL I-MISC 946982
mutants O X
defective O X
in O X
YaeT I-MISC 944870
associations O X
and O X
the O X
yfgL I-MISC 946982
background O X
were O X
used O X
to O X
show O X
that O X
SurA O X
binds O X
to O X
YaeT I-MISC 944870
( O X
or O X
another O X
complex O X
member O X
) O X
without O X
going O X
through O X
YfgL I-MISC 946982
. O X

###18309291	179424,179338

Spindle O X
assembly O X
checkpoint O X
gene O X
mdf I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
regulates O X
germ O X
cell O X
proliferation O X
in O X
response O X
to O X
nutrition O X
signals O X
in O X
C O X
. O X
elegans O X
. O X

When O X
newly O X
hatched O X
Caenorhabditis O X
elegans O X
larvae O X
are O X
starved O X
, O X
their O X
primordial O X
germ O X
cells O X
( O X
PGCs O X
) O X
arrest O X
in O X
the O X
post O X
- O X
S O X
phase O X
. O X

This O X
starvation O X
- O X
induced O X
PGC O X
arrest O X
is O X
mediated O X
by O X
the O X
DAF I-MISC 176869
- I-MISC 176869
18 I-MISC 176869
/ O X
PTEN O X
- O X
AKT I-MISC 179424
- I-MISC 179424
1 I-MISC 179424
/ O X
PKB O X
nutrient O X
- O X
sensing O X
pathway O X
. O X

Here O X
, O X
we O X
report O X
that O X
the O X
conserved O X
spindle O X
assembly O X
checkpoint O X
( O X
SAC O X
) O X
component O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
/ O X
MAD1 O X
is O X
required O X
for O X
the O X
PGC O X
arrest O X
. O X

We O X
identified O X
2 O X
Akt O X
kinase O X
phosphorylation O X
sites O X
on O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
. O X

Expression O X
of O X
a O X
non O X
- O X
phosphorylatable O X
mutant O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
partially O X
suppressed O X
the O X
defect O X
in O X
the O X
starvation O X
- O X
induced O X
PGC O X
arrest O X
in O X
L1 O X
larvae O X
lacking O X
DAF I-MISC 176869
- I-MISC 176869
18 I-MISC 176869
, O X
suggesting O X
that O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
regulates O X
germ O X
cell O X
proliferation O X
as O X
a O X
downstream O X
target O X
of O X
AKT I-MISC 179424
- I-MISC 179424
1 I-MISC 179424
, O X
thereby O X
demonstrating O X
a O X
functional O X
link O X
between O X
cell O X
- O X
cycle O X
regulation O X
by O X
the O X
SAC O X
components O X
and O X
nutrient O X
sensing O X
by O X
DAF I-MISC 176869
- I-MISC 176869
18 I-MISC 176869
- O X
AKT I-MISC 179424
- I-MISC 179424
1 I-MISC 179424
during O X
post O X
- O X
embryonic O X
development O X
. O X

The O X
phosphorylation O X
status O X
of O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
affects O X
its O X
binding O X
to O X
another O X
SAC O X
component O X
, O X
MDF I-MISC 177046
- I-MISC 177046
2 I-MISC 177046
/ O X
MAD2 O X
. O X

The O X
loss O X
of O X
MDF I-MISC 177046
- I-MISC 177046
2 I-MISC 177046
or O X
another O X
SAC O X
component O X
also O X
caused O X
inappropriate O X
germ O X
cell O X
proliferation O X
, O X
but O X
the O X
defect O X
was O X
less O X
severe O X
than O X
that O X
caused O X
by O X
mdf I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
hemizygosity O X
, O X
suggesting O X
that O X
MDF I-MISC 179338
- I-MISC 179338
1 I-MISC 179338
causes O X
the O X
PGC O X
arrest O X
by O X
two O X
mechanisms O X
, O X
one O X
involving O X
MDF I-MISC 177046
- I-MISC 177046
2 I-MISC 177046
and O X
another O X
that O X
is O X
independent O X
of O X
other O X
SAC O X
components O X
. O X

###20801936	9675,80185

Tel2 I-MISC 852991
structure O X
and O X
function O X
in O X
the O X
Hsp90 I-MISC 855836
- O X
dependent O X
maturation O X
of O X
mTOR O X
and O X
ATR O X
complexes O X
. O X

We O X
reported O X
previously O X
that O X
the O X
stability O X
of O X
all O X
mammalian O X
phosphatidylinositol O X
3 O X
- O X
kinase O X
- O X
related O X
protein O X
kinases O X
( O X
PIKKs O X
) O X
depends O X
on O X
their O X
interaction O X
with O X
Tel2 I-MISC 51513
, O X
the O X
ortholog O X
of O X
yeast O X
Tel2 I-MISC 852991
and O X
Caenorhabditis O X
elegans O X
Clk I-MISC 176065
- I-MISC 176065
2 I-MISC 176065
. O X

Here O X
we O X
provide O X
evidence O X
that O X
Tel2 I-MISC 852991
acts O X
with O X
Hsp90 I-MISC 855836
in O X
the O X
maturation O X
of O X
PIKK O X
complexes O X
. O X

Quantitative O X
immunoblotting O X
showed O X
that O X
the O X
abundance O X
of O X
Tel2 I-MISC 852991
is O X
low O X
compared O X
with O X
the O X
PIKKs O X
, O X
and O X
Tel2 I-MISC 852991
preferentially O X
bound O X
newly O X
synthesized O X
ATM O X
, O X
ATR O X
, O X
mTOR O X
, O X
and O X
DNA O X
- O X
PKcs O X
. O X

Tel2 I-MISC 852991
complexes O X
contained O X
, O X
in O X
addition O X
to O X
Tti1 I-MISC 9675
- O X
Tti2 I-MISC 80185
, O X
the O X
Hsp90 I-MISC 855836
chaperone O X
, O X
and O X
inhibition O X
of O X
Hsp90 I-MISC 855836
interfered O X
with O X
the O X
interaction O X
of O X
Tel2 I-MISC 852991
with O X
the O X
PIKKs O X
. O X

Analysis O X
of O X
in O X
vivo O X
labeled O X
nascent O X
protein O X
complexes O X
showed O X
that O X
Tel2 I-MISC 852991
and O X
Hsp90 I-MISC 855836
mediate O X
the O X
formation O X
of O X
the O X
mTOR O X
TORC1 O X
and O X
TORC2 O X
complexes O X
and O X
the O X
association O X
of O X
ATR O X
with O X
ATRIP O X
. O X

The O X
structure O X
of O X
yeast O X
Tel2 I-MISC 852991
, O X
reported O X
here O X
, O X
shows O X
that O X
Tel2 I-MISC 852991
consists O X
of O X
HEAT O X
- O X
like O X
helical O X
repeats O X
that O X
assemble O X
into O X
two O X
separate O X
a O X
- O X
solenoids O X
. O X

Through O X
mutagenesis O X
, O X
we O X
identify O X
a O X
surface O X
patch O X
of O X
conserved O X
residues O X
involved O X
in O X
binding O X
to O X
the O X
Tti1 I-MISC 9675
- O X
Tti2 I-MISC 80185
complex O X
in O X
vitro O X
. O X

In O X
vivo O X
, O X
mutation O X
of O X
this O X
conserved O X
patch O X
affects O X
cell O X
growth O X
, O X
levels O X
of O X
PIKKs O X
, O X
and O X
ATM O X
/ O X
ATR O X
- O X
mediated O X
checkpoint O X
signaling O X
, O X
highlighting O X
the O X
importance O X
of O X
Tti1 I-MISC 9675
- O X
Tti2 I-MISC 80185
binding O X
to O X
the O X
function O X
of O X
Tel2 I-MISC 852991
. O X

Taken O X
together O X
, O X
our O X
data O X
suggest O X
that O X
the O X
Tel2 I-MISC 852991
- O X
Tti1 I-MISC 9675
- O X
Tti2 I-MISC 80185
complex O X
is O X
a O X
PIKK O X
- O X
specific O X
cochaperone O X
for O X
Hsp90 I-MISC 855836
. O X

###15067009	2993,2993	3674,3674

Dimerization O X
of O X
the O X
transmembrane O X
domain O X
of O X
Integrin I-MISC 3674
alphaIIb I-MISC 3674
subunit O X
in O X
cell O X
membranes O X
. O X

Homo O X
- O X
and O X
hetero O X
- O X
oligomeric O X
interactions O X
between O X
the O X
transmembrane O X
( O X
TM O X
) O X
helices O X
of O X
integrin O X
alpha O X
and O X
beta O X
subunits O X
may O X
play O X
an O X
important O X
role O X
in O X
integrin O X
activation O X
and O X
clustering O X
. O X

As O X
a O X
first O X
step O X
to O X
understanding O X
these O X
interactions O X
, O X
we O X
used O X
the O X
TOXCAT O X
assay O X
to O X
measure O X
oligomerization O X
of O X
the O X
wild O X
- O X
type O X
alpha O X
( O X
IIb O X
) O X
TM O X
helix O X
and O X
single O X
- O X
site O X
TM O X
domain O X
mutants O X
. O X

TOXCAT O X
measures O X
the O X
oligomerization O X
of O X
a O X
chimeric O X
protein O X
containing O X
a O X
TM O X
helix O X
in O X
the O X
Escherichia O X
coli O X
inner O X
membrane O X
via O X
the O X
transcriptional O X
activation O X
of O X
the O X
gene O X
for O X
chloramphenicol O X
acetyltransferase O X
. O X

We O X
found O X
the O X
amount O X
of O X
chloramphenicol O X
acetyltransferase O X
induced O X
by O X
the O X
wild O X
- O X
type O X
alpha O X
( O X
IIb O X
) O X
TM O X
helix O X
was O X
approximately O X
half O X
that O X
induced O X
by O X
the O X
strongly O X
dimerizing O X
TM O X
helix O X
of O X
glycophorin I-MISC 2993
A I-MISC 2993
, O X
confirming O X
that O X
the O X
alpha O X
( O X
IIb O X
) O X
TM O X
domain O X
oligomerizes O X
in O X
biological O X
membranes O X
. O X

Mutating O X
each O X
of O X
the O X
alpha O X
( O X
IIb O X
) O X
TM O X
domain O X
residues O X
to O X
either O X
Ala O X
, O X
Leu O X
, O X
Ile O X
, O X
or O X
Val O X
revealed O X
that O X
a O X
GXXXG O X
motif O X
mediates O X
oligomerization O X
. O X

Further O X
, O X
we O X
found O X
that O X
the O X
residue O X
preceding O X
each O X
glycine O X
contributed O X
to O X
the O X
oligomerization O X
interface O X
, O X
as O X
did O X
the O X
residue O X
at O X
position O X
i O X
+ O X
4 O X
after O X
the O X
second O X
Gly O X
of O X
GXXXG O X
. O X

Thus O X
, O X
the O X
sequence O X
XXVGXXGGXXXLXX O X
is O X
critical O X
for O X
oligomerization O X
of O X
alpha O X
( O X
IIb O X
) O X
TM O X
helix O X
. O X

These O X
data O X
were O X
used O X
to O X
generate O X
an O X
atomic O X
model O X
of O X
the O X
alpha O X
( O X
IIb O X
) O X
homodimer O X
, O X
revealing O X
a O X
family O X
of O X
structures O X
with O X
right O X
- O X
handed O X
crossing O X
angles O X
of O X
40 O X
degrees O X
to O X
60 O X
degrees O X
, O X
consistent O X
with O X
a O X
4 O X
. O X
0 O X
- O X
residue O X
periodicity O X
, O X
and O X
with O X
an O X
interface O X
rotated O X
by O X
50 O X
degrees O X
relative O X
to O X
glycophorin I-MISC 2993
A I-MISC 2993
. O X

Thus O X
, O X
although O X
the O X
alpha O X
( O X
IIb O X
) O X
TM O X
helix O X
makes O X
use O X
of O X
the O X
GXXXG O X
framework O X
, O X
neighboring O X
residues O X
have O X
evolved O X
to O X
engineer O X
its O X
dimerization O X
interface O X
, O X
enabling O X
it O X
to O X
subserve O X
specific O X
and O X
specialized O X
functions O X
. O X

###22796944	851136,852582

Pol O X
II O X
CTD O X
kinases O X
Bur1 O X
and O X
Kin28 O X
promote O X
Spt5 I-MISC 6829
CTR B-MISC 799
- O X
independent O X
recruitment O X
of O X
Paf1 I-MISC 852582
complex O X
. O X

Paf1 I-MISC 852582
complex O X
( O X
Paf1C O X
) O X
is O X
a O X
transcription O X
elongation O X
factor O X
whose O X
recruitment O X
is O X
stimulated O X
by O X
Spt5 I-MISC 6829
and O X
the O X
CDKs O X
Kin28 O X
and O X
Bur1 O X
, O X
which O X
phosphorylate O X
the O X
Pol O X
II O X
C O X
- O X
terminal O X
domain O X
( O X
CTD O X
) O X
on O X
Serines O X
2 O X
, O X
5 O X
, O X
and O X
7 O X
. O X

Bur1 O X
promotes O X
Paf1C O X
recruitment O X
by O X
phosphorylating O X
C O X
- O X
terminal O X
repeats O X
( O X
CTRs O X
) O X
in O X
Spt5 I-MISC 6829
, O X
and O X
we O X
show O X
that O X
Kin28 O X
enhances O X
Spt5 I-MISC 6829
phosphorylation O X
by O X
promoting O X
Bur1 O X
recruitment O X
. O X

It O X
was O X
unclear O X
, O X
however O X
, O X
whether O X
CTD O X
phosphorylation O X
by O X
Kin28 O X
or O X
Bur1 O X
also O X
stimulates O X
Paf1C O X
recruitment O X
. O X

We O X
find O X
that O X
Paf1C O X
and O X
its O X
Cdc73 I-MISC 851136
subunit O X
bind O X
diphosphorylated O X
CTD O X
repeats O X
( O X
pCTD O X
) O X
and O X
phosphorylated O X
Spt5 I-MISC 6829
CTRs O X
( O X
pCTRs O X
) O X
in O X
vitro O X
, O X
and O X
that O X
cdc73 I-MISC 851136
mutations O X
eliminating O X
both O X
activities O X
reduce O X
Paf1C O X
recruitment O X
in O X
vivo O X
. O X

Phosphomimetic O X
( O X
acidic O X
) O X
substitutions O X
in O X
the O X
Spt5 I-MISC 6829
CTR B-MISC 799
sustain O X
high O X
- O X
level O X
Paf1C O X
recruitment O X
in O X
otherwise O X
wild O X
- O X
type O X
cells O X
, O X
but O X
not O X
following O X
inactivation O X
of O X
Bur1 O X
or O X
Kin28 O X
. O X

Furthermore O X
, O X
inactivating O X
the O X
pCTD O X
/ O X
pCTR O X
- O X
interaction O X
domain O X
( O X
PCID O X
) O X
in O X
Cdc73 I-MISC 851136
decreases O X
Paf1C O X
- O X
dependent O X
histone O X
methylation O X
in O X
cells O X
containing O X
non O X
- O X
phosphorylatable O X
Spt5 I-MISC 6829
CTRs O X
. O X

These O X
results O X
identify O X
an O X
Spt5 I-MISC 6829
pCTR O X
- O X
independent O X
pathway O X
of O X
Paf1C O X
recruitment O X
requiring O X
Kin28 O X
, O X
Bur1 O X
, O X
and O X
the O X
Cdc73 I-MISC 851136
PCID O X
. O X

We O X
propose O X
that O X
pCTD O X
repeats O X
and O X
Spt5 I-MISC 6829
pCTRs O X
provide O X
separate O X
interaction O X
surfaces O X
that O X
cooperate O X
to O X
ensure O X
high O X
- O X
level O X
Paf1C O X
recruitment O X
. O X

###18775314	3267,6845

Molecular O X
basis O X
for O X
the O X
sorting O X
of O X
the O X
SNARE O X
VAMP7 I-MISC 6845
into O X
endocytic O X
clathrin O X
- O X
coated O X
vesicles O X
by O X
the O X
ArfGAP O X
Hrb I-MISC 3267
. O X

SNAREs O X
provide O X
the O X
specificity O X
and O X
energy O X
for O X
the O X
fusion O X
of O X
vesicles O X
with O X
their O X
target O X
membrane O X
, O X
but O X
how O X
they O X
are O X
sorted O X
into O X
the O X
appropriate O X
vesicles O X
on O X
post O X
- O X
Golgi O X
trafficking O X
pathways O X
is O X
largely O X
unknown O X
. O X

We O X
demonstrate O X
that O X
the O X
clathrin O X
- O X
mediated O X
endocytosis O X
of O X
the O X
SNARE O X
VAMP7 I-MISC 6845
is O X
directly O X
mediated O X
by O X
Hrb I-MISC 3267
, O X
a O X
clathrin O X
adaptor O X
and O X
ArfGAP O X
. O X

Hrb I-MISC 3267
wraps O X
20 O X
residues O X
of O X
its O X
unstructured O X
C O X
- O X
terminal O X
tail O X
around O X
the O X
folded O X
VAMP7 I-MISC 6845
longin O X
domain O X
, O X
demonstrating O X
that O X
unstructured O X
regions O X
of O X
clathrin O X
adaptors O X
can O X
select O X
cargo O X
. O X

Disrupting O X
this O X
interaction O X
by O X
mutation O X
of O X
the O X
VAMP7 I-MISC 6845
longin O X
domain O X
or O X
depletion O X
of O X
Hrb I-MISC 3267
causes O X
VAMP7 I-MISC 6845
to O X
accumulate O X
on O X
the O X
cell O X
' O X
s O X
surface O X
. O X

However O X
, O X
the O X
SNARE O X
helix O X
of O X
VAMP7 I-MISC 6845
binds O X
back O X
onto O X
its O X
longin O X
domain O X
, O X
outcompeting O X
Hrb I-MISC 3267
for O X
binding O X
to O X
the O X
same O X
groove O X
and O X
suggesting O X
that O X
Hrb I-MISC 3267
- O X
mediated O X
endocytosis O X
of O X
VAMP7 I-MISC 6845
occurs O X
only O X
when O X
VAMP7 I-MISC 6845
is O X
incorporated O X
into O X
a O X
cis O X
- O X
SNARE O X
complex O X
. O X

These O X
results O X
elucidate O X
the O X
mechanism O X
of O X
retrieval O X
of O X
a O X
postfusion O X
SNARE O X
complex O X
in O X
clathrin O X
- O X
coated O X
vesicles O X
. O X

###16996049	174233,173137

Interaction O X
of O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
with O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
is O X
required O X
for O X
maintenance O X
but O X
not O X
establishment O X
of O X
PAR O X
asymmetry O X
in O X
C O X
. O X
elegans O X
. O X

Caenorhabditis O X
elegans O X
embryonic O X
polarity O X
requires O X
the O X
asymmetrically O X
distributed O X
proteins O X
PAR I-MISC 175783
- I-MISC 175783
3 I-MISC 175783
, O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
and O X
PKC I-MISC 173914
- I-MISC 173914
3 I-MISC 173914
. O X

The O X
rho O X
family O X
GTPase O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
regulates O X
the O X
activities O X
of O X
these O X
proteins O X
in O X
mammals O X
, O X
flies O X
and O X
worms O X
. O X

To O X
clarify O X
its O X
mode O X
of O X
action O X
in O X
C O X
. O X
elegans O X
we O X
disrupted O X
the O X
interaction O X
between O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
and O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
in O X
vivo O X
, O X
and O X
also O X
determined O X
the O X
distribution O X
of O X
GFP O X
- O X
tagged O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
in O X
the O X
early O X
embryo O X
. O X

Mutant O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
proteins O X
unable O X
to O X
interact O X
with O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
accumulated O X
asymmetrically O X
, O X
at O X
a O X
reduced O X
level O X
, O X
but O X
this O X
asymmetry O X
was O X
not O X
maintained O X
during O X
the O X
first O X
division O X
. O X

We O X
also O X
determined O X
that O X
constitutively O X
active O X
GFP O X
:: O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
becomes O X
enriched O X
in O X
the O X
anterior O X
during O X
the O X
first O X
cell O X
cycle O X
in O X
a O X
domain O X
that O X
overlaps O X
with O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
. O X

The O X
asymmetry O X
is O X
dependent O X
on O X
PAR I-MISC 175275
- I-MISC 175275
2 I-MISC 175275
, O X
PAR I-MISC 178113
- I-MISC 178113
5 I-MISC 178113
and O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
. O X

Furthermore O X
, O X
we O X
found O X
that O X
overexpression O X
of O X
constitutively O X
active O X
GFP O X
:: O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
increased O X
the O X
size O X
of O X
the O X
anterior O X
domain O X
. O X

We O X
conclude O X
that O X
the O X
CDC I-MISC 174233
- I-MISC 174233
42 I-MISC 174233
interaction O X
with O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
is O X
not O X
required O X
for O X
the O X
initial O X
establishment O X
of O X
asymmetry O X
but O X
is O X
required O X
for O X
maximal O X
cortical O X
accumulation O X
of O X
PAR I-MISC 173137
- I-MISC 173137
6 I-MISC 173137
and O X
to O X
maintain O X
its O X
asymmetry O X
. O X

###19207211	831841,819122

The O X
targeting O X
of O X
the O X
oxysterol O X
- O X
binding O X
protein O X
ORP3a I-MISC 831841
to O X
the O X
endoplasmic O X
reticulum O X
relies O X
on O X
the O X
plant O X
VAP33 O X
homolog O X
PVA12 I-MISC 819122
. O X

In O X
plants O X
, O X
sterols O X
play O X
fundamental O X
roles O X
as O X
membrane O X
constituents O X
in O X
the O X
biosynthesis O X
of O X
steroid O X
hormones O X
, O X
and O X
act O X
as O X
precursors O X
for O X
cell O X
wall O X
deposition O X
. O X

Sterols O X
are O X
synthesized O X
in O X
the O X
endoplasmic O X
reticulum O X
( O X
ER O X
), O X
but O X
mainly O X
accumulate O X
in O X
the O X
plasma O X
membrane O X
. O X

How O X
sterols O X
are O X
trafficked O X
in O X
plant O X
cells O X
is O X
largely O X
unknown O X
. O X

In O X
non O X
- O X
plant O X
systems O X
, O X
oxysterol O X
- O X
binding O X
proteins O X
have O X
been O X
involved O X
in O X
sterol O X
trafficking O X
and O X
homeostasis O X
. O X

There O X
are O X
at O X
least O X
twelve O X
homologs O X
of O X
oxysterol O X
- O X
binding O X
proteins O X
in O X
the O X
Arabidopsis O X
genome O X
, O X
but O X
the O X
biology O X
of O X
these O X
proteins O X
remains O X
for O X
the O X
most O X
part O X
obscure O X
. O X

Here O X
, O X
we O X
report O X
our O X
analysis O X
of O X
the O X
targeting O X
requirements O X
and O X
the O X
sterol O X
- O X
binding O X
properties O X
of O X
a O X
small O X
Arabidopsis O X
oxysterol O X
- O X
binding O X
protein O X
, O X
ORP3a I-MISC 831841
. O X

We O X
have O X
determined O X
that O X
ORP3a I-MISC 831841
is O X
a O X
bona O X
fide O X
sterol O X
- O X
binding O X
protein O X
with O X
sitosterol O X
- O X
binding O X
properties O X
. O X

Live O X
- O X
cell O X
imaging O X
analyses O X
revealed O X
that O X
ORP3a I-MISC 831841
is O X
localized O X
at O X
the O X
ER O X
, O X
and O X
that O X
binding O X
to O X
this O X
organelle O X
depends O X
on O X
a O X
direct O X
interaction O X
with O X
PVA12 I-MISC 819122
, O X
a O X
member O X
of O X
the O X
largely O X
uncharacterized O X
VAP33 O X
family O X
of O X
plant O X
proteins O X
. O X

Molecular O X
modeling O X
analyses O X
and O X
site O X
- O X
directed O X
mutagenesis O X
led O X
to O X
the O X
identification O X
of O X
a O X
novel O X
protein O X
domain O X
that O X
is O X
responsible O X
for O X
the O X
PVA12 I-MISC 819122
- O X
ORP3a I-MISC 831841
interaction O X
. O X

Disruption O X
of O X
the O X
integrity O X
of O X
this O X
domain O X
caused O X
redistribution O X
of O X
ORP3a I-MISC 831841
to O X
the O X
Golgi O X
apparatus O X
, O X
suggesting O X
that O X
ORP3a I-MISC 831841
may O X
cycle O X
between O X
the O X
ER O X
and O X
the O X
Golgi O X
. O X

These O X
results O X
represent O X
new O X
insights O X
into O X
the O X
biology O X
of O X
sterol O X
- O X
binding O X
proteins O X
in O X
plant O X
cells O X
, O X
and O X
elucidate O X
a O X
hitherto O X
unknown O X
relationship O X
between O X
members O X
of O X
oxysterol O X
- O X
binding O X
protein O X
and O X
VAP33 O X
families O X
of O X
plant O X
proteins O X
in O X
the O X
early O X
plant O X
secretory O X
pathway O X
. O X

###21382479	637,857

Caveolin I-MISC 857
- I-MISC 857
1 I-MISC 857
mediates O X
Fas O X
- O X
BID I-MISC 637
signaling O X
in O X
hyperoxia O X
- O X
induced O X
apoptosis O X
. O X

Fas O X
- O X
mediated O X
apoptosis O X
is O X
a O X
crucial O X
cellular O X
event O X
. O X

Fas O X
, O X
the O X
Fas O X
- O X
associated O X
death O X
domain O X
, O X
and O X
caspase I-MISC 841
8 I-MISC 841
form O X
the O X
death O X
- O X
inducing O X
signaling O X
complex O X
( O X
DISC O X
). O X

Activated O X
caspase I-MISC 841
8 I-MISC 841
mediates O X
the O X
extrinsic O X
pathways O X
and O X
cleaves O X
cytosolic O X
BID I-MISC 637
. O X

Truncated O X
BID I-MISC 637
( O X
tBID O X
) O X
translocates O X
to O X
the O X
mitochondria O X
, O X
facilitates O X
the O X
release O X
of O X
cytochrome I-MISC 54205
c I-MISC 54205
, O X
and O X
activates O X
the O X
intrinsic O X
pathways O X
. O X

However O X
, O X
the O X
mechanism O X
causing O X
these O X
DISC O X
components O X
to O X
aggregate O X
and O X
form O X
the O X
complex O X
remains O X
unclear O X
. O X

We O X
found O X
that O X
Cav O X
- O X
1 O X
regulated O X
Fas O X
signaling O X
and O X
mediated O X
the O X
communication O X
between O X
extrinsic O X
and O X
intrinsic O X
pathways O X
. O X

Shortly O X
after O X
hyperoxia O X
( O X
4 O X
h O X
), O X
the O X
colocalization O X
and O X
interaction O X
of O X
Cav O X
- O X
1 O X
and O X
Fas O X
increased O X
, O X
followed O X
by O X
Fas O X
multimer O X
and O X
DISC O X
formation O X
. O X

Deletion O X
of O X
Cav O X
- O X
1 O X
( O X
Cav O X
- O X
1 O X
-/-) O X
disrupted O X
DISC O X
formation O X
. O X

Further O X
, O X
Cav O X
- O X
1 O X
interacted O X
with O X
BID I-MISC 637
. O X

Mutation O X
of O X
Cav O X
- O X
1 O X
Y14 O X
tyrosine O X
to O X
phenylalanine O X
( O X
Y14F O X
) O X
disrupted O X
the O X
hyperoxia O X
- O X
induced O X
interaction O X
between O X
BID I-MISC 637
and O X
Cav O X
- O X
1 O X
and O X
subsequently O X
yielded O X
a O X
decreased O X
level O X
of O X
tBID O X
and O X
resistance O X
to O X
hyperoxia O X
- O X
induced O X
apoptosis O X
. O X

The O X
reactive O X
oxygen O X
species O X
( O X
ROS O X
) O X
scavenger O X
N O X
- O X
acetylcysteine O X
decreased O X
the O X
Cav O X
- O X
1 O X
- O X
Fas O X
interaction O X
. O X

Deletion O X
of O X
glutathione O X
peroxidase O X
- O X
2 O X
using O X
siRNA O X
aggravated O X
the O X
BID I-MISC 637
- O X
Cav O X
- O X
1 O X
interaction O X
and O X
tBID O X
formation O X
. O X

Taken O X
together O X
, O X
these O X
results O X
indicate O X
that O X
Cav O X
- O X
1 O X
regulates O X
hyperoxia O X
/ O X
ROS O X
- O X
induced O X
apoptosis O X
through O X
interactions O X
with O X
Fas O X
and O X
BID I-MISC 637
, O X
probably O X
via O X
Fas O X
palmitoylation O X
and O X
Cav O X
- O X
1 O X
Y14 O X
phosphorylation O X
, O X
respectively O X
. O X

###16236155	836733,817014

An O X
Arabidopsis O X
GRIP I-MISC 836733
domain O X
protein O X
locates O X
to O X
the O X
trans O X
- O X
Golgi O X
and O X
binds O X
the O X
small O X
GTPase O X
ARL1 I-MISC 852462
. O X

GRIP I-MISC 836733
domain O X
proteins O X
are O X
a O X
class O X
of O X
golgins O X
that O X
have O X
been O X
described O X
in O X
yeast O X
and O X
animals O X
. O X

They O X
locate O X
to O X
the O X
trans O X
- O X
Golgi O X
network O X
and O X
are O X
thought O X
to O X
play O X
a O X
role O X
in O X
endosome O X
- O X
to O X
- O X
Golgi O X
trafficking O X
. O X

The O X
Arabidopsis O X
GRIP I-MISC 836733
domain O X
protein O X
, O X
AtGRIP I-MISC 836733
, O X
fused O X
to O X
the O X
green O X
fluorescent O X
protein O X
( O X
GFP O X
), O X
locates O X
to O X
Golgi O X
stacks O X
but O X
does O X
not O X
exactly O X
co O X
- O X
locate O X
with O X
the O X
Golgi O X
marker O X
sialyl O X
transferase O X
( O X
ST O X
)- O X
mRFP O X
, O X
nor O X
with O X
the O X
t O X
- O X
SNAREs O X
Memb11 O X
, O X
SYP31 O X
and O X
BS14a O X
. O X

We O X
conclude O X
that O X
the O X
location O X
of O X
AtGRIP I-MISC 836733
is O X
further O X
to O X
the O X
trans O X
side O X
of O X
the O X
stack O X
than O X
STtmd O X
- O X
mRFP O X
. O X

The O X
185 O X
- O X
aa O X
C O X
- O X
terminus O X
of O X
AtGRIP I-MISC 836733
containing O X
the O X
GRIP I-MISC 836733
domain O X
targeted O X
GFP O X
to O X
the O X
Golgi O X
, O X
although O X
a O X
proportion O X
of O X
the O X
fusion O X
protein O X
was O X
still O X
found O X
in O X
the O X
cytosol O X
. O X

Mutation O X
of O X
a O X
conserved O X
tyrosine O X
( O X
Y717 O X
) O X
to O X
alanine O X
in O X
the O X
GRIP I-MISC 836733
domain O X
disrupted O X
Golgi O X
localization O X
. O X

ARL1 I-MISC 852462
is O X
a O X
small O X
GTPase O X
required O X
for O X
Golgi O X
targeting O X
of O X
GRIP I-MISC 836733
domain O X
proteins O X
in O X
other O X
systems O X
. O X

An O X
Arabidopsis O X
ARL1 I-MISC 852462
homologue O X
was O X
isolated O X
and O X
shown O X
to O X
target O X
to O X
Golgi O X
stacks O X
. O X

The O X
GDP O X
- O X
restricted O X
mutant O X
of O X
ARL1 I-MISC 852462
, O X
AtARL1 I-MISC 817014
- O X
T31N O X
, O X
was O X
observed O X
to O X
locate O X
partially O X
to O X
the O X
cytosol O X
, O X
whereas O X
the O X
GTP O X
- O X
restricted O X
mutant O X
AtARL1 I-MISC 817014
- O X
Q71L O X
labelled O X
the O X
Golgi O X
and O X
a O X
population O X
of O X
small O X
structures O X
. O X

Increasing O X
the O X
levels O X
of O X
AtARL1 I-MISC 817014
in O X
epidermal O X
cells O X
increased O X
the O X
proportion O X
of O X
GRIP I-MISC 836733
- O X
GFP O X
fusion O X
protein O X
on O X
Golgi O X
stacks O X
. O X

We O X
show O X
, O X
moreover O X
, O X
that O X
AtARL1 I-MISC 817014
interacted O X
with O X
the O X
GRIP I-MISC 836733
domain O X
in O X
a O X
GTP O X
- O X
dependent O X
manner O X
in O X
vitro O X
in O X
affinity O X
chromatography O X
and O X
in O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

This O X
indicates O X
that O X
AtGRIP I-MISC 836733
and O X
AtARL1 I-MISC 817014
interact O X
directly O X
. O X

We O X
conclude O X
that O X
the O X
pathway O X
involving O X
ARL1 I-MISC 852462
and O X
GRIP I-MISC 836733
domain O X
golgins O X
is O X
conserved O X
in O X
plants O X
. O X

###11777938	2542880,2541957

Polo O X
boxes O X
and O X
Cut23 I-MISC 2542880
( O X
Apc8 I-MISC 2541957
) O X
mediate O X
an O X
interaction O X
between O X
polo O X
kinase O X
and O X
the O X
anaphase O X
- O X
promoting O X
complex O X
for O X
fission O X
yeast O X
mitosis O X
. O X

The O X
fission O X
yeast O X
plo1 O X
(+) O X
gene O X
encodes O X
a O X
polo O X
- O X
like O X
kinase O X
, O X
a O X
member O X
of O X
a O X
conserved O X
family O X
of O X
kinases O X
which O X
play O X
multiple O X
roles O X
during O X
the O X
cell O X
cycle O X
. O X

We O X
show O X
that O X
Plo1 O X
kinase O X
physically O X
interacts O X
with O X
the O X
anaphase O X
- O X
promoting O X
complex O X
( O X
APC O X
)/ O X
cyclosome O X
through O X
the O X
noncatalytic O X
domain O X
of O X
Plo1 O X
and O X
the O X
tetratricopeptide O X
repeat O X
domain O X
of O X
the O X
subunit O X
, O X
Cut23 I-MISC 2542880
. O X

A O X
new O X
cut23 I-MISC 2542880
mutation O X
, O X
which O X
specifically O X
disrupts O X
the O X
interaction O X
with O X
Plo1 O X
, O X
results O X
in O X
a O X
metaphase O X
arrest O X
. O X

This O X
arrest O X
can O X
be O X
rescued O X
by O X
high O X
expression O X
of O X
Plo1 O X
kinase O X
. O X

We O X
suggest O X
that O X
this O X
physical O X
interaction O X
is O X
crucial O X
for O X
mitotic O X
progression O X
by O X
targeting O X
polo O X
kinase O X
activity O X
toward O X
the O X
APC O X
. O X

###11741893	51765,51765

Cloning O X
of O X
MASK I-MISC 51765
, O X
a O X
novel O X
member O X
of O X
the O X
mammalian O X
germinal O X
center O X
kinase O X
III O X
subfamily O X
, O X
with O X
apoptosis O X
- O X
inducing O X
properties O X
. O X

We O X
have O X
cloned O X
a O X
novel O X
human O X
GCK O X
family O X
kinase O X
that O X
has O X
been O X
designated O X
as O X
MASK I-MISC 51765
( O X
Mst3 I-MISC 51765
and I-MISC 51765
SOK1 I-MISC 51765
- I-MISC 51765
related I-MISC 51765
kinase I-MISC 51765
). O X

MASK I-MISC 51765
is O X
widely O X
expressed O X
and O X
encodes O X
a O X
protein O X
of O X
416 O X
amino O X
acid O X
residues O X
, O X
with O X
an O X
N O X
- O X
terminal O X
kinase O X
domain O X
and O X
a O X
unique O X
C O X
- O X
terminal O X
region O X
. O X

Like O X
other O X
GCK O X
- O X
III O X
subfamily O X
kinases O X
, O X
MASK I-MISC 51765
does O X
not O X
activate O X
any O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
pathways O X
. O X

Wild O X
type O X
MASK I-MISC 51765
, O X
but O X
not O X
a O X
form O X
lacking O X
the O X
C O X
terminus O X
, O X
exhibits O X
homophilic O X
binding O X
in O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
and O X
in O X
coimmunoprecipitation O X
experiments O X
. O X

Additionally O X
, O X
deletion O X
of O X
this O X
C O X
- O X
terminal O X
region O X
of O X
MASK I-MISC 51765
leads O X
to O X
an O X
increased O X
kinase O X
activity O X
toward O X
itself O X
as O X
well O X
as O X
toward O X
an O X
exogenous O X
substrate O X
, O X
myelin I-MISC 4155
basic I-MISC 4155
protein I-MISC 4155
. O X

A O X
potential O X
caspase I-MISC 836
3 I-MISC 836
cleavage O X
site O X
( O X
DESDS O X
) O X
is O X
present O X
in O X
the O X
C O X
- O X
terminal O X
region O X
of O X
MASK I-MISC 51765
, O X
and O X
we O X
show O X
that O X
MASK I-MISC 51765
is O X
cleaved O X
in O X
vitro O X
by O X
caspase I-MISC 836
3 I-MISC 836
. O X

Finally O X
, O X
wild O X
type O X
and O X
C O X
- O X
terminally O X
truncated O X
forms O X
of O X
MASK I-MISC 51765
can O X
both O X
induce O X
apoptosis O X
upon O X
overexpression O X
in O X
mammalian O X
cells O X
that O X
is O X
abrogated O X
by O X
CrmA O X
, O X
suggesting O X
involvement O X
of O X
MASK I-MISC 51765
in O X
the O X
apoptotic O X
machinery O X
in O X
mammalian O X
cells O X
. O X

###25040622	9051,26191

Proline I-MISC 9051
- I-MISC 9051
serine I-MISC 9051
- I-MISC 9051
threonine I-MISC 9051
phosphatase I-MISC 9051
interacting I-MISC 9051
protein I-MISC 9051
1 I-MISC 9051
inhibition O X
of O X
T I-MISC 6962
- I-MISC 6962
cell I-MISC 6962
receptor I-MISC 6962
signaling O X
depends O X
on O X
its O X
SH3 O X
domain O X
. O X

Proline I-MISC 9051
- I-MISC 9051
serine I-MISC 9051
- I-MISC 9051
threonine I-MISC 9051
phosphatase I-MISC 9051
interacting I-MISC 9051
protein I-MISC 9051
1 I-MISC 9051
( O X
PSTPIP1 I-MISC 9051
) O X
is O X
an O X
adaptor O X
protein O X
associated O X
with O X
the O X
cytoskeleton O X
that O X
is O X
mainly O X
expressed O X
in O X
hematopoietic O X
cells O X
. O X

Mutations O X
in O X
PSTPIP1 I-MISC 9051
cause O X
the O X
rare O X
autoinflammatory O X
disease O X
called O X
pyogenic O X
arthritis O X
, O X
pyoderma O X
gangrenosum O X
, O X
and O X
acne O X
. O X

We O X
carried O X
out O X
this O X
study O X
to O X
further O X
our O X
knowledge O X
on O X
PSTPIP1 I-MISC 9051
function O X
in O X
T O X
cells O X
, O X
particularly O X
in O X
relation O X
to O X
the O X
phosphatase O X
lymphoid I-MISC 26191
phosphatase I-MISC 26191
( O X
LYP I-MISC 26191
), O X
which O X
is O X
involved O X
in O X
several O X
autoimmune O X
diseases O X
. O X

LYP I-MISC 26191
- O X
PSTPIP1 I-MISC 9051
binding O X
occurs O X
through O X
the O X
C O X
- O X
terminal O X
homology O X
domain O X
of O X
LYP I-MISC 26191
and O X
the O X
F O X
- O X
BAR O X
domain O X
of O X
PSTPIP1 I-MISC 9051
. O X

PSTPIP1 I-MISC 9051
inhibits O X
T O X
- O X
cell O X
activation O X
upon O X
T I-MISC 6962
- I-MISC 6962
cell I-MISC 6962
receptor I-MISC 6962
( O X
TCR I-MISC 6962
) O X
and O X
CD28 I-MISC 940
engagement O X
, O X
regardless O X
of O X
CD2 I-MISC 914
costimulation O X
. O X

This O X
function O X
of O X
PSTPIP1 I-MISC 9051
depends O X
on O X
the O X
presence O X
of O X
an O X
intact O X
SH3 O X
domain O X
rather O X
than O X
on O X
the O X
F O X
- O X
BAR O X
domain O X
, O X
indicating O X
that O X
ligands O X
of O X
the O X
F O X
- O X
BAR O X
domain O X
, O X
such O X
as O X
the O X
PEST O X
phosphatases O X
LYP I-MISC 26191
and O X
PTP I-MISC 5782
- I-MISC 5782
PEST I-MISC 5782
, O X
are O X
not O X
critical O X
for O X
its O X
negative O X
regulatory O X
role O X
in O X
TCR I-MISC 6962
signaling O X
. O X

Additionally O X
, O X
PSTPIP1 I-MISC 9051
mutations O X
that O X
cause O X
the O X
pyogenic O X
arthritis O X
, O X
pyoderma O X
gangrenosum O X
and O X
acne O X
syndrome O X
do O X
not O X
affect O X
PSTPIP1 I-MISC 9051
function O X
in O X
T O X
- O X
cell O X
activation O X
through O X
the O X
TCR I-MISC 6962
. O X

###16537536	723780,374074	723780,418514	723780,100857439	723780,100858049

Asf1 I-MISC 723780
is O X
required O X
for O X
viability O X
and O X
chromatin O X
assembly O X
during O X
DNA O X
replication O X
in O X
vertebrate O X
cells O X
. O X

Asf1 I-MISC 853327
( O X
anti I-MISC 853327
- I-MISC 853327
silencing I-MISC 853327
function I-MISC 853327
1 I-MISC 853327
), O X
a O X
well O X
conserved O X
protein O X
from O X
yeast O X
to O X
humans O X
, O X
acts O X
as O X
a O X
histone O X
chaperone O X
and O X
is O X
predicted O X
to O X
participate O X
in O X
a O X
variety O X
of O X
chromatin O X
- O X
mediated O X
cellular O X
processes O X
. O X

To O X
investigate O X
the O X
physiological O X
role O X
of O X
vertebrate O X
Asf1 I-MISC 723780
in O X
vivo O X
, O X
we O X
generated O X
a O X
conditional O X
Asf1 I-MISC 723780
- O X
deficient O X
mutant O X
from O X
chicken O X
DT40 O X
cells O X
. O X

Induction O X
of O X
Asf1 I-MISC 723780
depletion O X
resulted O X
in O X
the O X
accumulation O X
of O X
cells O X
in O X
S O X
phase O X
with O X
decreased O X
DNA O X
replication O X
and O X
increased O X
mitotic O X
aberrancy O X
forming O X
multipolar O X
spindles O X
, O X
leading O X
to O X
cell O X
death O X
. O X

In O X
addition O X
, O X
nascent O X
chromatin O X
in O X
Asf1 I-MISC 723780
- O X
depleted O X
cells O X
showed O X
increased O X
nuclease O X
sensitivity O X
, O X
indicating O X
impaired O X
nucleosome O X
assembly O X
during O X
DNA O X
replication O X
. O X

Complementation O X
analyses O X
revealed O X
that O X
the O X
functional O X
domain O X
of O X
Asf1 I-MISC 723780
for O X
cell O X
viability O X
was O X
confined O X
to O X
the O X
N O X
- O X
terminal O X
core O X
domain O X
( O X
amino O X
acids O X
1 O X
- O X
155 O X
) O X
that O X
is O X
a O X
binding O X
platform O X
for O X
histones I-MISC 100857439
H3 I-MISC 100857439
/ O X
H4 O X
, O X
CAF I-MISC 418514
- I-MISC 418514
1p60 I-MISC 418514
, O X
and O X
HIRA I-MISC 374074
, O X
whereas O X
Asf1 I-MISC 723780
mutant O X
proteins O X
, O X
abolishing O X
binding O X
abilities O X
with O X
both O X
p60 I-MISC 395726
and O X
HIRA I-MISC 374074
, O X
exhibit O X
no O X
effect O X
on O X
viability O X
. O X

These O X
results O X
together O X
indicate O X
that O X
the O X
vertebrate O X
Asf1 I-MISC 723780
plays O X
a O X
crucial O X
role O X
in O X
replication O X
- O X
coupled O X
chromatin O X
assembly O X
, O X
cell O X
cycle O X
progression O X
, O X
and O X
cellular O X
viability O X
and O X
provide O X
a O X
clue O X
of O X
a O X
possible O X
role O X
in O X
a O X
CAF I-MISC 422733
- I-MISC 422733
1 I-MISC 422733
- O X
and O X
HIRA I-MISC 374074
- O X
independent O X
chromatin O X
- O X
modulating O X
process O X
for O X
cell O X
proliferation O X
. O X

###8922390	396422,395832	396422,395832

Identification O X
of O X
LIM3 I-MISC 8022
as O X
the O X
principal O X
determinant O X
of O X
paxillin I-MISC 395832
focal O X
adhesion O X
localization O X
and O X
characterization O X
of O X
a O X
novel O X
motif O X
on O X
paxillin I-MISC 395832
directing O X
vinculin I-MISC 396422
and O X
focal I-MISC 5747
adhesion I-MISC 5747
kinase I-MISC 5747
binding O X
. O X

Paxillin I-MISC 395832
is O X
a O X
68 O X
- O X
kD O X
focal O X
adhesion O X
phosphoprotein O X
that O X
interacts O X
with O X
several O X
proteins O X
including O X
members O X
of O X
the O X
src O X
family O X
of O X
tyrosine O X
kinases O X
, O X
the O X
transforming O X
protein O X
v O X
- O X
crk O X
, O X
and O X
the O X
cytoskeletal O X
proteins O X
vinculin I-MISC 396422
and O X
the O X
tyrosine O X
kinase O X
, O X
focal I-MISC 5747
adhesion I-MISC 5747
kinase I-MISC 5747
( O X
FAK I-MISC 5747
). O X

This O X
suggests O X
a O X
function O X
for O X
paxillin I-MISC 395832
as O X
a O X
molecular O X
adaptor O X
, O X
responsible O X
for O X
the O X
recruitment O X
of O X
structural O X
and O X
signaling O X
molecules O X
to O X
focal O X
adhesions O X
. O X

The O X
current O X
study O X
defines O X
the O X
vinculin I-MISC 396422
- O X
and O X
FAK I-MISC 5747
- O X
interaction O X
domains O X
on O X
paxillin I-MISC 395832
and O X
identifies O X
the O X
principal O X
paxillin I-MISC 395832
focal O X
adhesion O X
targeting O X
motif O X
. O X

Using O X
truncation O X
and O X
deletion O X
mutagenesis O X
, O X
we O X
have O X
localized O X
the O X
vinculin I-MISC 396422
- O X
binding O X
site O X
on O X
paxillin I-MISC 395832
to O X
a O X
contiguous O X
stretch O X
of O X
21 O X
amino O X
acids O X
spanning O X
residues O X
143 O X
- O X
164 O X
. O X

In O X
contrast O X
, O X
maximal O X
binding O X
of O X
FAK I-MISC 5747
to O X
paxillin I-MISC 395832
requires O X
, O X
in O X
addition O X
to O X
the O X
region O X
of O X
paxillin I-MISC 395832
spanning O X
amino O X
acids O X
143 O X
- O X
164 O X
, O X
a O X
carboxyl O X
- O X
terminal O X
domain O X
encompassing O X
residues O X
265 O X
- O X
313 O X
. O X

These O X
data O X
demonstrate O X
the O X
presence O X
of O X
a O X
single O X
binding O X
site O X
for O X
vinculin I-MISC 396422
, O X
and O X
at O X
least O X
two O X
binding O X
sites O X
for O X
FAK I-MISC 5747
that O X
are O X
separated O X
by O X
an O X
intervening O X
stretch O X
of O X
100 O X
amino O X
acids O X
. O X

Vinculin I-MISC 396422
- O X
and O X
FAK I-MISC 5747
- O X
binding O X
activities O X
within O X
amino O X
acids O X
143 O X
- O X
164 O X
were O X
separable O X
since O X
mutation O X
of O X
amino O X
acid O X
151 O X
from O X
a O X
negatively O X
charged O X
glutamic O X
acid O X
to O X
the O X
uncharged O X
polar O X
residue O X
glutamine O X
( O X
E151Q O X
) O X
reduced O X
binding O X
of O X
vinculin I-MISC 396422
to O X
paxillin I-MISC 395832
by O X
> O X
90 O X
%, O X
with O X
no O X
reduction O X
in O X
the O X
binding O X
capacity O X
for O X
FAK I-MISC 5747
. O X

The O X
requirement O X
for O X
focal O X
adhesion O X
targeting O X
of O X
the O X
vinculin I-MISC 396422
- O X
and O X
FAK I-MISC 5747
- O X
binding O X
regions O X
within O X
paxillin I-MISC 395832
was O X
determined O X
by O X
transfection O X
into O X
CHO O X
. O X
K1 O X
fibroblasts O X
. O X

Significantly O X
and O X
surprisingly O X
, O X
paxillin I-MISC 395832
constructs O X
containing O X
both O X
deletion O X
and O X
point O X
mutations O X
that O X
abrogate O X
binding O X
of O X
FAK I-MISC 5747
and O X
/ O X
or O X
vinculin I-MISC 396422
were O X
found O X
to O X
target O X
effectively O X
to O X
focal O X
adhesions O X
. O X

Additionally O X
, O X
expression O X
of O X
the O X
amino O X
- O X
terminal O X
313 O X
amino O X
acids O X
of O X
paxillin I-MISC 395832
containing O X
intact O X
vinculin I-MISC 396422
- O X
and O X
FAK I-MISC 5747
- O X
binding O X
domains O X
failed O X
to O X
target O X
to O X
focal O X
adhesions O X
. O X

This O X
indicated O X
other O X
regions O X
of O X
paxillin I-MISC 395832
were O X
functioning O X
as O X
focal O X
adhesion O X
localization O X
motifs O X
. O X

The O X
carboxyl O X
- O X
terminal O X
half O X
of O X
paxillin I-MISC 395832
( O X
amino O X
acids O X
313 O X
- O X
559 O X
) O X
contains O X
four O X
contiguous O X
double O X
zinc O X
finger O X
LIM O X
domains O X
. O X

Transfection O X
analyses O X
of O X
sequential O X
carboxyl O X
- O X
terminal O X
truncations O X
of O X
the O X
four O X
individual O X
LIM O X
motifs O X
and O X
site O X
- O X
directed O X
mutagenesis O X
of O X
LIM O X
domains O X
1 O X
, O X
2 O X
, O X
and O X
3 O X
, O X
as O X
well O X
as O X
deletion O X
mutagenesis O X
, O X
revealed O X
that O X
the O X
principal O X
mechanism O X
of O X
targeting O X
paxillin I-MISC 395832
to O X
focal O X
adhesions O X
is O X
through O X
LIM3 I-MISC 8022
. O X

These O X
data O X
demonstrate O X
that O X
paxillin I-MISC 395832
localizes O X
to O X
focal O X
adhesions O X
independent O X
of O X
interactions O X
with O X
vinculin I-MISC 396422
and O X
/ O X
or O X
FAK I-MISC 5747
, O X
and O X
represents O X
the O X
first O X
definitive O X
demonstration O X
of O X
LIM O X
domains O X
functioning O X
as O X
a O X
primary O X
determinant O X
of O X
protein O X
subcellular O X
localization O X
to O X
focal O X
adhesions O X
. O X

###15175337	100297344,79239

Heme I-MISC 79239
oxygenase I-MISC 79239
- I-MISC 79239
2 I-MISC 79239
is O X
activated O X
by O X
calcium O X
- O X
calmodulin I-MISC 100297344
. O X

The O X
heme O X
oxygenase O X
family O X
of O X
enzymes O X
catalyzes O X
the O X
metabolism O X
of O X
heme O X
to O X
biliverdin O X
, O X
ferrous O X
iron O X
, O X
and O X
carbon O X
monoxide O X
( O X
CO O X
). O X

At O X
least O X
two O X
isoforms O X
exist O X
, O X
heme I-MISC 3162
oxygenase I-MISC 3162
- I-MISC 3162
1 I-MISC 3162
( O X
HO1 I-MISC 3162
) O X
and O X
heme I-MISC 79239
oxygenase I-MISC 79239
- I-MISC 79239
2 I-MISC 79239
( O X
HO2 I-MISC 79239
), O X
which O X
are O X
encoded O X
by O X
separate O X
genes O X
. O X

HO2 I-MISC 79239
is O X
selectively O X
enriched O X
in O X
neurons O X
, O X
and O X
substantial O X
evidence O X
suggests O X
that O X
HO2 I-MISC 79239
- O X
derived O X
CO O X
functions O X
as O X
a O X
neurotransmitter O X
/ O X
neuromodulator O X
. O X

However O X
, O X
a O X
molecular O X
mechanism O X
for O X
the O X
rapid O X
activation O X
of O X
HO2 I-MISC 79239
during O X
neuronal O X
activity O X
has O X
not O X
been O X
described O X
. O X

Through O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
we O X
identified O X
calmodulin I-MISC 100297344
as O X
a O X
potential O X
regulator O X
of O X
HO2 I-MISC 79239
activity O X
. O X

Calmodulin I-MISC 100297344
binds O X
with O X
nanomolar O X
affinity O X
to O X
HO2 I-MISC 79239
in O X
a O X
calcium O X
- O X
dependent O X
manner O X
via O X
a O X
canonical O X
1 O X
- O X
10 O X
motif O X
, O X
resulting O X
in O X
a O X
3 O X
- O X
fold O X
increase O X
in O X
catalytic O X
activity O X
. O X

Mutations O X
within O X
this O X
motif O X
block O X
calmodulin I-MISC 100297344
binding O X
and O X
calcium O X
- O X
dependent O X
stimulation O X
of O X
enzyme O X
activity O X
in O X
vitro O X
and O X
in O X
intact O X
cells O X
. O X

The O X
calcium O X
mobilizing O X
agents O X
ionomycin O X
and O X
glutamate O X
stimulate O X
endogenous O X
HO2 I-MISC 79239
activity O X
in O X
primary O X
cortical O X
cultures O X
, O X
establishing O X
in O X
vivo O X
relevance O X
. O X

Calcium O X
- O X
calmodulin I-MISC 100297344
provides O X
a O X
mechanism O X
for O X
rapid O X
and O X
transient O X
activation O X
of O X
HO2 I-MISC 79239
during O X
neuronal O X
activity O X
. O X

###21398549	1137497,1137497

The O X
dimer O X
interface O X
of O X
Agrobacterium O X
tumefaciens O X
VirB8 I-MISC 1137497
is O X
important O X
for O X
type O X
IV O X
secretion O X
system O X
function O X
, O X
stability O X
, O X
and O X
association O X
of O X
VirB2 I-MISC 1224319
with O X
the O X
core O X
complex O X
. O X

Type O X
IV O X
secretion O X
systems O X
are O X
virulence O X
factors O X
used O X
by O X
many O X
gram O X
- O X
negative O X
bacteria O X
to O X
translocate O X
macromolecules O X
across O X
the O X
cell O X
envelope O X
. O X

VirB8 I-MISC 1137497
is O X
an O X
essential O X
inner O X
membrane O X
component O X
of O X
type O X
IV O X
secretion O X
systems O X
, O X
and O X
it O X
is O X
believed O X
to O X
form O X
a O X
homodimer O X
. O X

In O X
the O X
absence O X
of O X
VirB8 I-MISC 1137497
, O X
the O X
levels O X
of O X
several O X
other O X
VirB O X
proteins O X
were O X
reduced O X
( O X
VirB1 I-MISC 1224318
, O X
VirB3 I-MISC 6381980
, O X
VirB4 I-MISC 6381981
, O X
VirB5 I-MISC 6381942
, O X
VirB6 I-MISC 1224323
, O X
VirB7 I-MISC 6382049
, O X
and O X
VirB11 I-MISC 1224328
) O X
in O X
Agrobacterium O X
tumefaciens O X
, O X
underlining O X
its O X
importance O X
for O X
complex O X
stability O X
. O X

To O X
assess O X
the O X
importance O X
of O X
dimerization O X
, O X
we O X
changed O X
residues O X
at O X
the O X
predicted O X
dimer O X
interface O X
( O X
V97 O X
, O X
A100 O X
, O X
Q93 O X
, O X
and O X
E94 O X
) O X
in O X
order O X
to O X
strengthen O X
or O X
to O X
abolish O X
dimerization O X
. O X

We O X
verified O X
the O X
impact O X
of O X
the O X
changes O X
on O X
dimerization O X
in O X
vitro O X
with O X
purified O X
V97 O X
variants O X
, O X
followed O X
by O X
analysis O X
of O X
the O X
in O X
vivo O X
consequences O X
in O X
a O X
complemented O X
virB8 I-MISC 1137497
deletion O X
strain O X
. O X

Dimer O X
formation O X
was O X
observed O X
in O X
vivo O X
after O X
the O X
introduction O X
of O X
a O X
cysteine O X
residue O X
at O X
the O X
predicted O X
interface O X
( O X
V97C O X
), O X
and O X
this O X
variant O X
supported O X
DNA O X
transfer O X
, O X
but O X
the O X
formation O X
of O X
elongated O X
T O X
pili O X
was O X
not O X
detected O X
by O X
the O X
standard O X
pilus O X
isolation O X
technique O X
. O X

Variants O X
with O X
changes O X
at O X
V97 O X
and O X
A100 O X
that O X
weaken O X
dimerization O X
did O X
not O X
support O X
type O X
IV O X
secretion O X
system O X
functions O X
. O X

The O X
T O X
- O X
pilus O X
component O X
VirB2 I-MISC 1224319
cofractionated O X
with O X
high O X
- O X
molecular O X
- O X
mass O X
core O X
protein O X
complexes O X
extracted O X
from O X
the O X
membranes O X
, O X
and O X
the O X
presence O X
of O X
VirB8 I-MISC 1137497
as O X
well O X
as O X
its O X
dimer O X
interface O X
were O X
important O X
for O X
this O X
association O X
. O X

We O X
conclude O X
that O X
the O X
VirB8 I-MISC 1137497
dimer O X
interface O X
is O X
required O X
for O X
T4SS O X
function O X
, O X
for O X
the O X
stabilization O X
of O X
many O X
VirB O X
proteins O X
, O X
and O X
for O X
targeting O X
of O X
VirB2 I-MISC 1224319
to O X
the O X
T O X
- O X
pilus O X
assembly O X
site O X
. O X

###17947231	825414,822277

Spontaneous O X
assembly O X
of O X
photosynthetic O X
supramolecular O X
complexes O X
as O X
mediated O X
by O X
the O X
intrinsically O X
unstructured O X
protein O X
CP12 I-MISC 825414
. O X

CP12 I-MISC 825414
is O X
a O X
protein O X
of O X
8 O X
. O X
7 O X
kDa O X
that O X
contributes O X
to O X
Calvin O X
cycle O X
regulation O X
by O X
acting O X
as O X
a O X
scaffold O X
element O X
in O X
the O X
formation O X
of O X
a O X
supramolecular O X
complex O X
with O X
glyceraldehyde O X
- O X
3 O X
- O X
phosphate O X
dehydrogenase O X
( O X
GAPDH O X
) O X
and O X
phosphoribulokinase O X
( O X
PRK O X
) O X
in O X
photosynthetic O X
organisms O X
. O X

NMR O X
studies O X
of O X
recombinant O X
CP12 I-MISC 825414
( O X
isoform O X
2 O X
) O X
of O X
Arabidopsis O X
thaliana O X
show O X
that O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
is O X
poorly O X
structured O X
. O X

CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
is O X
monomeric O X
in O X
solution O X
and O X
contains O X
four O X
cysteines O X
, O X
which O X
can O X
form O X
two O X
intramolecular O X
disulfides O X
with O X
midpoint O X
redox O X
potentials O X
of O X
- O X
326 O X
and O X
- O X
352 O X
mV O X
, O X
respectively O X
, O X
at O X
pH O X
7 O X
. O X
9 O X
. O X

Site O X
- O X
specific O X
mutants O X
indicate O X
that O X
the O X
C O X
- O X
terminal O X
disulfide O X
is O X
involved O X
in O X
the O X
interaction O X
between O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
and O X
GAPDH I-MISC 822277
( I-MISC 822277
isoform I-MISC 822277
A I-MISC 822277
( I-MISC 822277
4 I-MISC 822277
)), O X
whereas O X
the O X
N O X
- O X
terminal O X
disulfide O X
is O X
involved O X
in O X
the O X
interaction O X
between O X
this O X
binary O X
complex O X
and O X
PRK O X
. O X

In O X
the O X
presence O X
of O X
NAD O X
, O X
oxidized O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
interacts O X
with O X
A I-MISC 822277
( I-MISC 822277
4 I-MISC 822277
)- I-MISC 822277
GAPDH I-MISC 822277
( O X
K O X
( O X
D O X
) O X
= O X
0 O X
. O X
18 O X
microm O X
) O X
to O X
form O X
a O X
binary O X
complex O X
of O X
170 O X
kDa O X
with O X
( O X
A I-MISC 822277
( I-MISC 822277
4 I-MISC 822277
)- I-MISC 822277
GAPDH I-MISC 822277
)-( O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
)( O X
2 O X
) O X
stoichiometry O X
, O X
as O X
determined O X
by O X
isothermal O X
titration O X
calorimetry O X
and O X
multiangle O X
light O X
scattering O X
analysis O X
. O X

PRK O X
is O X
a O X
dimer O X
and O X
by O X
interacting O X
with O X
this O X
binary O X
complex O X
( O X
K O X
( O X
D O X
) O X
= O X
0 O X
. O X
17 O X
microm O X
) O X
leads O X
to O X
a O X
498 O X
- O X
kDa O X
ternary O X
complex O X
constituted O X
by O X
two O X
binary O X
complexes O X
and O X
two O X
PRK O X
dimers O X
, O X
i O X
. O X
e O X
. O X

(( O X
A I-MISC 822277
( I-MISC 822277
4 I-MISC 822277
)- I-MISC 822277
GAPDH I-MISC 822277
)-( O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
)( O X
2 O X
)-( O X
PRK O X
))( O X
2 O X
). O X

Thermodynamic O X
parameters O X
indicate O X
that O X
assembly O X
of O X
both O X
binary O X
and O X
ternary O X
complexes O X
is O X
exoergonic O X
although O X
penalized O X
by O X
a O X
decrease O X
in O X
entropy O X
that O X
suggests O X
an O X
induced O X
folding O X
of O X
CP12 I-MISC 825414
- I-MISC 825414
2 I-MISC 825414
upon O X
binding O X
to O X
partner O X
proteins O X
. O X

The O X
redox O X
dependence O X
of O X
events O X
leading O X
to O X
supramolecular O X
complexes O X
is O X
consistent O X
with O X
a O X
role O X
of O X
CP12 I-MISC 825414
in O X
coordinating O X
the O X
reversible O X
inactivation O X
of O X
chloroplast O X
enzymes O X
A I-MISC 822277
( I-MISC 822277
4 I-MISC 822277
)- I-MISC 822277
GAPDH I-MISC 822277
and O X
PRK O X
during O X
darkness O X
in O X
photosynthetic O X
tissues O X
. O X

###17906639	7157,5300

The O X
prolyl O X
isomerase O X
Pin1 I-MISC 5300
orchestrates O X
p53 I-MISC 7157
acetylation O X
and O X
dissociation O X
from O X
the O X
apoptosis O X
inhibitor O X
iASPP I-MISC 10848
. O X

The O X
tumor O X
- O X
suppressor O X
function O X
of O X
p53 I-MISC 7157
relies O X
on O X
its O X
transcriptional O X
activity O X
, O X
which O X
is O X
modulated O X
by O X
post O X
- O X
translational O X
modifications O X
and O X
interactions O X
with O X
regulatory O X
proteins O X
. O X

The O X
prolyl O X
isomerase O X
Pin1 I-MISC 5300
has O X
a O X
central O X
role O X
in O X
transducing O X
phosphorylation O X
of O X
p53 I-MISC 7157
into O X
conformational O X
changes O X
that O X
affect O X
p53 I-MISC 7157
stability O X
and O X
function O X
. O X

We O X
found O X
that O X
Pin1 I-MISC 5300
is O X
required O X
for O X
efficient O X
loading O X
of O X
p53 I-MISC 7157
on O X
target O X
promoters O X
upon O X
stress O X
. O X

In O X
addition O X
, O X
Pin1 I-MISC 5300
is O X
recruited O X
to O X
chromatin O X
by O X
p53 I-MISC 7157
and O X
stimulates O X
binding O X
of O X
the O X
p300 I-MISC 2033
acetyltransferase O X
and O X
consequent O X
p53 I-MISC 7157
acetylation O X
. O X

Accordingly O X
, O X
tumor O X
- O X
associated O X
mutations O X
at O X
Pin1 I-MISC 5300
- O X
binding O X
residues O X
within O X
the O X
p53 I-MISC 7157
proline O X
- O X
rich O X
domain O X
hamper O X
acetylation O X
of O X
p53 I-MISC 7157
by O X
p300 I-MISC 2033
. O X

After O X
phosphorylation O X
of O X
p53 I-MISC 7157
at O X
Ser46 O X
triggered O X
by O X
cytotoxic O X
stimuli O X
, O X
Pin1 I-MISC 5300
also O X
mediates O X
p53 I-MISC 7157
' O X
s O X
dissociation O X
from O X
the O X
apoptosis O X
inhibitor O X
iASPP I-MISC 10848
, O X
promoting O X
cell O X
death O X
. O X

In O X
tumors O X
bearing O X
wild O X
- O X
type O X
p53 I-MISC 7157
, O X
expression O X
of O X
Pin1 I-MISC 5300
and O X
iASPP I-MISC 10848
are O X
inversely O X
correlated O X
, O X
supporting O X
the O X
clinical O X
relevance O X
of O X
these O X
interactions O X
. O X

###20224574	9656,4683

A O X
divalent O X
FHA O X
/ O X
BRCT O X
- O X
binding O X
mechanism O X
couples O X
the O X
MRE11 I-MISC 4361
- O X
RAD50 I-MISC 10111
- O X
NBS1 I-MISC 4683
complex O X
to O X
damaged O X
chromatin O X
. O X

The O X
MRE11 I-MISC 4361
- O X
RAD50 I-MISC 10111
- O X
NBS1 I-MISC 4683
( O X
MRN O X
) O X
complex O X
accumulates O X
at O X
sites O X
of O X
DNA O X
double O X
- O X
strand O X
breaks O X
in O X
large O X
chromatin O X
domains O X
flanking O X
the O X
lesion O X
site O X
. O X

The O X
mechanism O X
of O X
MRN O X
accumulation O X
involves O X
direct O X
binding O X
of O X
the O X
Nijmegen I-MISC 4683
breakage I-MISC 4683
syndrome I-MISC 4683
1 I-MISC 4683
( O X
NBS1 I-MISC 4683
) O X
subunit O X
to O X
phosphorylated O X
mediator O X
of O X
the O X
DNA O X
damage O X
checkpoint O X
1 O X
( O X
MDC1 I-MISC 9656
), O X
a O X
large O X
nuclear O X
adaptor O X
protein O X
that O X
interacts O X
directly O X
with O X
phosphorylated O X
H2AX I-MISC 3014
. O X

NBS1 I-MISC 4683
contains O X
an O X
FHA O X
domain O X
and O X
two O X
BRCT O X
domains O X
at O X
its O X
amino O X
terminus O X
. O X

Here O X
, O X
we O X
show O X
that O X
both O X
of O X
these O X
domains O X
participate O X
in O X
the O X
interaction O X
with O X
phosphorylated O X
MDC1 I-MISC 9656
. O X

Point O X
mutations O X
in O X
key O X
amino O X
acid O X
residues O X
of O X
either O X
the O X
FHA O X
or O X
the O X
BRCT O X
domains O X
compromise O X
the O X
interaction O X
with O X
MDC1 I-MISC 9656
and O X
lead O X
to O X
defects O X
in O X
MRN O X
accumulation O X
at O X
sites O X
of O X
DNA O X
damage O X
. O X

Surprisingly O X
, O X
only O X
mutation O X
in O X
the O X
FHA O X
domain O X
, O X
but O X
not O X
in O X
the O X
BRCT O X
domains O X
, O X
yields O X
a O X
G2 O X
/ O X
M O X
checkpoint O X
defect O X
, O X
indicating O X
that O X
MDC1 I-MISC 9656
- O X
dependent O X
chromatin O X
accumulation O X
of O X
the O X
MRN O X
complex O X
at O X
sites O X
of O X
DNA O X
breaks O X
is O X
not O X
required O X
for O X
G2 O X
/ O X
M O X
checkpoint O X
activation O X
. O X

###16888629	4780,9817

Structure O X
of O X
the O X
Keap1 I-MISC 9817
: O X
Nrf2 I-MISC 4780
interface O X
provides O X
mechanistic O X
insight O X
into O X
Nrf2 I-MISC 4780
signaling O X
. O X

Keap1 I-MISC 9817
is O X
a O X
BTB O X
- O X
Kelch O X
substrate O X
adaptor O X
protein O X
that O X
regulates O X
steady O X
- O X
state O X
levels O X
of O X
Nrf2 I-MISC 4780
, O X
a O X
bZIP O X
transcription O X
factor O X
, O X
in O X
response O X
to O X
oxidative O X
stress O X
. O X

We O X
have O X
determined O X
the O X
structure O X
of O X
the O X
Kelch O X
domain O X
of O X
Keap1 I-MISC 9817
bound O X
to O X
a O X
16 O X
- O X
mer O X
peptide O X
from O X
Nrf2 I-MISC 4780
containing O X
a O X
highly O X
conserved O X
DxETGE O X
motif O X
. O X

The O X
Nrf2 I-MISC 4780
peptide O X
contains O X
two O X
short O X
antiparallel O X
beta O X
- O X
strands O X
connected O X
by O X
two O X
overlapping O X
type O X
I O X
beta O X
- O X
turns O X
stabilized O X
by O X
the O X
aspartate O X
and O X
threonine O X
residues O X
. O X

The O X
beta O X
- O X
turn O X
region O X
fits O X
into O X
a O X
binding O X
pocket O X
on O X
the O X
top O X
face O X
of O X
the O X
Kelch O X
domain O X
and O X
the O X
glutamate O X
residues O X
form O X
multiple O X
hydrogen O X
bonds O X
with O X
highly O X
conserved O X
residues O X
in O X
Keap1 I-MISC 9817
. O X

Mutagenesis O X
experiments O X
confirmed O X
the O X
role O X
of O X
individual O X
amino O X
acids O X
for O X
binding O X
of O X
Nrf2 I-MISC 4780
to O X
Keap1 I-MISC 9817
and O X
for O X
Keap1 I-MISC 9817
- O X
mediated O X
repression O X
of O X
Nrf2 I-MISC 4780
- O X
dependent O X
gene O X
expression O X
. O X

Our O X
results O X
provide O X
a O X
detailed O X
picture O X
of O X
how O X
a O X
BTB O X
- O X
Kelch O X
substrate O X
adaptor O X
protein O X
binds O X
to O X
its O X
cognate O X
substrate O X
and O X
will O X
enable O X
the O X
rational O X
design O X
of O X
novel O X
chemopreventive O X
agents O X
. O X

###20168298	5310,5311

A O X
polycystin I-MISC 5311
- I-MISC 5311
2 I-MISC 5311
( O X
TRPP2 I-MISC 5311
) O X
dimerization O X
domain O X
essential O X
for O X
the O X
function O X
of O X
heteromeric O X
polycystin O X
complexes O X
. O X

Autosomal O X
dominant O X
polycystic O X
kidney O X
disease O X
( O X
ADPKD O X
) O X
is O X
caused O X
by O X
mutations O X
in O X
two O X
genes O X
, O X
PKD1 I-MISC 5310
and O X
PKD2 I-MISC 5311
, O X
which O X
encode O X
polycystin I-MISC 5310
- I-MISC 5310
1 I-MISC 5310
( O X
PC1 I-MISC 5310
) O X
and O X
polycystin I-MISC 5311
- I-MISC 5311
2 I-MISC 5311
( O X
PC2 I-MISC 5311
), O X
respectively O X
. O X

Earlier O X
work O X
has O X
shown O X
that O X
PC1 I-MISC 5310
and O X
PC2 I-MISC 5311
assemble O X
into O X
a O X
polycystin O X
complex O X
implicated O X
in O X
kidney O X
morphogenesis O X
. O X

PC2 I-MISC 5311
also O X
assembles O X
into O X
homomers O X
of O X
uncertain O X
functional O X
significance O X
. O X

However O X
, O X
little O X
is O X
known O X
about O X
the O X
molecular O X
mechanisms O X
that O X
direct O X
polycystin O X
complex O X
assembly O X
and O X
specify O X
its O X
functions O X
. O X

We O X
have O X
identified O X
a O X
coiled O X
coil O X
in O X
the O X
C O X
- O X
terminus O X
of O X
PC2 I-MISC 5311
that O X
functions O X
as O X
a O X
homodimerization O X
domain O X
essential O X
for O X
PC1 I-MISC 5310
binding O X
but O X
not O X
for O X
its O X
self O X
- O X
oligomerization O X
. O X

Dimerization O X
- O X
defective O X
PC2 I-MISC 5311
mutants O X
were O X
unable O X
to O X
reconstitute O X
PC1 I-MISC 5310
/ O X
PC2 I-MISC 5311
complexes O X
either O X
at O X
the O X
plasma O X
membrane O X
( O X
PM O X
) O X
or O X
at O X
PM O X
- O X
endoplasmic O X
reticulum O X
( O X
ER O X
) O X
junctions O X
but O X
could O X
still O X
function O X
as O X
ER O X
Ca O X
( O X
2 O X
+)- O X
release O X
channels O X
. O X

Expression O X
of O X
dimerization O X
- O X
defective O X
PC2 I-MISC 5311
mutants O X
in O X
zebrafish O X
resulted O X
in O X
a O X
cystic O X
phenotype O X
but O X
had O X
lesser O X
effects O X
on O X
organ O X
laterality O X
. O X

We O X
conclude O X
that O X
C O X
- O X
terminal O X
dimerization O X
of O X
PC2 I-MISC 5311
specifies O X
the O X
formation O X
of O X
polycystin O X
complexes O X
but O X
not O X
formation O X
of O X
ER O X
- O X
localized O X
PC2 I-MISC 5311
channels O X
. O X

Mutations O X
that O X
affect O X
PC2 I-MISC 5311
C O X
- O X
terminal O X
homo O X
- O X
and O X
heteromerization O X
are O X
the O X
likely O X
molecular O X
basis O X
of O X
cyst O X
formation O X
in O X
ADPKD O X
. O X

###22001206	1803,1803

Role O X
of O X
a O X
propeller O X
loop O X
in O X
the O X
quaternary O X
structure O X
and O X
enzymatic O X
activity O X
of O X
prolyl O X
dipeptidases O X
DPP I-MISC 1803
- I-MISC 1803
IV I-MISC 1803
and O X
DPP9 I-MISC 91039
. O X

The O X
dipeptidyl O X
peptidase O X
( O X
DPP O X
) O X
family O X
members O X
, O X
including O X
DPP I-MISC 1803
- I-MISC 1803
IV I-MISC 1803
, O X
DPP8 I-MISC 54878
, O X
DPP9 I-MISC 91039
and O X
others O X
, O X
cleave O X
the O X
peptide O X
bond O X
after O X
the O X
penultimate O X
proline O X
residue O X
and O X
are O X
drug O X
target O X
rich O X
. O X

The O X
dimerization O X
of O X
DPP I-MISC 1803
- I-MISC 1803
IV I-MISC 1803
is O X
required O X
for O X
its O X
activity O X
. O X

A O X
propeller O X
loop O X
located O X
at O X
the O X
dimer O X
interface O X
is O X
highly O X
conserved O X
within O X
the O X
family O X
. O X

Here O X
we O X
carried O X
out O X
site O X
- O X
directed O X
mutagenesis O X
on O X
the O X
loop O X
of O X
DPPIV I-MISC 1803
and O X
identified O X
several O X
residues O X
important O X
for O X
dimer O X
formation O X
and O X
enzymatic O X
activity O X
. O X

Interestingly O X
, O X
the O X
corresponding O X
residues O X
on O X
DPP9 I-MISC 91039
have O X
a O X
different O X
impact O X
whereby O X
the O X
mutations O X
decrease O X
activity O X
without O X
changing O X
dimerization O X
. O X

Thus O X
the O X
propeller O X
loop O X
seems O X
to O X
play O X
a O X
varying O X
role O X
in O X
different O X
DPPs O X
. O X

###12670962	948430,947335

Subunit O X
oligomerization O X
and O X
substrate O X
recognition O X
of O X
the O X
Escherichia O X
coli O X
ClpYQ O X
( O X
HslUV O X
) O X
protease O X
implicated O X
by O X
in O X
vivo O X
protein O X
- O X
protein O X
interactions O X
in O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

The O X
Escherichia O X
coli O X
ClpYQ O X
( O X
HslUV O X
) O X
is O X
an O X
ATP O X
- O X
dependent O X
protease O X
that O X
consists O X
of O X
an O X
ATPase O X
large O X
subunit O X
with O X
homology O X
to O X
other O X
Clp O X
family O X
ATPases O X
and O X
a O X
peptidase O X
small O X
subunit O X
related O X
to O X
the O X
proteasomal O X
beta O X
- O X
subunits O X
of O X
eukaryotes O X
. O X

Six O X
identical O X
subunits O X
of O X
both O X
ClpY I-MISC 948430
and O X
ClpQ O X
self O X
- O X
assemble O X
into O X
an O X
oligomeric O X
ring O X
, O X
and O X
two O X
rings O X
of O X
each O X
subunit O X
, O X
two O X
ClpQ O X
rings O X
surrounded O X
by O X
single O X
ClpY I-MISC 948430
rings O X
, O X
form O X
a O X
dumbbell O X
shape O X
complex O X
. O X

The O X
ClpYQ O X
protease O X
degrades O X
the O X
cell O X
division O X
inhibitor O X
, O X
SulA I-MISC 947335
, O X
and O X
a O X
positive O X
regulator O X
of O X
capsule O X
transcription O X
, O X
RcsA O X
, O X
as O X
well O X
as O X
RpoH O X
, O X
a O X
heat O X
shock O X
sigma O X
transcription O X
factor O X
. O X

Using O X
the O X
yeast O X
- O X
two O X
hybrid O X
system O X
, O X
we O X
explored O X
the O X
in O X
vivo O X
protein O X
- O X
protein O X
interactions O X
of O X
the O X
individual O X
subunits O X
of O X
the O X
ClpYQ O X
protease O X
involved O X
in O X
self O X
- O X
oligomerization O X
, O X
as O X
well O X
as O X
in O X
recognition O X
of O X
specific O X
substrates O X
. O X

Interactions O X
were O X
detected O X
with O X
ClpQ O X
/ O X
ClpQ O X
, O X
ClpQ O X
/ O X
ClpY I-MISC 948430
, O X
and O X
ClpY I-MISC 948430
/ O X
SulA I-MISC 947335
. O X

No O X
interactions O X
were O X
observed O X
in O X
experiments O X
with O X
ClpY I-MISC 948430
/ O X
ClpY I-MISC 948430
, O X
ClpQ O X
/ O X
RcsA O X
, O X
and O X
ClpQ O X
/ O X
SulA I-MISC 947335
. O X

However O X
, O X
ClpY I-MISC 948430
, O X
lacking O X
domain O X
I O X
( O X
ClpY I-MISC 948430
( O X
Delta O X
I O X
)) O X
was O X
able O X
to O X
interact O X
with O X
itself O X
and O X
with O X
intact O X
ClpY I-MISC 948430
. O X

The O X
C O X
- O X
terminal O X
region O X
of O X
ClpY I-MISC 948430
is O X
important O X
for O X
interaction O X
with O X
other O X
ClpY I-MISC 948430
subunits O X
. O X

The O X
previously O X
defined O X
PDZ O X
- O X
like O X
domains O X
at O X
the O X
C O X
terminus O X
of O X
ClpY I-MISC 948430
, O X
including O X
both O X
D1 O X
and O X
D2 O X
, O X
were O X
determined O X
to O X
be O X
indispensable O X
for O X
substrate O X
binding O X
. O X

Various O X
deletion O X
and O X
random O X
point O X
mutants O X
of O X
SulA I-MISC 947335
were O X
also O X
made O X
to O X
verify O X
significant O X
interactions O X
with O X
ClpY I-MISC 948430
. O X

Thus O X
, O X
we O X
demonstrated O X
in O X
vivo O X
hetero O X
- O X
and O X
homointeractions O X
of O X
ClpQ O X
and O X
ClpY I-MISC 948430
molecules O X
, O X
as O X
well O X
as O X
a O X
direct O X
association O X
between O X
ClpY I-MISC 948430
and O X
substrate O X
SulA I-MISC 947335
, O X
thereby O X
supporting O X
previous O X
in O X
vitro O X
biochemical O X
findings O X
. O X

###10722738	466,1460853	1385,1460853	1387,1460853

cAMP O X
- O X
independent O X
activation O X
of O X
the O X
adenovirus O X
type O X
12 O X
E2 O X
promoter O X
correlates O X
with O X
the O X
recruitment O X
of O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
/ O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
, O X
E1A I-MISC 1460853
( O X
12S O X
), O X
and O X
CBP I-MISC 1387
to O X
the O X
E2 O X
- O X
CRE O X
. O X

Expression O X
of O X
the O X
transcription O X
unit O X
early O X
region O X
2 O X
( O X
E2 O X
) O X
is O X
of O X
crucial O X
importance O X
for O X
adenoviruses O X
because O X
this O X
region O X
encodes O X
proteins O X
essential O X
for O X
viral O X
replication O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
the O X
E1A I-MISC 1460853
( O X
12S O X
) O X
protein O X
of O X
the O X
oncogenic O X
adenovirus O X
serotype O X
12 O X
activates O X
the O X
E2 O X
promoter O X
in O X
dependence O X
of O X
the O X
N O X
terminus O X
and O X
the O X
conserved O X
region O X
1 O X
. O X

Activation O X
is O X
mediated O X
through O X
a O X
cAMP O X
- O X
response O X
element O X
that O X
is O X
bound O X
by O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
and O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
. O X

Moreover O X
, O X
the O X
Ad12 O X
E2 O X
promoter O X
is O X
inducible O X
by O X
protein O X
kinase O X
A O X
and O X
repressed O X
by O X
either O X
a O X
dominant O X
- O X
negative O X
cAMP I-MISC 1385
- I-MISC 1385
response I-MISC 1385
element I-MISC 1385
- I-MISC 1385
binding I-MISC 1385
protein I-MISC 1385
( O X
CREB I-MISC 1385
) O X
mutant O X
or O X
the O X
highly O X
specific O X
protein O X
kinase O X
A O X
inhibitor O X
protein O X
underscoring O X
the O X
participation O X
of O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
/ O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
in O X
promoter O X
activation O X
. O X

E1A I-MISC 1460853
( O X
12S O X
) O X
binds O X
to O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
and O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
in O X
dependence O X
of O X
the O X
N O X
terminus O X
and O X
CR1 O X
and O X
is O X
recruited O X
to O X
the O X
E2 O X
cAMP O X
- O X
response O X
element O X
through O X
both O X
cellular O X
transcription O X
factors O X
. O X

Most O X
interestingly O X
, O X
point O X
mutations O X
revealed O X
that O X
E1A I-MISC 1460853
( O X
12S O X
) O X
domains O X
essential O X
for O X
binding O X
to O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
/ O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
and O X
for O X
activation O X
of O X
the O X
Ad12 O X
E2 O X
promoter O X
are O X
also O X
essential O X
for O X
binding O X
to O X
the O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
. O X

Due O X
to O X
these O X
data O X
and O X
results O X
obtained O X
in O X
DNA O X
- O X
dependent O X
protein O X
- O X
protein O X
interaction O X
assays O X
, O X
we O X
propose O X
a O X
model O X
in O X
which O X
the O X
cAMP O X
- O X
independent O X
activation O X
of O X
the O X
Ad12 O X
E2 O X
promoter O X
is O X
mediated O X
through O X
a O X
ternary O X
complex O X
consisting O X
of O X
CREB I-MISC 1385
- I-MISC 1385
1 I-MISC 1385
/ O X
ATF I-MISC 466
- I-MISC 466
1 I-MISC 466
, O X
E1A I-MISC 1460853
( O X
12S O X
), O X
and O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
, O X
which O X
assembles O X
on O X
the O X
E2 O X
cAMP O X
- O X
response O X
element O X
. O X

###16474402	4193,7874	7157,7874

Molecular O X
recognition O X
of O X
p53 I-MISC 7157
and O X
MDM2 I-MISC 4193
by O X
USP7 I-MISC 7874
/ O X
HAUSP I-MISC 7874
. O X

The O X
ubiquitin O X
- O X
specific O X
protease O X
, O X
USP7 I-MISC 7874
, O X
has O X
key O X
roles O X
in O X
the O X
p53 I-MISC 7157
pathway O X
whereby O X
it O X
stabilizes O X
both O X
p53 I-MISC 7157
and O X
MDM2 I-MISC 4193
. O X

We O X
show O X
that O X
the O X
N O X
- O X
terminal O X
domain O X
of O X
USP7 I-MISC 7874
binds O X
two O X
closely O X
spaced O X
4 O X
- O X
residue O X
sites O X
in O X
both O X
p53 I-MISC 7157
and O X
MDM2 I-MISC 4193
, O X
falling O X
between O X
p53 I-MISC 7157
residues O X
359 O X
- O X
367 O X
and O X
MDM2 I-MISC 4193
residues O X
147 O X
- O X
159 O X
. O X

Cocrystal O X
structures O X
with O X
USP7 I-MISC 7874
were O X
determined O X
for O X
both O X
p53 I-MISC 7157
peptides O X
and O X
for O X
one O X
MDM2 I-MISC 4193
peptide O X
. O X

These O X
peptides O X
bind O X
the O X
same O X
surface O X
of O X
USP7 I-MISC 7874
as O X
Epstein O X
- O X
Barr O X
nuclear O X
antigen O X
- O X
1 O X
, O X
explaining O X
the O X
competitive O X
nature O X
of O X
the O X
interactions O X
. O X

The O X
structures O X
and O X
mutagenesis O X
data O X
indicate O X
a O X
preference O X
for O X
a O X
P O X
/ O X
AXXS O X
motif O X
in O X
peptides O X
that O X
bind O X
USP7 I-MISC 7874
. O X

Contacts O X
made O X
by O X
serine O X
are O X
identical O X
and O X
crucial O X
for O X
all O X
peptides O X
, O X
and O X
Trp165 O X
in O X
the O X
peptide O X
- O X
binding O X
pocket O X
of O X
USP7 I-MISC 7874
is O X
also O X
crucial O X
. O X

These O X
results O X
help O X
to O X
elucidate O X
the O X
mechanism O X
of O X
substrate O X
recognition O X
by O X
USP7 I-MISC 7874
and O X
the O X
regulation O X
of O X
the O X
p53 I-MISC 7157
pathway O X
. O X

###10415025	5778,5594

Direct O X
suppression O X
of O X
TCR I-MISC 6962
- O X
mediated O X
activation O X
of O X
extracellular I-MISC 5594
signal I-MISC 5594
- I-MISC 5594
regulated I-MISC 5594
kinase I-MISC 5594
by O X
leukocyte I-MISC 5778
protein I-MISC 5778
tyrosine I-MISC 5778
phosphatase I-MISC 5778
, O X
a O X
tyrosine O X
- O X
specific O X
phosphatase O X
. O X

Leukocyte I-MISC 5778
protein I-MISC 5778
tyrosine I-MISC 5778
phosphatase I-MISC 5778
( O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
)/ O X
hemopoietic O X
PTP I-MISC 10076
is O X
a O X
human O X
cytoplasmic O X
PTP I-MISC 10076
that O X
is O X
predominantly O X
expressed O X
in O X
the O X
hemopoietic O X
cells O X
. O X

Recently O X
, O X
it O X
was O X
reported O X
that O X
hemopoietic O X
PTP I-MISC 10076
inhibited O X
TCR I-MISC 6962
- O X
mediated O X
signal O X
transduction O X
. O X

However O X
, O X
the O X
precise O X
mechanism O X
of O X
the O X
inhibition O X
was O X
not O X
identified O X
. O X

Here O X
we O X
report O X
that O X
extracellular I-MISC 5594
signal I-MISC 5594
- I-MISC 5594
regulated I-MISC 5594
kinase I-MISC 5594
( O X
ERK I-MISC 5594
) O X
is O X
the O X
direct O X
target O X
of O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
. O X

LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
dephosphorylated O X
ERK2 I-MISC 5594
in O X
vitro O X
. O X

Expression O X
of O X
wild O X
- O X
type O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
in O X
293T O X
cells O X
suppressed O X
the O X
phosphorylation O X
of O X
ERK2 I-MISC 5594
by O X
a O X
mutant O X
MEK1 I-MISC 5604
, O X
which O X
was O X
constitutively O X
active O X
regardless O X
of O X
upstream O X
activation O X
signals O X
. O X

No O X
suppression O X
of O X
the O X
phosphorylation O X
was O X
observed O X
by O X
LC O X
- O X
PTPCS O X
, O X
a O X
catalytically O X
inactive O X
mutant O X
. O X

In O X
Jurkat O X
cells O X
, O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
suppressed O X
the O X
ERK I-MISC 5594
and O X
p38 I-MISC 5594
mitogen O X
- O X
activated O X
protein O X
kinase O X
cascades O X
. O X

LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
and O X
LC O X
- O X
PTPCS O X
made O X
complexes O X
with O X
ERK1 I-MISC 5595
, O X
ERK2 I-MISC 5594
, O X
and O X
p38alpha I-MISC 1432
, O X
but O X
not O X
with O X
the O X
gain O X
- O X
of O X
- O X
function O X
sevenmaker O X
ERK2 I-MISC 5594
mutant O X
( O X
D321N O X
). O X

A O X
small O X
deletion O X
( O X
aa O X
1 O X
- O X
46 O X
) O X
in O X
the O X
N O X
- O X
terminal O X
portion O X
of O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
or O X
Arg O X
to O X
Ala O X
substitutions O X
at O X
aa O X
41 O X
and O X
42 O X
resulted O X
in O X
the O X
loss O X
of O X
ERK I-MISC 5594
binding O X
activity O X
. O X

These O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
mutants O X
revealed O X
little O X
inhibition O X
of O X
the O X
ERK I-MISC 5594
cascade O X
activated O X
by O X
TCR I-MISC 6962
cross O X
- O X
linking O X
. O X

On O X
the O X
other O X
hand O X
, O X
the O X
wild O X
- O X
type O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
did O X
not O X
suppress O X
the O X
phosphorylation O X
of O X
sevenmaker O X
ERK2 I-MISC 5594
mutant O X
. O X

Thus O X
, O X
the O X
complex O X
formation O X
of O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
with O X
ERK I-MISC 5594
is O X
the O X
essential O X
mechanism O X
for O X
the O X
suppression O X
. O X

Taken O X
collectively O X
, O X
these O X
results O X
indicate O X
that O X
LC I-MISC 5778
- I-MISC 5778
PTP I-MISC 5778
suppresses O X
mitogen O X
- O X
activated O X
protein O X
kinase O X
directly O X
in O X
vivo O X
. O X

###23949442	23557,120892

LRRK2 I-MISC 120892
phosphorylates O X
Snapin I-MISC 23557
and O X
inhibits O X
interaction O X
of O X
Snapin I-MISC 295217
with O X
SNAP I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
. O X

Leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
is O X
a O X
gene O X
that O X
, O X
upon O X
mutation O X
, O X
causes O X
autosomal O X
- O X
dominant O X
familial O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

Yeast O X
two O X
- O X
hybrid O X
screening O X
revealed O X
that O X
Snapin I-MISC 295217
, O X
a O X
SNAP I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
( O X
synaptosomal I-MISC 25012
- I-MISC 25012
associated I-MISC 25012
protein I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
) O X
interacting O X
protein O X
, O X
interacts O X
with O X
LRRK2 I-MISC 120892
. O X

An O X
in O X
vitro O X
kinase O X
assay O X
exhibited O X
that O X
Snapin I-MISC 295217
is O X
phosphorylated O X
by O X
LRRK2 I-MISC 120892
. O X

A O X
glutathione I-MISC 58962
- I-MISC 58962
S I-MISC 58962
- I-MISC 58962
transferase I-MISC 58962
( O X
GST O X
) O X
pull O X
- O X
down O X
assay O X
showed O X
that O X
LRRK2 I-MISC 120892
may O X
interact O X
with O X
Snapin I-MISC 295217
via O X
its O X
Ras O X
- O X
of O X
- O X
complex O X
( O X
ROC O X
) O X
and O X
N O X
- O X
terminal O X
domains O X
, O X
with O X
no O X
significant O X
difference O X
on O X
interaction O X
of O X
Snapin I-MISC 295217
with O X
LRRK2 I-MISC 120892
wild O X
type O X
( O X
WT O X
) O X
or O X
its O X
pathogenic O X
mutants O X
. O X

Further O X
analysis O X
by O X
mutation O X
study O X
revealed O X
that O X
Threonine O X
117 O X
of O X
Snapin I-MISC 295217
is O X
one O X
of O X
the O X
sites O X
phosphorylated O X
by O X
LRRK2 I-MISC 120892
. O X

Furthermore O X
, O X
a O X
Snapin I-MISC 295217
T117D O X
phosphomimetic O X
mutant O X
decreased O X
its O X
interaction O X
with O X
SNAP I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
in O X
the O X
GST O X
pull O X
- O X
down O X
assay O X
. O X

SNAP I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
is O X
a O X
component O X
of O X
the O X
SNARE O X
( O X
Soluble O X
NSF O X
Attachment O X
protein O X
REceptor O X
) O X
complex O X
and O X
is O X
critical O X
for O X
the O X
exocytosis O X
of O X
synaptic O X
vesicles O X
. O X

Incubation O X
of O X
rat O X
brain O X
lysate O X
with O X
recombinant O X
Snapin I-MISC 295217
T117D O X
, O X
but O X
not O X
WT O X
, O X
protein O X
caused O X
decreased O X
interaction O X
of O X
synaptotagmin O X
with O X
the O X
SNARE O X
complex O X
based O X
on O X
a O X
co O X
- O X
immunoprecipitation O X
assay O X
. O X

We O X
further O X
found O X
that O X
LRRK2 I-MISC 120892
- O X
dependent O X
phosphorylation O X
of O X
Snapin I-MISC 295217
in O X
the O X
hippocampal O X
neurons O X
resulted O X
in O X
a O X
decrease O X
in O X
the O X
number O X
of O X
readily O X
releasable O X
vesicles O X
and O X
the O X
extent O X
of O X
exocytotic O X
release O X
. O X

Combined O X
, O X
these O X
data O X
suggest O X
that O X
LRRK2 I-MISC 120892
may O X
regulate O X
neurotransmitter O X
release O X
via O X
control O X
of O X
Snapin I-MISC 295217
function O X
by O X
inhibitory O X
phosphorylation O X
. O X

###18583962	16871,16392

Implementing O X
the O X
LIM O X
code O X
: O X
the O X
structural O X
basis O X
for O X
cell O X
type O X
- O X
specific O X
assembly O X
of O X
LIM O X
- O X
homeodomain O X
complexes O X
. O X

LIM O X
- O X
homeodomain O X
( O X
LIM O X
- O X
HD O X
) O X
transcription O X
factors O X
form O X
a O X
combinatorial O X
' O X
LIM O X
code O X
' O X
that O X
contributes O X
to O X
the O X
specification O X
of O X
cell O X
types O X
. O X

In O X
the O X
ventral O X
spinal O X
cord O X
, O X
the O X
binary O X
LIM I-MISC 16871
homeobox I-MISC 16871
protein I-MISC 16871
3 I-MISC 16871
( O X
Lhx3 I-MISC 16871
)/ O X
LIM O X
domain O X
- O X
binding O X
protein O X
1 O X
( O X
Ldb1 O X
) O X
complex O X
specifies O X
the O X
formation O X
of O X
V2 O X
interneurons O X
. O X

The O X
additional O X
expression O X
of O X
islet I-MISC 16392
- I-MISC 16392
1 I-MISC 16392
( O X
Isl1 I-MISC 16392
) O X
in O X
adjacent O X
cells O X
instead O X
specifies O X
the O X
formation O X
of O X
motor O X
neurons O X
through O X
assembly O X
of O X
a O X
ternary O X
complex O X
in O X
which O X
Isl1 I-MISC 16392
contacts O X
both O X
Lhx3 I-MISC 16871
and O X
Ldb1 O X
, O X
displacing O X
Lhx3 I-MISC 16871
as O X
the O X
binding O X
partner O X
of O X
Ldb1 O X
. O X

However O X
, O X
little O X
is O X
known O X
about O X
how O X
this O X
molecular O X
switch O X
occurs O X
. O X

Here O X
, O X
we O X
have O X
identified O X
the O X
30 O X
- O X
residue O X
Lhx3 I-MISC 16871
- O X
binding O X
domain O X
on O X
Isl1 I-MISC 16392
( O X
Isl1 I-MISC 16392
( I-MISC 16392
LBD I-MISC 16392
)). O X

Although O X
the O X
LIM O X
interaction O X
domain O X
of O X
Ldb1 O X
( O X
Ldb1 O X
( O X
LID O X
)) O X
and O X
Isl1 I-MISC 16392
( I-MISC 16392
LBD I-MISC 16392
) I-MISC 16392
share O X
low O X
levels O X
of O X
sequence O X
homology O X
, O X
X O X
- O X
ray O X
and O X
NMR O X
structures O X
reveal O X
that O X
they O X
bind O X
Lhx3 I-MISC 16871
in O X
an O X
identical O X
manner O X
, O X
that O X
is O X
, O X
Isl1 I-MISC 16392
( I-MISC 16392
LBD I-MISC 16392
) I-MISC 16392
mimics O X
Ldb1 O X
( O X
LID O X
). O X

These O X
data O X
provide O X
a O X
structural O X
basis O X
for O X
the O X
formation O X
of O X
cell O X
type O X
- O X
specific O X
protein O X
- O X
protein O X
interactions O X
in O X
which O X
unstructured O X
linear O X
motifs O X
with O X
diverse O X
sequences O X
compete O X
to O X
bind O X
protein O X
partners O X
. O X

The O X
resulting O X
alternate O X
protein O X
complexes O X
can O X
target O X
different O X
genes O X
to O X
regulate O X
key O X
biological O X
events O X
. O X

###18583960	13205,56480

The O X
DEAD O X
- O X
box O X
helicase O X
DDX3X I-MISC 13205
is O X
a O X
critical O X
component O X
of O X
the O X
TANK I-MISC 56480
- I-MISC 56480
binding I-MISC 56480
kinase I-MISC 56480
1 I-MISC 56480
- O X
dependent O X
innate O X
immune O X
response O X
. O X

TANK I-MISC 56480
- I-MISC 56480
binding I-MISC 56480
kinase I-MISC 56480
1 I-MISC 56480
( O X
TBK1 I-MISC 56480
) O X
is O X
of O X
central O X
importance O X
for O X
the O X
induction O X
of O X
type O X
- O X
I O X
interferon O X
( O X
IFN O X
) O X
in O X
response O X
to O X
pathogens O X
. O X

We O X
identified O X
the O X
DEAD O X
- O X
box O X
helicase O X
DDX3X I-MISC 13205
as O X
an O X
interaction O X
partner O X
of O X
TBK1 I-MISC 56480
. O X

TBK1 I-MISC 56480
and O X
DDX3X I-MISC 13205
acted O X
synergistically O X
in O X
their O X
ability O X
to O X
stimulate O X
the O X
IFN O X
promoter O X
, O X
whereas O X
RNAi O X
- O X
mediated O X
reduction O X
of O X
DDX3X I-MISC 13205
expression O X
led O X
to O X
an O X
impairment O X
of O X
IFN O X
production O X
. O X

Chromatin O X
immunoprecipitation O X
indicated O X
that O X
DDX3X I-MISC 13205
is O X
recruited O X
to O X
the O X
IFN O X
promoter O X
upon O X
infection O X
with O X
Listeria O X
monocytogenes O X
, O X
suggesting O X
a O X
transcriptional O X
mechanism O X
of O X
action O X
. O X

DDX3X I-MISC 13205
was O X
found O X
to O X
be O X
a O X
TBK1 I-MISC 56480
substrate O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

Phosphorylation O X
- O X
deficient O X
mutants O X
of O X
DDX3X I-MISC 13205
failed O X
to O X
synergize O X
with O X
TBK1 I-MISC 56480
in O X
their O X
ability O X
to O X
stimulate O X
the O X
IFN O X
promoter O X
. O X

Overall O X
, O X
our O X
data O X
imply O X
that O X
DDX3X I-MISC 13205
is O X
a O X
critical O X
effector O X
of O X
TBK1 I-MISC 56480
that O X
is O X
necessary O X
for O X
type O X
I O X
IFN O X
induction O X
. O X

###16266891	5292,6223

Interactions O X
between O X
RPS19 I-MISC 6223
, O X
mutated O X
in O X
Diamond O X
- O X
Blackfan O X
anemia O X
, O X
and O X
the O X
PIM I-MISC 5292
- I-MISC 5292
1 I-MISC 5292
oncoprotein O X
. O X

BACKGROUND O X
AND O X
OBJECTIVES O X
: O X
Diamond O X
Blackfan O X
anemia O X
( O X
DBA O X
) O X
is O X
a O X
congenital O X
disease O X
characterized O X
by O X
defective O X
erythroid O X
progenitor O X
maturation O X
. O X

Patients O X
' O X
bone O X
marrow O X
progenitor O X
cells O X
do O X
not O X
respond O X
to O X
erythropoietic O X
growth O X
factors O X
, O X
such O X
as O X
erythropoietin I-MISC 2056
. O X

Mutations O X
in O X
the O X
gene O X
encoding O X
for O X
ribosomal I-MISC 6223
protein I-MISC 6223
( I-MISC 6223
RP I-MISC 6223
) I-MISC 6223
S19 I-MISC 6223
account O X
for O X
25 O X
% O X
of O X
cases O X
of O X
DBA O X
. O X

The O X
link O X
between O X
defective O X
erythropoiesis O X
and O X
RPS19 I-MISC 6223
is O X
still O X
unclear O X
. O X

Two O X
not O X
mutually O X
exclusive O X
hypotheses O X
have O X
been O X
proposed O X
: O X
altered O X
protein O X
synthesis O X
and O X
loss O X
of O X
unknown O X
extraribosomal O X
functions O X
. O X

DESIGN O X
AND O X
METHODS O X
: O X
We O X
used O X
yeast O X
two O X
- O X
hybrid O X
screening O X
and O X
a O X
human O X
liver O X
cDNA O X
library O X
obtained O X
at O X
19 O X
- O X
24 O X
weeks O X
of O X
gestation O X
, O X
when O X
hepatic O X
erythropoiesis O X
is O X
efficient O X
, O X
to O X
search O X
for O X
proteins O X
interacting O X
with O X
RPS19 I-MISC 6223
. O X

RESULTS O X
: O X
We O X
found O X
that O X
RPS19 I-MISC 6223
binds O X
PIM I-MISC 5292
- I-MISC 5292
1 I-MISC 5292
, O X
an O X
ubiquitous O X
serine O X
- O X
threonine O X
kinase O X
whose O X
expression O X
can O X
be O X
induced O X
in O X
erythropoietic O X
cells O X
by O X
several O X
growth O X
factors O X
, O X
such O X
as O X
erythropoietin I-MISC 2056
. O X

The O X
PIM I-MISC 5292
- I-MISC 5292
1 I-MISC 5292
/ O X
RPS19 I-MISC 6223
interaction O X
was O X
demonstrated O X
both O X
in O X
vitro O X
and O X
in O X
living O X
cells O X
and O X
led O X
to O X
phosphorylation O X
of O X
RPS19 I-MISC 6223
in O X
an O X
in O X
vitro O X
kinase O X
assay O X
. O X

We O X
also O X
showed O X
that O X
in O X
human O X
293T O X
cells O X
PIM I-MISC 5292
- I-MISC 5292
1 I-MISC 5292
interacts O X
with O X
ribosomes O X
and O X
may O X
be O X
involved O X
in O X
translational O X
control O X
. O X

Three O X
DBA O X
- O X
associated O X
RPS19 I-MISC 6223
mutations O X
alter O X
the O X
binding O X
between O X
RPS19 I-MISC 6223
and O X
PIM I-MISC 5292
- I-MISC 5292
1 I-MISC 5292
. O X

INTERPRETATION O X
AND O X
CONCLUSIONS O X
: O X
A O X
link O X
between O X
erythropoietic O X
growth O X
factor O X
signaling O X
and O X
RPS19 I-MISC 6223
has O X
been O X
identified O X
for O X
the O X
first O X
time O X
. O X

###9341137	83583,24803	83583,81754

Isolation O X
and O X
characterization O X
of O X
a O X
dual O X
prenylated O X
Rab O X
and O X
VAMP2 I-MISC 24803
receptor O X
. O X

Rab O X
GTPases O X
have O X
been O X
implicated O X
in O X
intracellular O X
vesicle O X
trafficking O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
we O X
have O X
isolated O X
a O X
rat O X
clone O X
that O X
interacts O X
with O X
Rab3A I-MISC 25531
as O X
well O X
as O X
with O X
Rab1 I-MISC 81754
. O X

The O X
gene O X
encodes O X
a O X
20 O X
. O X
6 O X
- O X
kDa O X
protein O X
with O X
two O X
extensive O X
hydrophobic O X
domains O X
and O X
is O X
broadly O X
expressed O X
in O X
all O X
tissues O X
. O X

This O X
protein O X
binds O X
to O X
prenylated O X
Rab O X
GTPases O X
but O X
not O X
to O X
other O X
small O X
Ras O X
- O X
like O X
GTPases O X
such O X
as O X
the O X
Rho O X
/ O X
Rac O X
family O X
. O X

This O X
prenylated O X
Rab O X
acceptor O X
( O X
PRA1 I-MISC 83583
) O X
also O X
binds O X
specifically O X
to O X
the O X
synaptic O X
vesicle O X
protein O X
VAMP2 I-MISC 24803
( O X
or O X
synaptobrevin O X
II O X
) O X
but O X
shows O X
no O X
affinity O X
for O X
VAMP1 I-MISC 25624
or O X
cellubrevin I-MISC 29528
in O X
both O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
and O X
in O X
vitro O X
binding O X
assays O X
. O X

This O X
specificity O X
resides O X
, O X
in O X
part O X
, O X
in O X
the O X
proline O X
- O X
rich O X
domain O X
of O X
VAMP2 I-MISC 24803
as O X
a O X
chimera O X
containing O X
this O X
domain O X
of O X
VAMP2 I-MISC 24803
fused O X
to O X
VAMP1 I-MISC 25624
is O X
able O X
to O X
bind O X
to O X
PRA1 I-MISC 83583
. O X

The O X
transmembrane O X
domain O X
of O X
VAMP2 I-MISC 24803
is O X
also O X
essential O X
as O X
its O X
deletion O X
abolished O X
binding O X
to O X
PRA1 I-MISC 83583
. O X

Replacement O X
of O X
the O X
deleted O X
VAMP2 I-MISC 24803
transmembrane O X
domain O X
by O X
a O X
CAAX O X
prenylation O X
signal O X
can O X
not O X
restore O X
binding O X
to O X
PRA1 I-MISC 83583
. O X

This O X
interaction O X
is O X
therefore O X
distinct O X
from O X
that O X
required O X
for O X
VAMP2 I-MISC 24803
binding O X
to O X
either O X
syntaxin O X
or O X
both O X
syntaxin O X
and O X
SNAP I-MISC 25012
- I-MISC 25012
25 I-MISC 25012
. O X

Deletion O X
analysis O X
on O X
PRA1 I-MISC 83583
indicates O X
that O X
the O X
critical O X
Rab O X
- O X
and O X
VAMP2 I-MISC 24803
- O X
interacting O X
residues O X
reside O X
in O X
two O X
regions O X
: O X
the O X
amino O X
- O X
terminal O X
residues O X
30 O X
- O X
54 O X
and O X
the O X
extreme O X
carboxyl O X
- O X
terminal O X
domain O X
. O X

This O X
dual O X
Rab O X
and O X
VAMP2 I-MISC 24803
binding O X
characteristic O X
suggests O X
that O X
PRA1 I-MISC 83583
may O X
serve O X
to O X
link O X
these O X
two O X
protein O X
families O X
in O X
the O X
control O X
of O X
vesicle O X
docking O X
and O X
fusion O X
. O X

###15254196	7157,29031019

p53 I-MISC 7157
targets O X
simian I-MISC 29031019
virus I-MISC 29031019
40 I-MISC 29031019
large O X
T O X
antigen O X
for O X
acetylation O X
by O X
CBP I-MISC 1387
. O X

Simian I-MISC 29031019
virus I-MISC 29031019
40 I-MISC 29031019
( O X
SV40 I-MISC 29031019
) O X
large O X
T O X
antigen O X
( O X
T O X
Ag O X
) O X
interacts O X
with O X
the O X
tumor O X
suppressor O X
p53 I-MISC 7157
and O X
the O X
transcriptional O X
coactivators O X
CBP I-MISC 1387
and O X
p300 I-MISC 2033
. O X

Binding O X
of O X
these O X
cellular O X
proteins O X
in O X
a O X
ternary O X
complex O X
has O X
been O X
implicated O X
in O X
T O X
Ag O X
- O X
mediated O X
transformation O X
. O X

It O X
has O X
been O X
suggested O X
that O X
the O X
ability O X
of O X
CBP I-MISC 1387
/ I-MISC 1387
p300 I-MISC 1387
to O X
modulate O X
p53 I-MISC 7157
function O X
underlies O X
p53 I-MISC 7157
' O X
s O X
regulation O X
of O X
cell O X
proliferation O X
and O X
tumorigenesis O X
. O X

In O X
this O X
study O X
, O X
we O X
provide O X
further O X
evidence O X
that O X
CBP I-MISC 1387
activity O X
may O X
be O X
mediated O X
through O X
its O X
synergistic O X
action O X
with O X
p53 I-MISC 7157
. O X

We O X
demonstrate O X
that O X
SV40 I-MISC 29031019
T O X
Ag O X
is O X
acetylated O X
in O X
vivo O X
in O X
a O X
p53 I-MISC 7157
- O X
dependent O X
manner O X
and O X
T O X
Ag O X
acetylation O X
is O X
largely O X
mediated O X
by O X
CBP I-MISC 1387
. O X

The O X
acetylation O X
of O X
T O X
Ag O X
is O X
dependent O X
on O X
its O X
interaction O X
with O X
p53 I-MISC 7157
and O X
on O X
p53 I-MISC 7157
' O X
s O X
interaction O X
with O X
CBP I-MISC 1387
. O X

We O X
have O X
mapped O X
the O X
site O X
of O X
acetylation O X
on O X
T O X
Ag O X
to O X
the O X
C O X
- O X
terminal O X
lysine O X
residue O X
697 O X
. O X

This O X
acetylation O X
site O X
is O X
conserved O X
between O X
the O X
T O X
antigens O X
of O X
the O X
human O X
polyomaviruses O X
JC O X
and O X
BK O X
, O X
which O X
are O X
also O X
known O X
to O X
interact O X
with O X
p53 I-MISC 7157
. O X

We O X
show O X
that O X
both O X
JC O X
and O X
BK O X
T O X
antigens O X
are O X
also O X
acetylated O X
at O X
corresponding O X
sites O X
in O X
vivo O X
. O X

While O X
other O X
proteins O X
are O X
known O X
to O X
be O X
acetylated O X
by O X
CBP I-MISC 1387
/ I-MISC 1387
p300 I-MISC 1387
, O X
none O X
are O X
known O X
to O X
depend O X
on O X
p53 I-MISC 7157
for O X
acetylation O X
. O X

T O X
Ag O X
acetylation O X
may O X
provide O X
a O X
regulatory O X
mechanism O X
for O X
T O X
Ag O X
binding O X
to O X
a O X
cellular O X
factor O X
or O X
play O X
a O X
role O X
in O X
another O X
aspect O X
of O X
T O X
Ag O X
function O X
. O X

###20969867	1387,4297

Leu628 O X
of O X
the O X
KIX O X
domain O X
of O X
CBP I-MISC 1387
is O X
a O X
key O X
residue O X
for O X
the O X
interaction O X
with O X
the O X
MLL I-MISC 4297
transactivation O X
domain O X
. O X

Physical O X
interaction O X
between O X
the O X
transactivation O X
domain O X
( O X
TAD O X
) O X
of O X
the O X
mixed I-MISC 4297
- I-MISC 4297
lineage I-MISC 4297
leukemia I-MISC 4297
protein I-MISC 4297
( O X
MLL I-MISC 4297
) O X
and O X
the O X
KIX O X
domain O X
of O X
the O X
cyclic I-MISC 1385
- I-MISC 1385
AMP I-MISC 1385
response I-MISC 1385
element I-MISC 1385
binding I-MISC 1385
protein I-MISC 1385
( O X
CREB I-MISC 1387
) I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
( O X
CBP I-MISC 1387
) O X
is O X
necessary O X
for O X
MLL I-MISC 4297
- O X
mediated O X
transcriptional O X
activation O X
. O X

We O X
show O X
by O X
alanine O X
- O X
scanning O X
mutagenesis O X
that O X
hydrophobic O X
surface O X
residues O X
of O X
KIX O X
, O X
especially O X
L628 O X
, O X
are O X
energetically O X
important O X
for O X
binding O X
the O X
MLL I-MISC 4297
TAD O X
. O X

NMR O X
studies O X
of O X
the O X
KIX O X
- O X
L628A O X
mutant O X
suggest O X
that O X
L628 O X
plays O X
a O X
crucial O X
role O X
in O X
conformational O X
transitions O X
at O X
the O X
MLL I-MISC 4297
binding O X
site O X
, O X
necessary O X
for O X
high O X
affinity O X
interactions O X
with O X
MLL I-MISC 4297
. O X

Unexpectedly O X
, O X
MLL I-MISC 4297
also O X
binds O X
to O X
the O X
c I-MISC 4602
- I-MISC 4602
Myb I-MISC 4602
/ O X
phosphorylated O X
kinase O X
- O X
inducible O X
domain O X
of O X
CREB I-MISC 1385
( O X
pKID O X
) O X
site O X
of O X
KIX O X
, O X
highlighting O X
the O X
complex O X
nature O X
of O X
interactions O X
involving O X
intrinsically O X
disordered O X
transcriptional O X
activators O X
. O X

###15156152	3693,17909

Myosin I-MISC 17909
- I-MISC 17909
X I-MISC 17909
provides O X
a O X
motor O X
- O X
based O X
link O X
between O X
integrins I-MISC 3693
and O X
the O X
cytoskeleton O X
. O X

Unconventional O X
myosins O X
are O X
actin O X
- O X
based O X
motors O X
with O X
a O X
growing O X
number O X
of O X
attributed O X
functions O X
. O X

Interestingly O X
, O X
it O X
has O X
been O X
proposed O X
that O X
integrins I-MISC 3693
are O X
transported O X
by O X
unidentified O X
myosins O X
to O X
facilitate O X
cellular O X
remodelling O X
. O X

Here O X
we O X
present O X
an O X
interaction O X
between O X
the O X
unconventional I-MISC 17909
myosin I-MISC 17909
- I-MISC 17909
X I-MISC 17909
( O X
Myo10 I-MISC 17909
) O X
FERM O X
( O X
band I-MISC 2035
4 I-MISC 2035
. I-MISC 2035
1 I-MISC 2035
/ O X
ezrin I-MISC 7430
/ I-MISC 7430
radixin O X
/ O X
moesin O X
) O X
domain O X
and O X
an O X
NPXY O X
motif O X
within O X
beta I-MISC 3693
- I-MISC 3693
integrin I-MISC 3693
cytoplasmic O X
domains O X
. O X

Importantly O X
, O X
knock O X
- O X
down O X
of O X
Myo10 I-MISC 17909
by O X
short O X
interfering O X
RNA O X
impaired O X
integrin O X
function O X
in O X
cell O X
adhesion O X
, O X
whereas O X
overexpression O X
of O X
Myo10 I-MISC 17909
stimulated O X
the O X
formation O X
and O X
elongation O X
of O X
filopodia O X
in O X
an O X
integrin O X
- O X
dependent O X
manner O X
and O X
relocalized O X
integrins I-MISC 3693
together O X
with O X
Myo10 I-MISC 17909
to O X
the O X
tips O X
of O X
filopodia O X
. O X

This O X
integrin O X
relocalization O X
and O X
filopodia O X
elongation O X
did O X
not O X
occur O X
with O X
Myo10 I-MISC 17909
mutants O X
deficient O X
in O X
integrin O X
binding O X
or O X
with O X
a O X
beta O X
( O X
1 O X
)- O X
integrin O X
point O X
mutant O X
deficient O X
in O X
Myo10 I-MISC 17909
binding O X
. O X

Taken O X
together O X
, O X
these O X
results O X
indicate O X
that O X
Myo10 I-MISC 17909
- O X
mediated O X
relocalization O X
of O X
integrins I-MISC 3693
might O X
serve O X
to O X
form O X
adhesive O X
structures O X
and O X
thereby O X
promote O X
filopodial O X
extension O X
. O X

###26221972	4068,4063

A O X
polymorphism O X
in O X
a O X
phosphotyrosine O X
signalling O X
motif O X
of O X
CD229 I-MISC 4063
( O X
Ly9 I-MISC 4063
, O X
SLAMF3 I-MISC 4063
) O X
alters O X
SH2 O X
domain O X
binding O X
and O X
T O X
- O X
cell O X
activation O X
. O X

UNASSIGNED O X
: O X
Signalling O X
lymphocyte O X
activation O X
molecule O X
( O X
SLAM O X
) O X
family O X
members O X
regulate O X
activation O X
and O X
inhibition O X
in O X
the O X
innate O X
and O X
adaptive O X
immune O X
systems O X
. O X

Genome O X
- O X
wide O X
association O X
studies O X
identified O X
their O X
genetic O X
locus O X
( O X
1q23 O X
) O X
as O X
highly O X
polymorphic O X
and O X
associated O X
with O X
susceptibility O X
to O X
systemic O X
lupus O X
erythematosus O X
( O X
SLE O X
). O X

Here O X
we O X
show O X
that O X
the O X
Val602 O X
variant O X
of O X
the O X
non O X
- O X
synonymous O X
single O X
nucleotide O X
polymorphism O X
( O X
SNP O X
) O X
rs509749 O X
in O X
the O X
SLAM O X
family O X
member O X
CD229 I-MISC 4063
( O X
Ly9 I-MISC 4063
, O X
SLAMF3 I-MISC 4063
) O X
has O X
a O X
two O X
- O X
fold O X
lower O X
affinity O X
compared O X
with O X
the O X
SLE O X
- O X
associated O X
Met602 O X
variant O X
for O X
the O X
small O X
adaptor O X
protein O X
SAP I-MISC 4068
. O X

Comparison O X
of O X
the O X
two O X
variants O X
in O X
T O X
- O X
cell O X
lines O X
revealed O X
the O X
Val602 O X
variant O X
to O X
be O X
significantly O X
more O X
highly O X
expressed O X
than O X
CD229 I-MISC 4063
Met602 O X
. O X

Activation O X
was O X
diminished O X
in O X
cells O X
expressing O X
CD229 I-MISC 4063
Val602 O X
compared O X
with O X
CD229 I-MISC 4063
Met602 O X
as O X
measured O X
by O X
up O X
- O X
regulation O X
of O X
CD69 I-MISC 969
. O X

There O X
was O X
no O X
correlation O X
between O X
homozygosity O X
at O X
rs509749 O X
and O X
activation O X
in O X
peripheral O X
blood O X
mononuclear O X
cells O X
from O X
healthy O X
donors O X
. O X

These O X
findings O X
identify O X
potential O X
mechanisms O X
by O X
which O X
a O X
single O X
SNP O X
can O X
perturb O X
fine O X
- O X
tuning O X
in O X
the O X
immune O X
system O X
with O X
significant O X
functional O X
consequences O X
. O X

###18715871	151987,5531

PP4R4 I-MISC 57718
/ O X
KIAA1622 I-MISC 57718
forms O X
a O X
novel O X
stable O X
cytosolic O X
complex O X
with O X
phosphoprotein I-MISC 5531
phosphatase I-MISC 5531
4 I-MISC 5531
. O X

Protein I-MISC 5531
serine I-MISC 5531
/ I-MISC 5531
threonine I-MISC 5531
phosphatase I-MISC 5531
4 I-MISC 5531
( O X
PP4c I-MISC 5531
) O X
is O X
an O X
essential O X
polypeptide O X
involved O X
in O X
critical O X
cellular O X
processes O X
such O X
as O X
microtubule O X
growth O X
and O X
organization O X
, O X
DNA O X
damage O X
checkpoint O X
recovery O X
, O X
apoptosis O X
, O X
and O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
alpha I-MISC 7124
signaling O X
. O X

Like O X
other O X
phosphatases O X
of O X
the O X
PP2A I-MISC 5524
family O X
, O X
PP4c I-MISC 5531
interacts O X
with O X
regulatory O X
proteins O X
, O X
which O X
specify O X
substrate O X
targeting O X
and O X
intracellular O X
localization O X
. O X

The O X
identification O X
of O X
these O X
regulatory O X
proteins O X
is O X
, O X
therefore O X
, O X
key O X
to O X
fully O X
understanding O X
the O X
function O X
of O X
this O X
enzyme O X
class O X
. O X

Here O X
, O X
using O X
a O X
sensitive O X
affinity O X
purification O X
/ O X
mass O X
spectrometry O X
approach O X
, O X
we O X
identify O X
a O X
novel O X
, O X
stable O X
cytosolic O X
PP4c I-MISC 5531
interacting O X
partner O X
, O X
KIAA1622 I-MISC 57718
, O X
which O X
we O X
have O X
renamed O X
PP4R4 I-MISC 57718
. O X

PP4R4 I-MISC 57718
displays O X
weak O X
sequence O X
homology O X
with O X
the O X
A O X
( O X
scaffolding O X
) O X
subunit O X
of O X
the O X
PP2A I-MISC 5524
holoenzyme O X
and O X
specifically O X
associates O X
with O X
PP4c I-MISC 5531
( O X
and O X
not O X
with O X
the O X
related O X
PP2Ac I-MISC 5515
or O X
PP6c I-MISC 5537
phosphatases O X
). O X

The O X
PP4c I-MISC 5531
. O X
PP4R4 I-MISC 57718
interaction O X
is O X
disrupted O X
by O X
mutations O X
analogous O X
to O X
those O X
abrogating O X
the O X
association O X
of O X
PP2Ac I-MISC 5515
with O X
PP2A I-MISC 5524
A O X
subunit O X
. O X

However O X
, O X
unlike O X
the O X
PP2A I-MISC 5524
A O X
subunit O X
, O X
which O X
plays O X
a O X
scaffolding O X
role O X
, O X
PP4R4 I-MISC 57718
does O X
not O X
bridge O X
PP4c I-MISC 5531
with O X
previously O X
characterized O X
PP4 I-MISC 5531
regulatory O X
subunits O X
. O X

PP4c I-MISC 5531
. O X
PP4R4 I-MISC 57718
complexes O X
exhibit O X
phosphatase O X
activity O X
toward O X
a O X
fluorogenic O X
substrate O X
and O X
gammaH2AX O X
, O X
but O X
this O X
activity O X
is O X
lower O X
than O X
that O X
associated O X
with O X
the O X
PP4c I-MISC 5531
. O X
PP4R2 I-MISC 151987
. O X
PP4R3 I-MISC 55671
complex O X
, O X
which O X
itself O X
is O X
less O X
active O X
than O X
the O X
free O X
PP4c I-MISC 5531
catalytic O X
subunit O X
. O X

Our O X
data O X
demonstrate O X
that O X
PP4R4 I-MISC 57718
forms O X
a O X
novel O X
cytosolic O X
complex O X
with O X
PP4c I-MISC 5531
, O X
independent O X
from O X
the O X
complexes O X
containing O X
PP4R1 I-MISC 9989
, O X
PP4R2 I-MISC 151987
. O X
PP4R3 I-MISC 55671
, O X
and O X
alpha4 I-MISC 3476
, O X
and O X
that O X
the O X
regulatory O X
subunits O X
of O X
PP4c I-MISC 5531
have O X
evolved O X
different O X
modes O X
of O X
interaction O X
with O X
the O X
catalytic O X
subunit O X
. O X

###20547845	3146,7099

A O X
critical O X
cysteine O X
is O X
required O X
for O X
HMGB1 I-MISC 3146
binding O X
to O X
Toll I-MISC 7099
- I-MISC 7099
like I-MISC 7099
receptor I-MISC 7099
4 I-MISC 7099
and O X
activation O X
of O X
macrophage O X
cytokine O X
release O X
. O X

During O X
infection O X
, O X
vertebrates O X
develop O X
" O X
sickness O X
syndrome O X
," O X
characterized O X
by O X
fever O X
, O X
anorexia O X
, O X
behavioral O X
withdrawal O X
, O X
acute O X
- O X
phase O X
protein O X
responses O X
, O X
and O X
inflammation O X
. O X

These O X
pathophysiological O X
responses O X
are O X
mediated O X
by O X
cytokines O X
, O X
including O X
TNF I-MISC 7124
and I-MISC 7124
IL I-MISC 7124
- I-MISC 7124
1 I-MISC 7124
, O X
released O X
during O X
the O X
innate O X
immune O X
response O X
to O X
invasion O X
. O X

Even O X
in O X
the O X
absence O X
of O X
infection O X
, O X
qualitatively O X
similar O X
physiological O X
syndromes O X
occur O X
following O X
sterile O X
injury O X
, O X
ischemia O X
reperfusion O X
, O X
crush O X
injury O X
, O X
and O X
autoimmune O X
- O X
mediated O X
tissue O X
damage O X
. O X

Recent O X
advances O X
implicate O X
high I-MISC 3146
- I-MISC 3146
mobility I-MISC 3146
group I-MISC 3146
box I-MISC 3146
1 I-MISC 3146
( O X
HMGB1 I-MISC 3146
), O X
a O X
nuclear O X
protein O X
with O X
inflammatory O X
cytokine O X
activities O X
, O X
in O X
stimulating O X
cytokine O X
release O X
. O X

HMGB1 I-MISC 3146
is O X
passively O X
released O X
during O X
cell O X
injury O X
and O X
necrosis O X
, O X
or O X
actively O X
secreted O X
during O X
immune O X
cell O X
activation O X
, O X
positioning O X
it O X
at O X
the O X
intersection O X
of O X
sterile O X
and O X
infection O X
- O X
associated O X
inflammation O X
. O X

To O X
date O X
, O X
eight O X
candidate O X
receptors O X
have O X
been O X
implicated O X
in O X
mediating O X
the O X
biological O X
responses O X
to O X
HMGB1 I-MISC 3146
, O X
but O X
the O X
mechanism O X
of O X
HMGB1 I-MISC 3146
- O X
dependent O X
cytokine O X
release O X
is O X
unknown O X
. O X

Here O X
we O X
show O X
that O X
Toll I-MISC 7099
- I-MISC 7099
like I-MISC 7099
receptor I-MISC 7099
4 I-MISC 7099
( I-MISC 7099
TLR4 I-MISC 7099
), O X
a O X
pivotal O X
receptor O X
for O X
activation O X
of O X
innate O X
immunity O X
and O X
cytokine O X
release O X
, O X
is O X
required O X
for O X
HMGB1 I-MISC 3146
- O X
dependent O X
activation O X
of O X
macrophage O X
TNF I-MISC 7124
release O X
. O X

Surface O X
plasmon O X
resonance O X
studies O X
indicate O X
that O X
HMGB1 I-MISC 3146
binds O X
specifically O X
to O X
TLR4 I-MISC 7099
, O X
and O X
that O X
this O X
binding O X
requires O X
a O X
cysteine O X
in O X
position O X
106 O X
. O X

A O X
wholly O X
synthetic O X
20 O X
- O X
mer O X
peptide O X
containing O X
cysteine O X
106 O X
from O X
within O X
the O X
cytokine O X
- O X
stimulating O X
B O X
box O X
mediates O X
TLR4 I-MISC 7099
- O X
dependent O X
activation O X
of O X
macrophage O X
TNF I-MISC 7124
release O X
. O X

Inhibition O X
of O X
TLR4 I-MISC 7099
binding O X
with O X
neutralizing O X
anti O X
- O X
HMGB1 I-MISC 3146
mAb O X
or O X
by O X
mutating O X
cysteine O X
106 O X
prevents O X
HMGB1 I-MISC 3146
activation O X
of O X
cytokine O X
release O X
. O X

These O X
results O X
have O X
implications O X
for O X
rationale O X
, O X
design O X
, O X
and O X
development O X
of O X
experimental O X
therapeutics O X
for O X
use O X
in O X
sterile O X
and O X
infectious O X
inflammation O X
. O X

###12681510	10672,9138

Mutation O X
of O X
an O X
N O X
- O X
terminal O X
acidic O X
- O X
rich O X
region O X
of O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
dissociates O X
alpha13 I-MISC 10672
binding O X
and O X
alpha13 I-MISC 10672
- O X
promoted O X
plasma O X
membrane O X
recruitment O X
. O X

The O X
Ras O X
homology O X
( O X
Rho O X
) O X
guanine O X
nucleotide O X
exchange O X
factor O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
couples O X
the O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
) I-MISC 10672
heterotrimeric O X
guanine O X
nucleotide O X
binding O X
protein O X
( O X
G O X
protein O X
) O X
subunit O X
to O X
Rho O X
GTPase O X
. O X

Alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
) I-MISC 10672
binds O X
to O X
a O X
regulator O X
of O X
G O X
protein O X
signaling O X
( O X
RGS O X
) O X
domain O X
in O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
, O X
but O X
the O X
mechanism O X
of O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
) I-MISC 10672
activation O X
of O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
is O X
poorly O X
understood O X
. O X

In O X
this O X
report O X
, O X
we O X
demonstrate O X
in O X
cell O X
- O X
based O X
assays O X
that O X
the O X
acidic O X
- O X
rich O X
N O X
- O X
terminus O X
, O X
adjacent O X
to O X
the O X
RGS O X
domain O X
, O X
is O X
required O X
for O X
binding O X
to O X
activated O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
), O X
and O X
refine O X
the O X
importance O X
of O X
this O X
region O X
by O X
showing O X
that O X
mutation O X
of O X
glutamic O X
acids O X
27 O X
and O X
29 O X
in O X
full O X
- O X
length O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
is O X
sufficient O X
to O X
prevent O X
interaction O X
with O X
activated O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
). O X

However O X
, O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
)- O X
interacting O X
deficient O X
N O X
- O X
terminal O X
mutants O X
of O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
retain O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
)- O X
dependent O X
plasma O X
membrane O X
recruitment O X
. O X

Overall O X
, O X
these O X
findings O X
demonstrate O X
a O X
critical O X
role O X
for O X
the O X
N O X
- O X
terminal O X
extension O X
of O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
in O X
mediating O X
binding O X
to O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
) I-MISC 10672
and O X
dissociate O X
two O X
activities O X
of O X
p115 I-MISC 9138
- I-MISC 9138
RhoGEF I-MISC 9138
: O X
binding O X
to O X
activated O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
) I-MISC 10672
and O X
translocation O X
to O X
the O X
PM O X
in O X
response O X
to O X
activated O X
alpha I-MISC 10672
( I-MISC 10672
13 I-MISC 10672
). O X

###21320496	10006,11350

Identification O X
and O X
functional O X
analysis O X
of O X
a O X
new O X
phosphorylation O X
site O X
( O X
Y398 O X
) O X
in O X
the O X
SH3 O X
domain O X
of O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
. O X

Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
is O X
an O X
adaptor O X
protein O X
for O X
Abelson O X
kinase O X
( O X
c I-MISC 11350
- I-MISC 11350
Abl I-MISC 11350
), O X
and O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
promotes O X
the O X
Abl I-MISC 11350
- O X
mediated O X
phosphorylation O X
of O X
Mammalian I-MISC 55740
Enabled I-MISC 55740
( O X
Mena I-MISC 55740
) O X
by O X
binding O X
both O X
c I-MISC 11350
- I-MISC 11350
Abl I-MISC 11350
and O X
Mena I-MISC 55740
. O X

Here O X
, O X
we O X
identified O X
a O X
new O X
phosphorylation O X
site O X
( O X
Y398 O X
) O X
in O X
the O X
SH3 O X
domain O X
of O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
, O X
and O X
disruption O X
of O X
Y398 O X
, O X
combined O X
with O X
the O X
previously O X
identified O X
phosphorylation O X
site O X
Y213 O X
, O X
significantly O X
weakens O X
the O X
binding O X
of O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
to O X
c I-MISC 11350
- I-MISC 11350
Abl I-MISC 11350
. O X

The O X
SH3 O X
domain O X
of O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
and O X
the O X
proline O X
- O X
rich O X
domain O X
of O X
c I-MISC 11350
- I-MISC 11350
Abl I-MISC 11350
are O X
involved O X
in O X
this O X
interaction O X
. O X

Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
phosphorylation O X
at O X
both O X
sites O X
stimulates O X
the O X
phosphorylation O X
of O X
Mena I-MISC 55740
through O X
the O X
activation O X
of O X
c I-MISC 11350
- I-MISC 11350
Abl I-MISC 11350
kinase O X
. O X

The O X
phosphorylation O X
of O X
Abi I-MISC 10006
- I-MISC 10006
1 I-MISC 10006
also O X
plays O X
a O X
role O X
in O X
enhancing O X
the O X
adhesion O X
of O X
Bcr O X
- O X
Abl I-MISC 11350
- O X
transformed O X
leukemic O X
cells O X
. O X

###24469399	268749,8517	268749,7316

Mechanism O X
underlying O X
IkB I-MISC 16151
kinase I-MISC 16151
activation O X
mediated O X
by O X
the O X
linear O X
ubiquitin O X
chain O X
assembly O X
complex O X
. O X

The O X
linear O X
ubiquitin O X
chain O X
assembly O X
complex O X
( O X
LUBAC O X
) O X
ligase O X
, O X
consisting O X
of O X
HOIL I-MISC 268749
- I-MISC 268749
1L I-MISC 268749
, O X
HOIP I-MISC 55072
, O X
and O X
SHARPIN I-MISC 81858
, O X
specifically O X
generates O X
linear O X
polyubiquitin O X
chains O X
. O X

LUBAC O X
- O X
mediated O X
linear O X
polyubiquitination O X
has O X
been O X
implicated O X
in O X
NF I-MISC 16151
- I-MISC 16151
kB I-MISC 16151
activation O X
. O X

NEMO I-MISC 8517
, O X
a O X
component O X
of O X
the O X
IkB I-MISC 16151
kinase I-MISC 16151
( O X
IKK I-MISC 16151
) O X
complex O X
, O X
is O X
a O X
substrate O X
of O X
LUBAC O X
, O X
but O X
the O X
precise O X
molecular O X
mechanism O X
underlying O X
linear O X
chain O X
- O X
mediated O X
NF I-MISC 16151
- I-MISC 16151
kB I-MISC 16151
activation O X
has O X
not O X
been O X
fully O X
elucidated O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
linearly O X
polyubiquitinated O X
NEMO I-MISC 8517
activates O X
IKK I-MISC 16151
more O X
potently O X
than O X
unanchored O X
linear O X
chains O X
. O X

In O X
mutational O X
analyses O X
based O X
on O X
the O X
crystal O X
structure O X
of O X
the O X
complex O X
between O X
the O X
HOIP I-MISC 55072
NZF1 B-MISC 23040
and O X
NEMO I-MISC 8517
CC2 O X
- O X
LZ O X
domains O X
, O X
which O X
are O X
involved O X
in O X
the O X
HOIP I-MISC 55072
- O X
NEMO I-MISC 8517
interaction O X
, O X
NEMO I-MISC 8517
mutations O X
that O X
impaired O X
linear O X
ubiquitin O X
recognition O X
activity O X
and O X
prevented O X
recognition O X
by O X
LUBAC O X
synergistically O X
suppressed O X
signal O X
- O X
induced O X
NF I-MISC 16151
- I-MISC 16151
kB I-MISC 16151
activation O X
. O X

HOIP I-MISC 55072
NZF1 B-MISC 23040
bound O X
to O X
NEMO I-MISC 8517
and O X
ubiquitin O X
simultaneously O X
, O X
and O X
HOIP I-MISC 55072
NZF1 B-MISC 23040
mutants O X
defective O X
in O X
interaction O X
with O X
either O X
NEMO I-MISC 8517
or O X
ubiquitin I-MISC 7316
could O X
not O X
restore O X
signal O X
- O X
induced O X
NF I-MISC 16151
- I-MISC 16151
kB I-MISC 16151
activation O X
. O X

Furthermore O X
, O X
linear O X
chain O X
- O X
mediated O X
activation O X
of O X
IKK2 I-MISC 3551
involved O X
homotypic O X
interaction O X
of O X
the O X
IKK2 I-MISC 3551
kinase O X
domain O X
. O X

Collectively O X
, O X
these O X
results O X
demonstrate O X
that O X
linear O X
polyubiquitination O X
of O X
NEMO I-MISC 8517
plays O X
crucial O X
roles O X
in O X
IKK I-MISC 16151
activation O X
and O X
that O X
this O X
modification O X
involves O X
the O X
HOIP I-MISC 55072
NZF1 B-MISC 23040
domain O X
and O X
recognition O X
of O X
NEMO I-MISC 8517
- O X
conjugated O X
linear O X
ubiquitin O X
chains O X
by O X
NEMO I-MISC 8517
on O X
another O X
IKK I-MISC 16151
complex O X
. O X

###26752685	55662,55611

FIH O X
Regulates O X
Cellular O X
Metabolism O X
through O X
Hydroxylation O X
of O X
the O X
Deubiquitinase O X
OTUB1 I-MISC 55611
. O X

The O X
asparagine O X
hydroxylase O X
, O X
factor O X
inhibiting O X
HIF I-MISC 55662
( O X
FIH O X
), O X
confers O X
oxygen O X
- O X
dependence O X
upon O X
the O X
hypoxia I-MISC 55662
- I-MISC 55662
inducible I-MISC 55662
factor I-MISC 55662
( O X
HIF I-MISC 55662
), O X
a O X
master O X
regulator O X
of O X
the O X
cellular O X
adaptive O X
response O X
to O X
hypoxia O X
. O X

Studies O X
investigating O X
whether O X
asparagine O X
hydroxylation O X
is O X
a O X
general O X
regulatory O X
oxygen O X
- O X
dependent O X
modification O X
have O X
identified O X
multiple O X
non O X
- O X
HIF I-MISC 55662
targets O X
for O X
FIH O X
. O X

However O X
, O X
the O X
functional O X
consequences O X
of O X
this O X
outside O X
of O X
the O X
HIF I-MISC 55662
pathway O X
remain O X
unclear O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
the O X
deubiquitinase O X
ovarian I-MISC 55611
tumor I-MISC 55611
domain I-MISC 55611
containing I-MISC 55611
ubiquitin I-MISC 55611
aldehyde I-MISC 55611
binding I-MISC 55611
protein I-MISC 55611
1 I-MISC 55611
( O X
OTUB1 I-MISC 55611
) O X
is O X
a O X
substrate O X
for O X
hydroxylation O X
by O X
FIH O X
on O X
N22 O X
. O X

Mutation O X
of O X
N22 O X
leads O X
to O X
a O X
profound O X
change O X
in O X
the O X
interaction O X
of O X
OTUB1 I-MISC 55611
with O X
proteins O X
important O X
in O X
cellular O X
metabolism O X
. O X

Furthermore O X
, O X
in O X
cultured O X
cells O X
, O X
overexpression O X
of O X
N22A O X
mutant O X
OTUB1 I-MISC 55611
impairs O X
cellular O X
metabolic O X
processes O X
when O X
compared O X
to O X
wild O X
type O X
. O X

Based O X
on O X
these O X
data O X
, O X
we O X
hypothesize O X
that O X
OTUB1 I-MISC 55611
is O X
a O X
target O X
for O X
functional O X
hydroxylation O X
by O X
FIH O X
. O X

Additionally O X
, O X
we O X
propose O X
that O X
our O X
results O X
provide O X
new O X
insight O X
into O X
the O X
regulation O X
of O X
cellular O X
energy O X
metabolism O X
during O X
hypoxic O X
stress O X
and O X
the O X
potential O X
for O X
targeting O X
hydroxylases O X
for O X
therapeutic O X
benefit O X
. O X

###10677492	851366,852862	851366,854252

Studies O X
on O X
the O X
role O X
of O X
the O X
hydrophobic O X
domain O X
of O X
Ost4p I-MISC 851366
in O X
interactions O X
with O X
other O X
subunits O X
of O X
yeast O X
oligosaccharyl O X
transferase O X
. O X

In O X
the O X
yeast O X
, O X
Saccharomyces O X
cerevisiae O X
, O X
oligosaccharyl O X
transferase O X
( O X
OT O X
), O X
which O X
catalyzes O X
the O X
transfer O X
of O X
dolichol O X
- O X
linked O X
oligosaccharide O X
chains O X
to O X
nascent O X
polypeptides O X
in O X
the O X
endoplasmic O X
reticulum O X
, O X
consists O X
of O X
nine O X
nonidentical O X
membrane O X
protein O X
subunits O X
. O X

Genetic O X
and O X
biochemical O X
evidence O X
indicated O X
these O X
nine O X
proteins O X
exist O X
in O X
three O X
subcomplexes O X
. O X

Three O X
of O X
the O X
OT O X
subunits O X
( O X
Ost4p I-MISC 851366
, O X
Ost3p I-MISC 854252
, O X
and O X
Stt3p I-MISC 852862
) O X
have O X
been O X
proposed O X
to O X
exist O X
in O X
one O X
subcomplex O X
. O X

To O X
investigate O X
the O X
interaction O X
of O X
these O X
three O X
membrane O X
proteins O X
, O X
initially O X
we O X
carried O X
out O X
a O X
mutational O X
analysis O X
of O X
Ost4p I-MISC 851366
, O X
which O X
is O X
an O X
extraordinarily O X
small O X
membrane O X
protein O X
containing O X
only O X
36 O X
amino O X
acid O X
residues O X
. O X

This O X
analysis O X
indicated O X
that O X
when O X
single O X
amino O X
acid O X
residues O X
in O X
a O X
region O X
close O X
to O X
the O X
luminal O X
face O X
of O X
the O X
putative O X
transmembrane O X
domain O X
of O X
Ost4p I-MISC 851366
were O X
changed O X
into O X
an O X
ionizable O X
amino O X
acid O X
such O X
as O X
Lys O X
or O X
Asp O X
, O X
growth O X
at O X
37 O X
degrees O X
C O X
and O X
OT O X
activity O X
measured O X
in O X
vitro O X
were O X
impaired O X
. O X

In O X
addition O X
, O X
using O X
immunoprecipitation O X
techniques O X
and O X
Western O X
blot O X
analysis O X
, O X
we O X
found O X
that O X
with O X
these O X
mutations O X
the O X
interaction O X
between O X
Ost4p I-MISC 851366
, O X
Ost3p I-MISC 854252
, O X
and O X
Stt3p I-MISC 852862
was O X
disrupted O X
. O X

Introduction O X
of O X
Lys O X
or O X
Asp O X
residues O X
at O X
other O X
positions O X
in O X
the O X
putative O X
transmembrane O X
domain O X
or O X
at O X
the O X
N O X
or O X
C O X
terminus O X
of O X
Ost4p I-MISC 851366
had O X
no O X
effect O X
on O X
disrupting O X
subunit O X
interactions O X
or O X
impairing O X
the O X
activity O X
of O X
OT O X
. O X

These O X
findings O X
suggest O X
that O X
a O X
localized O X
region O X
of O X
the O X
putative O X
transmembrane O X
domain O X
of O X
Ost4p I-MISC 851366
mediates O X
in O X
stabilization O X
of O X
the O X
interaction O X
with O X
the O X
two O X
other O X
OT O X
subunits O X
( O X
Ost3p I-MISC 854252
and O X
Stt3p I-MISC 852862
) O X
in O X
a O X
subcomplex O X
in O X
the O X
endoplasmic O X
reticulum O X
membrane O X
. O X

###15930137	7957,378884

Insights O X
into O X
Lafora O X
disease O X
: O X
malin I-MISC 378884
is O X
an O X
E3 O X
ubiquitin O X
ligase O X
that O X
ubiquitinates O X
and O X
promotes O X
the O X
degradation O X
of O X
laforin I-MISC 7957
. O X

Lafora O X
disease O X
( O X
LD O X
) O X
is O X
a O X
fatal O X
form O X
of O X
progressive O X
myoclonus O X
epilepsy O X
caused O X
by O X
recessive O X
mutations O X
in O X
either O X
a O X
gene O X
encoding O X
a O X
dual O X
- O X
specificity O X
phosphatase O X
, O X
known O X
as O X
laforin I-MISC 7957
, O X
or O X
a O X
recently O X
identified O X
gene O X
encoding O X
the O X
protein O X
known O X
as O X
malin I-MISC 378884
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
malin I-MISC 378884
is O X
a O X
single O X
subunit O X
E3 O X
ubiquitin O X
( O X
Ub O X
) O X
ligase O X
and O X
that O X
its O X
RING O X
domain O X
is O X
necessary O X
and O X
sufficient O X
to O X
mediate O X
ubiquitination O X
. O X

Additionally O X
, O X
malin I-MISC 378884
interacts O X
with O X
and O X
polyubiquitinates O X
laforin I-MISC 7957
, O X
leading O X
to O X
its O X
degradation O X
. O X

Missense O X
mutations O X
in O X
malin I-MISC 378884
that O X
are O X
present O X
in O X
LD O X
patients O X
abolish O X
its O X
ability O X
to O X
polyubiquitinate O X
and O X
signal O X
the O X
degradation O X
of O X
laforin I-MISC 7957
. O X

Our O X
results O X
demonstrate O X
that O X
laforin I-MISC 7957
is O X
a O X
physiologic O X
substrate O X
of O X
malin I-MISC 378884
, O X
and O X
we O X
propose O X
possible O X
models O X
to O X
explain O X
how O X
recessive O X
mutations O X
in O X
either O X
malin I-MISC 378884
or O X
laforin I-MISC 7957
result O X
in O X
LD O X
. O X

Furthermore O X
, O X
these O X
data O X
distinguish O X
malin I-MISC 378884
as O X
an O X
E3 O X
Ub O X
ligase O X
whose O X
activity O X
is O X
necessary O X
to O X
prevent O X
a O X
neurodegenerative O X
disease O X
that O X
involves O X
formation O X
of O X
nonproteinacious O X
inclusion O X
bodies O X
. O X

###12782684	855625,851209

Ras O X
recruits O X
mitotic O X
exit O X
regulator O X
Lte1 I-MISC 851209
to O X
the O X
bud O X
cortex O X
in O X
budding O X
yeast O X
. O X

ACdc25 O X
family O X
protein O X
Lte1 I-MISC 851209
( O X
low O X
temperature O X
essential O X
) O X
is O X
essential O X
for O X
mitotic O X
exit O X
at O X
a O X
lowered O X
temperature O X
and O X
has O X
been O X
presumed O X
to O X
be O X
a O X
guanine O X
nucleotide O X
exchange O X
factor O X
( O X
GEF O X
) O X
for O X
a O X
small O X
GTPase O X
Tem1 I-MISC 854938
, O X
which O X
is O X
a O X
key O X
regulator O X
of O X
mitotic O X
exit O X
. O X

We O X
found O X
that O X
Lte1 I-MISC 851209
physically O X
associates O X
with O X
Ras2 I-MISC 855625
- O X
GTP O X
both O X
in O X
vivo O X
and O X
in O X
vitro O X
and O X
that O X
the O X
Cdc25 O X
homology O X
domain O X
( O X
CHD O X
) O X
of O X
Lte1 I-MISC 851209
is O X
essential O X
for O X
the O X
interaction O X
with O X
Ras2 I-MISC 855625
. O X

Furthermore O X
, O X
we O X
found O X
that O X
the O X
proper O X
localization O X
of O X
Lte1 I-MISC 851209
to O X
the O X
bud O X
cortex O X
is O X
dependent O X
on O X
active O X
Ras O X
and O X
that O X
the O X
overexpression O X
of O X
a O X
derivative O X
of O X
Lte1 I-MISC 851209
without O X
the O X
CHD O X
suppresses O X
defects O X
in O X
mitotic O X
exit O X
of O X
a O X
Deltalte1 O X
mutant O X
and O X
a O X
Deltaras1 O X
Deltaras2 O X
mutant O X
. O X

These O X
results O X
suggest O X
that O X
Lte1 I-MISC 851209
is O X
a O X
downstream O X
effector O X
protein O X
of O X
Ras O X
in O X
mitotic O X
exit O X
and O X
that O X
the O X
Ras O X
GEF O X
domain O X
of O X
Lte1 I-MISC 851209
is O X
not O X
essential O X
for O X
mitotic O X
exit O X
but O X
required O X
for O X
its O X
localization O X
. O X

###10887186	280756,4901

The O X
leucine O X
zipper O X
of O X
NRL I-MISC 4901
interacts O X
with O X
the O X
CRX I-MISC 280756
homeodomain O X
. O X

A O X
possible O X
mechanism O X
of O X
transcriptional O X
synergy O X
in O X
rhodopsin I-MISC 6010
regulation O X
. O X

Photoreceptor O X
- O X
specific O X
expression O X
of O X
rhodopsin I-MISC 6010
is O X
mediated O X
by O X
multiple O X
cis O X
- O X
acting O X
elements O X
in O X
the O X
proximal O X
promoter O X
region O X
. O X

NRL I-MISC 4901
( O X
neural I-MISC 4901
retina I-MISC 4901
leucine I-MISC 4901
zipper I-MISC 4901
) O X
and O X
CRX I-MISC 280756
( O X
cone I-MISC 280756
rod I-MISC 280756
homeobox I-MISC 280756
) O X
proteins O X
bind O X
to O X
the O X
adjacent O X
NRE O X
and O X
Ret O X
- O X
4 O X
sites O X
, O X
respectively O X
, O X
within O X
this O X
region O X
. O X

Although O X
NRL I-MISC 4901
and O X
CRX I-MISC 280756
are O X
each O X
individually O X
able O X
to O X
induce O X
rhodopsin I-MISC 6010
promoter O X
activity O X
, O X
when O X
expressed O X
together O X
they O X
exhibit O X
transcriptional O X
synergy O X
in O X
rhodopsin I-MISC 6010
promoter O X
activation O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
method O X
and O X
glutathione O X
S O X
- O X
transferase O X
pull O X
- O X
down O X
assays O X
, O X
we O X
demonstrate O X
that O X
the O X
leucine O X
zipper O X
of O X
NRL I-MISC 4901
can O X
physically O X
interact O X
with O X
CRX I-MISC 280756
. O X

Deletion O X
analysis O X
revealed O X
that O X
the O X
CRX I-MISC 280756
homeodomain O X
( O X
CRX I-MISC 280756
- O X
HD O X
) O X
plays O X
an O X
important O X
role O X
in O X
the O X
interaction O X
with O X
the O X
NRL I-MISC 4901
leucine O X
zipper O X
. O X

Although O X
binding O X
with O X
the O X
CRX I-MISC 280756
- O X
HD O X
alone O X
was O X
weak O X
, O X
a O X
strong O X
interaction O X
was O X
detected O X
when O X
flanking O X
regions O X
including O X
the O X
glutamine O X
- O X
rich O X
and O X
the O X
basic O X
regions O X
that O X
follow O X
the O X
HD O X
were O X
included O X
. O X

A O X
reciprocal O X
deletion O X
analysis O X
showed O X
that O X
the O X
leucine O X
zipper O X
of O X
NRL I-MISC 4901
is O X
required O X
for O X
interaction O X
with O X
CRX I-MISC 280756
- O X
HD O X
. O X

Two O X
disease O X
- O X
causing O X
mutations O X
in O X
CRX I-MISC 280756
- O X
HD O X
( O X
R41W O X
and O X
R90W O X
) O X
that O X
exhibit O X
reduced O X
DNA O X
binding O X
and O X
transcriptional O X
synergy O X
also O X
decrease O X
its O X
interaction O X
with O X
NRL I-MISC 4901
. O X

These O X
studies O X
suggest O X
novel O X
possibilities O X
for O X
protein O X
- O X
protein O X
interaction O X
between O X
two O X
conserved O X
DNA O X
- O X
binding O X
motifs O X
and O X
imply O X
that O X
cross O X
- O X
talk O X
among O X
distinct O X
regulatory O X
pathways O X
contributes O X
to O X
the O X
establishment O X
and O X
maintenance O X
of O X
photoreceptor O X
function O X
. O X

###12084722	335,19

Naturally O X
occurring O X
mutations O X
in O X
the O X
largest O X
extracellular O X
loops O X
of O X
ABCA1 I-MISC 19
can O X
disrupt O X
its O X
direct O X
interaction O X
with O X
apolipoprotein I-MISC 335
A I-MISC 335
- I-MISC 335
I I-MISC 335
. O X

The O X
ABCA1 I-MISC 19
transporter O X
contains O X
two O X
large O X
domains O X
into O X
which O X
many O X
of O X
the O X
genetic O X
mutations O X
in O X
individuals O X
with O X
Tangier O X
disease O X
fall O X
. O X

To O X
investigate O X
the O X
structural O X
requirements O X
for O X
the O X
cellular O X
cholesterol O X
efflux O X
mediated O X
by O X
ABCA1 I-MISC 19
, O X
we O X
have O X
determined O X
the O X
topology O X
of O X
these O X
two O X
domains O X
and O X
generated O X
transporters O X
harboring O X
five O X
naturally O X
occurring O X
missense O X
mutations O X
in O X
them O X
. O X

These O X
mutants O X
, O X
unlike O X
wild O X
type O X
ABCA1 I-MISC 19
, O X
produced O X
little O X
or O X
no O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
- O X
stimulated O X
cholesterol O X
efflux O X
when O X
transfected O X
into O X
293 O X
cells O X
, O X
establishing O X
their O X
causality O X
in O X
Tangier O X
disease O X
. O X

Because O X
all O X
five O X
mutant O X
proteins O X
were O X
well O X
expressed O X
and O X
detectable O X
on O X
the O X
plasma O X
membrane O X
, O X
their O X
interaction O X
with O X
the O X
ABCA1 I-MISC 19
ligand O X
, O X
apolipoprotein I-MISC 335
( I-MISC 335
apo I-MISC 335
) I-MISC 335
A I-MISC 335
- I-MISC 335
I I-MISC 335
, O X
was O X
measured O X
using O X
bifunctional O X
cross O X
- O X
linking O X
agents O X
. O X

Four O X
of O X
five O X
mutants O X
had O X
a O X
marked O X
decline O X
in O X
cross O X
- O X
linking O X
to O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
, O X
whereas O X
one O X
( O X
W590S O X
) O X
retained O X
full O X
cross O X
- O X
linking O X
activity O X
. O X

Cross O X
- O X
linking O X
of O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
was O X
temperature O X
- O X
dependent O X
, O X
rapid O X
in O X
onset O X
, O X
and O X
detectable O X
with O X
both O X
lipid O X
- O X
and O X
water O X
- O X
soluble O X
cross O X
- O X
linking O X
agents O X
. O X

These O X
results O X
suggest O X
that O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
- O X
stimulated O X
cholesterol O X
efflux O X
cannot O X
occur O X
without O X
a O X
direct O X
interaction O X
between O X
the O X
apoprotein O X
and O X
critical O X
residues O X
in O X
two O X
extracellular O X
loops O X
of O X
ABCA1 I-MISC 19
. O X

The O X
behavior O X
of O X
the O X
W590S O X
mutant O X
indicates O X
that O X
although O X
binding O X
of O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
by O X
ABCA1 I-MISC 19
may O X
be O X
necessary O X
, O X
it O X
is O X
not O X
sufficient O X
for O X
stimulation O X
of O X
cholesterol O X
efflux O X
. O X

###22960107	24392,25472

Adenosine O X
- O X
triphosphate O X
- O X
sensitive O X
K O X
+ O X
channel O X
( O X
Kir6 I-MISC 25472
. I-MISC 25472
1 I-MISC 25472
): O X
a O X
novel O X
phosphospecific O X
interaction O X
partner O X
of O X
connexin I-MISC 24392
43 I-MISC 24392
( O X
Cx43 I-MISC 24392
). O X

Connexin I-MISC 24392
43 I-MISC 24392
( O X
Cx43 I-MISC 24392
) O X
is O X
a O X
phosphoprotein O X
expressed O X
in O X
a O X
wide O X
variety O X
of O X
cells O X
. O X

Cx43 I-MISC 24392
and O X
adenosine O X
- O X
triphosphate O X
- O X
sensitive O X
K O X
(+) O X
channels O X
[ O X
K O X
(+)( O X
ATP O X
)] O X
are O X
part O X
of O X
same O X
signaling O X
pathway O X
that O X
regulates O X
cell O X
survival O X
during O X
stress O X
and O X
ischemia O X
preconditioning O X
. O X

Molecular O X
mechanism O X
for O X
their O X
coordinated O X
role O X
in O X
ischemia O X
/ O X
hypoxia O X
preconditioning O X
is O X
not O X
well O X
known O X
. O X

Using O X
pull O X
down O X
, O X
co O X
- O X
immunoprecipitation O X
assays O X
and O X
co O X
- O X
localization O X
studies O X
we O X
provide O X
evidence O X
, O X
for O X
the O X
first O X
time O X
that O X
Kir6 I-MISC 25472
. I-MISC 25472
1 I-MISC 25472
, O X
a O X
K O X
(+)( O X
ATP O X
) O X
channel O X
protein O X
component O X
, O X
can O X
interact O X
with O X
Cx43 I-MISC 24392
. O X

Further O X
we O X
show O X
that O X
the O X
interaction O X
was O X
phospho O X
- O X
specific O X
such O X
that O X
Cx43 I-MISC 24392
phosphorylated O X
at O X
serine O X
262 O X
( O X
S262 O X
) O X
interacted O X
with O X
Kir6 I-MISC 25472
. I-MISC 25472
1 I-MISC 25472
in O X
preference O X
to O X
the O X
unphosphorylated O X
form O X
of O X
Cx43 I-MISC 24392
. O X

Introduction O X
of O X
phospho O X
- O X
deficient O X
mutation O X
at O X
serine O X
262 O X
( O X
S262A O X
) O X
in O X
Cx43 I-MISC 24392
completely O X
abolished O X
the O X
interaction O X
. O X

Our O X
data O X
provide O X
an O X
interesting O X
lead O X
about O X
a O X
possible O X
partnership O X
between O X
Cx43 I-MISC 24392
and O X
Kir6 I-MISC 25472
. I-MISC 25472
1 I-MISC 25472
, O X
which O X
will O X
help O X
in O X
better O X
understanding O X
their O X
role O X
in O X
ischemia O X
/ O X
hypoxia O X
preconditioning O X
. O X

###11793469	4292,107984056

Polymorphisms O X
and O X
HNPCC I-MISC 107984056
: O X
PMS2 I-MISC 5395
- O X
MLH1 I-MISC 4292
protein O X
interactions O X
diminished O X
by O X
single O X
nucleotide O X
polymorphisms O X
. O X

Hereditary O X
nonpolyposis O X
colorectal O X
cancer O X
( O X
HNPCC I-MISC 107984056
) O X
is O X
one O X
of O X
the O X
most O X
common O X
autosomal O X
dominant O X
inherited O X
diseases O X
. O X

Mutations O X
in O X
the O X
human O X
mismatch O X
repair O X
( O X
MMR O X
) O X
proteins O X
MLH1 I-MISC 4292
, O X
MSH2 I-MISC 4436
, O X
MSH6 I-MISC 2956
, O X
PMS1 I-MISC 5378
, O X
and O X
PMS2 I-MISC 5395
have O X
been O X
found O X
to O X
co O X
- O X
segregate O X
with O X
HNPCC I-MISC 107984056
. O X

The O X
MLH1 I-MISC 4292
and O X
MSH2 I-MISC 4436
proteins O X
have O X
been O X
demonstrated O X
to O X
interact O X
with O X
PMS1 I-MISC 5378
, O X
PMS2 I-MISC 5395
, O X
and O X
MSH6 I-MISC 2956
proteins O X
. O X

A O X
previous O X
study O X
reported O X
that O X
missense O X
mutations O X
in O X
specific O X
regions O X
of O X
MLH1 I-MISC 4292
can O X
lead O X
to O X
defects O X
in O X
protein O X
- O X
protein O X
interactions O X
with O X
PMS2 I-MISC 5395
. O X

Here O X
we O X
report O X
that O X
three O X
missense O X
alterations O X
previously O X
identified O X
as O X
single O X
nucleotide O X
polymorphisms O X
( O X
SNPs O X
) O X
in O X
PMS2 I-MISC 5395
( O X
P511K O X
, O X
T597S O X
, O X
and O X
M622I O X
) O X
cause O X
defective O X
protein O X
- O X
protein O X
interactions O X
with O X
MLH1 I-MISC 4292
, O X
even O X
though O X
the O X
alterations O X
are O X
not O X
in O X
the O X
previously O X
reported O X
interaction O X
domain O X
. O X

These O X
results O X
suggest O X
that O X
an O X
additional O X
domain O X
in O X
PMS2 I-MISC 5395
affects O X
MLH1 I-MISC 4292
- O X
PMS2 I-MISC 5395
interaction O X
. O X

This O X
study O X
also O X
demonstrates O X
that O X
SNPs O X
can O X
result O X
in O X
gene O X
alterations O X
that O X
indeed O X
have O X
a O X
functional O X
effect O X
on O X
protein O X
phenotype O X
. O X

Thus O X
, O X
these O X
three O X
SNPs O X
may O X
ultimately O X
represent O X
variants O X
with O X
an O X
increased O X
risk O X
factor O X
for O X
tumorgenesis O X
in O X
HNPCC I-MISC 107984056
. O X

This O X
study O X
is O X
one O X
of O X
the O X
first O X
to O X
use O X
a O X
functional O X
assay O X
to O X
appraise O X
the O X
role O X
of O X
SNPs O X
and O X
suggests O X
that O X
traditional O X
definitions O X
of O X
polymorphisms O X
and O X
mutations O X
are O X
in O X
need O X
of O X
reconsideration O X
. O X

###15572661	1616,367

Negative O X
modulation O X
of O X
androgen I-MISC 367
receptor I-MISC 367
transcriptional O X
activity O X
by O X
Daxx I-MISC 1616
. O X

The O X
transcriptional O X
activity O X
of O X
the O X
androgen I-MISC 367
receptor I-MISC 367
( O X
AR I-MISC 367
) O X
modulated O X
by O X
positive O X
or O X
negative O X
regulators O X
plays O X
a O X
critical O X
role O X
in O X
controlling O X
the O X
growth O X
and O X
survival O X
of O X
prostate O X
cancer O X
cells O X
. O X

Although O X
numerous O X
positive O X
regulators O X
have O X
been O X
identified O X
, O X
negative O X
regulators O X
of O X
AR I-MISC 367
are O X
less O X
well O X
understood O X
. O X

We O X
report O X
here O X
that O X
Daxx I-MISC 1616
functions O X
as O X
a O X
negative O X
AR I-MISC 367
coregulator O X
through O X
direct O X
protein O X
- O X
protein O X
interactions O X
. O X

Overexpression O X
of O X
Daxx I-MISC 1616
suppressed O X
AR I-MISC 367
- O X
mediated O X
promoter O X
activity O X
in O X
COS O X
- O X
1 O X
and O X
LNCaP O X
cells O X
and O X
AR I-MISC 367
- O X
mediated O X
prostate O X
- O X
specific O X
antigen O X
expression O X
in O X
LNCaP O X
cells O X
. O X

Conversely O X
, O X
downregulation O X
of O X
endogenous O X
Daxx I-MISC 1616
expression O X
by O X
RNA O X
interference O X
enhances O X
androgen O X
- O X
induced O X
prostate O X
- O X
specific O X
antigen O X
expression O X
in O X
LNCaP O X
cells O X
. O X

In O X
vitro O X
and O X
in O X
vivo O X
interaction O X
studies O X
revealed O X
that O X
Daxx I-MISC 1616
binds O X
to O X
both O X
the O X
amino O X
- O X
terminal O X
and O X
the O X
DNA O X
- O X
binding O X
domain O X
of O X
the O X
AR I-MISC 367
. O X

Daxx I-MISC 1616
proteins O X
interfere O X
with O X
the O X
AR I-MISC 367
DNA O X
- O X
binding O X
activity O X
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

Moreover O X
, O X
sumoylation O X
of O X
AR I-MISC 367
at O X
its O X
amino O X
- O X
terminal O X
domain O X
is O X
involved O X
in O X
Daxx I-MISC 1616
interaction O X
and O X
trans O X
- O X
repression O X
. O X

Together O X
, O X
these O X
findings O X
not O X
only O X
provide O X
a O X
novel O X
role O X
of O X
Daxx I-MISC 1616
in O X
controlling O X
AR I-MISC 367
transactivation O X
activity O X
but O X
also O X
uncover O X
the O X
mechanism O X
underlying O X
sumoylation O X
- O X
dependent O X
transcriptional O X
repression O X
of O X
the O X
AR I-MISC 367
. O X

###21828050	8452,55975

Ubiquitin O X
ligase O X
activity O X
of O X
Cul3 I-MISC 8452
- O X
KLHL7 I-MISC 55975
protein O X
is O X
attenuated O X
by O X
autosomal O X
dominant O X
retinitis O X
pigmentosa O X
causative O X
mutation O X
. O X

Substrate O X
- O X
specific O X
protein O X
degradation O X
mediated O X
by O X
the O X
ubiquitin O X
proteasome O X
system O X
( O X
UPS O X
) O X
is O X
crucial O X
for O X
the O X
proper O X
function O X
of O X
the O X
cell O X
. O X

Proteins O X
are O X
specifically O X
recognized O X
and O X
ubiquitinated O X
by O X
the O X
ubiquitin O X
ligases O X
( O X
E3s O X
) O X
and O X
are O X
then O X
degraded O X
by O X
the O X
proteasome O X
. O X

BTB O X
proteins O X
act O X
as O X
the O X
substrate O X
recognition O X
subunit O X
that O X
recruits O X
their O X
cognate O X
substrates O X
to O X
the O X
Cullin O X
3 O X
- O X
based O X
multisubunit O X
E3s O X
. O X

Recently O X
, O X
it O X
was O X
reported O X
that O X
missense O X
mutations O X
in O X
KLHL7 I-MISC 55975
, O X
a O X
BTB O X
- O X
Kelch O X
protein O X
, O X
are O X
related O X
to O X
autosomal O X
dominant O X
retinitis O X
pigmentosa O X
( O X
adRP O X
). O X

However O X
, O X
the O X
involvement O X
of O X
KLHL7 I-MISC 55975
in O X
the O X
UPS O X
and O X
the O X
outcome O X
of O X
the O X
adRP O X
causative O X
mutations O X
were O X
unknown O X
. O X

In O X
this O X
study O X
, O X
we O X
show O X
that O X
KLHL7 I-MISC 55975
forms O X
a O X
dimer O X
, O X
assembles O X
with O X
Cul3 I-MISC 8452
through O X
its O X
BTB O X
and O X
BACK O X
domains O X
, O X
and O X
exerts O X
E3 O X
activity O X
. O X

Lys O X
- O X
48 O X
- O X
linked O X
but O X
not O X
Lys O X
- O X
63 O X
- O X
linked O X
polyubiquitin O X
chain O X
co O X
- O X
localized O X
with O X
KLHL7 I-MISC 55975
, O X
which O X
increased O X
upon O X
proteasome O X
inhibition O X
suggesting O X
that O X
KLHL7 I-MISC 55975
mediates O X
protein O X
degradation O X
via O X
UPS O X
. O X

An O X
adRP O X
- O X
causative O X
missense O X
mutation O X
in O X
the O X
BACK O X
domain O X
of O X
KLHL7 I-MISC 55975
attenuated O X
only O X
the O X
Cul3 I-MISC 8452
interaction O X
but O X
not O X
dimerization O X
. O X

Nevertheless O X
, O X
the O X
incorporation O X
of O X
the O X
mutant O X
as O X
a O X
heterodimer O X
in O X
the O X
Cul3 I-MISC 8452
- O X
KLHL7 I-MISC 55975
complex O X
diminished O X
the O X
E3 O X
ligase O X
activity O X
. O X

Together O X
, O X
our O X
results O X
suggest O X
that O X
KLHL7 I-MISC 55975
constitutes O X
a O X
Cul3 I-MISC 8452
- O X
based O X
E3 O X
and O X
that O X
the O X
disease O X
- O X
causing O X
mutation O X
inhibits O X
ligase O X
activity O X
in O X
a O X
dominant O X
negative O X
manner O X
, O X
which O X
may O X
lead O X
to O X
the O X
inappropriate O X
accumulation O X
of O X
the O X
substrates O X
targeted O X
for O X
proteasomal O X
degradation O X
. O X

###14675752	11765,9685

Characterization O X
of O X
a O X
gamma I-MISC 11765
- I-MISC 11765
adaptin I-MISC 11765
ear O X
- O X
binding O X
motif O X
in O X
enthoprotin I-MISC 9685
. O X

Enthoprotin I-MISC 9685
, O X
a O X
newly O X
identified O X
component O X
of O X
clathrin O X
- O X
coated O X
vesicles O X
, O X
interacts O X
with O X
the O X
trans O X
- O X
Golgi O X
network O X
( O X
TGN O X
) O X
clathrin O X
adapters O X
AP O X
- O X
1 O X
and O X
GGA2 I-MISC 23062
. O X

Here O X
we O X
perform O X
a O X
multi O X
- O X
faceted O X
analysis O X
of O X
the O X
site O X
in O X
enthoprotin I-MISC 9685
that O X
is O X
responsible O X
for O X
the O X
binding O X
to O X
the O X
gamma I-MISC 11765
- I-MISC 11765
adaptin I-MISC 11765
ear O X
( O X
gamma O X
- O X
ear O X
) O X
domain O X
of O X
AP O X
- O X
1 O X
. O X

Alanine O X
scan O X
mutagenesis O X
and O X
nuclear O X
magnetic O X
resonance O X
( O X
NMR O X
) O X
studies O X
reveal O X
the O X
full O X
extent O X
of O X
the O X
site O X
as O X
well O X
as O X
critical O X
residues O X
for O X
this O X
interaction O X
. O X

NMR O X
studies O X
of O X
the O X
gamma O X
- O X
ear O X
in O X
complex O X
with O X
a O X
synthetic O X
peptide O X
from O X
enthoprotin I-MISC 9685
provide O X
structural O X
details O X
of O X
the O X
binding O X
site O X
for O X
TGN O X
accessory O X
proteins O X
within O X
the O X
gamma O X
- O X
ear O X
. O X

###14675757	853534,856677	856465,856677

Mapping O X
eIF5A I-MISC 856677
binding O X
sites O X
for O X
Dys1 I-MISC 856465
and O X
Lia1 I-MISC 853534
: O X
in O X
vivo O X
evidence O X
for O X
regulation O X
of O X
eIF5A I-MISC 856677
hypusination O X
. O X

The O X
evolutionarily O X
conserved O X
factor O X
eIF5A I-MISC 856677
is O X
the O X
only O X
protein O X
known O X
to O X
undergo O X
hypusination O X
, O X
a O X
unique O X
posttranslational O X
modification O X
triggered O X
by O X
deoxyhypusine I-MISC 856465
synthase I-MISC 856465
( O X
Dys1 I-MISC 856465
). O X

Although O X
eIF5A I-MISC 856677
is O X
essential O X
for O X
cell O X
viability O X
, O X
the O X
function O X
of O X
this O X
putative O X
translation O X
initiation O X
factor O X
is O X
still O X
obscure O X
. O X

To O X
identify O X
eIF5A I-MISC 856677
- O X
binding O X
proteins O X
that O X
could O X
clarify O X
its O X
function O X
, O X
we O X
screened O X
a O X
two O X
- O X
hybrid O X
library O X
and O X
identified O X
two O X
eIF O X
- O X
5A O X
partners O X
in O X
S O X
. O X
cerevisiae O X
: O X
Dys1 I-MISC 856465
and O X
the O X
protein O X
encoded O X
by O X
the O X
gene O X
YJR070C I-MISC 853534
, O X
named O X
Lia1 I-MISC 853534
( O X
Ligand O X
of O X
eIF5A I-MISC 856677
). O X

The O X
interactions O X
were O X
confirmed O X
by O X
GST O X
pulldown O X
. O X

Mapping O X
binding O X
sites O X
for O X
these O X
proteins O X
revealed O X
that O X
both O X
eIF5A I-MISC 856677
domains O X
can O X
bind O X
to O X
Dys1 I-MISC 856465
, O X
whereas O X
the O X
C O X
- O X
terminal O X
domain O X
is O X
sufficient O X
to O X
bind O X
Lia1 I-MISC 853534
. O X

We O X
demonstrate O X
for O X
the O X
first O X
time O X
in O X
vivo O X
that O X
the O X
N O X
- O X
terminal O X
alpha O X
- O X
helix O X
of O X
Dys1 I-MISC 856465
can O X
modulate O X
enzyme O X
activity O X
by O X
inhibiting O X
eIF5A I-MISC 856677
interaction O X
. O X

We O X
suggest O X
that O X
this O X
inhibition O X
be O X
abrogated O X
in O X
the O X
cell O X
when O X
hypusinated O X
and O X
functional O X
eIF5A I-MISC 856677
is O X
required O X
. O X

###9990021	5147,6103

The O X
retinitis O X
pigmentosa O X
GTPase O X
regulator O X
, O X
RPGR I-MISC 6103
, O X
interacts O X
with O X
the O X
delta O X
subunit O X
of O X
rod O X
cyclic O X
GMP O X
phosphodiesterase O X
. O X

Recently O X
, O X
the O X
retinitis O X
pigmentosa O X
3 O X
( O X
RP3 I-MISC 6103
) O X
gene O X
has O X
been O X
cloned O X
and O X
named O X
retinitis O X
pigmentosa O X
GTPase O X
regulator O X
( O X
RPGR I-MISC 6103
). O X

The O X
amino O X
- O X
terminal O X
half O X
of O X
RPGR I-MISC 6103
is O X
homologous O X
to O X
regulator O X
of O X
chromosome O X
condensation O X
( O X
RCC1 I-MISC 1104
), O X
the O X
nucleotide O X
exchange O X
factor O X
for O X
the O X
small O X
GTP O X
- O X
binding O X
protein O X
Ran I-MISC 5901
. O X

In O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
we O X
identified O X
the O X
delta O X
subunit O X
of O X
rod O X
cyclic O X
GMP O X
phosphodiesterase O X
( O X
PDEdelta I-MISC 5147
) O X
as O X
interacting O X
with O X
the O X
RCC1 I-MISC 1104
- O X
like O X
domain O X
( O X
RLD O X
) O X
of O X
RPGR I-MISC 6103
( O X
RPGR392 I-MISC 6103
). O X

The O X
interaction O X
of O X
RPGR I-MISC 6103
with O X
PDEdelta I-MISC 5147
was O X
confirmed O X
by O X
pull O X
- O X
down O X
assays O X
and O X
plasmon O X
surface O X
resonance O X
. O X

The O X
binding O X
affinity O X
was O X
determined O X
to O X
be O X
90 O X
nM O X
. O X

Six O X
missense O X
mutations O X
at O X
evolutionary O X
conserved O X
residues O X
within O X
the O X
RLD O X
, O X
which O X
were O X
found O X
in O X
RP3 I-MISC 6103
patients O X
, O X
were O X
analyzed O X
by O X
using O X
the O X
two O X
- O X
hybrid O X
system O X
. O X

All O X
missense O X
mutations O X
showed O X
reduced O X
interaction O X
with O X
PDEdelta I-MISC 5147
. O X

A O X
non O X
- O X
RP3 I-MISC 6103
- O X
associated O X
missense O X
substitution O X
outside O X
the O X
RLD O X
, O X
V36F O X
, O X
did O X
not O X
abolish O X
the O X
interaction O X
with O X
PDEdelta I-MISC 5147
. O X

PDEdelta I-MISC 5147
is O X
widely O X
expressed O X
and O X
highly O X
conserved O X
across O X
evolution O X
and O X
is O X
proposed O X
to O X
regulate O X
the O X
membrane O X
insertion O X
or O X
solubilization O X
of O X
prenylated O X
proteins O X
, O X
including O X
the O X
catalytic O X
subunits O X
of O X
the O X
PDE O X
holoenzyme O X
involved O X
in O X
phototransduction O X
and O X
small O X
GTP O X
- O X
binding O X
proteins O X
of O X
the O X
Rab O X
family O X
. O X

These O X
results O X
suggest O X
that O X
RPGR I-MISC 6103
mutations O X
give O X
rise O X
to O X
retinal O X
degeneration O X
by O X
dysregulation O X
of O X
intracellular O X
processes O X
that O X
determine O X
protein O X
localization O X
and O X
protein O X
transport O X
. O X

###19322201	1994,7316

Ubiquitin I-MISC 7316
- O X
mediated O X
proteolysis O X
of O X
HuR I-MISC 1994
by O X
heat O X
shock O X
. O X

The O X
RNA O X
- O X
binding O X
protein O X
HuR I-MISC 1994
regulates O X
the O X
stability O X
and O X
translation O X
of O X
numerous O X
mRNAs O X
encoding O X
stress O X
- O X
response O X
and O X
proliferative O X
proteins O X
. O X

Although O X
its O X
post O X
- O X
transcriptional O X
influence O X
has O X
been O X
linked O X
primarily O X
to O X
its O X
cytoplasmic O X
translocation O X
, O X
here O X
we O X
report O X
that O X
moderate O X
heat O X
shock O X
( O X
HS O X
) O X
potently O X
reduces O X
HuR I-MISC 1994
levels O X
, O X
thereby O X
altering O X
the O X
expression O X
of O X
HuR I-MISC 1994
target O X
mRNAs O X
. O X

HS O X
did O X
not O X
change O X
HuR I-MISC 1994
mRNA O X
levels O X
or O X
de O X
novo O X
translation O X
, O X
but O X
instead O X
reduced O X
HuR I-MISC 1994
protein O X
stability O X
. O X

Supporting O X
the O X
involvement O X
of O X
the O X
ubiquitin I-MISC 7316
- O X
proteasome O X
system O X
in O X
this O X
process O X
were O X
results O X
showing O X
that O X
( O X
1 O X
) O X
HuR I-MISC 1994
was O X
ubiquitinated O X
in O X
vitro O X
and O X
in O X
intact O X
cells O X
, O X
( O X
2 O X
) O X
proteasome O X
inhibition O X
increased O X
HuR I-MISC 1994
abundance O X
after O X
HS O X
, O X
and O X
( O X
3 O X
) O X
the O X
HuR I-MISC 1994
kinase O X
checkpoint I-MISC 11200
kinase I-MISC 11200
2 I-MISC 11200
protected O X
against O X
the O X
loss O X
of O X
HuR I-MISC 1994
by O X
HS O X
. O X

Within O X
a O X
central O X
, O X
HS O X
- O X
labile O X
approximately O X
110 O X
- O X
amino O X
- O X
acid O X
region O X
, O X
K182 O X
was O X
found O X
to O X
be O X
essential O X
for O X
HuR I-MISC 1994
ubiquitination O X
and O X
proteolysis O X
as O X
mutant O X
HuR I-MISC 1994
( O X
K182R O X
) O X
was O X
left O X
virtually O X
unubiquitinated O X
and O X
was O X
refractory O X
to O X
HS O X
- O X
triggered O X
degradation O X
. O X

Our O X
findings O X
reveal O X
that O X
HS O X
transiently O X
lowers O X
HuR I-MISC 1994
by O X
proteolysis O X
linked O X
to O X
K182 O X
ubiquitination O X
and O X
that O X
HuR I-MISC 1994
reduction O X
enhances O X
cell O X
survival O X
following O X
HS O X
. O X

###22878415	10208,6612

Ubiquitin I-MISC 10208
- I-MISC 10208
specific I-MISC 10208
protease I-MISC 10208
- I-MISC 10208
like I-MISC 10208
1 I-MISC 10208
( O X
USPL1 I-MISC 10208
) O X
is O X
a O X
SUMO I-MISC 6612
isopeptidase O X
with O X
essential O X
, O X
non O X
- O X
catalytic O X
functions O X
. O X

Isopeptidases O X
are O X
essential O X
regulators O X
of O X
protein O X
ubiquitination O X
and O X
sumoylation O X
. O X

However O X
, O X
only O X
two O X
families O X
of O X
SUMO I-MISC 6612
isopeptidases O X
are O X
at O X
present O X
known O X
. O X

Here O X
, O X
we O X
report O X
an O X
activity O X
- O X
based O X
search O X
with O X
the O X
suicide O X
inhibitor O X
haemagglutinin O X
( O X
HA O X
)- O X
SUMO I-MISC 6612
- O X
vinylmethylester O X
that O X
led O X
to O X
the O X
identification O X
of O X
a O X
surprising O X
new O X
SUMO I-MISC 6612
protease O X
, O X
ubiquitin I-MISC 10208
- I-MISC 10208
specific I-MISC 10208
protease I-MISC 10208
- I-MISC 10208
like I-MISC 10208
1 I-MISC 10208
( O X
USPL1 I-MISC 10208
). O X

Indeed O X
, O X
USPL1 I-MISC 10208
neither O X
binds O X
nor O X
cleaves O X
ubiquitin O X
, O X
but O X
is O X
a O X
potent O X
SUMO I-MISC 6612
isopeptidase O X
both O X
in O X
vitro O X
and O X
in O X
cells O X
. O X

C13orf22l O X
-- O X
an O X
essential O X
but O X
distant O X
zebrafish O X
homologue O X
of O X
USPL1 I-MISC 10208
-- O X
also O X
acts O X
on O X
SUMO I-MISC 6612
, O X
indicating O X
functional O X
conservation O X
. O X

We O X
have O X
identified O X
invariant O X
USPL1 I-MISC 10208
residues O X
required O X
for O X
SUMO I-MISC 6612
binding O X
and O X
cleavage O X
. O X

USPL1 I-MISC 10208
is O X
a O X
low O X
- O X
abundance O X
protein O X
that O X
colocalizes O X
with O X
coilin O X
in O X
Cajal O X
bodies O X
. O X

Its O X
depletion O X
does O X
not O X
affect O X
global O X
sumoylation O X
, O X
but O X
causes O X
striking O X
coilin O X
mislocalization O X
and O X
impairs O X
cell O X
proliferation O X
, O X
functions O X
that O X
are O X
not O X
dependent O X
on O X
USPL1 I-MISC 10208
catalytic O X
activity O X
. O X

Thus O X
, O X
USPL1 I-MISC 10208
represents O X
a O X
third O X
type O X
of O X
SUMO I-MISC 6612
protease O X
, O X
with O X
essential O X
functions O X
in O X
Cajal O X
body O X
biology O X
. O X

###22555612	639,15182

SUMOylation O X
of O X
Blimp I-MISC 639
- I-MISC 639
1 I-MISC 639
is O X
critical O X
for O X
plasma O X
cell O X
differentiation O X
. O X

Transcriptional O X
repressor O X
B I-MISC 639
lymphocyte I-MISC 639
- I-MISC 639
induced I-MISC 639
maturation I-MISC 639
protein I-MISC 639
- I-MISC 639
1 I-MISC 639
( O X
Blimp I-MISC 639
- I-MISC 639
1 I-MISC 639
) O X
is O X
a O X
master O X
regulator O X
of O X
plasma O X
cell O X
differentiation O X
. O X

Here O X
we O X
show O X
that O X
Blimp I-MISC 639
- I-MISC 639
1 I-MISC 639
is O X
covalently O X
modified O X
by O X
SUMO1 I-MISC 7341
at O X
lysine O X
816 O X
, O X
a O X
modification O X
mediated O X
by O X
SUMO O X
E3 O X
ligase O X
PIAS1 I-MISC 8554
. O X

Mutation O X
of O X
Blimp I-MISC 639
- I-MISC 639
1 I-MISC 639
lysine O X
816 O X
reduces O X
transcriptional O X
repression O X
-- O X
correlating O X
with O X
a O X
reduced O X
interaction O X
with O X
a O X
histone O X
deacetylase O X
, O X
HDAC2 I-MISC 15182
-- O X
and O X
impairs O X
differentiation O X
of O X
antibody O X
- O X
secreting O X
cells O X
. O X

Thus O X
, O X
the O X
SUMO O X
pathway O X
critically O X
regulates O X
Blimp I-MISC 639
- I-MISC 639
1 I-MISC 639
function O X
during O X
plasma O X
cell O X
differentiation O X
. O X

###17446860	856021,851641

Dual O X
mechanisms O X
specify O X
Doa4 I-MISC 851641
- O X
mediated O X
deubiquitination O X
at O X
multivesicular O X
bodies O X
. O X

Doa4 I-MISC 851641
is O X
a O X
ubiquitin O X
- O X
specific O X
protease O X
in O X
Saccharomyces O X
cerevisiae O X
that O X
deubiquitinates O X
integral O X
membrane O X
proteins O X
sorted O X
into O X
the O X
lumenal O X
vesicles O X
of O X
late O X
- O X
endosomal O X
multivesicular O X
bodies O X
( O X
MVBs O X
). O X

We O X
show O X
that O X
the O X
non O X
- O X
catalytic O X
N O X
terminus O X
of O X
Doa4 I-MISC 851641
mediates O X
its O X
recruitment O X
to O X
endosomes O X
through O X
its O X
association O X
with O X
Bro1 I-MISC 856021
, O X
which O X
is O X
one O X
of O X
several O X
highly O X
conserved O X
class O X
E O X
Vps O X
proteins O X
that O X
comprise O X
the O X
core O X
MVB O X
sorting O X
machinery O X
. O X

In O X
turn O X
, O X
Bro1 I-MISC 856021
directly O X
stimulates O X
deubiquitination O X
by O X
interacting O X
with O X
a O X
YPxL O X
motif O X
in O X
the O X
catalytic O X
domain O X
of O X
Doa4 I-MISC 851641
. O X

Mutations O X
in O X
either O X
Doa4 I-MISC 851641
or O X
Bro1 I-MISC 856021
that O X
disrupt O X
catalytic O X
activation O X
of O X
Doa4 I-MISC 851641
impair O X
deubiquitination O X
and O X
sorting O X
of O X
MVB O X
cargo O X
proteins O X
and O X
lead O X
to O X
the O X
formation O X
of O X
lumenal O X
MVB O X
vesicles O X
that O X
are O X
predominantly O X
small O X
compared O X
with O X
the O X
vesicles O X
seen O X
in O X
wild O X
- O X
type O X
cells O X
. O X

Thus O X
, O X
by O X
recruiting O X
Doa4 I-MISC 851641
to O X
late O X
endosomes O X
and O X
stimulating O X
its O X
catalytic O X
activity O X
, O X
Bro1 I-MISC 856021
fulfills O X
a O X
novel O X
dual O X
role O X
in O X
coordinating O X
deubiquitination O X
in O X
the O X
MVB O X
pathway O X
. O X

###17054981	10392,8767

Solution O X
structure O X
of O X
NOD1 I-MISC 10392
CARD O X
and O X
mutational O X
analysis O X
of O X
its O X
interaction O X
with O X
the O X
CARD O X
of O X
downstream O X
kinase O X
RICK I-MISC 8767
. O X

NOD1 I-MISC 10392
is O X
a O X
cytosolic O X
signalling O X
host O X
pattern O X
- O X
recognition O X
receptor O X
composed O X
of O X
a O X
caspase O X
- O X
activating O X
and O X
recruitment O X
domain O X
( O X
CARD O X
), O X
a O X
nucleotide O X
- O X
binding O X
and O X
oligomerization O X
domain O X
( O X
NOD O X
) O X
and O X
leucine O X
- O X
rich O X
repeats O X
. O X

It O X
plays O X
a O X
crucial O X
role O X
in O X
innate O X
immunity O X
by O X
activating O X
the O X
NF O X
- O X
kappaB O X
pathway O X
via O X
its O X
downstream O X
effector O X
the O X
kinase O X
RICK I-MISC 8767
( O X
RIP2 I-MISC 8767
) O X
following O X
the O X
recognition O X
of O X
a O X
specific O X
bacterial O X
ligand O X
. O X

RICK I-MISC 8767
is O X
recruited O X
by O X
NOD1 I-MISC 10392
through O X
interaction O X
of O X
their O X
respective O X
CARDs O X
. O X

Here O X
we O X
present O X
the O X
high O X
resolution O X
NMR O X
structure O X
of O X
the O X
NOD1 I-MISC 10392
CARD O X
. O X

It O X
is O X
generally O X
similar O X
to O X
other O X
CARDs O X
of O X
known O X
structure O X
, O X
consisting O X
of O X
six O X
tightly O X
packed O X
helices O X
, O X
although O X
the O X
length O X
and O X
orientation O X
of O X
the O X
last O X
helix O X
is O X
unusual O X
. O X

Mutations O X
in O X
both O X
the O X
NOD1 I-MISC 10392
and O X
RICK I-MISC 8767
CARD O X
domains O X
were O X
assayed O X
by O X
immuno O X
- O X
precipitation O X
of O X
cell O X
lysates O X
and O X
in O X
vivo O X
NF O X
- O X
kappaB O X
activation O X
in O X
order O X
to O X
define O X
residues O X
important O X
for O X
CARD O X
- O X
CARD O X
interaction O X
and O X
downstream O X
signalling O X
. O X

The O X
results O X
show O X
that O X
the O X
interaction O X
is O X
critically O X
dependent O X
on O X
three O X
acidic O X
residues O X
on O X
NOD1 I-MISC 10392
CARD O X
and O X
three O X
basic O X
residues O X
on O X
RICK I-MISC 8767
CARD O X
and O X
thus O X
is O X
likely O X
to O X
have O X
a O X
strong O X
electrostatic O X
component O X
, O X
similar O X
to O X
other O X
characterised O X
CARD O X
- O X
CARD O X
interactions O X
. O X

###10488108	836616,817857

The O X
RING O X
finger O X
motif O X
of O X
photomorphogenic O X
repressor O X
COP1 I-MISC 817857
specifically O X
interacts O X
with O X
the O X
RING O X
- O X
H2 O X
motif O X
of O X
a O X
novel O X
Arabidopsis O X
protein O X
. O X

The O X
constitutive I-MISC 817857
photomorphogenic I-MISC 817857
1 I-MISC 817857
( O X
COP1 I-MISC 817857
) O X
protein O X
of O X
Arabidopsis O X
functions O X
as O X
a O X
molecular O X
switch O X
for O X
the O X
seedling O X
developmental O X
fates O X
: O X
photomorphogenesis O X
under O X
light O X
conditions O X
and O X
skotomorphogenesis O X
in O X
darkness O X
. O X

The O X
COP1 I-MISC 817857
protein O X
contains O X
a O X
cysteine O X
- O X
rich O X
zinc O X
- O X
binding O X
RING O X
finger O X
motif O X
found O X
in O X
diverse O X
groups O X
of O X
regulatory O X
proteins O X
. O X

To O X
understand O X
the O X
role O X
of O X
the O X
COP1 I-MISC 817857
RING O X
finger O X
in O X
mediating O X
protein O X
- O X
protein O X
interaction O X
, O X
we O X
have O X
performed O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
and O X
isolated O X
a O X
novel O X
protein O X
with O X
a O X
RING O X
- O X
H2 O X
motif O X
, O X
a O X
variant O X
type O X
of O X
the O X
RING O X
finger O X
. O X

This O X
protein O X
, O X
designated O X
COP1 I-MISC 836616
Interacting I-MISC 836616
Protein I-MISC 836616
8 I-MISC 836616
( O X
CIP8 I-MISC 836616
), O X
is O X
encoded O X
by O X
a O X
single O X
copy O X
gene O X
and O X
localized O X
to O X
cytosol O X
in O X
a O X
transient O X
assay O X
. O X

In O X
addition O X
to O X
the O X
RING O X
- O X
H2 O X
motif O X
, O X
the O X
predicted O X
protein O X
has O X
a O X
C4 O X
zinc O X
finger O X
, O X
an O X
acidic O X
region O X
, O X
a O X
glycine O X
- O X
rich O X
cluster O X
, O X
and O X
a O X
serine O X
- O X
rich O X
cluster O X
. O X

The O X
COP1 I-MISC 817857
RING O X
finger O X
and O X
the O X
CIP8 I-MISC 836616
RING O X
- O X
H2 O X
domains O X
are O X
sufficient O X
for O X
their O X
interaction O X
with O X
each O X
other O X
both O X
in O X
vitro O X
and O X
in O X
yeast O X
, O X
whereas O X
neither O X
motif O X
displayed O X
significant O X
self O X
- O X
association O X
. O X

Moreover O X
, O X
site O X
- O X
directed O X
mutagenesis O X
studies O X
demonstrated O X
that O X
the O X
expected O X
zinc O X
- O X
binding O X
ligands O X
of O X
the O X
RING O X
finger O X
and O X
RING O X
- O X
H2 O X
fingers O X
are O X
essential O X
for O X
their O X
interaction O X
. O X

Our O X
findings O X
indicate O X
that O X
the O X
RING O X
finger O X
motif O X
, O X
in O X
this O X
case O X
, O X
serves O X
as O X
autonomous O X
protein O X
- O X
protein O X
interaction O X
domain O X
. O X

The O X
allele O X
specific O X
effect O X
of O X
cop1 I-MISC 817857
mutations O X
on O X
the O X
CIP8 I-MISC 836616
protein O X
accumulation O X
in O X
seedlings O X
indicates O X
that O X
its O X
stability O X
in O X
vivo O X
is O X
dependent O X
on O X
the O X
COP1 I-MISC 817857
protein O X
. O X

###26278368	1045103,1045103

An O X
additional O X
cysteine O X
in O X
a O X
typical O X
2 O X
- O X
Cys O X
peroxiredoxin I-MISC 1045103
of O X
Pseudomonas O X
promotes O X
functional O X
switching O X
between O X
peroxidase O X
and O X
molecular O X
chaperone O X
. O X

UNASSIGNED O X
: O X
Peroxiredoxins I-MISC 1045103
( O X
Prx I-MISC 1045103
) O X
have O X
received O X
considerable O X
attention O X
during O X
recent O X
years O X
. O X

This O X
study O X
demonstrates O X
that O X
two O X
typical O X
Pseudomonas O X
- O X
derived O X
2 O X
- O X
Cys O X
Prx I-MISC 1045103
proteins O X
, O X
PpPrx O X
and O X
PaPrx O X
can O X
alternatively O X
function O X
as O X
a O X
peroxidase O X
and O X
chaperone O X
. O X

The O X
amino O X
acid O X
sequences O X
of O X
these O X
two O X
Prx I-MISC 1045103
proteins O X
exhibit O X
93 O X
% O X
homology O X
, O X
but O X
PpPrx O X
possesses O X
an O X
additional O X
cysteine O X
residue O X
, O X
Cys112 O X
, O X
instead O X
of O X
the O X
alanine O X
found O X
in O X
PaPrx O X
. O X

PpPrx O X
predominates O X
with O X
a O X
high O X
molecular O X
weight O X
( O X
HMW O X
) O X
complex O X
and O X
chaperone O X
activity O X
, O X
whereas O X
PaPrx O X
has O X
mainly O X
low O X
molecular O X
weight O X
( O X
LMW O X
) O X
structures O X
and O X
peroxidase O X
activity O X
. O X

Mass O X
spectrometry O X
and O X
structural O X
analyses O X
showed O X
the O X
involvement O X
of O X
Cys112 O X
in O X
the O X
formation O X
of O X
an O X
inter O X
- O X
disulfide O X
bond O X
, O X
the O X
instability O X
of O X
LMW O X
structures O X
, O X
the O X
formation O X
of O X
HMW O X
complexes O X
, O X
and O X
increased O X
hydrophobicity O X
leading O X
to O X
functional O X
switching O X
of O X
Prx I-MISC 1045103
proteins O X
between O X
peroxidase O X
and O X
chaperone O X
. O X

###9520446	9020,1147

NF I-MISC 9020
- I-MISC 9020
kappaB I-MISC 9020
- I-MISC 9020
inducing I-MISC 9020
kinase I-MISC 9020
activates O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
by O X
phosphorylation O X
of O X
Ser O X
- O X
176 O X
. O X

Activation O X
of O X
the O X
transcription O X
factor O X
NF O X
- O X
kappaB O X
by O X
inflammatory O X
cytokines O X
involves O X
the O X
successive O X
action O X
of O X
NF I-MISC 9020
- I-MISC 9020
kappaB I-MISC 9020
- I-MISC 9020
inducing I-MISC 9020
kinase I-MISC 9020
( O X
NIK I-MISC 9020
) O X
and O X
two O X
IkappaB O X
kinases O X
, O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
and O X
IKK I-MISC 3551
- I-MISC 3551
beta I-MISC 3551
. O X

Here O X
we O X
show O X
that O X
NIK I-MISC 9020
preferentially O X
phosphorylates O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
over O X
IKK I-MISC 3551
- I-MISC 3551
beta I-MISC 3551
, O X
leading O X
to O X
the O X
activation O X
of O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
kinase O X
activity O X
. O X

This O X
phosphorylation O X
of O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
occurs O X
specifically O X
on O X
Ser O X
- O X
176 O X
in O X
the O X
activation O X
loop O X
between O X
kinase O X
subdomains O X
VII O X
and O X
VIII I-MISC 1351
. O X

A O X
mutant O X
form O X
of O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
containing O X
alanine O X
at O X
residue O X
176 O X
cannot O X
be O X
phosphorylated O X
or O X
activated O X
by O X
NIK I-MISC 9020
and O X
acts O X
as O X
a O X
dominant O X
negative O X
inhibitor O X
of O X
interleukin O X
1 O X
- O X
and O X
tumor O X
necrosis O X
factor O X
- O X
induced O X
NF O X
- O X
kappaB O X
activation O X
. O X

Conversely O X
, O X
a O X
mutant O X
form O X
of O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
containing O X
glutamic O X
acid O X
at O X
residue O X
176 O X
is O X
constitutively O X
active O X
. O X

Thus O X
, O X
the O X
phosphorylation O X
of O X
IKK I-MISC 1147
- I-MISC 1147
alpha I-MISC 1147
on O X
Ser O X
- O X
176 O X
by O X
NIK I-MISC 9020
may O X
be O X
required O X
for O X
cytokine O X
- O X
mediated O X
NF O X
- O X
kappaB O X
activation O X
. O X

###24464040	120892,24679

LRRK2 I-MISC 120892
regulates O X
synaptogenesis O X
and O X
dopamine O X
receptor O X
activation O X
through O X
modulation O X
of O X
PKA O X
activity O X
. O X

Leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
is O X
enriched O X
in O X
the O X
striatal O X
projection O X
neurons O X
( O X
SPNs O X
). O X

We O X
found O X
that O X
LRRK2 I-MISC 120892
negatively O X
regulates O X
protein O X
kinase O X
A O X
( O X
PKA O X
) O X
activity O X
in O X
the O X
SPNs O X
during O X
synaptogenesis O X
and O X
in O X
response O X
to O X
dopamine O X
receptor O X
Drd1 I-MISC 13488
activation O X
. O X

LRRK2 I-MISC 120892
interacted O X
with O X
PKA I-MISC 24679
regulatory I-MISC 24679
subunit I-MISC 24679
IIb I-MISC 24679
( O X
PKARIIb I-MISC 24679
). O X

A O X
lack O X
of O X
LRRK2 I-MISC 120892
promoted O X
the O X
synaptic O X
translocation O X
of O X
PKA O X
and O X
increased O X
PKA O X
- O X
mediated O X
phosphorylation O X
of O X
actin O X
- O X
disassembling O X
enzyme O X
cofilin O X
and O X
glutamate O X
receptor O X
GluR1 I-MISC 14799
, O X
resulting O X
in O X
abnormal O X
synaptogenesis O X
and O X
transmission O X
in O X
the O X
developing O X
SPNs O X
. O X

Furthermore O X
, O X
PKA O X
- O X
dependent O X
phosphorylation O X
of O X
GluR1 I-MISC 14799
was O X
also O X
aberrantly O X
enhanced O X
in O X
the O X
striatum O X
of O X
young O X
and O X
aged O X
Lrrk2 I-MISC 120892
(-/-) O X
mice O X
after O X
treatment O X
with O X
a O X
Drd1 I-MISC 13488
agonist O X
. O X

Notably O X
, O X
a O X
Parkinson O X
' O X
s O X
disease O X
- O X
related O X
Lrrk2 I-MISC 120892
R1441C O X
missense O X
mutation O X
that O X
impaired O X
the O X
interaction O X
of O X
LRRK2 I-MISC 120892
with O X
PKARIIb I-MISC 24679
also O X
induced O X
excessive O X
PKA O X
activity O X
in O X
the O X
SPNs O X
. O X

Our O X
findings O X
reveal O X
a O X
previously O X
unknown O X
regulatory O X
role O X
for O X
LRRK2 I-MISC 120892
in O X
PKA O X
signaling O X
and O X
suggest O X
a O X
pathogenic O X
mechanism O X
of O X
SPN O X
dysfunction O X
in O X
Parkinson O X
' O X
s O X
disease O X
. O X

###18335997	4756,148738

Neogenin I-MISC 4756
interacts O X
with O X
hemojuvelin I-MISC 148738
through O X
its O X
two O X
membrane O X
- O X
proximal O X
fibronectin O X
type O X
III O X
domains O X
. O X

Hemojuvelin I-MISC 148738
is O X
a O X
recently O X
identified O X
iron O X
- O X
regulatory O X
protein O X
that O X
plays O X
an O X
important O X
role O X
in O X
affecting O X
the O X
expression O X
of O X
hepcidin I-MISC 57817
, O X
a O X
key O X
iron O X
regulatory O X
hormone O X
. O X

Although O X
the O X
underlying O X
mechanism O X
of O X
this O X
process O X
is O X
not O X
clear O X
, O X
several O X
hemojuvelin I-MISC 148738
- O X
binding O X
proteins O X
, O X
including O X
the O X
cell O X
surface O X
receptor O X
neogenin I-MISC 4756
and O X
bone I-MISC 649
morphogenetic I-MISC 649
protein I-MISC 649
( O X
BMP I-MISC 649
) O X
cytokines O X
, O X
have O X
been O X
identified O X
. O X

The O X
ectodomain O X
of O X
neogenin I-MISC 4756
is O X
composed O X
of O X
four O X
immunoglobulin O X
- O X
like O X
( O X
Ig O X
) O X
domains O X
followed O X
by O X
six O X
fibronectin O X
type O X
III O X
- O X
like O X
( O X
FNIII O X
) O X
domains O X
. O X

Here O X
we O X
report O X
expression O X
of O X
soluble O X
versions O X
of O X
hemojuvelin I-MISC 148738
and O X
neogenin I-MISC 4756
for O X
biochemical O X
characterization O X
of O X
their O X
interaction O X
and O X
the O X
interaction O X
of O X
HJV I-MISC 148738
with O X
BMP I-MISC 650
- I-MISC 650
2 I-MISC 650
. O X

Hemojuvelin I-MISC 148738
normally O X
undergoes O X
an O X
autocatalytic O X
cleavage O X
, O X
and O X
as O X
in O X
vivo O X
, O X
recombinant O X
hemojuvelin I-MISC 148738
exists O X
as O X
a O X
mixture O X
of O X
cleaved O X
and O X
uncleaved O X
forms O X
. O X

Neogenin I-MISC 4756
binds O X
to O X
cleaved O X
and O X
noncleaved O X
hemojuvelin I-MISC 148738
, O X
as O X
verified O X
by O X
its O X
binding O X
to O X
an O X
uncleaved O X
mutant O X
hemojuvelin I-MISC 148738
. O X

We O X
localized O X
the O X
hemojuvelin I-MISC 148738
binding O X
site O X
on O X
neogenin I-MISC 4756
to O X
the O X
membrane O X
- O X
proximal O X
fifth O X
and O X
sixth O X
FNIII O X
domains O X
and O X
the O X
juxtamembrane O X
linker O X
and O X
showed O X
that O X
a O X
fragment O X
containing O X
only O X
this O X
region O X
binds O X
2 O X
- O X
3 O X
orders O X
of O X
magnitude O X
more O X
tightly O X
than O X
the O X
entire O X
neogenin I-MISC 4756
ectodomain O X
. O X

Binding O X
to O X
the O X
most O X
membrane O X
- O X
proximal O X
region O X
of O X
neogenin I-MISC 4756
may O X
play O X
a O X
role O X
in O X
regulating O X
the O X
levels O X
of O X
soluble O X
and O X
membrane O X
- O X
bound O X
forms O X
of O X
hemojuvelin I-MISC 148738
, O X
which O X
in O X
turn O X
would O X
influence O X
the O X
amount O X
of O X
free O X
BMP I-MISC 650
- I-MISC 650
2 I-MISC 650
available O X
for O X
binding O X
to O X
its O X
receptors O X
and O X
triggering O X
transcription O X
of O X
the O X
hepcidin I-MISC 57817
gene O X
. O X

Our O X
finding O X
that O X
BMP I-MISC 650
- I-MISC 650
2 I-MISC 650
and O X
neogenin I-MISC 4756
bind O X
simultaneously O X
to O X
hemojuvelin I-MISC 148738
raises O X
the O X
possibility O X
that O X
neogenin I-MISC 4756
is O X
part O X
of O X
a O X
multiprotein O X
complex O X
at O X
the O X
hepatocyte O X
membrane O X
involving O X
BMP I-MISC 649
, O X
its O X
receptors O X
, O X
and O X
hemojuvelin I-MISC 148738
. O X

###16717130	28964,395832	28964,5058

Paxillin O X
phosphorylation O X
at O X
Ser273 O X
localizes O X
a O X
GIT1 I-MISC 28964
- O X
PIX I-MISC 395832
- O X
PAK I-MISC 5058
complex O X
and O X
regulates O X
adhesion O X
and O X
protrusion O X
dynamics O X
. O X

Continuous O X
adhesion O X
formation O X
and O X
disassembly O X
( O X
adhesion O X
turnover O X
) O X
in O X
the O X
protrusions O X
of O X
migrating O X
cells O X
is O X
regulated O X
by O X
unclear O X
mechanisms O X
. O X

We O X
show O X
that O X
p21 O X
- O X
activated O X
kinase O X
( O X
PAK I-MISC 5058
)- O X
induced O X
phosphorylation O X
of O X
serine O X
273 O X
in O X
paxillin O X
is O X
a O X
critical O X
regulator O X
of O X
this O X
turnover O X
. O X

Paxillin O X
- O X
S273 O X
phosphorylation O X
dramatically O X
increases O X
migration O X
, O X
protrusion O X
, O X
and O X
adhesion O X
turnover O X
by O X
increasing O X
paxillin O X
- O X
GIT1 I-MISC 28964
binding O X
and O X
promoting O X
the O X
localization O X
of O X
a O X
GIT1 I-MISC 28964
- O X
PIX I-MISC 395832
- O X
PAK I-MISC 5058
signaling O X
module O X
near O X
the O X
leading O X
edge O X
. O X

Mutants O X
that O X
interfere O X
with O X
the O X
formation O X
of O X
this O X
ternary O X
module O X
abrogate O X
the O X
effects O X
of O X
paxillin O X
- O X
S273 O X
phosphorylation O X
. O X

PAK I-MISC 5058
- O X
dependent O X
paxillin O X
- O X
S273 O X
phosphorylation O X
functions O X
in O X
a O X
positive O X
- O X
feedback O X
loop O X
, O X
as O X
active O X
PAK I-MISC 5058
, O X
active O X
Rac O X
, O X
and O X
myosin O X
II O X
activity O X
are O X
all O X
downstream O X
effectors O X
of O X
this O X
turnover O X
pathway O X
. O X

Finally O X
, O X
our O X
studies O X
led O X
us O X
to O X
identify O X
in O X
highly O X
motile O X
cells O X
a O X
class O X
of O X
small O X
adhesions O X
that O X
reside O X
near O X
the O X
leading O X
edge O X
, O X
turnover O X
in O X
20 O X
- O X
30 O X
s O X
, O X
and O X
resemble O X
those O X
seen O X
with O X
paxillin O X
- O X
S273 O X
phosphorylation O X
. O X

These O X
adhesions O X
appear O X
to O X
be O X
regulated O X
by O X
the O X
GIT1 I-MISC 28964
- O X
PIX I-MISC 395832
- O X
PAK I-MISC 5058
module O X
near O X
the O X
leading O X
edge O X
. O X

###10835346	8818,54344	8813,54344

Human O X
dolichol O X
- O X
phosphate O X
- O X
mannose O X
synthase O X
consists O X
of O X
three O X
subunits O X
, O X
DPM1 I-MISC 8813
, O X
DPM2 I-MISC 8818
and O X
DPM3 I-MISC 54344
. O X

Dolichol O X
- O X
phosphate O X
- O X
mannose O X
( O X
DPM O X
) O X
synthase O X
generates O X
mannosyl O X
donors O X
for O X
glycosylphosphatidylinositols O X
, O X
N O X
- O X
glycan O X
and O X
protein O X
O O X
- O X
and O X
C O X
- O X
mannosylation O X
. O X

In O X
Saccharomyces O X
cerevisiae O X
, O X
this O X
enzyme O X
is O X
encoded O X
by O X
DPM1 I-MISC 856313
. O X

We O X
reported O X
previously O X
that O X
mammalian O X
DPM O X
synthase O X
contains O X
catalytic O X
DPM1 I-MISC 8813
and O X
regulatory O X
DPM2 I-MISC 8818
subunits O X
, O X
and O X
that O X
DPM1 I-MISC 8813
requires O X
DPM2 I-MISC 8818
for O X
its O X
stable O X
expression O X
in O X
the O X
endoplasmic O X
reticulum O X
. O X

Here O X
we O X
report O X
that O X
human O X
DPM O X
synthase O X
consists O X
of O X
three O X
subunits O X
. O X

The O X
third O X
subunit O X
, O X
DPM3 I-MISC 54344
, O X
comprises O X
92 O X
amino O X
acids O X
associated O X
with O X
DPM1 I-MISC 8813
via O X
its O X
C O X
- O X
terminal O X
domain O X
and O X
with O X
DPM2 I-MISC 8818
via O X
its O X
N O X
- O X
terminal O X
portion O X
. O X

The O X
stability O X
of O X
DPM3 I-MISC 54344
was O X
dependent O X
upon O X
DPM2 I-MISC 8818
. O X

However O X
, O X
overexpression O X
of O X
DPM3 I-MISC 54344
in O X
Lec15 O X
cells O X
, O X
a O X
null O X
mutant O X
of O X
DPM2 I-MISC 8818
, O X
restored O X
the O X
biosynthesis O X
of O X
DPM O X
with O X
an O X
increase O X
in O X
DPM1 I-MISC 8813
, O X
indicating O X
that O X
DPM3 I-MISC 54344
directly O X
stabilized O X
DPM1 I-MISC 8813
. O X

Therefore O X
, O X
DPM2 I-MISC 8818
stabilizes O X
DPM3 I-MISC 54344
and O X
DPM3 I-MISC 54344
stabilizes O X
DPM1 I-MISC 8813
. O X

DPM O X
synthase O X
activity O X
was O X
10 O X
times O X
higher O X
in O X
the O X
presence O X
of O X
DPM2 I-MISC 8818
, O X
indicating O X
that O X
DPM2 I-MISC 8818
also O X
plays O X
a O X
role O X
in O X
the O X
enzymatic O X
reaction O X
. O X

Schizosaccharomyces O X
pombe O X
has O X
proteins O X
that O X
resemble O X
three O X
human O X
subunits O X
; O X
S O X
. O X
pombe O X
DPM3 I-MISC 54344
restored O X
biosynthesis O X
of O X
DPM O X
in O X
Lec15 O X
cells O X
, O X
indicating O X
its O X
orthologous O X
relationship O X
to O X
human O X
DPM3 I-MISC 54344
. O X

###12692227	1050,1489080

The O X
Papillomavirus O X
E2 I-MISC 7320
protein I-MISC 7320
binds O X
to O X
and O X
synergizes O X
with O X
C O X
/ O X
EBP O X
factors O X
involved O X
in O X
keratinocyte O X
differentiation O X
. O X

The O X
papillomavirus O X
life O X
cycle O X
is O X
closely O X
linked O X
to O X
the O X
differentiation O X
program O X
of O X
the O X
host O X
keratinocyte O X
. O X

Thus O X
, O X
late O X
gene O X
expression O X
and O X
viral O X
maturation O X
are O X
restricted O X
to O X
terminally O X
differentiated O X
keratinocytes O X
. O X

A O X
variety O X
of O X
cellular O X
transcription O X
factors O X
including O X
those O X
of O X
the O X
C O X
/ O X
EBP O X
family O X
are O X
involved O X
in O X
the O X
regulation O X
of O X
keratinocyte O X
differentiation O X
. O X

In O X
this O X
study O X
we O X
show O X
that O X
the O X
papillomavirus O X
transcription O X
factor O X
E2 O X
cooperates O X
with O X
C I-MISC 1050
/ I-MISC 1050
EBPalpha I-MISC 1050
and I-MISC 1050
- I-MISC 1050
beta I-MISC 1050
in O X
transcriptional O X
activation O X
. O X

This O X
synergism O X
was O X
independent O X
of O X
an O X
E2 O X
binding O X
site O X
. O X

E2 I-MISC 1489080
and I-MISC 106478911
C I-MISC 106478911
/ O X
EBP O X
factors O X
synergistically O X
transactivated O X
a O X
synthetic O X
promoter O X
construct O X
containing O X
classical O X
C I-MISC 1051
/ I-MISC 1051
EBPbeta I-MISC 1051
sites O X
and O X
the O X
C I-MISC 1050
/ I-MISC 1050
EBPalpha I-MISC 1050
- O X
responsive O X
proximal O X
promoter O X
of O X
the O X
involucrin I-MISC 3713
gene O X
, O X
which O X
is O X
naturally O X
expressed O X
in O X
differentiating O X
keratinocytes O X
. O X

C I-MISC 1050
/ I-MISC 1050
EBPalpha I-MISC 1050
or O X
- O X
beta O X
coprecipitated O X
with O X
E2 O X
proteins O X
derived O X
from O X
human O X
papillomavirus O X
type O X
8 O X
( O X
HPV8 O X
), O X
HPV16 O X
, O X
HPV18 O X
, O X
and O X
bovine O X
papillomavirus O X
type O X
1 O X
in O X
vitro O X
and O X
in O X
vivo O X
, O X
indicating O X
complex O X
formation O X
by O X
the O X
cellular O X
and O X
viral O X
factors O X
. O X

The O X
interaction O X
domains O X
could O X
be O X
mapped O X
to O X
the O X
C O X
terminus O X
of O X
E2 O X
and O X
amino O X
acids O X
261 O X
to O X
302 O X
located O X
within O X
the O X
bZIP O X
motif O X
of O X
C I-MISC 1051
/ I-MISC 1051
EBPbeta I-MISC 1051
. O X

Our O X
data O X
suggest O X
that O X
E2 O X
, O X
via O X
its O X
interaction O X
with O X
C O X
/ O X
EBP O X
factors O X
, O X
may O X
contribute O X
to O X
enhancing O X
keratinocyte O X
differentiation O X
, O X
which O X
is O X
suppressed O X
by O X
the O X
viral O X
oncoproteins O X
E6 O X
and O X
E7 O X
in O X
HPV O X
- O X
induced O X
lesions O X
. O X

###11231056	83431,18472

NudE I-MISC 81565
- I-MISC 81565
L I-MISC 81565
, O X
a O X
novel O X
Lis1 I-MISC 5048
- O X
interacting O X
protein O X
, O X
belongs O X
to O X
a O X
family O X
of O X
vertebrate O X
coiled O X
- O X
coil O X
proteins O X
. O X

The O X
LIS1 I-MISC 5048
- O X
encoded O X
protein O X
( O X
Lis1 I-MISC 5048
) O X
plays O X
a O X
role O X
in O X
brain O X
development O X
because O X
a O X
hemizygous O X
deletion O X
or O X
mutation O X
of O X
the O X
human O X
gene O X
causes O X
neuronal O X
migration O X
disorders O X
, O X
such O X
as O X
Miller O X
- O X
Dieker O X
syndrome O X
( O X
MDS O X
) O X
or O X
isolated O X
lissencephaly O X
sequence O X
( O X
ILS O X
). O X

Using O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
we O X
have O X
isolated O X
a O X
novel O X
protein O X
that O X
interacts O X
with O X
mouse O X
Lis1 I-MISC 18472
( O X
mLis1 I-MISC 18472
) O X
which O X
is O X
termed O X
mouse O X
NudE I-MISC 67203
- O X
like O X
protein O X
( O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
) O X
because O X
of O X
its O X
49 O X
% O X
amino O X
acid O X
conservation O X
with O X
NudE I-MISC 67203
, O X
a O X
protein O X
involved O X
in O X
nuclear O X
migration O X
in O X
Aspergillus O X
nidulans O X
. O X

GST O X
pull O X
- O X
down O X
assays O X
and O X
co O X
- O X
immunoprecipitation O X
of O X
fusion O X
proteins O X
expressed O X
in O X
mammalian O X
cells O X
confirmed O X
the O X
interaction O X
of O X
mLis1 I-MISC 18472
and O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
. O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
gives O X
rise O X
to O X
a O X
approximately O X
2 O X
. O X
3 O X
kb O X
mRNA O X
and O X
encodes O X
an O X
ORF O X
corresponding O X
to O X
approximately O X
38 O X
kDa O X
protein O X
. O X

The O X
overall O X
amino O X
acid O X
sequence O X
of O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
is O X
49 O X
- O X
95 O X
% O X
identical O X
to O X
proteins O X
found O X
in O X
a O X
variety O X
of O X
organisms O X
, O X
thus O X
establishing O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
as O X
a O X
new O X
member O X
of O X
a O X
protein O X
family O X
. O X

The O X
hallmark O X
of O X
this O X
family O X
is O X
an O X
N O X
- O X
terminal O X
region O X
predicted O X
to O X
form O X
a O X
coiled O X
- O X
coil O X
domain O X
. O X

We O X
show O X
that O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
and O X
mLis1 I-MISC 18472
are O X
coexpressed O X
in O X
the O X
postnatal O X
and O X
adult O X
cerebral O X
cortices O X
and O X
in O X
the O X
Purkinje O X
neurons O X
of O X
the O X
cerebellum O X
. O X

In O X
contrast O X
to O X
mLis1 I-MISC 18472
, O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
transcripts O X
are O X
absent O X
in O X
the O X
mitral O X
cell O X
layer O X
of O X
the O X
olfactory O X
bulb O X
and O X
in O X
the O X
inward O X
migrating O X
granular O X
neurons O X
of O X
the O X
developing O X
cerebellum O X
. O X

Mutant O X
mLis1 I-MISC 18472
proteins O X
modelling O X
mutations O X
found O X
in O X
human O X
lissencephaly O X
patients O X
fail O X
to O X
interact O X
with O X
mNudE I-MISC 83431
- I-MISC 83431
L I-MISC 83431
, O X
raising O X
the O X
possibility O X
that O X
phenotypic O X
changes O X
result O X
, O X
in O X
part O X
, O X
from O X
the O X
inability O X
of O X
mutant O X
Lis1 I-MISC 5048
proteins O X
to O X
interact O X
with O X
the O X
human O X
NudE I-MISC 81565
- I-MISC 81565
L I-MISC 81565
polypeptide O X
. O X

###22612223	11140,120892

The O X
G2385R O X
variant O X
of O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
associated O X
with O X
Parkinson O X
' O X
s O X
disease O X
is O X
a O X
partial O X
loss O X
- O X
of O X
- O X
function O X
mutation O X
. O X

Autosomal O X
- O X
dominant O X
missense O X
mutations O X
in O X
LRRK2 I-MISC 120892
( O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
) O X
are O X
a O X
common O X
genetic O X
cause O X
of O X
PD O X
( O X
Parkinson O X
' O X
s O X
disease O X
). O X

LRRK2 I-MISC 120892
is O X
a O X
multidomain O X
protein O X
with O X
kinase O X
and O X
GTPase O X
activities O X
. O X

Dominant O X
mutations O X
are O X
found O X
in O X
the O X
domains O X
that O X
have O X
these O X
two O X
enzyme O X
activities O X
, O X
including O X
the O X
common O X
G2019S O X
mutation O X
that O X
increases O X
kinase O X
activity O X
2 O X
- O X
3 O X
- O X
fold O X
. O X

However O X
, O X
there O X
is O X
also O X
a O X
genetic O X
variant O X
in O X
some O X
populations O X
, O X
G2385R O X
, O X
that O X
lies O X
in O X
a O X
C O X
- O X
terminal O X
WD40 O X
domain O X
of O X
LRRK2 I-MISC 120892
and O X
acts O X
as O X
a O X
risk O X
factor O X
for O X
PD O X
. O X

In O X
the O X
present O X
study O X
we O X
show O X
that O X
the O X
G2385R O X
mutation O X
causes O X
a O X
partial O X
loss O X
of O X
the O X
kinase O X
function O X
of O X
LRRK2 I-MISC 120892
and O X
deletion O X
of O X
the O X
C O X
- O X
terminus O X
completely O X
abolishes O X
kinase O X
activity O X
. O X

This O X
effect O X
is O X
strong O X
enough O X
to O X
overcome O X
the O X
kinase O X
- O X
activating O X
effects O X
of O X
the O X
G2019S O X
mutation O X
in O X
the O X
kinase O X
domain O X
. O X

Hsp90 I-MISC 11140
( O X
heat I-MISC 11140
- I-MISC 11140
shock I-MISC 11140
protein I-MISC 11140
of I-MISC 11140
90 I-MISC 11140
kDa I-MISC 11140
) O X
has O X
an O X
increased O X
affinity O X
for O X
the O X
G2385R O X
variant O X
compared O X
with O X
WT O X
( O X
wild O X
- O X
type O X
) O X
LRRK2 I-MISC 120892
, O X
and O X
inhibition O X
of O X
the O X
chaperone O X
binding O X
combined O X
with O X
proteasome O X
inhibition O X
leads O X
to O X
association O X
of O X
mutant O X
LRRK2 I-MISC 120892
with O X
high O X
molecular O X
mass O X
native O X
fractions O X
that O X
probably O X
represent O X
proteasome O X
degradation O X
pathways O X
. O X

The O X
loss O X
- O X
of O X
- O X
function O X
of O X
G2385R O X
correlates O X
with O X
several O X
cellular O X
phenotypes O X
that O X
have O X
been O X
proposed O X
to O X
be O X
kinase O X
- O X
dependent O X
. O X

These O X
results O X
suggest O X
that O X
the O X
C O X
- O X
terminus O X
of O X
LRRK2 I-MISC 120892
plays O X
an O X
important O X
role O X
in O X
maintaining O X
enzymatic O X
function O X
of O X
the O X
protein O X
and O X
that O X
G2385R O X
may O X
be O X
associated O X
with O X
PD O X
in O X
a O X
way O X
that O X
is O X
different O X
from O X
kinase O X
- O X
activating O X
mutations O X
. O X

These O X
results O X
may O X
be O X
important O X
in O X
understanding O X
the O X
differing O X
mechanism O X
( O X
s O X
) O X
by O X
which O X
mutations O X
in O X
LRRK2 I-MISC 120892
act O X
and O X
may O X
also O X
have O X
implications O X
for O X
therapeutic O X
strategies O X
for O X
PD O X
. O X

###11265755	2099,10499

Synergy O X
between O X
estrogen I-MISC 2099
receptor I-MISC 2099
alpha I-MISC 2099
activation O X
functions O X
AF1 I-MISC 3460
and O X
AF2 O X
mediated O X
by O X
transcription O X
intermediary O X
factor O X
TIF2 I-MISC 10499
. O X

The O X
activation O X
function O X
AF2 O X
in O X
the O X
ligand O X
- O X
binding O X
domain O X
of O X
estrogen O X
receptors O X
ER I-MISC 2099
alpha I-MISC 2099
and O X
ER I-MISC 2100
beta I-MISC 2100
signals O X
through O X
the O X
recruitment O X
of O X
nuclear O X
receptor O X
coactivators O X
. O X

Recent O X
evidence O X
indicates O X
that O X
coactivators O X
, O X
such O X
as O X
the O X
transcription O X
intermediary O X
factor O X
TIF2 I-MISC 10499
, O X
also O X
bind O X
to O X
and O X
transactivate O X
the O X
N O X
- O X
terminal O X
AF1 I-MISC 3460
function O X
of O X
the O X
two O X
ERs O X
. O X

We O X
have O X
generated O X
TIF2 I-MISC 10499
mutant O X
proteins O X
that O X
are O X
deficient O X
in O X
either O X
AF1 I-MISC 3460
or O X
AF2 O X
interaction O X
and O X
use O X
these O X
mutants O X
to O X
investigate O X
the O X
relative O X
contribution O X
of O X
both O X
AFs O X
to O X
TIF2 I-MISC 10499
recruitment O X
and O X
transactivation O X
. O X

We O X
observe O X
that O X
TIF2 I-MISC 10499
is O X
capable O X
of O X
interacting O X
simultaneously O X
with O X
both O X
the O X
isolated O X
N O X
- O X
and O X
C O X
- O X
terminus O X
of O X
ER I-MISC 2099
alpha I-MISC 2099
in O X
transfected O X
mammalian O X
cells O X
and O X
in O X
vitro O X
, O X
indicating O X
that O X
TIF2 I-MISC 10499
can O X
bridge O X
both O X
receptor O X
domains O X
. O X

The O X
concomitant O X
interaction O X
of O X
TIF2 I-MISC 10499
with O X
both O X
AFs O X
results O X
in O X
synergistic O X
activation O X
of O X
transcription O X
. O X

Thus O X
, O X
synergy O X
between O X
ER I-MISC 2099
alpha I-MISC 2099
AF1 B-MISC 3460
and O X
AF2 O X
is O X
a O X
result O X
of O X
the O X
cooperative O X
recruitment O X
of O X
TIF2 I-MISC 10499
and O X
/ O X
or O X
other O X
members O X
of O X
the O X
p160 I-MISC 10514
coactivator O X
family O X
. O X

###11278869	83853,10566	10566,54763

Identification O X
of O X
sperm O X
- O X
specific O X
proteins O X
that O X
interact O X
with O X
A O X
- O X
kinase O X
anchoring O X
proteins O X
in O X
a O X
manner O X
similar O X
to O X
the O X
type O X
II O X
regulatory O X
subunit O X
of O X
PKA O X
. O X

The O X
cAMP O X
- O X
dependent O X
protein O X
kinase O X
( O X
PKA O X
) O X
is O X
targeted O X
to O X
specific O X
subcellular O X
compartments O X
through O X
its O X
interaction O X
with O X
A O X
- O X
kinase O X
anchoring O X
proteins O X
( O X
AKAPs O X
). O X

AKAPs O X
contain O X
an O X
amphipathic O X
helix O X
domain O X
that O X
binds O X
to O X
the O X
type O X
II O X
regulatory O X
subunit O X
of O X
PKA O X
( O X
RII O X
). O X

Synthetic O X
peptides O X
containing O X
this O X
amphipathic O X
helix O X
domain O X
bind O X
to O X
RII O X
with O X
high O X
affinity O X
and O X
competitively O X
inhibit O X
the O X
binding O X
of O X
PKA O X
with O X
AKAPs O X
. O X

Addition O X
of O X
these O X
anchoring O X
inhibitor O X
peptides O X
to O X
spermatozoa O X
inhibits O X
motility O X
( O X
Vijayaraghavan O X
, O X
S O X
., O X
Goueli O X
, O X
S O X
. O X
A O X
., O X
Davey O X
, O X
M O X
. O X
P O X
., O X
and O X
Carr O X
, O X
D O X
. O X
W O X
. O X
( O X
1997 O X
) O X
J O X
. O X
Biol O X
. O X

Chem O X
. O X

272 O X
, O X
4747 O X
- O X
4752 O X
). O X

However O X
, O X
inhibition O X
of O X
the O X
PKA O X
catalytic O X
activity O X
does O X
not O X
mimic O X
these O X
peptides O X
, O X
suggesting O X
that O X
the O X
peptides O X
are O X
disrupting O X
the O X
interaction O X
of O X
AKAP I-MISC 8165
( O X
s O X
) O X
with O X
proteins O X
other O X
than O X
PKA O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
we O X
have O X
now O X
identified O X
two O X
sperm O X
- O X
specific O X
human O X
proteins O X
that O X
interact O X
with O X
the O X
amphipathic O X
helix O X
region O X
of O X
AKAP110 I-MISC 10566
. O X

These O X
proteins O X
, O X
ropporin I-MISC 54763
( O X
a O X
protein O X
previously O X
shown O X
to O X
interact O X
with O X
the O X
Rho O X
signaling O X
pathway O X
) O X
and O X
AKAP I-MISC 83853
- I-MISC 83853
associated I-MISC 83853
sperm I-MISC 83853
protein I-MISC 83853
, O X
are O X
39 O X
% O X
identical O X
to O X
each O X
other O X
and O X
share O X
a O X
strong O X
sequence O X
similarity O X
with O X
the O X
conserved O X
domain O X
on O X
the O X
N O X
terminus O X
of O X
RII O X
that O X
is O X
involved O X
in O X
dimerization O X
and O X
AKAP I-MISC 8165
binding O X
. O X

Mutation O X
of O X
conserved O X
residues O X
in O X
ropporin I-MISC 54763
or O X
RII O X
prevents O X
binding O X
to O X
AKAP110 I-MISC 10566
. O X

These O X
data O X
suggest O X
that O X
sperm O X
contains O X
several O X
proteins O X
that O X
bind O X
to O X
AKAPs O X
in O X
a O X
manner O X
similar O X
to O X
RII O X
and O X
imply O X
that O X
AKAPs O X
may O X
have O X
additional O X
and O X
perhaps O X
unique O X
functions O X
in O X
spermatozoa O X
. O X

###15805117	5111,5111

Proliferating I-MISC 5111
cell I-MISC 5111
nuclear I-MISC 5111
antigen I-MISC 5111
( O X
PCNA I-MISC 5111
) O X
may O X
function O X
as O X
a O X
double O X
homotrimer O X
complex O X
in O X
the O X
mammalian O X
cell O X
. O X

The O X
diverse O X
function O X
of O X
proliferating I-MISC 5111
cell I-MISC 5111
nuclear I-MISC 5111
antigen I-MISC 5111
( O X
PCNA I-MISC 5111
) O X
may O X
be O X
regulated O X
by O X
interactions O X
with O X
different O X
protein O X
partners O X
. O X

Interestingly O X
, O X
the O X
binding O X
sites O X
for O X
all O X
known O X
PCNA I-MISC 5111
- O X
associating O X
proteins O X
are O X
on O X
the O X
outer O X
surface O X
or O X
the O X
C O X
termini O X
(" O X
front O X
") O X
sides O X
of O X
the O X
PCNA I-MISC 5111
trimer O X
. O X

Using O X
cell O X
extracts O X
and O X
purified O X
human O X
PCNA I-MISC 5111
protein O X
, O X
we O X
show O X
here O X
that O X
two O X
PCNA I-MISC 5111
homotrimers O X
form O X
a O X
back O X
- O X
to O X
- O X
back O X
doublet O X
. O X

Mutation O X
analysis O X
suggests O X
that O X
the O X
Arg O X
- O X
5 O X
and O X
Lys O X
- O X
110 O X
residues O X
on O X
the O X
PCNA I-MISC 5111
back O X
side O X
are O X
the O X
contact O X
points O X
of O X
the O X
two O X
homotrimers O X
in O X
the O X
doublet O X
. O X

Furthermore O X
, O X
short O X
synthetic O X
peptides O X
encompassing O X
either O X
Arg O X
- O X
5 O X
or O X
Lys O X
- O X
110 O X
inhibit O X
double O X
trimer O X
formation O X
. O X

We O X
also O X
found O X
that O X
a O X
PCNA I-MISC 5111
double O X
trimer O X
, O X
but O X
not O X
a O X
homotrimer O X
alone O X
, O X
can O X
simultaneously O X
accommodate O X
chromatin O X
assembly O X
factor O X
- O X
1 O X
and O X
polymerase O X
delta O X
. O X

Together O X
, O X
our O X
data O X
supports O X
a O X
model O X
that O X
chromatin O X
remodeling O X
by O X
chromatin O X
assembly O X
factor O X
- O X
1 O X
( O X
and O X
, O X
possibly O X
, O X
many O X
other O X
cellular O X
activities O X
) O X
are O X
tightly O X
coupled O X
with O X
DNA O X
replication O X
( O X
and O X
repair O X
) O X
through O X
a O X
PCNA I-MISC 5111
double O X
trimer O X
complex O X
. O X

###12668732	6868,1739

Identification O X
of O X
SAP97 I-MISC 1739
as O X
an O X
intracellular O X
binding O X
partner O X
of O X
TACE I-MISC 6868
. O X

Tumor I-MISC 6868
necrosis I-MISC 6868
factor I-MISC 6868
alpha I-MISC 6868
converting I-MISC 6868
enzyme I-MISC 6868
( O X
TACE I-MISC 6868
) O X
is O X
the O X
metalloprotease O X
- O X
disintegrin O X
responsible O X
for O X
the O X
ectodomain O X
shedding O X
of O X
several O X
proteins O X
, O X
including O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
alpha I-MISC 7124
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
we O X
identified O X
the O X
scaffolding O X
protein O X
synapse I-MISC 1739
associated I-MISC 1739
protein I-MISC 1739
97 I-MISC 1739
( O X
SAP97 I-MISC 1739
) O X
as O X
a O X
binding O X
partner O X
of O X
the O X
cytoplasmic O X
domain O X
of O X
TACE I-MISC 6868
. O X

By O X
deletions O X
and O X
site O X
- O X
directed O X
mutagenesis O X
, O X
we O X
demonstrated O X
that O X
this O X
interaction O X
involved O X
the O X
PDZ3 O X
domain O X
of O X
SAP97 I-MISC 1739
and O X
the O X
extreme O X
C O X
- O X
terminal O X
amino O X
- O X
acid O X
sequence O X
of O X
TACE I-MISC 6868
. O X

This O X
interaction O X
as O X
well O X
as O X
the O X
identification O X
of O X
the O X
specific O X
domains O X
involved O X
was O X
confirmed O X
in O X
vitro O X
by O X
affinity O X
purification O X
and O X
in O X
mammalian O X
cells O X
by O X
co O X
- O X
immunoprecipitation O X
and O X
alteration O X
of O X
localization O X
analyzed O X
by O X
immunofluorescence O X
microscopy O X
. O X

In O X
addition O X
, O X
confocal O X
microscopy O X
showed O X
that O X
endogenous O X
TACE I-MISC 6868
and O X
SAP97 I-MISC 1739
colocalized O X
in O X
some O X
intracellular O X
areas O X
of O X
COS O X
- O X
7 O X
cells O X
and O X
CACO O X
- O X
2 O X
cells O X
. O X

Furthermore O X
, O X
overexpression O X
of O X
SAP97 I-MISC 1739
, O X
unlike O X
that O X
of O X
a O X
mutant O X
form O X
of O X
SAP97 I-MISC 1739
deleted O X
for O X
its O X
PDZ3 O X
domain O X
, O X
altered O X
the O X
ability O X
of O X
TACE I-MISC 6868
to O X
release O X
its O X
substrates O X
. O X

Altogether O X
, O X
these O X
results O X
demonstrate O X
an O X
interaction O X
between O X
TACE I-MISC 6868
and O X
SAP97 I-MISC 1739
, O X
which O X
may O X
have O X
a O X
functional O X
implication O X
for O X
the O X
regulation O X
of O X
TACE I-MISC 6868
shedding O X
activity O X
. O X

###16831423	10174,25	10174,25

Abl I-MISC 25
kinase O X
interacts O X
with O X
and O X
phosphorylates O X
vinexin I-MISC 10174
. O X

Non O X
- O X
receptor O X
tyrosine O X
kinase O X
Abl I-MISC 25
is O X
a O X
well O X
known O X
regulator O X
of O X
the O X
actin O X
- O X
cytoskeleton O X
, O X
including O X
the O X
formation O X
of O X
stress O X
fibers O X
and O X
membrane O X
ruffles O X
. O X

Vinexin I-MISC 10174
is O X
an O X
adapter O X
protein O X
consisting O X
of O X
three O X
SH3 O X
domains O X
, O X
and O X
involved O X
in O X
signal O X
transduction O X
and O X
the O X
reorganization O X
of O X
actin O X
cytoskeleton O X
. O X

In O X
this O X
study O X
, O X
we O X
found O X
that O X
vinexin I-MISC 10174
alpha O X
as O X
well O X
as O X
beta O X
interacts O X
with O X
c O X
- O X
Abl I-MISC 25
mainly O X
through O X
the O X
third O X
SH3 O X
domain O X
, O X
and O X
that O X
vinexin I-MISC 10174
and O X
c O X
- O X
Abl I-MISC 25
were O X
colocalized O X
at O X
membrane O X
ruffles O X
in O X
rat O X
astrocytes O X
. O X

This O X
interaction O X
was O X
reduced O X
by O X
latrunculin O X
B O X
, O X
suggesting O X
an O X
F O X
- O X
actin O X
- O X
mediated O X
regulatory O X
mechanism O X
. O X

We O X
also O X
found O X
that O X
vinexin I-MISC 10174
alpha O X
but O X
not O X
beta O X
was O X
phosphorylated O X
at O X
tyrosine O X
residue O X
when O X
c O X
- O X
Abl I-MISC 25
or O X
v O X
- O X
Abl I-MISC 25
was O X
co O X
- O X
expressed O X
. O X

A O X
mutational O X
analysis O X
identified O X
tyrosine O X
127 O X
on O X
vinexin I-MISC 10174
alpha O X
as O X
a O X
major O X
site O X
of O X
phosphorylation O X
by O X
c O X
- O X
or O X
v O X
- O X
Abl I-MISC 25
. O X

These O X
results O X
suggest O X
that O X
vinexin I-MISC 10174
alpha O X
is O X
a O X
novel O X
substrate O X
for O X
Abl I-MISC 25
. O X

###21763312	1137497,1137497	1137499,1137497

A O X
single O X
amino O X
acid O X
change O X
in O X
the O X
transmembrane O X
domain O X
of O X
the O X
VirB8 I-MISC 1137497
protein O X
affects O X
dimerization O X
, O X
interaction O X
with O X
VirB10 I-MISC 1137499
and O X
Brucella O X
suis O X
virulence O X
. O X

VirB8 I-MISC 1137497
is O X
a O X
critical O X
component O X
of O X
the O X
Brucella O X
suis O X
type O X
IV O X
secretion O X
system O X
( O X
T4SS O X
). O X

We O X
previously O X
showed O X
that O X
the O X
transmembrane O X
( O X
TM O X
) O X
domain O X
plays O X
an O X
essential O X
role O X
in O X
interactions O X
of O X
this O X
protein O X
with O X
itself O X
and O X
the O X
other O X
proteins O X
of O X
the O X
T4SS O X
. O X

We O X
report O X
that O X
a O X
point O X
mutation O X
in O X
this O X
TM O X
domain O X
stabilizes O X
homodimers O X
of O X
VirB8 I-MISC 1137497
and O X
heterodimers O X
with O X
VirB10 I-MISC 1137499
. O X

A O X
similar O X
variant O X
of O X
Agrobacterium O X
tumefaciens O X
VirB8 I-MISC 1137497
showed O X
the O X
same O X
phenotype O X
. O X

The O X
B O X
. O X
suis O X
VirB8 I-MISC 1137497
variant O X
was O X
unable O X
to O X
complement O X
a O X
virB8 I-MISC 1137497
mutant O X
and O X
displayed O X
a O X
dominant O X
negative O X
phenotype O X
when O X
expressed O X
in O X
wild O X
type O X
B O X
. O X
suis O X
. O X

We O X
suggest O X
that O X
interaction O X
of O X
VirB8 I-MISC 1137497
with O X
VirB10 I-MISC 1137499
could O X
play O X
a O X
major O X
role O X
in O X
the O X
correct O X
function O X
of O X
the O X
B O X
. O X
suis O X
VirB O X
T4SS O X
. O X

###12813456	1489079,8850

Interaction O X
of O X
the O X
HPV O X
E7 I-MISC 1489079
proteins O X
with O X
the O X
pCAF I-MISC 8850
acetyltransferase O X
. O X

Most O X
cervical O X
carcinomas O X
express O X
the O X
E6 O X
and O X
E7 I-MISC 1489079
proteins O X
of O X
a O X
high O X
- O X
risk O X
human O X
papillomavirus O X
( O X
HPV O X
). O X

These O X
proteins O X
affect O X
growth O X
control O X
by O X
interfering O X
with O X
the O X
functions O X
of O X
cell O X
regulatory O X
proteins O X
, O X
promoting O X
oncogenic O X
transformation O X
. O X

A O X
key O X
target O X
of O X
E7 I-MISC 1489079
is O X
the O X
tumor O X
suppressor O X
protein O X
pRb I-MISC 5925
, O X
which O X
directly O X
interacts O X
with O X
E7 I-MISC 1489079
. O X

However O X
, O X
binding O X
to O X
additional O X
cellular O X
regulatory O X
proteins O X
is O X
clearly O X
required O X
for O X
oncogenesis O X
, O X
as O X
mutants O X
of O X
E7 I-MISC 1489079
have O X
been O X
identified O X
that O X
bind O X
to O X
pRb I-MISC 5925
, O X
yet O X
fail O X
to O X
transform O X
efficiently O X
. O X

Here O X
we O X
demonstrate O X
the O X
interaction O X
of O X
the O X
HPV O X
6 O X
, O X
16 O X
and O X
18 O X
E7 I-MISC 1489079
proteins O X
with O X
the O X
pCAF I-MISC 8850
acetyltransferase O X
, O X
which O X
has O X
been O X
reported O X
to O X
function O X
as O X
a O X
coactivator O X
for O X
a O X
variety O X
of O X
transcription O X
factors O X
including O X
p53 I-MISC 7157
. O X

Mutation O X
of O X
a O X
highly O X
conserved O X
leucine O X
residue O X
within O X
the O X
zinc O X
finger O X
region O X
of O X
HPV O X
16 O X
E7 I-MISC 1489079
disrupts O X
binding O X
to O X
pCAF I-MISC 8850
and O X
also O X
impairs O X
transformation O X
and O X
transcriptional O X
activation O X
. O X

HPV O X
16 O X
E7 I-MISC 1489079
interacts O X
with O X
the O X
acetyltransferase O X
domain O X
of O X
pCAF I-MISC 8850
, O X
and O X
reduces O X
its O X
acetyltransferase O X
activity O X
in O X
vitro O X
. O X

Our O X
analysis O X
of O X
the O X
interaction O X
between O X
the O X
pCAF I-MISC 8850
acetyltransferase O X
and O X
E7 I-MISC 1489079
provides O X
new O X
insight O X
into O X
the O X
mechanisms O X
by O X
which O X
the O X
E7 I-MISC 1489079
oncoproteins O X
can O X
alter O X
cellular O X
gene O X
expression O X
and O X
growth O X
. O X

###24024660	910696,910696

A O X
S52P O X
mutation O X
in O X
the O X
' O X
a O X
- O X
crystallin O X
domain O X
' O X
of O X
Mycobacterium O X
leprae O X
HSP18 I-MISC 910696
reduces O X
its O X
oligomeric O X
size O X
and O X
chaperone O X
function O X
. O X

Mycobacterium O X
leprae O X
HSP18 I-MISC 910696
is O X
a O X
small O X
heat O X
shock O X
protein O X
( O X
sHSP O X
). O X

It O X
is O X
a O X
major O X
immunodominant O X
antigen O X
of O X
M O X
. O X
leprae O X
pathogen O X
. O X

Previously O X
, O X
we O X
have O X
reported O X
the O X
existence O X
of O X
two O X
M O X
. O X
leprae O X
HSP18 I-MISC 910696
variants O X
in O X
various O X
leprotic O X
patients O X
. O X

One O X
of O X
the O X
variants O X
has O X
serine O X
at O X
position O X
52 O X
, O X
whereas O X
the O X
other O X
one O X
has O X
proline O X
at O X
the O X
same O X
position O X
. O X

We O X
have O X
also O X
reported O X
that O X
HSP18 I-MISC 910696
having O X
proline O X
at O X
position O X
52 O X
( O X
HSP18P O X
( O X
52 O X
)) O X
is O X
a O X
nonameric O X
protein O X
and O X
exhibits O X
chaperone O X
function O X
. O X

However O X
, O X
the O X
structural O X
and O X
functional O X
characterization O X
of O X
wild O X
- O X
type O X
HSP18 I-MISC 910696
having O X
serine O X
at O X
position O X
52 O X
( O X
HSP18S O X
( O X
52 O X
)) O X
is O X
yet O X
to O X
be O X
explored O X
. O X

Furthermore O X
, O X
the O X
implications O X
of O X
the O X
S52P O X
mutation O X
on O X
the O X
structure O X
and O X
chaperone O X
function O X
of O X
HSP18 I-MISC 910696
are O X
not O X
well O X
understood O X
. O X

Therefore O X
, O X
we O X
cloned O X
and O X
purified O X
these O X
two O X
HSP18 I-MISC 910696
variants O X
. O X

We O X
found O X
that O X
HSP18S O X
( O X
52 O X
) O X
is O X
also O X
a O X
molecular O X
chaperone O X
and O X
an O X
oligomeric O X
protein O X
. O X

Intrinsic O X
tryptophan O X
fluorescence O X
and O X
far O X
- O X
UV O X
CD O X
measurements O X
revealed O X
that O X
the O X
S52P O X
mutation O X
altered O X
the O X
tertiary O X
and O X
secondary O X
structure O X
of O X
HSP18 I-MISC 910696
. O X

This O X
point O X
mutation O X
also O X
reduced O X
the O X
oligomeric O X
assembly O X
and O X
decreased O X
the O X
surface O X
hydrophobicity O X
of O X
HSP18 I-MISC 910696
, O X
as O X
revealed O X
by O X
HPLC O X
and O X
4 O X
, O X
4 O X
'- O X
dianilino O X
- O X
1 O X
, O X
1 O X
'- O X
binaphthyl O X
- O X
5 O X
, O X
5 O X
'- O X
disulfonic O X
acid O X
binding O X
studies O X
, O X
respectively O X
. O X

Mutant O X
protein O X
was O X
less O X
stable O X
against O X
thermal O X
and O X
chemical O X
denaturation O X
and O X
was O X
more O X
susceptible O X
towards O X
tryptic O X
cleavage O X
than O X
wild O X
- O X
type O X
HSP18 I-MISC 910696
. O X

HSP18P O X
( O X
52 O X
) O X
had O X
lower O X
chaperone O X
function O X
and O X
was O X
less O X
effective O X
in O X
protecting O X
thermal O X
killing O X
of O X
Escherichia O X
coli O X
than O X
HSP18S O X
( O X
52 O X
). O X

Taken O X
together O X
, O X
our O X
data O X
suggest O X
that O X
serine O X
52 O X
is O X
important O X
for O X
the O X
larger O X
oligomerization O X
and O X
chaperone O X
function O X
of O X
HSP18 I-MISC 910696
. O X

Because O X
both O X
variants O X
differ O X
in O X
stability O X
and O X
function O X
, O X
they O X
may O X
have O X
different O X
roles O X
in O X
the O X
survival O X
of O X
M O X
. O X
leprae O X
in O X
infected O X
hosts O X
. O X

###23348841	172391,177435

An O X
unusual O X
arrangement O X
of O X
two O X
14 O X
- O X
3 O X
- O X
3 O X
- O X
like O X
domains O X
in O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
heterodimer O X
is O X
required O X
for O X
efficient O X
nonsense O X
- O X
mediated O X
mRNA O X
decay O X
. O X

The O X
nonsense O X
- O X
mediated O X
mRNA O X
decay O X
( O X
NMD O X
) O X
pathway O X
triggers O X
the O X
rapid O X
degradation O X
of O X
aberrant O X
mRNAs O X
containing O X
premature O X
translation O X
termination O X
codons O X
( O X
PTCs O X
). O X

In O X
metazoans O X
, O X
NMD O X
requires O X
three O X
14 O X
- O X
3 O X
- O X
3 O X
- O X
like O X
proteins O X
: O X
SMG5 I-MISC 23381
, O X
SMG6 I-MISC 23293
, O X
and O X
SMG7 I-MISC 9887
. O X

These O X
proteins O X
are O X
recruited O X
to O X
PTC O X
- O X
containing O X
mRNAs O X
through O X
the O X
interaction O X
of O X
their O X
14 O X
- O X
3 O X
- O X
3 O X
- O X
like O X
domains O X
with O X
phosphorylated O X
UPF1 I-MISC 5976
, O X
the O X
central O X
NMD O X
effector O X
. O X

Recruitment O X
of O X
SMG5 I-MISC 23381
, O X
SMG6 I-MISC 23293
, O X
and O X
SMG7 I-MISC 9887
causes O X
NMD O X
target O X
degradation O X
. O X

In O X
this O X
study O X
, O X
we O X
report O X
the O X
crystal O X
structure O X
of O X
the O X
Caenorhabditis O X
elegans O X
SMG5 I-MISC 172391
- O X
SMG7 I-MISC 177435
complex O X
. O X

The O X
14 O X
- O X
3 O X
- O X
3 O X
- O X
like O X
phosphopeptide O X
recognition O X
domains O X
of O X
SMG5 I-MISC 23381
and O X
SMG7 I-MISC 9887
heterodimerize O X
in O X
an O X
unusual O X
perpendicular O X
back O X
- O X
to O X
- O X
back O X
orientation O X
in O X
which O X
the O X
peptide O X
- O X
binding O X
sites O X
face O X
opposite O X
directions O X
. O X

Structure O X
- O X
based O X
mutants O X
and O X
functional O X
assays O X
indicate O X
that O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
interaction O X
is O X
conserved O X
and O X
is O X
crucial O X
for O X
efficient O X
NMD O X
in O X
human O X
cells O X
. O X

Notably O X
, O X
we O X
demonstrate O X
that O X
heterodimerization O X
increases O X
the O X
affinity O X
of O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
complex O X
for O X
UPF1 I-MISC 5976
. O X

Furthermore O X
, O X
we O X
show O X
that O X
the O X
degradative O X
activity O X
of O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
complex O X
resides O X
in O X
SMG7 I-MISC 9887
and O X
that O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
complex O X
and O X
SMG6 I-MISC 23293
play O X
partially O X
redundant O X
roles O X
in O X
the O X
degradation O X
of O X
aberrant O X
mRNAs O X
. O X

We O X
propose O X
that O X
the O X
SMG5 I-MISC 23381
- O X
SMG7 I-MISC 9887
complex O X
binds O X
to O X
phosphorylated O X
UPF1 I-MISC 5976
with O X
high O X
affinity O X
and O X
recruits O X
decay O X
factors O X
to O X
the O X
mRNA O X
target O X
through O X
SMG7 I-MISC 9887
, O X
thus O X
promoting O X
target O X
degradation O X
. O X

###20371544	231134,18198

Mutations O X
in O X
MUSK I-MISC 18198
causing O X
congenital O X
myasthenic O X
syndrome O X
impair O X
MuSK I-MISC 18198
- O X
Dok I-MISC 231134
- I-MISC 231134
7 I-MISC 231134
interaction O X
. O X

We O X
describe O X
a O X
severe O X
congenital O X
myasthenic O X
syndrome O X
( O X
CMS O X
) O X
caused O X
by O X
two O X
missense O X
mutations O X
in O X
the O X
gene O X
encoding O X
the O X
muscle O X
specific O X
receptor O X
tyrosine O X
kinase O X
( O X
MUSK I-MISC 18198
). O X

The O X
identified O X
MUSK I-MISC 18198
mutations O X
M605I O X
and O X
A727V O X
are O X
both O X
located O X
in O X
the O X
kinase O X
domain O X
of O X
MuSK I-MISC 18198
. O X

Intracellular O X
microelectrode O X
recordings O X
and O X
microscopy O X
studies O X
of O X
the O X
neuromuscular O X
junction O X
conducted O X
in O X
an O X
anconeus O X
muscle O X
biopsy O X
revealed O X
decreased O X
miniature O X
endplate O X
potential O X
amplitudes O X
, O X
reduced O X
endplate O X
size O X
and O X
simplification O X
of O X
secondary O X
synaptic O X
folds O X
, O X
which O X
were O X
consistent O X
with O X
postsynaptic O X
deficit O X
. O X

The O X
study O X
also O X
showed O X
a O X
striking O X
reduction O X
of O X
the O X
endplate O X
potential O X
quantal O X
content O X
, O X
consistent O X
with O X
additional O X
presynaptic O X
failure O X
. O X

Expression O X
studies O X
in O X
MuSK I-MISC 18198
deficient O X
myotubes O X
revealed O X
that O X
A727V O X
, O X
which O X
is O X
located O X
within O X
the O X
catalytic O X
loop O X
of O X
the O X
enzyme O X
, O X
caused O X
severe O X
impairment O X
of O X
agrin I-MISC 375790
- O X
dependent O X
MuSK I-MISC 18198
phosphorylation O X
, O X
aggregation O X
of O X
acetylcholine O X
receptors O X
( O X
AChRs O X
) O X
and O X
interaction O X
of O X
MuSK I-MISC 18198
with O X
Dok I-MISC 231134
- I-MISC 231134
7 I-MISC 231134
, O X
an O X
essential O X
intracellular O X
binding O X
protein O X
of O X
MuSK I-MISC 18198
. O X

In O X
contrast O X
, O X
M605I O X
, O X
resulted O X
in O X
only O X
moderate O X
impairment O X
of O X
agrin I-MISC 375790
- O X
dependent O X
MuSK I-MISC 18198
phosphorylation O X
, O X
aggregation O X
of O X
AChRs O X
and O X
interaction O X
of O X
MuSK I-MISC 18198
with O X
Dok I-MISC 231134
- I-MISC 231134
7 I-MISC 231134
. O X

There O X
was O X
no O X
impairment O X
of O X
interaction O X
of O X
mutants O X
with O X
either O X
the O X
low O X
- O X
density O X
lipoprotein O X
receptor O X
- O X
related O X
protein O X
, O X
Lrp4 I-MISC 4038
( O X
a O X
co O X
- O X
receptor O X
of O X
agrin I-MISC 375790
) O X
or O X
with O X
the O X
mammalian O X
homolog O X
of O X
the O X
Drosophila O X
tumorous O X
imaginal O X
discs O X
( O X
Tid1 I-MISC 9093
). O X

Our O X
findings O X
demonstrate O X
that O X
missense O X
mutations O X
in O X
MUSK I-MISC 18198
can O X
result O X
in O X
a O X
severe O X
form O X
of O X
CMS O X
and O X
indicate O X
that O X
the O X
inability O X
of O X
MuSK I-MISC 18198
mutants O X
to O X
interact O X
with O X
Dok I-MISC 231134
- I-MISC 231134
7 I-MISC 231134
, O X
but O X
not O X
with O X
Lrp4 I-MISC 4038
or O X
Tid1 I-MISC 9093
, O X
is O X
a O X
major O X
determinant O X
of O X
the O X
pathogenesis O X
of O X
the O X
CMS O X
caused O X
by O X
MUSK I-MISC 18198
mutations O X
. O X

###17644582	1149310,1149309

Structure O X
- O X
function O X
analysis O X
of O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
LcrV I-MISC 1149310
from O X
Yersinia O X
pestis O X
. O X

LcrV I-MISC 1149310
, O X
a O X
multifunctional O X
protein O X
, O X
acts O X
as O X
a O X
positive O X
regulator O X
of O X
effector O X
protein O X
secretion O X
for O X
the O X
type O X
III O X
secretion O X
system O X
( O X
T3SS O X
) O X
in O X
Yersinia O X
pestis O X
by O X
interaction O X
with O X
the O X
negative O X
regulator O X
LcrG I-MISC 1149309
. O X

In O X
this O X
study O X
, O X
LcrV I-MISC 1149310
was O X
analyzed O X
to O X
identify O X
regions O X
required O X
for O X
LcrG I-MISC 1149309
interaction O X
. O X

Random O X
- O X
linker O X
insertion O X
mutagenesis O X
, O X
deletion O X
analysis O X
, O X
and O X
site O X
- O X
directed O X
mutagenesis O X
of O X
hydrophobic O X
amino O X
acids O X
between O X
residues O X
290 O X
and O X
311 O X
allowed O X
the O X
isolation O X
of O X
an O X
LcrV I-MISC 1149310
mutant O X
( O X
LcrV I-MISC 1149310
L291R O X
F308R O X
) O X
defective O X
for O X
LcrG I-MISC 1149309
interaction O X
. O X

The O X
new O X
residues O X
identified O X
in O X
LcrG I-MISC 1149309
interaction O X
lie O X
in O X
helix O X
12 O X
of O X
LcrV I-MISC 1149310
; O X
residues O X
in O X
helix O X
7 O X
of O X
LcrV I-MISC 1149310
are O X
known O X
to O X
be O X
involved O X
in O X
LcrG I-MISC 1149309
interaction O X
. O X

Helix O X
7 O X
and O X
helix O X
12 O X
of O X
LcrV I-MISC 1149310
interact O X
to O X
form O X
an O X
intramolecular O X
coiled O X
coil O X
; O X
these O X
new O X
results O X
suggest O X
that O X
the O X
intramolecular O X
coiled O X
coil O X
in O X
LcrV I-MISC 1149310
is O X
required O X
for O X
LcrG I-MISC 1149309
interaction O X
and O X
activation O X
of O X
the O X
T3SS O X
. O X

###22491013	1601,4040

Disabled I-MISC 1601
- I-MISC 1601
2 I-MISC 1601
( O X
Dab2 I-MISC 1601
) O X
inhibits O X
Wnt O X
/ O X
b O X
- O X
catenin O X
signalling O X
by O X
binding O X
LRP6 I-MISC 4040
and O X
promoting O X
its O X
internalization O X
through O X
clathrin O X
. O X

Canonical O X
Wnt O X
signalling O X
requires O X
caveolin O X
- O X
dependent O X
internalization O X
of O X
low I-MISC 4040
- I-MISC 4040
density I-MISC 4040
lipoprotein I-MISC 4040
receptor I-MISC 4040
- I-MISC 4040
related I-MISC 4040
protein I-MISC 4040
6 I-MISC 4040
( O X
LRP6 I-MISC 4040
). O X

Here O X
we O X
report O X
that O X
the O X
tumour O X
suppressor O X
and O X
endocytic O X
adaptor O X
disabled I-MISC 1601
- I-MISC 1601
2 I-MISC 1601
( O X
Dab2 I-MISC 1601
), O X
previously O X
described O X
as O X
an O X
inhibitor O X
of O X
Wnt O X
/ O X
b O X
- O X
catenin O X
signalling O X
, O X
selectively O X
recruits O X
LRP6 I-MISC 4040
to O X
the O X
clathrin O X
- O X
dependent O X
endocytic O X
route O X
, O X
thereby O X
sequestering O X
it O X
from O X
caveolin O X
- O X
mediated O X
endocytosis O X
. O X

Wnt O X
stimulation O X
induces O X
the O X
casein I-MISC 13000
kinase I-MISC 13000
2 I-MISC 13000
( O X
CK2 I-MISC 13000
)- O X
dependent O X
phosphorylation O X
of O X
LRP6 I-MISC 4040
at O X
S1579 I-MISC 1077951
, O X
promoting O X
its O X
binding O X
to O X
Dab2 I-MISC 1601
and O X
internalization O X
with O X
clathrin O X
. O X

LRP6 I-MISC 4040
receptor O X
mutant O X
( O X
S1579A O X
), O X
deficient O X
in O X
CK2 I-MISC 13000
- O X
mediated O X
phosphorylation O X
and O X
Dab2 I-MISC 1601
binding O X
, O X
fails O X
to O X
associate O X
with O X
clathrin O X
, O X
and O X
thus O X
escapes O X
the O X
inhibitory O X
effects O X
of O X
Dab2 I-MISC 1601
on O X
Wnt O X
/ O X
b O X
- O X
catenin O X
signalling O X
. O X

Our O X
data O X
suggest O X
that O X
the O X
S1579 I-MISC 1077951
site O X
of O X
LRP6 I-MISC 4040
is O X
a O X
negative O X
regulatory O X
point O X
during O X
LRP6 I-MISC 4040
- O X
mediated O X
dorsoventral O X
patterning O X
in O X
zebrafish O X
and O X
in O X
allograft O X
mouse O X
tumour O X
models O X
. O X

We O X
conclude O X
that O X
the O X
tumour O X
suppressor O X
functions O X
of O X
Dab2 I-MISC 1601
involve O X
modulation O X
of O X
canonical O X
Wnt O X
signalling O X
by O X
regulating O X
the O X
endocytic O X
fate O X
of O X
the O X
LRP6 I-MISC 4040
receptor O X
. O X

###9263453	542351,542354

Interaction O X
of O X
the O X
maize O X
and O X
Arabidopsis O X
kinase O X
interaction O X
domains O X
with O X
a O X
subset O X
of O X
receptor O X
- O X
like O X
protein O X
kinases O X
: O X
implications O X
for O X
transmembrane O X
signaling O X
in O X
plants O X
. O X

The O X
kinase O X
interaction O X
( O X
KI O X
) O X
domain O X
of O X
kinase I-MISC 832048
- I-MISC 832048
associated I-MISC 832048
protein I-MISC 832048
phosphatase I-MISC 832048
( O X
KAPP I-MISC 832048
) O X
interacts O X
with O X
the O X
phosphorylated O X
form O X
of O X
an O X
Arabidopsis O X
thaliana O X
receptor I-MISC 828413
- I-MISC 828413
like I-MISC 828413
protein I-MISC 828413
kinase I-MISC 828413
( O X
RLK I-MISC 828413
). O X

The O X
KI O X
domain O X
may O X
recruit O X
KAPP I-MISC 542351
into O X
an O X
RLK I-MISC 100527941
- O X
initiated O X
signaling O X
complex O X
. O X

To O X
examine O X
additional O X
roles O X
that O X
this O X
domain O X
may O X
play O X
in O X
plant O X
signal O X
transduction O X
, O X
a O X
search O X
was O X
conducted O X
for O X
other O X
KI O X
domain O X
- O X
containing O X
proteins O X
. O X

One O X
gene O X
was O X
isolated O X
which O X
encodes O X
a O X
KI O X
domain O X
, O X
the O X
maize O X
homolog O X
of O X
KAPP I-MISC 542351
. O X

To O X
test O X
whether O X
the O X
maize O X
KI O X
domain O X
associates O X
with O X
other O X
maize O X
proteins O X
, O X
it O X
was O X
used O X
as O X
a O X
probe O X
in O X
a O X
protein O X
- O X
protein O X
interaction O X
cloning O X
strategy O X
. O X

A O X
new O X
maize O X
RLK I-MISC 100527941
, O X
KI I-MISC 542354
domain I-MISC 542354
interacting I-MISC 542354
kinase I-MISC 542354
1 I-MISC 542354
( O X
KIK1 I-MISC 542354
), O X
was O X
identified O X
by O X
its O X
interaction O X
with O X
the O X
maize O X
KI O X
domain O X
. O X

The O X
maize O X
KI O X
domain O X
and O X
the O X
KIK1 I-MISC 542354
kinase O X
domain O X
association O X
required O X
phosphorylation O X
of O X
the O X
kinase O X
. O X

This O X
work O X
establishes O X
that O X
the O X
KI O X
domain O X
phosphorylation O X
- O X
dependent O X
signaling O X
mechanism O X
is O X
present O X
in O X
both O X
monocots O X
and O X
dicots O X
. O X

Additionally O X
, O X
it O X
was O X
determined O X
that O X
both O X
the O X
maize O X
and O X
Arabidopsis O X
KI O X
domains O X
interact O X
with O X
several O X
but O X
not O X
all O X
of O X
the O X
active O X
RLKs O X
assayed O X
. O X

These O X
multiple O X
associations O X
imply O X
that O X
KAPP I-MISC 542351
may O X
function O X
in O X
a O X
number O X
of O X
RLK I-MISC 100527941
- O X
initiated O X
signaling O X
pathways O X
. O X

###23892456	71950,20674

A O X
direct O X
physical O X
interaction O X
between O X
Nanog I-MISC 71950
and O X
Sox2 I-MISC 20674
regulates O X
embryonic O X
stem O X
cell O X
self O X
- O X
renewal O X
. O X

Embryonic O X
stem O X
( O X
ES O X
) O X
cell O X
self O X
- O X
renewal O X
efficiency O X
is O X
determined O X
by O X
the O X
Nanog I-MISC 71950
protein O X
level O X
. O X

However O X
, O X
the O X
protein O X
partners O X
of O X
Nanog I-MISC 71950
that O X
function O X
to O X
direct O X
self O X
- O X
renewal O X
are O X
unclear O X
. O X

Here O X
, O X
we O X
identify O X
a O X
Nanog I-MISC 71950
interactome O X
of O X
over O X
130 O X
proteins O X
including O X
transcription O X
factors O X
, O X
chromatin O X
modifying O X
complexes O X
, O X
phosphorylation O X
and O X
ubiquitination O X
enzymes O X
, O X
basal O X
transcriptional O X
machinery O X
members O X
, O X
and O X
RNA O X
processing O X
factors O X
. O X

Sox2 I-MISC 20674
was O X
identified O X
as O X
a O X
robust O X
interacting O X
partner O X
of O X
Nanog I-MISC 71950
. O X

The O X
purified O X
Nanog I-MISC 71950
- O X
Sox2 I-MISC 20674
complex O X
identified O X
a O X
DNA O X
recognition O X
sequence O X
present O X
in O X
multiple O X
overlapping O X
Nanog I-MISC 71950
/ O X
Sox2 I-MISC 20674
ChIP O X
- O X
Seq O X
data O X
sets O X
. O X

The O X
Nanog I-MISC 71950
tryptophan O X
repeat O X
region O X
is O X
necessary O X
and O X
sufficient O X
for O X
interaction O X
with O X
Sox2 I-MISC 20674
, O X
with O X
tryptophan O X
residues O X
required O X
. O X

In O X
Sox2 I-MISC 20674
, O X
tyrosine O X
to O X
alanine O X
mutations O X
within O X
a O X
triple O X
- O X
repeat O X
motif O X
( O X
S O X
X O X
T O X
/ O X
S O X
Y O X
) O X
abrogates O X
the O X
Nanog I-MISC 71950
- O X
Sox2 I-MISC 20674
interaction O X
, O X
alters O X
expression O X
of O X
genes O X
associated O X
with O X
the O X
Nanog I-MISC 71950
- O X
Sox2 I-MISC 20674
cognate O X
sequence O X
, O X
and O X
reduces O X
the O X
ability O X
of O X
Sox2 I-MISC 20674
to O X
rescue O X
ES O X
cell O X
differentiation O X
induced O X
by O X
endogenous O X
Sox2 I-MISC 20674
deletion O X
. O X

Substitution O X
of O X
the O X
tyrosines O X
with O X
phenylalanine O X
rescues O X
both O X
the O X
Sox2 I-MISC 20674
- O X
Nanog I-MISC 71950
interaction O X
and O X
efficient O X
self O X
- O X
renewal O X
. O X

These O X
results O X
suggest O X
that O X
aromatic O X
stacking O X
of O X
Nanog I-MISC 71950
tryptophans O X
and O X
Sox2 I-MISC 20674
tyrosines O X
mediates O X
an O X
interaction O X
central O X
to O X
ES O X
cell O X
self O X
- O X
renewal O X
. O X

###11846417	88,7273	7273,8557

Titin I-MISC 7273
mutations O X
as O X
the O X
molecular O X
basis O X
for O X
dilated O X
cardiomyopathy O X
. O X

Dilated O X
cardiomyopathy O X
( O X
DCM O X
) O X
is O X
a O X
heterogeneous O X
cardiac O X
disease O X
characterized O X
by O X
ventricular O X
dilatation O X
and O X
systolic O X
dysfunction O X
. O X

Recent O X
genetic O X
studies O X
have O X
revealed O X
that O X
mutations O X
in O X
genes O X
for O X
cardiac O X
sarcomere O X
components O X
lead O X
to O X
DCM O X
. O X

The O X
cardiac O X
sarcomere O X
consists O X
of O X
thick O X
and O X
thin O X
filaments O X
and O X
a O X
giant O X
protein O X
, O X
titin I-MISC 7273
. O X

Because O X
one O X
of O X
the O X
loci O X
of O X
familial O X
DCM O X
was O X
mapped O X
to O X
the O X
region O X
of O X
the O X
titin I-MISC 7273
gene O X
, O X
we O X
searched O X
for O X
titin I-MISC 7273
mutations O X
in O X
the O X
patients O X
and O X
identified O X
four O X
possible O X
disease O X
- O X
associated O X
mutations O X
. O X

Two O X
mutations O X
, O X
Val54Met O X
and O X
Ala743Val O X
, O X
were O X
found O X
in O X
the O X
Z O X
- O X
line O X
region O X
of O X
titin I-MISC 7273
and O X
decreased O X
binding O X
affinities O X
of O X
titin I-MISC 7273
to O X
Z O X
- O X
line O X
proteins O X
T I-MISC 8557
- I-MISC 8557
cap I-MISC 8557
/ O X
telethonin I-MISC 8557
and O X
alpha I-MISC 88
- I-MISC 88
actinin I-MISC 88
, O X
respectively O X
, O X
in O X
yeast O X
two O X
- O X
hybrid O X
assays O X
. O X

The O X
other O X
two O X
mutations O X
were O X
found O X
in O X
the O X
cardiac O X
- O X
specific O X
N2 O X
- O X
B O X
region O X
of O X
titin I-MISC 7273
and O X
one O X
of O X
them O X
was O X
a O X
nonsense O X
mutation O X
, O X
Glu4053ter O X
, O X
presumably O X
encoding O X
for O X
a O X
truncated O X
nonfunctional O X
molecule O X
. O X

These O X
observations O X
suggest O X
that O X
titin I-MISC 7273
mutations O X
may O X
cause O X
DCM O X
in O X
a O X
subset O X
of O X
the O X
patients O X
. O X

###18307994	10133,29110

Enhanced O X
binding O X
of O X
TBK1 I-MISC 29110
by O X
an O X
optineurin I-MISC 10133
mutant O X
that O X
causes O X
a O X
familial O X
form O X
of O X
primary O X
open O X
angle O X
glaucoma O X
. O X

TANK I-MISC 29110
- I-MISC 29110
binding I-MISC 29110
kinase I-MISC 29110
1 I-MISC 29110
( O X
TBK1 I-MISC 29110
) O X
was O X
identified O X
as O X
a O X
binding O X
partner O X
for O X
Optineurin I-MISC 10133
( O X
OPTN I-MISC 10133
) O X
in O X
two O X
- O X
hybrid O X
screens O X
, O X
an O X
interaction O X
confirmed O X
by O X
overexpression O X
/ O X
immunoprecipitation O X
experiments O X
in O X
HEK293 O X
cells O X
and O X
by O X
coimmunoprecipitation O X
of O X
endogenous O X
OPTN I-MISC 10133
and O X
TBK1 I-MISC 29110
from O X
cell O X
extracts O X
. O X

A O X
TBK1 I-MISC 29110
binding O X
site O X
was O X
located O X
between O X
residues O X
1 O X
- O X
127 O X
of O X
OPTN I-MISC 10133
, O X
residues O X
78 O X
- O X
121 O X
displaying O X
striking O X
homology O X
to O X
the O X
TBK1 I-MISC 29110
- O X
binding O X
domain O X
of O X
TANK I-MISC 10010
. O X

The O X
OPTN I-MISC 10133
- O X
binding O X
domain O X
was O X
localised O X
to O X
residues O X
601 O X
- O X
729 O X
of O X
TBK1 I-MISC 29110
, O X
while O X
TBK1 I-MISC 29110
[ O X
1 O X
- O X
688 O X
] O X
which O X
cannot O X
bind O X
to O X
TANK I-MISC 10010
, O X
did O X
not O X
interact O X
with O X
OPTN I-MISC 10133
. O X

The O X
OPTN I-MISC 10133
[ O X
E50K O X
] O X
mutant O X
associated O X
with O X
Primary O X
Open O X
Angle O X
Glaucoma O X
( O X
POAG O X
) O X
displayed O X
strikingly O X
enhanced O X
binding O X
to O X
TBK1 I-MISC 29110
, O X
suggesting O X
that O X
this O X
interaction O X
may O X
contribute O X
to O X
familial O X
POAG O X
caused O X
by O X
this O X
mutation O X
. O X

###15582318	7273,8557	8048,8557	51778,8557

Tcap I-MISC 8557
gene O X
mutations O X
in O X
hypertrophic O X
cardiomyopathy O X
and O X
dilated O X
cardiomyopathy O X
. O X

OBJECTIVES O X
: O X
We O X
sought O X
to O X
explore O X
the O X
relationship O X
between O X
a O X
Tcap I-MISC 8557
gene O X
( O X
TCAP I-MISC 8557
) O X
abnormality O X
and O X
cardiomyopathy O X
. O X

BACKGROUND O X
: O X
Hypertrophic O X
cardiomyopathy O X
( O X
HCM O X
) O X
and O X
dilated O X
cardiomyopathy O X
( O X
DCM O X
) O X
cause O X
severe O X
heart O X
failure O X
and O X
sudden O X
death O X
. O X

Recent O X
genetic O X
investigations O X
have O X
revealed O X
that O X
mutations O X
of O X
genes O X
encoding O X
Z O X
- O X
disc O X
components O X
, O X
including O X
titin I-MISC 7273
and O X
muscle I-MISC 8048
LIM I-MISC 8048
protein I-MISC 8048
( O X
MLP I-MISC 8048
), O X
are O X
the O X
primary O X
cause O X
of O X
both O X
HCM O X
and O X
DCM O X
. O X

The O X
Z O X
- O X
disc O X
plays O X
a O X
role O X
in O X
establishing O X
the O X
mechanical O X
coupling O X
of O X
sarcomeric O X
contraction O X
and O X
stretching O X
, O X
with O X
the O X
titin I-MISC 7273
/ O X
Tcap I-MISC 8557
/ O X
MLP I-MISC 8048
complex O X
serving O X
as O X
a O X
mechanical O X
stretch O X
sensor O X
. O X

Tcap I-MISC 8557
interacts O X
with O X
the O X
calsarcin O X
, O X
which O X
tethers O X
the O X
calcineurin O X
to O X
the O X
Z O X
- O X
disc O X
. O X

METHODS O X
: O X
The O X
TCAP I-MISC 8557
was O X
analyzed O X
in O X
346 O X
patients O X
with O X
HCM O X
( O X
236 O X
familial O X
and O X
110 O X
sporadic O X
cases O X
) O X
and O X
136 O X
patients O X
with O X
DCM O X
( O X
34 O X
familial O X
and O X
102 O X
sporadic O X
cases O X
). O X

Two O X
different O X
in O X
vitro O X
qualitative O X
assays O X
- O X
yeast O X
two O X
- O X
hybrid O X
and O X
glutathion O X
S O X
- O X
transferase O X
pull O X
- O X
down O X
competition O X
- O X
were O X
performed O X
in O X
order O X
to O X
investigate O X
functional O X
changes O X
in O X
Tcap I-MISC 8557
' O X
s O X
interaction O X
with O X
MLP I-MISC 8048
, O X
titin I-MISC 7273
, O X
and O X
calsarcin I-MISC 51778
- I-MISC 51778
1 I-MISC 51778
caused O X
by O X
the O X
identified O X
mutations O X
and O X
a O X
reported O X
DCM O X
- O X
associated O X
mutation O X
, O X
R87Q O X
. O X

RESULTS O X
: O X
Two O X
TCAP I-MISC 8557
mutations O X
, O X
T137I O X
and O X
R153H O X
, O X
were O X
found O X
in O X
patients O X
with O X
HCM O X
, O X
and O X
another O X
TCAP I-MISC 8557
mutation O X
, O X
E132Q O X
, O X
was O X
identified O X
in O X
a O X
patient O X
with O X
DCM O X
. O X

It O X
was O X
demonstrated O X
by O X
the O X
qualitative O X
assays O X
that O X
the O X
HCM O X
- O X
associated O X
mutations O X
augment O X
the O X
ability O X
of O X
Tcap I-MISC 8557
to O X
interact O X
with O X
titin I-MISC 7273
and O X
calsarcin I-MISC 51778
- I-MISC 51778
1 I-MISC 51778
, O X
whereas O X
the O X
DCM O X
- O X
associated O X
mutations O X
impair O X
the O X
interaction O X
of O X
Tcap I-MISC 8557
with O X
MLP I-MISC 8048
, O X
titin I-MISC 7273
, O X
and O X
calsarcin I-MISC 51778
- I-MISC 51778
1 I-MISC 51778
. O X

CONCLUSIONS O X
: O X
These O X
observations O X
suggest O X
that O X
the O X
difference O X
in O X
clinical O X
phenotype O X
( O X
HCM O X
or O X
DCM O X
) O X
may O X
be O X
correlated O X
with O X
the O X
property O X
of O X
altered O X
binding O X
among O X
the O X
Z O X
- O X
disc O X
components O X
. O X

###10921886	836,5979

The O X
RET I-MISC 5979
proto O X
- O X
oncogene O X
induces O X
apoptosis O X
: O X
a O X
novel O X
mechanism O X
for O X
Hirschsprung O X
disease O X
. O X

The O X
RET I-MISC 5979
( O X
rearranged O X
during O X
transfection O X
) O X
proto O X
- O X
oncogene O X
encodes O X
a O X
tyrosine O X
kinase O X
receptor O X
involved O X
in O X
both O X
multiple O X
endocrine O X
neoplasia O X
type O X
2 O X
( O X
MEN O X
2 O X
), O X
an O X
inherited O X
cancer O X
syndrome O X
, O X
and O X
Hirschsprung O X
disease O X
( O X
HSCR O X
), O X
a O X
developmental O X
defect O X
of O X
enteric O X
neurons O X
. O X

We O X
report O X
here O X
that O X
the O X
expression O X
of O X
RET I-MISC 5979
receptor O X
induces O X
apoptosis O X
. O X

This O X
pro O X
- O X
apoptotic O X
effect O X
of O X
RET I-MISC 5979
is O X
inhibited O X
in O X
the O X
presence O X
of O X
its O X
ligand O X
glial I-MISC 2668
cell I-MISC 2668
line I-MISC 2668
- I-MISC 2668
derived I-MISC 2668
neurotrophic I-MISC 2668
factor I-MISC 2668
( O X
GDNF I-MISC 2668
). O X

Furthermore O X
, O X
we O X
present O X
evidence O X
that O X
RET I-MISC 5979
induces O X
apoptosis O X
via O X
its O X
own O X
cleavage O X
by O X
caspases I-MISC 836
, O X
a O X
phenomenon O X
allowing O X
the O X
liberation O X
/ O X
exposure O X
of O X
a O X
pro O X
- O X
apoptotic O X
domain O X
of O X
RET I-MISC 5979
. O X

In O X
addition O X
, O X
we O X
report O X
that O X
Hirschsprung O X
- O X
associated O X
RET I-MISC 5979
mutations O X
impair O X
GDNF I-MISC 2668
control O X
of O X
RET I-MISC 5979
pro O X
- O X
apoptotic O X
activity O X
. O X

These O X
results O X
indicate O X
that O X
HSCR O X
may O X
result O X
from O X
apoptosis O X
of O X
RET I-MISC 5979
- O X
expressing O X
enteric O X
neuroblasts O X
. O X

###12679340	855993,853357

Yeast O X
epiarginase O X
regulation O X
, O X
an O X
enzyme O X
- O X
enzyme O X
activity O X
control O X
: O X
identification O X
of O X
residues O X
of O X
ornithine I-MISC 853357
carbamoyltransferase I-MISC 853357
and O X
arginase I-MISC 855993
responsible O X
for O X
enzyme O X
catalytic O X
and O X
regulatory O X
activities O X
. O X

In O X
the O X
presence O X
of O X
ornithine O X
and O X
arginine O X
, O X
ornithine I-MISC 853357
carbamoyltransferase I-MISC 853357
( O X
OTCase I-MISC 853357
) O X
and O X
arginase I-MISC 855993
form O X
a O X
one O X
- O X
to O X
- O X
one O X
enzyme O X
complex O X
in O X
which O X
the O X
activity O X
of O X
OTCase I-MISC 853357
is O X
inhibited O X
whereas O X
arginase I-MISC 855993
remains O X
catalytically O X
active O X
. O X

The O X
mechanism O X
by O X
which O X
these O X
nonallosteric O X
enzymes O X
form O X
a O X
stable O X
complex O X
triggered O X
by O X
the O X
binding O X
of O X
their O X
respective O X
substrates O X
raises O X
the O X
question O X
of O X
how O X
such O X
a O X
cooperative O X
association O X
is O X
induced O X
. O X

Analyses O X
of O X
mutations O X
in O X
both O X
enzymes O X
identify O X
residues O X
that O X
are O X
required O X
for O X
their O X
association O X
, O X
some O X
of O X
them O X
being O X
important O X
for O X
catalysis O X
. O X

In O X
arginase I-MISC 855993
, O X
two O X
cysteines O X
at O X
the O X
C O X
terminus O X
of O X
the O X
protein O X
are O X
crucial O X
for O X
its O X
epiarginase O X
function O X
but O X
not O X
for O X
its O X
catalytic O X
activity O X
and O X
trimeric O X
structure O X
. O X

In O X
OTCase I-MISC 853357
, O X
mutations O X
of O X
putative O X
ornithine O X
binding O X
residues O X
, O X
Asp O X
- O X
182 O X
, O X
Asn O X
- O X
184 O X
, O X
Asn O X
- O X
185 O X
, O X
Cys O X
- O X
289 O X
, O X
and O X
Glu O X
- O X
256 O X
greatly O X
reduced O X
the O X
affinity O X
for O X
ornithine O X
and O X
impaired O X
the O X
interaction O X
with O X
arginase I-MISC 855993
. O X

The O X
four O X
lysine O X
residues O X
located O X
in O X
the O X
SMG O X
loop O X
, O X
Lys O X
- O X
260 O X
, O X
Lys O X
- O X
263 O X
, O X
Lys O X
- O X
265 O X
, O X
and O X
Lys O X
- O X
268 O X
, O X
also O X
play O X
an O X
important O X
role O X
in O X
mediating O X
the O X
sensitivity O X
of O X
OTCase I-MISC 853357
to O X
ornithine O X
and O X
to O X
arginase I-MISC 855993
and O X
appear O X
to O X
be O X
involved O X
in O X
transducing O X
and O X
enhancing O X
the O X
signal O X
given O X
by O X
ornithine O X
for O X
the O X
closure O X
of O X
the O X
catalytic O X
domain O X
. O X

###15533940	281078,3092	281698,3092	281078,29816	281698,29816	281080,281698

Huntingtin I-MISC 3092
- I-MISC 3092
interacting I-MISC 3092
protein I-MISC 3092
1 I-MISC 3092
( O X
Hip1 I-MISC 3092
) O X
and O X
Hip1 I-MISC 29816
- I-MISC 29816
related I-MISC 29816
protein I-MISC 29816
( O X
Hip1R I-MISC 29816
) O X
bind O X
the O X
conserved O X
sequence O X
of O X
clathrin I-MISC 281078,281698
light I-MISC 281078,281698
chains I-MISC 281078,281698
and O X
thereby O X
influence O X
clathrin O X
assembly O X
in O X
vitro O X
and O X
actin O X
distribution O X
in O X
vivo O X
. O X

Clathrin O X
heavy O X
and O X
light O X
chains O X
form O X
triskelia O X
, O X
which O X
assemble O X
into O X
polyhedral O X
coats O X
of O X
membrane O X
vesicles O X
that O X
mediate O X
transport O X
for O X
endocytosis O X
and O X
organelle O X
biogenesis O X
. O X

Light O X
chain O X
subunits O X
regulate O X
clathrin O X
assembly O X
in O X
vitro O X
by O X
suppressing O X
spontaneous O X
self O X
- O X
assembly O X
of O X
the O X
heavy O X
chains O X
. O X

The O X
residues O X
that O X
play O X
this O X
regulatory O X
role O X
are O X
at O X
the O X
N O X
terminus O X
of O X
a O X
conserved O X
22 O X
- O X
amino O X
acid O X
sequence O X
that O X
is O X
shared O X
by O X
all O X
vertebrate O X
light O X
chains O X
. O X

Here O X
we O X
show O X
that O X
these O X
regulatory O X
residues O X
and O X
others O X
in O X
the O X
conserved O X
sequence O X
mediate O X
light O X
chain O X
interaction O X
with O X
Hip1 I-MISC 3092
and O X
Hip1R I-MISC 29816
. O X

These O X
related O X
proteins O X
were O X
previously O X
found O X
to O X
be O X
enriched O X
in O X
clathrin O X
- O X
coated O X
vesicles O X
and O X
to O X
promote O X
clathrin O X
assembly O X
in O X
vitro O X
. O X

We O X
demonstrate O X
Hip1R I-MISC 29816
binding O X
preference O X
for O X
light O X
chains O X
associated O X
with O X
clathrin I-MISC 281080
heavy I-MISC 281080
chain I-MISC 281080
and O X
show O X
that O X
Hip1R I-MISC 29816
stimulation O X
of O X
clathrin O X
assembly O X
in O X
vitro O X
is O X
blocked O X
by O X
mutations O X
in O X
the O X
conserved O X
sequence O X
of O X
light O X
chains O X
that O X
abolish O X
interaction O X
with O X
Hip1 I-MISC 3092
and O X
Hip1R I-MISC 29816
. O X

In O X
vivo O X
overexpression O X
of O X
a O X
fragment O X
of O X
clathrin O X
light O X
chain O X
comprising O X
the O X
Hip1R I-MISC 29816
- O X
binding O X
region O X
affected O X
cellular O X
actin O X
distribution O X
. O X

Together O X
these O X
results O X
suggest O X
that O X
the O X
roles O X
of O X
Hip1 I-MISC 3092
and O X
Hip1R I-MISC 29816
in O X
affecting O X
clathrin O X
assembly O X
and O X
actin O X
distribution O X
are O X
mediated O X
by O X
their O X
interaction O X
with O X
the O X
conserved O X
sequence O X
of O X
clathrin I-MISC 281078,281698
light I-MISC 281078,281698
chains I-MISC 281078,281698
. O X

###16873060	1457,5371

A O X
CK2 I-MISC 1457
- O X
dependent O X
mechanism O X
for O X
degradation O X
of O X
the O X
PML I-MISC 5371
tumor O X
suppressor O X
. O X

The O X
PML I-MISC 5371
tumor O X
suppressor O X
controls O X
key O X
pathways O X
for O X
growth O X
suppression O X
, O X
induction O X
of O X
apoptosis O X
, O X
and O X
cellular O X
senescence O X
. O X

PML I-MISC 5371
loss O X
occurs O X
frequently O X
in O X
human O X
tumors O X
through O X
unknown O X
posttranslational O X
mechanisms O X
. O X

Casein O X
kinase O X
2 O X
( O X
CK2 I-MISC 1457
) O X
is O X
oncogenic O X
and O X
frequently O X
upregulated O X
in O X
human O X
tumors O X
. O X

Here O X
we O X
show O X
that O X
CK2 I-MISC 1457
regulates O X
PML I-MISC 5371
protein O X
levels O X
by O X
promoting O X
its O X
ubiquitin O X
- O X
mediated O X
degradation O X
dependent O X
on O X
direct O X
phosphorylation O X
at O X
Ser517 O X
. O X

Consequently O X
, O X
PML I-MISC 5371
mutants O X
that O X
are O X
resistant O X
to O X
CK2 I-MISC 1457
phosphorylation O X
display O X
increased O X
tumor O X
- O X
suppressive O X
functions O X
. O X

In O X
a O X
faithful O X
mouse O X
model O X
of O X
lung O X
cancer O X
, O X
we O X
demonstrate O X
that O X
Pml I-MISC 18854
inactivation O X
leads O X
to O X
increased O X
tumorigenesis O X
. O X

Furthermore O X
, O X
CK2 I-MISC 1457
pharmacological O X
inhibition O X
enhances O X
the O X
PML I-MISC 5371
tumor O X
- O X
suppressive O X
property O X
in O X
vivo O X
. O X

Importantly O X
, O X
we O X
found O X
an O X
inverse O X
correlation O X
between O X
CK2 I-MISC 1457
kinase O X
activity O X
and O X
PML I-MISC 5371
protein O X
levels O X
in O X
human O X
lung O X
cancer O X
- O X
derived O X
cell O X
lines O X
and O X
primary O X
specimens O X
. O X

These O X
data O X
identify O X
a O X
key O X
posttranslational O X
mechanism O X
that O X
controls O X
PML I-MISC 5371
protein O X
levels O X
and O X
provide O X
therapeutic O X
means O X
toward O X
PML I-MISC 5371
restoration O X
through O X
CK2 I-MISC 1457
inhibition O X
. O X

###14507921	84168,3361714

Binding O X
of O X
anthrax O X
toxin O X
to O X
its O X
receptor O X
is O X
similar O X
to O X
alpha O X
integrin O X
- O X
ligand O X
interactions O X
. O X

The O X
secreted O X
protein O X
toxin O X
produced O X
by O X
Bacillus O X
anthracis O X
contributes O X
to O X
virulence O X
of O X
this O X
pathogen O X
and O X
can O X
cause O X
many O X
of O X
the O X
symptoms O X
seen O X
during O X
an O X
anthrax O X
infection O X
, O X
including O X
shock O X
and O X
sudden O X
death O X
. O X

The O X
cell O X
- O X
binding O X
component O X
of O X
anthrax O X
toxin O X
, O X
protective I-MISC 3361714
antigen I-MISC 3361714
, O X
mediates O X
entry O X
of O X
the O X
toxin O X
into O X
cells O X
by O X
first O X
binding O X
directly O X
to O X
the O X
extracellular O X
integrin O X
- O X
like O X
inserted O X
( O X
I O X
) O X
domain O X
of O X
the O X
cellular O X
anthrax O X
toxin O X
receptor O X
, O X
ATR I-MISC 84168
. O X

Here O X
we O X
report O X
that O X
this O X
interaction O X
requires O X
an O X
intact O X
metal O X
ion O X
- O X
dependent O X
adhesion O X
site O X
( O X
MIDAS O X
) O X
in O X
the O X
receptor O X
as O X
well O X
as O X
the O X
presence O X
of O X
specific O X
divalent O X
cations O X
. O X

Also O X
, O X
we O X
demonstrate O X
that O X
the O X
toxin O X
- O X
receptor O X
interaction O X
is O X
critically O X
dependent O X
on O X
the O X
Asp O X
- O X
683 O X
carboxylate O X
group O X
of O X
protective O X
antigen O X
, O X
which O X
projects O X
from O X
the O X
receptor O X
binding O X
surface O X
. O X

We O X
propose O X
that O X
this O X
carboxylate O X
group O X
completes O X
the O X
coordination O X
of O X
the O X
MIDAS O X
metal O X
of O X
ATR I-MISC 84168
, O X
mimicking O X
integrin O X
- O X
ligand O X
interactions O X
. O X

###9202023	10413,22377

Characterization O X
of O X
the O X
WW O X
domain O X
of O X
human O X
yes I-MISC 10413
- I-MISC 10413
associated I-MISC 10413
protein I-MISC 10413
and O X
its O X
polyproline O X
- O X
containing O X
ligands O X
. O X

We O X
had O X
previously O X
identified O X
the O X
WW O X
domain O X
as O X
a O X
novel O X
globular O X
domain O X
that O X
is O X
composed O X
of O X
38 O X
- O X
40 O X
semiconserved O X
amino O X
acids O X
and O X
is O X
involved O X
in O X
mediating O X
protein O X
- O X
protein O X
interaction O X
. O X

The O X
WW O X
domain O X
is O X
shared O X
by O X
proteins O X
of O X
diverse O X
functions O X
including O X
structural O X
, O X
regulatory O X
, O X
and O X
signaling O X
proteins O X
in O X
yeast O X
, O X
nematode O X
, O X
and O X
mammals O X
. O X

Functionally O X
it O X
is O X
similar O X
to O X
the O X
Src O X
homology O X
3 O X
domain O X
in O X
that O X
it O X
binds O X
polyproline O X
ligands O X
. O X

By O X
screening O X
a O X
16 O X
- O X
day O X
mouse O X
embryo O X
expression O X
library O X
, O X
we O X
identified O X
two O X
putative O X
ligands O X
of O X
the O X
WW O X
domain O X
of O X
Yes O X
kinase O X
- O X
associated O X
protein O X
which O X
we O X
named O X
WW I-MISC 22377
domain I-MISC 22377
- I-MISC 22377
binding I-MISC 22377
proteins I-MISC 22377
1 I-MISC 22377
and I-MISC 22377
2 I-MISC 22377
. O X

These O X
proteins O X
interacted O X
with O X
the O X
WW O X
domain O X
via O X
a O X
short O X
proline O X
- O X
rich O X
motif O X
with O X
the O X
consensus O X
sequence O X
of O X
four O X
consecutive O X
prolines O X
followed O X
by O X
a O X
tyrosine O X
. O X

Herein O X
, O X
we O X
report O X
the O X
cDNA O X
cloning O X
and O X
characterization O X
of O X
the O X
human O X
orthologs O X
of O X
WW I-MISC 23559
domain I-MISC 23559
- I-MISC 23559
binding I-MISC 23559
proteins I-MISC 23559
1 I-MISC 23559
and I-MISC 23559
2 I-MISC 23559
. O X

The O X
products O X
encoded O X
by O X
these O X
cDNA O X
clones O X
represent O X
novel O X
proteins O X
with O X
no O X
known O X
function O X
. O X

Furthermore O X
, O X
these O X
proteins O X
show O X
no O X
homology O X
to O X
each O X
other O X
except O X
for O X
a O X
proline O X
- O X
rich O X
motif O X
. O X

By O X
fluorescence O X
in O X
situ O X
hybridization O X
on O X
human O X
metaphase O X
chromosomes O X
, O X
we O X
mapped O X
the O X
human O X
genes O X
for O X
WW I-MISC 23559
domain I-MISC 23559
- I-MISC 23559
binding I-MISC 23559
proteins I-MISC 23559
1 I-MISC 23559
and I-MISC 23559
2 I-MISC 23559
to O X
chromosomes O X
2p12 O X
and O X
17q25 O X
, O X
respectively O X
. O X

In O X
addition O X
, O X
using O X
site O X
- O X
directed O X
mutagenesis O X
, O X
we O X
determined O X
which O X
residues O X
in O X
the O X
WW O X
domain O X
of O X
Yes O X
kinase O X
- O X
associated O X
protein O X
are O X
critical O X
for O X
binding O X
. O X

Finally O X
, O X
by O X
synthesizing O X
peptides O X
in O X
which O X
the O X
various O X
positions O X
of O X
the O X
four O X
consecutive O X
proline O X
- O X
tyrosine O X
motif O X
and O X
the O X
five O X
surrounding O X
residues O X
were O X
replaced O X
by O X
all O X
possible O X
amino O X
acid O X
residues O X
, O X
we O X
further O X
elucidated O X
the O X
binding O X
requirements O X
of O X
this O X
motif O X
. O X

###20493856	11845,30957

The O X
scaffold O X
protein O X
JIP3 I-MISC 30957
functions O X
as O X
a O X
downstream O X
effector O X
of O X
the O X
small O X
GTPase O X
ARF6 I-MISC 11845
to O X
regulate O X
neurite O X
morphogenesis O X
of O X
cortical O X
neurons O X
. O X

The O X
small O X
GTPase O X
ADP I-MISC 11845
- I-MISC 11845
ribosylation I-MISC 11845
factor I-MISC 11845
6 I-MISC 11845
( O X
ARF6 I-MISC 11845
) O X
plays O X
crucial O X
roles O X
in O X
a O X
wide O X
variety O X
of O X
cell O X
functions O X
. O X

To O X
better O X
understand O X
the O X
molecular O X
mechanisms O X
of O X
ARF6 I-MISC 11845
- O X
mediated O X
signaling O X
and O X
cellular O X
functions O X
, O X
we O X
sought O X
new O X
ARF6 I-MISC 11845
- O X
binding O X
proteins O X
in O X
the O X
mouse O X
brain O X
. O X

We O X
identified O X
the O X
signaling O X
scaffold O X
protein O X
JNK I-MISC 30957
- I-MISC 30957
interacting I-MISC 30957
protein I-MISC 30957
3 I-MISC 30957
( O X
JIP3 I-MISC 30957
), O X
which O X
is O X
exclusively O X
expressed O X
in O X
neurons O X
, O X
as O X
a O X
downstream O X
effector O X
of O X
ARF6 I-MISC 11845
. O X

Overexpression O X
of O X
a O X
unique O X
dominant O X
negative O X
mutant O X
of O X
ARF6 I-MISC 11845
, O X
which O X
was O X
unable O X
to O X
interact O X
with O X
JIP3 I-MISC 30957
, O X
and O X
knockdown O X
of O X
JIP3 I-MISC 30957
in O X
mouse O X
cortical O X
neurons O X
stimulated O X
the O X
elongation O X
and O X
branching O X
of O X
neurites O X
. O X

These O X
results O X
provide O X
evidence O X
that O X
ARF6 I-MISC 11845
/ O X
JIP3 I-MISC 30957
signaling O X
regulates O X
neurite O X
morphogenesis O X
. O X

###9343432	41168,31181

A O X
domain O X
shared O X
by O X
the O X
Polycomb I-MISC 40358
group O X
proteins O X
Scm I-MISC 41168
and O X
ph I-MISC 31181
mediates O X
heterotypic O X
and O X
homotypic O X
interactions O X
. O X

The O X
Sex I-MISC 41168
comb I-MISC 41168
on I-MISC 41168
midleg I-MISC 41168
( O X
Scm I-MISC 41168
) O X
and O X
polyhomeotic I-MISC 31181
( O X
ph I-MISC 31181
) O X
proteins O X
are O X
members O X
of O X
the O X
Polycomb I-MISC 40358
group O X
( O X
PcG O X
) O X
of O X
transcriptional O X
repressors O X
. O X

PcG O X
proteins O X
maintain O X
differential O X
patterns O X
of O X
homeotic O X
gene O X
expression O X
during O X
development O X
in O X
Drosophila O X
flies O X
. O X

The O X
Scm I-MISC 41168
and O X
ph I-MISC 31181
proteins O X
share O X
a O X
homology O X
domain O X
with O X
38 O X
% O X
identity O X
over O X
a O X
length O X
of O X
65 O X
amino O X
acids O X
, O X
termed O X
the O X
SPM O X
domain O X
, O X
that O X
is O X
located O X
at O X
their O X
respective O X
C O X
termini O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
and O X
in O X
vitro O X
protein O X
- O X
binding O X
assays O X
, O X
we O X
show O X
that O X
the O X
SPM O X
domain O X
mediates O X
direct O X
interaction O X
between O X
Scm I-MISC 41168
and O X
ph I-MISC 31181
. O X

Binding O X
studies O X
with O X
isolated O X
SPM O X
domains O X
from O X
Scm I-MISC 41168
and O X
ph I-MISC 31181
show O X
that O X
the O X
domain O X
is O X
sufficient O X
for O X
these O X
protein O X
interactions O X
. O X

These O X
studies O X
also O X
show O X
that O X
the O X
Scm I-MISC 41168
- O X
ph I-MISC 31181
and O X
Scm I-MISC 41168
- O X
Scm I-MISC 41168
domain O X
interactions O X
are O X
much O X
stronger O X
than O X
the O X
ph I-MISC 31181
- O X
ph I-MISC 31181
domain O X
interaction O X
, O X
indicating O X
that O X
the O X
isolated O X
domain O X
has O X
intrinsic O X
binding O X
specificity O X
determinants O X
. O X

Analysis O X
of O X
site O X
- O X
directed O X
point O X
mutations O X
identifies O X
residues O X
that O X
are O X
important O X
for O X
SPM O X
domain O X
function O X
. O X

These O X
binding O X
properties O X
, O X
predicted O X
alpha O X
- O X
helical O X
secondary O X
structure O X
, O X
and O X
conservation O X
of O X
hydrophobic O X
residues O X
prompt O X
comparisons O X
of O X
the O X
SPM O X
domain O X
to O X
the O X
helix O X
- O X
loop O X
- O X
helix O X
and O X
leucine O X
zipper O X
domains O X
used O X
for O X
homotypic O X
and O X
heterotypic O X
protein O X
interactions O X
in O X
other O X
transcriptional O X
regulators O X
. O X

In O X
addition O X
to O X
in O X
vitro O X
studies O X
, O X
we O X
show O X
colocalization O X
of O X
the O X
Scm I-MISC 41168
and O X
ph I-MISC 31181
proteins O X
at O X
polytene O X
chromosome O X
sites O X
in O X
vivo O X
. O X

We O X
discuss O X
the O X
possible O X
roles O X
of O X
the O X
SPM O X
domain O X
in O X
the O X
assembly O X
or O X
function O X
of O X
molecular O X
complexes O X
of O X
PcG O X
proteins O X
. O X

###21816275	945741,945740

The O X
Min O X
oscillator O X
uses O X
MinD I-MISC 945740
- O X
dependent O X
conformational O X
changes O X
in O X
MinE I-MISC 945741
to O X
spatially O X
regulate O X
cytokinesis O X
. O X

In O X
E O X
. O X
coli O X
, O X
MinD I-MISC 945740
recruits O X
MinE I-MISC 945741
to O X
the O X
membrane O X
, O X
leading O X
to O X
a O X
coupled O X
oscillation O X
required O X
for O X
spatial O X
regulation O X
of O X
the O X
cytokinetic O X
Z O X
ring O X
. O X

How O X
these O X
proteins O X
interact O X
, O X
however O X
, O X
is O X
not O X
clear O X
because O X
the O X
MinD I-MISC 945740
- O X
binding O X
regions O X
of O X
MinE I-MISC 945741
are O X
sequestered O X
within O X
a O X
six O X
- O X
stranded O X
b O X
sheet O X
and O X
masked O X
by O X
N O X
- O X
terminal O X
helices O X
. O X

minE I-MISC 945741
mutations O X
that O X
restore O X
interaction O X
between O X
some O X
MinD I-MISC 945740
and O X
MinE I-MISC 945741
mutants O X
were O X
isolated O X
. O X

These O X
mutations O X
alter O X
the O X
MinE I-MISC 945741
structure O X
leading O X
to O X
release O X
of O X
the O X
MinD I-MISC 945740
- O X
binding O X
regions O X
and O X
the O X
N O X
- O X
terminal O X
helices O X
that O X
bind O X
the O X
membrane O X
. O X

Crystallization O X
of O X
MinD I-MISC 945740
- O X
MinE I-MISC 945741
complexes O X
revealed O X
a O X
four O X
- O X
stranded O X
b O X
sheet O X
MinE I-MISC 945741
dimer O X
with O X
the O X
released O X
b O X
strands O X
( O X
MinD I-MISC 945740
- O X
binding O X
regions O X
) O X
converted O X
to O X
a O X
helices O X
bound O X
to O X
MinD I-MISC 945740
dimers O X
. O X

These O X
results O X
identify O X
the O X
MinD I-MISC 945740
- O X
dependent O X
conformational O X
changes O X
in O X
MinE I-MISC 945741
that O X
convert O X
it O X
from O X
a O X
latent O X
to O X
an O X
active O X
form O X
and O X
lead O X
to O X
a O X
model O X
of O X
how O X
MinE I-MISC 945741
persists O X
at O X
the O X
MinD I-MISC 945740
- O X
membrane O X
surface O X
. O X

###10413501	6050,283	6050,282340

Superadditive O X
and O X
subadditive O X
effects O X
of O X
" O X
hot O X
spot O X
" O X
mutations O X
within O X
the O X
interfaces O X
of O X
placental I-MISC 6050
ribonuclease I-MISC 6050
inhibitor I-MISC 6050
with O X
angiogenin I-MISC 283
and O X
ribonuclease O X
A O X
. O X

Previous O X
single O X
- O X
site O X
mutagenesis O X
studies O X
on O X
the O X
complexes O X
of O X
ribonuclease I-MISC 6050
inhibitor I-MISC 6050
( O X
RI I-MISC 6050
) O X
with O X
angiogenin I-MISC 283
( O X
Ang I-MISC 283
) O X
and O X
RNase I-MISC 282340
A I-MISC 282340
suggested O X
that O X
in O X
both O X
cases O X
a O X
substantial O X
fraction O X
of O X
the O X
binding O X
energy O X
is O X
concentrated O X
within O X
one O X
small O X
part O X
of O X
the O X
crystallographically O X
observed O X
interface O X
, O X
involving O X
RI I-MISC 6050
residues O X
434 O X
- O X
438 O X
. O X

Such O X
energetic O X
" O X
hot O X
spots O X
" O X
are O X
common O X
in O X
protein O X
- O X
protein O X
complexes O X
, O X
but O X
their O X
physical O X
meaning O X
is O X
generally O X
unclear O X
. O X

Here O X
we O X
have O X
investigated O X
this O X
question O X
by O X
examining O X
the O X
detailed O X
interactions O X
within O X
the O X
RI I-MISC 6050
. O X
ligand O X
hot O X
spots O X
and O X
the O X
extent O X
to O X
which O X
they O X
function O X
independently O X
. O X

The O X
effects O X
of O X
Phe O X
versus O X
Ala O X
substitutions O X
show O X
that O X
the O X
key O X
residue O X
Tyr434 O X
interacts O X
with O X
both O X
ligands O X
primarily O X
through O X
its O X
phenyl O X
ring O X
; O X
for O X
Tyr437 O X
, O X
the O X
OH O X
group O X
forms O X
the O X
important O X
contacts O X
with O X
RNase I-MISC 282340
A I-MISC 282340
, O X
whereas O X
the O X
phenyl O X
group O X
interacts O X
with O X
Ang I-MISC 283
. O X

Kinetic O X
characterization O X
of O X
complexes O X
containing O X
multiple O X
substitutions O X
reveals O X
striking O X
, O X
but O X
distinctive O X
, O X
cooperativity O X
in O X
the O X
interactions O X
of O X
RI I-MISC 6050
with O X
the O X
two O X
ligands O X
. O X

The O X
losses O X
in O X
binding O X
energy O X
for O X
the O X
RNase O X
complex O X
associated O X
with O X
replacements O X
of O X
Tyr434 O X
and O X
Asp435 O X
, O X
and O X
Tyr434 O X
and O X
Tyr437 O X
, O X
are O X
markedly O X
less O X
than O X
additive O X
( O X
i O X
. O X
e O X
., O X
by O X
2 O X
. O X
4 O X
and O X
1 O X
. O X
3 O X
kcal O X
/ O X
mol O X
, O X
respectively O X
). O X

In O X
contrast O X
, O X
the O X
energetic O X
effects O X
of O X
the O X
434 O X
and O X
435 O X
, O X
and O X
434 O X
and O X
437 O X
, O X
substitution O X
pairs O X
on O X
binding O X
of O X
Ang I-MISC 283
are O X
fully O X
additive O X
and O X
2 O X
. O X
5 O X
kcal O X
/ O X
mol O X
beyond O X
additive O X
, O X
respectively O X
. O X

Superadditivities O X
( O X
0 O X
. O X
9 O X
- O X
2 O X
. O X
4 O X
kcal O X
/ O X
mol O X
) O X
are O X
also O X
observed O X
for O X
several O X
multisite O X
replacements O X
involving O X
these O X
inhibitor O X
residues O X
and O X
two O X
Ang I-MISC 283
residues O X
, O X
Arg5 O X
and O X
Lys40 O X
, O X
from O X
this O X
part O X
of O X
the O X
interface O X
. O X

Consequently O X
, O X
the O X
decreases O X
in O X
binding O X
energy O X
for O X
some O X
triple O X
- O X
variant O X
complexes O X
are O X
as O X
large O X
as O X
8 O X
. O X
5 O X
- O X
10 O X
. O X
1 O X
kcal O X
/ O X
mol O X
( O X
compared O X
to O X
a O X
total O X
DeltaG O X
of O X
- O X
21 O X
. O X
0 O X
kcal O X
/ O X
mol O X
for O X
the O X
wild O X
- O X
type O X
complex O X
). O X

Potential O X
explanations O X
for O X
these O X
functional O X
couplings O X
, O X
many O X
of O X
which O X
occur O X
over O X
distances O X
of O X
> O X
13 O X
A O X
and O X
are O X
not O X
mediated O X
by O X
direct O X
or O X
triangulated O X
contacts O X
, O X
are O X
proposed O X
. O X

These O X
findings O X
show O X
that O X
the O X
basis O X
for O X
the O X
generation O X
of O X
hot O X
spots O X
can O X
be O X
complex O X
, O X
and O X
that O X
these O X
sites O X
can O X
assume O X
significantly O X
more O X
( O X
as O X
with O X
Ang I-MISC 283
) O X
or O X
less O X
( O X
as O X
with O X
RNase O X
) O X
importance O X
than O X
indicated O X
from O X
the O X
effects O X
of O X
single O X
- O X
site O X
mutations O X
. O X

###10982829	20848,3569

The O X
coiled O X
- O X
coil O X
domain O X
of O X
Stat3 I-MISC 20848
is O X
essential O X
for O X
its O X
SH2 O X
domain O X
- O X
mediated O X
receptor O X
binding O X
and O X
subsequent O X
activation O X
induced O X
by O X
epidermal I-MISC 1950
growth I-MISC 1950
factor I-MISC 1950
and O X
interleukin I-MISC 3569
- I-MISC 3569
6 I-MISC 3569
. O X

STAT O X
proteins O X
are O X
a O X
family O X
of O X
latent O X
transcription O X
factors O X
that O X
mediate O X
the O X
response O X
to O X
various O X
cytokines O X
and O X
growth O X
factors O X
. O X

Upon O X
stimulation O X
by O X
cytokines O X
, O X
STAT O X
proteins O X
are O X
recruited O X
to O X
the O X
receptors O X
via O X
their O X
SH2 O X
domains O X
, O X
phosphorylated O X
on O X
a O X
specific O X
tyrosine O X
, O X
dimerized O X
, O X
and O X
translocated O X
into O X
the O X
nucleus O X
, O X
where O X
they O X
bind O X
specific O X
DNA O X
sequences O X
and O X
activate O X
the O X
target O X
gene O X
transcription O X
. O X

STATs O X
share O X
highly O X
conserved O X
structures O X
, O X
including O X
an O X
N O X
- O X
domain O X
, O X
a O X
coiled O X
- O X
coil O X
domain O X
, O X
a O X
DNA O X
- O X
binding O X
domain O X
, O X
a O X
linker O X
domain O X
, O X
and O X
an O X
SH2 O X
domain O X
. O X

To O X
investigate O X
the O X
role O X
of O X
the O X
coiled O X
- O X
coil O X
domain O X
, O X
we O X
performed O X
a O X
systematic O X
deletion O X
analysis O X
of O X
the O X
N O X
- O X
domain O X
and O X
each O X
of O X
the O X
alpha O X
- O X
helices O X
and O X
mutagenesis O X
of O X
conserved O X
residues O X
in O X
the O X
coiled O X
- O X
coil O X
region O X
of O X
Stat3 I-MISC 20848
. O X

Our O X
results O X
indicate O X
that O X
the O X
coiled O X
- O X
coil O X
domain O X
is O X
essential O X
for O X
Stat3 I-MISC 20848
recruitment O X
to O X
the O X
receptor O X
and O X
the O X
subsequent O X
tyrosine O X
phosphorylation O X
and O X
tyrosine O X
phosphorylation O X
- O X
dependent O X
activities O X
, O X
such O X
as O X
dimer O X
formation O X
, O X
nuclear O X
translocation O X
, O X
and O X
DNA O X
binding O X
, O X
stimulated O X
by O X
epidermal I-MISC 1950
growth I-MISC 1950
factor I-MISC 1950
( O X
EGF O X
) O X
or O X
interleukin I-MISC 3569
- I-MISC 3569
6 I-MISC 3569
( O X
IL I-MISC 3569
- I-MISC 3569
6 I-MISC 3569
). O X

Single O X
mutation O X
of O X
Asp170 O X
or O X
, O X
to O X
a O X
lesser O X
extent O X
, O X
Lys177 O X
in O X
alpha O X
- O X
helix O X
1 O X
diminishes O X
both O X
receptor O X
binding O X
and O X
tyrosine O X
phosphorylation O X
. O X

Furthermore O X
, O X
the O X
Asp170 O X
mutant O X
retains O X
its O X
ability O X
to O X
bind O X
to O X
DNA O X
when O X
phosphorylated O X
on O X
Tyr705 O X
by O X
Src O X
kinase O X
in O X
vitro O X
, O X
implying O X
a O X
functional O X
SH2 O X
domain O X
. O X

Finally O X
, O X
we O X
demonstrate O X
a O X
direct O X
binding O X
of O X
Stat3 I-MISC 20848
to O X
the O X
receptor O X
. O X

Taken O X
together O X
, O X
our O X
data O X
reveal O X
a O X
novel O X
role O X
for O X
the O X
coiled O X
- O X
coil O X
domain O X
that O X
regulates O X
the O X
early O X
events O X
in O X
Stat3 I-MISC 20848
activation O X
and O X
function O X
. O X

###8940099	4792,5770

Site O X
- O X
specific O X
tyrosine O X
phosphorylation O X
of O X
IkappaBalpha I-MISC 4792
negatively O X
regulates O X
its O X
inducible O X
phosphorylation O X
and O X
degradation O X
. O X

The O X
transcription O X
factor O X
NF O X
- O X
kappaB O X
is O X
retained O X
in O X
the O X
cytoplasm O X
by O X
its O X
interaction O X
with O X
the O X
inhibitory O X
subunit O X
known O X
as O X
IkappaB O X
. O X

Signal O X
- O X
induced O X
serine O X
phosphorylation O X
and O X
subsequent O X
ubiquitination O X
of O X
IkappaBalpha I-MISC 4792
target O X
it O X
for O X
degradation O X
by O X
the O X
26 O X
S O X
proteasome O X
. O X

Recently O X
, O X
pervanadate O X
, O X
a O X
protein O X
- O X
tyrosine O X
phosphatase O X
inhibitor O X
, O X
was O X
shown O X
to O X
block O X
the O X
degradation O X
of O X
IkappaBalpha I-MISC 4792
, O X
thus O X
inhibiting O X
NF O X
- O X
kappaB O X
activation O X
. O X

We O X
investigated O X
the O X
mechanism O X
by O X
which O X
pervanadate O X
inhibits O X
the O X
degradation O X
of O X
IkappaBalpha I-MISC 4792
. O X

Western O X
blot O X
analysis O X
of O X
IkappaBalpha I-MISC 4792
from O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
- O X
treated O X
cells O X
revealed O X
a O X
slower O X
migrating O X
IkappaBalpha I-MISC 4792
species O X
that O X
was O X
subsequently O X
degraded O X
. O X

However O X
, O X
pervanadate O X
- O X
treated O X
cells O X
also O X
revealed O X
a O X
slower O X
migrating O X
species O X
of O X
IkappaBalpha I-MISC 4792
that O X
appeared O X
in O X
a O X
time O X
- O X
and O X
dose O X
- O X
dependent O X
manner O X
and O X
was O X
not O X
degraded O X
by O X
tumor I-MISC 7124
necrosis I-MISC 7124
factor I-MISC 7124
. O X

The O X
slower O X
migrating O X
species O X
of O X
IkappaBalpha I-MISC 4792
from O X
pervanadate O X
- O X
treated O X
cells O X
was O X
tyrosine O X
- O X
phosphorylated O X
as O X
revealed O X
by O X
cross O X
- O X
reactivity O X
with O X
anti O X
- O X
phosphotyrosine O X
antibodies O X
, O X
by O X
the O X
ability O X
of O X
the O X
specific O X
tyrosine O X
phosphatase O X
PTP1B I-MISC 5770
to O X
dephosphorylate O X
it O X
, O X
and O X
by O X
phosphoamino O X
acid O X
analysis O X
of O X
IkappaBalpha I-MISC 4792
immunoprecipitated O X
from O X
32P O X
- O X
labeled O X
cells O X
. O X

By O X
site O X
- O X
specific O X
mutagenesis O X
and O X
deletion O X
analysis O X
, O X
we O X
identified O X
Tyr O X
- O X
42 O X
on O X
IkappaBalpha I-MISC 4792
as O X
the O X
phosphoacceptor O X
site O X
. O X

Furthermore O X
, O X
in O X
an O X
in O X
vitro O X
reconstitution O X
system O X
, O X
tyrosine O X
- O X
phosphorylated O X
IkappaBalpha I-MISC 4792
was O X
protected O X
from O X
degradation O X
. O X

Our O X
results O X
demonstrate O X
that O X
inducible O X
phosphorylation O X
and O X
degradation O X
of O X
IkappaBalpha I-MISC 4792
are O X
negatively O X
regulated O X
by O X
phosphorylation O X
at O X
Tyr O X
- O X
42 O X
, O X
thus O X
preventing O X
NF O X
- O X
kappaB O X
activation O X
. O X

###11278422	396171,7159

Yes I-MISC 396171
- I-MISC 396171
associated I-MISC 396171
protein I-MISC 396171
and O X
p53 I-MISC 7159
- I-MISC 7159
binding I-MISC 7159
protein I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
interact O X
through O X
their O X
WW O X
and O X
SH3 O X
domains O X
. O X

To O X
understand O X
the O X
role O X
of O X
the O X
Yes I-MISC 396171
- I-MISC 396171
associated I-MISC 396171
protein I-MISC 396171
( O X
YAP I-MISC 396171
), O X
binding O X
partners O X
of O X
its O X
WW1 O X
domain O X
were O X
isolated O X
by O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
. O X

One O X
of O X
the O X
interacting O X
proteins O X
was O X
identified O X
as O X
p53 I-MISC 7159
- I-MISC 7159
binding I-MISC 7159
protein I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
( O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
). O X

YAP I-MISC 396171
and O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
interacted O X
in O X
vitro O X
and O X
in O X
vivo O X
using O X
their O X
WW1 O X
and O X
SH3 O X
domains O X
, O X
respectively O X
. O X

The O X
YAP I-MISC 396171
WW1 O X
domain O X
bound O X
to O X
the O X
YPPPPY O X
motif O X
of O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
, O X
whereas O X
the O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
SH3 O X
domain O X
interacted O X
with O X
the O X
VPMRLR O X
sequence O X
of O X
YAP I-MISC 396171
, O X
which O X
is O X
different O X
from O X
other O X
known O X
SH3 O X
domain O X
- O X
binding O X
motifs O X
. O X

By O X
mutagenesis O X
, O X
we O X
showed O X
that O X
this O X
unusual O X
SH3 O X
domain O X
interaction O X
was O X
due O X
to O X
the O X
presence O X
of O X
three O X
consecutive O X
tryptophans O X
located O X
within O X
the O X
betaC O X
strand O X
of O X
the O X
SH3 O X
domain O X
. O X

A O X
point O X
mutation O X
within O X
this O X
triplet O X
, O X
W976R O X
, O X
restored O X
the O X
binding O X
selectivity O X
to O X
the O X
general O X
consensus O X
sequence O X
for O X
SH3 O X
domains O X
, O X
the O X
PXXP O X
motif O X
. O X

A O X
constitutively O X
active O X
form O X
of O X
c I-MISC 7525
- I-MISC 7525
Yes I-MISC 7525
was O X
observed O X
to O X
decrease O X
the O X
binding O X
affinity O X
between O X
YAP I-MISC 396171
and O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
using O X
chloramphenicol O X
acetyltransferase O X
/ O X
enzyme O X
- O X
linked O X
immunosorbent O X
assay O X
, O X
whereas O X
the O X
overexpression O X
of O X
c I-MISC 7525
- I-MISC 7525
Yes I-MISC 7525
did O X
not O X
modify O X
this O X
interaction O X
. O X

Since O X
overexpression O X
of O X
an O X
activated O X
form O X
of O X
c I-MISC 7525
- I-MISC 7525
Yes I-MISC 7525
resulted O X
in O X
tyrosine O X
phosphorylation O X
of O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
, O X
we O X
propose O X
that O X
the O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
phosphorylation O X
, O X
possibly O X
in O X
the O X
WW1 O X
domain O X
- O X
binding O X
motif O X
, O X
might O X
negatively O X
regulate O X
the O X
YAP I-MISC 396171
. O X
p53BP I-MISC 7159
- I-MISC 7159
2 I-MISC 7159
complex O X
. O X

###12434308	516175,5925

Protein O X
Phosphatase O X
1 O X
binds O X
strongly O X
to O X
the O X
retinoblastoma O X
protein O X
but O X
not O X
to O X
p107 O X
or O X
p130 I-MISC 5934
in O X
vitro O X
and O X
in O X
vivo O X
. O X

PURPOSE O X
: O X
To O X
identify O X
and O X
characterize O X
retinoblastoma O X
protein O X
( O X
pRb I-MISC 5925
) O X
binding O X
proteins O X
that O X
may O X
influence O X
retinoblast O X
proliferation O X
and O X
retinal O X
pigment O X
epithelial O X
cell O X
survival O X
. O X

METHODS O X
: O X
The O X
yeast O X
two O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
screen O X
a O X
bovine O X
retinal O X
cDNA O X
library O X
and O X
to O X
characterize O X
positive O X
clones O X
. O X

DNA O X
sequencing O X
and O X
site O X
- O X
directed O X
mutagenesis O X
were O X
used O X
for O X
further O X
analysis O X
. O X

Co O X
- O X
immunoprecipitation O X
experiments O X
were O X
used O X
to O X
confirm O X
the O X
results O X
of O X
the O X
two O X
- O X
hybrid O X
system O X
in O X
vivo O X
. O X

RESULTS O X
: O X
In O X
the O X
two O X
- O X
hybrid O X
system O X
, O X
Protein I-MISC 516175
Phosphatase I-MISC 516175
1alpha1 I-MISC 516175
( O X
PP1alpha1 I-MISC 516175
) O X
binds O X
the O X
retinoblastoma O X
protein O X
. O X

Unlike O X
several O X
other O X
pRb I-MISC 5925
binding O X
proteins O X
, O X
PP1alpha1 I-MISC 516175
binds O X
only O X
weakly O X
to O X
the O X
Rb O X
family O X
member O X
p107 O X
, O X
and O X
does O X
not O X
demonstrate O X
detectable O X
binding O X
to O X
p130 I-MISC 5934
. O X

Confirming O X
the O X
two O X
- O X
hybrid O X
results O X
, O X
endogenous O X
PP1 I-MISC 5464
in O X
a O X
human O X
retinal O X
pigment O X
epithelial O X
( O X
RPE O X
) O X
cell O X
line O X
co O X
- O X
immunoprecipitates O X
with O X
endogenous O X
pRb I-MISC 5925
but O X
not O X
p107 O X
or O X
p130 I-MISC 5934
. O X

Site O X
directed O X
mutagenesis O X
of O X
two O X
pRb I-MISC 5925
binding O X
motifs O X
in O X
PP1alpha1 I-MISC 516175
from O X
LXSXE O X
to O X
LXCXE O X
leads O X
to O X
slight O X
increases O X
in O X
its O X
two O X
- O X
hybrid O X
interaction O X
with O X
pRb I-MISC 5925
but O X
does O X
not O X
alter O X
its O X
binding O X
preference O X
for O X
pRb I-MISC 5925
over O X
the O X
other O X
family O X
members O X
. O X

The O X
complete O X
sequence O X
of O X
bovine O X
PP1alpha1 I-MISC 516175
is O X
reported O X
. O X

CONCLUSIONS O X
: O X
The O X
strong O X
two O X
- O X
hybrid O X
interaction O X
between O X
PP1alpha1 I-MISC 516175
and O X
pRb I-MISC 5925
, O X
but O X
not O X
p107 O X
or O X
p130 I-MISC 5934
, O X
suggests O X
that O X
the O X
phosphorylation O X
status O X
of O X
members O X
of O X
the O X
pRb I-MISC 5925
family O X
may O X
be O X
regulated O X
by O X
different O X
phosphatases O X
, O X
contributing O X
to O X
fine O X
control O X
of O X
cell O X
cycle O X
progression O X
. O X

Conversely O X
, O X
PP1 I-MISC 5464
activity O X
may O X
be O X
specifically O X
regulated O X
by O X
pRb I-MISC 5925
and O X
not O X
p107 O X
or O X
p130 I-MISC 5934
. O X

Mutagenesis O X
studies O X
suggest O X
that O X
PP1alpha1 I-MISC 516175
' O X
s O X
LXSXE O X
motif O X
is O X
not O X
responsible O X
for O X
its O X
binding O X
preference O X
for O X
pRb I-MISC 5925
over O X
p107 O X
and O X
p130 I-MISC 5934
. O X

Disruption O X
of O X
the O X
PP1 I-MISC 5464
- O X
pRb I-MISC 5925
interaction O X
may O X
influence O X
retinoblastoma O X
tumorigenesis O X
as O X
well O X
as O X
RPE O X
cell O X
proliferation O X
and O X
survival O X
. O X

###14685257	26986,10605	26986,51247

Structural O X
basis O X
of O X
ligand O X
recognition O X
by O X
PABC O X
, O X
a O X
highly O X
specific O X
peptide O X
- O X
binding O X
domain O X
found O X
in O X
poly O X
( O X
A O X
)- O X
binding O X
protein O X
and O X
a O X
HECT O X
ubiquitin O X
ligase O X
. O X

The O X
C O X
- O X
terminal O X
domain O X
of O X
poly O X
( O X
A O X
)- O X
binding O X
protein O X
( O X
PABC O X
) O X
is O X
a O X
peptide O X
- O X
binding O X
domain O X
found O X
in O X
poly O X
( O X
A O X
)- O X
binding O X
proteins O X
( O X
PABPs O X
) O X
and O X
a O X
HECT O X
( O X
homologous O X
to O X
E6 O X
- O X
AP O X
C O X
- O X
terminus O X
) O X
family O X
E3 O X
ubiquitin O X
ligase O X
. O X

In O X
protein O X
synthesis O X
, O X
the O X
PABC O X
domain O X
of O X
PABP I-MISC 26986
functions O X
to O X
recruit O X
several O X
translation O X
factors O X
possessing O X
the O X
PABP I-MISC 26986
- O X
interacting O X
motif O X
2 O X
( O X
PAM2 O X
) O X
to O X
the O X
mRNA O X
poly O X
( O X
A O X
) O X
tail O X
. O X

We O X
have O X
determined O X
the O X
solution O X
structure O X
of O X
the O X
human O X
PABC O X
domain O X
in O X
complex O X
with O X
two O X
peptides O X
from O X
PABP I-MISC 10605
- I-MISC 10605
interacting I-MISC 10605
protein I-MISC 10605
- I-MISC 10605
1 I-MISC 10605
( O X
Paip1 I-MISC 10605
) O X
and O X
Paip2 I-MISC 51247
. O X

The O X
structures O X
show O X
a O X
novel O X
mode O X
of O X
peptide O X
recognition O X
, O X
in O X
which O X
the O X
peptide O X
binds O X
as O X
a O X
pair O X
of O X
beta O X
- O X
turns O X
with O X
extensive O X
hydrophobic O X
, O X
electrostatic O X
and O X
aromatic O X
stacking O X
interactions O X
. O X

Mutagenesis O X
of O X
PABC O X
and O X
peptide O X
residues O X
was O X
used O X
to O X
identify O X
key O X
protein O X
- O X
peptide O X
interactions O X
and O X
quantified O X
by O X
isothermal O X
calorimetry O X
, O X
surface O X
plasmon O X
resonance O X
and O X
GST O X
pull O X
- O X
down O X
assays O X
. O X

The O X
results O X
provide O X
insight O X
into O X
the O X
specificity O X
of O X
PABC O X
in O X
mediating O X
PABP I-MISC 26986
- O X
protein O X
interactions O X
. O X

###18588881	14248,108058

Flightless I-MISC 14248
- I-MISC 14248
I I-MISC 14248
, O X
a O X
gelsolin O X
family O X
member O X
and O X
transcriptional O X
regulator O X
, O X
preferentially O X
binds O X
directly O X
to O X
activated O X
cytosolic O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
. O X

In O X
order O X
to O X
evaluate O X
links O X
between O X
Ca2 I-MISC 108058
+/ I-MISC 108058
calmodulin I-MISC 108058
( I-MISC 108058
CaM I-MISC 108058
)- I-MISC 108058
dependent I-MISC 108058
protein I-MISC 108058
kinase I-MISC 108058
type I-MISC 108058
II I-MISC 108058
( O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
) O X
and O X
cell O X
cycle O X
progression O X
, O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
binding O X
partners O X
were O X
sought O X
in O X
proliferating O X
cells O X
by O X
epitope O X
- O X
tag O X
tandem O X
mass O X
spectrometry O X
. O X

One O X
protein O X
identified O X
was O X
the O X
gelsolin O X
family O X
member O X
, O X
flightless I-MISC 14248
- I-MISC 14248
I I-MISC 14248
( O X
Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
). O X

Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
is O X
not O X
a O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
substrate O X
, O X
but O X
binds O X
directly O X
and O X
preferentially O X
to O X
constitutively O X
active O X
( O X
T287D O X
) O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
over O X
inactive O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
. O X

Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
gradually O X
enters O X
the O X
nucleus O X
upon O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
inhibition O X
and O X
is O X
retained O X
in O X
the O X
cytosol O X
by O X
T287D O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
. O X

CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
inhibition O X
and O X
Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
overexpression O X
suppress O X
transcription O X
of O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
dependent O X
transcriptional O X
reporters O X
, O X
whereas O X
Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
suppression O X
enhances O X
their O X
transcription O X
. O X

These O X
findings O X
support O X
a O X
novel O X
mechanism O X
whereby O X
cytosolic O X
CaMK I-MISC 108058
- I-MISC 108058
II I-MISC 108058
influences O X
beta I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
dependent O X
gene O X
expression O X
through O X
Fli I-MISC 14248
- I-MISC 14248
I I-MISC 14248
. O X

###19749176	851513,853347

Distinct O X
subsets O X
of O X
Sit4 I-MISC 851513
holophosphatases O X
are O X
required O X
for O X
inhibition O X
of O X
Saccharomyces O X
cerevisiae O X
growth O X
by O X
rapamycin O X
and O X
zymocin O X
. O X

Protein O X
phosphatase O X
Sit4 I-MISC 851513
is O X
required O X
for O X
growth O X
inhibition O X
of O X
Saccharomyces O X
cerevisiae O X
by O X
the O X
antifungals O X
rapamycin O X
and O X
zymocin O X
. O X

Here O X
, O X
we O X
show O X
that O X
the O X
rapamycin O X
effector O X
Tap42 I-MISC 855043
, O X
which O X
interacts O X
with O X
Sit4 I-MISC 851513
, O X
is O X
dispensable O X
for O X
zymocin O X
action O X
. O X

Although O X
Tap42 I-MISC 855043
binding O X
- O X
deficient O X
sit4 I-MISC 851513
mutants O X
are O X
resistant O X
to O X
zymocin O X
, O X
these O X
mutations O X
also O X
block O X
interaction O X
between O X
Sit4 I-MISC 851513
and O X
the O X
Sit4 I-MISC 851513
- O X
associating O X
proteins O X
Sap185 I-MISC 853347
and O X
Sap190 I-MISC 853899
, O X
previously O X
shown O X
to O X
mediate O X
zymocin O X
toxicity O X
. O X

Among O X
the O X
four O X
different O X
SAP O X
genes O X
, O X
we O X
found O X
that O X
SAP190 I-MISC 853899
deletions O X
specifically O X
induce O X
rapamycin O X
resistance O X
but O X
that O X
this O X
phenotype O X
is O X
reversed O X
in O X
the O X
additional O X
absence O X
of O X
SAP155 I-MISC 850601
. O X

Similarly O X
, O X
the O X
rapamycin O X
resistance O X
of O X
an O X
rrd1Delta O X
mutant O X
lacking O X
the O X
Sit4 I-MISC 851513
interactor O X
Rrd1 I-MISC 854653
specifically O X
requires O X
the O X
Sit4 I-MISC 851513
/ O X
Sap190 I-MISC 853899
complex O X
. O X

Thus O X
, O X
Sit4 I-MISC 851513
/ O X
Sap190 I-MISC 853899
and O X
Sit4 I-MISC 851513
/ O X
Sap155 I-MISC 850601
holophosphatases O X
apparently O X
play O X
opposing O X
roles O X
following O X
rapamycin O X
treatment O X
, O X
although O X
rapamycin O X
inhibition O X
is O X
operational O X
in O X
the O X
absence O X
of O X
all O X
Sap O X
family O X
members O X
or O X
Sit4 I-MISC 851513
. O X

We O X
further O X
identified O X
a O X
Sit4 I-MISC 851513
- O X
interacting O X
region O X
on O X
Sap185 I-MISC 853347
in O X
sap190Delta O X
cells O X
that O X
mediates O X
Sit4 I-MISC 851513
/ O X
Sap185 I-MISC 853347
complex O X
formation O X
and O X
is O X
essential O X
for O X
dephosphorylation O X
of O X
Elp1 I-MISC 851100
, O X
a O X
subunit O X
of O X
the O X
Elongator O X
complex O X
. O X

This O X
suggests O X
that O X
Sit4 I-MISC 851513
/ O X
Sap185 I-MISC 853347
and O X
Sit4 I-MISC 851513
/ O X
Sap190 I-MISC 853899
holophosphatases O X
promote O X
Elongator O X
functions O X
, O X
a O X
notion O X
supported O X
by O X
data O X
showing O X
that O X
their O X
inactivation O X
eliminates O X
Elongator O X
- O X
dependent O X
processes O X
, O X
including O X
tRNA O X
suppression O X
by O X
SUP4 I-MISC 853519
and O X
tRNA O X
cleavage O X
by O X
zymocin O X
. O X

###17932487	4137,1639

Interaction O X
of O X
tau I-MISC 1639
protein O X
with O X
the O X
dynactin O X
complex O X
. O X

Tau I-MISC 1639
is O X
an O X
axonal O X
microtubule O X
- O X
associated O X
protein O X
involved O X
in O X
microtubule O X
assembly O X
and O X
stabilization O X
. O X

Mutations O X
in O X
Tau I-MISC 1639
cause O X
frontotemporal O X
dementia O X
and O X
parkinsonism O X
linked O X
to O X
chromosome O X
17 O X
( O X
FTDP I-MISC 4137
- I-MISC 4137
17 I-MISC 4137
), O X
and O X
tau I-MISC 1639
aggregates O X
are O X
present O X
in O X
Alzheimer O X
' O X
s O X
disease O X
and O X
other O X
tauopathies O X
. O X

The O X
mechanisms O X
leading O X
from O X
tau I-MISC 1639
dysfunction O X
to O X
neurodegeneration O X
are O X
still O X
debated O X
. O X

The O X
dynein O X
- O X
activator O X
complex O X
dynactin O X
has O X
an O X
essential O X
role O X
in O X
axonal O X
transport O X
and O X
mutations O X
in O X
its O X
gene O X
are O X
associated O X
with O X
lower O X
motor O X
neuron O X
disease O X
. O X

We O X
show O X
here O X
for O X
the O X
first O X
time O X
that O X
the O X
N O X
- O X
terminal O X
projection O X
domain O X
of O X
tau I-MISC 1639
binds O X
to O X
the O X
C O X
- O X
terminus O X
of O X
the O X
p150 O X
subunit O X
of O X
the O X
dynactin O X
complex O X
. O X

Tau I-MISC 1639
and O X
dynactin O X
show O X
extensive O X
colocalization O X
, O X
and O X
the O X
attachment O X
of O X
the O X
dynactin O X
complex O X
to O X
microtubules O X
is O X
enhanced O X
by O X
tau I-MISC 1639
. O X

Mutations O X
of O X
a O X
conserved O X
arginine O X
residue O X
in O X
the O X
N O X
- O X
terminus O X
of O X
tau I-MISC 1639
, O X
found O X
in O X
patients O X
with O X
FTDP I-MISC 4137
- I-MISC 4137
17 I-MISC 4137
, O X
affect O X
its O X
binding O X
to O X
dynactin O X
, O X
which O X
is O X
abnormally O X
distributed O X
in O X
the O X
retinal O X
ganglion O X
cell O X
axons O X
of O X
transgenic O X
mice O X
expressing O X
human O X
tau I-MISC 1639
with O X
a O X
mutation O X
in O X
the O X
microtubule O X
- O X
binding O X
domain O X
. O X

These O X
findings O X
, O X
which O X
suggest O X
a O X
direct O X
involvement O X
of O X
tau I-MISC 1639
in O X
axonal O X
transport O X
, O X
have O X
implications O X
for O X
understanding O X
the O X
pathogenesis O X
of O X
tauopathies O X
. O X

###21763481	380718,232987

Disruption O X
of O X
a O X
ciliary O X
B9 O X
protein O X
complex O X
causes O X
Meckel O X
syndrome O X
. O X

Nearly O X
every O X
ciliated O X
organism O X
possesses O X
three O X
B9 O X
domain O X
- O X
containing O X
proteins O X
: O X
MKS1 I-MISC 54903
, O X
B9D1 I-MISC 27077
, O X
and O X
B9D2 I-MISC 80776
. O X

Mutations O X
in O X
human O X
MKS1 I-MISC 54903
cause O X
Meckel O X
syndrome O X
( O X
MKS O X
), O X
a O X
severe O X
ciliopathy O X
characterized O X
by O X
occipital O X
encephalocele O X
, O X
liver O X
ductal O X
plate O X
malformations O X
, O X
polydactyly O X
, O X
and O X
kidney O X
cysts O X
. O X

Mouse O X
mutations O X
in O X
either O X
Mks1 I-MISC 380718
or O X
B9d2 I-MISC 232987
compromise O X
ciliogenesis O X
and O X
result O X
in O X
phenotypes O X
similar O X
to O X
those O X
of O X
MKS O X
. O X

Given O X
the O X
importance O X
of O X
these O X
two O X
B9 O X
proteins O X
to O X
ciliogenesis O X
, O X
we O X
examined O X
the O X
role O X
of O X
the O X
third O X
B9 O X
protein O X
, O X
B9d1 I-MISC 27077
. O X

Mice O X
lacking O X
B9d1 I-MISC 27078
displayed O X
polydactyly O X
, O X
kidney O X
cysts O X
, O X
ductal O X
plate O X
malformations O X
, O X
and O X
abnormal O X
patterning O X
of O X
the O X
neural O X
tube O X
, O X
concomitant O X
with O X
compromised O X
ciliogenesis O X
, O X
ciliary O X
protein O X
localization O X
, O X
and O X
Hedgehog O X
( O X
Hh O X
) O X
signal O X
transduction O X
. O X

These O X
data O X
prompted O X
us O X
to O X
screen O X
MKS O X
patients O X
for O X
mutations O X
in O X
B9D1 I-MISC 27077
and O X
B9D2 I-MISC 80776
. O X

We O X
identified O X
a O X
homozygous O X
c O X
. O X
301A O X
> O X
C O X
( O X
p O X
. O X
Ser101Arg O X
) O X
B9D2 I-MISC 80776
mutation O X
that O X
segregates O X
with O X
MKS O X
, O X
affects O X
an O X
evolutionarily O X
conserved O X
residue O X
, O X
and O X
is O X
absent O X
from O X
controls O X
. O X

Unlike O X
wild O X
- O X
type O X
B9D2 I-MISC 436667
mRNA O X
, O X
the O X
p O X
. O X
Ser101Arg O X
mutation O X
failed O X
to O X
rescue O X
zebrafish O X
phenotypes O X
induced O X
by O X
the O X
suppression O X
of O X
b9d2 I-MISC 436667
. O X

With O X
coimmunoprecipitation O X
and O X
mass O X
spectrometric O X
analyses O X
, O X
we O X
found O X
that O X
Mks1 I-MISC 54903
, O X
B9d1 I-MISC 27077
, O X
and O X
B9d2 I-MISC 80776
interact O X
physically O X
, O X
but O X
that O X
the O X
p O X
. O X
Ser101Arg O X
mutation O X
abrogates O X
the O X
ability O X
of O X
B9d2 I-MISC 80776
to O X
interact O X
with O X
Mks1 I-MISC 54903
, O X
further O X
suggesting O X
that O X
the O X
mutation O X
compromises O X
B9d2 I-MISC 80776
function O X
. O X

Our O X
data O X
indicate O X
that O X
B9d1 I-MISC 27077
is O X
required O X
for O X
normal O X
Hh O X
signaling O X
, O X
ciliogenesis O X
, O X
and O X
ciliary O X
protein O X
localization O X
and O X
that O X
B9d1 I-MISC 27077
and O X
B9d2 I-MISC 80776
are O X
essential O X
components O X
of O X
a O X
B9 O X
protein O X
complex O X
, O X
disruption O X
of O X
which O X
causes O X
MKS O X
. O X

###9488481	11911,13144	13144,13144

ZIP I-MISC 13144
kinase I-MISC 13144
, O X
a O X
novel O X
serine O X
/ O X
threonine O X
kinase O X
which O X
mediates O X
apoptosis O X
. O X

We O X
have O X
identified O X
a O X
novel O X
serine O X
/ O X
threonine O X
kinase O X
, O X
designated O X
ZIP I-MISC 13144
kinase I-MISC 13144
, O X
which O X
mediates O X
apoptosis O X
. O X

ZIP I-MISC 13144
kinase I-MISC 13144
contains O X
a O X
leucine O X
zipper O X
structure O X
at O X
its O X
C O X
terminus O X
, O X
in O X
addition O X
to O X
a O X
kinase O X
domain O X
at O X
its O X
N O X
terminus O X
. O X

ZIP I-MISC 13144
kinase I-MISC 13144
physically O X
binds O X
to O X
ATF4 I-MISC 11911
, O X
a O X
member O X
of O X
the O X
activating O X
transcription O X
factor O X
/ O X
cyclic O X
AMP O X
- O X
responsive O X
element O X
- O X
binding O X
protein O X
( O X
ATF O X
/ O X
CREB O X
) O X
family O X
, O X
through O X
interaction O X
between O X
their O X
leucine O X
zippers O X
. O X

The O X
leucine O X
zipper O X
domain O X
is O X
necessary O X
for O X
the O X
homodimerization O X
of O X
ZIP I-MISC 13144
kinase I-MISC 13144
as O X
well O X
as O X
for O X
the O X
activation O X
of O X
kinase O X
. O X

Immunostaining O X
study O X
showed O X
that O X
ZIP I-MISC 13144
kinase I-MISC 13144
localizes O X
in O X
the O X
nuclei O X
. O X

Overexpression O X
of O X
intact O X
ZIP I-MISC 13144
kinase I-MISC 13144
but O X
not O X
catalytically O X
inactive O X
kinase O X
mutants O X
led O X
to O X
the O X
morphological O X
changes O X
of O X
apoptosis O X
in O X
NIH O X
3T3 O X
cells O X
, O X
suggesting O X
that O X
the O X
cell O X
death O X
- O X
inducing O X
activity O X
of O X
ZIP I-MISC 13144
kinase I-MISC 13144
depends O X
on O X
its O X
intrinsic O X
kinase O X
activity O X
. O X

Interestingly O X
, O X
the O X
catalytic O X
domain O X
of O X
ZIP I-MISC 13144
kinase I-MISC 13144
is O X
closely O X
related O X
to O X
that O X
of O X
death O X
- O X
associated O X
protein O X
kinase O X
( O X
DAP O X
kinase O X
), O X
which O X
is O X
a O X
mediator O X
of O X
apoptosis O X
induced O X
by O X
gamma O X
interferon O X
. O X

Therefore O X
, O X
both O X
ZIP O X
and O X
DAP O X
kinases O X
represent O X
a O X
novel O X
kinase O X
family O X
, O X
which O X
mediates O X
apoptosis O X
through O X
their O X
catalytic O X
activities O X
. O X

###16630557	854016,851752

The O X
decapping O X
enzyme O X
Dcp1 I-MISC 854016
participates O X
in O X
translation O X
termination O X
through O X
its O X
interaction O X
with O X
the O X
release O X
factor O X
eRF3 O X
in O X
budding O X
yeast O X
. O X

One O X
of O X
the O X
rate O X
- O X
limiting O X
steps O X
in O X
messenger O X
RNA O X
decay O X
pathway O X
is O X
the O X
5 O X
'- O X
cap O X
cleavage O X
of O X
mRNAs O X
, O X
decapping O X
reaction O X
, O X
which O X
is O X
conducted O X
by O X
the O X
protein O X
complex O X
of O X
Dcp1 I-MISC 854016
and O X
Dcp2 I-MISC 855605
. O X

We O X
find O X
here O X
that O X
Dcp1p I-MISC 854016
can O X
interact O X
with O X
the O X
release O X
factor O X
eRF3p O X
( O X
Sup35p I-MISC 851752
) O X
in O X
Saccharomyces O X
cerevisiae O X
. O X

Knockout O X
of O X
DCP1 I-MISC 854016
caused O X
not O X
only O X
the O X
accumulation O X
of O X
nonsense O X
mRNAs O X
possibly O X
due O X
to O X
the O X
impaired O X
decapping O X
activity O X
but O X
also O X
the O X
enhancement O X
of O X
the O X
read O X
- O X
through O X
of O X
nonsense O X
codon O X
. O X

To O X
examine O X
the O X
relationship O X
between O X
the O X
two O X
DCP1 I-MISC 854016
- O X
knockout O X
phenotypes O X
, O X
we O X
produced O X
DCP1 I-MISC 854016
point O X
mutants O X
that O X
lack O X
the O X
ability O X
to O X
support O X
the O X
translation O X
termination O X
. O X

Interestingly O X
, O X
decapping O X
activity O X
of O X
Dcp1p I-MISC 854016
was O X
still O X
intact O X
, O X
but O X
its O X
interaction O X
with O X
eRF3p O X
was O X
abolished O X
in O X
the O X
DCP1 I-MISC 854016
mutants O X
, O X
indicating O X
that O X
the O X
two O X
functions O X
originated O X
from O X
different O X
entities O X
of O X
Dcp1p I-MISC 854016
. O X

These O X
results O X
suggest O X
that O X
the O X
decapping O X
enzyme O X
Dcp1p I-MISC 854016
may O X
have O X
an O X
additional O X
role O X
in O X
the O X
translation O X
termination O X
through O X
its O X
interaction O X
with O X
eRF3p O X
. O X

###10656681	4297,4297	40133,40133	41737,41737

Self O X
- O X
association O X
of O X
the O X
SET O X
domains O X
of O X
human O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
and O X
of O X
Drosophila O X
TRITHORAX I-MISC 41737
and O X
ASH1 I-MISC 40133
proteins O X
. O X

The O X
human O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
gene O X
is O X
involved O X
in O X
acute O X
leukemia O X
through O X
gene O X
fusions O X
, O X
partial O X
tandem O X
duplications O X
or O X
a O X
specific O X
deletion O X
. O X

Several O X
sequence O X
motifs O X
within O X
the O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
protein O X
, O X
such O X
as O X
the O X
SET O X
domain O X
, O X
PHD O X
fingers O X
and O X
the O X
region O X
with O X
homology O X
to O X
DNA O X
methyl O X
transferase O X
are O X
shared O X
with O X
other O X
proteins O X
involved O X
in O X
transcription O X
regulation O X
through O X
chromatin O X
alterations O X
. O X

However O X
, O X
the O X
function O X
of O X
these O X
motifs O X
is O X
still O X
not O X
clear O X
. O X

Studying O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
presents O X
an O X
additional O X
challenge O X
because O X
the O X
gene O X
is O X
the O X
human O X
homologue O X
of O X
Drosophila O X
trithorax I-MISC 41737
. O X

The O X
latter O X
is O X
a O X
member O X
of O X
the O X
trithorax I-MISC 41737
- O X
Polycomb O X
gene O X
family O X
which O X
acts O X
to O X
determine O X
the O X
body O X
pattern O X
of O X
Drosophila O X
by O X
maintaining O X
expression O X
or O X
repression O X
of O X
the O X
Antennapedia O X
- O X
bithorax O X
homeotic O X
gene O X
complex O X
. O X

Here O X
we O X
apply O X
yeast O X
two O X
hybrid O X
methodology O X
, O X
in O X
vivo O X
immunoprecipitation O X
and O X
in O X
vitro O X
' O X
pull O X
down O X
' O X
techniques O X
to O X
show O X
self O X
association O X
of O X
the O X
SET O X
motifs O X
of O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
, O X
TRITHORAX I-MISC 41737
and O X
ASH1 I-MISC 40133
proteins O X
( O X
Drosophila O X
ASH1 I-MISC 40133
is O X
encoded O X
by O X
a O X
trithorax I-MISC 41737
- O X
group O X
gene O X
). O X

Point O X
mutations O X
in O X
evolutionary O X
conserved O X
residues O X
of O X
TRITHORAX I-MISC 41737
SET O X
, O X
abolish O X
the O X
interaction O X
. O X

SET O X
- O X
SET O X
interactions O X
might O X
act O X
in O X
integrating O X
the O X
activity O X
of O X
ALL I-MISC 4297
- I-MISC 4297
1 I-MISC 4297
( O X
TRX I-MISC 41737
and O X
ASH1 I-MISC 40133
) O X
protein O X
molecules O X
, O X
simultaneously O X
positioned O X
at O X
different O X
maintenance O X
elements O X
and O X
directing O X
expression O X
of O X
the O X
same O X
or O X
different O X
target O X
genes O X
. O X

###22773792	939508,936772

Physical O X
interaction O X
between O X
coat O X
morphogenetic O X
proteins O X
SpoVID I-MISC 936772
and O X
CotE I-MISC 939508
is O X
necessary O X
for O X
spore O X
encasement O X
in O X
Bacillus O X
subtilis O X
. O X

Endospore O X
formation O X
by O X
Bacillus O X
subtilis O X
is O X
a O X
complex O X
and O X
dynamic O X
process O X
. O X

One O X
of O X
the O X
major O X
challenges O X
of O X
sporulation O X
is O X
the O X
assembly O X
of O X
a O X
protective O X
, O X
multilayered O X
, O X
proteinaceous O X
spore O X
coat O X
, O X
composed O X
of O X
at O X
least O X
70 O X
different O X
proteins O X
. O X

Spore O X
coat O X
formation O X
can O X
be O X
divided O X
into O X
two O X
distinct O X
stages O X
. O X

The O X
first O X
is O X
the O X
recruitment O X
of O X
proteins O X
to O X
the O X
spore O X
surface O X
, O X
dependent O X
on O X
the O X
morphogenetic O X
protein O X
SpoIVA O X
. O X

The O X
second O X
step O X
, O X
known O X
as O X
encasement O X
, O X
involves O X
the O X
migration O X
of O X
the O X
coat O X
proteins O X
around O X
the O X
circumference O X
of O X
the O X
spore O X
in O X
successive O X
waves O X
, O X
a O X
process O X
dependent O X
on O X
the O X
morphogenetic O X
protein O X
SpoVID I-MISC 936772
and O X
the O X
transcriptional O X
regulation O X
of O X
individual O X
coat O X
genes O X
. O X

We O X
provide O X
genetic O X
and O X
biochemical O X
evidence O X
supporting O X
the O X
hypothesis O X
that O X
SpoVID I-MISC 936772
promotes O X
encasement O X
of O X
the O X
spore O X
by O X
establishing O X
direct O X
protein O X
- O X
protein O X
interactions O X
with O X
other O X
coat O X
morphogenetic O X
proteins O X
. O X

It O X
was O X
previously O X
demonstrated O X
that O X
SpoVID I-MISC 936772
directly O X
interacts O X
with O X
SpoIVA O X
and O X
the O X
inner O X
coat O X
morphogenetic O X
protein O X
, O X
SafA O X
. O X

Here O X
, O X
we O X
show O X
by O X
yeast O X
two O X
- O X
hybrid O X
and O X
pulldown O X
assays O X
that O X
SpoVID I-MISC 936772
also O X
interacts O X
directly O X
with O X
the O X
outer O X
coat O X
morphogenetic O X
protein O X
, O X
CotE I-MISC 939508
. O X

Furthermore O X
, O X
by O X
mutational O X
analysis O X
, O X
we O X
identified O X
a O X
specific O X
residue O X
in O X
the O X
N O X
- O X
terminal O X
domain O X
of O X
SpoVID I-MISC 936772
that O X
is O X
essential O X
for O X
the O X
interaction O X
with O X
CotE I-MISC 939508
but O X
dispensable O X
for O X
the O X
interaction O X
with O X
SafA O X
. O X

We O X
propose O X
an O X
updated O X
model O X
of O X
coat O X
assembly O X
and O X
spore O X
encasement O X
that O X
incorporates O X
several O X
physical O X
interactions O X
between O X
the O X
principal O X
coat O X
morphogenetic O X
proteins O X
. O X

###12527904	675,6118

Interaction O X
between O X
BRCA2 I-MISC 675
and O X
replication I-MISC 6118
protein I-MISC 6118
A I-MISC 6118
is O X
compromised O X
by O X
a O X
cancer O X
- O X
predisposing O X
mutation O X
in O X
BRCA2 I-MISC 675
. O X

Mutations O X
in O X
the O X
BRCA1 I-MISC 672
and O X
BRCA2 I-MISC 675
genes O X
predispose O X
women O X
to O X
familial O X
, O X
early O X
- O X
onset O X
breast O X
cancer O X
. O X

Both O X
the O X
BRCA1 I-MISC 672
and O X
BRCA2 I-MISC 675
proteins O X
appear O X
to O X
function O X
in O X
the O X
homologous O X
recombination O X
pathway O X
of O X
DNA O X
double O X
- O X
strand O X
break O X
repair O X
. O X

Both O X
BRCA1 I-MISC 672
and O X
BRCA2 I-MISC 675
have O X
also O X
been O X
implicated O X
in O X
transcription O X
by O X
RNA O X
polymerase O X
II O X
, O X
for O X
both O X
proteins O X
have O X
domains O X
which O X
, O X
when O X
tethered O X
adjacent O X
to O X
a O X
promoter O X
, O X
can O X
activate O X
transcription O X
. O X

In O X
experiments O X
reported O X
here O X
, O X
we O X
have O X
used O X
protein O X
affinity O X
chromatography O X
and O X
coimmunoprecipitation O X
techniques O X
to O X
show O X
that O X
the O X
putative O X
N O X
- O X
terminal O X
acidic O X
transcriptional O X
activation O X
domain O X
of O X
BRCA2 I-MISC 675
interacts O X
with O X
replication I-MISC 6118
protein I-MISC 6118
A I-MISC 6118
( O X
RPA I-MISC 6118
), O X
a O X
protein O X
essential O X
for O X
DNA O X
repair O X
, O X
replication O X
and O X
recombination O X
. O X

This O X
interaction O X
was O X
not O X
mediated O X
by O X
DNA O X
and O X
was O X
specific O X
for O X
human O X
RPA I-MISC 6118
but O X
not O X
yeast O X
RPA I-MISC 6118
. O X

Since O X
the O X
cancer O X
- O X
predisposing O X
mutation O X
Y42C O X
in O X
BRCA2 I-MISC 675
significantly O X
compromised O X
the O X
interaction O X
between O X
RPA I-MISC 6118
and O X
BRCA2 I-MISC 675
, O X
this O X
interaction O X
may O X
be O X
biologically O X
important O X
. O X

That O X
BRCA2 I-MISC 675
protein O X
in O X
HeLa O X
cell O X
extract O X
also O X
coimmunoprecipitated O X
with O X
RPA I-MISC 6118
suggested O X
that O X
this O X
interaction O X
occurs O X
in O X
vivo O X
. O X

Therefore O X
, O X
the O X
transcriptional O X
activation O X
domains O X
within O X
BRCA2 I-MISC 675
, O X
and O X
perhaps O X
BRCA1 I-MISC 672
, O X
may O X
provide O X
links O X
to O X
RPA I-MISC 6118
and O X
DNA O X
repair O X
processes O X
rather O X
than O X
transcription O X
. O X

###11579209	11651,5770

Phosphorylation O X
of O X
PTP1B I-MISC 5770
at O X
Ser O X
( O X
50 O X
) O X
by O X
Akt I-MISC 11651
impairs O X
its O X
ability O X
to O X
dephosphorylate O X
the O X
insulin I-MISC 16337
receptor I-MISC 16337
. O X

PTP1B I-MISC 5770
is O X
a O X
protein O X
tyrosine O X
phosphatase O X
that O X
negatively O X
regulates O X
insulin O X
sensitivity O X
by O X
dephosphorylating O X
the O X
insulin I-MISC 16337
receptor I-MISC 16337
. O X

Akt I-MISC 11651
is O X
a O X
ser O X
/ O X
thr O X
kinase O X
effector O X
of O X
insulin O X
signaling O X
that O X
phosphorylates O X
substrates O X
at O X
the O X
consensus O X
motif O X
RXRXXS O X
/ O X
T O X
. O X

Interestingly O X
, O X
PTP1B I-MISC 5770
contains O X
this O X
motif O X
( O X
RYRDVS O X
( O X
50 O X
)), O X
and O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
( O X
but O X
not O X
mutants O X
with O X
substitutions O X
for O X
Ser O X
( O X
50 O X
)) O X
was O X
significantly O X
phosphorylated O X
by O X
Akt I-MISC 11651
in O X
vitro O X
. O X

To O X
determine O X
whether O X
PTP1B I-MISC 5770
is O X
a O X
substrate O X
for O X
Akt I-MISC 11651
in O X
intact O X
cells O X
, O X
NIH O X
- O X
3T3 O X
( O X
IR O X
) O X
cells O X
transfected O X
with O X
either O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
or O X
PTP1B I-MISC 5770
- O X
S50A O X
were O X
labeled O X
with O X
[( O X
32 O X
) O X
P O X
]- O X
orthophosphate O X
. O X

Insulin O X
stimulation O X
caused O X
a O X
significant O X
increase O X
in O X
phosphorylation O X
of O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
that O X
could O X
be O X
blocked O X
by O X
pretreatment O X
of O X
cells O X
with O X
wortmannin O X
or O X
cotransfection O X
of O X
a O X
dominant O X
inhibitory O X
Akt I-MISC 11651
mutant O X
. O X

Similar O X
results O X
were O X
observed O X
with O X
endogenous O X
PTP1B I-MISC 5770
in O X
untransfected O X
HepG2 O X
cells O X
. O X

Cotransfection O X
of O X
constitutively O X
active O X
Akt I-MISC 11651
caused O X
robust O X
phosphorylation O X
of O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
both O X
in O X
the O X
absence O X
and O X
presence O X
of O X
insulin O X
. O X

By O X
contrast O X
, O X
PTP1B I-MISC 5770
- O X
S50A O X
did O X
not O X
undergo O X
phosphorylation O X
in O X
response O X
to O X
insulin O X
. O X

We O X
tested O X
the O X
functional O X
significance O X
of O X
phosphorylation O X
at O X
Ser O X
( O X
50 O X
) O X
by O X
evaluating O X
insulin I-MISC 16337
receptor I-MISC 16337
autophosphorylation O X
in O X
transfected O X
Cos O X
- O X
7 O X
cells O X
. O X

Insulin O X
treatment O X
caused O X
robust O X
receptor O X
autophosphorylation O X
that O X
could O X
be O X
substantially O X
reduced O X
by O X
coexpression O X
of O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
. O X

Similar O X
results O X
were O X
obtained O X
with O X
coexpression O X
of O X
PTP1B I-MISC 5770
- O X
S50A O X
. O X

However O X
, O X
under O X
the O X
same O X
conditions O X
, O X
PTP1B I-MISC 5770
- O X
S50D O X
had O X
an O X
impaired O X
ability O X
to O X
dephosphorylate O X
the O X
insulin I-MISC 16337
receptor I-MISC 16337
. O X

Moreover O X
, O X
cotransfection O X
of O X
constitutively O X
active O X
Akt I-MISC 11651
significantly O X
inhibited O X
the O X
ability O X
of O X
wild O X
- O X
type O X
PTP1B I-MISC 5770
, O X
but O X
not O X
PTP1B I-MISC 5770
- O X
S50A O X
, O X
to O X
dephosphorylate O X
the O X
insulin I-MISC 16337
receptor I-MISC 16337
. O X

We O X
conclude O X
that O X
PTP1B I-MISC 5770
is O X
a O X
novel O X
substrate O X
for O X
Akt I-MISC 11651
and O X
that O X
phosphorylation O X
of O X
PTP1B I-MISC 5770
by O X
Akt I-MISC 11651
at O X
Ser O X
( O X
50 O X
) O X
may O X
negatively O X
modulate O X
its O X
phosphatase O X
activity O X
creating O X
a O X
positive O X
feedback O X
mechanism O X
for O X
insulin O X
signaling O X
. O X

###23064147	179592,178345

SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
coiled O X
- O X
coil O X
structure O X
and O X
interaction O X
with O X
SAS I-MISC 179592
- I-MISC 179592
5 I-MISC 179592
suggest O X
a O X
regulatory O X
mechanism O X
in O X
C O X
. O X
elegans O X
centriole O X
assembly O X
. O X

The O X
centriole O X
is O X
a O X
conserved O X
microtubule O X
- O X
based O X
organelle O X
essential O X
for O X
both O X
centrosome O X
formation O X
and O X
cilium O X
biogenesis O X
. O X

Five O X
conserved O X
proteins O X
for O X
centriole O X
duplication O X
have O X
been O X
identified O X
. O X

Two O X
of O X
them O X
, O X
SAS I-MISC 179592
- I-MISC 179592
5 I-MISC 179592
and O X
SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
, O X
physically O X
interact O X
with O X
each O X
other O X
and O X
are O X
codependent O X
for O X
their O X
targeting O X
to O X
procentrioles O X
. O X

However O X
, O X
it O X
remains O X
unclear O X
how O X
these O X
two O X
proteins O X
interact O X
at O X
the O X
molecular O X
level O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
the O X
short O X
SAS I-MISC 179592
- I-MISC 179592
5 I-MISC 179592
C O X
- O X
terminal O X
domain O X
( O X
residues O X
390 O X
- O X
404 O X
) O X
specifically O X
binds O X
to O X
a O X
narrow O X
central O X
region O X
( O X
residues O X
275 O X
- O X
288 O X
) O X
of O X
the O X
SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
coiled O X
coil O X
. O X

This O X
was O X
supported O X
by O X
the O X
crystal O X
structure O X
of O X
the O X
SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
coiled O X
- O X
coil O X
domain O X
( O X
CCD O X
), O X
which O X
, O X
together O X
with O X
mutagenesis O X
studies O X
, O X
indicated O X
that O X
the O X
association O X
is O X
mediated O X
by O X
synergistic O X
hydrophobic O X
and O X
electrostatic O X
interactions O X
. O X

The O X
crystal O X
structure O X
also O X
shows O X
a O X
periodic O X
charge O X
pattern O X
along O X
the O X
SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
CCD O X
, O X
which O X
gives O X
rise O X
to O X
an O X
anti O X
- O X
parallel O X
tetramer O X
. O X

Overall O X
, O X
our O X
findings O X
establish O X
the O X
molecular O X
basis O X
of O X
the O X
specific O X
interaction O X
between O X
SAS I-MISC 179592
- I-MISC 179592
5 I-MISC 179592
and O X
SAS I-MISC 178345
- I-MISC 178345
6 I-MISC 178345
, O X
and O X
suggest O X
that O X
both O X
proteins O X
individually O X
adopt O X
an O X
oligomeric O X
conformation O X
that O X
is O X
disrupted O X
upon O X
the O X
formation O X
of O X
the O X
hetero O X
- O X
complex O X
to O X
facilitate O X
the O X
correct O X
assembly O X
of O X
the O X
nine O X
- O X
fold O X
symmetric O X
centriole O X
. O X

###11880648	887477,887598

Mycobacterium O X
tuberculosis O X
WhiB3 I-MISC 887598
interacts O X
with O X
RpoV I-MISC 887477
to O X
affect O X
host O X
survival O X
but O X
is O X
dispensable O X
for O X
in O X
vivo O X
growth O X
. O X

Previous O X
work O X
established O X
that O X
the O X
principal O X
sigma O X
factor O X
( O X
RpoV I-MISC 887477
) O X
of O X
virulent O X
Mycobacterium O X
bovis O X
, O X
a O X
member O X
of O X
the O X
Mycobacterium O X
tuberculosis O X
complex O X
, O X
restores O X
virulence O X
to O X
an O X
attenuated O X
strain O X
containing O X
a O X
point O X
mutation O X
( O X
Arg O X
- O X
515 O X
--> O X
His O X
) O X
in O X
the O X
4 O X
. O X
2 O X
domain O X
of O X
RpoV I-MISC 887477
. O X

We O X
used O X
the O X
4 O X
. O X
2 O X
domain O X
of O X
RpoV I-MISC 887477
as O X
bait O X
in O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
of O X
an O X
M O X
. O X
tuberculosis O X
H37Rv O X
library O X
and O X
identified O X
a O X
putative O X
transcription O X
factor O X
, O X
WhiB3 I-MISC 887598
, O X
which O X
selectively O X
interacts O X
with O X
the O X
4 O X
. O X
2 O X
domain O X
of O X
RpoV I-MISC 887477
in O X
virulent O X
strains O X
but O X
not O X
with O X
the O X
mutated O X
( O X
Arg O X
- O X
515 O X
--> O X
His O X
) O X
allele O X
. O X

Infection O X
of O X
mice O X
and O X
guinea O X
pigs O X
with O X
a O X
M O X
. O X
tuberculosis O X
H37Rv O X
whiB3 I-MISC 887598
deletion O X
mutant O X
strain O X
showed O X
that O X
whiB3 I-MISC 887598
is O X
not O X
necessary O X
for O X
in O X
vivo O X
bacterial O X
replication O X
in O X
either O X
animal O X
model O X
. O X

In O X
contrast O X
, O X
an O X
M O X
. O X
bovis O X
whiB3 I-MISC 887598
deletion O X
mutant O X
was O X
completely O X
attenuated O X
for O X
growth O X
in O X
guinea O X
pigs O X
. O X

However O X
, O X
we O X
found O X
that O X
immunocompetent O X
mice O X
infected O X
with O X
the O X
M O X
. O X
tuberculosis O X
H37Rv O X
whiB3 I-MISC 887598
mutant O X
strain O X
had O X
significantly O X
longer O X
mean O X
survival O X
times O X
as O X
compared O X
with O X
mice O X
challenged O X
with O X
wild O X
- O X
type O X
M O X
. O X
tuberculosis O X
. O X

Remarkably O X
, O X
the O X
bacterial O X
organ O X
burdens O X
of O X
both O X
mutant O X
and O X
wild O X
- O X
type O X
infected O X
mice O X
were O X
identical O X
during O X
the O X
acute O X
and O X
persistent O X
phases O X
of O X
infection O X
. O X

Our O X
results O X
imply O X
that O X
M O X
. O X
tuberculosis O X
replication O X
per O X
se O X
is O X
not O X
a O X
sufficient O X
condition O X
for O X
virulence O X
in O X
vivo O X
. O X

They O X
also O X
indicate O X
a O X
different O X
role O X
for O X
M O X
. O X
bovis O X
and O X
M O X
. O X
tuberculosis O X
whiB3 I-MISC 887598
genes O X
in O X
pathogenesis O X
generated O X
in O X
different O X
animal O X
models O X
. O X

We O X
propose O X
that O X
M O X
. O X
tuberculosis O X
WhiB3 I-MISC 887598
functions O X
as O X
a O X
transcription O X
factor O X
regulating O X
genes O X
that O X
influence O X
the O X
immune O X
response O X
of O X
the O X
host O X
. O X

###22998870	120892,6456

LRRK2 I-MISC 120892
controls O X
an O X
EndoA I-MISC 42265
phosphorylation O X
cycle O X
in O X
synaptic O X
endocytosis O X
. O X

LRRK2 I-MISC 120892
is O X
a O X
kinase O X
mutated O X
in O X
Parkinson O X
' O X
s O X
disease O X
, O X
but O X
how O X
the O X
protein O X
affects O X
synaptic O X
function O X
remains O X
enigmatic O X
. O X

We O X
identified O X
LRRK2 I-MISC 120892
as O X
a O X
critical O X
regulator O X
of O X
EndophilinA I-MISC 6456
. O X

Using O X
genetic O X
and O X
biochemical O X
studies O X
involving O X
Lrrk I-MISC 42447
loss O X
- O X
of O X
- O X
function O X
mutants O X
and O X
Parkinson O X
- O X
related O X
LRRK2 I-MISC 120892
( O X
G2019S O X
) O X
gain O X
- O X
of O X
- O X
kinase O X
function O X
, O X
we O X
show O X
that O X
LRRK2 I-MISC 120892
affects O X
synaptic O X
endocytosis O X
by O X
phosphorylating O X
EndoA I-MISC 42265
at O X
S75 O X
, O X
a O X
residue O X
in O X
the O X
BAR O X
domain O X
. O X

We O X
show O X
that O X
LRRK2 I-MISC 120892
- O X
mediated O X
EndoA I-MISC 42265
phosphorylation O X
has O X
profound O X
effects O X
on O X
EndoA I-MISC 42265
- O X
dependent O X
membrane O X
tubulation O X
and O X
membrane O X
association O X
in O X
vitro O X
and O X
in O X
vivo O X
and O X
on O X
synaptic O X
vesicle O X
endocytosis O X
at O X
Drosophila O X
neuromuscular O X
junctions O X
in O X
vivo O X
. O X

Our O X
work O X
uncovers O X
a O X
regulatory O X
mechanism O X
that O X
indicates O X
that O X
reduced O X
LRRK2 I-MISC 120892
kinase O X
activity O X
facilitates O X
EndoA I-MISC 42265
membrane O X
association O X
, O X
while O X
increased O X
kinase O X
activity O X
inhibits O X
membrane O X
association O X
. O X

Consequently O X
, O X
both O X
too O X
much O X
and O X
too O X
little O X
LRRK2 I-MISC 120892
- O X
dependent O X
EndoA I-MISC 42265
phosphorylation O X
impedes O X
synaptic O X
endocytosis O X
, O X
and O X
we O X
propose O X
a O X
model O X
in O X
which O X
LRRK2 I-MISC 120892
kinase O X
activity O X
is O X
part O X
of O X
an O X
EndoA I-MISC 42265
phosphorylation O X
cycle O X
that O X
facilitates O X
efficient O X
vesicle O X
formation O X
at O X
synapses O X
. O X

###18273061	1956,867	4233,867	867,6850	867,10253	867,81848

Structural O X
basis O X
for O X
a O X
novel O X
intrapeptidyl O X
H O X
- O X
bond O X
and O X
reverse O X
binding O X
of O X
c I-MISC 867
- I-MISC 867
Cbl I-MISC 867
- O X
TKB O X
domain O X
substrates O X
. O X

The O X
c I-MISC 867
- I-MISC 867
Cbl I-MISC 867
tyrosine O X
kinase O X
binding O X
domain O X
( O X
Cbl I-MISC 867
- O X
TKB O X
), O X
essentially O X
an O X
' O X
embedded O X
' O X
SH2 O X
domain O X
, O X
has O X
a O X
critical O X
role O X
in O X
targeting O X
proteins O X
for O X
ubiquitination O X
. O X

To O X
address O X
how O X
this O X
domain O X
can O X
bind O X
to O X
disparate O X
recognition O X
mofits O X
and O X
to O X
determine O X
whether O X
this O X
results O X
in O X
variations O X
in O X
substrate O X
- O X
binding O X
affinity O X
, O X
we O X
compared O X
crystal O X
structures O X
of O X
the O X
Cbl I-MISC 867
- O X
TKB O X
domain O X
complexed O X
with O X
phosphorylated O X
peptides O X
of O X
Sprouty2 I-MISC 10253
, O X
Sprouty4 I-MISC 81848
, O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
, O X
Syk I-MISC 6850
, O X
and O X
c I-MISC 4233
- I-MISC 4233
Met I-MISC 4233
receptors O X
and O X
validated O X
the O X
binding O X
with O X
point O X
- O X
mutational O X
analyses O X
using O X
full O X
- O X
length O X
proteins O X
. O X

An O X
obligatory O X
, O X
intrapeptidyl O X
H O X
- O X
bond O X
between O X
the O X
phosphotyrosine O X
and O X
the O X
conserved O X
asparagine O X
or O X
adjacent O X
arginine O X
is O X
essential O X
for O X
binding O X
and O X
orients O X
the O X
peptide O X
into O X
a O X
positively O X
charged O X
pocket O X
on O X
c I-MISC 867
- I-MISC 867
Cbl I-MISC 867
. O X

Surprisingly O X
, O X
c I-MISC 4233
- I-MISC 4233
Met I-MISC 4233
bound O X
to O X
Cbl I-MISC 867
in O X
the O X
reverse O X
direction O X
, O X
which O X
is O X
unprecedented O X
for O X
SH2 O X
domain O X
binding O X
. O X

The O X
necessity O X
of O X
this O X
intrapeptidyl O X
H O X
- O X
bond O X
was O X
confirmed O X
with O X
isothermal O X
titration O X
calorimetry O X
experiments O X
that O X
also O X
showed O X
Sprouty2 I-MISC 10253
to O X
have O X
the O X
highest O X
binding O X
affinity O X
to O X
c I-MISC 867
- I-MISC 867
Cbl I-MISC 867
; O X
this O X
may O X
enable O X
the O X
selective O X
sequestration O X
of O X
c I-MISC 867
- I-MISC 867
Cbl I-MISC 867
from O X
other O X
target O X
proteins O X
. O X

###9024666	175643,3565776

Interaction O X
between O X
the O X
C O X
. O X
elegans O X
cell O X
- O X
death O X
regulators O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
and O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
. O X

Programmed O X
cell O X
death O X
( O X
apoptosis O X
) O X
is O X
an O X
evolutionarily O X
conserved O X
process O X
used O X
by O X
multicellular O X
organisms O X
to O X
eliminate O X
cells O X
that O X
are O X
not O X
needed O X
or O X
are O X
potentially O X
detrimental O X
to O X
the O X
organism O X
. O X

Members O X
of O X
the O X
Bcl I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
of O X
mammalian O X
proteins O X
are O X
intimately O X
involved O X
in O X
the O X
regulation O X
of O X
apoptosis O X
, O X
but O X
, O X
their O X
precise O X
mechanism O X
of O X
action O X
remains O X
unresolved O X
. O X

In O X
Caenorhabditis O X
elegans O X
, O X
the O X
Bcl I-MISC 596
- I-MISC 596
2 I-MISC 596
homologue O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
prevents O X
cell O X
death O X
by O X
antagonizing O X
the O X
death O X
- O X
promoting O X
activities O X
of O X
CED I-MISC 178272
- I-MISC 178272
3 I-MISC 178272
, O X
a O X
member O X
of O X
the O X
Caspase O X
family O X
of O X
death O X
proteases O X
, O X
and O X
of O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
, O X
a O X
protein O X
with O X
no O X
known O X
mammalian O X
homologue O X
. O X

Here O X
we O X
show O X
that O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
interacts O X
physically O X
with O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
. O X

Mutations O X
that O X
reduce O X
or O X
eliminate O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
activity O X
also O X
disrupt O X
its O X
ability O X
to O X
bind O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
, O X
suggesting O X
that O X
this O X
interaction O X
is O X
important O X
for O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
function O X
. O X

Thus O X
, O X
CED I-MISC 3565776
- I-MISC 3565776
9 I-MISC 3565776
might O X
control O X
C O X
. O X
elegans O X
cell O X
death O X
by O X
binding O X
to O X
and O X
regulating O X
CED I-MISC 175643
- I-MISC 175643
4 I-MISC 175643
activity O X
. O X

We O X
propose O X
that O X
mammalian O X
Bcl I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
members O X
might O X
control O X
apoptosis O X
in O X
a O X
similar O X
way O X
through O X
interaction O X
and O X
regulation O X
of O X
CED I-MISC 9994
- I-MISC 9994
4 I-MISC 9994
homologues O X
or O X
analogues O X
. O X

###16254079	5036,25942

The O X
ErbB3 I-MISC 2065
binding O X
protein O X
Ebp1 I-MISC 5036
interacts O X
with O X
Sin3A I-MISC 25942
to O X
repress O X
E2F1 I-MISC 1869
and O X
AR I-MISC 367
- O X
mediated O X
transcription O X
. O X

Ectopic O X
expression O X
of O X
ebp1 I-MISC 5036
, O X
a O X
member O X
of O X
the O X
PA2G4 I-MISC 5036
family O X
, O X
inhibits O X
the O X
proliferation O X
and O X
induces O X
the O X
differentiation O X
of O X
human O X
breast O X
and O X
prostate O X
cancer O X
cell O X
lines O X
. O X

Ebp1 I-MISC 5036
inhibits O X
transcription O X
of O X
E2F1 I-MISC 1869
and O X
androgen I-MISC 367
receptor I-MISC 367
regulated O X
genes O X
such O X
as O X
prostate I-MISC 354
specific I-MISC 354
antigen I-MISC 354
( O X
PSA O X
) O X
through O X
its O X
interactions O X
with O X
histone O X
deacetylases O X
( O X
HDACs O X
). O X

To O X
further O X
understand O X
Ebp1 I-MISC 5036
' O X
s O X
interactions O X
with O X
other O X
components O X
of O X
the O X
transcriptional O X
repression O X
machinery O X
, O X
we O X
examined O X
the O X
association O X
of O X
Ebp1 I-MISC 5036
with O X
the O X
corepressor O X
Sin3A I-MISC 25942
. O X

Ebp1 I-MISC 5036
interacted O X
with O X
Sin3A I-MISC 25942
both O X
in O X
vitro O X
and O X
in O X
vivo O X
as O X
demonstrated O X
by O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
( O X
GST O X
) O X
pull O X
- O X
down O X
and O X
coimmunoprecipitation O X
analysis O X
. O X

The O X
C O X
- O X
terminal O X
domain O X
of O X
Ebp1 I-MISC 5036
, O X
responsible O X
for O X
its O X
ability O X
to O X
repress O X
transcription O X
and O X
arrest O X
cell O X
growth O X
, O X
was O X
necessary O X
and O X
sufficient O X
for O X
binding O X
Sin3A I-MISC 25942
. O X

The O X
C O X
- O X
terminal O X
domain O X
of O X
Sin3A I-MISC 25942
, O X
containing O X
the O X
paired O X
amphipathic O X
domain O X
4 O X
and O X
the O X
HDAC O X
interacting O X
domain O X
, O X
bound O X
Ebp1 I-MISC 5036
. O X

Recombinant O X
Sin3A I-MISC 25942
bound O X
Ebp1 I-MISC 5036
directly O X
, O X
but O X
recombinant O X
HDAC2 I-MISC 3066
failed O X
to O X
bind O X
Ebp1 I-MISC 5036
. O X

Chromatin O X
immunoprecipitation O X
( O X
ChIP O X
) O X
and O X
DNA O X
affinity O X
precipitation O X
analysis O X
demonstrated O X
that O X
Ebp1 I-MISC 5036
and O X
Sin3A I-MISC 25942
associate O X
at O X
the O X
PSA O X
and O X
E2F1 I-MISC 1869
promoters O X
. O X

Functionally O X
, O X
Sin3A I-MISC 25942
enhanced O X
the O X
ability O X
of O X
Ebp1 I-MISC 5036
to O X
repress O X
transcription O X
of O X
androgen I-MISC 367
receptor I-MISC 367
( O X
AR I-MISC 367
) O X
and O X
E2F1 I-MISC 1869
regulated O X
genes O X
. O X

These O X
results O X
demonstrate O X
that O X
Ebp1 I-MISC 5036
participates O X
in O X
transcriptional O X
regulation O X
via O X
its O X
interaction O X
with O X
the O X
Sin3 O X
- O X
HDAC O X
. O X

###20388642	10133,4218

Overexpression O X
of O X
optineurin I-MISC 10133
E50K O X
disrupts O X
Rab8 I-MISC 4218
interaction O X
and O X
leads O X
to O X
a O X
progressive O X
retinal O X
degeneration O X
in O X
mice O X
. O X

Glaucoma O X
is O X
one O X
of O X
the O X
leading O X
causes O X
of O X
bilateral O X
blindness O X
affecting O X
nearly O X
8 O X
million O X
people O X
worldwide O X
. O X

Glaucoma O X
is O X
characterized O X
by O X
a O X
progressive O X
loss O X
of O X
retinal O X
ganglion O X
cells O X
( O X
RGCs O X
) O X
and O X
is O X
often O X
associated O X
with O X
elevated O X
intraocular O X
pressure O X
( O X
IOP O X
). O X

However O X
, O X
patients O X
with O X
normal O X
tension O X
glaucoma O X
( O X
NTG O X
), O X
a O X
subtype O X
of O X
primary O X
open O X
- O X
angle O X
glaucoma O X
( O X
POAG O X
), O X
develop O X
the O X
disease O X
without O X
IOP O X
elevation O X
. O X

The O X
molecular O X
pathways O X
leading O X
to O X
the O X
pathology O X
of O X
NTG O X
and O X
POAG O X
are O X
still O X
unclear O X
. O X

Here O X
, O X
we O X
describe O X
the O X
phenotypic O X
characteristics O X
of O X
transgenic O X
mice O X
overexpressing O X
wild O X
- O X
type O X
( O X
Wt O X
) O X
or O X
mutated O X
optineurin I-MISC 10133
( O X
Optn I-MISC 10133
). O X

Mutations O X
E50K O X
, O X
H486R O X
and O X
Optn I-MISC 10133
with O X
a O X
deletion O X
of O X
the O X
first O X
( O X
amino O X
acids O X
153 O X
- O X
174 O X
) O X
or O X
second O X
( O X
amino O X
acids O X
426 O X
- O X
461 O X
) O X
leucine O X
zipper O X
were O X
used O X
for O X
overexpression O X
. O X

After O X
16 O X
months O X
, O X
histological O X
abnormalities O X
were O X
exclusively O X
observed O X
in O X
the O X
retina O X
of O X
E50K O X
mutant O X
mice O X
with O X
loss O X
of O X
RGCs O X
and O X
connecting O X
synapses O X
in O X
the O X
peripheral O X
retina O X
leading O X
to O X
a O X
thinning O X
of O X
the O X
nerve O X
fiber O X
layer O X
at O X
the O X
optic O X
nerve O X
head O X
at O X
normal O X
IOP O X
. O X

E50K O X
mice O X
also O X
showed O X
massive O X
apoptosis O X
and O X
degeneration O X
of O X
entire O X
retina O X
, O X
leading O X
to O X
approximately O X
a O X
28 O X
% O X
reduction O X
of O X
the O X
retina O X
thickness O X
. O X

At O X
the O X
molecular O X
level O X
, O X
introduction O X
of O X
the O X
E50K O X
mutation O X
disrupts O X
the O X
interaction O X
between O X
Optn I-MISC 10133
and O X
Rab8 I-MISC 4218
GTPase O X
, O X
a O X
protein O X
involved O X
in O X
the O X
regulation O X
of O X
vesicle O X
transport O X
from O X
Golgi O X
to O X
plasma O X
membrane O X
. O X

Wt O X
Optn I-MISC 10133
and O X
an O X
active O X
GTP O X
- O X
bound O X
form O X
of O X
Rab8 I-MISC 4218
complex O X
were O X
localized O X
at O X
the O X
Golgi O X
complex O X
. O X

These O X
data O X
suggest O X
that O X
alternation O X
of O X
the O X
Optn I-MISC 10133
sequence O X
can O X
initiate O X
significant O X
retinal O X
degeneration O X
in O X
mice O X
. O X

###20553494	5087,4212

An O X
autoinhibitory O X
effect O X
of O X
the O X
homothorax O X
domain O X
of O X
Meis2 I-MISC 4212
. O X

Myeloid I-MISC 4212
ecotropic I-MISC 4212
insertion I-MISC 4212
site I-MISC 4212
( I-MISC 4212
Meis I-MISC 4212
) I-MISC 4212
2 I-MISC 4212
is O X
a O X
homeodomain O X
protein O X
containing O X
a O X
conserved O X
homothorax O X
( O X
Hth I-MISC 41273
) O X
domain O X
that O X
is O X
present O X
in O X
all O X
Meis O X
and O X
Prep O X
family O X
proteins O X
and O X
in O X
the O X
Drosophila O X
Hth I-MISC 41273
protein O X
. O X

The O X
Hth I-MISC 41273
domain O X
mediates O X
interaction O X
with O X
Pbx O X
homeodomain O X
proteins O X
, O X
allowing O X
for O X
efficient O X
DNA O X
binding O X
. O X

Here O X
we O X
show O X
that O X
, O X
like O X
Meis1 I-MISC 41273
, O X
Meis2 I-MISC 4212
has O X
a O X
strong O X
C O X
- O X
terminal O X
transcriptional O X
activation O X
domain O X
, O X
which O X
is O X
required O X
for O X
full O X
activation O X
of O X
transcription O X
by O X
homeodomain O X
protein O X
complexes O X
composed O X
of O X
Meis2 I-MISC 4212
and O X
Pbx1 I-MISC 5087
. O X

We O X
also O X
show O X
that O X
the O X
activity O X
of O X
the O X
activation O X
domain O X
is O X
inhibited O X
by O X
the O X
Hth I-MISC 41273
domain O X
, O X
and O X
that O X
this O X
autoinhibition O X
can O X
be O X
partially O X
relieved O X
by O X
the O X
interaction O X
of O X
Pbx1 I-MISC 5087
with O X
the O X
Hth I-MISC 41273
domain O X
of O X
Meis2 I-MISC 4212
. O X

Targeting O X
of O X
the O X
Hth I-MISC 41273
domain O X
to O X
DNA O X
suggests O X
that O X
it O X
is O X
not O X
a O X
portable O X
trans O X
- O X
acting O X
repression O X
domain O X
. O X

However O X
, O X
the O X
Hth I-MISC 41273
domain O X
can O X
inhibit O X
a O X
linked O X
activation O X
domain O X
, O X
and O X
this O X
inhibition O X
is O X
not O X
limited O X
to O X
the O X
Meis2 I-MISC 4212
activation O X
domain O X
. O X

Database O X
searching O X
reveals O X
that O X
the O X
Meis3 O X
. O X
2 O X
splice O X
variant O X
, O X
which O X
is O X
found O X
in O X
several O X
vertebrate O X
species O X
, O X
disrupts O X
the O X
Hth I-MISC 41273
domain O X
by O X
removing O X
17 O X
codons O X
from O X
the O X
5 O X
'- O X
end O X
of O X
exon O X
6 O X
. O X

We O X
show O X
that O X
the O X
equivalent O X
deletion O X
in O X
Meis2 I-MISC 4212
derepresses O X
the O X
C O X
- O X
terminal O X
activation O X
domain O X
and O X
weakens O X
interaction O X
with O X
Pbx1 I-MISC 5087
. O X

This O X
work O X
suggests O X
that O X
the O X
transcriptional O X
activity O X
of O X
all O X
members O X
of O X
the O X
Meis O X
/ O X
Prep O X
Hth I-MISC 41273
protein O X
family O X
is O X
subject O X
to O X
autoinhibition O X
by O X
their O X
Hth I-MISC 41273
domains O X
, O X
and O X
that O X
the O X
Meis3 O X
. O X
2 O X
splice O X
variant O X
encodes O X
a O X
protein O X
that O X
bypasses O X
this O X
autoinhibitory O X
effect O X
. O X

###17545281	880376,877857

Protein O X
modulator O X
of O X
multidrug O X
efflux O X
gene O X
expression O X
in O X
Pseudomonas O X
aeruginosa O X
. O X

nalC O X
multidrug O X
- O X
resistant O X
mutants O X
of O X
Pseudomonas O X
aeruginosa O X
show O X
enhanced O X
expression O X
of O X
the O X
mexAB O X
- O X
oprM O X
multidrug O X
efflux O X
system O X
as O X
a O X
direct O X
result O X
of O X
the O X
production O X
of O X
a O X
ca O X
. O X

6 O X
, O X
100 O X
- O X
Da O X
protein O X
, O X
PA3719 I-MISC 880376
, O X
in O X
these O X
mutants O X
. O X

Using O X
a O X
bacterial O X
two O X
- O X
hybrid O X
system O X
, O X
PA3719 I-MISC 880376
was O X
shown O X
to O X
interact O X
in O X
vivo O X
with O X
MexR I-MISC 877857
, O X
a O X
repressor O X
of O X
mexAB O X
- O X
oprM O X
expression O X
. O X

Isothermal O X
titration O X
calorimetry O X
( O X
ITC O X
) O X
studies O X
confirmed O X
a O X
high O X
- O X
affinity O X
interaction O X
( O X
equilibrium O X
dissociation O X
constant O X
[ O X
K O X
( O X
D O X
)], O X
158 O X
. O X
0 O X
+/- O X
18 O X
. O X
1 O X
nM O X
) O X
of O X
PA3719 I-MISC 880376
with O X
MexR I-MISC 877857
in O X
vitro O X
. O X

PA3719 I-MISC 880376
binding O X
to O X
and O X
formation O X
of O X
a O X
complex O X
with O X
MexR I-MISC 877857
obviated O X
repressor O X
binding O X
to O X
its O X
operator O X
, O X
which O X
overlaps O X
the O X
efflux O X
operon O X
promoter O X
, O X
suggesting O X
that O X
mexAB O X
- O X
oprM O X
hyperexpression O X
in O X
nalC O X
mutants O X
results O X
from O X
PA3719 I-MISC 880376
modulation O X
of O X
MexR I-MISC 877857
repressor O X
activity O X
. O X

Consistent O X
with O X
this O X
, O X
MexR I-MISC 877857
repression O X
of O X
mexA O X
transcription O X
in O X
an O X
in O X
vitro O X
transcription O X
assay O X
was O X
alleviated O X
by O X
PA3719 I-MISC 880376
. O X

Mutations O X
in O X
MexR I-MISC 877857
compromising O X
its O X
interaction O X
with O X
PA3719 I-MISC 880376
in O X
vivo O X
were O X
isolated O X
and O X
shown O X
to O X
be O X
located O X
internally O X
and O X
distributed O X
throughout O X
the O X
protein O X
, O X
suggesting O X
that O X
they O X
impacted O X
PA3719 I-MISC 880376
binding O X
by O X
altering O X
MexR I-MISC 877857
structure O X
or O X
conformation O X
rather O X
than O X
by O X
having O X
residues O X
interacting O X
specifically O X
with O X
PA3719 I-MISC 880376
. O X

Four O X
of O X
six O X
mutant O X
MexR I-MISC 877857
proteins O X
studied O X
retained O X
repressor O X
activity O X
even O X
in O X
a O X
nalC O X
strain O X
producing O X
PA3719 I-MISC 880376
. O X

Again O X
, O X
this O X
is O X
consistent O X
with O X
a O X
PA3719 I-MISC 880376
interaction O X
with O X
MexR I-MISC 877857
being O X
necessary O X
to O X
obviate O X
MexR I-MISC 877857
repressor O X
activity O X
. O X

The O X
gene O X
encoding O X
PA3719 I-MISC 880376
has O X
thus O X
been O X
renamed O X
armR O X
( O X
antirepressor O X
for O X
MexR I-MISC 877857
). O X

A O X
representative O X
" O X
noninteracting O X
" O X
mutant O X
MexR I-MISC 877857
protein O X
, O X
MexR I-MISC 877857
( O X
I104F O X
), O X
was O X
purified O X
, O X
and O X
ITC O X
confirmed O X
that O X
it O X
bound O X
PA3719 I-MISC 880376
with O X
reduced O X
affinity O X
( O X
5 O X
. O X
4 O X
- O X
fold O X
reduced O X
; O X
K O X
( O X
D O X
), O X
853 O X
. O X
2 O X
+/- O X
151 O X
. O X
1 O X
nM O X
). O X

Consistent O X
with O X
this O X
, O X
MexR I-MISC 877857
( O X
I104F O X
) O X
repressor O X
activity O X
, O X
as O X
assessed O X
using O X
the O X
in O X
vitro O X
transcription O X
assay O X
, O X
was O X
only O X
weakly O X
compromised O X
by O X
PA3719 I-MISC 880376
. O X

Finally O X
, O X
two O X
mutations O X
( O X
L36P O X
and O X
W45A O X
) O X
in O X
ArmR O X
compromising O X
its O X
interaction O X
with O X
MexR I-MISC 877857
have O X
been O X
isolated O X
and O X
mapped O X
to O X
a O X
putative O X
C O X
- O X
terminal O X
alpha O X
- O X
helix O X
of O X
the O X
protein O X
that O X
alone O X
is O X
sufficient O X
for O X
interaction O X
with O X
MexR I-MISC 877857
. O X

###21795333	3783750,7329

Epstein O X
- O X
Barr O X
virus O X
latent I-MISC 3783750
membrane I-MISC 3783750
protein I-MISC 3783750
1 I-MISC 3783750
( O X
LMP1 I-MISC 3783750
) O X
C O X
- O X
terminal O X
- O X
activating O X
region O X
3 O X
contributes O X
to O X
LMP1 I-MISC 3783750
- O X
mediated O X
cellular O X
migration O X
via O X
its O X
interaction O X
with O X
Ubc9 I-MISC 7329
. O X

Epstein O X
- O X
Barr O X
virus O X
( O X
EBV O X
) O X
latent I-MISC 3783750
membrane I-MISC 3783750
protein I-MISC 3783750
1 I-MISC 3783750
( O X
LMP1 I-MISC 3783750
), O X
the O X
principal O X
viral O X
oncoprotein O X
and O X
a O X
member O X
of O X
the O X
tumor O X
necrosis O X
factor O X
receptor O X
superfamily O X
, O X
is O X
a O X
constitutively O X
active O X
membrane O X
signaling O X
protein O X
that O X
regulates O X
multiple O X
signal O X
transduction O X
pathways O X
via O X
its O X
C O X
- O X
terminal O X
- O X
activating O X
region O X
1 O X
( O X
CTAR1 O X
) O X
and O X
CTAR2 O X
, O X
and O X
also O X
the O X
less O X
- O X
studied O X
CTAR3 O X
. O X

Because O X
protein O X
sumoylation O X
among O X
other O X
posttranslational O X
modifications O X
may O X
regulate O X
many O X
signaling O X
pathways O X
induced O X
by O X
LMP1 I-MISC 3783750
, O X
we O X
investigated O X
whether O X
during O X
EBV O X
latency O X
LMP1 I-MISC 3783750
regulates O X
sumoylation O X
processes O X
that O X
control O X
cellular O X
activation O X
and O X
cellular O X
responses O X
. O X

By O X
immunoprecipitation O X
experiments O X
, O X
we O X
show O X
that O X
LMP1 I-MISC 3783750
interacts O X
with O X
Ubc9 I-MISC 7329
, O X
the O X
single O X
reported O X
SUMO O X
- O X
conjugating O X
enzyme O X
. O X

Requirements O X
for O X
LMP1 I-MISC 3783750
- O X
Ubc9 I-MISC 7329
interactions O X
include O X
enzymatically O X
active O X
Ubc9 I-MISC 7329
: O X
expression O X
of O X
inactive O X
Ubc9 I-MISC 7329
( O X
Ubc9 I-MISC 7329
C93S O X
) O X
inhibited O X
the O X
LMP1 I-MISC 3783750
- O X
Ubc9 I-MISC 7329
interaction O X
. O X

LMP1 I-MISC 3783750
CTAR3 I-MISC 9260
, O X
but O X
not O X
CTAR1 O X
and O X
CTAR2 O X
, O X
participated O X
in O X
the O X
LMP1 I-MISC 3783750
- O X
Ubc9 I-MISC 7329
interaction O X
, O X
and O X
amino O X
acid O X
sequences O X
found O X
in O X
CTAR3 O X
, O X
including O X
the O X
JAK O X
- O X
interacting O X
motif O X
, O X
contributed O X
to O X
this O X
interaction O X
. O X

Furthermore O X
, O X
LMP1 I-MISC 3783750
expression O X
coincided O X
with O X
increased O X
sumoylation O X
of O X
cellular O X
proteins O X
, O X
and O X
disruption O X
of O X
the O X
Ubc9 I-MISC 7329
- O X
LMP1 I-MISC 3783750
CTAR3 O X
interaction O X
almost O X
completely O X
abrogated O X
LMP1 I-MISC 3783750
- O X
induced O X
protein O X
sumoylation O X
, O X
suggesting O X
that O X
this O X
interaction O X
promotes O X
the O X
sumoylation O X
of O X
downstream O X
targets O X
. O X

Additional O X
consequences O X
of O X
the O X
disruption O X
of O X
the O X
LMP1 I-MISC 3783750
CTAR3 O X
- O X
Ubc9 I-MISC 7329
interaction O X
revealed O X
effects O X
on O X
cellular O X
migration O X
, O X
a O X
hallmark O X
of O X
oncogenesis O X
. O X

Together O X
, O X
these O X
data O X
demonstrate O X
that O X
LMP1 I-MISC 3783750
CTAR3 I-MISC 9260
does O X
in O X
fact O X
function O X
in O X
intracellular O X
signaling O X
and O X
leads O X
to O X
biological O X
effects O X
. O X

We O X
propose O X
that O X
LMP1 I-MISC 3783750
, O X
by O X
interaction O X
with O X
Ubc9 I-MISC 7329
, O X
modulates O X
sumoylation O X
processes O X
, O X
which O X
regulate O X
signal O X
transduction O X
pathways O X
that O X
affect O X
phenotypic O X
changes O X
associated O X
with O X
oncogenesis O X
. O X

###10675337	2553,3054

The O X
novel O X
coactivator O X
C1 O X
( O X
HCF I-MISC 3054
) O X
coordinates O X
multiprotein O X
enhancer O X
formation O X
and O X
mediates O X
transcription O X
activation O X
by O X
GABP I-MISC 2553
. O X

Transcription O X
of O X
the O X
herpes O X
simplex O X
virus O X
1 O X
( O X
HSV O X
- O X
1 O X
) O X
immediate O X
early O X
( O X
IE O X
) O X
genes O X
is O X
determined O X
by O X
multiprotein O X
enhancer O X
complexes O X
. O X

The O X
core O X
enhancer O X
assembly O X
requires O X
the O X
interactions O X
of O X
the O X
POU O X
- O X
homeodomain O X
protein O X
Oct I-MISC 5451
- I-MISC 5451
1 I-MISC 5451
, O X
the O X
viral O X
transactivator O X
alphaTIF O X
and O X
the O X
cellular O X
factor I-MISC 3054
C1 I-MISC 3054
( O X
HCF I-MISC 3054
). O X

In O X
this O X
context O X
, O X
the O X
C1 I-MISC 3054
factor I-MISC 3054
interacts O X
with O X
each O X
protein O X
to O X
assemble O X
the O X
stable O X
enhancer O X
complex O X
. O X

In O X
addition O X
, O X
the O X
IE O X
enhancer O X
cores O X
contain O X
adjacent O X
binding O X
sites O X
for O X
other O X
cellular O X
transcription O X
factors O X
such O X
as O X
Sp1 I-MISC 6667
and O X
GA I-MISC 2553
- I-MISC 2553
binding I-MISC 2553
protein I-MISC 2553
( O X
GABP I-MISC 2553
). O X

In O X
this O X
study O X
, O X
a O X
direct O X
interaction O X
of O X
the O X
C1 I-MISC 3054
factor I-MISC 3054
with O X
GABP I-MISC 2553
is O X
demonstrated O X
, O X
defining O X
the O X
C1 I-MISC 3054
factor I-MISC 3054
as O X
the O X
critical O X
coordinator O X
of O X
the O X
enhancer O X
complex O X
assembly O X
. O X

In O X
addition O X
, O X
mutations O X
that O X
reduce O X
the O X
GABP I-MISC 2553
transactivation O X
potential O X
also O X
impair O X
the O X
C1 I-MISC 3054
- I-MISC 3183
GABP I-MISC 2553
interaction O X
, O X
indicating O X
that O X
the O X
C1 I-MISC 3054
factor I-MISC 3054
functions O X
as O X
a O X
novel O X
coactivator O X
of O X
GABP I-MISC 2553
- O X
mediated O X
transcription O X
. O X

The O X
interaction O X
and O X
coordinated O X
assembly O X
of O X
the O X
enhancer O X
proteins O X
by O X
the O X
C1 I-MISC 3054
factor I-MISC 3054
may O X
be O X
critical O X
for O X
the O X
regulation O X
of O X
the O X
HSV O X
lytic O X
- O X
latent O X
cycle O X
. O X

###12592399	945829,945829

The O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
dimerization O X
domain O X
defines O X
a O X
new O X
fold O X
contributing O X
to O X
DNA O X
recognition O X
. O X

H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
, O X
a O X
protein O X
found O X
in O X
Gram O X
- O X
negative O X
bacteria O X
, O X
is O X
involved O X
in O X
structuring O X
the O X
bacterial O X
chromosome O X
and O X
acts O X
as O X
a O X
global O X
regulator O X
for O X
the O X
expression O X
of O X
a O X
wide O X
variety O X
of O X
genes O X
. O X

These O X
functions O X
are O X
correlated O X
with O X
both O X
its O X
DNA O X
- O X
binding O X
and O X
oligomerization O X
properties O X
. O X

We O X
have O X
identified O X
the O X
minimal O X
dimerization O X
domain O X
of O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
, O X
a O X
46 O X
amino O X
acid O X
- O X
long O X
N O X
- O X
terminal O X
fragment O X
, O X
and O X
determined O X
its O X
structure O X
using O X
heteronuclear O X
NMR O X
spectroscopy O X
. O X

The O X
highly O X
intertwined O X
structure O X
of O X
the O X
dimer O X
, O X
reminiscent O X
of O X
a O X
handshake O X
, O X
defines O X
a O X
new O X
structural O X
fold O X
, O X
which O X
may O X
offer O X
a O X
possibility O X
for O X
discriminating O X
prokaryotic O X
from O X
eukaryotic O X
proteins O X
in O X
drug O X
design O X
. O X

Using O X
mutational O X
analysis O X
, O X
we O X
also O X
show O X
that O X
this O X
N O X
- O X
terminal O X
domain O X
actively O X
contributes O X
to O X
DNA O X
binding O X
, O X
conversely O X
to O X
the O X
current O X
paradigm O X
. O X

Together O X
, O X
our O X
data O X
allows O X
us O X
to O X
propose O X
a O X
model O X
for O X
the O X
action O X
of O X
full O X
length O X
H I-MISC 945829
- I-MISC 945829
NS I-MISC 945829
. O X

###10747027	27221,12412	12412,21849

The O X
structure O X
of O X
mouse O X
HP1 I-MISC 12419
suggests O X
a O X
unique O X
mode O X
of O X
single O X
peptide O X
recognition O X
by O X
the O X
shadow O X
chromo O X
domain O X
dimer O X
. O X

The O X
heterochromatin I-MISC 12419
protein I-MISC 12419
1 I-MISC 12419
( O X
HP1 I-MISC 12419
) O X
family O X
of O X
proteins O X
is O X
involved O X
in O X
gene O X
silencing O X
via O X
the O X
formation O X
of O X
heterochromatic O X
structures O X
. O X

They O X
are O X
composed O X
of O X
two O X
related O X
domains O X
: O X
an O X
N O X
- O X
terminal O X
chromo O X
domain O X
and O X
a O X
C O X
- O X
terminal O X
shadow O X
chromo O X
domain O X
. O X

Present O X
results O X
suggest O X
that O X
chromo O X
domains O X
may O X
function O X
as O X
protein O X
interaction O X
motifs O X
, O X
bringing O X
together O X
different O X
proteins O X
in O X
multi O X
- O X
protein O X
complexes O X
and O X
locating O X
them O X
in O X
heterochromatin O X
. O X

We O X
have O X
previously O X
determined O X
the O X
structure O X
of O X
the O X
chromo O X
domain O X
from O X
the O X
mouse O X
HP1beta I-MISC 12412
protein O X
, O X
MOD1 I-MISC 12412
. O X

We O X
show O X
here O X
that O X
, O X
in O X
contrast O X
to O X
the O X
chromo O X
domain O X
, O X
the O X
shadow O X
chromo O X
domain O X
is O X
a O X
homodimer O X
. O X

The O X
intact O X
HP1beta I-MISC 12412
protein O X
is O X
also O X
dimeric O X
, O X
where O X
the O X
interaction O X
is O X
mediated O X
by O X
the O X
shadow O X
chromo O X
domain O X
, O X
with O X
the O X
chromo O X
domains O X
moving O X
independently O X
of O X
each O X
other O X
at O X
the O X
end O X
of O X
flexible O X
linkers O X
. O X

Mapping O X
studies O X
, O X
with O X
fragments O X
of O X
the O X
CAF1 I-MISC 27221
and O X
TIF1beta I-MISC 21849
proteins O X
, O X
show O X
that O X
an O X
intact O X
, O X
dimeric O X
, O X
shadow O X
chromo O X
domain O X
structure O X
is O X
required O X
for O X
complex O X
formation O X
. O X

###15546359	827103,825473

The O X
IAA1 O X
protein O X
is O X
encoded O X
by O X
AXR5 I-MISC 827103
and O X
is O X
a O X
substrate O X
of O X
SCF I-MISC 4254
( O X
TIR1 I-MISC 825473
). O X

Recent O X
studies O X
of O X
auxin O X
response O X
have O X
focused O X
on O X
the O X
functions O X
of O X
three O X
sets O X
of O X
proteins O X
: O X
the O X
auxin O X
( O X
Aux O X
) O X
response O X
factors O X
( O X
ARFs O X
), O X
the O X
Aux O X
/ O X
IAAs O X
, O X
and O X
the O X
F O X
- O X
box O X
protein O X
TIR1 I-MISC 825473
. O X

The O X
ARF O X
proteins O X
bind O X
DNA O X
and O X
directly O X
activate O X
or O X
repress O X
transcription O X
of O X
target O X
genes O X
while O X
the O X
Aux O X
/ O X
IAA O X
proteins O X
repress O X
ARF O X
function O X
. O X

TIR1 I-MISC 825473
is O X
part O X
of O X
a O X
ubiquitin O X
protein O X
ligase O X
required O X
for O X
degradation O X
of O X
Aux O X
/ O X
IAA O X
proteins O X
. O X

Here O X
we O X
report O X
the O X
isolation O X
and O X
characterization O X
of O X
a O X
novel O X
mutant O X
of O X
Arabidopsis O X
called O X
axr5 I-MISC 827103
- O X
1 O X
. O X

Mutant O X
plants O X
are O X
resistant O X
to O X
auxin O X
and O X
display O X
a O X
variety O X
of O X
auxin O X
- O X
related O X
growth O X
defects O X
including O X
defects O X
in O X
root O X
and O X
shoot O X
tropisms O X
. O X

Further O X
, O X
the O X
axr5 I-MISC 827103
- O X
1 O X
mutation O X
results O X
in O X
a O X
decrease O X
in O X
auxin O X
- O X
regulated O X
transcription O X
. O X

The O X
molecular O X
cloning O X
of O X
AXR5 I-MISC 827103
revealed O X
that O X
the O X
gene O X
encodes O X
the O X
IAA1 O X
protein O X
, O X
a O X
member O X
of O X
the O X
Aux O X
/ O X
IAA O X
family O X
of O X
proteins O X
. O X

AXR5 I-MISC 827103
is O X
expressed O X
throughout O X
plant O X
development O X
consistent O X
with O X
the O X
pleiotropic O X
mutant O X
phenotype O X
. O X

The O X
axr5 I-MISC 827103
- O X
1 O X
mutation O X
results O X
in O X
an O X
amino O X
acid O X
substitution O X
in O X
conserved O X
domain O X
II O X
of O X
the O X
protein O X
, O X
similar O X
to O X
gain O X
- O X
of O X
- O X
function O X
mutations O X
recovered O X
in O X
other O X
members O X
of O X
this O X
gene O X
family O X
. O X

Biochemical O X
studies O X
show O X
that O X
IAA1 O X
/ O X
AXR5 I-MISC 827103
interacts O X
with O X
TIR1 I-MISC 825473
in O X
an O X
auxin O X
- O X
dependent O X
manner O X
. O X

The O X
mutation O X
prevents O X
this O X
interaction O X
suggesting O X
that O X
the O X
mutant O X
phenotype O X
is O X
caused O X
by O X
the O X
accumulation O X
of O X
IAA1 O X
/ O X
AXR5 I-MISC 827103
. O X

Our O X
results O X
provide O X
further O X
support O X
for O X
a O X
model O X
in O X
which O X
most O X
members O X
of O X
the O X
Aux O X
/ O X
IAA O X
family O X
are O X
targeted O X
for O X
degradation O X
by O X
SCFTIR1 I-MISC 825473
in O X
response O X
to O X
auxin O X
. O X

###15009215	2010,9774

Emerin I-MISC 2010
binding O X
to O X
Btf I-MISC 9774
, O X
a O X
death O X
- O X
promoting O X
transcriptional O X
repressor O X
, O X
is O X
disrupted O X
by O X
a O X
missense O X
mutation O X
that O X
causes O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
. O X

Loss O X
of O X
functional O X
emerin I-MISC 2010
, O X
a O X
nuclear O X
membrane O X
protein O X
, O X
causes O X
X O X
- O X
linked O X
recessive O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
. O X

In O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
, O X
we O X
found O X
that O X
emerin I-MISC 2010
interacts O X
with O X
Btf I-MISC 9774
, O X
a O X
death O X
- O X
promoting O X
transcriptional O X
repressor O X
, O X
which O X
is O X
expressed O X
at O X
high O X
levels O X
in O X
skeletal O X
muscle O X
. O X

Biochemical O X
analysis O X
showed O X
that O X
emerin I-MISC 2010
binds O X
Btf I-MISC 9774
with O X
an O X
equilibrium O X
affinity O X
( O X
KD O X
) O X
of O X
100 O X
nm O X
. O X

Using O X
a O X
collection O X
of O X
21 O X
clustered O X
alanine O X
- O X
substitution O X
mutations O X
in O X
emerin I-MISC 2010
, O X
the O X
residues O X
required O X
for O X
binding O X
to O X
Btf I-MISC 9774
mapped O X
to O X
two O X
regions O X
of O X
emerin I-MISC 2010
that O X
flank O X
its O X
lamin O X
- O X
binding O X
domain O X
. O X

Two O X
disease O X
- O X
causing O X
mutations O X
in O X
emerin I-MISC 2010
, O X
S54F O X
and O X
Delta95 O X
- O X
99 O X
, O X
disrupted O X
binding O X
to O X
Btf I-MISC 9774
. O X

The O X
Delta95 O X
- O X
99 O X
mutation O X
was O X
relatively O X
uninformative O X
, O X
as O X
this O X
mutation O X
also O X
disrupts O X
emerin I-MISC 2010
binding O X
to O X
lamin O X
A O X
and O X
a O X
different O X
transcription O X
repressor O X
named O X
germ I-MISC 64396
cell I-MISC 64396
- I-MISC 64396
less I-MISC 64396
( O X
GCL I-MISC 64396
). O X

In O X
striking O X
contrast O X
, O X
emerin I-MISC 2010
mutant O X
S54F O X
, O X
which O X
binds O X
normally O X
to O X
barrier I-MISC 8815
- I-MISC 8815
to I-MISC 8815
- I-MISC 8815
autointegration I-MISC 8815
factor I-MISC 8815
, O X
lamin O X
A O X
and O X
GCL I-MISC 64396
, O X
selectively O X
disrupted O X
emerin I-MISC 2010
binding O X
to O X
Btf I-MISC 9774
. O X

We O X
localized O X
endogenous O X
Btf I-MISC 9774
in O X
HeLa O X
cells O X
by O X
indirect O X
immunoflurorescence O X
using O X
affinity O X
- O X
purified O X
antibodies O X
against O X
Btf I-MISC 9774
. O X

In O X
nonapoptotic O X
HeLa O X
cells O X
Btf I-MISC 9774
was O X
found O X
in O X
dot O X
- O X
like O X
structures O X
throughout O X
the O X
nuclear O X
interior O X
. O X

However O X
, O X
within O X
3 O X
h O X
after O X
treating O X
cells O X
with O X
Fas O X
antibody O X
to O X
induce O X
apoptosis O X
, O X
the O X
distribution O X
of O X
Btf I-MISC 9774
changed O X
, O X
and O X
Btf I-MISC 9774
concentrated O X
in O X
a O X
distinct O X
zone O X
near O X
the O X
nuclear O X
envelope O X
. O X

These O X
results O X
suggest O X
that O X
Btf I-MISC 9774
localization O X
is O X
regulated O X
by O X
apoptotic O X
signals O X
, O X
and O X
that O X
loss O X
of O X
emerin I-MISC 2010
binding O X
to O X
Btf I-MISC 9774
may O X
be O X
relevant O X
to O X
muscle O X
wasting O X
in O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
. O X

###22404908	5364,29984

Effect O X
of O X
cancer O X
- O X
associated O X
mutations O X
in O X
the O X
PlexinB1 I-MISC 5364
gene O X
. O X

BACKGROUND O X
: O X
Semaphorins O X
act O X
as O X
chemotactic O X
cues O X
for O X
cell O X
movement O X
via O X
their O X
transmembrane O X
receptors O X
, O X
plexins O X
. O X

Somatic O X
missense O X
mutations O X
in O X
the O X
plexinB1 I-MISC 5364
gene O X
coupled O X
with O X
overexpression O X
of O X
the O X
protein O X
frequently O X
occur O X
in O X
prostate O X
tumours O X
, O X
indicating O X
a O X
role O X
for O X
plexinB1 I-MISC 5364
in O X
the O X
pathogenesis O X
of O X
prostate O X
cancer O X
. O X

RESULTS O X
: O X
Two O X
specific O X
mutations O X
found O X
in O X
prostate O X
cancer O X
enhance O X
RhoD I-MISC 29984
binding O X
and O X
one O X
other O X
mutation O X
results O X
in O X
loss O X
of O X
inhibition O X
of O X
Rac O X
- O X
dependent O X
Pak1 I-MISC 5058
phosphorylation O X
and O X
lamellipodia O X
formation O X
and O X
in O X
impairment O X
of O X
trafficking O X
of O X
plexinB1 I-MISC 5364
to O X
the O X
membrane O X
. O X

None O X
of O X
the O X
three O X
characterised O X
mutations O X
affect O X
PDZRhoGEF O X
binding O X
, O X
RhoA O X
activity O X
, O X
the O X
interaction O X
of O X
plexinB1 I-MISC 5364
with O X
the O X
oncogenes O X
ErbB2 I-MISC 2064
or O X
c I-MISC 4233
- I-MISC 4233
Met I-MISC 4233
or O X
ErbB2 I-MISC 2064
phosphorylation O X
. O X

The O X
mutations O X
have O X
the O X
net O X
effect O X
of O X
increasing O X
cell O X
motility O X
by O X
blocking O X
plexinB1 I-MISC 5364
- O X
mediated O X
inhibition O X
of O X
Rac O X
while O X
enhancing O X
the O X
interaction O X
with O X
RhoD I-MISC 29984
, O X
an O X
anti O X
- O X
migratory O X
factor O X
. O X

CONCLUSIONS O X
: O X
PlexinB1 I-MISC 5364
mutations O X
block O X
plexinB1 I-MISC 5364
- O X
mediated O X
signalling O X
pathways O X
that O X
inhibit O X
cell O X
motility O X
. O X

###15526038	43,8292

The O X
synaptic O X
acetylcholinesterase I-MISC 43
tetramer O X
assembles O X
around O X
a O X
polyproline O X
II O X
helix O X
. O X

Functional O X
localization O X
of O X
acetylcholinesterase I-MISC 43
( O X
AChE I-MISC 43
) O X
in O X
vertebrate O X
muscle O X
and O X
brain O X
depends O X
on O X
interaction O X
of O X
the O X
tryptophan O X
amphiphilic O X
tetramerization O X
( O X
WAT O X
) O X
sequence O X
, O X
at O X
the O X
C O X
- O X
terminus O X
of O X
its O X
major O X
splice O X
variant O X
( O X
T O X
), O X
with O X
a O X
proline O X
- O X
rich O X
attachment O X
domain O X
( O X
PRAD O X
), O X
of O X
the O X
anchoring O X
proteins O X
, O X
collagenous I-MISC 8292
( O X
ColQ I-MISC 8292
) O X
and O X
proline O X
- O X
rich O X
membrane O X
anchor O X
. O X

The O X
crystal O X
structure O X
of O X
the O X
WAT O X
/ O X
PRAD O X
complex O X
reveals O X
a O X
novel O X
supercoil O X
structure O X
in O X
which O X
four O X
parallel O X
WAT O X
chains O X
form O X
a O X
left O X
- O X
handed O X
superhelix O X
around O X
an O X
antiparallel O X
left O X
- O X
handed O X
PRAD O X
helix O X
resembling O X
polyproline O X
II O X
. O X

The O X
WAT O X
coiled O X
coils O X
possess O X
a O X
WWW O X
motif O X
making O X
repetitive O X
hydrophobic O X
stacking O X
and O X
hydrogen O X
- O X
bond O X
interactions O X
with O X
the O X
PRAD O X
. O X

The O X
WAT O X
chains O X
are O X
related O X
by O X
an O X
approximately O X
4 O X
- O X
fold O X
screw O X
axis O X
around O X
the O X
PRAD O X
. O X

Each O X
WAT O X
makes O X
similar O X
but O X
unique O X
interactions O X
, O X
consistent O X
with O X
an O X
asymmetric O X
pattern O X
of O X
disulfide O X
linkages O X
between O X
the O X
AChE I-MISC 43
tetramer O X
subunits O X
and O X
ColQ I-MISC 8292
. O X

The O X
P59Q O X
mutation O X
in O X
ColQ I-MISC 8292
, O X
which O X
causes O X
congenital O X
endplate O X
AChE I-MISC 43
deficiency O X
, O X
and O X
is O X
located O X
within O X
the O X
PRAD O X
, O X
disrupts O X
crucial O X
WAT O X
- O X
WAT O X
and O X
WAT O X
- O X
PRAD O X
interactions O X
. O X

A O X
model O X
is O X
proposed O X
for O X
the O X
synaptic O X
AChE I-MISC 43
( O X
T O X
) O X
tetramer O X
. O X

###19497856	2139,6495

Biochemical O X
and O X
functional O X
characterization O X
of O X
six O X
SIX1 I-MISC 6495
Branchio O X
- O X
oto O X
- O X
renal O X
syndrome O X
mutations O X
. O X

Branchio O X
- O X
oto O X
- O X
renal O X
syndrome O X
( O X
BOR O X
) O X
is O X
an O X
autosomal O X
dominant O X
developmental O X
disorder O X
characterized O X
by O X
hearing O X
loss O X
, O X
branchial O X
arch O X
defects O X
, O X
and O X
renal O X
anomalies O X
. O X

Recently O X
, O X
eight O X
mutations O X
in O X
the O X
SIX1 I-MISC 6495
homeobox O X
gene O X
were O X
discovered O X
in O X
BOR O X
patients O X
. O X

To O X
characterize O X
the O X
effect O X
of O X
SIX1 I-MISC 6495
BOR O X
mutations O X
on O X
the O X
EYA I-MISC 2139
- O X
SIX1 I-MISC 6495
- O X
DNA O X
complex O X
, O X
we O X
expressed O X
and O X
purified O X
six O X
of O X
the O X
eight O X
mutants O X
in O X
Escherichia O X
coli O X
. O X

We O X
demonstrate O X
that O X
only O X
the O X
most O X
N O X
- O X
terminal O X
mutation O X
in O X
SIX1 I-MISC 6495
( O X
V17E O X
) O X
completely O X
abolishes O X
SIX1 I-MISC 6495
- O X
EYA I-MISC 2139
complex O X
formation O X
, O X
whereas O X
all O X
of O X
the O X
other O X
mutants O X
are O X
able O X
to O X
form O X
a O X
stable O X
complex O X
with O X
EYA I-MISC 2139
. O X

We O X
further O X
show O X
that O X
only O X
the O X
V17E O X
mutant O X
fails O X
to O X
localize O X
EYA I-MISC 2139
to O X
the O X
nucleus O X
and O X
cannot O X
be O X
stabilized O X
by O X
EYA I-MISC 2139
in O X
the O X
cell O X
. O X

The O X
remaining O X
five O X
SIX1 I-MISC 6495
mutants O X
are O X
instead O X
all O X
deficient O X
in O X
DNA O X
binding O X
. O X

In O X
contrast O X
, O X
V17E O X
alone O X
has O X
a O X
DNA O X
binding O X
affinity O X
similar O X
to O X
that O X
of O X
wild O X
type O X
SIX1 I-MISC 6495
in O X
complex O X
with O X
the O X
EYA I-MISC 2139
co O X
- O X
factor O X
. O X

Finally O X
, O X
we O X
show O X
that O X
all O X
SIX1 I-MISC 6495
BOR O X
mutants O X
are O X
defective O X
in O X
transcriptional O X
activation O X
using O X
luciferase O X
reporter O X
assays O X
. O X

Taken O X
together O X
, O X
our O X
experiments O X
demonstrate O X
that O X
the O X
SIX1 I-MISC 6495
BOR O X
mutations O X
contribute O X
to O X
the O X
pathology O X
of O X
the O X
disease O X
through O X
at O X
least O X
two O X
different O X
mechanisms O X
that O X
involve O X
: O X
1 O X
) O X
abolishing O X
the O X
formation O X
of O X
the O X
SIX1 I-MISC 6495
- O X
EYA I-MISC 2139
complex O X
or O X
2 O X
) O X
diminishing O X
the O X
ability O X
of O X
SIX1 I-MISC 6495
to O X
bind O X
DNA O X
. O X

Furthermore O X
, O X
our O X
data O X
demonstrate O X
for O X
the O X
first O X
time O X
that O X
EYA I-MISC 2138
: I-MISC 2138
1 I-MISC 2138
) O X
requires O X
the O X
N O X
- O X
terminal O X
region O X
of O X
the O X
SIX1 I-MISC 6495
Six O X
domain O X
for O X
its O X
interaction O X
, O X
2 O X
) O X
increases O X
the O X
level O X
of O X
the O X
SIX1 I-MISC 6495
protein O X
within O X
the O X
cell O X
, O X
and O X
3 O X
) O X
increases O X
the O X
DNA O X
binding O X
affinity O X
of O X
SIX1 I-MISC 6495
. O X

###16830178	836733,817014

ARL1 I-MISC 839024
plays O X
a O X
role O X
in O X
the O X
binding O X
of O X
the O X
GRIP I-MISC 836733
domain O X
of O X
a O X
peripheral O X
matrix O X
protein O X
to O X
the O X
Golgi O X
apparatus O X
in O X
plant O X
cells O X
. O X

ARF I-MISC 817014
GTPases O X
play O X
a O X
central O X
role O X
in O X
regulating O X
membrane O X
dynamics O X
and O X
protein O X
transport O X
in O X
eukaryotic O X
cells O X
. O X

ARF I-MISC 817014
- I-MISC 819014
like I-MISC 819014
( O X
ARL I-MISC 819014
) O X
proteins O X
are O X
close O X
relatives O X
of O X
the O X
ARF I-MISC 817014
regulators O X
of O X
vesicular O X
transport O X
, O X
but O X
their O X
function O X
in O X
plant O X
cells O X
is O X
poorly O X
characterized O X
. O X

Here O X
, O X
by O X
means O X
of O X
live O X
cell O X
imaging O X
and O X
site O X
- O X
directed O X
mutagenesis O X
, O X
we O X
have O X
investigated O X
the O X
cellular O X
function O X
of O X
the O X
plant O X
GTPase O X
ARL1 I-MISC 839024
. O X

We O X
provide O X
direct O X
evidence O X
for O X
a O X
role O X
of O X
this O X
ARL I-MISC 819014
family O X
member O X
in O X
the O X
association O X
of O X
a O X
plant O X
golgin O X
with O X
the O X
plant O X
Golgi O X
apparatus O X
. O X

Our O X
data O X
reveal O X
the O X
existence O X
of O X
key O X
residues O X
within O X
the O X
conserved O X
GRIP I-MISC 836733
- O X
domain O X
of O X
the O X
golgin O X
and O X
within O X
the O X
GTPase O X
ARL1 I-MISC 839024
that O X
are O X
central O X
to O X
ARL1 I-MISC 839024
- O X
GRIP I-MISC 836733
interaction O X
. O X

Mutations O X
of O X
these O X
residues O X
abolish O X
the O X
interaction O X
of O X
GRIP I-MISC 836733
with O X
the O X
GTP O X
- O X
bound O X
ARL1 I-MISC 839024
and O X
induce O X
a O X
redistribution O X
of O X
GRIP I-MISC 836733
into O X
the O X
cytosol O X
. O X

This O X
indicates O X
that O X
the O X
localization O X
of O X
GRIP I-MISC 836733
to O X
the O X
Golgi O X
apparatus O X
is O X
strongly O X
influenced O X
by O X
the O X
interaction O X
of O X
GRIP I-MISC 836733
with O X
Golgi O X
- O X
localized O X
ARL1 I-MISC 839024
. O X

Our O X
results O X
assign O X
a O X
cellular O X
role O X
to O X
a O X
member O X
of O X
the O X
Arabidopsis O X
ARL I-MISC 819014
family O X
in O X
the O X
plant O X
secretory O X
pathway O X
and O X
propose O X
mechanisms O X
for O X
localization O X
of O X
peripheral O X
golgins O X
to O X
the O X
plant O X
Golgi O X
apparatus O X
. O X

###22978324	13528,5566	13528,314906

Phosphorylation O X
on O X
threonine O X
11 O X
of O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
alters O X
its O X
interaction O X
with O X
kinesin I-MISC 314906
heavy I-MISC 314906
chain I-MISC 314906
. O X

Dystrobrevin I-MISC 13528
family I-MISC 13528
members I-MISC 13528
( I-MISC 13528
a I-MISC 13528
and I-MISC 13528
b I-MISC 13528
) I-MISC 13528
are O X
cytoplasmic O X
components O X
of O X
the O X
dystrophin I-MISC 1756
- O X
associated O X
glycoprotein O X
complex O X
, O X
a O X
multimeric O X
protein O X
complex O X
first O X
isolated O X
from O X
skeletal O X
muscle O X
, O X
which O X
links O X
the O X
extracellular O X
matrix O X
to O X
the O X
actin O X
cytoskeleton O X
. O X

Dystrobrevin I-MISC 13528
shares O X
high O X
homology O X
with O X
the O X
cysteine O X
- O X
rich O X
and O X
C O X
- O X
terminal O X
domains O X
of O X
dystrophin I-MISC 1756
and O X
a O X
common O X
domain O X
organization O X
. O X

The O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
isoform O X
is O X
restricted O X
to O X
nonmuscle O X
tissues O X
, O X
serves O X
as O X
a O X
scaffold O X
for O X
signaling O X
complexes O X
, O X
and O X
may O X
participate O X
in O X
intracellular O X
transport O X
through O X
its O X
interaction O X
with O X
kinesin I-MISC 314906
heavy I-MISC 314906
chain I-MISC 314906
. O X

We O X
have O X
previously O X
characterized O X
the O X
molecular O X
determinants O X
affecting O X
the O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
- O X
kinesin I-MISC 314906
heavy I-MISC 314906
chain I-MISC 314906
interaction O X
, O X
among O X
which O X
is O X
cAMP O X
- O X
dependent O X
protein O X
kinase O X
[ O X
protein I-MISC 5566
kinase I-MISC 5566
A I-MISC 5566
( I-MISC 5566
PKA I-MISC 5566
)] O X
phosphorylation O X
of O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
. O X

In O X
this O X
study O X
, O X
we O X
have O X
identified O X
b O X
- O X
dystrobrevin I-MISC 13528
residues O X
phosphorylated O X
in O X
vitro O X
by O X
PKA O X
with O X
pull O X
- O X
down O X
assays O X
, O X
surface O X
plasmon O X
resonance O X
measurements O X
, O X
and O X
MS O X
analysis O X
. O X

Among O X
the O X
identified O X
phosphorylated O X
residues O X
, O X
we O X
demonstrated O X
, O X
by O X
site O X
- O X
directed O X
mutagenesis O X
, O X
that O X
Thr11 O X
is O X
the O X
regulatory O X
site O X
for O X
the O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
- O X
kinesin I-MISC 314906
interaction O X
. O X

As O X
dystrobrevin I-MISC 13528
may O X
function O X
as O X
a O X
signaling O X
scaffold O X
for O X
kinases O X
/ O X
phosphatases O X
, O X
we O X
also O X
investigated O X
whether O X
b I-MISC 13528
- I-MISC 13528
dystrobrevin I-MISC 13528
is O X
phosphorylated O X
in O X
vitro O X
by O X
kinases O X
other O X
than O X
PKA O X
. O X

Thr11 O X
was O X
phosphorylated O X
by O X
protein O X
kinase O X
C O X
, O X
suggesting O X
that O X
this O X
represents O X
a O X
key O X
residue O X
modified O X
by O X
the O X
activation O X
of O X
different O X
signaling O X
pathways O X
. O X

###23871208	26191,22031

The O X
autoimmunity O X
- O X
associated O X
gene O X
PTPN22 I-MISC 26191
potentiates O X
toll O X
- O X
like O X
receptor O X
- O X
driven O X
, O X
type O X
1 O X
interferon O X
- O X
dependent O X
immunity O X
. O X

Immune O X
cells O X
sense O X
microbial O X
products O X
through O X
Toll O X
- O X
like O X
receptors O X
( O X
TLR O X
), O X
which O X
trigger O X
host O X
defense O X
responses O X
including O X
type O X
1 O X
interferons O X
( O X
IFNs O X
) O X
secretion O X
. O X

A O X
coding O X
polymorphism O X
in O X
the O X
protein I-MISC 26191
tyrosine I-MISC 26191
phosphatase I-MISC 26191
nonreceptor I-MISC 26191
type I-MISC 26191
22 I-MISC 26191
( O X
PTPN22 I-MISC 26191
) O X
gene O X
is O X
a O X
susceptibility O X
allele O X
for O X
human O X
autoimmune O X
and O X
infectious O X
disease O X
. O X

We O X
report O X
that O X
Ptpn22 I-MISC 26191
selectively O X
regulated O X
type O X
1 O X
IFN O X
production O X
after O X
TLR O X
engagement O X
in O X
myeloid O X
cells O X
. O X

Ptpn22 I-MISC 26191
promoted O X
host O X
antiviral O X
responses O X
and O X
was O X
critical O X
for O X
TLR O X
agonist O X
- O X
induced O X
, O X
type O X
1 O X
IFN O X
- O X
dependent O X
suppression O X
of O X
inflammation O X
in O X
colitis O X
and O X
arthritis O X
. O X

PTPN22 I-MISC 26191
directly O X
associated O X
with O X
TNF I-MISC 22031
receptor I-MISC 22031
- I-MISC 22031
associated I-MISC 22031
factor I-MISC 22031
3 I-MISC 22031
( O X
TRAF3 I-MISC 22031
) O X
and O X
promotes O X
TRAF3 I-MISC 22031
lysine O X
63 O X
- O X
linked O X
ubiquitination O X
. O X

The O X
disease O X
- O X
associated O X
PTPN22W O X
variant O X
failed O X
to O X
promote O X
TRAF3 I-MISC 22031
ubiquitination O X
, O X
type O X
1 O X
IFN O X
upregulation O X
, O X
and O X
type O X
1 O X
IFN O X
- O X
dependent O X
suppression O X
of O X
arthritis O X
. O X

The O X
findings O X
establish O X
a O X
candidate O X
innate O X
immune O X
mechanism O X
of O X
action O X
for O X
a O X
human O X
autoimmunity O X
" O X
risk O X
" O X
gene O X
in O X
the O X
regulation O X
of O X
host O X
defense O X
and O X
inflammation O X
. O X

###21615688	5605,1739

Identification O X
of O X
mitogen I-MISC 5605
- I-MISC 5605
activated I-MISC 5605
protein I-MISC 5605
/ I-MISC 5605
extracellular I-MISC 5605
signal I-MISC 5605
- I-MISC 5605
responsive I-MISC 5605
kinase I-MISC 5605
kinase I-MISC 5605
2 I-MISC 5605
as O X
a O X
novel O X
partner O X
of O X
the O X
scaffolding O X
protein O X
human O X
homolog O X
of O X
disc O X
- O X
large O X
. O X

Human O X
disc O X
- O X
large O X
homolog O X
( O X
hDlg I-MISC 1739
), O X
also O X
known O X
as O X
synapse I-MISC 1739
- I-MISC 1739
associated I-MISC 1739
protein I-MISC 1739
97 I-MISC 1739
, O X
is O X
a O X
scaffold O X
protein O X
, O X
a O X
member O X
of O X
the O X
membrane O X
- O X
associated O X
guanylate O X
kinase O X
family O X
, O X
implicated O X
in O X
neuronal O X
synapses O X
and O X
epithelial O X
- O X
epithelial O X
cell O X
junctions O X
whose O X
expression O X
and O X
function O X
remains O X
poorly O X
characterized O X
in O X
most O X
tissues O X
, O X
particularly O X
in O X
the O X
vasculature O X
. O X

In O X
human O X
vascular O X
tissues O X
, O X
hDlg I-MISC 1739
is O X
highly O X
expressed O X
in O X
smooth O X
muscle O X
cells O X
( O X
VSMCs O X
). O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
to O X
screen O X
a O X
human O X
aorta O X
cDNA O X
library O X
, O X
we O X
identified O X
mitogen I-MISC 5605
- I-MISC 5605
activated I-MISC 5605
protein I-MISC 5605
/ I-MISC 5605
extracellular I-MISC 5605
signal I-MISC 5605
- I-MISC 5605
responsive I-MISC 5605
kinase I-MISC 5605
( I-MISC 5605
ERK I-MISC 5605
) I-MISC 5605
kinase I-MISC 5605
( I-MISC 5605
MEK I-MISC 5605
) I-MISC 5605
2 I-MISC 5605
, O X
a O X
member O X
of O X
the O X
ERK O X
cascade O X
, O X
as O X
an O X
hDlg I-MISC 1739
binding O X
partner O X
. O X

Site O X
- O X
directed O X
mutagenesis O X
showed O X
a O X
major O X
involvement O X
of O X
the O X
PSD I-MISC 1742
- I-MISC 1742
95 I-MISC 1742
, O X
disc O X
- O X
large O X
, O X
ZO O X
- O X
1 O X
domain O X
- O X
2 O X
of O X
hDlg I-MISC 1739
and O X
the O X
C O X
- O X
terminal O X
sequence O X
RTAV O X
of O X
MEK2 I-MISC 5605
in O X
this O X
interaction O X
. O X

Coimmunoprecipitation O X
assays O X
in O X
both O X
human O X
VSMCs O X
and O X
human O X
embryonic O X
kidney O X
293 O X
cells O X
, O X
demonstrated O X
that O X
endogenous O X
hDlg I-MISC 1739
physically O X
interacts O X
with O X
MEK2 I-MISC 5605
but O X
not O X
with O X
MEK1 I-MISC 5604
. O X

Confocal O X
microscopy O X
suggested O X
a O X
colocalization O X
of O X
the O X
two O X
proteins O X
at O X
the O X
inner O X
layer O X
of O X
the O X
plasma O X
membrane O X
of O X
confluent O X
human O X
embryonic O X
kidney O X
293 O X
cells O X
, O X
and O X
in O X
a O X
perinuclear O X
area O X
in O X
human O X
VSMCs O X
. O X

Additionally O X
, O X
hDlg I-MISC 1739
also O X
associates O X
with O X
the O X
endoplasmic O X
reticulum O X
and O X
microtubules O X
in O X
these O X
latter O X
cells O X
. O X

Taken O X
together O X
, O X
these O X
findings O X
allow O X
us O X
to O X
hypothesize O X
that O X
hDlg I-MISC 1739
acts O X
as O X
a O X
MEK2 I-MISC 5605
- O X
specific O X
scaffold O X
protein O X
for O X
the O X
ERK O X
signaling O X
pathway O X
, O X
and O X
may O X
improve O X
our O X
understanding O X
of O X
how O X
scaffold O X
proteins O X
, O X
such O X
as O X
hDlg I-MISC 1739
, O X
differentially O X
tune O X
MEK1 I-MISC 5604
/ O X
MEK2 I-MISC 5605
signaling O X
and O X
cell O X
responses O X
. O X

###15141091	14048,20471

SIX1 I-MISC 20471
mutations O X
cause O X
branchio O X
- O X
oto O X
- O X
renal O X
syndrome O X
by O X
disruption O X
of O X
EYA1 I-MISC 14048
- O X
SIX1 I-MISC 20471
- O X
DNA O X
complexes O X
. O X

Urinary O X
tract O X
malformations O X
constitute O X
the O X
most O X
frequent O X
cause O X
of O X
chronic O X
renal O X
failure O X
in O X
the O X
first O X
two O X
decades O X
of O X
life O X
. O X

Branchio O X
- O X
otic O X
( O X
BO O X
) O X
syndrome O X
is O X
an O X
autosomal O X
dominant O X
developmental O X
disorder O X
characterized O X
by O X
hearing O X
loss O X
. O X

In O X
branchio O X
- O X
oto O X
- O X
renal O X
( O X
BOR O X
) O X
syndrome O X
, O X
malformations O X
of O X
the O X
kidney O X
or O X
urinary O X
tract O X
are O X
associated O X
. O X

Haploinsufficiency O X
for O X
the O X
human O X
gene O X
EYA1 I-MISC 14048
, O X
a O X
homologue O X
of O X
the O X
Drosophila O X
gene O X
eyes O X
absent O X
( O X
eya I-MISC 33916
), O X
causes O X
BOR O X
and O X
BO O X
syndromes O X
. O X

We O X
recently O X
mapped O X
a O X
locus O X
for O X
BOR O X
/ O X
BO O X
syndrome O X
( O X
BOS3 O X
) O X
to O X
human O X
chromosome O X
14q23 O X
. O X
1 O X
. O X

Within O X
the O X
33 O X
- O X
megabase O X
critical O X
genetic O X
interval O X
, O X
we O X
located O X
the O X
SIX1 I-MISC 20471
, O X
SIX4 I-MISC 51804
, O X
and O X
SIX6 I-MISC 4990
genes O X
, O X
which O X
act O X
within O X
a O X
genetic O X
network O X
of O X
EYA I-MISC 33916
and O X
PAX O X
genes O X
to O X
regulate O X
organogenesis O X
. O X

These O X
genes O X
, O X
therefore O X
, O X
represented O X
excellent O X
candidate O X
genes O X
for O X
BOS3 O X
. O X

By O X
direct O X
sequencing O X
of O X
exons O X
, O X
we O X
identified O X
three O X
different O X
SIX1 I-MISC 20471
mutations O X
in O X
four O X
BOR O X
/ O X
BO O X
kindreds O X
, O X
thus O X
identifying O X
SIX1 I-MISC 20471
as O X
a O X
gene O X
causing O X
BOR O X
and O X
BO O X
syndromes O X
. O X

To O X
elucidate O X
how O X
these O X
mutations O X
cause O X
disease O X
, O X
we O X
analyzed O X
the O X
functional O X
role O X
of O X
these O X
SIX1 I-MISC 20471
mutations O X
with O X
respect O X
to O X
protein O X
- O X
protein O X
and O X
protein O X
- O X
DNA O X
interactions O X
. O X

We O X
demonstrate O X
that O X
all O X
three O X
mutations O X
are O X
crucial O X
for O X
Eya1 I-MISC 14048
- O X
Six1 I-MISC 20471
interaction O X
, O X
and O X
the O X
two O X
mutations O X
within O X
the O X
homeodomain O X
region O X
are O X
essential O X
for O X
specific O X
Six1 I-MISC 20471
- O X
DNA O X
binding O X
. O X

Identification O X
of O X
SIX1 I-MISC 20471
mutations O X
as O X
causing O X
BOR O X
/ O X
BO O X
offers O X
insights O X
into O X
the O X
molecular O X
basis O X
of O X
otic O X
and O X
renal O X
developmental O X
diseases O X
in O X
humans O X
. O X

###10430869	65178,11772	11772,13858	11772,117277	11772,60668

Crystal O X
structure O X
of O X
the O X
alpha O X
appendage O X
of O X
AP I-MISC 11772
- I-MISC 11772
2 I-MISC 11772
reveals O X
a O X
recruitment O X
platform O X
for O X
clathrin O X
- O X
coat O X
assembly O X
. O X

AP I-MISC 11772
- I-MISC 11772
2 I-MISC 11772
adaptors O X
regulate O X
clathrin O X
- O X
bud O X
formation O X
at O X
the O X
cell O X
surface O X
by O X
recruiting O X
clathrin O X
trimers O X
to O X
the O X
plasma O X
membrane O X
and O X
by O X
selecting O X
certain O X
membrane O X
proteins O X
for O X
inclusion O X
within O X
the O X
developing O X
clathrin O X
- O X
coat O X
structure O X
. O X

These O X
functions O X
are O X
performed O X
by O X
discrete O X
subunits O X
of O X
the O X
adaptor O X
heterotetramer O X
. O X

The O X
carboxyl O X
- O X
terminal O X
appendage O X
of O X
the O X
AP I-MISC 11772
- I-MISC 11772
2 I-MISC 11772
alpha I-MISC 11772
subunit O X
appears O X
to O X
regulate O X
the O X
translocation O X
of O X
several O X
endocytic O X
accessory O X
proteins O X
to O X
the O X
bud O X
site O X
. O X

We O X
have O X
determined O X
the O X
crystal O X
structure O X
of O X
the O X
alpha O X
appendage O X
at O X
1 O X
. O X
4 O X
- O X
A O X
resolution O X
by O X
multiwavelength O X
anomalous O X
diffraction O X
phasing O X
. O X

It O X
is O X
composed O X
of O X
two O X
distinct O X
structural O X
modules O X
, O X
a O X
beta O X
- O X
sandwich O X
domain O X
and O X
a O X
mixed O X
alpha O X
- O X
beta O X
platform O X
domain O X
. O X

Structure O X
- O X
based O X
mutagenesis O X
shows O X
that O X
alterations O X
to O X
the O X
molecular O X
surface O X
of O X
a O X
highly O X
conserved O X
region O X
on O X
the O X
platform O X
domain O X
differentially O X
affect O X
associations O X
of O X
the O X
appendage O X
with O X
amphiphysin I-MISC 60668
, O X
eps15 I-MISC 13858
, O X
epsin I-MISC 117277
, O X
and O X
AP180 I-MISC 65178
, O X
revealing O X
a O X
common O X
protein O X
- O X
binding O X
interface O X
. O X

###16247757	4000,7112

Thymopoietin I-MISC 7112
( I-MISC 7112
lamina I-MISC 7112
- I-MISC 7112
associated I-MISC 7112
polypeptide I-MISC 7112
2 I-MISC 7112
) O X
gene O X
mutation O X
associated O X
with O X
dilated O X
cardiomyopathy O X
. O X

Thymopoietin O X
or O X
TMPO I-MISC 7112
( O X
indicated O X
by O X
its O X
alternative O X
gene O X
symbol O X
, O X
LAP2 I-MISC 7112
, O X
in O X
this O X
work O X
) O X
has O X
been O X
proposed O X
as O X
a O X
candidate O X
disease O X
gene O X
for O X
dilated O X
cardiomyopathy O X
( O X
DCM O X
), O X
since O X
a O X
LAP2 I-MISC 7112
product O X
associates O X
with O X
nucleoplasmic O X
lamins O X
A O X
/ O X
C O X
, O X
which O X
are O X
encoded O X
by O X
the O X
DCM O X
gene O X
LMNA I-MISC 4000
. O X

We O X
developed O X
a O X
study O X
to O X
screen O X
for O X
genetic O X
mutations O X
in O X
LAP2 I-MISC 7112
in O X
a O X
large O X
collection O X
of O X
DCM O X
patients O X
and O X
families O X
. O X

A O X
total O X
of O X
113 O X
subjects O X
from O X
88 O X
families O X
( O X
56 O X
with O X
familial O X
DCM O X
( O X
FDC O X
) O X
and O X
32 O X
with O X
sporadic O X
DCM O X
) O X
were O X
screened O X
for O X
LAP2 I-MISC 7112
mutations O X
using O X
denaturing O X
high O X
- O X
performance O X
liquid O X
chromatography O X
and O X
sequence O X
analysis O X
. O X

We O X
found O X
a O X
single O X
putative O X
mutation O X
affecting O X
the O X
LAP2alpha I-MISC 7112
isoform O X
in O X
one O X
FDC O X
pedigree O X
. O X

The O X
mutation O X
predicts O X
an O X
Arg690Cys O X
substitution O X
( O X
c O X
. O X
2068C O X
> O X
T O X
; O X
p O X
. O X
R690C O X
) O X
located O X
in O X
the O X
C O X
- O X
terminal O X
domain O X
of O X
the O X
LAP2alpha I-MISC 7112
protein O X
, O X
a O X
region O X
that O X
is O X
known O X
to O X
interact O X
with O X
lamin I-MISC 4000
A I-MISC 4000
/ I-MISC 4000
C I-MISC 4000
. O X

RT O X
- O X
PCR O X
, O X
Western O X
blot O X
analyses O X
, O X
and O X
immunolocalization O X
revealed O X
low O X
- O X
level O X
LAP2alpha I-MISC 7112
expression O X
in O X
adult O X
cardiac O X
muscle O X
, O X
and O X
localization O X
to O X
a O X
subset O X
of O X
nuclei O X
. O X

Mutated O X
Arg690Cys O X
LAP2alpha I-MISC 7112
expressed O X
in O X
HeLa O X
cells O X
localized O X
to O X
the O X
nucleoplasm O X
like O X
wild O X
- O X
type O X
LAP2alpha I-MISC 7112
, O X
with O X
no O X
effect O X
on O X
peripheral O X
and O X
nucleoplasmic O X
lamin I-MISC 4000
A I-MISC 4000
distribution O X
. O X

However O X
, O X
the O X
in O X
vitro O X
interaction O X
of O X
mutated O X
LAP2alpha I-MISC 7112
with O X
the O X
pre O X
- O X
lamin I-MISC 4000
A I-MISC 4000
C O X
- O X
terminus O X
was O X
significantly O X
compromised O X
compared O X
to O X
the O X
wild O X
- O X
type O X
protein O X
. O X

LAP2 I-MISC 7112
mutations O X
may O X
represent O X
a O X
rare O X
cause O X
of O X
DCM O X
. O X

The O X
Arg690Cys O X
mutation O X
altered O X
the O X
observed O X
LAP2alpha I-MISC 7112
interaction O X
with O X
A O X
- O X
type O X
lamins O X
. O X

Our O X
finding O X
implicates O X
a O X
novel O X
nuclear O X
lamina O X
- O X
associated O X
protein O X
in O X
the O X
pathogenesis O X
of O X
genetic O X
forms O X
of O X
dilated O X
cardiomyopathy O X
. O X

###20594350	55749,97064

A O X
novel O X
mechanism O X
of O X
cell O X
growth O X
regulation O X
by O X
Cell O X
Cycle O X
and O X
Apoptosis O X
Regulatory O X
Protein O X
( O X
CARP O X
)- O X
1 O X
. O X

BACKGROUND O X
: O X
CARP O X
- O X
1 O X
/ O X
CCAR1 I-MISC 55749
, O X
a O X
perinuclear O X
phospho O X
- O X
protein O X
, O X
regulates O X
signaling O X
by O X
adriamycin O X
, O X
steroids O X
, O X
or O X
growth O X
factors O X
. O X

However O X
, O X
intracellular O X
events O X
that O X
regulate O X
CARP O X
- O X
1 O X
- O X
dependent O X
cell O X
growth O X
are O X
not O X
fully O X
understood O X
. O X

RESULTS O X
: O X
Here O X
we O X
investigated O X
whether O X
CARP O X
- O X
1 O X
is O X
involved O X
in O X
signaling O X
induced O X
by O X
the O X
protein O X
kinase O X
A O X
inhibitor O X
H89 O X
. O X

Treatments O X
of O X
human O X
breast O X
cancer O X
cells O X
with O X
H89 O X
resulted O X
in O X
apoptosis O X
that O X
involved O X
enhanced O X
CARP O X
- O X
1 O X
threonine O X
phosphorylation O X
and O X
expression O X
. O X

Depletion O X
of O X
CARP O X
- O X
1 O X
, O X
on O X
the O X
other O X
hand O X
, O X
abrogates O X
apoptosis O X
induced O X
by O X
H89 O X
. O X

CARP O X
- O X
1 O X
binds O X
with O X
signal O X
transducer O X
TAZ I-MISC 97064
and O X
over O X
- O X
expression O X
of O X
TAZ I-MISC 97064
inhibits O X
apoptosis O X
by O X
CARP O X
- O X
1 O X
. O X

CARP O X
- O X
1 O X
( O X
651 O X
- O X
759 O X
) O X
interacts O X
with O X
a O X
novel O X
, O X
N O X
- O X
terminal O X
epitope O X
of O X
TAZ I-MISC 97064
. O X

H89 O X
treatment O X
stimulates O X
threonine O X
phosphorylation O X
of O X
CARP O X
- O X
1 O X
( O X
651 O X
- O X
759 O X
), O X
while O X
substitution O X
of O X
threonine667 O X
to O X
alanine O X
interferes O X
with O X
its O X
binding O X
with O X
TAZ I-MISC 97064
and O X
apoptosis O X
by O X
H89 O X
. O X

In O X
addition O X
, O X
expression O X
of O X
wild O X
type O X
or O X
CARP O X
- O X
1 O X
( O X
651 O X
- O X
759 O X
) O X
causes O X
loss O X
of O X
c O X
- O X
myc O X
expression O X
due O X
, O X
in O X
part O X
, O X
to O X
suppression O X
of O X
c O X
- O X
myc O X
transcription O X
. O X

CONCLUSIONS O X
: O X
CARP O X
- O X
1 O X
threonine667 O X
regulates O X
H89 O X
- O X
dependent O X
signaling O X
by O X
a O X
novel O X
pathway O X
that O X
involves O X
modulation O X
of O X
CARP O X
- O X
1 O X
interaction O X
with O X
TAZ I-MISC 97064
and O X
transcriptional O X
down O X
- O X
regulation O X
of O X
c O X
- O X
myc O X
. O X

###24726729	60421,7555

Arginine O X
methylation O X
of O X
the O X
cellular I-MISC 7555
nucleic I-MISC 7555
acid I-MISC 7555
binding I-MISC 7555
protein I-MISC 7555
does O X
not O X
affect O X
its O X
subcellular O X
localization O X
but O X
impedes O X
RNA O X
binding O X
. O X

Cellular I-MISC 7555
nucleic I-MISC 7555
acid I-MISC 7555
binding I-MISC 7555
protein I-MISC 7555
( O X
CNBP I-MISC 7555
) O X
contains O X
seven O X
zinc O X
finger O X
( O X
ZF O X
) O X
repeats O X
and O X
an O X
arginine O X
and O X
glycine O X
( O X
RG O X
) O X
rich O X
sequence O X
between O X
the O X
first O X
and O X
the O X
second O X
ZF O X
. O X

CNBP I-MISC 7555
interacts O X
with O X
protein O X
arginine O X
methyltransferase O X
PRMT1 I-MISC 60421
. O X

Full O X
- O X
length O X
but O X
not O X
RG O X
- O X
deleted O X
or O X
mutated O X
CNBP I-MISC 7555
can O X
be O X
methylated O X
. O X

Treatment O X
with O X
a O X
methylation O X
inhibitor O X
AdOx O X
reduced O X
CNBP I-MISC 7555
methylation O X
, O X
but O X
did O X
not O X
affect O X
the O X
concentrated O X
nuclear O X
localization O X
of O X
CNBP I-MISC 7555
. O X

Nevertheless O X
, O X
arginine O X
methylation O X
of O X
CNBP I-MISC 7555
appeared O X
to O X
interfere O X
with O X
its O X
RNA O X
binding O X
activity O X
. O X

Our O X
findings O X
show O X
that O X
arginine O X
methylation O X
of O X
CNBP I-MISC 7555
in O X
the O X
RG O X
motif O X
did O X
not O X
change O X
the O X
subcellular O X
localization O X
, O X
but O X
regulated O X
its O X
RNA O X
binding O X
activity O X
. O X

###11842245	1489608,10210	4192013,10210	10210,7157

Topors I-MISC 10210
, O X
a O X
p53 I-MISC 7157
and O X
topoisomerase O X
I O X
binding O X
protein O X
, O X
interacts O X
with O X
the O X
adeno O X
- O X
associated O X
virus O X
( O X
AAV O X
- O X
2 O X
) O X
Rep78 I-MISC 1489608,4192013
/ I-MISC 1489608,4192013
68 I-MISC 1489608,4192013
proteins O X
and O X
enhances O X
AAV O X
- O X
2 O X
gene O X
expression O X
. O X

The O X
adeno O X
- O X
associated O X
virus O X
type O X
2 O X
( O X
AAV O X
- O X
2 O X
) O X
Rep O X
proteins O X
are O X
essential O X
for O X
AAV O X
DNA O X
replication O X
and O X
regulation O X
of O X
AAV O X
gene O X
expression O X
. O X

We O X
have O X
identified O X
a O X
cellular O X
protein O X
interacting O X
with O X
Rep78 I-MISC 1489608
and O X
Rep68 I-MISC 4192013
in O X
yeast O X
two O X
- O X
hybrid O X
analysis O X
and O X
in O X
GST O X
pull O X
- O X
down O X
assays O X
. O X

This O X
protein O X
has O X
recently O X
been O X
described O X
as O X
both O X
a O X
p53 I-MISC 7157
( O X
p53BP3 I-MISC 10210
) O X
and O X
a O X
topoisomerase I-MISC 10210
I I-MISC 10210
interacting I-MISC 10210
protein I-MISC 10210
( I-MISC 10210
Topors I-MISC 10210
). O X

It O X
contains O X
an O X
arginine O X
/ O X
serine O X
- O X
rich O X
domain O X
, O X
a O X
RING O X
finger O X
domain O X
and O X
five O X
PEST O X
sequences O X
. O X

A O X
minimal O X
sequence O X
sufficient O X
for O X
interaction O X
with O X
Rep O X
was O X
mapped O X
to O X
Topors I-MISC 10210
amino O X
acids O X
871 O X
to O X
917 O X
. O X

We O X
show O X
that O X
the O X
same O X
region O X
is O X
also O X
involved O X
in O X
the O X
interaction O X
with O X
p53 I-MISC 7157
. O X

Rep O X
sequences O X
involved O X
in O X
interaction O X
with O X
Topors I-MISC 10210
were O X
mapped O X
to O X
Rep O X
amino O X
acids O X
172 O X
to O X
481 O X
. O X

Overexpression O X
of O X
Topors I-MISC 10210
stimulated O X
AAV O X
gene O X
expression O X
in O X
the O X
absence O X
of O X
helper O X
virus O X
, O X
suggesting O X
a O X
function O X
of O X
Topors I-MISC 10210
as O X
a O X
transcriptional O X
regulator O X
. O X

###21097510	11315,229603

DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
enhances O X
cell O X
survival O X
through O X
the O X
binding O X
of O X
Cezanne I-MISC 229603
, O X
a O X
negative O X
regulator O X
of O X
NF O X
- O X
kappaB O X
. O X

Heightened O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
( O X
Park7 I-MISC 11315
) O X
expression O X
is O X
associated O X
with O X
a O X
reduction O X
in O X
chemotherapeutic O X
- O X
induced O X
cell O X
death O X
and O X
poor O X
prognosis O X
in O X
several O X
cancers O X
, O X
whereas O X
the O X
loss O X
of O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
function O X
is O X
found O X
in O X
a O X
subgroup O X
of O X
Parkinson O X
disease O X
associated O X
with O X
neuronal O X
death O X
. O X

This O X
study O X
describes O X
a O X
novel O X
pathway O X
by O X
which O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
modulates O X
cell O X
survival O X
. O X

Mass O X
spectrometry O X
shows O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
interacts O X
with O X
BBS1 I-MISC 52028
, O X
CLCF1 I-MISC 56708
, O X
MTREF O X
, O X
and O X
Cezanne I-MISC 229603
/ O X
OTUD7B I-MISC 229603
/ O X
Za20d1 I-MISC 229603
. O X

Among O X
these O X
, O X
Cezanne I-MISC 229603
is O X
a O X
known O X
deubiquitination O X
enzyme O X
that O X
inhibits O X
NF O X
- O X
kB O X
activity O X
. O X

DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
/ O X
Cezanne I-MISC 229603
interaction O X
is O X
confirmed O X
by O X
co O X
- O X
immunoprecipitation O X
of O X
overexpressed O X
and O X
endogenous O X
proteins O X
, O X
maps O X
to O X
the O X
amino O X
- O X
terminal O X
70 O X
residues O X
of O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
, O X
and O X
leads O X
to O X
the O X
inhibition O X
of O X
the O X
deubiquitinating O X
activity O X
of O X
Cezanne I-MISC 229603
. O X

Microarray O X
profiling O X
of O X
shRNA O X
- O X
transduced O X
cells O X
shows O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
and O X
Cezanne I-MISC 229603
regulate O X
IL I-MISC 20309
- I-MISC 20309
8 I-MISC 20309
and O X
ICAM I-MISC 15894
- I-MISC 15894
1 I-MISC 15894
expression O X
in O X
opposing O X
directions O X
. O X

Similarly O X
, O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
enhances O X
NF O X
- O X
kB O X
nuclear O X
translocation O X
and O X
cell O X
survival O X
, O X
whereas O X
Cezanne I-MISC 229603
reduces O X
these O X
outcomes O X
. O X

Analysis O X
of O X
mouse O X
Park7 I-MISC 11315
(-/-) O X
primary O X
cells O X
confirms O X
the O X
regulation O X
of O X
ICAM I-MISC 15894
- I-MISC 15894
1 I-MISC 15894
by O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
and O X
Cezanne I-MISC 229603
. O X

As O X
NF O X
- O X
kB O X
is O X
important O X
in O X
cellular O X
survival O X
and O X
transformation O X
, O X
IL I-MISC 20309
- I-MISC 20309
8 I-MISC 20309
functions O X
as O X
an O X
angiogenic O X
factor O X
and O X
pro O X
- O X
survival O X
signal O X
, O X
and O X
ICAM I-MISC 15894
- I-MISC 15894
1 I-MISC 15894
has O X
been O X
implicated O X
in O X
tumor O X
progression O X
, O X
invasion O X
, O X
and O X
metastasis O X
; O X
these O X
data O X
provide O X
an O X
additional O X
modality O X
by O X
which O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
controls O X
cell O X
survival O X
and O X
possibly O X
tumor O X
progression O X
via O X
interaction O X
with O X
Cezanne I-MISC 229603
. O X

###23059983	7099,7099

Metal O X
allergens O X
nickel O X
and O X
cobalt O X
facilitate O X
TLR4 I-MISC 7099
homodimerization O X
independently O X
of O X
MD2 I-MISC 23643
. O X

Development O X
of O X
contact O X
allergy O X
requires O X
cooperation O X
of O X
adaptive O X
and O X
innate O X
immunity O X
. O X

Ni O X
( O X
2 O X
+) O X
stimulates O X
innate O X
immunity O X
via O X
TLR4 I-MISC 7099
/ O X
MD2 I-MISC 23643
, O X
the O X
bacterial O X
LPS O X
receptor O X
. O X

This O X
likely O X
involves O X
receptor O X
dimerization O X
, O X
but O X
direct O X
proof O X
is O X
pending O X
and O X
it O X
is O X
unclear O X
if O X
related O X
haptens O X
share O X
this O X
mechanism O X
. O X

We O X
reveal O X
Co O X
( O X
2 O X
+) O X
as O X
second O X
metal O X
stimulating O X
TLR4 I-MISC 7099
and O X
confirm O X
necessity O X
of O X
H456 O X
/ O X
H458 O X
therein O X
. O X

Experiments O X
with O X
a O X
new O X
TLR4 I-MISC 7099
dimerization O X
mutant O X
established O X
dimerization O X
as O X
a O X
mechanism O X
of O X
metal O X
- O X
and O X
LPS O X
- O X
induced O X
TLR4 I-MISC 7099
activation O X
. O X

Yet O X
, O X
in O X
interaction O X
studies O X
only O X
LPS O X
- O X
but O X
not O X
metal O X
- O X
induced O X
dimerization O X
required O X
MD2 I-MISC 23643
. O X

Consistently O X
, O X
soluble O X
TLR4 I-MISC 7099
expressed O X
without O X
MD2 I-MISC 23643
inhibited O X
metal O X
- O X
but O X
not O X
LPS O X
- O X
induced O X
responses O X
, O X
opening O X
new O X
therapeutic O X
perspectives O X
. O X

###9025305	837225,832123

Characterization O X
of O X
proteins O X
that O X
interact O X
with O X
the O X
GTP O X
- O X
bound O X
form O X
of O X
the O X
regulatory O X
GTPase O X
Ran I-MISC 5901
in O X
Arabidopsis O X
. O X

Ran I-MISC 5901
, O X
a O X
small O X
soluble O X
GTP O X
- O X
binding O X
protein O X
, O X
has O X
been O X
shown O X
to O X
be O X
essential O X
for O X
the O X
nuclear O X
translocation O X
of O X
proteins O X
and O X
it O X
is O X
also O X
thought O X
to O X
be O X
involved O X
in O X
regulating O X
cell O X
cycle O X
progression O X
in O X
mammalian O X
and O X
yeast O X
cells O X
. O X

Genes O X
encoding O X
Ran I-MISC 5901
- O X
like O X
proteins O X
have O X
been O X
isolated O X
from O X
different O X
higher O X
plant O X
species O X
. O X

Overexpression O X
of O X
plant O X
Ran I-MISC 5901
cDNAs O X
, O X
similarly O X
to O X
their O X
mammalian O X
/ O X
yeast O X
homologues O X
, O X
suppresses O X
the O X
phenotype O X
of O X
the O X
pim46 O X
- O X
1 O X
cell O X
cycle O X
mutant O X
in O X
yeast O X
cells O X
. O X

The O X
mammalian O X
/ O X
yeast O X
Ran I-MISC 5901
proteins O X
have O X
been O X
shown O X
to O X
interact O X
with O X
a O X
battery O X
of O X
Ran I-MISC 5901
- O X
binding O X
proteins O X
, O X
including O X
the O X
guanidine O X
nucleotide O X
exchange O X
factor O X
RCC1 O X
, O X
the O X
GTPase O X
- O X
activating O X
Ran I-MISC 5901
- O X
GAP O X
, O X
nucleoporins O X
and O X
other O X
Ran I-MISC 5901
- O X
binding O X
proteins O X
( O X
RanBPs O X
) O X
specific O X
for O X
Ran I-MISC 5901
- O X
GTP O X
. O X

Here O X
, O X
the O X
characterization O X
of O X
the O X
first O X
Ran I-MISC 5901
- O X
binding O X
proteins O X
from O X
higher O X
plants O X
is O X
reported O X
. O X

The O X
yeast O X
two O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
isolate O X
cDNA O X
clones O X
encoding O X
proteins O X
of O X
approximately O X
28 O X
kDa O X
( O X
At O X
- O X
RanBP1a O X
, O X
At O X
- O X
RanBP1b O X
) O X
that O X
interact O X
with O X
the O X
GTP O X
- O X
bound O X
forms O X
of O X
the O X
Ran1 I-MISC 832123
, O X
Ran2 I-MISC 832124
and O X
Ran3 I-MISC 835612
proteins O X
of O X
Arabidopsis O X
thaliana O X
. O X

The O X
deduced O X
amino O X
acid O X
sequences O X
of O X
the O X
At O X
- O X
RanBP1s O X
display O X
high O X
similarity O X
( O X
60 O X
%) O X
to O X
mammalian O X
/ O X
yeast O X
RanBP1 I-MISC 837225
proteins O X
and O X
contain O X
the O X
characteristic O X
Ran I-MISC 5901
- O X
binding O X
domains O X
. O X

Furthermore O X
, O X
interaction O X
of O X
the O X
plant O X
Ran I-MISC 5901
and O X
RanBP1 I-MISC 837225
proteins O X
, O X
is O X
shown O X
to O X
require O X
the O X
acidic O X
C O X
- O X
terminal O X
domain O X
(- O X
DEDDDL O X
) O X
of O X
Ran I-MISC 5901
proteins O X
in O X
addition O X
to O X
the O X
presence O X
of O X
an O X
intact O X
Ran I-MISC 5901
- O X
binding O X
domain O X
. O X

In O X
whole O X
cell O X
extracts O X
, O X
the O X
GST O X
- O X
RanBP1a O X
fusion O X
protein O X
binds O X
specifically O X
to O X
GTP O X
- O X
Ran I-MISC 5901
and O X
will O X
not O X
interact O X
with O X
Rab O X
/ O X
Ypt O X
- O X
type O X
small O X
GTP O X
- O X
binding O X
proteins O X
. O X

Finally O X
, O X
in O X
good O X
agreement O X
with O X
their O X
proposed O X
biological O X
function O X
, O X
the O X
At O X
- O X
Ran I-MISC 5901
and O X
the O X
At O X
- O X
RanBP O X
genes O X
are O X
expressed O X
coordinately O X
and O X
show O X
the O X
highest O X
level O X
of O X
expression O X
in O X
meristematic O X
tissues O X
. O X

###10097141	5310,5311	5311,7220	5311,7220

Specific O X
association O X
of O X
the O X
gene O X
product O X
of O X
PKD2 I-MISC 5311
with O X
the O X
TRPC1 I-MISC 7220
channel O X
. O X

The O X
function O X
( O X
s O X
) O X
of O X
the O X
genes O X
( O X
PKD1 I-MISC 5310
and O X
PKD2 I-MISC 5311
) O X
responsible O X
for O X
the O X
majority O X
of O X
cases O X
of O X
autosomal O X
dominant O X
polycystic O X
kidney O X
disease O X
is O X
unknown O X
. O X

While O X
PKD1 I-MISC 5310
encodes O X
a O X
large O X
integral O X
membrane O X
protein O X
containing O X
several O X
structural O X
motifs O X
found O X
in O X
known O X
proteins O X
involved O X
in O X
cell O X
- O X
cell O X
or O X
cell O X
- O X
matrix O X
interactions O X
, O X
PKD2 I-MISC 5311
has O X
homology O X
to O X
PKD1 I-MISC 5310
and O X
the O X
major O X
subunit O X
of O X
the O X
voltage O X
- O X
activated O X
Ca2 O X
+ O X
channels O X
. O X

We O X
now O X
describe O X
sequence O X
homology O X
between O X
PKD2 I-MISC 5311
and O X
various O X
members O X
of O X
the O X
mammalian O X
transient O X
receptor O X
potential O X
channel O X
( O X
TRPC O X
) O X
proteins O X
, O X
thought O X
to O X
be O X
activated O X
by O X
G O X
protein O X
- O X
coupled O X
receptor O X
activation O X
and O X
/ O X
or O X
depletion O X
of O X
internal O X
Ca2 O X
+ O X
stores O X
. O X

We O X
show O X
that O X
PKD2 I-MISC 5311
can O X
directly O X
associate O X
with O X
TRPC1 I-MISC 7220
but O X
not O X
TRPC3 I-MISC 7222
in O X
transfected O X
cells O X
and O X
in O X
vitro O X
. O X

This O X
association O X
is O X
mediated O X
by O X
two O X
distinct O X
domains O X
in O X
PKD2 I-MISC 5311
. O X

One O X
domain O X
involves O X
a O X
minimal O X
region O X
of O X
73 O X
amino O X
acids O X
in O X
the O X
C O X
- O X
terminal O X
cytoplasmic O X
tail O X
of O X
PKD2 I-MISC 5311
shown O X
previously O X
to O X
constitute O X
an O X
interacting O X
domain O X
with O X
PKD1 I-MISC 5310
. O X

However O X
, O X
distinct O X
residues O X
within O X
this O X
region O X
mediate O X
specific O X
interactions O X
with O X
TRPC1 I-MISC 7220
or O X
PKD1 I-MISC 5310
. O X

The O X
C O X
- O X
terminal O X
domain O X
is O X
sufficient O X
but O X
not O X
necessary O X
for O X
the O X
PKD2 I-MISC 5311
- O X
TRPC1 I-MISC 7220
association O X
. O X

A O X
more O X
N O X
- O X
terminal O X
domain O X
located O X
within O X
transmembrane O X
segments O X
S2 O X
and O X
S5 O X
, O X
including O X
a O X
putative O X
pore O X
helical O X
region O X
between O X
S5 O X
and O X
S6 O X
, O X
is O X
also O X
responsible O X
for O X
the O X
association O X
. O X

Given O X
the O X
ability O X
of O X
the O X
TRPC O X
to O X
form O X
functional O X
homo O X
- O X
and O X
heteromultimeric O X
complexes O X
, O X
these O X
data O X
provide O X
evidence O X
that O X
PKD2 I-MISC 5311
may O X
be O X
functionally O X
related O X
to O X
TRPC O X
proteins O X
and O X
suggest O X
a O X
possible O X
role O X
of O X
PKD2 I-MISC 5311
in O X
modulating O X
Ca2 O X
+ O X
entry O X
in O X
response O X
to O X
G O X
protein O X
- O X
coupled O X
receptor O X
activation O X
and O X
/ O X
or O X
store O X
depletion O X
. O X

###16763556	7316,5429	11201,7316

Controlling O X
the O X
subcellular O X
localization O X
of O X
DNA I-MISC 5429
polymerases I-MISC 5429
iota I-MISC 5429
and O X
eta I-MISC 1909
via O X
interactions O X
with O X
ubiquitin I-MISC 7316
. O X

Y O X
- O X
family O X
DNA O X
polymerases O X
have O X
spacious O X
active O X
sites O X
that O X
can O X
accommodate O X
a O X
wide O X
variety O X
of O X
geometric O X
distortions O X
. O X

As O X
a O X
consequence O X
, O X
they O X
are O X
considerably O X
more O X
error O X
- O X
prone O X
than O X
high O X
- O X
fidelity O X
replicases O X
. O X

It O X
is O X
hardly O X
surprising O X
, O X
therefore O X
, O X
that O X
the O X
in O X
vivo O X
activity O X
of O X
these O X
polymerases O X
is O X
tightly O X
regulated O X
, O X
so O X
as O X
to O X
minimize O X
their O X
inadvertent O X
access O X
to O X
primer O X
- O X
termini O X
. O X

We O X
report O X
here O X
that O X
one O X
such O X
mechanism O X
employed O X
by O X
human O X
cells O X
relies O X
on O X
a O X
specific O X
and O X
direct O X
interaction O X
between O X
DNA I-MISC 5429
polymerases I-MISC 5429
iota I-MISC 5429
and O X
eta I-MISC 1909
with O X
ubiquitin I-MISC 7316
( O X
Ub I-MISC 7316
). O X

Indeed O X
, O X
we O X
show O X
that O X
both O X
polymerases O X
interact O X
noncovalently O X
with O X
free O X
polyUb O X
chains O X
, O X
as O X
well O X
as O X
mono O X
- O X
ubiquitinated O X
proliferating O X
cell O X
nuclear O X
antigen O X
( O X
Ub O X
- O X
PCNA I-MISC 5111
). O X

Mutants O X
of O X
poliota O X
( O X
P692R O X
) O X
and O X
poleta O X
( O X
H654A O X
) O X
were O X
isolated O X
that O X
are O X
defective O X
in O X
their O X
interactions O X
with O X
polyUb O X
and O X
Ub O X
- O X
PCNA I-MISC 5111
, O X
whilst O X
retaining O X
their O X
ability O X
to O X
interact O X
with O X
unmodified O X
PCNA I-MISC 5111
. O X

Interestingly O X
, O X
the O X
polymerase O X
mutants O X
exhibit O X
significantly O X
lower O X
levels O X
of O X
replication O X
foci O X
in O X
response O X
to O X
DNA O X
damage O X
, O X
thereby O X
highlighting O X
the O X
biological O X
importance O X
of O X
the O X
polymerase O X
- O X
Ub O X
interaction O X
in O X
regulating O X
the O X
access O X
of O X
the O X
TLS O X
polymerases O X
to O X
stalled O X
replication O X
forks O X
in O X
vivo O X
. O X

###11027267	855408,850298

Yeast O X
Krr1p I-MISC 850298
physically O X
and O X
functionally O X
interacts O X
with O X
a O X
novel O X
essential O X
Kri1p I-MISC 855408
, O X
and O X
both O X
proteins O X
are O X
required O X
for O X
40S O X
ribosome O X
biogenesis O X
in O X
the O X
nucleolus O X
. O X

Using O X
a O X
two O X
- O X
hybrid O X
screening O X
with O X
TOM1 I-MISC 852068
, O X
a O X
putative O X
ubiquitin O X
- O X
ligase O X
gene O X
of O X
Saccharomyces O X
cerevisiae O X
, O X
we O X
isolated O X
KRR1 I-MISC 850298
, O X
a O X
homologue O X
of O X
human O X
HRB2 I-MISC 11103
( O X
for O X
human O X
immunodeficiency O X
virus O X
type O X
1 O X
Rev O X
- O X
binding O X
protein O X
2 O X
). O X

To O X
characterize O X
the O X
gene O X
function O X
, O X
we O X
constructed O X
temperature O X
- O X
sensitive O X
krr1 I-MISC 850298
mutants O X
and O X
isolated O X
two O X
multicopy O X
suppressors O X
. O X

One O X
suppressor O X
is O X
RPS14A I-MISC 850397
, O X
encoding O X
a O X
40S O X
ribosomal O X
protein O X
. O X

The O X
C O X
- O X
terminal O X
- O X
truncated O X
rpS14p O X
, O X
which O X
was O X
reported O X
to O X
have O X
diminished O X
binding O X
activity O X
to O X
18S O X
rRNA O X
, O X
failed O X
to O X
suppress O X
the O X
krr1 I-MISC 850298
mutant O X
. O X

The O X
other O X
suppressor O X
is O X
a O X
novel O X
gene O X
, O X
KRI1 I-MISC 855408
( O X
for O X
KRR1 I-MISC 850298
interacting O X
protein O X
; O X
YNL308c I-MISC 855408
). O X

KRI1 I-MISC 855408
is O X
essential O X
for O X
viability O X
, O X
and O X
Kri1p I-MISC 855408
is O X
localized O X
to O X
the O X
nucleolus O X
. O X

We O X
constructed O X
a O X
galactose O X
- O X
dependent O X
kri1 I-MISC 855408
strain O X
by O X
placing O X
KRI1 I-MISC 855408
under O X
control O X
of O X
the O X
GAL1 I-MISC 852308
promoter O X
, O X
so O X
that O X
expression O X
of O X
KRI1 I-MISC 855408
was O X
shut O X
off O X
when O X
transferring O X
the O X
culture O X
to O X
glucose O X
medium O X
. O X

Polysome O X
and O X
40S O X
ribosome O X
fractions O X
were O X
severely O X
decreased O X
in O X
the O X
krr1 I-MISC 850298
mutant O X
and O X
Kri1p I-MISC 855408
- O X
depleted O X
cells O X
. O X

Pulse O X
- O X
chase O X
analysis O X
of O X
newly O X
synthesized O X
rRNAs O X
demonstrated O X
that O X
18S O X
rRNA O X
is O X
not O X
produced O X
in O X
either O X
mutant O X
. O X

However O X
, O X
wild O X
- O X
type O X
levels O X
of O X
25S O X
rRNA O X
are O X
made O X
in O X
either O X
mutant O X
. O X

Northern O X
analysis O X
revealed O X
that O X
the O X
steady O X
- O X
state O X
levels O X
of O X
18S O X
rRNA O X
and O X
20S O X
pre O X
- O X
rRNAs O X
were O X
reduced O X
in O X
both O X
mutants O X
. O X

Precursors O X
for O X
18S O X
rRNA O X
were O X
detected O X
but O X
probably O X
very O X
unstable O X
in O X
both O X
mutants O X
. O X

A O X
myc O X
- O X
tagged O X
Kri1p I-MISC 855408
coimmunoprecipitated O X
with O X
a O X
hemagglutinin O X
- O X
tagged O X
Krr1p I-MISC 850298
. O X

Furthermore O X
, O X
the O X
krr1 I-MISC 850298
mutant O X
protein O X
was O X
defective O X
in O X
its O X
interaction O X
with O X
Kri1p I-MISC 855408
. O X

These O X
data O X
lead O X
us O X
to O X
conclude O X
that O X
Krr1p I-MISC 850298
physically O X
and O X
functionally O X
interacts O X
with O X
Kri1p I-MISC 855408
to O X
form O X
a O X
complex O X
which O X
is O X
required O X
for O X
40S O X
ribosome O X
biogenesis O X
in O X
the O X
nucleolus O X
. O X

###9389648	4089,4087	4087,398070	4089,398070

Dual O X
role O X
of O X
the O X
Smad4 I-MISC 4089
/ O X
DPC4 I-MISC 4089
tumor O X
suppressor O X
in O X
TGFbeta O X
- O X
inducible O X
transcriptional O X
complexes O X
. O X

Upon O X
ligand O X
binding O X
, O X
the O X
receptors O X
of O X
the O X
TGFbeta O X
family O X
phosphorylate O X
Smad O X
proteins O X
, O X
which O X
then O X
move O X
into O X
the O X
nucleus O X
where O X
they O X
activate O X
transcription O X
. O X

To O X
carry O X
out O X
this O X
function O X
, O X
the O X
receptor O X
- O X
activated O X
Smads O X
1 O X
and O X
2 O X
require O X
association O X
with O X
the O X
product O X
of O X
deleted I-MISC 4089
in I-MISC 4089
pancreatic I-MISC 4089
carcinoma I-MISC 4089
, I-MISC 4089
locus I-MISC 4089
4 I-MISC 4089
( O X
DPC4 I-MISC 4089
), O X
Smad4 I-MISC 4089
. O X

We O X
investigated O X
the O X
step O X
at O X
which O X
Smad4 I-MISC 4089
is O X
required O X
for O X
transcriptional O X
activation O X
. O X

Smad4 I-MISC 4089
is O X
not O X
required O X
for O X
nuclear O X
translocation O X
of O X
Smads I-MISC 4086
1 I-MISC 4086
or I-MISC 4086
2 I-MISC 4086
, O X
or O X
for O X
association O X
of O X
Smad2 I-MISC 4087
with O X
a O X
DNA O X
binding O X
partner O X
, O X
the O X
winged O X
helix O X
protein O X
FAST I-MISC 398070
- I-MISC 398070
1 I-MISC 398070
. O X

Receptor O X
- O X
activated O X
Smad2 I-MISC 4087
takes O X
Smad4 I-MISC 4089
into O X
the O X
nucleus O X
where O X
they O X
form O X
a O X
complex O X
with O X
FAST I-MISC 398070
- I-MISC 398070
1 I-MISC 398070
that O X
requires O X
these O X
three O X
components O X
to O X
activate O X
transcription O X
. O X

Smad4 I-MISC 4089
contributes O X
two O X
functions O X
: O X
Through O X
its O X
amino O X
- O X
terminal O X
domain O X
, O X
Smad4 I-MISC 4089
promotes O X
binding O X
of O X
the O X
Smad2 I-MISC 4087
/ O X
Smad4 I-MISC 4089
/ O X
FAST I-MISC 398070
- I-MISC 398070
1 I-MISC 398070
complex O X
to O X
DNA O X
; O X
through O X
its O X
carboxy O X
- O X
terminal O X
domain O X
, O X
Smad4 I-MISC 4089
provides O X
an O X
activation O X
function O X
required O X
for O X
Smad1 I-MISC 4086
or O X
Smad2 I-MISC 4087
to O X
stimulate O X
transcription O X
. O X

The O X
dual O X
function O X
of O X
Smad4 I-MISC 4089
in O X
transcriptional O X
activation O X
underscores O X
its O X
central O X
role O X
in O X
TGFbeta O X
signaling O X
. O X

###21984795	945420,946345	945843,946345	946345,946345

The O X
same O X
periplasmic O X
ExbD I-MISC 946345
residues O X
mediate O X
in O X
vivo O X
interactions O X
between O X
ExbD I-MISC 946345
homodimers O X
and O X
ExbD I-MISC 946345
- O X
TonB I-MISC 945843
heterodimers O X
. O X

The O X
TonB I-MISC 945843
system O X
couples O X
cytoplasmic O X
membrane O X
proton O X
motive O X
force O X
to O X
TonB I-MISC 945843
- O X
gated O X
outer O X
membrane O X
transporters O X
for O X
active O X
transport O X
of O X
nutrients O X
into O X
the O X
periplasm O X
. O X

In O X
Escherichia O X
coli O X
, O X
cytoplasmic O X
membrane O X
proteins O X
ExbB I-MISC 945420
and O X
ExbD I-MISC 946345
promote O X
conformational O X
changes O X
in O X
TonB I-MISC 945843
, O X
which O X
transmits O X
this O X
energy O X
to O X
the O X
transporters O X
. O X

The O X
only O X
known O X
energy O X
- O X
dependent O X
interaction O X
occurs O X
between O X
the O X
periplasmic O X
domains O X
of O X
TonB I-MISC 945843
and O X
ExbD I-MISC 946345
. O X

This O X
study O X
identified O X
sites O X
of O X
in O X
vivo O X
homodimeric O X
interactions O X
within O X
ExbD I-MISC 946345
periplasmic O X
domain O X
residues O X
92 O X
to O X
121 O X
. O X

ExbD I-MISC 946345
was O X
active O X
as O X
a O X
homodimer O X
( O X
ExbD I-MISC 946345
( O X
2 O X
)) O X
but O X
not O X
through O X
all O X
Cys O X
substitution O X
sites O X
, O X
suggesting O X
the O X
existence O X
of O X
conformationally O X
dynamic O X
regions O X
in O X
the O X
ExbD I-MISC 946345
periplasmic O X
domain O X
. O X

A O X
subset O X
of O X
homodimeric O X
interactions O X
could O X
not O X
be O X
modeled O X
on O X
the O X
nuclear O X
magnetic O X
resonance O X
( O X
NMR O X
) O X
structure O X
without O X
significant O X
distortion O X
. O X

Most O X
importantly O X
, O X
the O X
majority O X
of O X
ExbD I-MISC 946345
Cys O X
substitutions O X
that O X
mediated O X
homodimer O X
formation O X
also O X
mediated O X
ExbD I-MISC 946345
- O X
TonB I-MISC 945843
heterodimer O X
formation O X
with O X
TonB I-MISC 945843
A150C O X
. O X

Consistent O X
with O X
the O X
implied O X
competition O X
, O X
ExbD I-MISC 946345
homodimer O X
formation O X
increased O X
in O X
the O X
absence O X
of O X
TonB I-MISC 945843
. O X

Although O X
ExbD I-MISC 946345
D25 O X
was O X
not O X
required O X
for O X
their O X
formation O X
, O X
ExbD I-MISC 946345
dimers O X
interacted O X
in O X
vivo O X
with O X
ExbB I-MISC 945420
. O X

ExbD I-MISC 946345
- O X
TonB I-MISC 945843
interactions O X
required O X
ExbD I-MISC 946345
transmembrane O X
domain O X
residue O X
D25 O X
. O X

These O X
results O X
suggested O X
a O X
model O X
where O X
ExbD I-MISC 946345
( O X
2 O X
) O X
assembled O X
with O X
ExbB I-MISC 945420
undergoes O X
a O X
transmembrane O X
domain O X
- O X
dependent O X
transition O X
and O X
exchanges O X
partners O X
in O X
localized O X
homodimeric O X
interfaces O X
to O X
form O X
an O X
ExbD I-MISC 946345
( O X
2 O X
)- O X
TonB I-MISC 945843
heterotrimer O X
. O X

The O X
findings O X
here O X
were O X
also O X
consistent O X
with O X
our O X
previous O X
hypothesis O X
that O X
ExbD I-MISC 946345
guides O X
the O X
conformation O X
of O X
the O X
TonB I-MISC 945843
periplasmic O X
domain O X
, O X
which O X
itself O X
is O X
conformationally O X
dynamic O X
. O X

###16103886	1489078,23513

The O X
hScrib I-MISC 23513
/ O X
Dlg O X
apico O X
- O X
basal O X
control O X
complex O X
is O X
differentially O X
targeted O X
by O X
HPV O X
- O X
16 O X
and O X
HPV O X
- O X
18 O X
E6 I-MISC 1489078
proteins O X
. O X

The O X
E6 I-MISC 1489078
proteins O X
of O X
the O X
high O X
- O X
risk O X
Human O X
papillomaviruses O X
( O X
HPV O X
) O X
types O X
have O X
a O X
well O X
- O X
documented O X
ability O X
to O X
target O X
certain O X
cellular O X
proteins O X
for O X
ubiquitin O X
- O X
mediated O X
degradation O X
via O X
the O X
proteasome O X
. O X

Previous O X
studies O X
have O X
shown O X
that O X
E6 I-MISC 1489078
proteins O X
interact O X
differently O X
with O X
different O X
target O X
proteins O X
, O X
and O X
that O X
the O X
viral O X
proteins O X
, O X
depending O X
upon O X
the O X
target O X
, O X
may O X
recruit O X
diverse O X
cellular O X
ubiquitin O X
- O X
protein O X
ligases O X
. O X

In O X
this O X
study O X
, O X
we O X
have O X
examined O X
the O X
abilities O X
of O X
E6 I-MISC 1489078
proteins O X
from O X
HPV O X
- O X
16 O X
and O X
HPV O X
- O X
18 O X
to O X
interact O X
with O X
and O X
induce O X
the O X
degradation O X
of O X
two O X
PDZ O X
domain O X
- O X
containing O X
targets O X
, O X
Dlg O X
and O X
hScrib I-MISC 23513
. O X

We O X
have O X
also O X
mapped O X
the O X
binding O X
site O X
of O X
E6 I-MISC 1489078
on O X
hScrib I-MISC 23513
and O X
shown O X
that O X
the O X
interaction O X
of O X
E6 I-MISC 1489078
with O X
hScrib I-MISC 23513
is O X
distinct O X
from O X
its O X
interactions O X
with O X
other O X
PDZ O X
domain O X
- O X
containing O X
targets O X
. O X

This O X
is O X
reflected O X
in O X
the O X
efficiency O X
with O X
which O X
the O X
two O X
viral O X
E6 I-MISC 1489078
proteins O X
can O X
inhibit O X
hScrib I-MISC 23513
' O X
s O X
suppression O X
of O X
cell O X
transformation O X
. O X
Dlg O X
and O X
hScrib I-MISC 23513
have O X
complementary O X
activities O X
in O X
the O X
control O X
of O X
epithelial O X
cell O X
polarity O X
and O X
the O X
fact O X
that O X
both O X
are O X
targeted O X
by O X
high O X
- O X
risk O X
HPV O X
E6 I-MISC 1489078
proteins O X
underlines O X
their O X
importance O X
. O X

Our O X
finding O X
that O X
they O X
are O X
each O X
targeted O X
differently O X
by O X
HPV O X
- O X
16 O X
and O X
HPV O X
- O X
18 O X
E O X
6 O X
s O X
suggests O X
that O X
the O X
two O X
viruses O X
are O X
subjected O X
to O X
somewhat O X
different O X
constraints O X
and O X
provides O X
a O X
possible O X
explanation O X
for O X
the O X
apparent O X
redundancy O X
in O X
targeting O X
both O X
parts O X
of O X
this O X
important O X
control O X
mechanism O X
. O X

###15350535	58480,5058

Wrch1 I-MISC 58480
is O X
a O X
GTPase O X
- O X
deficient O X
Cdc42 I-MISC 12540
- O X
like O X
protein O X
with O X
unusual O X
binding O X
characteristics O X
and O X
cellular O X
effects O X
. O X

The O X
Rho O X
family O X
of O X
small O X
GTPases O X
controls O X
many O X
biological O X
processes O X
, O X
including O X
cytoskeletal O X
regulation O X
, O X
membrane O X
trafficking O X
, O X
cell O X
adhesion O X
, O X
cell O X
polarization O X
, O X
transcriptional O X
activity O X
, O X
apoptosis O X
, O X
and O X
cell O X
proliferation O X
. O X

Wrch1 I-MISC 58480
, O X
which O X
belongs O X
to O X
the O X
Cdc42 I-MISC 12540
subfamily O X
, O X
is O X
one O X
of O X
the O X
least O X
characterized O X
family O X
member O X
. O X

Despite O X
its O X
homology O X
to O X
other O X
Cdc42 I-MISC 12540
- O X
like O X
proteins O X
, O X
we O X
found O X
that O X
Wrch1 I-MISC 58480
has O X
unique O X
characteristics O X
. O X

Biochemical O X
experiments O X
showed O X
that O X
Wrch1 I-MISC 58480
has O X
no O X
detectable O X
GTPase O X
activity O X
in O X
vitro O X
and O X
that O X
its O X
intrinsic O X
nucleotide O X
exchange O X
rate O X
is O X
very O X
high O X
in O X
comparison O X
to O X
Cdc42 I-MISC 12540
. O X

Furthermore O X
, O X
NIH3T3 O X
cells O X
transiently O X
transfected O X
with O X
Wrch1 I-MISC 58480
showed O X
an O X
up O X
- O X
rounded O X
, O X
retracted O X
phenotype O X
. O X

In O X
addition O X
, O X
Wrch1 I-MISC 58480
was O X
shown O X
to O X
be O X
more O X
efficient O X
than O X
Cdc42 I-MISC 12540
in O X
triggering O X
the O X
formation O X
of O X
filopodia O X
. O X

Serum O X
stimulation O X
of O X
cells O X
expressing O X
Wrch1 I-MISC 58480
induces O X
vigorous O X
membrane O X
blebbing O X
, O X
a O X
phenomenon O X
dependent O X
on O X
the O X
activity O X
of O X
ROCK O X
. O X

In O X
a O X
search O X
for O X
proteins O X
interacting O X
with O X
Wrch1 I-MISC 58480
, O X
PAK1 I-MISC 5058
and O X
NCKbeta I-MISC 17974
were O X
identified O X
as O X
binding O X
partners O X
. O X

Interestingly O X
, O X
the O X
interaction O X
to O X
NCKbeta I-MISC 17974
was O X
shown O X
to O X
be O X
mediated O X
via O X
PxxP O X
motifs O X
present O X
in O X
an O X
N O X
- O X
terminal O X
extension O X
of O X
Wrch1 I-MISC 58480
to O X
the O X
second O X
and O X
third O X
SH3 O X
domains O X
of O X
NCKbeta I-MISC 17974
. O X

###12586840	7020,2033

Physical O X
and O X
functional O X
interactions O X
among O X
AP I-MISC 7020
- I-MISC 7020
2 I-MISC 7020
transcription O X
factors O X
, O X
p300 I-MISC 2033
/ O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
, O X
and O X
CITED2 I-MISC 10370
. O X

The O X
transcriptional O X
co O X
- O X
activators O X
and O X
histone O X
acetyltransferases O X
p300 I-MISC 2033
/ O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
( O X
CBP I-MISC 1387
) O X
interact O X
with O X
CITED2 I-MISC 10370
, O X
a O X
transcription O X
factor O X
AP I-MISC 7020
- I-MISC 7020
2 I-MISC 7020
( O X
TFAP2 I-MISC 7020
) O X
co O X
- O X
activator O X
. O X

p300 I-MISC 2033
/ O X
CBP I-MISC 1387
, O X
CITED2 I-MISC 10370
, O X
and O X
TFAP2A I-MISC 7020
are O X
essential O X
for O X
normal O X
neural O X
tube O X
and O X
cardiac O X
development O X
. O X

Here O X
we O X
show O X
that O X
p300 I-MISC 2033
and O X
CBP I-MISC 1387
co O X
- O X
activate O X
TFAP2A I-MISC 7020
in O X
the O X
presence O X
of O X
CITED2 I-MISC 10370
. O X

TFAP2A I-MISC 21418
transcriptional O X
activity O X
was O X
modestly O X
impaired O X
in O X
p300 I-MISC 328572
(+/-) O X
and O X
CBP I-MISC 12914
(+/-) O X
mouse O X
embryonic O X
fibroblasts O X
; O X
this O X
was O X
rescued O X
by O X
ectopic O X
expression O X
of O X
p300 I-MISC 328572
/ O X
CBP I-MISC 12914
. O X

p300 I-MISC 328572
, O X
TFAP2A I-MISC 21418
, O X
and O X
endogenous O X
CITED2 I-MISC 17684
could O X
be O X
co O X
- O X
immunoprecipitated O X
from O X
transfected O X
U2 O X
- O X
OS O X
cells O X
indicating O X
that O X
they O X
can O X
interact O X
physically O X
in O X
vivo O X
. O X

CITED2 I-MISC 10370
interacted O X
with O X
the O X
dimerization O X
domain O X
of O X
TFAP2C I-MISC 7022
, O X
which O X
is O X
highly O X
conserved O X
in O X
TFAP2A I-MISC 7020
/ I-MISC 7020
B I-MISC 7020
. O X

In O X
mammalian O X
two O X
- O X
hybrid O X
experiments O X
, O X
full O X
- O X
length O X
p300 I-MISC 2033
and O X
TFAP2A I-MISC 7020
interacted O X
only O X
when O X
CITED2 I-MISC 10370
was O X
co O X
- O X
transfected O X
. O X

N O X
- O X
terminal O X
residues O X
of O X
TFAP2A I-MISC 7020
, O X
containing O X
the O X
transactivation O X
domain O X
, O X
are O X
both O X
necessary O X
and O X
sufficient O X
for O X
interaction O X
with O X
p300 I-MISC 2033
, O X
and O X
this O X
interaction O X
was O X
independent O X
of O X
CITED2 I-MISC 10370
. O X

Consistent O X
with O X
this O X
, O X
N O X
- O X
terminal O X
residues O X
of O X
TFAP2A I-MISC 7020
were O X
required O X
for O X
p300 I-MISC 2033
- O X
and O X
CITED2 I-MISC 10370
- O X
dependent O X
co O X
- O X
activation O X
. O X

A O X
histone O X
acetyltransferase O X
- O X
deficient O X
p300 I-MISC 2033
mutant O X
( O X
D1399Y O X
) O X
did O X
not O X
co O X
- O X
activate O X
TFAP2A I-MISC 7020
and O X
did O X
not O X
affect O X
the O X
expression O X
or O X
cellular O X
localization O X
of O X
TFAP2A I-MISC 7020
or O X
CITED2 I-MISC 10370
. O X

In O X
mammalian O X
two O X
- O X
hybrid O X
experiments O X
p300D1399Y O X
failed O X
to O X
interact O X
with O X
TFAP2A I-MISC 7020
, O X
explaining O X
, O X
at O X
least O X
in O X
part O X
, O X
its O X
failure O X
to O X
function O X
as O X
a O X
co O X
- O X
activator O X
. O X

Our O X
results O X
suggest O X
a O X
model O X
wherein O X
interactions O X
among O X
TFAP2A I-MISC 7020
, O X
CITED2 I-MISC 10370
, O X
and O X
p300 I-MISC 2033
/ O X
CBP I-MISC 1387
are O X
necessary O X
for O X
TFAP2A I-MISC 7020
- O X
mediated O X
transcriptional O X
activation O X
and O X
for O X
normal O X
neural O X
tube O X
and O X
cardiac O X
development O X
. O X

###19153231	3661,29110	9641,911827

Ebola O X
virus O X
protein O X
VP35 I-MISC 911827
impairs O X
the O X
function O X
of O X
interferon O X
regulatory O X
factor O X
- O X
activating O X
kinases O X
IKKepsilon I-MISC 9641
and O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
. O X

The O X
Ebola O X
virus O X
( O X
EBOV O X
) O X
VP35 I-MISC 911827
protein O X
antagonizes O X
the O X
early O X
antiviral O X
alpha O X
/ O X
beta O X
interferon O X
( O X
IFN I-MISC 3439
- I-MISC 3439
alpha I-MISC 3439
/ O X
beta O X
) O X
response O X
. O X

We O X
previously O X
demonstrated O X
that O X
VP35 I-MISC 911827
inhibits O X
the O X
virus O X
- O X
induced O X
activation O X
of O X
the O X
IFN I-MISC 3456
- I-MISC 3456
beta I-MISC 3456
promoter O X
by O X
blocking O X
the O X
phosphorylation O X
of O X
IFN I-MISC 3661
- I-MISC 3661
regulatory I-MISC 3661
factor I-MISC 3661
3 I-MISC 3661
( O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
), O X
a O X
transcription O X
factor O X
that O X
is O X
crucial O X
for O X
the O X
induction O X
of O X
IFN I-MISC 3439
- I-MISC 3439
alpha I-MISC 3439
/ O X
beta O X
expression O X
. O X

Furthermore O X
, O X
VP35 I-MISC 911827
blocks O X
IFN I-MISC 3456
- I-MISC 3456
beta I-MISC 3456
promoter O X
activation O X
induced O X
by O X
any O X
of O X
several O X
components O X
of O X
the O X
retinoic I-MISC 23586
acid I-MISC 23586
- I-MISC 23586
inducible I-MISC 23586
gene I-MISC 23586
I I-MISC 23586
( O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
)/ O X
melanoma O X
differentiation O X
- O X
associated O X
gene O X
5 O X
( O X
MDA I-MISC 64135
- I-MISC 64135
5 I-MISC 64135
)- O X
activated O X
signaling O X
pathways O X
including O X
RIG I-MISC 23586
- I-MISC 23586
I I-MISC 23586
, O X
IFN I-MISC 57506
- I-MISC 57506
beta I-MISC 57506
promoter I-MISC 57506
stimulator I-MISC 57506
1 I-MISC 57506
( O X
IPS I-MISC 57506
- I-MISC 57506
1 I-MISC 57506
), O X
TANK I-MISC 29110
- I-MISC 29110
binding I-MISC 29110
kinase I-MISC 29110
1 I-MISC 29110
( O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
), O X
and O X
IkappaB I-MISC 9641
kinase I-MISC 9641
epsilon I-MISC 9641
( O X
IKKepsilon I-MISC 9641
). O X

These O X
results O X
suggested O X
that O X
VP35 I-MISC 911827
may O X
target O X
the O X
IRF O X
kinases O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
and O X
IKKepsilon I-MISC 9641
. O X

Coimmunoprecipitation O X
experiments O X
now O X
demonstrate O X
physical O X
interactions O X
of O X
VP35 I-MISC 911827
with O X
IKKepsilon I-MISC 9641
and O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
, O X
and O X
the O X
use O X
of O X
an O X
IKKepsilon I-MISC 9641
deletion O X
construct O X
further O X
demonstrates O X
that O X
the O X
amino O X
- O X
terminal O X
kinase O X
domain O X
of O X
IKKepsilon I-MISC 9641
is O X
sufficient O X
for O X
interactions O X
with O X
either O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
or O X
VP35 I-MISC 911827
. O X

In O X
vitro O X
, O X
either O X
IKKepsilon I-MISC 9641
or O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
phosphorylates O X
not O X
only O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
but O X
also O X
VP35 I-MISC 911827
. O X

Moreover O X
, O X
VP35 I-MISC 911827
overexpression O X
impairs O X
IKKepsilon I-MISC 9641
- O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
, O X
IKKepsilon I-MISC 9641
- O X
IRF I-MISC 3665
- I-MISC 3665
7 I-MISC 3665
, O X
and O X
IKKepsilon I-MISC 9641
- O X
IPS I-MISC 57506
- I-MISC 57506
1 I-MISC 57506
interactions O X
. O X

Finally O X
, O X
lysates O X
from O X
cells O X
overexpressing O X
IKKepsilon I-MISC 9641
contain O X
kinase O X
activity O X
that O X
can O X
phosphorylate O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
in O X
vitro O X
. O X

When O X
VP35 I-MISC 911827
is O X
expressed O X
in O X
the O X
IKKepsilon I-MISC 9641
- O X
expressing O X
cells O X
, O X
this O X
kinase O X
activity O X
is O X
suppressed O X
. O X

These O X
data O X
suggest O X
that O X
VP35 I-MISC 911827
exerts O X
its O X
IFN O X
- O X
antagonist O X
function O X
, O X
at O X
least O X
in O X
part O X
, O X
by O X
blocking O X
necessary O X
interactions O X
between O X
the O X
kinases O X
IKKepsilon I-MISC 9641
and O X
TBK I-MISC 29110
- I-MISC 29110
1 I-MISC 29110
and O X
their O X
normal O X
interaction O X
partners O X
, O X
including O X
their O X
substrates O X
, O X
IRF I-MISC 3661
- I-MISC 3661
3 I-MISC 3661
and O X
IRF I-MISC 3665
- I-MISC 3665
7 I-MISC 3665
. O X

###23856421	8813,54344

Congenital O X
disorder O X
of O X
glycosylation O X
due O X
to O X
DPM1 I-MISC 8813
mutations O X
presenting O X
with O X
dystroglycanopathy O X
- O X
type O X
congenital O X
muscular O X
dystrophy O X
. O X

Congenital O X
disorders O X
of O X
glycosylation O X
( O X
CDG O X
) O X
are O X
rare O X
genetic O X
defects O X
mainly O X
in O X
the O X
post O X
- O X
translational O X
modification O X
of O X
proteins O X
via O X
attachment O X
of O X
carbohydrate O X
chains O X
. O X

We O X
describe O X
an O X
infant O X
with O X
the O X
phenotype O X
of O X
a O X
congenital O X
muscular O X
dystrophy O X
, O X
with O X
borderline O X
microcephaly O X
, O X
hypotonia O X
, O X
camptodactyly O X
, O X
severe O X
motor O X
delay O X
, O X
and O X
elevated O X
creatine O X
kinase O X
. O X

Muscle O X
biopsy O X
showed O X
muscular O X
dystrophy O X
and O X
reduced O X
a O X
- O X
dystroglycan O X
immunostaining O X
with O X
glycoepitope O X
- O X
specific O X
antibodies O X
in O X
a O X
pattern O X
diagnostic O X
of O X
dystroglycanopathy O X
. O X

Carbohydrate O X
deficient O X
transferrin I-MISC 7018
testing O X
showed O X
a O X
pattern O X
pointing O X
to O X
a O X
CDG O X
type O X
I O X
. O X
Sanger O X
sequencing O X
of O X
DPM1 I-MISC 8813
( O X
dolichol O X
- O X
P O X
- O X
mannose O X
synthase O X
subunit O X
1 O X
) O X
revealed O X
a O X
novel O X
Gly O X
> O X
Val O X
change O X
c O X
. O X
455G O X
> O X
T O X
missense O X
mutation O X
resulting O X
in O X
p O X
. O X
Gly152Val O X
) O X
of O X
unknown O X
pathogenicity O X
and O X
deletion O X
/ O X
duplication O X
analysis O X
revealed O X
an O X
intragenic O X
deletion O X
from O X
exons O X
3 O X
to O X
7 O X
on O X
the O X
other O X
allele O X
. O X

DPM1 I-MISC 8813
activity O X
in O X
fibroblasts O X
was O X
reduced O X
by O X
80 O X
%, O X
while O X
affinity O X
for O X
the O X
substrate O X
was O X
not O X
depressed O X
, O X
suggesting O X
a O X
decrease O X
in O X
the O X
amount O X
of O X
active O X
enzyme O X
. O X

Transfected O X
cells O X
expressing O X
tagged O X
versions O X
of O X
wild O X
type O X
and O X
the O X
p O X
. O X
Gly152Val O X
mutant O X
displayed O X
reduced O X
binding O X
to O X
DPM3 I-MISC 54344
, O X
an O X
essential O X
, O X
non O X
- O X
catalytic O X
subunit O X
of O X
the O X
DPM O X
complex O X
, O X
suggesting O X
a O X
mechanism O X
for O X
pathogenicity O X
. O X

The O X
present O X
case O X
is O X
the O X
first O X
individual O X
described O X
with O X
DPM1 I-MISC 8813
- O X
CDG O X
( O X
CDG O X
- O X
Ie O X
) O X
to O X
also O X
have O X
clinical O X
and O X
muscle O X
biopsy O X
findings O X
consistent O X
with O X
dystroglycanopathy O X
. O X

###9428767	856382,854387

Interaction O X
of O X
a O X
G O X
- O X
protein O X
beta O X
- O X
subunit O X
with O X
a O X
conserved O X
sequence O X
in O X
Ste20 I-MISC 856382
/ O X
PAK O X
family O X
protein O X
kinases O X
. O X

Serine O X
/ O X
threonine O X
protein O X
kinases O X
of O X
the O X
Ste20 I-MISC 856382
/ O X
PAK O X
family O X
have O X
been O X
implicated O X
in O X
the O X
signalling O X
from O X
heterotrimeric O X
G O X
proteins O X
to O X
mitogen O X
- O X
activated O X
protein O X
( O X
MAP O X
) O X
kinase O X
cascades O X
. O X

In O X
the O X
yeast O X
Saccharomyces O X
cerevisiae O X
, O X
Ste20 I-MISC 856382
is O X
involved O X
in O X
transmitting O X
the O X
mating O X
- O X
pheromone O X
signal O X
from O X
the O X
betagamma O X
- O X
subunits O X
( O X
encoded O X
by O X
the O X
STE4 I-MISC 854387
and O X
STE18 I-MISC 853548
genes O X
, O X
respectively O X
) O X
of O X
a O X
heterotrimeric O X
G O X
protein O X
to O X
a O X
downstream O X
MAP O X
kinase O X
cascade O X
. O X

We O X
have O X
identified O X
a O X
binding O X
site O X
for O X
the O X
G O X
- O X
protein O X
beta O X
- O X
subunit O X
( O X
Gbeta I-MISC 8801
) O X
in O X
the O X
non O X
- O X
catalytic O X
carboxy O X
- O X
terminal O X
regions O X
of O X
Ste20 I-MISC 856382
and O X
its O X
mammalian O X
homologues O X
, O X
the O X
p21 O X
- O X
activated O X
protein O X
kinases O X
( O X
PAKs O X
). O X

Association O X
of O X
Gbeta I-MISC 8801
with O X
this O X
site O X
in O X
Ste20 I-MISC 856382
was O X
regulated O X
by O X
binding O X
of O X
pheromone O X
to O X
the O X
receptor O X
. O X

Mutations O X
in O X
Gbeta I-MISC 8801
and O X
Ste20 I-MISC 856382
that O X
prevented O X
this O X
association O X
blocked O X
activation O X
of O X
the O X
MAP O X
kinase O X
cascade O X
. O X

Considering O X
the O X
high O X
degree O X
of O X
structural O X
and O X
functional O X
conservation O X
of O X
Ste20 I-MISC 856382
/ O X
PAK O X
family O X
members O X
and O X
G O X
- O X
protein O X
subunits O X
, O X
our O X
results O X
provide O X
a O X
possible O X
model O X
for O X
a O X
role O X
of O X
these O X
kinases O X
in O X
Gbetagamma O X
- O X
mediated O X
signal O X
transduction O X
in O X
organisms O X
ranging O X
from O X
yeast O X
to O X
mammals O X
. O X

###18498651	155030,6780	155030,155030

The O X
host O X
protein O X
Staufen1 O X
interacts O X
with O X
the O X
Pr55Gag I-MISC 155030
zinc O X
fingers O X
and O X
regulates O X
HIV O X
- O X
1 O X
assembly O X
via O X
its O X
N O X
- O X
terminus O X
. O X

BACKGROUND O X
: O X
The O X
formation O X
of O X
new O X
infectious O X
human O X
immunodeficiency O X
type O X
1 O X
virus O X
( O X
HIV O X
- O X
1 O X
) O X
mainly O X
relies O X
on O X
the O X
homo O X
- O X
multimerization O X
of O X
the O X
viral O X
structural O X
polyprotein O X
Pr55Gag I-MISC 155030
and O X
on O X
the O X
recruitment O X
of O X
host O X
factors O X
. O X

We O X
have O X
previously O X
shown O X
that O X
the O X
double O X
- O X
stranded O X
RNA O X
- O X
binding O X
protein O X
Staufen O X
1 O X
( O X
Stau1 I-MISC 6780
), O X
likely O X
through O X
an O X
interaction O X
between O X
its O X
third O X
double O X
- O X
stranded O X
RNA O X
- O X
binding O X
domain O X
( O X
dsRBD3 O X
) O X
and O X
the O X
nucleocapsid O X
( O X
NC O X
) O X
domain O X
of O X
Pr55Gag I-MISC 155030
, O X
participates O X
in O X
HIV O X
- O X
1 O X
assembly O X
by O X
influencing O X
Pr55Gag I-MISC 155030
multimerization O X
. O X

RESULTS O X
: O X
We O X
now O X
report O X
the O X
fine O X
mapping O X
of O X
Stau1 I-MISC 6780
/ O X
Pr55Gag I-MISC 155030
association O X
using O X
co O X
- O X
immunoprecipitation O X
and O X
live O X
cell O X
bioluminescence O X
resonance O X
energy O X
transfer O X
( O X
BRET O X
) O X
assays O X
. O X

On O X
the O X
one O X
hand O X
, O X
our O X
results O X
show O X
that O X
the O X
Stau1 I-MISC 6780
- O X
Pr55Gag I-MISC 155030
interaction O X
requires O X
the O X
integrity O X
of O X
at O X
least O X
one O X
of O X
the O X
two O X
zinc O X
fingers O X
in O X
the O X
NC O X
domain O X
of O X
Pr55Gag I-MISC 155030
but O X
not O X
that O X
of O X
the O X
NC O X
N O X
- O X
terminal O X
basic O X
region O X
. O X

Disruption O X
of O X
both O X
zinc O X
fingers O X
dramatically O X
impeded O X
Pr55Gag I-MISC 155030
multimerization O X
and O X
virus O X
particle O X
release O X
. O X

In O X
parallel O X
, O X
we O X
tested O X
several O X
Stau1 I-MISC 6780
deletion O X
mutants O X
for O X
their O X
capacity O X
to O X
influence O X
Pr55Gag I-MISC 155030
multimerization O X
using O X
the O X
Pr55Gag I-MISC 155030
/ O X
Pr55Gag I-MISC 155030
BRET O X
assay O X
in O X
live O X
cells O X
. O X

Our O X
results O X
revealed O X
that O X
a O X
molecular O X
determinant O X
of O X
12 O X
amino O X
acids O X
at O X
the O X
N O X
- O X
terminal O X
end O X
of O X
Stau1 I-MISC 6780
is O X
necessary O X
to O X
increase O X
Pr55Gag I-MISC 155030
multimerization O X
and O X
particle O X
release O X
. O X

However O X
, O X
this O X
region O X
is O X
not O X
required O X
for O X
Stau1 I-MISC 6780
interaction O X
with O X
the O X
viral O X
polyprotein O X
Pr55Gag I-MISC 155030
. O X

CONCLUSION O X
: O X
These O X
data O X
highlight O X
that O X
Stau1 I-MISC 6780
is O X
a O X
modular O X
protein O X
and O X
that O X
Stau1 I-MISC 6780
influences O X
Pr55Gag I-MISC 155030
multimerization O X
via O X
1 O X
) O X
an O X
interaction O X
between O X
its O X
dsRBD3 O X
and O X
Pr55Gag I-MISC 155030
zinc O X
fingers O X
and O X
2 O X
) O X
a O X
regulatory O X
domain O X
within O X
the O X
N O X
- O X
terminus O X
that O X
could O X
recruit O X
host O X
machineries O X
that O X
are O X
critical O X
for O X
the O X
completion O X
of O X
new O X
HIV O X
- O X
1 O X
capsids O X
. O X

###17540175	3265,18706

Binding O X
of O X
ras I-MISC 3265
to O X
phosphoinositide O X
3 O X
- O X
kinase O X
p110alpha I-MISC 18706
is O X
required O X
for O X
ras I-MISC 3265
- O X
driven O X
tumorigenesis O X
in O X
mice O X
. O X

Ras I-MISC 3265
proteins O X
signal O X
through O X
direct O X
interaction O X
with O X
a O X
number O X
of O X
effector O X
enzymes O X
, O X
including O X
type O X
I O X
phosphoinositide O X
( O X
PI O X
) O X
3 O X
- O X
kinases O X
. O X

Although O X
the O X
ability O X
of O X
Ras I-MISC 3265
to O X
control O X
PI O X
3 O X
- O X
kinase O X
has O X
been O X
well O X
established O X
in O X
manipulated O X
cell O X
culture O X
models O X
, O X
evidence O X
for O X
a O X
role O X
of O X
the O X
interaction O X
of O X
endogenous O X
Ras I-MISC 3265
with O X
PI O X
3 O X
- O X
kinase O X
in O X
normal O X
and O X
malignant O X
cell O X
growth O X
in O X
vivo O X
has O X
been O X
lacking O X
. O X

Here O X
we O X
generate O X
mice O X
with O X
mutations O X
in O X
the O X
Pi3kca O X
gene O X
encoding O X
the O X
catalytic O X
p110alpha I-MISC 18706
isoform O X
that O X
block O X
its O X
interaction O X
with O X
Ras I-MISC 3265
. O X

Cells O X
from O X
these O X
mice O X
show O X
proliferative O X
defects O X
and O X
selective O X
disruption O X
of O X
signaling O X
from O X
growth O X
factors O X
to O X
PI O X
3 O X
- O X
kinase O X
. O X

The O X
mice O X
display O X
defective O X
development O X
of O X
the O X
lymphatic O X
vasculature O X
, O X
resulting O X
in O X
perinatal O X
appearance O X
of O X
chylous O X
ascites O X
. O X

Most O X
importantly O X
, O X
they O X
are O X
highly O X
resistant O X
to O X
endogenous O X
Ras I-MISC 3265
oncogene O X
- O X
induced O X
tumorigenesis O X
. O X

The O X
interaction O X
of O X
Ras I-MISC 3265
with O X
p110alpha I-MISC 18706
is O X
thus O X
required O X
in O X
vivo O X
for O X
certain O X
normal O X
growth O X
factor O X
signaling O X
and O X
for O X
Ras I-MISC 3265
- O X
driven O X
tumor O X
formation O X
. O X

###20642453	120892,7531

14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
to O X
LRRK2 I-MISC 66725
is O X
disrupted O X
by O X
multiple O X
Parkinson O X
' O X
s O X
disease O X
- O X
associated O X
mutations O X
and O X
regulates O X
cytoplasmic O X
localization O X
. O X

LRRK2 I-MISC 120892
( O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
protein I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
) O X
is O X
mutated O X
in O X
a O X
significant O X
number O X
of O X
Parkinson O X
' O X
s O X
disease O X
patients O X
, O X
but O X
still O X
little O X
is O X
understood O X
about O X
how O X
it O X
is O X
regulated O X
or O X
functions O X
. O X

In O X
the O X
present O X
study O X
we O X
have O X
demonstrated O X
that O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
protein O X
isoforms O X
interact O X
with O X
LRRK2 I-MISC 66725
. O X

Consistent O X
with O X
this O X
, O X
endogenous O X
LRRK2 I-MISC 66725
isolated O X
from O X
Swiss O X
3T3 O X
cells O X
or O X
various O X
mouse O X
tissues O X
is O X
associated O X
with O X
endogenous O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
isoforms O X
. O X

We O X
have O X
established O X
that O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
is O X
mediated O X
by O X
phosphorylation O X
of O X
LRRK2 I-MISC 66725
at O X
two O X
conserved O X
residues O X
( O X
Ser910 O X
and O X
Ser935 O X
) O X
located O X
before O X
the O X
leucine O X
- O X
rich O X
repeat O X
domain O X
. O X

Our O X
results O X
suggests O X
that O X
mutation O X
of O X
Ser910 O X
and O X
/ O X
or O X
Ser935 O X
to O X
disrupt O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
does O X
not O X
affect O X
intrinsic O X
protein O X
kinase O X
activity O X
, O X
but O X
induces O X
LRRK2 I-MISC 66725
to O X
accumulate O X
within O X
discrete O X
cytoplasmic O X
pools O X
, O X
perhaps O X
resembling O X
inclusion O X
bodies O X
. O X

To O X
investigate O X
links O X
between O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
and O X
Parkinson O X
' O X
s O X
disease O X
, O X
we O X
studied O X
how O X
41 O X
reported O X
mutations O X
of O X
LRRK2 I-MISC 66725
affected O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
and O X
cellular O X
localization O X
. O X

Strikingly O X
, O X
we O X
found O X
that O X
five O X
of O X
the O X
six O X
most O X
common O X
pathogenic O X
mutations O X
( O X
R1441C O X
, O X
R1441G O X
, O X
R1441H O X
, O X
Y1699C O X
and O X
I2020T O X
) O X
display O X
markedly O X
reduced O X
phosphorylation O X
of O X
Ser910 O X
/ O X
Ser935 O X
thereby O X
disrupting O X
interaction O X
with O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
. O X

We O X
have O X
also O X
demonstrated O X
that O X
Ser910 O X
/ O X
Ser935 O X
phosphorylation O X
and O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binding O X
to O X
endogenous O X
LRRK2 I-MISC 66725
is O X
significantly O X
reduced O X
in O X
tissues O X
of O X
homozygous O X
LRRK2 I-MISC 66725
( O X
R1441C O X
) O X
knock O X
- O X
in O X
mice O X
. O X

Consistent O X
with O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
regulating O X
localization O X
, O X
all O X
of O X
the O X
common O X
pathogenic O X
mutations O X
displaying O X
reduced O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- O X
binding O X
accumulated O X
within O X
inclusion O X
bodies O X
. O X

We O X
also O X
found O X
that O X
three O X
of O X
the O X
41 O X
LRRK2 I-MISC 66725
mutations O X
analysed O X
displayed O X
elevated O X
protein O X
kinase O X
activity O X
( O X
R1728H O X
, O X
~ O X
2 O X
- O X
fold O X
; O X
G2019S O X
, O X
~ O X
3 O X
- O X
fold O X
; O X
and O X
T2031S O X
, O X
~ O X
4 O X
- O X
fold O X
). O X

These O X
results O X
provide O X
the O X
first O X
evidence O X
suggesting O X
that O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
regulates O X
LRRK2 I-MISC 66725
and O X
that O X
disruption O X
of O X
the O X
interaction O X
of O X
LRRK2 I-MISC 66725
with O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
may O X
be O X
linked O X
to O X
Parkinson O X
' O X
s O X
disease O X
. O X

###15965644	567,3077	3077,7037

The O X
Q283P O X
amino O X
- O X
acid O X
change O X
in O X
HFE I-MISC 3077
leads O X
to O X
structural O X
and O X
functional O X
consequences O X
similar O X
to O X
those O X
described O X
for O X
the O X
mutated O X
282Y O X
HFE I-MISC 3077
protein O X
. O X

In O X
Caucasians O X
, O X
4 O X
- O X
35 O X
% O X
of O X
hemochromatosis O X
patients O X
carry O X
at O X
least O X
one O X
chromosome O X
without O X
a O X
common O X
HFE I-MISC 3077
mutation O X
( O X
i O X
. O X
e O X
. O X

C282Y O X
, O X
H63D O X
and O X
S65C O X
). O X

Several O X
studies O X
have O X
now O X
shown O X
that O X
iron O X
overload O X
phenotypes O X
in O X
such O X
patients O X
can O X
be O X
associated O X
with O X
uncommon O X
HFE I-MISC 3077
mutations O X
. O X

We O X
previously O X
supported O X
implication O X
of O X
the O X
C282Y O X
/ O X
Q283P O X
compound O X
heterozygous O X
genotype O X
in O X
hemochromatosis O X
phenotypes O X
and O X
, O X
based O X
on O X
molecular O X
dynamics O X
simulations O X
, O X
proposed O X
that O X
the O X
Q283P O X
substitution O X
prevents O X
normal O X
folding O X
of O X
the O X
HFE I-MISC 3077
alpha3 O X
- O X
domain O X
. O X

In O X
the O X
current O X
work O X
, O X
we O X
have O X
used O X
HeLa O X
cells O X
carrying O X
wild O X
- O X
type O X
or O X
Q283P O X
- O X
mutant O X
HFE I-MISC 3077
cDNA O X
under O X
the O X
control O X
of O X
a O X
tetracycline O X
- O X
sensitive O X
promoter O X
to O X
functionally O X
characterise O X
the O X
Q283P O X
mutation O X
. O X

Experiments O X
using O X
cells O X
over O X
- O X
expressing O X
wild O X
- O X
type O X
HFE I-MISC 3077
confirm O X
the O X
existence O X
of O X
beta2microglobulin I-MISC 567
( O X
beta2m O X
)/ O X
HFE I-MISC 3077
and O X
HFE I-MISC 7037
/ I-MISC 7037
transferrin I-MISC 7037
receptor I-MISC 7037
1 I-MISC 7037
( O X
TfR1 I-MISC 7037
) O X
interactions O X
, O X
as O X
well O X
as O X
the O X
capacity O X
of O X
HFE I-MISC 3077
to O X
reduce O X
transferrin O X
- O X
mediated O X
iron O X
uptake O X
. O X

In O X
contrast O X
, O X
neither O X
beta2m O X
/ O X
HFE I-MISC 3077
nor O X
HFE I-MISC 3077
/ O X
TfR1 I-MISC 7037
complex O X
formation O X
was O X
detected O X
in O X
cells O X
over O X
- O X
expressing O X
the O X
mutated O X
form O X
of O X
HFE I-MISC 3077
. O X

Moreover O X
, O X
the O X
283P O X
HFE I-MISC 3077
protein O X
was O X
found O X
to O X
have O X
a O X
very O X
limited O X
effect O X
on O X
the O X
major O X
cellular O X
iron O X
uptake O X
pathway O X
. O X

Combined O X
, O X
our O X
results O X
indicate O X
that O X
the O X
Q283P O X
mutation O X
leads O X
to O X
structural O X
and O X
functional O X
consequences O X
similar O X
to O X
those O X
described O X
for O X
the O X
main O X
hereditary O X
hemochromatosis O X
mutation O X
. O X

As O X
a O X
consequence O X
, O X
our O X
study O X
has O X
implications O X
for O X
the O X
screening O X
of O X
hemochromatosis O X
patients O X
that O X
have O X
one O X
or O X
two O X
copies O X
of O X
HFE I-MISC 3077
which O X
lack O X
the O X
main O X
mutations O X
. O X

It O X
also O X
highlights O X
that O X
protein O X
structure O X
prediction O X
methods O X
could O X
be O X
more O X
generally O X
used O X
to O X
better O X
interpret O X
relationships O X
between O X
rare O X
genotypes O X
and O X
molecular O X
diagnosis O X
of O X
a O X
human O X
inherited O X
disorder O X
. O X

###11112409	1616,7329

Interaction O X
of O X
Daxx I-MISC 1616
, O X
a O X
Fas I-MISC 1616
binding I-MISC 1616
protein I-MISC 1616
, O X
with O X
sentrin I-MISC 7341
and O X
Ubc9 I-MISC 7329
. O X

Sentrin I-MISC 7341
is O X
a O X
ubiquitin O X
- O X
like O X
protein O X
that O X
can O X
covalently O X
modify O X
cellular O X
proteins O X
, O X
and O X
is O X
a O X
Fas I-MISC 1616
binding I-MISC 1616
protein I-MISC 1616
that O X
protects O X
cells O X
against O X
anti O X
- O X
Fas O X
induced O X
cell O X
death O X
. O X

However O X
, O X
the O X
mechanism O X
by O X
which O X
sentrin I-MISC 7341
exerts O X
its O X
effect O X
upon O X
Fas O X
- O X
mediated O X
apoptosis O X
is O X
not O X
well O X
known O X
. O X

Thus O X
, O X
this O X
study O X
examined O X
the O X
interaction O X
of O X
sentrin I-MISC 7341
with O X
Daxx I-MISC 1616
. O X

Sentrin I-MISC 7341
interacted O X
with O X
Daxx I-MISC 1616
but O X
not O X
with O X
FADD I-MISC 8772
when O X
analyzed O X
by O X
yeast O X
two O X
- O X
hybrid O X
assay O X
. O X

In O X
vitro O X
translated O X
Daxx I-MISC 1616
bound O X
to O X
GST O X
- O X
sentrin I-MISC 7341
fusion O X
protein O X
. O X

FLAG O X
- O X
sentrin I-MISC 7341
fusion O X
protein O X
was O X
also O X
coimmunoprecipitated O X
with O X
Daxx I-MISC 1616
in O X
BOSC23 O X
cells O X
. O X

Also O X
, O X
Daxx I-MISC 1616
interacted O X
with O X
Ubc9 I-MISC 7329
, O X
an O X
essential O X
protein O X
as O X
a O X
key O X
conjugating O X
enzyme O X
. O X

Amino O X
acids O X
625 O X
- O X
740 O X
of O X
Daxx I-MISC 1616
, O X
known O X
as O X
Fas O X
binding O X
region O X
, O X
was O X
also O X
mapped O X
as O X
sentrin I-MISC 7341
and O X
Ubc9 I-MISC 7329
binding O X
region O X
. O X

Colocalization O X
of O X
Fas O X
, O X
sentrin I-MISC 7341
, O X
and O X
Ubc9 I-MISC 7329
binding O X
regions O X
suggests O X
the O X
importance O X
of O X
that O X
region O X
upon O X
the O X
regulation O X
of O X
Daxx I-MISC 1616
. O X

Our O X
data O X
also O X
demonstrated O X
that O X
sentrin I-MISC 7341
could O X
homooligomerize O X
by O X
protein O X
- O X
protein O X
interaction O X
. O X

###11230129	821016,835697

The O X
NAF O X
domain O X
defines O X
a O X
novel O X
protein O X
- O X
protein O X
interaction O X
module O X
conserved O X
in O X
Ca2 O X
+- O X
regulated O X
kinases O X
. O X

The O X
Arabidopsis O X
calcineurin O X
B O X
- O X
like O X
calcium O X
sensor O X
proteins O X
( O X
AtCBLs O X
) O X
interact O X
with O X
a O X
group O X
of O X
serine O X
- O X
threonine O X
protein O X
kinases O X
( O X
AtCIPKs O X
) O X
in O X
a O X
calcium O X
- O X
dependent O X
manner O X
. O X

Here O X
we O X
identify O X
a O X
24 O X
amino O X
acid O X
domain O X
( O X
NAF O X
domain O X
) O X
unique O X
to O X
these O X
kinases O X
as O X
being O X
required O X
and O X
sufficient O X
for O X
interaction O X
with O X
all O X
known O X
AtCBLs O X
. O X

Mutation O X
of O X
conserved O X
residues O X
either O X
abolished O X
or O X
significantly O X
diminished O X
the O X
affinity O X
of O X
AtCIPK1 I-MISC 821016
for O X
AtCBL2 I-MISC 835697
. O X

Comprehensive O X
two O X
- O X
hybrid O X
screens O X
with O X
various O X
AtCBLs O X
identified O X
15 O X
CIPKs O X
as O X
potential O X
targets O X
of O X
CBL I-MISC 824872
proteins O X
. O X

Database O X
analyses O X
revealed O X
additional O X
kinases O X
from O X
Arabidopsis O X
and O X
other O X
plant O X
species O X
harbouring O X
the O X
NAF O X
interaction O X
module O X
. O X

Several O X
of O X
these O X
kinases O X
have O X
been O X
implicated O X
in O X
various O X
signalling O X
pathways O X
mediating O X
responses O X
to O X
stress O X
, O X
hormones O X
and O X
environmental O X
cues O X
. O X

Full O X
- O X
length O X
CIPKs O X
show O X
preferential O X
interaction O X
with O X
distinct O X
CBLs O X
in O X
yeast O X
and O X
in O X
vitro O X
assays O X
. O X

Our O X
findings O X
suggest O X
differential O X
interaction O X
affinity O X
as O X
one O X
of O X
the O X
mechanisms O X
generating O X
the O X
temporal O X
and O X
spatial O X
specificity O X
of O X
calcium O X
signals O X
within O X
plant O X
cells O X
and O X
that O X
different O X
combinations O X
of O X
CBL I-MISC 824872
- O X
CIPK O X
proteins O X
contribute O X
to O X
the O X
complex O X
network O X
that O X
connects O X
various O X
extracellular O X
signals O X
to O X
defined O X
cellular O X
responses O X
. O X

###7935368	3643,3667

Characterization O X
of O X
an O X
interaction O X
between O X
insulin I-MISC 3643
receptor I-MISC 3643
substrate O X
1 O X
and O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
by O X
using O X
the O X
two O X
- O X
hybrid O X
system O X
. O X

Insulin I-MISC 3643
receptor I-MISC 3643
substrate O X
1 O X
( O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
) O X
is O X
a O X
major O X
substrate O X
of O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
and O X
has O X
been O X
implicated O X
in O X
insulin O X
signaling O X
. O X

Although O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
is O X
thought O X
to O X
interact O X
with O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
, O X
the O X
nature O X
of O X
the O X
interaction O X
has O X
not O X
been O X
defined O X
. O X

In O X
this O X
study O X
, O X
we O X
used O X
the O X
two O X
- O X
hybrid O X
assay O X
of O X
protein O X
- O X
protein O X
interaction O X
in O X
the O X
yeast O X
Saccharomyces O X
cerevisiae O X
to O X
study O X
the O X
interaction O X
between O X
human O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
and O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
. O X

We O X
demonstrate O X
that O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
forms O X
a O X
specific O X
complex O X
with O X
the O X
cytoplasmic O X
domain O X
of O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
when O X
both O X
are O X
expressed O X
as O X
hybrid O X
proteins O X
in O X
yeast O X
cells O X
. O X

We O X
show O X
that O X
the O X
interaction O X
is O X
strictly O X
dependent O X
upon O X
receptor O X
tyrosine O X
kinase O X
activity O X
, O X
since O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
shows O X
no O X
interaction O X
with O X
a O X
kinase O X
- O X
inactive O X
receptor O X
hybrid O X
containing O X
a O X
mutated O X
ATP O X
- O X
binding O X
site O X
. O X

Furthermore O X
, O X
mutation O X
of O X
receptor O X
tyrosine O X
960 O X
to O X
phenylalanine O X
eliminates O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
interaction O X
in O X
the O X
two O X
- O X
hybrid O X
assay O X
. O X

These O X
data O X
suggest O X
that O X
the O X
interaction O X
between O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
and O X
the O X
receptor O X
is O X
direct O X
and O X
provide O X
evidence O X
that O X
the O X
juxtamembrane O X
domain O X
of O X
the O X
receptor O X
is O X
involved O X
. O X

Furthermore O X
, O X
we O X
show O X
that O X
a O X
356 O X
- O X
amino O X
- O X
acid O X
region O X
encompassed O X
by O X
amino O X
acids O X
160 O X
through O X
516 O X
of O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
is O X
sufficient O X
for O X
interaction O X
with O X
the O X
receptor O X
in O X
the O X
two O X
- O X
hybrid O X
assay O X
. O X

Lastly O X
, O X
in O X
agreement O X
with O X
our O X
findings O X
for O X
yeast O X
cells O X
, O X
we O X
show O X
that O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
is O X
unable O X
to O X
phosphorylate O X
an O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
protein O X
containing O X
a O X
deletion O X
of O X
amino O X
acids O X
45 O X
to O X
516 O X
when O X
expressed O X
in O X
COS O X
cells O X
. O X

The O X
two O X
- O X
hybrid O X
assay O X
should O X
provide O X
a O X
facile O X
means O X
by O X
which O X
to O X
pursue O X
a O X
detailed O X
understanding O X
of O X
this O X
interaction O X
. O X

###12601044	1410,1410	1415,1410	1420,1410	1410,102724652	1410,102724652	1415,102724652	1420,102724652	3315,102724652

Alteration O X
of O X
protein O X
- O X
protein O X
interactions O X
of O X
congenital O X
cataract O X
crystallin O X
mutants O X
. O X

PURPOSE O X
: O X
A O X
recent O X
study O X
demonstrated O X
the O X
presence O X
of O X
protein O X
- O X
protein O X
interactions O X
among O X
lens O X
crystallins O X
in O X
a O X
mammalian O X
cell O X
two O X
- O X
hybrid O X
system O X
assay O X
and O X
speculated O X
about O X
the O X
significance O X
of O X
these O X
interactions O X
for O X
protein O X
solubility O X
and O X
lens O X
transparency O X
. O X

The O X
current O X
study O X
extends O X
those O X
findings O X
to O X
the O X
following O X
crystallin O X
genes O X
involved O X
in O X
some O X
congenital O X
cataracts O X
: O X
CRYAA I-MISC 102724652
( O X
R116C O X
), O X
CRYAB I-MISC 1410
( O X
R120G O X
), O X
and O X
CRYGC I-MISC 1420
( O X
T5P O X
). O X

METHODS O X
: O X
A O X
mammalian O X
two O X
- O X
hybrid O X
system O X
was O X
used O X
to O X
assay O X
the O X
protein O X
- O X
protein O X
interactions O X
. O X

Congenital O X
cataract O X
crystallin O X
genes O X
were O X
cloned O X
and O X
fused O X
into O X
the O X
two O X
- O X
hybrid O X
system O X
vectors O X
( O X
target O X
and O X
prey O X
proteins O X
). O X

Together O X
, O X
with O X
the O X
third O X
vector O X
containing O X
a O X
reporter O X
gene O X
, O X
chloramphenicol O X
acetyltransferase O X
( O X
CAT O X
), O X
they O X
were O X
cotransfected O X
into O X
human O X
HeLa O X
cells O X
. O X

The O X
presence O X
of O X
protein O X
- O X
protein O X
interactions O X
and O X
the O X
strength O X
of O X
these O X
interactions O X
were O X
assayed O X
by O X
CAT O X
ELISA O X
. O X

RESULTS O X
: O X
The O X
pattern O X
of O X
changes O X
in O X
protein O X
- O X
protein O X
interactions O X
of O X
those O X
congenital O X
cataract O X
gene O X
products O X
with O X
the O X
three O X
major O X
crystallins I-MISC 102724652
, I-MISC 102724652
alphaA I-MISC 102724652
- I-MISC 102724652
or O X
alphaB O X
-, O X
betaB2 O X
-, O X
and O X
gammaC I-MISC 1420
- I-MISC 1420
crystallins O X
, O X
differed O X
. O X

For O X
the O X
T5P O X
gammaC I-MISC 1420
- I-MISC 1420
crystallin I-MISC 1420
, O X
most O X
of O X
the O X
interactions O X
were O X
decreased O X
; O X
for O X
the O X
R116C O X
alphaA I-MISC 102724652
- I-MISC 102724652
crystallin I-MISC 102724652
, O X
the O X
interactions O X
with O X
betaB2 I-MISC 1415
- I-MISC 1415
and O X
gammaC I-MISC 1420
- I-MISC 1420
crystallin I-MISC 1420
decreased O X
and O X
those O X
with O X
alphaB I-MISC 1410
- I-MISC 1410
crystallin I-MISC 1410
and I-MISC 3315
heat I-MISC 3315
- I-MISC 3315
shock I-MISC 3315
protein I-MISC 3315
( I-MISC 3315
Hsp I-MISC 3315
) I-MISC 3315
27 I-MISC 3315
increased O X
; O X
and O X
for O X
the O X
R120G O X
alphaB I-MISC 1410
- I-MISC 1410
crystallin I-MISC 1410
, O X
the O X
interactions O X
with O X
alphaA I-MISC 102724652
- I-MISC 102724652
and O X
alphaB I-MISC 1410
- I-MISC 1410
crystallin I-MISC 1410
decreased O X
, O X
but O X
those O X
with O X
betaB2 I-MISC 1415
- I-MISC 1415
and O X
gammaC I-MISC 1420
- I-MISC 1420
crystallin I-MISC 1420
increased O X
slightly O X
. O X

An O X
attempt O X
was O X
made O X
to O X
interpret O X
the O X
results O X
on O X
the O X
basis O X
of O X
conformational O X
change O X
and O X
disruption O X
of O X
dimeric O X
interaction O X
involving O X
beta O X
- O X
strands O X
. O X

CONCLUSIONS O X
: O X
The O X
results O X
clearly O X
indicate O X
that O X
crystallin O X
mutations O X
involved O X
in O X
congenital O X
cataracts O X
altered O X
protein O X
- O X
protein O X
interactions O X
, O X
which O X
may O X
contribute O X
to O X
decreased O X
protein O X
solubility O X
and O X
formation O X
of O X
cataract O X
. O X

###20561531	14794,5074	5074,80176	5074,92369

Structural O X
basis O X
for O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
recognition O X
by O X
the O X
SPRY O X
domain O X
- O X
and O X
SOCS O X
box O X
- O X
containing O X
proteins O X
SPSB1 I-MISC 80176
, O X
SPSB2 I-MISC 14794
, O X
and O X
SPSB4 I-MISC 92369
. O X

The O X
mammalian O X
SPRY O X
domain O X
- O X
and O X
SOCS O X
box O X
- O X
containing O X
proteins O X
, O X
SPSB1 I-MISC 80176
to O X
SPSB4 I-MISC 92369
, O X
belong O X
to O X
the O X
SOCS O X
box O X
family O X
of O X
E3 O X
ubiquitin O X
ligases O X
. O X

Substrate O X
recognition O X
sites O X
for O X
the O X
SPRY O X
domain O X
are O X
identified O X
only O X
for O X
human O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
( O X
ELNNNL O X
) O X
and O X
for O X
the O X
Drosophila O X
orthologue O X
GUSTAVUS O X
binding O X
to O X
the O X
DEAD O X
- O X
box O X
RNA O X
helicase O X
VASA I-MISC 26067080
( O X
DINNNN O X
). O X

To O X
further O X
investigate O X
this O X
consensus O X
motif O X
, O X
we O X
determined O X
the O X
crystal O X
structures O X
of O X
SPSB1 I-MISC 80176
, O X
SPSB2 I-MISC 14794
, O X
and O X
SPSB4 I-MISC 92369
, O X
as O X
well O X
as O X
their O X
binding O X
modes O X
and O X
affinities O X
for O X
both O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
and O X
VASA I-MISC 26067080
. O X

Mutation O X
of O X
each O X
of O X
the O X
three O X
Asn O X
residues O X
in O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
abrogated O X
binding O X
to O X
all O X
three O X
SPSB O X
proteins O X
, O X
while O X
changing O X
EL O X
to O X
DI O X
enhanced O X
binding O X
. O X

By O X
comparison O X
to O X
SPSB1 I-MISC 80176
and O X
SPSB4 I-MISC 92369
, O X
the O X
more O X
divergent O X
protein O X
SPSB2 I-MISC 14794
showed O X
only O X
weak O X
binding O X
to O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
and O X
was O X
hypersensitive O X
to O X
DI O X
substitution O X
. O X

Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
(( O X
59 O X
- O X
77 O X
)) O X
binding O X
perturbed O X
NMR O X
resonances O X
from O X
a O X
number O X
of O X
SPSB2 I-MISC 14794
residues O X
flanking O X
the O X
ELNNN O X
binding O X
site O X
, O X
including O X
loop O X
D O X
, O X
which O X
binds O X
the O X
EL O X
/ O X
DI O X
sequence O X
. O X

Although O X
interactions O X
with O X
the O X
consensus O X
peptide O X
motif O X
were O X
conserved O X
in O X
all O X
structures O X
, O X
flanking O X
sites O X
in O X
SPSB2 I-MISC 14794
were O X
identified O X
as O X
sites O X
of O X
structural O X
change O X
. O X

These O X
structural O X
changes O X
limit O X
high O X
- O X
affinity O X
interactions O X
for O X
SPSB2 I-MISC 14794
to O X
aspartate O X
- O X
containing O X
sequences O X
, O X
whereas O X
SPSB1 I-MISC 80176
and O X
SPSB4 I-MISC 92369
bind O X
strongly O X
to O X
both O X
Par I-MISC 5074
- I-MISC 5074
4 I-MISC 5074
and O X
VASA I-MISC 26067080
peptides O X
. O X

###19927120	66724,78294	68652,78294

Structural O X
basis O X
for O X
specific O X
recognition O X
of O X
Lys O X
63 O X
- O X
linked O X
polyubiquitin O X
chains O X
by O X
NZF O X
domains O X
of O X
TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
. O X

TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
activate O X
the O X
Jun O X
N O X
- O X
terminal O X
kinase O X
and O X
nuclear O X
factor O X
- O X
kappaB O X
pathways O X
through O X
the O X
specific O X
recognition O X
of O X
Lys O X
63 O X
- O X
linked O X
polyubiquitin O X
chains O X
by O X
its O X
Npl4 I-MISC 55666
zinc O X
- O X
finger O X
( O X
NZF O X
) O X
domain O X
. O X

Here O X
we O X
report O X
crystal O X
structures O X
of O X
the O X
TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
NZF O X
domains O X
in O X
complex O X
with O X
Lys O X
63 O X
- O X
linked O X
diubiquitin O X
at O X
1 O X
. O X
18 O X
and O X
1 O X
. O X
40 O X
A O X
resolutions O X
, O X
respectively O X
. O X

Both O X
NZF O X
domains O X
bind O X
to O X
the O X
distal O X
ubiquitin I-MISC 78294
through O X
a O X
conserved O X
Thr O X
- O X
Phe O X
dipeptide O X
that O X
has O X
been O X
shown O X
to O X
be O X
important O X
for O X
the O X
interaction O X
of O X
the O X
NZF O X
domain O X
of O X
Npl4 I-MISC 55666
with O X
monoubiquitin O X
. O X

In O X
contrast O X
, O X
a O X
surface O X
specific O X
to O X
TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
binds O X
the O X
proximal O X
ubiquitin I-MISC 78294
. O X

Both O X
the O X
distal O X
and O X
proximal O X
binding O X
sites O X
of O X
the O X
TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
NZF O X
domains O X
recognize O X
the O X
Ile O X
44 O X
- O X
centred O X
hydrophobic O X
patch O X
on O X
ubiquitin I-MISC 78294
but O X
do O X
not O X
interact O X
with O X
the O X
Lys O X
63 O X
- O X
linked O X
isopeptide O X
bond O X
. O X

Mutagenesis O X
experiments O X
show O X
that O X
both O X
binding O X
sites O X
are O X
required O X
to O X
enable O X
binding O X
of O X
Lys O X
63 O X
- O X
linked O X
diubiquitin O X
. O X

We O X
therefore O X
propose O X
a O X
mechanism O X
for O X
the O X
recognition O X
of O X
Lys O X
63 O X
- O X
linked O X
polyubiquitin O X
chains O X
by O X
TAB2 I-MISC 68652
and O X
TAB3 I-MISC 66724
NZF O X
domains O X
in O X
which O X
diubiquitin O X
units O X
are O X
specifically O X
recognized O X
by O X
a O X
single O X
NZF O X
domain O X
. O X

###21751375	1387,1499

Functional O X
analysis O X
of O X
novel O X
phosphorylation O X
sites O X
of O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
using O X
mass O X
spectrometry O X
and O X
mammalian O X
two O X
- O X
hybrid O X
assays O X
. O X

In O X
the O X
Wnt O X
/ O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
pathway O X
, O X
p300 I-MISC 2033
/ O X
CBP I-MISC 1387
( O X
CREB I-MISC 1387
- I-MISC 1387
binding I-MISC 1387
protein I-MISC 1387
) O X
is O X
recruited O X
by O X
nuclear O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
to O X
regulate O X
a O X
wide O X
array O X
of O X
T I-MISC 3172
- I-MISC 3172
cell I-MISC 3172
factor I-MISC 3172
( O X
TCF I-MISC 3172
)- O X
dependent O X
gene O X
expression O X
. O X

Previous O X
studies O X
have O X
indicated O X
that O X
CBP I-MISC 1387
/ I-MISC 1387
b I-MISC 1387
- B-MISC 1499
catenin I-MISC 1499
complex O X
- O X
mediated O X
transcription O X
is O X
critical O X
for O X
cell O X
proliferation O X
. O X

Both O X
CBP I-MISC 1387
and O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
are O X
phosphoproteins O X
. O X

The O X
interaction O X
domain O X
has O X
been O X
mapped O X
to O X
the O X
N O X
- O X
terminal O X
region O X
of O X
CBP I-MISC 1387
( O X
amino O X
acids O X
1 O X
- O X
111 O X
) O X
and O X
the O X
C O X
- O X
terminal O X
region O X
of O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
, O X
but O X
it O X
is O X
unclear O X
whether O X
phosphorylation O X
on O X
specific O X
residues O X
of O X
these O X
regions O X
is O X
required O X
for O X
the O X
interaction O X
. O X

To O X
address O X
this O X
unmet O X
challenge O X
, O X
phosphoproteomic O X
profile O X
of O X
the O X
critical O X
N O X
- O X
terminus O X
of O X
CBP I-MISC 1387
was O X
determined O X
by O X
utilizing O X
TiO O X
( O X
2 O X
) O X
affinity O X
chromatography O X
followed O X
by O X
LC O X
- O X
MS O X
/ O X
MS O X
analysis O X
. O X

Two O X
unique O X
and O X
novel O X
phosphorylation O X
sites O X
Ser77 O X
and O X
Ser92 O X
were O X
identified O X
. O X

Further O X
studies O X
aided O X
by O X
site O X
- O X
directed O X
mutagenesis O X
, O X
immunoprecipitation O X
and O X
mammalian O X
two O X
- O X
hybrid O X
assay O X
have O X
concluded O X
that O X
the O X
phosphorylation O X
of O X
a O X
Proline O X
- O X
directed O X
Ser92 O X
residue O X
modulates O X
the O X
selective O X
binding O X
ability O X
of O X
CBP I-MISC 1387
with O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
. O X

The O X
specific O X
Mitogen O X
- O X
activated O X
protein O X
kinase O X
inhibitor O X
PD98059 O X
, O X
which O X
promotes O X
cell O X
cycle O X
G1 O X
arrest O X
, O X
concomitantly O X
inhibits O X
the O X
interaction O X
, O X
and O X
the O X
evidences O X
suggest O X
that O X
the O X
MEK I-MISC 5609
/ O X
ERK O X
( O X
extracellular O X
signal O X
- O X
regulated O X
kinase O X
) O X
cascade O X
activation O X
is O X
the O X
upstream O X
signal O X
required O X
for O X
Ser92 O X
phosphorylation O X
, O X
leading O X
to O X
enhancement O X
of O X
the O X
interaction O X
of O X
CBP I-MISC 1387
with O X
b I-MISC 1499
- I-MISC 1499
catenin I-MISC 1499
. O X

###15983381	1616,11315

Interaction O X
of O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
with O X
Daxx I-MISC 1616
inhibits O X
apoptosis I-MISC 4217
signal I-MISC 4217
- I-MISC 4217
regulating I-MISC 4217
kinase I-MISC 4217
1 I-MISC 4217
activity O X
and O X
cell O X
death O X
. O X

Investigations O X
into O X
the O X
cellular O X
and O X
molecular O X
biology O X
of O X
genes O X
that O X
cause O X
inherited O X
forms O X
of O X
Parkinson O X
' O X
s O X
disease O X
, O X
as O X
well O X
as O X
the O X
downstream O X
pathways O X
that O X
they O X
trigger O X
, O X
shed O X
considerable O X
light O X
on O X
our O X
understanding O X
the O X
fundamental O X
determinants O X
of O X
life O X
and O X
death O X
in O X
dopaminergic O X
neurons O X
. O X

Homozygous O X
deletion O X
or O X
missense O X
mutation O X
in O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
results O X
in O X
autosomal O X
recessively O X
inherited O X
Parkinson O X
' O X
s O X
disease O X
, O X
suggesting O X
that O X
wild O X
- O X
type O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
has O X
a O X
favorable O X
role O X
in O X
maintaining O X
these O X
neurons O X
. O X

Here O X
, O X
we O X
show O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
protects O X
against O X
oxidative O X
stress O X
- O X
induced O X
cell O X
death O X
, O X
but O X
that O X
its O X
relatively O X
modest O X
ability O X
to O X
quench O X
reactive O X
oxygen O X
species O X
is O X
insufficient O X
to O X
account O X
for O X
its O X
more O X
robust O X
cytoprotective O X
effect O X
. O X

To O X
elucidate O X
the O X
mechanism O X
of O X
this O X
cell O X
- O X
preserving O X
function O X
, O X
we O X
have O X
screened O X
out O X
the O X
death O X
protein O X
Daxx I-MISC 1616
as O X
a O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
- O X
interacting O X
partner O X
. O X

We O X
demonstrate O X
that O X
wild O X
- O X
type O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
sequesters O X
Daxx I-MISC 1616
in O X
the O X
nucleus O X
, O X
prevents O X
it O X
from O X
gaining O X
access O X
to O X
the O X
cytoplasm O X
, O X
from O X
binding O X
to O X
and O X
activating O X
its O X
effector O X
kinase O X
apoptosis I-MISC 4217
signal I-MISC 4217
- I-MISC 4217
regulating I-MISC 4217
kinase I-MISC 4217
1 I-MISC 4217
, O X
and O X
therefore O X
, O X
from O X
triggering O X
the O X
ensuing O X
death O X
pathway O X
. O X

All O X
these O X
steps O X
are O X
impaired O X
by O X
the O X
disease O X
- O X
causing O X
L166P O X
mutant O X
isoform O X
of O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
. O X

These O X
findings O X
suggest O X
that O X
the O X
regulated O X
sequestration O X
of O X
Daxx I-MISC 1616
in O X
the O X
nucleus O X
and O X
keeping O X
apoptosis I-MISC 4217
signal I-MISC 4217
- I-MISC 4217
regulating I-MISC 4217
kinase I-MISC 4217
1 I-MISC 4217
activation O X
in O X
check O X
is O X
a O X
critical O X
mechanism O X
by O X
which O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
exerts O X
its O X
cytoprotective O X
function O X
. O X

###21785459	8772,11315

DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
inhibits O X
TRAIL I-MISC 8743
- O X
induced O X
apoptosis O X
by O X
blocking O X
pro O X
- O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
recruitment O X
to O X
FADD I-MISC 8772
. O X

DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
was O X
initially O X
identified O X
as O X
an O X
oncogene O X
product O X
involved O X
in O X
human O X
tumorigenesis O X
in O X
cooperation O X
with O X
Ras O X
. O X

Increased O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
expression O X
is O X
associated O X
with O X
tumorigenesis O X
in O X
many O X
cancers O X
, O X
whereas O X
the O X
loss O X
of O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
function O X
is O X
linked O X
to O X
an O X
autosomal O X
recessive O X
form O X
of O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

It O X
has O X
been O X
reported O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
protects O X
cells O X
from O X
TRAIL I-MISC 8743
( O X
tumor I-MISC 8743
necrosis I-MISC 8743
factor I-MISC 8743
- I-MISC 8743
related I-MISC 8743
apoptosis I-MISC 8743
- I-MISC 8743
inducing I-MISC 8743
ligand I-MISC 8743
)- O X
induced O X
apoptosis O X
. O X

However O X
, O X
the O X
mechanism O X
by O X
which O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
is O X
involved O X
is O X
still O X
largely O X
unknown O X
. O X

Here O X
we O X
show O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
inhibits O X
TRAIL I-MISC 8743
- O X
induced O X
apoptosis O X
by O X
blocking O X
Fas I-MISC 8772
- I-MISC 8772
associated I-MISC 8772
protein I-MISC 8772
death I-MISC 8772
domain I-MISC 8772
( O X
FADD I-MISC 8772
)- O X
mediated O X
pro O X
- O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
activation O X
. O X

Wild O X
- O X
type O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
, O X
but O X
not O X
the O X
PD O X
- O X
associated O X
mutant O X
L166P O X
, O X
binds O X
to O X
FADD I-MISC 8772
to O X
inhibit O X
the O X
formation O X
of O X
the O X
death O X
- O X
inducing O X
signaling O X
complex O X
( O X
DISC O X
). O X

DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
competes O X
with O X
pro O X
- O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
to O X
bind O X
to O X
FADD I-MISC 8772
at O X
the O X
death O X
effector O X
domain O X
, O X
thereby O X
repressing O X
the O X
recruitment O X
and O X
activation O X
of O X
pro O X
- O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
to O X
the O X
active O X
form O X
of O X
caspase I-MISC 841
- I-MISC 841
8 I-MISC 841
. O X

Thus O X
, O X
our O X
study O X
suggests O X
that O X
DJ I-MISC 11315
- I-MISC 11315
1 I-MISC 11315
protects O X
against O X
TRAIL I-MISC 8743
- O X
induced O X
apoptosis O X
through O X
the O X
regulation O X
of O X
DISC O X
formation O X
. O X

###12626716	856222,850983	853555,856222

Functional O X
dissection O X
of O X
the O X
zinc O X
finger O X
and O X
flanking O X
domains O X
of O X
the O X
Yth1 I-MISC 856222
cleavage O X
/ O X
polyadenylation O X
factor O X
. O X

Yth1 I-MISC 856222
, O X
a O X
subunit O X
of O X
yeast O X
Cleavage O X
Polyadenylation O X
Factor O X
( O X
CPF O X
), O X
contains O X
five O X
CCCH O X
zinc O X
fingers O X
. O X

Yth1 I-MISC 856222
was O X
previously O X
shown O X
to O X
interact O X
with O X
pre O X
- O X
mRNA O X
and O X
with O X
two O X
CPF O X
subunits O X
, O X
Brr5 I-MISC 850983
/ O X
Ysh1 I-MISC 850983
and O X
the O X
polyadenylation O X
- O X
specific O X
Fip1 I-MISC 853555
, O X
and O X
to O X
act O X
in O X
both O X
steps O X
of O X
mRNA O X
3 O X
' O X
end O X
processing O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
have O X
identified O X
new O X
domains O X
involved O X
in O X
each O X
interaction O X
and O X
have O X
analyzed O X
the O X
consequences O X
of O X
mutating O X
these O X
regions O X
on O X
Yth1 I-MISC 856222
function O X
in O X
vivo O X
and O X
in O X
vitro O X
. O X

We O X
have O X
found O X
that O X
the O X
essential O X
fourth O X
zinc O X
finger O X
( O X
ZF4 O X
) O X
of O X
Yth1 I-MISC 856222
is O X
critical O X
for O X
interaction O X
with O X
Fip1 I-MISC 853555
and O X
RNA O X
, O X
but O X
not O X
for O X
cleavage O X
, O X
and O X
a O X
single O X
point O X
mutation O X
in O X
ZF4 O X
impairs O X
only O X
polyadenylation O X
. O X

Deletion O X
of O X
the O X
essential O X
N O X
- O X
terminal O X
region O X
that O X
includes O X
the O X
ZF1 O X
or O X
deletion O X
of O X
ZF4 O X
weakened O X
the O X
interaction O X
with O X
Brr5 I-MISC 850983
in O X
vitro O X
. O X

In O X
vitro O X
assays O X
showed O X
that O X
the O X
N O X
- O X
terminus O X
is O X
necessary O X
for O X
both O X
processing O X
steps O X
. O X

Of O X
particular O X
importance O X
, O X
we O X
find O X
that O X
the O X
binding O X
of O X
Fip1 I-MISC 853555
to O X
Yth1 I-MISC 856222
blocks O X
the O X
RNA O X
- O X
Yth1 I-MISC 856222
interaction O X
, O X
and O X
that O X
this O X
inhibition O X
requires O X
the O X
Yth1 I-MISC 856222
- O X
interacting O X
domain O X
on O X
Fip1 I-MISC 853555
. O X

Our O X
results O X
suggest O X
a O X
role O X
for O X
Yth1 I-MISC 856222
not O X
only O X
in O X
the O X
execution O X
of O X
cleavage O X
and O X
poly O X
( O X
A O X
) O X
addition O X
, O X
but O X
also O X
in O X
the O X
transition O X
from O X
one O X
step O X
to O X
the O X
other O X
. O X

###17558407	261734,23322

Mutations O X
in O X
the O X
gene O X
encoding O X
the O X
basal O X
body O X
protein O X
RPGRIP1L I-MISC 23322
, O X
a O X
nephrocystin I-MISC 261734
- I-MISC 261734
4 I-MISC 261734
interactor O X
, O X
cause O X
Joubert O X
syndrome O X
. O X

Protein O X
- O X
protein O X
interaction O X
analyses O X
have O X
uncovered O X
a O X
ciliary O X
and O X
basal O X
body O X
protein O X
network O X
that O X
, O X
when O X
disrupted O X
, O X
can O X
result O X
in O X
nephronophthisis O X
( O X
NPHP O X
), O X
Leber O X
congenital O X
amaurosis O X
, O X
Senior O X
- O X
L O X
ken O X
syndrome O X
( O X
SLSN O X
) O X
or O X
Joubert O X
syndrome O X
( O X
JBTS O X
). O X

However O X
, O X
details O X
of O X
the O X
molecular O X
mechanisms O X
underlying O X
these O X
disorders O X
remain O X
poorly O X
understood O X
. O X

RPGRIP1 I-MISC 23322
- I-MISC 23322
like I-MISC 23322
protein I-MISC 23322
( O X
RPGRIP1L I-MISC 23322
) O X
is O X
a O X
homolog O X
of O X
RPGRIP1 I-MISC 57096
( O X
RPGR I-MISC 57096
- I-MISC 57096
interacting I-MISC 57096
protein I-MISC 57096
1 I-MISC 57096
), O X
a O X
ciliary O X
protein O X
defective O X
in O X
Leber O X
congenital O X
amaurosis O X
. O X

We O X
show O X
that O X
RPGRIP1L I-MISC 23322
interacts O X
with O X
nephrocystin I-MISC 261734
- I-MISC 261734
4 I-MISC 261734
and O X
that O X
mutations O X
in O X
the O X
gene O X
encoding O X
nephrocystin I-MISC 261734
- I-MISC 261734
4 I-MISC 261734
( O X
NPHP4 I-MISC 261734
) O X
that O X
are O X
known O X
to O X
cause O X
SLSN O X
disrupt O X
this O X
interaction O X
. O X

RPGRIP1L I-MISC 23322
is O X
ubiquitously O X
expressed O X
, O X
and O X
its O X
protein O X
product O X
localizes O X
to O X
basal O X
bodies O X
. O X

Therefore O X
, O X
we O X
analyzed O X
RPGRIP1L I-MISC 23322
as O X
a O X
candidate O X
gene O X
for O X
JBTS O X
and O X
identified O X
loss O X
- O X
of O X
- O X
function O X
mutations O X
in O X
three O X
families O X
with O X
typical O X
JBTS O X
, O X
including O X
the O X
characteristic O X
mid O X
- O X
hindbrain O X
malformation O X
. O X

This O X
work O X
identifies O X
RPGRIP1L I-MISC 23322
as O X
a O X
gene O X
responsible O X
for O X
JBTS O X
and O X
establishes O X
a O X
central O X
role O X
for O X
cilia O X
and O X
basal O X
bodies O X
in O X
the O X
pathophysiology O X
of O X
this O X
disorder O X
. O X

###18976727	19712,144165

A O X
homozygous O X
mutation O X
in O X
human O X
PRICKLE1 I-MISC 144165
causes O X
an O X
autosomal O X
- O X
recessive O X
progressive O X
myoclonus O X
epilepsy O X
- O X
ataxia O X
syndrome O X
. O X

Progressive O X
myoclonus O X
epilepsy O X
( O X
PME O X
) O X
is O X
a O X
syndrome O X
characterized O X
by O X
myoclonic O X
seizures O X
( O X
lightning O X
- O X
like O X
jerks O X
), O X
generalized O X
convulsive O X
seizures O X
, O X
and O X
varying O X
degrees O X
of O X
neurological O X
decline O X
, O X
especially O X
ataxia O X
and O X
dementia O X
. O X

Previously O X
, O X
we O X
characterized O X
three O X
pedigrees O X
of O X
individuals O X
with O X
PME O X
and O X
ataxia O X
, O X
where O X
either O X
clinical O X
features O X
or O X
linkage O X
mapping O X
excluded O X
known O X
PME O X
loci O X
. O X

This O X
report O X
identifies O X
a O X
mutation O X
in O X
PRICKLE1 I-MISC 144165
( O X
also O X
known O X
as O X
RILP I-MISC 83547
for O X
REST I-MISC 19712
/ O X
NRSF I-MISC 19712
interacting O X
LIM O X
domain O X
protein O X
) O X
in O X
all O X
three O X
of O X
these O X
pedigrees O X
. O X

The O X
identified O X
PRICKLE1 I-MISC 368249
mutation O X
blocks O X
the O X
PRICKLE1 I-MISC 368249
and O X
REST I-MISC 19712
interaction O X
in O X
vitro O X
and O X
disrupts O X
the O X
normal O X
function O X
of O X
PRICKLE1 I-MISC 368249
in O X
an O X
in O X
vivo O X
zebrafish O X
overexpression O X
system O X
. O X

PRICKLE1 I-MISC 106042
is O X
expressed O X
in O X
brain O X
regions O X
implicated O X
in O X
epilepsy O X
and O X
ataxia O X
in O X
mice O X
and O X
humans O X
, O X
and O X
, O X
to O X
our O X
knowledge O X
, O X
is O X
the O X
first O X
molecule O X
in O X
the O X
noncanonical O X
WNT O X
signaling O X
pathway O X
to O X
be O X
directly O X
implicated O X
in O X
human O X
epilepsy O X
. O X

###19609323	79728,675

Structural O X
basis O X
for O X
recruitment O X
of O X
BRCA2 I-MISC 675
by O X
PALB2 I-MISC 79728
. O X

The O X
breast O X
cancer O X
2 O X
, O X
early O X
onset O X
protein O X
( O X
BRCA2 I-MISC 675
) O X
is O X
central O X
to O X
the O X
repair O X
of O X
DNA O X
damage O X
by O X
homologous O X
recombination O X
. O X

BRCA2 I-MISC 675
recruits O X
the O X
recombinase O X
RAD51 O X
to O X
sites O X
of O X
damage O X
, O X
regulates O X
its O X
assembly O X
into O X
nucleoprotein O X
filaments O X
and O X
thereby O X
promotes O X
homologous O X
recombination O X
. O X

Localization O X
of O X
BRCA2 I-MISC 675
to O X
nuclear O X
foci O X
requires O X
its O X
association O X
with O X
the O X
partner O X
and O X
localizer O X
of O X
BRCA2 I-MISC 675
( O X
PALB2 I-MISC 79728
), O X
mutations O X
in O X
which O X
are O X
associated O X
with O X
cancer O X
predisposition O X
, O X
as O X
well O X
as O X
subtype O X
N O X
of O X
Fanconi O X
anaemia O X
. O X

We O X
have O X
determined O X
the O X
structure O X
of O X
the O X
PALB2 I-MISC 79728
carboxy O X
- O X
terminal O X
beta O X
- O X
propeller O X
domain O X
in O X
complex O X
with O X
a O X
BRCA2 I-MISC 675
peptide O X
. O X

The O X
structure O X
shows O X
the O X
molecular O X
determinants O X
of O X
this O X
important O X
protein O X
- O X
protein O X
interaction O X
and O X
explains O X
the O X
effects O X
of O X
both O X
cancer O X
- O X
associated O X
truncating O X
mutants O X
in O X
PALB2 I-MISC 79728
and O X
missense O X
mutations O X
in O X
the O X
amino O X
- O X
terminal O X
region O X
of O X
BRCA2 I-MISC 675
. O X

###25680527	8544,602

Pirin I-MISC 8544
regulates O X
epithelial O X
to O X
mesenchymal O X
transition O X
independently O X
of O X
Bcl3 I-MISC 602
- O X
Slug I-MISC 6591
signaling O X
. O X

UNASSIGNED O X
: O X
Epithelial O X
to O X
mesenchymal O X
transition O X
( O X
EMT O X
) O X
is O X
an O X
important O X
mechanism O X
for O X
the O X
initial O X
step O X
of O X
metastasis O X
. O X

Proteomic O X
analysis O X
indicates O X
that O X
Pirin I-MISC 8544
is O X
involved O X
in O X
metastasis O X
. O X

However O X
, O X
there O X
are O X
no O X
reports O X
demonstrating O X
its O X
direct O X
contribution O X
. O X

Here O X
we O X
investigated O X
the O X
involvement O X
of O X
Pirin I-MISC 8544
in O X
EMT O X
. O X

In O X
HeLa O X
cells O X
, O X
Pirin I-MISC 8544
suppressed O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
expression O X
and O X
regulated O X
the O X
expression O X
of O X
other O X
EMT O X
markers O X
. O X

Furthermore O X
, O X
cells O X
expressing O X
Pirin I-MISC 8544
exhibited O X
a O X
spindle O X
- O X
like O X
morphology O X
, O X
which O X
is O X
reminiscent O X
of O X
EMT O X
. O X

A O X
Pirin I-MISC 8544
mutant O X
defective O X
for O X
Bcl3 I-MISC 602
binding O X
decreased O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
expression O X
similar O X
to O X
wild O X
- O X
type O X
, O X
suggesting O X
that O X
Pirin I-MISC 8544
regulates O X
E I-MISC 999
- I-MISC 999
cadherin I-MISC 999
independently O X
of O X
Bcl3 I-MISC 602
- O X
Slug I-MISC 6591
signaling O X
. O X

These O X
data O X
provide O X
direct O X
evidence O X
that O X
Pirin I-MISC 8544
contributes O X
to O X
cancer O X
metastasis O X
. O X

###11302744	191575,4221

Menin I-MISC 4221
, O X
a O X
gene O X
product O X
responsible O X
for O X
multiple I-MISC 4221
endocrine I-MISC 4221
neoplasia I-MISC 4221
type I-MISC 4221
1 I-MISC 4221
, O X
interacts O X
with O X
the O X
putative O X
tumor O X
metastasis O X
suppressor O X
nm23 I-MISC 191575
. O X

Although O X
the O X
gene O X
responsible O X
for O X
multiple I-MISC 4221
endocrine I-MISC 4221
neoplasia I-MISC 4221
type I-MISC 4221
1 I-MISC 4221
( O X
MEN1 I-MISC 4221
) O X
has O X
been O X
identified O X
, O X
the O X
function O X
of O X
its O X
gene O X
product O X
, O X
menin I-MISC 4221
, O X
is O X
unknown O X
. O X

To O X
examine O X
the O X
biological O X
role O X
of O X
the O X
MEN1 I-MISC 4221
gene O X
, O X
we O X
searched O X
for O X
associated O X
proteins O X
with O X
a O X
yeast O X
two O X
- O X
hybrid O X
system O X
using O X
the O X
MEN1 I-MISC 4221
cDNA O X
fragment O X
as O X
bait O X
. O X

On O X
screening O X
a O X
rat O X
fetal O X
brain O X
embryonic O X
day O X
17 O X
library O X
, O X
in O X
which O X
a O X
high O X
level O X
of O X
MEN1 I-MISC 4221
expression O X
was O X
detected O X
, O X
we O X
identified O X
a O X
putative O X
tumor O X
metastasis O X
suppressor O X
nm23 I-MISC 191575
/ O X
nucleoside O X
diphosphate O X
( O X
NDP O X
) O X
kinase O X
as O X
an O X
associated O X
protein O X
. O X

This O X
finding O X
was O X
confirmed O X
by O X
in O X
vitro O X
interaction O X
assays O X
based O X
on O X
glutathione O X
S O X
- O X
transferase O X
pull O X
down O X
experiments O X
. O X

The O X
association O X
required O X
almost O X
the O X
entire O X
menin I-MISC 4221
protein O X
, O X
and O X
several O X
missense O X
MEN1 I-MISC 4221
mutations O X
reported O X
in O X
MEN1 I-MISC 4221
patients O X
caused O X
a O X
loss O X
of O X
the O X
binding O X
activity O X
for O X
nm23 I-MISC 191575
. O X

This O X
result O X
suggests O X
that O X
this O X
interaction O X
may O X
play O X
important O X
roles O X
in O X
the O X
biological O X
functions O X
of O X
the O X
menin I-MISC 4221
protein O X
, O X
including O X
tumor O X
suppressor O X
activity O X
. O X

###15173383	2542083,2540255

The O X
C O X
- O X
terminal O X
zinc O X
finger O X
of O X
the O X
catalytic O X
subunit O X
of O X
DNA I-MISC 2540255
polymerase I-MISC 2540255
delta I-MISC 2540255
is O X
responsible O X
for O X
direct O X
interaction O X
with O X
the O X
B O X
- O X
subunit O X
. O X

DNA I-MISC 2540255
polymerase I-MISC 2540255
delta I-MISC 2540255
( O X
Pol I-MISC 2540255
delta I-MISC 2540255
) O X
plays O X
a O X
central O X
role O X
in O X
eukaryotic O X
chromosomal O X
DNA O X
replication O X
, O X
repair O X
and O X
recombination O X
. O X

In O X
fission O X
yeast O X
, O X
Pol I-MISC 2540255
delta I-MISC 2540255
is O X
a O X
tetrameric O X
enzyme O X
, O X
comprising O X
the O X
catalytic O X
subunit O X
Pol3 O X
and O X
three O X
smaller O X
subunits O X
, O X
Cdc1 I-MISC 2542083
, O X
Cdc27 O X
and O X
Cdm1 O X
. O X

Previous O X
studies O X
have O X
demonstrated O X
a O X
direct O X
interaction O X
between O X
Pol3 O X
and O X
Cdc1 I-MISC 2542083
, O X
the O X
B O X
- O X
subunit O X
of O X
the O X
complex O X
. O X

Here O X
it O X
is O X
shown O X
that O X
removal O X
of O X
the O X
tandem O X
zinc O X
finger O X
modules O X
located O X
at O X
the O X
C O X
- O X
terminus O X
of O X
Pol3 O X
by O X
targeted O X
proteolysis O X
renders O X
the O X
Pol3 O X
protein O X
non O X
- O X
functional O X
in O X
vivo O X
, O X
and O X
that O X
the O X
C O X
- O X
terminal O X
zinc O X
finger O X
module O X
ZnF2 O X
is O X
both O X
necessary O X
and O X
sufficient O X
for O X
binding O X
to O X
the O X
B O X
- O X
subunit O X
in O X
vivo O X
and O X
in O X
vitro O X
. O X

Extensive O X
mutagenesis O X
of O X
the O X
ZnF2 O X
module O X
identifies O X
important O X
residues O X
for O X
B O X
- O X
subunit O X
binding O X
. O X

In O X
particular O X
, O X
disruption O X
of O X
the O X
ZnF2 O X
module O X
by O X
substitution O X
of O X
the O X
putative O X
metal O X
- O X
coordinating O X
cysteines O X
with O X
alanine O X
abolishes O X
B O X
- O X
subunit O X
binding O X
and O X
in O X
vivo O X
function O X
. O X

Finally O X
, O X
evidence O X
is O X
presented O X
suggesting O X
that O X
the O X
ZnF O X
region O X
is O X
post O X
- O X
translationally O X
modified O X
in O X
fission O X
yeast O X
cells O X
. O X

###9515927	946441,944877

In O X
vivo O X
protein O X
interactions O X
within O X
the O X
Escherichia O X
coli O X
DNA O X
polymerase O X
III O X
core O X
. O X

The O X
mechanisms O X
that O X
control O X
the O X
fidelity O X
of O X
DNA O X
replication O X
are O X
being O X
investigated O X
by O X
a O X
number O X
of O X
approaches O X
, O X
including O X
detailed O X
kinetic O X
and O X
structural O X
studies O X
. O X

Important O X
tools O X
in O X
these O X
studies O X
are O X
mutant O X
versions O X
of O X
DNA O X
polymerases O X
that O X
affect O X
the O X
fidelity O X
of O X
DNA O X
replication O X
. O X

It O X
has O X
been O X
suggested O X
that O X
proper O X
interactions O X
within O X
the O X
core O X
of O X
DNA O X
polymerase O X
III O X
( O X
Pol O X
III O X
) O X
of O X
Escherichia O X
coli O X
could O X
be O X
essential O X
for O X
maintaining O X
the O X
optimal O X
fidelity O X
of O X
DNA O X
replication O X
( O X
H O X
. O X
Maki O X
and O X
A O X
. O X
Kornberg O X
, O X
Proc O X
. O X

Natl O X
. O X

Acad O X
. O X

Sci O X
. O X

USA O X
84 O X
: O X
4389 O X
- O X
4392 O X
, O X
1987 O X
). O X

We O X
have O X
been O X
particularly O X
interested O X
in O X
elucidating O X
the O X
physiological O X
role O X
of O X
the O X
interactions O X
between O X
the O X
DnaE I-MISC 944877
( O X
alpha O X
subunit O X
[ O X
possessing O X
DNA O X
polymerase O X
activity O X
]) O X
and O X
DnaQ I-MISC 946441
( O X
epsilon O X
subunit O X
[ O X
possessing O X
3 O X
'--> O X
5 O X
' O X
exonucleolytic O X
proofreading O X
activity O X
]) O X
proteins O X
. O X

In O X
an O X
attempt O X
to O X
achieve O X
this O X
goal O X
, O X
we O X
have O X
used O X
the O X
Saccharomyces O X
cerevisiae O X
two O X
- O X
hybrid O X
system O X
to O X
analyze O X
specific O X
in O X
vivo O X
protein O X
interactions O X
. O X

In O X
this O X
report O X
, O X
we O X
demonstrate O X
interactions O X
between O X
the O X
DnaE I-MISC 944877
and O X
DnaQ I-MISC 946441
proteins O X
and O X
between O X
the O X
DnaQ I-MISC 946441
and O X
HolE O X
( O X
theta O X
subunit O X
) O X
proteins O X
. O X

We O X
also O X
tested O X
the O X
interactions O X
of O X
the O X
wild O X
- O X
type O X
DnaE I-MISC 944877
and O X
HolE O X
proteins O X
with O X
three O X
well O X
- O X
known O X
mutant O X
forms O X
of O X
DnaQ I-MISC 946441
( O X
MutD5 O X
, O X
DnaQ926 O X
, O X
and O X
DnaQ49 O X
), O X
each O X
of O X
which O X
leads O X
to O X
a O X
strong O X
mutator O X
phenotype O X
. O X

Our O X
results O X
show O X
that O X
the O X
mutD5 O X
and O X
dnaQ926 O X
mutations O X
do O X
not O X
affect O X
the O X
epsilon O X
subunit O X
- O X
alpha O X
subunit O X
and O X
epsilon O X
subunit O X
- O X
theta O X
subunit O X
interactions O X
. O X

However O X
, O X
the O X
dnaQ49 O X
mutation O X
greatly O X
reduces O X
the O X
strength O X
of O X
interaction O X
of O X
the O X
epsilon O X
subunit O X
with O X
both O X
the O X
alpha O X
and O X
the O X
theta O X
subunits O X
. O X

Thus O X
, O X
the O X
mutator O X
phenotype O X
of O X
dnaQ49 O X
may O X
be O X
the O X
result O X
of O X
an O X
altered O X
conformation O X
of O X
the O X
epsilon O X
protein O X
, O X
which O X
leads O X
to O X
altered O X
interactions O X
within O X
the O X
Pol O X
III O X
core O X
. O X

###17097642	5037,5894

Regulation O X
of O X
RKIP I-MISC 5037
binding O X
to O X
the O X
N O X
- O X
region O X
of O X
the O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
kinase O X
. O X

The O X
Raf I-MISC 5037
kinase I-MISC 5037
inhibitory I-MISC 5037
protein I-MISC 5037
( O X
RKIP I-MISC 5037
) O X
binds O X
to O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
interfering O X
with O X
binding O X
of O X
the O X
MEK I-MISC 5609
substrate O X
and O X
potentially O X
also O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
activation O X
. O X

In O X
response O X
to O X
mitogen O X
stimulation O X
RKIP I-MISC 5037
dissociates O X
from O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
and O X
later O X
re O X
- O X
associates O X
. O X

Here O X
, O X
using O X
a O X
combination O X
of O X
mutational O X
approaches O X
, O X
biochemical O X
studies O X
, O X
peptide O X
arrays O X
and O X
plasmon O X
surface O X
resonance O X
( O X
BIAcore O X
), O X
we O X
fine O X
map O X
and O X
characterize O X
a O X
minimal O X
24 O X
amino O X
acid O X
long O X
RKIP I-MISC 5037
binding O X
domain O X
in O X
the O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
N O X
- O X
region O X
, O X
which O X
consists O X
of O X
constitutive O X
elements O X
at O X
both O X
flanks O X
and O X
a O X
center O X
element O X
that O X
is O X
regulated O X
by O X
phosphorylation O X
and O X
enhances O X
the O X
re O X
- O X
binding O X
of O X
RKIP I-MISC 5037
to O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
in O X
the O X
later O X
phase O X
of O X
mitogen O X
stimulation O X
. O X

###19262565	80854,5970

Negative O X
regulation O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
action O X
by O X
Set9 I-MISC 80854
- O X
mediated O X
lysine O X
methylation O X
of O X
the O X
RelA I-MISC 5970
subunit O X
. O X

Proper O X
regulation O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
activity O X
is O X
critical O X
to O X
maintain O X
and O X
balance O X
the O X
inflammatory O X
response O X
. O X

Inactivation O X
of O X
the O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
complex O X
relies O X
in O X
part O X
on O X
the O X
proteasome O X
- O X
mediated O X
degradation O X
of O X
promoter O X
- O X
bound O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
, O X
but O X
the O X
detailed O X
molecular O X
mechanism O X
initiating O X
this O X
process O X
remains O X
elusive O X
. O X

Here O X
, O X
we O X
show O X
that O X
the O X
methylation O X
of O X
the O X
RelA I-MISC 5970
subunit O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
has O X
an O X
important O X
function O X
in O X
this O X
process O X
. O X

Lysine O X
methyltransferase O X
Set9 I-MISC 80854
physically O X
associates O X
with O X
RelA I-MISC 5970
in O X
vitro O X
and O X
in O X
vivo O X
in O X
response O X
to O X
TNF I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
stimulation O X
. O X

Mutational O X
and O X
mass O X
spectrometric O X
analyses O X
reveal O X
that O X
RelA I-MISC 5970
is O X
monomethylated O X
by O X
Set9 I-MISC 80854
at O X
lysine O X
residues O X
314 O X
and O X
315 O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

Methylation O X
of O X
RelA I-MISC 5970
inhibits O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
action O X
by O X
inducing O X
the O X
proteasome O X
- O X
mediated O X
degradation O X
of O X
promoter O X
- O X
associated O X
RelA I-MISC 5970
. O X

Depletion O X
of O X
Set9 I-MISC 80854
by O X
siRNA O X
or O X
mutation O X
of O X
the O X
RelA I-MISC 5970
methylation O X
sites O X
prolongs O X
DNA O X
binding O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
and O X
enhances O X
TNF I-MISC 7124
- I-MISC 7124
alpha I-MISC 7124
- O X
induced O X
expression O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
target O X
genes O X
. O X

Together O X
, O X
these O X
findings O X
unveil O X
a O X
novel O X
mechanism O X
by O X
which O X
methylation O X
of O X
RelA I-MISC 5970
dictates O X
the O X
turnover O X
of O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
and O X
controls O X
the O X
NF I-MISC 4790
- I-MISC 4790
kappaB I-MISC 4790
- O X
mediated O X
inflammatory O X
response O X
. O X

###11697903	3753,688173

Specific O X
interaction O X
of O X
the O X
potassium I-MISC 3753
channel I-MISC 3753
beta I-MISC 3753
- I-MISC 3753
subunit I-MISC 3753
minK I-MISC 3753
with O X
the O X
sarcomeric O X
protein O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
suggests O X
a O X
T O X
- O X
tubule O X
- O X
myofibril O X
linking O X
system O X
. O X

Ion O X
- O X
channel O X
beta O X
- O X
subunits O X
are O X
ancillary O X
proteins O X
that O X
co O X
- O X
assemble O X
with O X
alpha O X
- O X
subunits O X
to O X
modulate O X
gating O X
kinetics O X
and O X
enhance O X
stability O X
of O X
multimeric O X
channel O X
complexes O X
. O X

They O X
provide O X
binding O X
sites O X
for O X
other O X
regulatory O X
proteins O X
and O X
are O X
medically O X
important O X
as O X
the O X
targets O X
of O X
many O X
pharmacological O X
compounds O X
. O X

MinK I-MISC 3753
is O X
the O X
beta O X
- O X
subunit O X
of O X
the O X
slow O X
activating O X
component O X
of O X
the O X
delayed O X
rectifier O X
potassium O X
current O X
( O X
I O X
( O X
Ks O X
)) O X
channel O X
, O X
and O X
associates O X
with O X
the O X
alpha O X
- O X
subunit O X
, O X
KvLQT1 O X
. O X

We O X
report O X
here O X
that O X
minK I-MISC 3753
specifically O X
interacts O X
with O X
the O X
sarcomeric O X
Z O X
- O X
line O X
component O X
, O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
( O X
also O X
called O X
telethonin I-MISC 688173
). O X

In O X
vitro O X
interaction O X
studies O X
indicated O X
that O X
the O X
cytoplasmic O X
domain O X
of O X
minK I-MISC 3753
specifically O X
binds O X
to O X
the O X
sixteen O X
C O X
- O X
terminal O X
residues O X
of O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
; O X
these O X
residues O X
are O X
sufficient O X
for O X
its O X
interaction O X
with O X
minK I-MISC 3753
. O X

Consistent O X
with O X
our O X
in O X
vitro O X
studies O X
, O X
immunofluorescence O X
staining O X
followed O X
by O X
confocal O X
analysis O X
revealed O X
that O X
both O X
minK I-MISC 3753
and O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
are O X
localized O X
within O X
the O X
Z O X
- O X
line O X
region O X
in O X
cardiac O X
muscle O X
. O X

Striated O X
staining O X
of O X
minK I-MISC 3753
was O X
observed O X
in O X
non O X
- O X
washed O X
, O X
membrane O X
- O X
intact O X
cardiac O X
myofibrils O X
, O X
but O X
not O X
in O X
well O X
- O X
washed O X
, O X
membrane O X
- O X
removed O X
cardiac O X
myofibrils O X
, O X
suggesting O X
that O X
minK I-MISC 3753
localizes O X
on O X
T O X
- O X
tubular O X
membranes O X
surrounding O X
the O X
Z O X
- O X
line O X
in O X
the O X
inner O X
ventricular O X
myocardium O X
. O X

Together O X
with O X
our O X
previous O X
data O X
on O X
the O X
colocalization O X
and O X
interaction O X
of O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
with O X
the O X
N O X
- O X
terminus O X
of O X
the O X
giant O X
protein O X
titin O X
in O X
the O X
periphery O X
of O X
the O X
Z O X
- O X
line O X
, O X
these O X
data O X
suggest O X
that O X
T I-MISC 688173
- I-MISC 688173
cap I-MISC 688173
functions O X
as O X
an O X
adapter O X
protein O X
to O X
link O X
together O X
myofibrillar O X
components O X
with O X
the O X
membranous O X
beta O X
- O X
subunit O X
of O X
the O X
I O X
( O X
Ks O X
) O X
channel O X
. O X

We O X
speculate O X
that O X
this O X
interaction O X
may O X
contribute O X
to O X
a O X
stretch O X
- O X
dependent O X
regulation O X
of O X
potassium O X
flux O X
in O X
cardiac O X
muscle O X
, O X
providing O X
a O X
" O X
mechano O X
- O X
electrical O X
feedback O X
" O X
system O X
. O X

###10660620	29992,5777

PILRalpha I-MISC 29992
, O X
a O X
novel O X
immunoreceptor O X
tyrosine O X
- O X
based O X
inhibitory O X
motif O X
- O X
bearing O X
protein O X
, O X
recruits O X
SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
upon O X
tyrosine O X
phosphorylation O X
and O X
is O X
paired O X
with O X
the O X
truncated O X
counterpart O X
PILRbeta I-MISC 29990
. O X

SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
- O X
mediated O X
dephosphorylation O X
of O X
protein O X
tyrosine O X
residues O X
is O X
central O X
to O X
the O X
regulation O X
of O X
several O X
cell O X
signaling O X
pathways O X
, O X
the O X
specificity O X
of O X
which O X
is O X
dictated O X
by O X
the O X
intrinsic O X
affinity O X
of O X
SH2 O X
domains O X
for O X
the O X
flanking O X
sequences O X
of O X
phosphotyrosine O X
residues O X
. O X

By O X
using O X
a O X
modified O X
yeast O X
two O X
- O X
hybrid O X
system O X
and O X
SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
as O X
bait O X
, O X
we O X
have O X
cloned O X
a O X
human O X
cDNA O X
, O X
PILRalpha I-MISC 29992
, O X
encoding O X
a O X
303 O X
- O X
amino O X
acid O X
immunoglobulin O X
- O X
like O X
transmembrane O X
receptor O X
bearing O X
two O X
cytoplasmic O X
tyrosines O X
positioned O X
within O X
an O X
immunoreceptor O X
tyrosine O X
- O X
based O X
inhibitory O X
motif O X
. O X

Substrate O X
trapping O X
in O X
combination O X
with O X
pervanadate O X
treatment O X
of O X
293T O X
cells O X
confirms O X
that O X
PILRalpha I-MISC 29992
associates O X
with O X
SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
in O X
vivo O X
upon O X
tyrosine O X
phosphorylation O X
. O X

Mutation O X
of O X
the O X
tyrosine O X
residues O X
in O X
PILRalpha I-MISC 29992
indicates O X
the O X
pivotal O X
role O X
of O X
the O X
Tyr O X
- O X
269 O X
residue O X
in O X
recruiting O X
SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
. O X

Surface O X
plasmon O X
resonance O X
analysis O X
further O X
suggests O X
that O X
the O X
association O X
between O X
PILRalpha I-MISC 29992
- O X
Tyr O X
- O X
269 O X
and O X
SHP I-MISC 5777
- I-MISC 5777
1 I-MISC 5777
is O X
mediated O X
primarily O X
via O X
the O X
amino O X
- O X
terminal O X
SH2 O X
domain O X
of O X
the O X
latter O X
. O X

Polymerase O X
chain O X
reaction O X
amplification O X
of O X
cDNA O X
in O X
combination O X
with O X
genomic O X
sequence O X
analysis O X
revealed O X
a O X
second O X
gene O X
, O X
PILRbeta I-MISC 29990
, O X
coding O X
for O X
a O X
putative O X
activating O X
receptor O X
as O X
suggested O X
by O X
a O X
truncated O X
cytoplasmic O X
tail O X
and O X
a O X
charged O X
lysine O X
residue O X
in O X
its O X
transmembrane O X
region O X
. O X

The O X
PILRalpha I-MISC 29992
and O X
PILRbeta I-MISC 29990
genes O X
are O X
localized O X
to O X
chromosome O X
7 O X
which O X
is O X
in O X
contrast O X
with O X
the O X
mapping O X
of O X
known O X
members O X
of O X
the O X
inhibitory O X
receptor O X
superfamily O X
. O X

###12907709	2542097,2541942

Rpb7 I-MISC 2542097
subunit O X
of O X
RNA O X
polymerase O X
II O X
interacts O X
with O X
an O X
RNA O X
- O X
binding O X
protein O X
involved O X
in O X
processing O X
of O X
transcripts O X
. O X

Rpb4 O X
- O X
Rpb7 I-MISC 2542097
, O X
a O X
dissociable O X
subcomplex O X
of O X
RNA O X
polymerase O X
II O X
( O X
pol O X
II O X
), O X
is O X
required O X
for O X
transcription O X
initiation O X
. O X

To O X
understand O X
the O X
role O X
of O X
Rpb7 I-MISC 2542097
in O X
transcription O X
initiation O X
or O X
other O X
processes O X
in O X
transcription O X
, O X
we O X
carried O X
out O X
a O X
two O X
- O X
hybrid O X
screen O X
for O X
proteins O X
that O X
interact O X
with O X
Rpb7 I-MISC 2542097
of O X
the O X
fission O X
yeast O X
Schizosaccharomyces O X
pombe O X
. O X

The O X
screen O X
identified O X
the O X
S O X
. O X
pombe O X
homolog O X
of O X
the O X
Saccharomyces O X
cerevisiae O X
Nrd1 I-MISC 855470
, O X
an O X
RNA O X
- O X
binding O X
protein O X
implicated O X
in O X
3 O X
' O X
end O X
formation O X
of O X
small O X
nucleolar O X
and O X
small O X
nuclear O X
RNAs O X
transcribed O X
by O X
pol O X
II O X
. O X

The O X
S O X
. O X
pombe O X
protein O X
, O X
named O X
Seb1 I-MISC 2541942
for O X
seven O X
binding O X
, O X
was O X
essential O X
for O X
cell O X
viability O X
, O X
and O X
bound O X
directly O X
to O X
Rpb7 I-MISC 2542097
in O X
vitro O X
. O X

Saccharomyces O X
cerevisiae O X
Rpb7 I-MISC 2542097
also O X
interacted O X
with O X
Nrd1 I-MISC 855470
, O X
indicating O X
that O X
the O X
interaction O X
is O X
conserved O X
in O X
evolution O X
. O X

Glu166 O X
and O X
/ O X
or O X
Asp167 O X
of O X
S O X
. O X
pombe O X
Rpb7 I-MISC 2542097
, O X
residues O X
near O X
the O X
C O X
- O X
terminus O X
of O X
the O X
172 O X
amino O X
acid O X
protein O X
, O X
were O X
found O X
to O X
be O X
important O X
for O X
its O X
interaction O X
with O X
Seb1 I-MISC 2541942
. O X

Our O X
results O X
suggest O X
that O X
Rpb7 I-MISC 2542097
may O X
function O X
to O X
anchor O X
a O X
processing O X
factor O X
to O X
the O X
pol O X
II O X
apparatus O X
, O X
thereby O X
coupling O X
RNA O X
processing O X
to O X
transcription O X
. O X

The O X
role O X
for O X
Rpb7 I-MISC 2542097
is O X
consistent O X
with O X
its O X
location O X
in O X
the O X
pol O X
II O X
complex O X
determined O X
by O X
recent O X
structural O X
studies O X
. O X

###23164639	2950,9588

Functional O X
interaction O X
of O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
pi I-MISC 2950
and O X
peroxiredoxin I-MISC 9588
6 I-MISC 9588
in O X
intact O X
cells O X
. O X

Peroxiredoxin I-MISC 9588
6 I-MISC 9588
( O X
Prdx6 I-MISC 9588
) O X
is O X
a O X
1 O X
- O X
Cys O X
member O X
of O X
the O X
peroxiredoxin O X
superfamily O X
that O X
plays O X
an O X
important O X
role O X
in O X
antioxidant O X
defense O X
. O X

Glutathionylation O X
of O X
recombinant O X
Prdx6 I-MISC 9588
mediated O X
by O X
glutathione I-MISC 373156
S I-MISC 373156
- I-MISC 373156
transferase I-MISC 373156
( O X
GST I-MISC 373156
) O X
is O X
required O X
for O X
reduction O X
of O X
the O X
oxidized O X
Cys O X
and O X
completion O X
of O X
the O X
peroxidatic O X
catalytic O X
cycle O X
in O X
vitro O X
. O X

This O X
study O X
investigated O X
the O X
requirement O X
for O X
GST I-MISC 373156
in O X
intact O X
cells O X
. O X

Transfection O X
with O X
a O X
plasmid O X
construct O X
expressing O X
GST I-MISC 373156
into O X
MCF7 O X
, O X
a O X
cell O X
line O X
that O X
lacks O X
endogenous O X
GST I-MISC 373156
, O X
significantly O X
increased O X
phospholipid O X
peroxidase O X
activity O X
as O X
measured O X
in O X
cell O X
lysates O X
and O X
protected O X
intact O X
cells O X
against O X
a O X
peroxidative O X
stress O X
. O X

siRNA O X
knockdown O X
indicated O X
that O X
this O X
increased O X
peroxidase O X
activity O X
was O X
Prdx6 I-MISC 9588
dependent O X
. O X

Interaction O X
between O X
GST I-MISC 373156
and O X
Prdx6 I-MISC 9588
, O X
evaluated O X
by O X
the O X
Duolink O X
Proximity O X
Ligation O X
Assay O X
, O X
was O X
minimal O X
under O X
basal O X
conditions O X
but O X
increased O X
dramatically O X
following O X
treatment O X
of O X
cells O X
with O X
the O X
oxidant O X
, O X
tert O X
- O X
butyl O X
hydroperoxide O X
. O X

Interaction O X
was O X
abolished O X
by O X
mutation O X
of O X
C47 O X
, O X
the O X
active O X
site O X
for O X
Prdx6 I-MISC 9588
peroxidase O X
activity O X
. O X

Depletion O X
of O X
cellular O X
GSH O X
by O X
treatment O X
of O X
cells O X
with O X
buthionine O X
sulfoximine O X
had O X
no O X
effect O X
on O X
the O X
interaction O X
of O X
Prdx6 I-MISC 9588
and O X
GST I-MISC 373156
. O X

These O X
data O X
are O X
consistent O X
with O X
the O X
hypothesis O X
that O X
oxidation O X
of O X
the O X
catalytic O X
cysteine O X
in O X
Prdx6 I-MISC 9588
is O X
required O X
for O X
its O X
interaction O X
with O X
GST I-MISC 373156
and O X
that O X
the O X
interaction O X
plays O X
an O X
important O X
role O X
in O X
regenerating O X
the O X
peroxidase O X
activity O X
of O X
Prdx6 I-MISC 9588
. O X

###19644450	382,9043

The O X
structural O X
basis O X
of O X
Arf O X
effector O X
specificity O X
: O X
the O X
crystal O X
structure O X
of O X
ARF6 I-MISC 382
in O X
a O X
complex O X
with O X
JIP4 I-MISC 9043
. O X

The O X
JNK O X
- O X
interacting O X
proteins O X
, O X
JIP3 I-MISC 23162
and O X
JIP4 I-MISC 9043
, O X
are O X
specific O X
effectors O X
of O X
the O X
small O X
GTP O X
- O X
binding O X
protein O X
ARF6 I-MISC 382
. O X

The O X
interaction O X
of O X
ARF6 I-MISC 382
- O X
GTP O X
with O X
the O X
second O X
leucine O X
zipper O X
( O X
LZII O X
) O X
domains O X
of O X
JIP3 I-MISC 23162
/ O X
JIP4 I-MISC 9043
regulates O X
the O X
binding O X
of O X
JIPs O X
to O X
kinesin O X
- O X
1 O X
and O X
dynactin O X
. O X

Here O X
, O X
we O X
report O X
the O X
crystal O X
structure O X
of O X
ARF6 I-MISC 382
- O X
GTP O X
bound O X
to O X
the O X
JIP4 I-MISC 9043
- O X
LZII O X
at O X
1 O X
. O X
9 O X
A O X
resolution O X
. O X

The O X
complex O X
is O X
a O X
heterotetramer O X
with O X
dyad O X
symmetry O X
arranged O X
in O X
an O X
ARF6 I-MISC 382
-( O X
JIP4 I-MISC 9043
)( O X
2 O X
)- O X
ARF6 I-MISC 382
configuration O X
. O X

Comparison O X
of O X
the O X
ARF6 I-MISC 382
- O X
JIP4 I-MISC 9043
interface O X
with O X
the O X
equivalent O X
region O X
of O X
ARF1 I-MISC 375
shows O X
the O X
structural O X
basis O X
of O X
JIP4 I-MISC 9043
' O X
s O X
specificity O X
for O X
ARF6 I-MISC 382
. O X

Using O X
site O X
- O X
directed O X
mutagenesis O X
and O X
surface O X
plasmon O X
resonance O X
, O X
we O X
further O X
show O X
that O X
non O X
- O X
conserved O X
residues O X
at O X
the O X
switch O X
region O X
borders O X
are O X
the O X
key O X
structural O X
determinants O X
of O X
JIP4 I-MISC 9043
specificity O X
. O X

A O X
structure O X
- O X
derived O X
model O X
of O X
the O X
association O X
of O X
the O X
ARF6 I-MISC 382
- O X
JIP3 I-MISC 23162
/ O X
JIP4 I-MISC 9043
complex O X
with O X
membranes O X
shows O X
that O X
the O X
JIP4 I-MISC 9043
- O X
LZII O X
coiled O X
- O X
coil O X
should O X
lie O X
along O X
the O X
membrane O X
to O X
prevent O X
steric O X
hindrances O X
, O X
resulting O X
in O X
only O X
one O X
ARF6 I-MISC 382
molecule O X
bound O X
. O X

Such O X
a O X
heterotrimeric O X
complex O X
gives O X
insights O X
to O X
better O X
understand O X
the O X
ARF6 I-MISC 382
- O X
mediated O X
motor O X
switch O X
regulatory O X
function O X
. O X

###20158519	19262,6714

Catalytically O X
active O X
membrane O X
- O X
distal O X
phosphatase O X
domain O X
of O X
receptor I-MISC 19262
protein I-MISC 19262
- I-MISC 19262
tyrosine I-MISC 19262
phosphatase I-MISC 19262
alpha I-MISC 19262
is O X
required O X
for O X
Src I-MISC 6714
activation O X
. O X

Receptor I-MISC 19262
protein I-MISC 19262
- I-MISC 19262
tyrosine I-MISC 19262
phosphatase I-MISC 19262
alpha I-MISC 19262
( O X
RPTPalpha I-MISC 19262
) O X
is O X
a O X
transmembrane O X
protein O X
with O X
tandem O X
cytoplasmic O X
phosphatase O X
domains O X
. O X

Most O X
of O X
the O X
catalytic O X
activity O X
is O X
contained O X
by O X
the O X
membrane O X
- O X
proximal O X
catalytic O X
domain O X
( O X
D1 O X
). O X

We O X
found O X
a O X
spontaneous O X
Arg554 O X
to O X
His O X
mutation O X
in O X
the O X
pTyr O X
recognition O X
loop O X
of O X
the O X
membrane O X
- O X
distal O X
phosphatase O X
domain O X
( O X
D2 O X
) O X
of O X
a O X
human O X
patient O X
. O X

This O X
mutation O X
was O X
not O X
linked O X
to O X
the O X
disease O X
. O X

Here O X
, O X
we O X
report O X
that O X
the O X
R554H O X
mutation O X
abolished O X
RPTPalpha I-MISC 19262
- O X
D2 O X
catalytic O X
activity O X
. O X

The O X
R554H O X
mutation O X
impaired O X
Src I-MISC 6714
binding O X
to O X
RPTPalpha I-MISC 19262
. O X

RPTPalpha I-MISC 19262
, O X
with O X
a O X
catalytic O X
site O X
cysteine O X
to O X
serine O X
mutation O X
in O X
D2 O X
, O X
also O X
displayed O X
diminished O X
binding O X
to O X
Src I-MISC 6714
. O X

Concomitant O X
with O X
decreased O X
Src I-MISC 6714
binding O X
of O X
the O X
R554H O X
and O X
C723S O X
mutants O X
compared O X
with O X
wild O X
- O X
type O X
RPTPalpha I-MISC 19262
, O X
enhanced O X
phosphorylation O X
of O X
the O X
inhibitory O X
Src I-MISC 6714
Tyr527 O X
site O X
was O X
observed O X
, O X
as O X
well O X
as O X
reduced O X
Src I-MISC 6714
activation O X
. O X

To O X
confirm O X
that O X
catalytic O X
activity O X
of O X
RPTPalpha I-MISC 19262
- O X
D2 O X
was O X
required O X
for O X
these O X
effects O X
, O X
we O X
analyzed O X
a O X
third O X
mutant O X
, O X
RPTPalpha I-MISC 19262
- O X
R729K O X
, O X
which O X
had O X
an O X
inactive O X
D2 O X
. O X

Again O X
, O X
Src I-MISC 6714
binding O X
was O X
reduced O X
and O X
Tyr527 O X
phosphorylation O X
was O X
enhanced O X
. O X

Our O X
results O X
suggest O X
that O X
a O X
catalytically O X
active O X
D2 O X
is O X
required O X
for O X
RPTPalpha I-MISC 19262
to O X
bind O X
and O X
dephosphorylate O X
its O X
well O X
- O X
characterized O X
substrate O X
, O X
Src I-MISC 6714
. O X

###14519764	24414,24669	24669,81672	24418,24669

Group O X
I O X
metabotropic O X
glutamate O X
receptors O X
bind O X
to O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
. O X

Mapping O X
and O X
modeling O X
of O X
interacting O X
sequences O X
. O X

The O X
modulation O X
of O X
neurotransmitter O X
receptors O X
by O X
kinases O X
and O X
phosphatases O X
represents O X
a O X
key O X
mechanism O X
in O X
controlling O X
synaptic O X
signal O X
transduction O X
. O X

However O X
, O X
molecular O X
determinants O X
involved O X
in O X
the O X
specific O X
targeting O X
and O X
interactions O X
of O X
these O X
enzymes O X
are O X
largely O X
unknown O X
. O X

Here O X
, O X
we O X
identified O X
both O X
catalytic O X
gamma O X
- O X
isoforms O X
of O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
( O X
PP1gamma1 O X
and O X
PP1gamma2 O X
) O X
as O X
binding O X
partners O X
of O X
the O X
group O X
I O X
metabotropic O X
glutamate I-MISC 24414
receptors I-MISC 24414
type I-MISC 24414
1a I-MISC 24414
, O X
5a O X
, O X
and O X
5b O X
in O X
yeast O X
cells O X
and O X
pull O X
- O X
down O X
assays O X
, O X
using O X
recombinant O X
and O X
native O X
protein O X
preparations O X
. O X

The O X
tissue O X
distribution O X
of O X
interacting O X
proteins O X
was O X
compared O X
, O X
and O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
was O X
detected O X
in O X
dendrites O X
of O X
retinal O X
bipolar O X
cells O X
expressing O X
the O X
respective O X
interacting O X
glutamate O X
receptors O X
. O X

We O X
mapped O X
interacting O X
domains O X
within O X
binding O X
partners O X
and O X
identified O X
five O X
amino O X
acids O X
in O X
the O X
intracellular O X
C O X
termini O X
of O X
the O X
metabotropic O X
glutamate I-MISC 24414
receptors I-MISC 24414
type I-MISC 24414
1a I-MISC 24414
, O X
5a O X
, O X
5b O X
, O X
and O X
7b O X
being O X
both O X
necessary O X
and O X
sufficient O X
to O X
bind O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
. O X

Furthermore O X
, O X
we O X
show O X
a O X
dose O X
- O X
dependent O X
competition O X
of O X
these O X
C O X
termini O X
in O X
binding O X
the O X
enzyme O X
. O X

Based O X
on O X
our O X
data O X
, O X
we O X
investigated O X
the O X
structure O X
of O X
the O X
identified O X
amino O X
acids O X
bound O X
to O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
by O X
homology O X
- O X
based O X
molecular O X
modeling O X
. O X

In O X
summary O X
, O X
these O X
results O X
provide O X
a O X
molecular O X
description O X
of O X
the O X
interaction O X
between O X
protein I-MISC 24669
phosphatase I-MISC 24669
1C I-MISC 24669
and O X
metabotropic O X
glutamate O X
receptors O X
and O X
thereby O X
increase O X
our O X
understanding O X
of O X
glutamatergic O X
signal O X
transduction O X
. O X

###23178720	30011,829

Dab1 I-MISC 13131
stabilizes O X
its O X
interaction O X
with O X
Cin85 I-MISC 30011
by O X
suppressing O X
Cin85 I-MISC 30011
phosphorylation O X
at O X
serine O X
587 O X
. O X

Crk I-MISC 12928
and O X
CrkL O X
adaptors O X
play O X
essential O X
neuronal O X
positioning O X
roles O X
downstream O X
of O X
Reelin I-MISC 19699
- O X
induced O X
Dab1 I-MISC 13131
tyrosine O X
phosphorylation O X
. O X

Recently O X
we O X
identified O X
Cin85 I-MISC 30011
to O X
be O X
a O X
CrkL O X
- O X
SH3 O X
binding O X
partner O X
from O X
embryonic O X
murine O X
brain O X
while O X
others O X
found O X
Cin85 I-MISC 30011
binds O X
directly O X
to O X
Dab1 I-MISC 13131
. O X

Here O X
using O X
mass O X
spectrometry O X
, O X
biochemical O X
and O X
mutational O X
analyses O X
we O X
show O X
that O X
Dab1 I-MISC 13131
suppresses O X
Cin85 I-MISC 30011
phosphorylation O X
at O X
Ser587 O X
. O X

Furthermore O X
a O X
Cin85 I-MISC 30011
Ser587 O X
phosphomimetic O X
disrupts O X
the O X
Dab1 I-MISC 13131
- O X
Cin85 I-MISC 30011
complex O X
without O X
affecting O X
the O X
Cin85 I-MISC 30011
- O X
CapZ I-MISC 829
complex O X
. O X

These O X
data O X
provide O X
an O X
early O X
glimpse O X
into O X
how O X
Cin85 I-MISC 30011
phosphorylation O X
might O X
alter O X
the O X
composition O X
of O X
its O X
scaffolding O X
partners O X
to O X
regulate O X
its O X
diverse O X
roles O X
including O X
vesicular O X
trafficking O X
, O X
receptor O X
endocytosis O X
and O X
actin O X
remodeling O X
. O X

###20972225	850883,850883

The O X
Bowen O X
- O X
Conradi O X
syndrome O X
protein O X
Nep1 I-MISC 850883
( O X
Emg1 I-MISC 850883
) O X
has O X
a O X
dual O X
role O X
in O X
eukaryotic O X
ribosome O X
biogenesis O X
, O X
as O X
an O X
essential O X
assembly O X
factor O X
and O X
in O X
the O X
methylation O X
of O X
1191 O X
in O X
yeast O X
18S O X
rRNA O X
. O X

The O X
Nep1 I-MISC 10436
( O X
Emg1 I-MISC 10436
) O X
SPOUT O X
- O X
class O X
methyltransferase O X
is O X
an O X
essential O X
ribosome O X
assembly O X
factor O X
and O X
the O X
human O X
Bowen O X
- O X
Conradi O X
syndrome O X
( O X
BCS O X
) O X
is O X
caused O X
by O X
a O X
specific O X
Nep1 I-MISC 10436
( I-MISC 10436
D86G I-MISC 10436
) O X
mutation O X
. O X

We O X
recently O X
showed O X
in O X
vitro O X
that O X
Methanocaldococcus O X
jannaschii O X
Nep1 I-MISC 850883
is O X
a O X
sequence O X
- O X
specific O X
pseudouridine O X
- O X
N1 O X
- O X
methyltransferase O X
. O X

Here O X
, O X
we O X
show O X
that O X
in O X
yeast O X
the O X
in O X
vivo O X
target O X
site O X
for O X
Nep1 I-MISC 850883
- O X
catalyzed O X
methylation O X
is O X
located O X
within O X
loop O X
35 O X
of O X
the O X
18S O X
rRNA O X
that O X
contains O X
the O X
unique O X
hypermodification O X
of O X
U1191 O X
to O X
1 O X
- O X
methyl O X
- O X
3 O X
-( O X
3 O X
- O X
amino O X
- O X
3 O X
- O X
carboxypropyl O X
)- O X
pseudouri O X
- O X
dine O X
( O X
m1acp3 O X
). O X

Specific O X
( O X
14 O X
) O X
C O X
- O X
methionine O X
labelling O X
of O X
18S O X
rRNA O X
in O X
yeast O X
mutants O X
showed O X
that O X
Nep1 I-MISC 850883
is O X
not O X
required O X
for O X
acp O X
- O X
modification O X
but O X
suggested O X
a O X
function O X
in O X
1191 O X
methylation O X
. O X

ESI O X
MS O X
analysis O X
of O X
acp O X
- O X
modified O X
- O X
nucleosides O X
in O X
a O X
/\ O X
nep1 I-MISC 850883
- O X
mutant O X
showed O X
that O X
Nep1 I-MISC 850883
catalyzes O X
the O X
1191 O X
methylation O X
in O X
vivo O X
. O X

Remarkably O X
, O X
the O X
restored O X
growth O X
of O X
a O X
nep1 I-MISC 850883
- O X
1 O X
( O X
ts O X
) O X
mutant O X
upon O X
addition O X
of O X
S O X
- O X
adenosylmethionine O X
was O X
even O X
observed O X
after O X
preventing O X
U1191 O X
methylation O X
in O X
a O X
/\ O X
snr35 O X
mutant O X
. O X

This O X
strongly O X
suggests O X
a O X
dual O X
Nep1 I-MISC 850883
function O X
, O X
as O X
1191 O X
- O X
methyltransferase O X
and O X
ribosome O X
assembly O X
factor O X
. O X

Interestingly O X
, O X
the O X
Nep1 I-MISC 850883
methyltransferase O X
activity O X
is O X
not O X
affected O X
upon O X
introduction O X
of O X
the O X
BCS O X
mutation O X
. O X

Instead O X
, O X
the O X
mutated O X
protein O X
shows O X
enhanced O X
dimerization O X
propensity O X
and O X
increased O X
affinity O X
for O X
its O X
RNA O X
- O X
target O X
in O X
vitro O X
. O X

Furthermore O X
, O X
the O X
BCS O X
mutation O X
prevents O X
nucleolar O X
accumulation O X
of O X
Nep1 I-MISC 850883
, O X
which O X
could O X
be O X
the O X
reason O X
for O X
reduced O X
growth O X
in O X
yeast O X
and O X
the O X
Bowen O X
- O X
Conradi O X
syndrome O X
. O X

###21360678	11140,5536	5536,10963

Label O X
- O X
free O X
quantitative O X
proteomics O X
and O X
SAINT O X
analysis O X
enable O X
interactome O X
mapping O X
for O X
the O X
human O X
Ser O X
/ O X
Thr O X
protein O X
phosphatase O X
5 O X
. O X

Affinity O X
purification O X
coupled O X
to O X
mass O X
spectrometry O X
( O X
AP O X
- O X
MS O X
) O X
represents O X
a O X
powerful O X
and O X
proven O X
approach O X
for O X
the O X
analysis O X
of O X
protein O X
- O X
protein O X
interactions O X
. O X

However O X
, O X
the O X
detection O X
of O X
true O X
interactions O X
for O X
proteins O X
that O X
are O X
commonly O X
considered O X
background O X
contaminants O X
is O X
currently O X
a O X
limitation O X
of O X
AP O X
- O X
MS O X
. O X

Here O X
using O X
spectral O X
counts O X
and O X
the O X
new O X
statistical O X
tool O X
, O X
Significance O X
Analysis O X
of O X
INTeractome O X
( O X
SAINT O X
), O X
true O X
interaction O X
between O X
the O X
serine I-MISC 5536
/ I-MISC 5536
threonine I-MISC 5536
protein I-MISC 5536
phosphatase I-MISC 5536
5 I-MISC 5536
( O X
PP5 I-MISC 5536
) O X
and O X
a O X
chaperonin O X
, O X
heat I-MISC 3320
shock I-MISC 3320
protein I-MISC 3320
90 I-MISC 3320
( O X
Hsp90 I-MISC 3320
), O X
is O X
discerned O X
. O X

Furthermore O X
, O X
we O X
report O X
and O X
validate O X
a O X
new O X
interaction O X
between O X
PP5 I-MISC 5536
and O X
an O X
Hsp90 I-MISC 3320
adaptor O X
protein O X
, O X
stress I-MISC 10963
- I-MISC 10963
induced I-MISC 10963
phosphoprotein I-MISC 10963
1 I-MISC 10963
( O X
STIP1 I-MISC 10963
; O X
HOP O X
). O X

Mutation O X
of O X
PP5 I-MISC 5536
, O X
replacing O X
key O X
basic O X
amino O X
acids O X
( O X
K97A O X
and O X
R101A O X
) O X
in O X
the O X
tetratricopeptide O X
repeat O X
( O X
TPR O X
) O X
region O X
known O X
to O X
be O X
necessary O X
for O X
the O X
interactions O X
with O X
Hsp90 I-MISC 3320
, O X
abolished O X
both O X
the O X
known O X
interaction O X
of O X
PP5 I-MISC 5536
with O X
cell I-MISC 11140
division I-MISC 11140
cycle I-MISC 11140
37 I-MISC 11140
homolog I-MISC 11140
and O X
the O X
novel O X
interaction O X
of O X
PP5 I-MISC 5536
with O X
stress I-MISC 10963
- I-MISC 10963
induced I-MISC 10963
phosphoprotein I-MISC 10963
1 I-MISC 10963
. O X

Taken O X
together O X
, O X
the O X
results O X
presented O X
demonstrate O X
the O X
usefulness O X
of O X
label O X
- O X
free O X
quantitative O X
proteomics O X
and O X
statistical O X
tools O X
to O X
discriminate O X
between O X
noise O X
and O X
true O X
interactions O X
, O X
even O X
for O X
proteins O X
normally O X
considered O X
as O X
background O X
contaminants O X
. O X

###12839993	821879,825648

Arabidopsis O X
AXR6 O X
encodes O X
CUL1 I-MISC 825648
implicating O X
SCF I-MISC 4254
E3 O X
ligases O X
in O X
auxin O X
regulation O X
of O X
embryogenesis O X
. O X

The O X
AXR6 O X
gene O X
is O X
required O X
for O X
auxin O X
signaling O X
in O X
the O X
Arabidopsis O X
embryo O X
and O X
during O X
postembryonic O X
development O X
. O X

One O X
of O X
the O X
effects O X
of O X
auxin O X
is O X
to O X
stimulate O X
degradation O X
of O X
the O X
Aux O X
/ O X
IAA O X
auxin O X
response O X
proteins O X
through O X
the O X
action O X
of O X
the O X
ubiquitin O X
protein O X
ligase O X
SCF I-MISC 4254
( O X
TIR1 O X
). O X

Here O X
we O X
show O X
that O X
AXR6 O X
encodes O X
the O X
SCF I-MISC 4254
subunit O X
CUL1 I-MISC 825648
. O X

The O X
axr6 O X
mutations O X
affect O X
the O X
ability O X
of O X
mutant O X
CUL1 I-MISC 825648
to O X
assemble O X
into O X
stable O X
SCF I-MISC 4254
complexes O X
resulting O X
in O X
reduced O X
degradation O X
of O X
the O X
SCF I-MISC 4254
( O X
TIR1 O X
) O X
substrate O X
AXR2 I-MISC 821879
/ O X
IAA7 O X
. O X

In O X
addition O X
, O X
we O X
show O X
that O X
CUL1 I-MISC 825648
is O X
required O X
for O X
lateral O X
organ O X
initiation O X
in O X
the O X
shoot O X
apical O X
meristem O X
and O X
the O X
inflorescence O X
meristem O X
. O X

These O X
results O X
indicate O X
that O X
the O X
embryonic O X
axr6 O X
phenotype O X
is O X
related O X
to O X
a O X
defect O X
in O X
SCF I-MISC 4254
function O X
and O X
accumulation O X
of O X
Aux O X
/ O X
IAA O X
proteins O X
such O X
as O X
BDL O X
/ O X
IAA12 O X
. O X

In O X
addition O X
, O X
we O X
show O X
that O X
CUL1 I-MISC 825648
has O X
a O X
role O X
in O X
auxin O X
response O X
throughout O X
the O X
life O X
cycle O X
of O X
the O X
plant O X
. O X

###9882311	29031019,6908

Interaction O X
of O X
the O X
transcription O X
factor O X
TFIID I-MISC 6908
with O X
simian I-MISC 29031019
virus I-MISC 29031019
40 I-MISC 29031019
( O X
SV40 I-MISC 29031019
) O X
large I-MISC 29031019
T I-MISC 29031019
antigen I-MISC 29031019
interferes O X
with O X
replication O X
of O X
SV40 I-MISC 29031019
DNA O X
in O X
vitro O X
. O X

Simian I-MISC 29031019
virus I-MISC 29031019
40 I-MISC 29031019
( O X
SV40 I-MISC 29031019
) O X
large O X
tumor O X
( O X
T O X
) O X
antigen O X
is O X
the O X
major O X
regulatory O X
protein O X
that O X
directs O X
the O X
course O X
of O X
viral O X
infection O X
, O X
primarily O X
by O X
interacting O X
with O X
host O X
cell O X
proteins O X
and O X
modulating O X
their O X
functions O X
. O X

Initiation O X
of O X
viral O X
DNA O X
replication O X
requires O X
specific O X
interactions O X
of O X
T O X
antigen O X
bound O X
to O X
the O X
viral O X
origin O X
of O X
DNA O X
replication O X
with O X
cellular O X
replication O X
proteins O X
. O X

Transcription O X
factors O X
are O X
thought O X
to O X
stimulate O X
initiation O X
of O X
viral O X
DNA O X
replication O X
, O X
but O X
the O X
mechanism O X
of O X
stimulation O X
is O X
poorly O X
understood O X
. O X

Since O X
the O X
transcription O X
factor O X
TATA I-MISC 6908
- I-MISC 6908
binding I-MISC 6908
protein I-MISC 6908
( O X
TBP I-MISC 6908
) O X
binds O X
to O X
sequences O X
within O X
the O X
origin O X
of O X
replication O X
and O X
interacts O X
specifically O X
with O X
T O X
antigen O X
, O X
we O X
examined O X
whether O X
TBP I-MISC 6908
complexes O X
stimulate O X
SV40 I-MISC 29031019
DNA O X
replication O X
in O X
vitro O X
. O X

On O X
the O X
contrary O X
, O X
we O X
found O X
that O X
depletion O X
of O X
TBP I-MISC 6908
complexes O X
from O X
human O X
cell O X
extracts O X
increased O X
their O X
ability O X
to O X
support O X
viral O X
DNA O X
replication O X
, O X
and O X
readdition O X
of O X
TBP I-MISC 6908
complexes O X
to O X
the O X
depleted O X
extracts O X
diminished O X
their O X
activity O X
. O X

We O X
have O X
mapped O X
the O X
sites O X
of O X
interaction O X
between O X
the O X
proteins O X
to O X
residues O X
181 O X
to O X
205 O X
of O X
T O X
antigen O X
and O X
184 O X
to O X
220 O X
of O X
TBP I-MISC 6908
. O X

Titration O X
of O X
fusion O X
proteins O X
containing O X
either O X
of O X
these O X
peptides O X
into O X
undepleted O X
cell O X
extracts O X
stimulated O X
their O X
replication O X
activity O X
, O X
suggesting O X
that O X
they O X
prevented O X
the O X
T O X
antigen O X
- O X
TBP I-MISC 6908
interaction O X
that O X
interfered O X
with O X
replication O X
activity O X
. O X

TBP I-MISC 6908
complexes O X
also O X
interfered O X
with O X
origin O X
DNA O X
unwinding O X
by O X
purified O X
T O X
antigen O X
, O X
and O X
addition O X
of O X
either O X
the O X
T O X
antigen O X
or O X
the O X
TBP I-MISC 6908
fusion O X
peptide O X
relieved O X
the O X
inhibition O X
. O X

These O X
results O X
suggest O X
that O X
TBP I-MISC 6908
complexes O X
associate O X
with O X
a O X
T O X
- O X
antigen O X
surface O X
that O X
is O X
also O X
required O X
for O X
origin O X
DNA O X
unwinding O X
and O X
viral O X
DNA O X
replication O X
. O X

We O X
speculate O X
that O X
competition O X
among O X
cellular O X
proteins O X
for O X
T O X
antigen O X
may O X
play O X
a O X
role O X
in O X
regulating O X
the O X
course O X
of O X
viral O X
infection O X
. O X

###15674350	2099,672

Structural O X
determinants O X
of O X
the O X
BRCA1 I-MISC 672
: O X
estrogen I-MISC 2099
receptor I-MISC 2099
interaction O X
. O X

Previously O X
, O X
we O X
showed O X
that O X
the O X
BRCA1 I-MISC 672
protein O X
interacts O X
directly O X
and O X
functionally O X
with O X
estrogen I-MISC 2099
receptor I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
( O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
), O X
resulting O X
in O X
the O X
inhibition O X
of O X
estradiol O X
( O X
E2 O X
)- O X
stimulated O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
transcriptional O X
activity O X
. O X

The O X
interaction O X
sites O X
were O X
mapped O X
to O X
the O X
N O X
- O X
terminus O X
of O X
BRCA1 I-MISC 672
( O X
within O X
amino O X
acids O X
( O X
aa O X
) O X
1 O X
- O X
302 O X
) O X
and O X
the O X
ligand O X
- O X
binding O X
domain O X
/ O X
activation O X
function O X
- O X
2 O X
( O X
LBD O X
/ O X
AF O X
- O X
2 O X
) O X
region O X
( O X
within O X
aa O X
282 O X
- O X
420 O X
) O X
of O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
. O X

In O X
this O X
study O X
, O X
we O X
have O X
further O X
characterized O X
the O X
structure O X
/ O X
function O X
relationship O X
for O X
the O X
BRCA1 I-MISC 672
: O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
interaction O X
. O X

We O X
found O X
that O X
the O X
N O X
- O X
terminal O X
RING O X
domain O X
( O X
aa O X
20 O X
- O X
64 O X
) O X
is O X
not O X
required O X
for O X
the O X
BRCA1 I-MISC 672
: O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
interaction O X
. O X

We O X
identified O X
two O X
separate O X
contact O X
points O X
for O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
, O X
one O X
within O X
aa O X
1 O X
- O X
100 O X
and O X
the O X
other O X
within O X
aa O X
100 O X
- O X
200 O X
of O X
BRCA1 I-MISC 672
; O X
and O X
we O X
showed O X
that O X
each O X
of O X
these O X
BRCA1 I-MISC 672
peptides O X
interacts O X
with O X
BRCA1 I-MISC 672
in O X
vitro O X
and O X
in O X
vivo O X
. O X

By O X
using O X
different O X
fragments O X
of O X
the O X
BRCA1 I-MISC 672
N O X
- O X
terminus O X
, O X
we O X
found O X
that O X
aa O X
67 O X
- O X
100 O X
and O X
101 O X
- O X
133 O X
are O X
required O X
for O X
the O X
interaction O X
with O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
, O X
but O X
that O X
aa O X
1 O X
- O X
67 O X
and O X
134 O X
- O X
302 O X
are O X
dispensible O X
. O X

Previously O X
, O X
we O X
showed O X
that O X
BRCA1 I-MISC 672
aa O X
1 O X
- O X
302 O X
does O X
not O X
inhibit O X
E2 O X
- O X
stimulated O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
transcriptional O X
activity O X
but O X
does O X
bind O X
to O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
and O X
acts O X
as O X
a O X
dominant O X
negative O X
inhibitor O X
of O X
the O X
full O X
- O X
length O X
BRCA1 I-MISC 672
protein O X
. O X

Somewhat O X
surprisingly O X
, O X
we O X
found O X
that O X
BRCA1 I-MISC 672
aa O X
1 O X
- O X
100 O X
and O X
BRCA1 I-MISC 672
aa O X
101 O X
- O X
200 O X
( O X
but O X
not O X
aa O X
201 O X
- O X
300 O X
) O X
each O X
inhibited O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
activity O X
, O X
although O X
not O X
as O X
efficiently O X
as O X
full O X
- O X
length O X
BRCA1 I-MISC 672
. O X

Mutations O X
within O X
an O X
HIV O X
Rev O X
- O X
like O X
nuclear O X
export O X
signal O X
that O X
resembles O X
a O X
nuclear O X
receptor O X
corepressor O X
motif O X
( O X
aa O X
86 O X
- O X
95 O X
) O X
impaired O X
the O X
ability O X
of O X
both O X
truncated O X
( O X
aa O X
1 O X
- O X
100 O X
) O X
and O X
full O X
- O X
length O X
( O X
aa O X
1 O X
- O X
1863 O X
) O X
BRCA1 I-MISC 672
proteins O X
to O X
interact O X
with O X
and O X
/ O X
or O X
repress O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
activity O X
. O X

Based O X
on O X
these O X
findings O X
, O X
a O X
partial O X
BRCA1 I-MISC 672
: O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
three O X
- O X
dimensional O X
structure O X
is O X
proposed O X
. O X

The O X
implications O X
of O X
these O X
findings O X
for O X
understanding O X
the O X
BRCA1 I-MISC 672
: O X
ER I-MISC 2099
- I-MISC 2099
alpha I-MISC 2099
interaction O X
are O X
discussed O X
. O X

###12163175	856862,854183

PY O X
motifs O X
of O X
Rod1 I-MISC 854183
are O X
required O X
for O X
binding O X
to O X
Rsp5 I-MISC 856862
and O X
for O X
drug O X
resistance O X
. O X

In O X
Saccharomyces O X
cerevisiae O X
, O X
the O X
overexpression O X
of O X
ROD1 I-MISC 854183
confers O X
resistance O X
to O X
o O X
- O X
dinitrobenzene O X
( O X
o O X
- O X
DNB O X
), O X
a O X
representative O X
of O X
target O X
drugs O X
of O X
glutathione O X
S O X
- O X
transferase O X
. O X

The O X
roles O X
of O X
Rod1 I-MISC 854183
in O X
drug O X
resistance O X
have O X
remained O X
to O X
be O X
determined O X
. O X

We O X
isolated O X
the O X
rog3 I-MISC 850578
mutation O X
as O X
a O X
suppressor O X
mutation O X
of O X
the O X
temperature O X
sensitivity O X
of O X
the O X
strain O X
, O X
in O X
that O X
two O X
of O X
the O X
total O X
four O X
glycogen O X
synthase O X
kinase O X
3 O X
homologs O X
were O X
deleted O X
. O X

Rog3 I-MISC 850578
is O X
homologous O X
to O X
Rod1 I-MISC 854183
, O X
and O X
its O X
overexpression O X
also O X
conferred O X
resistance O X
to O X
o O X
- O X
DNB O X
. O X

Furthermore O X
, O X
these O X
two O X
proteins O X
have O X
PY O X
- O X
motifs O X
, O X
and O X
bound O X
to O X
Rsp5 I-MISC 856862
, O X
a O X
hect O X
- O X
type O X
ubiquitin O X
ligase O X
. O X

The O X
rsp5 I-MISC 856862
- O X
101 O X
mutant O X
showed O X
sensitivity O X
to O X
o O X
- O X
DNB O X
as O X
did O X
the O X
rod1 I-MISC 854183
mutant O X
, O X
a O X
mutant O X
Rod1 I-MISC 854183
containing O X
altered O X
PY O X
motifs O X
was O X
defective O X
in O X
ability O X
to O X
bind O X
to O X
Rsp5 I-MISC 856862
and O X
in O X
conferring O X
o O X
- O X
DNB O X
resistance O X
. O X

These O X
results O X
suggest O X
that O X
interaction O X
of O X
Rod1 I-MISC 854183
and O X
Rsp5 I-MISC 856862
is O X
important O X
for O X
drug O X
resistance O X
. O X

###17666011	121504,816486	121504,829072

Identification O X
and O X
characterization O X
of O X
two O X
closely O X
related O X
histone I-MISC 121504
H4 I-MISC 121504
arginine O X
3 O X
methyltransferases O X
in O X
Arabidopsis O X
thaliana O X
. O X

Arginine O X
methylation O X
of O X
histone O X
H3 O X
and O X
H4 O X
plays O X
important O X
roles O X
in O X
transcriptional O X
regulation O X
in O X
eukaryotes O X
such O X
as O X
yeasts O X
, O X
fruitflies O X
, O X
nematode O X
worms O X
, O X
fish O X
and O X
mammals O X
; O X
however O X
, O X
less O X
is O X
known O X
in O X
plants O X
. O X

In O X
the O X
present O X
paper O X
, O X
we O X
report O X
the O X
identification O X
and O X
characterization O X
of O X
two O X
Arabidopsis O X
thaliana O X
protein O X
arginine O X
N O X
- O X
methyltransferases O X
, O X
AtPRMT1a I-MISC 816486
and O X
AtPRMT1b I-MISC 829072
, O X
which O X
exhibit O X
high O X
homology O X
with O X
human O X
PRMT1 I-MISC 3276
. O X

Both O X
AtPRMT1a I-MISC 816486
and O X
AtPRMT1b I-MISC 829072
methylated O X
histone I-MISC 121504
H4 I-MISC 121504
, O X
H2A O X
, O X
and O X
myelin O X
basic O X
protein O X
in O X
vitro O X
. O X

Site O X
- O X
directed O X
mutagenesis O X
of O X
the O X
third O X
arginine O X
( O X
R3 O X
) O X
on O X
the O X
N O X
- O X
terminus O X
of O X
histone I-MISC 121504
H4 I-MISC 121504
to O X
lysine O X
( O X
H4R3N O X
) O X
completely O X
abolished O X
the O X
methylation O X
of O X
histone I-MISC 121504
H4 I-MISC 121504
. O X

When O X
fused O X
to O X
GFP O X
( O X
green O X
fluorescent O X
protein O X
), O X
both O X
methyltransferases O X
localized O X
to O X
the O X
cytoplasm O X
as O X
well O X
as O X
to O X
the O X
nucleus O X
. O X

Consistent O X
with O X
their O X
subcellular O X
distribution O X
, O X
GST O X
( O X
glutathione O X
transferase O X
) O X
pull O X
- O X
down O X
assays O X
revealed O X
an O X
interaction O X
between O X
the O X
two O X
methyltransferases O X
, O X
suggesting O X
that O X
both O X
proteins O X
may O X
act O X
together O X
in O X
a O X
functional O X
unit O X
. O X

In O X
addition O X
, O X
we O X
demonstrated O X
that O X
AtFib2 I-MISC 828668
( O X
Arabidopsis O X
thaliana O X
fibrillarin O X
2 O X
), O X
an O X
RNA O X
methyltransferase O X
, O X
is O X
a O X
potential O X
substrate O X
for O X
AtPRMT1a I-MISC 816486
and O X
AtPRMT1b I-MISC 829072
, O X
and O X
, O X
furthermore O X
, O X
uncovered O X
a O X
direct O X
interaction O X
between O X
the O X
protein O X
methyltransferase O X
and O X
the O X
RNA O X
methyltransferase O X
. O X

Taken O X
together O X
, O X
our O X
findings O X
implicate O X
AtPRMT1a I-MISC 816486
and O X
AtPRMT1b I-MISC 829072
as O X
H4 O X
- O X
R3 O X
protein O X
arginine O X
N O X
- O X
methyltransferases O X
in O X
Arabidopsis O X
and O X
may O X
be O X
involved O X
in O X
diverse O X
biological O X
processes O X
inside O X
and O X
outside O X
the O X
nucleus O X
. O X

###15169891	13043,7454	13043,281577

Erk I-MISC 2048
/ O X
Src I-MISC 6714
phosphorylation O X
of O X
cortactin I-MISC 13043
acts O X
as O X
a O X
switch O X
on O X
- O X
switch O X
off O X
mechanism O X
that O X
controls O X
its O X
ability O X
to O X
activate O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
. O X

The O X
Arp2 I-MISC 10097
/ O X
3 O X
complex O X
can O X
be O X
independently O X
activated O X
to O X
initiate O X
actin O X
polymerization O X
by O X
the O X
VCA O X
domain O X
of O X
WASP I-MISC 7454
family O X
members O X
and O X
by O X
the O X
acidic O X
N O X
- O X
terminal O X
and O X
F O X
- O X
actin O X
- O X
binding O X
repeat O X
region O X
of O X
cortactin I-MISC 13043
, O X
which O X
possesses O X
a O X
C O X
- O X
terminal O X
SH3 O X
domain O X
. O X

Cortactin I-MISC 13043
is O X
a O X
target O X
for O X
phosphorylation O X
by O X
Src I-MISC 6714
tyrosine O X
kinases O X
and O X
by O X
serine O X
/ O X
threonine O X
kinases O X
that O X
include O X
Erk I-MISC 2048
. O X

Here O X
we O X
demonstrate O X
that O X
cortactin I-MISC 13043
binds O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
and O X
WASP I-MISC 7454
via O X
its O X
SH3 O X
domain O X
, O X
induces O X
in O X
vitro O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
- O X
mediated O X
actin O X
polymerization O X
, O X
and O X
colocalizes O X
with O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
and O X
WASP I-MISC 7454
at O X
sites O X
of O X
active O X
actin O X
polymerization O X
. O X

Erk I-MISC 2048
phosphorylation O X
and O X
a O X
mimicking O X
S405 O X
, O X
418D O X
double O X
mutation O X
enhanced O X
cortactin I-MISC 13043
binding O X
and O X
activation O X
of O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
. O X

In O X
contrast O X
, O X
Src I-MISC 6714
phosphorylation O X
inhibited O X
the O X
ability O X
of O X
cortactin I-MISC 13043
previously O X
phosphorylated O X
by O X
Erk I-MISC 2048
, O X
and O X
that O X
of O X
S405 O X
, O X
418D O X
double O X
mutant O X
cortactin I-MISC 13043
, O X
to O X
bind O X
and O X
activate O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
. O X

Furthermore O X
, O X
Y O X
--> O X
D O X
mutation O X
of O X
three O X
tyrosine O X
residues O X
targeted O X
by O X
Src I-MISC 6714
( O X
Y421 O X
, O X
Y466 O X
, O X
and O X
Y482 O X
) O X
inhibited O X
the O X
ability O X
of O X
S405 O X
, O X
418D O X
cortactin I-MISC 13043
to O X
activate O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
. O X

We O X
propose O X
that O X
Erk I-MISC 2048
phosphorylation O X
liberates O X
the O X
SH3 O X
domain O X
of O X
cortactin I-MISC 13043
from O X
intramolecular O X
interactions O X
with O X
proline O X
- O X
rich O X
regions O X
, O X
causing O X
it O X
to O X
synergize O X
with O X
WASP I-MISC 7454
and O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
in O X
activating O X
the O X
Arp2 I-MISC 10097
/ O X
3 O X
complex O X
, O X
and O X
that O X
Src I-MISC 6714
phosphorylation O X
terminates O X
cortactin I-MISC 13043
activation O X
of O X
N I-MISC 281577
- I-MISC 281577
WASP I-MISC 281577
and O X
WASP I-MISC 7454
. O X

###11799244	10142,3784

Requirement O X
of O X
a O X
macromolecular O X
signaling O X
complex O X
for O X
beta O X
adrenergic O X
receptor O X
modulation O X
of O X
the O X
KCNQ1 I-MISC 3784
- O X
KCNE1 I-MISC 3753
potassium O X
channel O X
. O X

Sympathetic O X
nervous O X
system O X
( O X
SNS O X
) O X
regulation O X
of O X
cardiac O X
action O X
potential O X
duration O X
( O X
APD O X
) O X
is O X
mediated O X
by O X
beta O X
adrenergic O X
receptor O X
( O X
betaAR O X
) O X
activation O X
, O X
which O X
increases O X
the O X
slow O X
outward O X
potassium O X
ion O X
current O X
( O X
IKS O X
). O X

Mutations O X
in O X
two O X
human O X
I O X
( O X
KS O X
) O X
channel O X
subunits O X
, O X
hKCNQ1 I-MISC 3784
and O X
hKCNE1 I-MISC 3753
, O X
prolong O X
APD O X
and O X
cause O X
inherited O X
cardiac O X
arrhythmias O X
known O X
as O X
LQTS O X
( O X
long O X
QT O X
syndrome O X
). O X

We O X
show O X
that O X
betaAR O X
modulation O X
of O X
I O X
( O X
KS O X
) O X
requires O X
targeting O X
of O X
adenosine O X
3 O X
', O X
5 O X
'- O X
monophosphate O X
( O X
cAMP O X
)- O X
dependent O X
protein O X
kinase O X
( O X
PKA O X
) O X
and O X
protein I-MISC 5540
phosphatase I-MISC 5540
1 I-MISC 5540
( O X
PP1 I-MISC 5540
) O X
to O X
hKCNQ1 I-MISC 3784
through O X
the O X
targeting O X
protein O X
yotiao I-MISC 10142
. O X

Yotiao I-MISC 10142
binds O X
to O X
hKCNQ1 I-MISC 3784
by O X
a O X
leucine O X
zipper O X
motif O X
, O X
which O X
is O X
disrupted O X
by O X
an O X
LQTS O X
mutation O X
( O X
hKCNQ1 I-MISC 3784
- O X
G589D O X
). O X

Identification O X
of O X
the O X
hKCNQ1 I-MISC 3784
macromolecular O X
complex O X
provides O X
a O X
mechanism O X
for O X
SNS O X
modulation O X
of O X
cardiac O X
APD O X
through O X
IKS O X
. O X

###18571510	842733,830586

NPR1 I-MISC 842733
preferentially O X
binds O X
to O X
the O X
DNA O X
- O X
inactive O X
form O X
of O X
Arabidopsis O X
TGA2 I-MISC 830586
. O X

Systemic O X
acquired O X
resistance O X
( O X
SAR O X
) O X
is O X
triggered O X
by O X
hormone O X
defense O X
cues O X
and O X
is O X
associated O X
with O X
the O X
onset O X
of O X
expression O X
of O X
pathogenesis O X
- O X
related O X
( O X
PR O X
) O X
genes O X
that O X
encode O X
for O X
anti O X
- O X
microbial O X
proteins O X
in O X
plants O X
. O X

In O X
the O X
case O X
of O X
PR O X
- O X
1 O X
, O X
transcriptional O X
activation O X
involves O X
promoter O X
- O X
specific O X
recruitment O X
of O X
transcription O X
factors O X
such O X
as O X
TGA2 I-MISC 830586
through O X
a O X
mechanism O X
that O X
may O X
involve O X
transient O X
physical O X
interaction O X
with O X
the O X
NPR1 I-MISC 842733
protein O X
. O X

This O X
stimulus O X
- O X
inducible O X
recruitment O X
process O X
has O X
yet O X
to O X
be O X
fully O X
explained O X
at O X
the O X
functional O X
and O X
mechanistic O X
level O X
. O X

To O X
investigate O X
this O X
question O X
further O X
, O X
we O X
initially O X
looked O X
to O X
see O X
whether O X
NPR1 I-MISC 842733
preferentially O X
forms O X
a O X
complex O X
with O X
the O X
DNA O X
bound O X
or O X
unbound O X
fraction O X
of O X
TGA2 I-MISC 830586
. O X

As O X
shown O X
here O X
, O X
NPR1 I-MISC 842733
appears O X
to O X
preferentially O X
interact O X
with O X
the O X
non O X
- O X
DNA O X
bound O X
fraction O X
of O X
TGA2 I-MISC 830586
. O X

We O X
subsequently O X
mutated O X
this O X
transcription O X
factor O X
to O X
identify O X
key O X
residues O X
in O X
its O X
conserved O X
carboxyl O X
terminal O X
( O X
CT O X
) O X
domain O X
that O X
mediate O X
complex O X
formation O X
with O X
NPR1 I-MISC 842733
. O X

These O X
approaches O X
revealed O X
that O X
two O X
non O X
- O X
overlapping O X
regions O X
of O X
the O X
CT O X
domain O X
of O X
TGA2 I-MISC 830586
bind O X
independently O X
to O X
NPR1 I-MISC 842733
. O X

The O X
specificity O X
and O X
biological O X
significance O X
of O X
these O X
findings O X
were O X
inferred O X
with O X
a O X
mutant O X
form O X
of O X
NPR1 I-MISC 842733
that O X
fails O X
to O X
activate O X
SAR O X
in O X
vivo O X
. O X

These O X
and O X
other O X
findings O X
raise O X
the O X
possibility O X
that O X
NPR1 I-MISC 842733
may O X
transiently O X
interact O X
with O X
the O X
DNA O X
unbound O X
fraction O X
of O X
TGA2 I-MISC 830586
to O X
promote O X
its O X
recruitment O X
to O X
an O X
active O X
form O X
on O X
cognate O X
target O X
promoters O X
. O X

###12044636	6622,9627

Analysis O X
of O X
synphilin I-MISC 9627
- I-MISC 9627
1 I-MISC 9627
and O X
synuclein O X
interactions O X
by O X
yeast O X
two O X
- O X
hybrid O X
beta I-MISC 2720
- I-MISC 2720
galactosidase I-MISC 2720
liquid O X
assay O X
. O X

Synphilin I-MISC 9627
- I-MISC 9627
1 I-MISC 9627
interacts O X
with O X
alpha I-MISC 6622
- I-MISC 6622
synuclein I-MISC 6622
, O X
which O X
has O X
been O X
implicated O X
in O X
the O X
pathogenesis O X
of O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
). O X

By O X
examination O X
of O X
their O X
interactions O X
quantitatively O X
, O X
with O X
the O X
use O X
of O X
the O X
yeast O X
two O X
- O X
hybrid O X
beta I-MISC 2720
- I-MISC 2720
galactosidase I-MISC 2720
assay O X
, O X
we O X
find O X
that O X
the O X
synuclein O X
amino O X
acid O X
( O X
aa O X
) O X
1 O X
- O X
65 O X
region O X
is O X
sufficient O X
for O X
an O X
interaction O X
. O X

A O X
central O X
domain O X
of O X
synphilin I-MISC 9627
- I-MISC 9627
1 I-MISC 9627
, O X
aa O X
349 O X
- O X
555 O X
, O X
is O X
both O X
necessary O X
and O X
sufficient O X
for O X
an O X
interaction O X
with O X
alpha I-MISC 6622
- I-MISC 6622
synuclein I-MISC 6622
. O X

We O X
did O X
not O X
observe O X
an O X
effect O X
of O X
the O X
synuclein O X
A53T O X
mutation O X
, O X
which O X
causes O X
one O X
familial O X
form O X
of O X
PD O X
, O X
on O X
interactions O X
with O X
synphilin I-MISC 9627
- I-MISC 9627
1 I-MISC 9627
. O X

However O X
, O X
the O X
A30P O X
mutation O X
caused O X
an O X
increase O X
in O X
the O X
interaction O X
between O X
the O X
synuclein O X
aa O X
1 O X
- O X
65 O X
fragment O X
and O X
the O X
synphilin I-MISC 9627
- I-MISC 9627
1 I-MISC 9627
central O X
domain O X
. O X

###22510884	673,673	673,5894

Distinct O X
requirement O X
for O X
an O X
intact O X
dimer O X
interface O X
in O X
wild O X
- O X
type O X
, O X
V600E O X
and O X
kinase O X
- O X
dead O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
signalling O X
. O X

The O X
dimerisation O X
of O X
Raf O X
kinases O X
involves O X
a O X
central O X
cluster O X
within O X
the O X
kinase O X
domain O X
, O X
the O X
dimer O X
interface O X
( O X
DIF O X
). O X

Yet O X
, O X
the O X
importance O X
of O X
the O X
DIF O X
for O X
the O X
signalling O X
potential O X
of O X
wild O X
- O X
type O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( I-MISC 673
wt I-MISC 673
)) O X
and O X
its O X
oncogenic O X
counterparts O X
remains O X
unknown O X
. O X

Here O X
, O X
we O X
show O X
that O X
the O X
DIF O X
plays O X
a O X
pivotal O X
role O X
for O X
the O X
activity O X
of O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( I-MISC 673
wt I-MISC 673
) I-MISC 673
and O X
several O X
of O X
its O X
gain O X
- O X
of O X
- O X
function O X
( O X
g O X
- O X
o O X
- O X
f O X
) O X
mutants O X
. O X

In O X
contrast O X
, O X
the O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( O X
V600E O X
), O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( O X
insT O X
) O X
and O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( O X
G469A O X
) O X
oncoproteins O X
are O X
remarkably O X
resistant O X
to O X
mutations O X
in O X
the O X
DIF O X
. O X

However O X
, O X
compared O X
with O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( I-MISC 673
wt I-MISC 673
), O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( O X
V600E O X
) O X
displays O X
extended O X
protomer O X
contacts O X
, O X
increased O X
homodimerisation O X
and O X
incorporation O X
into O X
larger O X
protein O X
complexes O X
. O X

In O X
contrast O X
, O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
( I-MISC 673
wt I-MISC 673
) I-MISC 673
and O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
( O X
wt O X
) O X
mediated O X
signalling O X
triggered O X
by O X
oncogenic O X
Ras O X
as O X
well O X
as O X
the O X
paradoxical O X
activation O X
of O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
by O X
kinase O X
- O X
inactivated O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
require O X
an O X
intact O X
DIF O X
. O X

Surprisingly O X
, O X
the O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
DIF O X
is O X
not O X
required O X
for O X
dimerisation O X
between O X
Raf I-MISC 5894
- I-MISC 5894
1 I-MISC 5894
and O X
B I-MISC 673
- I-MISC 673
Raf I-MISC 673
, O X
which O X
was O X
inactivated O X
by O X
the O X
D594A O X
mutation O X
, O X
sorafenib O X
or O X
PLX4720 O X
. O X

This O X
suggests O X
that O X
paradoxical O X
MEK I-MISC 5609
/ O X
ERK I-MISC 5594
activation O X
represents O X
a O X
two O X
- O X
step O X
mechanism O X
consisting O X
of O X
dimerisation O X
and O X
DIF O X
- O X
dependent O X
transactivation O X
. O X

Our O X
data O X
further O X
implicate O X
the O X
Raf O X
DIF O X
as O X
a O X
potential O X
target O X
against O X
Ras O X
- O X
driven O X
Raf O X
- O X
mediated O X
( O X
paradoxical O X
) O X
ERK I-MISC 5594
activation O X
. O X

###9162036	116563,192152

Serine O X
331 O X
and O X
tyrosine O X
333 O X
are O X
both O X
involved O X
in O X
the O X
interaction O X
between O X
the O X
cytosolic O X
domain O X
of O X
TGN38 I-MISC 192152
and O X
the O X
mu2 I-MISC 116563
subunit O X
of O X
the O X
AP2 O X
clathrin O X
adaptor O X
complex O X
. O X

TGN38 I-MISC 192152
is O X
a O X
type O X
I O X
integral O X
membrane O X
protein O X
that O X
cycles O X
between O X
the O X
trans O X
- O X
Golgi O X
network O X
and O X
the O X
plasma O X
membrane O X
. O X

Internalization O X
at O X
the O X
cell O X
surface O X
and O X
targeting O X
back O X
to O X
the O X
trans O X
- O X
Golgi O X
network O X
is O X
dependent O X
on O X
a O X
hexapeptide O X
motif O X
, O X
SDYQRL O X
, O X
in O X
the O X
cytosolic O X
tail O X
of O X
the O X
protein O X
. O X

It O X
was O X
recently O X
demonstrated O X
that O X
this O X
motif O X
specifically O X
interacts O X
with O X
the O X
mu2 I-MISC 116563
subunit O X
of O X
the O X
AP2 O X
adaptor O X
complex O X
. O X

We O X
have O X
studied O X
the O X
interaction O X
between O X
the O X
entire O X
cytosolic O X
domain O X
of O X
TGN38 I-MISC 192152
and O X
mu2 I-MISC 116563
using O X
the O X
yeast O X
two O X
hybrid O X
system O X
, O X
in O X
vitro O X
binding O X
of O X
recombinant O X
fusion O X
proteins O X
and O X
IAsys O X
optical O X
biosensor O X
technology O X
. O X

A O X
specific O X
interaction O X
has O X
been O X
demonstrated O X
in O X
each O X
of O X
the O X
systems O X
we O X
have O X
employed O X
. O X

We O X
have O X
shown O X
an O X
absolute O X
requirement O X
for O X
Tyr O X
- O X
333 O X
of O X
TGN38 I-MISC 192152
in O X
binding O X
to O X
mu2 I-MISC 116563
. O X

In O X
addition O X
we O X
found O X
that O X
mutation O X
of O X
Ser O X
- O X
331 O X
to O X
alanine O X
reduces O X
the O X
affinity O X
of O X
the O X
interaction O X
. O X

By O X
measuring O X
tryptophan O X
fluorescence O X
at O X
equilibrium O X
, O X
we O X
have O X
also O X
determined O X
the O X
dissociation O X
constant O X
for O X
the O X
interaction O X
between O X
the O X
entire O X
cytosolic O X
tail O X
of O X
TGN38 I-MISC 192152
and O X
mu2 I-MISC 116563
as O X
58 O X
nM O X
. O X

In O X
contrast O X
to O X
previously O X
published O X
work O X
, O X
our O X
data O X
suggest O X
that O X
not O X
only O X
Tyr O X
- O X
333 O X
but O X
also O X
its O X
context O X
is O X
important O X
in O X
determining O X
the O X
specificity O X
of O X
binding O X
of O X
TGN38 I-MISC 192152
to O X
mu2 I-MISC 116563
. O X

###16278047	26260,6500

Characterization O X
of O X
FBX25 I-MISC 26260
, O X
encoding O X
a O X
novel O X
brain O X
- O X
expressed O X
F O X
- O X
box O X
protein O X
. O X

F O X
- O X
box O X
proteins O X
( O X
FBPs O X
) O X
confer O X
substrate O X
specificity O X
to O X
the O X
SCF O X
- O X
type O X
( O X
Skp1 I-MISC 6500
/ O X
Cul1 I-MISC 8454
/ O X
FBP I-MISC 8056
) O X
of O X
ubiquitin O X
ligase O X
complexes O X
through O X
their O X
F O X
- O X
box O X
. O X

Multiple O X
FBPs O X
have O X
been O X
predicted O X
, O X
but O X
experimental O X
evidence O X
is O X
lagging O X
. O X

We O X
report O X
on O X
the O X
predicted O X
human O X
FBP I-MISC 8056
hFBX25 I-MISC 26260
which O X
we O X
found O X
to O X
be O X
disrupted O X
in O X
a O X
mentally O X
retarded O X
translocation O X
carrier O X
suffering O X
from O X
epileptic O X
seizures O X
. O X

We O X
investigated O X
hFBX25 I-MISC 26260
' O X
s O X
genomic O X
organization O X
and O X
established O X
hFBX25 I-MISC 26260
as O X
an O X
FBP I-MISC 8056
by O X
verifying O X
its O X
interaction O X
with O X
Skp1 I-MISC 6500
and O X
Cul1 I-MISC 8454
. O X

In O X
the O X
process O X
, O X
we O X
identified O X
an O X
atypical O X
serine O X
residue O X
in O X
the O X
F O X
- O X
box O X
which O X
is O X
crucial O X
for O X
the O X
hFBX25 I-MISC 26260
- O X
Skp1 I-MISC 6500
binding O X
. O X

We O X
determined O X
hFBX25 I-MISC 26260
' O X
s O X
subcellular O X
localization O X
. O X

We O X
found O X
strong O X
transcription O X
in O X
human O X
brain O X
. O X

In O X
mouse O X
embryonic O X
sections O X
, O X
mFbx25 I-MISC 66822
shows O X
predominantly O X
neuronal O X
expression O X
and O X
in O X
adult O X
mouse O X
brain O X
, O X
expression O X
is O X
confined O X
to O X
the O X
hippocampus O X
, O X
the O X
cerebral O X
cortex O X
and O X
the O X
Purkinje O X
cell O X
layer O X
. O X

Interestingly O X
, O X
aberrations O X
in O X
the O X
ubiquitin O X
pathway O X
have O X
been O X
linked O X
to O X
neurological O X
conditions O X
. O X

###16096643	20617,22629

14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
is O X
a O X
novel O X
regulator O X
of O X
parkin O X
ubiquitin O X
ligase O X
. O X

Mutation O X
of O X
the O X
parkin O X
gene O X
, O X
which O X
encodes O X
an O X
E3 O X
ubiquitin O X
- O X
protein O X
ligase O X
, O X
is O X
the O X
major O X
cause O X
of O X
autosomal O X
recessive O X
juvenile O X
parkinsonism O X
( O X
ARJP O X
). O X

Although O X
various O X
substrates O X
for O X
parkin O X
have O X
been O X
identified O X
, O X
the O X
mechanisms O X
that O X
regulate O X
the O X
ubiquitin O X
ligase O X
activity O X
of O X
parkin O X
are O X
poorly O X
understood O X
. O X

Here O X
we O X
report O X
that O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
, O X
a O X
chaperone O X
- O X
like O X
protein O X
present O X
abundantly O X
in O X
neurons O X
, O X
could O X
bind O X
to O X
parkin O X
and O X
negatively O X
regulate O X
its O X
ubiquitin O X
ligase O X
activity O X
. O X

Furthermore O X
, O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
could O X
bind O X
to O X
the O X
linker O X
region O X
of O X
parkin O X
but O X
not O X
parkin O X
with O X
ARJP O X
- O X
causing O X
R42P O X
, O X
K161N O X
, O X
and O X
T240R O X
mutations O X
. O X

Intriguingly O X
, O X
alpha I-MISC 20617
- I-MISC 20617
synuclein I-MISC 20617
( O X
alpha I-MISC 20617
- I-MISC 20617
SN I-MISC 20617
), O X
another O X
familial O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
) O X
gene O X
product O X
, O X
abrogated O X
the O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
- O X
induced O X
suppression O X
of O X
parkin O X
activity O X
. O X

alpha I-MISC 20617
- I-MISC 20617
SN I-MISC 20617
could O X
bind O X
tightly O X
to O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
and O X
consequently O X
sequester O X
it O X
from O X
the O X
parkin O X
- O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
complex O X
. O X

PD O X
- O X
causing O X
A30P O X
and O X
A53T O X
mutants O X
of O X
alpha I-MISC 20617
- I-MISC 20617
SN I-MISC 20617
could O X
not O X
bind O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
, O X
and O X
failed O X
to O X
activate O X
parkin O X
. O X

Our O X
findings O X
indicate O X
that O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
is O X
a O X
regulator O X
that O X
functionally O X
links O X
parkin O X
and O X
alpha I-MISC 20617
- I-MISC 20617
SN I-MISC 20617
. O X

The O X
alpha I-MISC 20617
- I-MISC 20617
SN I-MISC 20617
- O X
positive O X
and O X
14 I-MISC 22629
- I-MISC 22629
3 I-MISC 22629
- I-MISC 22629
3eta I-MISC 22629
- O X
negative O X
control O X
of O X
parkin O X
activity O X
sheds O X
new O X
light O X
on O X
the O X
pathophysiological O X
roles O X
of O X
parkin O X
. O X

###11134024	173914,180367

A O X
novel O X
adapter O X
protein O X
employs O X
a O X
phosphotyrosine O X
binding O X
domain O X
and O X
exceptionally O X
basic O X
N O X
- O X
terminal O X
domains O X
to O X
capture O X
and O X
localize O X
an O X
atypical O X
protein O X
kinase O X
C O X
: O X
characterization O X
of O X
Caenorhabditis O X
elegans O X
C O X
kinase O X
adapter O X
1 O X
, O X
a O X
protein O X
that O X
avidly O X
binds O X
protein O X
kinase O X
C3 O X
. O X

Atypical O X
protein O X
kinase O X
C O X
isoforms O X
( O X
aPKCs O X
) O X
transmit O X
regulatory O X
signals O X
to O X
effector O X
proteins O X
located O X
in O X
the O X
cytoplasm O X
, O X
nucleus O X
, O X
cytoskeleton O X
, O X
and O X
membranes O X
. O X

Mechanisms O X
by O X
which O X
aPKCs O X
encounter O X
and O X
control O X
effector O X
proteins O X
in O X
various O X
microenvironments O X
are O X
poorly O X
understood O X
. O X

By O X
using O X
a O X
protein O X
interaction O X
screen O X
, O X
we O X
discovered O X
two O X
novel O X
proteins O X
that O X
adapt O X
a O X
Caenorhabditis O X
elegans O X
aPKC O X
( O X
PKC3 I-MISC 173914
) O X
for O X
specialized O X
( O X
localized O X
) O X
functions O X
; O X
protein O X
kinase O X
C O X
adapter O X
1 O X
( O X
CKA1 I-MISC 180367
, O X
593 O X
amino O X
acids O X
) O X
and O X
CKA1S O X
( O X
549 O X
amino O X
acids O X
) O X
are O X
derived O X
from O X
a O X
unique O X
mRNA O X
by O X
alternative O X
utilization O X
of O X
two O X
translation O X
initiation O X
codons O X
. O X

CKA1S O X
and O X
CKA1 I-MISC 180367
are O X
routed O X
to O X
the O X
cell O X
periphery O X
by O X
exceptionally O X
basic O X
N O X
- O X
terminal O X
regions O X
that O X
include O X
classical O X
phosphorylation O X
site O X
domains O X
( O X
PSDs O X
). O X

Tethering O X
of O X
PKC3 I-MISC 173914
is O X
mediated O X
by O X
a O X
segment O X
of O X
CKA1 I-MISC 180367
that O X
constitutes O X
a O X
phosphotyrosine O X
binding O X
( O X
PTB O X
) O X
domain O X
. O X

Two O X
aromatic O X
amino O X
acids O X
( O X
Phe O X
( O X
175 O X
) O X
and O X
Phe O X
( O X
221 O X
)) O X
are O X
indispensable O X
for O X
creation O X
of O X
a O X
PKC3 I-MISC 173914
- O X
binding O X
surface O X
and O X
/ O X
or O X
stabilization O X
of O X
CKA1 I-MISC 180367
. O X
aPKC O X
complexes O X
. O X

Patterns O X
of O X
CKA1 I-MISC 180367
gene O X
promoter O X
activity O X
and O X
CKA1 I-MISC 180367
/ O X
CKA1S O X
protein O X
localization O X
in O X
vivo O X
overlap O X
with O X
patterns O X
established O X
for O X
PKC3 I-MISC 173914
expression O X
and O X
distribution O X
. O X

Transfection O X
experiments O X
demonstrated O X
that O X
CKA1 I-MISC 180367
/ O X
CKA1S O X
sequesters O X
PKC3 I-MISC 173914
in O X
intact O X
cells O X
. O X

Structural O X
information O X
in O X
CKA1 I-MISC 180367
/ O X
CKA1S O X
enables O X
delivery O X
of O X
adapters O X
to O X
the O X
lateral O X
plasma O X
membrane O X
surface O X
( O X
near O X
tight O X
junctions O X
) O X
in O X
polarized O X
epithelial O X
cells O X
. O X

Thus O X
, O X
a O X
PTB O X
domain O X
and O X
PSDs O X
collaborate O X
in O X
a O X
novel O X
fashion O X
in O X
CKA1 I-MISC 180367
/ O X
CKA1S O X
to O X
enable O X
tethering O X
and O X
targeting O X
of O X
PKC3 I-MISC 173914
. O X

Avid O X
ligation O X
of O X
a O X
PKC O X
isoform O X
is O X
a O X
previously O X
unappreciated O X
function O X
for O X
a O X
PTB O X
module O X
. O X

###18688255	51692,53981

Conserved O X
motifs O X
in O X
both O X
CPSF73 I-MISC 51692
and O X
CPSF100 I-MISC 53981
are O X
required O X
to O X
assemble O X
the O X
active O X
endonuclease O X
for O X
histone O X
mRNA O X
3 O X
'- O X
end O X
maturation O X
. O X

In O X
eukaryotes O X
, O X
the O X
process O X
of O X
messenger O X
RNA O X
3 O X
'- O X
end O X
formation O X
involves O X
endonucleolytic O X
cleavage O X
of O X
the O X
transcript O X
followed O X
by O X
synthesis O X
of O X
the O X
poly O X
( O X
A O X
) O X
tail O X
. O X

The O X
complex O X
machinery O X
involved O X
in O X
this O X
maturation O X
process O X
contains O X
two O X
proteins O X
of O X
the O X
metallo O X
- O X
beta O X
- O X
lactamase O X
( O X
MBL O X
) O X
superfamily O X
, O X
the O X
73 O X
and O X
100 O X
kDa O X
subunits O X
of O X
the O X
cleavage O X
and O X
polyadenylation O X
specificity O X
factor O X
( O X
CPSF O X
). O X

By O X
using O X
an O X
in O X
vitro O X
system O X
to O X
assess O X
point O X
mutations O X
in O X
these O X
two O X
mammalian O X
proteins O X
, O X
we O X
found O X
that O X
conserved O X
residues O X
from O X
the O X
MBL O X
motifs O X
of O X
both O X
polypeptides O X
are O X
required O X
for O X
assembly O X
of O X
the O X
endonuclease O X
activity O X
that O X
cleaves O X
histone O X
pre O X
- O X
mRNAs O X
. O X

This O X
indicates O X
that O X
CPSF73 I-MISC 51692
and O X
CPSF100 I-MISC 53981
act O X
together O X
in O X
the O X
process O X
of O X
maturation O X
of O X
eukaryotic O X
pre O X
- O X
messenger O X
RNAs O X
, O X
similar O X
to O X
other O X
members O X
of O X
the O X
MBL O X
family O X
, O X
RNases O X
Z O X
and O X
J O X
, O X
which O X
function O X
as O X
homodimers O X
. O X

###16282325	329,7186	329,56616

Distinct O X
BIR O X
domains O X
of O X
cIAP1 I-MISC 329
mediate O X
binding O X
to O X
and O X
ubiquitination O X
of O X
tumor O X
necrosis O X
factor O X
receptor O X
- O X
associated O X
factor O X
2 O X
and O X
second O X
mitochondrial O X
activator O X
of O X
caspases O X
. O X

Inhibitor O X
of O X
apoptosis O X
proteins O X
( O X
IAPs O X
) O X
regulate O X
apoptosis O X
primarily O X
by O X
inhibiting O X
caspase O X
- O X
family O X
proteases O X
. O X

However O X
, O X
many O X
IAPs O X
also O X
possess O X
E3 O X
ligase O X
( O X
ubiquitin O X
- O X
protein O X
isopeptide O X
ligase O X
) O X
activities O X
implicated O X
in O X
both O X
caspase O X
- O X
dependent O X
and O X
- O X
independent O X
functions O X
of O X
these O X
proteins O X
. O X

Here O X
, O X
we O X
compared O X
the O X
structural O X
features O X
of O X
cIAP1 I-MISC 329
responsible O X
for O X
its O X
interactions O X
with O X
two O X
known O X
target O X
proteins O X
, O X
TRAF2 I-MISC 7186
and O X
SMAC I-MISC 56616
. O X

The O X
N O X
- O X
terminal O X
( O X
BIR1 I-MISC 3763
) O X
and O X
C O X
- O X
terminal O X
( O X
BIR3 O X
) O X
BIR O X
domains O X
of O X
cIAP1 I-MISC 329
were O X
determined O X
to O X
be O X
necessary O X
and O X
sufficient O X
for O X
binding O X
TRAF2 I-MISC 7186
and O X
SMAC I-MISC 56616
, O X
respectively O X
. O X

Mutational O X
analysis O X
of O X
the O X
BIR1 I-MISC 3763
and O X
BIR3 O X
domains O X
identified O X
critical O X
residues O X
required O X
for O X
TRAF2 I-MISC 7186
and O X
SMAC I-MISC 56616
binding O X
. O X

Using O X
these O X
mutants O X
, O X
cIAP1 I-MISC 329
- O X
mediated O X
ubiquitination O X
of O X
TRAF2 I-MISC 7186
and O X
SMAC I-MISC 56616
in O X
vitro O X
was O X
determined O X
to O X
be O X
correspondingly O X
dependent O X
on O X
intact O X
binding O X
sites O X
on O X
BIR1 I-MISC 3763
and O X
BIR3 O X
. O X

Because O X
TRAF2 I-MISC 7186
regulates O X
NF O X
- O X
kappaB O X
activation O X
, O X
the O X
effects O X
of O X
cIAP1 I-MISC 329
on O X
TRAF2 I-MISC 7186
- O X
mediated O X
induction O X
of O X
NF O X
- O X
kappaB O X
transcriptional O X
activity O X
were O X
studied O X
using O X
reporter O X
gene O X
assays O X
. O X

Expression O X
of O X
a O X
fragment O X
of O X
cIAP1 I-MISC 329
encompassing O X
the O X
three O X
BIR O X
domains O X
( O X
but O X
not O X
full O X
- O X
length O X
cIAP1 I-MISC 329
) O X
greatly O X
enhanced O X
TRAF2 I-MISC 7186
- O X
induced O X
increases O X
in O X
NF O X
- O X
kappaB O X
activity O X
, O X
providing O X
a O X
convenient O X
assay O X
for O X
monitoring O X
BIR O X
- O X
dependent O X
effects O X
of O X
cIAP1 I-MISC 329
on O X
TRAF2 I-MISC 7186
in O X
cells O X
. O X

BIR1 I-MISC 3763
mutants O X
of O X
the O X
BIR1 I-MISC 3763
- O X
3 O X
fragment O X
of O X
cIAP1 I-MISC 329
that O X
failed O X
to O X
bind O X
TRAF2 I-MISC 7186
lost O X
the O X
ability O X
to O X
modulate O X
NF O X
- O X
kappaB O X
activity O X
, O X
demonstrating O X
a O X
requirement O X
for O X
BIR1 I-MISC 3763
- O X
mediated O X
interactions O X
with O X
TRAF2 I-MISC 7186
. O X

Altogether O X
, O X
these O X
findings O X
demonstrate O X
the O X
modularity O X
and O X
diversification O X
of O X
BIR O X
domains O X
, O X
showing O X
that O X
a O X
single O X
cIAP O X
can O X
direct O X
its O X
E3 O X
ligase O X
activity O X
toward O X
different O X
substrates O X
and O X
can O X
alter O X
the O X
cellular O X
functions O X
of O X
different O X
protein O X
targets O X
in O X
accordance O X
with O X
differences O X
in O X
the O X
specificity O X
of O X
individual O X
BIR O X
domains O X
. O X

###21209940	15902,17927

A O X
two O X
- O X
hybrid O X
assay O X
to O X
study O X
protein O X
interactions O X
within O X
the O X
secretory O X
pathway O X
. O X

Interactions O X
of O X
transcriptional O X
activators O X
are O X
difficult O X
to O X
study O X
using O X
transcription O X
- O X
based O X
two O X
- O X
hybrid O X
assays O X
due O X
to O X
potent O X
activation O X
resulting O X
in O X
false O X
positives O X
. O X

Here O X
we O X
report O X
the O X
development O X
of O X
the O X
Golgi O X
two O X
- O X
hybrid O X
( O X
G2H O X
), O X
a O X
method O X
that O X
interrogates O X
protein O X
interactions O X
within O X
the O X
Golgi O X
, O X
where O X
transcriptional O X
activators O X
can O X
be O X
assayed O X
with O X
negligible O X
background O X
. O X

The O X
G2H O X
relies O X
on O X
cell O X
surface O X
glycosylation O X
to O X
report O X
extracellularly O X
on O X
protein O X
- O X
protein O X
interactions O X
occurring O X
within O X
the O X
secretory O X
pathway O X
. O X

In O X
the O X
G2H O X
, O X
protein O X
pairs O X
are O X
fused O X
to O X
modular O X
domains O X
of O X
the O X
reporter O X
glycosyltransferase O X
, O X
Och1p O X
, O X
and O X
proper O X
cell O X
wall O X
formation O X
due O X
to O X
Och1p O X
activity O X
is O X
observed O X
only O X
when O X
a O X
pair O X
of O X
proteins O X
interacts O X
. O X

Cells O X
containing O X
interacting O X
protein O X
pairs O X
are O X
identified O X
by O X
selectable O X
phenotypes O X
associated O X
with O X
Och1p O X
activity O X
and O X
proper O X
cell O X
wall O X
formation O X
: O X
cells O X
that O X
have O X
interacting O X
proteins O X
grow O X
under O X
selective O X
conditions O X
and O X
display O X
weak O X
wheat O X
germ O X
agglutinin O X
( O X
WGA O X
) O X
binding O X
by O X
flow O X
cytometry O X
, O X
whereas O X
cells O X
that O X
lack O X
interacting O X
proteins O X
display O X
stunted O X
growth O X
and O X
strong O X
WGA O X
binding O X
. O X

Using O X
this O X
assay O X
, O X
we O X
detected O X
the O X
interaction O X
between O X
transcription O X
factor O X
MyoD I-MISC 17927
and O X
its O X
binding O X
partner O X
Id2 I-MISC 15902
. O X

Interfering O X
mutations O X
along O X
the O X
MyoD I-MISC 17927
: O X
Id2 I-MISC 15902
interaction O X
interface O X
ablated O X
signal O X
in O X
the O X
G2H O X
assay O X
. O X

Furthermore O X
, O X
we O X
used O X
the O X
G2H O X
to O X
detect O X
interactions O X
of O X
the O X
activation O X
domain O X
of O X
Gal4p O X
with O X
a O X
variety O X
of O X
binding O X
partners O X
. O X

Finally O X
, O X
selective O X
conditions O X
were O X
used O X
to O X
enrich O X
for O X
cells O X
encoding O X
interacting O X
partners O X
. O X

The O X
G2H O X
detects O X
protein O X
- O X
protein O X
interactions O X
that O X
cannot O X
be O X
identified O X
via O X
traditional O X
two O X
- O X
hybrid O X
methods O X
and O X
should O X
be O X
broadly O X
useful O X
for O X
probing O X
previously O X
inaccessible O X
subsets O X
of O X
the O X
interactome O X
, O X
including O X
transcriptional O X
activators O X
and O X
proteins O X
that O X
traffic O X
through O X
the O X
secretory O X
pathway O X
. O X

###17280616	79370,9833

Involvement O X
of O X
maternal I-MISC 9833
embryonic I-MISC 9833
leucine I-MISC 9833
zipper I-MISC 9833
kinase I-MISC 9833
( O X
MELK I-MISC 9833
) O X
in O X
mammary O X
carcinogenesis O X
through O X
interaction O X
with O X
Bcl I-MISC 79370
- I-MISC 79370
G I-MISC 79370
, O X
a O X
pro O X
- O X
apoptotic O X
member O X
of O X
the O X
Bcl O X
- O X
2 O X
family O X
. O X

INTRODUCTION O X
: O X
Cancer O X
therapies O X
directed O X
at O X
specific O X
molecular O X
targets O X
in O X
signaling O X
pathways O X
of O X
cancer O X
cells O X
, O X
such O X
as O X
tamoxifen O X
, O X
aromatase O X
inhibitors O X
and O X
trastuzumab O X
, O X
have O X
proven O X
useful O X
for O X
treatment O X
of O X
advanced O X
breast O X
cancers O X
. O X

However O X
, O X
increased O X
risk O X
of O X
endometrial O X
cancer O X
with O X
long O X
- O X
term O X
tamoxifen O X
administration O X
and O X
of O X
bone O X
fracture O X
due O X
to O X
osteoporosis O X
in O X
postmenopausal O X
women O X
undergoing O X
aromatase O X
inhibitor O X
therapy O X
are O X
recognized O X
side O X
effects O X
. O X

These O X
side O X
effects O X
as O X
well O X
as O X
drug O X
resistance O X
make O X
it O X
necessary O X
to O X
search O X
for O X
novel O X
molecular O X
targets O X
for O X
drugs O X
on O X
the O X
basis O X
of O X
well O X
- O X
characterized O X
mechanisms O X
of O X
action O X
. O X

METHODS O X
: O X
Using O X
accurate O X
genome O X
- O X
wide O X
expression O X
profiles O X
of O X
breast O X
cancers O X
, O X
we O X
found O X
maternal I-MISC 9833
embryonic I-MISC 9833
leucine I-MISC 9833
- I-MISC 9833
zipper I-MISC 9833
kinase I-MISC 9833
( O X
MELK I-MISC 9833
) O X
to O X
be O X
significantly O X
overexpressed O X
in O X
the O X
great O X
majority O X
of O X
breast O X
cancer O X
cells O X
. O X

To O X
assess O X
whether O X
MELK I-MISC 9833
has O X
a O X
role O X
in O X
mammary O X
carcinogenesis O X
, O X
we O X
knocked O X
down O X
the O X
expression O X
of O X
endogenous O X
MELK I-MISC 9833
in O X
breast O X
cancer O X
cell O X
lines O X
using O X
mammalian O X
vector O X
- O X
based O X
RNA O X
interference O X
. O X

Furthermore O X
, O X
we O X
identified O X
a O X
long O X
isoform O X
of O X
Bcl I-MISC 79370
- I-MISC 79370
G I-MISC 79370
( O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
), O X
a O X
pro O X
- O X
apoptotic O X
member O X
of O X
the O X
Bcl O X
- O X
2 O X
family O X
, O X
as O X
a O X
possible O X
substrate O X
for O X
MELK I-MISC 9833
by O X
pull O X
- O X
down O X
assay O X
with O X
recombinant O X
wild O X
- O X
type O X
and O X
kinase O X
- O X
dead O X
MELK I-MISC 9833
. O X

Finally O X
, O X
we O X
performed O X
TUNEL O X
assays O X
and O X
FACS O X
analysis O X
, O X
measuring O X
proportions O X
of O X
apoptotic O X
cells O X
, O X
to O X
investigate O X
whether O X
MELK I-MISC 9833
is O X
involved O X
in O X
the O X
apoptosis O X
cascade O X
through O X
the O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
- O X
related O X
pathway O X
. O X

RESULTS O X
: O X
Northern O X
blot O X
analyses O X
on O X
multiple O X
human O X
tissues O X
and O X
cancer O X
cell O X
lines O X
demonstrated O X
that O X
MELK I-MISC 9833
was O X
overexpressed O X
at O X
a O X
significantly O X
high O X
level O X
in O X
a O X
great O X
majority O X
of O X
breast O X
cancers O X
and O X
cell O X
lines O X
, O X
but O X
was O X
not O X
expressed O X
in O X
normal O X
vital O X
organs O X
( O X
heart O X
, O X
liver O X
, O X
lung O X
and O X
kidney O X
). O X

Suppression O X
of O X
MELK I-MISC 9833
expression O X
by O X
small O X
interfering O X
RNA O X
significantly O X
inhibited O X
growth O X
of O X
human O X
breast O X
cancer O X
cells O X
. O X

We O X
also O X
found O X
that O X
MELK I-MISC 9833
physically O X
interacted O X
with O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
through O X
its O X
amino O X
- O X
terminal O X
region O X
. O X

Immunocomplex O X
kinase O X
assay O X
showed O X
that O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
was O X
specifically O X
phosphorylated O X
by O X
MELK I-MISC 9833
in O X
vitro O X
. O X

TUNEL O X
assays O X
and O X
FACS O X
analysis O X
revealed O X
that O X
overexpression O X
of O X
wild O X
- O X
type O X
MELK I-MISC 9833
suppressed O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
- O X
induced O X
apoptosis O X
, O X
while O X
that O X
of O X
D150A O X
- O X
MELK I-MISC 9833
did O X
not O X
. O X

CONCLUSION O X
: O X
Our O X
findings O X
suggest O X
that O X
the O X
kinase O X
activity O X
of O X
MELK I-MISC 9833
is O X
likely O X
to O X
affect O X
mammary O X
carcinogenesis O X
through O X
inhibition O X
of O X
the O X
pro O X
- O X
apoptotic O X
function O X
of O X
Bcl I-MISC 79370
- I-MISC 79370
GL I-MISC 79370
. O X

The O X
kinase O X
activity O X
of O X
MELK I-MISC 9833
could O X
be O X
a O X
promising O X
molecular O X
target O X
for O X
development O X
of O X
therapy O X
for O X
patients O X
with O X
breast O X
cancers O X
. O X

###9012831	12229,2969

BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
, O X
a O X
target O X
for O X
Bruton I-MISC 12229
' I-MISC 12229
s I-MISC 12229
tyrosine I-MISC 12229
kinase I-MISC 12229
in O X
response O X
to O X
B O X
cell O X
receptor O X
engagement O X
. O X

Bruton I-MISC 12229
' I-MISC 12229
s I-MISC 12229
tyrosine I-MISC 12229
kinase I-MISC 12229
( O X
Btk I-MISC 12229
) O X
is O X
essential O X
for O X
B O X
cell O X
activation O X
, O X
but O X
downstream O X
targets O X
of O X
Btk I-MISC 12229
have O X
not O X
been O X
defined O X
. O X

We O X
now O X
describe O X
a O X
protein O X
, O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
, O X
that O X
is O X
associated O X
with O X
Btk I-MISC 12229
in O X
B O X
cells O X
and O X
is O X
a O X
substrate O X
for O X
phosphorylation O X
by O X
Btk I-MISC 12229
. O X

BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
, O X
which O X
exhibits O X
no O X
detectable O X
homology O X
to O X
known O X
proteins O X
, O X
contains O X
six O X
occurrences O X
of O X
a O X
hitherto O X
undescribed O X
amino O X
acid O X
repeat O X
and O X
two O X
motifs O X
, O X
similar O X
to O X
the O X
Src I-MISC 6714
autophosphorylation O X
site O X
, O X
that O X
represent O X
potential O X
targets O X
for O X
tyrosine O X
phosphorylation O X
. O X

The O X
pleckstrin O X
homology O X
domain O X
of O X
Btk I-MISC 12229
comprises O X
the O X
principal O X
site O X
of O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
binding O X
. O X

Btk I-MISC 12229
- O X
dependent O X
phosphorylation O X
of O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
is O X
abolished O X
by O X
mutations O X
that O X
impair O X
activation O X
of O X
Btk I-MISC 12229
by O X
Src I-MISC 6714
- O X
related O X
kinases O X
. O X

Btk I-MISC 12229
and O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
exist O X
in O X
a O X
complex O X
before O X
B I-MISC 613
cell I-MISC 613
antigen I-MISC 613
receptor I-MISC 613
( O X
BCR I-MISC 613
) O X
engagement O X
; O X
in O X
response O X
to O X
BCR I-MISC 613
crosslinking O X
, O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
is O X
transiently O X
phosphorylated O X
on O X
tyrosine O X
. O X

Taken O X
together O X
, O X
these O X
observations O X
suggest O X
that O X
BAP I-MISC 2969
- I-MISC 2969
135 I-MISC 2969
may O X
reside O X
downstream O X
of O X
Btk I-MISC 12229
in O X
a O X
signaling O X
pathway O X
originating O X
at O X
the O X
BCR I-MISC 613
. O X

###21242966	26272,7531

Phosphorylation O X
- O X
dependent O X
regulation O X
of O X
SCF I-MISC 4254
( O X
Fbx4 I-MISC 26272
) O X
dimerization O X
and O X
activity O X
involves O X
a O X
novel O X
component O X
, O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
. O X

Fbx4 I-MISC 26272
is O X
an O X
F O X
- O X
box O X
constituent O X
of O X
Skp I-MISC 4254
- I-MISC 4254
Cullin I-MISC 4254
- I-MISC 4254
F I-MISC 4254
- I-MISC 4254
box I-MISC 4254
( O X
SCF I-MISC 4254
) O X
ubiquitin O X
ligases O X
that O X
directs O X
ubiquitylation O X
of O X
cyclin I-MISC 595
D1 I-MISC 595
. O X

Ubiquitylation O X
of O X
cyclin I-MISC 595
D1 I-MISC 595
requires O X
phosphorylation O X
of O X
both O X
cyclin I-MISC 595
D1 I-MISC 595
and O X
Fbx4 I-MISC 26272
by O X
GSK3b I-MISC 2932
. O X

GSK3b I-MISC 2932
- O X
mediated O X
phosphorylation O X
of O X
Fbx4 I-MISC 26272
Ser12 B-MISC 3190177
during O X
the O X
G1 O X
/ O X
S O X
transition O X
regulates O X
Fbx4 I-MISC 26272
dimerization O X
, O X
which O X
in O X
turn O X
governs O X
Fbx4 I-MISC 26272
- O X
driven O X
E3 O X
ligase O X
activity O X
. O X

In O X
esophageal O X
carcinomas O X
that O X
overexpress O X
cyclin I-MISC 595
D1 I-MISC 595
, O X
Fbx4 I-MISC 26272
is O X
subject O X
to O X
inactivating O X
mutations O X
that O X
specifically O X
disrupt O X
dimerization O X
, O X
highlighting O X
the O X
biological O X
significance O X
of O X
this O X
regulatory O X
mechanism O X
. O X

In O X
an O X
effort O X
to O X
elucidate O X
the O X
mechanisms O X
that O X
regulate O X
dimerization O X
, O X
we O X
sought O X
to O X
identify O X
proteins O X
that O X
differentially O X
bind O X
to O X
wild O X
- O X
type O X
Fbx4 I-MISC 26272
versus O X
a O X
cancer O X
- O X
derived O X
dimerization O X
- O X
deficient O X
mutant O X
. O X

We O X
provide O X
evidence O X
that O X
phosphorylation O X
of O X
Ser12 I-MISC 3190177
generates O X
a O X
docking O X
site O X
for O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
. O X

14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binds O X
to O X
endogenous O X
Fbx4 I-MISC 26272
and O X
this O X
association O X
is O X
impaired O X
by O X
mutations O X
that O X
target O X
either O X
Ser8 O X
or O X
Ser12 I-MISC 3190177
in O X
Fbx4 I-MISC 26272
, O X
suggesting O X
that O X
this O X
N O X
- O X
terminal O X
motif O X
in O X
Fbx4 I-MISC 26272
directs O X
its O X
interaction O X
with O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
. O X

Knockdown O X
of O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
inhibited O X
Fbx4 I-MISC 26272
dimerization O X
, O X
reduced O X
SCF I-MISC 4254
( O X
Fbx4 I-MISC 26272
) O X
E3 O X
ligase O X
activity O X
and O X
stabilized O X
cyclin I-MISC 595
D1 I-MISC 595
. O X

Collectively O X
, O X
the O X
current O X
results O X
suggest O X
a O X
model O X
wherein O X
14 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
- I-MISC 7531
3 I-MISC 7531
binds O X
to O X
Ser12 I-MISC 3190177
- O X
phosphorylated O X
Fbx4 I-MISC 26272
to O X
mediate O X
dimerization O X
and O X
function O X
. O X

###15161910	79858,4751

Nucleolar O X
Nek11 I-MISC 79858
is O X
a O X
novel O X
target O X
of O X
Nek2A I-MISC 4751
in O X
G1 O X
/ O X
S O X
- O X
arrested O X
cells O X
. O X

We O X
previously O X
reported O X
that O X
Nek11 I-MISC 79858
, O X
a O X
member O X
of O X
the O X
NIMA O X
( O X
never O X
- O X
in O X
- O X
mitosis O X
A O X
) O X
family O X
of O X
kinases O X
, O X
is O X
activated O X
in O X
G O X
( O X
1 O X
)/ O X
S O X
- O X
arrested O X
cells O X
. O X

We O X
provide O X
herein O X
several O X
lines O X
of O X
evidence O X
for O X
a O X
novel O X
interaction O X
between O X
Nek11 I-MISC 79858
and O X
Nek2A I-MISC 4751
. O X

Both O X
Nek11 I-MISC 79858
and O X
Nek2A I-MISC 4751
, O X
but O X
not O X
Nek2B O X
, O X
were O X
detected O X
at O X
nucleoli O X
, O X
and O X
the O X
Nek2A I-MISC 4751
- O X
specific O X
C O X
- O X
terminal O X
end O X
( O X
amino O X
acids O X
399 O X
- O X
445 O X
) O X
was O X
responsible O X
for O X
nucleolar O X
localization O X
. O X

Endogenous O X
Nek11 I-MISC 79858
coimmunoprecipitated O X
with O X
endogenous O X
Nek2A I-MISC 4751
, O X
and O X
non O X
- O X
catalytic O X
regions O X
of O X
each O X
kinase O X
were O X
involved O X
in O X
the O X
complex O X
formation O X
. O X

Nek11L O X
interacted O X
with O X
phosphorylated O X
Nek2A I-MISC 4751
but O X
barely O X
with O X
the O X
kinase O X
- O X
inactive O X
Nek2A I-MISC 4751
( O X
K37R O X
) O X
mutant O X
. O X

In O X
addition O X
, O X
both O X
Nek2A I-MISC 4751
autophosphorylation O X
activity O X
and O X
the O X
Nek11L O X
- O X
Nek2A I-MISC 4751
complex O X
formation O X
increased O X
in O X
G O X
( O X
1 O X
)/ O X
S O X
- O X
arrested O X
cells O X
. O X

These O X
results O X
indicate O X
that O X
autophosphorylation O X
of O X
Nek2A I-MISC 4751
could O X
stimulate O X
its O X
interaction O X
with O X
Nek11L O X
at O X
the O X
nucleolus O X
. O X

Moreover O X
, O X
Nek2 I-MISC 4751
directly O X
phosphorylated O X
Nek11 I-MISC 79858
in O X
the O X
C O X
- O X
terminal O X
non O X
- O X
catalytic O X
region O X
and O X
elevated O X
Nek11 I-MISC 79858
kinase O X
activity O X
. O X

The O X
non O X
- O X
catalytic O X
region O X
of O X
Nek11 I-MISC 79858
showed O X
autoinhibitory O X
activity O X
through O X
intramolecular O X
interaction O X
with O X
its O X
N O X
- O X
terminal O X
catalytic O X
domain O X
. O X

Nek2 I-MISC 4751
dissociated O X
this O X
autoinhibitory O X
interaction O X
. O X

Altogether O X
, O X
our O X
studies O X
demonstrate O X
a O X
unique O X
mechanism O X
of O X
Nek11 I-MISC 79858
activation O X
by O X
Nek2A I-MISC 4751
in O X
G O X
( O X
1 O X
)/ O X
S O X
- O X
arrested O X
cells O X
and O X
suggest O X
a O X
novel O X
possibility O X
for O X
nucleolar O X
function O X
of O X
the O X
NIMA O X
family O X
. O X

###16239229	948665,948655

Leu309 O X
plays O X
a O X
critical O X
role O X
in O X
the O X
encapsulation O X
of O X
substrate O X
protein O X
into O X
the O X
internal O X
cavity O X
of O X
GroEL I-MISC 948665
. O X

In O X
the O X
crystal O X
structure O X
of O X
the O X
native O X
GroEL I-MISC 948665
. O X
GroES I-MISC 948655
. O X
substrate O X
protein O X
complex O X
from O X
Thermus O X
thermophilus O X
, O X
one O X
GroEL I-MISC 948665
subunit O X
makes O X
contact O X
with O X
two O X
GroES I-MISC 948655
subunits O X
. O X

One O X
contact O X
is O X
through O X
the O X
H O X
- O X
I O X
helices O X
, O X
and O X
the O X
other O X
is O X
through O X
a O X
novel O X
GXXLE O X
region O X
. O X

The O X
side O X
chain O X
of O X
Leu O X
, O X
in O X
the O X
GXXLE O X
region O X
, O X
forms O X
a O X
hydrophobic O X
cluster O X
with O X
residues O X
of O X
the O X
H O X
helix O X
( O X
Shimamura O X
, O X
T O X
., O X
Koike O X
- O X
Takeshita O X
, O X
A O X
., O X
Yokoyama O X
, O X
K O X
., O X
Masui O X
, O X
R O X
., O X
Murai O X
, O X
N O X
., O X
Yoshida O X
, O X
M O X
., O X
Taguchi O X
, O X
H O X
., O X
and O X
Iwata O X
, O X
S O X
. O X
( O X
2004 O X
) O X
Structure O X
( O X
Camb O X
.) O X

12 O X
, O X
1471 O X
- O X
1480 O X
). O X

Here O X
, O X
we O X
investigated O X
the O X
functional O X
role O X
of O X
Leu O X
in O X
the O X
GXXLE O X
region O X
, O X
using O X
Escherichia O X
coli O X
GroEL I-MISC 948665
. O X

The O X
results O X
are O X
as O X
follows O X
: O X
( O X
i O X
) O X
cross O X
- O X
linking O X
between O X
introduced O X
cysteines O X
confirmed O X
that O X
the O X
GXXLE O X
region O X
in O X
the O X
E O X
. O X
coli O X
GroEL I-MISC 948665
. O X
GroES I-MISC 948655
complex O X
is O X
also O X
in O X
contact O X
with O X
GroES I-MISC 948655
; O X
( O X
ii O X
) O X
when O X
Leu O X
was O X
replaced O X
by O X
Lys O X
( O X
GroEL I-MISC 948665
( O X
L309K O X
)) O X
or O X
other O X
charged O X
residues O X
, O X
chaperone O X
activity O X
was O X
largely O X
lost O X
; O X
( O X
iii O X
) O X
the O X
GroEL I-MISC 948665
( O X
L309K O X
). O X
substrate O X
complex O X
failed O X
to O X
bind O X
GroES I-MISC 948655
to O X
produce O X
a O X
stable O X
GroEL I-MISC 948665
( O X
L309K O X
). O X
GroES I-MISC 948655
. O X
substrate O X
complex O X
, O X
whereas O X
free O X
GroEL I-MISC 948665
( O X
L309K O X
) O X
bound O X
GroES I-MISC 948655
normally O X
; O X
( O X
iv O X
) O X
the O X
GroEL I-MISC 948665
( O X
L309K O X
). O X
GroES I-MISC 948655
. O X
substrate O X
complex O X
was O X
stabilized O X
with O X
BeF O X
( O X
x O X
), O X
but O X
the O X
substrate O X
protein O X
in O X
the O X
complex O X
was O X
readily O X
digested O X
by O X
protease O X
, O X
indicating O X
that O X
it O X
was O X
not O X
properly O X
encapsulated O X
into O X
the O X
internal O X
cavity O X
of O X
the O X
complex O X
. O X

Thus O X
, O X
conformational O X
communication O X
between O X
the O X
two O X
GroES I-MISC 948655
contact O X
sites O X
, O X
the O X
H O X
helix O X
and O X
the O X
GXXLE O X
region O X
( O X
through O X
Leu O X
( O X
309 O X
)), O X
appears O X
to O X
play O X
a O X
critical O X
role O X
in O X
encapsulation O X
of O X
the O X
substrate O X
. O X

###18570893	801,4651	810,4651

Interaction O X
with O X
the O X
IQ3 O X
motif O X
of O X
myosin I-MISC 4628
- I-MISC 4628
10 I-MISC 4628
is O X
required O X
for O X
calmodulin I-MISC 810
- I-MISC 810
like I-MISC 810
protein I-MISC 810
- O X
dependent O X
filopodial O X
extension O X
. O X

Calmodulin I-MISC 810
- I-MISC 810
like I-MISC 810
protein I-MISC 810
( O X
CLP I-MISC 810
) O X
is O X
a O X
specific O X
light O X
chain O X
of O X
unconventional I-MISC 4651
myosin I-MISC 4651
- I-MISC 4651
10 I-MISC 4651
( O X
Myo10 I-MISC 4628
) O X
and O X
enhances O X
Myo10 I-MISC 4628
- O X
dependent O X
filopodial O X
extension O X
. O X

Here O X
we O X
show O X
that O X
phenylalanine O X
- O X
795 O X
in O X
the O X
third O X
IQ O X
domain O X
( O X
IQ3 O X
) O X
of O X
Myo10 I-MISC 4628
is O X
critical O X
for O X
CLP I-MISC 810
binding O X
. O X

Remarkably O X
, O X
mutation O X
of O X
F795 O X
to O X
alanine O X
had O X
little O X
effect O X
on O X
calmodulin I-MISC 801
binding O X
to O X
IQ3 O X
. O X

Fluorescence O X
microscopy O X
and O X
time O X
- O X
lapse O X
video O X
microscopy O X
showed O X
that O X
HeLa O X
cells O X
expressing O X
CLP I-MISC 810
and O X
transiently O X
transfected O X
with O X
GFP O X
- O X
Myo10 I-MISC 4628
- O X
F795A O X
exhibited O X
significantly O X
shorter O X
filopodia O X
and O X
decreased O X
intrafilopodial O X
motility O X
compared O X
to O X
wildtype O X
GFP O X
- O X
Myo10 I-MISC 4628
- O X
transfected O X
cells O X
. O X

Thus O X
, O X
F795 O X
represents O X
a O X
unique O X
anchor O X
for O X
CLP I-MISC 810
and O X
is O X
essential O X
for O X
CLP I-MISC 810
- O X
mediated O X
Myo10 I-MISC 4628
function O X
in O X
filopodial O X
extension O X
and O X
motility O X
. O X

###16775625	5218,7529	5218,7531	5218,7533	5218,10971

A O X
Cdc2 I-MISC 8558
- I-MISC 8558
related I-MISC 8558
protein I-MISC 8558
kinase I-MISC 8558
hPFTAIRE1 I-MISC 5218
from O X
human O X
brain O X
interacting O X
with O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
. O X

hPFTAIRE1 I-MISC 5218
( O X
PFTK1 I-MISC 5218
), O X
a O X
Cdc2 I-MISC 8558
- I-MISC 8558
related I-MISC 8558
protein I-MISC 8558
kinase I-MISC 8558
, O X
is O X
highly O X
expressed O X
in O X
human O X
brain O X
. O X

It O X
exhibits O X
cytoplasmic O X
distribution O X
in O X
Hela O X
cells O X
, O X
although O X
it O X
contains O X
two O X
nuclear O X
localization O X
signals O X
( O X
NLSs O X
) O X
in O X
its O X
N O X
- O X
terminus O X
. O X

To O X
search O X
for O X
its O X
substrates O X
and O X
regulatory O X
components O X
, O X
we O X
screened O X
a O X
two O X
- O X
hybrid O X
library O X
by O X
using O X
the O X
full O X
- O X
length O X
hPFTAIRE1 I-MISC 5218
as O X
a O X
bait O X
. O X

Four I-MISC 1909
14 I-MISC 7529
- I-MISC 7529
3 I-MISC 7529
- I-MISC 7529
3 I-MISC 7529
isoforms I-MISC 7529
( I-MISC 1909
beta I-MISC 1909
, I-MISC 1909
epsilon I-MISC 1909
, I-MISC 1909
eta I-MISC 1909
, O X
tau O X
) O X
were O X
identified O X
interacting O X
with O X
the O X
hPFTAIRE1 I-MISC 5218
. O X

We O X
found O X
a O X
putative O X
14 O X
- O X
3 O X
- O X
3 O X
binding O X
consensus O X
motif O X
( O X
RHSSPSS O X
) O X
in O X
the O X
hPFTAIRE1 I-MISC 5218
, O X
which O X
overlapped O X
with O X
its O X
second O X
NLS O X
. O X

Deletion O X
of O X
the O X
RHSSPSS O X
motif O X
or O X
substitution O X
of O X
Ser119 O X
with O X
Ala O X
in O X
the O X
conserved O X
binding O X
motif O X
abolished O X
the O X
specific O X
interaction O X
between O X
the O X
hPFTAIRE1 I-MISC 5218
and O X
the O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
. O X

The O X
mutant O X
S120A O X
hPFTAIRE1 I-MISC 5218
also O X
showed O X
a O X
weak O X
interaction O X
to O X
the O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
. O X

The O X
results O X
suggested O X
that O X
the O X
Ser119 O X
is O X
crucial O X
for O X
the O X
interaction O X
between O X
hPFTAIRE1 I-MISC 5218
and O X
the O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
. O X

All O X
the O X
hPFTAIRE1 I-MISC 5218
mutants O X
distributed O X
in O X
cytoplasm O X
of O X
Hela O X
cells O X
and O X
human O X
neuroblastoma O X
cells O X
( O X
SH O X
- O X
SY5Y O X
) O X
when O X
fused O X
to O X
the O X
C O X
- O X
terminus O X
of O X
a O X
green O X
fluorescent O X
protein O X
( O X
GFP O X
), O X
indicating O X
that O X
binding O X
with O X
the O X
14 O X
- O X
3 O X
- O X
3 O X
proteins O X
does O X
not O X
contribute O X
to O X
the O X
subcellular O X
localization O X
of O X
the O X
hPFTAIRE1 I-MISC 5218
, O X
although O X
the O X
binding O X
may O X
be O X
involved O X
in O X
its O X
signaling O X
regulation O X
. O X

###20618438	567,3077

N O X
- O X
glycosylation O X
is O X
important O X
for O X
the O X
correct O X
intracellular O X
localization O X
of O X
HFE I-MISC 3077
and O X
its O X
ability O X
to O X
decrease O X
cell O X
surface O X
transferrin I-MISC 7018
binding O X
. O X

HFE I-MISC 3077
is O X
a O X
type O X
1 O X
transmembrane O X
protein O X
that O X
becomes O X
N O X
- O X
glycosylated O X
during O X
transport O X
to O X
the O X
cell O X
membrane O X
. O X

It O X
influences O X
cellular O X
iron O X
concentrations O X
through O X
multiple O X
mechanisms O X
, O X
including O X
regulation O X
of O X
transferrin I-MISC 7018
binding O X
to O X
transferrin I-MISC 7018
receptors O X
. O X

The O X
importance O X
of O X
glycosylation O X
in O X
HFE I-MISC 3077
localization O X
and O X
function O X
has O X
not O X
yet O X
been O X
studied O X
. O X

Here O X
we O X
employed O X
bioinformatics O X
to O X
identify O X
putative O X
N O X
- O X
glycosylation O X
sites O X
at O X
residues O X
N110 O X
, O X
N130 O X
and O X
N234 O X
of O X
the O X
human O X
HFE I-MISC 3077
protein O X
, O X
and O X
used O X
site O X
- O X
directed O X
mutagenesis O X
to O X
create O X
combinations O X
of O X
single O X
, O X
double O X
or O X
triple O X
mutants O X
. O X

Compared O X
with O X
the O X
wild O X
- O X
type O X
protein O X
, O X
which O X
co O X
- O X
localizes O X
with O X
the O X
type O X
1 O X
transferrin I-MISC 7018
receptor O X
in O X
the O X
endosomal O X
recycling O X
compartment O X
and O X
on O X
distributed O X
punctae O X
, O X
the O X
triple O X
mutant O X
co O X
- O X
localized O X
with O X
BiP I-MISC 3309
in O X
the O X
endoplasmic O X
reticulum O X
. O X

This O X
was O X
similar O X
to O X
the O X
localization O X
pattern O X
described O X
previously O X
for O X
the O X
misfolding O X
HFE I-MISC 3077
- O X
C282Y O X
mutant O X
that O X
causes O X
type O X
1 O X
hereditary O X
haemachromatosis O X
. O X

We O X
also O X
observed O X
that O X
the O X
triple O X
mutant O X
was O X
functionally O X
deficient O X
in O X
beta2 I-MISC 567
- I-MISC 567
microglobulin I-MISC 567
interactions O X
and O X
incapable O X
of O X
regulating O X
transferrin I-MISC 7018
binding O X
, O X
once O X
again O X
, O X
reminiscent O X
of O X
the O X
HFE I-MISC 3077
- O X
C282Y O X
variant O X
. O X

Single O X
and O X
double O X
mutants O X
that O X
undergo O X
limited O X
glycosylation O X
appeared O X
to O X
have O X
a O X
mixed O X
phenotype O X
, O X
with O X
characteristics O X
primarily O X
of O X
the O X
wild O X
- O X
type O X
, O X
but O X
also O X
some O X
from O X
the O X
glycosylation O X
- O X
deficient O X
protein O X
. O X

Therefore O X
, O X
although O X
they O X
displayed O X
an O X
endosomal O X
recycling O X
compartment O X
/ O X
punctate O X
localization O X
like O X
the O X
wild O X
- O X
type O X
protein O X
, O X
many O X
cells O X
simultaneously O X
displayed O X
additional O X
reticular O X
localization O X
. O X

Furthermore O X
, O X
although O X
the O X
majority O X
of O X
cells O X
expressing O X
these O X
single O X
and O X
double O X
mutants O X
showed O X
decreased O X
surface O X
binding O X
of O X
transferrin I-MISC 7018
, O X
a O X
number O X
appeared O X
to O X
have O X
lost O X
this O X
ability O X
. O X

We O X
conclude O X
that O X
glycosylation O X
is O X
important O X
for O X
the O X
normal O X
intracellular O X
trafficking O X
and O X
functional O X
activity O X
of O X
HFE I-MISC 3077
. O X

###21122069	280930,280930

Structure O X
- O X
cytotoxicity O X
relationships O X
in O X
bovine O X
seminal I-MISC 280930
ribonuclease I-MISC 280930
: O X
new O X
insights O X
from O X
heat O X
and O X
chemical O X
denaturation O X
studies O X
on O X
variants O X
. O X

Bovine O X
seminal I-MISC 280930
ribonuclease I-MISC 280930
( O X
BS O X
- O X
RNase O X
), O X
a O X
homodimeric O X
protein O X
displaying O X
selective O X
cytotoxicity O X
towards O X
tumor O X
cells O X
, O X
is O X
isolated O X
as O X
a O X
mixture O X
of O X
two O X
isoforms O X
, O X
a O X
dimeric O X
form O X
in O X
which O X
the O X
chains O X
swap O X
their O X
N O X
- O X
termini O X
, O X
and O X
an O X
unswapped O X
dimer O X
. O X

In O X
the O X
cytosolic O X
reducing O X
environment O X
, O X
the O X
dimeric O X
form O X
in O X
which O X
the O X
chains O X
swap O X
their O X
N O X
- O X
termini O X
is O X
converted O X
into O X
a O X
noncovalent O X
dimer O X
( O X
termed O X
NCD O X
), O X
in O X
which O X
the O X
monomers O X
remain O X
intertwined O X
through O X
their O X
N O X
- O X
terminal O X
ends O X
. O X

The O X
quaternary O X
structure O X
renders O X
the O X
reduced O X
protein O X
resistant O X
to O X
the O X
ribonuclease I-MISC 517087
inhibitor I-MISC 517087
, O X
a O X
protein O X
that O X
binds O X
most O X
ribonucleases O X
with O X
very O X
high O X
affinity O X
. O X

On O X
the O X
other O X
hand O X
, O X
upon O X
selective O X
reduction O X
, O X
the O X
unswapped O X
dimer O X
is O X
converted O X
in O X
two O X
monomers O X
, O X
which O X
are O X
readily O X
bound O X
and O X
inactivated O X
by O X
the O X
ribonuclease I-MISC 517087
inhibitor I-MISC 517087
. O X

On O X
the O X
basis O X
of O X
these O X
considerations O X
, O X
it O X
has O X
been O X
proposed O X
that O X
the O X
cytotoxic O X
activity O X
of O X
BS O X
- O X
RNase O X
relies O X
on O X
the O X
3D O X
structure O X
and O X
stability O X
of O X
its O X
NCD O X
derivative O X
. O X

Here O X
, O X
we O X
report O X
a O X
comparison O X
of O X
the O X
thermodynamic O X
and O X
chemical O X
stability O X
of O X
the O X
NCD O X
form O X
of O X
BS O X
- O X
RNase O X
with O X
that O X
of O X
the O X
monomeric O X
derivative O X
, O X
together O X
with O X
an O X
investigation O X
of O X
the O X
thermal O X
dissociation O X
mechanism O X
revealing O X
the O X
presence O X
of O X
a O X
dimeric O X
intermediate O X
. O X

In O X
addition O X
, O X
we O X
report O X
that O X
the O X
replacement O X
of O X
of O X
Arg80 O X
by O X
Ser O X
significantly O X
decreases O X
the O X
cytotoxic O X
activity O X
of O X
BS O X
- O X
RNase O X
and O X
the O X
stability O X
of O X
the O X
NCD O X
form O X
with O X
respect O X
to O X
the O X
parent O X
protein O X
, O X
but O X
does O X
not O X
affect O X
the O X
ribonucleolytic O X
activity O X
or O X
the O X
dissociation O X
mechanism O X
. O X

The O X
data O X
show O X
the O X
importance O X
of O X
Arg80 O X
for O X
the O X
cytotoxicity O X
of O X
BS O X
- O X
RNase O X
, O X
and O X
also O X
support O X
the O X
hypothesis O X
that O X
the O X
reduced O X
derivative O X
of O X
BS O X
- O X
RNase O X
is O X
responsible O X
for O X
its O X
cytotoxic O X
activity O X
. O X

###18974936	830015,843296

Stress O X
induced O X
and O X
nuclear O X
localized O X
HIPP26 I-MISC 830015
from O X
Arabidopsis O X
thaliana O X
interacts O X
via O X
its O X
heavy O X
metal O X
associated O X
domain O X
with O X
the O X
drought O X
stress O X
related O X
zinc O X
finger O X
transcription O X
factor O X
ATHB29 I-MISC 843296
. O X

HIPP26 I-MISC 830015
from O X
Arabidopsis O X
thaliana O X
belongs O X
to O X
a O X
novel O X
class O X
of O X
plant O X
proteins O X
, O X
characterized O X
by O X
a O X
heavy O X
metal O X
associated O X
domain O X
and O X
an O X
additional O X
isoprenylation O X
motif O X
. O X

It O X
is O X
induced O X
during O X
cold O X
, O X
salt O X
and O X
drought O X
stress O X
. O X

The O X
nuclear O X
localization O X
of O X
HIPP26 I-MISC 830015
, O X
predicted O X
by O X
a O X
NLS O X
motif O X
, O X
could O X
be O X
confirmed O X
in O X
onion O X
epidermal O X
cells O X
overexpressing O X
GFP O X
- O X
HIPP26 I-MISC 830015
. O X

Experiments O X
with O X
modified O X
HIPP26 I-MISC 830015
indicate O X
that O X
the O X
isoprenylation O X
plays O X
a O X
role O X
in O X
the O X
spatial O X
distribution O X
in O X
the O X
nucleus O X
. O X

Using O X
promoter O X
- O X
GUS O X
constructs O X
, O X
a O X
tissue O X
specific O X
expression O X
pattern O X
of O X
HIPP26 I-MISC 830015
could O X
be O X
shown O X
, O X
with O X
high O X
expression O X
in O X
the O X
vascular O X
tissue O X
. O X

By O X
a O X
yeast O X
- O X
two O X
- O X
hybrid O X
approach O X
a O X
strong O X
interaction O X
of O X
HIPP26 I-MISC 830015
with O X
the O X
zinc O X
finger O X
homeodomain O X
transcription O X
factor O X
ATHB29 I-MISC 843296
, O X
which O X
is O X
known O X
to O X
play O X
a O X
role O X
in O X
dehydration O X
stress O X
response O X
could O X
be O X
detected O X
. O X

This O X
was O X
confirmed O X
by O X
GST O X
pull O X
- O X
down O X
assays O X
. O X

When O X
using O X
a O X
modified O X
HIPP26 I-MISC 830015
lacking O X
the O X
two O X
central O X
cysteines O X
of O X
the O X
heavy O X
metal O X
associated O X
domain O X
, O X
ATHB29 I-MISC 843296
was O X
not O X
bound O X
in O X
the O X
GST O X
pull O X
- O X
down O X
assay O X
, O X
indicating O X
that O X
this O X
structure O X
is O X
necessary O X
for O X
the O X
interaction O X
. O X

Further O X
yeast O X
- O X
two O X
- O X
hybrid O X
analyses O X
testing O X
interaction O X
of O X
different O X
members O X
of O X
the O X
HIPP O X
family O X
with O X
related O X
zinc O X
finger O X
transcription O X
factors O X
revealed O X
a O X
specific O X
interaction O X
of O X
ATHB29 I-MISC 843296
with O X
several O X
HIPP O X
proteins O X
. O X

A O X
functional O X
relationship O X
between O X
HIPP26 I-MISC 830015
and O X
ATHB29 I-MISC 843296
is O X
also O X
indicated O X
by O X
experiments O X
with O X
mutants O X
of O X
HIPP26 I-MISC 830015
showing O X
altered O X
expression O X
levels O X
of O X
such O X
genes O X
known O X
to O X
be O X
regulated O X
by O X
ATHB29 I-MISC 843296
. O X

###12917342	6602,24413

BAF60a I-MISC 6602
mediates O X
critical O X
interactions O X
between O X
nuclear O X
receptors O X
and O X
the O X
BRG1 I-MISC 6597
chromatin O X
- O X
remodeling O X
complex O X
for O X
transactivation O X
. O X

Nuclear O X
hormone O X
receptors O X
are O X
ligand O X
- O X
dependent O X
transcriptional O X
regulators O X
that O X
modulate O X
chromatin O X
structure O X
. O X

However O X
, O X
the O X
precise O X
molecular O X
mechanisms O X
by O X
which O X
receptors O X
recruit O X
chromatin O X
- O X
remodeling O X
activity O X
are O X
not O X
fully O X
elucidated O X
. O X

We O X
show O X
that O X
in O X
the O X
absence O X
of O X
its O X
ligand O X
- O X
binding O X
domain O X
, O X
the O X
glucocorticoid I-MISC 24413
receptor I-MISC 24413
( O X
GR I-MISC 24413
) O X
is O X
able O X
to O X
interact O X
with O X
both O X
nuclear O X
receptor O X
coactivators O X
and O X
the O X
BRG1 I-MISC 6597
chromatin O X
- O X
remodeling O X
complex O X
in O X
vivo O X
. O X

Individually O X
, O X
the O X
GR I-MISC 24413
makes O X
direct O X
interactions O X
with O X
BRG1 I-MISC 6602
- I-MISC 6602
associated I-MISC 6602
factor I-MISC 6602
60a I-MISC 6602
( O X
BAF60a I-MISC 6602
) O X
and O X
BAF57 I-MISC 6605
, O X
but O X
not O X
with O X
BRG1 I-MISC 6597
, O X
BAF155 I-MISC 6599
, O X
or O X
BAF170 I-MISC 6601
. O X

Further O X
, O X
BAF60a I-MISC 6602
possesses O X
at O X
least O X
two O X
interaction O X
surfaces O X
, O X
one O X
for O X
GR I-MISC 24413
and O X
BRG1 I-MISC 6597
and O X
a O X
second O X
for O X
BAF155 I-MISC 6599
and O X
BAF170 I-MISC 6601
. O X

A O X
GR I-MISC 24413
mutant O X
, O X
GR I-MISC 24413
( O X
R488Q O X
), O X
that O X
fails O X
to O X
interact O X
with O X
BAF60a I-MISC 6602
in O X
vitro O X
has O X
reduced O X
chromatin O X
- O X
remodeling O X
activity O X
and O X
reduced O X
transcriptional O X
activity O X
from O X
the O X
promoter O X
assembled O X
as O X
chromatin O X
in O X
vivo O X
. O X

Stable O X
expression O X
of O X
a O X
BAF60a I-MISC 6602
truncation O X
mutant O X
, O X
BAF60a4 O X
- O X
140 O X
, O X
caused O X
chromatin O X
- O X
specific O X
loss O X
of O X
GR I-MISC 24413
functions O X
in O X
vivo O X
. O X

In O X
the O X
presence O X
of O X
the O X
BAF60a I-MISC 6602
mutant O X
, O X
the O X
GR I-MISC 24413
fails O X
to O X
interact O X
with O X
the O X
BRG1 I-MISC 6597
complex O X
and O X
consequently O X
is O X
also O X
deficient O X
in O X
its O X
ability O X
to O X
activate O X
transcription O X
from O X
chromatin O X
. O X

Thus O X
, O X
in O X
addition O X
to O X
previously O X
identified O X
BAF250 I-MISC 8289
, O X
BAF60a I-MISC 6602
may O X
provide O X
another O X
critical O X
and O X
direct O X
link O X
between O X
nuclear O X
receptors O X
and O X
the O X
BRG1 I-MISC 6597
complex O X
that O X
is O X
required O X
for O X
promoter O X
recruitment O X
and O X
subsequent O X
chromatin O X
remodeling O X
. O X

###16443932	19,998

Apolipoprotein I-MISC 335
A I-MISC 335
- I-MISC 335
I I-MISC 335
activates O X
Cdc42 I-MISC 998
signaling O X
through O X
the O X
ABCA1 I-MISC 19
transporter O X
. O X

It O X
has O X
been O X
suggested O X
that O X
the O X
signal O X
transduction O X
initiated O X
by O X
apolipoprotein I-MISC 335
A I-MISC 335
- I-MISC 335
I I-MISC 335
( O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
) O X
activates O X
key O X
proteins O X
involved O X
in O X
cholesterol O X
efflux O X
. O X

ABCA1 I-MISC 19
serves O X
as O X
a O X
binding O X
partner O X
for O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
, O X
but O X
its O X
participation O X
in O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
- O X
induced O X
signaling O X
remains O X
uncertain O X
. O X

We O X
show O X
that O X
the O X
exposure O X
of O X
human O X
fibroblasts O X
to O X
ABCA1 I-MISC 19
ligands O X
( O X
apolipoproteins O X
and O X
amphipathic O X
helical O X
peptides O X
) O X
results O X
in O X
the O X
generation O X
of O X
intracellular O X
signals O X
, O X
including O X
activation O X
of O X
the O X
small O X
G O X
- O X
protein O X
Cdc42 I-MISC 998
, O X
protein O X
kinases O X
( O X
PAK I-MISC 5058
- I-MISC 5058
1 I-MISC 5058
and O X
p54JNK O X
), O X
and O X
actin O X
polymerization O X
. O X

ApoA I-MISC 335
- I-MISC 335
I I-MISC 335
- O X
induced O X
signaling O X
was O X
abrogated O X
by O X
glyburide O X
, O X
an O X
inhibitor O X
of O X
the O X
ABC O X
transporter O X
family O X
, O X
and O X
in O X
fibroblasts O X
from O X
patients O X
with O X
Tangier O X
disease O X
, O X
which O X
do O X
not O X
express O X
ABCA1 I-MISC 19
. O X

Conversely O X
, O X
induction O X
of O X
ABCA1 I-MISC 19
expression O X
with O X
the O X
liver O X
X O X
receptor O X
agonist O X
, O X
T0901317 O X
, O X
and O X
the O X
retinoid I-MISC 6256
X I-MISC 6256
receptor I-MISC 6256
agonist O X
, O X
R0264456 O X
, O X
potentiated O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
- O X
induced O X
signaling O X
. O X

Similar O X
effects O X
were O X
observed O X
in O X
HEK293 O X
cells O X
overexpressing O X
ABCA1 I-MISC 19
- O X
green O X
fluorescent O X
protein O X
( O X
GFP O X
) O X
fusion O X
protein O X
, O X
but O X
not O X
ABCA1 I-MISC 19
- O X
GFP O X
( O X
K939M O X
), O X
which O X
fails O X
to O X
hydrolyze O X
ATP O X
, O X
or O X
a O X
nonfunctional O X
ABCA1 I-MISC 19
- O X
GFP O X
with O X
a O X
truncated O X
C O X
terminus O X
. O X

We O X
further O X
found O X
that O X
Cdc42 I-MISC 998
coimmunoprecipitates O X
with O X
ABCA1 I-MISC 19
in O X
ABCA1 I-MISC 19
- O X
GFP O X
- O X
expressing O X
HEK293 O X
cells O X
exposed O X
to O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
but O X
not O X
in O X
cells O X
expressing O X
ABCA1 I-MISC 19
mutants O X
. O X

We O X
conclude O X
that O X
ABCA1 I-MISC 19
transduces O X
signals O X
from O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
by O X
complexing O X
and O X
activating O X
Cdc42 I-MISC 998
and O X
downstream O X
kinases O X
and O X
, O X
therefore O X
, O X
acts O X
as O X
a O X
full O X
apoA I-MISC 335
- I-MISC 335
I I-MISC 335
receptor O X
. O X

###11971877	9051,5782

Mutations O X
in O X
CD2BP1 I-MISC 9051
disrupt O X
binding O X
to O X
PTP I-MISC 5782
PEST I-MISC 5782
and O X
are O X
responsible O X
for O X
PAPA O X
syndrome O X
, O X
an O X
autoinflammatory O X
disorder O X
. O X

PAPA O X
syndrome O X
( O X
pyogenic O X
sterile O X
arthritis O X
, O X
pyoderma O X
gangrenosum O X
, O X
and O X
acne O X
, O X
OMIM O X
# O X
604416 O X
) O X
and O X
familial O X
recurrent O X
arthritis O X
( O X
FRA O X
) O X
are O X
rare O X
inherited O X
disorders O X
of O X
early O X
onset O X
, O X
primarily O X
affecting O X
skin O X
and O X
joint O X
tissues O X
. O X

Recurring O X
inflammatory O X
episodes O X
lead O X
to O X
accumulation O X
of O X
sterile O X
, O X
pyogenic O X
, O X
neutrophil O X
- O X
rich O X
material O X
within O X
the O X
affected O X
joints O X
, O X
ultimately O X
resulting O X
in O X
significant O X
destruction O X
. O X

We O X
recently O X
localized O X
the O X
genes O X
for O X
PAPA O X
syndrome O X
and O X
FRA O X
to O X
chromosome O X
15q O X
and O X
suggested O X
that O X
they O X
are O X
the O X
same O X
disorder O X
. O X

We O X
have O X
now O X
established O X
this O X
by O X
the O X
identification O X
of O X
co O X
- O X
segregating O X
disease O X
- O X
causing O X
mutations O X
in O X
the O X
CD2 I-MISC 9051
- I-MISC 9051
binding I-MISC 9051
protein I-MISC 9051
1 I-MISC 9051
( O X
CD2BP1 I-MISC 9051
; O X
GenBank O X
accession O X
no O X
XM O X
044569 O X
) O X
gene O X
in O X
the O X
two O X
reported O X
families O X
with O X
this O X
disorder O X
. O X

E250Q O X
or O X
A230T O X
amino O X
acid O X
substitutions O X
occur O X
within O X
a O X
domain O X
highly O X
homologous O X
to O X
yeast O X
cleavage O X
furrow O X
- O X
associated O X
protein O X
CDC15 I-MISC 851274
. O X

CD2BP1 I-MISC 9051
and O X
its O X
murine O X
ortholog O X
, O X
proline I-MISC 9051
- I-MISC 9051
serine I-MISC 9051
- I-MISC 9051
threonine I-MISC 9051
phosphatase I-MISC 9051
interacting I-MISC 9051
protein I-MISC 9051
( O X
PSTPIP1 I-MISC 9051
), O X
are O X
adaptor O X
proteins O X
known O X
to O X
interact O X
with O X
PEST O X
- O X
type O X
protein O X
tyrosine O X
phosphatases O X
( O X
PTP O X
). O X

Yeast O X
two O X
- O X
hybrid O X
assays O X
demonstrate O X
severely O X
reduced O X
binding O X
between O X
PTP I-MISC 5782
PEST I-MISC 5782
and O X
both O X
the O X
E250Q O X
and O X
A230T O X
mutant O X
proteins O X
. O X

Previous O X
evidence O X
supports O X
the O X
integral O X
role O X
of O X
CD2BP1 I-MISC 9051
and O X
its O X
interacting O X
proteins O X
in O X
actin O X
reorganization O X
during O X
cytoskeletal O X
- O X
mediated O X
events O X
. O X

We O X
hypothesize O X
that O X
the O X
disease O X
- O X
causing O X
mutations O X
that O X
we O X
have O X
identified O X
compromise O X
physiologic O X
signaling O X
necessary O X
for O X
the O X
maintenance O X
of O X
proper O X
inflammatory O X
response O X
. O X

Accordingly O X
we O X
suggest O X
classification O X
of O X
PAPA O X
syndrome O X
as O X
an O X
autoinflammatory O X
disease O X
. O X

This O X
CD2BP1 I-MISC 9051
- O X
mediated O X
biochemical O X
pathway O X
( O X
s O X
) O X
may O X
function O X
in O X
common O X
inflammatory O X
disorders O X
with O X
apparent O X
etiological O X
overlap O X
, O X
such O X
as O X
rheumatoid O X
arthritis O X
and O X
inflammatory O X
bowel O X
disease O X
. O X

###10837255	853100,852794	854191,852794

Complex O X
formation O X
between O X
Mad1p I-MISC 852794
, O X
Bub1p I-MISC 853100
and O X
Bub3p I-MISC 854191
is O X
crucial O X
for O X
spindle O X
checkpoint O X
function O X
. O X

The O X
spindle O X
checkpoint O X
delays O X
the O X
metaphase O X
to O X
anaphase O X
transition O X
in O X
response O X
to O X
defects O X
in O X
kinetochore O X
- O X
microtubule O X
interactions O X
in O X
the O X
mitotic O X
apparatus O X
( O X
see O X
[ O X
1 O X
] O X
[ O X
2 O X
] O X
[ O X
3 O X
] O X
[ O X
4 O X
] O X
for O X
reviews O X
). O X

The O X
Mad O X
and O X
Bub O X
proteins O X
were O X
identified O X
as O X
key O X
components O X
of O X
the O X
spindle O X
checkpoint O X
through O X
budding O X
yeast O X
genetics O X
[ O X
5 O X
] O X
[ O X
6 O X
] O X
and O X
are O X
highly O X
conserved O X
[ O X
3 O X
]. O X

Most O X
of O X
the O X
spindle O X
checkpoint O X
proteins O X
have O X
been O X
localised O X
to O X
kinetochores O X
, O X
yet O X
almost O X
nothing O X
is O X
known O X
about O X
the O X
molecular O X
events O X
which O X
take O X
place O X
there O X
. O X

Mad1p I-MISC 852794
forms O X
a O X
tight O X
complex O X
with O X
Mad2p I-MISC 853422
[ O X
7 O X
], O X
and O X
has O X
been O X
shown O X
to O X
recruit O X
Mad2p I-MISC 853422
to O X
kinetochores O X
[ O X
8 O X
]. O X

Similarly O X
, O X
Bub3p I-MISC 854191
binds O X
to O X
Bub1p I-MISC 853100
[ O X
9 O X
] O X
and O X
may O X
target O X
it O X
to O X
kinetochores O X
[ O X
10 O X
]. O X

Here O X
, O X
we O X
show O X
that O X
budding O X
yeast O X
Mad1p I-MISC 852794
has O X
a O X
regulated O X
association O X
with O X
Bub1p I-MISC 853100
and O X
Bub3p I-MISC 854191
during O X
a O X
normal O X
cell O X
cycle O X
and O X
that O X
this O X
complex O X
is O X
found O X
at O X
significantly O X
higher O X
levels O X
once O X
the O X
spindle O X
checkpoint O X
is O X
activated O X
. O X

We O X
find O X
that O X
formation O X
of O X
this O X
complex O X
requires O X
Mad2p I-MISC 853422
and O X
Mps1p I-MISC 851533
but O X
not O X
Mad3p I-MISC 853439
or O X
Bub2p I-MISC 855077
. O X

In O X
addition O X
, O X
we O X
identify O X
a O X
conserved O X
motif O X
within O X
Mad1p I-MISC 852794
that O X
is O X
essential O X
for O X
Mad1p I-MISC 852794
- O X
Bub1p I-MISC 853100
- O X
Bub3p I-MISC 854191
complex O X
formation O X
. O X

Mutation O X
of O X
this O X
motif O X
abolishes O X
checkpoint O X
function O X
, O X
indicating O X
that O X
formation O X
of O X
the O X
Mad1p I-MISC 852794
- O X
Bub1p I-MISC 853100
- O X
Bub3p I-MISC 854191
complex O X
is O X
a O X
crucial O X
step O X
in O X
the O X
spindle O X
checkpoint O X
mechanism O X
. O X

###11226162	817857,830996

Identification O X
of O X
a O X
structural O X
motif O X
that O X
confers O X
specific O X
interaction O X
with O X
the O X
WD40 O X
repeat O X
domain O X
of O X
Arabidopsis O X
COP1 I-MISC 817857
. O X

Arabidopsis O X
COP1 I-MISC 817857
is O X
a O X
photomorphogenesis O X
repressor O X
capable O X
of O X
directly O X
interacting O X
with O X
the O X
photomorphogenesis O X
- O X
promoting O X
factor O X
HY5 I-MISC 830996
. O X

This O X
interaction O X
between O X
HY5 I-MISC 830996
and O X
COP1 I-MISC 817857
results O X
in O X
targeted O X
deg O X
radation O X
of O X
HY5 I-MISC 830996
by O X
the O X
26S O X
proteasome O X
. O X

Here O X
we O X
characterized O X
the O X
WD40 O X
repeat O X
domain O X
- O X
mediated O X
interactions O X
of O X
COP1 I-MISC 817857
with O X
HY5 I-MISC 830996
and O X
two O X
new O X
proteins O X
. O X

Mutational O X
analysis O X
of O X
those O X
interactive O X
partners O X
revealed O X
a O X
conserved O X
motif O X
responsible O X
for O X
the O X
interaction O X
with O X
the O X
WD40 O X
domain O X
. O X

This O X
novel O X
motif O X
, O X
with O X
the O X
core O X
sequence O X
V O X
- O X
P O X
- O X
E O X
/ O X
D O X
- O X
_ O X
- O X
G O X
( O X
_ O X
= O X
hydrophobic O X
residue O X
) O X
in O X
conjunction O X
with O X
an O X
upstream O X
stretch O X
of O X
4 O X
- O X
5 O X
negatively O X
charged O X
residues O X
, O X
interacts O X
with O X
a O X
defined O X
surface O X
area O X
of O X
the O X
ss O X
- O X
propeller O X
assembly O X
of O X
the O X
COP1 I-MISC 817857
WD40 O X
repeat O X
domain O X
through O X
both O X
hydrophobic O X
and O X
ionic O X
interactions O X
. O X

Several O X
residues O X
in O X
the O X
COP1 I-MISC 817857
WD40 O X
domain O X
that O X
are O X
critical O X
for O X
the O X
interaction O X
with O X
this O X
motif O X
have O X
been O X
revealed O X
. O X

The O X
fact O X
that O X
point O X
mutations O X
either O X
in O X
the O X
COP1 I-MISC 817857
WD40 O X
domain O X
or O X
in O X
the O X
HY5 I-MISC 830996
motif O X
that O X
abolish O X
the O X
interaction O X
between O X
COP1 I-MISC 817857
and O X
HY5 I-MISC 830996
in O X
yeast O X
result O X
in O X
a O X
dramatic O X
reduction O X
of O X
HY5 I-MISC 830996
degradation O X
in O X
transgenic O X
plants O X
validates O X
the O X
biological O X
significance O X
of O X
this O X
defined O X
interaction O X
. O X

###11283256	8476,8476

Intermolecular O X
and O X
intramolecular O X
interactions O X
regulate O X
catalytic O X
activity O X
of O X
myotonic I-MISC 8476
dystrophy I-MISC 8476
kinase I-MISC 8476
- I-MISC 8476
related I-MISC 8476
Cdc42 I-MISC 8476
- I-MISC 8476
binding I-MISC 8476
kinase I-MISC 8476
alpha I-MISC 8476
. O X

Myotonic I-MISC 8476
dystrophy I-MISC 8476
kinase I-MISC 8476
- I-MISC 8476
related I-MISC 8476
Cdc42 I-MISC 8476
- I-MISC 8476
binding I-MISC 8476
kinase I-MISC 8476
( O X
MRCK I-MISC 8476
) O X
is O X
a O X
Cdc42 I-MISC 998
- O X
binding O X
serine O X
/ O X
threonine O X
kinase O X
with O X
multiple O X
functional O X
domains O X
. O X

We O X
had O X
previously O X
shown O X
MRCKalpha I-MISC 8476
to O X
be O X
implicated O X
in O X
Cdc42 I-MISC 998
- O X
mediated O X
peripheral O X
actin O X
formation O X
and O X
neurite O X
outgrowth O X
in O X
HeLa O X
and O X
PC12 O X
cells O X
, O X
respectively O X
. O X

Here O X
we O X
demonstrate O X
that O X
native O X
MRCK I-MISC 8476
exists O X
in O X
high O X
- O X
molecular O X
- O X
weight O X
complexes O X
. O X

We O X
further O X
show O X
that O X
the O X
three O X
independent O X
coiled O X
- O X
coil O X
( O X
CC O X
) O X
domains O X
and O X
the O X
N O X
- O X
terminal O X
region O X
preceding O X
the O X
kinase O X
domain O X
are O X
responsible O X
for O X
intermolecular O X
interactions O X
leading O X
to O X
MRCKalpha I-MISC 8476
multimerization O X
. O X

N O X
terminus O X
- O X
mediated O X
dimerization O X
and O X
consequent O X
transautophosphorylation O X
are O X
critical O X
processes O X
regulating O X
MRCKalpha I-MISC 8476
catalytic O X
activities O X
. O X

A O X
region O X
containing O X
the O X
two O X
distal O X
CC O X
domains O X
( O X
CC2 O X
and O X
CC3 O X
; O X
residues O X
658 O X
to O X
930 O X
) O X
was O X
found O X
to O X
interact O X
intramolecularly O X
with O X
the O X
kinase O X
domain O X
and O X
negatively O X
regulates O X
its O X
activity O X
. O X

Its O X
deletion O X
also O X
resulted O X
in O X
an O X
active O X
kinase O X
, O X
confirming O X
a O X
negative O X
autoregulatory O X
role O X
. O X

We O X
provide O X
evidence O X
that O X
the O X
N O X
terminus O X
- O X
mediated O X
dimerization O X
and O X
activation O X
of O X
MRCK I-MISC 8476
and O X
the O X
negative O X
autoregulatory O X
kinase O X
- O X
distal O X
CC O X
interaction O X
are O X
two O X
mutually O X
exclusive O X
events O X
that O X
tightly O X
regulate O X
the O X
catalytic O X
state O X
of O X
the O X
kinase O X
. O X

Disruption O X
of O X
this O X
interaction O X
by O X
a O X
mutant O X
kinase O X
domain O X
resulted O X
in O X
increased O X
kinase O X
activity O X
. O X

MRCK I-MISC 8476
kinase O X
activity O X
was O X
also O X
elevated O X
when O X
cells O X
were O X
treated O X
with O X
phorbol O X
ester O X
, O X
which O X
can O X
interact O X
directly O X
with O X
a O X
cysteine O X
- O X
rich O X
domain O X
next O X
to O X
the O X
distal O X
CC O X
domain O X
. O X

We O X
therefore O X
suggest O X
that O X
binding O X
of O X
phorbol O X
ester O X
to O X
MRCK I-MISC 8476
releases O X
its O X
autoinhibition O X
, O X
allowing O X
N O X
- O X
terminal O X
dimerization O X
and O X
subsequent O X
kinase O X
activation O X
. O X

###17314099	4830,11171

NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
tumor O X
suppressor O X
physically O X
interacts O X
with O X
serine I-MISC 11171
- I-MISC 11171
threonine I-MISC 11171
kinase I-MISC 11171
receptor I-MISC 11171
- I-MISC 11171
associated I-MISC 11171
protein I-MISC 11171
, O X
a O X
transforming I-MISC 7040
growth I-MISC 7040
factor I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
( O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
) O X
receptor O X
- O X
interacting O X
protein O X
, O X
and O X
negatively O X
regulates O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
signaling O X
. O X

NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
is O X
a O X
member O X
of O X
the O X
NM23 I-MISC 4830
/ O X
NDP O X
kinase O X
gene O X
family O X
and O X
a O X
putative O X
metastasis O X
suppressor O X
. O X

Previously O X
, O X
a O X
screen O X
for O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
- O X
interacting O X
proteins O X
that O X
could O X
potentially O X
modulate O X
its O X
activity O X
identified O X
serine I-MISC 11171
- I-MISC 11171
threonine I-MISC 11171
kinase I-MISC 11171
receptor I-MISC 11171
- I-MISC 11171
associated I-MISC 11171
protein I-MISC 11171
( O X
STRAP I-MISC 11171
), O X
a O X
transforming O X
growth O X
factor O X
( O X
TGF O X
)- O X
beta O X
receptor O X
- O X
interacting O X
protein O X
. O X

Through O X
the O X
use O X
of O X
cysteine O X
to O X
serine O X
amino O X
acid O X
substitution O X
mutants O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
( O X
C4S I-MISC 720
, O X
C109S O X
, O X
and O X
C145S O X
) O X
and O X
STRAP I-MISC 11171
( O X
C152S O X
, O X
C270S O X
, O X
and O X
C152S O X
/ O X
C270S O X
), O X
we O X
demonstrated O X
that O X
the O X
association O X
between O X
these O X
two O X
proteins O X
is O X
dependent O X
on O X
Cys O X
( O X
145 O X
) O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
and O X
Cys O X
( O X
152 O X
) O X
and O X
Cys O X
( O X
270 O X
) O X
of O X
STRAP I-MISC 11171
but O X
did O X
not O X
appear O X
to O X
involve O X
Cys O X
( O X
4 O X
) O X
and O X
Cys O X
( O X
109 O X
) O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
, O X
suggesting O X
that O X
a O X
disulfide O X
linkage O X
involving O X
Cys O X
( O X
145 O X
) O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
and O X
Cys O X
( O X
152 O X
) O X
or O X
Cys O X
( O X
270 O X
) O X
of O X
STRAP I-MISC 11171
mediates O X
complex O X
formation O X
. O X

The O X
interaction O X
was O X
dependent O X
on O X
the O X
presence O X
of O X
dithiothreitol O X
or O X
beta O X
- O X
mercaptoethanol O X
but O X
not O X
H O X
( O X
2 O X
) O X
O O X
( O X
2 O X
). O X

Ectopic O X
expression O X
of O X
wild O X
- O X
type O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
, O X
but O X
not O X
NM23 I-MISC 4830
- O X
H1 O X
( O X
C145S O X
), O X
negatively O X
regulated O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
signaling O X
in O X
a O X
dose O X
- O X
dependent O X
manner O X
, O X
enhanced O X
stable O X
association O X
between O X
the O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
receptor O X
and O X
Smad7 I-MISC 4092
, O X
and O X
prevented O X
nuclear O X
translocation O X
of O X
Smad3 I-MISC 4088
. O X

Similarly O X
, O X
wild O X
- O X
type O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
inhibited O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
- O X
induced O X
apoptosis O X
and O X
growth O X
inhibition O X
, O X
whereas O X
NM23 I-MISC 4830
- O X
H1 O X
( O X
C145S O X
) O X
had O X
no O X
effect O X
. O X

Knockdown O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
by O X
small O X
interfering O X
RNA O X
stimulated O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
signaling O X
. O X

Coexpression O X
of O X
wild O X
- O X
type O X
STRAP I-MISC 11171
, O X
but O X
not O X
STRAP I-MISC 11171
( O X
C152S O X
/ O X
C270S O X
), O X
significantly O X
stimulated O X
NM23 I-MISC 4830
- O X
H1 O X
- O X
induced O X
growth O X
of O X
HaCaT O X
cells O X
. O X

These O X
results O X
suggest O X
that O X
the O X
direct O X
interaction O X
of O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
and O X
STRAP I-MISC 11171
is O X
important O X
for O X
the O X
regulation O X
of O X
TGF I-MISC 7040
- I-MISC 7040
beta I-MISC 7040
- O X
dependent O X
biological O X
activity O X
as O X
well O X
as O X
NM23 I-MISC 4830
- I-MISC 4830
H1 I-MISC 4830
activity O X
. O X

###16628218	1124,5879

Phospholipase O X
Cgamma O X
/ O X
diacylglycerol O X
- O X
dependent O X
activation O X
of O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
restricts O X
EGF O X
- O X
induced O X
Rac O X
signaling O X
. O X

Although O X
receptor O X
- O X
mediated O X
regulation O X
of O X
small O X
G O X
- O X
proteins O X
and O X
the O X
cytoskeleton O X
is O X
intensively O X
studied O X
, O X
the O X
mechanisms O X
for O X
attenuation O X
of O X
these O X
signals O X
are O X
poorly O X
understood O X
. O X

In O X
this O X
study O X
, O X
we O X
have O X
identified O X
the O X
Rac O X
- O X
GAP O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
as O X
an O X
effector O X
of O X
the O X
epidermal I-MISC 1956
growth I-MISC 1956
factor I-MISC 1956
receptor I-MISC 1956
( O X
EGFR I-MISC 1956
) O X
via O X
coupling O X
to O X
phospholipase O X
Cgamma O X
( O X
PLCgamma O X
) O X
and O X
generation O X
of O X
the O X
lipid O X
second O X
messenger O X
diacylglycerol O X
( O X
DAG O X
). O X

EGF O X
redistributes O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
to O X
promote O X
its O X
association O X
with O X
the O X
small O X
GTPase O X
Rac1 I-MISC 5879
at O X
the O X
plasma O X
membrane O X
, O X
as O X
determined O X
by O X
FRET O X
. O X

This O X
relocalization O X
and O X
association O X
with O X
Rac1 I-MISC 5879
were O X
impaired O X
by O X
disruption O X
of O X
the O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
C1 O X
domain O X
as O X
well O X
as O X
by O X
PLCgamma1 I-MISC 5335
RNAi O X
, O X
thus O X
defining O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
as O X
a O X
novel O X
DAG O X
effector O X
. O X

On O X
the O X
other O X
hand O X
, O X
GAP O X
- O X
deficient O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
mutants O X
show O X
enhanced O X
translocation O X
and O X
sustained O X
Rac1 I-MISC 5879
association O X
in O X
the O X
FRET O X
assays O X
. O X

Remarkably O X
, O X
RNAi O X
depletion O X
of O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
significantly O X
extended O X
the O X
duration O X
of O X
Rac O X
activation O X
by O X
EGF O X
, O X
suggesting O X
that O X
beta2 I-MISC 10242
- O X
chimaerin I-MISC 1124
serves O X
as O X
a O X
mechanism O X
that O X
self O X
- O X
limits O X
Rac O X
activity O X
in O X
response O X
to O X
EGFR I-MISC 1956
activation O X
. O X

Our O X
results O X
represent O X
the O X
first O X
direct O X
evidence O X
of O X
divergence O X
in O X
DAG O X
signaling O X
downstream O X
of O X
a O X
tyrosine O X
- O X
kinase O X
receptor O X
via O X
a O X
PKC O X
- O X
independent O X
mechanism O X
. O X

###22334672	23636,24271474

Herpes O X
simplex O X
virus O X
ICP27 O X
protein O X
directly O X
interacts O X
with O X
the O X
nuclear O X
pore O X
complex O X
through O X
Nup62 I-MISC 23636
, O X
inhibiting O X
host O X
nucleocytoplasmic O X
transport O X
pathways O X
. O X

The O X
herpes O X
simplex O X
virus O X
ICP27 O X
protein O X
is O X
important O X
for O X
the O X
expression O X
and O X
nuclear O X
export O X
of O X
viral O X
mRNAs O X
. O X

Although O X
several O X
binding O X
sites O X
have O X
been O X
mapped O X
along O X
the O X
ICP27 O X
sequence O X
for O X
various O X
RNA O X
and O X
protein O X
partners O X
, O X
including O X
the O X
transport O X
receptor O X
TAP O X
of O X
the O X
host O X
cell O X
nuclear O X
transport O X
machinery O X
, O X
several O X
aspects O X
of O X
ICP27 O X
trafficking O X
through O X
the O X
nuclear O X
pore O X
complex O X
remain O X
unclear O X
. O X

We O X
investigated O X
if O X
ICP27 O X
could O X
interact O X
directly O X
with O X
the O X
nuclear O X
pore O X
complex O X
itself O X
, O X
finding O X
that O X
ICP27 O X
directly O X
binds O X
the O X
core O X
nucleoporin I-MISC 24271474
Nup62 I-MISC 24271474
. O X

This O X
is O X
confirmed O X
through O X
co O X
- O X
immunoprecipitation O X
and O X
in O X
vitro O X
binding O X
assays O X
with O X
purified O X
components O X
. O X

Mapping O X
with O X
ICP27 O X
deletion O X
and O X
point O X
mutants O X
further O X
shows O X
that O X
the O X
interaction O X
requires O X
sequences O X
in O X
both O X
the O X
N O X
and O X
C O X
termini O X
of O X
ICP27 O X
. O X

Expression O X
of O X
wild O X
type O X
ICP27 O X
protein O X
inhibited O X
both O X
classical O X
, O X
importin O X
a O X
/ O X
b O X
- O X
dependent O X
and O X
transportin O X
- O X
dependent O X
nuclear O X
import O X
. O X

In O X
contrast O X
, O X
an O X
ICP27 O X
point O X
mutant O X
that O X
does O X
not O X
interact O X
with O X
Nup62 I-MISC 23636
had O X
no O X
such O X
inhibitory O X
effect O X
. O X

We O X
suggest O X
that O X
ICP27 O X
association O X
with O X
Nup62 I-MISC 23636
provides O X
additional O X
binding O X
sites O X
at O X
the O X
nuclear O X
pore O X
for O X
ICP27 O X
shuttling O X
, O X
thus O X
supporting O X
ICP27 O X
- O X
mediated O X
transport O X
. O X

We O X
propose O X
that O X
ICP27 O X
competes O X
with O X
some O X
host O X
cell O X
transport O X
receptors O X
for O X
binding O X
, O X
resulting O X
in O X
inhibition O X
of O X
those O X
host O X
transport O X
pathways O X
. O X

###17237231	84376,4481

The O X
microtubule O X
- O X
binding O X
protein O X
Hook3 I-MISC 84376
interacts O X
with O X
a O X
cytoplasmic O X
domain O X
of O X
scavenger O X
receptor O X
A O X
. O X

The O X
class O X
A O X
scavenger O X
receptor O X
( O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
) O X
is O X
a O X
multifunctional O X
transmembrane O X
glycoprotein O X
that O X
is O X
implicated O X
in O X
atherogenesis O X
, O X
innate O X
immunity O X
, O X
and O X
cell O X
adhesion O X
. O X

Despite O X
extensive O X
structure O X
- O X
function O X
studies O X
of O X
the O X
receptor O X
, O X
intracellular O X
molecules O X
that O X
directly O X
interact O X
with O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
and O X
regulate O X
the O X
receptor O X
trafficking O X
have O X
not O X
been O X
determined O X
. O X

In O X
the O X
current O X
study O X
, O X
we O X
have O X
identified O X
a O X
microtubule O X
- O X
binding O X
protein O X
, O X
Hook3 I-MISC 84376
, O X
as O X
a O X
novel O X
interacting O X
partner O X
of O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
. O X

The O X
association O X
between O X
a O X
rat O X
Hook3 I-MISC 306548
isoform O X
and O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
was O X
suggested O X
by O X
yeast O X
two O X
- O X
hybrid O X
screening O X
and O X
mass O X
spectrometry O X
analysis O X
of O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
- O X
cytoplasmic O X
domain O X
- O X
bound O X
proteins O X
in O X
rat O X
alveolar O X
macrophages O X
. O X

The O X
binding O X
of O X
overexpressed O X
and O X
endogenous O X
human O X
Hook3 I-MISC 84376
to O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
was O X
demonstrated O X
by O X
pull O X
- O X
down O X
assay O X
and O X
co O X
- O X
immunoprecipitations O X
. O X

Furthermore O X
, O X
endogenous O X
murine O X
SR I-MISC 20288
- I-MISC 20288
A I-MISC 20288
and O X
HK3 I-MISC 3101
co O X
- O X
sedimented O X
from O X
cell O X
lysates O X
isolated O X
from O X
Raw264 O X
. O X
7 O X
murine O X
macrophage O X
cells O X
. O X

The O X
interaction O X
of O X
Hook3 I-MISC 84376
with O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
was O X
significantly O X
stimulated O X
after O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
had O X
recognized O X
the O X
extracellular O X
ligand O X
. O X

Studies O X
using O X
truncations O X
demonstrated O X
that O X
the O X
positively O X
charged O X
C O X
- O X
terminal O X
Val614 O X
- O X
Ala717 O X
region O X
of O X
human O X
Hook3 I-MISC 84376
was O X
required O X
for O X
the O X
interaction O X
with O X
the O X
negatively O X
charged O X
residues O X
, O X
Glu12 O X
, O X
Asp13 O X
, O X
and O X
Asp15 O X
in O X
the O X
human O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
cytoplasmic O X
domain O X
. O X

By O X
transfecting O X
small O X
interfering O X
RNA O X
targeting O X
Hook3 I-MISC 84376
, O X
total O X
and O X
surface O X
expression O X
, O X
receptor O X
- O X
mediated O X
ligand O X
uptake O X
and O X
protein O X
stability O X
of O X
SR I-MISC 4481
- I-MISC 4481
A I-MISC 4481
were O X
significantly O X
promoted O X
, O X
whereas O X
the O X
protein O X
synthesis O X
and O X
maturation O X
were O X
not O X
altered O X
. O X

We O X
propose O X
for O X
the O X
first O X
time O X
that O X
Hook3 I-MISC 84376
may O X
participate O X
in O X
the O X
turnover O X
of O X
the O X
endocytosed O X
scavenger O X
receptor O X
. O X

###19395483	946467,948430	947970,948430	947335,948430	1446481,948430

Characterization O X
of O X
the O X
Escherichia O X
coli O X
ClpY O X
( O X
HslU O X
) O X
substrate O X
recognition O X
site O X
in O X
the O X
ClpYQ I-MISC 948430
( O X
HslUV I-MISC 948430
) O X
protease O X
using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
. O X

In O X
Escherichia O X
coli O X
, O X
ClpYQ I-MISC 948430
( O X
HslUV I-MISC 948430
) O X
is O X
a O X
two O X
- O X
component O X
ATP O X
- O X
dependent O X
protease O X
in O X
which O X
ClpQ O X
is O X
the O X
peptidase O X
subunit O X
and O X
ClpY O X
is O X
the O X
ATPase O X
and O X
the O X
substrate O X
- O X
binding O X
subunit O X
. O X

The O X
ATP O X
- O X
dependent O X
proteolysis O X
is O X
mediated O X
by O X
substrate O X
recognition O X
in O X
the O X
ClpYQ I-MISC 948430
complex O X
. O X

ClpY O X
has O X
three O X
domains O X
, O X
N O X
, O X
I O X
, O X
and O X
C O X
, O X
and O X
these O X
domains O X
are O X
discrete O X
and O X
exhibit O X
different O X
binding O X
preferences O X
. O X

In O X
vivo O X
, O X
ClpYQ I-MISC 948430
targets O X
SulA I-MISC 947335
, O X
RcsA I-MISC 946467
, O X
RpoH I-MISC 947970
, O X
and O X
TraJ I-MISC 1446481
molecules O X
. O X

In O X
this O X
study O X
, O X
ClpY O X
was O X
analyzed O X
to O X
identify O X
the O X
molecular O X
determinants O X
required O X
for O X
the O X
binding O X
of O X
its O X
natural O X
protein O X
substrates O X
. O X

Using O X
yeast O X
two O X
- O X
hybrid O X
analysis O X
, O X
we O X
showed O X
that O X
domain O X
I O X
of O X
ClpY O X
contains O X
the O X
residues O X
responsible O X
for O X
recognition O X
of O X
its O X
natural O X
substrates O X
, O X
while O X
domain O X
C O X
is O X
necessary O X
to O X
engage O X
ClpQ O X
. O X

Moreover O X
, O X
the O X
specific O X
residues O X
that O X
lie O X
in O X
the O X
amino O X
acid O X
( O X
aa O X
) O X
137 O X
to O X
150 O X
( O X
loop O X
1 O X
) O X
and O X
aa O X
175 O X
to O X
209 O X
( O X
loop O X
2 O X
) O X
double O X
loops O X
in O X
domain O X
I O X
of O X
ClpY O X
were O X
shown O X
to O X
be O X
necessary O X
for O X
natural O X
substrate O X
interaction O X
. O X

Additionally O X
, O X
the O X
two O X
- O X
hybrid O X
system O X
, O X
together O X
with O X
random O X
PCR O X
mutagenesis O X
, O X
allowed O X
the O X
isolation O X
of O X
ClpY O X
mutants O X
that O X
displayed O X
a O X
range O X
of O X
binding O X
activities O X
with O X
SulA I-MISC 947335
, O X
including O X
a O X
mutant O X
with O X
no O X
SulA I-MISC 947335
binding O X
trait O X
. O X

Subsequently O X
, O X
via O X
methyl O X
methanesulfonate O X
tests O X
and O X
cpsB O X
:: O X
lacZ O X
assays O X
with O X
, O X
e O X
. O X
g O X
., O X
SulA I-MISC 947335
and O X
RcsA O X
as O X
targets O X
, O X
we O X
concluded O X
that O X
aa O X
175 O X
to O X
209 O X
of O X
loop O X
2 O X
are O X
involved O X
in O X
the O X
tethering O X
of O X
natural O X
substrates O X
, O X
and O X
it O X
is O X
likely O X
that O X
both O X
loops O X
, O X
aa O X
137 O X
to O X
150 O X
and O X
aa O X
175 O X
to O X
209 O X
, O X
of O X
ClpY O X
domain O X
I O X
may O X
assist O X
in O X
the O X
delivery O X
of O X
substrates O X
into O X
the O X
inner O X
core O X
for O X
ultimate O X
degradation O X
by O X
ClpQ O X
. O X

###15131699	598,581	598,598

Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
sequesters O X
its O X
C O X
- O X
terminal O X
membrane O X
anchor O X
in O X
soluble O X
, O X
cytosolic O X
homodimers O X
. O X

Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
is O X
a O X
potent O X
inhibitor O X
of O X
apoptosis O X
. O X

While O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
can O X
be O X
bound O X
to O X
mitochondria O X
, O X
a O X
substantial O X
fraction O X
, O X
depending O X
on O X
the O X
cell O X
type O X
or O X
tissue O X
, O X
is O X
found O X
in O X
the O X
cytosol O X
of O X
healthy O X
cells O X
. O X

Gel O X
filtration O X
and O X
crosslinking O X
experiments O X
reveal O X
that O X
, O X
unlike O X
monomeric O X
Bax I-MISC 581
, O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
migrates O X
in O X
a O X
complex O X
of O X
approximately O X
50 O X
kDa O X
in O X
the O X
cytosol O X
. O X

Co O X
- O X
immunoprecipitation O X
experiments O X
indicate O X
that O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
in O X
the O X
cytosol O X
forms O X
homodimers O X
. O X

The O X
C O X
- O X
terminal O X
hydrophobic O X
tails O X
of O X
two O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
molecules O X
are O X
involved O X
in O X
homodimer O X
formation O X
, O X
and O X
analysis O X
of O X
mutants O X
demonstrates O X
that O X
the O X
C O X
- O X
terminal O X
lysine O X
residue O X
and O X
the O X
G138 O X
residue O X
lining O X
the O X
BH3 O X
- O X
binding O X
pocket O X
are O X
required O X
for O X
homodimerization O X
. O X

The O X
flexible O X
loop O X
preceding O X
the O X
C O X
- O X
terminal O X
tail O X
in O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( O X
L O X
) O X
is O X
longer O X
than O X
that O X
of O X
several O X
monomeric O X
Bcl I-MISC 596
- I-MISC 596
2 I-MISC 596
family O X
members O X
and O X
is O X
a O X
requisite O X
for O X
the O X
homodimer O X
formation O X
. O X

Bad O X
binding O X
to O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
dissociates O X
the O X
homodimers O X
and O X
triggers O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
binding O X
to O X
mitochondrial O X
membranes O X
. O X

The O X
C O X
- O X
terminal O X
tail O X
of O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
is O X
also O X
required O X
to O X
mediate O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
)/ O X
Bax I-MISC 581
heterodimer O X
formation O X
. O X

Both O X
mitochondrial O X
import O X
and O X
antiapoptotic O X
activity O X
of O X
different O X
Bcl I-MISC 598
- I-MISC 598
x I-MISC 598
( I-MISC 598
L I-MISC 598
) I-MISC 598
mutants O X
correlate O X
with O X
their O X
ability O X
to O X
form O X
homodimers O X
. O X

###9430655	4771,9368

NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
, O X
a O X
regulatory O X
cofactor O X
for O X
Na O X
(+)- O X
H O X
+ O X
exchange O X
, O X
is O X
a O X
common O X
interactor O X
for O X
merlin I-MISC 4771
and I-MISC 4771
ERM I-MISC 4771
( O X
MERM O X
) O X
proteins O X
. O X

We O X
have O X
identified O X
the O X
human O X
homologue O X
of O X
a O X
regulatory I-MISC 9368
cofactor I-MISC 9368
of I-MISC 9368
Na I-MISC 9368
(+)- I-MISC 9368
H I-MISC 9368
+ I-MISC 9368
exchanger I-MISC 9368
( O X
NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
) O X
as O X
a O X
novel O X
interactor O X
for O X
merlin I-MISC 4771
, O X
the O X
neurofibromatosis O X
2 O X
tumor O X
suppressor O X
protein O X
. O X

NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
mediates O X
protein O X
kinase O X
A O X
regulation O X
of O X
Na O X
(+)- O X
H O X
+ O X
exchanger O X
NHE3 O X
to O X
which O X
it O X
is O X
thought O X
to O X
bind O X
via O X
one O X
of O X
its O X
two O X
PDZ O X
domains O X
. O X

The O X
carboxyl O X
- O X
terminal O X
region O X
of O X
NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
, O X
downstream O X
of O X
the O X
PDZ O X
domains O X
, O X
interacts O X
with O X
the O X
amino O X
- O X
terminal O X
protein O X
4 O X
. O X
1 O X
domain O X
- O X
containing O X
segment O X
of O X
merlin I-MISC 4771
in O X
yeast O X
two O X
- O X
hybrid O X
assays O X
. O X

This O X
interaction O X
also O X
occurs O X
in O X
affinity O X
binding O X
assays O X
with O X
full O X
- O X
length O X
NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
expressed O X
in O X
COS O X
- O X
7 O X
cells O X
. O X

NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
binds O X
to O X
the O X
related O X
ERM O X
proteins O X
, O X
moesin I-MISC 4478
and O X
radixin O X
. O X

We O X
have O X
localized O X
human O X
NHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
to O X
actin O X
- O X
rich O X
structures O X
such O X
as O X
membrane O X
ruffles O X
, O X
microvilli O X
, O X
and O X
filopodia O X
in O X
HeLa O X
and O X
COS O X
- O X
7 O X
cells O X
, O X
where O X
it O X
co O X
- O X
localizes O X
with O X
merlin I-MISC 4771
and O X
moesin I-MISC 4478
. O X

These O X
findings O X
suggest O X
that O X
hNHE I-MISC 9368
- I-MISC 9368
RF I-MISC 9368
and O X
its O X
binding O X
partners O X
may O X
participate O X
in O X
a O X
larger O X
complex O X
( O X
one O X
component O X
of O X
which O X
might O X
be O X
a O X
Na O X
(+)- O X
H O X
+ O X
exchanger O X
) O X
that O X
could O X
be O X
crucial O X
for O X
the O X
actin O X
filament O X
assembly O X
activated O X
by O X
the O X
ERM O X
proteins O X
and O X
for O X
the O X
tumor O X
suppressor O X
function O X
of O X
merlin I-MISC 4771
. O X

###10202051	7454,7456

Mutations O X
that O X
cause O X
the O X
Wiskott O X
- O X
Aldrich O X
syndrome O X
impair O X
the O X
interaction O X
of O X
Wiskott I-MISC 7454
- I-MISC 7454
Aldrich I-MISC 7454
syndrome I-MISC 7454
protein I-MISC 7454
( O X
WASP I-MISC 7454
) O X
with O X
WASP I-MISC 7456
interacting I-MISC 7456
protein I-MISC 7456
. O X

Wiskott O X
- O X
Aldrich O X
syndrome O X
( O X
WAS O X
) O X
is O X
an O X
X O X
- O X
linked O X
recessive O X
disorder O X
characterized O X
by O X
thrombocytopenia O X
, O X
eczema O X
, O X
immune O X
deficiency O X
, O X
and O X
a O X
proclivity O X
toward O X
lymphoid O X
malignancy O X
. O X

Lymphocytes O X
of O X
affected O X
individuals O X
show O X
defects O X
of O X
activation O X
, O X
motility O X
, O X
and O X
cytoskeletal O X
structure O X
. O X

The O X
disease O X
gene O X
encodes O X
a O X
502 O X
- O X
amino O X
acid O X
protein O X
named O X
the O X
WAS I-MISC 7454
protein I-MISC 7454
( O X
WASP I-MISC 7454
). O X

Studies O X
have O X
identified O X
a O X
number O X
of O X
important O X
interactions O X
that O X
place O X
WASP I-MISC 7454
in O X
a O X
role O X
of O X
integrating O X
signaling O X
pathways O X
with O X
cytoskeletal O X
function O X
. O X

We O X
performed O X
a O X
two O X
- O X
hybrid O X
screen O X
to O X
identify O X
proteins O X
interacting O X
with O X
WASP I-MISC 7454
and O X
cloned O X
a O X
proline O X
- O X
rich O X
protein O X
as O X
a O X
specific O X
WASP I-MISC 7454
interactor O X
. O X

Our O X
clone O X
of O X
this O X
protein O X
, O X
termed O X
WASP I-MISC 7456
interacting I-MISC 7456
protein I-MISC 7456
( O X
WIP I-MISC 7456
) O X
by O X
others O X
, O X
shows O X
a O X
difference O X
in O X
seven O X
amino O X
acid O X
residues O X
, O X
compared O X
with O X
the O X
previously O X
published O X
sequence O X
revealing O X
an O X
additional O X
profilin O X
binding O X
motif O X
. O X

Deletion O X
mutant O X
analysis O X
reveals O X
that O X
WASP I-MISC 7454
residues O X
101 O X
- O X
151 O X
are O X
necessary O X
for O X
WASP I-MISC 7454
- O X
WIP I-MISC 7456
interaction O X
. O X

Point O X
mutant O X
analyses O X
in O X
the O X
two O X
- O X
hybrid O X
system O X
and O X
in O X
vitro O X
show O X
impairment O X
of O X
WASP I-MISC 7454
- O X
WIP I-MISC 7456
interaction O X
with O X
three O X
WASP I-MISC 7454
missense O X
mutants O X
known O X
to O X
cause O X
WAS O X
. O X

We O X
conclude O X
that O X
impaired O X
WASP I-MISC 7454
- O X
WIP I-MISC 7456
interaction O X
may O X
contribute O X
to O X
WAS O X
. O X

###23220480	120892,120892

Dominant O X
- O X
negative O X
effects O X
of O X
LRRK2 I-MISC 120892
heterodimers O X
: O X
a O X
possible O X
mechanism O X
of O X
neurodegeneration O X
in O X
Parkinson O X
' O X
s O X
disease O X
caused O X
by O X
LRRK2 I-MISC 120892
I2020T O X
mutation O X
. O X

Leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
is O X
the O X
molecule O X
responsible O X
for O X
autosomal O X
- O X
dominant O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
), O X
PARK8 I-MISC 120892
, O X
but O X
the O X
etiologic O X
effects O X
of O X
its O X
mutation O X
remain O X
unknown O X
. O X

In O X
the O X
present O X
study O X
, O X
we O X
investigated O X
a O X
novel O X
mechanism O X
for O X
the O X
neurodegeneration O X
induced O X
by O X
I2020T O X
mutant O X
LRRK2 I-MISC 120892
. O X

Using O X
native O X
gel O X
electrophoresis O X
and O X
immunoprecipitation O X
, O X
we O X
found O X
that O X
wild O X
- O X
type O X
( O X
WT O X
) O X
LRRK2 I-MISC 120892
formed O X
a O X
heterodimer O X
with O X
I2020T O X
LRRK2 I-MISC 120892
in O X
transfected O X
cells O X
, O X
and O X
that O X
the O X
heterodimer O X
exhibited O X
a O X
markedly O X
lower O X
intracellular O X
protein O X
level O X
than O X
the O X
WT O X
/ O X
WT O X
- O X
homodimer O X
. O X

An O X
increased O X
amount O X
of O X
I2020T O X
LRRK2 I-MISC 120892
decreased O X
the O X
protein O X
level O X
of O X
co O X
- O X
transfected O X
WT O X
LRRK2 I-MISC 120892
. O X

A O X
pulse O X
- O X
chase O X
experiment O X
revealed O X
that O X
the O X
intracellular O X
protein O X
lifetime O X
of O X
WT O X
LRRK2 I-MISC 120892
was O X
shortened O X
by O X
co O X
- O X
transfection O X
with O X
I2020T O X
LRRK2 I-MISC 120892
. O X

These O X
results O X
suggest O X
that O X
I2020T O X
LRRK2 I-MISC 120892
enhances O X
the O X
intracellular O X
degradation O X
of O X
WT O X
LRRK2 I-MISC 120892
through O X
WT O X
/ O X
I2020T O X
- O X
heterodimer O X
formation O X
. O X

Overexpression O X
of O X
WT O X
LRRK2 I-MISC 120892
in O X
HEK293 O X
cells O X
increased O X
the O X
phosphorylation O X
level O X
of O X
Akt1 I-MISC 207
( O X
S473 O X
), O X
a O X
possible O X
physiological O X
substrate O X
of O X
LRRK2 I-MISC 120892
, O X
and O X
made O X
cells O X
resistant O X
to O X
hydrogen O X
peroxide O X
- O X
induced O X
apoptosis O X
. O X

However O X
, O X
both O X
Akt1 I-MISC 207
phosphorylation O X
and O X
apoptosis O X
resistance O X
were O X
reduced O X
in O X
WT O X
/ O X
I2020T O X
- O X
expressing O X
cells O X
in O X
comparison O X
with O X
WT O X
/ O X
WT O X
- O X
expressing O X
cells O X
. O X

Reduction O X
of O X
Akt1 I-MISC 207
phosphorylation O X
and O X
apoptosis O X
resistance O X
were O X
also O X
evident O X
when O X
a O X
neuroblastoma O X
SH O X
- O X
SY5Y O X
clone O X
overexpressing O X
WT O X
LRRK2 I-MISC 120892
was O X
transfected O X
with O X
the O X
I2020T O X
LRRK2 I-MISC 120892
. O X

Altogether O X
, O X
these O X
results O X
suggest O X
that O X
the O X
I2020T O X
mutation O X
enhances O X
the O X
intracellular O X
degradation O X
of O X
LRRK2 I-MISC 120892
through O X
WT O X
/ O X
I2020T O X
- O X
heterodimer O X
formation O X
, O X
leading O X
to O X
reduced O X
Akt1 I-MISC 207
phosphorylation O X
and O X
diminished O X
protectivity O X
against O X
apoptosis O X
. O X

Our O X
findings O X
suggest O X
the O X
possibility O X
of O X
a O X
dominant O X
- O X
negative O X
mechanism O X
of O X
neurodegeneration O X
in O X
PD O X
caused O X
by O X
I2020T O X
LRRK2 I-MISC 120892
mutation O X
. O X

###15716268	19017,93759

SIRT1 I-MISC 93759
functionally O X
interacts O X
with O X
the O X
metabolic O X
regulator O X
and O X
transcriptional O X
coactivator O X
PGC I-MISC 19017
- I-MISC 19017
1 I-MISC 19017
{ I-MISC 19017
alpha I-MISC 19017
}. O X

In O X
lower O X
organisms O X
, O X
increased O X
expression O X
of O X
the O X
NAD O X
- O X
dependent O X
deacetylase O X
Sir2 I-MISC 93759
augments O X
lifespan O X
. O X

The O X
mechanism O X
through O X
which O X
this O X
life O X
extension O X
is O X
mediated O X
remains O X
incompletely O X
understood O X
. O X

Here O X
we O X
have O X
examined O X
the O X
cellular O X
effects O X
of O X
overexpression O X
of O X
SIRT1 I-MISC 93759
, O X
the O X
closest O X
mammalian O X
ortholog O X
of O X
Sir2 I-MISC 93759
. O X

In O X
PC12 O X
cells O X
, O X
increased O X
expression O X
of O X
the O X
NAD O X
- O X
dependent O X
deacetylase O X
SIRT1 I-MISC 93759
reduces O X
cellular O X
oxygen O X
consumption O X
by O X
approximately O X
25 O X
%. O X

We O X
further O X
demonstrate O X
that O X
SIRT1 I-MISC 93759
expression O X
can O X
alter O X
the O X
transcriptional O X
activity O X
of O X
the O X
mitochondrial O X
biogenesis O X
coactivator O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
. O X

In O X
addition O X
, O X
SIRT1 I-MISC 93759
and O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
directly O X
interact O X
and O X
can O X
be O X
co O X
- O X
immunoprecipitated O X
as O X
a O X
molecular O X
complex O X
. O X

A O X
single O X
amino O X
acid O X
mutation O X
in O X
the O X
putative O X
ADP O X
- O X
ribosyltransferase O X
domain O X
of O X
SIRT1 I-MISC 93759
inhibits O X
the O X
interaction O X
of O X
SIRT1 I-MISC 93759
with O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
but O X
does O X
not O X
effect O X
the O X
interaction O X
of O X
SIRT1 I-MISC 93759
with O X
either O X
p53 I-MISC 7157
or O X
Foxo3a I-MISC 2309
. O X

We O X
further O X
show O X
that O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
is O X
acetylated O X
in O X
vivo O X
. O X

This O X
acetylation O X
is O X
augmented O X
by O X
treatment O X
with O X
the O X
SIRT1 I-MISC 93759
inhibitor O X
nicotinamide O X
or O X
by O X
expression O X
of O X
the O X
transcriptional O X
coactivator O X
p300 I-MISC 2033
. O X

Finally O X
we O X
demonstrate O X
that O X
SIRT1 I-MISC 93759
catalyzes O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
deacetylation O X
both O X
in O X
vitro O X
and O X
in O X
vivo O X
. O X

These O X
results O X
provide O X
a O X
direct O X
link O X
between O X
the O X
sirtuins O X
, O X
a O X
family O X
of O X
proteins O X
linked O X
to O X
lifespan O X
determination O X
and O X
PGC I-MISC 19017
- I-MISC 19017
1alpha I-MISC 19017
, O X
a O X
coactivator O X
that O X
regulates O X
cellular O X
metabolism O X
. O X

###25036739	801,6262

Altered O X
RyR2 I-MISC 6262
regulation O X
by O X
the O X
calmodulin I-MISC 801
F90L O X
mutation O X
associated O X
with O X
idiopathic O X
ventricular O X
fibrillation O X
and O X
early O X
sudden O X
cardiac O X
death O X
. O X

Calmodulin I-MISC 801
( O X
CaM I-MISC 801
) O X
association O X
with O X
the O X
cardiac O X
muscle O X
ryanodine O X
receptor O X
( O X
RyR2 I-MISC 6262
) O X
regulates O X
excitation O X
- O X
contraction O X
coupling O X
. O X

Defective O X
CaM I-MISC 801
- O X
RyR2 I-MISC 6262
interaction O X
is O X
associated O X
with O X
heart O X
failure O X
. O X

A O X
novel O X
CaM I-MISC 801
mutation O X
( O X
CaM I-MISC 801
( O X
F90L O X
)) O X
was O X
recently O X
identified O X
in O X
a O X
family O X
with O X
idiopathic O X
ventricular O X
fibrillation O X
( O X
IVF O X
) O X
and O X
early O X
onset O X
sudden O X
cardiac O X
death O X
. O X

We O X
report O X
the O X
first O X
biochemical O X
characterization O X
of O X
CaM I-MISC 801
( O X
F90L O X
). O X

F90L O X
confers O X
a O X
deleterious O X
effect O X
on O X
protein O X
stability O X
. O X

Ca O X
( O X
2 O X
+)- O X
binding O X
studies O X
reveal O X
reduced O X
Ca O X
( O X
2 O X
+)- O X
binding O X
affinity O X
and O X
a O X
loss O X
of O X
co O X
- O X
operativity O X
. O X

Moreover O X
, O X
CaM I-MISC 801
( O X
F90L O X
) O X
displays O X
reduced O X
RyR2 I-MISC 6262
interaction O X
and O X
defective O X
modulation O X
of O X
[( O X
3 O X
) O X
H O X
] O X
ryanodine O X
binding O X
. O X

Hence O X
, O X
dysregulation O X
of O X
RyR2 I-MISC 6262
- O X
mediated O X
Ca O X
( O X
2 O X
+) O X
release O X
via O X
aberrant O X
CaM I-MISC 801
( O X
F90L O X
)- O X
RyR2 I-MISC 6262
interaction O X
is O X
a O X
potential O X
mechanism O X
that O X
underlies O X
familial O X
IVF O X
. O X

###9038200	832217,832217	832217,832217

TOUSLED I-MISC 832217
is O X
a O X
nuclear O X
serine O X
/ O X
threonine O X
protein O X
kinase O X
that O X
requires O X
a O X
coiled O X
- O X
coil O X
region O X
for O X
oligomerization O X
and O X
catalytic O X
activity O X
. O X

The O X
TOUSLED I-MISC 832217
( O X
TSL I-MISC 832217
) O X
gene O X
is O X
essential O X
for O X
the O X
proper O X
morphogenesis O X
of O X
leaves O X
and O X
flowers O X
in O X
Arabidopsis O X
thaliana O X
. O X

Protein O X
sequence O X
analysis O X
predicts O X
TSL I-MISC 832217
is O X
composed O X
of O X
a O X
carboxyl O X
- O X
terminal O X
protein O X
kinase O X
catalytic O X
domain O X
and O X
a O X
large O X
amino O X
- O X
terminal O X
regulatory O X
domain O X
. O X

TSL I-MISC 832217
fusion O X
proteins O X
, O X
expressed O X
in O X
and O X
purified O X
from O X
yeast O X
, O X
were O X
used O X
to O X
demonstrate O X
TSL I-MISC 832217
protein O X
kinase O X
activity O X
in O X
vitro O X
. O X

TSL I-MISC 832217
trans O X
- O X
autophosphorylates O X
on O X
serine O X
and O X
threonine O X
residues O X
, O X
and O X
phosphorylates O X
exogenous O X
substrates O X
. O X

Using O X
the O X
yeast O X
two O X
- O X
hybrid O X
system O X
, O X
TSL I-MISC 832217
was O X
found O X
to O X
oligomerize O X
via O X
its O X
NH2 O X
- O X
terminal O X
domain O X
. O X

A O X
deletion O X
series O X
indicates O X
that O X
a O X
region O X
containing O X
two O X
alpha O X
- O X
helical O X
segments O X
predicted O X
to O X
participate O X
in O X
a O X
coiled O X
- O X
coil O X
structure O X
is O X
essential O X
for O X
oligomerization O X
. O X

TSL I-MISC 832217
localizes O X
to O X
the O X
nucleus O X
in O X
plant O X
cells O X
through O X
an O X
essential O X
NH2 O X
- O X
terminal O X
nuclear O X
localization O X
signal O X
; O X
however O X
, O X
this O X
signal O X
is O X
not O X
necessary O X
for O X
protein O X
kinase O X
activity O X
. O X

Finally O X
, O X
deletion O X
mutants O X
demonstrate O X
a O X
strict O X
correlation O X
between O X
catalytic O X
activity O X
and O X
the O X
ability O X
to O X
oligomerize O X
, O X
arguing O X
that O X
activation O X
of O X
the O X
protein O X
kinase O X
requires O X
interaction O X
between O X
TSL I-MISC 832217
molecules O X
. O X

###10713164	4851,22938

SKIP I-MISC 42601
, O X
a O X
CBF1 O X
- O X
associated O X
protein O X
, O X
interacts O X
with O X
the O X
ankyrin O X
repeat O X
domain O X
of O X
NotchIC I-MISC 4851
To O X
facilitate O X
NotchIC I-MISC 4851
function O X
. O X

Notch O X
proteins O X
are O X
transmembrane O X
receptors O X
that O X
mediate O X
intercell O X
communication O X
and O X
direct O X
individual O X
cell O X
fate O X
decisions O X
. O X

The O X
activated O X
intracellular O X
form O X
of O X
Notch O X
, O X
NotchIC I-MISC 4851
, O X
translocates O X
to O X
the O X
nucleus O X
, O X
where O X
it O X
targets O X
the O X
DNA O X
binding O X
protein O X
CBF1 O X
. O X

CBF1 O X
mediates O X
transcriptional O X
repression O X
through O X
the O X
recruitment O X
of O X
an O X
SMRT O X
- O X
histone O X
deacetylase O X
- O X
containing O X
corepressor O X
complex O X
. O X

We O X
have O X
examined O X
the O X
mechanism O X
whereby O X
NotchIC I-MISC 4851
overcomes O X
CBF1 O X
- O X
mediated O X
transcriptional O X
repression O X
. O X

We O X
identified O X
SKIP I-MISC 42601
( O X
Ski I-MISC 22938
- I-MISC 22938
interacting I-MISC 22938
protein I-MISC 22938
) O X
as O X
a O X
CBF1 O X
binding O X
protein O X
in O X
a O X
yeast O X
two O X
- O X
hybrid O X
screen O X
. O X

Both O X
CBF1 O X
and O X
SKIP I-MISC 42601
are O X
highly O X
conserved O X
evolutionarily O X
, O X
and O X
the O X
SKIP I-MISC 42601
- O X
CBF1 O X
interaction O X
is O X
also O X
conserved O X
in O X
assays O X
using O X
the O X
Caenorhabditis O X
elegans O X
and O X
Drosophila O X
melanogaster O X
SKIP I-MISC 42601
homologs O X
. O X

Protein O X
- O X
protein O X
interaction O X
assays O X
demonstrated O X
interaction O X
between O X
SKIP I-MISC 42601
and O X
the O X
corepressor O X
SMRT O X
. O X

More O X
surprisingly O X
, O X
SKIP I-MISC 42601
also O X
interacted O X
with O X
NotchIC I-MISC 4851
. O X

The O X
SMRT O X
and O X
NotchIC I-MISC 4851
interactions O X
were O X
mutually O X
exclusive O X
. O X

In O X
competition O X
binding O X
experiments O X
SMRT O X
displaced O X
NotchIC I-MISC 4851
from O X
CBF1 O X
and O X
from O X
SKIP I-MISC 42601
. O X

Contact O X
with O X
SKIP I-MISC 42601
is O X
required O X
for O X
biological O X
activity O X
of O X
NotchIC I-MISC 4851
. O X

A O X
mutation O X
in O X
the O X
fourth O X
ankyrin O X
repeat O X
that O X
abolished O X
Notch O X
signal O X
transduction O X
did O X
not O X
affect O X
interaction O X
with O X
CBF1 O X
but O X
abolished O X
interaction O X
with O X
SKIP I-MISC 42601
. O X

Further O X
, O X
NotchIC I-MISC 4851
was O X
unable O X
to O X
block O X
muscle O X
cell O X
differentiation O X
in O X
myoblasts O X
expressing O X
antisense O X
SKIP I-MISC 42601
. O X

The O X
results O X
suggest O X
a O X
model O X
in O X
which O X
NotchIC I-MISC 4851
activates O X
responsive O X
promoters O X
by O X
competing O X
with O X
the O X
SMRT O X
- O X
corepressor O X
complex O X
for O X
contacts O X
on O X
both O X
CBF1 O X
and O X
SKIP I-MISC 42601
. O X

###8670882	23647,5879

Identification O X
of O X
a O X
novel O X
Rac1 I-MISC 5879
- O X
interacting O X
protein O X
involved O X
in O X
membrane O X
ruffling O X
. O X

The O X
Rac O X
GTP O X
binding O X
proteins O X
are O X
implicated O X
in O X
actin O X
cytoskeleton O X
- O X
membrane O X
interaction O X
in O X
mammalian O X
cells O X
. O X

In O X
fibroblast O X
cells O X
, O X
Rac O X
has O X
been O X
shown O X
to O X
mediate O X
growth O X
factor O X
- O X
induced O X
polymerization O X
of O X
actin O X
to O X
form O X
membrane O X
ruffles O X
and O X
lamellipodia O X
. O X

We O X
report O X
here O X
the O X
isolation O X
of O X
a O X
noval O X
Rac1 I-MISC 5879
- O X
interacting O X
protein O X
, O X
POR1 I-MISC 23647
. O X

POR1 I-MISC 23647
binds O X
directly O X
to O X
Rac1 I-MISC 5879
, O X
and O X
the O X
interaction O X
of O X
POR1 I-MISC 23647
with O X
Rac1 I-MISC 5879
is O X
GTP O X
dependent O X
. O X

A O X
mutation O X
in O X
the O X
Rac1 I-MISC 5879
effector O X
binding O X
loop O X
shown O X
to O X
abolish O X
membrane O X
ruffling O X
also O X
abolishes O X
interaction O X
with O X
POR1 I-MISC 23647
. O X

Truncated O X
versions O X
of O X
POR1 I-MISC 23647
inhibit O X
the O X
induction O X
of O X
membrane O X
ruffling O X
by O X
an O X
activated O X
mutant O X
of O X
Rac1 I-MISC 363875
, O X
V12Rac1 O X
, O X
in O X
quiescent O X
rat O X
embryonic O X
fibroblast O X
REF52 O X
cells O X
. O X

Furthermore O X
, O X
POR1 I-MISC 23647
synergizes O X
with O X
an O X
activated O X
mutant O X
of O X
Ras O X
, O X
V12Ras O X
, O X
in O X
the O X
induction O X
of O X
membrane O X
ruffling O X
. O X

These O X
results O X
suggest O X
a O X
potential O X
role O X
for O X
POR1 I-MISC 23647
in O X
Rac1 I-MISC 5879
- O X
mediated O X
signaling O X
pathways O X
. O X

###23584531	10059,10059

Structural O X
insights O X
into O X
oligomerization O X
and O X
mitochondrial O X
remodelling O X
of O X
dynamin I-MISC 10059
1 I-MISC 10059
- I-MISC 10059
like I-MISC 10059
protein I-MISC 10059
. O X

Dynamin I-MISC 10059
1 I-MISC 10059
- I-MISC 10059
like I-MISC 10059
protein I-MISC 10059
( O X
DNM1L I-MISC 10059
) O X
mediates O X
fission O X
of O X
mitochondria O X
and O X
peroxisomes O X
, O X
and O X
dysfunction O X
of O X
DNM1L I-MISC 10059
has O X
been O X
implicated O X
in O X
several O X
neurological O X
disorders O X
. O X

To O X
study O X
the O X
molecular O X
basis O X
of O X
mitochondrial O X
remodelling O X
, O X
we O X
determined O X
the O X
crystal O X
structure O X
of O X
DNM1L I-MISC 10059
that O X
is O X
comprised O X
of O X
a O X
G O X
domain O X
, O X
a O X
bundle O X
signalling O X
element O X
and O X
a O X
stalk O X
. O X

DNM1L I-MISC 10059
assembled O X
via O X
a O X
central O X
stalk O X
interface O X
, O X
and O X
mutations O X
in O X
this O X
interface O X
disrupted O X
dimerization O X
and O X
interfered O X
with O X
membrane O X
binding O X
and O X
mitochondrial O X
targeting O X
. O X

Two O X
sequence O X
stretches O X
at O X
the O X
tip O X
of O X
the O X
stalk O X
were O X
shown O X
to O X
be O X
required O X
for O X
ordered O X
assembly O X
of O X
DNM1L I-MISC 10059
on O X
membranes O X
and O X
its O X
function O X
in O X
mitochondrial O X
fission O X
. O X

In O X
the O X
crystals O X
, O X
DNM1L I-MISC 10059
dimers O X
further O X
assembled O X
via O X
a O X
second O X
, O X
previously O X
undescribed O X
, O X
stalk O X
interface O X
to O X
form O X
a O X
linear O X
filament O X
. O X

Mutations O X
in O X
this O X
interface O X
interfered O X
with O X
liposome O X
tubulation O X
and O X
mitochondrial O X
remodelling O X
. O X

Based O X
on O X
these O X
results O X
and O X
electron O X
microscopy O X
reconstructions O X
, O X
we O X
propose O X
an O X
oligomerization O X
mode O X
for O X
DNM1L I-MISC 10059
which O X
differs O X
from O X
that O X
of O X
dynamin O X
and O X
might O X
be O X
adapted O X
to O X
the O X
remodelling O X
of O X
mitochondria O X
. O X

###21775823	7157,9821

p53 I-MISC 7157
inhibits O X
autophagy O X
by O X
interacting O X
with O X
the O X
human O X
ortholog O X
of O X
yeast O X
Atg17 I-MISC 851142
, O X
RB1CC1 I-MISC 9821
/ O X
FIP200 I-MISC 9821
. O X

The O X
tumor O X
suppressor O X
protein O X
p53 I-MISC 7157
tonically O X
suppresses O X
autophagy O X
when O X
it O X
is O X
present O X
in O X
the O X
cytoplasm O X
. O X

This O X
effect O X
is O X
phylogenetically O X
conserved O X
from O X
mammals O X
to O X
nematodes O X
, O X
and O X
human O X
p53 I-MISC 7157
can O X
inhibit O X
autophagy O X
in O X
yeast O X
, O X
as O X
we O X
show O X
here O X
. O X

Bioinformatic O X
investigations O X
of O X
the O X
p53 I-MISC 7157
interactome O X
in O X
relationship O X
to O X
the O X
autophagy O X
- O X
relevant O X
protein O X
network O X
underscored O X
the O X
possible O X
relevance O X
of O X
a O X
direct O X
molecular O X
interaction O X
between O X
p53 I-MISC 7157
and O X
the O X
mammalian O X
ortholog O X
of O X
the O X
essential O X
yeast O X
autophagy O X
protein O X
Atg17 I-MISC 851142
, O X
namely O X
RB1 I-MISC 9821
- I-MISC 9821
inducible I-MISC 9821
coiled I-MISC 9821
- I-MISC 9821
coil I-MISC 9821
protein I-MISC 9821
1 I-MISC 9821
( O X
RB1CC1 I-MISC 9821
), O X
also O X
called O X
FAK O X
family O X
kinase O X
- O X
interacting O X
protein O X
of O X
200 O X
KDa O X
( O X
FIP200 I-MISC 9821
). O X

Mutational O X
analyses O X
revealed O X
that O X
a O X
single O X
point O X
mutation O X
in O X
p53 I-MISC 7157
( O X
K382R O X
) O X
abolished O X
its O X
capacity O X
to O X
inhibit O X
autophagy O X
upon O X
transfection O X
into O X
p53 I-MISC 7157
- O X
deficient O X
human O X
colon O X
cancer O X
or O X
yeast O X
cells O X
. O X

In O X
conditions O X
in O X
which O X
wild O X
- O X
type O X
p53 I-MISC 7157
co O X
- O X
immunoprecipitated O X
with O X
RB1CC1 I-MISC 9821
/ O X
FIP200 I-MISC 9821
, O X
p53 I-MISC 7157
( O X
K382R O X
) O X
failed O X
to O X
do O X
so O X
, O X
underscoring O X
the O X
importance O X
of O X
the O X
physical O X
interaction O X
between O X
these O X
proteins O X
for O X
the O X
control O X
of O X
autophagy O X
. O X

In O X
conclusion O X
, O X
p53 I-MISC 7157
regulates O X
autophagy O X
through O X
a O X
direct O X
molecular O X
interaction O X
with O X
RB1CC1 I-MISC 9821
/ O X
FIP200 I-MISC 9821
, O X
a O X
protein O X
that O X
is O X
essential O X
for O X
the O X
very O X
apical O X
step O X
of O X
autophagy O X
initiation O X
. O X

###21896487	24904,24904

The O X
large O X
extracellular O X
loop O X
of O X
organic I-MISC 24904
cation I-MISC 24904
transporter I-MISC 24904
1 I-MISC 24904
influences O X
substrate O X
affinity O X
and O X
is O X
pivotal O X
for O X
oligomerization O X
. O X

Polyspecific O X
organic O X
anion O X
transporters O X
( O X
OATs O X
) O X
and O X
organic O X
cation O X
transporters O X
( O X
OCTs O X
) O X
of O X
the O X
SLC22 O X
transporter O X
family O X
play O X
a O X
pivotal O X
role O X
in O X
absorption O X
, O X
distribution O X
, O X
and O X
excretion O X
of O X
drugs O X
. O X

Polymorphisms O X
in O X
these O X
transporters O X
influence O X
therapeutic O X
effects O X
. O X

On O X
the O X
basis O X
of O X
functional O X
characterizations O X
, O X
homology O X
modeling O X
, O X
and O X
mutagenesis O X
, O X
hypotheses O X
for O X
how O X
OCTs O X
bind O X
and O X
translocate O X
structurally O X
different O X
cations O X
were O X
raised O X
, O X
assuming O X
functionally O X
competent O X
monomers O X
. O X

However O X
, O X
homo O X
- O X
oligomerization O X
has O X
been O X
described O X
for O X
OATs O X
and O X
OCTs O X
. O X

In O X
the O X
present O X
study O X
, O X
evidence O X
is O X
provided O X
that O X
the O X
large O X
extracellular O X
loops O X
( O X
EL O X
) O X
of O X
rat O X
Oct1 I-MISC 24904
( O X
rOct1 I-MISC 24904
) O X
and O X
rat O X
Oat1 I-MISC 29509
( O X
rOat1 I-MISC 29509
) O X
mediate O X
homo O X
- O X
but O X
not O X
hetero O X
- O X
oligomerization O X
. O X

Replacement O X
of O X
the O X
cysteine O X
residues O X
in O X
the O X
EL O X
of O X
rOct1 I-MISC 24904
by O X
serine O X
residues O X
( O X
rOct1 I-MISC 24904
( O X
6 O X
/\ O X
C O X
- O X
l O X
)) O X
or O X
breaking O X
disulfide O X
bonds O X
with O X
dithiothreitol O X
prevented O X
oligomerization O X
. O X

rOct1 I-MISC 24904
chimera O X
containing O X
the O X
EL O X
of O X
rOat1 I-MISC 29509
( O X
rOct1 I-MISC 24904
( O X
rOat1 I-MISC 29509
- O X
l O X
)) O X
showed O X
oligomerization O X
but O X
reduced O X
transporter O X
amount O X
in O X
the O X
plasma O X
membrane O X
. O X

For O X
rOct1 I-MISC 24904
( O X
6 O X
/\ O X
C O X
- O X
l O X
) O X
and O X
rOct1 I-MISC 24904
( O X
rOat1 I-MISC 29509
- O X
l O X
), O X
similar O X
K O X
( O X
m O X
) O X
values O X
for O X
1 O X
- O X
methyl O X
- O X
4 O X
- O X
phenylpyridinium O X
(+) O X
( O X
MPP O X
(+)) O X
and O X
tetraethylammonium O X
(+) O X
( O X
TEA O X
(+)) O X
were O X
obtained O X
that O X
were O X
higher O X
compared O X
with O X
rOct1 I-MISC 24904
wild O X
type O X
. O X

The O X
increased O X
K O X
( O X
m O X
) O X
of O X
rOct1 I-MISC 24904
( O X
rOat1 I-MISC 29509
- O X
l O X
) O X
indicates O X
an O X
allosteric O X
effect O X
of O X
EL O X
on O X
the O X
cation O X
binding O X
region O X
. O X

The O X
similar O X
substrate O X
affinity O X
of O X
the O X
oligomerizing O X
and O X
non O X
- O X
oligomerizing O X
loop O X
mutants O X
suggests O X
that O X
oligomerization O X
does O X
not O X
influence O X
transport O X
function O X
. O X

Independent O X
transport O X
function O X
of O X
rOct1 I-MISC 24904
monomers O X
was O X
also O X
demonstrated O X
by O X
showing O X
that O X
K O X
( O X
m O X
) O X
values O X
for O X
MPP O X
(+) O X
and O X
TEA O X
(+) O X
were O X
not O X
changed O X
after O X
treatment O X
with O X
dithiothreitol O X
and O X
that O X
a O X
tandem O X
protein O X
with O X
two O X
rOct1 I-MISC 24904
monomers O X
showed O X
about O X
50 O X
% O X
activity O X
with O X
unchanged O X
K O X
( O X
m O X
) O X
values O X
for O X
MPP O X
(+) O X
and O X
TEA O X
(+) O X
when O X
one O X
monomer O X
was O X
blocked O X
. O X

The O X
data O X
help O X
to O X
understand O X
how O X
OCTs O X
work O X
and O X
how O X
mutations O X
in O X
patients O X
may O X
affect O X
their O X
functions O X
. O X

###23901104	64601,65082

Structural O X
basis O X
of O X
Vps33A I-MISC 65082
recruitment O X
to O X
the O X
human O X
HOPS O X
complex O X
by O X
Vps16 I-MISC 64601
. O X

The O X
multisubunit O X
homotypic O X
fusion O X
and O X
vacuole O X
protein O X
sorting O X
( O X
HOPS O X
) O X
membrane O X
- O X
tethering O X
complex O X
is O X
required O X
for O X
late O X
endosome O X
- O X
lysosome O X
and O X
autophagosome O X
- O X
lysosome O X
fusion O X
in O X
mammals O X
. O X

We O X
have O X
determined O X
the O X
crystal O X
structure O X
of O X
the O X
human O X
HOPS O X
subunit O X
Vps33A I-MISC 65082
, O X
confirming O X
its O X
identity O X
as O X
a O X
Sec1 I-MISC 653677
/ O X
Munc18 O X
family O X
member O X
. O X

We O X
show O X
that O X
HOPS O X
subunit O X
Vps16 I-MISC 64601
recruits O X
Vps33A I-MISC 65082
to O X
the O X
human O X
HOPS O X
complex O X
and O X
that O X
residues O X
642 O X
- O X
736 O X
are O X
necessary O X
and O X
sufficient O X
for O X
this O X
interaction O X
, O X
and O X
we O X
present O X
the O X
crystal O X
structure O X
of O X
Vps33A I-MISC 65082
in O X
complex O X
with O X
Vps16 I-MISC 64601
( O X
642 O X
- O X
736 O X
). O X

Mutations O X
at O X
the O X
binding O X
interface O X
disrupt O X
the O X
Vps33A I-MISC 65082
- O X
Vps16 I-MISC 64601
interaction O X
both O X
in O X
vitro O X
and O X
in O X
cells O X
, O X
preventing O X
recruitment O X
of O X
Vps33A I-MISC 65082
to O X
the O X
HOPS O X
complex O X
. O X

The O X
Vps33A I-MISC 65082
- O X
Vps16 I-MISC 64601
complex O X
provides O X
a O X
structural O X
framework O X
for O X
studying O X
the O X
association O X
between O X
Sec1 I-MISC 653677
/ O X
Munc18 O X
proteins O X
and O X
tethering O X
complexes O X
. O X

###15020601	114548,29108

Cryopyrin I-MISC 114548
- O X
induced O X
interleukin I-MISC 3553
1beta I-MISC 3553
secretion O X
in O X
monocytic O X
cells O X
: O X
enhanced O X
activity O X
of O X
disease O X
- O X
associated O X
mutants O X
and O X
requirement O X
for O X
ASC I-MISC 29108
. O X

Several O X
autoinflammatory O X
disorders O X
are O X
associated O X
with O X
missense O X
mutations O X
within O X
the O X
nucleotide O X
- O X
binding O X
oligomerization O X
domain O X
of O X
cryopyrin I-MISC 114548
. O X

The O X
mechanism O X
by O X
which O X
cryopyrin I-MISC 114548
mutations O X
cause O X
inflammatory O X
disease O X
remains O X
elusive O X
. O X

To O X
understand O X
the O X
molecular O X
bases O X
of O X
these O X
diseases O X
, O X
we O X
generated O X
constructs O X
to O X
express O X
three O X
common O X
cryopyrin I-MISC 114548
disease O X
- O X
associated O X
mutations O X
, O X
R260W O X
, O X
D303N O X
, O X
and O X
E637G O X
, O X
and O X
compared O X
their O X
activity O X
with O X
that O X
of O X
the O X
wild O X
- O X
type O X
protein O X
. O X

All O X
cryopyrin I-MISC 114548
mutant O X
proteins O X
tested O X
were O X
found O X
to O X
induce O X
potent O X
NF O X
- O X
kappaB O X
activity O X
when O X
compared O X
with O X
the O X
wild O X
- O X
type O X
protein O X
. O X

This O X
activation O X
was O X
dependent O X
on O X
the O X
expression O X
of O X
ASC I-MISC 29108
, O X
an O X
adaptor O X
protein O X
previously O X
suggested O X
to O X
mediate O X
cryopyrin I-MISC 114548
signaling O X
. O X

When O X
the O X
disease O X
- O X
associated O X
mutants O X
were O X
expressed O X
in O X
monocytic O X
THP O X
- O X
1 O X
cells O X
( O X
which O X
express O X
endogenous O X
ASC I-MISC 29108
), O X
each O X
induced O X
spontaneous O X
IL I-MISC 3553
- I-MISC 3553
1beta I-MISC 3553
secretion O X
, O X
whereas O X
wild O X
- O X
type O X
protein O X
did O X
not O X
. O X

In O X
the O X
absence O X
of O X
stimuli O X
, O X
wild O X
- O X
type O X
cryopyrin I-MISC 114548
was O X
unable O X
to O X
bind O X
to O X
ASC I-MISC 29108
, O X
whereas O X
the O X
three O X
mutants O X
coimmunoprecipitated O X
with O X
ASC I-MISC 29108
, O X
suggesting O X
a O X
mechanism O X
involved O X
in O X
the O X
constitutive O X
activation O X
of O X
mutant O X
proteins O X
. O X

The O X
induction O X
of O X
cryopyrin I-MISC 114548
activity O X
by O X
enforced O X
oligomerization O X
in O X
THP O X
- O X
1 O X
cells O X
resulted O X
in O X
ASC I-MISC 29108
binding O X
and O X
the O X
secretion O X
of O X
IL I-MISC 3553
- I-MISC 3553
1beta I-MISC 3553
, O X
an O X
effect O X
that O X
was O X
abolished O X
by O X
the O X
inhibition O X
of O X
ASC I-MISC 29108
expression O X
with O X
small O X
interfering O X
RNAs O X
. O X

Thus O X
, O X
cryopyrin I-MISC 114548
- O X
mediated O X
IL I-MISC 3553
- I-MISC 3553
1beta I-MISC 3553
secretion O X
requires O X
ASC I-MISC 29108
in O X
monocytic O X
cells O X
. O X

Further O X
, O X
these O X
results O X
indicate O X
that O X
cryopyrin I-MISC 114548
disease O X
- O X
associated O X
mutants O X
are O X
constitutively O X
active O X
and O X
able O X
to O X
induce O X
NF O X
- O X
kappaB O X
activation O X
and O X
IL I-MISC 3553
- I-MISC 3553
1beta I-MISC 3553
secretion O X
at O X
least O X
in O X
part O X
by O X
an O X
increased O X
ability O X
to O X
interact O X
with O X
ASC I-MISC 29108
. O X

###10067897	42034,32567

Structure O X
of O X
a O X
DNA O X
- O X
bound O X
Ultrabithorax I-MISC 42034
- O X
Extradenticle I-MISC 32567
homeodomain O X
complex O X
. O X

During O X
the O X
development O X
of O X
multicellular O X
organisms O X
, O X
gene O X
expression O X
must O X
be O X
tightly O X
regulated O X
, O X
both O X
spatially O X
and O X
temporally O X
. O X

One O X
set O X
of O X
transcription O X
factors O X
that O X
are O X
important O X
in O X
animal O X
development O X
is O X
encoded O X
by O X
the O X
homeotic O X
( O X
Hox O X
) O X
genes O X
, O X
which O X
govern O X
the O X
choice O X
between O X
alternative O X
developmental O X
pathways O X
along O X
the O X
anterior O X
- O X
posterior O X
axis O X
. O X

Hox O X
proteins O X
, O X
such O X
as O X
Drosophila O X
Ultrabithorax I-MISC 42034
, O X
have O X
low O X
DNA O X
- O X
binding O X
specificity O X
by O X
themselves O X
but O X
gain O X
affinity O X
and O X
specificity O X
when O X
they O X
bind O X
together O X
with O X
the O X
homeoprotein O X
Extradenticle I-MISC 32567
( O X
or O X
Pbxl I-MISC 32567
in O X
mammals O X
). O X

To O X
understand O X
the O X
structural O X
basis O X
of O X
Hox O X
- O X
Extradenticle I-MISC 32567
pairing O X
, O X
we O X
determine O X
here O X
the O X
crystal O X
structure O X
of O X
an O X
Ultrabithorax I-MISC 42034
- O X
Extradenticle I-MISC 32567
- O X
DNA O X
complex O X
at O X
2 O X
. O X
4 O X
A O X
resolution O X
, O X
using O X
the O X
minimal O X
polypeptides O X
that O X
form O X
a O X
cooperative O X
heterodimer O X
. O X

The O X
Ultrabithorax I-MISC 42034
and O X
Extradenticle I-MISC 32567
homeodomains O X
bind O X
opposite O X
faces O X
of O X
the O X
DNA O X
, O X
with O X
their O X
DNA O X
- O X
recognition O X
helices O X
almost O X
touching O X
each O X
other O X
. O X

However O X
, O X
most O X
of O X
the O X
cooperative O X
interactions O X
arise O X
from O X
the O X
YPWM O X
amino O X
- O X
acid O X
motif O X
of O X
Ultrabithorax I-MISC 42034
- O X
located O X
amino O X
- O X
terminally O X
to O X
its O X
homeodomain O X
- O X
which O X
forms O X
a O X
reverse O X
turn O X
and O X
inserts O X
into O X
a O X
hydrophobic O X
pocket O X
on O X
the O X
Extradenticle I-MISC 32567
homeodomain O X
surface O X
. O X

Together O X
, O X
these O X
protein O X
- O X
DNA O X
and O X
protein O X
- O X
protein O X
interactions O X
define O X
the O X
general O X
principles O X
by O X
which O X
homeotic O X
proteins O X
interact O X
with O X
Extradenticle I-MISC 32567
( O X
or O X
Pbx1 I-MISC 32567
) O X
to O X
affect O X
development O X
along O X
the O X
anterior O X
- O X
posterior O X
axis O X
of O X
animals O X
. O X

###16525503	10277,4287	4287,7415

An O X
arginine O X
/ O X
lysine O X
- O X
rich O X
motif O X
is O X
crucial O X
for O X
VCP I-MISC 7415
/ O X
p97 I-MISC 7415
- O X
mediated O X
modulation O X
of O X
ataxin I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
fibrillogenesis O X
. O X

Arginine O X
/ O X
lysine O X
- O X
rich O X
motifs O X
typically O X
function O X
as O X
targeting O X
signals O X
for O X
the O X
translocation O X
of O X
proteins O X
to O X
the O X
nucleus O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
such O X
a O X
motif O X
consisting O X
of O X
four O X
basic O X
amino O X
acids O X
in O X
the O X
polyglutamine O X
protein O X
ataxin I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
( O X
Atx I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
) O X
serves O X
as O X
a O X
recognition O X
site O X
for O X
the O X
interaction O X
with O X
the O X
molecular O X
chaperone O X
VCP I-MISC 7415
. O X

Through O X
this O X
interaction O X
, O X
VCP I-MISC 7415
modulates O X
the O X
fibrillogenesis O X
of O X
pathogenic O X
forms O X
of O X
Atx I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
in O X
a O X
concentration O X
- O X
dependent O X
manner O X
, O X
with O X
low O X
concentrations O X
of O X
VCP I-MISC 7415
stimulating O X
fibrillogenesis O X
and O X
excess O X
concentrations O X
suppressing O X
it O X
. O X

No O X
such O X
effect O X
was O X
observed O X
with O X
a O X
mutant O X
Atx I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
variant O X
, O X
which O X
does O X
not O X
contain O X
a O X
functional O X
VCP I-MISC 7415
interaction O X
motif O X
. O X

Strikingly O X
, O X
a O X
stretch O X
of O X
four O X
basic O X
amino O X
acids O X
in O X
the O X
ubiquitin I-MISC 10277
chain I-MISC 10277
assembly I-MISC 10277
factor I-MISC 10277
E4B I-MISC 10277
was O X
also O X
discovered O X
to O X
be O X
critical O X
for O X
VCP I-MISC 7415
binding O X
, O X
indicating O X
that O X
arginine O X
/ O X
lysine O X
- O X
rich O X
motifs O X
might O X
be O X
generally O X
utilized O X
by O X
VCP I-MISC 7415
for O X
the O X
targeting O X
of O X
proteins O X
. O X

In O X
vivo O X
studies O X
with O X
Drosophila O X
models O X
confirmed O X
that O X
VCP I-MISC 7415
selectively O X
modulates O X
aggregation O X
and O X
neurotoxicity O X
induced O X
by O X
pathogenic O X
Atx I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
. O X

Together O X
, O X
these O X
results O X
define O X
the O X
VCP I-MISC 7415
- O X
Atx I-MISC 4287
- I-MISC 4287
3 I-MISC 4287
association O X
as O X
a O X
potential O X
target O X
for O X
therapeutic O X
intervention O X
and O X
suggest O X
that O X
it O X
might O X
influence O X
the O X
progression O X
of O X
spinocerebellar O X
ataxia O X
type O X
3 O X
. O X

###7541045	3480,3667	3480,6464

Non O X
- O X
SH2 O X
domains O X
within O X
insulin I-MISC 3667
receptor I-MISC 3667
substrate I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
and O X
SHC I-MISC 6464
mediate O X
their O X
phosphotyrosine O X
- O X
dependent O X
interaction O X
with O X
the O X
NPEY O X
motif O X
of O X
the O X
insulin I-MISC 3480
- I-MISC 3480
like I-MISC 3480
growth I-MISC 3480
factor I-MISC 3480
I I-MISC 3480
receptor I-MISC 3480
. O X

Insulin I-MISC 3667
receptor I-MISC 3667
substrate I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
( O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
) O X
and O X
SHC I-MISC 6464
become O X
rapidly O X
phosphorylated O X
upon O X
tyrosines O X
after O X
insulin I-MISC 3480
- I-MISC 3480
like I-MISC 3480
growth I-MISC 3480
factor I-MISC 3480
I I-MISC 3480
receptor I-MISC 3480
( O X
IGFIR I-MISC 3480
) O X
activation O X
. O X

In O X
this O X
study O X
we O X
demonstrate O X
that O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
, O X
SHC I-MISC 6464
, O X
and O X
the O X
p85 I-MISC 5296
subunit O X
of O X
phosphatidylinositol O X
3 O X
- O X
kinase O X
interact O X
directly O X
and O X
specifically O X
with O X
the O X
IGFIR I-MISC 3480
. O X

The O X
interaction O X
of O X
all O X
three O X
proteins O X
is O X
dependent O X
upon O X
IGFIR I-MISC 3480
kinase O X
activity O X
and O X
, O X
furthermore O X
, O X
substitution O X
of O X
Tyr O X
- O X
950 O X
with O X
Phe O X
within O X
the O X
NPEY O X
motif O X
of O X
the O X
IGFIR I-MISC 3480
eliminated O X
interaction O X
with O X
both O X
SHC I-MISC 6464
and O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
but O X
had O X
no O X
effect O X
upon O X
p85 I-MISC 5296
interaction O X
. O X

We O X
show O X
that O X
residues O X
160 O X
- O X
516 O X
of O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
and I-MISC 3667
1 I-MISC 3667
- O X
238 O X
of O X
SHC I-MISC 6464
are O X
sufficient O X
and O X
necessary O X
for O X
receptor O X
interaction O X
in O X
the O X
yeast O X
two O X
- O X
hybrid O X
assay O X
. O X

We O X
also O X
demonstrate O X
a O X
direct O X
in O X
vitro O X
interaction O X
between O X
the O X
IGFIR I-MISC 3480
and O X
a O X
fusion O X
protein O X
containing O X
SHC I-MISC 6464
amino O X
acids O X
1 O X
- O X
238 O X
. O X

No O X
interaction O X
was O X
observed O X
with O X
a O X
SHC I-MISC 6464
protein O X
containing O X
only O X
the O X
SH2 O X
domain O X
. O X

We O X
conclude O X
that O X
SHC I-MISC 6464
and O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
interact O X
with O X
the O X
tyrosine O X
- O X
phosphorylated O X
NPEY O X
motif O X
of O X
the O X
IGFIR I-MISC 3480
, O X
and O X
that O X
both O X
proteins O X
interact O X
via O X
related O X
motifs O X
located O X
in O X
their O X
amino O X
termini O X
. O X

We O X
conclude O X
that O X
the O X
interactions O X
of O X
SHC I-MISC 6464
and O X
IRS I-MISC 3667
- I-MISC 3667
1 I-MISC 3667
with O X
the O X
IGFIR I-MISC 3480
are O X
similar O X
to O X
those O X
which O X
we O X
have O X
previously O X
defined O X
with O X
the O X
insulin I-MISC 3643
receptor I-MISC 3643
. O X

###12354775	44843,32078

Zinc O X
- O X
dependent O X
interaction O X
between O X
dishevelled I-MISC 32078
and O X
the O X
Drosophila O X
Wnt I-MISC 35975
antagonist O X
naked O X
cuticle O X
. O X

During O X
Drosophila O X
development O X
, O X
the O X
naked O X
cuticle O X
( O X
nkd I-MISC 44843
) O X
gene O X
attenuates O X
wingless O X
/ O X
Wnt I-MISC 35975
signaling O X
through O X
a O X
negative O X
feedback O X
loop O X
mechanism O X
. O X

Fly O X
and O X
vertebrate O X
Nkd I-MISC 44843
proteins O X
contain O X
a O X
putative O X
calcium O X
- O X
binding O X
EF O X
- O X
hand O X
motif O X
, O X
the O X
EFX O X
domain O X
, O X
that O X
interacts O X
with O X
the O X
basic O X
/ O X
PDZ O X
region O X
of O X
the O X
Wnt I-MISC 35975
signal O X
transducer O X
, O X
dishevelled I-MISC 32078
( O X
Dsh I-MISC 32078
). O X

Here O X
we O X
show O X
that O X
Dsh I-MISC 32078
binding O X
by O X
Drosophila O X
Nkd I-MISC 44843
in O X
vitro O X
is O X
mediated O X
by O X
the O X
EFX O X
domain O X
as O X
well O X
as O X
an O X
adjacent O X
C O X
- O X
terminal O X
sequence O X
. O X

In O X
vivo O X
data O X
suggest O X
that O X
both O X
of O X
these O X
regions O X
contribute O X
to O X
the O X
ability O X
of O X
Nkd I-MISC 44843
to O X
antagonize O X
Wnt I-MISC 35975
signaling O X
. O X

Mutations O X
in O X
the O X
Nkd I-MISC 44843
EF O X
- O X
hand O X
designed O X
to O X
eliminate O X
potential O X
ion O X
binding O X
affected O X
Nkd I-MISC 44843
- O X
Dsh I-MISC 32078
interactions O X
in O X
the O X
yeast O X
two O X
- O X
hybrid O X
assay O X
but O X
not O X
in O X
the O X
glutathione O X
S O X
- O X
transferase O X
pull O X
- O X
down O X
assay O X
. O X

Addition O X
of O X
the O X
chelating O X
agent O X
EDTA O X
abolished O X
the O X
in O X
vitro O X
Nkd I-MISC 44843
- O X
Dsh I-MISC 32078
interaction O X
. O X

Surprisingly O X
zinc O X
, O X
but O X
not O X
calcium O X
, O X
was O X
able O X
to O X
restore O X
Nkd I-MISC 44843
- O X
Dsh I-MISC 32078
binding O X
, O X
suggesting O X
a O X
zinc O X
- O X
mediated O X
interaction O X
. O X

Calcium O X
45 O X
- O X
and O X
zinc O X
65 O X
- O X
blotting O X
experiments O X
show O X
that O X
Nkd I-MISC 44843
is O X
a O X
zinc O X
- O X
binding O X
metalloprotein O X
. O X

The O X
results O X
further O X
clarify O X
how O X
Nkd I-MISC 44843
may O X
antagonize O X
Wnt I-MISC 35975
signaling O X
via O X
interaction O X
with O X
Dsh I-MISC 32078
, O X
and O X
identify O X
a O X
novel O X
zinc O X
- O X
binding O X
domain O X
in O X
Drosophila O X
Nkd I-MISC 44843
that O X
collaborates O X
with O X
the O X
conserved O X
EFX O X
domain O X
to O X
bind O X
Dsh I-MISC 32078
. O X

###17462627	2010,23224	2010,23345

Distinct O X
functional O X
domains O X
in O X
nesprin O X
- O X
1alpha O X
and O X
nesprin O X
- O X
2beta O X
bind O X
directly O X
to O X
emerin I-MISC 2010
and O X
both O X
interactions O X
are O X
disrupted O X
in O X
X O X
- O X
linked O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
. O X

Emerin I-MISC 2010
and O X
specific O X
isoforms O X
of O X
nesprin I-MISC 23345
- I-MISC 23345
1 I-MISC 23345
and I-MISC 64009
- I-MISC 64009
2 I-MISC 64009
are O X
nuclear O X
membrane O X
proteins O X
which O X
are O X
binding O X
partners O X
in O X
multi O X
- O X
protein O X
complexes O X
spanning O X
the O X
nuclear O X
envelope O X
. O X

We O X
report O X
here O X
the O X
characterisation O X
of O X
the O X
residues O X
both O X
in O X
emerin I-MISC 2010
and O X
in O X
nesprin I-MISC 23345
- I-MISC 23345
1alpha I-MISC 23345
and O X
- O X
2beta O X
which O X
are O X
involved O X
in O X
their O X
interaction O X
and O X
show O X
that O X
emerin I-MISC 2010
requires O X
nesprin I-MISC 23345
- I-MISC 23345
1 I-MISC 23345
or I-MISC 64009
- I-MISC 64009
2 I-MISC 64009
to O X
retain O X
it O X
at O X
the O X
nuclear O X
membrane O X
. O X

Using O X
several O X
protein O X
- O X
protein O X
interaction O X
methods O X
, O X
we O X
show O X
that O X
residues O X
368 O X
to O X
627 O X
of O X
nesprin O X
- O X
1alpha O X
and O X
residues O X
126 O X
to O X
219 O X
of O X
nesprin O X
- O X
2beta O X
, O X
which O X
show O X
high O X
homology O X
to O X
one O X
another O X
, O X
both O X
mediate O X
binding O X
to O X
emerin I-MISC 2010
residues O X
140 O X
- O X
176 O X
. O X

This O X
region O X
has O X
previously O X
been O X
implicated O X
in O X
binding O X
to O X
F O X
- O X
actin O X
, O X
beta I-MISC 12387
- I-MISC 12387
catenin I-MISC 12387
and O X
lamin I-MISC 16905
A I-MISC 16905
/ I-MISC 16905
C I-MISC 16905
suggesting O X
that O X
it O X
is O X
critical O X
for O X
emerin I-MISC 2010
function O X
. O X

Confirmation O X
that O X
these O X
protein O X
domains O X
interact O X
in O X
vivo O X
was O X
shown O X
using O X
GFP O X
- O X
dominant O X
negative O X
assays O X
. O X

Exogenous O X
expression O X
of O X
either O X
of O X
these O X
nesprin O X
fragments O X
in O X
mouse O X
myoblast O X
C2C12 O X
cells O X
displaced O X
endogenous O X
emerin I-MISC 2010
from O X
the O X
nuclear O X
envelope O X
and O X
reduced O X
the O X
targeting O X
of O X
newly O X
synthesised O X
emerin I-MISC 2010
. O X

Furthermore O X
, O X
we O X
are O X
the O X
first O X
to O X
report O X
that O X
emerin I-MISC 2010
mutations O X
which O X
give O X
rise O X
to O X
X O X
- O X
linked O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
, O X
disrupt O X
binding O X
to O X
both O X
nesprin I-MISC 23345
- I-MISC 23345
1alpha I-MISC 23345
and O X
- O X
2beta O X
isoforms O X
, O X
further O X
indicating O X
a O X
role O X
of O X
nesprins O X
in O X
the O X
pathology O X
of O X
Emery O X
- O X
Dreifuss O X
muscular O X
dystrophy O X
. O X

###20638386	827837,817592

Crystal O X
structure O X
of O X
tubulin I-MISC 817592
folding I-MISC 817592
cofactor I-MISC 817592
A I-MISC 817592
from O X
Arabidopsis O X
thaliana O X
and O X
its O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
binding O X
characterization O X
. O X

Microtubules O X
are O X
composed O X
of O X
polymerized O X
alpha O X
/ O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
heterodimers O X
. O X

Biogenesis O X
of O X
assembly O X
- O X
competent O X
tubulin O X
dimers O X
is O X
a O X
complex O X
multistep O X
process O X
that O X
requires O X
sequential O X
actions O X
of O X
distinct O X
molecular O X
chaperones O X
and O X
cofactors O X
. O X

Tubulin I-MISC 817592
folding I-MISC 817592
cofactor I-MISC 817592
A I-MISC 817592
( O X
TFCA I-MISC 817592
), O X
which O X
captures O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
during O X
the O X
folding O X
pathway O X
, O X
has O X
been O X
identified O X
in O X
many O X
organisms O X
. O X

Here O X
, O X
we O X
report O X
the O X
crystal O X
structure O X
of O X
Arabidopsis O X
thaliana O X
TFC I-MISC 817592
A I-MISC 817592
( O X
KIESEL I-MISC 817592
, O X
KIS I-MISC 817592
), O X
which O X
forms O X
a O X
monomeric O X
three O X
- O X
helix O X
bundle O X
. O X

The O X
functional O X
binding O X
analysis O X
demonstrated O X
that O X
KIS I-MISC 817592
interacts O X
with O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
in O X
plant O X
. O X

Furthermore O X
, O X
mutagenesis O X
studies O X
indicated O X
that O X
the O X
alpha O X
- O X
helical O X
regions O X
of O X
KIS I-MISC 817592
participate O X
in O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
binding O X
. O X

Unlike O X
the O X
budding O X
yeast O X
TFC I-MISC 817592
A I-MISC 817592
, O X
the O X
two O X
loop O X
regions O X
of O X
KIS I-MISC 817592
are O X
not O X
required O X
for O X
this O X
interaction O X
suggesting O X
a O X
distinct O X
binding O X
mechanism O X
of O X
TFC I-MISC 817592
A I-MISC 817592
to O X
beta I-MISC 827837
- I-MISC 827837
tubulin I-MISC 827837
in O X
plants O X
. O X

###25174448	8200,8200

Biophysical O X
and O X
structural O X
characterization O X
of O X
a O X
folded O X
core O X
domain O X
within O X
the O X
proregion O X
of O X
growth I-MISC 8200
and I-MISC 8200
differentiation I-MISC 8200
factor I-MISC 8200
- I-MISC 8200
5 I-MISC 8200
. O X

The O X
structure O X
and O X
function O X
( O X
s O X
) O X
of O X
the O X
very O X
large O X
proregions O X
of O X
the O X
transforming O X
growth O X
factor O X
- O X
b O X
structure O X
family O X
are O X
known O X
in O X
only O X
a O X
few O X
cases O X
. O X

The O X
proregion O X
of O X
growth I-MISC 8200
and I-MISC 8200
differentiation I-MISC 8200
factor I-MISC 8200
( I-MISC 8200
GDF I-MISC 8200
) I-MISC 8200
5 I-MISC 8200
comprises O X
354 O X
residues O X
. O X

GDF5 I-MISC 8200
therefore O X
belongs O X
to O X
the O X
group O X
of O X
those O X
growth O X
factors O X
with O X
the O X
largest O X
proregions O X
. O X

Here O X
, O X
we O X
report O X
a O X
biophysical O X
analysis O X
of O X
the O X
proform O X
( O X
proGDF5 O X
) O X
and O X
the O X
separate O X
proregion O X
. O X

In O X
the O X
absence O X
of O X
the O X
mature O X
part O X
, O X
the O X
proregion O X
folds O X
reversibly O X
to O X
form O X
a O X
monomeric O X
polypeptide O X
that O X
is O X
stabilized O X
by O X
an O X
intramolecular O X
disulfide O X
bond O X
. O X

In O X
the O X
context O X
of O X
the O X
mature O X
part O X
, O X
i O X
. O X
e O X
. O X

in O X
proGDF5 O X
, O X
the O X
proregion O X
shows O X
increased O X
thermodynamic O X
stability O X
and O X
contains O X
a O X
higher O X
proportion O X
of O X
secondary O X
structural O X
elements O X
than O X
in O X
its O X
isolated O X
form O X
. O X

A O X
subdomain O X
within O X
the O X
proregion O X
represents O X
a O X
well O X
- O X
folded O X
structure O X
as O X
monitored O X
via O X
biophysical O X
analysis O X
and O X
NMR O X
spectroscopy O X
. O X

Furthermore O X
, O X
two O X
point O X
mutations O X
that O X
are O X
associated O X
with O X
skeletal O X
malformations O X
lead O X
to O X
reduced O X
thermodynamic O X
stability O X
, O X
which O X
is O X
interpreted O X
on O X
the O X
basis O X
of O X
a O X
homology O X
model O X
with O X
the O X
structure O X
of O X
the O X
related O X
latency O X
- O X
associated O X
peptide O X
, O X
representing O X
the O X
proregion O X
of O X
transforming I-MISC 7040
growth I-MISC 7040
factor I-MISC 7040
- I-MISC 7040
b1 I-MISC 7040
. O X

###24349490	54734,5289

Rab39a I-MISC 54734
interacts O X
with O X
phosphatidylinositol I-MISC 5289
3 I-MISC 5289
- I-MISC 5289
kinase I-MISC 5289
and O X
negatively O X
regulates O X
autophagy O X
induced O X
by O X
lipopolysaccharide O X
stimulation O X
in O X
macrophages O X
. O X

Rab39a I-MISC 54734
has O X
pleiotropic O X
functions O X
in O X
phagosome O X
maturation O X
, O X
inflammatory O X
activation O X
and O X
neuritogenesis O X
. O X

Here O X
, O X
we O X
characterized O X
Rab39a I-MISC 54734
function O X
in O X
membrane O X
trafficking O X
of O X
phagocytosis O X
and O X
autophagy O X
induction O X
in O X
macrophages O X
. O X

Rab39a I-MISC 54734
localized O X
to O X
the O X
periphery O X
of O X
LAMP2 I-MISC 3920
- O X
positive O X
vesicles O X
and O X
showed O X
the O X
similar O X
kinetics O X
on O X
the O X
phagosome O X
to O X
that O X
of O X
LAMP1 I-MISC 3916
. O X

The O X
depletion O X
of O X
Rab39a I-MISC 54734
did O X
not O X
influence O X
the O X
localization O X
of O X
LAMP2 I-MISC 3920
to O X
the O X
phagosome O X
, O X
but O X
it O X
augments O X
the O X
autophagosome O X
formation O X
and O X
LC3 O X
processing O X
by O X
lipopolysaccharide O X
( O X
LPS O X
) O X
stimulation O X
. O X

The O X
augmentation O X
of O X
autophagosome O X
formation O X
in O X
Rab39a I-MISC 54734
- O X
knockdown O X
macrophages O X
was O X
suppressed O X
by O X
Atg5 I-MISC 9474
depletion O X
or O X
an O X
inhibitor O X
for O X
phosphatidylinostol I-MISC 5289
3 I-MISC 5289
- I-MISC 5289
kinase I-MISC 5289
( O X
PI3K I-MISC 5289
). O X

Immunoprecipitation O X
analysis O X
revealed O X
that O X
Rab39a I-MISC 54734
interacts O X
with O X
PI3K I-MISC 5289
and O X
that O X
the O X
amino O X
acid O X
residues O X
from O X
34 O X
( O X
th O X
) O X
to O X
41 O X
( O X
st O X
) O X
in O X
Rab39a I-MISC 54734
were O X
indispensable O X
for O X
this O X
interaction O X
. O X

These O X
results O X
suggest O X
that O X
Rab39a I-MISC 54734
negatively O X
regulates O X
the O X
LPS O X
- O X
induced O X
autophagy O X
in O X
macrophages O X
. O X

###25225338	1832,22919

Disease O X
mutations O X
in O X
desmoplakin I-MISC 1832
inhibit O X
Cx43 I-MISC 2697
membrane O X
targeting O X
mediated O X
by O X
desmoplakin I-MISC 1832
- O X
EB1 I-MISC 22919
interactions O X
. O X

Mechanisms O X
by O X
which O X
microtubule O X
plus O X
ends O X
interact O X
with O X
regions O X
of O X
cell O X
- O X
cell O X
contact O X
during O X
tissue O X
development O X
and O X
morphogenesis O X
are O X
not O X
fully O X
understood O X
. O X

We O X
characterize O X
a O X
previously O X
unreported O X
interaction O X
between O X
the O X
microtubule O X
binding O X
protein O X
end I-MISC 22919
- I-MISC 22919
binding I-MISC 22919
1 I-MISC 22919
( O X
EB1 I-MISC 22919
) O X
and O X
the O X
desmosomal O X
protein O X
desmoplakin I-MISC 1832
( O X
DP I-MISC 1832
), O X
and O X
demonstrate O X
that O X
DP I-MISC 1832
- O X
EB1 I-MISC 22919
interactions O X
enable O X
DP I-MISC 1832
to O X
modify O X
microtubule O X
organization O X
and O X
dynamics O X
near O X
sites O X
of O X
cell O X
- O X
cell O X
contact O X
. O X

EB1 I-MISC 22919
interacts O X
with O X
a O X
region O X
of O X
the O X
DP I-MISC 1832
N O X
terminus O X
containing O X
a O X
hotspot O X
for O X
pathogenic O X
mutations O X
associated O X
with O X
arrhythmogenic O X
cardiomyopathy O X
( O X
AC O X
). O X

We O X
show O X
that O X
a O X
subset O X
of O X
AC O X
mutations O X
, O X
in O X
addition O X
to O X
a O X
mutation O X
associated O X
with O X
skin O X
fragility O X
/ O X
woolly O X
hair O X
syndrome O X
, O X
impair O X
gap O X
junction O X
localization O X
and O X
function O X
by O X
misregulating O X
DP I-MISC 1832
- O X
EB1 I-MISC 22919
interactions O X
and O X
altering O X
microtubule O X
dynamics O X
. O X

This O X
work O X
identifies O X
a O X
novel O X
function O X
for O X
a O X
desmosomal O X
protein O X
in O X
regulating O X
microtubules O X
that O X
affect O X
membrane O X
targeting O X
of O X
gap O X
junction O X
components O X
, O X
and O X
elucidates O X
a O X
mechanism O X
by O X
which O X
DP I-MISC 1832
mutations O X
may O X
contribute O X
to O X
the O X
development O X
of O X
cardiac O X
and O X
cutaneous O X
diseases O X
. O X

###19372599	7439,7439

Human O X
disease O X
- O X
causing O X
mutations O X
disrupt O X
an O X
N O X
- O X
C O X
- O X
terminal O X
interaction O X
and O X
channel O X
function O X
of O X
bestrophin I-MISC 7439
1 I-MISC 7439
. O X

Mutations O X
in O X
the O X
human O X
bestrophin I-MISC 7439
1 I-MISC 7439
( O X
hBest1 I-MISC 7439
) O X
chloride O X
channel O X
cause O X
Best O X
vitelliform O X
macular O X
dystrophy O X
. O X

Although O X
mutations O X
in O X
its O X
transmembrane O X
domains O X
were O X
found O X
to O X
alter O X
biophysical O X
properties O X
of O X
the O X
channel O X
, O X
the O X
mechanism O X
for O X
disease O X
- O X
causing O X
mutations O X
in O X
its O X
N O X
and O X
C O X
termini O X
remains O X
elusive O X
. O X

We O X
hypothesized O X
that O X
these O X
mutations O X
lead O X
to O X
channel O X
dysfunction O X
through O X
disruption O X
of O X
an O X
N O X
- O X
C O X
- O X
terminal O X
interaction O X
. O X

Here O X
, O X
we O X
present O X
data O X
demonstrating O X
that O X
hBest1 I-MISC 7439
N O X
and O X
C O X
termini O X
indeed O X
interact O X
both O X
in O X
vivo O X
and O X
in O X
vitro O X
. O X

In O X
addition O X
, O X
using O X
a O X
spectrum O X
- O X
based O X
fluorescence O X
resonance O X
energy O X
transfer O X
method O X
, O X
we O X
showed O X
that O X
functional O X
hBest1 I-MISC 7439
channels O X
in O X
the O X
plasma O X
membrane O X
were O X
multimers O X
. O X

Disease O X
- O X
causing O X
mutations O X
in O X
the O X
N O X
terminus O X
( O X
R19C O X
, O X
R25C O X
, O X
and O X
K30C O X
) O X
and O X
the O X
C O X
terminus O X
( O X
G299E O X
, O X
D301N O X
, O X
and O X
D312N O X
) O X
caused O X
channel O X
dysfunction O X
and O X
disruption O X
of O X
the O X
N O X
- O X
C O X
interaction O X
. O X

Consistent O X
with O X
the O X
functional O X
and O X
biochemical O X
results O X
, O X
mutants O X
D301N O X
and O X
D312N O X
clearly O X
reduced O X
fluorescence O X
resonance O X
energy O X
transfer O X
signal O X
, O X
indicating O X
that O X
the O X
N O X
- O X
C O X
interaction O X
was O X
indeed O X
perturbed O X
. O X

These O X
results O X
suggest O X
that O X
hBest1 I-MISC 7439
functions O X
as O X
a O X
multimer O X
in O X
the O X
plasma O X
membrane O X
, O X
and O X
disruption O X
of O X
the O X
N O X
- O X
C O X
interaction O X
by O X
mutations O X
leads O X
to O X
hBest1 I-MISC 7439
channel O X
dysfunction O X
. O X

###22363216	246310,120892

GTPase O X
activity O X
and O X
neuronal O X
toxicity O X
of O X
Parkinson O X
' O X
s O X
disease O X
- O X
associated O X
LRRK2 I-MISC 120892
is O X
regulated O X
by O X
ArfGAP1 I-MISC 246310
. O X

Mutations O X
in O X
the O X
leucine I-MISC 120892
- I-MISC 120892
rich I-MISC 120892
repeat I-MISC 120892
kinase I-MISC 120892
2 I-MISC 120892
( O X
LRRK2 I-MISC 120892
) O X
gene O X
are O X
the O X
most O X
common O X
cause O X
of O X
autosomal O X
dominant O X
familial O X
Parkinson O X
' O X
s O X
disease O X
( O X
PD O X
) O X
and O X
also O X
contribute O X
to O X
idiopathic O X
PD O X
. O X

LRRK2 I-MISC 120892
encodes O X
a O X
large O X
multi O X
- O X
domain O X
protein O X
with O X
GTPase O X
and O X
kinase O X
activity O X
. O X

Initial O X
data O X
indicates O X
that O X
an O X
intact O X
functional O X
GTPase O X
domain O X
is O X
critically O X
required O X
for O X
LRRK2 I-MISC 120892
kinase O X
activity O X
. O X

PD O X
- O X
associated O X
mutations O X
in O X
LRRK2 I-MISC 120892
, O X
including O X
the O X
most O X
common O X
G2019S O X
variant O X
, O X
have O X
variable O X
effects O X
on O X
enzymatic O X
activity O X
but O X
commonly O X
alter O X
neuronal O X
process O X
morphology O X
. O X

The O X
mechanisms O X
underlying O X
the O X
intrinsic O X
and O X
extrinsic O X
regulation O X
of O X
LRRK2 I-MISC 120892
GTPase O X
and O X
kinase O X
activity O X
, O X
and O X
the O X
pathogenic O X
effects O X
of O X
familial O X
mutations O X
, O X
are O X
incompletely O X
understood O X
. O X

Here O X
, O X
we O X
identify O X
a O X
novel O X
functional O X
interaction O X
between O X
LRRK2 I-MISC 120892
and O X
ADP I-MISC 246310
- I-MISC 246310
ribosylation I-MISC 246310
factor I-MISC 246310
GTPase I-MISC 246310
- I-MISC 246310
activating I-MISC 246310
protein I-MISC 246310
1 I-MISC 246310
( O X
ArfGAP1 I-MISC 246310
). O X

LRRK2 I-MISC 120892
and O X
ArfGAP1 I-MISC 246310
interact O X
in O X
vitro O X
in O X
mammalian O X
cells O X
and O X
in O X
vivo O X
in O X
brain O X
, O X
and O X
co O X
- O X
localize O X
in O X
the O X
cytoplasm O X
and O X
at O X
Golgi O X
membranes O X
. O X

PD O X
- O X
associated O X
and O X
functional O X
mutations O X
that O X
alter O X
the O X
GTPase O X
activity O X
of O X
LRRK2 I-MISC 120892
modulate O X
the O X
interaction O X
with O X
ArfGAP1 I-MISC 246310
. O X

The O X
GTP O X
hydrolysis O X
activity O X
of O X
LRRK2 I-MISC 120892
is O X
markedly O X
enhanced O X
by O X
ArfGAP1 I-MISC 246310
supporting O X
a O X
role O X
for O X
ArfGAP1 I-MISC 246310
as O X
a O X
GTPase O X
- O X
activating O X
protein O X
for O X
LRRK2 I-MISC 120892
. O X

Unexpectedly O X
, O X
ArfGAP1 I-MISC 246310
promotes O X
the O X
kinase O X
activity O X
of O X
LRRK2 I-MISC 120892
suggesting O X
a O X
potential O X
role O X
for O X
GTP O X
hydrolysis O X
in O X
kinase O X
activation O X
. O X

Furthermore O X
, O X
LRRK2 I-MISC 120892
robustly O X
and O X
directly O X
phosphorylates O X
ArfGAP1 I-MISC 246310
in O X
vitro O X
. O X

Silencing O X
of O X
ArfGAP1 I-MISC 246310
expression O X
in O X
primary O X
cortical O X
neurons O X
rescues O X
the O X
neurite O X
shortening O X
phenotype O X
induced O X
by O X
G2019S O X
LRRK2 I-MISC 120892
overexpression O X
, O X
whereas O X
the O X
co O X
- O X
expression O X
of O X
ArfGAP1 I-MISC 246310
and O X
LRRK2 I-MISC 120892
synergistically O X
promotes O X
neurite O X
shortening O X
in O X
a O X
manner O X
dependent O X
upon O X
LRRK2 I-MISC 120892
GTPase O X
activity O X
. O X

Neurite O X
shortening O X
induced O X
by O X
ArfGAP1 I-MISC 246310
overexpression O X
is O X
also O X
attenuated O X
by O X
silencing O X
of O X
LRRK2 I-MISC 120892
. O X

Our O X
data O X
reveal O X
a O X
novel O X
role O X
for O X
ArfGAP1 I-MISC 246310
in O X
regulating O X
the O X
GTPase O X
activity O X
and O X
neuronal O X
toxicity O X
of O X
LRRK2 I-MISC 120892
; O X
reciprocally O X
, O X
LRRK2 I-MISC 120892
phosphorylates O X
ArfGAP1 I-MISC 246310
and O X
is O X
required O X
for O X
ArfGAP1 I-MISC 246310
neuronal O X
toxicity O X
. O X

ArfGAP1 I-MISC 246310
may O X
represent O X
a O X
promising O X
target O X
for O X
interfering O X
with O X
LRRK2 I-MISC 120892
- O X
dependent O X
neurodegeneration O X
in O X
familial O X
and O X
sporadic O X
PD O X
. O X

###25132288	814514,811723

Identification O X
of O X
a O X
Plasmodium O X
falciparum O X
inhibitor I-MISC 814514
- I-MISC 814514
2 I-MISC 814514
motif O X
involved O X
in O X
the O X
binding O X
and O X
regulation O X
activity O X
of O X
protein I-MISC 811723
phosphatase I-MISC 811723
type I-MISC 811723
1 I-MISC 811723
. O X

The O X
regulation O X
of O X
Plasmodium O X
falciparum O X
protein I-MISC 811723
phosphatase I-MISC 811723
type I-MISC 811723
1 I-MISC 811723
( O X
PfPP1 I-MISC 811723
) O X
activity O X
remains O X
to O X
be O X
deciphered O X
. O X

Data O X
from O X
homologous O X
eukaryotic O X
type I-MISC 811723
1 I-MISC 811723
protein I-MISC 811723
phosphatases O X
( O X
PP1 I-MISC 811723
) O X
suggest O X
that O X
several O X
protein O X
regulators O X
should O X
be O X
involved O X
in O X
this O X
essential O X
process O X
. O X

One O X
such O X
regulator O X
, O X
named O X
PfI2 I-MISC 814514
based O X
on O X
its O X
primary O X
sequence O X
homology O X
with O X
eukaryotic O X
inhibitor I-MISC 814514
2 I-MISC 814514
( O X
I2 I-MISC 814514
), O X
was O X
recently O X
shown O X
to O X
be O X
able O X
to O X
interact O X
with O X
PfPP1 I-MISC 811723
and O X
to O X
inhibit O X
its O X
phosphatase O X
activity O X
, O X
mainly O X
through O X
the O X
canonical O X
' O X
RVxF O X
' O X
binding O X
motif O X
. O X

The O X
details O X
of O X
the O X
structural O X
and O X
functional O X
characteristics O X
of O X
this O X
interaction O X
are O X
investigated O X
here O X
. O X

Using O X
NMR O X
spectroscopy O X
, O X
a O X
second O X
site O X
of O X
interaction O X
is O X
suggested O X
to O X
reside O X
between O X
residues O X
D94 O X
and O X
T117 O X
and O X
contains O X
the O X
' O X
FxxR O X
/ O X
KxR O X
/ O X
K O X
' O X
binding O X
motif O X
present O X
in O X
other O X
I2 I-MISC 814514
proteins O X
. O X

This O X
site O X
seems O X
to O X
play O X
in O X
concert O X
/ O X
synergy O X
with O X
the O X
' O X
RVxF O X
' O X
motif O X
to O X
bind O X
PP1 I-MISC 811723
, O X
because O X
only O X
mutations O X
in O X
both O X
motifs O X
were O X
able O X
to O X
abolish O X
this O X
interaction O X
completely O X
. O X

However O X
, O X
regarding O X
the O X
structure O X
/ O X
function O X
relationship O X
, O X
mutation O X
of O X
either O X
the O X
' O X
RVxF O X
' O X
or O X
' O X
FxxR O X
/ O X
KxR O X
/ O X
K O X
' O X
motif O X
is O X
more O X
drastic O X
, O X
because O X
each O X
mutation O X
prevents O X
the O X
capacity O X
of O X
PfI2 I-MISC 814514
to O X
trigger O X
germinal O X
vesicle O X
breakdown O X
in O X
microinjected O X
Xenopus O X
oocytes O X
. O X

This O X
indicates O X
that O X
the O X
tight O X
association O X
of O X
the O X
PfI2 I-MISC 814514
regulator O X
to O X
PP1 I-MISC 811723
, O X
mediated O X
by O X
a O X
two O X
- O X
site O X
interaction O X
, O X
is O X
necessary O X
to O X
exert O X
its O X
function O X
. O X

Based O X
on O X
these O X
results O X
, O X
the O X
use O X
of O X
a O X
peptide O X
derived O X
from O X
the O X
' O X
FxxR O X
/ O X
KxR O X
/ O X
K O X
' O X
PfI2 I-MISC 814514
motif O X
was O X
investigated O X
for O X
its O X
potential O X
effect O X
on O X
Plasmodium O X
growth O X
. O X

This O X
peptide O X
, O X
fused O X
at O X
its O X
N O X
- O X
terminus O X
to O X
a O X
penetrating O X
sequence O X
, O X
was O X
shown O X
to O X
accumulate O X
specifically O X
in O X
infected O X
erythrocytes O X
and O X
to O X
have O X
an O X
antiplasmodial O X
effect O X
. O X

STRUCTURED O X
DIGITAL O X
ABSTRACT O X
: O X
PfPP1 I-MISC 811723
and O X
PfI2 I-MISC 814514
bind O X
by O X
nuclear O X
magnetic O X
resonance O X
( O X
1 O X
, O X
2 O X
) O X
PP1 I-MISC 811723
physically O X
interacts O X
with O X
PfPP1 I-MISC 811723
by O X
anti O X
tag O X
coimmunoprecipitation O X
( O X
View O X
interaction O X
) O X
PfI2 I-MISC 814514
binds O X
to O X
PfPP1 I-MISC 811723
by O X
enzyme O X
linked O X
immunosorbent O X
assay O X
( O X
View O X
interaction O X
) O X
PfI2 I-MISC 814514
binds O X
to O X
PfPP1 I-MISC 811723
by O X
surface O X
plasmon O X
resonance O X
( O X
1 O X
, O X
2 O X
, O X
3 O X
, O X
4 O X
). O X

###17377852	140290,140290

Identification O X
of O X
TCP10L I-MISC 140290
as O X
primate O X
- O X
specific O X
gene O X
derived O X
via O X
segmental O X
duplication O X
and O X
homodimerization O X
of O X
TCP10L I-MISC 140290
through O X
the O X
leucine O X
zipper O X
motif O X
. O X

TCP10L I-MISC 140290
, O X
a O X
transcriptional O X
repression O X
factor O X
gene O X
that O X
was O X
localized O X
on O X
human O X
chromosome O X
21q22 O X
. O X
11 O X
, O X
was O X
identified O X
to O X
be O X
derived O X
through O X
segmental O X
duplication O X
since O X
the O X
divergence O X
of O X
primates O X
and O X
rodents O X
. O X

It O X
was O X
elucidated O X
that O X
TCP10L I-MISC 140290
gene O X
was O X
a O X
primate O X
- O X
specific O X
gene O X
in O X
this O X
study O X
. O X

Subsequently O X
it O X
was O X
demonstrated O X
that O X
the O X
putative O X
leucine O X
zipper O X
motif O X
mediated O X
the O X
homodimerization O X
of O X
TCP10L I-MISC 140290
. O X

Using O X
in O X
vitro O X
and O X
in O X
vivo O X
methodologies O X
, O X
it O X
was O X
shown O X
that O X
either O X
deletion O X
or O X
point O X
mutation O X
of O X
the O X
leucine O X
zipper O X
motif O X
was O X
sufficient O X
to O X
abolish O X
TCP10L I-MISC 140290
homodimerization O X
. O X

In O X
Hela O X
cells O X
, O X
both O X
the O X
exogenous O X
wild O X
type O X
TCP10L I-MISC 140290
and O X
endogenous O X
TCP10L I-MISC 140290
were O X
detected O X
on O X
nuclei O X
with O X
immunofluorescence O X
assay O X
. O X

However O X
, O X
the O X
leucine O X
zipper O X
motif O X
mutants O X
of O X
TCP10L I-MISC 140290
could O X
also O X
be O X
detected O X
on O X
nuclei O X
. O X

The O X
results O X
suggested O X
that O X
the O X
leucine O X
zipper O X
motif O X
enabled O X
TCP10L I-MISC 140290
to O X
homodimerize O X
, O X
but O X
was O X
not O X
essential O X
for O X
the O X
TCP10L I-MISC 140290
nuclear O X
localization O X
. O X

###21239585	899430,899430

Effects O X
of O X
metal O X
on O X
the O X
biochemical O X
properties O X
of O X
Helicobacter O X
pylori O X
HypB I-MISC 899430
, O X
a O X
maturation O X
factor O X
of O X
[ O X
NiFe O X
]- O X
hydrogenase O X
and O X
urease O X
. O X

The O X
biosyntheses O X
of O X
the O X
[ O X
NiFe O X
]- O X
hydrogenase O X
and O X
urease O X
enzymes O X
in O X
Helicobacter O X
pylori O X
require O X
several O X
accessory O X
proteins O X
for O X
proper O X
construction O X
of O X
the O X
nickel O X
- O X
containing O X
metallocenters O X
. O X

The O X
hydrogenase O X
accessory O X
proteins O X
HypA O X
and O X
HypB I-MISC 899430
, O X
a O X
GTPase O X
, O X
have O X
been O X
implicated O X
in O X
the O X
nickel O X
delivery O X
steps O X
of O X
both O X
enzymes O X
. O X

In O X
this O X
study O X
, O X
the O X
metal O X
- O X
binding O X
properties O X
of O X
H O X
. O X
pylori O X
HypB I-MISC 899430
were O X
characterized O X
, O X
and O X
the O X
effects O X
of O X
metal O X
binding O X
on O X
the O X
biochemical O X
behavior O X
of O X
the O X
protein O X
were O X
examined O X
. O X

The O X
protein O X
can O X
bind O X
stoichiometric O X
amounts O X
of O X
Zn O X
( O X
II O X
) O X
or O X
Ni O X
( O X
II O X
), O X
each O X
with O X
nanomolar O X
affinity O X
. O X

Mutation O X
of O X
Cys106 O X
and O X
His107 O X
, O X
which O X
are O X
located O X
between O X
two O X
major O X
GTPase O X
motifs O X
, O X
results O X
in O X
undetectable O X
Ni O X
( O X
II O X
) O X
binding O X
, O X
and O X
the O X
Zn O X
( O X
II O X
) O X
affinity O X
is O X
weakened O X
by O X
2 O X
orders O X
of O X
magnitude O X
. O X

These O X
two O X
residues O X
are O X
also O X
required O X
for O X
the O X
metal O X
- O X
dependent O X
dimerization O X
observed O X
in O X
the O X
presence O X
of O X
Ni O X
( O X
II O X
) O X
but O X
not O X
Zn O X
( O X
II O X
). O X

The O X
addition O X
of O X
metals O X
to O X
the O X
protein O X
has O X
distinct O X
impacts O X
on O X
GTPase O X
activity O X
, O X
with O X
zinc O X
significantly O X
reducing O X
GTP O X
hydrolysis O X
to O X
below O X
detectable O X
levels O X
and O X
nickel O X
only O X
slightly O X
altering O X
the O X
k O X
( O X
cat O X
) O X
and O X
K O X
( O X
m O X
) O X
of O X
the O X
reaction O X
. O X

The O X
regulation O X
of O X
HypB I-MISC 899430
activities O X
by O X
metal O X
binding O X
may O X
contribute O X
to O X
the O X
maturation O X
of O X
the O X
nickel O X
- O X
containing O X
enzymes O X
. O X

###18154663	13858,9185

Binding O X
to O X
DPF O X
- O X
motif O X
by O X
the O X
POB1 I-MISC 194590
EH O X
domain O X
is O X
responsible O X
for O X
POB1 I-MISC 194590
- O X
Eps15 I-MISC 13858
interaction O X
. O X

BACKGROUND O X
: O X
Eps15 I-MISC 13858
homology O X
( O X
EH O X
) O X
domains O X
are O X
protein O X
interaction O X
modules O X
binding O X
to O X
peptides O X
containing O X
Asn O X
- O X
Pro O X
- O X
Phe O X
( O X
NPF O X
) O X
motifs O X
and O X
mediating O X
critical O X
events O X
during O X
endocytosis O X
and O X
signal O X
transduction O X
. O X

The O X
EH O X
domain O X
of O X
POB1 I-MISC 9185
associates O X
with O X
Eps15 I-MISC 2060
, O X
a O X
protein O X
characterized O X
by O X
a O X
striking O X
string O X
of O X
DPF O X
triplets O X
, O X
15 O X
in O X
human O X
and O X
13 O X
in O X
mouse O X
Eps15 I-MISC 13858
, O X
at O X
the O X
C O X
- O X
terminus O X
and O X
lacking O X
the O X
typical O X
EH O X
- O X
binding O X
NPF O X
motif O X
. O X

RESULTS O X
: O X
By O X
screening O X
a O X
multivalent O X
nonapeptide O X
phage O X
display O X
library O X
we O X
have O X
demonstrated O X
that O X
the O X
EH O X
domain O X
of O X
POB1 I-MISC 194590
has O X
a O X
different O X
recognition O X
specificity O X
since O X
it O X
binds O X
to O X
both O X
NPF O X
and O X
DPF O X
motifs O X
. O X

The O X
region O X
of O X
mouse O X
Eps15 I-MISC 13858
responsible O X
for O X
the O X
interaction O X
with O X
the O X
EH O X
domain O X
of O X
POB1 I-MISC 194590
maps O X
within O X
a O X
18 O X
amino O X
acid O X
peptide O X
( O X
residues O X
623 O X
- O X
640 O X
) O X
that O X
includes O X
three O X
DPF O X
repeats O X
. O X

Finally O X
, O X
mutational O X
analysis O X
in O X
the O X
EH O X
domain O X
of O X
POB1 I-MISC 194590
, O X
revealed O X
that O X
several O X
solvent O X
exposed O X
residues O X
, O X
while O X
distal O X
to O X
the O X
binding O X
pocket O X
, O X
mediate O X
specific O X
recognition O X
of O X
binding O X
partners O X
through O X
both O X
hydrophobic O X
and O X
electrostatic O X
contacts O X
. O X

CONCLUSION O X
: O X
In O X
the O X
present O X
study O X
we O X
have O X
analysed O X
the O X
binding O X
specificity O X
of O X
the O X
POB1 I-MISC 194590
EH O X
domain O X
. O X

We O X
show O X
that O X
it O X
differs O X
from O X
other O X
EH O X
domains O X
since O X
it O X
interacts O X
with O X
both O X
NPF O X
- O X
and O X
DPF O X
- O X
containing O X
sequences O X
. O X

These O X
unusual O X
binding O X
properties O X
could O X
be O X
attributed O X
to O X
a O X
different O X
conformation O X
of O X
the O X
binding O X
pocket O X
that O X
allows O X
to O X
accommodate O X
negative O X
charges O X
; O X
moreover O X
, O X
we O X
identified O X
a O X
cluster O X
of O X
solvent O X
exposed O X
Lys O X
residues O X
, O X
which O X
are O X
only O X
found O X
in O X
the O X
EH O X
domain O X
of O X
POB1 I-MISC 194590
, O X
and O X
influence O X
binding O X
to O X
both O X
NPF O X
and O X
DPF O X
motifs O X
. O X

The O X
characterization O X
of O X
structures O X
of O X
the O X
DPF O X
ligands O X
described O X
in O X
this O X
study O X
and O X
the O X
POB1 I-MISC 194590
EH O X
domain O X
will O X
clearly O X
determine O X
the O X
involvement O X
of O X
the O X
positive O X
patch O X
and O X
the O X
rationalization O X
of O X
our O X
findings O X
. O X

###21239581	11241639,936340

The O X
sporulation O X
protein O X
SirA I-MISC 936340
inhibits O X
the O X
binding O X
of O X
DnaA I-MISC 11241639
to O X
the O X
origin O X
of O X
replication O X
by O X
contacting O X
a O X
patch O X
of O X
clustered O X
amino O X
acids O X
. O X

Bacteria O X
regulate O X
the O X
frequency O X
and O X
timing O X
of O X
DNA O X
replication O X
initiation O X
by O X
controlling O X
the O X
activity O X
of O X
the O X
replication O X
initiator O X
protein O X
DnaA I-MISC 11241639
. O X

SirA I-MISC 936340
is O X
a O X
recently O X
discovered O X
regulator O X
of O X
DnaA I-MISC 11241639
in O X
Bacillus O X
subtilis O X
whose O X
synthesis O X
is O X
turned O X
on O X
at O X
the O X
start O X
of O X
sporulation O X
. O X

Here O X
, O X
we O X
demonstrate O X
that O X
SirA I-MISC 936340
contacts O X
DnaA I-MISC 11241639
at O X
a O X
patch O X
of O X
3 O X
residues O X
located O X
on O X
the O X
surface O X
of O X
domain O X
I O X
of O X
the O X
replication O X
initiator O X
protein O X
, O X
corresponding O X
to O X
the O X
binding O X
site O X
used O X
by O X
two O X
unrelated O X
regulators O X
of O X
DnaA I-MISC 11241639
found O X
in O X
other O X
bacteria O X
. O X

We O X
show O X
that O X
the O X
interaction O X
of O X
SirA I-MISC 936340
with O X
domain O X
I O X
inhibits O X
the O X
ability O X
of O X
DnaA I-MISC 11241639
to O X
bind O X
to O X
the O X
origin O X
of O X
replication O X
. O X

DnaA I-MISC 11241639
mutants O X
containing O X
amino O X
acid O X
substitutions O X
of O X
the O X
3 O X
residues O X
are O X
functional O X
in O X
replication O X
initiation O X
but O X
are O X
immune O X
to O X
inhibition O X
by O X
SirA I-MISC 936340
. O X

